PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Skelton, MR; Schaefer, TL; Graham, DL; Degrauw, TJ; Clark, JF; Williams, MT; Vorhees, CV				Skelton, Matthew R.; Schaefer, Tori L.; Graham, Devon L.; degrauw, Ton J.; Clark, Joseph F.; Williams, Michael T.; Vorhees, Charles V.			Creatine Transporter (CrT; Slc6a8) Knockout Mice as a Model of Human CrT Deficiency	PLOS ONE			English	Article							MORRIS WATER MAZE; MENTAL-RETARDATION; LOCOMOTOR-ACTIVITY; GENE SLC6A8; BRAIN; DEFECT; LOCALIZATION; EXPRESSION; MONOAMINES; CLONING	Mutations in the creatine (Cr) transporter (CrT; Slc6a8) gene lead to absence of brain Cr and intellectual disabilities, loss of speech, and behavioral abnormalities. To date, no mouse model of CrT deficiency exists in which to understand and develop treatments for this condition. The purpose of this study was to generate a mouse model of human CrT deficiency. We created mice with exons 2-4 of Slc6a8 flanked by loxP sites and crossed these to Cre:CMV mice to create a line of ubiquitous CrT knockout expressing mice. Mice were tested for learning and memory deficits and assayed for Cr and neurotransmitter levels. Male CrT-/y (affected) mice lack Cr in the brain and muscle with significant reductions of Cr in other tissues including heart and testes. CrT-/y mice showed increased path length during acquisition and reversal learning in the Morris water maze. During probe trials, CrT-/y mice showed increased average distance from the platform site. CrT-/y mice showed reduced novel object recognition and conditioned fear memory compared to CrT+/y. CrT-/y mice had increased serotonin and 5-hydroxyindole acetic acid in the hippocampus and prefrontal cortex. Ubiquitous CrT knockout mice have learning and memory deficits resembling human CrT deficiency and this model should be useful in understanding this disorder.	[Skelton, Matthew R.; Schaefer, Tori L.; Graham, Devon L.; degrauw, Ton J.; Williams, Michael T.; Vorhees, Charles V.] Univ Cincinnati, Coll Med, Div Neurol, Cincinnati Childrens Res Fdn, Cincinnati, OH 45221 USA; [Skelton, Matthew R.; Schaefer, Tori L.; Graham, Devon L.; degrauw, Ton J.; Williams, Michael T.; Vorhees, Charles V.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Clark, Joseph F.] Univ Cincinnati, Coll Med, Dept Neurol, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Skelton, MR (corresponding author), Univ Cincinnati, Coll Med, Div Neurol, Cincinnati Childrens Res Fdn, Cincinnati, OH 45221 USA.	Matthew.skelton@cchmc.org		Vorhees, Charles/0000-0003-3558-8812; Graham, Devon/0000-0003-0318-4602; Skelton, Matthew/0000-0003-4941-3546; Williams, Michael/0000-0001-9841-9683	National Institutes of Health (NIH) [DA021394, ES015689, T32 ES007051, NS049172]; Division of Neurology at CCHMC; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015689, T32ES007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021394] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Neurology at CCHMC; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health (NIH) grants DA021394 (CVV), ES015689 (MTW), T32 ES007051 (TLS & DLG), and NS049172 (JFC) and the Division of Neurology at CCHMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta ML, 2005, AM J PHYSIOL-CELL PH, V289, pC1015, DOI 10.1152/ajpcell.00137.2005; Agostinho FR, 2009, BRAIN RES BULL, V80, P337, DOI 10.1016/j.brainresbull.2009.09.002; Alvarez C, 2002, NEUROSCIENCE, V115, P753, DOI 10.1016/S0306-4522(02)00484-0; Anselm IM, 2006, J INHERIT METAB DIS, V29, P214, DOI 10.1007/s10545-006-0123-4; BARNWELL LFS, 1995, GENE, V159, P287, DOI 10.1016/0378-1119(95)00104-E; Braissant O, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-9; Braissant O, 2001, MOL BRAIN RES, V86, P193, DOI 10.1016/S0169-328X(00)00269-2; BRAISSANT O, 2008, J INHERIT METAB DIS; Braissant Olivier, 2007, V46, P67; Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652; Cecil KM, 2001, ANN NEUROL, V49, P401, DOI 10.1002/ana.79; Chen S, 2007, MOL CELL NEUROSCI, V36, P472, DOI 10.1016/j.mcn.2007.08.004; Clark AJ, 2006, HUM GENET, V119, P604, DOI 10.1007/s00439-006-0162-9; Clark RE, 2000, J NEUROSCI, V20, P8853; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; deGrauw TJ, 2003, MOL CELL BIOCHEM, V244, P45, DOI 10.1023/A:1022487218904; DeGrauw TJ, 2002, NEUROPEDIATRICS, V33, P232, DOI 10.1055/s-2002-36743; Ehrman LA, 2006, GENES BRAIN BEHAV, V5, P540, DOI 10.1111/j.1601-183X.2006.00209.x; Fons C, 2008, J INHERIT METAB DIS, V31, P724, DOI 10.1007/s10545-008-0902-1; Garcia-Miranda P, 2009, J PHYSIOL PHARMACOL, V60, P127; Grace CE, 2010, NEUROTOXICOL TERATOL, V32, P346, DOI 10.1016/j.ntt.2010.01.006; GREGOR P, 1995, GENOMICS, V25, P332, DOI 10.1016/0888-7543(95)80155-F; Li L, 2009, NEUROSCI BIOBEHAV R, V33, P1157, DOI 10.1016/j.neubiorev.2009.02.001; Lion-Francois L, 2006, NEUROLOGY, V67, P1713, DOI 10.1212/01.wnl.0000239153.39710.81; Mak CSW, 2009, NEUROSCIENCE, V163, P571, DOI 10.1016/j.neuroscience.2009.06.065; Mancardi MM, 2007, EPILEPSIA, V48, P1211, DOI 10.1111/j.1528-1167.2007.01148.x; Martinez-Munoz C, 2008, GENE, V418, P53, DOI 10.1016/j.gene.2008.04.003; Peters J, 2010, SCIENCE, V328, P1288, DOI 10.1126/science.1186909; Pimenta AF, 2005, MENT RETARD DEV D R, V11, P295, DOI 10.1002/mrdd.20084; Poo-Arguelles P, 2006, J INHERIT METAB DIS, V29, P220, DOI 10.1007/s10545-006-0212-4; PUUSEPP H, 2009, J INHERIT METAB DIS; Pyne-Geithman GJ, 2004, MOL CELL BIOCHEM, V262, P35, DOI 10.1023/B:MCBI.0000038213.15646.4a; Rasbach KA, 2010, J PHARMACOL EXP THER, V332, P632, DOI 10.1124/jpet.109.159947; Rosenberg EH, 2006, J INHERIT METAB DIS, V29, P345, DOI 10.1007/s10545-006-0271-6; Salomons GS, 2003, J INHERIT METAB DIS, V26, P309, DOI 10.1023/A:1024405821638; Salomons GS, 2001, AM J HUM GENET, V68, P1497, DOI 10.1086/320595; Santos PM, 2009, BRAIN RES BULL, V80, P327, DOI 10.1016/j.brainresbull.2009.09.007; Schaefer TL, 2009, NEUROSCIENCE, V164, P1431, DOI 10.1016/j.neuroscience.2009.09.059; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Scott AL, 2008, NEUROREPORT, V19, P739, DOI 10.1097/WNR.0b013e3282fd6e88; SEMPERE A, 2009, J INHERIT METAB DIS; Skelton MR, 2003, BRAIN RES, V984, P1, DOI 10.1016/S0006-8993(03)02839-7; Tachikawa Masanori, 2007, V46, P83; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107	45	75	78	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16187	10.1371/journal.pone.0016187	http://dx.doi.org/10.1371/journal.pone.0016187			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249153	Green Submitted, Green Published, gold			2022-12-27	WOS:000286515000029
J	Deshmane, SL; Mukerjee, R; Fan, SS; Sawaya, BE				Deshmane, Satish L.; Mukerjee, Ruma; Fan, Shongshan; Sawaya, Bassel E.			High-Performance Capillary Electrophoresis for Determining HIV-1 Tat Protein in Neurons	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MICROTUBULE-ASSOCIATED PROTEIN-2; CELLS; APOPTOSIS; TRANSCRIPTION; MECHANISM; DEATH; EXPRESSION; NEUROAIDS; INFECTION	The HIV-1 protein, Tat has been implicated in AIDS pathogenesis however, the amount of circulating Tat is believed to be very low and its quantification has been difficult. We performed the quantification of Tat released from infected cells and taken up by neurons using high performance capillary electrophoresis. This is the first report to successfully measure the amount of Tat in neurons and places Tat as a key player involved in HIV-associated neurocognitive disorders.	[Deshmane, Satish L.] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA; [Deshmane, Satish L.] Temple Univ, Sch Med, Ctr Neurovirol, Philadelphia, PA 19122 USA; [Mukerjee, Ruma; Sawaya, Bassel E.] Temple Univ, Sch Med, Dept Neurol, Lab Mol Studies Neurodegenerat Dis, Philadelphia, PA 19122 USA; [Fan, Shongshan] Temple Univ, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Deshmane, SL (corresponding author), Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA.	sawaya@temple.edu			NIH [R01NS059327]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059327] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH R01NS059327. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini S, 2005, MOL CELL BIOL, V25, P8126, DOI 10.1128/MCB.25.18.8126-8138.2005; Aprea S, 2006, J NEUROSCI, V26, P4054, DOI 10.1523/JNEUROSCI.0603-06.2006; Baba M, 2004, CURR TOP MED CHEM, V4, P871, DOI 10.2174/1568026043388466; Bieniasz PD, 1998, EMBO J, V17, P7056, DOI 10.1093/emboj/17.23.7056; Brailoiu E, 2006, J NEUROVIROL, V12, P17, DOI 10.1080/13550280500516427; Cheng J, 1998, NEUROSCIENCE, V82, P97, DOI 10.1016/S0306-4522(97)00174-7; Deshmane SL, 2009, J BIOL CHEM, V284, P11364, DOI 10.1074/jbc.M809266200; EDLUND T, 1985, SCIENCE, V230, P912, DOI 10.1126/science.3904002; Eugenin EA, 2005, GLIA, V49, P501, DOI 10.1002/glia.20137; Everall IP, 2002, MOL CELL NEUROSCI, V21, P493, DOI 10.1006/mcne.2002.1196; Gendelman HE, 1997, AIDS, V11, pS35; Kaul M, 2008, FRONT BIOSCI-LANDMRK, V13, P2484, DOI 10.2741/2860; Kaul M, 2006, J NEUROIMMUNE PHARM, V1, P138, DOI 10.1007/s11481-006-9011-9; KOLSON DL, 1994, J GEN VIROL, V75, P1927, DOI 10.1099/0022-1317-75-8-1927; Kruman II, 1998, EXP NEUROL, V154, P276, DOI 10.1006/exnr.1998.6958; Lim RWL, 2000, J BIOL CHEM, V275, P20578, DOI 10.1074/jbc.M001887200; Ma MH, 1997, J VIROL, V71, P2495, DOI 10.1128/JVI.71.3.2495-2499.1997; Mukerjee R, 2008, CELL CYCLE, V7, P2682, DOI 10.4161/cc.7.17.6450; New DR, 1997, J NEUROVIROL, V3, P168, DOI 10.3109/13550289709015806; Noorbakhsh F, 2005, J IMMUNOL, V174, P7320, DOI 10.4049/jimmunol.174.11.7320; Ramirez SH, 2001, J NEUROCHEM, V78, P874, DOI 10.1046/j.1471-4159.2001.00467.x; Rom I, 2009, BRAIN RES, V1275, P81, DOI 10.1016/j.brainres.2009.03.024; Sawaya BE, 2000, J BIOL CHEM, V275, P35209, DOI 10.1074/jbc.M005197200; Shivji M, 2005, J BIOL CHEM, V280, P15219, DOI 10.1074/jbc.M413946200; Skinner S, 2009, HIV MED, V10, P246, DOI 10.1111/j.1468-1293.2008.00679.x; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466	27	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e16148	10.1371/journal.pone.0016148	http://dx.doi.org/10.1371/journal.pone.0016148			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249135	Green Published, Green Submitted, gold			2022-12-27	WOS:000286512900024
J	Priest, PC; Duncan, AR; Jennings, LC; Baker, MG				Priest, Patricia C.; Duncan, Alasdair R.; Jennings, Lance C.; Baker, Michael G.			Thermal Image Scanning for Influenza Border Screening: Results of an Airport Screening Study	PLOS ONE			English	Article							INFECTION; FEVER; SARS	Background: Infrared thermal image scanners (ITIS) appear an attractive option for the mass screening of travellers for influenza, but there are no published data on their performance in airports. Methods: ITIS was used to measure cutaneous temperature in 1275 airline travellers who had agreed to tympanic temperature measurement and respiratory sampling. The prediction by ITIS of tympanic temperature (37.8 degrees C and 37.5 degrees C) and of influenza infection was assessed using Receiver Operating Characteristic (ROC) curves and estimated sensitivity, specificity and positive predictive value (PPV). Findings: Using front of face ITIS for prediction of tympanic temperature >= 37.8 degrees C, the area under the ROC curve was 0.86 (95%CI 0.75-0.97) and setting sensitivity at 86% gave specificity of 71%. The PPV in this population of travellers, of whom 0.5% were febrile using this definition, was 1.5%. We identified influenza virus infection in 30 travellers (3 Type A and 27 Type B). For ITIS prediction of influenza infection the area under the ROC curve was 0.66 (0.56-0.75), a sensitivity of 87% gave specificity of 39%, and PPV of 2.8%. None of the 30 influenza-positive travellers had tympanic temperature >= 37.8 degrees C at screening (95% CI 0% to 12%); three had no influenza symptoms. Conclusion: ITIS performed moderately well in detecting fever but in this study, during a seasonal epidemic of predominantly influenza type B, the proportion of influenza-infected travellers who were febrile was low and ITIS were not much better than chance at identifying travellers likely to be influenza-infected. Although febrile illness is more common in influenza A infections than influenza B infections, many influenza A infections are afebrile. Our findings therefore suggest that ITIS is unlikely to be effective for entry screening of travellers to detect influenza infection with the intention of preventing entry of the virus into a country.	[Priest, Patricia C.] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand; [Duncan, Alasdair R.] Canterbury Dist Hlth Board, Christchurch, New Zealand; [Jennings, Lance C.] Canterbury Hlth Labs, Virol Sect, Christchurch, New Zealand; [Baker, Michael G.] Univ Otago Wellington, Dept Publ Hlth, Wellington, New Zealand	University of Otago; Canterbury Health Laboratories; University of Otago	Priest, PC (corresponding author), Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand.	patricia.priest@otago.ac.nz			Centers for Disease Control and Prevention, United States [1 U01 CI000445-01]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000445] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention, United States(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was funded by the Centers for Disease Control and Prevention, United States (www.cdc.gov grant 1 U01 CI000445-01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1994, BRIT MED J, V309, P188, DOI 10.1136/bmj.309.6948.188; [Anonymous], 2004, Can Commun Dis Rep, V30, P165; Bell DM, 2004, EMERG INFECT DIS, V10, P1900, DOI 10.3201/eid1011.040729; Bitar D, 2009, EUROSURVEILLANCE, V14; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; *CDCP, 2008, MAN SURV VACC PREV D; Chan LS, 2004, J TRAVEL MED, V11, P273, DOI 10.2310/7060.2004.19102; Cowling BJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-82; Duncan AR, 2009, AM J PUBLIC HEALTH, V99, pS360, DOI 10.2105/AJPH.2008.158071; Gerrard J, 2009, LANCET, V374, P1673, DOI 10.1016/S0140-6736(09)61983-8; Hausfater P, 2008, EMERG INFECT DIS, V14, P1255, DOI 10.3201/eid1408.080059; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3675; John RKS, 2005, EMERG INFECT DIS, V11, P6, DOI 10.3201/eid1101.040835; Liu CC, 2004, INFECT CONT HOSP EP, V25, P1109, DOI 10.1086/502351; MCBRIDE WJ, 2007, INVESTIGATION OPTIMA; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Mukherjee P, 2010, EMERG INFECT DIS, V16, P21, DOI 10.3201/eid1601.091376; Ng EYK, 2004, MICROVASC RES, V68, P104, DOI 10.1016/j.mvr.2004.05.003; Pitman RJ, 2005, BRIT MED J, V331, P1242, DOI 10.1136/bmj.38573.696100.3A; *WORLD HLTH ASS, 2005, REV INT HLTH REG; Zambon M, 2001, ARCH INTERN MED, V161, P2116, DOI 10.1001/archinte.161.17.2116	23	51	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e14490	10.1371/journal.pone.0014490	http://dx.doi.org/10.1371/journal.pone.0014490			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21245928	Green Published, gold			2022-12-27	WOS:000286511200004
J	Plews, JR; Li, JL; Jones, M; Moore, HD; Mason, C; Andrews, PW; Na, J				Plews, Jordan R.; Li, JianLiang; Jones, Mark; Moore, Harry D.; Mason, Chris; Andrews, Peter W.; Na, Jie			Activation of Pluripotency Genes in Human Fibroblast Cells by a Novel mRNA Based Approach	PLOS ONE			English	Article							HUMAN IPSC INDUCTION; STEM-CELLS; DENDRITIC CELLS; GENERATION; EXPRESSION; MOLECULES; IMPROVE; VECTOR	Background: Several methods have been used to induce somatic cells to re-enter the pluripotent state. Viral transduction of reprogramming genes yields higher efficiency but involves random insertions of viral sequences into the human genome. Although induced pluripotent stem (iPS) cells can be obtained with the removable PiggyBac transposon system or an episomal system, both approaches still use DNA constructs so that resulting cell lines need to be thoroughly analyzed to confirm they are free of harmful genetic modification. Thus a method to change cell fate without using DNA will be very useful in regenerative medicine. Methodology/Principal Findings: In this study, we synthesized mRNAs encoding OCT4, SOX2, cMYC, KLF4 and SV40 large T (LT) and electroporated them into human fibroblast cells. Upon transfection, fibroblasts expressed these factors at levels comparable to, or higher than those in human embryonic stem (ES) cells. Ectopically expressed OCT4 localized to the cell nucleus within 4 hours after mRNA introduction. Transfecting fibroblasts with a mixture of mRNAs encoding all five factors significantly increased the expression of endogenous OCT4, NANOG, DNMT3 beta, REX1 and SALL4. When such transfected fibroblasts were also exposed to several small molecules (valproic acid, BIX01294 and 5'-aza-2'-deoxycytidine) and cultured in human embryonic stem cell (ES) medium they formed small aggregates positive for alkaline phosphatase activity and OCT4 protein within 30 days. Conclusion/Significance: Our results demonstrate that mRNA transfection can be a useful approach to precisely control the protein expression level and short-term expression of reprogramming factors is sufficient to activate pluripotency genes in differentiated cells.	[Plews, Jordan R.; Li, JianLiang; Jones, Mark; Moore, Harry D.; Andrews, Peter W.; Na, Jie] Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England; [Plews, Jordan R.; Mason, Chris] UCL, Dept Biochem Engn, London, England; [Na, Jie] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	University of Sheffield; University of London; University College London; Tsinghua University	Plews, JR (corresponding author), Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England.	P.W.Andrews@sheffield.ac.uk; JieNajie.na@tsinghua.edu.cn	Na, Jie/U-4518-2019; Na, Jie/N-3522-2018	Na, Jie/0000-0003-1820-0548; Na, Jie/0000-0003-1820-0548; Andrews, Peter/0000-0001-7215-4410	MRC; European Commission; Engineering and Physical Sciences Research Council (EPSRC); MRC [G0700785, G0500491] Funding Source: UKRI; Medical Research Council [G0500491, G0700785] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by grants to PWA from the MRC and from the European Commission under the Sixth Framework Programme to the ESTOOLS Integrated Project Consortium. JN was supported by an MRC Stem Cell Career Development Fellowship. JP was supported by an Engineering and Physical Sciences Research Council (EPSRC) PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Angel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011756; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Bhutani N., 2009, NATURE; Boczkowski D, 2009, CANCER GENE THER, V16, P900, DOI 10.1038/cgt.2009.39; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Cheng JW, 2009, SEMIN CANCER BIOL, V19, P218, DOI 10.1016/j.semcancer.2009.03.002; Desponts C, 2010, METHODS MOL BIOL, V636, P207, DOI 10.1007/978-1-60761-691-7_13; Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; GLOVER AB, 1987, CANCER TREAT REP, V71, P959; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huangfu D, 2008, NAT BIOTECHNOL; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kocabas AM, 2006, P NATL ACAD SCI USA, V103, P14027, DOI 10.1073/pnas.0603227103; Lee J, 2008, IMMUNOLOGY, V125, P229, DOI 10.1111/j.1365-2567.2008.02833.x; LEMAIRE P, 1995, CELL, V81, P85, DOI 10.1016/0092-8674(95)90373-9; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Ma DK, 2008, STEM CELLS; Mali P, 2008, STEM CELLS; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Melhem NM, 2007, EUR J IMMUNOL, V37, P2164, DOI 10.1002/eji.200636782; Papapetrou EP, 2009, MOL THER, V17, pS22; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Pereira CF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000170; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Smits E, 2004, LEUKEMIA, V18, P1898, DOI 10.1038/sj.leu.2403463; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Vierbuchen T, 2010, NATURE; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wiehe JM, 2007, J CELL MOL MED, V11, P521, DOI 10.1111/j.1582-4934.2007.00038.x; Wong CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001955; Yakubov E, 2010, BIOCHEM BIOPH RES CO, V394, P189, DOI 10.1016/j.bbrc.2010.02.150; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Yu JY, 2006, STEM CELLS, V24, P168, DOI 10.1634/stemcells.2005-0292; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	46	69	99	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e14397	10.1371/journal.pone.0014397	http://dx.doi.org/10.1371/journal.pone.0014397			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209933	Green Published, gold			2022-12-27	WOS:000285793600001
J	Wang, J; Taherbhoy, AM; Hunt, HW; Seyedin, SN; Miller, DW; Miller, DJ; Huang, DT; Schulman, BA				Wang, Jing; Taherbhoy, Asad M.; Hunt, Harold W.; Seyedin, Steven N.; Miller, David W.; Miller, Darcie J.; Huang, Danny T.; Schulman, Brenda A.			Crystal Structure of UBA2(ufd)-Ubc9: Insights into E1-E2 Interactions in Sumo Pathways	PLOS ONE			English	Article							CONJUGATING ENZYME; E3 LIGASE; SUBSTRATE RECOGNITION; PROTEIN-ACTIVATION; ACTIVE-SITE; UBIQUITIN; UBC9; COMPLEX; E1; E2	Canonical ubiquitin-like proteins (UBLs) such as ubiquitin, Sumo, NEDD8, and ISG15 are ligated to targets by E1-E2-E3 multienzyme cascades. The Sumo cascade, conserved among all eukaryotes, regulates numerous biological processes including protein localization, transcription, DNA replication, and mitosis. Sumo conjugation is initiated by the heterodimeric Aos1-Uba2 E1 enzyme (in humans called Sae1-Uba2), which activates Sumo's C-terminus, binds the dedicated E2 enzyme Ubc9, and promotes Sumo C-terminal transfer between the Uba2 and Ubc9 catalytic cysteines. To gain insights into details of E1-E2 interactions in the Sumo pathway, we determined crystal structures of the C-terminal ubiquitin fold domain (ufd) from yeast Uba2 (Uba2(ufd)), alone and in complex with Ubc9. The overall structures of both yeast Uba2(ufd) and Ubc9 superimpose well on their individual human counterparts, suggesting conservation of fundamental features of Sumo conjugation. Docking the Uba2(ufd)-Ubc9 and prior full-length human Uba2 structures allows generation of models for steps in Sumo transfer from Uba2 to Ubc9, and supports the notion that Uba2 undergoes remarkable conformational changes during the reaction. Comparisons to previous structures from the NEDD8 cascade demonstrate that UBL cascades generally utilize some parallel E1-E2 interaction surfaces. In addition, the structure of the Uba2(ufd)-Ubc9 complex reveals interactions unique to Sumo E1 and E2. Comparison with a previous Ubc9-E3 complex structure demonstrates overlap between Uba2 and E3 binding sites on Ubc9, indicating that loading with Sumo and E3-catalyzed transfer to substrates are strictly separate steps. The results suggest mechanisms establishing specificity and order in Sumo conjugation cascades.	[Wang, Jing; Taherbhoy, Asad M.; Hunt, Harold W.; Seyedin, Steven N.; Miller, David W.; Miller, Darcie J.; Huang, Danny T.; Schulman, Brenda A.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Taherbhoy, Asad M.; Schulman, Brenda A.] Univ Tennessee, Hlth Sci Ctr, Integrated Program Biomed Sci, Memphis, TN USA; [Schulman, Brenda A.] St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Howard Hughes Medical Institute; St Jude Children's Research Hospital	Wang, J (corresponding author), St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA.	Brenda.Schulman@stjude.org	Huang, Danny/AAM-3631-2021	Huang, Danny/0000-0002-6192-259X; Seyedin, Steven/0000-0002-6841-968X	Howard Hughes Medical Institute; NIH [R01GM069530, 5P30CA021765]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077053, R01GM069530] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Howard Hughes Medical Institute. BAS is an Investigator of the Howard Hughes Medical Institute. URL: www.hhmi.org. NIH: R01GM069530 (to BAS); 5P30CA021765 (to St. Jude Cancer Center). ALSAC: http://www.stjude.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Biggins S, 2001, GENETICS, V159, P453; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Capili AD, 2007, J MOL BIOL, V369, P608, DOI 10.1016/j.jmb.2007.04.006; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; Desterro JMP, 1999, J BIOL CHEM, V274, P10618, DOI 10.1074/jbc.274.15.10618; Duan XY, 2009, MOL CELL, V35, P657, DOI 10.1016/j.molcel.2009.06.032; Duda DM, 2007, J MOL BIOL, V369, P619, DOI 10.1016/j.jmb.2007.04.007; Durfee LA, 2008, J BIOL CHEM, V283, P23895, DOI 10.1074/jbc.M804069200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Giraud MF, 1998, ACTA CRYSTALLOGR D, V54, P891, DOI 10.1107/S0907444998002480; Gong LM, 1999, FEBS LETT, V448, P185, DOI 10.1016/S0014-5793(99)00367-1; Hannoun Z, 2010, POSTTRANSLATIONAL MO; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Huang DT, 2009, MOL CELL, V33, P483, DOI 10.1016/j.molcel.2009.01.011; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Lin DH, 2002, J BIOL CHEM, V277, P21740, DOI 10.1074/jbc.M108418200; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Okuma T, 1999, BIOCHEM BIOPH RES CO, V254, P693, DOI 10.1006/bbrc.1998.9995; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pichler A, 2004, NAT STRUCT MOL BIOL, V11, P984, DOI 10.1038/nsmb834; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Saitoh H, 1998, CURR BIOL, V8, P121, DOI 10.1016/S0960-9822(98)70044-2; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Schwarz SE, 1998, P NATL ACAD SCI USA, V95, P560, DOI 10.1073/pnas.95.2.560; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Takahashi Y, 1999, BIOCHEM BIOPH RES CO, V259, P582, DOI 10.1006/bbrc.1999.0821; Tatham MH, 2005, NAT STRUCT MOL BIOL, V12, P67, DOI 10.1038/nsmb878; Tatham MH, 2003, BIOCHEMISTRY-US, V42, P3168, DOI 10.1021/bi026861x; Tong H, 1997, J BIOL CHEM, V272, P21381, DOI 10.1074/jbc.272.34.21381; Ulrich HD, 2008, MOL CELL, V32, P301, DOI 10.1016/j.molcel.2008.10.010; Ulrich Helle D., 2009, V497, P3, DOI 10.1007/978-1-59745-566-4_1; van Waardenburg RCAM, 2006, MOL CELL BIOL, V26, P4958, DOI 10.1128/MCB.00160-06; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; WANG J, 2010, J BIOL CHEM; Wang JH, 2007, MOL CELL, V27, P228, DOI 10.1016/j.molcel.2007.05.023; Wang JH, 2009, J BIOL CHEM, V284, P20340, DOI 10.1074/jbc.M109.000257; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	57	22	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15805	10.1371/journal.pone.0015805	http://dx.doi.org/10.1371/journal.pone.0015805			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209884	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000285793600041
J	Conroy, AL; Phiri, H; Hawkes, M; Glover, S; Mallewa, M; Seydel, KB; Taylor, TE; Molyneux, ME; Kain, KC				Conroy, Andrea L.; Phiri, Happy; Hawkes, Michael; Glover, Simon; Mallewa, Mac; Seydel, Karl B.; Taylor, Terrie E.; Molyneux, Malcolm E.; Kain, Kevin C.			Endothelium-Based Biomarkers Are Associated with Cerebral Malaria in Malawian Children: A Retrospective Case-Control Study	PLOS ONE			English	Article							GROWTH-FACTOR; PLASMODIUM-FALCIPARUM; ANGIOPOIETIN-2; VEGF; RETINOPATHY; ADHESION; CELLS; COAGULATION; ACTIVATION	Background: Differentiating cerebral malaria (CM) from other causes of serious illness in African children is problematic, owing to the non-specific nature of the clinical presentation and the high prevalence of incidental parasitaemia. CM is associated with endothelial activation. In this study we tested the hypothesis that endothelium-derived biomarkers are associated with the pathophysiology of severe malaria and may help identify children with CM. Methods and Findings: Plasma samples were tested from children recruited with uncomplicated malaria (UM; n = 32), cerebral malaria with retinopathy (CM-R; n = 38), clinically defined CM without retinopathy (CM-N; n = 29), or non-malaria febrile illness with decreased consciousness (CNS; n = 24). Admission levels of angiopoietin-2 (Ang-2), Ang-1, soluble Tie-2 (sTie-2), von Willebrand factor (VWF), its propeptide (VWFpp), vascular endothelial growth factor (VEGF), soluble ICAM-1 (sICAM-1) and interferon-inducible protein 10 (IP-10) were measured by ELISA. Children with CM-R had significantly higher median levels of Ang-2, Ang-2: Ang-1, sTie-2, VWFpp and sICAM-1 compared to children with CM-N. Children with CM-R had significantly lower median levels of Ang-1 and higher median concentrations of Ang-2: Ang-1, sTie-2, VWF, VWFpp, VEGF and sICAM-1 compared to UM, and significantly lower median levels of Ang-1 and higher median levels of Ang-2, Ang-2: Ang-1, VWF and VWFpp compared to children with fever and altered consciousness due to other causes. Ang-1 was the best discriminator between UM and CM-R and between CNS and CM-R (areas under the ROC curve of 0.96 and 0.93, respectively). A comparison of biomarker levels in CM-R between admission and recovery showed uniform increases in Ang-1 levels, suggesting this biomarker may have utility in monitoring clinical response. Conclusions: These results suggest that endothelial proteins are informative biomarkers of malarial disease severity. These results require validation in prospective studies to confirm that this group of biomarkers improves the diagnostic accuracy of CM from similar conditions causing fever and altered consciousness.	[Conroy, Andrea L.; Hawkes, Michael; Kain, Kevin C.] Univ Toronto, Sandra A Rotman Labs, McLaughlin Rotman Ctr Global Hlth, Univ Hlth Network Toronto Gen Hosp, Toronto, ON, Canada; [Phiri, Happy; Mallewa, Mac; Molyneux, Malcolm E.] Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Glover, Simon; Molyneux, Malcolm E.] Univ Liverpool, Sch Trop Med, Liverpool L69 3BX, Merseyside, England; [Seydel, Karl B.; Taylor, Terrie E.] Univ Malawi, Coll Med, Blantyre Malaria Project, Blantyre, Malawi; [Seydel, Karl B.; Taylor, Terrie E.] Michigan State Univ, Coll Osteopath Med, Dept Internal Med, E Lansing, MI 48824 USA; [Kain, Kevin C.] Univ Toronto, Dept Med, Div Infect Dis, Trop Dis Unit, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi; Michigan State University; Michigan State University College of Osteopathic Medicine; University of Toronto	Conroy, AL (corresponding author), Univ Toronto, Sandra A Rotman Labs, McLaughlin Rotman Ctr Global Hlth, Univ Hlth Network Toronto Gen Hosp, Toronto, ON, Canada.	kevin.kain@uhn.on.ca	, Michael/AAP-3049-2020; Conroy, Andrea/AAA-8356-2020; Conroy, Andrea/ABC-5715-2020	Conroy, Andrea/0000-0002-5328-6511; Conroy, Andrea/0000-0002-5328-6511; Hawkes, Michael/0000-0002-4122-0937; Kain, Kevin/0000-0001-6068-1272	Canadian Institutes of Health Research (CIHR) [MOP-13721]; Genome Canada through the Ontario Genomics Institute; CIHR Canada Research Chair; Defense Advanced Research Projects Agency; Wellcome Trust, United Kingdom; National Institutes of Health, United States of America [5R01AI034969]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034969] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Genome Canada through the Ontario Genomics Institute(Genome Canada); CIHR Canada Research Chair(Canadian Institutes of Health Research (CIHR)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Wellcome Trust, United Kingdom(Wellcome Trust); National Institutes of Health, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded in part by a Canadian Institutes of Health Research (CIHR) Team Grant in Malaria (KCK), CIHR MOP-13721 (KCK), Genome Canada through the Ontario Genomics Institute (KCK), CIHR Canada Research Chair (KCK), CIHR studentship (ALC), a Defense Advanced Research Projects Agency grant (KCK) and a kind donation from Mr. D. Kirkwood. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Enrollment, clinical characterization and sampling of patients were funded by grants from The Wellcome Trust, United Kingdom, and the National Institutes of Health, United States of America (5R01AI034969).	Armah HB, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-147; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Beare NAV, 2006, AM J TROP MED HYG, V75, P790, DOI 10.4269/ajtmh.2006.75.790; Berkley JA, 1999, QJM-INT J MED, V92, P151, DOI 10.1093/qjmed/92.3.151; Bridges DJ, 2009, BLOOD; Brown H, 1999, NEUROPATH APPL NEURO, V25, P331; Brown H, 2001, AM J TROP MED HYG, V64, P207, DOI 10.4269/ajtmh.2001.64.207; Burton M, 2004, TROP DOCT, V34, P214, DOI 10.1177/004947550403400409; Carmeliet P, 2002, SEMIN CELL DEV BIOL, V13, P39, DOI 10.1006/scdb.2001.0290; Casals-Pascual C, 2008, P NATL ACAD SCI USA, V105, P2634, DOI 10.1073/pnas.0709715105; Conroy AL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-295; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Findley CM, 2007, ARTERIOSCL THROM VAS, V27, P2619, DOI 10.1161/ATVBAHA.107.150482; Francischetti IMB, 2007, J THROMB HAEMOST, V5, P155, DOI 10.1111/j.1538-7836.2006.02232.x; Hollestelle MJ, 2006, BRIT J HAEMATOL, V133, P562, DOI 10.1111/j.1365-2141.2006.06067.x; Jain V, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-83; JAKOBSEN PH, 1994, IMMUNOLOGY, V83, P665; Kentaro U, 2009, BRIT J HAEMATOL, V148, P285; Kim I, 2001, CIRC RES, V89, P477, DOI 10.1161/hh1801.097034; Kim IJ, 2002, FASEB J, V16, pA305; Larkin D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000349; Lewallen S, 2008, T ROY SOC TROP MED H, V102, P1089, DOI 10.1016/j.trstmh.2008.06.014; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Lovegrove FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004912; Matsushita K, 2005, BLOOD, V105, P207, DOI 10.1182/blood-2004-04-1519; Medana IM, 2006, INT J PARASITOL, V36, P555, DOI 10.1016/j.ijpara.2006.02.004; Moxon CA, 2009, MOL BIOCHEM PARASIT, V166, P99, DOI 10.1016/j.molbiopara.2009.03.006; Nicoletti JN, 2008, NEUROSCIENCE, V151, P232, DOI 10.1016/j.neuroscience.2007.09.083; Oh H, 1999, J BIOL CHEM, V274, P15732, DOI 10.1074/jbc.274.22.15732; Okubadejo N U, 2004, Niger Postgrad Med J, V11, P10; Pickkers P, 2005, SHOCK, V24, P508, DOI 10.1097/01.shk.0000190827.36406.6e; Sachanonta N, 2008, ASIAN PAC J ALLERGY, V26, P37; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Satchell SC, 2004, J AM SOC NEPHROL, V15, P566, DOI 10.1097/01.ASN.0000115397.22519.03; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Tchinda VHM, 2007, ACTA TROP, V102, P20, DOI 10.1016/j.actatropica.2007.02.011; Turner GDH, 1998, AM J PATHOL, V152, P1477; TURNER GDH, 1994, AM J PATHOL, V145, P1057; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; WRIGHT PW, 1993, PEDIATR INFECT DIS J, V12, P37, DOI 10.1097/00006454-199301000-00009; Yeo TW, 2008, P NATL ACAD SCI USA, V105, P17097, DOI 10.1073/pnas.0805782105; Yuan HT, 2009, MOL CELL BIOL, P01472	43	100	102	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15291	10.1371/journal.pone.0015291	http://dx.doi.org/10.1371/journal.pone.0015291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209923	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793200022
J	Pyo, CW; Guethlein, LA; Vu, QY; Wang, RH; Abi-Rached, L; Norman, PJ; Marsh, SGE; Miller, JS; Parham, P; Geraghty, DE				Pyo, Chul-Woo; Guethlein, Lisbeth A.; Vu, Quyen; Wang, Ruihan; Abi-Rached, Laurent; Norman, Paul J.; Marsh, Steven G. E.; Miller, Jeffrey S.; Parham, Peter; Geraghty, Daniel E.			Different Patterns of Evolution in the Centromeric and Telomeric Regions of Group A and B Haplotypes of the Human Killer Cell Ig-Like Receptor Locus	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE RECEPTOR; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE SEQUENCE ALIGNMENT; ACUTE MYELOGENOUS LEUKEMIA; KIR HAPLOTYPES; GENE-CONTENT; CUTTING EDGE; HLA-C; PHYLOGENETIC ANALYSIS; ALLELIC POLYMORPHISM	The fast evolving human KIR gene family encodes variable lymphocyte receptors specific for polymorphic HLA class I determinants. Nucleotide sequences for 24 representative human KIR haplotypes were determined. With three previously defined haplotypes, this gave a set of 12 group A and 15 group B haplotypes for assessment of KIR variation. The seven gene-content haplotypes are all combinations of four centromeric and two telomeric motifs. 2DL5, 2DS5 and 2DS3 can be present in centromeric and telomeric locations. With one exception, haplotypes having identical gene content differed in their combinations of KIR alleles. Sequence diversity varied between haplotype groups and between centromeric and telomeric halves of the KIR locus. The most variable A haplotype genes are in the telomeric half, whereas the most variable genes characterizing B haplotypes are in the centromeric half. Of the highly polymorphic genes, only the 3DL3 framework gene exhibits a similar diversity when carried by A and B haplotypes. Phylogenetic analysis and divergence time estimates, point to the centromeric gene-content motifs that distinguish A and B haplotypes having emerged similar to 6 million years ago, contemporaneously with the separation of human and chimpanzee ancestors. In contrast, the telomeric motifs that distinguish A and B haplotypes emerged more recently, similar to 1.7 million years ago, before the emergence of Homo sapiens. Thus the centromeric and telomeric motifs that typify A and B haplotypes have likely been present throughout human evolution. The results suggest the common ancestor of A and B haplotypes combined a B-like centromeric region with an Alike telomeric region.	[Pyo, Chul-Woo; Vu, Quyen; Wang, Ruihan; Geraghty, Daniel E.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Guethlein, Lisbeth A.; Abi-Rached, Laurent; Norman, Paul J.; Parham, Peter] Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA; [Miller, Jeffrey S.] Univ Minnesota, Minneapolis, MN USA; [Marsh, Steven G. E.] Anthony Nolan Res Inst, London, England	Fred Hutchinson Cancer Center; Stanford University; University of Minnesota System; University of Minnesota Twin Cities	Pyo, CW (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	geraghty@fhcrc.org	Marsh, Steven GE/C-1638-2008; Abi-Rached, Laurent/H-7236-2012	Marsh, Steven GE/0000-0003-2855-4120; Miller, Jeffrey S/0000-0002-0339-4944; Norman, Paul/0000-0001-8370-7703	National Institutes of Health [CA111412, RR018669]; NATIONAL CANCER INSTITUTE [P01CA111412] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R41RR018669, R42RR018669] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Institutes of Health grants CA111412 to J.S.M. and RR018669 to D. E. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Rached L, 2005, J EXP MED, V201, P1319, DOI 10.1084/jem.20042558; Barten R, 2001, TRENDS IMMUNOL, V22, P52, DOI 10.1016/S1471-4906(00)01802-0; Bashirova AA, 2006, ANNU REV GENOM HUM G, V7, P277, DOI 10.1146/annurev.genom.7.080505.115726; Beatty PG, 2000, HUM IMMUNOL, V61, P834, DOI 10.1016/S0198-8859(00)00138-5; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Bovee D, 2008, NAT GENET, V40, P96, DOI 10.1038/ng.2007.34; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Cooley S, 2009, BLOOD, V113, P726, DOI 10.1182/blood-2008-07-171926; Cooper MA, 2009, EMBO REP, V10, P1103, DOI 10.1038/embor.2009.203; Daza-Vamenta R, 2004, GENOME RES, V14, P1501, DOI 10.1101/gr.2134504; Du Z, 2008, GENES IMMUN, V9, P470, DOI 10.1038/gene.2008.39; Gendzekhadze K, 2006, IMMUNOGENETICS, V58, P474, DOI 10.1007/s00251-006-0108-3; Gendzekhadze K, 2009, P NATL ACAD SCI USA, V106, P18692, DOI 10.1073/pnas.0906051106; Geraghty DE, 2002, IMMUNOL REV, V190, P69, DOI 10.1034/j.1600-065X.2002.19006.x; Gomez-Lozano N, 2005, EUR J IMMUNOL, V35, P16, DOI 10.1002/eji.200425493; Gomez-Lozano N, 2003, EUR J IMMUNOL, V33, P639, DOI 10.1002/eji.200323741; Gomez-Lozano N, 2002, IMMUNOGENETICS, V54, P314, DOI 10.1007/s00251-002-0476-2; Guethlein LA, 2007, J IMMUNOL, V179, P491, DOI 10.4049/jimmunol.179.1.491; Hansasuta P, 2004, EUR J IMMUNOL, V34, P1673, DOI 10.1002/eji.200425089; Hiby SE, 2004, J EXP MED, V200, P957, DOI 10.1084/jem.20041214; Hsu KC, 2005, BLOOD, V105, P4878, DOI 10.1182/blood-2004-12-4825; Hsu KC, 2002, J IMMUNOL, V169, P5118, DOI 10.4049/jimmunol.169.9.5118; Hsu KC, 2002, IMMUNOL REV, V190, P40, DOI 10.1034/j.1600-065X.2002.19004.x; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Joncker NT, 2008, IMMUNOL REV, V224, P85, DOI 10.1111/j.1600-065X.2008.00658.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Locatelli F, 2009, CLIN IMMUNOL, V133, P171, DOI 10.1016/j.clim.2009.04.009; Luszczek W, 2004, HUM IMMUNOL, V65, P758, DOI 10.1016/j.humimm.2004.05.008; Marsh SGE, 2005, TISSUE ANTIGENS, V65, P301, DOI 10.1111/j.1399-0039.2005.00379.x; Marsh SGE, 2003, IMMUNOGENETICS, V55, P220, DOI 10.1007/s00251-003-0571-z; Martin AM, 2004, GENE, V335, P121, DOI 10.1016/j.gene.2004.03.018; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Martin MP, 2008, IMMUNOGENETICS, V60, P767, DOI 10.1007/s00251-008-0334-y; Martin MP, 2003, J IMMUNOL, V171, P2192, DOI 10.4049/jimmunol.171.5.2192; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Martin MP, 2002, J IMMUNOL, V169, P2818, DOI 10.4049/jimmunol.169.6.2818; Middleton D, 2007, IMMUNOGENETICS, V59, P145, DOI 10.1007/s00251-006-0181-7; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Momot T, 2004, ARTHRITIS RHEUM-US, V50, P1561, DOI 10.1002/art.20216; Moretta A, 2009, CLIN EXP IMMUNOL, V157, P325, DOI 10.1111/j.1365-2249.2009.03983.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Nelson GW, 2004, J IMMUNOL, V173, P4273, DOI 10.4049/jimmunol.173.7.4273; Norman PJ, 2009, GENOME RES, V19, P757, DOI 10.1101/gr.085738.108; Norman PJ, 2004, IMMUNOGENETICS, V56, P225, DOI 10.1007/s00251-004-0674-1; Norman PJ, 2002, GENES IMMUN, V3, P86, DOI 10.1038/sj.gene.6363836; Ordonez D, 2008, GENES IMMUN, V9, P431, DOI 10.1038/gene.2008.34; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; PYO CW, 2006, IMMUNOGENET IN PRESS; Raymond CK, 2005, GENOMICS, V86, P759, DOI 10.1016/j.ygeno.2005.08.013; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Sambrook JG, 2007, CURR OPIN IMMUNOL, V19, P553, DOI 10.1016/j.coi.2007.08.002; Sambrook JG, 2005, GENOME RES, V15, P25, DOI 10.1101/gr.2381205; Shilling HG, 2002, J IMMUNOL, V168, P2307, DOI 10.4049/jimmunol.168.5.2307; Smith WP, 2006, GENOMICS, V87, P561, DOI 10.1016/j.ygeno.2005.11.020; Sun JC, 2009, EUR J IMMUNOL, V39, P2059, DOI 10.1002/eji.200939435; Suzuki Y, 2004, J INVEST DERMATOL, V122, P1133, DOI 10.1111/j.0022-202X.2004.22517.x; Thananchai H, 2007, J IMMUNOL, V178, P33, DOI 10.4049/jimmunol.178.1.33; Trowsdale J, 2001, IMMUNOL REV, V181, P20, DOI 10.1034/j.1600-065X.2001.1810102.x; Uhrberg M, 2002, IMMUNOGENETICS, V54, P221, DOI 10.1007/s00251-002-0463-7; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; van der Slik AR, 2003, DIABETES, V52, P2639, DOI 10.2337/diabetes.52.10.2639; Vely F, 2001, J IMMUNOL, V166, P2487, DOI 10.4049/jimmunol.166.4.2487; Whang DH, 2005, HUM IMMUNOL, V66, P146, DOI 10.1016/j.humimm.2004.10.013; Williams F, 2003, GENES IMMUN, V4, pS1; Wilson MJ, 2000, P NATL ACAD SCI USA, V97, P4778, DOI 10.1073/pnas.080588597; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yawata M, 2002, CRIT REV IMMUNOL, V22, P463; Yawata M, 2002, IMMUNOGENETICS, V54, P543, DOI 10.1007/s00251-002-0497-x; Yen JH, 2001, J EXP MED, V193, P1159, DOI 10.1084/jem.193.10.1159	73	177	181	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15115	10.1371/journal.pone.0015115	http://dx.doi.org/10.1371/journal.pone.0015115			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206914	Green Published, Green Submitted, gold			2022-12-27	WOS:000285793200015
J	Yu, WH; Hu, H; Zhou, QD; Xia, Y; Amar, S				Yu, Wen-Han; Hu, Han; Zhou, Qingde; Xia, Yu; Amar, Salomon			Bioinformatics Analysis of Macrophages Exposed to Porphyromonas gingivalis: Implications in Acute vs. Chronic Infections	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; SIGNALING PATHWAYS; COMPLEMENT RECEPTOR-3; BONE-RESORPTION; INNATE IMMUNITY; TNF-ALPHA; LIPOPOLYSACCHARIDE; ACTIVATION; COMPONENTS; CYTOKINE	Background: Periodontitis is the most common human infection affecting tooth-supporting structures. It was shown to play a role in aggravating atherosclerosis. To deepen our understanding of the pathogenesis of this disease, we exposed human macrophages to an oral bacteria, Porphyromonas gingivalis (P. gingivalis), either as live bacteria or its LPS or fimbria. Microarray data from treated macrophages or control cells were analyzed to define molecular signatures. Changes in genes identified in relevant pathways were validated by RT-PCR. Methodology/Principal Findings: We focused our analysis on three important groups of genes. Group PG (genes differentially expressed by live bacteria only); Group LFG (genes differentially expressed in response to exposure to LPS and/or FimA); Group CG (core gene set jointly activated by all 3 stimulants). A total of 842 macrophage genes were differentially expressed in at least one of the three conditions compared to naive cells. Using pathway analysis, we found that group CG activates the initial phagocytosis process and induces genes relevant to immune response, whereas group PG can deactivate the phagocytosis process associated with phagosome-lysosome fusion. LFG mostly affected RIG-I-like receptor signaling pathway. Conclusion/Significance: In light of the fact that acute infections involve live bacteria while chronic infections involve a combination of live bacteria and their byproducts, group PG could represent acute P. gingivalis infection while group LFG could represent chronic P. gingivalis infection. Group CG may be associated with core immune pathways, triggered irrespective of the specific stimulants and indispensable to mount an appropriate immune response. Implications in acute vs. chronic infection are discussed.	[Yu, Wen-Han; Hu, Han; Xia, Yu; Amar, Salomon] Boston Univ, Bioinformat Grad Program, Boston, MA 02215 USA; [Hu, Han; Zhou, Qingde; Amar, Salomon] Boston Univ, Sch Dent Med, Ctr Anti Inflammatory Therapeut, Boston, MA 02215 USA	Boston University; Boston University	Yu, WH (corresponding author), Boston Univ, Bioinformat Grad Program, Boston, MA 02215 USA.	samar@bu.edu	Xia, Yu/W-6150-2019	Xia, Yu/0000-0002-5596-5518; Yu, Wen-Han/0000-0002-1671-9744; Amar, Salomon/0000-0002-0017-5930	National Institutes of Health [R01 DE014079, DE15989, HL7680]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015989, R01DE014079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health grants R01 DE014079, DE15989 and HL7680 (SA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, BIOCHEM SOC T, V31, P637, DOI 10.1042/BST0310637; Amano A, 2003, J PERIODONTOL, V74, P90, DOI 10.1902/jop.2003.74.1.90; Antonov AV, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r179; Batut J, 2004, NAT REV MICROBIOL, V2, P933, DOI 10.1038/nrmicro1044; Burns E, 2006, J IMMUNOL, V177, P8296, DOI 10.4049/jimmunol.177.12.8296; Furukawa S, 2006, J BACTERIOL, V188, P1211, DOI 10.1128/JB.188.4.1211-1217.2006; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibson FC, 2008, FRONT BIOSCI-LANDMRK, V13, P2041, DOI 10.2741/2822; Graves DT, 2005, J ENDOTOXIN RES, V11, P13, DOI 10.1179/096805105225006722; Hajishengallis G, 2007, FRONT BIOSCI-LANDMRK, V12, P4547, DOI 10.2741/2409; Hajishengallis G, 2006, INFECT IMMUN, V74, P5658, DOI 10.1128/IAI.00784-06; Hajishengallis G, 2008, ADV EXP MED BIOL, V632, P203, DOI 10.1007/978-0-387-78952-1_15; Holt SC, 1999, PERIODONTOL 2000, V20, P168, DOI 10.1111/j.1600-0757.1999.tb00162.x; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kong L, 2009, CELL HOST MICROBE, V6, P150, DOI 10.1016/j.chom.2009.06.008; Li L, 2002, INFECT IMMUN, V70, P3915, DOI 10.1128/IAI.70.7.3915-3922.2002; Manes S, 2003, NAT REV IMMUNOL, V3, P557, DOI 10.1038/nri1129; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; OGAWA T, 1994, MICROBIOL-UK, V140, P1209, DOI 10.1099/13500872-140-5-1209; Simons K, 2000, TRENDS CELL BIOL, V10, P459, DOI 10.1016/S0962-8924(00)01847-X; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Srinivasan S, 2010, CLIN VACCINE IMMUNOL, V17, P699, DOI 10.1128/CVI.00510-09; Tang XR, 2006, P NATL ACAD SCI USA, V103, P13777, DOI 10.1073/pnas.0605988103; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Walter C, 2004, INFECT IMMUN, V72, P5910, DOI 10.1128/IAI.72.10.5910-5918.2004; Wang J, 2008, J IMMUNOL, V180, P8011, DOI 10.4049/jimmunol.180.12.8011; Wang M, 2008, CELL MICROBIOL, V10, P2029, DOI 10.1111/j.1462-5822.2008.01185.x; Wang PL, 2002, CRIT REV ORAL BIOL M, V13, P132, DOI 10.1177/154411130201300204; Yoshimura F, 2009, J PERIODONTAL RES, V44, P1, DOI 10.1111/j.1600-0765.2008.01135.x; Zanotti- Cavazzoni S. L., 2009, CRIT CARE CLIN, V25, pvii; Zanotti-Cavazzoni SL, 2009, CRIT CARE CLIN, V25, P703, DOI 10.1016/j.ccc.2009.08.005; Zhou Q, 2005, INFECT IMMUN, V73, P935, DOI 10.1128/IAI.73.2.935-943.2005; Zhou QD, 2007, J IMMUNOL, V179, P7777, DOI 10.4049/jimmunol.179.11.7777	38	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15613	10.1371/journal.pone.0015613	http://dx.doi.org/10.1371/journal.pone.0015613			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203416	Green Submitted, Green Published, gold			2022-12-27	WOS:000285579200026
J	Cattoglio, C; Maruggi, G; Bartholomae, C; Malani, N; Pellin, D; Cocchiarella, F; Magnani, Z; Ciceri, F; Ambrosi, A; von Kalle, C; Bushman, FD; Bonini, C; Schmidt, M; Mavilio, F; Recchia, A				Cattoglio, Claudia; Maruggi, Giulietta; Bartholomae, Cynthia; Malani, Nirav; Pellin, Danilo; Cocchiarella, Fabienne; Magnani, Zulma; Ciceri, Fabio; Ambrosi, Alessandro; von Kalle, Christof; Bushman, Frederic D.; Bonini, Chiara; Schmidt, Manfred; Mavilio, Fulvio; Recchia, Alessandra			High-Definition Mapping of Retroviral Integration Sites Defines the Fate of Allogeneic T Cells After Donor Lymphocyte Infusion	PLOS ONE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; GRAFT-VERSUS-LEUKEMIA; SCID-X1 GENE-THERAPY; VECTOR INTEGRATION; LENTIVIRAL VECTOR; HUMAN GENOME; SELECTION; IMMUNODEFICIENCY; TRANSPLANTATION; METHYLATIONS	The infusion of donor lymphocytes transduced with a retroviral vector expressing the HSV-TK suicide gene in patients undergoing hematopoietic stem cell transplantation for leukemia/lymphoma promotes immune reconstitution and prevents infections and graft-versus-host disease. Analysis of the clonal dynamics of genetically modified lymphocytes in vivo is of crucial importance to understand the potential genotoxic risk of this therapeutic approach. We used linear amplification-mediated PCR and pyrosequencing to build a genome-wide, high-definition map of retroviral integration sites in the genome of peripheral blood T cells from two different donors and used gene expression profiling and bioinformatics to associate integration clusters to transcriptional activity and to genetic and epigenetic features of the T cell genome. Comparison with matched random controls and with integrations obtained from CD34(+) hematopoietic stem/progenitor cells showed that integration clusters occur within chromatin regions bearing epigenetic marks associated with active promoters and regulatory elements in a cell-specific fashion. Analysis of integration sites in T cells obtained ex vivo two months after infusion showed no evidence of integration-related clonal expansion or dominance, but rather loss of cells harboring integration events interfering with RNA post-transcriptional processing. The study shows that high-definition maps of retroviral integration sites are a powerful tool to analyze the fate of genetically modified T cells in patients and the biological consequences of retroviral transduction.	[Cattoglio, Claudia; Mavilio, Fulvio] Ist Sci San Raffaele, IIT Unit Mol Neurosci, Milan, Italy; [Maruggi, Giulietta; Cocchiarella, Fabienne; Mavilio, Fulvio; Recchia, Alessandra] Univ Modena, Ctr Regenerat Med, I-41100 Modena, Italy; [Maruggi, Giulietta; Cocchiarella, Fabienne; Mavilio, Fulvio; Recchia, Alessandra] Univ Reggio Emilia, Ctr Regenerat Med, Modena, Italy; [Bartholomae, Cynthia; von Kalle, Christof; Schmidt, Manfred] Natl Ctr Tumor Dis NCT, Dept Translat Oncol, Heidelberg, Germany; [Bartholomae, Cynthia; von Kalle, Christof; Schmidt, Manfred] German Canc Res Ctr, Heidelberg, Germany; [Malani, Nirav; Bushman, Frederic D.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Pellin, Danilo; Ambrosi, Alessandro] Univ Vita Salute San Raffaele, Ctr Stat Biomed Sci, Milan, Italy; [Magnani, Zulma; Bonini, Chiara] Ist Sci San Raffaele, Div Regenerat Med Gene Therapy & Stem Cells, PIBIC, Expt Hematol Unit, Milan, Italy; [Ciceri, Fabio] Ist Sci San Raffaele, Hematol Unit, Milan, Italy	Istituto Italiano di Tecnologia - IIT; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Pennsylvania; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Cattoglio, C (corresponding author), Ist Sci San Raffaele, IIT Unit Mol Neurosci, Milan, Italy.	alessandra.recchia@unimore.it	Magnani, Zulma Irene/AAN-7588-2020; bonini, chiara/I-9202-2012; ambrosi, alessandro/H-4424-2011; Recchia, Alessandra/B-7954-2015; MAVILIO, Fulvio/J-6125-2013	Magnani, Zulma Irene/0000-0001-7612-6097; ambrosi, alessandro/0000-0003-1976-5663; Recchia, Alessandra/0000-0002-3467-1094; Mavilio, Fulvio/0000-0003-0459-4320; Bushman, Frederic/0000-0003-4740-4056; BONINI, Maria Chiara/0000-0002-0772-1674	Italian Ministry of Health; Italian Ministry of University and Research; Telethon [GGP08095]; European Commission; NIH [AI52845, AI082020]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082020, R01AI052845] Funding Source: NIH RePORTER	Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Telethon(Fondazione Telethon); European Commission(European CommissionEuropean Commission Joint Research Centre); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the Italian Ministry of Health, the Italian Ministry of University and Research, Telethon (GGP08095), the European Commission (FP7-PERSIST), and NIH grants AI52845 and AI082020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiuti A, 2007, J CLIN INVEST, V117, P2233, DOI 10.1172/JCI31666; Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Barr SD, 2005, J VIROL, V79, P12035, DOI 10.1128/JVI.79.18.12035-12044.2005; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berry C, 2006, PLOS COMPUT BIOL, V2, P1450, DOI 10.1371/journal.pcbi.0020157; Bonini C, 2003, NAT MED, V9, P367, DOI 10.1038/nm0403-367; Bonini C, 1997, SCIENCE, V276, P1719, DOI 10.1126/science.276.5319.1719; Brady T, 2009, GENE DEV, V23, P633, DOI 10.1101/gad.1762309; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cattoglio C, 2007, BLOOD, V110, P1770, DOI 10.1182/blood-2007-01-068759; Ciceri F, 2007, BLOOD, V109, P4698, DOI 10.1182/blood-2006-05-023416; Ciceri F, 2009, LANCET ONCOL, V10, P489, DOI 10.1016/S1470-2045(09)70074-9; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Deichmann A, 2007, J CLIN INVEST, V117, P2225, DOI 10.1172/JCI31659; Felice B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004571; Ferrari F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-264; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Newrzela S, 2008, BLOOD, V112, P2278, DOI 10.1182/blood-2007-12-128751; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Recchia A, 2006, P NATL ACAD SCI USA, V103, P1457, DOI 10.1073/pnas.0507496103; Schwarzwaelder K, 2007, J CLIN INVEST, V117, P2241, DOI 10.1172/JCI31661; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Tiberghien P, 2001, BLOOD, V97, P63, DOI 10.1182/blood.V97.1.63; TRAVERSARI C, 2007, BLOOD; Verzeletti S, 1998, HUM GENE THER, V9, P2243, DOI 10.1089/hum.1998.9.15-2243; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Wang GP, 2010, BLOOD, V115, P4356, DOI 10.1182/blood-2009-12-257352; Wang GP, 2009, MOL THER, V17, P844, DOI 10.1038/mt.2009.16; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154	36	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15688	10.1371/journal.pone.0015688	http://dx.doi.org/10.1371/journal.pone.0015688			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203516	gold, Green Published, Green Submitted			2022-12-27	WOS:000285578000046
J	Ferreira, RS; Poteaux, C; Delabie, JHC; Fresneau, D; Rybak, F				Ferreira, Ronara Souza; Poteaux, Chantal; Delabie, Jacques Hubert Charles; Fresneau, Dominique; Rybak, Fanny			Stridulations Reveal Cryptic Speciation in Neotropical Sympatric Ants	PLOS ONE			English	Article							SPECIES COMPLEX; HYMENOPTERA; RECRUITMENT; ORTHOPTERA; EVOLUTION; BEHAVIOR; MIMICRY; MYRMECOMORPHY; COMMUNICATION; MORPHOLOGY	The taxonomic challenge posed by cryptic species underlines the importance of using multiple criteria in species delimitation. In the current paper we tested the use of acoustic analysis as a tool to assess the real diversity in a cryptic species complex of Neotropical ants. In order to understand the potential of acoustics and to improve consistency in the conclusions by comparing different approaches, phylogenetic relationships of all the morphs considered were assessed by the analysis of a fragment of the mitochondrial DNA cytochrome b. We observed that each of the cryptic morph studied presents a morphologically distinct stridulatory organ and that all sympatric morphs produce distinctive stridulations. This is the first evidence of such a degree of specialization in the acoustic organ and signals in ants, which suggests that stridulations may be among the cues used by these ants during inter-specific interactions. Mitochondrial DNA variation corroborated the acoustic differences observed, confirming acoustics as a helpful tool to determine cryptic species in this group of ants, and possibly in stridulating ants in general. Congruent morphological, acoustic and genetic results constitute sufficient evidence to propose each morph studied here as a valid new species, suggesting that P. apicalis is a complex of at least 6 to 9 species, even if they present different levels of divergence. Finally, our results highlight that ant stridulations may be much more informative than hitherto thought, as much for ant communication as for integrative taxonomists.	[Ferreira, Ronara Souza; Poteaux, Chantal; Fresneau, Dominique] Univ Paris 13, LEEC EA 4443, Lab Ethol Expt & Comparee, F-93430 Villetaneuse, France; [Delabie, Jacques Hubert Charles] Ctr Pesquisas Cacau, Convenio UESC CEPLAC, UPA Lab Mirmecol, Itabuna, Brazil; [Rybak, Fanny] Univ Paris Sud, Ctr Neurosci Paris Sud, UMR 8195, Orsay, France; [Rybak, Fanny] CNRS, F-91405 Orsay, France	Universite Paris 13; Universidade Estadual de Santa Cruz; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet; Centre National de la Recherche Scientifique (CNRS)	Ferreira, RS (corresponding author), Univ Paris 13, LEEC EA 4443, Lab Ethol Expt & Comparee, F-93430 Villetaneuse, France.	ronara@leec.univ-paris13.fr	CHARLES, Hubert/B-9392-2011; Delabie, Jacques H C/F-3405-2010; Ferreira-Châline, Ronara/J-7952-2012	CHARLES, Hubert/0000-0002-0809-4705; Delabie, Jacques H C/0000-0002-2695-1061; Ferreira-Châline, Ronara/0000-0001-7335-2179; Poteaux, Chantal/0000-0002-6815-4650	Programme AlBan; European Union [E06D101212BR]; French Entomological Society; PRONEX FAPESB/CNPq [PNX0011/2009]	Programme AlBan(European Commission); European Union(European Commission); French Entomological Society; PRONEX FAPESB/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Programme AlBan, the European Union Programme of High Level Scholarships for Latin America, scholarship n<SUP>o</SUP> E06D101212BR, http://www.programalban.org/; the French Entomological Society (Grant Germaine Cousin), http://www.lasef.org/; PRONEX FAPESB/CNPq PNX0011/2009, www.fapesb.ba.gov.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, INSETOS SOCIAIS BIOL; [Anonymous], 1802, HIST NATURELLE FOURM, DOI DOI 10.5962/BHL.TITLE.11138; Balakrishnan R, 2005, SYST BIOL, V54, P689, DOI 10.1080/10635150590950308; Barbero F, 2009, J EXP BIOL, V212, P4084, DOI 10.1242/jeb.032912; Barbero F, 2009, SCIENCE, V323, P782, DOI 10.1126/science.1163583; BARONIURBANI C, 1988, INSECT SOC, V35, P241, DOI 10.1007/BF02224057; Berkov A, 2002, BIOL J LINN SOC, V76, P195, DOI 10.1111/j.1095-8312.2002.tb02082.x; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bolton Barry, 1995, P1; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Brown W. L. jr., 1957, Bulletin of the Museum of Comparative Zoology Harvard, V116, P228; Broza M, 1998, SYST ENTOMOL, V23, P125, DOI 10.1046/j.1365-3113.1998.00048.x; Cade WH, 2000, T AM ENTOMOL SOC, V126, P117; Claridge M. F., 1997, V54, P247; CROZIER RH, 1993, GENETICS, V133, P97; Cushing PE, 1997, FLA ENTOMOL, V80, P165, DOI 10.2307/3495552; DELABIE JH, 2000, MEASURING MONITORING, P145; Devries P, 1991, AM MUS NOVIT, V3025, P1; DEVRIES PJ, 1990, SCIENCE, V248, P1104, DOI 10.1126/science.248.4959.1104; Emery C., 1890, ANN SOC ENTOMOL FR, V10, P55; Fernandez Fernando, 2004, Biota Colombiana, V5, P3; Ferreira R. S., 2009, LANGAGES CAHIERS INF, P71; Forel A., 1922, Revue Suisse de Zoologie, V30, P87; FRESNEAU D, 1994, THESIS U VILLETANEUS; Gavrilets S, 2003, EVOLUTION, V57, P2197; Grasso DA, 2000, ITAL J ZOOL, V67, P281, DOI 10.1080/11250000009356325; Grasso DA, 1998, ITAL J ZOOL, V65, P167, DOI 10.1080/11250009809386741; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; HENRY CS, 1994, TRENDS ECOL EVOL, V9, P388, DOI 10.1016/0169-5347(94)90061-2; Hickling R, 2000, J ACOUST SOC AM, V108, P1920, DOI 10.1121/1.1290515; HOLLDOBLER B, 1978, BEHAV ECOL SOCIOBIOL, V4, P163, DOI 10.1007/BF00354978; Holldobler B., 1990, pi; Holldobler B., 2009, SUPERORGANISM BEAUTY; JANET C, 1893, ANN SOC ENTOMOL FRAN, V62, P159; JANET C, 1894, ANN SOC ENTOMOL FRAN, V63, P109; KERMARREC A, 1976, INSECT SOC, V23, P29, DOI 10.1007/BF02283904; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; LANDOIS H, 1874, THIERSTIMMEN, P129; Lubbock J., 1877, MONTHLY MICROSCOPICA, V18, P121; Lucas C, 2002, BIOL J LINN SOC, V75, P249, DOI 10.1111/j.1095-8312.2002.tb01425.x; Majer JD, 1999, INSECT SOC, V46, P281, DOI 10.1007/s000400050147; Majer Jonathan D., 1993, Journal of Plant Protection in the Tropics, V10, P43; Mariano Clea S.F., 2006, Myrmecologische Nachrichten, V8, P277; Mariano CSF, 2000, NATURALIA, V24, P215; MARKL H, 1977, INSECT SOC, V24, P191, DOI 10.1007/BF02227171; MARKL H, 1968, Z VERGL PHYSIOL, V60, P103, DOI 10.1007/BF00878447; MARKL H, 1965, SCIENCE, V149, P1392, DOI 10.1126/science.149.3690.1392; Markl H., 1973, Proceedings Congr Int Un Study Soc Ins, V7, P258; MASCHWITZ U, 1983, OECOLOGIA, V57, P175, DOI 10.1007/BF00379578; Mbu Nyamsi Ruben G., 1994, Bioacoustics, V5, P187; MCIVER JD, 1993, ANNU REV ENTOMOL, V38, P351, DOI 10.1146/annurev.en.38.010193.002031; Mercier JL, 2007, INSECT SOC, V54, P403, DOI 10.1007/s00040-007-0960-7; Molbo D, 2003, P NATL ACAD SCI USA, V100, P5867, DOI 10.1073/pnas.0930903100; Morales MA, 2008, P ROY SOC B-BIOL SCI, V275, P1935, DOI 10.1098/rspb.2008.0410; Noor MAF, 1998, ANIM BEHAV, V56, P115, DOI 10.1006/anbe.1998.0779; Pavan G., 1997, Bioacoustics, V8, P209; REISKIND J, 1977, BIOTROPICA, V9, P1, DOI 10.2307/2387854; RITCHIE MG, 1995, J EVOLUTION BIOL, V8, P463, DOI 10.1046/j.1420-9101.1995.8040463.x; Roces F, 2001, J ACOUST SOC AM, V109, P3080, DOI 10.1121/1.1370085; ROCES F, 1993, NATURWISSENSCHAFTEN, V80, P521, DOI 10.1007/BF01140810; Saez AG, 2005, NATURE, V433, P111, DOI 10.1038/433111a; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Sharp D., 1893, Transactions of the Entomological Society of London, P199; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; SPANGLER HG, 1967, SCIENCE, V155, P1687, DOI 10.1126/science.155.3770.1687; Specht R., 2008, AVISOFT SASLAB VERSI; SPJOTVOLL E, 1973, J AM STAT ASSOC, V68, P975, DOI 10.2307/2284534; *STATSOFT BREM, 2007, STATISTICA LOG AN DO; STUART R J, 1980, Psyche (Cambridge), V87, P199, DOI 10.1155/1980/46583; Sueur J, 2006, CONT T ENT, P207; TAJIMA F, 1993, GENETICS, V135, P599; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TAYLOR RW, 1978, SCIENCE, V201, P979, DOI 10.1126/science.201.4360.979; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Travassos MA, 2000, ANIM BEHAV, V60, P13, DOI 10.1006/anbe.1999.1364; Walker TJ, 2003, ANN ENTOMOL SOC AM, V96, P433, DOI 10.1603/0013-8746(2003)096[0433:TRCOTG]2.0.CO;2; Wilcox TP, 1997, MOL PHYLOGENET EVOL, V7, P208, DOI 10.1006/mpev.1996.0388; Wild AL, 2005, ZOOTAXA, P1; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032	81	30	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15363	10.1371/journal.pone.0015363	http://dx.doi.org/10.1371/journal.pone.0015363			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203529	gold, Green Published, Green Submitted			2022-12-27	WOS:000285578000032
J	Timmermann, B; Kerick, M; Roehr, C; Fischer, A; Isau, M; Boerno, ST; Wunderlich, A; Barmeyer, C; Seemann, P; Koenig, J; Lappe, M; Kuss, AW; Garshasbi, M; Bertram, L; Trappe, K; Werber, M; Herrmann, BG; Zatloukal, K; Lehrach, H; Schweiger, MR				Timmermann, Bernd; Kerick, Martin; Roehr, Christina; Fischer, Axel; Isau, Melanie; Boerno, Stefan T.; Wunderlich, Andrea; Barmeyer, Christian; Seemann, Petra; Koenig, Jana; Lappe, Michael; Kuss, Andreas W.; Garshasbi, Masoud; Bertram, Lars; Trappe, Kathrin; Werber, Martin; Herrmann, Bernhard G.; Zatloukal, Kurt; Lehrach, Hans; Schweiger, Michal R.			Somatic Mutation Profiles of MSI and MSS Colorectal Cancer Identified by Whole Exome Next Generation Sequencing and Bioinformatics Analysis	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; MICROSATELLITE INSTABILITY; JUVENILE POLYPOSIS; COLON-CANCER; HUMAN BREAST; GENE; GENOME; RESOURCES; GERMLINE; PATHWAYS	Background: Colorectal cancer (CRC) is with approximately 1 million cases the third most common cancer worldwide. Extensive research is ongoing to decipher the underlying genetic patterns with the hope to improve early cancer diagnosis and treatment. In this direction, the recent progress in next generation sequencing technologies has revolutionized the field of cancer genomics. However, one caveat of these studies remains the large amount of genetic variations identified and their interpretation. Methodology/Principal Findings: Here we present the first work on whole exome NGS of primary colon cancers. We performed 454 whole exome pyrosequencing of tumor as well as adjacent not affected normal colonic tissue from microsatellite stable (MSS) and microsatellite instable (MSI) colon cancer patients and identified more than 50,000 small nucleotide variations for each tissue. According to predictions based on MSS and MSI pathomechanisms we identified eight times more somatic non-synonymous variations in MSI cancers than in MSS and we were able to reproduce the result in four additional CRCs. Our bioinformatics filtering approach narrowed down the rate of most significant mutations to 359 for MSI and 45 for MSS CRCs with predicted altered protein functions. In both CRCs, MSI and MSS, we found somatic mutations in the intracellular kinase domain of bone morphogenetic protein receptor 1A, BMPR1A, a gene where so far germline mutations are associated with juvenile polyposis syndrome, and show that the mutations functionally impair the protein function. Conclusions/Significance: We conclude that with deep sequencing of tumor exomes one may be able to predict the microsatellite status of CRC and in addition identify potentially clinically relevant mutations.	[Timmermann, Bernd] Max Planck Inst Mol Genet, Next Generat Sequencing Grp, Berlin, Germany; [Kerick, Martin; Roehr, Christina; Fischer, Axel; Isau, Melanie; Boerno, Stefan T.; Wunderlich, Andrea; Bertram, Lars; Trappe, Kathrin; Lehrach, Hans; Schweiger, Michal R.] Max Planck Inst Mol Genet, Dept Vertebrate Genom, Berlin, Germany; [Roehr, Christina; Isau, Melanie; Boerno, Stefan T.; Wunderlich, Andrea] Free Univ Berlin, Dept Biol Chem & Pharm, D-1000 Berlin, Germany; [Barmeyer, Christian] Charite, Dept Gastroenterol, D-13353 Berlin, Germany; [Seemann, Petra; Koenig, Jana] Charite, Berlin Brandenburg Ctr Regenerat Therapies BCRT, D-13353 Berlin, Germany; [Lappe, Michael] Max Planck Inst Mol Genet, Otto Warburg Lab, Berlin, Germany; [Kuss, Andreas W.; Garshasbi, Masoud] Max Planck Inst Mol Genet, Dept Human Mol Genet, Berlin, Germany; [Kuss, Andreas W.] Ernst Moritz Arndt Univ Greifswald, Inst Human Genet, Greifswald, Germany; [Werber, Martin; Herrmann, Bernhard G.] Max Planck Inst Mol Genet, Dept Dev Genet, Berlin, Germany; [Zatloukal, Kurt] Med Univ, Dept Pathol, Graz, Austria	Max Planck Society; Max Planck Society; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Max Planck Society; Ernst Moritz Arndt Universitat Greifswald; Max Planck Society; Medical University of Graz	Timmermann, B (corresponding author), Max Planck Inst Mol Genet, Next Generat Sequencing Grp, Berlin, Germany.	mschweig@molgen.mpg.de	Bertram, Lars/K-3889-2015; Seemann, Petra/G-3606-2011; Kerick, Martin/AAD-8303-2022; Schweiger, Michal R/H-5270-2015	Bertram, Lars/0000-0002-0108-124X; Seemann, Petra/0000-0002-6056-6669; Schweiger, Michal R/0000-0002-4672-0623; Fischer, Axel/0000-0001-6130-6984; Kuss, Andreas/0000-0002-9401-4627; Garshasbi, Masoud/0000-0002-5508-7903; Kerick, Martin/0000-0002-6298-4514	German Federal Ministry of Education and Research [01GS08105, 01GS08111]; Max Planck Society	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck Society)	This work was supported by the German Federal Ministry of Education and Research (01GS08105 "Mutanom," 01GS08111 "Intestinal Modifers") and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bodmer WF, 2006, J HUM GENET, V51, P391, DOI 10.1007/s10038-006-0373-x; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; DEGRASSI A, PLOS BIOL, V8; Fallik D, 2003, CANCER RES, V63, P5738; Goel A, 2007, GASTROENTEROLOGY, V132, P127, DOI 10.1053/j.gastro.2006.09.018; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Hampf M, 2006, ANAL BIOCHEM, V356, P94, DOI 10.1016/j.ab.2006.04.046; Hedges D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008232; Howe JR, 2004, J MED GENET, V41, P484, DOI 10.1136/jmg.2004.018598; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Lipkin SM, 2001, HUM MUTAT, V17, P389, DOI 10.1002/humu.1114; Lynch HT, 2009, CLIN GENET, V76, P1, DOI 10.1111/j.1399-0004.2009.01230.x; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; PEINADO MA, 1992, P NATL ACAD SCI USA, V89, P10065, DOI 10.1073/pnas.89.21.10065; Pieper U, 2004, NUCLEIC ACIDS RES, V32, pD217, DOI 10.1093/nar/gkh095; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Schweiger MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005548; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stiller M, 2009, GENOME RES, V19, P1843, DOI 10.1101/gr.095760.109; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	39	161	167	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15661	10.1371/journal.pone.0015661	http://dx.doi.org/10.1371/journal.pone.0015661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203531	Green Published, Green Submitted, gold			2022-12-27	WOS:000285578000042
J	Leroy, Q; Lebrigand, K; Armougom, F; Barbry, P; Thiery, R; Raoult, D				Leroy, Quentin; Lebrigand, Kevin; Armougom, Fabrice; Barbry, Pascal; Thiery, Richard; Raoult, Didier			Coxiella burnetii Transcriptional Analysis Reveals Serendipity Clusters of Regulation in Intracellular Bacteria	PLOS ONE			English	Article							TROPHERYMA-WHIPPLEI; STRINGENT RESPONSE; GENOME SEQUENCE; GENE-EXPRESSION; CELL-DIVISION; RNA; PROTEINS; PPGPP; MICROARRAY; STARVATION	Coxiella burnetii, the causative agent of the zoonotic disease Q fever, is mainly transmitted to humans through an aerosol route. A spore-like form allows C. burnetii to resist different environmental conditions. Because of this, analysis of the survival strategies used by this bacterium to adapt to new environmental conditions is critical for our understanding of C. burnetii pathogenicity. Here, we report the early transcriptional response of C. burnetii under temperature stresses. Our data show that C. burnetii exhibited minor changes in gene regulation under short exposure to heat or cold shock. While small differences were observed, C. burnetii seemed to respond similarly to cold and heat shock. The expression profiles obtained using microarrays produced in-house were confirmed by quantitative RT-PCR. Under temperature stresses, 190 genes were differentially expressed in at least one condition, with a fold change of up to 4. Globally, the differentially expressed genes in C. burnetii were associated with bacterial division, (p) ppGpp synthesis, wall and membrane biogenesis and, especially, lipopolysaccharide and peptidoglycan synthesis. These findings could be associated with growth arrest and witnessed transformation of the bacteria to a spore-like form. Unexpectedly, clusters of neighboring genes were differentially expressed. These clusters do not belong to operons or genetic networks; they have no evident associated functions and are not under the control of the same promoters. We also found undescribed but comparable clusters of regulation in previously reported transcriptomic analyses of intracellular bacteria, including Rickettsia sp. and Listeria monocytogenes. The transcriptomic patterns of C. burnetii observed under temperature stresses permits the recognition of unpredicted clusters of regulation for which the trigger mechanism remains unidentified but which may be the result of a new mechanism of epigenetic regulation.	[Leroy, Quentin; Armougom, Fabrice; Raoult, Didier] Univ Mediterranee, Fac Med, CNRS IRD, Unite Rech Malad Infect & Trop Emergentes,UMR 623, Marseille, France; [Lebrigand, Kevin; Barbry, Pascal] CNRS UNSA, UMR 6079, IPMC, Sophia Antipolis, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Cote d'Azur	Leroy, Q (corresponding author), Univ Mediterranee, Fac Med, CNRS IRD, Unite Rech Malad Infect & Trop Emergentes,UMR 623, Marseille, France.	didier.raoult@gmail.com	RAOULT, Didier/A-8434-2008; Barbry, Pascal/O-5021-2016; Thiery, Richard/GRR-1496-2022	RAOULT, Didier/0000-0002-0633-5974; Barbry, Pascal/0000-0001-9632-6483; Thiery, Richard/0000-0003-2049-918X	Agence National pour la Recherche, France [ANR-06-PNRA-031]	Agence National pour la Recherche, France(French National Research Agency (ANR))	This work was supported by a grant from the Agence National pour la Recherche, France (contract number: ANR-06-PNRA-031; VIACOX project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFSETH G, 1995, J BACTERIOL, V177, P2946, DOI 10.1128/jb.177.10.2946-2949.1995; Albrecht M, 2010, NUCLEIC ACIDS RES, V38, P868, DOI 10.1093/nar/gkp1032; AMANO KI, 1984, J BACTERIOL, V160, P982, DOI 10.1128/JB.160.3.982-988.1984; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Audia JP, 2008, APPL ENVIRON MICROB, V74, P7809, DOI 10.1128/AEM.00896-08; Beare PA, 2009, J BACTERIOL, V191, P1369, DOI 10.1128/JB.01580-08; Beare PA, 2009, INFECT IMMUN, V77, P642, DOI 10.1128/IAI.01141-08; Bechah Y, 2010, GENOME RES, V20, P655, DOI 10.1101/gr.103564.109; Bendezu FO, 2008, J BACTERIOL, V190, P1792, DOI 10.1128/JB.01322-07; Bouvier M, 2008, MOL CELL, V32, P827, DOI 10.1016/j.molcel.2008.10.027; Chatterji D, 2001, CURR OPIN MICROBIOL, V4, P160, DOI 10.1016/S1369-5274(00)00182-X; Chatterji D, 2007, FEMS MICROBIOL LETT, V267, P51, DOI 10.1111/j.1574-6968.2006.00532.x; Crapoulet N, 2006, J BACTERIOL, V188, P5228, DOI 10.1128/JB.00507-06; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Dambach MD, 2009, CURR OPIN MICROBIOL, V12, P161, DOI 10.1016/j.mib.2009.01.012; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Dreher-Lesnick SM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-61; Edgar R, 2006, MOL MICROBIOL, V59, P276, DOI 10.1111/j.1365-2958.2005.04933.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellison DW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005612; Faucher SP, 2010, P NATL ACAD SCI USA, V107, P7533, DOI 10.1073/pnas.0911764107; Feucht A, 2005, MICROBIOL-SGM, V151, P2053, DOI 10.1099/mic.0.27899-0; Frohlich KS, 2009, CURR OPIN MICROBIOL, V12, P674, DOI 10.1016/j.mib.2009.09.009; HACKSTADT T, 1985, INFECT IMMUN, V48, P359, DOI 10.1128/IAI.48.2.359-365.1985; Heinzen RA, 1999, TRENDS MICROBIOL, V7, P149, DOI 10.1016/S0966-842X(99)01475-4; Henkin TM, 2008, GENE DEV, V22, P3383, DOI 10.1101/gad.1747308; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Klinkert B, 2009, CELL MOL LIFE SCI, V66, P2661, DOI 10.1007/s00018-009-0041-3; La MV, 2008, FEMS MICROBIOL REV, V32, P440, DOI 10.1111/j.1574-6976.2008.00103.x; La MV, 2007, J MICROBIOL METH, V71, P292, DOI 10.1016/j.mimet.2007.09.017; La MV, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-349; Leroy Q, 2010, J MICROBIOL METH, V81, P81, DOI 10.1016/j.mimet.2010.02.008; Martinez-Nunez MA, 2010, MICROBIOL-SGM, V156, P14, DOI 10.1099/mic.0.033266-0; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; MCCAUL TF, 1981, J BACTERIOL, V147, P1063, DOI 10.1128/JB.147.3.1063-1076.1981; OGASAWARA N, 1992, MOL MICROBIOL, V6, P629, DOI 10.1111/j.1365-2958.1992.tb01510.x; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Raghavan R, 2007, J BACTERIOL, V189, P6572, DOI 10.1128/JB.00812-07; Raoult D, 2003, GENOME RES, V13, P1800, DOI 10.1101/gr.1474603; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Renesto P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003681; Rouillard JM, 2003, NUCLEIC ACIDS RES, V31, P3057, DOI 10.1093/nar/gkg426; Rouillard JM, 2002, BIOINFORMATICS, V18, P486, DOI 10.1093/bioinformatics/18.3.486; Saito M, 2008, BIOSCI BIOTECH BIOCH, V72, P1394, DOI 10.1271/bbb.80093; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Traxler MF, 2008, MOL MICROBIOL, V68, P1128, DOI 10.1111/j.1365-2958.2008.06229.x; Varma A, 2009, J BACTERIOL, V191, P3526, DOI 10.1128/JB.01812-08; Weber Michael H. W., 2003, Science Progress, V86, P9, DOI 10.3184/003685003783238707; Weiss DS, 2004, MOL MICROBIOL, V54, P588, DOI 10.1111/j.1365-2958.2004.04283.x; WIEBE ME, 1972, J BACTERIOL, V110, P368, DOI 10.1128/JB.110.1.368-377.1972; Yim L, 2006, NUCLEIC ACIDS RES, V34, P5892, DOI 10.1093/nar/gkl752; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	59	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15321	10.1371/journal.pone.0015321	http://dx.doi.org/10.1371/journal.pone.0015321			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203564	Green Published, Green Submitted, gold			2022-12-27	WOS:000285576900027
J	Purdy, MA; Khudyakov, YE				Purdy, Michael A.; Khudyakov, Yury E.			Evolutionary History and Population Dynamics of Hepatitis E Virus	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; UNITED-STATES; BLOOD-DONORS; PIG LIVERS; INFECTION; HEV; PREVALENCE; TIME; IDENTIFICATION; EPIDEMIOLOGY	Background: Hepatitis E virus (HEV) is an enterically transmitted hepatropic virus. It segregates as four genotypes. All genotypes infect humans while only genotypes 3 and 4 also infect several animal species. It has been suggested that hepatitis E is zoonotic, but no study has analyzed the evolutionary history of HEV. We present here an analysis of the evolutionary history of HEV. Methods and Findings: The times to the most recent common ancestors for all four genotypes of HEV were calculated using BEAST to conduct a Bayesian analysis of HEV. The population dynamics for genotypes 1, 3 and 4 were analyzed using skyline plots. Bayesian analysis showed that the most recent common ancestor for modern HEV existed between 536 and 1344 years ago. The progenitor of HEV appears to have given rise to anthropotropic and enzootic forms of HEV, which evolved into genotypes 1 and 2 and genotypes 3 and 4, respectively. Population dynamics suggest that genotypes 1, 3 and 4 experienced a population expansion during the 20(th) century. Genotype 1 has increased in infected population size,3035 years ago. Genotype 3 and 4 have experienced an increase in population size starting late in the 19(th) century until ca. 1940-45, with genotype 3 having undergone additional rapid expansion until ca. 1960. The effective population size for both genotype 3 and 4 rapidly declined to pre-expansion levels starting in ca. 1990. Genotype 4 was further examined as Chinese and Japanese sequences, which exhibited different population dynamics, suggesting that this genotype experienced different evolutionary history in these two countries. Conclusions: HEV appears to have evolved through a series of steps, in which the ancestors of HEV may have adapted to a succession of animal hosts leading to humans. Analysis of the population dynamics of HEV suggests a substantial temporal variation in the rate of transmission among HEV genotypes in different geographic regions late in the 20(th) Century.	[Purdy, Michael A.; Khudyakov, Yury E.] Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Purdy, MA (corresponding author), Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA 30333 USA.	mup3@cdc.gov						Albarella U, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P209; Bilic L, 2009, J GEN VIROL, V90, P863, DOI 10.1099/vir.0.007179-0; Bouwknegt M, 2007, J FOOD PROTECT, V70, P2889, DOI 10.4315/0362-028X-70.12.2889; Bradley DW, 1993, VIRAL HEPATITIS SCI, P379; Christensen PB, 2008, CLIN INFECT DIS, V47, P1026, DOI 10.1086/591970; Cooper K, 2005, J CLIN MICROBIOL, V43, P1684, DOI 10.1128/JCM.43.4.1684-1688.2005; Dalton HR, 2008, LANCET INFECT DIS, V8, P698, DOI 10.1016/S1473-3099(08)70255-X; Davis K, 1955, AM J SOCIOL, V60, P429, DOI 10.1086/221602; DONOGHUE HD, 2007, P 6 WORLD C MUMM STU; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; EMERSON SU, 2004, VIRUS TAXONOMY, P853; Feagins AR, 2007, J GEN VIROL, V88, P912, DOI 10.1099/vir.0.82613-0; Holmes EC, 2007, CURR TOP MICROBIOL, V315, P51; Holmes EC, 2003, J VIROL, V77, P3893, DOI 10.1128/JVI.77.7.3893-3897.2003; Huang FF, 2004, J GEN VIROL, V85, P1609, DOI 10.1099/vir.0.79841-0; Ijaz S, 2009, J CLIN VIROL, V44, P272, DOI 10.1016/j.jcv.2009.01.005; Johne R, 2010, J GEN VIROL, V91, P750, DOI 10.1099/vir.0.016584-0; Kulkarni MA, 2008, J MED VIROL, V80, P1387, DOI 10.1002/jmv.21220; Kuniholm MH, 2009, J INFECT DIS, V200, P48, DOI 10.1086/599319; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lemma E, 2008, FEMS MICROBIOL LETT, V283, P54, DOI 10.1111/j.1574-6968.2008.01150.x; Meng XJ, 1998, ARCH VIROL, V143, P1405, DOI 10.1007/s007050050384; Meng XJ, 2002, J CLIN MICROBIOL, V40, P117, DOI 10.1128/JCM.40.1.117-122.2002; Moratorio G, 2007, J GEN VIROL, V88, P3039, DOI 10.1099/vir.0.83038-0; Morrison DA, 2006, AUST SYST BOT, V19, P479, DOI 10.1071/SB06020; Mushahwar IK, 2008, J MED VIROL, V80, P646, DOI 10.1002/jmv.21116; NEWTON MA, 1994, J R STAT SOC B, V56, P3; Okamoto H, 2007, VIRUS RES, V127, P216, DOI 10.1016/j.virusres.2007.02.002; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rambaut A., 2009, FIGTREE; Reuter G, 2009, J CLIN VIROL, V44, P277, DOI 10.1016/j.jcv.2009.01.008; Sonoda H, 2004, J CLIN MICROBIOL, V42, P5371, DOI 10.1128/JCM.42.11.5371-5374.2004; Subramanian S, 2009, TRENDS GENET, V25, P482, DOI 10.1016/j.tig.2009.09.005; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Takahashi K, 2004, HEPATOL RES, V29, P212, DOI 10.1016/j.hepres.2004.04.004; Tanaka Y, 2006, J GEN VIROL, V87, P949, DOI 10.1099/vir.0.81661-0; Teo CG, 2006, CURR OPIN INFECT DIS, V19, P460, DOI 10.1097/01.qco.0000244052.61629.49; Zhang W, 2008, ZOONOSES PUBLIC HLTH, V55, P291, DOI 10.1111/j.1863-2378.2008.01136.x; Zhao CY, 2009, J MED VIROL, V81, P1371, DOI 10.1002/jmv.21536	42	85	86	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e14376	10.1371/journal.pone.0014376	http://dx.doi.org/10.1371/journal.pone.0014376			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21203540	Green Published, gold			2022-12-27	WOS:000285572900009
J	Ng, CA; Hunter, MJ; Perry, MD; Mobli, M; Ke, Y; Kuchel, PW; King, GF; Stock, D; Vandenberg, JI				Ng, Chai Ann; Hunter, Mark J.; Perry, Matthew D.; Mobli, Mehdi; Ke, Ying; Kuchel, Philip W.; King, Glenn F.; Stock, Daniela; Vandenberg, Jamie I.			The N-Terminal Tail of hERG Contains an Amphipathic alpha-Helix That Regulates Channel Deactivation	PLOS ONE			English	Article							K+ CHANNELS; POTASSIUM CHANNEL; CARDIAC-ARRHYTHMIA; MOLECULAR-BASIS; PAS DOMAIN; MUTATIONS; FAMILY	The cytoplasmic N-terminal domain of the human ether-a-go-go related gene (hERG) K+ channel is critical for the slow deactivation kinetics of the channel. However, the mechanism(s) by which the N-terminal domain regulates deactivation remains to be determined. Here we show that the solution NMR structure of the N-terminal 135 residues of hERG contains a previously described Per-Arnt-Sim (PAS) domain (residues 26-135) as well as an amphipathic alpha-helix (residues 13-23) and an initial unstructured segment (residues 2-9). Deletion of residues 2-25, only the unstructured segment (residues 2-9) or replacement of the alpha-helix with a flexible linker all result in enhanced rates of deactivation. Thus, both the initial flexible segment and the alpha-helix are required but neither is sufficient to confer slow deactivation kinetics. Alanine scanning mutagenesis identified R5 and G6 in the initial flexible segment as critical for slow deactivation. Alanine mutants in the helical region had less dramatic phenotypes. We propose that the PAS domain is bound close to the central core of the channel and that the N-terminal alpha-helix ensures that the flexible tail is correctly orientated for interaction with the activation gating machinery to stabilize the open state of the channel.	[Ng, Chai Ann; Hunter, Mark J.; Perry, Matthew D.; Ke, Ying; Vandenberg, Jamie I.] Victor Chang Cardiac Res Inst, Mol Cardiol & Biophys Div, Darlinghurst, NSW, Australia; [Ng, Chai Ann; Kuchel, Philip W.; Vandenberg, Jamie I.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Mobli, Mehdi; King, Glenn F.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Stock, Daniela] Victor Chang Cardiac Res Inst, Struct & Computat Biol Div, Darlinghurst, NSW, Australia; [Stock, Daniela; Vandenberg, Jamie I.] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW, Australia	Victor Chang Cardiac Research Institute; University of Sydney; University of Queensland; Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Ng, CA (corresponding author), Victor Chang Cardiac Res Inst, Mol Cardiol & Biophys Div, Darlinghurst, NSW, Australia.	j.vandenberg@victorchang.edu.au	Mobli, Mehdi/O-7244-2014; Vandenberg, Jamie I/B-6608-2013; King, Glenn F/J-5059-2012	Mobli, Mehdi/0000-0003-2420-4262; Vandenberg, Jamie I/0000-0002-3859-3716; King, Glenn F/0000-0002-2308-2200; Kuchel, Philip/0000-0003-4100-7332; Ng, Chai Ann/0000-0002-3120-5450	Australian Research Council [DP0986316]; National Health & Medical Research Council [459401]; National Heart Foundation of Australia [G09S-450]	Australian Research Council(Australian Research Council); National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia)	This work was funded by grants from the Australian Research Council (DP0986316; http://www.arc.gov.au/), the National Health & Medical Research Council (459401; http://www.nhmrc.gov.au/), National Heart Foundation of Australia (G09S-450; www.heartfoundation.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhavan A, 2005, J CELL SCI, V118, P2803, DOI 10.1242/jcs.02423; Al-Owais M, 2009, EUR BIOPHYS J BIOPHY, V38, P569, DOI 10.1007/s00249-009-0408-2; [Anonymous], 2008, AMBER 10; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clarke CE, 2006, J PHYSIOL-LONDON, V573, P291, DOI 10.1113/jphysiol.2006.108332; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Guntert Peter, 2004, Methods Mol Biol, V278, P353; GUSTINA A, 2009, P NATL ACAD SCI US; Kolbe K, 2010, J PHYSIOL-LONDON, V588, P2999, DOI 10.1113/jphysiol.2010.192468; LI Q, 2010, BIOCH BIOPHYS RES CO; Mobli M, 2008, CONCEPT MAGN RESON A, V32A, P436, DOI 10.1002/cmr.a.20126; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Muskett F.W., 2010, J BIOL CHEM; Pandini A, 2005, PROTEIN ENG DES SEL, V18, P127, DOI 10.1093/protein/gzi017; Perrin MJ, 2008, PROG BIOPHYS MOL BIO, V98, P137, DOI 10.1016/j.pbiomolbio.2008.10.006; Ponting CP, 1997, CURR BIOL, V7, pR674, DOI 10.1016/S0960-9822(06)00352-6; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SCHONHERR R, 1996, J PHYSL; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Van Slyke AC, 2010, BIOPHYS J, V99, P2841, DOI 10.1016/j.bpj.2010.08.030; Vandenberg JI, 2004, EUR BIOPHYS J BIOPHY, V33, P89, DOI 10.1007/s00249-003-0338-3; Vandenberg JI, 2001, TRENDS PHARMACOL SCI, V22, P240, DOI 10.1016/S0165-6147(00)01662-X; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Wang JL, 2000, J GEN PHYSIOL, V115, P749, DOI 10.1085/jgp.115.6.749	30	69	69	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16191	10.1371/journal.pone.0016191	http://dx.doi.org/10.1371/journal.pone.0016191			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249148	Green Submitted, gold, Green Published			2022-12-27	WOS:000286515000031
J	Kenney, J; Aravantinou, M; Singer, R; Hsu, M; Rodriguez, A; Kizima, L; Abraham, CJ; Menon, R; Seidor, S; Chudolij, A; Gettie, A; Blanchard, J; Lifson, JD; Piatak, M; Fernandez-Romero, JA; Zydowsky, TM; Robbiani, M				Kenney, Jessica; Aravantinou, Meropi; Singer, Rachel; Hsu, Mayla; Rodriguez, Aixa; Kizima, Larisa; Abraham, Ciby J.; Menon, Radhika; Seidor, Samantha; Chudolij, Anne; Gettie, Agegnehu; Blanchard, James; Lifson, Jeffrey D.; Piatak, Michael, Jr.; Fernandez-Romero, Jose A.; Zydowsky, Thomas M.; Robbiani, Melissa			An Antiretroviral/Zinc Combination Gel Provides 24 Hours of Complete Protection against Vaginal SHIV Infection in Macaques	PLOS ONE			English	Article							SIMIAN-IMMUNODEFICIENCY-VIRUS; REVERSE-TRANSCRIPTASE INHIBITORS; PLACEBO-CONTROLLED TRIAL; RHESUS MACAQUES; INTRAVAGINAL INOCULATION; DENDRITIC CELLS; VIRAL LOAD; TRANSIENT VIREMIA; SIV; TRANSMISSION	Background: Repeated use, coitus-independent microbicide gels that do not contain antiretroviral agents also used as first line HIV therapy are urgently needed to curb HIV spread. Current formulations require high doses (millimolar range) of antiretroviral drugs and typically only provide short-term protection in macaques. We used the macaque model to test the efficacy of a novel combination microbicide gel containing zinc acetate and micromolar doses of the novel non-nucleoside reverse transcriptase inhibitor MIV-150 for up to 24 h after repeated gel application. Methods and Findings: Rhesus macaques were vaginally challenged with SHIV-RT up to 24 h after repeated administration of microbicide versus placebo gels. Infection status was determined by measuring virologic and immunologic parameters. Combination microbicide gels containing 14 mM zinc acetate dihydrate and 50 mM MIV-150 afforded full protection (21 of 21 animals) for up to 24 h after 2 weeks of daily application. Partial protection was achieved with the MIV-150 gel (56% of control at 8 h after last application, 11% at 24 h), while the zinc acetate gel afforded more pronounced protection (67% at 8-24 h). Marked protection persisted when the zinc acetate or MIV-150/zinc acetate gels were applied every other day for 4 weeks prior to challenge 24 h after the last gel was administered (11 of 14 protected). More MIV-150 was associated with cervical tissue 8 h after daily dosing of MIV-150/zinc acetate versus MIV-150, while comparable MIV-150 levels were associated with vaginal tissues and at 24 h. Conclusions: A combination MIV-150/zinc acetate gel and a zinc acetate gel provide significant protection against SHIV-RT infection for up to 24 h. This represents a novel advancement, identifying microbicides that do not contain anti-viral agents used to treat HIV infection and which can be used repeatedly and independently of coitus, and underscores the need for future clinical testing of their safety and ability to prevent HIV transmission in humans.	[Kenney, Jessica; Aravantinou, Meropi; Singer, Rachel; Hsu, Mayla; Rodriguez, Aixa; Kizima, Larisa; Abraham, Ciby J.; Menon, Radhika; Seidor, Samantha; Chudolij, Anne; Fernandez-Romero, Jose A.; Zydowsky, Thomas M.; Robbiani, Melissa] Populat Council, New York, NY 10021 USA; [Gettie, Agegnehu] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA; [Blanchard, James] Tulane Univ, Tulane Natl Primate Res Ctr, Covington, LA USA; [Lifson, Jeffrey D.; Piatak, Michael, Jr.] NCI, AIDS & Canc Virus Program, SAIC Frederick, Frederick, MD 21701 USA	Population Council; Rockefeller University; Tulane University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Kenney, J (corresponding author), Populat Council, 1230 York Ave, New York, NY 10021 USA.	mrobbiani@popcouncil.org			National Institutes of Health (NIH) [U19 AI065412, RR00164]; United States Agency for International Development (USAID) [GPO-A-00-04-00019-00]; Swedish Ministry of Foreign Affairs; Swedish International Development Cooperation Agency; National Cancer Institute, NIH [HHSN261200800001E]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI065412] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Swedish Ministry of Foreign Affairs; Swedish International Development Cooperation Agency; National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (NIH) grant U19 AI065412, the United States Agency for International Development (USAID) Cooperative Agreement GPO-A-00-04-00019-00, the Swedish Ministry of Foreign Affairs, the Swedish International Development Cooperation Agency, the NIH base grant RR00164, and in part, with federal funds from the National Cancer Institute, NIH, under contract HHSN261200800001E. This research is made possible by the generous support of the American people through the USAID. The contents of this manuscript are the sole responsibility of the Population Council and do not necessarily reflect the views of USAID or the United States government. MR is a 2002 Elizabeth Glaser Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002230; Arens M, 2000, J CLIN MICROBIOL, V38, P1758, DOI 10.1128/JCM.38.5.1758-1762.2000; Bacci A, 2002, J IMMUNOL, V168, P2904, DOI 10.4049/jimmunol.168.6.2904; Butler DM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000447; Cline AN, 2005, J MED PRIMATOL, V34, P303; Cranage M, 2008, PLOS MED, V5, P1238, DOI 10.1371/journal.pmed.0050157; Crostarosa F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008060; Cummins JE, 2007, ANTIMICROB AGENTS CH, V51, P1770, DOI 10.1128/AAC.01129-06; Fernandez-Romero JA, 2007, SEX TRANSM DIS, V34, P9, DOI 10.1097/01.olq.0000223287.46097.4b; Ford N, 2010, CURR OPIN HIV AIDS, V5, P38, DOI 10.1097/COH.0b013e3283339b41; Foss AM, 2003, AIDS, V17, P1227, DOI 10.1097/00002030-200305230-00015; Frank I, 2008, J VIROL, V82, P5329, DOI 10.1128/JVI.01987-07; Frank I, 2002, J VIROL, V76, P2936, DOI 10.1128/JVI.76.6.2936-2951.2002; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gupta P, 1997, J VIROL, V71, P6271, DOI 10.1128/JVI.71.8.6271-6275.1997; HAASE AT, NATURE, V464, P217; Halfon P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010569; Halvas EK, 2010, J INFECT DIS, V201, P672, DOI 10.1086/650542; Haraguchi Y, 1999, ANTIVIR RES, V43, P123, DOI 10.1016/S0166-3542(99)00040-6; Hirano T, 2008, ADV IMMUNOL, V97, P149, DOI 10.1016/S0065-2776(08)00003-5; Hoare A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010981; Kapiga SH, 2007, J INFECT DIS, V195, P1260, DOI 10.1086/513566; Karim QA, 2010, SCI EXPRESS; Kilmarx PH, 2008, SEX TRANSM DIS, V35, P226, DOI 10.1097/OLQ.0b013e31815d6e0d; Kilmarx PH, 2006, JAIDS-J ACQ IMM DEF, V43, P327, DOI 10.1097/01.qai.0000243056.59860.c1; Kim EY, 2005, J VIROL, V79, P4886, DOI 10.1128/JVI.79.8.4886-4895.2005; KUMAR N, 1990, J STEROID BIOCHEM, V37, P587, DOI 10.1016/0960-0760(90)90405-A; KUMEL G, 1990, J GEN VIROL, V71, P2989, DOI 10.1099/0022-1317-71-12-2989; Lederman MM, 2004, SCIENCE, V306, P485, DOI 10.1126/science.1099288; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Lifson JD, 2001, J VIROL, V75, P10187, DOI 10.1128/JVI.75.21.10187-10199.2001; Llibre JM, 2010, CLIN INFECT DIS, V50, P872, DOI 10.1086/650732; Ma ZM, 2004, J VIROL, V78, P14048, DOI 10.1128/JVI.78.24.14048-14052.2004; Maguire RA, 2001, SEX TRANSM DIS, V28, P259, DOI 10.1097/00007435-200105000-00003; Martin S, 2010, J WOMENS HEALTH, V19, P1; Marx PA, 1996, NAT MED, V2, P1084, DOI 10.1038/nm1096-1084; McChesney MB, 1998, J VIROL, V72, P10029, DOI 10.1128/JVI.72.12.10029-10035.1998; McLean CA, 2010, AIDS, V24, P717, DOI 10.1097/QAD.0b013e328333bf89; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; MILLER CJ, 1994, J VIROL, V68, P6391, DOI 10.1128/JVI.68.10.6391-6400.1994; Nuttall JP, 2008, ANTIMICROB AGENTS CH, V52, P909, DOI 10.1128/AAC.00330-07; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Pasquier C, 2009, J CLIN MICROBIOL, V47, P2883, DOI 10.1128/JCM.02131-08; Patton DL, 2007, ANTIMICROB AGENTS CH, V51, P1608, DOI 10.1128/AAC.00984-06; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Smith SM, 1999, AIDS RES HUM RETROV, V15, P1691, DOI 10.1089/088922299309739; Soderberg K, 2002, J VIROL, V76, P5803, DOI 10.1128/JVI.76.11.5803-5806.2002; Turville SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003162; UBERLA K, 1995, P NATL ACAD SCI USA, V92, P8210, DOI 10.1073/pnas.92.18.8210; Veazey RS, 2008, P NATL ACAD SCI USA, V105, P10531, DOI 10.1073/pnas.0802666105; Veazey RS, 2008, CURR OPIN HIV AIDS, V3, P567, DOI 10.1097/COH.0b013e32830891bb; Veazey RS, 2009, J INFECT DIS, V199, P1525, DOI 10.1086/598685; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Veazey RS, 2005, NATURE, V438, P99, DOI 10.1038/nature04055; Whitehead SJ, 2006, AIDS, V20, P2141, DOI 10.1097/QAD.0b013e32801086c9; Wilkin Timothy J, 2010, Top HIV Med, V18, P66; Zhu TF, 2004, VIROLOGY, V323, P208, DOI 10.1016/j.virol.2004.03.004	57	74	74	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15835	10.1371/journal.pone.0015835	http://dx.doi.org/10.1371/journal.pone.0015835			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246052	Green Submitted, Green Published, gold			2022-12-27	WOS:000286511200018
J	Tse, JR; Engler, AJ				Tse, Justin R.; Engler, Adam J.			Stiffness Gradients Mimicking In Vivo Tissue Variation Regulate Mesenchymal Stem Cell Fate	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; RIGIDITY; MIGRATION; ADHESION; FIBRONECTIN; FIBROBLASTS; MECHANICS; DUROTAXIS; MOVEMENT; FORCES	Mesenchymal stem cell (MSC) differentiation is regulated in part by tissue stiffness, yet MSCs can often encounter stiffness gradients within tissues caused by pathological, e.g., myocardial infarction similar to 8.7 +/- 1.5 kPa/mm, or normal tissue variation, e.g., myocardium similar to 0.6 +/- 0.9 kPa/mm; since migration predominantly occurs through physiological rather than pathological gradients, it is not clear whether MSC differentiate or migrate first. MSCs cultured up to 21 days on a hydrogel containing a physiological gradient of 1.0 +/- 0.1 kPa/mm undergo directed migration, or durotaxis, up stiffness gradients rather than remain stationary. Temporal assessment of morphology and differentiation markers indicates that MSCs migrate to stiffer matrix and then differentiate into a more contractile myogenic phenotype. In those cells migrating from soft to stiff regions however, phenotype is not completely determined by the stiff hydrogel as some cells retain expression of a neural marker. These data may indicate that stiffness variation, not just stiffness alone, can be an important regulator of MSC behavior.	[Tse, Justin R.; Engler, Adam J.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Tse, JR (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	aengler@ucsd.edu		Tse, Justin/0000-0003-2408-3763	National Institutes of Health [1DP02OD006460]; American Heart Association [0865150F]; National Science Foundation [0754718]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006460] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (1DP02OD006460), American Heart Association (0865150F), and National Science Foundation (0754718). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badylak Stephen F., 2005, Anatomical Record Part B:The New Anatomist, V287, P36, DOI 10.1002/ar.b.20081; Berry MF, 2006, AM J PHYSIOL-HEART C, V290, pH2196, DOI 10.1152/ajpheart.01017.2005; Burdick JA, 2004, LANGMUIR, V20, P5153, DOI 10.1021/la049298n; Chamberlain G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002934; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Domke J, 1998, LANGMUIR, V14, P3320, DOI 10.1021/la9713006; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2009, J CELL SCI, V122, P1647, DOI 10.1242/jcs.040824; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007; Gray DS, 2003, J BIOMED MATER RES A, V66A, P605, DOI 10.1002/jbm.a.10585; Guilak F, 2000, BIORHEOLOGY, V37, P27; Hadjipanayi E, 2009, CELL MOTIL CYTOSKEL, V66, P121, DOI 10.1002/cm.20331; Hay E.D., 1991, CELL BIOL EXTRACELLU, DOI 10.1007/978-1-4615-3770-0; Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Isenberg BC, 2009, BIOPHYS J, V97, P1313, DOI 10.1016/j.bpj.2009.06.021; Jacot JG, 2008, BIOPHYS J, V95, P3479, DOI 10.1529/biophysj.107.124545; Jiang GY, 2006, BIOPHYS J, V90, P1804, DOI 10.1529/biophysj.105.072462; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kloxin AM, 2010, BIOMATERIALS, V31, P1, DOI 10.1016/j.biomaterials.2009.09.025; Kong HJ, 2005, P NATL ACAD SCI USA, V102, P4300, DOI 10.1073/pnas.0405873102; Lazopoulos KA, 2008, J BIOMECH, V41, P1289, DOI 10.1016/j.jbiomech.2008.01.008; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lynch HA, 2003, J BIOMECH ENG-T ASME, V125, P726, DOI 10.1115/1.1614819; Marklein RA, 2010, SOFT MATTER, V6, P136, DOI 10.1039/b916933d; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Provenzano PP, 2008, BIOPHYS J, V95, P5374, DOI 10.1529/biophysj.108.133116; Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009; Rotsch C, 1999, P NATL ACAD SCI USA, V96, P921, DOI 10.1073/pnas.96.3.921; Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8; Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008; Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217; Thibault MM, 2007, STEM CELLS DEV, V16, P489, DOI 10.1089/scd.2006.0100; Tse J.R., 2010, CURR PROTOC CELL BIO, V10, pUnit, DOI [DOI 10.1002/0471143030.CB1016S47, 10.1002/0471143030.cb1016s47]; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p; Zaari N, 2004, ADV MATER, V16, P2133, DOI 10.1002/adma.200400883; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103; Zemel A, 2010, NAT PHYS, V6, P468, DOI 10.1038/NPHYS1613	44	335	347	0	152	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15978	10.1371/journal.pone.0015978	http://dx.doi.org/10.1371/journal.pone.0015978			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246050	Green Published, gold			2022-12-27	WOS:000286511200030
J	Bock, J; Fukuyo, Y; Kang, S; Phipps, ML; Alexandrov, LB; Rasmussen, KO; Bishop, AR; Rosen, ED; Martinez, JS; Chen, HT; Rodriguez, G; Alexandrov, BS; Usheva, A				Bock, Jonathan; Fukuyo, Yayoi; Kang, Sona; Phipps, M. Lisa; Alexandrov, Ludmil B.; Rasmussen, Kim O.; Bishop, Alan R.; Rosen, Evan D.; Martinez, Jennifer S.; Chen, Hou-Tong; Rodriguez, George; Alexandrov, Boian S.; Usheva, Anny			Mammalian Stem Cells Reprogramming in Response to Terahertz Radiation	PLOS ONE			English	Article							GENE-EXPRESSION; TRANSCRIPTION FACTOR; NUCLEAR RECEPTOR; DNA; ACTIVATION; DYNAMICS; MODEL	We report that extended exposure to broad-spectrum terahertz radiation results in specific changes in cellular functions that are closely related to DNA-directed gene transcription. Our gene chip survey of gene expression shows that whereas 89% of the protein coding genes in mouse stem cells do not respond to the applied terahertz radiation, certain genes are activated, while other are repressed. RT-PCR experiments with selected gene probes corresponding to transcripts in the three groups of genes detail the gene specific effect. The response was not only gene specific but also irradiation conditions dependent. Our findings suggest that the applied terahertz irradiation accelerates cell differentiation toward adipose phenotype by activating the transcription factor peroxisome proliferator-activated receptor gamma (PPARG). Finally, our molecular dynamics computer simulations indicate that the local breathing dynamics of the PPARG promoter DNA coincides with the gene specific response to the THz radiation. We propose that THz radiation is a potential tool for cellular reprogramming.	[Bock, Jonathan; Fukuyo, Yayoi; Kang, Sona; Alexandrov, Ludmil B.; Rosen, Evan D.; Usheva, Anny] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA; [Phipps, M. Lisa; Martinez, Jennifer S.; Chen, Hou-Tong; Rodriguez, George] Los Alamos Natl Lab, Ctr Integrated Nanotechnol, Los Alamos, NM USA; [Rasmussen, Kim O.; Bishop, Alan R.; Alexandrov, Boian S.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Bock, J (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA.	ausheva@bidmc.harvard.edu	Rasmussen, Kim O/B-5464-2009; Rodriguez, George/G-7571-2012; Alexandrov, Ludmil/AAS-1454-2021; Alexandrov, Boian/D-2488-2010; Chen, Hou-Tong/C-6860-2009; Alexandrov, Ludmil/B-6582-2014	Rasmussen, Kim O/0000-0002-4029-4723; Rodriguez, George/0000-0002-6044-9462; Alexandrov, Ludmil/0000-0003-3596-4515; Alexandrov, Boian/0000-0001-8636-4603; Chen, Hou-Tong/0000-0003-2014-7571; Alexandrov, Ludmil/0000-0003-3596-4515	U.S. Department of Energy, Office of Basic Energy Sciences [DE- AC52-06NA25396]; Sandia National Laboratories [DE- AC04-94AL85000]; NIH [R01GM73911]; Richard and Susan Smith Family Foundation [ADA 1-08-PPG-02]; NIH ARRA supplement [3R01GM73911-4S1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073911] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Sandia National Laboratories(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Richard and Susan Smith Family Foundation; NIH ARRA supplement(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was performed, in part, at the Center for Integrated Nanotechnologies, U.S. Department of Energy, Office of Basic Energy Sciences user facility at Los Alamos National Laboratory (Contract DE- AC52-06NA25396) and Sandia National Laboratories (Contract DE- AC04-94AL85000); NIH grants R01GM73911; NIH ARRA supplement (3R01GM73911-4S1); Richard and Susan Smith Family Foundation Pinnacle Award ADA 1-08-PPG-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov BS, 2010, PHYS LETT A, V374, P1214, DOI 10.1016/j.physleta.2009.12.077; Alexandrov B, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/3/034107; Alexandrov BS, 2010, NUCLEIC ACIDS RES, V38, P1790, DOI 10.1093/nar/gkp1084; Alexandrov BS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000313; Alexandrov BS, 2009, NUCLEIC ACIDS RES, V37, P2405, DOI 10.1093/nar/gkp016; BAXA CA, 1989, BIOCHEMISTRY-US, V28, P8683, DOI 10.1021/bi00448a003; Cherkasova OP, 2009, OPT SPECTROSC+, V107, P534, DOI 10.1134/S0030400X09100063; Choi CH, 2004, BIOPHYS CHEM, V111, P9, DOI 10.1016/j.bpc.2004.03.007; Choi CH, 2004, NUCLEIC ACIDS RES, V32, P1584, DOI 10.1093/nar/gkh335; Choi CH, 2008, BIOPHYS J, V95, P597, DOI 10.1529/biophysj.107.123471; Davies AG, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70016-6; Diez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293; DOSTER W, 1989, NATURE, V337, P754, DOI 10.1038/337754a0; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fischer BM, 2002, PHYS MED BIOL, V47, P3807, DOI 10.1088/0031-9155/47/21/319; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; Kauzmann W, 1942, REV MOD PHYS, V14, P0012, DOI 10.1103/RevModPhys.14.12; Kennedy RE, 2006, BIOINFORMATICS, V22, P1272, DOI 10.1093/bioinformatics/btl108; Kennedy RE, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-154; Kim KY, 2008, NAT PHOTONICS, V2, P605, DOI 10.1038/nphoton.2008.153; Korenstein-Ilan A, 2008, RADIAT RES, V170, P224, DOI 10.1667/RR0944.1; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Olshevskaya JS, 2008, 2008 IEEE REGION 8 INTERNATIONAL CONFERENCE ON COMPUTATIONAL TECHNOLOGIES IN ELECTRICAL AND ELECTRONICS ENGINEERING: SIBIRCON 2008, PROCEEDINGS, P210, DOI 10.1109/SIBIRCON.2008.4602607; Orlando AR, 2009, J INFRARED MILLIM TE, V30, P1308, DOI 10.1007/s10762-009-9561-z; PETERSON MG, 1990, SCIENCE, V248, P1625, DOI 10.1126/science.2363050; PEYRARD M, 1989, PHYS REV LETT, V62, P2755, DOI 10.1103/PhysRevLett.62.2755; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; SARTOR H, 1992, GENOMICS, V13, P911, DOI 10.1016/0888-7543(92)90190-4; Sherwin MS, 2004, OPPORTUNITIES THZ SC; Shiurba R, 2006, PHOTOCH PHOTOBIO SCI, V5, P799, DOI 10.1039/b601741j; Tonouchi M, 2007, NAT PHOTONICS, V1, P97, DOI 10.1038/nphoton.2007.3; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Woolard DL, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051903; Xu Z, 2008, P NATL ACAD SCI USA, V105, P2421, DOI 10.1073/pnas.0707082105	35	94	103	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15806	10.1371/journal.pone.0015806	http://dx.doi.org/10.1371/journal.pone.0015806			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209821	Green Submitted, Green Published, gold			2022-12-27	WOS:000285838900036
J	Dahmani-Mardas, F; Troadec, C; Boualem, A; Leveque, S; Alsadon, AA; Aldoss, AA; Dogimont, C; Bendahmane, A				Dahmani-Mardas, Fatima; Troadec, Christelle; Boualem, Adnane; Leveque, Sylvie; Alsadon, Abdullah A.; Aldoss, Abdullah A.; Dogimont, Catherine; Bendahmane, Abdelhafid			Engineering Melon Plants with Improved Fruit Shelf Life Using the TILLING Approach	PLOS ONE			English	Article							ACC OXIDASE GENE; ISOPENICILLIN N-SYNTHASE; CUCUMIS-MELO; REVERSE GENETICS; ARABIDOPSIS-THALIANA; CRYSTAL-STRUCTURE; ETHYLENE BIOSYNTHESIS; SIGNAL-TRANSDUCTION; CLIMACTERIC FRUIT; TRANSGENIC PLANTS	Background: Fruit ripening and softening are key traits that have an effect on food supply, fruit nutritional value and consequently, human health. Since ethylene induces ripening of climacteric fruit, it is one of the main targets to control fruit over ripening that leads to fruit softening and deterioration. The characterization of the ethylene pathway in Arabidopsis and tomato identified key genes that control fruit ripening. Methodology/Principal Findings: To engineer melon fruit with improved shelf-life, we conducted a translational research experiment. We set up a TILLING platform in a monoecious and climacteric melon line, cloned genes that control ethylene production and screened for induced mutations that lead to fruits with enhanced shelf life. Two missense mutations, L124F and G194D, of the ethylene biosynthetic enzyme, ACC oxidase 1, were identified and the mutant plants were characterized with respect to fruit maturation. The L124F mutation is a conservative mutation occurring away from the enzyme active site and thus was predicted to not affect ethylene production and thus fruit ripening. In contrast, G194D modification occurs in a highly conserved amino acid position predicted, by crystallographic analysis, to affect the enzymatic activity. Phenotypic analysis of the G194D mutant fruit showed complete delayed ripening and yellowing with improved shelf life and, as predicted, the L124F mutation did not have an effect. Conclusions/Significance: We constructed a mutant collection of 4023 melon M2 families. Based on the TILLING of 11 genes, we calculated the overall mutation rate of one mutation every 573 kb and identified 8 alleles per tilled kilobase. We also identified a TILLING mutant with enhanced fruit shelf life. This work demonstrates the effectiveness of TILLING as a reverse genetics tool to improve crop species. As cucurbits are model species in different areas of plant biology, we anticipate that the developed tool will be widely exploited by the scientific community.	[Dahmani-Mardas, Fatima; Troadec, Christelle; Boualem, Adnane; Bendahmane, Abdelhafid] UMR1165 ERL8196 INRA UEVE CNRS, Unite Rech Genom Vegetale, Evry, France; [Leveque, Sylvie; Dogimont, Catherine] INRA UR1052, Unite Genet & Ameliorat Fruits & Legumes, Montfavet, France; [Alsadon, Abdullah A.; Aldoss, Abdullah A.; Bendahmane, Abdelhafid] King Saud Univ, Dept Plant Prod, Coll Food & Agr Sci, Riyadh, Saudi Arabia	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; King Saud University	Dahmani-Mardas, F (corresponding author), UMR1165 ERL8196 INRA UEVE CNRS, Unite Rech Genom Vegetale, Evry, France.	bendahm@evry.inra.fr	Boualem, Adnane/ABC-5019-2021; Al-Doss, Abdullah/AAL-7883-2021; Al-Doss, Abdullah A/F-8539-2016	Boualem, Adnane/0000-0003-4428-6496; Al-Doss, Abdullah/0000-0003-3828-2384; Catherine, DOGIMONT/0000-0001-7399-768X; Bendahmane, Abdelhafid/0000-0003-3246-868X; TROADEC, Christelle/0000-0003-1927-7352	INRA-KSU Plant biotechnology network; MELRIP Plant-KBBE	INRA-KSU Plant biotechnology network; MELRIP Plant-KBBE	This work was supported by INRA-KSU Plant biotechnology network and the MELRIP Plant-KBBE program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Phillips L, 2004, PLANT MOL BIOL, V54, P387, DOI 10.1023/B:PLAN.0000036371.30528.26; Alexander L, 2002, J EXP BOT, V53, P2039, DOI 10.1093/jxb/erf072; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Ayub R, 1996, NAT BIOTECHNOL, V14, P862, DOI 10.1038/nbt0796-862; Barry CS, 2007, J PLANT GROWTH REGUL, V26, P143, DOI 10.1007/s00344-007-9002-y; Boualem A, 2008, SCIENCE, V321, P836, DOI 10.1126/science.1159023; Boualem A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006144; BRADY CJ, 1987, ANNU REV PLANT PHYS, V38, P155, DOI 10.1146/annurev.pp.38.060187.001103; Brummell DA, 2001, PLANT MOL BIOL, V47, P311, DOI 10.1023/A:1010656104304; Caldwell DG, 2004, PLANT J, V40, P143, DOI 10.1111/j.1365-313X.2004.02190.x; Chawade A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-86; Cooper JL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-9; Dalmais M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r43; Deleu W, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-90; Elkins JM, 2002, BIOCHEMISTRY-US, V41, P5185, DOI 10.1021/bi016014e; Ezura H, 2008, PLANT SCI, V175, P121, DOI 10.1016/j.plantsci.2008.02.004; Fernandez-Silva I, 2008, THEOR APPL GENET, V118, P139, DOI 10.1007/s00122-008-0883-3; Gilchrist EJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-262; Giovannoni J, 2001, ANNU REV PLANT PHYS, V52, P725, DOI 10.1146/annurev.arplant.52.1.725; Giovannoni JJ, 2007, CURR OPIN PLANT BIOL, V10, P283, DOI 10.1016/j.pbi.2007.04.008; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Gomez G, 2005, PLANT J, V41, P107, DOI 10.1111/j.1365-313X.2004.02278.x; Gonzalez VM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-339; Gonzalez-Ibeas D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-306; Gottwald Sven, 2009, BMC Res Notes, V2, P258, DOI 10.1186/1756-0500-2-258; Greene EA, 2003, GENETICS, V164, P731; HAMILTON AJ, 1990, NATURE, V346, P284, DOI 10.1038/346284a0; Haritatos E, 1996, PLANTA, V198, P614, DOI 10.1007/BF00262649; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Jeffrey C., 1990, BIOL UTILIZATION CUC, P3; Le Signor C, 2009, PLANT BIOTECHNOL J, V7, P430, DOI 10.1111/j.1467-7652.2009.00410.x; Lin ZF, 2009, J EXP BOT, V60, P3311, DOI 10.1093/jxb/erp204; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Martin A, 2009, NATURE, V461, P1135, DOI 10.1038/nature08498; Mascarell-Creus A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-467; Minoia Silvia, 2010, BMC Res Notes, V3, P69, DOI 10.1186/1756-0500-3-69; Moens Cecilia B., 2008, Briefings in Functional Genomics & Proteomics, V7, P454, DOI 10.1093/bfgp/eln046; Morales M, 2005, THEOR APPL GENET, V111, P914, DOI 10.1007/s00122-005-0019-y; Murray A. J., 1993, Postharvest Biology and Technology, V2, P301, DOI 10.1016/0925-5214(93)90035-2; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nunez-Palenius HG, 2006, PLANT CELL REP, V25, P198, DOI 10.1007/s00299-005-0042-0; Pech JC, 2008, PLANT SCI, V175, P114, DOI 10.1016/j.plantsci.2008.01.003; Perin C, 2002, PLANT PHYSIOL, V129, P300, DOI 10.1104/pp.010613; Piron F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011313; ROACH PL, 1995, NATURE, V375, P700, DOI 10.1038/375700a0; Roach PL, 1997, NATURE, V387, P827, DOI 10.1038/42990; Seymour G, 2008, CURR OPIN PLANT BIOL, V11, P58, DOI 10.1016/j.pbi.2007.09.003; Silva JA, 2004, POSTHARVEST BIOL TEC, V32, P263, DOI 10.1016/j.postharvbio.2004.01.002; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Stephenson P, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-62; Till BJ, 2003, GENOME RES, V13, P524, DOI 10.1101/gr.977903; Till BJ, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-19; Till Bradley J., 2004, BMC Plant Biology, V4, P12, DOI 10.1186/1471-2229-4-12; Triques K, 2007, PLANT J, V51, P1116, DOI 10.1111/j.1365-313X.2007.03201.x; Uauy C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-115; Valegard K, 1998, NATURE, V394, P805, DOI 10.1038/29575; van Leeuwen H, 2003, PLANT MOL BIOL, V51, P703, DOI 10.1023/A:1022573230486; VOSS DH, 1992, HORTSCIENCE, V27, P1256, DOI 10.21273/HORTSCI.27.12.1256; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; Wang N, 2008, NEW PHYTOL, V180, P751, DOI 10.1111/j.1469-8137.2008.02619.x; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; WILKINSON JQ, 1995, SCIENCE, V270, P1807, DOI 10.1126/science.270.5243.1807; Winkler S, 2005, GENOME RES, V15, P718, DOI 10.1101/gr.3721805; Wu JL, 2005, PLANT MOL BIOL, V59, P85, DOI 10.1007/s11103-004-5112-0; Xiong AS, 2005, PLANT CELL REP, V23, P639, DOI 10.1007/s00299-004-0887-7; Zhang ZH, 2004, CHEM BIOL, V11, P1383, DOI 10.1016/j.chembiol.2004.08.012; Zhang ZH, 2000, NAT STRUCT BIOL, V7, P127	68	77	78	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15776	10.1371/journal.pone.0015776	http://dx.doi.org/10.1371/journal.pone.0015776			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209891	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793600037
J	Kanda, T; Jeong, SH; Imazeki, F; Fujiwara, K; Yokosuka, O				Kanda, Tatsuo; Jeong, Sook-Hyang; Imazeki, Fumio; Fujiwara, Keiichi; Yokosuka, Osamu			Analysis of 5 ' Nontranslated Region of Hepatitis A Viral RNA Genotype I from South Korea: Comparison with Disease Severities	PLOS ONE			English	Article							ENTRY-SITE; NUCLEOTIDE-SEQUENCE; VIRUS-RNA; STRAINS; TRANSLATION; AMANTADINE; VACCINE; IRES	The aim of the study was to analyze genotype I hepatitis A virus (HAV) 5' nontranslated region (NTR) sequences from a recent outbreak in South Korea and compare them with reported sequences from Japan. We collected a total of 54 acute hepatitis A patients' sera from HAV genotype I [27 severe disease (prothrombin time INR >= 1.50) and 27 mild hepatitis (prothrombin time INR <1.00)], performed nested RT-PCR of 5' NTR of HAV directly sequenced from PCR products (similar to 300 bp), and compared them with each other. We could detect HAV 5'NTR sequences in 19 of the 54 (35.1%) cases [12 of 27 severe cases (44.4%) and 7 of 27 self-limited cases (25.9%)], all of which were subgenotype IA. Sequence analysis revealed that sequences of severe disease had 93.6%-99.0% homology and of self-limited disease 94.3%-98.6% homology, compared to subgenotype IA HAV GBM wild-type IA sequence. In this study, confirmation of the 5'NTR sequence differences between severe disease and mild disease was not carried out. Comparison with Japanese HAV A10 revealed (222)C to G or T substitution in 8/12 cases of severe disease and (222)C to G or T and (392)G to A substitutions in 5/7 and 4/7 cases of mild disease, respectively, although the nucleotide sequences in this study showed high homology (93.6%-100%). In conclusion, HAV 5'NTR subgenotype IA from Korea had relatively high homology to Japanese sequences previously reported from Japan, and this region would be considered one of the antiviral targets. Further studies will be needed.	[Kanda, Tatsuo; Imazeki, Fumio; Fujiwara, Keiichi; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Med & Clin Oncol, Chiba, Japan; [Jeong, Sook-Hyang] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea	Chiba University; Seoul National University (SNU)	Kanda, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Med & Clin Oncol, Chiba, Japan.	kandat-cib@umin.ac.jp	Jeong, Sook-Hyang/D-5726-2012	Kanda, Tatsuo/0000-0002-1654-5385	Ministry of Education, Culture, Sports, Science and Technology, Japan [15790338, 21590829, 21590828, 21390225]; Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology; Japanese Government	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Government	This work was supported by grants for Scientific Research 15790338, 21590829, 21590828, and 21390225 from the Ministry of Education, Culture, Sports, Science and Technology, Japan (TK, FI, and OY), a grant from the Ministry of Health, Labour and Welfare of Japan (OY), a Special Coordination Fund for Promoting Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology, the Japanese Government (TK). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALCAREK KB, 1995, J INFECT DIS, V171, pS70, DOI 10.1093/infdis/171.Supplement_1.S70; BROWN EA, 1994, J VIROL, V68, P1066, DOI 10.1128/JVI.68.2.1066-1074.1994; COHEN JI, 1987, J VIROL, V61, P50, DOI 10.1128/JVI.61.1.50-59.1987; Dagan R, 2005, JAMA-J AM MED ASSOC, V294, P202, DOI 10.1001/jama.294.2.202; Daniels Danni, 2009, Morbidity and Mortality Weekly Report, V58, P1; Davidkin I, 2007, J MED VIROL, V79, P657, DOI 10.1002/jmv.20843; Fujiwara K, 2002, GUT, V51, P82, DOI 10.1136/gut.51.1.82; Gharbi-Khelifi H, 2006, J VIROL METHODS, V138, P109, DOI 10.1016/j.jviromet.2006.08.001; GRAFF J, 1994, J VIROL, V68, P548, DOI 10.1128/JVI.68.1.548-554.1994; Kanda T, 2005, BIOCHEM BIOPH RES CO, V331, P621, DOI 10.1016/j.bbrc.2005.03.212; Kanda T, 2005, BIOCHEM BIOPH RES CO, V330, P1217, DOI 10.1016/j.bbrc.2005.03.105; Kanda T, 2010, J VIRAL HEPATITIS, V17, P618, DOI 10.1111/j.1365-2893.2009.01221.x; Kanda T, 2010, HEPATOL RES, V40, P415, DOI 10.1111/j.1872-034X.2010.00617.x; KURAMOTO I, 1994, J GASTROEN HEPATOL, V9, P228, DOI 10.1111/j.1440-1746.1994.tb01714.x; Lee D, 2008, INTERVIROLOGY, V51, P70, DOI 10.1159/000127428; LEMON SM, 1992, VACCINE, V10, pS40, DOI 10.1016/0264-410X(92)90540-Z; Yun H, 2008, J MED VIROL, V80, P777, DOI 10.1002/jmv.21127	17	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15139	10.1371/journal.pone.0015139	http://dx.doi.org/10.1371/journal.pone.0015139			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203430	gold, Green Published, Green Submitted			2022-12-27	WOS:000285792500022
J	Shein Idelson, M; Ben-Jacob, E; Hanein, Y				Shein Idelson, Mark; Ben-Jacob, Eshel; Hanein, Yael			Innate Synchronous Oscillations in Freely-Organized Small Neuronal Circuits	PLOS ONE			English	Article							SYNAPTIC MECHANISMS; ACTIVITY PATTERNS; NETWORKS; PLASTICITY; SYNCHRONIZATION	Background: Information processing in neuronal networks relies on the network's ability to generate temporal patterns of action potentials. Although the nature of neuronal network activity has been intensively investigated in the past several decades at the individual neuron level, the underlying principles of the collective network activity, such as the synchronization and coordination between neurons, are largely unknown. Here we focus on isolated neuronal clusters in culture and address the following simple, yet fundamental questions: What is the minimal number of cells needed to exhibit collective dynamics? What are the internal temporal characteristics of such dynamics and how do the temporal features of network activity alternate upon crossover from minimal networks to large networks? Methodology/Principal Findings: We used network engineering techniques to induce self-organization of cultured networks into neuronal clusters of different sizes. We found that small clusters made of as few as 40 cells already exhibit spontaneous collective events characterized by innate synchronous network oscillations in the range of 25 to 100 Hz. The oscillation frequency of each network appeared to be independent of cluster size. The duration and rate of the network events scale with cluster size but converge to that of large uniform networks. Finally, the investigation of two coupled clusters revealed clear activity propagation with master/slave asymmetry. Conclusions/Significance: The nature of the activity patterns observed in small networks, namely the consistent emergence of similar activity across networks of different size and morphology, suggests that neuronal clusters self-regulate their activity to sustain network bursts with internal oscillatory features. We therefore suggest that clusters of as few as tens of cells can serve as a minimal but sufficient functional network, capable of sustaining oscillatory activity. Interestingly, the frequencies of these oscillations are similar those observed in vivo.	[Shein Idelson, Mark; Hanein, Yael] Tel Aviv Univ, Sch Elect Engn, IL-69978 Tel Aviv, Israel; [Ben-Jacob, Eshel] Tel Aviv Univ, Sch Phys, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University	Shein Idelson, M (corresponding author), Tel Aviv Univ, Sch Elect Engn, IL-69978 Tel Aviv, Israel.	eshel@tamar.tau.ac.il; YaelHa@tauex.tau.ac.il	Shein, Mark/M-9170-2018; Hanein, Yael/A-7179-2008; Hanein, Yael/AAG-5980-2021	Shein, Mark/0000-0001-8132-2826; Hanein, Yael/0000-0002-4213-9575	ISF	ISF(Israel Science Foundation)	This study was partially supported by an ISF grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Baruchi I, 2006, CHAOS, V16, DOI 10.1063/1.2183408; Baruchi I, 2008, EUR J NEUROSCI, V28, P1825, DOI 10.1111/j.1460-9568.2008.06487.x; Baruchi I, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.050901; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Cellot G, 2009, NAT NANOTECHNOL, V4, P126, DOI [10.1038/NNANO.2008.374, 10.1038/nnano.2008.374]; DeMarse TB, 2001, AUTON ROBOT, V11, P305, DOI 10.1023/A:1012407611130; DOUGLAS RJ, 1991, TRENDS NEUROSCI, V14, P286, DOI 10.1016/0166-2236(91)90139-L; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; Feinerman O, 2007, J NEUROPHYSIOL; Fuchs E, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/3/036018; Gabay T, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/3/035201; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; Goaillard JM, 2009, NAT NEUROSCI, V12, P1424, DOI 10.1038/nn.2404; Gross GW, 1999, J INTEL MAT SYST STR, V10, P558, DOI 10.1106/XC9U-BMJ8-FE1A-EUNQ; Hulata E, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198105; Jimbo Y, 1999, BIOPHYS J, V76, P670, DOI 10.1016/S0006-3495(99)77234-6; Kaiser M, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/5/110; Kamioka H, 1996, NEUROSCI LETT, V206, P109, DOI 10.1016/S0304-3940(96)12448-4; KLEINFELD D, 1988, J NEUROSCI, V8, P4098; Koch C, 2000, NAT NEUROSCI, V3, P1171, DOI 10.1038/81444; KRIEGSTEIN AR, 1983, J NEUROSCI, V3, P1634; Lau PM, 2005, P NATL ACAD SCI USA, V102, P10333, DOI 10.1073/pnas.0500717102; Madhavan R, 2007, PHYS BIOL, V4, P181, DOI 10.1088/1478-3975/4/3/005; Nusbaum MP, 2002, NATURE, V417, P343, DOI 10.1038/417343a; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Raichman N, 2006, NEUROCOMPUTING, V69, P1150, DOI 10.1016/j.neucom.2005.12.064; Segev R, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118102; Segev R, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.168101; Segev R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.118102; Selverston AI, 2010, PHILOS T R SOC B, V365, P2329, DOI 10.1098/rstb.2009.0270; SHAW GL, 1982, EXP NEUROL, V77, P324, DOI 10.1016/0014-4886(82)90249-7; Shefi O, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.021905; Shein M, 2009, BIOMED MICRODEVICES, V11, P495, DOI 10.1007/s10544-008-9255-7; Shein M, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/3/036008; Sorkin R, 2006, J NEURAL ENG, V3, P95, DOI 10.1088/1741-2560/3/2/003; Sorkin R, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/1/015101; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Stoica P., 1997, SPECTRAL ANAL SIGNAL; Streit J, 2001, EUR J NEUROSCI, V14, P191, DOI 10.1046/j.0953-816x.2001.01636.x; Suzuki I, 2007, BIOCHEM BIOPH RES CO, V356, P470, DOI 10.1016/j.bbrc.2007.03.006; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Volman V, 2005, PHYS BIOL, V2, P98, DOI 10.1088/1478-3975/2/2/003; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Yuste R, 2005, NAT REV NEUROSCI, V6, P477, DOI 10.1038/nrn1686	48	35	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14443	10.1371/journal.pone.0014443	http://dx.doi.org/10.1371/journal.pone.0014443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203438	Green Published, gold, Green Submitted			2022-12-27	WOS:000285792500019
J	Tsiperson, V; Li, XS; Schwartz, GJ; Raine, CS; Shafit-Zagardo, B				Tsiperson, Vladislav; Li, Xiaosong; Schwartz, Gary J.; Raine, Cedric S.; Shafit-Zagardo, Bridget			GAS6 Enhances Repair Following Cuprizone-Induced Demyelination	PLOS ONE			English	Article							ARREST-SPECIFIC GENE; RECEPTOR TYROSINE KINASES; CENTRAL-NERVOUS-SYSTEM; SUPERIOR CEREBELLAR PEDUNCLE; MULTIPLE-SCLEROSIS LESIONS; GROWTH-ARREST; APOPTOTIC CELLS; PROTEIN-S; CORTICAL-NEURONS; AXONAL DAMAGE	Growth arrest-specific protein 6 (gas6) activities are mediated through the Tyro3, Axl, and Mer family of receptor tyrosine kinases. Gas6 is expressed and secreted by a wide variety of cell types, including cells of the central nervous system (CNS). In this study, we tested the hypothesis that administration of recombinant human Gas6 (rhGas6) protein into the CNS improves recovery following cuprizone withdrawal. After a 4-week cuprizone diet, cuprizone was removed and PBS or rhGas6 (400 ng/ml, 4 mg/ml and 40 mg/ml) was delivered by osmotic mini-pump into the corpus callosum of C57Bl6 mice for 14 days. Nine of 11 (82%) PBS-treated mice had abundant lipid-associated debris in the corpus callosum by Oil-Red-O staining while only 4 of 19 (21%) mice treated with rhGas6 had low Oil-Red-O positive droplets. In rhGas6-treated mice, SMI32-positive axonal spheroids and APP-positive deposits were reduced in number relative to PBS-treated mice. Compared to PBS, rhGas6 enhanced remyelination as revealed by MBP immunostaining and electron microscopy. The rhGas6-treated mice had more oligodendrocytes expressing Olig1 in the cytoplasm, indicative of oligodendrocyte progenitor cell maturation. Relative to PBS-treated mice, rhGas6-treated mice had fewer activated microglia in the corpus callosum by Iba1 immunostaining. The data show that rhGas6 treatment resulted in more efficient repair following cuprizone-induced injury.	[Tsiperson, Vladislav; Raine, Cedric S.; Shafit-Zagardo, Bridget] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Li, Xiaosong; Schwartz, Gary J.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Raine, Cedric S.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Tsiperson, V (corresponding author), Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA.	bridget.shafit-zagardo@einstein.yu.edu	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763	National Institutes of Health [R21NS061128, T32 NS 07098]; National Multiple Sclerosis Society [RG 4046-A-6, RG 1001-K-11]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007098, R21NS061128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant (R21NS061128), National Multiple Sclerosis Society Grant (RG 4046-A-6) to BSZ and RG 1001-K-11 to CSR. VT was supported by NIH Training grant T32 NS 07098. CSR is the Wollowick Family Professor of Multiple Sclerosis Research at this Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MP, 1999, MOL ENDOCRINOL, V13, P191, DOI 10.1210/me.13.2.191; Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; BARBARESE E, 1995, J NEURO-ONCOL, V26, P25, DOI 10.1007/BF01054766; Binder MD, 2008, J NEUROSCI, V28, P5195, DOI 10.1523/JNEUROSCI.1180-08.2008; BLAKEMORE WF, 1973, J NEUROL SCI, V20, P63, DOI 10.1016/0022-510X(73)90118-4; BLAKEMORE WF, 1973, J NEUROL SCI, V20, P73, DOI 10.1016/0022-510X(73)90119-6; Budagian V, 2005, MOL CELL BIOL, V25, P9324, DOI 10.1128/MCB.25.21.9324-9339.2005; Caraux A, 2006, NAT IMMUNOL, V7, P747, DOI 10.1038/ni1353; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Gallicchio M, 2005, BLOOD, V105, P1970, DOI 10.1182/blood-2004-04-1469; Gao X, 2000, MOL CELL NEUROSCI, V16, P338, DOI 10.1006/mcne.2000.0883; Gould WR, 2005, J THROMB HAEMOST, V3, P733, DOI 10.1111/j.1538-7836.2005.01186.x; Grommes C, 2008, J NEUROIMMUNE PHARM, V3, P130, DOI 10.1007/s11481-007-9090-2; Hafizi S, 2006, FEBS J, V273, P5231, DOI 10.1111/j.1742-4658.2006.05529.x; Hall MO, 2003, ADV EXP MED BIOL, V533, P331; Hall MO, 2002, EXP EYE RES, V75, P391, DOI 10.1006/exer.2002.2030; Hasanbasic I, 2005, J THROMB HAEMOST, V3, P2790, DOI 10.1111/j.1538-7836.2005.01662.x; Herrero-Herranz E, 2008, NEUROBIOL DIS, V30, P162, DOI 10.1016/j.nbd.2008.01.001; Hiremath MM, 1998, J NEUROIMMUNOL, V92, P38, DOI 10.1016/S0165-5728(98)00168-4; Hoehn HJ, 2008, BRAIN RES, V1240, P1, DOI 10.1016/j.brainres.2008.08.076; Irvine KA, 2006, J NEUROIMMUNOL, V175, P69, DOI 10.1016/j.jneuroim.2006.03.002; Ishimoto Y, 2000, J BIOCHEM-TOKYO, V127, P411, DOI 10.1093/oxfordjournals.jbchem.a022622; Jackson SJ, 2005, NEUROSCIENCE, V134, P261, DOI 10.1016/j.neuroscience.2005.02.045; Jurevics H, 2002, J NEUROCHEM, V82, P126, DOI 10.1046/j.1471-4159.2002.00954.x; Li RH, 1996, J NEUROSCI, V16, P2012; Lindner M, 2008, NEUROPATH APPL NEURO, V34, P105, DOI 10.1111/j.1365-2990.2007.00879.x; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; Mark MR, 1996, J BIOL CHEM, V271, P9785, DOI 10.1074/jbc.271.16.9785; Mason JL, 2000, J NEUROSCI, V20, P5703, DOI 10.1523/JNEUROSCI.20-15-05703.2000; Mason JL, 2001, NEUROPATH APPL NEURO, V27, P50, DOI 10.1046/j.0305-1846.2001.00301.x; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; McCreary CR, 2009, NEUROIMAGE, V45, P1173, DOI 10.1016/j.neuroimage.2008.12.071; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; Nakano T, 1997, BIOCHEM J, V323, P387, DOI 10.1042/bj3230387; OHASHI K, 1995, J BIOL CHEM, V270, P22681, DOI 10.1074/jbc.270.39.22681; OKEBE CO, 2000, BRAIN RES, V877, P85; Petzold A, 2008, EXP NEUROL, V213, P326, DOI 10.1016/j.expneurol.2008.06.008; Prieto AL, 2000, J COMP NEUROL, V425, P295; Sainaghi PP, 2008, J NEUROL SCI, V269, P138, DOI 10.1016/j.jns.2008.01.005; Saller F, 2006, BLOOD CELL MOL DIS, V36, P373, DOI 10.1016/j.bcmd.2005.12.038; Sather S, 2007, BLOOD, V109, P1026, DOI 10.1182/blood-2006-05-021634; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Shankar SL, 2006, J NEUROSCI, V26, P5638, DOI 10.1523/JNEUROSCI.5063-05.2006; Shankar SL, 2003, J NEUROSCI, V23, P4208; Sidman Richard L., 1971, ATLAS MOUSE BRAIN SP; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Stidworthy MF, 2003, BRAIN PATHOL, V13, P329; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; Weinger JG, 2009, AM J PATHOL, V175, P283, DOI 10.2353/ajpath.2009.080807; Wu Y, 2005, J CELL SCI, V118, P539, DOI 10.1242/jcs.01632; Xiong W, 2008, REPRODUCTION, V135, P77, DOI 10.1530/REP-07-0287; Yagami T, 2003, BRAIN RES, V985, P142, DOI 10.1016/S0006-8993(03)03043-9; Yagami T, 2002, NEUROPHARMACOLOGY, V43, P1289, DOI 10.1016/S0028-3908(02)00333-7; Yanagita M, 2002, J CLIN INVEST, V110, P239, DOI 10.1172/JCI200214861	54	43	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15748	10.1371/journal.pone.0015748	http://dx.doi.org/10.1371/journal.pone.0015748			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203420	Green Published, Green Submitted, gold			2022-12-27	WOS:000285579200037
J	McComb, S; Mulligan, R; Sad, S				McComb, Scott; Mulligan, Rebecca; Sad, Subash			Caspase-3 Is Transiently Activated without Cell Death during Early Antigen Driven Expansion of CD8(+) T Cells In Vivo	PLOS ONE			English	Article							LYMPHOCYTE-ACTIVATION; SURVIVIN EXPRESSION; MEDIATES APOPTOSIS; VIRAL-INFECTION; MEMORY; FAS; DIFFERENTIATION; PROLIFERATION; INFLAMMATION; EFFECTOR	Background: CD8(+) T cell responses develop rapidly during infection and are swiftly reduced during contraction, wherein >90% of primed CD8(+) T cells are eliminated. The role of apoptotic mechanisms in controlling this rapid proliferation and contraction of CD8(+) T cells remains unclear. Surprisingly, evidence has shown non-apoptotic activation of caspase-3 to occur during in vitro T-cell proliferation, but the relevance of these mechanisms to in vivo CD8(+) T cell responses has yet to be examined. Methods and Findings: We have evaluated the activity of caspase-3, a key downstream inducer of apoptosis, throughout the entirety of a CD8+ T cell response. We utilized two infection models that differ in the intensity, onset and duration of antigen-presentation and inflammation. Expression of cleaved caspase-3 in antigen specific CD8(+) T cells was coupled to the timing and strength of antigen presentation in lymphoid organs. We also observed coordinated activation of additional canonical apoptotic markers, including phosphatidylserine exposure. Limiting dilution analysis directly showed that in the presence of IL7, very little cell death occurred in both caspase-3(hi) and caspase-3(low) CD8(+) T cells. The expression of active caspase-3 peaked before effector phenotype (CD62L(low)) CD8(+) T cells emerged, and was undetectable in effector-phenotype cells. In addition, OVA-specific CD8(+) cells remained active caspase-3(low) throughout the contraction phase. Conclusions: Our results specifically implicate antigen and not inflammation in driving activation of apoptotic mechanisms without cell death in proliferating CD8(+) T cells. Furthermore, the contraction of CD8(+) T cell response following expansion is likely not mediated by the key downstream apoptosis inducer, caspase-3.	[McComb, Scott; Mulligan, Rebecca; Sad, Subash] Univ Ottawa, Dept Biochem Microbiol & Immunol, NRC Inst Biol Sci, Ottawa, ON, Canada	National Research Council Canada; University of Ottawa	McComb, S (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, NRC Inst Biol Sci, Ottawa, ON, Canada.	subash.sad@nrc.ca		Sad, Subash/0000-0002-2462-7137	Canadian Institute of Health Research (CIHR); NRC	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NRC(National Research Centre (NRC))	Funding for this study was provided by a grant from the Canadian Institute of Health Research (CIHR) and NRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; Albaghdadi H, 2009, J IMMUNOL, V183, P3778, DOI 10.4049/jimmunol.0900843; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Badovinac VP, 2006, J IMMUNOL, V177, P999, DOI 10.4049/jimmunol.177.2.999; Badovinac VP, 2004, NAT IMMUNOL, V5, P809, DOI 10.1038/ni1098; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Ch'en IL, 2008, P NATL ACAD SCI USA, V105, P17463, DOI 10.1073/pnas.0808043105; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Demo SD, 1999, CYTOMETRY, V36, P340, DOI 10.1002/(SICI)1097-0320(19990801)36:4<340::AID-CYTO9>3.0.CO;2-C; Desbarats J, 1999, P NATL ACAD SCI USA, V96, P8104, DOI 10.1073/pnas.96.14.8104; Dillon SR, 2000, J IMMUNOL, V164, P1322, DOI 10.4049/jimmunol.164.3.1322; Dudani R, 2002, INFECT IMMUN, V70, P1957, DOI 10.1128/IAI.70.4.1957-1964.2002; Dudani R, 2008, J IMMUNOL, V180, P2933, DOI 10.4049/jimmunol.180.5.2933; Falk M, 2004, J IMMUNOL, V173, P5077, DOI 10.4049/jimmunol.173.8.5077; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Fischer K, 2006, BLOOD, V108, p307A; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Galluzzi L, 2008, CELL, V135, P1161, DOI 10.1016/j.cell.2008.12.004; Gao G, 2000, J CELL BIOCHEM, V80, P53; Grayson JM, 2003, J IMMUNOL, V170, P4745, DOI 10.4049/jimmunol.170.9.4745; Grayson JM, 2002, J IMMUNOL, V169, P3760, DOI 10.4049/jimmunol.169.7.3760; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Haring JS, 2006, IMMUNITY, V25, P19, DOI 10.1016/j.immuni.2006.07.001; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Hughes PD, 2008, IMMUNITY, V28, P197, DOI 10.1016/j.immuni.2007.12.017; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; Kornacker M, 2001, IMMUNOL LETT, V76, P169, DOI 10.1016/S0165-2478(01)00186-9; Kuranaga E, 2007, TRENDS CELL BIOL, V17, P135, DOI 10.1016/j.tcb.2007.01.001; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Luu RA, 2006, J IMMUNOL, V177, P1516, DOI 10.4049/jimmunol.177.3.1516; Ma SB, 2003, CELL BIOL INT, V27, P959, DOI 10.1016/S1065-6995(03)00170-7; Marshall DR, 2001, P NATL ACAD SCI USA, V98, P6313, DOI 10.1073/pnas.101132698; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Nagy G, 2003, J IMMUNOL, V171, P5188, DOI 10.4049/jimmunol.171.10.5188; Nussbaum AK, 2004, J IMMUNOL, V173, P6611, DOI 10.4049/jimmunol.173.11.6611; Puga I, 2008, IMMUNITY, V29, P193, DOI 10.1016/j.immuni.2008.06.010; Ruckenstuhl C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004592; Russell MS, 2007, J IMMUNOL, V179, P211, DOI 10.4049/jimmunol.179.1.211; Sabbagh L, 2005, MOL IMMUNOL, V42, P1345, DOI 10.1016/j.molimm.2004.12.011; Sad S, 2008, J IMMUNOL, V180, P5853, DOI 10.4049/jimmunol.180.9.5853; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Sharma AK, 2004, J BIOL CHEM, V279, P35564, DOI 10.1074/jbc.M401037200; Song JX, 2005, IMMUNITY, V22, P621, DOI 10.1016/j.immuni.2005.03.012; Sordet O, 2002, BLOOD, V100, P4446, DOI 10.1182/blood-2002-06-1778; SPRENT J, 1994, SCIENCE, V265, P1395, DOI 10.1126/science.8073282; Sprent J, 2001, SCIENCE, V293, P245, DOI 10.1126/science.1062416; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Stark FC, 2009, CANCER RES, V69, P4327, DOI 10.1158/0008-5472.CAN-08-3160; Strasser A, 2004, TRENDS IMMUNOL, V25, P610, DOI 10.1016/j.it.2004.08.012; Suzuki I, 2000, P NATL ACAD SCI USA, V97, P1707, DOI 10.1073/pnas.97.4.1707; TELFORD WG, 1994, J IMMUNOL METHODS, V172, P1, DOI 10.1016/0022-1759(94)90373-5; Wojciechowski S, 2006, EUR J IMMUNOL, V36, P1694, DOI 10.1002/eji.200635897; Yi CH, 2009, DEV CELL, V16, P21, DOI 10.1016/j.devcel.2008.12.012; Zermati Y, 2001, J EXP MED, V193, P247, DOI 10.1084/jem.193.2.247; Zhang J, 2001, J BIOL CHEM, V276, P29815, DOI 10.1074/jbc.M103838200	64	40	40	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15328	10.1371/journal.pone.0015328	http://dx.doi.org/10.1371/journal.pone.0015328			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203525	Green Published, gold, Green Submitted			2022-12-27	WOS:000285578000029
J	Dans, AL; Teo, K; Gao, P; Chen, JH; Jae-Hyung, K; Yusoff, K; Chaithiraphan, S; Jun, Z; Liu, LS; Yusuf, S				Dans, Antonio L.; Teo, Koon; Gao, Peggy; Chen, Jyh-Hong; Jae-Hyung, Kim; Yusoff, Khalid; Chaithiraphan, Suphachai; Jun Zhu; Liu Lisheng; Yusuf, Salim		ONTARGET INVESTIGATORS	In a Subgroup of High-Risk Asians, Telmisartan Was Non-Inferior to Ramipril and Better Tolerated in the Prevention of Cardiovascular Events	PLOS ONE			English	Article							CONVERTING-ENZYME-INHIBITORS; CHINESE; TRIALS; INSERTION/DELETION; PHARMACODYNAMICS; PHARMACOKINETICS; POLYMORPHISM; INTOLERANT; DISEASE; COUGH	Background and Objectives: Results of the recently published ONTARGET study (The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial) showed that telmisartan (80 mg/day) was non-inferior to ramipril (10 mg/day) in reducing cardiovascular events. Clinicians in Asia doubt tolerability of these doses for their patients. We therefore analyzed data from this study and a parallel study TRANSCEND (Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease). Our objectives were to compare Asians and non-Asians with respect to the following: 1) Effectiveness of telmisartan vs. ramipril in reducing cardiovascular events; 2) Proportions who reached the full dose of telmisartan, ramipril or placebo; and 3) Proportions of overall discontinuations, and discontinuations due to adverse effects. Method: The ONTARGET study randomized 25,620 patients at risk of cardiovascular events to ramipril, telmisartan, or their combination. The primary composite endpoint was death caused by cardiovascular disease, acute MI, stroke, and hospitalization because of congestive heart failure. TRANSCEND randomized 5926 high-risk patients with a history of intolerance to ACE-inhibitors to telmisartan or placebo. The primary outcome was the same. In this substudy, we compared Asians and non-Asians as to how well they tolerated telmisartan (given in both studies) and ramipril (given in ONTARGET). Results: 1) Telmisartan was non-inferior to ramipril in lowering the primary endpoint among Asians (RR = 0.92; 95% CI: 0.74, 1.13); 2) more Asians achieved the full dose of either drug; 3) less withdrew (overall); and 4) less withdrew for adverse effects. Furthermore, telmisartan was better tolerated than ramipril. This advantage was greater among Asians. Conclusion and Significance: Although Asians had lower BMI than non-Asians, Asians tolerated both drugs better. Regulatory agencies require reporting of safety and effectiveness data by ethnicity, but few comply with this requirement. This study shows that safety data in ethnic subgroups can help assess applicability of results to specific populations.	[Dans, Antonio L.] Univ Philippines, Coll Med, Manila, Philippines; [Teo, Koon; Gao, Peggy; Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Chen, Jyh-Hong] Natl Cheng Kung Univ, Coll Med, Tainan 70101, Taiwan; [Jae-Hyung, Kim] Catholic Univ Korea, St Pauls Hosp, Seoul, South Korea; [Yusoff, Khalid] Univ Teknol MARA, Shah Alam, Malaysia; [Chaithiraphan, Suphachai] Chaophya Hosp, Bangkok, Thailand; [Jun Zhu; Liu Lisheng] Chinese Acad Med Sci, FuWai Hosp, Beijing 100037, Peoples R China	University of the Philippines System; University of the Philippines Manila; McMaster University; Population Health Research Institute; National Cheng Kung University; Catholic University of Korea; Universiti Teknologi MARA; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Dans, AL (corresponding author), Univ Philippines, Coll Med, Manila, Philippines.	tdans@skybroadband.com.ph	Zhuang, Jun/E-8081-2010; Yusoff, Khalid/I-7029-2019	Zhuang, Jun/0000-0003-4830-6570; Yusoff, Khalid/0000-0001-5669-5188; Teo, Koon/0000-0002-3731-0956; Yusuf, Salim/0000-0003-4776-5601	Bhoeringer Ingelheim	Bhoeringer Ingelheim(Boehringer Ingelheim)	This study was funded by Bhoeringer Ingelheim. The study was designed by the Population Health and Research institute in McMaster University, Hamilton, Ontario, Canada. The funders made suggestions in the study design, but played no role in data collection and analysis, decision to publish, or preparation of the manuscript.	[Agency-wide Race and Ethnicity Working Group from the Office of the Commissioner the Center for Biologics Evaluation and Research the Center for Drug Evaluation and Research the Center for Devices and Radiological Health of the Food and Drug Administration], 2005, GUID IND COLL RAC ET; Anderson PJ, 1996, EUR J CLIN PHARMACOL, V50, P57, DOI 10.1007/s002280050069; [Anonymous], MIDAS RET PHARM HOSP; Corbie-Smith G, 2003, J CLIN EPIDEMIOL, V56, P416, DOI 10.1016/S0895-4356(03)00031-3; Dagenais GR, 2006, LANCET, V368, P581, DOI 10.1016/S0140-6736(06)69201-5; Dans AL, 1998, JAMA-J AM MED ASSOC, V279, P545, DOI 10.1001/jama.279.7.545; Ding PYA, 2000, J HUM HYPERTENS, V14, P163, DOI 10.1038/sj.jhh.1000856; Lee YJ, 2001, METABOLISM, V50, P1346, DOI 10.1053/meta.2001.27212; McDowell SE, 2006, BMJ-BRIT MED J, V332, P1177, DOI 10.1136/bmj.38803.528113.55; Morimoto T, 2004, J GEN INTERN MED, V19, P684, DOI 10.1111/j.1525-1497.2004.30016.x; So WY, 2006, KIDNEY INT, V69, P1438, DOI 10.1038/sj.ki.5000097; Tatami Shinji, 2004, Drug Metab Pharmacokinet, V19, P15; Teo KK, 2004, AM HEART J, V148, P52, DOI 10.1016/j.ahj.2004.03.020; Yusuf S, 2008, LANCET, V372, P1174, DOI 10.1016/S0140-6736(08)61242-8; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Yusuf S, 2008, NEW ENGL J MED, V359, P1225, DOI 10.1056/NEJMoa0804593; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	17	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e13694	10.1371/journal.pone.0013694	http://dx.doi.org/10.1371/journal.pone.0013694			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21200437	gold, Green Published, Green Submitted			2022-12-27	WOS:000285576900001
J	Porco, D; Bedos, A; Deharveng, L				Porco, David; Bedos, Anne; Deharveng, Louis			Cuticular Compounds Bring New Insight in the Post-Glacial Recolonization of a Pyrenean Area: Deutonura deficiens Deharveng, 1979 Complex, a Case Study	PLOS ONE			English	Article							CONTACT SEX-PHEROMONE; MEADOW GRASSHOPPER; HYBRID ZONE; AGGREGATION PHEROMONES; SPECIES DELIMITATION; HYDROCARBONS; COLLEMBOLA; DIVERGENCE; PATTERNS; LIPIDS	Background: In most Arthropod groups, the study of systematics and evolution rely mostly on neutral characters, in this context cuticular compounds, as non-neutral characters, represent an underexplored but potentially informative type of characters at the infraspecific level as they have been routinely proven to be involved in sexual attraction. Methods and Findings: The collembolan species complex Deutonura deficiens was chosen as a model in order to test the utility of these characters for delineating four infraspecific entities of this group. Specimens were collected for three subspecies (D.d. deficiens, D.d. meridionalis, D.d. sylvatica) and two morphotypes (D.d. sylvatica morphoype A and B) of the complex; an additional species D. monticola was added. Cuticular compounds were extracted and separated by gas chromatography for each individual. Our results demonstrate that cuticular compounds succeeded in separating the different elements of this complex. Those data allowed also the reconstruction of the phylogenetic relationships among them. Conclusions: The discriminating power of cuticular compounds is directly related to their involvement in sexual attraction and mate recognition. These findings allowed a discussion on the potential involvement of intrinsic and paleoclimatic factors in the origin and the diversification of this complex in the Pyrenean zone. This character type brings the first advance from pattern to process concerning the origin of this species complex.	[Porco, David] Univ Toulouse 3, Lab Dynam Biodiversite, F-31062 Toulouse, France; [Bedos, Anne; Deharveng, Louis] Museum Natl Hist Nat, UMR CNRS Origine Struct & Evolut Biodiversite 720, F-75231 Paris, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Museum National d'Histoire Naturelle (MNHN)	Porco, D (corresponding author), Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada.	dporco@uoguelph.ca	Porco, David/D-7781-2011; Deharveng, Louis/D-7275-2012		Laboratoire d'Ecologie Terrestre (Universite Paul Sabatier - CNRS)	Laboratoire d'Ecologie Terrestre (Universite Paul Sabatier - CNRS)	This research was funded by the Laboratoire d'Ecologie Terrestre (Universite Paul Sabatier - CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audzijonyte A, 2008, MAR BIOL, V155, P599, DOI 10.1007/s00227-008-1055-3; Austin JW, 2007, ZOOTAXA, P1; BAGINE RKN, 1994, ANN ENTOMOL SOC AM, V87, P498, DOI 10.1093/aesa/87.5.498; Baracchi D, 2010, J ZOOL SYST EVOL RES, V48, P109, DOI 10.1111/j.1439-0469.2009.00543.x; Benoit JB, 2009, J INSECT BEHAV, V22, P121, DOI 10.1007/s10905-008-9159-7; Buckley SH, 2003, BIOL J LINN SOC, V78, P193, DOI 10.1046/j.1095-8312.2003.00147.x; Buczkowski G, 2006, ANIM BEHAV, V71, P327, DOI 10.1016/j.anbehav.2005.04.012; Carlson DA, 1997, J AM MOSQUITO CONTR, V13, P103; CHAPMAN RF, 1995, BIOCHEM SYST ECOL, V23, P383, DOI 10.1016/0305-1978(95)00032-P; Clement Jean-Luc, 1998, P126; de Freitas TRO, 2006, GENETICA, V126, P227, DOI 10.1007/s10709-005-1451-2; DEHARVENG L, 1984, REV ECOL BIOL SOL, V21, P533; Deharveng L, 1998, BIOL J LINN SOC, V64, P527, DOI 10.1006/bijl.1998.0246; Driscoll DA, 2007, AUST J ZOOL, V55, P371, DOI 10.1071/ZO08020; Gava A, 2004, J MAMMAL, V85, P1201, DOI 10.1644/BEL-017.1; Godinho R, 2008, MOL ECOL, V17, P4670, DOI 10.1111/j.1365-294X.2008.03929.x; Gonzalez J, 2008, J ORNITHOL, V149, P495, DOI 10.1007/s10336-008-0293-y; Guiot J, 1997, NATURE, V388, P25, DOI 10.1038/40282; Haverty MI, 2005, J CHEM ECOL, V31, P2119, DOI 10.1007/s10886-005-6081-8; Haverty MI, 1999, SOCIOBIOLOGY, V34, P1; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Higgie M, 2008, EVOLUTION, V62, P1192, DOI 10.1111/j.1558-5646.2008.00357.x; Hwang DS, 2008, MITOCHONDR DNA, V19, P418, DOI 10.1080/19401730802389525; JOOSSE ENG, 1979, ENTOMOL EXP APPL, V26, P197, DOI 10.1111/j.1570-7458.1979.tb02917.x; Kaib M, 2002, PHYSIOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-3032.2002.00292.x; Kovats E, 1965, ADV CHROMATOGR, V1, P229; Lahav S, 1999, NATURWISSENSCHAFTEN, V86, P246, DOI 10.1007/s001140050609; LOCKEY KH, 1988, COMP BIOCHEM PHYS B, V89, P595, DOI 10.1016/0305-0491(88)90305-7; Manica A, 2001, ENTOMOL EXP APPL, V99, P393, DOI 10.1023/A:1019227412274; Marten A, 2009, J CHEM ECOL, V35, P572, DOI 10.1007/s10886-009-9626-4; MERTENS J, 1977, BEHAV ECOL SOCIOBIOL, V2, P41, DOI 10.1007/BF00299287; Messer C, 1999, PEDOBIOLOGIA, V43, P174; Mpuru S, 2001, INSECT BIOCHEM MOLEC, V31, P139, DOI 10.1016/S0965-1748(00)00098-9; NEEMS RM, 1995, BIOL J LINN SOC, V54, P139, DOI 10.1006/bijl.1995.0008; Nelson DR, 2003, COMP BIOCHEM PHYS B, V135, P273, DOI 10.1016/S1096-4959(03)00080-0; Nojima S, 2007, J CHEM ECOL, V33, P923, DOI 10.1007/s10886-007-9266-5; Page M, 1997, J CHEM ECOL, V23, P1053, DOI 10.1023/B:JOEC.0000006388.92425.ec; Peterson MA, 2007, CHEMOECOLOGY, V17, P87, DOI 10.1007/s00049-007-0366-z; Porco D, 2004, PEDOBIOLOGIA, V48, P581, DOI 10.1016/j.pedobi.2004.05.010; Porco D, 2007, BIOCHEM SYST ECOL, V35, P160, DOI 10.1016/j.bse.2006.09.005; Porco D, 2009, PEDOBIOLOGIA, V53, P59, DOI 10.1016/j.pedobi.2009.03.003; Porco D, 2009, NATURWISSENSCHAFTEN, V96, P943, DOI 10.1007/s00114-009-0555-4; Previsic A, 2009, MOL ECOL, V18, P634, DOI 10.1111/j.1365-294X.2008.04046.x; PURRINGTON FF, 1991, GREAT LAKES ENTOMOL, V24, P75; Rougerie R, 2006, PEDOBIOLOGIA, V50, P83, DOI 10.1016/j.pedobi.2005.09.003; Singer TL, 1998, AM ZOOL, V38, P394; Smadja C, 2009, HEREDITY, V102, P77, DOI 10.1038/hdy.2008.55; Sugeno W, 2006, APPL ENTOMOL ZOOL, V41, P269, DOI 10.1303/aez.2006.269; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tregenza T, 2000, EVOLUTION, V54, P574, DOI 10.1111/j.0014-3820.2000.tb00060.x; Tregenza T, 2000, J CHEM ECOL, V26, P257, DOI 10.1023/A:1005457931869; Tregenza T, 2000, EVOLUTION, V54, P1; VERHOEF HA, 1977, J INSECT PHYSIOL, V23, P1009, DOI 10.1016/0022-1910(77)90128-7; Volobouev V, 2007, BIOL J LINN SOC, V91, P203, DOI 10.1111/j.1095-8312.2007.00773.x; WALDORF ES, 1974, ENVIRON ENTOMOL, V3, P916, DOI 10.1093/ee/3.6.916	55	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e14405	10.1371/journal.pone.0014405	http://dx.doi.org/10.1371/journal.pone.0014405			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21209797	Green Published, gold, Green Submitted			2022-12-27	WOS:000285576900015
J	Stokman, G; Stroo, I; Claessen, N; Teske, GJD; Weening, JJ; Leemans, JC; Florquin, S				Stokman, Geurt; Stroo, Ingrid; Claessen, Nike; Teske, Gwendoline J. D.; Weening, Jan J.; Leemans, Jaklien C.; Florquin, Sandrine			Stem Cell Factor Expression after Renal Ischemia Promotes Tubular Epithelial Survival	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; RECEPTOR C-KIT; ISCHEMIA/REPERFUSION INJURY; REPERFUSION INJURY; GROWTH-FACTOR; ADULT; ERYTHROPOIETIN; HEMATOPOIESIS; APOPTOSIS; MIGRATION	Background: Renal ischemia leads to apoptosis of tubular epithelial cells and results in decreased renal function. Tissue repair involves re-epithelialization of the tubular basement membrane. Survival of the tubular epithelium following ischemia is therefore important in the successful regeneration of renal tissue. The cytokine stem cell factor (SCF) has been shown to protect the tubular epithelium against apoptosis. Methodology/Principal Findings: In a mouse model for renal ischemia/reperfusion injury, we studied how expression of c-KIT on tubular epithelium and its ligand SCF protect cells against apoptosis. Administration of SCF specific antisense oligonucleotides significantly decreased specific staining of SCF following ischemia. Reduced SCF expression resulted in impaired renal function, increased tubular damage and increased tubular epithelial apoptosis, independent of inflammation. In an in vitro hypoxia model, stimulation of tubular epithelial cells with SCF activated survival signaling and decreased apoptosis. Conclusions/Significance: Our data indicate an important role for c-KIT and SCF in mediating tubular epithelial cell survival via an autocrine pathway.	[Stokman, Geurt; Stroo, Ingrid; Claessen, Nike; Teske, Gwendoline J. D.; Weening, Jan J.; Leemans, Jaklien C.; Florquin, Sandrine] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Stokman, G (corresponding author), Leiden Univ, Div Toxicol, LACDR, Leiden, Netherlands.	g.stokman@lacdr.leidenuniv.nl	Leemans, Jaklien/AAM-4958-2020; Florquin, Sandrine/B-8242-2012	Florquin, Sandrine/0000-0002-9676-1722	Netherlands Organisation for Scientific Research (NWO) [Vidi 917.36.336]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The present study was supported by a grant from the Netherlands Organisation for Scientific Research (NWO), project number Vidi 917.36.336. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anversa P, 2006, CIRCULATION, V113, P1451, DOI 10.1161/CIRCULATIONAHA.105.595181; ARGUELLO F, 1992, CANCER RES, V52, P2304; Ashman LK, 1999, INT J BIOCHEM CELL B, V31, P1037, DOI 10.1016/S1357-2725(99)00076-X; Bengatta S, 2009, J AM SOC NEPHROL, V20, P787, DOI 10.1681/ASN.2008050515; Blume-Jensen P, 1998, CURR BIOL, V8, P779, DOI 10.1016/S0960-9822(98)70302-1; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; Cantley LG, 2005, NAT CLIN PRACT NEPHR, V1, P22, DOI 10.1038/ncpneph0021; Duffield JS, 2005, J CLIN INVEST, V115, P1743, DOI 10.1172/JCI22593; Erlandsson A, 2004, EXP CELL RES, V301, P201, DOI 10.1016/j.yexcr.2004.08.009; FLANAGAN JG, 1991, CELL, V64, P1025, DOI 10.1016/0092-8674(91)90326-T; Han ZB, 2008, CARCINOGENESIS, V29, P1853, DOI 10.1093/carcin/bgn066; HUANG EJ, 1992, MOL BIOL CELL, V3, P349, DOI 10.1091/mbc.3.3.349; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Kato N, 2005, PATHOL INT, V55, P479, DOI 10.1111/j.1440-1827.2005.01856.x; Kim YH, 2001, J AM SOC NEPHROL, V12, P1795, DOI 10.1681/ASN.V1291795; KINASHI T, 1994, BLOOD, V83, P1033; Komuro T, 1996, HISTOL HISTOPATHOL, V11, P769; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Lin FM, 2003, J AM SOC NEPHROL, V14, P1188, DOI 10.1097/01.ASN.0000061595.28546.A0; Meldrum KK, 2001, J SURG RES, V99, P288, DOI 10.1006/jsre.2001.6201; Miliaras D, 2004, J CLIN PATHOL, V57, P463, DOI 10.1136/jcp.2003.013532; Miura M, 2001, AM J PATHOL, V159, P2137, DOI 10.1016/S0002-9440(10)63065-9; Molls RR, 2006, AM J PHYSIOL-RENAL, V290, pF1187, DOI 10.1152/ajprenal.00342.2005; Munugalavadla V, 2005, CRIT REV ONCOL HEMAT, V54, P63, DOI 10.1016/j.critrevonc.2004.11.005; Nishida T, 2000, HISTOL HISTOPATHOL, V15, P1293, DOI 10.14670/HH-15.1293; OKADA S, 1991, BLOOD, V78, P1706; Oliver JA, 2004, J CLIN INVEST, V114, P795, DOI 10.1172/JCI200420921; Padanilam BJ, 2003, AM J PHYSIOL-RENAL, V284, pF608, DOI 10.1152/ajprenal.00284.2002; Perez-Losada J, 2002, BLOOD, V100, P1274, DOI 10.1182/blood.V100.4.1274.h81602001274_1274_1286; Reber L, 2006, EUR J PHARMACOL, V533, P327, DOI 10.1016/j.ejphar.2005.12.067; Reilly JT, 2003, BLOOD REV, V17, P241, DOI 10.1016/S0268-960X(03)00024-9; Roelofs JJTH, 2006, J AM SOC NEPHROL, V17, P131, DOI 10.1681/ASN.2005010089; RONCO P, 1988, LAB INVEST, V58, P210; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; Rossi P, 2000, J ENDOCRINOL INVEST, V23, P609, DOI 10.1007/BF03343784; Schmidt-Ott KM, 2006, DEV BIOL, V299, P238, DOI 10.1016/j.ydbio.2006.07.026; Sharpies EJ, 2006, SEMIN NEPHROL, V26, P325, DOI 10.1016/j.semnephrol.2006.05.010; Stokman G, 2005, J AM SOC NEPHROL, V16, P1684, DOI 10.1681/ASN.2004080678; Sun LX, 2004, J CLIN INVEST, V113, P1364, DOI 10.1172/JCI200420001; Tamborini E, 2004, CLIN CANCER RES, V10, P8214, DOI 10.1158/1078-0432.CCR-04-1013; van de Water B, 2006, TOXICOL LETT, V162, P83, DOI 10.1016/j.toxlet.2005.10.014; Yoshida H, 2001, J INVEST DERM SYMP P, V6, P1, DOI 10.1046/j.0022-202x.2001.00006.x	43	23	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e14386	10.1371/journal.pone.0014386	http://dx.doi.org/10.1371/journal.pone.0014386			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21200435	Green Published, Green Submitted, gold			2022-12-27	WOS:000285576900005
J	Song, NN; Xiu, JB; Huang, Y; Chen, JY; Zhang, L; Gutknecht, L; Lesch, KP; Li, H; Ding, YQ				Song, Ning-Ning; Xiu, Jian-Bo; Huang, Ying; Chen, Jia-Yin; Zhang, Lei; Gutknecht, Lise; Lesch, Klaus Peter; Li, He; Ding, Yu-Qiang			Adult Raphe-Specific Deletion of Lmx1b Leads to Central Serotonin Deficiency	PLOS ONE			English	Article							MOLECULAR-GENETICS; SONIC HEDGEHOG; NEURONS; MICE; BRAIN; EXPRESSION; SYSTEM; PET-1; TRANSPORTER; DISORDERS	The transcription factor Lmx1b is essential for the differentiation and survival of central serotonergic (5-HTergic) neurons during embryonic development. However, the role of Lmx1b in adult 5-HTergic neurons is unknown. We used an inducible Cre-LoxP system to selectively inactivate Lmx1b expression in the raphe nuclei of adult mice. Pet1-CreER(T2) mice were generated and crossed with Lmx1b(flox/flox) mice to obtain Pet1-CreER(T2); Lmx1b(flox/flox) mice (which termed as Lmx1b iCKO). After administration of tamoxifen, the level of 5-HT in the brain of Lmx1b iCKO mice was reduced to 60% of that in control mice, and the expression of tryptophan hydroxylase 2 (Tph2), serotonin transporter (Sert) and vesicular monoamine transporter 2 (Vmat2) was greatly down-regulated. On the other hand, the expression of dopamine and norepinephrine as well as aromatic L-amino acid decarboxylase (Aadc) and Pet1 was unchanged. Our results reveal that Lmx1b is required for the biosynthesis of 5-HT in adult mouse brain, and it may be involved in maintaining normal functions of central 5-HTergic neurons by regulating the expression of Tph2, Sert and Vmat2.	[Song, Ning-Ning; Xiu, Jian-Bo; Huang, Ying; Chen, Jia-Yin; Zhang, Lei; Ding, Yu-Qiang] Tongji Univ, Dept Anat & Neurobiol, Sch Med, Shanghai 200092, Peoples R China; [Gutknecht, Lise; Lesch, Klaus Peter] Univ Wurzburg, Dept Psychiat & Psychotherapy, Wurzburg, Germany; [Li, He] Huazhong Univ Sci & Technol, Key Lab Nervous Syst Dis, Minist Educ China, Div Histol & Embryol,Dept Anat,Tongji Med Coll, Wuhan 430074, Peoples R China	Tongji University; University of Wurzburg; Huazhong University of Science & Technology; Ministry of Education, China	Song, NN (corresponding author), Tongji Univ, Dept Anat & Neurobiol, Sch Med, Shanghai 200092, Peoples R China.	songnn1982@gmail.com; dingyuqiang@gmail.com	Lesch, Klaus-Peter/J-4906-2013	Lesch, Klaus-Peter/0000-0001-8348-153X; Ding, Yu-Qiang/0000-0003-1202-4635; Song, Ning-Ning/0000-0001-5206-1911; Zhang, Lei/0000-0001-7242-5292	National Natural Science Foundation of China [30430260]; Ministry of Science and Technology of China [2006CB943903, 2007CB512303, 2009ZX09501-030]; Deutsche Forschungsgemeinschaft [KFO 125, SFB 581, SFB TRR 58]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the National Natural Science Foundation of China (30430260), the Ministry of Science and Technology of China (2006CB943903, 2007CB512303, 2009ZX09501-030) and the Deutsche Forschungsgemeinschaft (KFO 125, SFB 581, SFB TRR 58). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG DM, 1982, J COMP NEUROL, V212, P173, DOI 10.1002/cne.902120207; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; Bonnin A, 2007, NAT NEUROSCI, V10, P588, DOI 10.1038/nn1896; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Cheng LP, 2003, J NEUROSCI, V23, P9961; COPPEN ALEC, 1967, BRIT J PSYCHIAT, V113, P1237, DOI 10.1192/bjp.113.504.1237; Cordes SP, 2005, CLIN GENET, V68, P487, DOI 10.1111/j.1399-0004.2005.00534.x; Craven SE, 2004, DEVELOPMENT, V131, P1165, DOI 10.1242/dev.01024; Dai JX, 2008, P NATL ACAD SCI USA, V105, P11981, DOI 10.1073/pnas.0801329105; Dai JX, 2008, J COMP NEUROL, V509, P341, DOI 10.1002/cne.21759; Ding YQ, 2003, NAT NEUROSCI, V6, P933, DOI 10.1038/nn1104; Fon EA, 1997, NEURON, V19, P1271, DOI 10.1016/S0896-6273(00)80418-3; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Guo C, 2007, DEVELOPMENT, V134, P317, DOI 10.1242/dev.02745; Gutknecht L, 2008, J NEURAL TRANSM, V115, P1127, DOI 10.1007/s00702-008-0096-6; Gutknecht L, 2009, EUR NEUROPSYCHOPHARM, V19, P266, DOI 10.1016/j.euroneuro.2008.12.005; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Koed K, 2000, EUR NEUROPSYCHOPHARM, V10, P501, DOI 10.1016/S0924-977X(00)00121-8; Liu C, 2010, NAT NEUROSCI, V13, P1190, DOI 10.1038/nn.2623; Lowry CA, 2008, ANN NY ACAD SCI, V1148, P86, DOI 10.1196/annals.1410.004; Middlemiss DN, 2002, CURR OPIN PHARMACOL, V2, P18, DOI 10.1016/S1471-4892(01)00116-3; Naughton M, 2000, HUM PSYCHOPHARM CLIN, V15, P397, DOI 10.1002/1099-1077(200008)15:6<397::AID-HUP212>3.3.CO;2-C; Pattyn A, 2004, NAT NEUROSCI, V7, P589, DOI 10.1038/nn1247; Paxinos G, 2001, MOUSE BRAIN STEREOTA, pxxv; Scott MM, 2005, P NATL ACAD SCI USA, V102, P16472, DOI 10.1073/pnas.0504510102; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; van Doorninck J H, 1999, J Neurosci, V19, pRC12; Yan W, 1997, DEV BRAIN RES, V98, P185, DOI 10.1016/S0165-3806(96)00175-7; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Young P, 2008, NAT NEUROSCI, V11, P721, DOI 10.1038/nn.2118; Zhang XD, 2004, SCIENCE, V305, P217, DOI 10.1126/science.1097540; Zhao ZQ, 2006, J NEUROSCI, V26, P12781, DOI 10.1523/JNEUROSCI.4143-06.2006	34	58	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15998	10.1371/journal.pone.0015998	http://dx.doi.org/10.1371/journal.pone.0015998			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246047	Green Published, gold			2022-12-27	WOS:000286511200031
J	Woltman, AM; den Brouw, MLO; Biesta, PJ; Shi, CC; Janssen, HLA				Woltman, Andrea M.; den Brouw, Marjoleine L. Op; Biesta, Paula J.; Shi, Cui C.; Janssen, Harry L. A.			Hepatitis B Virus Lacks Immune Activating Capacity, but Actively Inhibits Plasmacytoid Dendritic Cell Function	PLOS ONE			English	Article							IFN-ALPHA PRODUCTION; NONPARENCHYMAL LIVER-CELLS; C VIRUS; VIRAL-INFECTION; GENE-EXPRESSION; NATURAL-KILLER; I INTERFERON; RECEPTOR; HBV; IMMUNOLOGY	Chronic hepatitis B virus (HBV) infection is caused by inadequate anti-viral immunity. Activation of plasmacytoid dendritic cells (pDC) leading to IFN alpha production is important for effective anti-viral immunity. Hepatitis B virus (HBV) infection lacks IFN alpha induction in animal models and patients and chronic HBV patients display impaired IFN alpha production by pDC. Therefore, HBV and HBV-derived proteins were examined for their effect on human pDC in vitro. In addition, the in vitro findings were compared to the function of pDC derived from chronic HBV patients ex vivo. In contrast to other viruses, HBV did not activate pDC. Moreover, HBV and HBsAg abrogated CpG-A/TLR9-induced, but not Loxoribine/TLR7-induced, mTOR-mediated S6 phosphorylation, subsequent IRF7 phosphorylation and IFN alpha gene transcription. HBV/HBsAg also diminished upregulation of co-stimulatory molecules, production of TNF alpha, IP-10 and IL-6 and pDC-induced NK cell function, whereas TLR7-induced pDC function was hardly affected. In line, HBsAg preferentially bound to TLR9-triggered pDC demonstrating that once pDC are able to bind HBV/HBsAg, the virus exerts its immune regulatory effect. HBV not only directly interfered with pDC function, but also indirectly by interfering with monocyte-pDC interaction. Also HBeAg diminished pDC function to a certain extent, but via another unknown mechanism. Interestingly, patients with HBeAg-positive chronic hepatitis B displayed impaired CpG-induced IFN alpha production by pDC without significant alterations in Loxoribine-induced pDC function compared to HBeAg-negative patients and healthy controls. The lack of activation and the active inhibition of pDC by HBV may both contribute to HBV persistence. The finding that the interaction between pDC and HBV may change upon activation may aid in the identification of a scavenging receptor supporting immunosuppressive effects of HBV and also in the design of novel treatment strategies for chronic HBV.	[Woltman, Andrea M.; den Brouw, Marjoleine L. Op; Biesta, Paula J.; Shi, Cui C.; Janssen, Harry L. A.] Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Shi, Cui C.] Rujin Hosp, Dept Infect Dis, Shanghai, Peoples R China	Erasmus University Rotterdam; Erasmus MC	Woltman, AM (corresponding author), Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands.	a.woltman@erasmusmc.nl	Woltman, Andrea/GYV-2656-2022	Woltman, Andrea/0000-0001-9904-6751	Netherlands Organisation for Scientific Research (NWO) [Veni 916.66.015, Vidi 917.59.329]; China Scholarship Council	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); China Scholarship Council(China Scholarship Council)	This study was supported by grants from the Netherlands Organisation for Scientific Research (NWO) to AW (Veni 916.66.015) and HJ (Vidi 917.59.329) and China Scholarship Council to CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boonstra A, 2008, BEST PRACT RES CL GA, V22, P1049, DOI 10.1016/j.bpg.2008.11.015; Cao W, 2006, J EXP MED, V203, P1399, DOI 10.1084/jem.20052454; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Chen M, 2005, J VIROL, V79, P3016, DOI 10.1128/JVI.79.5.3016-3027.2005; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Della Chiesa M, 2005, TRENDS MICROBIOL, V13, P128, DOI 10.1016/j.tim.2005.01.006; Della Chiesa M, 2006, BLOOD, V108, P3851, DOI 10.1182/blood-2006-02-004028; den Brouw MLO, 2008, J VIRAL HEPATITIS, V15, P675, DOI 10.1111/j.1365-2893.2008.00993.x; den Brouw MLO, 2009, VIROLOGY, V393, P84, DOI 10.1016/j.virol.2009.07.015; den Brouw MLO, 2009, IMMUNOLOGY, V126, P280, DOI 10.1111/j.1365-2567.2008.02896.x; Duan XZ, 2004, J CLIN IMMUNOL, V24, P637, DOI 10.1007/s10875-004-6249-y; Dunn C, 2009, GASTROENTEROLOGY, V137, P1289, DOI 10.1053/j.gastro.2009.06.054; Fanning SL, 2006, J IMMUNOL, V177, P5829, DOI 10.4049/jimmunol.177.9.5829; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Glebe D, 2007, WORLD J GASTROENTERO, V13, P22, DOI 10.3748/wjg.v13.i1.22; Hosel M, 2009, HEPATOLOGY, V50, P1773, DOI 10.1002/hep.23226; Ito T, 2005, SPRINGER SEMIN IMMUN, V26, P221, DOI 10.1007/s00281-004-0180-4; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Liu BS, 2009, J LEUKOCYTE BIOL, V85, P205, DOI 10.1189/jlb.0408241; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McHutchison JG, 2007, HEPATOLOGY, V46, P1341, DOI 10.1002/hep.21773; Meyer-Wentrup F, 2008, BLOOD, V111, P4245, DOI 10.1182/blood-2007-03-081398; Oliviero B, 2009, GASTROENTEROLOGY, V137, P1151, DOI 10.1053/j.gastro.2009.05.047; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Tavakoli S, 2008, CLIN EXP IMMUNOL, V151, P61, DOI 10.1111/j.1365-2249.2007.03547.x; TJWA ETT, J HEPATOL IN PRESS; van der Molen RG, 2006, HEPATOLOGY, V44, P907, DOI 10.1002/hep.21340; van der Molen RG, 2004, HEPATOLOGY, V40, P738, DOI 10.1002/hep.20366; Vanlandschoot P, 2002, J GEN VIROL, V83, P1281, DOI 10.1099/0022-1317-83-6-1281; Wieland S, 2004, P NATL ACAD SCI USA, V101, P6669, DOI 10.1073/pnas.0401771101; Woltman AM, 2010, GUT, V59, P115, DOI 10.1136/gut.2009.181040; Wu J, 2007, HEPATOLOGY, V46, P1769, DOI 10.1002/hep.21897; Wu J, 2009, HEPATOLOGY, V49, P1132, DOI 10.1002/hep.22751; Xie Q, 2009, MICROBES INFECT, V11, P515, DOI 10.1016/j.micinf.2009.02.008; Xu Y, 2009, MOL IMMUNOL, V46, P2640, DOI 10.1016/j.molimm.2009.04.031	39	109	141	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15324	10.1371/journal.pone.0015324	http://dx.doi.org/10.1371/journal.pone.0015324			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246041	Green Published, gold, Green Submitted			2022-12-27	WOS:000286511200007
J	Bohn, M; Heermann, DW				Bohn, Manfred; Heermann, Dieter W.			Repulsive Forces Between Looping Chromosomes Induce Entropy-Driven Segregation	PLOS ONE			English	Article							INTERPHASE CHROMOSOMES; GENE-REGULATION; MONTE-CARLO; CHROMATIN; GENOME; MODEL; CONFORMATION; ORGANIZATION; SIMULATION; POLYMERS	One striking feature of chromatin organization is that chromosomes are compartmentalized into distinct territories during interphase, the degree of intermingling being much smaller than expected for linear chains. A growing body of evidence indicates that the formation of loops plays a dominant role in transcriptional regulation as well as the entropic organization of interphase chromosomes. Using a recently proposed model, we quantitatively determine the entropic forces between chromosomes. This Dynamic Loop Model assumes that loops form solely on the basis of diffusional motion without invoking other long-range interactions. We find that introducing loops into the structure of chromatin results in a multi-fold higher repulsion between chromosomes compared to linear chains. Strong effects are observed for the tendency of a non-random alignment; the overlap volume between chromosomes decays fast with increasing loop number. Our results suggest that the formation of chromatin loops imposes both compartmentalization as well as order on the system without requiring additional energy-consuming processes.	[Bohn, Manfred; Heermann, Dieter W.] Univ Heidelberg, Inst Theoret Phys, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Bohn, M (corresponding author), Univ Heidelberg, Inst Theoret Phys, Heidelberg, Germany.	bohn@tphys.uni-heidelberg.de			Landesgraduiertenfoerderung Baden-Wuerttemberg	Landesgraduiertenfoerderung Baden-Wuerttemberg	MB acknowledges funding from the Landesgraduiertenfoerderung Baden-Wuerttemberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantignies F, 2003, GENE DEV, V17, P2406, DOI 10.1101/gad.269503; Binder K, 2002, MONTE CARLO SIMULATI; Binder K., 1995, MONTE CARLO MOL DYNA; BOHN M, 2009, MACROMOLECULES UNPUB; BOHN M, 2010, J CHEM PHYS IN PRESS; Bohn M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051805; Bohn M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012218; BRANCO M, 2006, PLOS BIOL, V4, P97; CARMESIN I, 1988, MACROMOLECULES, V21, P2819, DOI 10.1021/ma00187a030; Cook PR, 2009, J CELL BIOL, V186, P825, DOI 10.1083/jcb.200903083; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; DAUTENHAHN J, 1994, MACROMOLECULES, V27, P5399, DOI 10.1021/ma00097a021; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DEUTSCH HP, 1991, J CHEM PHYS, V94, P2294, DOI 10.1063/1.459901; Diesinger PM, 2009, BIOPHYS J, V97, P2146, DOI 10.1016/j.bpj.2009.06.057; Galande S, 2007, CURR OPIN GENET DEV, V17, P408, DOI 10.1016/j.gde.2007.08.003; Goetze S, 2007, MOL CELL BIOL, V27, P4475, DOI 10.1128/MCB.00208-07; Langowski J, 2006, EUR PHYS J E, V19, P241, DOI 10.1140/epje/i2005-10067-9; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Marenduzzo D, 2007, TRENDS GENET, V23, P126, DOI 10.1016/j.tig.2007.01.007; Mateos-Langerak J, 2009, P NATL ACAD SCI USA, V106, P3812, DOI 10.1073/pnas.0809501106; Munkel C, 1999, J MOL BIOL, V285, P1053, DOI 10.1006/jmbi.1998.2361; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Rawdon EJ, 2008, MACROMOLECULES, V41, P8281, DOI 10.1021/ma801389c; Rosa A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000153; SACHS RK, 1995, P NATL ACAD SCI USA, V92, P2710, DOI 10.1073/pnas.92.7.2710; Schiessel H, 2001, BIOPHYS J, V80, P1940, DOI 10.1016/S0006-3495(01)76164-4; SIKORAV JL, 1994, BIOPHYS J, V66, P827, DOI 10.1016/S0006-3495(94)80859-8; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Sokal A, 1996, MONTE CARLO METHODS; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5	31	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2011	6	1							e14428	10.1371/journal.pone.0014428	http://dx.doi.org/10.1371/journal.pone.0014428			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KM	21245914	Green Published, Green Submitted, gold			2022-12-27	WOS:000286510500002
J	Maxwell, CR; Spangenberg, RJ; Hoek, JB; Silberstein, SD; Oshinsky, ML				Maxwell, Christina R.; Spangenberg, Rebecca Jay; Hoek, Jan B.; Silberstein, Stephen D.; Oshinsky, Michael L.			Acetate Causes Alcohol Hangover Headache in Rats	PLOS ONE			English	Article							CUTANEOUS ALLODYNIA; ETHANOL-METABOLISM; RED WINE; MIGRAINE; BLOOD; ACETALDEHYDE; DISULFIRAM; OXIDATION; PHONOPHOBIA; INHIBITION	Background: The mechanism of veisalgia cephalgia or hangover headache is unknown. Despite a lack of mechanistic studies, there are a number of theories positing congeners, dehydration, or the ethanol metabolite acetaldehyde as causes of hangover headache. Methods: We used a chronic headache model to examine how pure ethanol produces increased sensitivity for nociceptive behaviors in normally hydrated rats. Results: Ethanol initially decreased sensitivity to mechanical stimuli on the face (analgesia), followed 4 to 6 hours later by inflammatory pain. Inhibiting alcohol dehydrogenase extended the analgesia whereas inhibiting aldehyde dehydrogenase decreased analgesia. Neither treatment had nociceptive effects. Direct administration of acetate increased nociceptive behaviors suggesting that acetate, not acetaldehyde, accumulation results in hangover-like hypersensitivity in our model. Since adenosine accumulation is a result of acetate formation, we administered an adenosine antagonist that blocked hypersensitivity. Discussion: Our study shows that acetate contributes to hangover headache. These findings provide insight into the mechanism of hangover headache and the mechanism of headache induction.	[Maxwell, Christina R.; Spangenberg, Rebecca Jay; Silberstein, Stephen D.; Oshinsky, Michael L.] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA; [Hoek, Jan B.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Maxwell, CR (corresponding author), Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA.	Michael.Oshinsky@jefferson.edu		Hoek, Jan/0000-0001-7127-4218; Oshinsky, Michael/0000-0002-0976-1047	National Institutes of Health [F31-AA017852, R01-NS058695]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F31AA017852] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Institutes of Health (F31-AA017852 to CRM, R01-NS058695 to MLO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreou AP, 2010, EXPERT REV NEUROTHER, V10, P389, DOI 10.1586/ERN.10.16; Ashkenazi A, 2009, CEPHALALGIA, V29, P1042, DOI 10.1111/j.1468-2982.2008.01834.x; Ashkenazi A, 2010, J NEUROL NEUROSUR PS, V81, P1256, DOI 10.1136/jnnp.2009.198481; Blau JN, 2005, HEADACHE, V45, P757, DOI 10.1111/j.1526-4610.2005.05143_3.x; Blednow YA, 2003, P NATL ACAD SCI USA, V100, P277, DOI 10.1073/pnas.012682399; BLOOM F, 1982, BRIT J PHARMACOL, V75, P251, DOI 10.1111/j.1476-5381.1982.tb08780.x; BRIDGES SR, 1992, AM J CLIN NUTR, V56, P455, DOI 10.1093/ajcn/56.2.455; Burstein R, 2000, ANN NEUROL, V47, P614, DOI 10.1002/1531-8249(200005)47:5<614::AID-ANA9>3.3.CO;2-E; Burstein R, 2000, BRAIN, V123, P1703, DOI 10.1093/brain/123.8.1703; Campisi P, 1997, EUR J PHARMACOL, V325, P165, DOI 10.1016/S0014-2999(97)00124-6; CARMICHAEL FJ, 1991, J PHARMACOL EXP THER, V259, P403; Chandra D, 2008, ALCOHOL CLIN EXP RES, V32, P10, DOI 10.1111/j.1530-0277.2007.00563.x; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Christiansen I, 1999, CEPHALALGIA, V19, P660, DOI 10.1046/j.1468-2982.1999.019007660.x; Deelchand DK, 2009, J NEUROCHEM, V109, P46, DOI 10.1111/j.1471-4159.2009.05895.x; DEITRICH RA, 2007, NOVART FDN SYMP, V285, P40; Deitrich RA, 2007, NOVART FDN SYMP, V285, P198; Deitrich Richard A, 2007, Novartis Found Symp, V285, P23; DIAMOND SM, 1987, AM J KIDNEY DIS, V9, P3, DOI 10.1016/S0272-6386(87)80155-5; Edelmayer RM, 2009, ANN NEUROL, V65, P184, DOI 10.1002/ana.21537; Eriksson CJP, 2001, ALCOHOL CLIN EXP RES, V25, p15S, DOI 10.1111/j.1530-0277.2001.tb02369.x; FEIERMAN DE, 1986, BIOCHEM J, V239, P671, DOI 10.1042/bj2390671; FERKO AP, 1978, TOXICOL APPL PHARM, V46, P235, DOI 10.1016/0041-008X(78)90154-0; FRIEDMAN HJ, 1980, PHARMACOL BIOCHEM BE, V13, P773, DOI 10.1016/0091-3057(80)90205-1; GOLDBERG L, 1969, BIOCHEM PHARMACOL, V18, P1749, DOI 10.1016/0006-2952(69)90164-6; Gonzalez D, 2008, DURAL STIMULATION IN, V369, P1; HARADA S, 1982, Substance and Alcohol Actions-Misuse, V3, P107; Helander A, 2000, LIFE SCI, V67, P799, DOI 10.1016/S0024-3205(00)00674-3; Howland J, 2008, ADDICTION, V103, P758, DOI 10.1111/j.1360-0443.2008.02181.x; Jakubowski M, 2005, HEADACHE, V45, P850, DOI 10.1111/j.1526-4610.2005.05153.x; Karamanakos PN, 2001, PHARMACOL TOXICOL, V88, P106, DOI 10.1034/j.1600-0773.2001.d01-90.x; KAUFMAN HS, 1988, LANCET, V1, P992; Kumar S, 2009, PSYCHOPHARMACOLOGY, V205, P529, DOI 10.1007/s00213-009-1562-z; Kuster GW, 2006, HEADACHE, V46, P688, DOI 10.1111/j.1526-4610.2006.00419.x; LIEBER CS, 1982, ALCOHOL CLIN EXP RES, V6, P523, DOI 10.1111/j.1530-0277.1982.tb05017.x; LITTLEWOOD JT, 1988, LANCET, V1, P558, DOI 10.1016/S0140-6736(88)91353-0; LUNDQUIST F, 1962, NATURE, V193, P579, DOI 10.1038/193579b0; Nehlig A, 1999, NEUROSCI BIOBEHAV R, V23, P563, DOI 10.1016/S0149-7634(98)00050-5; Nurmi M, 1999, ALCOHOL, V19, P113, DOI 10.1016/S0741-8329(99)00022-1; Oshinsky ML, 2007, HEADACHE, V47, P1026, DOI 10.1111/j.1526-4610.2007.00871.x; Oshinsky Michael L, 2006, Curr Pain Headache Rep, V10, P225, DOI 10.1007/s11916-006-0050-y; Oshinsky ML, 2006, HEADACHE, V46, pS39, DOI 10.1111/j.1526-4610.2006.00489.x; Panconesi A, 2008, J HEADACHE PAIN, V9, P19, DOI 10.1007/s10194-008-0006-1; POHORECKY LA, 1987, LIFE SCI, V41, P1289, DOI 10.1016/0024-3205(87)90208-6; Prat G, 2009, HUM PSYCHOPHARM CLIN, V24, P259, DOI 10.1002/hup.1023; Rosman AS, 2000, ALCOHOL CLIN EXP RES, V24, P958, DOI 10.1097/00000374-200007000-00004; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Sjaastad O, 2004, J HEADACHE PAIN, V5, P230; Sjaastad O, 2004, J HEADACHE PAIN, V5, P181; Stephens R, 2008, ALCOHOL ALCOHOLISM, V43, P163, DOI 10.1093/alcalc/agm160; Swift R, 1998, ALCOHOL HEALTH RES W, V22, P54; TSUKAMOTO S, 1989, ALCOHOL ALCOHOLISM, V24, P101, DOI 10.1093/oxfordjournals.alcalc.a044872; Wall TL, 2000, J STUD ALCOHOL, V61, P13, DOI 10.15288/jsa.2000.61.13; WHITBY JD, 1980, ANAESTHESIA, V35, P502, DOI 10.1111/j.1365-2044.1980.tb03830.x; Wiese JG, 2000, ANN INTERN MED, V132, P897, DOI 10.7326/0003-4819-132-11-200006060-00008; Wieseler J, 2010, J NEUROSCI METH, V185, P236, DOI 10.1016/j.jneumeth.2009.10.006; Wu WP, 2006, NEUROSCI LETT, V402, P164, DOI 10.1016/j.neulet.2006.03.065; Yokoyama M, 2005, ALCOHOL CLIN EXP RES, V29, P1165, DOI 10.1097/01.ALC.0000172457.62535.EE; YOURICK JJ, 1989, BIOCHEM PHARMACOL, V38, P413, DOI 10.1016/0006-2952(89)90380-8; Zimatkin SM, 2006, ALCOHOL CLIN EXP RES, V30, P1500, DOI 10.1111/j.1530-0277.2006.00181.x; Zimatkin SM, 1998, ALCOHOL CLIN EXP RES, V22, P1623, DOI 10.1111/j.1530-0277.1998.tb03958.x	61	34	35	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15963	10.1371/journal.pone.0015963	http://dx.doi.org/10.1371/journal.pone.0015963			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209842	Green Published, gold, Green Submitted			2022-12-27	WOS:000285838900054
J	Strom, S; Rodriguez-Wallberg, K; Holm, F; Bergstrom, R; Eklund, L; Stromberg, AM; Hovatta, O				Strom, Susanne; Rodriguez-Wallberg, Kenny; Holm, Frida; Bergstrom, Rosita; Eklund, Linda; Stromberg, Anne-Marie; Hovatta, Outi			No Relationship between Embryo Morphology and Successful Derivation of Human Embryonic Stem Cell Lines	PLOS ONE			English	Article							SERUM REPLACEMENT MEDIUM; POOR-QUALITY EMBRYOS; MASS ISOLATION; HUMAN ZYGOTES; FEEDER CELLS; BLASTOCYST; DIFFERENTIATION; ENUCLEATION; FIBROBLASTS; EXPRESSION	Background: The large number (30) of permanent human embryonic stem cell (hESC) lines and additional 29 which did not continue growing, in our laboratory at Karolinska Institutet have given us a possibility to analyse the relationship between embryo morphology and the success of derivation of hESC lines. The derivation method has been improved during the period 2002-2009, towards fewer xeno-components. Embryo quality is important as regards the likelihood of pregnancy, but there is little information regarding likelihood of stem cell derivation. Methods: We evaluated the relationship of pronuclear zygote stage, the score based on embryo morphology and developmental rate at cleavage state, and the morphology of the blastocyst at the time of donation to stem cell research, to see how they correlated to successful establishment of new hESC lines. Results: Derivation of hESC lines succeeded from poor quality and good quality embryos in the same extent. In several blastocysts, no real inner cell mass (ICM) was seen, but permanent well growing hESC lines could be established. One tripronuclear (3PN) zygote, which developed to blastocyst stage, gave origin to a karyotypically normal hESC line. Conclusion: Even very poor quality embryos with few cells in the ICM can give origin to hESC lines.	[Strom, Susanne; Rodriguez-Wallberg, Kenny; Holm, Frida; Bergstrom, Rosita; Stromberg, Anne-Marie; Hovatta, Outi] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Rodriguez-Wallberg, Kenny; Eklund, Linda] Karolinska Univ Hosp, Fertil Unit, Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Strom, S (corresponding author), Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.	susanne.strom@ki.se		Rodriguez-Wallberg, Kenny A./0000-0003-4378-6181	Swedish Research Council; Karolinska Institutet; KID; R&D funding of Stockholm County	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); KID; R&D funding of Stockholm County	This study was supported by the Swedish Research Council and by Karolinska Institutet, KID-funding, and by the R&D funding of Stockholm County and Karolinska Institutet (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanova L, 2006, FERTIL STERIL, V86, P1193, DOI 10.1016/j.fertnstert.2005.12.081; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; Chung Y, 2008, CELL STEM CELL, V2, P113, DOI 10.1016/j.stem.2007.12.013; Cortes JL, 2008, STEM CELLS DEV, V17, P255, DOI 10.1089/scd.2007.0157; Ellerstrom C, 2006, STEM CELLS, V24, P2170, DOI 10.1634/stemcells.2006-0130; Escriba MJ, 2006, FERTIL STERIL, V86, P1601, DOI 10.1016/j.fertnstert.2006.04.047; Feki A, 2008, SWISS MED WKLY, V138, P540, DOI 2008/37/smw-12385; FINN A, 2010, J REPROD BIOMED ONLI, V21, P381; Gardner David K., 2000, Hum Fertil (Camb), V3, P229, DOI 10.1080/1464727002000199051; Heins N, 2004, STEM CELLS, V22, P367, DOI 10.1634/stemcells.22-3-367; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Hovatta O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010263; Inzunza J, 2005, STEM CELLS, V23, P544, DOI 10.1634/stemcells.2004-0201; Ivakhnenko V, 2000, HUM REPROD, V15, P911, DOI 10.1093/humrep/15.4.911; Kattera S, 2003, HUM REPROD, V18, P1319, DOI 10.1093/humrep/deg262; Klimanskaya I, 2007, NAT PROTOC, V2, P1963, DOI 10.1038/nprot.2007.274; Klimanskaya I, 2006, NATURE, V444, P481, DOI 10.1038/nature05142; Koivisto H, 2004, REPROD BIOMED ONLINE, V9, P330, DOI 10.1016/S1472-6483(10)62150-5; Lerou PH, 2008, NAT PROTOC, V3, P923, DOI 10.1038/nprot.2008.60; Lerou PH, 2008, NAT BIOTECHNOL, V26, P212, DOI 10.1038/nbt1378; Liu WQ, 2009, J GENET GENOMICS, V36, P229, DOI 10.1016/S1673-8527(08)60110-1; MOHR L R, 1985, Journal of In Vitro Fertilization and Embryo Transfer, V2, P1, DOI 10.1007/BF01130825; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Sathananthan AH, 1999, HUM REPROD UPDATE, V5, P553, DOI 10.1093/humupd/5.5.553; Skottman H, 2006, STEM CELLS, V24, P151, DOI 10.1634/stemcells.2004-0189; SOLTER D, 1975, P NATL ACAD SCI USA, V72, P5099, DOI 10.1073/pnas.72.12.5099; Stephenson EL, 2009, BJOG-INT J OBSTET GY, V116, P158, DOI 10.1111/j.1471-0528.2008.02009.x; Stephenson EL, 2007, REGEN MED, V2, P349, DOI 10.2217/17460751.2.4.349; Stephenson EL, 2006, REGEN MED, V1, P739, DOI 10.2217/17460751.1.6.739; Strelchenko N, 2004, REPROD BIOMED ONLINE, V9, P623, DOI 10.1016/S1472-6483(10)61772-5; Strom S, 2007, HUM REPROD, V22, P3051, DOI 10.1093/humrep/dem335; Strom S, 2010, IN VITRO CELL DEV-AN, V46, P337, DOI 10.1007/s11626-010-9308-0; Wells D, 2010, REPROD BIOMED ONLINE, V21, P274, DOI 10.1016/j.rbmo.2010.06.035; Zhang X, 2006, STEM CELLS, V24, P2669, DOI 10.1634/stemcells.2006-0377	34	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15329	10.1371/journal.pone.0015329	http://dx.doi.org/10.1371/journal.pone.0015329			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217828	Green Published, Green Submitted, gold			2022-12-27	WOS:000285838900020
J	Wierenga, CJ; Mullner, FE; Rinke, I; Keck, T; Stein, V; Bonhoeffer, T				Wierenga, Corette J.; Muellner, Fiona E.; Rinke, Ilka; Keck, Tara; Stein, Valentin; Bonhoeffer, Tobias			Molecular and Electrophysiological Characterization of GFP-Expressing CA1 Interneurons in GAD65-GFP Mice	PLOS ONE			English	Article							CAUDAL GANGLIONIC EMINENCE; RAT HIPPOCAMPUS; GABAERGIC INTERNEURONS; CORTICAL INTERNEURONS; PYRAMIDAL CELLS; MEDIAL SEPTUM; NEUROGLIAFORM CELLS; NEURONAL DIVERSITY; CEREBRAL-CORTEX; AREA	The use of transgenic mice in which subtypes of neurons are labeled with a fluorescent protein has greatly facilitated modern neuroscience research. GAD65-GFP mice, which have GABAergic interneurons labeled with GFP, are widely used in many research laboratories, although the properties of the labeled cells have not been studied in detail. Here we investigate these cells in the hippocampal area CA1 and show that they constitute similar to 20% of interneurons in this area. The majority of them expresses either reelin (70 +/- 2%) or vasoactive intestinal peptide (VIP; 15 +/- 2%), while expression of parvalbumin and somatostatin is virtually absent. This strongly suggests they originate from the caudal, and not the medial, ganglionic eminence. GFP-labeled interneurons can be subdivided according to the (partially overlapping) expression of neuropeptide Y (42 +/- 3%), cholecystokinin (25 +/- 3%), calbindin (20 +/- 2%) or calretinin (20 +/- 2%). Most of these subtypes (with the exception of calretinin-expressing interneurons) target the dendrites of CA1 pyramidal cells. GFP-labeled interneurons mostly show delayed onset of firing around threshold, and regular firing with moderate frequency adaptation at more depolarized potentials.	[Wierenga, Corette J.; Muellner, Fiona E.; Keck, Tara; Bonhoeffer, Tobias] Max Planck Inst Neurobiol, Dept Cellular & Syst Neurobiolgy, Martinsried, Germany	Max Planck Society	Wierenga, CJ (corresponding author), Max Planck Inst Neurobiol, Dept Cellular & Syst Neurobiolgy, Martinsried, Germany.	wierenga@neuro.mpg.de	Stein, Valentin/A-8025-2008; Wierenga, Corette J./H-2749-2019; Bonhoeffer, Tobias/B-9481-2009	Stein, Valentin/0000-0003-1222-4928; Wierenga, Corette J./0000-0001-9073-4099; Bonhoeffer, Tobias/0000-0001-7897-6634; Mullner, Fiona/0000-0002-7954-7273; Keck, Tara/0000-0001-6623-1037	IEF [40528]; ERG [256284]; German National Academic Foundation; Max Planck Society; Medical Research Council [G0901899B] Funding Source: researchfish	IEF; ERG; German National Academic Foundation; Max Planck Society(Max Planck Society); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Marie Curie grants IEF #40528 and ERG #256284 (CJW), the German National Academic Foundation (FEM) and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acsady L, 1996, NEUROSCIENCE, V73, P317, DOI 10.1016/0306-4522(95)00609-5; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Betley JN, 2009, CELL, V139, P161, DOI 10.1016/j.cell.2009.08.027; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Campo CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005505; Chai XJ, 2009, J NEUROSCI, V29, P288, DOI 10.1523/JNEUROSCI.2934-08.2009; Chameau P, 2009, P NATL ACAD SCI USA, V106, P7227, DOI 10.1073/pnas.0810764106; Cope DW, 2002, NEUROSCIENCE, V109, P63, DOI 10.1016/S0306-4522(01)00440-7; Danglot L, 2006, HIPPOCAMPUS, V16, P1032, DOI 10.1002/hipo.20225; Daw MI, 2009, J NEUROSCI, V29, P11112, DOI 10.1523/JNEUROSCI.5760-08.2009; Fiszman ML, 2005, J NEUROSCI, V25, P2024, DOI 10.1523/JNEUROSCI.4980-04.2005; Forster E, 2010, EUR J NEUROSCI, V31, P1511, DOI 10.1111/j.1460-9568.2010.07222.x; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; FROTSCHER M, 2010, NEUROSCIENCES, V33, P407; Fuentealba P, 2008, NEURON, V57, P917, DOI 10.1016/j.neuron.2008.01.034; Galarreta M, 2004, J NEUROSCI, V24, P9770, DOI 10.1523/JNEUROSCI.3027-04.2004; Galarreta M, 2008, CEREB CORTEX, V18, P2296, DOI 10.1093/cercor/bhm253; Gelman DM, 2010, EUR J NEUROSCI, V31, P2136, DOI 10.1111/j.1460-9568.2010.07267.x; Gelman DM, 2009, J NEUROSCI, V29, P9380, DOI 10.1523/JNEUROSCI.0604-09.2009; Gonchar Y, 1999, CEREB CORTEX, V9, P683, DOI 10.1093/cercor/9.7.683; Gulyas AI, 2003, EUR J NEUROSCI, V17, P1861, DOI 10.1046/j.1460-9568.2003.02630.x; Gulyas AI, 1996, HIPPOCAMPUS, V6, P525, DOI 10.1002/(SICI)1098-1063(1996)6:5<525::AID-HIPO5>3.0.CO;2-H; Gulyas AI, 1996, J NEUROSCI, V16, P3397; Jinno S, 2007, J NEUROSCI, V27, P8790, DOI 10.1523/JNEUROSCI.1847-07.2007; Jinno S, 2006, NEUROSCI RES, V56, P229, DOI 10.1016/j.neures.2006.07.007; Karagiannis A, 2009, J NEUROSCI, V29, P3642, DOI 10.1523/JNEUROSCI.0058-09.2009; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Klausberger T, 2009, EUR J NEUROSCI, V30, P947, DOI 10.1111/j.1460-9568.2009.06913.x; LEDRI M, 2010, HIPPOCAMPUS IN PRESS; Lopez-Bendito G, 2004, CEREB CORTEX, V14, P1122, DOI 10.1093/cercor/bhh072; Meskenaite V, 1997, J COMP NEUROL, V379, P113; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Nery S, 2002, NAT NEUROSCI, V5, P1279, DOI 10.1038/nn971; NIU S, 2010, J NEUROSCI, V28, P10339; Pawelzik H, 2002, J COMP NEUROL, V443, P346, DOI 10.1002/cne.10118; Price CJ, 2008, J NEUROSCI, V28, P6974, DOI 10.1523/JNEUROSCI.4673-07.2008; Price CJ, 2005, J NEUROSCI, V25, P6775, DOI 10.1523/JNEUROSCI.1135-05.2005; Pujadas L, 2010, J NEUROSCI, V30, P4636, DOI 10.1523/JNEUROSCI.5284-09.2010; Rinke I, 2010, J NEUROSCI, V30, P4776, DOI 10.1523/JNEUROSCI.6299-09.2010; Soriano E, 2005, NEURON, V46, P389, DOI 10.1016/j.neuron.2005.04.019; Takacs VT, 2008, EUR J NEUROSCI, V28, P148, DOI 10.1111/j.1460-9568.2008.06319.x; TOTH K, 1992, NEUROSCIENCE, V49, P793, DOI 10.1016/0306-4522(92)90357-8; Tricoire L, 2010, J NEUROSCI, V30, P2165, DOI 10.1523/JNEUROSCI.5123-09.2010; Vida I, 1998, J PHYSIOL-LONDON, V506, P755, DOI 10.1111/j.1469-7793.1998.755bv.x; Vucurovic K, 2010, CEREB CORTEX, V20, P2333, DOI 10.1093/cercor/bhp310; Wierenga CJ, 2008, NAT NEUROSCI, V11, P1044, DOI 10.1038/nn.2180; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004	49	42	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15915	10.1371/journal.pone.0015915	http://dx.doi.org/10.1371/journal.pone.0015915			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209836	Green Submitted, gold, Green Published			2022-12-27	WOS:000285838900049
J	Casey, GJ; Jolley, D; Phuc, TQ; Tinh, TT; Tho, DH; Montresor, A; Biggs, BA				Casey, Gerard J.; Jolley, Damien; Phuc, Tran Q.; Tinh, Ta T.; Tho, Dang H.; Montresor, Antonio; Biggs, Beverley-Ann			Long-Term Weekly Iron-Folic Acid and De-Worming Is Associated with Stabilised Haemoglobin and Increasing Iron Stores in Non-Pregnant Women in Vietnam	PLOS ONE			English	Article							REPRODUCTIVE AGE; ANEMIA; SUPPLEMENTATION; ASSAY; SERUM	Background: The prevalence of anaemia and iron deficiency in women remains high worldwide. WHO recommends weekly iron-folic acid supplementation where anaemia rates in non-pregnant women of reproductive age are higher than 20%. In 2006, a demonstration project consisting of weekly iron-folic acid supplementation and regular de-worming was set up in two districts in a northern province in Vietnam where anaemia and hookworm rates were 38% and 76% respectively. In 2008 the project was expanded to all districts in the province, targeting some 250,000 women. The objectives of this study were to: 1) examine changes in haemoglobin, iron stores and soil transmitted helminth infection prevalence over three years and 2) assess women's access to and compliance with the intervention. Methods and Findings: The study was a semi-cross-sectional, semi-longitudinal panel design with a baseline survey, three impact surveys at three-, twelve- and thirty months after commencement of the intervention, and three compliance surveys after ten weeks, eighteen and thirty six months. Results: After thirty months, mean haemoglobin stabilised at 130.3 g/L, an increase of 8.2 g/L from baseline, and mean serum ferritin rose from 23.9 mu g/L to 52 mu g/L. Hookworm prevalence fell from 76% to 22% over the same period. After thirty six months, 81% of the target population were receiving supplements and 87% were taking 75% or more of the supplements they received. Conclusions: Weekly iron-folic acid supplementation and regular de-worming was effective in significantly and sustainably reducing the prevalence of anaemia and soil transmitted helminth infections and high compliance rates were maintained over three years.	[Casey, Gerard J.; Biggs, Beverley-Ann] Univ Melbourne, Royal Melbourne Hosp, Dept Med RMH WH, Parkville, Vic, Australia; [Jolley, Damien] Monash Univ, Sch Publ Hlth Prevent Med, Alfred Ctr, Prahran, Vic, Australia; [Phuc, Tran Q.; Tinh, Ta T.] Natl Inst Malariol Parasitol & Entomol NIMPE, Hanoi, Vietnam; [Tho, Dang H.] Res & Training Ctr Community Dev, Hanoi, Vietnam; [Montresor, Antonio] WHO, CH-1211 Geneva, Switzerland; [Biggs, Beverley-Ann] Royal Melbourne Hosp, Ctr Clin Res Excellence Infect Dis, Parkville, Vic 3050, Australia	Royal Melbourne Hospital; University of Melbourne; Monash University; World Health Organization; Royal Melbourne Hospital	Casey, GJ (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med RMH WH, Parkville, Vic, Australia.	babiggs@unimelb.edu.au	Montresor, Antonio/J-3137-2019	Montresor, Antonio/0000-0003-3103-8872; Biggs, Beverley-Ann/0000-0002-2961-9793	Atlantic Philanthropies Inc.	Atlantic Philanthropies Inc.	This project was kindly funded by Atlantic Philanthropies Inc. URL: http://www.atlanticphilanthropies.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASH LR, 2004, TRAINING MANUAL DIAG; Berger J, 2005, NUTR REV, V63, pS95, DOI 10.1301/nr.2005.dec.S95-S108; Casey GJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-261; Christian P, 2009, AM J EPIDEMIOL, V170, P1127, DOI 10.1093/aje/kwp253; Cochran WG., 1963, SAMPLING TECHNIQUES; Kish L, 1995, SCI 1995; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Mihrshahi S, 2009, INT J PARASITOL, V39, P1037, DOI 10.1016/j.ijpara.2009.01.013; OBROIN S, 1992, J CLIN PATHOL, V45, P344, DOI 10.1136/jcp.45.4.344; Pasricha SR, 2008, AM J TROP MED HYG, V78, P375, DOI 10.4269/ajtmh.2008.78.375; Phuc TQ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-266; Rabe-Hesketh S, 2005, MULILEVEL LONGITUDIN; Stoltzfus RJ, 1997, NUTR REV, V55, P223, DOI 10.1111/j.1753-4887.1997.tb01609.x; Suominen P, 1998, BLOOD, V92, P2934, DOI 10.1182/blood.V92.8.2934.420k07_2934_2939; THURNHAM DI, 1988, CLIN CHEM, V34, P377; Trinh LTT, 2007, ASIA PAC J CLIN NUTR, V16, P310; Vir SC, 2008, FOOD NUTR BULL, V29, P186, DOI 10.1177/156482650802900304; Viteri FE, 2005, NUTR REV, V63, pS65, DOI 10.1301/nr.2005.dec.S65-S76; Waterton J., 1989, PANEL SURVEYS; WHO, 2006, THAL OTH HEM REP SEC; *WHO, 1999, WHOCDSCPCSIP993; WHO/CDC, 2005, ASS IR STAT POP REP; World Health Organization (WHO), 2009, WEEKL IR FOL AC SUPP; World Health Organization (WHO), WHONHD013	24	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15691	10.1371/journal.pone.0015691	http://dx.doi.org/10.1371/journal.pone.0015691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209902	gold, Green Published			2022-12-27	WOS:000285793600029
J	Di Modugno, F; Mottolese, M; DeMonte, L; Trono, P; Balsamo, M; Conidi, A; Melucci, E; Terrenato, I; Belleudi, F; Torrisi, MR; Alessio, M; Santoni, A; Nistico, P				Di Modugno, Francesca; Mottolese, Marcella; DeMonte, Lucia; Trono, Paola; Balsamo, Michele; Conidi, Andrea; Melucci, Elisa; Terrenato, Irene; Belleudi, Francesca; Torrisi, Maria Rosaria; Alessio, Massimo; Santoni, Angela; Nistico, Paola			The Cooperation between hMena Overexpression and HER2 Signalling in Breast Cancer	PLOS ONE			English	Article							CELL-LINES; ACTIN CYTOSKELETON; ENA/VASP PROTEINS; TUMOR CELLS; EXPRESSION; ERBB3; EGFR; IDENTIFICATION; REGULATORS; PROGNOSIS	hMena and the epithelial specific isoform hMena(11a) are actin cytoskeleton regulatory proteins belonging to the Ena/VASP family. EGF treatment of breast cancer cell lines upregulates hMena/hMena(11a) expression and phosphorylates hMena(11a), suggesting cross-talk between the ErbB receptor family and hMena/hMena(11a) in breast cancer. The aim of this study was to determine whether the hMena/hMena(11a) overexpression cooperates with HER-2 signalling, thereby affecting the HER2 mitogenic activity in breast cancer. In a cohort of breast cancer tissue samples a significant correlation among hMena, HER2 overexpression, the proliferation index (high Ki67), and phosphorylated MAPK and AKT was found and among the molecular subtypes the highest frequency of hMena overexpressing tumors was found in the HER2 subtype. From a clinical viewpoint, concomitant overexpression of HER2 and hMena identifies a subgroup of breast cancer patients showing the worst prognosis, indicating that hMena overexpression adds prognostic information to HER2 overexpressing tumors. To identify a functional link between HER2 and hMena, we show here that HER2 transfection in MCF7 cells increased hMena/hMena(11a) expression and hMena(11a) phosphorylation. On the other hand, hMena/hMena(11a) knock-down reduced HER3, AKT and p44/42 MAPK phosphorylation and inhibited the EGF and NRG1-dependent HER2 phosphorylation and cell proliferation. Of functional significance, hMena/hMena(11a) knock-down reduced the mitogenic activity of EGF and NRG1. Collectively these data provide new insights into the relevance of hMena and hMena(11a) as downstream effectors of the ErbB receptor family which may represent a novel prognostic indicator in breast cancer progression, helping to stratify patients.	[Di Modugno, Francesca; Trono, Paola; Balsamo, Michele; Conidi, Andrea; Nistico, Paola] Regina Elena Inst Canc Res, Immunol Lab, Rome, Italy; [Mottolese, Marcella; Melucci, Elisa] Regina Elena Inst Canc Res, Dept Pathol, Rome, Italy; [DeMonte, Lucia; Alessio, Massimo] Ist Sci San Raffaele, I-20132 Milan, Italy; [Balsamo, Michele] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Conidi, Andrea] Katholieke Univ Leuven, Dept Mol & Dev Genet, Louvain, Belgium; [Terrenato, Irene] Regina Elena Inst Canc Res, Dept Epidemiol, Rome, Italy; [Belleudi, Francesca] Azienda Osped S Andrea, Rome, Italy; [Torrisi, Maria Rosaria; Santoni, Angela] Univ Roma La Sapienza, Dept Clin & Mol Med, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Massachusetts Institute of Technology (MIT); KU Leuven; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Sapienza University Rome	Di Modugno, F (corresponding author), Regina Elena Inst Canc Res, Immunol Lab, Rome, Italy.	nistico@ifo.it	Di Modugno, Francesca/B-2865-2018; Nisticò, Paola/B-2862-2018; Melucci, Elisa/K-5860-2016; Alessio, Massimo/L-4518-2019; Terrenato, Irene/B-1308-2017; Balsamo, Michele/AAJ-3247-2020; Di Modugno, Francesca/ABH-9406-2020; DeMonte, Lucia/AAN-8336-2020; santoni, angela/K-8997-2016; Alessio, Massimo/K-7028-2014	Di Modugno, Francesca/0000-0003-1427-1883; Nisticò, Paola/0000-0003-4409-2261; Melucci, Elisa/0000-0003-4908-5271; Terrenato, Irene/0000-0002-0187-9323; Balsamo, Michele/0000-0002-2315-4761; Di Modugno, Francesca/0000-0003-1427-1883; santoni, angela/0000-0003-1206-7731; Alessio, Massimo/0000-0002-4133-3472; Trono, Paola/0000-0002-2053-6334; De Monte, Lucia/0000-0002-9406-7809	Associazione Italiana per la Ricerca sul Cancro (AIRC); Italian Ministry of Health Ricerca Finalizzata; Italian Ministry of Health [PIO-2006, 5/07]; Ludwig Fund Postdoctoral Fellowship	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health Ricerca Finalizzata(Ministry of Health, Italy); Italian Ministry of Health(Ministry of Health, Italy); Ludwig Fund Postdoctoral Fellowship	Associazione Italiana per la Ricerca sul Cancro (AIRC)(P.N.,M.M.); Italian Ministry of Health Ricerca Finalizzata (P.N.); Italian Ministry of Health PIO-2006 RO strategici 5/07 (M.A.). Ludwig Fund Postdoctoral Fellowship (M.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann C, 1999, J BIOL CHEM, V274, P23549, DOI 10.1074/jbc.274.33.23549; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Boeda B, 2007, MOL CELL, V28, P1071, DOI 10.1016/j.molcel.2007.10.033; Cao ZW, 2007, MOL CELL BIOL, V27, P2180, DOI 10.1128/MCB.01245-06; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Conti A, 2005, PROTEOMICS, V5, P4558, DOI 10.1002/pmic.200402088; Di Modugno F, 2006, CLIN CANCER RES, V12, P1470, DOI 10.1158/1078-0432.CCR-05-2027; Di Modugno F, 2004, INT J CANCER, V109, P909, DOI 10.1002/ijc.20094; Di Modugno F, 2007, CANCER RES, V67, P2657, DOI 10.1158/0008-5472.CAN-06-1997; Feldner JC, 2002, EXP CELL RES, V272, P93, DOI 10.1006/excr.2001.5385; Goswami S, 2009, CLIN EXP METASTAS, V26, P153, DOI 10.1007/s10585-008-9225-8; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Janssens K, 2009, CELL SIGNAL, V21, P282, DOI 10.1016/j.cellsig.2008.10.012; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Klapper LN, 2000, ADV CANCER RES, V77, P25; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Margadant C, 2007, J CELL SCI, V120, P66, DOI 10.1242/jcs.03301; Menard S, 2008, ANN ONCOL, V19, P1706, DOI 10.1093/annonc/mdn369; Mouneimne G, 2004, J CELL BIOL, V166, P697, DOI 10.1083/jcb.200405156; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; NISTICO P, 1994, J CLIN INVEST, V94, P1426, DOI 10.1172/JCI117479; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Philippar U, 2008, DEV CELL, V15, P813, DOI 10.1016/j.devcel.2008.09.003; Pino MS, 2008, CLIN CANCER RES, V14, P4943, DOI 10.1158/1078-0432.CCR-08-0436; Scott JA, 2006, MOL BIOL CELL, V17, P1085, DOI 10.1091/mbc.e05-07-0644; Siegel PM, 1999, EMBO J, V18, P2149, DOI 10.1093/emboj/18.8.2149; Staaf J, 2010, J CLIN ONCOL, V28, P1813, DOI 10.1200/JCO.2009.22.8775; TAVASSOLI FA, 2003, TUMORS BREAST; Vocaturo A, 2006, ONCOLOGIST, V11, P878, DOI 10.1634/theoncologist.11-8-878; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Wiseman SM, 2005, CANCER-AM CANCER SOC, V103, P1770, DOI 10.1002/cncr.20970; Yamagata A, 2002, PROTEOMICS, V2, P1267, DOI 10.1002/1615-9861(200209)2:9<1267::AID-PROT1267>3.0.CO;2-R; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Zhao TT, 2010, ONCOGENE, V29, P4682, DOI 10.1038/onc.2010.219	36	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15852	10.1371/journal.pone.0015852	http://dx.doi.org/10.1371/journal.pone.0015852			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209853	Green Published, Green Submitted, gold			2022-12-27	WOS:000285793600046
J	Drew, SC; Masters, CL; Barnham, KJ				Drew, Simon C.; Masters, Colin L.; Barnham, Kevin J.			Alzheimer's A beta Peptides with Disease-Associated N-Terminal Modifications: Influence of Isomerisation, Truncation and Mutation on Cu2+ Coordination	PLOS ONE			English	Article							METAL-ION CATALYSIS; AMYLOID-BETA; IN-VITRO; HYDROGEN-PEROXIDE; AMIDE HYDROLYSIS; COPPER(II) IONS; SENILE PLAQUES; CORE PROTEIN; PULSE EPR; BINDING	Background: The amyloid-beta (A beta) peptide is the primary component of the extracellular senile plaques characteristic of Alzheimer's disease (AD). The metals hypothesis implicates redox-active copper ions in the pathogenesis of AD and the Cu2+ coordination of various A beta peptides has been widely studied. A number of disease-associated modifications involving the first 3 residues are known, including isomerisation, mutation, truncation and cyclisation, but are yet to be characterised in detail. In particular, A beta in plaques contain a significant amount of truncated pyroglutamate species, which appear to correlate with disease progression. Methodology/Principal Findings: We previously characterised three Cu2+/A beta 1-16 coordination modes in the physiological pH range that involve the first two residues. Based upon our finding that the carbonyl of Ala2 is a Cu2+ ligand, here we speculate on a hypothetical Cu2+-mediated intramolecular cleavage mechanism as a source of truncations beginning at residue 3. Using EPR spectroscopy and site-specific isotopic labelling, we have also examined four A beta peptides with biologically relevant N-terminal modifications, A beta 1[isoAsp]-16, A beta 1-16(A2V), A beta 3-16 and A beta 3[pE]-16. The recessive A2V mutation preserved the first coordination sphere of Cu2+/A beta, but altered the outer coordination sphere. Isomerisation of Asp1 produced a single dominant species involving a stable 5-membered Cu2+ chelate at the amino terminus. The A beta 3-16 and A beta 3[pE]-16 peptides both exhibited an equilibrium between two Cu2+ coordination modes between pH 6-9 with nominally the same first coordination sphere, but with a dramatically different pH dependence arising from differences in H-bonding interactions at the N-terminus. Conclusions/Significance: N-terminal modifications significantly influence the Cu2+ coordination of A beta, which may be critical for alterations in aggregation propensity, redox-activity, resistance to degradation and the generation of the A beta 3-6 (x = 40/42) precursor of disease-associated A beta 3[pE]-x species.	[Drew, Simon C.; Barnham, Kevin J.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Drew, Simon C.; Barnham, Kevin J.] Univ Melbourne, Natl Neuroscience Facil, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic, Australia; [Drew, Simon C.; Masters, Colin L.; Barnham, Kevin J.] Univ Melbourne, Mental Hlth Res Inst, Melbourne, Vic, Australia; [Drew, Simon C.] Monash Univ, Sch Phys, Melbourne, Vic 3004, Australia; [Masters, Colin L.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne; University of Melbourne; Monash University; University of Melbourne	Drew, SC (corresponding author), Max Planck Inst Bioinorgan Chem, Mulheim, Germany.	drew@mpi-muelheim.mpg.de	Drew, Simon/ABB-8102-2021	Drew, Simon/0000-0002-1459-9865	National Health and Medical Research Council of Australia [400202]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia grant # 400202 (www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balland V, 2010, P NATL ACAD SCI USA, V107, P17113, DOI 10.1073/pnas.1011315107; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Blumberger J, 2007, J CHEM THEORY COMPUT, V3, P1837, DOI 10.1021/ct7000792; Bush AI, 2003, ALZ DIS ASSOC DIS, V17, P147, DOI 10.1097/00002093-200307000-00005; Bush AI, 2008, NEUROTHERAPEUTICS, V5, P421, DOI 10.1016/j.nurt.2008.05.001; Cummins PM, 1998, BBA-PROTEIN STRUCT M, V1429, P1, DOI 10.1016/S0167-4838(98)00248-9; Cynis H, 2006, BBA-PROTEINS PROTEOM, V1764, P1618, DOI 10.1016/j.bbapap.2006.08.003; Deligiannakis Y, 2000, COORDIN CHEM REV, V204, P1, DOI 10.1016/S0010-8545(99)00218-0; Di Fede G, 2009, SCIENCE, V323, P1473, DOI 10.1126/science.1168979; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; Dorlet P, 2009, ANGEW CHEM INT EDIT, V48, P9273, DOI 10.1002/anie.200904567; Drew SC, 2008, J BIOL INORG CHEM, V13, P899, DOI 10.1007/s00775-008-0377-4; Drew SC, 2009, J AM CHEM SOC, V131, P8760, DOI 10.1021/ja903669a; Drew SC, 2009, J AM CHEM SOC, V131, P1195, DOI 10.1021/ja808073b; DUERR BF, 1990, J CHEM SOC CHEM COMM, P1707, DOI 10.1039/c39900001707; FABIAN H, 1994, EUR J BIOCHEM, V221, P959, DOI 10.1111/j.1432-1033.1994.tb18811.x; FIFE TH, 1986, J AM CHEM SOC, V108, P4631, DOI 10.1021/ja00275a059; FISCHER WH, 1987, P NATL ACAD SCI USA, V84, P3628, DOI 10.1073/pnas.84.11.3628; Furlan S, 2010, J PHYS CHEM B, V114, P15119, DOI 10.1021/jp102928h; Garai K, 2006, BIOCHEM BIOPH RES CO, V345, P210, DOI 10.1016/j.bbrc.2006.04.056; Guntert A, 2006, NEUROSCIENCE, V143, P461, DOI 10.1016/j.neuroscience.2006.08.027; Hanson GR, 2004, J INORG BIOCHEM, V98, P903, DOI 10.1016/j.jinorgbio.2004.02.003; Harigaya Y, 2000, BIOCHEM BIOPH RES CO, V276, P422, DOI 10.1006/bbrc.2000.3490; Hosoda R, 1998, J NEUROPATH EXP NEUR, V57, P1089, DOI 10.1097/00005072-199811000-00012; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Innocenti M, 2010, J ALZHEIMERS DIS, V19, P1323, DOI 10.3233/JAD-2010-1338; Iwatsubo T, 1996, AM J PATHOL, V149, P1823; Jiang DL, 2010, J PHYS CHEM B, V114, P4896, DOI 10.1021/jp9095375; Jun S, 2009, BIOCHEMISTRY-US, V48, P10724, DOI 10.1021/bi9012935; Karr JW, 2007, J AM CHEM SOC, V129, P3796, DOI 10.1021/ja068952d; Karr JW, 2005, BIOCHEMISTRY-US, V44, P5478, DOI 10.1021/bi047611e; Kowalik-Jankowska T, 2003, J INORG BIOCHEM, V95, P270, DOI 10.1016/S0162-0134(03)00128-4; Kowalik-Jankowska T, 2004, J INORG BIOCHEM, V98, P940, DOI 10.1016/j.jinorgbio.2004.03.001; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Lou YC, 2006, J MOL BIOL, V355, P409, DOI 10.1016/j.jmb.2005.10.069; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Maeda J, 2007, J NEUROSCI, V27, P10957, DOI 10.1523/JNEUROSCI.0673-07.2007; MANTLE D, 1990, J NEUROL SCI, V98, P13, DOI 10.1016/0022-510X(90)90178-P; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mccoll G, 2009, J BIOL CHEM, V284, P22697, DOI 10.1074/jbc.C109.028514; MCDERMOTT JR, 1985, J NEUROCHEM, V45, P752, DOI 10.1111/j.1471-4159.1985.tb04056.x; Miura T, 2004, J INORG BIOCHEM, V98, P10, DOI 10.1016/j.jinorgbio.2003.10.008; MORI H, 1992, J BIOL CHEM, V267, P17062; Opazo C, 2002, J BIOL CHEM, V277, P40302, DOI 10.1074/jbc.M206428200; PEISACH J, 1974, ARCH BIOCHEM BIOPHYS, V165, P691, DOI 10.1016/0003-9861(74)90298-7; Pogni R, 1999, J INORG BIOCHEM, V73, P157, DOI 10.1016/S0162-0134(99)00012-4; ROHER AE, 1993, J BIOL CHEM, V268, P3072; Russo C, 2002, J NEUROCHEM, V82, P1480, DOI 10.1046/j.1471-4159.2002.01107.x; SAIDO TC, 1995, NEURON, V14, P457, DOI 10.1016/0896-6273(95)90301-1; Sarell CJ, 2010, J BIOL CHEM, V285, P41533, DOI 10.1074/jbc.M110.171355; SAYRE LM, 1986, J AM CHEM SOC, V108, P1632, DOI 10.1021/ja00267a037; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Schweiger A., 2001, PRINCIPLES PULSE ELE; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sevalle J, 2009, J NEUROCHEM, V109, P248, DOI 10.1111/j.1471-4159.2009.05950.x; Shimizu T, 2000, ARCH BIOCHEM BIOPHYS, V381, P225, DOI 10.1006/abbi.2000.1955; STEPHENSON RC, 1989, J BIOL CHEM, V264, P6164; SUGIURA Y, 1975, J AM CHEM SOC, V97, P5577, DOI 10.1021/ja00852a043; Tabner BJ, 2002, FREE RADICAL BIO MED, V32, P1076, DOI 10.1016/S0891-5849(02)00801-8; Tsvetkov PO, 2008, CHEMBIOCHEM, V9, P1564, DOI 10.1002/cbic.200700784; Van Doorslaer S, 2001, J PHYS CHEM B, V105, P1631, DOI 10.1021/jp003115y; Van Doorslaer S, 1999, J MAGN RESON, V136, P152, DOI 10.1006/jmre.1998.1609; Wirths O, 2010, J NEURAL TRANSM, V117, P85, DOI 10.1007/s00702-009-0314-x; Youssef I, 2008, NEUROBIOL AGING, V29, P1319, DOI 10.1016/j.neurobiolaging.2007.03.005; Zirah S, 2006, J BIOL CHEM, V281, P2151, DOI 10.1074/jbc.M504454200; Zou J, 2001, ANGEW CHEM INT EDIT, V40, P2274, DOI 10.1002/1521-3773(20010618)40:12<2274::AID-ANIE2274>3.0.CO;2-5	68	34	34	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15875	10.1371/journal.pone.0015875	http://dx.doi.org/10.1371/journal.pone.0015875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209855	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793600047
J	Carrozzo, M; Moscatelli, A; Lacquaniti, F				Carrozzo, Mauro; Moscatelli, Alessandro; Lacquaniti, Francesco			Tempo Rubato: Animacy Speeds Up Time in the Brain	PLOS ONE			English	Article							NEURAL MECHANISMS; MOTOR CONTROL; PERCEPTION; MOVEMENT; ANTHROPOMORPHISM; REPRESENTATION; ATTENTION; CORTEX; REAL	Background: How do we estimate time when watching an action? The idea that events are timed by a centralized clock has recently been called into question in favour of distributed, specialized mechanisms. Here we provide evidence for a critical specialization: animate and inanimate events are separately timed by humans. Methodology/Principal Findings: In different experiments, observers were asked to intercept a moving target or to discriminate the duration of a stationary flash while viewing different scenes. Time estimates were systematically shorter in the sessions involving human characters moving in the scene than in those involving inanimate moving characters. Remarkably, the animate/inanimate context also affected randomly intermingled trials which always depicted the same still character. Conclusions/Significance: The existence of distinct time bases for animate and inanimate events might be related to the partial segregation of the neural networks processing these two categories of objects, and could enhance our ability to predict critically timed actions.	[Carrozzo, Mauro] CNR, Inst Neurosci, Rome, Italy; [Carrozzo, Mauro; Moscatelli, Alessandro; Lacquaniti, Francesco] Santa Lucia Fdn, Lab Neuromotor Physiol, Rome, Italy; [Lacquaniti, Francesco] Univ Roma Tor Vergata, Ctr Space BioMed, Rome, Italy; [Lacquaniti, Francesco] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); IRCCS Santa Lucia; University of Rome Tor Vergata; University of Rome Tor Vergata	Carrozzo, M (corresponding author), CNR, Inst Neurosci, Rome, Italy.	lacquaniti@caspur.it	Lacquaniti, Francesco/J-9842-2016; Moscatelli, Alessandro/L-1391-2018	Lacquaniti, Francesco/0000-0003-0896-7315; Moscatelli, Alessandro/0000-0001-6269-4536	Italian Space Agency; Italian Ministry of University and Research; Italian Ministry of Health	Italian Space Agency(Agenzia Spaziale Italiana (ASI)); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health(Ministry of Health, Italy)	Research was supported by grants from the Italian Space Agency, the Italian Ministry of University and Research, and the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aymoz C, 2004, VISION RES, V44, P1547, DOI 10.1016/j.visres.2003.12.011; Bartneck C, 2009, INT J SOC ROBOT, V1, P71, DOI 10.1007/s12369-008-0001-3; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; Brown SW, 2008, PSYCHOLOGY OF TIME, P111, DOI 10.1016/B978-0-08046-977-5.00004-1; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Burr D, 2007, NAT NEUROSCI, V10, P423, DOI 10.1038/nn1874; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2010, PSYCHOL RES-PSYCH FO, V74, P400, DOI 10.1007/s00426-009-0262-y; Chaminade T, 2007, SOC COGN AFFECT NEUR, V2, P206, DOI 10.1093/scan/nsm017; Chang DHF, 2008, J VISION, V8, DOI 10.1167/8.5.3; Cicchini GM, 2009, J VISION, V9, DOI 10.1167/9.1.9; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Eagleman DM, 2008, CURR OPIN NEUROBIOL, V18, P131, DOI 10.1016/j.conb.2008.06.002; Eagleman DM, 2005, J NEUROSCI, V25, P10369, DOI 10.1523/JNEUROSCI.3487-05.2005; Faraggi D, 2003, STAT MED, V22, P1977, DOI 10.1002/sim.1368; Georgopoulos AP, 2002, CURR OPIN NEUROBIOL, V12, P678, DOI 10.1016/S0959-4388(02)00382-3; Grossman ED, 2001, VISION RES, V41, P1475, DOI 10.1016/S0042-6989(00)00317-5; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Jastorff J, 2009, J NEUROSCI, V29, P7315, DOI 10.1523/JNEUROSCI.4870-08.2009; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Johnston A, 2006, CURR BIOL, V16, P472, DOI 10.1016/j.cub.2006.01.032; Kanai R, 2006, J VISION, V6, P1421, DOI 10.1167/16.12.8; Kaneko S, 2009, J VISION, V9, DOI 10.1167/9.7.14; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; LACQUANITI F, 1983, ACTA PSYCHOL, V54, P115, DOI 10.1016/0001-6918(83)90027-6; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; LYON DR, 1995, ACTA PSYCHOL, V89, P239, DOI 10.1016/0001-6918(95)98945-Z; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Merchant H, 2004, CEREB CORTEX, V14, P314, DOI 10.1093/cercor/bhg130; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Neri P, 2006, NAT NEUROSCI, V9, P1186, DOI 10.1038/nn1759; Neri P, 2009, P ROY SOC B-BIOL SCI, V276, P861, DOI 10.1098/rspb.2008.1363; New J, 2007, P NATL ACAD SCI USA, V104, P16598, DOI 10.1073/pnas.0703913104; Nobrel AC, 2007, CURR OPIN NEUROBIOL, V17, P465, DOI 10.1016/j.conb.2007.07.006; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Oh S, 2008, PERCEPTION, V37, P317, DOI 10.1068/p5887; Opfer JE, 2011, WILEY BLACKWELL HDB, V2nd, P213, DOI DOI 10.1002/9780470996652.CH7; Pariyadath V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001264; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Saxe R, 2004, NEUROPSYCHOLOGIA, V42, P1435, DOI 10.1016/j.neuropsychologia.2004.04.015; Scholl BJ, 2000, TRENDS COGN SCI, V4, P299, DOI 10.1016/S1364-6613(00)01506-0; Schultz J, 2005, NEURON, V45, P625, DOI 10.1016/j.neuron.2004.12.052; Sebanz N, 2009, TOP COGN SCI, V1, P353, DOI 10.1111/j.1756-8765.2009.01024.x; SHEPARD RN, 1984, PSYCHOL REV, V91, P417, DOI 10.1037/0033-295X.91.4.417; Tadin D, 2002, NAT NEUROSCI, V5, P1010, DOI 10.1038/nn914; Terao M, 2008, NAT NEUROSCI, V11, P541, DOI 10.1038/nn.2111; Tremoulet PD, 2006, PERCEPT PSYCHOPHYS, V68, P1047, DOI 10.3758/BF03193364; Tse PU, 2004, PERCEPT PSYCHOPHYS, V66, P1171, DOI 10.3758/BF03196844; Watanabe K, 2008, COGNITION, V106, P1514, DOI 10.1016/j.cognition.2007.06.001; Wolpert DM, 2003, PHILOS T R SOC B, V358, P593, DOI 10.1098/rstb.2002.1238; Zago M, 2009, EXP BRAIN RES, V192, P571, DOI 10.1007/s00221-008-1691-3	54	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15638	10.1371/journal.pone.0015638	http://dx.doi.org/10.1371/journal.pone.0015638			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	701CZ	21206749	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793200033
J	Torres, M; Castillo, K; Armisen, R; Stutzin, A; Soto, C; Hetz, C				Torres, Mauricio; Castillo, Karen; Armisen, Ricardo; Stutzin, Andres; Soto, Claudio; Hetz, Claudio			Prion Protein Misfolding Affects Calcium Homeostasis and Sensitizes Cells to Endoplasmic Reticulum Stress	PLOS ONE			English	Article							AMYLOID-BETA; TRANSMEMBRANE FORM; PROTEASOMAL DEGRADATION; RETROGRADE TRANSPORT; APOPTOTIC PATHWAY; BCL-2 FAMILY; DISEASE; PRP; ACCUMULATION; PEPTIDES	Prion-related disorders (PrDs) are fatal neurodegenerative disorders characterized by progressive neuronal impairment as well as the accumulation of an abnormally folded and protease resistant form of the cellular prion protein, termed PrP RES. Altered endoplasmic reticulum (ER) homeostasis is associated with the occurrence of neurodegeneration in sporadic, infectious and familial forms of PrDs. The ER operates as a major intracellular calcium store, playing a crucial role in pathological events related to neuronal dysfunction and death. Here we investigated the possible impact of PrP misfolding on ER calcium homeostasis in infectious and familial models of PrDs. Neuro2A cells chronically infected with scrapie prions showed decreased ER-calcium content that correlated with a stronger upregulation of UPR-inducible chaperones, and a higher sensitivity to ER stress-induced cell death. Overexpression of the calcium pump SERCA stimulated calcium release and increased the neurotoxicity observed after exposure of cells to brain-derived infectious PrP RES. Furthermore, expression of PrP mutants that cause hereditary Creutzfeldt-Jakob disease or fatal familial insomnia led to accumulation of PrP RES and their partial retention at the ER, associated with a drastic decrease of ER calcium content and higher susceptibility to ER stress. Finally, similar results were observed when a transmembrane form of PrP was expressed, which is proposed as a neurotoxic intermediate. Our results suggest that alterations in calcium homeostasis and increased susceptibility to ER stress are common pathological features of both infectious and familial PrD models.	[Torres, Mauricio; Castillo, Karen; Armisen, Ricardo; Stutzin, Andres; Hetz, Claudio] Univ Chile, Fac Med, Ctr Mol Studies Cell, Inst Biomed Sci, Santiago 7, Chile; [Torres, Mauricio; Castillo, Karen; Hetz, Claudio] Univ Chile, Fac Med, Biomed Neurosci Inst, Santiago 7, Chile; [Soto, Claudio] Univ Texas Houston, Sch Med, Mitchell Ctr Alzheimers Dis & Related Brain Disor, Dept Neurol, Houston, TX USA; [Hetz, Claudio] Neurounion Biomed Fdn, Santiago, Chile; [Hetz, Claudio] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Universidad de Chile; Universidad de Chile; University of Texas System; University of Texas Health Science Center Houston; Harvard University; Harvard T.H. Chan School of Public Health	Torres, M (corresponding author), Univ Chile, Fac Med, Ctr Mol Studies Cell, Inst Biomed Sci, Santiago 7, Chile.	claudio.soto@uth.tmc.edu; chetz@med.uchile.cl	Hetz, Claudio/ABD-7514-2021; Armisen, Ricardo/A-7409-2012; Hetz, Claudio/I-1900-2013; Stutzin, Andrés/I-7605-2013	Armisen, Ricardo/0000-0003-2567-0521; Hetz, Claudio/0000-0001-7724-1767; Stutzin, Andrés/0000-0002-7264-066X; Castillo, Karen/0000-0003-0353-7025; Torres-Gutierrez, Mauricio Andres/0000-0002-5081-9044	FONDECYT [1070444, 3100112]; Millennium Nucleus [P07-048-F]; Michael J. Fox Foundation for Parkinson's Research; ICGEB; Alzheimer's Disease Foundation; FONDAP [15010006]; CONICYT; NIH [R01 NS05349]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Nucleus; Michael J. Fox Foundation for Parkinson's Research; ICGEB; Alzheimer's Disease Foundation; FONDAP; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by FONDECYT no. 1070444, Millennium Nucleus no. P07-048-F, Michael J. Fox Foundation for Parkinson's Research, and ICGEB, Alzheimer's Disease Foundation (to CH), FONDAP grant no. 15010006 (to AS and CH), FONDECYT no. 3100112 (KC), CONICYT PhD fellowship (MT); and the NIH grant R01 NS05349 (CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho P, 2003, EUR J NEUROSCI, V17, P1189, DOI 10.1046/j.1460-9568.2003.02546.x; Apodaca J, 2006, BIOCHEM BIOPH RES CO, V347, P319, DOI 10.1016/j.bbrc.2006.06.078; Barria MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000421; Beranger F, 2002, J BIOL CHEM, V277, P38972, DOI 10.1074/jbc.M205110200; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Bosque PJ, 2000, J VIROL, V74, P4377, DOI 10.1128/JVI.74.9.4377-4386.2000; Brown AR, 2005, BIOCHEM BIOPH RES CO, V334, P86, DOI 10.1016/j.bbrc.2005.06.060; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Ferreiro E, 2008, J NEUROCHEM, V104, P766, DOI 10.1111/j.1471-4159.2007.05048.x; Ferreiro E, 2008, NEUROBIOL DIS, V30, P331, DOI 10.1016/j.nbd.2008.02.003; Ferreiro E, 2006, NEUROBIOL DIS, V23, P669, DOI 10.1016/j.nbd.2006.05.011; Florio T, 1996, BIOCHEM BIOPH RES CO, V228, P397, DOI 10.1006/bbrc.1996.1673; Gleason MR, 2004, DEV BIOL, V276, P441, DOI 10.1016/j.ydbio.2004.09.008; Gorlach A, 2006, ANTIOXID REDOX SIGN, V8, P1391, DOI 10.1089/ars.2006.8.1391; Grenier C, 2006, J NEUROCHEM, V97, P1456, DOI 10.1111/j.1471-4159.2006.03837.x; Gu YP, 2007, J MOL NEUROSCI, V32, P90, DOI 10.1007/s12031-007-0023-6; Harris DA, 1999, CLIN MICROBIOL REV, V12, P429, DOI 10.1128/CMR.12.3.429; Hegde RS, 2003, TRENDS NEUROSCI, V26, P337, DOI 10.1016/S0166-2236(03)00143-7; Hetz C, 2005, J NEUROSCI, V25, P2793, DOI 10.1523/JNEUROSCI.4090-04.2005; Hetz C, 2003, EMBO J, V22, P5435, DOI 10.1093/emboj/cdg537; Hetz C, 2003, CELL MOL LIFE SCI, V60, P133, DOI 10.1007/s000180300009; Hetz CA, 2006, CURR MOL MED, V6, P37, DOI 10.2174/156652406775574578; Hetz C, 2008, P NATL ACAD SCI USA, V105, P757, DOI 10.1073/pnas.0711094105; Hetz C, 2007, J BIOL CHEM, V282, P12725, DOI 10.1074/jbc.M611909200; Hetz C, 2009, MOL CELL, V35, P551, DOI 10.1016/j.molcel.2009.08.021; Hetz CA, 2007, ANTIOXID REDOX SIGN, V9, P2345, DOI 10.1089/ars.2007.1793; Ivanova L, 2001, J BIOL CHEM, V276, P42409, DOI 10.1074/jbc.M106928200; Jin TC, 2000, J BIOL CHEM, V275, P38699, DOI 10.1074/jbc.M005543200; Kawahara M, 2000, J BIOL CHEM, V275, P14077, DOI 10.1074/jbc.275.19.14077; Kristiansen M, 2005, J BIOL CHEM, V280, P38851, DOI 10.1074/jbc.M506600200; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; Ma JY, 2001, P NATL ACAD SCI USA, V98, P14955, DOI 10.1073/pnas.011578098; Marella M, 2002, J BIOL CHEM, V277, P25457, DOI 10.1074/jbc.M203248200; Matus S, 2008, CURR MOL MED, V8, P157, DOI 10.2174/156652408784221324; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143416002001884; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; O'Donovan CN, 2001, J BIOL CHEM, V276, P43516, DOI 10.1074/jbc.M103894200; ONG DS, NAT CHEM BIOL, V6, P424; Orsi A, 2006, J BIOL CHEM, V281, P30431, DOI 10.1074/jbc.M605320200; PARK SW, P NATL ACAD SCI US; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Puzianowska-Kuznicka M, 2009, AGEING RES REV, V8, P160, DOI 10.1016/j.arr.2009.05.002; Rane NS, 2008, DEV CELL, V15, P359, DOI 10.1016/j.devcel.2008.06.015; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Singh N, 1997, J BIOL CHEM, V272, P28461, DOI 10.1074/jbc.272.45.28461; Soto C, 2000, LANCET, V355, P192, DOI 10.1016/S0140-6736(99)11419-3; Soto C, 2001, TRENDS MOL MED, V7, P109, DOI 10.1016/S1471-4914(01)01931-1; Steele AD, 2007, PRION, V1, P243, DOI 10.4161/pri.1.4.5551; Stewart RS, 2005, J BIOL CHEM, V280, P15855, DOI 10.1074/jbc.M412298200; Stewart RS, 2005, J NEUROSCI, V25, P3469, DOI 10.1523/JNEUROSCI.0105-05.2005; Stewart RS, 2001, MOL BIOL CELL, V12, P881, DOI 10.1091/mbc.12.4.881; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; TARABOULOS A, 1990, J CELL BIOL, V110, P2117, DOI 10.1083/jcb.110.6.2117; Thellung S, 2000, NEUROBIOL DIS, V7, P299, DOI 10.1006/nbdi.2000.0301; Varela D, 2007, CELL PHYSIOL BIOCHEM, V20, P773, DOI 10.1159/000110437; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; VIDAL R, 2011, CURR MOL ME IN PRESS; Xu CY, 2008, J BIOL CHEM, V283, P11477, DOI 10.1074/jbc.M708385200; XU K, J MOL NEUROSCI; Yedidia Y, 2001, EMBO J, V20, P5383, DOI 10.1093/emboj/20.19.5383; Yoo BC, 2002, NEUROSCI LETT, V334, P196, DOI 10.1016/S0304-3940(02)01071-6; Zanusso G, 1999, J BIOL CHEM, V274, P23396, DOI 10.1074/jbc.274.33.23396	66	61	62	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15658	10.1371/journal.pone.0015658	http://dx.doi.org/10.1371/journal.pone.0015658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209925	gold, Green Published, Green Submitted			2022-12-27	WOS:000285793200035
J	Annamalai, L; Westmoreland, SV; Domingues, HG; Walsh, DG; Gonzalez, G; O'Neil, SP				Annamalai, Lakshmanan; Westmoreland, Susan V.; Domingues, Heber G.; Walsh, Dennis G.; Gonzalez, Gilberto; O'Neil, Shawn P.			Myocarditis in CD8-Depleted SIV-Infected Rhesus Macaques after Short-Term Dual Therapy with Nucleoside and Nucleotide Reverse Transcriptase Inhibitors	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CORONARY-HEART-DISEASE; TUMOR-NECROSIS-FACTOR; ACTIVE ANTIRETROVIRAL THERAPY; LEFT-VENTRICULAR DYSFUNCTION; HIV-INFECTION; DILATED CARDIOMYOPATHY; PROTEASE INHIBITORS; CARDIOVASCULAR-DISEASE; CYTOKINE PRODUCTION	Background: Although highly active antiretroviral therapy (HAART) has dramatically reduced the morbidity and mortality associated with HIV infection, a number of antiretroviral toxicities have been described, including myocardial toxicity resulting from the use of nucleotide and nucleoside reverse transcriptase inhibitors (NRTIs). Current treatment guidelines recommend the use of HAART regimens containing two NRTIs for initial therapy of HIV-1 positive individuals; however, potential cardiotoxicity resulting from treatment with multiple NRTIs has not been addressed. Methodology/Principal Findings: We examined myocardial tissue from twelve CD8 lymphocyte-depleted adult rhesus macaques, including eight animals infected with simian immunodeficiency virus, four of which received combined antiretroviral therapy (CART) consisting of two NRTIs [(9-R-2-Phosphonomethoxypropyl Adenine) (PMPA) and (+/-)-beta-2',3'- dideoxy-5-fluoro-3'-thiacytidine (RCV)] for 28 days. Multifocal infiltrates of mononuclear inflammatory cells were present in the myocardium of all macaques that received CART, but not untreated SIV-positive animals or SIV-negative controls. Macrophages were the predominant inflammatory cells within lesions, as shown by immunoreactivity for the macrophage markers Iba1 and CD68. Heart specimens from monkeys that received CART had significantly lower virus burdens than untreated animals (p, 0.05), but significantly greater quantities of TNF-alpha mRNA than either SIV-positive untreated animals or uninfected controls (p, 0.05). Interferon-gamma (IFN-gamma), IL-1 beta and CXCL11 mRNA were upregulated in heart tissue from SIV-positive monkeys, independent of antiretroviral treatment, but CXCL9 mRNA was only upregulated in heart tissue from macaques that received CART. Conclusions/Significance: These results suggest that short-term treatment with multiple NRTIs may be associated with myocarditis, and demonstrate that the CD8-depleted SIV-positive rhesus monkey is a useful model for studying the cardiotoxic effects of combined antiretroviral therapy in the setting of immunodeficiency virus infection.	[Annamalai, Lakshmanan; Westmoreland, Susan V.; Domingues, Heber G.; Walsh, Dennis G.; O'Neil, Shawn P.] Harvard Univ, Sch Med, Div Comparat Pathol, New England Primate Res Ctr, Southborough, MA 01772 USA; [Gonzalez, Gilberto] Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA USA	Harvard University; Harvard University; Massachusetts General Hospital	Annamalai, L (corresponding author), Oregon Natl Primate Res Ctr, Dept Anim Resources, Beaverton, OR USA.	susan_westmoreland@hms.harvard.edu			NIH NINDS; NIH, NCRR [RR000150, NS048831, NS05004]; NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR000150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048831] Funding Source: NIH RePORTER	NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported in part by grants from NIH NINDS and NCRR, including RR000150 (SPO), NS048831 (SPO) and NS05004 (RGG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DW, 1988, J AM COLL CARDIOL, V11, P792, DOI 10.1016/0735-1097(88)90213-6; Barile M, 1998, GEN PHARMACOL, V31, P531, DOI 10.1016/S0306-3623(98)00041-X; BAROLDI G, 1988, J AM COLL CARDIOL, V12, P463, DOI 10.1016/0735-1097(88)90420-2; Bilate AMB, 2007, MICROBES INFECT, V9, P1104, DOI 10.1016/j.micinf.2007.05.014; Bolger AP, 2002, AM J CARDIOL, V90, P384, DOI 10.1016/S0002-9149(02)02494-3; Bozzette SA, 2003, NEW ENGL J MED, V348, P702, DOI 10.1056/NEJMoa022048; Brinkman K, 1998, AIDS, V12, P1735, DOI 10.1097/00002030-199814000-00004; Calabrese F, 2004, MODERN PATHOL, V17, P1108, DOI 10.1038/modpathol.3800158; Clumeck N, 2000, BIOMED PHARMACOTHER, V54, P7, DOI 10.1016/S0753-3322(00)88634-5; Currier JS, 2003, JAIDS-J ACQ IMM DEF, V33, P506, DOI 10.1097/00126334-200308010-00012; Fantoni M, 2001, ANN NY ACAD SCI, V946, P179, DOI 10.1111/j.1749-6632.2001.tb03912.x; Fiala Milan, 2004, Cardiovasc Toxicol, V4, P97, DOI 10.1385/CT:4:2:097; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Friis-Moller N, 2003, AIDS, V17, P1179, DOI 10.1097/00002030-200305230-00010; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; GRODY WW, 1990, AM J CARDIOL, V66, P203, DOI 10.1016/0002-9149(90)90589-S; Habib FM, 1996, LANCET, V347, P1151, DOI 10.1016/S0140-6736(96)90610-8; HERSKOWITZ A, 1994, J AM COLL CARDIOL, V24, P1025, DOI 10.1016/0735-1097(94)90865-6; HERSKOWITZ A, 1992, ANN INTERN MED, V116, P311, DOI 10.7326/0003-4819-116-4-311; Holmberg SD, 2002, LANCET, V360, P1747, DOI 10.1016/S0140-6736(02)11672-2; Klatt EC, 2003, ADV CARDIOL, V40, P23; Klein D, 2002, J ACQ IMMUN DEF SYND, V30, P471, DOI 10.1097/00126334-200208150-00002; LEWIS W, 1991, LAB INVEST, V65, P228; LEWIS W, 1994, CIRC RES, V74, P344, DOI 10.1161/01.RES.74.2.344; Loos T, 2006, LAB INVEST, V86, P902, DOI 10.1038/labinvest.3700453; Mallat Z, 2004, FASEB J, V18, P1752, DOI 10.1096/fj.04-2426fje; Mari D, 2002, CLIN REV ALLERG IMMU, V23, P325, DOI 10.1385/CRIAI:23:3:325; MATSUMORI A, 1994, CIRCULATION, V89, P955, DOI 10.1161/01.CIR.89.3.955; Meng QY, 2002, J ACQ IMMUN DEF SYND, V30, P306, DOI [10.1097/00126334-200207010-00006, 10.1097/01.QAI.0000017995.56638.F8]; Miller MD, 2001, NUCLEOS NUCLEOT NUCL, V20, P1025, DOI 10.1081/NCN-100002483; Mondal Debasis, 2004, Cardiovasc Toxicol, V4, P287, DOI 10.1385/CT:4:3:287; Monsuez JJ, 2007, INT J CARDIOL, V120, P150, DOI 10.1016/j.ijcard.2006.11.143; Mu H, 2007, WORLD J SURG, V31, P632, DOI 10.1007/s00268-006-0730-0; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; O'Neil SP, 2004, AM J PATHOL, V164, P1157, DOI 10.1016/S0002-9440(10)63204-X; Pugliese A, 2000, J INFECTION, V40, P282, DOI 10.1053/jinf.2000.0672; Reifenberg K, 2007, AM J PATHOL, V171, P463, DOI 10.2353/ajpath.2007.060906; REILLY JM, 1988, AM J CARDIOL, V62, P789, DOI 10.1016/0002-9149(88)91223-4; Ren ZG, 2002, LAB INVEST, V82, P245, DOI 10.1038/labinvest.3780418; Richman DD, 2001, NATURE, V410, P995, DOI 10.1038/35073673; Rogers JS, 2008, MAYO CLIN PROC, V83, P1275, DOI 10.4065/83.11.1275; Sani MU, 2008, WIEN KLIN WOCHENSCHR, V120, P77, DOI 10.1007/s00508-008-0935-3; Shannon RP, 2000, CIRCULATION, V101, P185, DOI 10.1161/01.CIR.101.2.185; Sklar P, 2003, NEW ENGL J MED, V349, P2065, DOI 10.1056/NEJMe038158; Srinivas RV, 1998, ANTIMICROB AGENTS CH, V42, P1484, DOI 10.1128/AAC.42.6.1484; Starc TJ, 2002, J PEDIATR-US, V141, P327, DOI 10.1067/mpd.2002.126301; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Vittecoq D, 2003, ADV CARDIOL, V40, P151; Wang MJ, 2006, CIRCULATION, V114, pI282, DOI 10.1161/CIRCULATIONAHA.105.001164; Westphal E, 2008, MOL MED, V14, P55, DOI 10.2119/2007-00058.Westphal; Williams K, 2005, J CLIN INVEST, V115, P2534, DOI 10.1172/JCI22953; Woldbaek PR, 2003, CARDIOVASC RES, V59, P122, DOI 10.1016/S0008-6363(03)00339-0; Yearley JH, 2008, AIDS, V22, P585, DOI 10.1097/QAD.0b013e3282f57f61; Yearley JH, 2006, AIDS RES HUM RETROV, V22, P529, DOI 10.1089/aid.2006.22.529; Yearley JH, 2009, LAB INVEST, V89, P657, DOI 10.1038/labinvest.2009.29; Zareba Karolina M., 2003, Curr Infect Dis Rep, V5, P513, DOI 10.1007/s11908-003-0096-5	57	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e14429	10.1371/journal.pone.0014429	http://dx.doi.org/10.1371/journal.pone.0014429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203448	Green Published, gold, Green Submitted			2022-12-27	WOS:000285579200010
J	Grant, MKO; Noetzel, MJ; De Lorme, KC; Jakubik, J; Dolezal, V; El-Fakahany, EE				Grant, Marianne K. O.; Noetzel, Meredith J.; De Lorme, Kayla C.; Jakubik, Jan; Dolezal, Vladimir; El-Fakahany, Esam E.			Pharmacological Evaluation of the Long-Term Effects of Xanomeline on the M-1 Muscarinic Acetylcholine Receptor	PLOS ONE			English	Article							AGONIST; PROTEIN; BINDING; DESENSITIZATION; SELECTIVITY; SUBTYPES; ACTIVATION; MECHANISMS; CELLS; M1	Xanomeline is a unique agonist of muscarinic receptors that possesses functional selectivity at the M-1 and M-4 receptor subtypes. It also exhibits wash-resistant binding to and activation of the receptor. In the present work we investigated the consequences of this type of binding of xanomeline on the binding characteristics and function of the M-1 muscarinic receptor. Pretreatment of CHO cells that stably express the M-1 receptor for 1 hr with increasing concentrations of xanomeline followed by washing and waiting for an additional 23 hr in control culture media transformed xanomeline-induced inhibition of [H-3] NMS binding from monophasic to biphasic. The high-affinity xanomeline binding site exhibited three orders of magnitude higher affinity than in the case of xanomeline added directly to the binding assay medium containing control cells. These effects were associated with a marked decrease in maximal radioligand binding and attenuation of agonist-induced increase in PI hydrolysis and were qualitatively similar to those caused by continuous incubation of cells with xanomeline for 24 hr. Attenuation of agonist-induced PI hydrolysis by persistently-bound xanomeline developed with a time course that parallels the return of receptor activation by prebound xanomeline towards basal levels. Additional data indicated that blockade of the receptor orthosteric site or the use of a non-functional receptor mutant reversed the long-term effects of xanomeline, but not its persistent binding at an allosteric site. Furthermore, the long-term effects of xanomeline on the receptor are mainly due to receptor down-regulation rather than internalization.	[Grant, Marianne K. O.; Noetzel, Meredith J.; De Lorme, Kayla C.; El-Fakahany, Esam E.] Univ Minnesota, Sch Med, Dept Psychiat, Minneapolis, MN 55455 USA; [El-Fakahany, Esam E.] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA; [El-Fakahany, Esam E.] Univ Minnesota, Sch Med, Dept Neurosci, Minneapolis, MN 55455 USA; [Jakubik, Jan; Dolezal, Vladimir] Acad Sci Czech Republic, Inst Physiol, Dept Neurochem, Prague, Czech Republic	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Grant, MKO (corresponding author), Univ Minnesota, Sch Med, Dept Psychiat, Minneapolis, MN 55455 USA.	jakubik@biomed.cas.cz	Grant, Marianne/AAL-1396-2020; Dolezal, Vladimir/A-8732-2008; Jakubik, Jan/B-7461-2012	Dolezal, Vladimir/0000-0003-3412-256X; Jakubik, Jan/0000-0002-1737-1487; Grant, Marianne/0000-0002-2963-4686	National Institutes of Health [RO1-NS25743, T32DE007288]; Grant Agency of the Czech Republic [GACR 305/09/0681]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants RO1-NS25743 (EEE-F) and T32DE007288 (MJN) and by Grant Agency of the Czech Republic grant GACR 305/09/0681 (JJ and VD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bymaster FP, 1997, DRUG DEVELOP RES, V40, P158, DOI 10.1002/(SICI)1098-2299(199702)40:2<158::AID-DDR6>3.0.CO;2-K; Bymaster FP, 1998, BRAIN RES, V795, P179, DOI 10.1016/S0006-8993(98)00267-4; CAULFIELD MP, 1993, PHARMACOL THERAPEUT, V58, P319, DOI 10.1016/0163-7258(93)90027-B; Christopoulos A, 1998, MOL PHARMACOL, V53, P1120; Christopoulos A, 1997, EUR J PHARMACOL, V334, pR3, DOI 10.1016/S0014-2999(97)01162-X; Christopoulos A, 1999, J PHARMACOL EXP THER, V289, P1220; Davis Christopher N., 2009, BMC Pharmacology, V9, P14, DOI 10.1186/1471-2210-9-14; De Lorme KC, 2007, J PHARMACOL EXP THER, V323, P868, DOI 10.1124/jpet.107.129940; De Lorme KC, 2006, NEUROSCI LETT, V410, P11, DOI 10.1016/j.neulet.2006.09.062; EHLERT FJ, 1985, MOL PHARMACOL, V28, P410; ELFAKAHANY EE, 1990, MEMBRANE BIOCHEM, V9, P9, DOI 10.3109/09687689009026820; FEIGENBAUM P, 1985, J PHARMACOL EXP THER, V233, P134; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ford DJ, 2002, J PHARMACOL EXP THER, V300, P810, DOI 10.1124/jpet.300.3.810; HU JR, 1991, J PHARMACOL EXP THER, V257, P938; HULME EC, 1990, ANNU REV PHARMACOL, V30, P633, DOI 10.1146/annurev.pa.30.040190.003221; Jakubik J, 2004, J PHARMACOL EXP THER, V308, P105, DOI 10.1124/jpet.103.058594; Jakubik J, 2002, J PHARMACOL EXP THER, V301, P1033, DOI 10.1124/jpet.301.3.1033; Jakubik J, 2006, MOL PHARMACOL, V70, P656, DOI 10.1124/mol.106.023762; Kelly E, 2008, BRIT J PHARMACOL, V153, pS379, DOI 10.1038/sj.bjp.0707604; LEFKOWITZ RJ, 1993, CELL, V74, P409, DOI 10.1016/0092-8674(93)80042-D; Lu ZL, 2002, TRENDS PHARMACOL SCI, V23, P140, DOI 10.1016/S0165-6147(00)01973-8; SHANNON HE, 1994, J PHARMACOL EXP THER, V269, P271; Shekhar A, 2008, AM J PSYCHIAT, V165, P1033, DOI 10.1176/appi.ajp.2008.06091591; Spalding TA, 1995, J PHARMACOL EXP THER, V275, P1274; WANG SZ, 1993, J PHARMACOL EXP THER, V266, P237; WESS J, 1993, LIFE SCI, V53, P1447, DOI 10.1016/0024-3205(93)90618-D; Wood MD, 1999, BRIT J PHARMACOL, V126, P1620, DOI 10.1038/sj.bjp.0702463; ZHU SZ, 1994, MOL PHARMACOL, V45, P517	30	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15722	10.1371/journal.pone.0015722	http://dx.doi.org/10.1371/journal.pone.0015722			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203415	Green Published, gold, Green Submitted			2022-12-27	WOS:000285579200032
J	Hock, K; Ng, KL; Fefferman, NH				Hock, Karlo; Ng, Kah Loon; Fefferman, Nina H.			Systems Approach to Studying Animal Sociality: Individual Position versus Group Organization in Dynamic Social Network Models	PLOS ONE			English	Article							DECISION-MAKING; INTERACTING PHENOTYPES; MULTILEVEL SELECTION; EVOLUTIONARY PROCESS; CENTRALITY; DOMINANCE; BEHAVIOR	Social networks can be used to represent group structure as a network of interacting components, and also to quantify both the position of each individual and the global properties of a group. In a series of simulation experiments based on dynamic social networks, we test the prediction that social behaviors that help individuals reach prominence within their social group may conflict with their potential to benefit from their social environment. In addition to cases where individuals were able to benefit from improving both their personal relative importance and group organization, using only simple rules of social affiliation we were able to obtain results in which individuals would face a trade-off between these factors. While selection would favor (or work against) social behaviors that concordantly increase (or decrease, respectively) fitness at both individual and group level, when these factors conflict with each other the eventual selective pressure would depend on the relative returns individuals get from their social environment and their position within it. The presented results highlight the importance of a systems approach to studying animal sociality, in which the effects of social behaviors should be viewed not only through the benefits that those provide to individuals, but also in terms of how they affect broader social environment and how in turn this is reflected back on an individual's fitness.	[Hock, Karlo; Fefferman, Nina H.] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA; [Ng, Kah Loon] Natl Univ Singapore, Dept Math, Singapore 117548, Singapore; [Fefferman, Nina H.] Rutgers State Univ, Ctr Discrete Math & Theoret Comp Sci DIMACS, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; National University of Singapore; Rutgers State University New Brunswick	Hock, K (corresponding author), Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA.	hock@aesop.rutgers.edu	Fefferman, Nina/AAQ-7378-2021; zhang, julie/G-2932-2011	Fefferman, Nina/0000-0003-0233-1404; Hock, Karlo/0000-0001-7858-1130	National Science Foundation through the Center for Discrete Mathematics and Theoretical Computer Science, Rutgers, The State University of New Jersey	National Science Foundation through the Center for Discrete Mathematics and Theoretical Computer Science, Rutgers, The State University of New Jersey	The National Science Foundation (http://www.nsf.gov/) funded Nina H. Fefferman through the Center for Discrete Mathematics and Theoretical Computer Science, Rutgers, The State University of New Jersey (http://dimacs.rutgers.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2001, BIOL REV, V76, P211, DOI 10.1017/S1464793101005656; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; Carrington P. J., 2005, MODELS METHODS SOCIA; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Conradt L, 2003, NATURE, V421, P155, DOI 10.1038/nature01294; Corner LAL, 2003, PREV VET MED, V59, P147, DOI 10.1016/S0167-5877(03)00075-8; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Creel S, 2001, TRENDS ECOL EVOL, V16, P491, DOI 10.1016/S0169-5347(01)02227-3; DREWS C, 1993, BEHAVIOUR, V125, P283, DOI 10.1163/156853993X00290; Everett MG, 1999, J MATH SOCIOL, V23, P181, DOI 10.1080/0022250X.1999.9990219; Fefferman NH, 2007, ANN ZOOL FENN, V44, P58; Fewell JH, 2003, SCIENCE, V301, P1867, DOI 10.1126/science.1088945; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Godfrey SS, 2009, BEHAV ECOL SOCIOBIOL, V63, P1045, DOI 10.1007/s00265-009-0730-9; Goodnight CJ, 2005, POPUL ECOL, V47, P3, DOI 10.1007/s10144-005-0207-2; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hemelrijk CK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002678; Hock K, 2009, BEHAVIOUR, V146, P69, DOI 10.1163/156853908X390931; Kudo H, 2001, ANIM BEHAV, V62, P711, DOI 10.1006/anbe.2001.1808; Linksvayer TA, 2009, AM NAT, V173, pE99, DOI 10.1086/596527; Lusseau D, 2007, EVOL ECOL, V21, P357, DOI 10.1007/s10682-006-9105-0; Madden JR, 2009, BEHAV ECOL SOCIOBIOL, V64, P81, DOI 10.1007/s00265-009-0820-8; Mallon EB, 2001, BEHAV ECOL SOCIOBIOL, V50, P352, DOI 10.1007/s002650100377; McComb K, 2001, SCIENCE, V292, P491, DOI 10.1126/science.1057895; McCowan B, 2008, APPL ANIM BEHAV SCI, V109, P396, DOI 10.1016/j.applanim.2007.02.009; McDonald DB, 2007, P NATL ACAD SCI USA, V104, P10910, DOI 10.1073/pnas.0701159104; Meyers LA, 2005, J THEOR BIOL, V232, P71, DOI 10.1016/j.jtbi.2004.07.026; Moore AJ, 1997, EVOLUTION, V51, P1352, DOI 10.1111/j.1558-5646.1997.tb01458.x; Naug D, 2009, BEHAV ECOL SOCIOBIOL, V63, P1023, DOI 10.1007/s00265-009-0721-x; Okasha S, 2004, EVOLUTION, V58, P486, DOI 10.1111/j.0014-3820.2004.tb01672.x; Puga-Gonzalez I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000630; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Sih A, 2005, BEHAVIOUR, V142, P1417, DOI 10.1163/156853905774539454; Sih A, 2009, BEHAV ECOL SOCIOBIOL, V63, P975, DOI 10.1007/s00265-009-0725-6; Silk JB, 2007, PHILOS T R SOC B, V362, P539, DOI 10.1098/rstb.2006.1994; VEHRENCAMP SL, 1983, ANIM BEHAV, V31, P667, DOI 10.1016/S0003-3472(83)80222-X; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wey T, 2008, ANIM BEHAV, V75, P333, DOI 10.1016/j.anbehav.2007.06.020; Williams R, 2006, BIOL LETTERS, V2, P497, DOI 10.1098/rsbl.2006.0510; Wilson DS, 2007, Q REV BIOL, V82, P327, DOI 10.1086/522809; WILSON DS, 1975, P NATL ACAD SCI USA, V72, P143, DOI 10.1073/pnas.72.1.143; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P13367, DOI 10.1073/pnas.0505858102; Wittemyer G, 2005, ANIM BEHAV, V69, P1357, DOI 10.1016/j.anbehav.2004.08.018; Wolf JB, 1999, AM NAT, V153, P254, DOI 10.1086/303168; Zar JH., 2010, BIOSTAT ANAL, V5th; [No title captured]	50	12	12	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15789	10.1371/journal.pone.0015789	http://dx.doi.org/10.1371/journal.pone.0015789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203425	Green Published, Green Submitted, gold			2022-12-27	WOS:000285579200041
J	Lenoir, J; Gegout, JC; Guisan, A; Vittoz, P; Wohlgemuth, T; Zimmermann, NE; Dullinger, S; Pauli, H; Willner, W; Grytnes, JA; Virtanen, R; Svenning, JC				Lenoir, Jonathan; Gegout, Jean-Claude; Guisan, Antoine; Vittoz, Pascal; Wohlgemuth, Thomas; Zimmermann, Niklaus E.; Dullinger, Stefan; Pauli, Harald; Willner, Wolfgang; Grytnes, John-Arvid; Virtanen, Risto; Svenning, Jens-Christian			Cross-Scale Analysis of the Region Effect on Vascular Plant Species Diversity in Southern and Northern European Mountain Ranges	PLOS ONE			English	Article							DECIDUOUS FORESTS; BETA-DIVERSITY; INDICATOR VALUES; GLOBAL PATTERNS; DISTANCE DECAY; CLIMATE-CHANGE; RICHNESS; HISTORY; VEGETATION; ECOLOGY	Background: The divergent glacial histories of southern and northern Europe affect present-day species diversity at coarse-grained scales in these two regions, but do these effects also penetrate to the more fine-grained scales of local communities? Methodology/Principal Findings: We carried out a cross-scale analysis to address this question for vascular plants in two mountain regions, the Alps in southern Europe and the Scandes in northern Europe, using environmentally paired vegetation plots in the two regions (n = 403 in each region) to quantify four diversity components: (i) total number of species occurring in a region (total gamma-diversity), (ii) number of species that could occur in a target plot after environmental filtering (habitat-specific gamma-diversity), (iii) pair-wise species compositional turnover between plots (plot-to-plot beta-diversity) and (iv) number of species present per plot (plot alpha-diversity). We found strong region effects on total gamma-diversity, habitat-specific gamma-diversity and plot-to-plot beta-diversity, with a greater diversity in the Alps even towards distances smaller than 50 m between plots. In contrast, there was a slightly greater plot alpha-diversity in the Scandes, but with a tendency towards contrasting region effects on high and low soil-acidity plots. Conclusions/Significance: We conclude that there are strong regional differences between coarse-grained (landscape-to regional-scale) diversity components of the flora in the Alps and the Scandes mountain ranges, but that these differences do not necessarily penetrate to the finest-grained (plot-scale) diversity component, at least not on acidic soils. Our findings are consistent with the contrasting regional Quaternary histories, but we also consider alternative explanatory models. Notably, ecological sorting and habitat connectivity may play a role in the unexpected limited or reversed region effect on plot alpha-diversity, and may also affect the larger-scale diversity components. For instance, plot connectivity and/or selection for high dispersal ability may increase plot alpha-diversity and compensate for low total gamma-diversity.	[Lenoir, Jonathan; Svenning, Jens-Christian] Aarhus Univ, Dept Biol Sci, Ecoinformat & Biodivers Grp, Aarhus, Denmark; [Gegout, Jean-Claude] AgroParisTech, INRA, LERFoB, Unite Mixte Rech 1092, Nancy, France; [Gegout, Jean-Claude] Pontificia Univ Catolica Chile, Dept Ecol, CASEB, Santiago, Chile; [Guisan, Antoine; Vittoz, Pascal] Univ Lausanne, Fac Biol & Med, Dept Ecol & Evolut, Lausanne, Switzerland; [Vittoz, Pascal] Univ Lausanne, Fac Geosci & Environm, Lausanne, Switzerland; [Wohlgemuth, Thomas; Zimmermann, Niklaus E.] Swiss Fed Res Inst Forest Snow & Landscape Res WS, Birmensdorf, Switzerland; [Dullinger, Stefan; Willner, Wolfgang] Vienna Inst Nat Conservat & Analyses, Vienna, Austria; [Pauli, Harald] Univ Vienna, Dept Conservat Biol Vegetat & Landscape Ecol, Fac Ctr Biodivers, Austrian Acad Sci,Inst Mt Res Man & Environm IGF, Vienna, Austria; [Grytnes, John-Arvid] Univ Bergen, Dept Biol, Bergen, Norway; [Virtanen, Risto] Univ Oulu, Dept Biol, Oulu, Finland	Aarhus University; AgroParisTech; INRAE; Pontificia Universidad Catolica de Chile; University of Lausanne; University of Lausanne; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Austrian Academy of Sciences; University of Vienna; University of Bergen; University of Oulu	Lenoir, J (corresponding author), Aarhus Univ, Dept Biol Sci, Ecoinformat & Biodivers Grp, Aarhus, Denmark.	lenoir.john@gmail.com	Lenoir, Jonathan/AAE-8441-2019; Willner, Wolfgang/AAA-4822-2019; Guisan, Antoine/A-1057-2011; Zimmermann, Niklaus E./A-4276-2008; Svenning, Jens-Christian/C-8977-2012; Grytnes, John-Arvid/L-6357-2013; Wohlgemuth, Thomas/E-6588-2016; Virtanen, Risto/G-1810-2010	Lenoir, Jonathan/0000-0003-0638-9582; Willner, Wolfgang/0000-0003-1591-8386; Guisan, Antoine/0000-0002-3998-4815; Zimmermann, Niklaus E./0000-0003-3099-9604; Svenning, Jens-Christian/0000-0002-3415-0862; Wohlgemuth, Thomas/0000-0002-4623-0894; Virtanen, Risto/0000-0002-8295-8217; Dullinger, Stefan/0000-0003-3919-0887; Pauli, Harald/0000-0002-9842-9934; Vittoz, Pascal/0000-0003-4218-4517; Gegout, Jean-Claude/0000-0002-5760-9920; Grytnes, John-Arvid/0000-0002-6365-9676	Danish Natural Science Research Council [272-07-0242]; European Commission [GOCE-CT-036866 ECOCHANGE]	Danish Natural Science Research Council(Danish Natural Science Research Council); European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors gratefully acknowledge grants from the Danish Natural Science Research Council (grant #272-07-0242 to J-C.S.) and from the European Commission (grant #GOCE-CT-036866 ECOCHANGE to S. D., A. G., P. V., and N.E.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez N, 2009, ECOL LETT, V12, P632, DOI 10.1111/j.1461-0248.2009.01312.x; [Anonymous], 2001, PLANT STRATEGIES VEG; [Anonymous], 2003, ALPINE PLANT LIFE, DOI DOI 10.1007/978-3-642-18970-8; Baselga A, 2008, ECOGRAPHY, V31, P263, DOI 10.1111/j.0906-7590.2008.5335.x; Baselga A, 2007, ECOGRAPHY, V30, P838, DOI 10.1111/j.2007.0906-7590.05191.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; BENNETT KD, 1991, J BIOGEOGR, V18, P103, DOI 10.2307/2845248; Bivand R., 2009, SPDEP SPATIAL DEPEND; BRISSE H, 1995, ANN BOT ROMA, V53, P177; Brochmann C, 2003, TAXON, V52, P417, DOI 10.2307/3647444; Brunet J, 1997, J VEG SCI, V8, P329, DOI 10.2307/3237321; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; CORNELL HV, 1992, J ANIM ECOL, V61, P1, DOI 10.2307/5503; Crawley MJ, 2001, SCIENCE, V291, P864, DOI 10.1126/science.291.5505.864; De Caceres M, 2008, OECOLOGIA, V156, P657, DOI 10.1007/s00442-008-1017-y; DIEKMANN M, 1995, ECOGRAPHY, V18, P178, DOI 10.1111/j.1600-0587.1995.tb00339.x; Diekmann M, 2003, BASIC APPL ECOL, V4, P493, DOI 10.1078/1439-1791-00185; Diekmann M, 1997, J VEG SCI, V8, P855, DOI 10.2307/3237030; Dupre C, 2010, GLOBAL CHANGE BIOL, V16, P344, DOI 10.1111/j.1365-2486.2009.01982.x; Dupre C, 1998, APPL VEG SCI, V1, DOI 10.2307/1479092; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; Ellenberg H., 1992, SCRIPTA GEOBOTANICA, V18, P1, DOI DOI 10.15468/TPNGMA; European C., 2005, SOIL ATLAS EUROPE; Ewald J, 2003, FOLIA GEOBOT, V38, P357, DOI 10.1007/BF02803244; Ewald J, 2002, J VEG SCI, V13, P191, DOI 10.1111/j.1654-1103.2002.tb02039.x; Gegout JC, 2005, J VEG SCI, V16, P257, DOI 10.1111/j.1654-1103.2005.tb02363.x; Graham CH, 2006, P NATL ACAD SCI USA, V103, P632, DOI 10.1073/pnas.0505754103; GRUBB PJ, 1987, ORG COMMUNITIES PAST, P99; Grytnes JA, 2003, ECOGRAPHY, V26, P291, DOI 10.1034/j.1600-0587.2003.03358.x; Grytnes JA, 2003, PLANT ECOL, V169, P273, DOI 10.1023/A:1026099705238; Hawkins BA, 2006, J BIOGEOGR, V33, P770, DOI 10.1111/j.1365-2699.2006.01452.x; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hennekens SM, 2001, J VEG SCI, V12, P589, DOI 10.2307/3237010; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Huntley B., 1983, ATLAS PRESENT POLLEN; IVERSEN J, 1958, SYSTEMATICS TODAY, P210; Jansson R, 2002, ANNU REV ECOL SYST, V33, P741, DOI 10.1146/annurev.ecolsys.33.010802.150520; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P59, DOI 10.1111/j.1466-8238.2007.00334.x; Koerner W, 1997, J ECOL, V85, P351, DOI 10.2307/2960507; LATHAM RE, 1993, OIKOS, V67, P325, DOI 10.2307/3545479; Leathwick JR, 1998, ECOGRAPHY, V21, P235, DOI 10.1111/j.1600-0587.1998.tb00561.x; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Legendre P., 2012, NUMERICAL ECOLOGY; Lichstein JW, 2007, PLANT ECOL, V188, P117, DOI 10.1007/s11258-006-9126-3; Loreau M, 2000, ECOL LETT, V3, P73, DOI 10.1046/j.1461-0248.2000.00127.x; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Normand S, 2006, PLANT ECOL, V186, P161, DOI 10.1007/s11258-006-9120-9; Partel M, 2002, ECOLOGY, V83, P2361, DOI 10.1890/0012-9658(2002)083[2361:LPDPAE]2.0.CO;2; Partel M, 1996, OIKOS, V75, P111, DOI 10.2307/3546327; PAULI H, 1993, UNTERSUCHUNGEN PHYTO; PELLISSIER L, 2010, PLANT ECOL, DOI DOI 10.1007/S11258-11010-19794-X; Pennisi E, 2005, SCIENCE, V309, P90, DOI 10.1126/science.309.5731.90; Qian H, 1999, AM NAT, V154, P160, DOI 10.1086/303230; Qian H, 2008, J BIOGEOGR, V35, P1362, DOI 10.1111/j.1365-2699.2008.01901.x; Qian H, 2007, ECOGRAPHY, V30, P471, DOI 10.1111/j.0906-7590.2007.05025.x; Qian H, 2007, ECOLOGY, V88, P1440, DOI 10.1890/06-0916; Qian H, 2009, GLOBAL ECOL BIOGEOGR, V18, P327, DOI 10.1111/j.1466-8238.2009.00450.x; *R DEV COR TEAM I, 2009, R LANG ENV STAT COMP; Ricklefs RE, 2004, ECOGRAPHY, V27, P129; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; Stehlik I, 2002, MOL ECOL, V11, P2027, DOI 10.1046/j.1365-294X.2002.01595.x; Steiner A, 2002, GEOBOT HELVETICA, V74, P1; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Svenning JC, 2007, ECOL LETT, V10, P453, DOI 10.1111/j.1461-0248.2007.01038.x; Svenning JC, 2009, ECOGRAPHY, V32, P13, DOI 10.1111/j.1600-0587.2008.05732.x; THIMONIER A, 1992, FOREST ECOL MANAG, V55, P149, DOI 10.1016/0378-1127(92)90098-T; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Turner JRG, 2004, BASIC APPL ECOL, V5, P435, DOI 10.1016/j.baae.2004.08.004; Tutin T.G., 2001, FLORA EUROPAEA; Tyler G, 2003, FOLIA GEOBOT, V38, P419, DOI 10.1007/BF02803249; Vare H., 2003, ECOL STU AN, P133, DOI 10.1007/978-3-642-18967-8_5; VIRTANEN R, 1997, ACTA PHYTOGEOGR SUEC, V82, P1; Vittoz P, 2005, BOT HELV, V115, P33, DOI 10.1007/s00035-005-0707-x; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335; WILLNER W, 2009, AUSTRIAN VEGETATION; Zobel M, 1997, TRENDS ECOL EVOL, V12, P266, DOI 10.1016/S0169-5347(97)01096-3	76	40	43	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15734	10.1371/journal.pone.0015734	http://dx.doi.org/10.1371/journal.pone.0015734			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203521	Green Published, gold			2022-12-27	WOS:000285578000050
J	Patel, VB; Singh, R; Connolly, C; Kasprowicz, V; Zumla, A; Ndungu, T; Dheda, K				Patel, Vinod B.; Singh, Ravesh; Connolly, Cathy; Kasprowicz, Victoria; Zumla, Allimudin; Ndungu, Thumbi; Dheda, Keertan			Comparison of a Clinical Prediction Rule and a LAM Antigen-Detection Assay for the Rapid Diagnosis of TBM in a High HIV Prevalence Setting	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CENTRAL-NERVOUS-SYSTEM; ACUTE BACTERIAL-MENINGITIS; TUBERCULOUS MENINGITIS; EXTRAPULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; URINARY LIPOARABINOMANNAN; MEDICAL-CENTER; ADULTS; INFECTION	Background/Objective: The diagnosis of tuberculous meningitis (TBM) in resource poor TB endemic environments is challenging. The accuracy of current tools for the rapid diagnosis of TBM is suboptimal. We sought to develop a clinical-prediction rule for the diagnosis of TBM in a high HIV prevalence setting, and to compare performance outcomes to conventional diagnostic modalities and a novel lipoarabinomannan (LAM) antigen detection test (Clearview-TB (R)) using cerebrospinal fluid (CSF). Methods: Patients with suspected TBM were classified as definite-TBM(CSF culture or PCR positive), probable-TBM and non-TBM. Results: Of the 150 patients, 84% were HIV-infected (median [IQR] CD4 count = 132 [54; 241] cells/mu l). There were 39, 55 and 54 patients in the definite, probable and non-TBM groups, respectively. The LAM sensitivity and specificity (95% CI) was 31% (17; 48) and 94% (85; 99), respectively (cut-point >= 0.18). By contrast, smear-microscopy was 100% specific but detected none of the definite-TBM cases. LAM positivity was associated with HIV co-infection and low CD4 T cell count (CD4<200 vs.>200 cells/mu l; p = 0.03). The sensitivity and specificity in those with a CD4<100 cells/mu l was 50% (27; 73) and 95% (74; 99), respectively. A clinical-prediction rule >= 6 derived from multivariate analysis had a sensitivity and specificity (95% CI) of 47% (31; 64) and 98% (90; 100), respectively. When LAM was combined with the clinical-prediction-rule, the sensitivity increased significantly (p<0.001) to 63% (47; 68) and specificity remained high at 93% (82; 98). Conclusions: Despite its modest sensitivity the LAM ELISA is an accurate rapid rule-in test for TBM that has incremental value over smear-microscopy. The rule-in value of LAM can be further increased by combination with a clinical-prediction rule, thus enhancing the rapid diagnosis of TBM in HIV-infected persons with advanced immunosuppression.	[Patel, Vinod B.] Univ KwaZulu Natal, Dept Neurol, Berea, South Africa; [Singh, Ravesh; Kasprowicz, Victoria; Ndungu, Thumbi] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Berea, South Africa; [Connolly, Cathy] MRC, Biostat Unit, Durban, South Africa; [Zumla, Allimudin; Dheda, Keertan] UCL, Ctr Infect Dis & Int Hlth, Dept Infect, London, England; [Dheda, Keertan] Univ Cape Town, Lung Infect & Immun Unit, Div Pulmonol, ZA-7925 Cape Town, South Africa; [Dheda, Keertan] Univ Cape Town, Lung Inst, Dept Med, ZA-7925 Cape Town, South Africa; [Dheda, Keertan] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa	University of Kwazulu Natal; University of Kwazulu Natal; University of London; University College London; University of Cape Town; University of Cape Town; University of Cape Town	Patel, VB (corresponding author), Univ KwaZulu Natal, Dept Neurol, Berea, South Africa.	keertan.dheda@uct.ac.za		Ndung'u, Thumbi/0000-0003-2962-3992; Zumla, Professor Sir Alimuddin/0000-0002-5111-5735	Fogarty International Center, National Institutes of Health [D43TW00231]; South African Medical Research Council; European Union; South African National Research Foundation Research Chairs Initiative; SA MRC Career Development Award; FOGARTY INTERNATIONAL CENTER [D43TW000231] Funding Source: NIH RePORTER	Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); South African National Research Foundation Research Chairs Initiative; SA MRC Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the Columbia University-Southern African Fogarty AIDS International Training and Research Program funded by the Fogarty International Center, National Institutes of Health (grant # D43TW00231; VP), a South African Medical Research Council (SA MRC) grant (VP and KD), the European Union Seventh Framework Programme (TBsusgent; VP and KD), the South African National Research Foundation Research Chairs Initiative (SARChI; TN and KD), a SA MRC Career Development Award (KD), and the European and Developing Countries Clinical Trials Partnership (TESA and TB-NEAT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENGUER J, 1992, NEW ENGL J MED, V326, P668, DOI 10.1056/NEJM199203053261004; Bhigjee AI, 2007, INT J INFECT DIS, V11, P348, DOI 10.1016/j.ijid.2006.07.007; BRAUNWALD E, 2001, HARRISONSS PRINCIPLE, P1028; CDC, 2005, EXTR TUB CAS PERC SI; Chan ED, 2000, AM J RESP CRIT CARE, V161, P1713, DOI 10.1164/ajrccm.161.5.9908125; CHAN J, 1991, INFECT IMMUN, V59, P1755, DOI 10.1128/IAI.59.5.1755-1761.1991; Dheda K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009848; DUBE MP, 1992, AM J MED, V93, P520, DOI 10.1016/0002-9343(92)90579-Z; Garcia-Monco JC, 1999, NEUROL CLIN, V17, P737, DOI 10.1016/S0733-8619(05)70164-X; Girgis NI, 1998, AM J TROP MED HYG, V58, P28, DOI 10.4269/ajtmh.1998.58.28; Hamasur B, 2001, J MICROBIOL METH, V45, P41, DOI 10.1016/S0167-7012(01)00239-1; JEREN T, 1982, ACTA CYTOL, V26, P678; Karstaedt AS, 1998, QJM-INT J MED, V91, P743, DOI 10.1093/qjmed/91.11.743; KASHYAP RS, 2009, INFECTION; KENNEDY DH, 1979, JAMA-J AM MED ASSOC, V241, P264, DOI 10.1001/jama.241.3.264; KILPATRICK ME, 1986, J HYG-CAMBRIDGE, V96, P231, DOI 10.1017/S0022172400066006; Lawn SD, 2009, AIDS, V23, P1875, DOI 10.1097/QAD.0b013e32832e05c8; Lipovsky MM, 2000, J NEUROIMMUNOL, V111, P10, DOI 10.1016/S0165-5728(00)00354-4; Marais S, 2010, LANCET INFECT DIS, V10, P803, DOI 10.1016/S1473-3099(10)70138-9; Moghtaderi A, 2009, SCAND J INFECT DIS, V41, P188, DOI 10.1080/00365540902721384; Mutetwa R, 2009, INT J TUBERC LUNG D, V13, P1253; OGAWA SK, 1987, MEDICINE, V66, P317, DOI 10.1097/00005792-198707000-00004; Ozbay B, 2002, CLIN CHEST MED, V23, P351, DOI 10.1016/S0272-5231(02)00002-3; Pai M, 2003, LANCET INFECT DIS, V3, P633, DOI 10.1016/S1473-3099(03)00772-2; PATEL VB, AM J RESP CRIT CARE; Patel VB, 2010, AM J RESP CRIT CARE, V182, P569, DOI 10.1164/rccm.200912-1931OC; Patel VB, 2009, FLUIDS BARRIERS CNS, V6, DOI 10.1186/1743-8454-6-13; Patil SA, 1996, CLIN IMMUNOL IMMUNOP, V81, P35, DOI 10.1006/clin.1996.0154; Peter J, 2010, CURR OPIN PULM MED, V16, P262, DOI 10.1097/MCP.0b013e328337f23a; Phypers M, 2006, INT J TUBERC LUNG D, V10, P99; Porkert MT, 1997, AM J MED SCI, V313, P325, DOI 10.1097/00000441-199706000-00002; Quan C, 2006, J CLIN MICROBIOL, V44, P3160, DOI 10.1128/JCM.00333-06; Rock RB, 2008, CLIN MICROBIOL REV, V21, P243, DOI 10.1128/CMR.00042-07; Schisterman EF, 2005, EPIDEMIOLOGY, V16, P73, DOI 10.1097/01.ede.0000147512.81966.ba; Shah M, 2010, J CLIN MICROBIOL, V48, P2972, DOI 10.1128/JCM.00363-10; Shah M, 2009, JAIDS-J ACQ IMM DEF, V52, P145, DOI 10.1097/QAI.0b013e3181b98430; Simmons CP, 2006, J IMMUNOL, V176, P2007, DOI 10.4049/jimmunol.176.3.2007; Steingart KR, 2007, THORAX, V62, P911, DOI 10.1136/thx.2006.075754; STEWART SM, 1953, J CLIN PATHOL, V6, P241, DOI 10.1136/jcp.6.3.241; Sumi MG, 2002, CLIN DIAGN LAB IMMUN, V9, P344, DOI 10.1128/CDLI.9.2.344-347.2002; Sumi MG, 2000, ACTA NEUROL SCAND, V101, P61, DOI 10.1034/j.1600-0404.2000.00012.x; Tessema TA, 2001, SCAND J INFECT DIS, V33, P279, DOI 10.1080/003655401300077306; Thwaites G, 2000, J NEUROL NEUROSUR PS, V68, P289, DOI 10.1136/jnnp.68.3.289; Thwaites GE, 2005, J INFECT DIS, V192, P2134, DOI 10.1086/498220; Thwaites GE, 2004, J CLIN MICROBIOL, V42, P378, DOI 10.1128/JCM.42.1.378-379.2004; Thwaites GE, 2002, LANCET, V360, P1287, DOI 10.1016/S0140-6736(02)11318-3; Thwaites G, 2009, J INFECTION, V59, P167, DOI 10.1016/j.jinf.2009.06.011; Verdon R, 1996, CLIN INFECT DIS, V22, P982, DOI 10.1093/clinids/22.6.982; Weinberg A, 2005, J INFECT DIS, V191, P234, DOI 10.1086/426402; World Health Organization, 2008, GLOB TUB CONTR SURV; Yechoor VK, 1996, ARCH INTERN MED, V156, P1710, DOI 10.1001/archinte.156.15.1710	51	35	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15664	10.1371/journal.pone.0015664	http://dx.doi.org/10.1371/journal.pone.0015664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203513	Green Published, gold, Green Submitted			2022-12-27	WOS:000285578000043
J	Chen, TJ; Wu, CC; Tang, MJ; Huang, JS; Su, FC				Chen, Ting-Jung; Wu, Chia-Ching; Tang, Ming-Jer; Huang, Jong-Shin; Su, Fong-Chin			Complexity of the Tensegrity Structure for Dynamic Energy and Force Distribution of Cytoskeleton during Cell Spreading	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; LIVING CELLS; ACTIN-FILAMENTS; MODEL; MICROTUBULES; MECHANICS; ARCHITECTURE; FIBROBLASTS; PRESTRESS; TRACTION	Cytoskeleton plays important roles in intracellular force equilibrium and extracellular force transmission from/to attaching substrate through focal adhesions (FAs). Numerical simulations of intracellular force distribution to describe dynamic cell behaviors are still limited. The tensegrity structure comprises tension-supporting cables and compression-supporting struts that represent the actin filament and microtubule respectively, and has many features consistent with living cells. To simulate the dynamics of intracellular force distribution and total stored energy during cell spreading, the present study employed different complexities of the tensegrity structures by using octahedron tensegrity (OT) and cuboctahedron tensegrity (COT). The spreading was simulated by assigning specific connection nodes for radial displacement and attachment to substrate to form FAs. The traction force on each FA was estimated by summarizing the force carried in sounding cytoskeletal elements. The OT structure consisted of 24 cables and 6 struts and had limitations soon after the beginning of spreading by declining energy stored in struts indicating the abolishment of compression in microtubules. The COT structure, double the amount of cables and struts than the OT structure, provided sufficient spreading area and expressed similar features with documented cell behaviors. The traction force pointed inward on peripheral FAs in the spread out COT structure. The complex structure in COT provided further investigation of various FA number during different spreading stages. Before the middle phase of spreading (half of maximum spreading area), cell attachment with 8 FAs obtained minimized cytoskeletal energy. The maximum number of 12 FAs in the COT structure was required to achieve further spreading. The stored energy in actin filaments increased as cells spread out, while the energy stored in microtubules increased at initial spreading, peaked in middle phase, and then declined as cells reached maximum spreading. The dynamic flows of energy in struts imply that microtubules contribute to structure stabilization.	[Chen, Ting-Jung; Su, Fong-Chin] Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 70101, Taiwan; [Wu, Chia-Ching] Natl Cheng Kung Univ, Dept Cell Biol & Anat, Tainan 70101, Taiwan; [Tang, Ming-Jer] Natl Cheng Kung Univ, Dept Physiol, Tainan 70101, Taiwan; [Huang, Jong-Shin] Natl Cheng Kung Univ, Dept Civil Engn, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Chen, TJ (corresponding author), Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 70101, Taiwan.	joshccwu@mail.ncku.edu.tw; fcsu@mail.ncku.edu.tw	SU, FONG-CHIN/C-8094-2011	SU, FONG-CHIN/0000-0002-3870-4842; Tang, Ming-Jer/0000-0002-0883-4363	National Science Council, Taiwan [NSC97-2320-B-006-005, NSC97-2314-B-006-063, NSC98-2627-B-006-010]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The financial support of the National Science Council, Taiwan (NSC97- 2320-B-006-005, NSC97-2314-B-006-063, and NSC98-2627-B-006-010) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NSC website: http://web1.nsc.gov.tw/mp.aspx?mp = 7.	BOAL DH, 1997, PHYS CANADA      SEP, P228; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Canadas P, 2002, J THEOR BIOL, V218, P155, DOI 10.1006/jtbi.2002.3064; Canadas P, 2006, J BIOMECH ENG-T ASME, V128, P487, DOI 10.1115/1.2205867; Chicurel ME, 1998, CURR OPIN CELL BIOL, V10, P232, DOI 10.1016/S0955-0674(98)80145-2; Coughlin MF, 2003, BIOPHYS J, V84, P1328, DOI 10.1016/S0006-3495(03)74948-0; Coughlin MF, 1998, J BIOMECH ENG-T ASME, V120, P770, DOI 10.1115/1.2834892; Coughlin MF, 1997, J APPL MECH-T ASME, V64, P480, DOI 10.1115/1.2788918; Dupuis DE, 1997, J MUSCLE RES CELL M, V18, P17, DOI 10.1023/A:1018672631256; Gavara N, 2008, BIOPHYS J, V95, P464, DOI 10.1529/biophysj.107.124180; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Hur SS, 2009, CELL MOL BIOENG, V2, P425, DOI 10.1007/s12195-009-0082-6; INGBER DE, 1994, INT REV CYTOL, V150, P173; Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359; Ingber DE, 2000, J APPL PHYSIOL, V89, P1663, DOI 10.1152/jappl.2000.89.4.1663; Ingber DE, 2008, PROG BIOPHYS MOL BIO, V97, P163, DOI 10.1016/j.pbiomolbio.2008.02.005; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Kenner H., 1976, GEODESIC MATH USE IT; KOJIMA H, 1994, P NATL ACAD SCI USA, V91, P12962, DOI 10.1073/pnas.91.26.12962; Laurent VM, 2003, ANN BIOMED ENG, V31, P1263, DOI 10.1114/1.1616932; Luo YZ, 2008, J BIOMECH, V41, P2379, DOI 10.1016/j.jbiomech.2008.05.026; Maurin B, 2008, J BIOMECH, V41, P2036, DOI 10.1016/j.jbiomech.2008.03.011; McGarry J G, 2004, Eur Cell Mater, V7, P27; Munevar S, 2001, BIOPHYS J, V80, p276A; Nagayama K, 2008, AM J PHYSIOL-CELL PH, V295, pC1569, DOI 10.1152/ajpcell.00098.2008; Paul R, 2008, BIOPHYS J, V94, P1470, DOI 10.1529/biophysj.107.108688; Pugh A, 1976, INTRO TENSEGRITY; Roy S, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.061916; Satcher R, 1997, MICROCIRCULATION-LON, V4, P439, DOI 10.3109/10739689709146808; Stamenovic D, 2002, AM J PHYSIOL-CELL PH, V282, pC617, DOI 10.1152/ajpcell.00271.2001; Stamenovic D, 2000, J BIOMECH ENG-T ASME, V122, P39, DOI 10.1115/1.429631; Stamenovic D, 1999, J THEOR BIOL, V201, P63, DOI 10.1006/jtbi.1999.1014; Sultan C, 2004, ANN BIOMED ENG, V32, P520, DOI 10.1023/B:ABME.0000019171.26711.37; Thoumine O, 1999, EUR BIOPHYS J BIOPHY, V28, P222, DOI 10.1007/s002490050203; Tolic-Norrelykke IM, 2005, J BIOMECH, V38, P1405, DOI 10.1016/j.jbiomech.2004.06.027; Tuszynski JA, 2005, EUR PHYS J E, V17, P29, DOI 10.1140/epje/i2004-10102-5; Volokh KY, 2000, J BIOMECH, V33, P1543, DOI 10.1016/S0021-9290(00)00157-3; WANG N, 1994, BIOPHYS J, V66, P2181, DOI 10.1016/S0006-3495(94)81014-8; Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598; Wendling Sylvie, 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P45, DOI 10.1080/1025584021000059413; Wendling Sylvie, 2002, Comput Methods Biomech Biomed Engin, V5, P1, DOI 10.1080/10255840290032162	41	20	20	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e14392	10.1371/journal.pone.0014392	http://dx.doi.org/10.1371/journal.pone.0014392			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21200440	Green Published, gold, Green Submitted			2022-12-27	WOS:000285576900007
J	Hachiya, A; Kodama, EN; Schuckmann, MM; Kirby, KA; Michailidis, E; Sakagami, Y; Oka, S; Singh, K; Sarafianos, SG				Hachiya, Atsuko; Kodama, Eiichi N.; Schuckmann, Matthew M.; Kirby, Karen A.; Michailidis, Eleftherios; Sakagami, Yasuko; Oka, Shinichi; Singh, Kamalendra; Sarafianos, Stefan G.			K70Q Adds High-Level Tenofovir Resistance to "Q151M Complex" HIV Reverse Transcriptase through the Enhanced Discrimination Mechanism	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NUCLEOSIDE ANALOG RESISTANCE; BETA-3-BETA-4 HAIRPIN LOOP; SITE-DIRECTED MUTAGENESIS; INHIBITORS IN-VITRO; POL GENE-MUTATIONS; FINGERS SUBDOMAIN; DRUG SUSCEPTIBILITY; NUCLEOTIDE ANALOGS; PRIMER UNBLOCKING	HIV-1 carrying the "Q151M complex" reverse transcriptase (RT) mutations (A62V/V75I/F77L/F116Y/Q151M, or Q151Mc) is resistant to many FDA-approved nucleoside RT inhibitors (NRTIs), but has been considered susceptible to tenofovir disoproxil fumarate (TFV-DF or TDF). We have isolated from a TFV-DF-treated HIV patient a Q151Mc-containing clinical isolate with high phenotypic resistance to TFV-DF. Analysis of the genotypic and phenotypic testing over the course of this patient's therapy lead us to hypothesize that TFV-DF resistance emerged upon appearance of the previously unreported K70Q mutation in the Q151Mc background. Virological analysis showed that HIV with only K70Q was not significantly resistant to TFV-DF. However, addition of K70Q to the Q151Mc background significantly enhanced resistance to several approved NRTIs, and also resulted in high-level (10-fold) resistance to TFV-DF. Biochemical experiments established that the increased resistance to tenofovir is not the result of enhanced excision, as K70Q/Q151Mc RT exhibited diminished, rather than enhanced ATP-based primer unblocking activity. Pre-steady state kinetic analysis of the recombinant enzymes demonstrated that addition of the K70Q mutation selectively decreases the binding of tenofovir-diphosphate (TFV-DP), resulting in reduced incorporation of TFV into the nascent DNA chain. Molecular dynamics simulations suggest that changes in the hydrogen bonding pattern in the polymerase active site of K70Q/Q151Mc RT may contribute to the observed changes in binding and incorporation of TFV-DP. The novel pattern of TFV-resistance may help adjust therapeutic strategies for NRTI-experienced patients with multi-drug resistant (MDR) mutations.	[Hachiya, Atsuko; Schuckmann, Matthew M.; Kirby, Karen A.; Michailidis, Eleftherios; Singh, Kamalendra; Sarafianos, Stefan G.] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65212 USA; [Hachiya, Atsuko; Oka, Shinichi] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Kodama, Eiichi N.] Tohoku Univ, Sch Med, Div Emerging Infect Dis, Sendai, Miyagi 980, Japan; [Sakagami, Yasuko] Kyoto Univ, Inst Virus Res, Kyoto 606, Japan	University of Missouri System; University of Missouri Columbia; National Center for Global Health & Medicine - Japan; Tohoku University; Kyoto University	Hachiya, A (corresponding author), Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65212 USA.	kodama515@m.tains.tohoku.ac.jp; sarafianoss@missouri.edu	Kodama, Eiichi N/C-4032-2009	Kodama, Eiichi N/0000-0002-6622-2752; Michailidis, Eleftherios/0000-0002-9907-4346; Kirby, Karen A./0000-0003-2468-4796; Sarafianos, Stefan G/0000-0002-5840-154X; Oka, Shinichi/0000-0002-9283-2167	Ministry of Health, Labor and Welfare; Korea Food & Drug Administration; Ministry of Knowledge and Economy, Republic of Korea; National Institutes of Health (NIH) [AI094715, AI076119, AI079801, AI074389]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI079801, R21AI079801, R01AI076119, R01AI074389, R21AI094715] Funding Source: NIH RePORTER	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Korea Food & Drug Administration(Ministry of Food & Drug Safety (MFDS), Republic of Korea); Ministry of Knowledge and Economy, Republic of Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant for the promotion of AIDS Research from the Ministry of Health, Labor and Welfare (AH and EK, http://www.mhlw.go.jp/english/index.html), by grants from the Korea Food & Drug Administration and the Ministry of Knowledge and Economy, Bilateral International Collaborative R&D Program, Republic of Korea (SGS) and by National Institutes of Health (NIH, http://nih.gov/) research grants AI094715, AI076119, AI079801, and AI074389 to SGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arion D, 1998, BIOCHEMISTRY-US, V37, P15908, DOI 10.1021/bi981200e; Boyer PL, 2002, J VIROL, V76, P9143, DOI 10.1128/JVI.76.18.9143-9151.2002; Boyer PL, 2001, J VIROL, V75, P4832, DOI 10.1128/JVI.75.10.4832-4842.2001; Chappell BJ, 2007, AIDS, V21, P761, DOI 10.1097/QAD.0b013e3280187533; CLARK S, 2006, HIV SEQUENCE COMPEND, V2005, P58; Das K, 2009, J BIOL CHEM, V284, P35092, DOI 10.1074/jbc.M109.022525; Delaugerre C, 2008, J MED VIROL, V80, P762, DOI 10.1002/jmv.21158; Deval J, 2002, J BIOL CHEM, V277, P42097, DOI 10.1074/jbc.M206725200; Deval J, 2004, J BIOL CHEM, V279, P25489, DOI 10.1074/jbc.M313534200; Feng JY, 2006, NUCLEOS NUCLEOT NUCL, V25, P89, DOI 10.1080/15257770500379157; Feng JY, 2005, ANTIVIR RES, V66, P153, DOI 10.1016/j.antiviral.2005.03.001; Frangeul A, 2008, ANTIVIR THER, V13, P115; Frangeul A, 2007, ANTIMICROB AGENTS CH, V51, P3162, DOI 10.1128/AAC.00145-07; Frankel FA, 2005, ANTIMICROB AGENTS CH, V49, P2657, DOI 10.1128/AAC.49.7.2657-2664.2005; Gao HQ, 2000, J MOL BIOL, V300, P403, DOI 10.1006/jmbi.2000.3823; Garforth SJ, 2007, J MOL BIOL, V365, P38, DOI 10.1016/j.jmb.2006.09.057; GU ZX, 1994, J BIOL CHEM, V269, P28118; Hachiya A, 2001, ANTIMICROB AGENTS CH, V45, P495, DOI 10.1128/AAC.45.2.495-501.2001; Hachiya A, 2008, J VIROL, V82, P3261, DOI 10.1128/JVI.01154-07; Harrigan PR, 2000, J INFECT DIS, V181, P912, DOI 10.1086/315317; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Iversen AKN, 1996, J VIROL, V70, P1086, DOI 10.1128/JVI.70.2.1086-1090.1996; Johnson Victoria A, 2009, Top HIV Med, V17, P138; Kagan RM, 2007, ANTIVIR RES, V75, P210, DOI 10.1016/j.antiviral.2007.03.006; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kew Y, 1998, J BIOL CHEM, V273, P7529, DOI 10.1074/jbc.273.13.7529; Kosalaraksa P, 1999, J VIROL, V73, P5356, DOI 10.1128/JVI.73.7.5356-5363.1999; LARDER BA, 1989, SCIENCE, V246, P1155, DOI 10.1126/science.2479983; Lerma JGG, 1999, ANTIMICROB AGENTS CH, V43, P264, DOI 10.1128/AAC.43.2.264; Maeda Y, 1998, J INFECT DIS, V177, P1207, DOI 10.1086/515282; Margot NA, 2002, AIDS, V16, P1227, DOI 10.1097/00002030-200206140-00004; Mas A, 2000, EMBO J, V19, P5752, DOI 10.1093/emboj/19.21.5752; Matamoros T, 2004, J BIOL CHEM, V279, P24569, DOI 10.1074/jbc.M312658200; Matsumi S, 2003, AIDS, V17, P1127, DOI 10.1097/00002030-200305230-00003; McColl DJ, 2003, J ANTIMICROB CHEMOTH, V51, P219, DOI 10.1093/jac/dkg109; Menendez-Arias L, 2008, VIRUS RES, V134, P1, DOI 10.1016/j.virusres.2008.01.009; Meyer PR, 2003, J VIROL, V77, P3871, DOI 10.1128/JVI.77.6.3871-3877.2003; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; Michailidis E, 2009, J BIOL CHEM, V284, P35681, DOI 10.1074/jbc.M109.036616; Miller MD, 2001, NUCLEOS NUCLEOT NUCL, V20, P1025, DOI 10.1081/NCN-100002483; Ren J, 2004, J MOL BIOL, V336, P569, DOI 10.1016/j.jmb.2003.12.055; Rigourd M, 2002, J BIOL CHEM, V277, P18611, DOI 10.1074/jbc.M110836200; Sarafianos SG, 1999, P NATL ACAD SCI USA, V96, P10027, DOI 10.1073/pnas.96.18.10027; Sarafianos SG, 2004, CURR OPIN STRUC BIOL, V14, P716, DOI 10.1016/j.sbi.2004.10.013; SARAFIANOS SG, 1995, J BIOL CHEM, V270, P19729, DOI 10.1074/jbc.270.34.19729; SARAFIANOS SG, 1995, BIOCHEMISTRY-US, V34, P7207, DOI 10.1021/bi00021a036; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; SCHUCKMANN MM, J BIOL CHEM; SHAFER RW, 1994, J INFECT DIS, V169, P722, DOI 10.1093/infdis/169.4.722; Shimura K, 2008, J VIROL, V82, P764, DOI 10.1128/JVI.01534-07; SHIRASAKA T, 1995, P NATL ACAD SCI USA, V92, P2398, DOI 10.1073/pnas.92.6.2398; Singh K, 2007, J BIOL CHEM, V282, P10594, DOI 10.1074/jbc.M611242200; Singh K, 2010, VIRUSES-BASEL, V2, P606, DOI 10.3390/v2020606; Sluis-Cremer N, 2000, BIOCHEM J, V348, P77, DOI 10.1042/0264-6021:3480077; Sluis-Cremer N, 2007, ANTIMICROB AGENTS CH, V51, P48, DOI 10.1128/AAC.00683-06; Smith RA, 2008, ANTIMICROB AGENTS CH, V52, P329, DOI 10.1128/AAC.01004-07; TU X, 2001, NAT STRUCT MOL BIOL, V17, P1202; Tuske S, 2004, NAT STRUCT MOL BIOL, V11, P469, DOI 10.1038/nsmb760; UENO T, 1995, J BIOL CHEM, V270, P23605, DOI 10.1074/jbc.270.40.23605; Van Houtte M, 2009, J MED VIROL, V81, P1702, DOI 10.1002/jmv.21585; Van Laethem K, 2007, INFECT GENET EVOL, V7, P600, DOI 10.1016/j.meegid.2007.05.006; Winters B, 2008, JAIDS-J ACQ IMM DEF, V48, P26, DOI 10.1097/QAI.0b013e31816d9bf4; Winters MA, 1997, ANTIMICROB AGENTS CH, V41, P757, DOI 10.1128/AAC.41.4.757	64	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16242	10.1371/journal.pone.0016242	http://dx.doi.org/10.1371/journal.pone.0016242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249155	Green Submitted, Green Published, gold			2022-12-27	WOS:000286515000035
J	Pantaleo, A; Ferru, E; Carta, F; Mannu, F; Simula, LF; Khadjavi, A; Pippia, P; Turrini, F				Pantaleo, Antonella; Ferru, Emanuela; Carta, Franco; Mannu, Franca; Simula, Luigi F.; Khadjavi, Amina; Pippia, Proto; Turrini, Francesco			Irreversible AE1 Tyrosine Phosphorylation Leads to Membrane Vesiculation in G6PD Deficient Red Cells	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; ERYTHROCYTE-MEMBRANE; BAND-3; PROTEIN; PHAGOCYTOSIS; ANTIBODIES; SYK; G6PD-DEFICIENT; PHOSPHATASE	Background: While G6PD deficiency is one of the major causes of acute hemolytic anemia, the membrane changes leading to red cell lysis have not been extensively studied. New findings concerning the mechanisms of G6PD deficient red cell destruction may facilitate our understanding of the large individual variations in susceptibility to pro-oxidant compounds and aid the prediction of the hemolytic activity of new drugs. Methodology/Principal Findings: Our results show that treatment of G6PD deficient red cells with diamide (0.25 mM) or divicine (0.5 mM) causes: (1) an increase in the oxidation and tyrosine phosphorylation of AE1; (2) progressive recruitment of phosphorylated AE1 in large membrane complexes which also contain hemichromes; (3) parallel red cell lysis and a massive release of vesicles containing hemichromes. We have observed that inhibition of AE1 phosphorylation by Syk kinase inhibitors prevented its clustering and the membrane vesiculation while increases in AE1 phosphorylation by tyrosine phosphatase inhibitors increased both red cell lysis and vesiculation rates. In control RBCs we observed only transient AE1 phosphorylation. Conclusions/Significance: Collectively, our findings indicate that persistent tyrosine phosphorylation produces extensive membrane destabilization leading to the loss of vesicles which contain hemichromes. The proposed mechanism of hemolysis may be applied to other hemolytic diseases characterized by the accumulation of hemoglobin denaturation products.	[Pantaleo, Antonella; Khadjavi, Amina; Turrini, Francesco] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; [Ferru, Emanuela] Univ Verona, Sect Internal Med, Dept Clin & Expt Med, I-37100 Verona, Italy; [Carta, Franco; Mannu, Franca] Nurex Srl, Sassari, Italy; [Simula, Luigi F.] Hosp Alghero, Sassari, Italy; [Pippia, Proto] Univ Sassari, Dept Physiol Biochem & Cell Sci, I-07100 Sassari, Italy	University of Turin; University of Verona; University of Sassari	Pantaleo, A (corresponding author), Univ Turin, Dept Genet Biol & Biochem, Turin, Italy.	francesco.turrini@unito.it	Pantaleo, Antonella/ABA-5190-2020	carta, franco/0000-0001-7776-8243				Arese P, 1989, Folia Haematol Int Mag Klin Morphol Blutforsch, V116, P745; Ayi K, 2004, BLOOD, V104, P3364, DOI 10.1182/blood-2003-11-3820; Baker M A, 1984, Toxicol Pathol, V12, P331; Barbero G, 2006, ANAL BIOCHEM, V349, P62, DOI 10.1016/j.ab.2005.10.020; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Beutler E, 2008, BLOOD, V111, P16, DOI 10.1182/blood-2007-04-077412; Beutler E, 2007, AM J TROP MED HYG, V77, P779, DOI 10.4269/ajtmh.2007.77.779; Bordin L, 2005, MOL MEMBR BIOL, V22, P411, DOI 10.1080/09687860500233679; Bordin L, 2005, BBA-MOL CELL RES, V1745, P20, DOI 10.1016/j.bbamcr.2004.12.010; Bordin L, 2002, BLOOD, V100, P276, DOI 10.1182/blood.V100.1.276; Brunati AM, 2000, BLOOD, V96, P1550, DOI 10.1182/blood.V96.4.1550.h8001550_1550_1557; Cappadoro M, 1998, BLOOD, V92, P2527, DOI 10.1182/blood.V92.7.2527.2527_2527_2534; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; CAPRARI P, 1991, BIOCHEM MED METAB B, V45, P16, DOI 10.1016/0885-4505(91)90004-5; CHEVION M, 1982, EUR J BIOCHEM, V127, P405, DOI 10.1111/j.1432-1033.1982.tb06886.x; COUPER KN, PLOS PATHOGENS, V6; Giribaldi G, 2001, BRIT J HAEMATOL, V113, P492, DOI 10.1046/j.1365-2141.2001.02707.x; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; GUTMANN C, AIDS LONDON ENGLAND, V24, P2347; HARRISON ML, 1994, J BIOL CHEM, V269, P955; JOHNSON RM, 1994, BLOOD, V83, P1117; KANNAN R, 1988, J BIOL CHEM, V263, P13766; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOW PS, 1985, SCIENCE, V227, P531, DOI 10.1126/science.2578228; Luzzatto L, 2006, HAEMATOLOGICA, V91, P1303; MANNU F, 1995, BLOOD, V86, P2014, DOI 10.1182/blood.V86.5.2014.bloodjournal8652014; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Nantakomol Duangdao, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P146; PANTALEO A, PROTEOMICS, V19, P3469; Pantaleo A, 2008, AUTOIMMUN REV, V7, P457, DOI 10.1016/j.autrev.2008.03.017; Pantaleo A, 2009, BIOCHEM J, V418, P359, DOI 10.1042/BJ20081557; Tavazzi D, 1998, HEMOGLOBIN, V22, P483, DOI 10.3109/03630269809071545; Terra HTMB, 1998, AM J HEMATOL, V58, P224, DOI 10.1002/(SICI)1096-8652(199807)58:3<224::AID-AJH11>3.0.CO;2-9; Tokumasu F, 2005, J CELL SCI, V118, P1091, DOI 10.1242/jcs.01662; Tokumasu F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005828; TURRINI F, 1994, BBA-BIOMEMBRANES, V1190, P297, DOI 10.1016/0005-2736(94)90087-6; TURRINI F, 1985, BLOOD, V66, P302; Turrini F, 2003, REDOX REP, V8, P300, DOI 10.1179/135100003225002943; WAGNER GM, 1986, J LAB CLIN MED, V108, P315; Westerman M, 2008, BRIT J HAEMATOL, V142, P126, DOI 10.1111/j.1365-2141.2008.07155.x; Westerman MP, 1999, J LAB CLIN MED, V134, P352, DOI 10.1016/S0022-2143(99)90149-X; Winograd E, 2005, MOL BIOCHEM PARASIT, V142, P98, DOI 10.1016/j.molbiopara.2005.03.013; Zipser Y, 1996, BIOCHEM J, V314, P881, DOI 10.1042/bj3140881; Zipser Y, 1997, FEBS LETT, V406, P126, DOI 10.1016/S0014-5793(97)00263-9	44	36	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15847	10.1371/journal.pone.0015847	http://dx.doi.org/10.1371/journal.pone.0015847			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246053	Green Published, gold, Green Submitted			2022-12-27	WOS:000286511200020
J	Pillot, MH; Gautrais, J; Arrufat, P; Couzin, ID; Bon, R; Deneubourg, JL				Pillot, Marie-Helene; Gautrais, Jacques; Arrufat, Patrick; Couzin, Iain D.; Bon, Richard; Deneubourg, Jean-Louis			Scalable Rules for Coherent Group Motion in a Gregarious Vertebrate	PLOS ONE			English	Article							COLLECTIVE DECISION-MAKING; LEADERSHIP; INFORMATION; MOVEMENTS; BEHAVIOR	Individuals of gregarious species that initiate collective movement require mechanisms of cohesion in order to maintain advantages of group living. One fundamental question in the study of collective movement is what individual rules are employed when making movement decisions. Previous studies have revealed that group movements often depend on social interactions among individual members and specifically that collective decisions to move often follow a quorum-like response. However, these studies either did not quantify the response function at the individual scale (but rather tested hypotheses based on group-level behaviours), or they used a single group size and did not demonstrate which social stimuli influence the individual decision-making process. One challenge in the study of collective movement has been to discriminate between a common response to an external stimulus and the synchronization of behaviours resulting from social interactions. Here we discriminate between these two mechanisms by triggering the departure of one trained Merino sheep (Ovis aries) from groups containing one, three, five and seven naive individuals. Each individual was thus exposed to various combinations of already-departed and non-departed individuals, depending on its rank of departure. To investigate which individual mechanisms are involved in maintaining group cohesion under conditions of leadership, we quantified the temporal dynamic of response at the individual scale. We found that individuals' decisions to move do not follow a quorum response but rather follow a rule based on a double mimetic effect: attraction to already-departed individuals and attraction to non-departed individuals. This rule is shown to be in agreement with an adaptive strategy that is inherently scalable as a function of group size.	[Pillot, Marie-Helene; Gautrais, Jacques; Arrufat, Patrick; Bon, Richard] Univ Toulouse, UPS, Ctr Rech Cognit Anim, Toulouse, France; [Pillot, Marie-Helene; Gautrais, Jacques; Arrufat, Patrick; Bon, Richard] CNRS, Ctr Rech Cognit Anim, Toulouse, France; [Pillot, Marie-Helene; Deneubourg, Jean-Louis] Univ Libre Bruxelles, Serv Ecol Sociale, Brussels, Belgium; [Couzin, Iain D.] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Libre de Bruxelles; Princeton University	Pillot, MH (corresponding author), Univ Toulouse, UPS, Ctr Rech Cognit Anim, Toulouse, France.	pillot@cict.fr	Gautrais, Jacques/B-4523-2008; Couzin, Iain D./Q-6862-2018	Gautrais, Jacques/0000-0002-7002-9920; Couzin, Iain D./0000-0001-8556-4558	French Agence Nationale de la Recherche [ANR-BLAN07-3_200418]; University Paul Sabatier of Toulouse; Centre National de la Recherche Scientifique [4423]; Searle Scholars Award [08-SPP-201]; DARPA [HR0011-05-1-0057]; National Science Foundation [PHY-0848755]; Office of Naval Research [N00014-09-1-1074]; Division Of Physics [0848755] Funding Source: National Science Foundation	French Agence Nationale de la Recherche(French National Research Agency (ANR)); University Paul Sabatier of Toulouse; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Searle Scholars Award; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Marie-Helene Pillot is supported by a PhD grant from the French Agence Nationale de la Recherche (PANURGE project ANR-BLAN07-3_200418), and by a ATUPS grant of the University Paul Sabatier of Toulouse. Jean-Louis Deneubourg is research associate from the Belgian National Funds for Scientific Research. This work was also supported by the project PICS n 4423 from the Centre National de la Recherche Scientifique and by a BQR grant of the University Paul Sabatier of Toulouse. Iain D. Couzin acknowledges support from Searle Scholars Award 08-SPP-201, DARPA Grant No. HR0011-05-1-0057, National Science Foundation Award PHY-0848755 and Office of Naval Research Award N00014-09-1-1074. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Camazine S., 2003, SELF ORG BIOL SYSTEM; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Conradt L, 2003, NATURE, V421, P155, DOI 10.1038/nature01294; Conradt L, 2009, PHILOS T R SOC B, V364, P719, DOI 10.1098/rstb.2008.0276; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Dawkins R., 1980, SOCIOBIOLOGY NATUREN, P331; Dostalkova I, 2010, J THEOR BIOL, V263, P437, DOI 10.1016/j.jtbi.2009.12.031; Dumont B, 2005, APPL ANIM BEHAV SCI, V95, P55, DOI 10.1016/j.applanim.2005.04.005; Dyer JRG, 2009, PHILOS T R SOC B, V364, P781, DOI 10.1098/rstb.2008.0233; Gautrais J, 2007, ANIM BEHAV, V74, P1443, DOI 10.1016/j.anbehav.2007.02.020; Giraldeau L.A., 2000, MG BEH ECOL; Gregoire G, 2003, PHYSICA D, V181, P157, DOI 10.1016/S0167-2789(03)00102-7; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; HOUSTON AI, 1993, TRENDS ECOL EVOL, V8, P194, DOI 10.1016/0169-5347(93)90096-8; Kendal RL, 2004, BEHAV ECOL, V15, P269, DOI 10.1093/beheco/arh008; King AJ, 2007, BIOL LETTERS, V3, P137, DOI 10.1098/rsbl.2007.0017; Petit O, 2009, P ROY SOC B-BIOL SCI, V276, P3495, DOI 10.1098/rspb.2009.0983; Pillot MH, 2010, BEHAV PROCESS, V84, P657, DOI 10.1016/j.beproc.2010.02.024; Pillot MH, 2010, BEHAV PROCESS, V83, P235, DOI 10.1016/j.beproc.2009.11.006; Pratt SC, 2002, BEHAV ECOL SOCIOBIOL, V52, P117, DOI 10.1007/s00265-002-0487-x; Pulliam HR., 1984, BEHAVIOURAL ECOLOGY, P122; Radford AN, 2004, ETHOLOGY, V110, P11, DOI 10.1046/j.1439-0310.2003.00943.x; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Rands SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011705; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; Sueur C, 2009, ANIM BEHAV, V78, P1087, DOI 10.1016/j.anbehav.2009.07.029; Sumpter DJT, 2009, PHILOS T R SOC B, V364, P743, DOI 10.1098/rstb.2008.0204; Visscher PK, 2007, BEHAV ECOL SOCIOBIOL, V61, P1615, DOI 10.1007/s00265-007-0393-3; Ward AJW, 2008, P NATL ACAD SCI USA, V105, P6948, DOI 10.1073/pnas.0710344105	31	36	36	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e14487	10.1371/journal.pone.0014487	http://dx.doi.org/10.1371/journal.pone.0014487			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21245930	Green Published, gold, Green Submitted			2022-12-27	WOS:000286511200002
J	Roggero, P; Gianni, ML; Liotto, N; Taroni, F; Orsi, A; Amato, O; Morlacchi, L; Piemontese, P; Agosti, M; Mosca, F				Roggero, Paola; Gianni, Maria L.; Liotto, Nadia; Taroni, Francesca; Orsi, Anna; Amato, Orsola; Morlacchi, Laura; Piemontese, Pasqua; Agosti, Massimo; Mosca, Fabio			Rapid Recovery of Fat Mass in Small for Gestational Age Preterm Infants after Term	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; BIRTH-WEIGHT INFANTS; CATCH-UP GROWTH; BODY-COMPOSITION; POSTNATAL-GROWTH; INSULIN-RESISTANCE; ALTERED ADIPOSITY; FETAL; LIFE; ASSOCIATION	Background: Preterm small for gestational age (SGA) infants may be at risk for increased adiposity, especially when experiencing rapid postnatal weight gain. Data on the dynamic features of body weight and fat mass (FM) gain that occurs early in life is scarce. We investigated the postnatal weight and FM gain during the first five months after term in a cohort of preterm infants. Methodology/Principal Findings: Changes in growth parameters and FM were prospectively monitored in 195 infants with birth weight <= 1500 g. The infants were categorized as born adequate for gestational age (AGA) without growth retardation at term (GR-), born AGA with growth retardation at term (GR+), born SGA. Weight and FM were assessed by an air displacement plethysmography system. At five months, weight z-score was comparable between the AGA (GR+) and the AGA (GR-), whereas the SGA showed a significantly lower weight. The mean weight (g) differences (95% CI) between SGA and AGA (GR-) and between SGA and AGA (GR+) infants at 5 months were -613 (-1215; -12) and -573 (-1227; -79), respectively. At term, the AGA (GR+) and the SGA groups showed a significantly lower FM than the AGA (GR-) group. In the first three months, change in FM was comparable between the AGA (GR+) and the SGA groups and significantly higher than that of the AGA (GR-) group. The mean difference (95% CI) in FM change between SGA and AGA (GR-) and between AGA (GR+) and AGA (GR-) from term to 3 months were 38.6 (12; 65); and 37.7 (10; 65). At three months, the FM was similar in all groups. Conclusions: Our data suggests that fetal growth pattern influences the potential to rapidly correct anthropometry whereas the restoration of fat stores takes place irrespective of birth weight. The metabolic consequences of these findings need to be elucidated.	[Roggero, Paola; Gianni, Maria L.; Liotto, Nadia; Taroni, Francesca; Orsi, Anna; Amato, Orsola; Morlacchi, Laura; Piemontese, Pasqua; Agosti, Massimo; Mosca, Fabio] Univ Milan, NICU, Dept Mother & Infant Sci, Fdn IRCCS Ca Granda,Osped Maggiore Policlin, Milan, Italy; [Agosti, Massimo] Del Ponte Hosp, Maternal & Child Hlth Dept, AO Di Circolo Fdn Macchi, Varese, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Ospedale Circolo & Fondazione Macchi	Roggero, P (corresponding author), Univ Milan, NICU, Dept Mother & Infant Sci, Fdn IRCCS Ca Granda,Osped Maggiore Policlin, Milan, Italy.	paola.roggero@unimi.it	Mosca, Fabio/C-5826-2017; Agosti, Massimo/Q-6222-2016; Taroni, Francesca/AAC-6481-2022; Giannì, Maria/C-2026-2017	Mosca, Fabio/0000-0001-6477-0299; Agosti, Massimo/0000-0003-1828-821X; Giannì, Maria/0000-0003-3901-9131; orsi, anna/0000-0002-5862-0371; AMATO, ORSOLA/0000-0003-4687-4654; LIOTTO, NADIA/0000-0003-0425-5046; taroni, francesca/0000-0001-7710-7795				Agostoni C, 1999, ARCH DIS CHILD, V81, P395, DOI 10.1136/adc.81.5.395; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Beltrand J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005343; Bertino E, 2009, EARLY HUM DEV, V85, P339, DOI 10.1016/j.earlhumdev.2008.12.014; Cooke RJ, 2009, ACTA PAEDIATR, V98, P1269, DOI 10.1111/j.1651-2227.2009.01354.x; Daniels SR, 1999, CIRCULATION, V99, P541, DOI 10.1161/01.CIR.99.4.541; Dulloo AG, 2006, INT J OBESITY, V30, pS23, DOI 10.1038/sj.ijo.0803516; Ellis KJ, 2007, AM J CLIN NUTR, V85, P90, DOI 10.1093/ajcn/85.1.90; Ezzahir N, 2005, PEDIATR RES, V58, P243, DOI 10.1203/01.PDR.0000169980.35179.89; Fenton TR, 2003, BMC PEDIATR, V16, P3; Gianni ML, 2009, ARCH DIS CHILD-FETAL, V94, pF368, DOI 10.1136/adc.2008.153163; Guilloteau P, 2009, J PHYSIOL PHARMACOL, V60, P17; Hack M, 2003, PEDIATRICS, V112, pE30, DOI 10.1542/peds.112.1.e30; Hay WW, 2005, ACTA PAEDIATR, V94, P37, DOI 10.1080/08035320510043547; Ibanez L, 2008, J CLIN ENDOCR METAB, V93, P925, DOI 10.1210/jc.2007-1618; Ibanez L, 2006, J CLIN ENDOCR METAB, V91, P2153, DOI 10.1210/jc.2005-2778; Jaquet D, 2005, DIABETOLOGIA, V48, P849, DOI 10.1007/s00125-005-1724-4; Jordan IM, 2005, BIOL NEONATE, V88, P57, DOI 10.1159/000084701; Latal-Hajnal B, 2003, J PEDIATR-US, V143, P163, DOI 10.1067/S0022-3476(03)00243-9; Lucas A, 1999, BRIT MED J, V319, P245, DOI 10.1136/bmj.319.7204.245; Ma GS, 2004, AM J CLIN NUTR, V79, P653; Maringhini S, 2010, J MATERN-FETAL NEO M, V23, P84, DOI 10.3109/14767058.2010.510245; Meas T, 2010, DIABETES METAB, V36, P11, DOI 10.1016/j.diabet.2009.09.001; Meas T, 2008, J CLIN ENDOCR METAB, V93, P3804, DOI 10.1210/jc.2008-0488; Morrison JL, 2010, PEDIATR NEPHROL, V25, P669, DOI 10.1007/s00467-009-1407-3; Mostyn A, 2009, P NUTR SOC, V68, P393, DOI 10.1017/S002966510999022X; Radmacher Paula G, 2003, J Perinatol, V23, P392, DOI 10.1038/sj.jp.7210947; ROGGERO P, 2010, PEDIAT RES IN PRESS; Roggero P, 2008, EARLY HUM DEV, V84, P555, DOI 10.1016/j.earlhumdev.2008.01.012; Roggero P, 2010, NEONATOLOGY, V97, P139, DOI 10.1159/000239767; Sauer PJJ, 2007, AM J CLIN NUTR, V85, p608S, DOI 10.1093/ajcn/85.2.608S; Uthaya S, 2005, PEDIATR RES, V57, P211, DOI 10.1203/01.PDR.0000148284.58934.1C; van Goudoever JB, 2000, AM J CLIN NUTR, V71, P816, DOI 10.1093/ajcn/71.3.816; Wells JCK, 2007, P NUTR SOC, V66, P423, DOI 10.1017/S0029665107005691; Willemsen RH, 2008, J CLIN ENDOCR METAB, V93, P452, DOI 10.1210/jc.2007-1913; Yeung MY, 2006, ACTA PAEDIATR, V95, P909, DOI 10.1080/08035250600724507	36	43	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e14489	10.1371/journal.pone.0014489	http://dx.doi.org/10.1371/journal.pone.0014489			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21245927	Green Published, gold, Green Submitted			2022-12-27	WOS:000286511200003
J	Mottin, S; Panasenko, G; Ganesh, SS				Mottin, Stephane; Panasenko, Grigory; Ganesh, S. Sivaji			Multiscale Modeling of Light Absorption in Tissues: Limitations of Classical Homogenization Approach	PLOS ONE			English	Article							MULTICOMPONENT HOMOGENIZATION; DISCRETE ABSORBERS; BLOOD-VESSELS; RESPONSES; OPERATOR	In biophotonics, the light absorption in a tissue is usually modeled by the Helmholtz equation with two constant parameters, the scattering coefficient and the absorption coefficient. This classic approximation of "haemoglobin diluted everywhere" (constant absorption coefficient) corresponds to the classical homogenization approach. The paper discusses the limitations of this approach. The scattering coefficient is supposed to be constant (equal to one) while the absorption coefficient is equal to zero everywhere except for a periodic set of thin parallel strips simulating the blood vessels, where it is a large parameter omega. The problem contains two other parameters which are small: epsilon, the ratio of the distance between the axes of vessels to the characteristic macroscopic size, and delta, the ratio of the thickness of thin vessels and the period. We construct asymptotic expansion in two cases: epsilon -> 0, omega -> infinity, delta -> 0, omega delta -> infinity, epsilon(2)omega delta -> 0, and epsilon -> 0, omega -> infinity, delta -> 0, epsilon(2)omega delta(2) -> infinity and prove that in the first case the classical homogenization (averaging) of the differential equation is true while in the second case it is wrong. This result may be applied in the biomedical optics, for instance, in the modeling of the skin and cosmetics.	[Mottin, Stephane] Univ St Etienne, Univ Lyon, CNRS, UMR5516, St Etienne, France; [Panasenko, Grigory] Univ St Etienne, Univ Lyon, LAMUSE, St Etienne, France; [Ganesh, S. Sivaji] Indian Inst Technol, Bombay, Maharashtra, India	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite Jean Monnet; Universite Jean Monnet; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Mottin, S (corresponding author), Univ St Etienne, Univ Lyon, CNRS, UMR5516, St Etienne, France.	mottin@univ-st-etienne.fr; grigory.panasenko@univ-st-etienne.fr	MOTTIN, Stéphane/F-6850-2011; Panasenko, Grigory/AAA-2618-2019; Panasenko, Grigory/J-4594-2013	MOTTIN, Stéphane/0000-0002-7088-4353; Panasenko, Grigory/0000-0003-1399-9661; Panasenko, Grigory/0000-0003-1399-9661; Sista, Sivaji Ganesh/0000-0001-8298-3546	Region Rhone-Alpes; CNRS; Russian Federal Agency on Research and Innovations [02.740.11.5091]	Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); CNRS(Centre National de la Recherche Scientifique (CNRS)); Russian Federal Agency on Research and Innovations	The results were supported by the Program Emergence of the Region Rhone-Alpes. The theoretical part was supported by the CNRS postdoctoral grant and by the grant of the Russian Federal Agency on Research and Innovations Contract No 02.740.11.5091 "Multiscale Models in Physics, Biology and Technologies: Asymptotic and Numerical Analysis". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaire G, 2004, ARCH RATION MECH AN, V174, P179, DOI 10.1007/s00205-004-0332-7; ARRIDGE SR, 1992, PHYS MED BIOL, V37, P1531, DOI 10.1088/0031-9155/37/7/005; BAKHVALOV N, 1989, MATH ITS APPL SOVIET; Bar T., 1980, ADV ANAT EMBRYOL CEL, V59, P1, DOI DOI 10.1007/978-3-642-67432-7_1; BENSOUSSAN A, 1978, STUDIES MATH ITS APP; BRADU A, 2001, 2001 JUN 19 21 MUN G, P85; Campillo F, 2001, STOCH PROC APPL, V93, P57, DOI 10.1016/S0304-4149(00)00095-8; Case K., 1967, ADDISON WESLEY SERIE; Cassot F, 2006, MICROCIRCULATION, V13, P1, DOI 10.1080/10739680500383407; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; Firbank M, 1997, PHYS MED BIOL, V42, P465, DOI 10.1088/0031-9155/42/3/002; Fleming WH, 1997, ANN PROBAB, V25, P1953, DOI 10.1214/aop/1023481117; Gibson AP, 2006, NEUROIMAGE, V30, P521, DOI 10.1016/j.neuroimage.2005.08.059; LIU H, 1995, MED PHYS, V22, P1209, DOI 10.1118/1.597520; Mottin S, 2003, J NEUROCHEM, V84, P633, DOI 10.1046/j.1471-4159.2003.01508.x; PANASENKO G, 1995, CR ACAD SCI I-MATH, V321, P1109; Panasenko G., 2005, MULTISCALE MODELLING; Panasenko GP, 2008, PHYS ATOM NUCL+, V71, P681, DOI 10.1134/S106377880804008X; PANASENKO GP, 1991, MATH USSR SB+, V69, P143, DOI 10.1070/SM1991v069n01ABEH001233; Ramstein S, 2005, APPL OPTICS, V44, P6197, DOI 10.1364/AO.44.006197; Risser L, 2009, INT J DEV NEUROSCI, V27, P185, DOI 10.1016/j.ijdevneu.2008.10.006; Shirinifard A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007190; Svaasand LO, 1995, LASER MED SCI, V10, P235, DOI 10.1007/BF02133615; Talsma A, 2001, J OPT SOC AM A, V18, P932, DOI 10.1364/JOSAA.18.000932; van Veen RLP, 2002, OPT LETT, V27, P246, DOI 10.1364/OL.27.000246; Verkruysse W, 1997, PHYS MED BIOL, V42, P51, DOI 10.1088/0031-9155/42/1/003; Vignal C, 2008, PHYS MED BIOL, V53, P2457, DOI 10.1088/0031-9155/53/10/001; WEINSTEIN MI, 1985, SIAM J APPL MATH, V45, P200, DOI 10.1137/0145011	28	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e14350	10.1371/journal.pone.0014350	http://dx.doi.org/10.1371/journal.pone.0014350			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217816	Green Published, gold			2022-12-27	WOS:000285838900002
J	Vera, PL; Wolfe, TE; Braley, AE; Meyer-Siegler, KL				Vera, Pedro L.; Wolfe, Terra E.; Braley, Alexander E.; Meyer-Siegler, Katherine L.			Thrombin Induces Macrophage Migration Inhibitory Factor Release and Upregulation in Urothelium: A Possible Contribution to Bladder Inflammation	PLOS ONE			English	Article							PROTEASE-ACTIVATED RECEPTORS; RAT BLADDER; INTERSTITIAL CYSTITIS; FACTOR MIF; CELLS; MECHANISM; CANCER; HYPERSENSITIVITY; URINE; VITRO	Purpose: Macrophage migration inhibitory factor (MIF) is a pro-inflammatory cytokine expressed by urothelial cells that mediates bladder inflammation. We investigated the effect of stimulation with thrombin, a Protease Activated Receptor-1 (PAR1) agonist, on MIF release and MIF mRNA upregulation in urothelial cells. Materials and Methods: MIF and PAR1 expression was examined in normal human immortalized urothelial cells (UROtsa) using real-time RT-PCR, Western blotting and dual immunostaining. MIF and PAR1 immunostaining was also examined in rat urothelium. The effect of thrombin stimulation (100 nM) on urothelial MIF release was examined in UROtsa cells (in vitro) and in rats (in vivo). UROtsa cells were stimulated with thrombin, culture media were collected at different time points and MIF amounts were determined by ELISA. Pentobarbital anesthetized rats received intravesical saline (control), thrombin, or thrombin +2% lidocaine (to block nerve activity) for 1 hr, intraluminal fluid was collected and MIF amounts determined by ELISA. Bladder or UROtsa MIF mRNA was measured using real time RT-PCR. Results: UROtsa cells constitutively express MIF and PAR1 and immunostaining for both was observed in these cells and in the basal and intermediate layers of rat urothelium. Thrombin stimulation of urothelial cells resulted in a concentration-and time-dependent increase in MIF release both in vitro (UROtsa; 2.8-fold increase at 1 hr) and in vivo (rat; 4.5-fold) while heat-inactivated thrombin had no effect. In rats, thrombin-induced MIF release was reduced but not abolished by intravesical lidocaine treatment. Thrombin also upregulated MIF mRNA in UROtsa cells (3.3-fold increase) and in the rat bladder (2-fold increase) where the effect was reduced (1.4-fold) by lidocaine treatment. Conclusions: Urothelial cells express both MIF and PAR1. Activation of urothelial PAR1 receptors, either by locally generated thrombin or proteases present in the urine, may mediate bladder inflammation by inducing urothelial MIF release and upregulating urothelial MIF expression.	[Vera, Pedro L.; Wolfe, Terra E.; Braley, Alexander E.; Meyer-Siegler, Katherine L.] Bay Pines VA Healthcare Syst, Res & Dev, Bay Pines, FL USA; [Vera, Pedro L.] Univ S Florida, Dept Surg, Div Urol, Tampa, FL 33620 USA; [Meyer-Siegler, Katherine L.] Univ S Florida, Dept Mol Med, Tampa, FL 33620 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Vera, PL (corresponding author), Bay Pines VA Healthcare Syst, Res & Dev, Bay Pines, FL USA.	pvera@health.usf.edu	Vera, Pedro/AAE-1514-2021	Braley, Alexander/0000-0002-1443-1472	Department of Veterans Affairs; National Institute of Diabetes and Digestive and Kidney Disorders [DK075059]; Bay Pines Foundation; Veterans Health Administration; Office of Research and Development; Biomedical Laboratory Research and Development; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK075059] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institute of Diabetes and Digestive and Kidney Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Bay Pines Foundation; Veterans Health Administration(US Department of Veterans Affairs); Office of Research and Development; Biomedical Laboratory Research and Development(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This material is based upon work supported (or supported in part) by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development (PLV; KLMS). This work was also supported by the National Institute of Diabetes and Digestive and Kidney Disorders DK075059 (PLV) and the Bay Pines Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; BOUCHER W, 1995, BRIT J UROL, V76, P94, DOI 10.1111/j.1464-410X.1995.tb07840.x; Bucala R, 2007, IMMUNITY, V26, P281, DOI 10.1016/j.immuni.2007.03.005; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Chin AC, 2008, J IMMUNOL, V181, P5702, DOI 10.4049/jimmunol.181.8.5702; D'Andrea MR, 2003, AM J PATHOL, V162, P907, DOI 10.1016/S0002-9440(10)63886-2; Dale C, 2008, J RECEPT SIG TRANSD, V28, P29, DOI [10.1080/10799890801941913, 10.1080/10799890801941913 ]; Dattilio A, 2005, J UROLOGY, V173, P635, DOI 10.1097/01.ju.0000143191.55468.1d; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; de Garavilla L, 2001, BRIT J PHARMACOL, V133, P975, DOI 10.1038/sj.bjp.0704152; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Flaster H, 2007, MOL ENDOCRINOL, V21, P1267, DOI 10.1210/me.2007-0065; Gao BC, 2006, J LEUKOCYTE BIOL, V80, P359, DOI 10.1189/jlb.1205738; Gao BC, 2003, J BIOL CHEM, V278, P22523, DOI 10.1074/jbc.M303161200; Giraudoux P., 2009, PGIRMESS DATA ANAL E; Hollenberg MD, 2008, BIOL CHEM, V389, P643, DOI 10.1515/BC.2008.077; Krasowska-Zoladek A, 2007, J NEUROSCI RES, V85, P205, DOI 10.1002/jnr.21088; Kuromitsu S, 2008, SCAND J UROL NEPHROL, V42, P455, DOI 10.1080/00365590802025881; McHowat J, 2001, J UROLOGY, V165, P2063, DOI 10.1016/S0022-5347(05)66295-7; Meyer-Siegler KL, 2010, CANCER LETT, V290, P49, DOI 10.1016/j.canlet.2009.08.025; Meyer-Siegler KL, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/535348; Meyer-Siegler KL, 2004, J UROLOGY, V172, P1504, DOI 10.1097/01.ju.0000140213.54457.97; Meyer-Siegler KL, 2004, J UROLOGY, V171, P1698, DOI 10.1097/01.ju.0000115883.49365.1a; Moffatt JD, 2007, N-S ARCH PHARMACOL, V375, P1, DOI 10.1007/s00210-007-0139-9; Petzoldt JL, 1995, UROL RES, V23, P377, DOI 10.1007/BF00698738; R Core Team, 2020, R LANG ENV STAT COMP; Rickard A, 2002, AM J PHYSIOL-RENAL, V283, pF944, DOI 10.1152/ajprenal.00072.2002; Ritz C, 2005, J STAT SOFTW, V12, P1; Rossi MR, 2001, ENVIRON HEALTH PERSP, V109, P801, DOI 10.1289/ehp.01109801; Saban Ricardo, 2007, BMC Physiology, V7, P4, DOI 10.1186/1472-6793-7-4; Shimizu T, 2004, J BIOL CHEM, V279, P13729, DOI 10.1074/jbc.M400150200; Suzuki T, 2009, AM J RESP CELL MOL, V41, P742, DOI 10.1165/rcmb.2008-0157OC; Vera PL, 2008, J UROLOGY, V180, P373, DOI 10.1016/j.juro.2008.02.040; Vera Pedro L, 2006, BMC Urol, V6, P24, DOI 10.1186/1471-2490-6-24; Vera PL, 2008, EXP BIOL MED, V233, P620, DOI 10.3181/0709-RM-240; Vera PL, 2010, NEUROUROL URODYNAM, V29, P1451, DOI 10.1002/nau.20878; Vera PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005835; Vera PL, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-17; Vergnolle N, 2009, PHARMACOL THERAPEUT, V123, P292, DOI 10.1016/j.pharmthera.2009.05.004; Verjans E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-230; Wadgaonkar R, 2008, J CELL BIOCHEM, V105, P1279, DOI 10.1002/jcb.21928	41	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15904	10.1371/journal.pone.0015904	http://dx.doi.org/10.1371/journal.pone.0015904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209875	Green Submitted, Green Published, gold			2022-12-27	WOS:000285838900047
J	Yang, CX; Tan, WJ; Whittle, C; Qiu, LH; Cao, LC; Akbarian, S; Xu, ZS				Yang, Chunxing; Tan, Weijia; Whittle, Catheryne; Qiu, Linghua; Cao, Lucheng; Akbarian, Schahram; Xu, Zuoshang			The C-Terminal TDP-43 Fragments Have a High Aggregation Propensity and Harm Neurons by a Dominant-Negative Mechanism	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; DNA-BINDING PROTEIN-43; NUCLEAR FACTOR TDP-43; TRANSGENIC MICE; CFTR EXON-9; FUNCTIONAL IMPLICATIONS; CELLULAR TOXICITY; GENE-EXPRESSION; MOTOR DEFICITS	TAR DNA binding protein 43 KD (TDP-43) is an essential gene that regulates gene transcription, mRNA splicing and stability. In amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), two fatal neurodegenerative diseases, TDP-43 is fragmented, generating multiple fragments that include the C-terminal fragment of similar to 25 KD. The role of these fragments in the pathogenesis of ALS and FTD is not clear. Here we investigated the aggregation propensity in various polypeptide regions of TDP-43 in mammalian cells and the effect of these fragments on cultured neurons. By expressing the full length and various TDP-43 fragments in motor neuron-derived NSC-34 cells and primary neurons, we found that both N- and C-terminal fragments of TDP-43 are prone to aggregate and the C-terminal end of RRM2 region is required, though not sufficient, for aggregation. The aggregation of the TDP-43 fragments can drive co-aggregation with the full-length TDP-43, consequently reducing the nuclear TDP-43. In addition, the TDP-43 fragments can impair neurite growth during neuronal differentiation. Importantly, overexpression of the full-length TDP-43 rescues the neurite growth phenotype whereas knockdown of the endogenous TDP-43 reproduces this phenotype. These results suggest that TDP-43 fragments, particularly the pathologically relevant C-terminal fragments, can impair neuronal differentiation by dominant-negatively interfering with the function of the full length TDP-43, thus playing a role in pathogenesis in ALS and FTD.	[Yang, Chunxing; Tan, Weijia; Qiu, Linghua; Cao, Lucheng; Xu, Zuoshang] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Whittle, Catheryne; Akbarian, Schahram] Univ Massachusetts, Sch Med, Dept Psychiat, Brudnick Neuropsychiat Res Inst, Worcester, MA 01655 USA; [Xu, Zuoshang] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; [Xu, Zuoshang] Univ Massachusetts, Sch Med, Neurosci Program, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Yang, CX (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	Zuoshang.xu@umassmed.edu			NIH/NINDS [RO1 NS048145, R21 NS062230]; ALS Association; Robert Pachard Center for ALS Research at Johns Hopkins; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS062230, R01NS048145] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ALS Association; Robert Pachard Center for ALS Research at Johns Hopkins; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the NIH/NINDS (RO1 NS048145 and R21 NS062230) ALS Association and The Robert Pachard Center for ALS Research at Johns Hopkins to ZX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya KK, 2006, DEV BIOL, V295, P781, DOI 10.1016/j.ydbio.2006.04.443; Ayala YM, 2006, FEBS LETT, V580, P1339, DOI 10.1016/j.febslet.2006.01.052; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chiang P-M, 2010, P NATL ACAD SCI; Dormann D, 2009, J NEUROCHEM, V110, P1082, DOI 10.1111/j.1471-4159.2009.06211.x; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Hart PJ, 2006, CURR OPIN CHEM BIOL, V10, P131, DOI 10.1016/j.cbpa.2006.02.034; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Iguchi Y, 2009, J BIOL CHEM, V284, P22059, DOI 10.1074/jbc.M109.012195; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Kim SH, 2010, J BIOL CHEM, V285, P34097, DOI 10.1074/jbc.M110.154831; Kraemer BC, 2010, ACTA NEUROPATHOL, V119, P409, DOI 10.1007/s00401-010-0659-0; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Lu YB, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-30; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimoto Y, 2010, J BIOL CHEM, V285, P608, DOI 10.1074/jbc.M109.022012; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Nonaka T, 2009, FEBS LETT, V583, P394, DOI 10.1016/j.febslet.2008.12.031; Qiu LH, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-77; Sato M, 2001, MOL REPROD DEV, V60, P446, DOI 10.1002/mrd.1109; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Stallings NR, 2010, NEUROBIOL DIS; Strong MJ, 2007, MOL CELL NEUROSCI; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Wang IF, 2008, J NEUROCHEM, V105, P797, DOI 10.1111/j.1471-4159.2007.05190.x; Wang IF, 2002, P NATL ACAD SCI USA, V99, P13583, DOI 10.1073/pnas.212483099; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106; Zhou HX, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000887; Zhou HX, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni061	51	90	94	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15878	10.1371/journal.pone.0015878	http://dx.doi.org/10.1371/journal.pone.0015878			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209826	Green Published, gold			2022-12-27	WOS:000285838900045
J	Chen, QA; Tang, MX; Mamiya, T; Im, HI; Xiong, XL; Joseph, A; Tang, YP				Chen, Qian; Tang, Mingxi; Mamiya, Takayoshi; Im, Heh-In; Xiong, Xiaoli; Joseph, Anu; Tang, Ya-Ping			Bi-Directional Effect of Cholecystokinin Receptor-2 Overexpression on Stress-Triggered Fear Memory and Anxiety in the Mouse	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PARAVENTRICULAR NUCLEUS; SYNAPTIC PLASTICITY; CCK ANTAGONISTS; PANIC-DISORDER; AMYGDALA; RATS; BRAIN; TETRAPEPTIDE; ASSOCIATION	Fear, an emotional response of animals to environmental stress/threats, plays an important role in initiating and driving adaptive response, by which the homeostasis in the body is maintained. Overwhelming/uncontrollable fear, however, represents a core symptom of anxiety disorders, and may disturb the homeostasis. Because to recall or imagine certain cue(s) of stress/threats is a compulsory inducer for the expression of anxiety, it is generally believed that the pathogenesis of anxiety is associated with higher attention (acquisition) selectively to stress or mal-enhanced fear memory, despite that the actual relationship between fear memory and anxiety is not yet really established. In this study, inducible forebrain-specific cholecystokinin receptor-2 transgenic (IF-CCKR-2 tg) mice, different stress paradigms, batteries of behavioral tests, and biochemical assays were used to evaluate how different CCKergic activities drive fear behavior and hormonal reaction in response to stresses with different intensities. We found that in IF-CCKR-2 tg mice, contextual fear was impaired following 1 trial of footshock, while overall fear behavior was enhanced following 36 trials of footshock, compared to their littermate controls. In contrast to a standard Yerkes-Dodson (inverted-U shaped) stress-fear relationship in control mice, a linearized stress-fear curve was observed in CCKR-2 tg mice following gradient stresses. Moreover, compared to 1 trial, 36 trials of footshock in these transgenic mice enhanced anxiety-like behavior in other behavioral tests, impaired spatial and recognition memories, and prolonged the activation of adrenocorticotropic hormone (ACTH) and glucocorticoids (CORT) following new acute stress. Taken together, these results indicate that stress may trigger two distinctive neurobehavioral systems, depending on both of the intensity of stress and the CCKergic tone in the brain. A "threshold theory" for this two-behavior system has been suggested.	[Chen, Qian; Mamiya, Takayoshi; Im, Heh-In; Xiong, Xiaoli; Joseph, Anu; Tang, Ya-Ping] Louisiana State Univ, Hlth Sci Ctr, Dept Cell Biol & Anat, New Orleans, LA USA; [Chen, Qian; Mamiya, Takayoshi; Joseph, Anu; Tang, Ya-Ping] Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, New Orleans, LA USA; [Tang, Mingxi] Luzhou Med Coll, Dept Pathol, Sichun, Peoples R China	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Southwest Medical University	Chen, QA (corresponding author), Astellas Res Inst Amer LLC, CNS, Skokie, IL USA.	ytang1@lsuhsc.edu	Tang, Ya-Ping/A-1035-2011; joseph, anu/K-4292-2019	Tang, Ya-Ping/0000-0002-0445-4072	Geraldi Norton Foundation; Christopher Eklund Family Foundation; National Institute of Mental Health/National Institutes of Health (NIMH/NIH) [MH066243, MH083530]; Alzheimer's Association [NIRG-02-4368]; National Science Foundation (NSF) [0213112]; National Alliance for Research on Schizophrenia and Depression (NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH083530, R21MH083530, R01MH066243] Funding Source: NIH RePORTER	Geraldi Norton Foundation; Christopher Eklund Family Foundation; National Institute of Mental Health/National Institutes of Health (NIMH/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Alzheimer's Association(Alzheimer's Association); National Science Foundation (NSF)(National Science Foundation (NSF)); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	HII was supported by the Geraldi Norton Foundation and Christopher Eklund Family Foundation. This work was partially conducted in the University of Chicago. This study was supported by grants from National Institute of Mental Health/National Institutes of Health (NIMH/NIH) (MH066243), NIMH/NIH (MH083530), Alzheimer's Association (NIRG-02-4368), National Science Foundation (NSF; 0213112), and National Alliance for Research on Schizophrenia and Depression (NARSAD), all to YPT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barco A, 2006, J NEUROCHEM, V97, P1520, DOI 10.1111/j.1471-4159.2006.03870.x; Bentz D, 2010, J ANXIETY DISORD, V24, P223, DOI 10.1016/j.janxdis.2009.10.011; Bereza BG, 2009, CLIN THER, V31, P1279, DOI 10.1016/j.clinthera.2009.06.004; Bhatnagar S, 2000, J NEUROSCI, V20, P5564, DOI 10.1523/JNEUROSCI.20-14-05564.2000; Binkley K, 2001, J ALLERGY CLIN IMMUN, V107, P887, DOI 10.1067/mai.2001.114798; Chen Q, 2006, P NATL ACAD SCI USA, V103, P3881, DOI 10.1073/pnas.0505407103; Chung L, 2009, J NEUROPHYSIOL, V102, P272, DOI 10.1152/jn.90769.2008; Cornelis MC, 2010, CURR PSYCHIAT REP, V12, P313, DOI 10.1007/s11920-010-0126-6; Damsa C, 2009, CURR OPIN PSYCHIATR, V22, P96, DOI 10.1097/YCO.0b013e328319bd10; DelBel EA, 1997, NEUROREPORT, V8, P3597, DOI 10.1097/00001756-199711100-00035; DELLAFERA MA, 1979, SCIENCE, V206, P471, DOI 10.1126/science.504989; Dere E, 2010, BEHAV BRAIN RES; Diamond DM, 2005, HIPPOCAMPUS, V15, P1006, DOI 10.1002/hipo.20107; EICHENBAUM H, 2007, ANN REV NEUROSCI; Farook JM, 2001, NEUROREPORT, V12, P2717, DOI 10.1097/00001756-200108280-00025; Gass P, 2004, MOL BRAIN RES, V130, P16, DOI 10.1016/j.molbrainres.2004.07.004; Greisen MH, 2005, BEHAV BRAIN RES, V161, P204, DOI 10.1016/j.bbr.2005.02.006; Gulpinar MA, 2004, CURR PROTEIN PEPT SC, V5, P457, DOI 10.2174/1389203043379341; Handwerger K, 2009, HARVARD REV PSYCHIAT, V17, P184, DOI 10.1080/10673220902996775; Harro J, 1996, N-S ARCH PHARMACOL, V354, P59; Hattori E, 2002, AM J MED GENET, V114, P523, DOI 10.1002/ajmg.10516; Hebb ALO, 2005, PROG NEURO-PSYCHOPH, V29, P1225, DOI 10.1016/j.pnpbp.2005.08.008; Herman JP, 2008, PROG BRAIN RES, V170, P353, DOI 10.1016/S0079-6123(08)00429-9; HILL DR, 1987, J NEUROSCI, V7, P2967; Hinkelmann K, 2010, J PSYCHIAT RES; Im HI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007424; Kellner M, 2000, BIOL PSYCHIAT, V47, P107, DOI 10.1016/S0006-3223(99)00118-3; Kennedy JL, 1999, MOL PSYCHIATR, V4, P284, DOI 10.1038/sj.mp.4000507; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Koks S, 2000, J PSYCHIATR NEUROSCI, V25, P33; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Lang PJ, 2006, PROG BRAIN RES, V156, P3, DOI 10.1016/S0079-6123(06)56001-7; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Lin CH, 2003, MOL PHARMACOL, V63, P44, DOI 10.1124/mol.63.1.44; Ma S, 2005, J NEUROENDOCRINOL, V17, P761, DOI 10.1111/j.1365-2826.2005.01372.x; Marsch R, 2007, J NEUROSCI, V27, P832, DOI 10.1523/JNEUROSCI.3303-06.2007; Matynia A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009857; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Packard MG, 2009, BRAIN RES, V1293, P121, DOI 10.1016/j.brainres.2009.03.029; PAVLASEVIC S, 1993, NEUROREPORT, V5, P225, DOI 10.1097/00001756-199312000-00009; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Rabinowitch I, 2006, J NEUROSCI, V26, P13474, DOI 10.1523/JNEUROSCI.4333-06.2006; Rodrigues SM, 2009, ANN REV NEUROSCI; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Rotzinger S, 2010, PEPTIDES, V31, P736, DOI 10.1016/j.peptides.2009.12.015; Schneider R, 2009, PSYCHOPHARMACOLOGY, V202, P559, DOI 10.1007/s00213-008-1332-3; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Sherrin T, 2009, MOL PSYCHIATR, V14, P291, DOI 10.1038/sj.mp.4002121; Shindo S, 2005, FORENSIC SCI INT, V150, P85, DOI 10.1016/j.forsciint.2004.10.001; Shors TJ, 2004, LEARN MEMORY, V11, P137, DOI 10.1101/lm.66604; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Tahara T, 2009, HEPATO-GASTROENTEROL, V56, P1245; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tiwari AK, 2010, PROG NEUROPSYCHOPHAR; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Wang H, 2005, NEUROSCI BIOBEHAV R, V29, P1361, DOI 10.1016/j.neubiorev.2005.05.008; Wang Z, 2002, AM J MED GENET, V114, P479, DOI 10.1002/ajmg.10408; WANK SA, 1995, AM J PHYSIOL-GASTR L, V269, pG628, DOI 10.1152/ajpgi.1995.269.5.G628; WETTSTEIN JG, 1994, PHARMACOL THERAPEUT, V62, P267, DOI 10.1016/0163-7258(94)90047-7; Wolf OT, 2009, BRAIN RES, V1293, P142, DOI 10.1016/j.brainres.2009.04.013; Wood GE, 1998, P NATL ACAD SCI USA, V95, P4066, DOI 10.1073/pnas.95.7.4066; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503; Yokoyama F, 2009, PSYCHOPHARMACOLOGY, V205, P177, DOI 10.1007/s00213-009-1528-1; ZOLAMORGAN S, 1989, J NEUROSCI, V9, P4355	65	17	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15999	10.1371/journal.pone.0015999	http://dx.doi.org/10.1371/journal.pone.0015999			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209861	Green Published, Green Submitted, gold			2022-12-27	WOS:000285793600054
J	Andrews, JR; Shah, NS; Weissman, D; Moll, AP; Friedland, G; Gandhi, NR				Andrews, Jason R.; Shah, N. Sarita; Weissman, Darren; Moll, Anthony P.; Friedland, Gerald; Gandhi, Neel R.			Predictors of Multidrug- and Extensively Drug-Resistant Tuberculosis in a High HIV Prevalence Community	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; SOUTH-AFRICA; PULMONARY TUBERCULOSIS; RISK-FACTORS; TRANSMISSION; THERAPY; POPULATION; RUSSIA; IMPACT; PERU	Background: Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) have emerged in high-HIV-prevalence settings, which generally lack laboratory infrastructure for diagnosing TB drug resistance. Even where available, inherent delays with current drug-susceptibility testing (DST) methods result in clinical deterioration and ongoing transmission of MDR and XDR-TB. Identifying clinical predictors of drug resistance may aid in risk stratification for earlier treatment and infection control. Methods: We performed a retrospective case-control study of patients with MDR (cases), XDR (cases) and drug-susceptible (controls) TB in a high-HIV-prevalence setting in South Africa to identify clinical and demographic risk factors for drug-resistant TB. Controls were selected in a 1: 1: 1 ratio and were not matched. We calculated odds ratios (OR) and performed multivariate logistic regression to identify independent predictors. Results: We enrolled 116, 123 and 139 patients with drug-susceptible, MDR, and XDR-TB. More than 85% in all three patient groups were HIV-infected. In multivariate analysis, MDR and XDR-TB were each strongly associated with history of TB treatment failure (adjusted OR 51.7 [CI 6.6-403.7] and 51.5 [CI 6.4-414.0], respectively) and hospitalization more than 14 days (aOR 3.8 [CI 1.1-13.3] and 6.1 [CI 1.8-21.0], respectively). Prior default from TB treatment was not a risk factor for MDR or XDR-TB. HIV was a risk factor for XDR (aOR 8.2, CI 1.3-52.6), but not MDR-TB. Comparing XDR with MDR-TB patients, the only significant risk factor for XDR-TB was HIV infection (aOR 5.3, CI 1.0-27.6). Discussion: In this high-HIV-prevalence and drug-resistant TB setting, a history of prolonged hospitalization and previous TB treatment failure were strong risk factors for both MDR and XDR-TB. Given high mortality observed among patients with HIV and drug-resistant TB co-infection, previously treated and hospitalized patients should be considered for empiric secondline TB therapy while awaiting confirmatory DST results in settings with a high-burden of MDR/XDR-TB.	[Andrews, Jason R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Infect Dis, Boston, MA 02115 USA; [Shah, N. Sarita; Weissman, Darren; Gandhi, Neel R.] Albert Einstein Coll Med, Dept Med, New York, NY USA; [Shah, N. Sarita; Gandhi, Neel R.] Albert Einstein Coll Med, Dept Epidemiol & Publ Hlth, New York, NY USA; [Shah, N. Sarita; Weissman, Darren; Gandhi, Neel R.] Montefiore Med Ctr, New York, NY USA; [Moll, Anthony P.] Philanjalo & Church Scotland Hosp, Tugela Ferry, Kwazulu Natal, South Africa; [Friedland, Gerald] Yale Univ, Sch Med, AIDS Program, New Haven, CT USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Yeshiva University; Yeshiva University; Montefiore Medical Center; Yale University	Andrews, JR (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Infect Dis, Boston, MA 02115 USA.	neelgandhi@alumni.williams.edu	alzahrani, saud hamed/C-2014-2012	Andrews, Jason/0000-0002-5967-251X	Doris Duke Charitable Foundation [NRG 2007070, NSS 2007071, 2007018]; Gilead Foundation; Irene Diamond Fund [R05130]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087465, R01AI089349] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Gilead Foundation(Gilead Sciences); Irene Diamond Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NRG and NSS are both recipients of the Doris Duke Charitable Foundation Clinical Scientist Development Award (NRG 2007070, NSS 2007071; www.ddcf.org). GF is also supported by the Doris Duke Charitable Foundation (2007018), the Gilead Foundation (www.gilead.com/Gilead_Foundation), and The Irene Diamond Fund (R05130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JR, 2008, J INFECT DIS, V198, P1582, DOI 10.1086/592991; Andrews JR, 2007, J INFECT DIS, V196, pS482, DOI 10.1086/521121; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5; Basu S, 2009, P NATL ACAD SCI USA, V106, P7672, DOI 10.1073/pnas.0812472106; Brust JCM, 2010, INT J TUBERC LUNG D, V14, P413; Calver AD, 2010, EMERG INFECT DIS, V16, P264, DOI 10.3201/eid1602.090968; Campos PE, 2003, EMERG INFECT DIS, V9, P1571, DOI 10.3201/eid0912.020731; Casal M, 2005, MICROB DRUG RESIST, V11, P62, DOI 10.1089/mdr.2005.11.62; Churchyard GJ, 2000, INT J TUBERC LUNG D, V4, P433; Costello C, 2005, JAIDS-J ACQ IMM DEF, V39, P242; Cox HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013901; Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8; Dowdy DW, 2008, P NATL ACAD SCI USA, V105, P11293, DOI 10.1073/pnas.0800965105; Drobniewski F, 2005, JAMA-J AM MED ASSOC, V293, P2726, DOI 10.1001/jama.293.22.2726; Escombe AR, 2008, PLOS MED, V5, P1387, DOI 10.1371/journal.pmed.0050188; Espinal MA, 2001, INT J TUBERC LUNG D, V5, P887; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Gordin FM, 1996, AM J RESP CRIT CARE, V154, P1478, DOI 10.1164/ajrccm.154.5.8912768; Hassim S, 2010, CLIN INFECT DIS, V50, P1053, DOI 10.1086/651119; Keshavjee S, 2008, LANCET, V372, P1403, DOI 10.1016/S0140-6736(08)61204-0; Kliiman K, 2009, ANN INTERN MED, V150, P766, DOI 10.7326/0003-4819-150-11-200906020-00004; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Mwaniki MK, 2009, B WORLD HEALTH ORGAN, V87, P263, DOI 10.2471/BLT.07.049148; Novelli EM, 2010, BRIT J HAEMATOL, V149, P711, DOI 10.1111/j.1365-2141.2010.08147.x; PATEL KB, 1995, NEW ENGL J MED, V332, P336, DOI 10.1056/NEJM199502023320518; Punnotok J, 2000, INT J TUBERC LUNG D, V4, P537; Schreiber YS, 2009, INT J TUBERC LUNG D, V13, P1274; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Seung KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007186; Shenoi SV, 2010, CLIN INFECT DIS, V50, pS231, DOI 10.1086/651496; Solari L, 2008, INT J TUBERC LUNG D, V12, P619; South African Department of Health, 2004, S AFR NAT TUB CONTR; Suchindran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005561; Vashakidze L, 2009, INT J TUBERC LUNG D, V13, P1148; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; *WHO, 2009, GLOB TUB CONTR SHORT	39	58	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15735	10.1371/journal.pone.0015735	http://dx.doi.org/10.1371/journal.pone.0015735			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209951	gold, Green Published, Green Submitted			2022-12-27	WOS:000285793200047
J	Lombarts, KMJMH; Heineman, MJ; Arah, OA				Lombarts, Kiki M. J. M. H.; Heineman, Maas Jan; Arah, Onyebuchi A.			Good Clinical Teachers Likely to be Specialist Role Models: Results from a Multicenter Cross-Sectional Survey	PLOS ONE			English	Article							RESIDENTS PERCEPTIONS; CONSUMER ASSESSMENT; VALIDATION; STUDENTS	Context: Medical educational reform includes enhancing role modelling of clinical teachers. This requires faculty being aware of their role model status and performance. We developed the System for Evaluation of Teaching Qualities (SETQ) to generate individualized feedback on previously defined teaching qualities and role model status for faculty in (non) academic hospitals. Objectives: (i) To examine whether teaching qualities of faculty were associated with their being seen as a specialist role model by residents, and (ii) to investigate whether those associations differed across residency years and specialties. Methods & Materials: Cross-sectional questionnaire survey amongst 549 Residents of 36 teaching programs in 15 hospitals in the Netherlands. The main outcome measure was faculty being seen as specialist role models by residents. Statistical analyses included (i) Pearson's correlation coefficients and (ii) multivariable logistic generalized estimating equations to assess the (adjusted) associations between each of five teaching qualities and 'being seen as a role model'. Results: 407 residents completed a total of 4123 evaluations of 662 faculty. All teaching qualities were positively correlated with 'being seen as a role model' with correlation coefficients ranging from 0.49 for 'evaluation of residents' to 0.64 for 'learning climate' (P<0.001). Faculty most likely to be seen as good role models were those rated highly on 'feedback' (odds ratio 2.91, 95% CI: 2.41-3.51), 'a professional attitude towards residents' (OR 2.70, 95% CI: 2.34-3.10) and 'creating a positive learning climate' (OR 2.45, 95% CI: 1.97-3.04). Results did not seem to vary much across residency years. The relative strength of associations between teaching qualities and being seen as a role model were more distinct when comparing specialties. Conclusions: Good clinical educators are more likely to be seen as specialist role models for most residents.	[Lombarts, Kiki M. J. M. H.; Arah, Onyebuchi A.] Univ Amsterdam, Acad Med Ctr, Dept Qual & Proc Innovat, NL-1105 AZ Amsterdam, Netherlands; [Heineman, Maas Jan] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynecol, NL-1105 AZ Amsterdam, Netherlands; [Arah, Onyebuchi A.] Univ Calif Los Angeles, Dept Epidemiol, UCLA Sch Publ Hlth, Los Angeles, CA USA; [Arah, Onyebuchi A.] Univ Calif Los Angeles, Ctr Hlth Policy Res, Los Angeles, CA USA; [Arah, Onyebuchi A.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Amsterdam; Academic Medical Center Amsterdam	Lombarts, KMJMH (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Qual & Proc Innovat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.j.lombarts@amc.uva.nl		Lombarts, Kiki/0000-0001-6167-0620; Arah, Onyebuchi/0000-0002-9067-1697	Academic Medical Center (AMC) of the University of Amsterdam; Netherlands Organization for Scientific Research (NWO) [916.96.059]	Academic Medical Center (AMC) of the University of Amsterdam; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The study was funded by the Academic Medical Center (AMC) of the University of Amsterdam. Dr. Arah is also supported by a grant (Veni number 916.96.059) from the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arah OA, 2006, HEALTH SERV RES, V41, P284, DOI 10.1111/j.1475-6773.2005.00462.x; Association of American Medical Colleges, COMP RES PHYS THEIR; Balmer D, 2007, AMBUL PEDIATR, V7, P176, DOI 10.1016/j.ambp.2006.11.005; Boor K, 2008, EUR J OBSTET GYN R B, V140, P152, DOI 10.1016/j.ejogrb.2008.03.010; Cruess SR, 2008, BRIT MED J, V336, P718, DOI 10.1136/bmj.39503.757847.BE; Damman OC, 2009, MED CARE, V47, P496, DOI 10.1097/MLR.0b013e31818afa05; Delnoij DMJ, 2006, EUR J PUBLIC HEALTH, V16, P652, DOI 10.1093/eurpub/ckl023; Elzubeir MA, 2001, MED EDUC, V35, P272, DOI 10.1046/j.1365-2923.2001.00870.x; Henry SG, 2006, THEOR MED BIOETH, V27, P187, DOI 10.1007/s11017-006-9005-x; Kenny NP, 2003, ACAD MED, V78, P1203, DOI 10.1097/00001888-200312000-00002; Kilminster S, 2007, MED TEACH, V29, P2, DOI 10.1080/01421590701210907; Litzelman DK, 1998, ACAD MED, V73, P688, DOI 10.1097/00001888-199806000-00016; Lombarts KMJMH, 2009, ANESTHESIOLOGY, V111, P709, DOI 10.1097/ALN.0b013e3181b76516; Lombarts M J M H, 2007, Ned Tijdschr Geneeskd, V151, P2004; Lombarts MJMH, NED TIJDSCHR GENEESK, V154, pA1222; Maker Vijay K, 2004, Curr Surg, V61, P111, DOI 10.1016/j.cursur.2003.09.003; Marvel M K, 1991, Fam Med, V23, P279; Metheny WP, 2005, AM J OBSTET GYNECOL, V192, P34, DOI 10.1016/j.ajog.2004.07.036; Park J, 2010, ACAD MED, V85, P134, DOI 10.1097/ACM.0b013e3181c47b25; Paukert JL, 2000, ACAD MED, V75, P843, DOI 10.1097/00001888-200008000-00019; Polanyi, 1962, PERSONAL KNOWLEDGE P; Ratanawongsa N, 2006, J GEN INTERN MED, V21, P758, DOI 10.1111/j.1525-1497.2006.00496.x; Roberts LJ, 2002, ANAESTH INTENS CARE, V30, P355, DOI 10.1177/0310057X0203000315; Schon Donald., 1987, ED REFLECTIVE PRACTI; Seifert CF, 2003, J APPL PSYCHOL, V88, P561, DOI 10.1037/0021-9010.88.3.561; SKEFF KM, 1992, ARCH INTERN MED, V152, P1156, DOI 10.1001/archinte.1992.00400180028004; Stegeman JH, 2008, THESIS U AMSTERDAM H; Streiner DL, 2015, HLTH MEASUREMENT SCA, DOI [10.1891/1521-0987.17.3.150, DOI 10.1891/1521-0987.17.3.150]; Sutkin Gary, 2008, Acad Med, V83, P452, DOI 10.1097/ACM.0b013e31816bee61; ULLIAN JA, 1994, ACAD MED, V69, P832, DOI 10.1097/00001888-199410000-00013; Williams BC, 2002, ACAD MED, V77, P177, DOI 10.1097/00001888-200202000-00020; Wright SM, 1998, NEW ENGL J MED, V339, P1986, DOI 10.1056/NEJM199812313392706; Wright SM, 2002, CAN MED ASSOC J, V167, P638	33	30	30	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15202	10.1371/journal.pone.0015202	http://dx.doi.org/10.1371/journal.pone.0015202			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	701CZ	21206906	Green Published, gold			2022-12-27	WOS:000285793200020
J	Shi, WF; Lei, FM; Zhu, CD; Sievers, F; Higgins, DG				Shi, Weifeng; Lei, Fumin; Zhu, Chaodong; Sievers, Fabian; Higgins, Desmond G.			A Complete Analysis of HA and NA Genes of Influenza A Viruses	PLOS ONE			English	Article							AVIAN INFLUENZA; WILD BIRDS; H5N1; TRANSMISSION; SWINE; EVOLUTION; INFECTION; DUCKS; PHYLOGENIES; GENERATION	Background: More and more nucleotide sequences of type A influenza virus are available in public databases. Although these sequences have been the focus of many molecular epidemiological and phylogenetic analyses, most studies only deal with a few representative sequences. In this paper, we present a complete analysis of all Haemagglutinin (HA) and Neuraminidase (NA) gene sequences available to allow large scale analyses of the evolution and epidemiology of type A influenza. Methodology/Principal Findings: This paper describes an analysis and complete classification of all HA and NA gene sequences available in public databases using multivariate and phylogenetic methods. Conclusions/Significance: We analyzed 18975 HA sequences and divided them into 280 subgroups according to multivariate and phylogenetic analyses. Similarly, we divided 11362 NA sequences into 202 subgroups. Compared to previous analyses, this work is more detailed and comprehensive, especially for the bigger datasets. Therefore, it can be used to show the full and complex phylogenetic diversity and provides a framework for studying the molecular evolution and epidemiology of type A influenza virus. For more than 85% of type A influenza HA and NA sequences into GenBank, they are categorized in one unambiguous and unique group. Therefore, our results are a kind of genetic and phylogenetic annotation for influenza HA and NA sequences. In addition, sequences of swine influenza viruses come from 56 HA and 45 NA subgroups. Most of these subgroups also include viruses from other hosts indicating cross species transmission of the viruses between pigs and other hosts. Furthermore, the phylogenetic diversity of swine influenza viruses from Eurasia is greater than that of North American strains and both of them are becoming more diverse. Apart from viruses from human, pigs, birds and horses, viruses from other species show very low phylogenetic diversity. This might indicate that viruses have not become established in these species. Based on current evidence, there is no simple pattern of inter-hemisphere transmission of avian influenza viruses and it appears to happen sporadically. However, for H6 subtype avian influenza viruses, such transmissions might have happened very frequently and multiple and bidirectional transmission events might exist.	[Shi, Weifeng; Sievers, Fabian; Higgins, Desmond G.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland; [Lei, Fumin; Zhu, Chaodong] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China	University College Dublin; Chinese Academy of Sciences; Institute of Zoology, CAS	Shi, WF (corresponding author), Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland.	weifeng.shi@ucd.ie	Sievers, Fabian/AAG-2021-2020; ZHU, Chao-Dong/E-5961-2011; Higgins, des g/J-6314-2012	Sievers, Fabian/0000-0002-7885-6867; ZHU, Chao-Dong/0000-0002-9347-3178; Higgins, Des/0000-0002-3952-3285	Science Foundation Ireland [07/IN.1/B1783]; CAS [KSCX2-YW-N-063]; NSFC [30925008]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); CAS(Chinese Academy of Sciences); NSFC(National Natural Science Foundation of China (NSFC))	This study was mainly supported by Science Foundation Ireland (PI grant 07/IN.1/B1783). FL was funded by CAS Innovation Program (KSCX2-YW-N-063) and NSFC (No. 30925008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2005, PHYLIP PHYLOGENY INF; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Belongie S, 2002, LECT NOTES COMPUT SC, V2352, P531; Belser JA, 2009, EMERG INFECT DIS, V15, P859, DOI 10.3201/eid1506.090072; Brown JD, 2008, EMERG INFECT DIS, V14, P136, DOI 10.3201/eid1401.070740; Chen JM, 2007, VIRUS GENES, V35, P33, DOI 10.1007/s11262-006-0025-4; Chen JM, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-137; Cheng MC, 2010, AVIAN DIS, V54, P109, DOI 10.1637/8960-061709-Reg.1; Cheng MC, 2010, AVIAN DIS, V54, P885, DOI 10.1637/9208-120609-Reg.1; Crawford PC, 2005, SCIENCE, V310, P482, DOI 10.1126/science.1117950; Daly JM, 2011, VET J, V189, P7, DOI 10.1016/j.tvjl.2010.06.026; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Donis R. O., 2008, Emerging Infectious Diseases, V14, pe1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feare CJ, 2007, AVIAN DIS, V51, P440, DOI 10.1637/7575-040106R1.1; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Gagnon CA, 2009, J CLIN MICROBIOL, V47, P796, DOI 10.1128/JCM.01228-08; Gaidet N, 2010, J APPL ECOL, V47, P1147, DOI 10.1111/j.1365-2664.2010.01845.x; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hatchette TF, 2004, J GEN VIROL, V85, P2327, DOI 10.1099/vir.0.79878-0; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P15; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Keawcharoen J, 2004, EMERG INFECT DIS, V10, P2189, DOI 10.3201/eid1012.040759; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; KIDA H, 1994, J GEN VIROL, V75, P2183, DOI 10.1099/0022-1317-75-9-2183; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koehler AV, 2008, MOL ECOL, V17, P4754, DOI 10.1111/j.1365-294X.2008.03953.x; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Kuiken C, 2008, NUCLEIC ACIDS RES, V36, pD512, DOI 10.1093/nar/gkm962; Lee DH, 2011, INFECT GENET EVOL, V11, P232, DOI 10.1016/j.meegid.2010.09.012; Leschnik M, 2007, EMERG INFECT DIS, V13, P243, DOI 10.3201/eid1302.060608; Li CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/j.virol.2005.06.025; Liang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013575; Liu S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005022; Ma HC, 2007, VIRUS GENES, V34, P283, DOI 10.1007/s11262-006-0018-3; Ma W, 2009, ZOONOSES PUBLIC HLTH, V56, P326, DOI 10.1111/j.1863-2378.2008.01217.x; Makarova NA, 1999, J GEN VIROL, V80, P3167, DOI 10.1099/0022-1317-80-12-3167; Normile D, 2006, SCIENCE, V311, P1225, DOI 10.1126/science.311.5765.1225; Normile D, 2005, SCIENCE, V310, P426, DOI 10.1126/science.310.5747.426; Okamatsu M, 2007, VET MICROBIOL, V124, P35, DOI 10.1016/j.vetmic.2007.04.025; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pearce JM, 2010, VIRUS RES, V148, P44, DOI 10.1016/j.virusres.2009.12.002; Pearce JM, 2009, EVOL APPL, V2, P457, DOI 10.1111/j.1752-4571.2009.00071.x; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; PENSAERT M, 1981, B WORLD HEALTH ORGAN, V59, P75; Pereda AJ, 2008, VIROLOGY, V378, P363, DOI 10.1016/j.virol.2008.06.010; Peterson AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000261; Procter JB, 2010, NAT METHODS, V7, pS16, DOI [10.1038/NMETH.1434, 10.1038/nmeth.1434]; Qi X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004682; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHOLTISSEK C, 1985, VIROLOGY, V147, P287, DOI 10.1016/0042-6822(85)90131-X; SCHOLTISSEK C, 1983, VIROLOGY, V129, P521, DOI 10.1016/0042-6822(83)90194-0; Shi WF, 2008, ARCH VIROL, V153, P211, DOI 10.1007/s00705-007-1083-1; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Smith GJD, 2009, P NATL ACAD SCI USA, V106, P11709, DOI 10.1073/pnas.0904991106; Songserm T, 2006, EMERG INFECT DIS, V12, P681, DOI 10.3201/eid1204.051396; Songserm T, 2006, EMERG INFECT DIS, V12, P1744, DOI 10.3201/eid1211.060542; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Takekawa JY, 2010, AVIAN BIOL RES, V3, P51, DOI 10.3184/175815510X12737339356701; Thanawongnuwech R, 2005, EMERG INFECT DIS, V11, P699, DOI 10.3201/eid1105.050007; TORGERSON WS, 1952, PSYCHOMETRIKA, V17, P401; Tzeng J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-179; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; YANG ZB, 1994, J MOL EVOL, V39, P105; Zhou JY, 2009, J VIROL, V83, P8957, DOI 10.1128/JVI.00793-09; Zhou NN, 1999, J VIROL, V73, P3366, DOI 10.1128/JVI.73.4.3366-3374.1999	73	27	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e14454	10.1371/journal.pone.0014454	http://dx.doi.org/10.1371/journal.pone.0014454			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209922	Green Published, Green Submitted, gold			2022-12-27	WOS:000285793200010
J	Wu, J; Zhang, FW; Wang, MR; Xu, CQ; Song, JD; Zhou, JF; Lin, XJ; Zhang, YH; Wu, XB; Tan, WJ; Lu, JA; Zhao, HL; Gao, JM; Zhao, P; Lu, JX; Wang, Y				Wu, Jia; Zhang, Fengwei; Wang, Maorong; Xu, Chunqiong; Song, Jingdong; Zhou, Jianfang; Lin, Xiaojing; Zhang, Yonghui; Wu, Xiaobing; Tan, Wenjie; Lu, Jian; Zhao, Honglan; Gao, Jimin; Zhao, Ping; Lu, Jianxin; Wang, Yue			Characterization of Neuraminidases from the Highly Pathogenic Avian H5N1 and 2009 Pandemic H1N1 Influenza A Viruses	PLOS ONE			English	Article							TRANSMEMBRANE DOMAIN; STALK LENGTH; HEMAGGLUTININ; PROTEIN; FUSION; CELLS	To study the precise role of the neuraminidase (NA), and its stalk region in particular, in the assembly, release, and entry of influenza virus, we deleted the 20-aa stalk segment from 2009 pandemic H1N1 NA (09N1) and inserted this segment, now designated 09s60, into the stalk region of a highly pathogenic avian influenza (HPAI) virus H5N1 NA (AH N1). The biological characterization of these wild-type and mutant NAs was analyzed by pseudotyped particles (pseudoparticles) system. Compared with the wild-type AH N1, the wild-type 09N1 exhibited higher NA activity and released more pseudoparticles. Deletion/insertion of the 09s60 segment did not alter this relationship. The infectivity of pseudoparticles harboring NA in combination with the hemagglutinin from HPAI H5N1 (AH H5) was decreased by insertion of 09s60 into AH N1 and was increased by deletion of 09s60 from 09N1. When isolated from the wild-type 2009H1N1 virus, 09N1 existed in the forms (in order of abundance) dimer>>tetramer>monomer, but when isolated from pseudoparticles, 09N1 existed in the forms dimer>monomer>>>tetramer. After deletion of 09s60, 09N1 existed in the forms monomer>>>dimer. AH N1 from pseudoparticles existed in the forms monomer>>dimer, but after insertion of 09s60, it existed in the forms dimer>>monomer. Deletion/insertion of 09s60 did not alter the NA glycosylation pattern of 09N1 or AH N1. The 09N1 was more sensitive than the AH N1 to the NA inhibitor oseltamivir, suggesting that the infectivity-enhancing effect of oseltamivir correlates with robust NA activity.	[Wu, Jia; Zhang, Fengwei; Xu, Chunqiong; Gao, Jimin; Lu, Jianxin] Wenzhou Med Coll, Key Lab Lab Med, Zhejiang Prov Key Lab Med Genet, Minist Educ,Sch Lab Med & Life Sci, Wenzhou, Peoples R China; [Wang, Maorong] 81st Hosp PLA, Liver Dis Ctr PLA, Nanjing, Peoples R China; [Xu, Chunqiong] NingXia Med Univ, Sch Clin Sci, Yinchuang, Peoples R China; [Wu, Jia; Zhang, Fengwei; Song, Jingdong; Zhou, Jianfang; Lin, Xiaojing; Zhang, Yonghui; Wu, Xiaobing; Tan, Wenjie; Lu, Jian; Zhao, Honglan; Wang, Yue] China Ctr Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Zhao, Ping] Second Mil Med Univ, Dept Microbiol, Shanghai Key Lab Med Biodef, Shanghai, Peoples R China	Wenzhou Medical University; Ningxia Medical University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Naval Medical University	Wu, J (corresponding author), Wenzhou Med Coll, Key Lab Lab Med, Zhejiang Prov Key Lab Med Genet, Minist Educ,Sch Lab Med & Life Sci, Wenzhou, Peoples R China.	pnzhao@163.com; jxlu313@163.com; euy-tokyo@umin.ac.jp		Wu, Xiaobing/0000-0002-2823-2634	863 Hi-Tech Research and Development Program of the People's Republic of China [2007AA02Z157]; State Special Key Program on Infectious Diseases of China [2009ZX10004-711]; National Natural Science Foundation of China (NSFC) [30970159]; Natural Science Foundation of Zhejiang Province [Y2101159]	863 Hi-Tech Research and Development Program of the People's Republic of China(National High Technology Research and Development Program of China); State Special Key Program on Infectious Diseases of China; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This study was supported by the 863 Hi-Tech Research and Development Program of the People's Republic of China (#2007AA02Z157), the State Special Key Program on Infectious Diseases of China (#2009ZX10004-711), the National Natural Science Foundation of China (NSFC#30970159), and the Natural Science Foundation of Zhejiang Province (Y2101159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barman S, 2000, J VIROL, V74, P6538, DOI 10.1128/JVI.74.14.6538-6545.2000; Bian T, 2009, BIOCHEM BIOPH RES CO, V378, P118, DOI 10.1016/j.bbrc.2008.11.024; CASTRUCCI MR, 1993, J VIROL, V67, P759, DOI 10.1128/JVI.67.2.759-764.1993; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; DOMS RW, 1986, J VIROL, V57, P603, DOI 10.1128/JVI.57.2.603-613.1986; Du N, 2010, J VIROL, V84, P7822, DOI 10.1128/JVI.00069-10; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Huang IC, 2008, J VIROL, V82, P4834, DOI 10.1128/JVI.00079-08; Knipe DM, 2007, FIELD VIROLOGY, V5th; Kundu A, 1996, J VIROL, V70, P6508, DOI 10.1128/JVI.70.9.6508-6515.1996; Lin XJ, 2009, BIOCHEM BIOPH RES CO, V390, P1305, DOI 10.1016/j.bbrc.2009.10.142; Lin XJ, 2009, BIOCHEM BIOPH RES CO, V385, P257, DOI 10.1016/j.bbrc.2009.05.068; Liu YA, 2010, VACCINE, V29, P183, DOI 10.1016/j.vaccine.2010.10.059; LUO GX, 1993, VIRUS RES, V29, P141; Matsuoka Y, 2009, J VIROL, V83, P4704, DOI 10.1128/JVI.01987-08; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Reid AH, 2000, P NATL ACAD SCI USA, V97, P6785, DOI 10.1073/pnas.100140097; Shu YL, 2006, NEW ENGL J MED, V354, P1421, DOI 10.1056/NEJMc053524; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; *WHO, 2009, PAND HINI; World Health Organization, CONF HUM CAS AV INFL; Xu XJ, 2008, J VIROL, V82, P10493, DOI 10.1128/JVI.00959-08; Zhang YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009167; Zhang YH, 2009, BIOCHEM BIOPH RES CO, V387, P405, DOI 10.1016/j.bbrc.2009.07.040; Zhou HB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006277	30	10	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15825	10.1371/journal.pone.0015825	http://dx.doi.org/10.1371/journal.pone.0015825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209916	Green Submitted, Green Published, gold			2022-12-27	WOS:000285793200061
J	Hendrich, L; Pons, J; Ribera, I; Balke, M				Hendrich, Lars; Pons, Joan; Ribera, Ignacio; Balke, Michael			Mitochondrial Cox1 Sequence Data Reliably Uncover Patterns of Insect Diversity But Suffer from High Lineage-Idiosyncratic Error Rates	PLOS ONE			English	Article							DNA TAXONOMY; COLEOPTERA; EVOLUTION; IDENTIFICATION; SOUTHEASTERN; BIODIVERSITY; DELIMITATION; LEPIDOPTERA; POPULATIONS; DIVERGENCE	Background: The demand for scientific biodiversity data is increasing, but taxonomic expertise is often limited or not available. DNA sequencing is a potential remedy to overcome this taxonomic impediment. Mitochondrial DNA is most commonly used, e. g., for species identification ("DNA barcoding"). Here, we present the first study in arthropods based on a near-complete species sampling of a family-level taxon from the entire Australian region. We aimed to assess how reliably mtDNA data can capture species diversity when many sister species pairs are included. Then, we contrasted phylogenetic subsampling with the hitherto more commonly applied geographical subsampling, where sister species are not necessarily captured. Methodology/Principal Findings: We sequenced 800 bp cox1 for 1,439 individuals including 260 Australian species (78% species coverage). We used clustering with thresholds of 1 to 10% and general mixed Yule Coalescent (GMYC) analysis for the estimation of species richness. The performance metrics used were taxonomic accuracy and agreement between the morphological and molecular species richness estimation. Clustering (at the 3% level) and GMYC reliably estimated species diversity for single or multiple geographic regions, with an error for larger clades of lower than 10%, thus outperforming parataxonomy. However, the rates of error were higher for some individual genera, with values of up to 45% when very recent species formed nonmonophyletic clusters. Taxonomic accuracy was always lower, with error rates above 20% and a larger variation at the genus level (0 to 70%). Sorensen similarity indices calculated for morphospecies, 3% clusters and GMYC entities for different pairs of localities was consistent among methods and showed expected decrease over distance. Conclusion/Significance: Cox1 sequence data are a powerful tool for large-scale species richness estimation, with a great potential for use in ecology and beta-diversity studies and for setting conservation priorities. However, error rates can be high in individual lineages.	[Hendrich, Lars; Balke, Michael] Zool State Collect, Dept Entomol, Munich, Germany; [Hendrich, Lars; Balke, Michael] Univ Munich, GeoBioCtr, Munich, Germany; [Pons, Joan] Inst Mediterrani Estudis Avancats, Dept Biodiversitat & Conservacio, Esporles, Spain; [Ribera, Ignacio] Inst Evolutionary Biol, Barcelona, Spain	University of Munich; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE)	Hendrich, L (corresponding author), Zool State Collect, Dept Entomol, Munich, Germany.	coleoptera-zsm@zsm.mwn.de	Ribera, Ignacio/K-2909-2017; Pons, Joan/A-5124-2008	Ribera, Ignacio/0000-0002-2791-7615; Pons, Joan/0000-0002-4683-8840	Deutsche Forschungsgemeinschaft [BA 2152/4-1, BA 2152/6-1, BA 2152/7-1, HE 5729/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (BA 2152/4-1, 6-1, 7-1, HE 5729/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balke M, 2007, ZOOL SCR, V36, P173, DOI 10.1111/j.1463-6409.2006.00265.x; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Caesar RM, 2006, DIVERS DISTRIB, V12, P483, DOI 10.1111/j.1366-9516.2006.00237.x; Chapple DG, 2005, MOL ECOL, V14, P1279, DOI 10.1111/j.1365-294X.2005.02463.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cognato AI, 2006, J ECON ENTOMOL, V99, P1037, DOI 10.1603/0022-0493-99.4.1037; DAVIS JI, 1992, SYST BIOL, V41, P421, DOI 10.2307/2992584; Davison A, 2009, MOL ECOL RESOUR, V9, P1092, DOI 10.1111/j.1755-0998.2009.02559.x; DeSaille R, 2007, BIOESSAYS, V29, P1289, DOI 10.1002/bies.20667; DeSalle R, 2006, CONSERV BIOL, V20, P1545, DOI 10.1111/j.1523-1739.2006.00543.x; Dickinson JA, 2002, J SEDIMENT RES, V72, P288, DOI 10.1306/082701720288; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; Frakes LA, 1987, FAUNA AUSTR A, P1; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Goloboff PA, 2004, CLADISTICS, V20, P84; Hart MW, 2007, BIOL LETTERS, V3, P509, DOI 10.1098/rsbl.2007.0307; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hendrich Lars, 2009, Zootaxa, V2288, P1; Jousselin E, 2009, P ROY SOC B-BIOL SCI, V276, P187, DOI 10.1098/rspb.2008.0679; Kelly RP, 2007, MOL ECOL NOTES, V7, P177, DOI 10.1111/j.1471-8286.2006.01641.x; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Krell FT, 2004, BIODIVERS CONSERV, V13, P795, DOI 10.1023/B:BIOC.0000011727.53780.63; Lohse K, 2009, SYST BIOL, V58, P439, DOI 10.1093/sysbio/syp039; Maddison WP, 2000, MACCLADE VERSION 4 0; MARKGRAF V, 1995, TRENDS ECOL EVOL, V10, P143, DOI 10.1016/S0169-5347(00)89023-0; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Monaghan MT, 2006, P ROY SOC B-BIOL SCI, V273, P887, DOI 10.1098/rspb.2005.3391; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Papadopoulou A, 2009, MOL PHYLOGENET EVOL, V53, P935, DOI 10.1016/j.ympev.2009.08.027; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Pons J, 2010, MOL PHYLOGENET EVOL, V56, P796, DOI 10.1016/j.ympev.2010.02.007; Ribera I, 2008, CLADISTICS, V24, P563, DOI 10.1111/j.1096-0031.2007.00192.x; Ribera I, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-29; Riedel A, 2010, ZOOL SCR, V39, P63, DOI 10.1111/j.1463-6409.2009.00404.x; Roe AD, 2007, MOL PHYLOGENET EVOL, V44, P325, DOI 10.1016/j.ympev.2006.12.005; Sheffield CS, 2009, MOL ECOL RESOUR, V9, P196, DOI 10.1111/j.1755-0998.2009.02645.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Sorensen T., 1948, BIOL SKAR, V5, P1; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Symula R, 2008, MOL PHYLOGENET EVOL, V47, P569, DOI 10.1016/j.ympev.2008.01.011; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Tautz D, 2002, NATURE, V418, P479, DOI 10.1038/418479a; TEMPLETON AR, 1992, GENETICS, V132, P619; Wahlberg N, 2003, SYST ENTOMOL, V28, P257, DOI 10.1046/j.1365-3113.2003.00212.x; Watts CHS, 2009, T ROY SOC SOUTH AUST, V133, P62, DOI 10.1080/03721426.2009.10887112; WATTS CHS, 1978, AUST J ZOOL, P1; Wheeler QD, 2004, PHILOS T R SOC B, V359, P571, DOI 10.1098/rstb.2003.1452; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Zwickl D. J, 2006, GENETIC ALGORITHM AP	57	84	88	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14448	10.1371/journal.pone.0014448	http://dx.doi.org/10.1371/journal.pone.0014448			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203427	Green Published, gold, Green Submitted			2022-12-27	WOS:000285792500020
J	Hovanessian, AG; Soundaramourty, C; El Khoury, D; Nondier, I; Svab, J; Krust, B				Hovanessian, Ara G.; Soundaramourty, Calaiselvy; El Khoury, Diala; Nondier, Isabelle; Svab, Josette; Krust, Bernard			Surface Expressed Nucleolin Is Constantly Induced in Tumor Cells to Mediate Calcium-Dependent Ligand Internalization	PLOS ONE			English	Article							PENTAMERIC PSEUDOPEPTIDE HB-19; INHIBITS HIV-INFECTION; BCL-2 MESSENGER-RNA; BINDING-PROTEIN; HEAT-SHOCK; ENVELOPE GLYCOPROTEIN; SCAVENGER RECEPTORS; PERMISSIVE CELLS; DNA-REPLICATION; PLASMA-MEMBRANE	Background: Nucleolin is one of the major proteins of the nucleolus, but it is also expressed on the cell surface where is serves as a binding protein for variety of ligands implicated in tumorigenesis and angiogenesis. Emerging evidence suggests that the cell-surface expressed nucleolin is a strategic target for an effective and nontoxic cancer therapy. Methodology/Principal Findings: By monitoring the expression of nucleolin mRNA, and by measuring the level of nucleolin protein recovered from the surface and nucleus of cells, here we show that the presence of nucleolin at the cell surface is dependent on the constant induction of nucleolin mRNA. Indeed, inhibitors of RNA transcription or translation block expression of surface nucleolin while no apparent effect is observed on the level of nucleolin in the nucleus. The estimated half-life of surface nucleolin is less than one hour, whereas that of nuclear nucleolin is more than 8 hours. Nucleolin mRNA induction is reduced markedly in normal fibroblasts that reach confluence, while it occurs continuously even in post-confluent epithelial tumor cells consistent with their capacity to proliferate without contact inhibition. Interestingly, cold and heat shock induce nucleolin mRNA concomitantly to enhanced mRNA expression of the heat shock protein 70, thus suggesting that surface nucleolin induction also occurs in response to an environmental insult. At the cell surface, one of the main functions of nucleolin is to shuttle specific extracellular ligands by an active transport mechanism, which we show here to be calcium dependent. Conclusion/Significance: Our results demonstrate that the expression of surface nucleolin is an early metabolic event coupled with tumor cell proliferation and stress response. The fact that surface nucleolin is constantly and abundantly expressed on the surface of tumor cells, makes them a preferential target for the inhibitory action of anticancer agents that target surface nucleolin.	[Hovanessian, Ara G.; Soundaramourty, Calaiselvy; El Khoury, Diala; Nondier, Isabelle; Svab, Josette; Krust, Bernard] Univ Paris 05, CNRS, Unite Regulat Transcript Maladies Genet, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Hovanessian, AG (corresponding author), Univ Paris 05, CNRS, Unite Regulat Transcript Maladies Genet, Paris, France.	ara.hovanessian@parisdescartes.fr			French National Center for Scientific Research (CNRS), France	French National Center for Scientific Research (CNRS), France(Centre National de la Recherche Scientifique (CNRS))	This work was funded by the French National Center for Scientific Research (CNRS), France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alete DE, 2006, FEBS J, V273, P4668, DOI 10.1111/j.1742-4658.2006.05471.x; Barel M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-145; Bates PJ, 2009, EXP MOL PATHOL, V86, P151, DOI 10.1016/j.yexmp.2009.01.004; Callebaut C, 1996, VIROLOGY, V218, P181, DOI 10.1006/viro.1996.0178; Callebaut C, 1998, J BIOL CHEM, V273, P21988, DOI 10.1074/jbc.273.34.21988; Callebaut C, 2001, VIROLOGY, V281, P248, DOI 10.1006/viro.2000.0767; Callebaut C, 1997, J BIOL CHEM, V272, P7159, DOI 10.1074/jbc.272.11.7159; Carpentier M, 2005, BIOCHEMISTRY-US, V44, P5804, DOI 10.1021/bi047831s; Christian S, 2003, J CELL BIOL, V163, P871, DOI 10.1083/jcb.200304132; Destouches D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002518; Di Segni A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002310; Dumler I, 1999, CURR BIOL, V9, P1468, DOI 10.1016/S0960-9822(00)80116-5; El Khoury D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-325; Fahling M, 2005, BBA-GENE STRUCT EXPR, V1731, P32, DOI 10.1016/j.bbaexp.2005.08.005; Fogal V, 2009, ANGIOGENESIS, V12, P91, DOI 10.1007/s10456-009-9137-5; Folkman J, 2007, BLOOD, V110, P2786, DOI 10.1182/blood-2007-08-102178; Gattoni-Celli S, 2009, AM J HEMATOL, V84, P535, DOI 10.1002/ajh.21461; Gilchrist JSC, 2002, J CELL BIOCHEM, V85, P268, DOI 10.1002/jcb.10121; Ginisty H, 1999, J CELL SCI, V112, P761; Girvan AC, 2006, MOL CANCER THER, V5, P1790, DOI 10.1158/1535-7163.MCT-05-0361; Grinstein E, 2007, CELL SIGNAL, V19, P2428, DOI 10.1016/j.cellsig.2007.06.021; Harms G, 2001, BIOCHEM J, V360, P531, DOI 10.1042/0264-6021:3600531; Hirano K, 2005, J BIOL CHEM, V280, P39284, DOI 10.1074/jbc.M505275200; Hovanessian AG, 2006, CELL RES, V16, P174, DOI 10.1038/sj.cr.7310024; Hovanessian AG, 2000, EXP CELL RES, V261, P312, DOI 10.1006/excr.2000.5071; Huang Y, 2006, BLOOD, V107, P3564, DOI 10.1182/blood-2005-07-2961; Hwang J, 2007, J BIOL CHEM, V282, P18645, DOI 10.1074/jbc.M702035200; Iliakis G, 2004, INT J HYPERTHER, V20, P240, DOI 10.1080/02656730310001656379; Inder KL, 2009, J BIOL CHEM, V284, P28410, DOI 10.1074/jbc.M109.001537; Jacotot E, 1996, VIROLOGY, V223, P318, DOI 10.1006/viro.1996.0483; Jiang BM, 2010, FEBS J, V277, P642, DOI 10.1111/j.1742-4658.2009.07510.x; Kadomatsu KJ, 2004, CANCER LETT, V204, P127, DOI 10.1016/S0304-3835(03)00450-6; Kato M, 1998, ONCOGENE, V17, P1885, DOI 10.1038/sj.onc.1202077; Kim K, 2005, MOL CELL BIOL, V25, P2463, DOI 10.1128/MCB.25.6.2463-2474.2005; Kim SK, 2003, DNA CELL BIOL, V22, P171, DOI 10.1089/104454903321655792; Kirkegaard T, 2010, NATURE, V463, P549, DOI 10.1038/nature08710; KLEINMAN HK, 1991, ARCH BIOCHEM BIOPHYS, V290, P320, DOI 10.1016/0003-9861(91)90547-V; KONISHI T, 1995, J BIOCHEM-TOKYO, V117, P1170, DOI 10.1093/oxfordjournals.jbchem.a124840; Krust B, 2001, P NATL ACAD SCI USA, V98, P14090, DOI 10.1073/pnas.221467298; Larrucea S, 1998, J BIOL CHEM, V273, P31718, DOI 10.1074/jbc.273.48.31718; Legrand D, 2004, EUR J BIOCHEM, V271, P303, DOI 10.1046/j.1432-1033.2003.03929.x; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; LLeonart ME, 2010, BBA-REV CANCER, V1805, P43, DOI 10.1016/j.bbcan.2009.11.001; Losfeld ME, 2009, EXP CELL RES, V315, P357, DOI 10.1016/j.yexcr.2008.10.039; Melendez AJ, 2008, BIOSCIENCE REP, V28, P287, DOI 10.1042/BSR20080082; Nisole S, 2002, J BIOL CHEM, V277, P20877, DOI 10.1074/jbc.M110024200; Nisole S, 2002, EXP CELL RES, V276, P155, DOI 10.1006/excr.2002.5522; Nisole S, 1999, J BIOL CHEM, V274, P27875, DOI 10.1074/jbc.274.39.27875; Nisole S, 2000, AIDS RES HUM RETROV, V16, P237, DOI 10.1089/088922200309331; Nylandsted J, 2004, J EXP MED, V200, P425, DOI 10.1084/jem.20040531; OHMORI H, 1990, EXP CELL RES, V189, P227, DOI 10.1016/0014-4827(90)90240-B; Otake Y, 2005, MOL PHARMACOL, V67, P319, DOI 10.1124/mol.104.006080; OTAKE Y, 2010, NEOPLASIA, V109, P3069; Otake Y, 2007, BLOOD, V109, P3069, DOI 10.1182/blood-2006-08-043257; Perez-Pinera P, 2008, CURR OPIN HEMATOL, V15, P210, DOI 10.1097/MOH.0b013e3282fdc69e; Pluddemann A, 2007, METHODS, V43, P207, DOI 10.1016/j.ymeth.2007.06.004; REY MA, 1989, VIROLOGY, V173, P258, DOI 10.1016/0042-6822(89)90242-0; Reyes-Reyes EM, 2008, EXP CELL RES, V314, P2212, DOI 10.1016/j.yexcr.2008.03.016; Said EA, 2005, FEBS J, V272, P4646, DOI 10.1111/j.1742-4658.2005.04870.x; Said EA, 2002, J BIOL CHEM, V277, P37492, DOI 10.1074/jbc.M201194200; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SEMENKOVICH CF, 1990, BIOCHEMISTRY-US, V29, P9708, DOI 10.1021/bi00493a028; Shi HB, 2007, BLOOD, V110, P2899, DOI 10.1182/blood-2007-01-064428; Shibata Y, 2002, MOL CELL BIOL, V22, P6788, DOI 10.1128/MCB.22.19.6788-6796.2002; Sinclair JF, 2002, J BIOL CHEM, V277, P2876, DOI 10.1074/jbc.M110230200; Sorokina EA, 1999, J BIOL CHEM, V274, P27491, DOI 10.1074/jbc.274.39.27491; Soundararajan S, 2008, CANCER RES, V68, P2358, DOI 10.1158/0008-5472.CAN-07-5723; Soundararajan S, 2009, MOL PHARMACOL, V76, P984, DOI 10.1124/mol.109.055947; Srivastava MD, 1999, FASEB J, V13, pA683; Stepanova V, 2008, BLOOD, V112, P100, DOI 10.1182/blood-2007-07-104455; STORCK S, 2007, SUBCELL BIOCH, V41; Tate A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-197; Teng Y, 2007, CANCER RES, V67, P10491, DOI 10.1158/0008-5472.CAN-06-4206; Theriault JR, 2006, J IMMUNOL, V177, P8604, DOI 10.4049/jimmunol.177.12.8604; Turck N, 2006, J CELL PHYSIOL, V206, P545, DOI 10.1002/jcp.20501; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Westmark CJ, 2001, J BIOL CHEM, V276, P1119, DOI 10.1074/jbc.M009435200; Xu XH, 2001, J BIOL CHEM, V276, P43221, DOI 10.1074/jbc.M104446200; Yang C, 2002, NUCLEIC ACIDS RES, V30, P2251, DOI 10.1093/nar/30.10.2251	80	145	146	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15787	10.1371/journal.pone.0015787	http://dx.doi.org/10.1371/journal.pone.0015787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203423	Green Submitted, gold, Green Published			2022-12-27	WOS:000285579200040
J	Ohshima, S; Ohashi-Suzuki, M; Miura, Y; Yabu, Y; Okada, N; Ohta, N; Suzuki, T				Ohshima, Shigeru; Ohashi-Suzuki, Mitsuko; Miura, Yutaka; Yabu, Yoshisada; Okada, Noriko; Ohta, Nobuo; Suzuki, Takashi			TbUNC119 and Its Binding Protein Complex Are Essential for Propagation, Motility, and Morphogenesis of Trypanosoma brucei Procyclic Form Cells	PLOS ONE			English	Article							FLAGELLAR MOTILITY; NERVOUS-SYSTEM; HRG4 UNC119; UNC-119; GENE; INVASION; ELEGANS; PARASITE; CLONING; DIFFERENTIATION	Flagellum-mediated motility of Trypanosoma brucei is considered to be essential for the parasite to complete stage development in the tsetse fly vector, while the mechanism by which flagellum-mediated motility is controlled are not fully understood. We thus compared T. brucei whole gene products (amino acid sequence) with Caenorhabditis elegans UNC (uncoordinated) proteins, in order to find uncharacterized motility-related T. brucei genes. Through in silico analysis, we found 88 gene products which were highly similar to C. elegans UNC proteins and categorized them as TbCEUN (T. brucei gene products which have high similarity to C. elegans UNC proteins). Approximately two thirds of the 88 TbCEUN gene products were kinesin-related molecules. A gene product highly similar to C. elegans UNC119 protein was designated as TbUNC119. RNAi-mediated depletion of TbUNC119 showed no apparent phenotype. However, knock-down analysis of both TbUNC119 and its binding protein (TbUNC119BP) which was found by yeast two-hybrid analysis showed characteristic phenotypes, including reduced motility, morphological change (extended cell shape), and cellular apoptosis. Based on the observed phenotypes, possible function of the TbUNC119 and TbUNC119BP is discussed.	[Ohshima, Shigeru] Nagoya City Univ, Grad Sch Med Sci, Dept Core Lab, Nagoya, Aichi, Japan; [Ohshima, Shigeru; Ohashi-Suzuki, Mitsuko; Ohta, Nobuo; Suzuki, Takashi] Nagoya City Univ, Grad Sch Med Sci, Dept Mol Parasitol, Nagoya, Aichi, Japan; [Ohshima, Shigeru; Ohashi-Suzuki, Mitsuko; Yabu, Yoshisada; Okada, Noriko; Suzuki, Takashi] Nagoya City Univ, Grad Sch Med Sci, Dept Immunol, Nagoya, Aichi, Japan; [Ohashi-Suzuki, Mitsuko; Ohta, Nobuo; Suzuki, Takashi] Tokyo Med & Dent Univ, Grad Sch, Dept Int Hlth Dev, Div Publ Hlth, Tokyo, Japan; [Miura, Yutaka] Nagoya City Univ, Grad Sch Med Sci, Dept Mol Neurol, Nagoya, Aichi, Japan	Nagoya City University; Nagoya City University; Nagoya City University; Tokyo Medical & Dental University (TMDU); Nagoya City University	Ohshima, S (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Core Lab, Nagoya, Aichi, Japan.	0897vip@tmd.ac.jp			Ministry of Education, Science, Culture and Sports of Japan [19590434 (2007-9)]; Japan Initiative Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Education, Science, Culture and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Initiative Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science, and Technology, Japan	This study was supported in part by a Grant-in-Aid for Scientific Research (C), 19590434 (2007-9), from the Ministry of Education, Science, Culture and Sports of Japan. This study was also supported in part by the Japan Initiative Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alpadi K, 2008, J BIOL CHEM, V283, P26461, DOI 10.1074/jbc.M801625200; Baron DM, 2007, J CELL SCI, V120, P478, DOI 10.1242/jcs.03352; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; BRUN R, 1979, ACTA TROP, V36, P289; CAVALLI A, 2009, Trypanosoma Leishman, V52, P7339, DOI DOI 10.1021/JM9004835; Cen O, 2003, J BIOL CHEM, V278, P8837, DOI 10.1074/jbc.M208261200; Chung S, 2007, GENE, V389, P45, DOI 10.1016/j.gene.2006.09.032; Dessens JT, 2003, MOL MICROBIOL, V49, P319, DOI 10.1046/j.1365-2958.2003.03566.x; Dobrowolski JM, 1997, MOL MICROBIOL, V26, P163, DOI 10.1046/j.1365-2958.1997.5671913.x; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; Gorska MM, 2004, J EXP MED, V199, P369, DOI 10.1084/jem.20030589; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Hendriks EF, 2001, EMBO J, V20, P6700, DOI 10.1093/emboj/20.23.6700; Higashide T, 1999, GENOMICS, V57, P446, DOI 10.1006/geno.1999.5791; Hill KL, 2003, EUKARYOT CELL, V2, P200, DOI 10.1128/EC.2.2.200-208.2003; Karim Z, 2010, CELL SIGNAL, V22, P128, DOI 10.1016/j.cellsig.2009.09.022; Knobel KM, 2001, DEVELOPMENT, V128, P4079; Kobayashi A, 2000, INVEST OPHTH VIS SCI, V41, P3268; Lopez R, 2003, NUCLEIC ACIDS RES, V31, P3795, DOI 10.1093/nar/gkg573; Lu S, 2007, PARASITOLOGY, V134, P1639, DOI 10.1017/S0031182007003046; MADURO M, 1995, GENETICS, V141, P977; Maduro MF, 2000, J NEUROGENET, V13, P191, DOI 10.3109/01677060009084494; Manning AG, 2004, GENESIS, V40, P223, DOI 10.1002/gene.20089; Manson MD, 1998, J BACTERIOL, V180, P1009, DOI 10.1128/JB.180.5.1009-1022.1998; Materi W, 2005, GENESIS, V42, P104, DOI 10.1002/gene.20130; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Nojiri S, 2004, BIOCHEM BIOPH RES CO, V314, P97, DOI 10.1016/j.bbrc.2003.12.054; Ottemann KM, 1997, MOL MICROBIOL, V24, P1109, DOI 10.1046/j.1365-2958.1997.4281787.x; Pinder JC, 1998, J CELL SCI, V111, P1831; Ralston KS, 2008, INT J PARASITOL, V38, P869, DOI 10.1016/j.ijpara.2008.03.003; Ralston KS, 2009, ANNU REV MICROBIOL, V63, P335, DOI 10.1146/annurev.micro.091208.073353; Ralston KS, 2006, EUKARYOT CELL, V5, P696, DOI 10.1128/EC.5.4.696-711.2006; Suzuki T, 2004, PARASITOL INT, V53, P235, DOI 10.1016/j.parint.2004.02.001; TETLEY L, 1985, J CELL SCI, V74, P1; Vepachedu R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005211; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Welburn SC, 2006, PARASITOLOGY, V132, pS7, DOI 10.1017/S0031182006000825	39	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15577	10.1371/journal.pone.0015577	http://dx.doi.org/10.1371/journal.pone.0015577			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203515	Green Published, Green Submitted, gold			2022-12-27	WOS:000285578000035
J	Bronsard, G; Botbol, M; Tordjman, S				Bronsard, Guillaume; Botbol, Michel; Tordjman, Sylvie			Aggression in Low Functioning Children and Adolescents with Autistic Disorder	PLOS ONE			English	Article							CHALLENGING BEHAVIORS; DIAGNOSTIC INTERVIEW; PHYSICAL AGGRESSION; ASPERGERS SYNDROME; INDIVIDUALS; CHILDHOOD; LANGUAGE; VIOLENCE; PEOPLE; MIND	Background: Parents, caregivers and mental health professionals have often reported violence and aggression in children or adolescents with autistic disorder. However, most of these observations derived from anecdotal reports, and studies on frequency and characterization of aggression in autism remain limited. Our objective was to better characterize and understand the different types of aggressive behaviors displayed by a large group of individuals with autism in different observational situations. Methodology/Findings: The study was conducted on 74 children and adolescents with autism and 115 typically developing control individuals matched for sex, age and pubertal stage. Other-Injurious Behaviors (OIB) were assessed in three observational situations (parents at home, two caregivers at day-care, a nurse and a child psychiatrist during blood drawing) using validated scales. The frequency of OIB was significantly higher in individuals with autism compared to typically developing control individuals during the blood drawing (23% vs. 0%, P<0.01). The parents observed significantly less OIB in their children than caregivers (34% vs. 58%, P<0.05). In addition, the most frequent concurrent behaviors occurring just before the appearance of OIB in individuals with autism were anxiety-related behaviors and excitation according to the parental as well as the caregiver observation. Conclusions/Significance: The results suggest that in a stressful situation, such as the blood drawing, individuals with autism release their stress through behaviors such as OIB, whereas typically developing individuals regulate and express their stress through cognitive skills such as mental coping strategies, symbolization skills with representation and anticipation of the stressful situation, social interaction and verbal or non-verbal communication. The findings underline also the key role of the environment in assessing OIB and developing therapeutic perspectives, with an individual who modulates his/her behavior according to the environment, and an environment that perceives this behavior and reacts to it with different tolerance thresholds according to the observers.	[Bronsard, Guillaume] Fac Med Timone, Maison Dept Adolescent, Marseille, France; [Bronsard, Guillaume] Fac Med Timone, Ctr Med Psychopedag Conseil Gen Bouches du Rhone, Lab Sante Publ EA3279, Marseille, France; [Botbol, Michel] Paris Catholic Univ, Ecole Psychol, Soc Psychanalyt Paris, Paris, France; [Tordjman, Sylvie] Univ Paris 05, CNRS, Lab Psychol Percept, UMR 8158, Paris, France; [Tordjman, Sylvie] Univ Rennes 1, Serv Hosp Univ Psychiat Enfant & Adolescent Renne, F-35014 Rennes, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; CHU Rennes; Universite de Rennes	Bronsard, G (corresponding author), Fac Med Timone, Maison Dept Adolescent, Marseille, France.	s.tordjman@ch-guillaumeregnier.fr			INSERM (National Scientific Institute of Medical Research)	INSERM (National Scientific Institute of Medical Research)(Institut National de la Sante et de la Recherche Medicale (Inserm))	The research was supported by the INSERM (National Scientific Institute of Medical Research). The funding was used to cover travel costs for the research team and participants including their families. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anastasi A., 1988, PSYCHOL TESTING; [Anonymous], HDB EVOLUTIONARY PSY; [Anonymous], 1996, GROWING CANADA NATL, P127; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Brereton AV, 2006, J AUTISM DEV DISORD, V36, P863, DOI 10.1007/s10803-006-0125-y; CAMPBELL SB, 1995, J CHILD PSYCHOL PSYC, V36, P113, DOI 10.1111/j.1469-7610.1995.tb01657.x; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; Cuccaro ML, 2003, CHILD PSYCHIAT HUM D, V34, P3, DOI 10.1023/A:1025321707947; Dominick KC, 2007, RES DEV DISABIL, V28, P145, DOI 10.1016/j.ridd.2006.02.003; Emerson E, 2000, CHALLENGING BEHAV AN, V2; Feshbach N.D., 1987, EMPATHY ITS DEV, P271; GHAZIUDDIN M, 1991, J AUTISM DEV DISORD, V21, P349, DOI 10.1007/BF02207331; HARRIS SL, 1990, AVERSIVE NONAVERSIVE; Horner RH, 2002, J AUTISM DEV DISORD, V32, P423, DOI 10.1023/A:1020593922901; Kohn Y, 1998, ISRAEL J PSYCHIAT, V35, P293; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Luiselli JK, 2000, J BEHAV THER EXP PSY, V31, P219, DOI 10.1016/S0005-7916(01)00007-6; Matson JL, 2007, RES DEV DISABIL, V28, P567, DOI 10.1016/j.ridd.2006.08.001; Matson JL, 2007, RES DEV DISABIL, V28, P353, DOI 10.1016/j.ridd.2006.01.005; MAWSON D, 1985, BRIT J PSYCHIAT, V147, P566, DOI 10.1192/bjp.147.5.566; McClintock K, 2003, J INTELL DISABIL RES, V47, P405, DOI 10.1046/j.1365-2788.2003.00517.x; Mises R., 1993, CIM 10 CLASSIFICATIO; Richell RA, 2003, NEUROPSYCHOLOGIA, V41, P523, DOI 10.1016/S0028-3932(02)00175-6; Sigafoos J, 2003, CHALLENGING BEHAV DE; Tanner J.H., 1962, GROWTH ADOLESCENTS; Tordjman S, 1997, J CHILD PSYCHOL PSYC, V38, P705, DOI 10.1111/j.1469-7610.1997.tb01697.x; Tordjman S, 1999, ENCEPHALE, V25, P122; Tordjman S, 2008, MANUAL OIBS SIBS OTH; TORDJMAN S, 2001, MOL PSYCHIATR, V5, P831; Tordjman S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005289; Tremblay R. E., 1999, CRIM BEHAV MENT HEAL, V9, P8, DOI [DOI 10.1002/CBM.288, 10.1002/CBM.288]; Tremblay RE, 2000, INT J BEHAV DEV, V24, P129, DOI 10.1080/016502500383232; Tremblay RE, 2004, PEDIATRICS, V114, pE43, DOI 10.1542/peds.114.1.e43; Tremblay RE, 1999, DEVELOPMENTAL HEALTH AND THE WEALTH OF NATIONS, P55; Tremblay RE, 2008, PHILOS T R SOC B, V363, P2613, DOI 10.1098/rstb.2008.0030; Vitiello B, 1997, J AM ACAD CHILD PSY, V36, P307, DOI 10.1097/00004583-199703000-00008	37	30	30	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e14358	10.1371/journal.pone.0014358	http://dx.doi.org/10.1371/journal.pone.0014358			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	698EY	21200441	Green Published, Green Submitted, gold			2022-12-27	WOS:000285576900003
J	Durk, RC; Singh, K; Cornelison, CA; Rai, DK; Matzek, KB; Leslie, MD; Schafer, E; Marchand, B; Adedeji, A; Michailidis, E; Dorst, CA; Moran, J; Pautler, C; Rodriguez, LL; McIntosh, MA; Rieder, E; Sarafianos, SG				Durk, Ryan C.; Singh, Kamalendra; Cornelison, Ceili A.; Rai, Devendra K.; Matzek, Kayla B.; Leslie, Maxwell D.; Schafer, Elizabeth; Marchand, Bruno; Adedeji, Adeyemi; Michailidis, Eleftherios; Dorst, Christopher A.; Moran, Jennifer; Pautler, Christie; Rodriguez, Luis L.; McIntosh, Mark A.; Rieder, Elizabeth; Sarafianos, Stefan G.			Inhibitors of Foot and Mouth Disease Virus Targeting a Novel Pocket of the RNA-Dependent RNA Polymerase	PLOS ONE			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; I KLENOW FRAGMENT; HEPATITIS-C; NS5B POLYMERASE; ACTIVE-SITE; NONNUCLEOSIDE INHIBITOR; DRUG-RESISTANCE; RIBAVIRIN; MECHANISMS; REPLICATION	Background: Foot-and-Mouth Disease Virus (FMDV) is a picornavirus that infects cloven-hoofed animals and leads to severe losses in livestock production. In the case of an FMD outbreak, emergency vaccination requires at least 7 days to trigger an effective immune response. There are currently no approved inhibitors for the treatment or prevention of FMDV infections. Methodology/Principal Findings: Using a luciferase-based assay we screened a library of compounds and identified seven novel inhibitors of 3Dpol, the RNA-dependent RNA polymerase of FMDV. The compounds inhibited specifically 3Dpol (IC(50)s from 2-17 mu M) and not other viral or bacterial polymerases. Enzyme kinetic studies on the inhibition mechanism by compounds 5D9 and 7F8 showed that they are non-competitive inhibitors with respect to NTP and nucleic acid substrates. Molecular modeling and docking studies into the 3Dpol structure revealed an inhibitor binding pocket proximal to, but distinct from the 3Dpol catalytic site. Residues surrounding this pocket are conserved among all 60 FMDV subtypes. Site directed mutagenesis of two residues located at either side of the pocket caused distinct resistance to the compounds, demonstrating that they indeed bind at this site. Several compounds inhibited viral replication with 5D9 suppressing virus production in FMDV-infected cells with EC50 = 12 mu M and EC90 = 20 mu M). Significance: We identified several non-competitive inhibitors of FMDV 3Dpol that target a novel binding pocket, which can be used for future structure-based drug design studies. Such studies can lead to the discovery of even more potent antivirals that could provide alternative or supplementary options to contain future outbreaks of FMD.	[Durk, Ryan C.; Singh, Kamalendra; Cornelison, Ceili A.; Rai, Devendra K.; Matzek, Kayla B.; Leslie, Maxwell D.; Marchand, Bruno; Adedeji, Adeyemi; Michailidis, Eleftherios; Dorst, Christopher A.; Moran, Jennifer; Pautler, Christie; Sarafianos, Stefan G.] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Christopher Bond Life Sci Ctr, Columbia, MO 65212 USA; [Schafer, Elizabeth; Rodriguez, Luis L.; Rieder, Elizabeth] ARS, Foreign Anim Dis Res Unit, USDA, Plum Isl Anim Dis Ctr, Greenport, NY USA	University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA)	Durk, RC (corresponding author), Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Christopher Bond Life Sci Ctr, Columbia, MO 65212 USA.	sarafianoss@missouri.edu	Rai, Devendra/J-3857-2013; Rai, Devendra/AAX-3100-2020; Adedeji, Adeyemi/AAO-5703-2020; Adedeji, Adeyemi O/I-1327-2019	Rai, Devendra/0000-0001-9035-685X; Adedeji, Adeyemi/0000-0002-5153-1990; Sarafianos, Stefan G/0000-0002-5840-154X; Michailidis, Eleftherios/0000-0002-9907-4346	United States Department of Agriculture [ARS-58-1940-5-519]; National Institutes of Health [AI076119, AI079801, AI074389]; AmfAR Mathilde Kim Fellowship; Korea Food & Drug Administration; Ministry of Knowledge and Economy, Republic of Korea; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074389, R21AI079801, R33AI079801, R01AI076119] Funding Source: NIH RePORTER	United States Department of Agriculture(United States Department of Agriculture (USDA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AmfAR Mathilde Kim Fellowship; Korea Food & Drug Administration(Ministry of Food & Drug Safety (MFDS), Republic of Korea); Ministry of Knowledge and Economy, Republic of Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the United States Department of Agriculture (ARS-58-1940-5-519 to SGS); Salary support was also provided by the National Institutes of Health (AI076119, AI079801, and AI074389); AmfAR Mathilde Kim Fellowship grant to BM; and from the Korea Food & Drug Administration and the Ministry of Knowledge and Economy, Bilateral International Collaborative R&D Program, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo R, 2008, J MOL BIOL, V382, P652, DOI 10.1016/j.jmb.2008.07.033; Airaksinen A, 2003, VIROLOGY, V311, P339, DOI 10.1016/S0042-6822(03)00144-2; Arias A, 2008, J VIROL, V82, P12346, DOI 10.1128/JVI.01297-08; BELSHAM GJ, 1993, PROG BIOPHYS MOL BIO, V60, P241, DOI 10.1016/0079-6107(93)90016-D; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; D'Abramo CM, 2006, J BIOL CHEM, V281, P24991, DOI 10.1074/jbc.M600474200; De Clercq E, 2005, ANTIVIR RES, V67, P56, DOI 10.1016/j.antiviral.2005.05.001; De Clercq E, 2002, NAT REV DRUG DISCOV, V1, P13, DOI 10.1038/nrd703; Deval J, 2007, ANTIMICROB AGENTS CH, V51, P2920, DOI 10.1128/AAC.00186-07; Ellingham M, 2006, RNA, V12, P1970, DOI 10.1261/rna.161006; Ferrer-Orta C, 2006, EMBO J, V25, P880, DOI 10.1038/sj.emboj.7600971; Ferrer-Orta C, 2004, J BIOL CHEM, V279, P47212, DOI 10.1074/jbc.M405465200; Ferrer-Orta C, 2007, P NATL ACAD SCI USA, V104, P9463, DOI 10.1073/pnas.0700518104; Ferrer-Orta C, 2010, J VIROL, V84, P6188, DOI 10.1128/JVI.02420-09; Furuta Y, 2009, ANTIVIR RES, V82, P95, DOI 10.1016/j.antiviral.2009.02.198; Giuliano C, 2005, XENOBIOTICA, V35, P1035, DOI 10.1080/00498250500356548; Graci JD, 2006, REV MED VIROL, V16, P37, DOI 10.1002/rmv.483; Grubman MJ, 2005, BIOLOGICALS, V33, P227, DOI 10.1016/j.biologicals.2005.08.009; Lahser FC, 2004, ANAL BIOCHEM, V325, P247, DOI 10.1016/j.ab.2003.10.034; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Love RA, 2003, J VIROL, V77, P7575, DOI 10.1128/JVI.77.13.7575-7581.2003; Ma H, 2007, J BIOL CHEM, V282, P29812, DOI 10.1074/jbc.M705274200; MCCORMICK JB, 1986, NEW ENGL J MED, V314, P20, DOI 10.1056/NEJM198601023140104; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Menendez-Arias L, 2008, VIRUS RES, V134, P1, DOI 10.1016/j.virusres.2008.01.009; Menendez-Arias L, 2010, ANTIVIR RES, V85, P210, DOI 10.1016/j.antiviral.2009.07.006; Michailidis E, 2009, J BIOL CHEM, V284, P35681, DOI 10.1074/jbc.M109.036616; Nayak A, 2005, J VIROL, V79, P7698, DOI 10.1128/JVI.79.12.7698-7706.2005; Nesya G, 2007, ANTIVIR RES, V73, P161, DOI 10.1016/j.antiviral.2006.09.007; Pace P, 2004, BIOORG MED CHEM LETT, V14, P3257, DOI 10.1016/j.bmcl.2004.03.087; Pariente N, 2005, VIRUS RES, V107, P183, DOI 10.1016/j.virusres.2004.11.008; Parniak M A, 2000, Adv Pharmacol, V49, P67; Paton DJ, 2005, REV SCI TECH OIE, V24, P981, DOI 10.20506/rst.24.3.1632; Paul AV, 1998, NATURE, V393, P280, DOI 10.1038/30529; Powdrill MH, 2010, ANTIMICROB AGENTS CH, V54, P977, DOI 10.1128/AAC.01216-09; RYAN MD, 1989, VIROLOGY, V173, P35, DOI 10.1016/0042-6822(89)90219-5; SARAFIANOS SG, 1995, BIOCHEMISTRY-US, V34, P7207, DOI 10.1021/bi00021a036; Sarafianos SG, 1996, BIOCHEM J, V319, P619, DOI 10.1042/bj3190619; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Shehu-Xhilaga M, 2005, CURR MED CHEM, V12, P1705, DOI 10.2174/0929867054367211; Sierra M, 2007, J VIROL, V81, P2012, DOI 10.1128/JVI.01606-06; Singh K, 2003, J BIOL CHEM, V278, P11289, DOI 10.1074/jbc.M211496200; Singh K, 2010, VIRUSES-BASEL, V2, P606, DOI 10.3390/v2020606; Sluis-Cremer N, 2008, VIRUS RES, V134, P147, DOI 10.1016/j.virusres.2008.01.002; SMITH DW, 1991, NEW ENGL J MED, V325, P24, DOI 10.1056/NEJM199107043250105; Tuske S, 2000, J BIOL CHEM, V275, P23759, DOI 10.1074/jbc.M001804200; Vagnozzi A, 2007, J VIROL, V81, P11669, DOI 10.1128/JVI.00557-07; Vandyck K, 2009, J MED CHEM, V52, P4099, DOI 10.1021/jm9005548; Xia Q, 2007, PROTEIN SCI, V16, P1728, DOI 10.1110/ps.072829007; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	51	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15049	10.1371/journal.pone.0015049	http://dx.doi.org/10.1371/journal.pone.0015049			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203539	Green Published, gold			2022-12-27	WOS:000285576900016
J	Balagam, R; Singh, V; Sagi, AR; Dixit, NM				Balagam, Rajesh; Singh, Vasantika; Sagi, Aparna Raju; Dixit, Narendra M.			Taking Multiple Infections of Cells and Recombination into Account Leads to Small Within-Host Effective-Population-Size Estimates of HIV-1	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; IN-VIVO; ANTIRETROVIRAL THERAPY; TYPE-1 INFECTION; DRUG-RESISTANCE; GENETIC DRIFT; GENERATION TIME; LYMPHOID-TISSUE; TARGET-CELLS; T-CELLS	Whether HIV-1 evolution in infected individuals is dominated by deterministic or stochastic effects remains unclear because current estimates of the effective population size of HIV-1 in vivo, N(e), are widely varying. Models assuming HIV-1 evolution to be neutral estimate N(e)similar to 10(2)-10(4), smaller than the inverse mutation rate of HIV-1 (similar to 10(5)), implying the predominance of stochastic forces. In contrast, a model that includes selection estimates N(e)>10(5), suggesting that deterministic forces would hold sway. The consequent uncertainty in the nature of HIV-1 evolution compromises our ability to describe disease progression and outcomes of therapy. We perform detailed bit-string simulations of viral evolution that consider large genome lengths and incorporate the key evolutionary processes underlying the genomic diversification of HIV-1 in infected individuals, namely, mutation, multiple infections of cells, recombination, selection, and epistatic interactions between multiple loci. Our simulations describe quantitatively the evolution of HIV-1 diversity and divergence in patients. From comparisons of our simulations with patient data, we estimate N(e)similar to 10(3)-10(4), implying predominantly stochastic evolution. Interestingly, we find that N(e) and the viral generation time are correlated with the disease progression time, presenting a route to a priori prediction of disease progression in patients. Further, we show that the previous estimate of N(e)>10(5) reduces as the frequencies of multiple infections of cells and recombination assumed increase. Our simulations with N(e)similar to 10(3)-10(4) may be employed to estimate markers of disease progression and outcomes of therapy that depend on the evolution of viral diversity and divergence.	[Balagam, Rajesh; Singh, Vasantika; Sagi, Aparna Raju; Dixit, Narendra M.] Indian Inst Sci, Dept Chem Engn, Bangalore 560012, Karnataka, India; [Dixit, Narendra M.] Indian Inst Sci, Bioinformat Ctr, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Balagam, R (corresponding author), Indian Inst Sci, Dept Chem Engn, Bangalore 560012, Karnataka, India.	narendra@chemeng.iisc.ernet.in	Suryawanshi, Vasantika/ABA-8637-2020	Suryawanshi, Vasantika/0000-0003-1497-7480	National Institutes of Health [AI065334]; Jawaharlal Nehru Centre for Advanced Scientific Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI065334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jawaharlal Nehru Centre for Advanced Scientific Research(Department of Science & Technology (India)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Grant AI065334. ARS acknowledges the Jawaharlal Nehru Centre for Advanced Scientific Research for a fellowship under JNCASR-SRFP-2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaz G, 2004, MOL BIOL EVOL, V21, P1902, DOI 10.1093/molbev/msh196; Althaus CL, 2005, J VIROL, V79, P13572, DOI 10.1128/JVI.79.21.13572-13578.2005; Arora P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000305; Bocharov G, 2005, J GEN VIROL, V86, P3109, DOI 10.1099/vir.0.81138-0; Boerlijst MC, 1996, P ROY SOC B-BIOL SCI, V263, P1577, DOI 10.1098/rspb.1996.0231; Bonhoeffer S, 2004, SCIENCE, V306, P1547, DOI 10.1126/science.1101786; Bretscher MT, 2004, BIOESSAYS, V26, P180, DOI 10.1002/bies.10386; Brown AJL, 1997, P NATL ACAD SCI USA, V94, P1862, DOI 10.1073/pnas.94.5.1862; Carvajal-Rodriguez A, 2007, INFECT GENET EVOL, V7, P476, DOI 10.1016/j.meegid.2007.02.001; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Chen BK, 1996, J VIROL, V70, P6044, DOI 10.1128/JVI.70.9.6044-6053.1996; Chen HY, 2007, P NATL ACAD SCI USA, V104, P19079, DOI 10.1073/pnas.0707449104; Chen JB, 2005, J VIROL, V79, P4140, DOI 10.1128/JVI.79.7.4140-4149.2005; Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07; Dang Q, 2004, P NATL ACAD SCI USA, V101, P632, DOI 10.1073/pnas.0307636100; DIMITROV DS, 1995, NATURE, V375, P194, DOI 10.1038/375194b0; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Dixit N. M., 2008, FUTURE HIV THER, V2, P375; Dixit NM, 2005, P NATL ACAD SCI USA, V102, P8198, DOI 10.1073/pnas.0407498102; Dixit NM, 2004, ANTIVIR THER, V9, P237; Dixit NM, 2004, J VIROL, V78, P8942, DOI 10.1128/JVI.78.16.8942-8945.2004; ESHEL I, 1970, Theoretical Population Biology, V1, P88, DOI 10.1016/0040-5809(70)90043-2; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fraser C, 2005, J ROY SOC INTERFACE, V2, P489, DOI 10.1098/rsif.2005.0064; Frost SDW, 2001, P NATL ACAD SCI USA, V98, P6975, DOI 10.1073/pnas.131056998; Gadhamsetty S, 2010, J VIROL, V84, P10230, DOI 10.1128/JVI.01010-10; Gheorghiu-Svirschevski S, 2007, MOL BIOL EVOL, V24, P574, DOI 10.1093/molbev/msl189; Gillespie JH, 2000, GENETICS, V155, P909; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Haase AT, 1996, SCIENCE, V274, P985, DOI 10.1126/science.274.5289.985; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Hockett RD, 1999, J EXP MED, V189, P1545, DOI 10.1084/jem.189.10.1545; JOSEFSSON L, 2010, 17 C RETR OPP INF; Jung A, 2002, NATURE, V418, P144, DOI 10.1038/418144a; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kouyos RD, 2007, TRENDS ECOL EVOL, V22, P308, DOI 10.1016/j.tree.2007.02.014; Kouyos RD, 2006, GENETICS, V173, P589, DOI 10.1534/genetics.105.053108; Kouyos RD, 2006, TRENDS MICROBIOL, V14, P507, DOI 10.1016/j.tim.2006.10.001; Lemey P, 2007, PLOS COMPUT BIOL, V3, P282, DOI 10.1371/journal.pcbi.0030029; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Liu Y, 2006, VIROLOGY, V347, P140, DOI 10.1016/j.virol.2005.11.036; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; McCutchan FE, 2006, J MED VIROL, V78, pS7, DOI 10.1002/jmv.20599; Murray J., 1910, REPORTS SCI EXPEDITI, P17; Nijhuis M, 1998, P NATL ACAD SCI USA, V95, P14441, DOI 10.1073/pnas.95.24.14441; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; Piguet V, 1999, CELL, V97, P63, DOI 10.1016/S0092-8674(00)80715-1; Rhodes T, 2003, J VIROL, V77, P11193, DOI 10.1128/JVI.77.20.11193-11200.2003; Ribeiro RM, 2010, J VIROL, V84, P6096, DOI 10.1128/JVI.00127-10; Rodrigo AG, 1999, P NATL ACAD SCI USA, V96, P2187, DOI 10.1073/pnas.96.5.2187; Rouzine IM, 2010, THEOR POPUL BIOL, V77, P189, DOI 10.1016/j.tpb.2010.02.001; Rouzine IM, 1999, P NATL ACAD SCI USA, V96, P10758, DOI 10.1073/pnas.96.19.10758; Rouzine IM, 2005, GENETICS, V170, P7, DOI 10.1534/genetics.104.029926; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Seo TK, 2002, GENETICS, V160, P1283; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Shriner D, 2004, GENETICS, V166, P1155, DOI 10.1534/genetics.166.3.1155; Suryavanshi GW, 2007, PLOS COMPUT BIOL, V3, P2003, DOI 10.1371/journal.pcbi.0030205; Telenti A, 2006, NAT REV MICROBIOL, V4, P865, DOI 10.1038/nrmicro1532; Telenti A, 2008, CURR OPIN HIV AIDS, V3, P28, DOI 10.1097/COH.0b013e3282f18ac0; Vijay NNV, 2008, J GEN VIROL, V89, P1467, DOI 10.1099/vir.0.83668-0; Voronin Y, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000431; Williamson S, 2005, MOL BIOL EVOL, V22, P456, DOI 10.1093/molbev/msi029; Wright S, 1931, GENETICS, V16, P0097	69	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e14531	10.1371/journal.pone.0014531	http://dx.doi.org/10.1371/journal.pone.0014531			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249189	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000286515000002
J	Petitbarat, M; Rahmati, M; Serazin, V; Dubanchet, S; Morvan, C; Wainer, R; de Mazancourt, P; Chaouat, G; Foidart, JM; Munaut, C; Ledee, N				Petitbarat, Marie; Rahmati, Mona; Serazin, Valerie; Dubanchet, Sylvie; Morvan, Corinne; Wainer, Robert; de Mazancourt, Philippe; Chaouat, Gerard; Foidart, Jean-Michel; Munaut, Carine; Ledee, Nathalie			TWEAK Appears as a Modulator of Endometrial IL-18 Related Cytotoxic Activity of Uterine Natural Killers	PLOS ONE			English	Article							IN-VITRO; MULTIFUNCTIONAL CYTOKINE; TNF SUPERFAMILY; NK CELLS; EXPRESSION; RECEPTOR; BIOLOGY; MODEL; PROLIFERATION; IMPLANTATION	Background: TWEAK (Tumor necrosis factor like WEAK inducer of apoptosis) is highly expressed by different immune cells and triggers multiple cellular responses, including control of angiogenesis. Our objective was to investigate its role in the human endometrium during the implantation window, using an ex-vivo endometrial microhistoculture model. Indeed, previous results suggested that basic TWEAK expression influences the IL-18 related uNK recruitment and local cytotoxicity. Methodology/Principal Findings: Endometrial biopsies were performed 7 to 9 days after the ovulation surge of women in monitored natural cycles. Biopsies were cut in micro-pieces and cultured on collagen sponge with appropriate medium. Morphology, functionality and cell death were analysed at different time of the culture. We used this ex vivo model to study mRNA expressions of NKp46 (a uNK cytotoxic receptor) and TGF-beta1 (protein which regulates uNK cytokine production) after adjunction of excess of recombinant IL-18 and either recombinant TWEAK or its antibody. NKp46 protein expression was also detailed by immunohistochemistry in selected patients with high basic mRNA level of IL-18 and either low or high mRNA level of TWEAK. The NKp46 immunostaining was stronger in patients with an IL-18 over-expression and a low TWEAK expression, when compared with patients with both IL-18 and TWEAK high expressions. We did not observe any difference for TWEAK expression when recombinant protein IL-18 or its antibody was added, or conversely, for IL-18 expression when TWEAK or its antibody was added in the culture medium. In a pro-inflammatory environment (obtained by an excess of IL-18), inhibition of TWEAK was able to increase significantly NKp46 and TGF-beta1 mRNA expressions. Conclusions/Significance: TWEAK doesn't act on IL-18 expression but seems to control IL-18 related cytotoxicity on uNK cells when IL-18 is over-expressed. Thus, TWEAK appears as a crucial physiological modulator to prevent endometrial uNK cytotoxicity in human.	[Petitbarat, Marie; Rahmati, Mona; Dubanchet, Sylvie; Chaouat, Gerard; Ledee, Nathalie] Univ Paris 11, Hop Antoine Beclere, INSERM, UMR S0782,U782, Clamart, France; [Serazin, Valerie; Morvan, Corinne; Wainer, Robert; de Mazancourt, Philippe] Univ Versailles St Quentin Yvelines, CHI Poissy St Germain Laye, Dept Reprod Med & Mol Biol, EA 2493, Poissy, France; [Foidart, Jean-Michel; Munaut, Carine] Univ Liege, CHU Sart Tilman, Lab Tumor & Dev Biol, Liege, Belgium	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Hospital Chi of Poissy Saint Germain; UDICE-French Research Universities; Universite Paris Saclay; University of Liege	Ledee, N (corresponding author), Univ Paris 11, Hop Antoine Beclere, INSERM, UMR S0782,U782, Clamart, France.	nathalie-ledee@orange.fr	Munaut, Carine/K-8138-2019; LEDEE, nathalie/AAE-8303-2019	LEDEE, nathalie/0000-0002-3166-2643	University Paris XI; Inserm Research Institute	University Paris XI; Inserm Research Institute	This work was supported by University Paris XI and Inserm Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ain R, 2003, DEV BIOL, V260, P176, DOI 10.1016/S0012-1606(03)00210-0; Arnold JT, 2001, HUM REPROD, V16, P836, DOI 10.1093/humrep/16.5.836; Bell E, 2006, NAT REV IMMUNOL, V6, P91, DOI 10.1038/nri1790; BENTINLEY U, 1994, J REPROD FERTIL, V101, P327; BERGH PA, 1992, FERTIL STERIL, V58, P537; Blauer M, 2005, HUM REPROD, V20, P864, DOI 10.1093/humrep/deh722; Burkly LC, 2007, CYTOKINE, V40, P1, DOI 10.1016/j.cyto.2007.09.007; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Croy BA, 2003, REPRODUCTION, V126, P149, DOI 10.1530/rep.0.1260149; Croy BA, 1997, AM J REPROD IMMUNOL, V37, P463; DUDLEY DJ, 1992, AM J OBSTET GYNECOL, V167, P1774, DOI 10.1016/0002-9378(92)91774-5; Eriksson M, 2004, J LEUKOCYTE BIOL, V76, P667, DOI 10.1189/jlb.0204090; Faye A, 2005, PLACENTA, V26, P262, DOI 10.1016/j.placenta.2004.08.005; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Krussel JS, 1999, MOL HUM REPROD, V5, P452, DOI 10.1093/molehr/5.5.452; Laird SM, 2005, PLACENTA, V26, pA26; Lash GE, 2006, J LEUKOCYTE BIOL, V80, P572, DOI 10.1189/jlb.0406250; Ledee N, 2008, J REPROD IMMUNOL, V77, P57, DOI 10.1016/j.jri.2007.07.006; Ledee-Bataille N, 2005, FERTIL STERIL, V83, P598, DOI 10.1016/j.fertnstert.2004.11.021; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Loke YW, 1996, AM J REPROD IMMUNOL, V35, P256; Lynch CN, 1999, J BIOL CHEM, V274, P8455, DOI 10.1074/jbc.274.13.8455; Manaster I, 2008, J IMMUNOL, V181, P1869, DOI 10.4049/jimmunol.181.3.1869; OSTEEN KG, 1994, P NATL ACAD SCI USA, V91, P10129, DOI 10.1073/pnas.91.21.10129; PETITBARAT M, 2009, FERTIL STERIL; Petitbarat M, 2010, FERTIL STERIL, V94, P1141, DOI 10.1016/j.fertnstert.2009.10.049; Phillips TA, 2001, PLACENTA, V22, P663, DOI 10.1053/plac.2001.0703; Pierro E, 2001, BIOL REPROD, V64, P831, DOI 10.1095/biolreprod64.3.831; Raine-Fenning NJ, 2004, HUM REPROD, V19, P330, DOI 10.1093/humrep/deh056; Raine-Fenning NJ, 2004, HUM REPROD, V19, P2605, DOI 10.1093/humrep/deh459; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wiley SR, 2003, CYTOKINE GROWTH F R, V14, P241, DOI 10.1016/S1359-6101(03)00019-4; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488	33	32	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e14497	10.1371/journal.pone.0014497	http://dx.doi.org/10.1371/journal.pone.0014497			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249128	Green Published, gold, Green Submitted			2022-12-27	WOS:000286512900003
J	Gattol, V; Saaksjarvi, M; Carbon, CC				Gattol, Valentin; Saaksjarvi, Maria; Carbon, Claus-Christian			Extending the Implicit Association Test (IAT): Assessing Consumer Attitudes Based on Multi-Dimensional Implicit Associations	PLOS ONE			English	Article							AFFECTIVE SIMON TASK; SOCIAL COGNITION; SELF-ESTEEM; INDIVIDUAL-DIFFERENCES; PREDICTIVE-VALIDITY; PREFERENCE; DESIGN; STEREOTYPES; PERSONALITY; DIMENSIONS	Background: The authors present a procedural extension of the popular Implicit Association Test (IAT; [1]) that allows for indirect measurement of attitudes on multiple dimensions (e.g., safe-unsafe; young-old; innovative-conventional, etc.) rather than on a single evaluative dimension only (e.g., good-bad). Methodology/Principal Findings: In two within-subjects studies, attitudes toward three automobile brands were measured on six attribute dimensions. Emphasis was placed on evaluating the methodological appropriateness of the new procedure, providing strong evidence for its reliability, validity, and sensitivity. Conclusions/Significance: This new procedure yields detailed information on the multifaceted nature of brand associations that can add up to a more abstract overall attitude. Just as the IAT, its multi-dimensional extension/application (dubbed md-IAT) is suited for reliably measuring attitudes consumers may not be consciously aware of, able to express, or willing to share with the researcher [2,3].	[Gattol, Valentin; Saaksjarvi, Maria] Delft Univ Technol, Dept Prod Innovat Management, Fac Ind Design Engn, Delft, Netherlands; [Carbon, Claus-Christian] Otto Friedrich Univ Bamberg, Dept Gen Psychol & Methodol, D-96047 Bamberg, Germany	Delft University of Technology; Otto Friedrich University Bamberg	Gattol, V (corresponding author), Delft Univ Technol, Dept Prod Innovat Management, Fac Ind Design Engn, Delft, Netherlands.	ccc@experimental-psychology.com	Carbon, Claus-Christian/GLQ-6274-2022; Carbon, Claus-Christian/A-7494-2008	Carbon, Claus-Christian/0000-0002-3446-9347; Carbon, Claus-Christian/0000-0002-3446-9347				Aaker JL, 1997, J MARKETING RES, V34, P347, DOI 10.2307/3151897; Banse R, 2007, INT J PSYCHOL, V42, P149, DOI 10.1080/00207590601067037; Bar-Anan Y, 2006, J EXP PSYCHOL GEN, V135, P609, DOI 10.1037/0096-3445.135.4.609; Bluemke M, 2006, J EXP SOC PSYCHOL, V42, P163, DOI 10.1016/j.jesp.2005.03.004; Brunel FF, 2004, J CONSUM PSYCHOL, V14, P385, DOI 10.1207/s15327663jcp1404_8; CARBON C.-C., 2006, PSYCHOL SCI, V48, P173; Carbon CC, 2005, PERCEPTION, V34, P1117, DOI 10.1068/p5192; Carbon CC, 2005, APPL COGNITIVE PSYCH, V19, P587, DOI 10.1002/acp.1098; Carbon CC, 2008, RES ENG DES, V19, P143, DOI 10.1007/s00163-008-0045-2; Carbon CC, 2010, ACTA PSYCHOL, V134, P233, DOI 10.1016/j.actpsy.2010.02.004; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cunningham WA, 2007, TRENDS COGN SCI, V11, P97, DOI 10.1016/j.tics.2006.12.005; De Houwer J, 2003, EXP PSYCHOL, V50, P77, DOI 10.1026//1618-3169.50.2.77; De Houwer J, 2001, J EXP SOC PSYCHOL, V37, P443, DOI 10.1006/jesp.2000.1464; De Houwer J, 2007, BRIT J SOC PSYCHOL, V46, P401, DOI 10.1348/014466606X130346; Eagly A. H., 1993, PSYCHOL ATTITUDES; Egloff B, 2002, J PERS SOC PSYCHOL, V83, P1441, DOI 10.1037/0022-3514.83.6.1441; FAERBER SJ, 2010, ACTA PSYCHOL; Fazio RH, 2003, ANNU REV PSYCHOL, V54, P297, DOI 10.1146/annurev.psych.54.101601.145225; FAZIO RH, 1986, J PERS SOC PSYCHOL, V50, P229, DOI 10.1037/0022-3514.50.2.229; Fishbein M., 1975, BELIEF ATTITUDE INTE; Friese M, 2006, PSYCHOL MARKET, V23, P727, DOI 10.1002/mar.20126; Gawronski B, 2006, CONSCIOUS COGN, V15, P485, DOI 10.1016/j.concog.2005.11.007; Govers PCM, 2005, J CONSUM MARK, V22, P189, DOI 10.1108/07363760510605308; Gray NS, 2005, J ABNORM PSYCHOL, V114, P304, DOI 10.1037/0021-843X.114.2.304; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2001, Z EXP PSYCHOL, V48, P85, DOI 10.1026//0949-3946.48.2.85; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Hess U, 2007, PSYCHOPHYSIOLOGY, V44, P431, DOI 10.1111/j.1469-8986.2007.00516.x; Hoffman AB, 2006, J EXP PSYCHOL LEARN, V32, P301, DOI 10.1037/0278-7393.32.3.301; Hofmann W, 2005, PERS SOC PSYCHOL B, V31, P1369, DOI 10.1177/0146167205275613; KATEMANN J, 2007, DREH FREUDE AUTO MOT, P140; Keller KL, 2003, J CONSUM RES, V29, P595, DOI 10.1086/346254; Lane K. A., 2007, IMPLICIT MEASURES AT, P59, DOI DOI 10.1016/J.BRAT.2008.02.003; Leder H, 2005, APPL COGNITIVE PSYCH, V19, P603, DOI 10.1002/acp.1088; Likert R., 1932, J ARCH PSYCHOL, V22, P5, DOI DOI 10.1097/AUD.0000000000000341; Maison D, 2004, J CONSUM PSYCHOL, V14, P405, DOI 10.1207/s15327663jcp1404_9; McClure SM, 2004, NEURON, V44, P379, DOI 10.1016/j.neuron.2004.09.019; Messner C, 2010, J MARKETING RES, V47, P374, DOI 10.1509/jmkr.47.2.374; Nosek BA, 2002, J PERS SOC PSYCHOL, V83, P44, DOI 10.1037//0022-3514.83.1.44; Nosek BA, 2005, PERS SOC PSYCHOL B, V31, P166, DOI 10.1177/0146167204271418; Nosek BA, 2001, SOC COGNITION, V19, P625, DOI 10.1521/soco.19.6.625.20886; Nosek BA, 2007, IMPLICIT ASS TEST AG, P265; Nosek BA, 2007, EUR REV SOC PSYCHOL, V18, P36, DOI 10.1080/10463280701489053; Nosek BA, 2007, CURR DIR PSYCHOL SCI, V16, P65, DOI 10.1111/j.1467-8721.2007.00477.x; Osgood C.E., 1957, MEASUREMENT MEANING; Person O, 2010, DES ISSUES, V26, P82, DOI 10.1162/desi.2010.26.1.82; Pinter B, 2005, EXP PSYCHOL, V52, P74, DOI 10.1027/1618-3169.52.1.74; Rudman LA, 2000, PERS SOC PSYCHOL B, V26, P1315, DOI 10.1177/0146167200263001; Saaksjarvi M, 2007, J INTERACT MARK, V21, P22, DOI 10.1002/dir.20072; Schnabel K, 2008, EUR J PSYCHOL ASSESS, V24, P210, DOI 10.1027/1015-5759.24.4.210; Schroder-Abe M, 2007, INT J PSYCHOL, V42, P174, DOI 10.1080/00207590601068134; Steffens MC, 2006, EUR J PSYCHOL ASSESS, V22, P13, DOI 10.1027/1015-5759.22.1.13; WINDHAGER S, 2010, COLL ANTHR	56	40	41	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15849	10.1371/journal.pone.0015849	http://dx.doi.org/10.1371/journal.pone.0015849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710KT	21246037	Green Published, gold			2022-12-27	WOS:000286511200021
J	Chuang-Smith, ON; Wells, CL; Henry-Stanley, MJ; Dunny, GM				Chuang-Smith, Olivia N.; Wells, Carol L.; Henry-Stanley, Michelle J.; Dunny, Gary M.			Acceleration of Enterococcus faecalis Biofilm Formation by Aggregation Substance Expression in an Ex Vivo Model of Cardiac Valve Colonization	PLOS ONE			English	Article							EXPERIMENTAL BACTERIAL-ENDOCARDITIS; HIGH-RESOLUTION VISUALIZATION; SCANNING-ELECTRON-MICROSCOPY; SEX-PHEROMONE; INFECTIVE ENDOCARDITIS; STREPTOCOCCUS-FAECALIS; GENETIC-DETERMINANTS; FUNCTIONAL DOMAINS; HUMAN NEUTROPHILS; TERMINAL DOMAIN	Infectious endocarditis involves formation of a microbial biofilm in vivo. Enterococcus faecalis Aggregation Substance (Asc10) protein enhances the severity of experimental endocarditis, where it has been implicated in formation of large vegetations and in microbial persistence during infection. In the current study, we developed an ex vivo porcine heart valve adherence model to study the initial interactions between Asc10(+) and Asc10(-) E. faecalis and valve tissue, and to examine formation of E. faecalis biofilms on a relevant tissue surface. Scanning electron microscopy of the infected valve tissue provided evidence for biofilm formation, including growing masses of bacterial cells and the increasing presence of exopolymeric matrix over time; accumulation of adherent biofilm populations on the cardiac valve surfaces during the first 2-4 h of incubation was over 10-fold higher than was observed on abiotic membranes incubated in the same culture medium. Asc10 expression accelerated biofilm formation via aggregation between E. faecalis cells; the results also suggested that in vivo adherence to host tissue and biofilm development by E. faecalis can proceed by Asc10-dependent or Asc10-independent pathways. Mutations in either of two Asc10 subdomains previously implicated in endocarditis virulence reduced levels of adherent bacterial populations in the ex vivo system. Interference with the molecular interactions involved in adherence and initiation of biofilm development in vivo with specific inhibitory compounds could lead to more effective treatment of infectious endocarditis.	[Chuang-Smith, Olivia N.; Dunny, Gary M.] Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; [Wells, Carol L.; Henry-Stanley, Michelle J.] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Chuang-Smith, ON (corresponding author), Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA.	dunny001@umn.edu			National Heart and Lung Institute [HL51987]; National Institute of Allergy and Infectious Disease [AI 58134]; National Institute of Dental and Craniofacial Research [T32DE07288]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058134, R56AI058134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095553] Funding Source: NIH RePORTER	National Heart and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health (NIH) grants HL51987 (from the National Heart and Lung Institute), AI 58134 (National Institute of Allergy and Infectious Disease) and MinnCResT training fellowship T32DE07288 from the National Institute of Dental and Craniofacial Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballering KS, 2009, J BACTERIOL, V191, P2806, DOI 10.1128/JB.01688-08; BEHNKE O, 1970, J ULTRA MOL STRUCT R, V31, P424, DOI 10.1016/S0022-5320(70)90159-0; Chandler JR, 2005, P NATL ACAD SCI USA, V102, P15617, DOI 10.1073/pnas.0505545102; Chuang ON, 2009, INFECT IMMUN, V77, P539, DOI 10.1128/IAI.01034-08; CREMIEUX AC, 1989, J INFECT DIS, V159, P938, DOI 10.1093/infdis/159.5.938; DUNNY G, 1982, J BACTERIOL, V151, P855, DOI 10.1128/JB.151.2.855-859.1982; DUNNY GM, 1978, P NATL ACAD SCI USA, V75, P3479, DOI 10.1073/pnas.75.7.3479; DURACK DT, 1975, J PATHOL, V115, P81, DOI 10.1002/path.1711150204; DURACK DT, 1972, BRIT J EXP PATHOL, V53, P44; Erlandsen SL, 2004, J HISTOCHEM CYTOCHEM, V52, P1427, DOI 10.1369/jhc.4A6428.2004; Hirt H, 2002, INFECT IMMUN, V70, P716, DOI 10.1128/IAI.70.2.716-723.2002; KAYE D, 2004, INFECT DIS, P569; Kristich CJ, 2008, APPL ENVIRON MICROB, V74, P3377, DOI 10.1128/AEM.02665-07; McCormick, 2000, Curr Infect Dis Rep, V2, P315, DOI 10.1007/s11908-000-0009-9; McCormick JK, 2002, J INFECT DIS, V185, P994, DOI 10.1086/339604; McCormick JK, 2001, INFECT IMMUN, V69, P3305, DOI 10.1128/IAI.69.5.3305-3314.2001; MOELLERING RC, 1992, CLIN INFECT DIS, V14, P1173, DOI 10.1093/clinids/14.6.1173; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; OLMSTED SB, 1993, J BACTERIOL, V175, P6229, DOI 10.1128/JB.175.19.6229-6237.1993; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Rakita RM, 1999, INFECT IMMUN, V67, P6067, DOI 10.1128/IAI.67.11.6067-6075.1999; Rantz LA, 1943, ARCH INTERN MED, V71, P516, DOI 10.1001/archinte.1943.00210040075008; SCHABERG DR, 1991, AM J MED, V91, pS72, DOI 10.1016/0002-9343(91)90346-Y; Schlievert PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013194; Schlievert PM, 1998, INFECT IMMUN, V66, P218, DOI 10.1128/IAI.66.1.218-223.1998; Singh KV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000716; Vanek NN, 1999, FEMS IMMUNOL MED MIC, V26, P49, DOI 10.1016/S0928-8244(99)00120-0; Veltrop MHAM, 1999, INFECT IMMUN, V67, P6130, DOI 10.1128/IAI.67.11.6130-6138.1999; Waters CM, 2004, MOL MICROBIOL, V52, P1159, DOI 10.1111/j.1365-2958.2004.04045.x; Waters CM, 2001, J BACTERIOL, V183, P5659, DOI 10.1128/JB.183.19.5659-5667.2001; WIRTH R, 1994, EUR J BIOCHEM, V222, P235, DOI 10.1111/j.1432-1033.1994.tb18862.x	32	73	76	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15798	10.1371/journal.pone.0015798	http://dx.doi.org/10.1371/journal.pone.0015798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209892	Green Published, Green Submitted, gold			2022-12-27	WOS:000285793600040
J	Lin, ZF; Wu, Z; Yin, XJ; Liu, YL; Yan, XX; Lin, SQ; Xiao, JA; Wang, XJ; Feng, WK; Li, XK				Lin, Zhuofeng; Wu, Zhen; Yin, Xiaojing; Liu, Yanlong; Yan, Xinxin; Lin, Shaoqiang; Xiao, Jian; Wang, Xiaojie; Feng, Wenke; Li, Xiaokun			Serum Levels of FGF-21 Are Increased in Coronary Heart Disease Patients and Are Independently Associated with Adverse Lipid Profile	PLOS ONE			English	Article							GROWTH-FACTOR 21; RESISTANCE SYNDROME PREDICTS; INSULIN SENSITIVITY; CHINESE SUBJECTS; PPAR-ALPHA; FIBROBLAST; OBESITY; MICE; FIBROBLAST-GROWTH-FACTOR-21; CHOLESTEROL	Background: Fibroblast growth factor 21 (FGF-21) is a metabolic regulator with multiple beneficial effects on glucose homeostasis and lipid metabolism in animal models. The relationship between plasma levels of FGF-21 and coronary heart disease (CHD) in unknown. Methodology/Principal Findings: This study aimed to investigate the correlation of serum FGF-21 levels and lipid metabolism in the patients with coronary heart disease. We performed a logistic regression analysis of the relation between serum levels of FGF-21 and CHD patients with and without diabetes and hypertension. This study was conducted in the Departments of Endocrinology and Cardiovascular Diseases at two University Hospitals. Participants consisted of one hundred and thirty-five patients who have been diagnosed to have CHD and sixty-one control subjects. Serum FGF-21 level and levels of fasting blood glucose; triglyceride; apolipoprotein B100; HOMA-IR; insulin; total cholesterol; HDL-cholesterol; LDL-cholesterol; and C-reactive protein were measured. We found that median serum FGF-21 levels were significantly higher in CHD than that of control subjects (P<0.0001). Serum FGF-21 levels in CHD patients with diabetes, hypertension, or both were higher than that of patients without these comorbidities. Serum FGF-21 levels correlated positively with triglycerides, fasting blood glucose, apolipoprotein B100, insulin and HOMA-IR but negatively with HDL-C and apolipoprotein A1 after adjusting for BMI, diabetes and hypertension. Logistic regression analysis demonstrated that FGF-21 showed an independent association with triglyceride and apolipoprotein A1. Conclusions/Significance: High levels of FGF-21 are associated with adverse lipid profiles in CHD patients. The paradoxical increase of serum FGF-21 in CHD patients may indicate a compensatory response or resistance to FGF-21.	[Lin, Zhuofeng; Liu, Yanlong; Yan, Xinxin; Lin, Shaoqiang; Xiao, Jian; Feng, Wenke; Li, Xiaokun] Wenzhou Med Coll, Sch Pharm, Wenzhou, Peoples R China; [Wu, Zhen] Sun Yat Sen Univ, Dept Endocrinol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Yin, Xiaojing] Sun Yat Sen Univ, Dept Cardiovasc Dis, Affiliated Hosp 6, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Yanlong; Feng, Wenke] Univ Louisville, Sch Med, Louisville, KY 40292 USA; [Wang, Xiaojie; Li, Xiaokun] Jilin Agr Univ, Bioreator Engn Res Ctr, Changchun, Peoples R China; [Lin, Zhuofeng; Li, Xiaokun] Jilin Univ, Key Lab Pathobiol, Minist Educ, Norman Bethune Coll Med, Changchun 130023, Peoples R China	Wenzhou Medical University; Sun Yat Sen University; Sun Yat Sen University; University of Louisville; Jilin Agricultural University; Jilin University	Lin, ZF (corresponding author), Wenzhou Med Coll, Sch Pharm, Wenzhou, Peoples R China.	wenke.feng@louisville.edu; xiaokunli@163.net	Lin, Zhuofeng/K-2431-2013		Scientific Projects of Guangzhou; Science and Technology Project of Guangdong Province; Changjiang Scholars and Innovative Group Program, China [30971515]; Zhejiang Natural Science Foundation [R2090550, Y2100048]	Scientific Projects of Guangzhou; Science and Technology Project of Guangdong Province; Changjiang Scholars and Innovative Group Program, China; Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This work was supported, in part, by grants from "Scientific Projects of Guangzhou" [Z. Lin], "Science and Technology Project of Guangdong Province" [Z. Wu], "Changjiang Scholars and Innovative Group Program [X. Li], China (30971515) and the Zhejiang Natural Science Foundation (R2090550, Y2100048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; Chen WW, 2008, EXP CLIN ENDOCR DIAB, V116, P65, DOI 10.1055/s-2007-985148; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; FU XB, 1995, CHINESE MED J-PEKING, V108, P209; Fu XB, 2004, WORLD J GASTROENTERO, V10, P3590, DOI 10.3748/wjg.v10.i24.3590; Fu Xiaobing, 1996, Wound Repair and Regeneration, V4, P297, DOI 10.1046/j.1524-475X.1996.40219.x; Fukumoto S, 2008, ENDOCR J, V55, P23, DOI 10.1507/endocrj.KR07E-002; Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jin KL, 2005, P NATL ACAD SCI USA, V102, P18189, DOI 10.1073/pnas.0506375102; Jones S, 2008, MOL PHARMACEUT, V5, P42, DOI 10.1021/mp700105z; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; Kuusisto J, 2001, DIABETES CARE, V24, P1629, DOI 10.2337/diacare.24.9.1629; Li HT, 2009, J CLIN ENDOCR METAB, V94, P2151, DOI 10.1210/jc.2008-2331; Lin ZF, 2005, WORLD J GASTROENTERO, V11, P5492, DOI 10.3748/wjg.v11.i35.5492; Luc G, 2002, ARTERIOSCL THROM VAS, V22, P1155, DOI 10.1161/01.ATV.0000022850.59845.E0; Mraz M, 2009, CLIN ENDOCRINOL, V71, P369, DOI 10.1111/j.1365-2265.2008.03502.x; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Nishimura T, 1999, BBA-GENE STRUCT EXPR, V1444, P148, DOI 10.1016/S0167-4781(98)00255-3; Ortega S, 1998, P NATL ACAD SCI USA, V95, P5672, DOI 10.1073/pnas.95.10.5672; Pyorala M, 2000, ARTERIOSCL THROM VAS, V20, P538, DOI 10.1161/01.ATV.20.2.538; Stein S, 2009, DIABETES CARE, V32, P126, DOI 10.2337/dc08-1054; Tan KCB, 2003, DIABETES CARE, V26, P2323, DOI 10.2337/diacare.26.8.2323; Walldius G, 2004, CLIN CHEM LAB MED, V42, P1355, DOI 10.1515/CCLM.2004.254; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	30	142	152	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15534	10.1371/journal.pone.0015534	http://dx.doi.org/10.1371/journal.pone.0015534			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206918	gold, Green Submitted, Green Published			2022-12-27	WOS:000285793200026
J	Mikalova, L; Strouhal, M; Cejkova, D; Zobanikova, M; Pospisilova, P; Norris, SJ; Sodergren, E; Weinstock, GM; Smajs, D				Mikalova, Lenka; Strouhal, Michal; Cejkova, Darina; Zobanikova, Marie; Pospisilova, Petra; Norris, Steven J.; Sodergren, Erica; Weinstock, George M.; Smajs, David			Genome Analysis of Treponema pallidum subsp. pallidum and subsp. pertenue Strains: Most of the Genetic Differences Are Localized in Six Regions	PLOS ONE			English	Article							REPEAT PROTEIN-K; ESCHERICHIA-COLI; MULTIPLE ALLELES; TPRK GENE; LATE YAWS; SYPHILIS; SEQUENCE; DNA; IDENTIFICATION; HYPOTHESIS	The genomes of eight treponemes including T. p. pallidum strains (Nichols, SS14, DAL-1 and Mexico A), T. p. pertenue strains (Samoa D, CDC-2 and Gauthier), and the Fribourg-Blanc isolate, were amplified in 133 overlapping amplicons, and the restriction patterns of these fragments were compared. The approximate sizes of the genomes investigated based on this whole genome fingerprinting (WGF) analysis ranged from 1139.3-1140.4 kb, with the estimated genome sequence identity of 99.57-99.98% in the homologous genome regions. Restriction target site analysis, detecting the presence of 1773 individual restriction sites found in the reference Nichols genome, revealed a high genome structure similarity of all strains. The unclassified simian Fribourg-Blanc isolate was more closely related to T. p. pertenue than to T. p. pallidum strains. Most of the genetic differences between T. p. pallidum and T. p. pertenue strains were accumulated in six genomic regions. These genome differences likely contribute to the observed differences in pathogenicity between T. p. pallidum and T. p. pertenue strains. These regions of sequence divergence could be used for the molecular detection and discrimination of syphilis and yaws strains.	[Mikalova, Lenka; Strouhal, Michal; Cejkova, Darina; Zobanikova, Marie; Pospisilova, Petra; Smajs, David] Masaryk Univ, Dept Biol, Fac Med, Brno, Czech Republic; [Norris, Steven J.] Univ Texas Houston, Sch Med, Dept Pathol & Lab Med, Houston, TX 77030 USA; [Sodergren, Erica; Weinstock, George M.] Washington Univ, Sch Med, Dept Genet, Genome Ctr, St Louis, MO 63110 USA	Masaryk University Brno; University of Texas System; University of Texas Health Science Center Houston; Washington University (WUSTL)	Mikalova, L (corresponding author), Masaryk Univ, Dept Biol, Fac Med, Brno, Czech Republic.	dsmajs@med.muni.cz	Mikalová, Lenka/AAM-1068-2020; Weinstock, George M/C-6314-2013; Pospisilova, Petra/L-8212-2018; Smajs, David/I-3479-2016; Cejkova, Darina/AAA-5820-2022; Norris, Steven James/K-6586-2019	Weinstock, George M/0000-0002-2997-4592; Cejkova, Darina/0000-0002-6989-6330; Norris, Steven James/0000-0002-2501-8034	U.S. Public Health Service [R01 DE12488, R01 DE13759, R01 AI49252, R03 AI69107]; Grant Agency of the Czech Republic [310/04/0021, 310/07/0321]; Ministry of Health of the Czech Republic [NR8967-4/2006]; Ministry of Education of the Czech Republic [VZ MSM0021622415]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI069107, R01AI049252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012488, R01DE013759] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants from the U.S. Public Health Service to G. M. W. (R01 DE12488 and R01 DE13759) and S.J.N. (R01 AI49252 and R03 AI69107), and by the grants of the Grant Agency of the Czech Republic (310/04/0021 and 310/07/0321), the grant of the Ministry of Health of the Czech Republic (NR8967-4/2006), and that of the Ministry of Education of the Czech Republic (VZ MSM0021622415) to D. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal GM, 2002, MICROBES INFECT, V4, P83, DOI 10.1016/S1286-4579(01)01513-1; BAKER BJ, 1988, CURR ANTHROPOL, V29, P703, DOI 10.1086/203691; BASEMAN JB, 1974, INFECT IMMUN, V10, P1062, DOI 10.1128/IAI.10.5.1062-1067.1974; Brinkman MB, 2008, INFECT IMMUN, V76, P1848, DOI 10.1128/IAI.01424-07; Calendini F., 2005, PAUPUP V1 0 3 1 FREE; Centurion-Lara A, 2004, MOL MICROBIOL, V52, P1579, DOI 10.1111/j.1365-2958.2004.04086.x; Centurion-Lara A, 1999, J EXP MED, V189, P647, DOI 10.1084/jem.189.4.647; Centurion-Lara A, 2000, INFECT IMMUN, V68, P824, DOI 10.1128/IAI.68.2.824-831.2000; Centurion-Lara A, 1998, J INFECT DIS, V177, P1036, DOI 10.1086/515247; Centurion-Lara A, 2000, J BACTERIOL, V182, P2332, DOI 10.1128/JB.182.8.2332-2335.2000; Centurion-Lara A, 2006, J CLIN MICROBIOL, V44, P3377, DOI 10.1128/JCM.00784-06; Citti C, 1997, INFECT IMMUN, V65, P1773, DOI 10.1128/IAI.65.5.1773-1785.1997; Coil DA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-218; Cox DL, 2010, INFECT IMMUN, V78, P5178, DOI 10.1128/IAI.00834-10; Fenno JC, 1996, J BACTERIOL, V178, P2489, DOI 10.1128/jb.178.9.2489-2497.1996; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; FRIBOURG-BLANC A, 1966, Bulletin de la Societe de Pathologie Exotique, V59, P54; Fribourg-Blanc A, 1969, Primates Med, V3, P113; FRIBOURG-BLANC A., 1963, BULL SOC PATHOL EXOTIQUE, V56, P474; GASTINEL P, 1963, Ann Dermatol Syphiligr (Paris), V90, P155; Gray RR, 2006, MOL BIOL EVOL, V23, P2220, DOI 10.1093/molbev/msl092; HACKETT CJ, 1963, B WORLD HEALTH ORGAN, V29, P7; Harper KN, 2008, FEMS IMMUNOL MED MIC, V53, P322, DOI 10.1111/j.1574-695X.2008.00427.x; Harper KN, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000148; HOLLANDER D. H., 1954, AMER JOUR SYPHILIS GONORRHEA AND VENEREAL DIS, V38, P489; HOLLANDER DH, 1981, SEX TRANSM DIS, V8, P34; HUDSON EH, 1965, B WORLD HEALTH ORGAN, V32, P735; Julvez J, 1998, Med Trop (Mars), V58, P38; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levrero F, 2007, AM J PHYS ANTHROPOL, V132, P568, DOI 10.1002/ajpa.20560; LISKA SL, 1982, CURR MICROBIOL, V7, P41, DOI 10.1007/BF01570978; Liu H, 2007, J MED MICROBIOL, V56, P715, DOI 10.1099/jmm.0.46943-0; LIVINGSTONE FB, 1991, CURR ANTHROPOL, V32, P587, DOI 10.1086/204004; Marra CM, 2006, J INFECT DIS, V194, P1771, DOI 10.1086/509512; Matejkova P, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-76; Medina R, 1963, 6364 WHOVDTRES; Morgan CA, 2003, INFECT IMMUN, V71, P5605, DOI 10.1128/IAI.71.10.5605-5612.2003; Morgan CA, 2002, J IMMUNOL, V169, P952, DOI 10.4049/jimmunol.169.2.952; Morgan CA, 2002, INFECT IMMUN, V70, P6811, DOI 10.1128/IAI.70.12.6811-6816.2002; Nichols HJ, 1913, J AMER MED ASSOC, V60, P108, DOI 10.1001/jama.1913.04340020016005; NOORDHOEK GT, 1990, INFECT IMMUN, V58, P2011, DOI 10.1128/IAI.58.6.2011-2013.1990; Norris SJ, 2001, J MOL MICROB BIOTECH, V3, P37; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pillay A, 1998, SEX TRANSM DIS, V25, P408, DOI 10.1097/00007435-199809000-00004; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rozen S, 2000, Methods Mol Biol, V132, P365; Smajs D, 2002, GENOME RES, V12, P515, DOI 10.1101/gr.207302; SMITH JL, 1971, BRIT J VENER DIS, V47, P226; SMITH JL, 1971, BRIT J VENER DIS, V47, P223; STAMM LV, 1983, INFECT IMMUN, V41, P709, DOI 10.1128/IAI.41.2.709-721.1983; Strouhal M, 2007, INFECT IMMUN, V75, P5859, DOI 10.1128/IAI.00709-07; Turner TB, 1957, BIOL TREPONEMATOSES; WALKER EM, 1995, J BACTERIOL, V177, P1797, DOI 10.1128/jb.177.7.1797-1804.1995; Weinstock G.M., 2000, VIRULENCE MECH BACTE, V3rd, P251; WENDEL GD, 1991, OBSTET GYNECOL, V78, P890; Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00; WILSON J, 1973, NEW ZEAL MED J, V77, P384	57	45	45	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15713	10.1371/journal.pone.0015713	http://dx.doi.org/10.1371/journal.pone.0015713			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209953	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793200041
J	Sheehan, EV; Stevens, TF; Attrill, MJ				Sheehan, Emma V.; Stevens, Timothy F.; Attrill, Martin J.			A Quantitative, Non-Destructive Methodology for Habitat Characterisation and Benthic Monitoring at Offshore Renewable Energy Developments	PLOS ONE			English	Article							MARINE PROTECTED AREA; CONTINENTAL-SHELF; ASSEMBLAGES; CALIFORNIA; SCALES	Following governments' policies to tackle global climate change, the development of offshore renewable energy sites is likely to increase substantially over coming years. All such developments interact with the seabed to some degree and so a key need exists for suitable methodology to monitor the impacts of large-scale Marine Renewable Energy Installations (MREIs). Many of these will be situated on mixed or rocky substrata, where conventional methods to characterise the habitat are unsuitable. Traditional destructive sampling is also inappropriate in conservation terms, particularly as safety zones around (MREIs) could function as Marine Protected Areas, with positive benefits for biodiversity. Here we describe a technique developed to effectively monitor the impact of MREIs and report the results of its field testing, enabling large areas to be surveyed accurately and cost-effectively. The methodology is based on a high-definition video camera, plus LED lights and laser scale markers, mounted on a "flying array" that maintains itself above the seabed grounded by a length of chain, thus causing minimal damage. Samples are taken by slow-speed tows of the gear behind a boat (200 m transects). The HD video and randomly selected frame grabs are analysed to quantify species distribution. The equipment was tested over two years in Lyme Bay, UK (25 m depth), then subsequently successfully deployed in demanding conditions at the deep (>50 m) high-energy Wave Hub site off Cornwall, UK, and a potential tidal stream energy site in Guernsey, Channel Islands (1.5 ms(-1) current), the first time remote samples from such a habitat have been achieved. The next stage in the monitoring development process is described, involving the use of Remote Operated Vehicles to survey the seabed post-deployment of MREI devices. The complete methodology provides the first quantitative, relatively non-destructive method for monitoring mixed-substrate benthic communities beneath MPAs and MREIs pre- and post-device deployment.	[Sheehan, Emma V.; Attrill, Martin J.] Univ Plymouth, Peninsula Res Inst Marine Renewable Energy PRIMaR, Inst Marine, Plymouth PL4 8AA, Devon, England; [Stevens, Timothy F.] Griffith Univ, Griffith Sch Environm, Gold Coast, Qld, Australia; [Stevens, Timothy F.] Griffith Univ, Australian Rivers Inst Coasts & Estuaries, Gold Coast, Qld, Australia	University of Plymouth; Griffith University; Griffith University	Sheehan, EV (corresponding author), Univ Plymouth, Peninsula Res Inst Marine Renewable Energy PRIMaR, Inst Marine, Plymouth PL4 8AA, Devon, England.	mattrill@plymouth.ac.uk	Langhamer, Olivia/J-3425-2012	Sheehan, Emma/0000-0002-1066-8237; Attrill, Martin/0000-0002-4039-031X	Defra; South West Regional Development Agency in the UK; EU	Defra(Department for Environment, Food & Rural Affairs (DEFRA)); South West Regional Development Agency in the UK; EU(European Commission)	Support for this work was provided through two major projects funded by Defra, the South West Regional Development Agency in the UK and the EU European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funds provided allowed staff to be employed and equipment purchased.	Barker BAJ, 1999, CONT SHELF RES, V19, P1161, DOI 10.1016/S0278-4343(99)00017-5; Bax NJ, 2001, MAR FRESHWATER RES, V52, P491, DOI 10.1071/MF00003; BERKELMANS R, 1992, REEF RES, V2, P10; Cailliet GM, 1999, OCEANOL ACTA, V22, P579, DOI 10.1016/S0399-1784(00)88949-5; CARLETON JH, 1995, CORAL REEFS, V14, P35, DOI 10.1007/BF00304070; *CSIRO, 1994, COMM AUSTR, V2, P773; *DECC, 2009, OFFSH EN SEA ENV REP; Freitas R, 2003, ICES J MAR SCI, V60, P599, DOI 10.1016/S1054-3139(03)00061-4; Goff JA, 1999, MAR GEOL, V154, P255, DOI 10.1016/S0025-3227(98)00117-0; Holme N. A., 1985, UNDERWATER PHOTOGRAP, P88; Inger R, 2009, J APPL ECOL, V46, P1145, DOI 10.1111/j.1365-2664.2009.01697.x; Parry DM, 2003, J EXP MAR BIOL ECOL, V285, P497, DOI 10.1016/S0022-0981(02)00546-4; Rees SE, 2010, OCEAN COAST MANAGE, V53, P135, DOI 10.1016/j.ocecoaman.2010.01.011; Sinden G, 2005, WIND POWER UK WIND R; Sinden G, 2007, ENERG POLICY, V35, P112, DOI 10.1016/j.enpol.2005.10.003; Stevens T, 2005, MAR FRESHWATER RES, V56, P111, DOI 10.1071/MF04233; Stevens T, 2005, MAR BIOL, V146, P345, DOI 10.1007/s00227-004-1454-z; Stevens T, 2004, BIOL CONSERV, V119, P351, DOI 10.1016/j.biocon.2003.12.001; STEVENS TF, 2003, THESIS GRIFFITH U; Stobart B, 2007, J EXP MAR BIOL ECOL, V345, P158, DOI 10.1016/j.jembe.2007.02.009; *UK HL, 2008, 27 REP SESS 2007 08, V1; [No title captured]	22	53	53	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e14461	10.1371/journal.pone.0014461	http://dx.doi.org/10.1371/journal.pone.0014461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206748	Green Published, Green Submitted, gold			2022-12-27	WOS:000285793200014
J	Flemming, JM; Jonsen, ID; Myers, RA; Field, CA				Flemming, Joanna Mills; Jonsen, Ian D.; Myers, Ransom A.; Field, Christopher A.			Hierarchical State-Space Estimation of Leatherback Turtle Navigation Ability	PLOS ONE			English	Article							SEA-TURTLES; DERMOCHELYS-CORIACEA; OCEAN; MIGRATION; MOVEMENTS; BEHAVIOR	Remotely sensed tracking technology has revealed remarkable migration patterns that were previously unknown; however, models to optimally use such data have developed more slowly. Here, we present a hierarchical Bayes state-space framework that allows us to combine tracking data from a collection of animals and make inferences at both individual and broader levels. We formulate models that allow the navigation ability of animals to be estimated and demonstrate how information can be combined over many animals to allow improved estimation. We also show how formal hypothesis testing regarding navigation ability can easily be accomplished in this framework. Using Argos satellite tracking data from 14 leatherback turtles, 7 males and 7 females, during their southward migration from Nova Scotia, Canada, we find that the circle of confusion (the radius around an animal's location within which it is unable to determine its location precisely) is approximately 96 km. This estimate suggests that the turtles' navigation does not need to be highly accurate, especially if they are able to use more reliable cues as they near their destination. Moreover, for the 14 turtles examined, there is little evidence to suggest that male and female navigation abilities differ. Because of the minimal assumptions made about the movement process, our approach can be used to estimate and compare navigation ability for many migratory species that are able to carry electronic tracking devices.	[Flemming, Joanna Mills; Field, Christopher A.] Dalhousie Univ, Dept Math & Stat, Halifax, NS, Canada; [Jonsen, Ian D.; Myers, Ransom A.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	Dalhousie University; Dalhousie University	Flemming, JM (corresponding author), Dalhousie Univ, Dept Math & Stat, Halifax, NS, Canada.	joanna.flemming@dal.ca		Jonsen, Ian/0000-0001-5423-6076; Mills Flemming, Joanna/0000-0002-3517-3089	National Science and Engineering Research Council; Sloan Foundation; Future of Marine Animal Populations	National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Sloan Foundation(Alfred P. Sloan Foundation); Future of Marine Animal Populations	This work was supported by National Science and Engineering Research Council (www.nserc.ca) funding to JMF, RAM and CAF; by Sloan (www.sloan.org) Foundation funding to RAM AND IDJ; and by Future of Marine Animal Populations (www.fmap.ca) funding to all authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrowman NJ, 2003, AM STAT, V57, P268, DOI 10.1198/0003130032369; Block BA, 2002, OCEANOL ACTA, V25, P255, DOI 10.1016/S0399-1784(02)01212-4; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Brillinger DR, 1998, CAN J STAT, V26, P431, DOI 10.2307/3315767; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; Efron B, 1996, J AM STAT ASSOC, V91, P538, DOI 10.2307/2291646; Flemming JEM, 2006, ENVIRONMETRICS, V17, P351, DOI 10.1002/env.774; Gelfand AE, 1998, BIOMETRIKA, V85, P1, DOI 10.1093/biomet/85.1.1; Gelman A., 2004, BAYESIAN DATA ANAL; Gelman A., 1006, BAYESIAN ANAL, V1, P515, DOI [10.1214/06-BA117AQ6, DOI 10.1214/06-BA117AQ6]; Girard C, 2006, MAR ECOL PROG SER, V322, P281, DOI 10.3354/meps322281; Hays GC, 2004, NATURE, V429, P522, DOI 10.1038/429522a; Hurford A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005632; IUCN, 2004, IUCN RED LIST THREAT; James MC, 2005, MAR BIOL, V147, P845, DOI 10.1007/s00227-005-1581-1; James MC, 2005, P ROY SOC B-BIOL SCI, V272, P1547, DOI 10.1098/rspb.2005.3110; Jonsen ID, 2003, ECOLOGY, V84, P3055, DOI 10.1890/02-0670; KENDALL DG, 1974, J R STAT SOC B, V36, P365; Lewis JS, 2007, J APPL ECOL, V44, P663, DOI 10.1111/j.1365-2664.2007.01286.x; Lohmann KJ, 2008, J EXP BIOL, V211, P1719, DOI 10.1242/jeb.015792; Lohmann KJ, 2004, NATURE, V428, P909, DOI 10.1038/428909a; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Luschi P, 2003, P ROY SOC B-BIOL SCI, V270, pS129, DOI 10.1098/rsbl.2003.0036; Luschi P, 2001, BEHAV ECOL SOCIOBIOL, V50, P528, DOI 10.1007/s002650100396; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; ROUSSEEUW PJ, 1984, J AM STAT ASSOC, V79, P871, DOI 10.2307/2288718; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Sherrill-Mix SA, 2008, BEHAV ECOL, V19, P231, DOI 10.1093/beheco/arm104; Simons AM, 2004, TRENDS ECOL EVOL, V19, P453, DOI 10.1016/j.tree.2004.07.001; Thorup K, 2003, P ROY SOC B-BIOL SCI, V270, pS8, DOI 10.1098/rsbl.2003.0014; Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x	31	19	19	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14245	10.1371/journal.pone.0014245	http://dx.doi.org/10.1371/journal.pone.0014245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203382	gold, Green Published			2022-12-27	WOS:000285792500001
J	Lin, TL; Wang, QJH; Brown, P; Peacock, C; Merchant, AA; Brennan, S; Jones, E; McGovern, K; Watkins, DN; Sakamoto, KM; Matsui, W				Lin, Tara L.; Wang, Qiuju H.; Brown, Patrick; Peacock, Craig; Merchant, Akil A.; Brennan, Sarah; Jones, Evan; McGovern, Karen; Watkins, D. Neil; Sakamoto, Kathleen M.; Matsui, William			Self-Renewal of Acute Lymphocytic Leukemia Cells Is Limited by the Hedgehog Pathway Inhibitors Cyclopamine and IPI-926	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; STEM-CELLS; ALDEHYDE DEHYDROGENASE; HUMAN HOMOLOG; PROGENITORS; GROWTH; SURVIVAL; IDENTIFICATION; REQUIREMENT; COMPARTMENT	Conserved embryonic signaling pathways such as Hedgehog (Hh), Wingless and Notch have been implicated in the pathogenesis of several malignancies. Recent data suggests that Hh signaling plays a role in normal B-cell development, and we hypothesized that Hh signaling may be important in precursor B-cell acute lymphocytic leukemia (B-ALL). We found that the expression of Hh pathway components was common in human B-ALL cell lines and clinical samples. Moreover, pathway activity could be modulated by Hh ligand or several pathway inhibitors including cyclopamine and the novel SMOOTHENED (SMO) inhibitor IPI-926. The inhibition of pathway activity primarily impacted highly clonogenic B-ALL cells expressing aldehyde dehydrogenase (ALDH) by limiting their self-renewal potential both in vitro and in vivo. These data demonstrate that Hh pathway activation is common in B-ALL and represents a novel therapeutic target regulating self-renewal and persistence of the malignant clone.	[Lin, Tara L.] LSU Hlth Sci Ctr, Dept Internal Med, Sect Hematol & Oncol, New Orleans, LA USA; [Wang, Qiuju H.; Brown, Patrick; Peacock, Craig; Merchant, Akil A.; Brennan, Sarah; Jones, Evan; Watkins, D. Neil; Matsui, William] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [McGovern, Karen] Infin Pharmaceut, Cambridge, MA USA; [Sakamoto, Kathleen M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Gwynne Hazen Cherry Mem Labs,Jonsson Comprehens C, Los Angeles, CA 90095 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Johns Hopkins University; Johns Hopkins Medicine; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lin, TL (corresponding author), LSU Hlth Sci Ctr, Dept Internal Med, Sect Hematol & Oncol, New Orleans, LA USA.	tlin@lsuhsc.edu; matsuwi@jhmi.edu	Watkins, David N/I-6113-2013	Matsui, William/0000-0002-3088-0964; Sakamoto, Kathleen/0000-0003-0494-8838; Lin, Tara/0000-0002-0242-6449	American Society of Clinical Oncology Foundation; National Institutes of Health [T32HL086345, R01CA127574, P01CA15396]; Gabrielle's Angel Foundation for Cancer Research; Sidney Kimmel Foundation for Cancer Research; Leukemia and Lymphoma Society; NIH [HL75826, HL83077]; St. Baldrick's Foundation; William Lawrence and Blanche Hughes Foundation; Abbott Laboratories; Genentech, Inc.; NATIONAL CANCER INSTITUTE [R01CA127574, P01CA015396] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL086345, R01HL083077, R01HL075826] Funding Source: NIH RePORTER	American Society of Clinical Oncology Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gabrielle's Angel Foundation for Cancer Research; Sidney Kimmel Foundation for Cancer Research; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Baldrick's Foundation; William Lawrence and Blanche Hughes Foundation; Abbott Laboratories(Abbott Laboratories); Genentech, Inc.(Roche HoldingGenentech); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	T.L.L. was supported by grants from the American Society of Clinical Oncology Foundation and National Institutes of Health T32HL086345. W. M. is supported by the National Institutes of Health R01CA127574, P01CA15396, the Gabrielle's Angel Foundation for Cancer Research, the Sidney Kimmel Foundation for Cancer Research, and the Leukemia and Lymphoma Society. K.M.S. is supported by NIH grants HL75826, HL83077, St. Baldrick's Foundation, William Lawrence and Blanche Hughes Foundation, and a grant from Abbott Laboratories, and Genentech, Inc. W.M. and K.M.S. are Scholars of the Leukemia and Lymphoma Society. K.M. is an employee of Infinity Pharmaceuticals. K. M. and Infinity Pharmaceuticals were involved in the design of the in vivo studies and preparation of the manuscript. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Cobaleda C, 2000, BLOOD, V95, P1007, DOI 10.1182/blood.V95.3.1007.003k35_1007_1013; Corti S, 2006, STEM CELLS, V24, P975, DOI 10.1634/stemcells.2005-0217; Dierks C, 2008, CANCER CELL, V14, P238, DOI 10.1016/j.ccr.2008.08.003; Dierks C, 2007, NAT MED, V13, P944, DOI 10.1038/nm1614; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hess DA, 2004, BLOOD, V104, P1648, DOI 10.1182/blood-2004-02-0448; Hotfilder M, 2005, CANCER RES, V65, P1442, DOI 10.1158/0008-5472.CAN-04-1356; Hotfilder M, 2002, BLOOD, V100, P640, DOI 10.1182/blood.V100.2.640; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Ji ZY, 2007, J BIOL CHEM, V282, P37370, DOI 10.1074/jbc.M703697200; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Jones RJ, 2009, BLOOD, V113, P5920, DOI 10.1182/blood-2008-11-189688; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; KASTAN MB, 1990, BLOOD, V75, P1947; Kawahara T, 2009, ANTICANCER RES, V29, P4629; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Matsui W, 2008, CANCER RES, V68, P190, DOI 10.1158/0008-5472.CAN-07-3096; Merchant AA, 2010, CLIN CANCER RES, V16, P3130, DOI 10.1158/1078-0432.CCR-09-2846; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Peacock CD, 2007, P NATL ACAD SCI USA, V104, P4048, DOI 10.1073/pnas.0611682104; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Siggins SL, 2009, BLOOD, V114, P995, DOI 10.1182/blood-2009-03-208330; Singh RR, 2010, LEUKEMIA, V24, P1025, DOI 10.1038/leu.2010.35; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Storms RW, 1999, P NATL ACAD SCI USA, V96, P9118, DOI 10.1073/pnas.96.16.9118; Theunissen JW, 2009, CANCER RES, V69, P6007, DOI 10.1158/0008-5472.CAN-09-0756; Tian H, 2009, P NATL ACAD SCI USA, V106, P4254, DOI 10.1073/pnas.0813203106; Tremblay MR, 2008, J MED CHEM, V51, P6646, DOI 10.1021/jm8008508; Uhmann A, 2007, BLOOD, V110, P1814, DOI 10.1182/blood-2007-02-075648; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Warzecha J, 2008, LEUKEMIA LYMPHOMA, V49, P2383, DOI 10.1080/10428190802510315; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737	47	62	76	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15262	10.1371/journal.pone.0015262	http://dx.doi.org/10.1371/journal.pone.0015262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203400	Green Published, Green Submitted, gold			2022-12-27	WOS:000285792500027
J	Lourenco, R; Lopes, SS; Saude, L				Lourenco, Raquel; Lopes, Susana S.; Saude, Leonor			Left-Right Function of dmrt2 Genes Is Not Conserved between Zebrafish and Mouse	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; SEGMENTATION CLOCK; NODAL EXPRESSION; BILATERAL SYMMETRY; VERTEBRATE EMBRYOS; NOTCH; SOMITOGENESIS; DOMAIN; AXIS; ESTABLISHMENT	Background: Members of the Dmrt family, generally associated with sex determination, were shown to be involved in several other functions during embryonic development. Dmrt2 has been studied in the context of zebrafish development where, due to a duplication event, two paralog genes dmrt2a and dmrt2b are present. Both zebrafish dmrt2a/terra and dmrt2b are important to regulate left-right patterning in the lateral plate mesoderm. In addition, dmrt2a/terra is necessary for symmetric somite formation while dmrt2b regulates somite differentiation impacting on slow muscle development. One dmrt2 gene is also expressed in the mouse embryo, where it is necessary for somite differentiation but with an impact on axial skeleton development. However, nothing was known about its role during left-right patterning in the lateral plate mesoderm or in the symmetric synchronization of somite formation. Methodology/Principal Findings: Using a dmrt2 mutant mouse line, we show that this gene is not involved in symmetric somite formation and does not regulate the laterality pathway that controls left-right asymmetric organ positioning. We reveal that dmrt2a/terra is present in the zebrafish laterality organ, the Kupffer's vesicle, while its homologue is excluded from the mouse equivalent structure, the node. On the basis of evolutionary sub-functionalization and neo-functionalization theories we discuss this absence of functional conservation. Conclusions/Significance: Our results show that the role of dmrt2 gene is not conserved during zebrafish and mouse embryonic development.	[Lourenco, Raquel; Lopes, Susana S.; Saude, Leonor] Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal; [Lourenco, Raquel; Lopes, Susana S.; Saude, Leonor] Univ Lisbon, Fac Med, Inst Histol & Biol Desenvolvimento, P-1699 Lisbon, Portugal; [Lourenco, Raquel; Lopes, Susana S.; Saude, Leonor] Inst Gulbenkian Ciencias, Oeiras, Portugal	Universidade de Lisboa; Universidade de Lisboa; Instituto Gulbenkian de Ciencia	Lourenco, R (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal.	msaude@fm.ul.pt	Lopes, Susana/AAB-3820-2019; Saúde, Leonor/D-2720-2012	Saúde, Leonor/0000-0001-5933-8872; Lopes, Susana/0000-0002-6733-6356; Lourenco, Raquel/0000-0002-6176-3066	Fundacao para a Ciencia e a Technologia (FCT) [PTDC/SAU-OBD/71596/2006, PTDC/SAU-OBD/64628/2006]	Fundacao para a Ciencia e a Technologia (FCT)(Portuguese Foundation for Science and Technology)	Two Fundacao para a Ciencia e a Technologia (FCT) (http://alfa.fct.mctes.pt) grants PTDC/SAU-OBD/71596/2006 and PTDC/SAU-OBD/64628/2006 supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade Raquel P., 2007, Birth Defects Research, V81, P65, DOI 10.1002/bdrc.20094; Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; Brend T, 2009, SEMIN CELL DEV BIOL, V20, P472, DOI 10.1016/j.semcdb.2008.11.009; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Dequeant ML, 2006, SCIENCE, V314, P1595, DOI 10.1126/science.1133141; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Force A, 1999, GENETICS, V151, P1531; Forsberg H, 1998, CURR BIOL, V8, P1027, DOI 10.1016/S0960-9822(07)00424-1; Goldbeter A, 2008, J THEOR BIOL, V252, P574, DOI 10.1016/j.jtbi.2008.01.006; Gourronc F, 2007, DEV DYNAM, V236, P2131, DOI 10.1002/dvdy.21249; Hong CS, 2007, DEV BIOL, V310, P1, DOI 10.1016/j.ydbio.2007.07.035; Isaac A, 1997, SCIENCE, V275, P1301, DOI 10.1126/science.275.5304.1301; Kanzler B, 1998, DEVELOPMENT, V125, P2587; Kawakami Y, 2005, NATURE, V435, P165, DOI 10.1038/nature03512; Kim SS, 2003, GENE EXPR PATTERNS, V3, P77, DOI 10.1016/S1567-133X(02)00071-6; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Krebs LT, 2003, GENE DEV, V17, P1207, DOI 10.1101/gad.1084703; Liu S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007261; Lourenco R, 2010, SYMMETRY-BASEL, V2, P1033, DOI 10.3390/sym2021033; Meng AM, 1999, DEVELOPMENT, V126, P1259; Meyers EN, 1999, SCIENCE, V285, P403, DOI 10.1126/science.285.5426.403; Minowada G, 1999, DEVELOPMENT, V126, P4465; Morales AV, 2007, EMBO REP, V8, P104, DOI 10.1038/sj.embor.7400867; Nakaya MA, 2005, DEVELOPMENT, V132, P5425, DOI 10.1242/dev.02149; Raya A, 2003, GENE DEV, V17, P1213, DOI 10.1101/gad.1084403; Saude L, 2005, NAT CELL BIOL, V7, P918, DOI 10.1038/ncb1294; Schilling TF, 1999, DEV BIOL, V210, P277, DOI 10.1006/dbio.1999.9214; Seo KW, 2006, DEV BIOL, V290, P200, DOI 10.1016/j.ydbio.2005.11.027; Sirbu IO, 2006, NAT CELL BIOL, V8, P271, DOI 10.1038/ncb1374; Tabin CJ, 2006, CELL, V127, P27, DOI 10.1016/j.cell.2006.09.018; Takeuchi JK, 2007, P NATL ACAD SCI USA, V104, P846, DOI 10.1073/pnas.0608118104; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Vermot J, 2005, SCIENCE, V308, P563, DOI 10.1126/science.1108363; Vermot J, 2005, NATURE, V435, P215, DOI 10.1038/nature03488; Vilhais-Neto GC, 2010, NATURE, V463, P953, DOI 10.1038/nature08763; Volff JN, 2003, J MOL EVOL, V57, pS241, DOI 10.1007/s00239-003-0033-0; Yoshioka H, 1998, CELL, V94, P299, DOI 10.1016/S0092-8674(00)81473-7; Zhou X, 2008, BIOCHIMIE, V90, P878, DOI 10.1016/j.biochi.2008.02.021	41	24	26	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14438	10.1371/journal.pone.0014438	http://dx.doi.org/10.1371/journal.pone.0014438			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203428	Green Published, gold, Green Submitted			2022-12-27	WOS:000285792500014
J	Thomassen, GOS; Weel-Sneve, R; Rowe, AD; Booth, JA; Lindvall, JM; Lagesen, K; Kristiansen, KI; Bjoras, M; Rognes, T				Thomassen, Gard O. S.; Weel-Sneve, Ragnhild; Rowe, Alexander D.; Booth, James A.; Lindvall, Jessica M.; Lagesen, Karin; Kristiansen, Knut I.; Bjoras, Magnar; Rognes, Torbjorn			Tiling Array Analysis of UV Treated Escherichia coli Predicts Novel Differentially Expressed Small Peptides	PLOS ONE			English	Article							OLIGONUCLEOTIDE ARRAYS; COMPARATIVE GENOMICS; NONCODING RNAS; BINDING-SITES; GENES; K-12; LEXA; RESOLUTION; DAMAGE; IDENTIFICATION	Background: Despite comprehensive investigation, the Escherichia coli SOS response system is not yet fully understood. We have applied custom designed whole genome tiling arrays to measure UV invoked transcriptional changes in E. coli. This study provides a more complete insight into the transcriptome and the UV irradiation response of this microorganism. Results: We detected a number of novel differentially expressed transcripts in addition to the expected SOS response genes (such as sulA, recN, uvrA, lexA, umuC and umuD) in the UV treated cells. Several of the differentially expressed transcripts might play important roles in regulation of the cellular response to UV damage. We have predicted 23 novel small peptides from our set of detected non-gene transcripts. Further, three of the predicted peptides were cloned into protein expression vectors to test the biological activity. All three constructs expressed the predicted peptides, in which two of them were highly toxic to the cell. Additionally, a remarkably high overlap with previously in-silico predicted non-coding RNAs (ncRNAs) was detected. Generally we detected a far higher transcriptional activity than the annotation suggests, and these findings correspond with previous transcription mappings from E. coli and other organisms. Conclusions: Here we demonstrate that the E. coli transcriptome consists of far more transcripts than the present annotation suggests, of which many transcripts seem important to the bacterial stress response. Sequence alignment of promoter regions suggest novel regulatory consensus sequences for some of the upregulated genes. Finally, several of the novel transcripts identified in this study encode putative small peptides, which are biologically active.	[Thomassen, Gard O. S.; Weel-Sneve, Ragnhild; Rowe, Alexander D.; Booth, James A.; Lagesen, Karin; Kristiansen, Knut I.; Bjoras, Magnar; Rognes, Torbjorn] Oslo Univ Hosp, Rikshosp, CMBN, Oslo, Norway; [Thomassen, Gard O. S.; Weel-Sneve, Ragnhild; Rowe, Alexander D.; Booth, James A.; Lagesen, Karin; Kristiansen, Knut I.; Bjoras, Magnar; Rognes, Torbjorn] Oslo Univ Hosp, Rikshosp, Dept Microbiol, Oslo, Norway; [Thomassen, Gard O. S.; Weel-Sneve, Ragnhild; Lagesen, Karin; Bjoras, Magnar] Univ Oslo, CMBN, Oslo, Norway; [Thomassen, Gard O. S.; Weel-Sneve, Ragnhild; Lagesen, Karin; Bjoras, Magnar] Univ Oslo, Dept Microbiol, Oslo, Norway; [Lindvall, Jessica M.; Rognes, Torbjorn] Univ Oslo, Dept Informat, N-0316 Oslo, Norway; [Bjoras, Magnar] Univ Oslo, Inst Clin Biochem, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Thomassen, GOS (corresponding author), Oslo Univ Hosp, Rikshosp, CMBN, Oslo, Norway.	torognes@ifi.uio.no	Rognes, Torbjørn/A-9692-2008; Lindvall, Jessica M/A-1762-2013; Bjørås, Magnar/N-9286-2017	Rognes, Torbjørn/0000-0002-9329-9974; Thomassen, Gard Olav Sundby/0000-0002-6979-8474; Lagesen, Karin/0000-0003-1329-9032; Booth, James/0000-0001-9452-3424; Lindvall, Jessica/0000-0002-5042-8481	Research Council of Norway (FUGE), Oslo University Hospital, University of Oslo; European Union	Research Council of Norway (FUGE), Oslo University Hospital, University of Oslo(Research Council of Norway); European Union(European Commission)	The study was funded by the Research Council of Norway (FUGE), Oslo University Hospital, University of Oslo and the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; BERG OG, 1988, NUCLEIC ACIDS RES, V16, P5089, DOI 10.1093/nar/16.11.5089; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Carter RJ, 2001, NUCLEIC ACIDS RES, V29, P3928, DOI 10.1093/nar/29.19.3928; Chen S, 2002, BIOSYSTEMS, V65, P157, DOI 10.1016/S0303-2647(02)00013-8; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Courcelle J, 2001, GENETICS, V158, P41; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; de Saizieu A, 1998, NAT BIOTECHNOL, V16, P45, DOI 10.1038/nbt0198-45; DEWITT SK, 1962, GENETICS, V47, P577; Fernandez de Henestrosa AR, 2000, MOL MICROBIOL, V35, P1560, DOI 10.1046/j.1365-2958.2000.01826.x; Fischer D, 1998, J BACTERIOL, V180, P6203; FRIEDBERG EC, 2006, AM SOC MICROBIOL, P463; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; Gene Expression Omnibus, GENE EXPRESSION OMNI; GIBERT I, 1990, MOL GEN GENET, V220, P400, DOI 10.1007/BF00391745; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; GUYER MS, 1980, COLD SPRING HARB SYM, V45, P135, DOI 10.1101/SQB.1981.045.01.022; Hemm MR, 2010, J BACTERIOL, V192, P46, DOI 10.1128/JB.00872-09; Hemm MR, 2008, MOL MICROBIOL, V70, P1487, DOI 10.1111/j.1365-2958.2008.06495.x; Hengge-Aronis R, 1999, CURR OPIN MICROBIOL, V2, P148, DOI 10.1016/S1369-5274(99)80026-5; Hershberg R, 2003, NUCLEIC ACIDS RES, V31, P1813, DOI 10.1093/nar/gkg297; JENSEN KF, 1993, J BACTERIOL, V175, P3401, DOI 10.1128/jb.175.11.3401-3407.1993; Jorgensen F, 1999, MICROBIOL-UK, V145, P835, DOI 10.1099/13500872-145-4-835; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Khil PP, 2002, MOL MICROBIOL, V44, P89, DOI 10.1046/j.1365-2958.2002.02878.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KRUEGER JH, 1983, J BACTERIOL, V153, P1368, DOI 10.1128/JB.153.3.1368-1378.1983; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; LEWIS LK, 1994, J MOL BIOL, V241, P507, DOI 10.1006/jmbi.1994.1528; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; MOUNT DW, 1972, J BACTERIOL, V112, P886, DOI 10.1128/JB.112.2.886-893.1972; Norris V, 2007, MICROBIOL MOL BIOL R, V71, P230, DOI 10.1128/MMBR.00035-06; Perocchi F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm683; Rivas E, 2001, CURR BIOL, V11, P1369, DOI 10.1016/S0960-9822(01)00401-8; Royce TE, 2007, BIOINFORMATICS, V23, P988, DOI 10.1093/bioinformatics/btm052; Saetrom P, 2005, NUCLEIC ACIDS RES, V33, P3263, DOI 10.1093/nar/gki644; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Thomassen GOS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005943; Tjaden B, 2002, NUCLEIC ACIDS RES, V30, P3732, DOI 10.1093/nar/gkf505; Tjaden Brian, 2002, Bioinformatics, V18 Suppl 1, pS337; Vogel J, 2004, CURR BIOL, V14, P2271, DOI 10.1016/j.cub.2004.12.003; WALKER GC, 1984, MICROBIOL REV, V48, P60, DOI 10.1128/MMBR.48.1.60-93.1984; Weel-Sneve R, 2008, NUCLEIC ACIDS RES, V36, P6249, DOI 10.1093/nar/gkn633; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Zhu H, 1998, P NATL ACAD SCI USA, V95, P14470, DOI 10.1073/pnas.95.24.14470	49	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15356	10.1371/journal.pone.0015356	http://dx.doi.org/10.1371/journal.pone.0015356			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203457	Green Published, Green Submitted, gold			2022-12-27	WOS:000285579200019
J	Bernardi, E; Deflorian, G; Pezzinenti, F; Diaz, VM; Mione, M; Blasi, F				Bernardi, Elisa; Deflorian, Gianluca; Pezzinenti, Federica; Diaz, Victor M.; Mione, Marina; Blasi, Francesco			Characterization of the Regulatory Region of the Zebrafish Prep1.1 Gene: Analogies to the Promoter of the Human PREP1	PLOS ONE			English	Article							EXPRESSION; PROTEINS; PBX; TRANSCRIPTION; MOUSE; CELLS; HOX; RHOMBOMERE-4; SENSITIVITY; MECHANISM	Prep1 is a developmentally essential TALE class homeodomain transcription factor. In zebrafish and mouse, Prep1 is already ubiquitously expressed at the earliest stages of development, with important tissue-specific peculiarities. The Prep1 gene in mouse is developmentally essential and has haploinsufficient tumor suppressor activity [ 1]. We have determined the human Prep1 transcription start site (TSS) by primer extension analysis and identified, within 20 bp, the transcription start region (TSR) of the zebrafish Prep1.1 promoter. The functions of the zebrafish 59 upstream sequences were analyzed both by transient transfections in Hela Cells and by injection in zebrafish embryos. This analysis revealed a complex promoter with regulatory sequences extending up to -1.8, possibly -5.0 Kb, responsible for tissue specific expression. Moreover, the first intron contains a conserved tissue-specific enhancer both in zebrafish and in human cells. Finally, a two nucleotides mutation of an EGR-1 site, conserved in all species including human and zebrafish and located at a short distance from the TSS, destroyed the promoter activity of the -5.0 Kb promoter. A transgenic fish expressing GFP under the 21.8 Kb zebrafish promoter/enhancer co-expressed GFP and endogenous Prep1.1 during embryonic development. In the adult fish, GFP was expressed in hematopoietic regions like the kidney, in agreement with the essential function of Prep1 in mouse hematopoiesis. Sequence comparison showed conservation from man to fish of the sequences around the TSS, within the first intron enhancer. Moreover, about 40% of the sequences spread throughout the 5 Kbof the zebrafish promoter are concentrated in the -3 to -5 Kb of the human upstream region.	[Bernardi, Elisa; Deflorian, Gianluca; Pezzinenti, Federica; Mione, Marina; Blasi, Francesco] IFOM FIRC Inst Mol Oncol Fdn, Milan, Italy; [Diaz, Victor M.; Blasi, Francesco] Univ Vita Salute San Raffaele, Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; Vita-Salute San Raffaele University	Bernardi, E (corresponding author), IFOM FIRC Inst Mol Oncol Fdn, Milan, Italy.	blasi.francesco@hsr.it	Mione, Maria Caterina/I-3073-2013; Mione, Maria Caterina/ABG-9926-2021; Díaz, Víctor Manuel/F-5013-2016	Díaz, Víctor Manuel/0000-0001-8561-7576; Mione, Maria Caterina/0000-0002-9040-3705; Blasi, Francesco/0000-0001-9406-1784	AIRC (Italian Association for Cancer Research); Telethon Onlus; Italian Ministry of Health	AIRC (Italian Association for Cancer Research)(Fondazione AIRC per la ricerca sul cancro); Telethon Onlus(Fondazione Telethon); Italian Ministry of Health(Ministry of Health, Italy)	This work was funded by grants from AIRC (Italian Association for Cancer Research), Telethon Onlus and the Italian Ministry of Health, to FB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthelsen J, 1998, EMBO J, V17, P1423, DOI 10.1093/emboj/17.5.1423; Costagli A, 2002, J COMP NEUROL, V450, P73, DOI 10.1002/cne.10292; Deflorian G, 2004, DEVELOPMENT, V131, P613, DOI 10.1242/dev.00948; DETRICH HW, 1995, P NATL ACAD SCI USA, V92, P10713, DOI 10.1073/pnas.92.23.10713; Di Rosa P, 2007, DEV BIOL, V311, P324, DOI 10.1016/j.ydbio.2007.08.031; Fernandez-Diaz LC, 2010, DEVELOPMENT, V137, P3393, DOI 10.1242/dev.050567; Ferrai C, 2009, MOL BIOL CELL, V20, P3543, DOI 10.1091/mbc.E09-02-0114; Ferretti E, 2000, DEVELOPMENT, V127, P155; Ferretti E, 2005, MOL CELL BIOL, V25, P8541, DOI 10.1128/MCB.25.19.8541-8552.2005; Ferretti E, 1999, MECH DEVELOP, V83, P53, DOI 10.1016/S0925-4773(99)00031-3; Ferretti E, 2006, MOL CELL BIOL, V26, P5650, DOI 10.1128/MCB.00313-06; Jacobs Y, 1999, MOL CELL BIOL, V19, P5134, DOI 10.1128/mcb.19.7.5134; Kawakami K, 2000, P NATL ACAD SCI USA, V97, P11403, DOI 10.1073/pnas.97.21.11403; Manzanares M, 2001, DEVELOPMENT, V128, P3595; Micali N, 2010, NUCLEIC ACIDS RES, V38, P3595, DOI 10.1093/nar/gkq019; Micali N, 2009, MOL CELL BIOL, V29, P1143, DOI 10.1128/MCB.01273-08; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; OBARDI E, 2010, MOL ONCOLOGY, V4, P226; Oriente F, 2008, MOL CELL BIOL, V28, P5634, DOI 10.1128/MCB.00117-08; Penkov D, 2005, MOL CELL BIOL, V25, P10768, DOI 10.1128/MCB.25.24.10768-10781.2005; Ryoo HD, 1999, DEVELOPMENT, V126, P5137; THISSE C, 1993, DEVELOPMENT, V119, P1203; Tumpel S, 2007, DEV BIOL, V302, P646, DOI 10.1016/j.ydbio.2006.10.029; Vaccari E, 2010, DEV BIOL, V343, P94, DOI 10.1016/j.ydbio.2010.04.016; Westerfield M, 2007, ZEBRAFISH BOOK	25	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15047	10.1371/journal.pone.0015047	http://dx.doi.org/10.1371/journal.pone.0015047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203543	Green Submitted, Green Published, gold			2022-12-27	WOS:000285578000019
J	Kaptchuk, TJ; Friedlander, E; Kelley, JM; Sanchez, MN; Kokkotou, E; Singer, JP; Kowalczykowski, M; Miller, FG; Kirsch, I; Lembo, AJ				Kaptchuk, Ted J.; Friedlander, Elizabeth; Kelley, John M.; Sanchez, M. Norma; Kokkotou, Efi; Singer, Joyce P.; Kowalczykowski, Magda; Miller, Franklin G.; Kirsch, Irving; Lembo, Anthony J.			Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome	PLOS ONE			English	Article							QUALITY-OF-LIFE; CLINICAL-TRIALS; END-POINT; VALIDATION; BLIND	Background: Placebo treatment can significantly influence subjective symptoms. However, it is widely believed that response to placebo requires concealment or deception. We tested whether open-label placebo (non-deceptive and non-concealed administration) is superior to a no-treatment control with matched patient-provider interactions in the treatment of irritable bowel syndrome (IBS). Methods: Two-group, randomized, controlled three week trial (August 2009-April 2010) conducted at a single academic center, involving 80 primarily female (70%) patients, mean age 47 +/- 18 with IBS diagnosed by Rome III criteria and with a score >= 150 on the IBS Symptom Severity Scale (IBS-SSS). Patients were randomized to either open-label placebo pills presented as "placebo pills made of an inert substance, like sugar pills, that have been shown in clinical studies to produce significant improvement in IBS symptoms through mind-body self-healing processes" or no-treatment controls with the same quality of interaction with providers. The primary outcome was IBS Global Improvement Scale (IBS-GIS). Secondary measures were IBS Symptom Severity Scale (IBS-SSS), IBS Adequate Relief (IBS-AR) and IBS Quality of Life (IBS-QoL). Findings: Open-label placebo produced significantly higher mean (+/- SD) global improvement scores (IBS-GIS) at both 11-day midpoint (5.2 +/- 1.0 vs. 4.0 +/- 1.1, p<.001) and at 21-day endpoint (5.0 +/- 1.5 vs. 3.9 +/- 1.3, p = .002). Significant results were also observed at both time points for reduced symptom severity (IBS-SSS, p = .008 and p = .03) and adequate relief (IBS-AR, p = .02 and p = .03); and a trend favoring open-label placebo was observed for quality of life (IBS-QoL) at the 21-day endpoint (p = .08). Conclusion: Placebos administered without deception may be an effective treatment for IBS. Further research is warranted in IBS, and perhaps other conditions, to elucidate whether physicians can benefit patients using placebos consistent with informed consent.	[Kaptchuk, Ted J.; Friedlander, Elizabeth; Sanchez, M. Norma; Kokkotou, Efi; Kowalczykowski, Magda; Lembo, Anthony J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Kaptchuk, Ted J.; Singer, Joyce P.] Harvard Univ, Sch Med, Osher Res Ctr, Boston, MA 02215 USA; [Kelley, John M.] Endicott Coll, Dept Psychol, Beverly, MA USA; [Kelley, John M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02215 USA; [Miller, Franklin G.] NIH, Dept Bioeth, Bethesda, MD 20892 USA; [Kirsch, Irving] Univ Hull, Dept Psychol, Kingston Upon Hull HU6 7RX, N Humberside, England	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; University of Hull	Kaptchuk, TJ (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA.	ted_kaptchuk@hms.harvard.edu	Kirsch, Irving/P-9316-2019		National Center for Complementary and Alternative Medicine-NIH [K24 AT004095, R01 AT00402-01, R01AT004662]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT004662] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT000402] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [K24AT004095] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was partially supported by grant K24 AT004095, R01 AT00402-01 and R01AT004662 from National Center for Complementary and Alternative Medicine-NIH and in part from a gift from The Bernard Osher Foundation. The opinions expressed by the authors are their views alone and do not reflect the official views or policy of the National Center for Complementary and Alternative Medicine, National Institutes of Health, Public Health Service or the U.S. Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM MED ASS, 2006, 2I2006 CEJA AM MED A; Brandt LJ, 2009, AM J GASTROENTEROL, V104, pS1, DOI 10.1038/ajg.2008.122; Camilleri M, 2000, LANCET, V355, P1035, DOI 10.1016/S0140-6736(00)02033-X; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Drossman DA, 2002, GASTROENTEROLOGY, V123, P2108, DOI 10.1053/gast.2002.37095; Drossman DA, 2000, AM J GASTROENTEROL, V95, P999; DROSSMAN DA, 2009, J CLINCAL GASTROENTE; Fassler M, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-15; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Francis CY, 1997, ALIMENT PHARM THERAP, V11, P395, DOI 10.1046/j.1365-2036.1997.142318000.x; Glaser B.G., 1968, DISCOV GROUNDED THEO; Gordon S, 2003, DIGEST DIS SCI, V48, P1317, DOI 10.1023/A:1024159226274; Gralnek IM, 2000, GASTROENTEROLOGY, V119, P654, DOI 10.1053/gast.2000.16484; GRYLL SL, 1978, PSYCHOPHARMOCOLOGY, V57, P129; Hammer J, 2004, GUT, V53, P666, DOI 10.1136/gut.2003.021857; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; Hrobjartsson A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003974.pub3; Kaptchuk TJ, 2008, BMJ-BRIT MED J, V336, P999, DOI 10.1136/bmj.39524.439618.25; Kaptchuk TJ, 2009, CULT MED PSYCHIAT, V33, P382, DOI 10.1007/s11013-009-9141-7; Kaptchuk TJ, 1998, B HIST MED, V72, P389, DOI 10.1353/bhm.1998.0159; Lembo T, 2001, AM J GASTROENTEROL, V96, P2662; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Mangel AW, 1998, J INT MED RES, V26, P76, DOI 10.1177/030006059802600203; Miller FG, 2009, AM J BIOETHICS, V9, P39, DOI 10.1080/15265160903316263; Miller FG, 2009, PERSPECT BIOL MED, V52, P518, DOI 10.1353/pbm.0.0115; Novick J, 2002, ALIMENT PHARM THER, V16, P1877, DOI 10.1046/j.1365-2036.2002.01372.x; Pare P, 2006, CLIN THER, V28, P1726, DOI 10.1016/j.clinthera.2006.10.010; PARK LC, 1965, ARCH GEN PSYCHIAT, V12, P336; Patel SM, 2005, NEUROGASTROENT MOTIL, V17, P332, DOI 10.1111/j.1365-2982.2005.00650.x; Rahimi R, 2008, CLIN THER, V30, P884, DOI 10.1016/j.clinthera.2008.05.002; Saito YA, 2002, AM J GASTROENTEROL, V97, P1910; Sandler AD, 2008, CHILD CARE HLTH DEV, V34, P104, DOI 10.1111/j.1365-2214.2007.00797.x; Silverman D., 2003, COLLECTING INTERPRET, P821; Spiro HM, 1986, DOCTORS PATIENTS PLA; Thompson WG, 1999, GUT, V45, P43; Tilburt JC, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1938; VANNER SJ, 2004, GUT, V53, P666	37	519	524	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15591	10.1371/journal.pone.0015591	http://dx.doi.org/10.1371/journal.pone.0015591			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203519	Green Submitted, Green Published, gold			2022-12-27	WOS:000285578000036
J	Ince, NF; Gupta, R; Arica, S; Tewfik, AH; Ashe, J; Pellizzer, G				Ince, Nuri F.; Gupta, Rahul; Arica, Sami; Tewfik, Ahmed H.; Ashe, James; Pellizzer, Giuseppe			High Accuracy Decoding of Movement Target Direction in Non-Human Primates Based on Common Spatial Patterns of Local Field Potentials	PLOS ONE			English	Article							PREMOTOR CORTEX; MOTOR CORTEX; CORTICAL CONTROL; DISCHARGE; SIGNALS; SYNCHRONIZATION; OSCILLATIONS; ORGANIZATION; INFERENCE; NEURONS	Background: The current development of brain-machine interface technology is limited, among other factors, by concerns about the long-term stability of single-and multi-unit neural signals. In addition, the understanding of the relation between potentially more stable neural signals, such as local field potentials, and motor behavior is still in its early stages. Methodology/Principal Findings: We tested the hypothesis that spatial correlation patterns of neural data can be used to decode movement target direction. In particular, we examined local field potentials (LFP), which are thought to be more stable over time than single unit activity (SUA). Using LFP recordings from chronically implanted electrodes in the dorsal premotor and primary motor cortex of non-human primates trained to make arm movements in different directions, we made the following observations: (i) it is possible to decode movement target direction with high fidelity from the spatial correlation patterns of neural activity in both primary motor (M1) and dorsal premotor cortex (PMd); (ii) the decoding accuracy of LFP was similar to the decoding accuracy obtained with the set of SUA recorded simultaneously; (iii) directional information varied with the LFP frequency sub-band, being greater in low (0.3-4 Hz) and high (48-200 Hz) frequency bands than in intermediate bands; (iv) the amount of directional information was similar in M1 and PMd; (v) reliable decoding was achieved well in advance of movement onset; and (vi) LFP were relatively stable over a period of one week. Conclusions/Significance: The results demonstrate that the spatial correlation patterns of LFP signals can be used to decode movement target direction. This finding suggests that parameters of movement, such as target direction, have a stable spatial distribution within primary motor and dorsal premotor cortex, which may be used for brain-machine interfaces.	[Ince, Nuri F.; Gupta, Rahul; Ashe, James; Pellizzer, Giuseppe] VA Hlth Care Syst, Brain Sci Ctr, Minneapolis, MN USA; [Ince, Nuri F.; Ashe, James; Pellizzer, Giuseppe] Univ Minnesota, Dept Neurosci, Minneapolis, MN USA; [Arica, Sami] Cukurova Univ, Dept Elect & Elect Engn, Adana, Turkey; [Tewfik, Ahmed H.] Univ Minnesota, Dept Elect & Comp Engn, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Cukurova University; University of Minnesota System; University of Minnesota Twin Cities	Ince, NF (corresponding author), VA Hlth Care Syst, Brain Sci Ctr, Minneapolis, MN USA.	ashe@umn.edu; pelli001@umn.edu	Arica, Sami/A-6647-2018; Pellizzer, Giuseppe/B-7540-2017	Arica, Sami/0000-0002-3820-029X; Pellizzer, Giuseppe/0000-0002-9254-5555	Department of Veterans Affairs	Department of Veterans Affairs(US Department of Veterans Affairs)	This study was supported by Merit Review awards (JA; GP) from the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RA, 2004, CURR OPIN NEUROBIOL, V14, P720, DOI 10.1016/j.conb.2004.10.005; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Bouckaert RR, 2004, LECT NOTES ARTIF INT, V3056, P3; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Churchland MM, 2006, J NEUROSCI, V26, P3697, DOI 10.1523/JNEUROSCI.3762-05.2006; Cisek P, 2004, NATURE, V431, P993, DOI 10.1038/nature03005; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Dickey AS, 2009, J NEUROPHYSIOL, V102, P1331, DOI 10.1152/jn.90920.2008; Dietterich TG, 1994, J ARTIF INTELL RES, V2, P263; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; FISHER NI, 1983, BIOMETRIKA, V70, P327, DOI 10.1093/biomet/70.2.327; Ganguly K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000153; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Georgopoulos AP, 2007, P NATL ACAD SCI USA, V104, P11068, DOI 10.1073/pnas.0611597104; Heldman DA, 2006, IEEE T NEUR SYS REH, V14, P180, DOI 10.1109/TNSRE.2006.875549; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Ince NF, 2009, I IEEE EMBS C NEUR E, P284; KOLES Z J, 1990, Brain Topography, V2, P275, DOI 10.1007/BF01129656; Mehring C, 2003, NAT NEUROSCI, V6, P1253, DOI 10.1038/nn1158; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3968, DOI 10.1152/jn.1996.76.6.3968; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Nadeau C, 2003, MACH LEARN, V52, P239, DOI 10.1023/A:1024068626366; Naselaris T, 2005, J NEUROPHYSIOL, V93, P2318, DOI 10.1152/jn.00581.2004; Naselaris T, 2006, J NEUROPHYSIOL, V96, P3237, DOI 10.1152/jn.00488.2006; Nicolelis MAL, 2003, P NATL ACAD SCI USA, V100, P11041, DOI 10.1073/pnas.1934665100; O'Leary JG, 2006, J NEUROPHYSIOL, V96, P1492, DOI 10.1152/jn.00106.2006; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pohlmeyer EA, 2007, J NEURAL ENG, V4, P369, DOI 10.1088/1741-2560/4/4/003; Porter R, 1993, CORTICOSPINAL FUNCTI; Proakis J. G., 1995, DIGIT SIGNAL PROCESS, V3rd; Rickert J, 2005, J NEUROSCI, V25, P8815, DOI 10.1523/JNEUROSCI.0816-05.2005; Santhanam G, 2006, NATURE, V442, P195, DOI 10.1038/nature04968; Scherberger H, 2005, NEURON, V46, P347, DOI 10.1016/j.neuron.2005.03.004; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Stark E, 2007, J NEUROSCI, V27, P8387, DOI 10.1523/JNEUROSCI.1321-07.2007; Suner S, 2005, IEEE T NEUR SYS REH, V13, P524, DOI 10.1109/TNSRE.2005.857687; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Tolias AS, 2007, J NEUROPHYSIOL, V98, P3780, DOI 10.1152/jn.00260.2007; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; WEINRICH M, 1984, BRAIN, V107, P385, DOI 10.1093/brain/107.2.385; Zhao QB, 2008, IEEE IJCNN, P2656, DOI 10.1109/IJCNN.2008.4634170	44	64	65	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e14384	10.1371/journal.pone.0014384	http://dx.doi.org/10.1371/journal.pone.0014384			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21200434	Green Published, Green Submitted, gold			2022-12-27	WOS:000285576900004
J	Sopko, NA; Turturice, BA; Becker, ME; Brown, CR; Dong, F; Popovic, ZB; Penn, MS				Sopko, Nikolai A.; Turturice, Benjamin A.; Becker, Mitchell E.; Brown, Chase R.; Dong, Feng; Popovic, Zoran B.; Penn, Marc S.			Bone Marrow Support of the Heart in Pressure Overload Is Lost with Aging	PLOS ONE			English	Article							CARDIAC STEM-CELLS; PROGENITOR CELLS; ISCHEMIC CARDIOMYOPATHY; HYPERTROPHY; EXPRESSION; STRESS; MICE; ANGIOGENESIS; REGENERATION; ACTIVATION	Rationale: Exogenous stem cell delivery is under investigation to prevent and treat cardiac dysfunction. It is less studied as to the extent endogenous bone marrow derived stem cells contribute to cardiac homeostais in response to stress and the affects of aging on this stress response. Objective: To determine the role of bone marrow (BM) derived stem cells on cardiac homeostasis in response to pressure overload (PO) and how this response is altered by aging. Methods and Results: Young (8 weeks) and old (>40 weeks) C57/b6 mice underwent homo-and heterochronic BM transplantation prior to transverse aortic constriction (TAC). We found that older BM is associated with decreased cardiac function following TAC. This decreased function is associated with decrease in BM cell engraftment, increased myocyte apoptosis, decreased myocyte hypertrophy, increased myocardial fibrosis and decreased cardiac function. Additionally, there is a decrease in activation of resident cells within the heart in response to PO in old mice. Interestingly, these effects are not due to alterations in vascular density or inflammation in response to PO or differences in ex vivo stem cell migration between young and old mice. Conclusions: BM derived stem cells are activated in response to cardiac PO, and the recruitment of BM derived cells are involved in cardiac myocyte hypertrophy and maintenance of function in response to PO which is lost with aging.	[Sopko, Nikolai A.] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA; [Sopko, Nikolai A.; Turturice, Benjamin A.; Becker, Mitchell E.; Brown, Chase R.; Dong, Feng; Penn, Marc S.] Cleveland Clin, Skirball Lab Cardiovasc Cellular Therapeut, Cleveland, OH 44106 USA; [Sopko, Nikolai A.; Dong, Feng; Penn, Marc S.] Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44106 USA; [Popovic, Zoran B.; Penn, Marc S.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA	Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Sopko, NA (corresponding author), Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA.	pennm@ccf.org	Sopko, Nikolai/AAL-2036-2020; Turturice, Benjamin/AAF-6819-2019	Sopko, Nikolai/0000-0003-4913-0570; Turturice, Benjamin/0000-0001-9382-4612; popovic, zoran/0000-0001-5692-2299	Skirball Foundation; American Heart Association; National Institutes of Health [T32 GM07250]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	Skirball Foundation; American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Skirball Foundation. NAS was a recipient of an American Heart Association Great Rivers Pre-Doctoral Fellowship and National Institutes of Health grant T32 GM07250. The funders had no role in study design, data collection, and analysis, decision to publish or preperation of the manuscript.	Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Bian J, 2007, CIRC RES, V100, P1626, DOI 10.1161/01.RES.0000269778.75877.68; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; D'Alessandro DA, 2009, CIRC RES, V105, P1128, DOI 10.1161/CIRCRESAHA.109.207266; Dimmeler S, 2004, J AM COLL CARDIOL, V44, P464, DOI 10.1016/j.jacc.2004.06.001; Dong F, 2010, CIRC RES, V106, P601, DOI 10.1161/CIRCRESAHA.109.208967; Faggiano Pompilio, 2006, Cardiovasc Ultrasound, V4, P27, DOI 10.1186/1476-7120-4-27; FAN M, EFFECT AGE EFFICACY; FAU KC, RECIPIENT AGE DETERM; Formigli L, 2007, J CELL MOL MED, V11, P1087, DOI 10.1111/j.1582-4934.2007.00111.x; Gong YQ, 2008, J CLIN INVEST, V118, P3012, DOI 10.1172/JCI32750; Gonzales C, 2009, EXP CELL RES, V315, P3077, DOI 10.1016/j.yexcr.2009.09.006; Haq S, 2001, CIRCULATION, V103, P670; Heineke J, 2007, J CLIN INVEST, V117, P3198, DOI 10.1172/JCI32573; Higashiyama H, 2007, INT J EXP PATHOL, V88, P31, DOI 10.1111/j.1365-2613.2006.00514.x; Hilfiker-Kleiner D, 2005, CIRCULATION, V112, P1470, DOI 10.1161/CIRCULATIONAHA.104.518472; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Kimura TE, 2010, CIRC RES; Li XM, 2009, CLIN EXP PHARMACOL P, V36, P1054, DOI 10.1111/j.1440-1681.2009.05243.x; Limana F, 2010, J MOL CELL CARDIOL, V48, P609, DOI 10.1016/j.yjmcc.2009.11.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livi U, 1992, G Ital Cardiol, V22, P1405; Matsuura K, 2009, J CLIN INVEST, V119, P2204, DOI 10.1172/JCI37456; Moens AL, 2008, CIRCULATION, V117, P2626, DOI 10.1161/CIRCULATIONAHA.107.737031; Mouquet F, 2005, CIRC RES, V97, P1090, DOI 10.1161/01.RES.0000194330.66545.f5; MULLER P, 2007, CARDIOVASCULAR RES; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Peng Y, 2009, AM J PHYSIOL-HEART C, V297, pH811, DOI 10.1152/ajpheart.00385.2009; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; Rauscher FM, 2003, CIRCULATION, V108, P457, DOI 10.1161/01.CIR.0000082924.75945.48; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; ROSS J, 1968, CIRCULATION, V38, pV61, DOI 10.1161/01.CIR.38.1S5.V-61; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Schenk S, 2007, STEM CELLS, V25, P245, DOI 10.1634/stemcells.2006-0293; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Urbanek K, 2003, P NATL ACAD SCI USA, V100, P10440, DOI 10.1073/pnas.1832855100; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Xia Y, 2009, HISTOCHEM CELL BIOL, V131, P471, DOI 10.1007/s00418-008-0541-5; Yasukawa H, 2001, J CLIN INVEST, V108, P1459, DOI 10.1172/JCI13939; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	42	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15187	10.1371/journal.pone.0015187	http://dx.doi.org/10.1371/journal.pone.0015187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203577	gold, Green Published, Green Submitted			2022-12-27	WOS:000285576900018
J	Zrimi, J; Ling, AN; Arifin, EGR; Feverati, G; Lesieur, C				Zrimi, Jihad; Ling, Alicia Ng; Arifin, Ernawati Giri-Rachman; Feverati, Giovanni; Lesieur, Claire			Cholera Toxin B Subunits Assemble into Pentamers - Proposition of a Fly-Casting Mechanism	PLOS ONE			English	Article							HEAT-LABILE ENTEROTOXIN; ESCHERICHIA-COLI; REASSEMBLY-COMPETENT; CIRCULAR-DICHROISM; CRYSTAL-STRUCTURE; PROTEIN FUNCTION; FOLDING FUNNELS; MOLECULAR-BASIS; IN-VITRO; BINDING	The cholera toxin B pentamer (CtxB(5)), which belongs to the AB(5) toxin family, is used as a model study for protein assembly. The effect of the pH on the reassembly of the toxin was investigated using immunochemical, electrophoretic and spectroscopic methods. Three pH-dependent steps were identified during the toxin reassembly: (i) acquisition of a fully assembly-competent fold by the CtxB monomer, (ii) association of CtxB monomer into oligomers, (iii) acquisition of the native fold by the CtxB pentamer. The results show that CtxB5 and the related heat labile enterotoxin LTB5 have distinct mechanisms of assembly despite sharing high sequence identity (84%) and almost identical atomic structures. The difference can be pinpointed to four histidines which are spread along the protein sequence and may act together. Thus, most of the toxin B amino acids appear negligible for the assembly, raising the possibility that assembly is driven by a small network of amino acids instead of involving all of them.	[Zrimi, Jihad; Feverati, Giovanni; Lesieur, Claire] Univ Savoie, LAPTH, CNRS, Annecy Le Vieux, France; [Ling, Alicia Ng; Lesieur, Claire] Natl Univ Singapore, Dept Phys, Singapore 117548, Singapore; [Arifin, Ernawati Giri-Rachman] Sch Life Sci & Technol, ITB, Bandung, Indonesia; [Lesieur, Claire] Univ Grenoble 1, CNRS, CEA, IRTSV,LBBSI, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; National University of Singapore; Institute Technology of Bandung; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Zrimi, J (corresponding author), Univ Savoie, LAPTH, CNRS, Annecy Le Vieux, France.	lesieur@lapp.in2p3.fr	Feverati, Giovanni/L-8248-2013	Giri-Rachman, Ernawati/0000-0002-1661-9073	CNRS (Centre National de Recherche Scientifique)	CNRS (Centre National de Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS))	The CNRS (Centre National de Recherche Scientifique) has supported the work (http://www.cnrs.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berchanski A, 2005, PROTEINS, V60, P202, DOI 10.1002/prot.20558; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; BHAKUNI V, 1991, BIOCHEMISTRY-US, V30, P5055, DOI 10.1021/bi00234a031; CHAFFOTTE AF, 1992, BIOCHEMISTRY-US, V31, P9694, DOI 10.1021/bi00155a024; Cheesman C, 2004, BIOCHEMISTRY-US, V43, P1618, DOI 10.1021/bi035499z; Cheesman C, 2004, BIOCHEMISTRY-US, V43, P1609, DOI 10.1021/bi0354987; de Vries SJ, 2008, CURR PROTEIN PEPT SC, V9, P394, DOI 10.2174/138920308785132712; DEWOLF M, 1985, BIOCHIM BIOPHYS ACTA, V832, P165, DOI 10.1016/0167-4838(85)90328-0; DEWOLF MJS, 1987, BIOCHEMISTRY-US, V26, P3799, DOI 10.1021/bi00387a010; FINKELSTEIN RA, 1974, J IMMUNOL, V113, P145; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Gabdoulline RR, 2001, J MOL BIOL, V306, P1139, DOI 10.1006/jmbi.2000.4404; Gabdoulline RR, 1997, BIOPHYS J, V72, P1917, DOI 10.1016/S0006-3495(97)78838-6; GOLDENBERG DP, 1982, J BIOL CHEM, V257, P7864; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HIRST TR, 1984, P NATL ACAD SCI-BIOL, V81, P7752, DOI 10.1073/pnas.81.24.7752; HIRST TR, 1995, BACTERIAL TOXINS VIR, P123; HOLMGREN J, 1975, P NATL ACAD SCI USA, V72, P2520, DOI 10.1073/pnas.72.7.2520; Jaenicke R, 2000, ADV PROTEIN CHEM, V53, P329; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; KING J, 1973, J MOL BIOL, V75, P339, DOI 10.1016/0022-2836(73)90025-9; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lesieur C, 1999, J BIOL CHEM, V274, P36722, DOI 10.1074/jbc.274.51.36722; Lesieur C, 2002, J BIOL CHEM, V277, P16697, DOI 10.1074/jbc.M110561200; Levy Y, 2004, P NATL ACAD SCI USA, V101, P511, DOI 10.1073/pnas.2534828100; Luke K, 2006, J MOL BIOL, V363, P729, DOI 10.1016/j.jmb.2006.08.058; Ma BY, 1999, PROTEIN ENG, V12, P713, DOI 10.1093/protein/12.9.713; MERRITT EA, 1995, CURR OPIN STRUC BIOL, V5, P165, DOI 10.1016/0959-440X(95)80071-9; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Perham M, 2005, J AM CHEM SOC, V127, P16402, DOI 10.1021/ja055574o; Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770; Reixach N, 2008, J BIOL CHEM, V283, P2098, DOI 10.1074/jbc.M708028200; RUDDOCK LW, 1995, J BIOL CHEM, V270, P29953; Ruddock LW, 1996, BIOCHEMISTRY-US, V35, P16069, DOI 10.1021/bi961865l; Ruddock LW, 1996, J BIOL CHEM, V271, P19118, DOI 10.1074/jbc.271.32.19118; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; SIXMA TK, 1992, NATURE, V355, P561, DOI 10.1038/355561a0; Spaar A, 2006, BIOPHYS J, V90, P1913, DOI 10.1529/biophysj.105.075507; STEIN PE, 1992, NATURE, V355, P748, DOI 10.1038/355748a0; STEIN PE, 1994, NAT STRUCT BIOL, V1, P591, DOI 10.1038/nsb0994-591; Tacnet P, 2008, BBA-PROTEINS PROTEOM, V1784, P518, DOI 10.1016/j.bbapap.2007.12.005; Tinker JK, 2003, INFECT IMMUN, V71, P4093, DOI 10.1128/IAI.71.7.4093-4101.2003; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; ZHANG RG, 1995, J MOL BIOL, V251, P563, DOI 10.1006/jmbi.1995.0456; Zhuravlev PI, 2010, CURR OPIN STRUC BIOL, V20, P16, DOI 10.1016/j.sbi.2009.12.010	48	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15347	10.1371/journal.pone.0015347	http://dx.doi.org/10.1371/journal.pone.0015347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203571	Green Published, Green Submitted, gold			2022-12-27	WOS:000285576900029
J	Lee, SJ; Lee, MH; Kim, DW; Lee, S; Huang, SM; Ryu, MJ; Kim, YK; Kim, SJ; Kim, SJ; Hwang, JH; Oh, S; Cho, H; Kim, JM; Lim, DS; Jo, YS; Shong, M				Lee, Seong Jin; Lee, Min Hee; Kim, Dong Wook; Lee, SeongEun; Huang, Songmei; Ryu, Min Jeong; Kim, Yong Kyung; Kim, Sung Jin; Kim, Soung Jung; Hwang, Jung Hwan; Oh, Sangphil; Cho, Heeyeong; Kim, Jin Man; Lim, Dae-Sik; Jo, Young Suk; Shong, Minho			Cross-Regulation between Oncogenic BRAF(V600E) Kinase and the MST1 Pathway in Papillary Thyroid Carcinoma	PLOS ONE			English	Article							PROMOTER METHYLATION PROFILE; TUMOR-SUPPRESSOR RASSF1A; PROTEIN-KINASE; BRAF MUTATION; SIGNALING PATHWAY; GROWTH-FACTOR; CLINICOPATHOLOGICAL FEATURES; TRANSCRIPTION FACTORS; CELL-PROLIFERATION; HIGH PREVALENCE	Background: The BRAF(V600E) mutation leading to constitutive signaling of MEK-ERK pathways causes papillary thyroid cancer (PTC). Ras association domain family 1A (RASSF1A), which is an important regulator of MST1 tumor suppressor pathways, is inactivated by hypermethylation of its promoter region in 20 to 32% of PTC. However, in PTC without RASSF1A methylation, the regulatory mechanisms of RASSF1A-MST1 pathways remain to be elucidated, and the functional cooperation or cross regulation between BRAF(V600E) and MST1, which activates Foxo3, has not been investigated. Methodology/Principal Findings: The negative regulators of the cell cycle, p21 and p27, are strongly induced by transcriptional activation of FoxO3 in BRAF(V600E) positive thyroid cancer cells. The FoxO3 transactivation is augmented by RASSF1A and the MST1 signaling pathway. Interestingly, introduction of BRAF(V600E) markedly abolished FoxO3 transactivation and resulted in the suppression of p21 and p27 expression. The suppression of FoxO3 transactivation by BRAF(V600E) is strongly increased by coexpression of MST1 but it is not observed in the cells in which MST1, but not MST2, is silenced. Mechanistically, BRAF(V600E) was able to bind to the C-terminal region of MST1 and resulted in the suppression of MST1 kinase activities. The induction of the G1-checkpoint CDK inhibitors, p21 and p27, by the RASSF1A-MST1-FoxO3 pathway facilitates cellular apoptosis, whereasaddition of BRAF(V600E) inhibits the apoptotic processes through the inactivation of MST1. Transgenic induction of BRAF(V600E) in the thyroid gland results in cancers resembling human papillary thyroid cancers. The development of BRAF(V600E) transgenic mice with the MST1 knockout background showed that these mice had abundant foci of poorly differentiated carcinomas and large areas without follicular architecture or colloid formation. Conclusions/Significance: The results of this study revealed that the oncogenic effect of BRAF(V600E) is associated with the inhibition of MST1 tumor suppressor pathways, and that the activity of RASSF1A-MST1-FoxO3 pathways determines the phenotypes of BRAF(V600E) tumors.	[Lee, Seong Jin; Lee, Min Hee; Kim, Dong Wook; Lee, SeongEun; Ryu, Min Jeong; Kim, Yong Kyung; Kim, Sung Jin; Kim, Soung Jung; Hwang, Jung Hwan; Shong, Minho] Chungnam Natl Univ, Sch Med, Dept Internal Med, Taejon, South Korea; [Huang, Songmei; Kim, Jin Man] Chungnam Natl Univ, Sch Med, Dept Pathol, Taejon, South Korea; [Lee, Seong Jin; Cho, Heeyeong] Korea Res Inst Chem Technol, Pharmacol Res Ctr, Taejon 305606, South Korea; [Hwang, Jung Hwan] Korea Res Inst Biosci & Biotechnol, Anim Model Ctr, Taejon, South Korea; [Oh, Sangphil; Lim, Dae-Sik] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Jo, Young Suk] Chungnam Natl Univ Hosp, Res Ctr Endocrine & Metab Dis, Taejon, South Korea	Chungnam National University; Chungnam National University; Korea Research Institute of Chemical Technology (KRICT); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Advanced Institute of Science & Technology (KAIST); Chungnam National University; Chungnam National University Hospital	Lee, SJ (corresponding author), Chungnam Natl Univ, Sch Med, Dept Internal Med, Taejon, South Korea.	ysmrj@cnuh.ac.kr; minhos@cnu.ac.kr	/H-7803-2012; Lim, Dae-Sik/C-1599-2011	Lim, Dae-Sik/0000-0003-2356-7555; Lee, Min Hee/0000-0002-7403-7274; Cho, Heeyeong/0000-0003-0755-915X; KIM, JIN MAN/0000-0003-0905-9730; shong, minho/0000-0002-0247-7115	Ministry of Education; Ministry of Science Technology [M10748000319-07N4800-31910]; Korea Healthcare Technology, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A100588]; Ministry of Science & Technology, Republic of Korea [M10748000319-07N4800-31910]	Ministry of Education; Ministry of Science Technology; Korea Healthcare Technology, Ministry for Health, Welfare & Family Affairs, Republic of Korea; Ministry of Science & Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of KoreaMinistry of Science & Technology (MOST), Republic of Korea)	This work was supported in part by the second phase of the BK 21 Program of the Ministry of Education, by the Research Program for New Drug Target Discovery (M10748000319-07N4800-31910) grant from the Ministry of Science & Technology and by a grant of the Korea Healthcare Technology R&D Project (A100588), Ministry for Health, Welfare & Family Affairs, Republic of Korea. MHL, SEL, SH, MJR, SJK, JMK and MS were supported in part by the second phase of the Brain Korea 21 program of the Ministry of Education. JMK, YSJ and MS were supported by the Research Program for New Drug Target Discovery (M10748000319-07N4800-31910) grant from the Ministry of Science & Technology, Republic of Korea. MHL, SEL, MJR, YKK, SJK, SJK, YSJ and MS were supported in part by a grant of the Korea Healthcare Technology R&D Project (A100588), Ministry for Health, Welfare & Family Affairs, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cinar B, 2007, EMBO J, V26, P4523, DOI 10.1038/sj.emboj.7601872; Cohen J, 2003, J NATL CANCER I, V95, P625, DOI 10.1093/jnci/95.8.625; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davies MA, 2009, CLIN CANCER RES, V15, P7538, DOI 10.1158/1078-0432.CCR-09-1985; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hingorani SR, 2003, CANCER RES, V63, P5198; Hoeflich MP, 2006, CANCER RES, V66, P999, DOI 10.1158/0008-5472.CAN-05-2720; Hoque MO, 2005, J CLIN ENDOCR METAB, V90, P4011, DOI 10.1210/jc.2005-0313; Hwang E, 2007, P NATL ACAD SCI USA, V104, P9236, DOI 10.1073/pnas.0610716104; Jang SW, 2007, J BIOL CHEM, V282, P30836, DOI 10.1074/jbc.M704542200; Jo YS, 2006, J CLIN ENDOCR METAB, V91, P3667, DOI 10.1210/jc.2005-2836; Jung HS, 2005, MOL ENDOCRINOL, V19, P2748, DOI 10.1210/me.2005-0122; Kimura ET, 2003, CANCER RES, V63, P1454; Knauf JA, 2005, CANCER RES, V65, P4238, DOI 10.1158/0008-5472.CAN-05-0047; Kyriakis JM, 2007, BBA-MOL CELL RES, V1773, P1238, DOI 10.1016/j.bbamcr.2006.11.003; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Maruyama R, 2001, CANCER RES, V61, P8659; Maruyama R, 2002, CLIN CANCER RES, V8, P514; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Mitsutake N, 2006, ENDOCRINOLOGY, V147, P1014, DOI 10.1210/en.2005-0280; Mitsutake N, 2005, CANCER RES, V65, P2465, DOI 10.1158/0008-5472.CAN-04-3314; Nakamura N, 2005, LAB INVEST, V85, p93A; Namba H, 2003, J CLIN ENDOCR METAB, V88, P4393, DOI 10.1210/jc.2003-030305; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; O'Neill E, 2005, CELL CYCLE, V4, P365, DOI 10.4161/cc.4.3.1531; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Obsil T, 2008, ONCOGENE, V27, P2263, DOI 10.1038/onc.2008.20; Oh HJ, 2006, CANCER RES, V66, P2562, DOI 10.1158/0008-5472.CAN-05-2951; Oh S, 2009, MOL CELL BIOL, V29, P6309, DOI 10.1128/MCB.00551-09; Packer LM, 2009, PIGM CELL MELANOMA R, V22, P785, DOI 10.1111/j.1755-148X.2009.00618.x; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Satyamoorthy K, 2003, CANCER RES, V63, P756; Schagdarsurengin U, 2002, CANCER RES, V62, P3698; Sharma A, 2005, CANCER RES, V65, P2412, DOI 10.1158/0008-5472.CAN-04-2423; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Uribe P, 2006, J INVEST DERMATOL, V126, P161, DOI 10.1038/sj.jid.5700011; van der Heide LP, 2005, TRENDS BIOCHEM SCI, V30, P81, DOI 10.1016/j.tibs.2004.12.002; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Vichalkovski A, 2008, CURR BIOL, V18, P1889, DOI 10.1016/j.cub.2008.10.060; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Xing MZ, 2007, ENDOCR REV, V28, P742, DOI 10.1210/er.2007-0007; Xing MZ, 2004, CANCER RES, V64, P1664, DOI 10.1158/0008-5472.CAN-03-3242; Xu XL, 2003, CANCER RES, V63, P4561; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Zou HZ, 2007, CANCER EPIDEM BIOMAR, V16, P2686, DOI 10.1158/1055-9965.EPI-07-0518	51	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16180	10.1371/journal.pone.0016180	http://dx.doi.org/10.1371/journal.pone.0016180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249150	Green Published, Green Submitted, gold			2022-12-27	WOS:000286515000027
J	Horvath, B; Lenzser, G; Benyo, B; Nemeth, T; Benko, R; Iring, A; Herman, P; Komjati, K; Lacza, Z; Sandor, P; Benyo, Z				Horvath, Bela; Lenzser, Gabor; Benyo, Balazs; Nemeth, Tamas; Benko, Rita; Iring, Andras; Herman, Peter; Komjati, Katalin; Lacza, Zsombor; Sandor, Peter; Benyo, Zoltan			Hypersensitivity to Thromboxane Receptor Mediated Cerebral Vasomotion and CBF Oscillations during Acute NO-Deficiency in Rats	PLOS ONE			English	Article							OXIDE SYNTHASE BLOCKADE; SMOOTH-MUSCLE; PROTEIN-KINASE; NITRIC-OXIDE; BLOOD-FLOW; LASER-DOPPLER; SUBARACHNOID HEMORRHAGE; PROSTAGLANDIN I-2; IN-VIVO; PHOSPHORYLATION	Background: Low frequency (4-12 cpm) spontaneous fluctuations of the cerebrovascular tone (vasomotion) and oscillations of the cerebral blood flow (CBF) have been reported in diseases associated with endothelial dysfunction. Since endothelium-derived nitric oxide (NO) suppresses constitutively the release and vascular effects of thromboxane A(2) (TXA(2)), NO-deficiency is often associated with activation of thromboxane receptors (TP). In the present study we hypothesized that in the absence of NO, overactivation of the TP-receptor mediated cerebrovascular signaling pathway contributes to the development of vasomotion and CBF oscillations. Methodology/Principal Findings: Effects of pharmacological modulation of TP-receptor activation and its downstream signaling pathway have been investigated on CBF oscillations (measured by laser-Doppler flowmetry in anesthetized rats) and vasomotion (measured by isometric tension recording in isolated rat middle cerebral arteries, MCAs) both under physiological conditions and after acute inhibition of NO synthesis. Administration of the TP-receptor agonist U-46619 (1 mu g/kg iv.) to control animals failed to induce any changes of the systemic or cerebral circulatory parameters. Inhibition of the NO synthesis by nitro-L-arginine methyl esther (L-NAME, 100 mg/kg iv.) resulted in increased mean arterial blood pressure and a decreased CBF accompanied by appearance of CBF-oscillations with a dominant frequency of 148+/-2 mHz. U-46619 significantly augmented the CBF-oscillations induced by L-NAME while inhibition of endogenous TXA(2) synthesis by ozagrel (10 mg/kg iv.) attenuated it. In isolated MCAs U-46619 in a concentration of 100 nM, which induced weak and stable contraction under physiological conditions, evoked sustained vasomotion in the absence of NO, which effect could be completely reversed by inhibition of Rho-kinase by 10 mu M Y-27632. Conclusion/Significance: These results suggest that hypersensitivity of the TP-receptor - Rho-kinase signaling pathway contributes to the development of low frequency cerebral vasomotion which may propagate to vasospasm in pathophysiological states associated with NO-deficiency.	[Horvath, Bela; Lenzser, Gabor; Nemeth, Tamas; Benko, Rita; Iring, Andras; Herman, Peter; Komjati, Katalin; Lacza, Zsombor; Sandor, Peter; Benyo, Zoltan] Semmelweis Univ, Inst Human Physiol & Clin Expt Res, Budapest, Hungary; [Horvath, Bela] NIAAA, NIH, Bethesda, MD USA; [Lenzser, Gabor] Univ Pecs, Dept Neurosurg, Pecs, Hungary; [Benyo, Balazs] Budapest Univ Technol & Econ, Dept Control Engn & Informat Technol, H-1117 Budapest, Hungary; [Herman, Peter] Yale Univ, Dept Diagnost Radiol, Magnet Resonance Res Ctr, New Haven, CT 06510 USA	Semmelweis University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Pecs; Budapest University of Technology & Economics; Yale University	Horvath, B (corresponding author), Semmelweis Univ, Inst Human Physiol & Clin Expt Res, Budapest, Hungary.	bela.horvath@nih.gov	Horvath, Bela/A-7368-2009; Benyó, Balázs/H-6208-2012; Herman, Peter/E-7028-2010; Benyó, Balázs/AAR-4275-2021; Iring, Andras/F-7092-2010; Benko, Rita/I-9646-2017	Benyó, Balázs/0000-0003-2770-9127; Benyó, Balázs/0000-0003-2770-9127; Iring, Andras/0000-0002-3087-4337; Herman, Peter/0000-0003-2218-9652; Benko, Rita/0000-0001-7740-9128; Benyo, Zoltan/0000-0001-6015-0359	EFSD) European Foundation for the Study of Diabetes/Servier; Hungarian Scientific Research Fund (OTKA) [K 62375, K82066]; NKTH National Office for Research and Technology [OMFB-00770/2009, ALAP1-01298/2009]; ESZCSM Health Science Council (ETT) [427/2009]; Tarsadalmi Megujulas Operativ Program (TAMOP) [4.2.2-08/1/KMR-2008-004, 4.2.1/B-09/1/KMR-2010-000]; NKTH-OTKA-EU [MB08-A 80238]	EFSD) European Foundation for the Study of Diabetes/Servier(Servier); Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); NKTH National Office for Research and Technology(National Office for Research and Technology); ESZCSM Health Science Council (ETT); Tarsadalmi Megujulas Operativ Program (TAMOP); NKTH-OTKA-EU(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This study was supported by an (EFSD) European Foundation for the Study of Diabetes/Servier grant as well as by grants from the The Hungarian Scientific Research Fund (Hungarian abbreviation: OTKA) (K 62375, K82066), NKTH National Office for Research and Technology (OMFB-00770/2009, ALAP1-01298/2009), ESZCSM Health Science Council (ETT)(427/2009) and Tarsadalmi Megujulas Operativ Program (TAMOP) (4.2.2-08/1/KMR-2008-004, 4.2.1/B-09/1/KMR-2010-000). Dr. Horvath was supported by an NKTH-OTKA-EU Fellowship (MB08-A 80238). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalkjaer C, 2005, BRIT J PHARMACOL, V144, P605, DOI 10.1038/sj.bjp.0706084; Ansar S, 2010, BRAIN RES, V1316, P163, DOI 10.1016/j.brainres.2009.12.031; Benyo Z, 1998, J CEREBR BLOOD F MET, V18, P616, DOI 10.1097/00004647-199806000-00003; BENYO Z, 1995, NEUROSCI LETT, V198, P127, DOI 10.1016/0304-3940(95)11981-2; Biswal B, 1997, J CEREBR BLOOD F MET, V17, P301, DOI 10.1097/00004647-199703000-00007; Chrissobolis S, 2006, STROKE, V37, P2174, DOI 10.1161/01.STR.0000231647.41578.df; DAVIES PW, 1957, FED PROC, V16, P689; DIEHL RR, 1995, STROKE, V26, P1801, DOI 10.1161/01.STR.26.10.1801; DORA E, 1981, ACTA PHYSIOL HUNG, V57, P261; DUHAMEL P, 1990, SIGNAL PROCESS, V19, P259, DOI 10.1016/0165-1684(90)90158-U; FASANO VA, 1988, ACTA NEUROCHIR, V95, P40, DOI 10.1007/BF01793081; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Frigo M, 1998, INT CONF ACOUST SPEE, P1381; FUNK W, 1983, INT J MICROCIRC, V2, P11; Hudetz AG, 1998, ADV EXP MED BIOL, V454, P551; HUDETZ AG, 1992, J CEREBR BLOOD F MET, V12, P491, DOI 10.1038/jcbfm.1992.67; Ichikawa K, 1999, PHARMACOLOGY, V59, P257, DOI 10.1159/000028328; Lacza Z, 2000, NEUROSCI LETT, V291, P65, DOI 10.1016/S0304-3940(00)01341-0; Lacza Z, 2001, STROKE, V32, P2609, DOI 10.1161/hs1101.098526; Lan C, 2004, AM J PHYSIOL-HEART C, V286, pH165, DOI 10.1152/ajpheart.00664.2003; LEFER DJ, 1990, MICROVASC RES, V39, P129, DOI 10.1016/0026-2862(90)90065-Y; Leszl-Ishiguro M, 2007, NEUROREPORT, V18, P1193, DOI 10.1097/WNR.0b013e3282202459; Manganello JM, 2003, J BIOL CHEM, V278, P124, DOI 10.1074/jbc.M209219200; Miyamoto A, 2007, VASC PHARMACOL, V46, P85, DOI 10.1016/j.vph.2006.06.018; MORITATSUZUKI Y, 1992, ACTA PHYSIOL SCAND, V146, P431, DOI 10.1111/j.1748-1716.1992.tb09444.x; Nakamura K, 2007, CIRC RES, V101, P712, DOI 10.1161/CIRCRESAHA.107.153981; Obrig H, 2000, NEUROIMAGE, V12, P623, DOI 10.1006/nimg.2000.0657; OSOL G, 1988, AM J PHYSIOL, V254, pH28, DOI 10.1152/ajpheart.1988.254.1.H28; Reid HM, 2003, J BIOL CHEM, V278, P51190, DOI 10.1074/jbc.M309314200; ROSENBLUM BR, 1987, J NEUROSURG, V66, P396, DOI 10.3171/jns.1987.66.3.0396; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Sawada N, 2001, BIOCHEM BIOPH RES CO, V280, P798, DOI 10.1006/bbrc.2000.4194; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Turalska M, 2008, ACTA NEUROCHIR SUPPL, V102, P43, DOI 10.1007/978-3-211-85578-2_9; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Wade ML, 1997, ARCH BIOCHEM BIOPHYS, V347, P174, DOI 10.1006/abbi.1997.0348; Wang GR, 1998, P NATL ACAD SCI USA, V95, P4888, DOI 10.1073/pnas.95.9.4888; Westermaier T, 2009, J NEUROSURG, V110, P996, DOI 10.3171/2008.8.JNS08591; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Wooldridge AA, 2004, J BIOL CHEM, V279, P34496, DOI 10.1074/jbc.M405957200; Wu XQ, 1998, J BIOL CHEM, V273, P11362, DOI 10.1074/jbc.273.18.11362; Xavier FE, 2009, BRIT J PHARMACOL, V158, P1787, DOI 10.1111/j.1476-5381.2009.00459.x	42	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e14477	10.1371/journal.pone.0014477	http://dx.doi.org/10.1371/journal.pone.0014477			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217826	gold, Green Submitted, Green Published			2022-12-27	WOS:000285838900006
J	Liu, WJ; Zong, WJ; Wu, G; Fujita, T; Li, WQ; Wu, J; Wan, Y				Liu, Weijun; Zong, Wenjun; Wu, George; Fujita, Takeo; Li, Wenqi; Wu, Judy; Wan, Yong			Turnover of BRCA1 Involves in Radiation-Induced Apoptosis	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; PROTEASOME-MEDIATED DEGRADATION; NUCLEOTIDE EXCISION-REPAIR; CANCER CELL-LINE; TUMOR-SUPPRESSOR; UBIQUITIN LIGASE; BREAST-CANCER; GENOTOXIC STRESS; SPORADIC BREAST; IN-VITRO	Background: Germ-line mutations of the breast cancer susceptibility gene-1 (BRCA1) increase the susceptibility to tumorigenesis. The function of BRCA1 is to regulate critical cellular processes, including cell cycle progression, genomic integrity, and apoptosis. Studies on the regulation of BRCA1 have focused intensely on transcription and phosphorylation mechanisms. Proteolytic regulation of BRCA1 in response to stress signaling remains largely unknown. The manuscript identified a novel mechanism by which BRCA1 is regulated by the ubiquitin-dependent degradation in response to ionization. Methodology/Principal Findings: Here, we report that severe ionization triggers rapid degradation of BRCA1, which in turn results in the activation of apoptosis. Ionization-induced BRCA1 turnover is mediated via an ubiquitin-proteasomal pathway. The stabilization of BRCA1 significantly delays the onset of ionization-induced apoptosis. We have mapped the essential region on BRCA1, which mediates its proteolysis in response to ionization. Moreover, we have demonstrated that BRCA1 protein is most sensitive to degradation when ionization occurs during G2/M and S phase. Conclusions/Significance: Our results suggest that ubiquitin-proteasome plays an important role in regulating BRCA1 during genotoxic stress. Proteolytic regulation of BRCA1 involves in ionization-induced apoptosis.	[Liu, Weijun] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Liu, WJ (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15260 USA.	yow4@pitt.edu	Liu, Weijun/D-5291-2017; Liu, Weijun/B-5896-2008	Liu, Weijun/0000-0002-4426-6148	National Institutes of Health [CA115943]; NATIONAL CANCER INSTITUTE [R01CA115943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants CA115943. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayad NG, 2005, METHOD ENZYMOL, V399, P404, DOI 10.1016/S0076-6879(05)99028-9; Baer R, 2002, CURR OPIN GENET DEV, V12, P86, DOI 10.1016/S0959-437X(01)00269-6; Boulton SJ, 2006, CELL CYCLE, V5, P1481, DOI 10.4161/cc.5.14.2930; Boulton SJ, 2004, CURR BIOL, V14, P33, DOI 10.1016/j.cub.2003.11.029; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Cable PL, 2003, MOL CARCINOGEN, V38, P85, DOI 10.1002/mc.10148; Chen A, 2002, J BIOL CHEM, V277, P22085, DOI 10.1074/jbc.M201252200; Chen YM, 1996, CANCER RES, V56, P3168; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Choi YH, 2001, INT J ONCOL, V19, P687; Choudhury AD, 2004, J BIOL CHEM, V279, P33909, DOI 10.1074/jbc.M403646200; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; DelloRusso C, 2007, MOL CANCER RES, V5, P35, DOI 10.1158/1541-7786.MCR-06-0234; Deng CX, 2000, BIOESSAYS, V22, P728; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Gowen LC, 1998, SCIENCE, V281, P1009, DOI 10.1126/science.281.5379.1009; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Hartman AR, 2002, NAT GENET, V32, P180, DOI 10.1038/ng953; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Jacquemont C, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S10; Jesenberger V, 2002, NAT REV MOL CELL BIO, V3, P112, DOI 10.1038/nrm731; Koberle B, 2006, DNA REPAIR, V5, P641, DOI 10.1016/j.dnarep.2005.12.001; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lafarge S, 2001, ONCOGENE, V20, P6597, DOI 10.1038/sj.onc.1204812; Liu WJ, 2007, MOL CELL BIOL, V27, P2967, DOI 10.1128/MCB.01830-06; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; MacFarlane M, 2002, J BIOL CHEM, V277, P36611, DOI 10.1074/jbc.M200317200; MacLachlan TK, 2002, MOL CELL BIOL, V22, P4280, DOI 10.1128/MCB.22.12.4280-4292.2002; Mailand N, 2002, EMBO J, V21, P5911, DOI 10.1093/emboj/cdf567; Mallery DL, 2002, EMBO J, V21, P6755, DOI 10.1093/emboj/cdf691; Martin SJ, 2002, CELL, V109, P793, DOI 10.1016/S0092-8674(02)00802-4; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Mueller CR, 2003, BREAST CANCER RES, V5, P45, DOI 10.1186/bcr557; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Quinn JE, 2003, CANCER RES, V63, P6221; Rodriguez JA, 2004, EXP CELL RES, V293, P14, DOI 10.1016/j.yexcr.2003.09.027; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Scully R, 2001, EXP CELL RES, V264, P67, DOI 10.1006/excr.2000.5132; Setlow RB, 2002, MUTAT RES-REV MUTAT, V511, P1, DOI 10.1016/S1383-5742(02)00004-2; Sylvain V, 2002, INT J ONCOL, V20, P845; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Wan Y, 2001, MOL CELL, V8, P1027, DOI 10.1016/S1097-2765(01)00382-3; Wang Q, 2000, ONCOGENE, V19, P6152, DOI 10.1038/sj.onc.1203974; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wang Y, 2000, GENE DEV, V14, P927; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Zhan QM, 2002, ONCOGENE, V21, P5335, DOI 10.1038/sj.onc.1205665; Zhang HG, 2004, ONCOGENE, V23, P2009, DOI 10.1038/sj.onc.1207373; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747	57	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e14484	10.1371/journal.pone.0014484	http://dx.doi.org/10.1371/journal.pone.0014484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217819	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000285838900013
J	Du, J; Sun, CQ; Hu, ZZ; Yang, Y; Zhu, YC; Zheng, DT; Gu, L; Lu, XA				Du, Jun; Sun, Chongqi; Hu, Zhenzhen; Yang, Yu; Zhu, Yichao; Zheng, Datong; Gu, Luo; Lu, Xiang			Lysophosphatidic Acid Induces MDA-MB-231 Breast Cancer Cells Migration through Activation of PI3K/PAK1/ERK Signaling	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ERK ACTIVATION; PHOSPHATIDYLINOSITOL 3-KINASE; CYTOSKELETAL REORGANIZATION; P21-ACTIVATED KINASES; BIOLOGICAL-ACTIVITIES; ENDOTHELIAL-CELLS; REGULATED KINASE; BONE METASTASES; STEM-CELLS	Background: Enhanced motility of cancer cells is a critical step in promoting tumor metastasis. Lysophosphatidic acid (LPA), representing the major mitogenic activity in serum, stimulates migration in various types of cancer cells. However, the underlying signaling mechanisms for LPA-induced motility of cancer cells remain to be elucidated. Methodology/Principal Findings: In this study, we found that LPA dose-dependently stimulated migration of MDA-MB-231 breast cancer cells, with 10 mu M being the most effective. LPA also increased ERK activity and the MEK inhibitor U0126 could block LPA-induced ERK activity and cell migration. In addition, LPA induced PAK1 activation while ERK activation and cell migration were inhibited by ectopic expression of an inactive mutant form of PAK1 in MDA-MB-231 cells. Furthermore, LPA increased PI3K activity, and the PI3K inhibitor LY294002 inhibited both LPA-induced PAK1/ERK activation and cell migration. Moreover, in the breast cancer cell, LPA treatment resulted in remarkable production of reactive oxygen species (ROS), while LPA-induced ROS generation, PI3K/PAK1/ERK activation and cell migration could be inhibited by N-acetyl-L-Cysteine, a scavenger of ROS. Conclusions/Significance: Taken together, this study identifies a PI3K/PAK1/ERK signaling pathway for LPA-stimulated breast cancer cell migration. These data also suggest that ROS generation plays an essential role in the activation of LPA-stimulated PI3K/PAK1/ERK signaling and breast cancer cell migration. These findings may provide a basis for designing future therapeutic strategy for blocking breast cancer metastasis.	[Du, Jun; Hu, Zhenzhen; Yang, Yu] Nanjing Med Univ, Dept Physiol, Nanjing, Peoples R China; [Sun, Chongqi] Nanjing Med Univ, Kangda Coll, Nanjing, Peoples R China; [Zhu, Yichao; Gu, Luo] Nanjing Med Univ, Ctr Canc, Nanjing, Peoples R China; [Zheng, Datong; Lu, Xiang] Nanjing Med Univ, Affiliated Hosp 2, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Du, J (corresponding author), Nanjing Med Univ, Dept Physiol, Nanjing, Peoples R China.	lgu@njmu.edu.cn; uxiang66@njmu.edu.cn			National Natural Science Foundation of China [30872926]; Program for Advanced Talents within Six Industries of Jiangsu Province [08-D]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Advanced Talents within Six Industries of Jiangsu Province	This work was supported by grants from the National Natural Science Foundation of China (No 30872926) and the Program for Advanced Talents within Six Industries of Jiangsu Province (08-D) to L.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam L, 2000, J BIOL CHEM, V275, P12041, DOI 10.1074/jbc.275.16.12041; Adam L, 1998, J BIOL CHEM, V273, P28238, DOI 10.1074/jbc.273.43.28238; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Boucharaba A, 2006, P NATL ACAD SCI USA, V103, P9643, DOI 10.1073/pnas.0600979103; Caldas-Lopes E, 2009, P NATL ACAD SCI USA, V106, P8368, DOI 10.1073/pnas.0903392106; Cechin SR, 2005, NEUROCHEM RES, V30, P603, DOI 10.1007/s11064-005-2747-4; Cheng CM, 2009, J BIOL CHEM, V284, P8786, DOI 10.1074/jbc.M806144200; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Gadalla SM, 2009, BRIT J CANCER, V100, P817, DOI 10.1038/sj.bjc.6604906; Hess AR, 2003, CANCER RES, V63, P4757; Huang Q, 2005, CELL MOL LIFE SCI, V62, P1167, DOI 10.1007/s00018-005-5050-2; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; Jung ID, 2004, EUR J BIOCHEM, V271, P1557, DOI 10.1111/j.1432-1033.2004.04066.x; Karagiosis SA, 2009, J CELL PHYSIOL, V219, P716, DOI 10.1002/jcp.21720; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Kovacs EM, 2002, J BIOL CHEM, V277, P6708, DOI 10.1074/jbc.M109640200; Kranenburg O, 2001, ONCOGENE, V20, P1540, DOI 10.1038/sj.onc.1204187; Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Lakka SS, 2002, ONCOGENE, V21, P5601, DOI 10.1038/sj.onc.1205646; Lee MJ, 2008, J CELL BIOCHEM, V104, P499, DOI 10.1002/jcb.21641; Lee NY, 2007, J BIOL CHEM, V282, P21507, DOI 10.1074/jbc.M700176200; Li TT, 2009, MOL CANCER RES, V7, P1064, DOI 10.1158/1541-7786.MCR-08-0578; Liu SY, 2009, CELL CYCLE, V8, P3695, DOI 10.4161/cc.8.22.9937; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Mehdi MZ, 2007, CELL BIOCHEM BIOPHYS, V47, P1; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; Molli PR, 2009, ONCOGENE, V28, P2545, DOI 10.1038/onc.2009.119; Moolenaar WH, 1999, EXP CELL RES, V253, P230, DOI 10.1006/excr.1999.4702; Panupinthu N, 2010, BRIT J CANCER, V102, P941, DOI 10.1038/sj.bjc.6605588; Papakonstanti EA, 2002, MOL BIOL CELL, V13, P2946, DOI 10.1091/mbc.02-01-0599; Park ER, 2007, CELL SIGNAL, V19, P1488, DOI 10.1016/j.cellsig.2007.01.018; Pintucci G, 2002, FASEB J, V16, P598, DOI 10.1096/fj.01-0815fje; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rhee S, 2006, J CELL BIOL, V172, P423, DOI 10.1083/jcb.200505175; Schmitz U, 2002, BIOCHEM BIOPH RES CO, V291, P687, DOI 10.1006/bbrc.2002.6493; Slack-Davis JK, 2003, J CELL BIOL, V162, P281, DOI 10.1083/jcb.200212141; Smith SD, 2008, J CELL SCI, V121, P3729, DOI 10.1242/jcs.027680; Stahle M, 2003, J CELL SCI, V116, P3835, DOI 10.1242/jcs.00679; Storz P, 2005, FRONT BIOSCI-LANDMRK, V10, P1881, DOI 10.2741/1667; Suzukawa K, 2000, J BIOL CHEM, V275, P13175, DOI 10.1074/jbc.275.18.13175; Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583; Turbov JM, 2002, J SURG ONCOL, V79, P17, DOI 10.1002/jso.10033; Vadlamudi Ratna K, 2004, Cancer Treat Res, V119, P77; Vadlamudi RK, 2000, J BIOL CHEM, V275, P36238, DOI 10.1074/jbc.M002138200; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; Veit C, 2004, CANCER RES, V64, P5291, DOI 10.1158/0008-5472.CAN-04-1112; Wang JR, 2009, EUR J CELL BIOL, V88, P103, DOI 10.1016/j.ejcb.2008.05.003; Weber DS, 2004, CIRC RES, V94, P1219, DOI 10.1161/01.RES.0000126848.54740.4A; Whaley-Connell AT, 2007, AM J NEPHROL, V27, P15, DOI 10.1159/000098432; Witt AE, 2006, J PROTEOME RES, V5, P599, DOI 10.1021/pr050395r; Wu WS, 2006, MOL CANCER RES, V4, P747, DOI 10.1158/1541-7786.MCR-06-0096; Yamada T, 2004, J BIOL CHEM, V279, P6595, DOI 10.1074/jbc.M308133200; Zang MW, 2002, J BIOL CHEM, V277, P4395, DOI 10.1074/jbc.M110000200; Zhang HS, 2006, FREE RADICAL BIO MED, V40, P1664, DOI 10.1016/j.freeradbiomed.2006.01.003; Zugasti O, 2001, MOL CELL BIOL, V21, P6706, DOI 10.1128/MCB.21.19.6706-6717.2001	58	78	83	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15940	10.1371/journal.pone.0015940	http://dx.doi.org/10.1371/journal.pone.0015940			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209852	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793600051
J	Keren, H; Donyo, M; Zeevi, D; Maayan, C; Pupko, T; Ast, G				Keren, Hadas; Donyo, Maya; Zeevi, David; Maayan, Channa; Pupko, Tal; Ast, Gil			Phosphatidylserine Increases IKBKAP Levels in Familial Dysautonomia Cells	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; ELONGATOR COMPLEX; MESSENGER-RNA; SPLICING DEFECT; LIFE-SPAN; EXPRESSION; KINETIN; GENE; IKAP; TOCOTRIENOLS	Familial Dysautonomia (FD) is an autosomal recessive congenital neuropathy that results from abnormal development and progressive degeneration of the sensory and autonomic nervous system. The mutation observed in almost all FD patients is a point mutation at position 6 of intron 20 of the IKBKAP gene; this gene encodes the IkB kinase complex-associated protein (IKAP). The mutation results in a tissue-specific splicing defect: Exon 20 is skipped, leading to reduced IKAP protein expression. Here we show that phosphatidylserine (PS), an FDA-approved food supplement, increased IKAP mRNA levels in cells derived from FD patients. Long-term treatment with PS led to a significant increase in IKAP protein levels in these cells. A conjugate of PS and an omega-3 fatty acid also increased IKAP mRNA levels. Furthermore, PS treatment released FD cells from cell cycle arrest and up-regulated a significant number of genes involved in cell cycle regulation. Our results suggest that PS has potential for use as a therapeutic agent for FD. Understanding its mechanism of action may reveal the mechanism underlying the FD disease.	[Keren, Hadas; Donyo, Maya; Ast, Gil] Tel Aviv Univ, Dept Human Mol Genet & Biochem, Sackler Fac Med, Ramat Aviv, Israel; [Zeevi, David; Pupko, Tal] Tel Aviv Univ, Dept Cell Res & Immunol, George S Wise Fac Life Sci, Ramat Aviv, Israel; [Maayan, Channa] Hadassah Univ Hosp, Dept Pediat, IL-91120 Jerusalem, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Hebrew University of Jerusalem	Keren, H (corresponding author), Tel Aviv Univ, Dept Human Mol Genet & Biochem, Sackler Fac Med, Ramat Aviv, Israel.	gilast@post.tau.ac.il	Pupko, Tal/HGF-1353-2022	Zeevi, David/0000-0002-6492-6078; Pupko, Tal/0000-0001-9463-2575	FD Hope; FD Foundation; Israel FD Foundation; Israel Science Foundation [ISF 61/09]	FD Hope; FD Foundation; Israel FD Foundation; Israel Science Foundation(Israel Science Foundation)	This work was supported by FD Hope, FD Foundation, Israel FD Foundation, and Israel Science Foundation (ISF 61/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIN C, 1993, MOL CELL BIOL, V13, P383, DOI 10.1128/MCB.13.1.383; Anderson SL, 2005, BIOCHEM BIOPH RES CO, V336, P150, DOI 10.1016/j.bbrc.2005.08.054; Anderson SL, 2003, BIOCHEM BIOPH RES CO, V310, P627, DOI 10.1016/j.bbrc.2003.09.019; Anderson SL, 2003, BIOCHEM BIOPH RES CO, V306, P303, DOI 10.1016/S0006-291X(03)00971-9; Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Andreassi C, 2001, HUM MOL GENET, V10, P2841, DOI 10.1093/hmg/10.24.2841; Axelrod FB, 2006, CLIN AUTON RES, V16, P90, DOI 10.1007/s10286-006-0326-7; Axelrod FB, 2004, MUSCLE NERVE, V29, P352, DOI 10.1002/mus.10499; Axelrod FB, 2002, J PEDIATR-US, V141, P518, DOI 10.1067/mpd.2002.127088; Barciszewski J, 2007, INT J BIOL MACROMOL, V40, P182, DOI 10.1016/j.ijbiomac.2006.06.024; Brichta L, 2003, HUM MOL GENET, V12, P2481, DOI 10.1093/hmg/ddg256; Bunea Ruxandra, 2004, Altern Med Rev, V9, P420; Chang JG, 2001, P NATL ACAD SCI USA, V98, P9808, DOI 10.1073/pnas.171105098; Cheishvili D, 2007, HUM MOL GENET, V16, P2097, DOI 10.1093/hmg/ddm157; Chen YT, 2009, MOL CELL BIOL, V29, P736, DOI 10.1128/MCB.01313-08; Close P, 2006, MOL CELL, V22, P521, DOI 10.1016/j.molcel.2006.04.017; Cornez I, 2008, BIOCHEM PHARMACOL, V75, P2122, DOI 10.1016/j.bcp.2008.03.006; CROOK T, 1998, TREATMENT AGE RELATE, P20; CROOK TH, 1991, NEUROLOGY, V41, P644, DOI 10.1212/WNL.41.5.644; Cuajungco MP, 2003, AM J HUM GENET, V72, P749, DOI 10.1086/368263; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Fares F, 2008, PRENATAL DIAG, V28, P236, DOI 10.1002/pd.1943; Grzeschik SM, 2005, ANN NEUROL, V58, P194, DOI 10.1002/ana.20548; Guillard J, 2007, BIOORG MED CHEM LETT, V17, P1934, DOI 10.1016/j.bmcl.2007.01.033; Hastings ML, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000208; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Hims MM, 2007, GENOMICS, V90, P389, DOI 10.1016/j.ygeno.2007.05.012; Hims MM, 2007, J MOL MED, V85, P149, DOI 10.1007/s00109-006-0137-2; Holmberg C, 2002, J BIOL CHEM, V277, P31918, DOI 10.1074/jbc.M200719200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Johansen LD, 2008, J CELL SCI, V121, P854, DOI 10.1242/jcs.013722; Jorissen BL, 2002, NUTR NEUROSCI, V5, P337, DOI 10.1080/1028415021000033802; Kidd P., 1996, ALTERN MED REV, V1, P70; Kingsley M, 2006, SPORTS MED, V36, P657, DOI 10.2165/00007256-200636080-00003; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lehavi O, 2003, GENET TEST, V7, P139, DOI 10.1089/109065703322146830; Lekishvili T, 2008, J CELL SCI, V121, P685, DOI 10.1242/jcs.020347; Moreno MD, 2003, CLIN THER, V25, P178; Nakamura H, 2001, FOOD CHEM TOXICOL, V39, P799, DOI 10.1016/S0278-6915(01)00025-4; NGUYEN L, TRENDS MOL MED, V16, P1; Nicholson P, 2010, CELL MOL LIFE SCI, V67, P677, DOI 10.1007/s00018-009-0177-1; Ohkubo T, 2010, J OLEO SCI, V59, P247, DOI 10.5650/jos.59.247; Pepeu G, 1996, PHARMACOL RES, V33, P73, DOI 10.1006/phrs.1996.0013; Rahl PB, 2005, MOL CELL, V17, P841, DOI 10.1016/j.molcel.2005.02.018; Rattan SIS, 2002, J ANTI-AGING MED, V5, P113, DOI 10.1089/109454502317629336; Riessland M, 2006, HUM GENET, V120, P101, DOI 10.1007/s00439-006-0186-1; Rubin BY, 2008, NEUROMOL MED, V10, P148, DOI 10.1007/s12017-007-8019-5; Sampalis Fotini, 2003, Altern Med Rev, V8, P171; Schreiber S, 2000, ISRAEL J PSYCHIAT, V37, P302; Sen CK, 2007, MOL ASPECTS MED, V28, P692, DOI 10.1016/j.mam.2007.03.001; SHARMA SP, 1995, BIOCHEM BIOPH RES CO, V216, P1067, DOI 10.1006/bbrc.1995.2729; Simson GG, 2009, PEDIATR RES, V65, P341, DOI 10.1203/PDR.0b013e318194fd52; Slaugenhaupt SA, 2004, HUM MOL GENET, V13, P429, DOI 10.1093/hmg/ddh046; Slaugenhaupt SA, 2002, CURR OPIN GENET DEV, V12, P307, DOI 10.1016/S0959-437X(02)00303-9; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Storim J, 2001, EXP CELL RES, V267, P233, DOI 10.1006/excr.2001.5250; Svejstrup JQ, 2007, CURR OPIN CELL BIOL, V19, P331, DOI 10.1016/j.ceb.2007.04.005; Vaisman N, 2008, AM J CLIN NUTR, V87, P1170, DOI 10.1093/ajcn/87.5.1170; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; Wood LD, 2001, ONCOGENE, V20, P278, DOI 10.1038/sj.onc.1204072	60	34	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15884	10.1371/journal.pone.0015884	http://dx.doi.org/10.1371/journal.pone.0015884			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209961	gold, Green Published			2022-12-27	WOS:000285793200065
J	Stewart, KR; Lewison, RL; Dunn, DC; Bjorkland, RH; Kelez, S; Halpin, PN; Crowder, LB				Stewart, Kelly R.; Lewison, Rebecca L.; Dunn, Daniel C.; Bjorkland, Rhema H.; Kelez, Shaleyla; Halpin, Patrick N.; Crowder, Larry B.			Characterizing Fishing Effort and Spatial Extent of Coastal Fisheries	PLOS ONE			English	Article							SMALL-SCALE FISHERIES; MARINE FOOD WEBS; GLOBAL FISHERIES; SEA; CONSERVATION; ECOSYSTEMS; CHALLENGES; MANAGEMENT; RESOURCE; IMPACTS	Biodiverse coastal zones are often areas of intense fishing pressure due to the high relative density of fishing capacity in these nearshore regions. Although overcapacity is one of the central challenges to fisheries sustainability in coastal zones, accurate estimates of fishing pressure in coastal zones are limited, hampering the assessment of the direct and collateral impacts (e. g., habitat degradation, bycatch) of fishing. We compiled a comprehensive database of fishing effort metrics and the corresponding spatial limits of fisheries and used a spatial analysis program (FEET) to map fishing effort density (measured as boat-meters per km(2)) in the coastal zones of six ocean regions. We also considered the utility of a number of socioeconomic variables as indicators of fishing pressure at the national level; fishing density increased as a function of population size and decreased as a function of coastline length. Our mapping exercise points to intra and interregional 'hotspots' of coastal fishing pressure. The significant and intuitive relationships we found between fishing density and population size and coastline length may help with coarse regional characterizations of fishing pressure. However, spatially-delimited fishing effort data are needed to accurately map fishing hotspots, i.e., areas of intense fishing activity. We suggest that estimates of fishing effort, not just target catch or yield, serve as a necessary measure of fishing activity, which is a key link to evaluating sustainability and environmental impacts of coastal fisheries.	[Stewart, Kelly R.] Natl Marine Fisheries Serv, Protected Resources Div, SW Fisheries Sci Ctr, La Jolla, CA 92038 USA; [Lewison, Rebecca L.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Dunn, Daniel C.; Halpin, Patrick N.] Duke Univ, Marine Lab, Nicholas Sch Environm, Marine Geospatial Ecol Lab, Beaufort, NC 28516 USA; [Bjorkland, Rhema H.; Kelez, Shaleyla; Crowder, Larry B.] Duke Univ, Marine Lab, Nicholas Sch Environm, Duke Ctr Marine Conservat, Beaufort, NC 28516 USA	National Oceanic Atmospheric Admin (NOAA) - USA; California State University System; San Diego State University; Duke University; Duke University	Stewart, KR (corresponding author), Natl Marine Fisheries Serv, Protected Resources Div, SW Fisheries Sci Ctr, La Jolla, CA 92038 USA.	rlewison@sciences.sdsu.edu	Kelez, Shaleyla/AAE-8259-2020	Kelez, Shaleyla/0000-0003-3296-8721; Lewison, Rebecca/0000-0003-3065-2926; Dunn, Daniel/0000-0001-8932-0681	Gordon and Betty Moore Foundation	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This work was supported by a grant from the Gordon and Betty Moore Foundation to Project GloBAL (Global Bycatch Assessment of Long-lived species http://bycatch.env.duke.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, DISCARDS WORLDS MARI; Begossi A, 2006, ECOL SOC, V11; Bhathal B, 2008, FISH RES, V91, P26, DOI 10.1016/j.fishres.2007.10.022; Booth AJ, 2000, ICES J MAR SCI, V57, P858, DOI 10.1006/jmsc.2000.0816; Bordalo-Machado P, 2006, REV FISH SCI, V14, P369, DOI 10.1080/10641260600893766; Brashares JS, 2004, SCIENCE, V306, P1180, DOI 10.1126/science.1102425; Caddy JF, 1998, REV FISH BIOL FISHER, V8, P431, DOI 10.1023/A:1008807129366; Christensen V, 1998, J FISH BIOL, V53, P128, DOI 10.1006/jfbi.1998.0809; Chuenpagdee R, 2003, FRONT ECOL ENVIRON, V1, P517; Chuenpagdee R, 2006, 148 FISH CTR, V14, P1, DOI DOI 10.14288/1.0074761; Chuenpagdee R, 2008, AM FISH S S, V49, P575; Davies RWD, 2009, MAR POLICY, V33, P661, DOI 10.1016/j.marpol.2009.01.003; Dunn DC, 2010, FISH RES, V102, P60, DOI 10.1016/j.fishres.2009.10.010; Gilman E, 2010, FISH FISH, V11, P57, DOI 10.1111/j.1467-2979.2009.00342.x; Greenstreet SPR, 1999, FISH RES, V40, P153, DOI 10.1016/S0165-7836(98)00210-0; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; He PG, 2006, MAR TECHNOL SOC J, V40, P12, DOI 10.4031/002533206787353187; Hinrichsen D, 1996, ISSUES SCI TECHNOL, V12, P39; Huitric M, 2005, ECOL SOC, V10; International Monetary Fund, 2009, WORLD EC OUTL DAT; Kappel CV, 2005, FRONT ECOL ENVIRON, V3, P275, DOI 10.2307/3868490; Le Pape O, 2001, ICES J MAR SCI, V58, P1232, DOI 10.1006/jmsc.2001.1121; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; LUNDIN CG, 1993, AMBIO, V22, P468; MACKENZIE CL, 2006, 0607 US DEP COMM NE; Madau FA, 2009, MAR POLICY, V33, P860, DOI 10.1016/j.marpol.2009.03.006; Mohammed E., 2003, MEXICO BRAZIL CENTRA, P11; Moore JE, 2010, BIOL CONSERV, V143, P795, DOI 10.1016/j.biocon.2009.12.023; Norse E.A., 1993, GLOBAL MARINE BIOL D; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Piet GJ, 2007, ICES J MAR SCI, V64, P110, DOI 10.1093/icesjms/fsl006; Purcell S., 2010, FAO FISHERIES AQUACU; Roberts CM, 1997, TRENDS ECOL EVOL, V12, P35, DOI 10.1016/S0169-5347(96)20109-0; Sala E, 2004, FISHERIES, V29, P19, DOI 10.1577/1548-8446(2004)29[19:FDCFWI]2.0.CO;2; Salas S, 2007, FISH RES, V87, P5, DOI 10.1016/j.fishres.2007.06.015; Snedecor G.W., 1989, AMES IOWA STATE U PR; Stobutzki IC, 2006, FISH RES, V78, P109, DOI 10.1016/j.fishres.2006.02.002; Sultana P, 2007, HUM ECOL, V35, P527, DOI 10.1007/s10745-006-9092-3; Sumaila UR, 2008, ICES J MAR SCI, V65, P832, DOI 10.1093/icesjms/fsn070; United Nations Commission on Human Security, 2007, HUM DEV REP 2007 200; Unsworth RKF, 2010, CONSERV LETT, V3, P63, DOI 10.1111/j.1755-263X.2010.00101.x; Verdoit M, 2003, AQUAT LIVING RESOUR, V16, P467, DOI 10.1016/j.aquliv.2003.07.002	42	110	111	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e14451	10.1371/journal.pone.0014451	http://dx.doi.org/10.1371/journal.pone.0014451			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206903	gold, Green Submitted, Green Published			2022-12-27	WOS:000285793200007
J	Phillips, TJC; Cherry, CL; Cox, S; Marshall, SJ; Rice, ASC				Phillips, Tudor J. C.; Cherry, Catherine L.; Cox, Sarah; Marshall, Sarah J.; Rice, Andrew S. C.			Pharmacological Treatment of Painful HIV-Associated Sensory Neuropathy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials	PLOS ONE			English	Review							ACETYL-L-CARNITINE; ANTIRETROVIRAL TOXIC NEUROPATHY; CONCENTRATION CAPSAICIN PATCH; PLACEBO-CONTROLLED TRIAL; NERVE GROWTH-FACTOR; PERIPHERAL NEUROPATHY; DOUBLE-BLIND; INFECTED PATIENTS; NATURAL-HISTORY; CLINICAL-TRIALS	Background: Significant pain from HIV-associated sensory neuropathy (HIV-SN) affects similar to 40% of HIV infected individuals treated with antiretroviral therapy (ART). The prevalence of HIV-SN has increased despite the more widespread use of ART. With the global HIV prevalence estimated at 33 million, and with infected individuals gaining increased access to ART, painful HIV-SN represents a large and expanding world health problem. There is an urgent need to develop effective pain management strategies for this condition. Method and Findings: Objective: To evaluate the clinical effectiveness of analgesics in treating painful HIV-SN. Design: Systematic review and meta-analysis. Data sources: Medline, Cochrane central register of controlled trials, www.clinicaltrials.gov, www.controlled-trials.com and the reference lists of retrieved articles. Selection criteria: Prospective, double-blinded, randomised controlled trials (RCTs) investigating the pharmacological treatment of painful HIV-SN with sufficient quality assessed using a modified Jadad scoring method. Review methods: Four authors assessed the eligibility of articles for inclusion. Agreement of inclusion was reached by consensus and arbitration. Two authors conducted data extraction and analysis. Dichotomous outcome measures (>= 30% and >= 50% pain reduction) were sought from RCTs reporting interventions with statistically significant efficacies greater than placebo. These data were used to calculate RR and NNT values. Results: Of 44 studies identified, 19 were RCTs. Of these, 14 fulfilled the inclusion criteria. Interventions demonstrating greater efficacy than placebo were smoked cannabis NNT 3.38 95% CI(1.38 to 4.10), topical capsaicin 8%, and recombinant human nerve growth factor (rhNGF). No superiority over placebo was reported in RCTs that examined amitriptyline (100mg/day), gabapentin (2.4g/day), pregabalin (1200mg/day), prosaptide (16mg/day), peptide-T (6mg/day), acetyl-L-carnitine (1g/day), mexilitine (600mg/day), lamotrigine (600mg/day) and topical capsaicin (0.075% q.d.s.). Conclusions: Evidence of efficacy exists only for capsaicin 8%, smoked cannabis and rhNGF. However, rhNGF is clinically unavailable and smoked cannabis cannot be recommended as routine therapy. Evaluation of novel management strategies for painful HIV-SN is urgently needed.	[Phillips, Tudor J. C.; Rice, Andrew S. C.] Univ London Imperial Coll Sci Technol & Med, Dept Anaesthet Pain Med & Intens Care, London, England; [Cherry, Catherine L.] Burnet Inst, Ctr Virol, Melbourne, Vic, Australia; [Cherry, Catherine L.] Alfred Hosp, Infect Dis Unit, Melbourne, Vic, Australia; [Cherry, Catherine L.] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; [Cox, Sarah] Chelsea & Westminster NHS Fdn Trust, London, England	Imperial College London; Burnet Institute; Florey Institute of Neuroscience & Mental Health; Monash University; Imperial College London	Phillips, TJC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Anaesthet Pain Med & Intens Care, Chelsea & Westminster Hosp Campus, London, England.	a.rice@imperial.ac.uk	Rice, Andrew/I-7501-2012	Cherry, Catherine Louise/0000-0001-9816-5193	Derek Butler Trust (UK Reg Charity) [1081995]; Pfizer; Eisai; Solvay; Spinifex; Organon; Lectus Astellas; Allergan; GSK; NeuroGsx; Esteve; Daiichi Sankyo; EU; Roche Australia; Zymes LLC	Derek Butler Trust (UK Reg Charity); Pfizer(Pfizer); Eisai(Eisai Co Ltd); Solvay(Solvay SA); Spinifex; Organon; Lectus Astellas; Allergan(AbbVieAllergan); GSK(GlaxoSmithKline); NeuroGsx; Esteve; Daiichi Sankyo(Daiichi Sankyo Company Limited); EU(European Commission); Roche Australia(Roche Holding); Zymes LLC	The investigator TJCP was funded by a grant from The Derek Butler Trust (UK Reg Charity 1081995). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; ASCR has received fees and associated expenses for research-related consultancy services contracted via Imperial College Consultants from Pfizer, Eisai, Solvay, Spinifex, Organon, Lectus Astellas, Allergan, GSK, NeuroGsx, Esteve and Daiichi Sankyo. ASCR is a member of the EU funded Innovative Medicines Initiative grant "Europain" in which a number of pharmaceutical companies are also participating: Astra-Zeneca, Esteve, Boehinger-Ingelheim, Pfizer, Eli Lilly, GlaxoSmithKline, Wyeth, UCB and Sanofi Aventis. ASCR has also received a research grant from Pfizer; CLC has had investigator initiated research grants from GlaxoSmithKline, Roche Australia and Zymes LLC; CLC is also on the advisory boards of Gilead Science and BMS Australia Virology, honoraria for both have been donated to charity. CLC undertakes consultancy work and is a principle investigator on two clinical studies for CNS Bio; TJCP, SM and SC have no financial interests that may be relevant to the submitted work. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abrams DI, 2007, NEUROLOGY, V68, P515, DOI 10.1212/01.wnl.0000253187.66183.9c; Armitage P., 2008, STAT METHODS MED RES; BACELLAR H, 1994, NEUROLOGY, V44, P1892, DOI 10.1212/WNL.44.10.1892; BAROHN RJ, 1993, ARCH NEUROL-CHICAGO, V50, P167, DOI 10.1001/archneur.1993.00540020045016; Baron R, 2009, PAIN, V146, P34, DOI 10.1016/j.pain.2009.06.001; Beaulieu P, 2007, CURR OPIN ANESTHESIO, V20, P473, DOI 10.1097/ACO.0b013e3282efd175; Blum AS, 1996, NEUROLOGY, V46, P999, DOI 10.1212/WNL.46.4.999; Bradley WG, 1996, NEUROLOGY, V47, P1446, DOI 10.1212/WNL.47.6.1446; Chiechio S, 2007, CNS DRUGS, V21, P31, DOI 10.2165/00023210-200721001-00005; Clifford D, 2010, 17 C RETR OPP INF FE; Dorfman D, 1999, AIDS, V13, P1589, DOI 10.1097/00002030-199908200-00025; Dworkin RH, 2005, NEUROLOGY, V65, pS7, DOI 10.1212/WNL.65.12_suppl_4.S7; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; Ellis RJ, 2010, ARCH NEUROL-CHICAGO, V67, P552, DOI 10.1001/archneurol.2010.76; Ellis RJ, 2009, NEUROPSYCHOPHARMACOL, V34, P672, DOI 10.1038/npp.2008.120; Estanislao L, 2004, JAIDS-J ACQ IMM DEF, V37, P1584, DOI 10.1097/00126334-200412150-00010; Evans SR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000551; Finnerup NB, 2010, PAIN, V150, P573, DOI 10.1016/j.pain.2010.06.019; Gatti A, 1998, NEUROLOGY, V50, pA216; Hahn K, 2004, J NEUROL, V251, P1260, DOI 10.1007/s00415-004-0529-6; Hart AM, 2004, AIDS, V18, P1549, DOI 10.1097/01.aids.0000131354.14408.fb; Hempenstall K, 2005, PLOS MED, V2, P628, DOI 10.1371/journal.pmed.0020164; Herzmann C, 2005, HIV CLIN TRIALS, V6, P344, DOI 10.1310/CH1N-YBNU-G3CU-JBXR; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kaptchuk TJ, 1999, JAMA-J AM MED ASSOC, V281, P1270, DOI 10.1001/jama.281.14.1270; Kemper CA, 1998, J ACQ IMMUN DEF SYND, V19, P367, DOI 10.1097/00042560-199812010-00007; Kieburtz K, 1998, NEUROLOGY, V51, P1682, DOI 10.1212/WNL.51.6.1682; King SA, 1999, JAMA-J AM MED ASSOC, V281, P1271; Konchalard Komwudh, 2007, Journal of the Medical Association of Thailand, V90, P774; La Spina I, 2001, EUR J NEUROL, V8, P71, DOI 10.1046/j.1468-1331.2001.00157.x; LABBE KA, 1987, ANN INTERN MED, V107, P224, DOI 10.7326/0003-4819-107-2-224; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lichtenstein KA, 2005, CLIN INFECT DIS, V40, P148, DOI 10.1086/426076; LIPKIN WI, 1985, NEUROLOGY, V35, P1479, DOI 10.1212/WNL.35.10.1479; Liu JP, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003937.pub2; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Maratou K, 2009, EUR J PAIN, V13, P387, DOI 10.1016/j.ejpain.2008.05.011; Maritz J, 2010, MUSCLE NERVE, V41, P599, DOI 10.1002/mus.21535; McArthur JC, 2000, NEUROLOGY, V54, P1080, DOI 10.1212/WNL.54.5.1080; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Morgello S, 2004, ARCH NEUROL-CHICAGO, V61, P546, DOI 10.1001/archneur.61.4.546; Navia BA, 1998, NEUROLOGY, V51, P221, DOI 10.1212/WNL.51.1.221; Newshan G, 1998, AIDS, V12, P219; Osio M, 2006, J PERIPHER NERV SYST, V11, P72, DOI 10.1111/j.1085-9489.2006.00066.x; Paice JA, 2000, J PAIN SYMPTOM MANAG, V19, P45, DOI 10.1016/S0885-3924(99)00139-6; Phillips KD, 2004, J ALTERN COMPLEM MED, V10, P449, DOI 10.1089/1075553041323678; Rice ASC, 2008, NAT CLIN PRACT NEURO, V4, P654, DOI 10.1038/ncpneuro0949; Rice ASC, 2008, REV METAANALYSES PAI; Saarto T, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005454, 10.1002/14651858.CD005454.pub2]; Scarpini E, 1997, J Peripher Nerv Syst, V2, P250; Schifitto G, 2001, NEUROLOGY, V57, P1313, DOI 10.1212/WNL.57.7.1313; Schifitto G, 2006, J NEUROVIROL, V12, P328, DOI 10.1080/13550280600873835; Scholz J, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000047; Shlay JC, 1998, JAMA-J AM MED ASSOC, V280, P1590, DOI 10.1001/jama.280.18.1590; Silver M, 2007, J PAIN SYMPTOM MANAG, V34, P446, DOI 10.1016/j.jpainsymman.2006.12.015; Simpson DM, 2006, NEUROLOGY, V66, P1679, DOI 10.1212/01.wnl.0000218303.48113.5d; Simpson DM, 2010, NEUROLOGY, V74, P413, DOI 10.1212/WNL.0b013e3181ccc6ef; Simpson DM, 2008, NEUROLOGY, V70, P2305, DOI 10.1212/01.wnl.0000314647.35825.9c; Simpson DM, 2008, J PAIN SYMPTOM MANAG, V35, P299, DOI 10.1016/j.jpainsymman.2007.04.015; Simpson DM, 1996, NEUROLOGY, V47, P1254, DOI 10.1212/WNL.47.5.1254; Simpson DM, 2003, NEUROLOGY, V60, P1508, DOI 10.1212/01.WNL.0000063304.88470.D9; Simpson DM, 2000, NEUROLOGY, V54, P2115, DOI 10.1212/WNL.54.11.2115; Smyth K, 2007, HIV MED, V8, P367, DOI 10.1111/j.1468-1293.2007.00478.x; Tan T, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1079; Ulett GA, 1999, JAMA-J AM MED ASSOC, V281, P1270; *UNAIDS, 2009, AIDS EP UPD; Vadivelu N, 1999, J PAIN SYMPTOM MANAG, V17, P155; von Gunten CF, 2007, PALLIATIVE MED, V21, P667, DOI 10.1177/0269216307083031; WIFFEN PJ, 2007, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD006044.PUB2; Woolridge E, 2005, J PAIN SYMPTOM MANAG, V29, P358, DOI 10.1016/j.jpainsymman.2004.07.011; Wright E, 2008, NEUROLOGY, V71, P50, DOI 10.1212/01.wnl.0000316390.17248.65; YARCHOAN R, 1988, LANCET, V1, P76; Youle M, 2007, HIV MED, V8, P241, DOI 10.1111/j.1468-1293.2007.00467.x; Youle M, 2007, CNS DRUGS, V21, P25, DOI 10.2165/00023210-200721001-00004	75	162	166	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14433	10.1371/journal.pone.0014433	http://dx.doi.org/10.1371/journal.pone.0014433			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203440	Green Submitted, Green Published, gold			2022-12-27	WOS:000285792500010
J	Reda, AA; Fisseha, S; Mengistie, B; Vandeweerd, JM				Reda, Ayalu A.; Fisseha, Shiferaw; Mengistie, Bezatu; Vandeweerd, Jean-Michel			Standard Precautions: Occupational Exposure and Behavior of Health Care Workers in Ethiopia	PLOS ONE			English	Article							NURSES	Background: Occupational exposure to blood and body fluids is a serious concern for health care workers, and presents a major risk for the transmission of infections such as HIV and hepatitis viruses. The objective of this study was to investigate occupational exposures and behavior of health care workers (HCWs) in eastern Ethiopia. Methods: We surveyed 475 HCWs working in 10 hospitals and 20 health centers in eastern Ethiopia using a structured questionnaire with a response rate of 84.4%. Descriptive statistics and multivariate analysis using logistic regression were performed. Results: Life time risks of needle stick (30.5%; 95% CI 26.4-34.6%) and sharps injuries (25.7%; 95% CI 21.8-29.6%) were high. The one year prevalence of needle stick and sharps injury were 17.5% (95% CI 14.1-20.9%) and 13.5% (95% CI 10.4-16.6%) respectively. There was a high prevalence of life time (28.8%; 95% CI = 24.7-32.9%) and one year (20.2%; 95% CI = 16.6-23.8%) exposures to blood and body fluids. Two hundred thirteen (44.8%) HCWs reported that they were dissatisfied by the supply of infection prevention materials. HCWs had sub-optimal practices and unfavorable attitudes related to standard precautions such as needle recapping (46.9%) and discriminatory attitudes (30.5%) toward HIV/AIDS patients. Conclusion: There was a high level of exposure to blood and body fluids among HCWs. We detected suboptimal practices and behavior that put both patients and HCWs at significant risk of acquiring occupational infections. Health authorities in the study area need to improve the training of HCWs and provision of infection prevention equipment. In addition, regular reporting and assessment of occupational exposures need to be implemented.	[Reda, Ayalu A.] Haramaya Univ, Coll Hlth Sci, Dept Publ Hlth, Harar, Ethiopia; [Fisseha, Shiferaw] E Hararghe Zone Hlth Bur, Environm Hlth Sect, Harar, Ethiopia; [Mengistie, Bezatu] Haramaya Univ, Coll Hlth Sci, Dept Environm Hlth Sci, Harar, Ethiopia; [Vandeweerd, Jean-Michel] Univ Namur, FUNDP, Namur, Belgium	Haramaya University; Haramaya University; University of Namur	Reda, AA (corresponding author), Haramaya Univ, Coll Hlth Sci, Dept Publ Hlth, Harar, Ethiopia.	ayaluaklilu@yahoo.com		mengistie, Bezatu/0000-0002-2127-4444	Ethiopian Public Health Association (EPHA); Haramaya University	Ethiopian Public Health Association (EPHA); Haramaya University	The Ethiopian Public Health Association (EPHA) and Haramaya University funded the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABABE A, 2003, EPIDEMIOL INFECT, P757; Ayele W, 2002, J MED VIROL, V68, P12, DOI 10.1002/jmv.10164; BENNET G, 2003, J CLIN NURS, P413; BISHOP GD, 2000, SINGAP MED J, P55; CDC, 1989, MMWR, V38; *CDC, 1987, MMWR, V36; CHEN Z, 1999, PEDIATR INFECT DIS J, V18, P262; CONNEL J, 2007, SOC SCI MED, P1876; Cutter J, 2004, J ADV NURS, V46, P441, DOI 10.1111/j.1365-2648.2004.03010.x; Diro Ermias, 2008, Ethiop Med J, V46, P7; Fingerhut M, 2005, SCAND J WORK ENV HEA, P58; Gessessew Amanuel, 2009, Ethiop Med J, V47, P213; Gostin LO, 2008, JAMA-J AM MED ASSOC, V299, P1827, DOI 10.1001/jama.299.15.1827; HENRY K, 1992, ANN EMERG MED, P234; HUTIN Y, 2003, B WORLD HEALTH ORGAN, P491; JACOB A, 2010, OCCUPATIONAL MED; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Kermode M, 2005, AM J INFECT CONTROL, V33, P34, DOI 10.1016/j.ajic.2004.07.015; Kermode M, 2005, AM J INFECT CONTROL, V33, P27, DOI 10.1016/j.ajic.2004.07.014; Kloos H, 1998, SOC SCI MED, V46, P505, DOI 10.1016/S0277-9536(97)00194-9; KNIGHT VM, 1997, J ADV NURS, P746; MBANYA DN, 2001, INT NURS REV, P241; Mccoy D, 2008, LANCET, V371, P675, DOI 10.1016/S0140-6736(08)60306-2; Molinari JA, 2003, J AM DENT ASSOC, V134, P569, DOI 10.14219/jada.archive.2003.0222; Nsubuga FM, 2005, TROP MED INT HEALTH, V10, P773, DOI 10.1111/j.1365-3156.2005.01453.x; Parmeggiani C, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-35; Pruss-Ustun A, 2005, AM J IND MED, V48, P482, DOI 10.1002/ajim.20230; Rahlenbeck SI, 1997, INT J STD AIDS, V8, P261, DOI 10.1258/0956462971919886; REDA AA, 2008, J HOSP INFECT, P163; REDECKI S, 2000, ARCH INTERN MED, P3107; Reis C, 2005, PLOS MED, V2, P743, DOI 10.1371/journal.pmed.0020246; ROSE G, 2009, BMJ-BRIT MED J, P291; SADOH WE, 2006, J NATL MED ASSOC, V98, P2006; SAGOEMOSES C, 2001, NEW ENGLAND J MED, V345; SHIMELIS T, 2008, SEXUALLY TRANSMITTED, P37; Simonsen L, 1999, B WORLD HEALTH ORGAN, V77, P789; TADESSE M, 2009, TROPICAL DOCTOR, P111; Trim JC, 2003, J HOSP INFECT, V53, P237, DOI 10.1053/jhin.2002.1378; WHO, 2002, WORLD HLTH REP RED R; Zhang M, 2009, AM J IND MED, V52, P89, DOI 10.1002/ajim.20645; 2005, JOINT ILO WHO GUIDEL; 2006, HLTH RELATED INDICAT; 2005, 6 REPORT AIDS ETHIOP; 2005, IDENTIFYING HIV AIDS	44	61	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e14420	10.1371/journal.pone.0014420	http://dx.doi.org/10.1371/journal.pone.0014420			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	698FO	21203449	gold, Green Published, Green Submitted			2022-12-27	WOS:000285579200006
J	Drafahl, KA; McAndrew, CW; Meyer, AN; Haas, M; Donoghue, DJ				Drafahl, Kristine A.; McAndrew, Christopher W.; Meyer, April N.; Haas, Martin; Donoghue, Daniel J.			The Receptor Tyrosine Kinase FGFR4 Negatively Regulates NF-kappaB Signaling	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; PROSTATE-CANCER PROGRESSION; B-KINASE; EPIDERMAL-GROWTH; IKK-BETA; POTENTIAL TARGET; TUMOR-GROWTH; CELL-DEATH; ACTIVATION; PHOSPHORYLATION	Background: NF kappa B signaling is of paramount importance in the regulation of apoptosis, proliferation, and inflammatory responses during human development and homeostasis, as well as in many human cancers. Receptor Tyrosine Kinases (RTKs), including the Fibroblast Growth Factor Receptors (FGFRs) are also important in development and disease. However, a direct relationship between growth factor signaling pathways and NFkB activation has not been previously described, although FGFs have been known to antagonize TNF alpha-induced apoptosis. Methodology/Principal Findings: Here, we demonstrate an interaction between FGFR4 and IKKb (Inhibitor of NF kappa B Kinase beta subunit), an essential component in the NF kappa B pathway. This novel interaction was identified utilizing a yeast two-hybrid screen [1] and confirmed by coimmunoprecipitation and mass spectrometry analysis. We demonstrate tyrosine phosphorylation of IKKb in the presence of activated FGFR4, but not kinase-dead FGFR4. Following stimulation by TNF alpha (Tumor Necrosis Factor a) to activate NF kappa B pathways, FGFR4 activation results in significant inhibition of NF kappa B signaling as measured by decreased nuclear NF kappa B localization, by reduced NFkB transcriptional activation in electophoretic mobility shift assays, and by inhibition of IKK beta kinase activity towards the substrate GST-I kappa B alpha in in vitro assays. FGF19 stimulation of endogenous FGFR4 in TNF alpha-treated DU145 prostate cancer cells also leads to a decrease in IKKb activity, concomitant reduction in NF kappa B nuclear localization, and reduced apoptosis. Microarray analysis demonstrates that FGF19 + TNF alpha treatment of DU145 cells, in comparison with TNFa alone, favors proliferative genes while downregulating genes involved in apoptotic responses and NF kappa B signaling. Conclusions/Significance: These results identify a compelling link between FGFR4 signaling and the NF kappa B pathway, and reveal that FGFR4 activation leads to a negative effect on NF kappa B signaling including an inhibitory effect on proapoptotic signaling. We anticipate that this interaction between an RTK and a component of NF kappa B signaling will not be limited to FGFR4 alone.	[Drafahl, Kristine A.; McAndrew, Christopher W.; Meyer, April N.; Donoghue, Daniel J.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Haas, Martin; Donoghue, Daniel J.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Drafahl, KA (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	ddonoghue@ucsd.edu			National Institutes of Health (NIH) [5 R01 CA090900]; University of California Cancer Research Coordinating Committee; University of California Breast Cancer Research [14IB-0065]; Ruth L. Kirschstein Institutional National Research Service [5 T32 CA009523]; NATIONAL CANCER INSTITUTE [T32CA009523, R01CA090900] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Cancer Research Coordinating Committee(University of California System); University of California Breast Cancer Research; Ruth L. Kirschstein Institutional National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) #5 R01 CA090900, the University of California Cancer Research Coordinating Committee, and the University of California Breast Cancer Research Program #14IB-0065 to DJD; a Ruth L. Kirschstein Institutional National Research Service Award #5 T32 CA009523 to KAD; the Achievement Rewards for College Scientists Foundation, and the UCSD Chancellor's Interdisciplinary Collaboratories Fellowship to CWM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek K, 2007, J MOL BIOL, V366, P563, DOI 10.1016/j.jmb.2006.11.057; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Biswas DK, 2000, P NATL ACAD SCI USA, V97, P8542, DOI 10.1073/pnas.97.15.8542; Brill LM, 2004, ANAL CHEM, V76, P2763, DOI 10.1021/ac035352d; Cai T, 2002, J CELL BIOL, V159, P103, DOI 10.1083/jcb.200205017; Chandler LA, 1999, INT J CANCER, V81, P451, DOI 10.1002/(SICI)1097-0215(19990505)81:3<451::AID-IJC20>3.3.CO;2-8; Chaudhari BR, 2006, IMMUNOL RES, V35, P249, DOI 10.1385/IR:35:3:249; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Desnoyers L, 2008, ONCOGENE, V27, P85, DOI 10.1038/sj.onc.1210623; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Dutta J, 2006, ONCOGENE, V25, P6800, DOI 10.1038/sj.onc.1209938; Gardner AM, 1996, J BIOL CHEM, V271, P14560, DOI 10.1074/jbc.271.24.14560; Gowardhan B, 2005, BRIT J CANCER, V92, P320, DOI 10.1038/sj.bjc.6602274; Guo GZ, 2004, ONCOGENE, V23, P535, DOI 10.1038/sj.onc.1207149; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hart KC, 2000, ONCOGENE, V19, P3309, DOI 10.1038/sj.onc.1203650; Ho HK, 2009, J HEPATOL, V50, P118, DOI 10.1016/j.jhep.2008.08.015; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Huang J, 2006, J PHARMACOL SCI, V102, P305, DOI 10.1254/jphs.FPJ06004X; Kang SM, 2007, CANCER CELL, V12, P201, DOI 10.1016/j.ccr.2007.08.003; Karin M, 2008, CELL RES, V18, P334, DOI 10.1038/cr.2008.30; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kong M, 2000, EMBO J, V19, P1378, DOI 10.1093/emboj/19.6.1378; Kong M, 2002, J BIOL CHEM, V277, P15962, DOI 10.1074/jbc.M102777200; KORHONEN J, 1992, INT J DEV BIOL, V36, P323; Koumakpayi IH, 2010, BRIT J CANCER, V102, P1163, DOI 10.1038/sj.bjc.6605571; Kwak YT, 2000, J BIOL CHEM, V275, P14752, DOI 10.1074/jbc.M001039200; Lamarca V, 2007, AM J PHYSIOL-CELL PH, V293, pC1347, DOI 10.1152/ajpcell.00431.2006; Mann DJ, 1999, EMBO J, V18, P654, DOI 10.1093/emboj/18.3.654; May MJ, 2002, J BIOL CHEM, V277, P45992, DOI 10.1074/jbc.M206494200; McAndrew CW, 2007, CELL CYCLE, V6, P1937, DOI 10.4161/cc.6.15.4520; Meyer AN, 2004, J BIOL CHEM, V279, P28450, DOI 10.1074/jbc.M403335200; Meyer AN, 2008, CANCER RES, V68, P7362, DOI 10.1158/0008-5472.CAN-08-0575; Mukherji M, 2006, BIOCHEMISTRY-US, V45, P15529, DOI 10.1021/bi060971c; Murphy T, 2010, J PATHOL, V220, P452, DOI 10.1002/path.2657; Nikolaidis NM, 2010, SHOCK, V33, P197, DOI 10.1097/SHK.0b013e3181ae8155; Noels H, 2009, TRENDS CARDIOVAS MED, V19, P76, DOI 10.1016/j.tcm.2009.05.002; O'Dea EL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100148; Ong SH, 2001, P NATL ACAD SCI USA, V98, P6074, DOI 10.1073/pnas.111114298; Pai R, 2008, CANCER RES, V68, P5086, DOI 10.1158/0008-5472.CAN-07-2325; Robertson SC, 1998, P NATL ACAD SCI USA, V95, P4567, DOI 10.1073/pnas.95.8.4567; ROIDL A, 2009, FGFR4 Y367C MUTANT I; Roidl A, 2009, CLIN CANCER RES, V15, P2058, DOI 10.1158/1078-0432.CCR-08-0890; Rokhlin OW, 2002, J BIOL CHEM, V277, P33213, DOI 10.1074/jbc.M204612200; Sahadevan K, 2007, J PATHOL, V213, P82, DOI 10.1002/path.2205; Sarkar FH, 2008, FRONT BIOSCI-LANDMRK, V13, P2950, DOI 10.2741/2900; Schmid JA, 2008, CYTOKINE GROWTH F R, V19, P157, DOI 10.1016/j.cytogfr.2008.01.006; Schomer-Miller B, 2006, J BIOL CHEM, V281, P15268, DOI 10.1074/jbc.M513793200; Sethi G, 2007, ONCOGENE, V26, P7324, DOI 10.1038/sj.onc.1210544; Shambharkar PB, 2007, EMBO J, V26, P1794, DOI 10.1038/sj.emboj.7601622; St Bernard R, 2005, ENDOCRINOLOGY, V146, P1145, DOI 10.1210/en.2004-1134; STARK KL, 1991, DEVELOPMENT, V113, P641; Sun L, 1998, ONCOGENE, V16, P2095, DOI 10.1038/sj.onc.1201731; Taghiyev AF, 2005, CANCER BIOL THER, V4, P382; Taylor JG, 2009, J CLIN INVEST, V119, P3395, DOI 10.1172/JCI39703; Vandermoere F, 2005, ONCOGENE, V24, P5482, DOI 10.1038/sj.onc.1208713; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wang JH, 2008, NEOPLASIA, V10, P847, DOI 10.1593/neo.08450; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Winkler GS, 2010, J CELL PHYSIOL, V222, P66, DOI 10.1002/jcp.21919; Woodworth CD, 2005, MOL CANCER THER, V4, P650, DOI 10.1158/1535-7163.MCT-04-0238; Xie MH, 1999, CYTOKINE, V11, P729, DOI 10.1006/cyto.1999.0485; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360	67	49	50	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14412	10.1371/journal.pone.0014412	http://dx.doi.org/10.1371/journal.pone.0014412			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203561	Green Submitted, Green Published, gold			2022-12-27	WOS:000285578000015
J	Verthelyi, D; Wang, VV				Verthelyi, Daniela; Wang, Vivian			Trace Levels of Innate Immune Response Modulating Impurities (IIRMIs) Synergize to Break Tolerance to Therapeutic Proteins	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; CPG OLIGODEOXYNUCLEOTIDES; BACTERIAL-DNA; GENE-EXPRESSION; DENDRITIC CELLS; LIPOPOLYSACCHARIDE; ACTIVATION; VACCINE; ANTIBODIES; ADJUVANTS	Therapeutic proteins such as monoclonal antibodies, replacement enzymes and toxins have significantly improved the therapeutic options for multiple diseases, including cancer and inflammatory diseases as well as enzyme deficiencies and inborn errors of metabolism. However, immune responses to these products are frequent and can seriously impact their safety and efficacy. Of the many factors that can impact protein immunogenicity, this study focuses on the role of innate immune response modulating impurities (IIRMIs) that could be present despite product purification and whether these impurities can synergize to facilitate an immunogenic response to therapeutic proteins. Using lipopolysaccharide (LPS) and CpG ODN as IIRMIs we showed that trace levels of these impurities synergized to induce IgM, IFN gamma, TNF alpha and IL-6 expression. In vivo, trace levels of these impurities synergized to increase antigen-specific IgG antibodies to ovalbumin. Further, whereas mice treated with human erythropoietin showed a transient increase in hematocrit, those that received human erythropoietin containing low levels of IIRMIs had reduced response to erythropoietin after the 1(st) dose and developed long-lasting anemia following subsequent doses. This suggests that the presence of IIRMIs facilitated a breach in tolerance to the endogenous mouse erythropoietin. Overall, these studies indicate that the risk of enhancing immunogenicity should be considered when establishing acceptance limits of IIRMIs for therapeutic proteins.	[Verthelyi, Daniela; Wang, Vivian] US FDA, Div Therapeut Prot, Off Biotechnol Prod, Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA	US Food & Drug Administration (FDA)	Verthelyi, D (corresponding author), US FDA, Div Therapeut Prot, Off Biotechnol Prod, Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA.	daniela.verthelyi@fda.hhs.gov						Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Bagchi A, 2007, J IMMUNOL, V178, P1164, DOI 10.4049/jimmunol.178.2.1164; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Casadevall N, 2002, NEPHROL DIAL TRANSPL, V17, P42, DOI 10.1093/ndt/17.suppl_5.42; Chen WH, 2010, INNATE IMMUN-LONDON, V16, P322, DOI 10.1177/1753425909346973; Chu RS, 1997, J EXP MED, V186, P1623, DOI 10.1084/jem.186.10.1623; Crampton SR, 2010, ANN NY ACAD SCI, V1183, P58, DOI 10.1111/j.1749-6632.2009.05123.x; Dasari P, 2005, CELL IMMUNOL, V236, P140, DOI 10.1016/j.cellimm.2005.08.020; Ellis RD, 2009, VACCINE, V27, P4104, DOI 10.1016/j.vaccine.2009.04.077; Gao JJ, 1999, J IMMUNOL, V163, P4095; Gao JJ, 2001, J IMMUNOL, V166, P6855, DOI 10.4049/jimmunol.166.11.6855; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x; Gouw SC, 2007, BLOOD, V109, P4693, DOI 10.1182/blood-2006-11-056317; Hume D A, 2001, BMC Immunol, V2, P11, DOI 10.1186/1471-2172-2-11; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kishnani PS, 2010, MOL GENET METAB, V99, P26, DOI 10.1016/j.ymgme.2009.08.003; Klinman DM, 2004, IMMUNOL REV, V199, P201, DOI 10.1111/j.0105-2896.2004.00148.x; Kornbluth RS, 2006, J LEUKOCYTE BIOL, V80, P1084, DOI 10.1189/jlb.0306147; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Kumar S, 2004, INFECT IMMUN, V72, P949, DOI 10.1128/IAI.72.2.949-957.2004; Li JZ, 2001, BLOOD, V98, P3241, DOI 10.1182/blood.V98.12.3241; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macdougall IC, 2005, NEPHROL DIAL TRANSPL, V20, P9, DOI 10.1093/ndt/gfh1087; MAEDA H, 1992, INT J HEMATOL, V55, P111; Makela SM, 2009, J LEUKOCYTE BIOL, V85, P664, DOI 10.1189/jlb.0808503; Marsland BJ, 2007, CURR OPIN IMMUNOL, V19, P611, DOI 10.1016/j.coi.2007.07.022; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; McCoy SL, 2004, J BIOL CHEM, V279, P17217, DOI 10.1074/jbc.M303837200; MORENO E, 1984, INFECT IMMUN, V46, P74, DOI 10.1128/IAI.46.1.74-80.1984; Mueller DL, 2010, NAT IMMUNOL, V11, P21, DOI 10.1038/ni.1817; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Richard K, 2008, J IMMUNOL, V181, P1746, DOI 10.4049/jimmunol.181.3.1746; Rifkin IR, 2005, IMMUNOL REV, V204, P27, DOI 10.1111/j.0105-2896.2005.00239.x; Rosenberg A S, 2003, Dev Biol (Basel), V112, P15; Ryan MH, 2006, INT IMMUNOPHARMACOL, V6, P647, DOI 10.1016/j.intimp.2005.10.001; Sato S, 2002, INT IMMUNOL, V14, P783, DOI 10.1093/intimm/dxf046; Schellekens H, 2002, CLIN THER, V24, P1720, DOI 10.1016/S0149-2918(02)80075-3; Schellekens H, 2004, J NEUROL, V251, P4, DOI 10.1007/s00415-004-1202-9; Schellekens Huub, 2006, J Immunotoxicol, V3, P123, DOI 10.1080/15476910600845567; Schellekens H, 2008, BIOTECHNOL ANN REV, V14, P191, DOI 10.1016/S1387-2656(08)00007-0; Schenk J, 1969, J IMMUNOL, V114, P770; Tada H, 2005, INFECT IMMUN, V73, P7967, DOI 10.1128/IAI.73.12.7967-7976.2005; Thawani N, 2006, EXP HEMATOL, V34, P1451, DOI 10.1016/j.exphem.2006.06.014; Verthelyi D, 2002, J IMMUNOL, V168, P1659, DOI 10.4049/jimmunol.168.4.1659; Verthelyi D, 2004, AIDS, V18, P1003, DOI 10.1097/00002030-200404300-00007; Verthelyi D, 2003, J IMMUNOL, V170, P4717, DOI 10.4049/jimmunol.170.9.4717; Verthelyi D, 2003, TRENDS IMMUNOL, V24, P519, DOI 10.1016/S1471-4906(03)00243-6; Wang JH, 2008, NAT BIOTECHNOL, V26, P901, DOI 10.1038/nbt.1484; Warger T, 2006, BLOOD, V108, P544, DOI 10.1182/blood-2005-10-4015; Weiner GJ, 1997, P NATL ACAD SCI USA, V94, P10833, DOI 10.1073/pnas.94.20.10833; WEN D, 1993, BLOOD, V82, P1507; *WHO, 1998, REQ US AN CELLS IN V, V878, P8; WOROBEC A, 2005, BIO PHARM INT, P22	55	46	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15252	10.1371/journal.pone.0015252	http://dx.doi.org/10.1371/journal.pone.0015252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203556	Green Submitted, Green Published, gold			2022-12-27	WOS:000285578000026
J	Harness, JV; Turovets, NA; Seiler, MJ; Nistor, G; Altun, G; Agapova, LS; Ferguson, D; Laurent, LC; Loring, JF; Keirstead, HS				Harness, Julie V.; Turovets, Nikolay A.; Seiler, Magdalene J.; Nistor, Gabriel; Altun, Gulsah; Agapova, Larissa S.; Ferguson, David; Laurent, Louise C.; Loring, Jeanne F.; Keirstead, Hans S.			Equivalence of Conventionally-Derived and Parthenote-Derived Human Embryonic Stem Cells	PLOS ONE			English	Article							PIGMENT EPITHELIAL-CELLS; IN-VITRO; LINES; TRANSDIFFERENTIATION; DERIVATION	Background: As human embryonic stem cell (hESC) lines can be derived via multiple means, it is important to determine particular characteristics of individual lines that may dictate the applications to which they are best suited. The objective of this work was to determine points of equivalence and differences between conventionally-derived hESC and parthenote-derived hESC lines (phESC) in the undifferentiated state and during neural differentiation. Methodology/Principal Findings: hESC and phESC were exposed to the same expansion conditions and subsequent neural and retinal pigmented epithelium (RPE) differentiation protocols. Growth rates and gross morphology were recorded during expansion. RTPCR for developmentally relevant genes and global DNA methylation profiling were used to compare gene expression and epigenetic characteristics. Parthenote lines proliferated more slowly than conventional hESC lines and yielded lower quantities of less mature differentiated cells in a neural progenitor cell (NPC) differentiation protocol. However, the cell lines performed similarly in a RPE differentiation protocol. The DNA methylation analysis showed similar general profiles, but the two cell types differed in methylation of imprinted genes. There were no major differences in gene expression between the lines before differentiation, but when differentiated into NPCs, the two cell types differed in expression of extracellular matrix (ECM) genes. Conclusions/Significance: These data show that hESC and phESC are similar in the undifferentiated state, and both cell types are capable of differentiation along neural lineages. The differences between the cell types, in proliferation and extent of differentiation, may be linked, in part, to the observed differences in ECM synthesis and methylation of imprinted genes.	[Harness, Julie V.; Seiler, Magdalene J.; Nistor, Gabriel; Ferguson, David; Keirstead, Hans S.] Univ Calif Irvine, Sch Med, Sue & Bill Gross Stem Cell Res Ctr, Dept Anat & Neurobiol,Reeve Irvine Res Ctr, Irvine, CA 92717 USA; [Turovets, Nikolay A.; Agapova, Larissa S.] Int Stem Cell Corp, Oceanside, CA USA; [Altun, Gulsah; Laurent, Louise C.; Loring, Jeanne F.] Scripps Res Inst, Ctr Regenerat Med, La Jolla, CA 92037 USA	University of California System; University of California Irvine; Scripps Research Institute	Keirstead, HS (corresponding author), Univ Calif Irvine, Sch Med, Sue & Bill Gross Stem Cell Res Ctr, Dept Anat & Neurobiol,Reeve Irvine Res Ctr, Irvine, CA 92717 USA.	hansk@uci.edu	Loring, Jeanne F/A-1620-2011; Seiler, Magdalene J./I-2942-2019	Loring, Jeanne F/0000-0001-6226-9767; Seiler, Magdalene J./0000-0002-0869-9923; Laurent, Louise/0000-0002-2095-7534	Bill and Joan Jackson Scholars Fund; National Institutes of Health (NIH); California Institute for Regenerative Medicine (CIRM) [CL-100502; TR1-01250, RT1-0118]; Bill and Melinda Gates Foundation; O'Keeffe Foundation; Millipore Foundation; NIH [2K12HD001259-11]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001259] Funding Source: NIH RePORTER	Bill and Joan Jackson Scholars Fund; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); O'Keeffe Foundation; Millipore Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This project was supported by individual donations to the Keirstead Research Group, a sponsored research agreement with International Stem Cell Corporation and the Lincy Foundation. JVH was supported by the Bill and Joan Jackson Scholars Fund. JFL, LCL, and GA are funded by grants from the National Institutes of Health (NIH), California Institute for Regenerative Medicine (CIRM) (CL-100502; TR1-01250; RT1-0118), the Bill and Melinda Gates Foundation, and unrestricted donations from the O'Keeffe Foundation and the Millipore Foundation. LCL was supported by an NIH Career Development Award (2K12HD001259-11) and a Hartwell Individual Biomedical Research Award. The funders had no role in study design or decision to publish. Employees of International Stem Cell Corporation contributed to design of experiments, data collection and analysis, and preparation of the manuscript.	Buchholz DE, 2009, STEM CELLS, V27, P2427, DOI 10.1002/stem.189; Burke JM, 1996, EXP EYE RES, V62, P63, DOI 10.1006/exer.1996.0008; Busch C, 2009, J PATHOL, V217, P589, DOI 10.1002/path.2486; Drukker M, 2006, STEM CELLS, V24, P221, DOI 10.1634/stemcells.2005-0188; Fernandez CA, 2003, J BIOL CHEM, V278, P40989, DOI 10.1074/jbc.M306176200; GRISANTI S, 1995, INVEST OPHTH VIS SCI, V36, pS750; Kiselyov VV, 2005, J NEUROCHEM, V94, P1169, DOI 10.1111/j.1471-4159.2005.03284.x; Klimanskaya I, 2004, CLONING STEM CELLS, V6, P217, DOI 10.1089/clo.2004.6.217; Klimanskaya I, 2006, NATURE, V444, P481, DOI 10.1038/nature05142; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Krieglstein K, 1998, EUR J NEUROSCI, V10, P2746, DOI 10.1046/j.1460-9568.1998.00324.x; Li L, 2004, STEM CELLS, V22, P448, DOI 10.1634/stemcells.22-4-448; Lin G, 2007, CELL RES, V17, P999, DOI 10.1038/cr.2007.97; Mai QY, 2007, CELL RES, V17, P1008, DOI 10.1038/cr.2007.102; Menendez P, 2005, STEM CELL REV, V1, P151, DOI 10.1385/SCR:1:2:151; OPAS M, 1994, DEV BIOL, V161, P440, DOI 10.1006/dbio.1994.1043; Ponsioen TL, 2008, INVEST OPHTH VIS SCI, V49, P4089, DOI 10.1167/iovs.07-1456; Revazova ES, 2008, CLONING STEM CELLS, V10, P11, DOI 10.1089/clo.2007.0063; Revazova ES, 2007, CLONING STEM CELLS, V9, P432, DOI 10.1089/clo.2007.0033; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao SL, 1997, INT REV CYTOL, V171, P225	23	17	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e14499	10.1371/journal.pone.0014499	http://dx.doi.org/10.1371/journal.pone.0014499			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249129	gold, Green Published			2022-12-27	WOS:000286512900004
J	Arthur, JW; Reichardt, JKV				Arthur, Jonathan W.; Reichardt, Juergen K. V.			Modeling Single Nucleotide Polymorphisms in the Human AKR1C1 and AKR1C2 Genes: Implications for Functional and Genotyping Analyses	PLOS ONE			English	Article							TYPE-3 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE; KETO REDUCTASE SUPERFAMILY; 3-DIMENSIONAL STRUCTURES; STRUCTURE VALIDATION; CRYSTAL-STRUCTURES; PROSTATE-CANCER; BINDING; IDENTIFICATION; PROTEINS; ANDROGEN	Enzymes encoded by the AKR1C1 and AKR1C2 genes are responsible for the metabolism of progesterone and 5 alpha-dihydrotestosterone (DHT), respectively. The effect of amino acid substitutions, resulting from single nucleotide polymorphisms (SNPs) in the AKR1C2 gene, on the enzyme kinetics of the AKR1C2 gene product were determined experimentally by Takashi et al. In this paper, we used homology modeling to predict and analyze the structure of AKR1C1 and AKR1C2 genetic variants. The experimental reduction in enzyme activity in the AKR1C2 variants F46Y and L172Q, as determined by Takahashi et al., is predicted to be due to increased instability in cofactor binding, caused by disruptions to the hydrogen bonds between NADP and AKR1C2, resulting from the insertion of polar residues into largely non-polar environments near the site of cofactor binding. Other AKR1C2 variants were shown to involve either conservative substitutions or changes taking place on the surface of the molecule and distant from the active site, confirming the experimental finding of Takahashi et al. that these variants do not result in any statistically significant reduction in enzyme activity. The AKR1C1 R258C variant is predicted to have no effect on enzyme activity for similar reasons. Thus, we provide further insight into the molecular mechanism of the enzyme kinetics of these proteins. Our data also highlight previously reported difficulties with online databases.	[Arthur, Jonathan W.] Univ Sydney, Sydney Med Sch, Discipline Med, Sydney, NSW 2006, Australia; [Reichardt, Juergen K. V.] Univ Sydney, Sydney Med Sch, Plunkett Chair Mol Biol Med, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Arthur, JW (corresponding author), Univ Sydney, Sydney Med Sch, Discipline Med, Sydney, NSW 2006, Australia.	jonathan.arthur@sydney.edu.au	Arthur, Jonathan/A-5367-2009	Arthur, Jonathan/0000-0003-3615-7352; Reichardt, Juergen/0000-0001-6458-2773	National Cancer Institute [P01 CA108964]; NATIONAL CANCER INSTITUTE [P01CA108964] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute (www.cancer.gov) grant P01 CA108964 (project 1) to JKVR who is also a Medical Foundation Fellow at the University of Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Bauman DR, 2006, ENDOCRINOLOGY, V147, P5806, DOI 10.1210/en.2006-0627; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BOHREN KM, 1989, J BIOL CHEM, V264, P9547; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Canutescu AA, 2005, BIOINFORMATICS, V21, P2914, DOI 10.1093/bioinformatics/bti438; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Couture JF, 2005, PROTEIN SCI, V14, P1485, DOI 10.1110/ps.051353205; Couture JF, 2003, J MOL BIOL, V331, P593, DOI 10.1016/S0022-2836(03)00762-9; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Day INM, 2010, HUM MUTAT, V31, P2, DOI 10.1002/humu.21149; Faucher F, 2007, J MOL BIOL, V369, P525, DOI 10.1016/j.jmb.2007.03.058; Faucher F, 2006, J MOL BIOL, V364, P747, DOI 10.1016/j.jmb.2006.09.030; Jin Y, 2001, BIOCHEMISTRY-US, V40, P10161, DOI 10.1021/bi010919a; Jin Y, 2006, BIOCHEMISTRY-US, V45, P13054, DOI 10.1021/bi060591r; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Musumeci L, 2010, HUM MUTAT, V31, P67, DOI 10.1002/humu.21137; Nahoum V, 2001, J BIOL CHEM, V276, P42091, DOI 10.1074/jbc.M105610200; Penning TM, 2000, BIOCHEM J, V351, P67, DOI 10.1042/0264-6021:3510067; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Takahashi RH, 2009, J PHARMACOL EXP THER, V329, P1032, DOI 10.1124/jpet.109.150995; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; XU Q, 2011, NUCL ACIDS IN PRESS	29	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15604	10.1371/journal.pone.0015604	http://dx.doi.org/10.1371/journal.pone.0015604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217827	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000285838900023
J	Mason, E; Tronc, G; Nones, K; Matigian, N; Kim, J; Aronow, BJ; Wolfinger, RD; Wells, C; Gibson, G				Mason, Elizabeth; Tronc, Graham; Nones, Katia; Matigian, Nick; Kim, Jinhee; Aronow, Bruce J.; Wolfinger, Russell D.; Wells, Christine; Gibson, Greg			Maternal Influences on the Transmission of Leukocyte Gene Expression Profiles in Population Samples from Brisbane, Australia	PLOS ONE			English	Article							THRIFTY PHENOTYPE HYPOTHESIS; UMBILICAL-CORD BLOOD; DEVELOPMENTAL ORIGINS; ADULT DISEASE; LYMPHOCYTES; EPIGENETICS; RECEPTORS; HEALTH; LINK	Two gene expression profiling studies designed to identify maternal influences on development of the neonate immune system and to address the population structure of the leukocyte transcriptome were carried out in Brisbane, Australia. In the first study, a comparison of 19 leukocyte samples obtained from mothers in the last three weeks of pregnancy with 37 umbilical cord blood samples documented differential expression of 7,382 probes at a false discovery rate of 1%, representing approximately half of the expressed transcriptome. An even larger component of the variation involving 8,432 probes, notably enriched for Vitamin E and methotrexate-responsive genes, distinguished two sets of individuals, with perfect transmission of the two profile types between each of 16 mother-child pairs in the study. A minor profile of variation was found to distinguish the gene expression profiles of obese mothers and children of gestational diabetic mothers from those of children born to obese mothers. The second study was of adult leukocyte profiles from a cross-section of Red Cross blood donors sampled throughout Brisbane. The first two axes in this study are related to the third and fourth axes of variation in the first study and also reflect variation in the abundance of CD4 and CD8 transcripts. One of the profiles associated with the third axis is largely excluded from samples from the central portion of the city. Despite enrichment of insulin signaling and aspects of central metabolism among the differentially expressed genes, there was little correlation between leukocyte expression profiles and body mass index overall. Our data is consistent with the notion that maternal health and cytokine milieu directly impact gene expression in fetal tissues, but that there is likely to be a complex interplay between cultural, genetic, and other environmental factors in the programming of gene expression in leukocytes of newborn children.	[Mason, Elizabeth; Gibson, Greg] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Tronc, Graham] Wesley Med Ctr, Auchenflower, Australia; [Nones, Katia; Matigian, Nick; Wells, Christine] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, Qld 4111, Australia; [Kim, Jinhee; Gibson, Greg] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Aronow, Bruce J.] Cincinnati Childrens Hosp Med Ctr, Computat Med Ctr, Cincinnati, OH USA; [Wolfinger, Russell D.] SAS Inst Inc, Cary, NC USA	University of Queensland; Wesley Hospital; Griffith University; University System of Georgia; Georgia Institute of Technology; Cincinnati Children's Hospital Medical Center; SAS Institute Inc	Mason, E (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.	greg.gibson@biology.gatech.edu	Nones, Katia/AAX-6453-2021; Mason, Elizabeth A/C-6193-2012; Aronow, Bruce J/F-8438-2012; Mason, Elizabeth/AAH-6851-2020; Matigian, Nicholas/AAF-9390-2020; Matigian, Nicholas A/A-4935-2009; Mason, Elizabeth A/N-2345-2014; Wells, Christine A/A-5071-2010	Nones, Katia/0000-0003-1925-5196; Mason, Elizabeth A/0000-0002-8823-0024; Matigian, Nicholas/0000-0001-7735-9415; Matigian, Nicholas A/0000-0001-7735-9415; Wells, Christine A/0000-0003-3133-3628	University of Queensland, Australia; Australian Research Council (ARC) [DP0880204]	University of Queensland, Australia(University of Queensland); Australian Research Council (ARC)(Australian Research Council)	This study was funded by the University of Queensland, Australia, and salary support for GG and EM was provided by the Australian Research Council (ARC DP0880204). RW is an employee of SAS Institute Inc., and was involved in data analysis as a long-term collaborator with the senior author, GG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHANDRA RK, 1975, AM J DIS CHILD, V129, P450, DOI 10.1001/archpedi.1975.02120410038013; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Colao A, 2008, EUR J ENDOCRINOL, V159, P389, DOI 10.1530/EJE-08-0201; D'Arena G, 1998, HAEMATOLOGICA, V83, P197; Durand EF, 2007, J COMMUN HEALTH NURS, V24, P167, DOI 10.1080/07370010701429579; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Evans D M, 1999, Twin Res, V2, P250, DOI 10.1375/136905299320565735; Ferreira MAR, 2010, AM J HUM GENET, V86, P88, DOI 10.1016/j.ajhg.2009.12.008; Fry RC, 2007, PLOS GENET, V3, P2180, DOI 10.1371/journal.pgen.0030207; Gluckman PD, 2005, MATERN CHILD NUTR, V1, P130, DOI 10.1111/j.1740-8709.2005.00020.x; Godfrey KM, 2007, PEDIATR RES, V61, p5R, DOI 10.1203/pdr.0b013e318045bedb; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Hong JA, 2004, J IMMUNOL, V172, P5870, DOI 10.4049/jimmunol.172.10.5870; Idaghdour Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000052; Idaghdour Y, 2010, NAT GENET, V42, P62, DOI 10.1038/ng.495; Jiang H, 2009, EXP HEMATOL, V37, P1201, DOI 10.1016/j.exphem.2009.07.010; Joss-Moore LA, 2009, CURR OPIN PEDIATR, V21, P230, DOI 10.1097/MOP.0b013e328326773b; Ling C, 2009, DIABETES, V58, P2718, DOI 10.2337/db09-1003; Marodi L, 2006, CLIN IMMUNOL, V118, P137, DOI 10.1016/j.clim.2005.10.012; Merkerova M, 2009, EUR J HAEMATOL, V83, P183, DOI 10.1111/j.1600-0609.2009.01281.x; Miller GE, 2009, P NATL ACAD SCI USA, V106, P14716, DOI 10.1073/pnas.0902971106; Montano M, 2006, GENES IMMUN, V7, P298, DOI 10.1038/sj.gene.6364297; Schonland SO, 2003, BLOOD, V102, P1428, DOI 10.1182/blood-2002-11-3591; Stone EA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000479; Thewissen M, 2008, CRIT REV IMMUNOL, V28, P363, DOI 10.1615/CritRevImmunol.v28.i5.10; Underhill DM, 2007, IMMUNOL REV, V219, P75, DOI 10.1111/j.1600-065X.2007.00548.x; Waterland RA, 2009, HORM RES, V71, P13, DOI 10.1159/000178030; Willment JA, 2008, TRENDS MICROBIOL, V16, P27, DOI 10.1016/j.tim.2007.10.012	30	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e14479	10.1371/journal.pone.0014479	http://dx.doi.org/10.1371/journal.pone.0014479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217831	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000285838900008
J	Schwarz, RF; Fletcher, W; Forster, F; Merget, B; Wolf, M; Schultz, J; Markowetz, F				Schwarz, Roland F.; Fletcher, William; Foerster, Frank; Merget, Benjamin; Wolf, Matthias; Schultz, Joerg; Markowetz, Florian			Evolutionary Distances in the Twilight Zone-A Rational Kernel Approach	PLOS ONE			English	Article							MULTIPLE-SEQUENCE ALIGNMENT; MAXIMUM-LIKELIHOOD ALIGNMENT; PROFILE DISTANCES; DNA-SEQUENCES; PHYLOGENY; TREES; INFERENCE; RECONSTRUCTION; CHLOROPHYCEAE; CONSTRUCTION	Phylogenetic tree reconstruction is traditionally based on multiple sequence alignments (MSAs) and heavily depends on the validity of this information bottleneck. With increasing sequence divergence, the quality of MSAs decays quickly. Alignment-free methods, on the other hand, are based on abstract string comparisons and avoid potential alignment problems. However, in general they are not biologically motivated and ignore our knowledge about the evolution of sequences. Thus, it is still a major open question how to define an evolutionary distance metric between divergent sequences that makes use of indel information and known substitution models without the need for a multiple alignment. Here we propose a new evolutionary distance metric to close this gap. It uses finite-state transducers to create a biologically motivated similarity score which models substitutions and indels, and does not depend on a multiple sequence alignment. The sequence similarity score is defined in analogy to pairwise alignments and additionally has the positive semi-definite property. We describe its derivation and show in simulation studies and real-world examples that it is more accurate in reconstructing phylogenies than competing methods. The result is a new and accurate way of determining evolutionary distances in and beyond the twilight zone of sequence alignments that is suitable for large datasets.	[Schwarz, Roland F.; Markowetz, Florian] Univ Cambridge, Canc Res UK Cambridge Res Inst, Cambridge, England; [Fletcher, William] UCL, Dept Genet Evolut & Environm, London, England; [Fletcher, William] UCL, Ctr Math & Phys Life Sci & Expt Biol, London, England; [Foerster, Frank; Merget, Benjamin; Wolf, Matthias; Schultz, Joerg] Univ Wurzburg, Dept Bioinformat, Bioctr, Wurzburg, Germany	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of London; University College London; University of London; University College London; University of Wurzburg	Schwarz, RF (corresponding author), Univ Cambridge, Canc Res UK Cambridge Res Inst, Cambridge, England.	rfs32@cam.ac.uk; florian.markowetz@cancer.org.uk	Markowetz, Florian/H-6883-2019; Förster, Frank/A-2181-2010; Wolf, Matthias/A-5580-2008	Markowetz, Florian/0000-0002-2784-5308; Förster, Frank/0000-0003-4166-5423; Wolf, Matthias/0000-0003-2004-1806; Schwarz, Roland/0000-0001-9155-4268	Cancer Research UK; Deutsche Forschungsgemeinschaft (DFG) [Mu-2831/1-1]; Engineering and Physical Sciences Research Council/Medical Research Council Doctoral Training Centre; University of Cambridge; Hutchison Whampoa Limited	Cancer Research UK(Cancer Research UK); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Engineering and Physical Sciences Research Council/Medical Research Council Doctoral Training Centre(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); University of Cambridge(University of Cambridge); Hutchison Whampoa Limited	This work was partially funded by Cancer Research UK. Further support was provided by the Deutsche Forschungsgemeinschaft (DFG) grant (Mu-2831/1-1). WF is financially supported by an Engineering and Physical Sciences Research Council/Medical Research Council Doctoral Training Centre studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the support of The University of Cambridge, Cancer Research UK and Hutchison Whampoa Limited.	Bemm F, 2009, FEBS LETT, V583, P3589, DOI 10.1016/j.febslet.2009.10.029; BISHOP MJ, 1986, J MOL BIOL, V190, P159, DOI 10.1016/0022-2836(86)90289-5; Buchheim MA, 2001, J PHYCOL, V37, P819, DOI 10.1046/j.1529-8817.2001.00162.x; Cortes C., 2004, J MACH LERN RES, V1, P1; DASKALAKIS C, 2010, ALIGNMENT FREE PHYLO; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; DOOLITTLE RF, 1987, URFS ORFS PRIMER ANA; DROSTE M, HDB WEIGHTED AUTOMAT, P1; Durbin R., 1998, BIOL SEQUENCE ANAL P; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J, 2009, PHYLIP PHYLOGENY INF; Fletcher W, 2010, MOL BIOL EVOL, V27, P2257, DOI 10.1093/molbev/msq115; Fletcher W, 2009, MOL BIOL EVOL, V26, P1879, DOI 10.1093/molbev/msp098; Friedrich J, 2005, BIOINFORMATICS, V21, P2108, DOI 10.1093/bioinformatics/bti289; Goldman N, 1998, BIOESSAYS, V20, P287, DOI 10.1002/(SICI)1521-1878(199804)20:4<287::AID-BIES4>3.0.CO;2-N; Hein J, 2003, P NATL ACAD SCI USA, V100, P14960, DOI 10.1073/pnas.2036252100; HIGHAM NJ, 1988, LINEAR ALGEBRA APPL, V103, P103, DOI 10.1016/0024-3795(88)90223-6; Hohl M, 2006, EVOL BIOINFORM, V2, P359; Hohl M, 2007, SYST BIOL, V56, P206, DOI 10.1080/10635150701294741; Keller A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-218; KUHNER MK, 1994, MOL BIOL EVOL, V11, P459; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Mailund T, 2004, BIOINFORMATICS, V20, P1636, DOI 10.1093/bioinformatics/bth097; Mohri M., 2003, International Journal of Foundations of Computer Science, V14, P957, DOI 10.1142/S0129054103002114; Mohri M., 1996, Natural Language Engineering, V2, P61, DOI 10.1017/S135132499600126X; Muller T, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-20; Ogden TH, 2006, SYST BIOL, V55, P314, DOI 10.1080/10635150500541730; Otu HH, 2003, BIOINFORMATICS, V19, P2122, DOI 10.1093/bioinformatics/btg295; Rivas E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000172; Roch S, 2010, SCIENCE, V327, P1376, DOI 10.1126/science.1182300; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suchard MA, 2006, BIOINFORMATICS, V22, P2047, DOI 10.1093/bioinformatics/btl175; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; THORNE JL, 1992, J MOL EVOL, V34, P3, DOI 10.1007/BF00163848; THORNE JL, 1991, J MOL EVOL, V33, P114, DOI 10.1007/BF02193625; Ulitsky I, 2006, J COMPUT BIOL, V13, P336, DOI 10.1089/cmb.2006.13.336; WANG LS, 2009, IMPACT MULTIPLE PROT; WATERMAN MS, 1977, J THEOR BIOL, V64, P199, DOI 10.1016/0022-5193(77)90351-4; Whelan S, 2001, TRENDS GENET, V17, P262, DOI 10.1016/S0168-9525(01)02272-7; Wolf M, 2002, PLANT SYST EVOL, V230, P161, DOI 10.1007/s006060200002; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532	45	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15788	10.1371/journal.pone.0015788	http://dx.doi.org/10.1371/journal.pone.0015788			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209825	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000285838900033
J	Tegethoff, M; Greene, N; Olsen, J; Meyer, AH; Meinlschmidt, G				Tegethoff, Marion; Greene, Naomi; Olsen, Jorn; Meyer, Andrea H.; Meinlschmidt, Gunther			Maternal Psychosocial Stress during Pregnancy and Placenta Weight: Evidence from a National Cohort Study	PLOS ONE			English	Article							PLASMA PROTEIN-A; BIRTH-WEIGHT; HUMAN FIBROBLASTS; PRENATAL STRESS; NEWBORN-INFANT; GROWTH-HORMONE; FETAL-GROWTH; FOLLOW-UP; IN-UTERO; LIFE	Background: To study in a large-scale cohort with prospective data the associations between psychosocial stress during pregnancy and placenta weight at birth. Animal data suggest that the placenta is involved in stress-related fetal programming. Methodology/Principal Findings: We defined a priori two types of psychosocial stress during pregnancy, life stress (perceived burdens in major areas of life) and emotional symptoms (e. g. anxiety). We estimated the associations of maternal stress during pregnancy with placenta weight at birth, controlled for length of gestation, by predicting gestational age-and sex-specific z-scores of placenta weight through multiple regression analysis, adjusted for potential confounders (N = 78017 singleton pregnancies). Life stress (per increase in stress score by 1, range: 0-18) during pregnancy was associated with increased placenta weight at birth (z-score, reported in 10(-3); B, 14.33; CI, 10.12-18.54). In contrast, emotional symptoms during pregnancy were not associated with placenta weight at birth. Conclusions/Significance: Maternal life stress but not emotional symptoms during pregnancy was associated with increased placenta weight at birth; yet, the association-estimate was rather small. Our results may contribute to a better understanding of the role of the placenta in the regulation of intrauterine processes in response to maternal stress.	[Tegethoff, Marion; Meyer, Andrea H.; Meinlschmidt, Gunther] Univ Basel, Dept Psychol, Div Clin Psychol & Psychotherapy, Basel, Switzerland; [Tegethoff, Marion] Univ Trier, Inst Psychobiol, Dept Neurobehav Genet, Trier, Germany; [Greene, Naomi; Olsen, Jorn] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Olsen, Jorn] Univ Aarhus, Inst Publ Hlth, Danish Epidemiol Sci Ctr, Dept Epidemiol, Aarhus, Denmark; [Meyer, Andrea H.] Univ Basel, Dept Psychol, Dept Appl Stat Life Sci, Basel, Switzerland; [Meinlschmidt, Gunther] Natl Ctr Competence Res Swiss Etiol Study Adjustm, Basel, Switzerland	University of Basel; Universitat Trier; University of California System; University of California Los Angeles; Aarhus University; University of Basel	Tegethoff, M (corresponding author), Univ Basel, Dept Psychol, Div Clin Psychol & Psychotherapy, Basel, Switzerland.	gunther.meinlschmidt@unibas.ch	Meinlschmidt, Gunther/AAD-3618-2019	Meinlschmidt, Gunther/0000-0002-3488-193X	Danish National Research Foundation; German National Academic Foundation; Swiss National Science Foundation (SNSF) [51A240-104890]	Danish National Research Foundation(Danmarks Grundforskningsfond); German National Academic Foundation; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	The Danish National Research Foundation has established the Danish Epidemiology Science Centre that initiated and created the Danish National Birth Cohort. The cohort is furthermore a result of a major grant from this Foundation. Additional support for the Danish National Birth Cohort is obtained from the Pharmacy Foundation, the Egmont Foundation, the March of Dimes Birth Defects Foundation, the Augustinus Foundation, and the Health Foundation. This project was financed by the German National Academic Foundation (to MT), and the Swiss National Science Foundation (SNSF), project no. 51A240-104890, (to GM). Validation of the stress scores was undertaken in part with data from the National Centre of Competence in Research 'Swiss Etiological Study of Adjustment and Mental Health (sesam)', funded by the Swiss National Science Foundation (SNSF), project no. 51A240-104890. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baptiste-Roberts Kesha, 2008, BMC Pregnancy Childbirth, V8, P44, DOI 10.1186/1471-2393-8-44; BARKER DJP, 1990, BRIT MED J, V301, P259, DOI 10.1136/bmj.301.6746.259; Bech BH, 2005, AM J EPIDEMIOL, V162, P983, DOI 10.1093/aje/kwi317; Bland JM, 2002, BRIT MED J, V324, P606, DOI 10.1136/bmj.324.7337.606; Carter FA, 2005, AUST NZ J PSYCHIAT, V39, P255, DOI 10.1111/j.1440-1614.2005.01562.x; Charalambous M, 2003, P NATL ACAD SCI USA, V100, P8292, DOI 10.1073/pnas.1532175100; CHOW GC, 1960, ECONOMETRICA, V28, P591, DOI 10.2307/1910133; Coall DA, 2008, PEDIAT DEV PATHOL, P1; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Coussons-Read ME, 2007, BRAIN BEHAV IMMUN, V21, P343, DOI 10.1016/j.bbi.2006.08.006; Coussons-Read ME, 2005, PSYCHOSOM MED, V67, P625, DOI 10.1097/01.psy.0000170331.74960.ad; Derogatis L. R., 1977, SCL 90 MANUAL SCORIN; Dole N, 2003, AM J EPIDEMIOL, V157, P14, DOI 10.1093/aje/kwf176; Fatayerji N, 1996, ALCOHOL CLIN EXP RES, V20, P94, DOI 10.1111/j.1530-0277.1996.tb01051.x; Figueras F, 2002, EUR J OBSTET GYN R B, V105, P25, DOI 10.1016/S0301-2115(02)00141-0; Fink P, 2004, J PSYCHOSOM RES, V56, P371, DOI 10.1016/S0022-3999(03)00071-0; Forbes K, 2008, HORM RES, V69, P129, DOI 10.1159/000112585; Fowden AL, 2008, J NEUROENDOCRINOL, V20, P439, DOI 10.1111/j.1365-2826.2008.01663.x; Fowden AL, 2006, PHYSIOLOGY, V21, P29, DOI 10.1152/physiol.00050.2005; Frank D, 2002, P NATL ACAD SCI USA, V99, P7490, DOI 10.1073/pnas.122039999; Fuglsang J, 2006, GROWTH HORM IGF RES, V16, P67, DOI 10.1016/j.ghir.2006.03.010; Glorio-Bottini F, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-38; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Godfrey KM, 2002, PLACENTA, V23, pS20, DOI 10.1053/plac.2002.0773; Goldberg D.P, 1972, DETECTION PSYCHIAT I; Gude NM, 2004, THROMB RES, V114, P397, DOI 10.1016/j.thromres.2004.06.038; Hafner E, 2003, PLACENTA, V24, P336, DOI 10.1053/plac.2002.0918; Hansen D, 2000, LANCET, V356, P875, DOI 10.1016/S0140-6736(00)02676-3; Hindmarsh PC, 2000, LANCET, V356, P719, DOI 10.1016/S0140-6736(00)02630-1; Jansson T, 2007, CLIN SCI, V113, P1, DOI 10.1042/CS20060339; KANNER A D, 1981, Journal of Behavioral Medicine, V4, P1, DOI 10.1007/BF00844845; Kramer MS, 2010, PAEDIATR PERINAT EP, V24, P390, DOI 10.1111/j.1365-3016.2010.01127.x; KRUGER H, 1970, AM J OBSTET GYNECOL, V106, P586; Kucuk M, 2009, J DIABETES COMPLICAT, V23, P25, DOI 10.1016/j.jdiacomp.2007.04.002; Lawrence JB, 1999, P NATL ACAD SCI USA, V96, P3149, DOI 10.1073/pnas.96.6.3149; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; Lumey LH, 1998, PLACENTA, V19, P105; MCLEAN M, 1995, NAT MED, V1, P460, DOI 10.1038/nm0595-460; MILLS NC, 1986, MOL BIOL REP, V11, P231, DOI 10.1007/BF00419602; Mittal P, 2007, J MATERN-FETAL NEO M, V20, P651, DOI 10.1080/14767050701463571; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; NAEYE RL, 1987, HUM PATHOL, V18, P387, DOI 10.1016/S0046-8177(87)80170-3; Niklasson A, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-8; NORBECK JS, 1984, RES NURS HEALTH, V7, P61, DOI 10.1002/nur.4770070110; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Olsen J, 2008, EPIDEMIOLOGY, V19, P635, DOI 10.1097/EDE.0b013e3181773494; Pacak K, 2001, ENDOCR REV, V22, P502, DOI 10.1210/er.22.4.502; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Resch ZT, 2006, ENDOCRINOLOGY, V147, P885, DOI 10.1210/en.2005-0908; Richardson HN, 2006, ENDOCRINOLOGY, V147, P2506, DOI 10.1210/en.2005-1054; Roberts CT, 2003, PLACENTA, V24, pS94, DOI 10.1053/plac.2002.0949; Salafia CM, 2008, PAEDIATR PERINAT EP, V22, P229, DOI 10.1111/j.1365-3016.2008.00935.x; de Paula CFS, 2008, J ULTRAS MED, V27, P1583, DOI 10.7863/jum.2008.27.11.1583; Sondergaard C, 2003, ACTA PAEDIATR, V92, P811, DOI 10.1080/08035250310003857; Taricco E, 2003, PLACENTA, V24, P343, DOI 10.1053/plac.2002.0913; Tegethoff M, 2010, PSYCHOSOM MED, V72, P419, DOI 10.1097/PSY.0b013e3181d2f0b0; USUI T, 1988, MOL ENDOCRINOL, V2, P871, DOI 10.1210/mend-2-9-871; Wadhwa P D, 2001, Matern Child Health J, V5, P119, DOI 10.1023/A:1011353216619; WADHWA PD, 1993, AM J OBSTET GYNECOL, V169, P858, DOI 10.1016/0002-9378(93)90016-C; WARREN WB, 1990, J PERINAT MED, V18, P39, DOI 10.1515/jpme.1990.18.1.39; Williams LA, 1997, BRIT MED J, V314, P1864, DOI 10.1136/bmj.314.7098.1864	61	39	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e14478	10.1371/journal.pone.0014478	http://dx.doi.org/10.1371/journal.pone.0014478			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	701RA	21217829	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000285838900007
J	Thao, S; Chen, CS; Zhu, H; Escalante-Semerena, JC				Thao, Sandy; Chen, Chien-Sheng; Zhu, Heng; Escalante-Semerena, Jorge C.			N-epsilon-Lysine Acetylation of a Bacterial Transcription Factor Inhibits Its DNA-Binding Activity	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; ERWINIA-AMYLOVORA; CAPSULE SYNTHESIS; RCS PHOSPHORELAY; COA SYNTHETASE; COLANIC ACID; RECOMBINANT PROTEINS; EXPRESSION; REGULATOR; SYSTEM	Evidence suggesting that eukaryotes and archaea use reversible N-epsilon-lysine (N-epsilon-Lys) acetylation to modulate gene expression has been reported, but evidence for bacterial use of N-epsilon-Lys acetylation for this purpose is lacking. Here, we report data in support of the notion that bacteria can control gene expression by modulating the acetylation state of transcription factors (TFs). We screened the E. coli proteome for substrates of the bacterial Gcn5-like protein acetyltransferase (Pat). Pat acetylated four TFs, including the RcsB global regulatory protein, which controls cell division, and capsule and flagellum biosynthesis in many bacteria. Pat acetylated residue Lys180 of RcsB, and the NAD+-dependent Sir2 (sirtuin)-like protein deacetylase (CobB) deacetylated acetylated RcsB (RcsB(Ac)), demonstrating that N-epsilon-Lys acetylation of RcsB is reversible. Analysis of RcsB(Ac) and variant RcsB proteins carrying substitutions at Lys180 provided biochemical and physiological evidence implicating Lys180 as a critical residue for RcsB DNA-binding activity. These findings further the likelihood that reversible N-epsilon-Lys acetylation of transcription factors is a mode of regulation of gene expression used by all cells.	[Thao, Sandy; Escalante-Semerena, Jorge C.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Chen, Chien-Sheng; Zhu, Heng] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Chen, Chien-Sheng; Zhu, Heng] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD USA; [Chen, Chien-Sheng] Natl Cent Univ, Grad Inst Syst Biol & Bioinformat, Jhongli, Taiwan	University of Wisconsin System; University of Wisconsin Madison; Johns Hopkins University; Johns Hopkins University; National Central University	Thao, S (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	escalante@bact.wisc.edu	Chen, Chien-Sheng/ACO-7414-2022		USPHS [R01-GM62203, U54 RR 020839]; NRSA [F31-GM083668]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM083668, R01GM062203] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	USPHS R01-GM62203 to JCE-S, USPHS U54 RR 020839 to HZ, NRSA Predoctoral Fellowship F31-GM083668 to ST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; BRILL JA, 1988, J BACTERIOL, V170, P2599, DOI 10.1128/jb.170.6.2599-2611.1988; Carballes F, 1999, MOL MICROBIOL, V34, P442, DOI 10.1046/j.1365-2958.1999.01605.x; Carroll RK, 2009, J BIOL CHEM, V284, P12008, DOI 10.1074/jbc.M806261200; Chen CS, 2008, NAT METHODS, V5, P69, DOI 10.1038/NMETH1148; Davalos-Garcia M, 2001, J BACTERIOL, V183, P5870, DOI 10.1128/JB.183.20.5870-5876.2001; Denu JM, 2005, CURR OPIN CHEM BIOL, V9, P431, DOI 10.1016/j.cbpa.2005.08.010; Ducros VMA, 2001, J MOL BIOL, V306, P759, DOI 10.1006/jmbi.2001.4443; Ebel W, 1997, J BACTERIOL, V179, P6858, DOI 10.1128/jb.179.21.6858-6861.1997; Francez-Charlot A, 2003, MOL MICROBIOL, V49, P823, DOI 10.1046/j.1365-2958.2003.03601.x; Fredericks CE, 2006, MOL MICROBIOL, V61, P734, DOI 10.1111/j.1365-2958.2006.05260.x; Garrity J, 2007, J BIOL CHEM, V282, P30239, DOI 10.1074/jbc.M704409200; Gupte G, 1997, J BACTERIOL, V179, P4328, DOI 10.1128/jb.179.13.4328-4335.1997; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Huang YH, 2006, RES MICROBIOL, V157, P206, DOI 10.1016/j.resmic.2005.11.005; Joos T, 2009, FRONT BIOSCI-LANDMRK, V14, P4376, DOI 10.2741/3534; Kelley WL, 1997, MOL MICROBIOL, V25, P913, DOI 10.1111/j.1365-2958.1997.mmi527.x; Kelm O, 1997, MOL GEN GENET, V256, P72, DOI 10.1007/s004380050547; Kim MY, 2006, MOL ENDOCRINOL, V20, P1479, DOI 10.1210/me.2005-0531; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Lemke JJ, 2009, MOL MICROBIOL, V74, P1368, DOI 10.1111/j.1365-2958.2009.06939.x; Li R, 2010, MOL MICROBIOL, V76, P1162, DOI 10.1111/j.1365-2958.2010.07125.x; Liarzi O, 2010, MOL MICROBIOL, V76, P932, DOI 10.1111/j.1365-2958.2010.07148.x; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Loh KD, 2006, P NATL ACAD SCI USA, V103, P5114, DOI 10.1073/pnas.0600521103; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Marsh VL, 2005, J BIOL CHEM, V280, P21122, DOI 10.1074/jbc.M501280200; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; Miller JH., 1972, EXPT MOL GENETICS; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; PARKS TD, 1994, ANAL BIOCHEM, V216, P413, DOI 10.1006/abio.1994.1060; Pristovsek P, 2003, J BIOL CHEM, V278, P17752, DOI 10.1074/jbc.M301328200; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Rocco CJ, 2008, PLASMID, V59, P231, DOI 10.1016/j.plasmid.2008.01.001; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Starai VJ, 2004, J MOL BIOL, V340, P1005, DOI 10.1016/j.jmb.2004.05.010; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Sturny R, 2003, J BACTERIOL, V185, P4298, DOI 10.1128/JB.185.15.4298-4304.2003; Torres M, 2001, EMBO J, V20, P3811, DOI 10.1093/emboj/20.14.3811; TORRESCABASSA AS, 1987, J BACTERIOL, V169, P981, DOI 10.1128/jb.169.3.981-989.1987; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Wehland M, 1999, J BIOL CHEM, V274, P3300, DOI 10.1074/jbc.274.6.3300; Wehland M, 2000, J BIOL CHEM, V275, P7013, DOI 10.1074/jbc.275.10.7013; Wisedchaisri G, 2005, J MOL BIOL, V354, P630, DOI 10.1016/j.jmb.2005.09.048; Yu BJ, 2008, J MICROBIOL BIOTECHN, V18, P1529; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhang XS, 2008, ISME J, V2, P615, DOI 10.1038/ismej.2008.24; Zhao KH, 2003, J BIOL CHEM, V278, P26071, DOI 10.1074/jbc.M303666200	53	114	120	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15123	10.1371/journal.pone.0015123	http://dx.doi.org/10.1371/journal.pone.0015123			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217812	Green Submitted, Green Published, gold			2022-12-27	WOS:000285838900014
J	Choi, KJ; Grass, S; Paek, S; St Geme, JW; Yeo, HJ				Choi, Kyoung-Jae; Grass, Susan; Paek, Seonghee; St. Geme, Joseph W., III; Yeo, Hye-Jeong			The Actinobacillus pleuropneumoniae HMW1C-Like Glycosyltransferase Mediates N-Linked Glycosylation of the Haemophilus influenzae HMW1 Adhesin	PLOS ONE			English	Article							O-GLCNAC TRANSFERASE; MYCOBACTERIUM-TUBERCULOSIS; TETRATRICOPEPTIDE REPEATS; SUBSTRATE-SPECIFICITY; CAMPYLOBACTER-JEJUNI; ESCHERICHIA-COLI; PROTEINS; GLUCOSYLTRANSFERASE; FAMILY; DOMAIN	The Haemophilus influenzae HMW1 adhesin is an important virulence exoprotein that is secreted via the two-partner secretion pathway and is glycosylated at multiple asparagine residues in consensus N-linked sequons. Unlike the heavily branched glycans found in eukaryotic N-linked glycoproteins, the modifying glycan structures in HMW1 are mono-hexoses or di-hexoses. Recent work demonstrated that the H. influenzae HMW1C protein is the glycosyltransferase responsible for transferring glucose and galactose to the acceptor sites of HMW1. An Actinobacillus pleuropneumoniae protein designated ApHMW1C shares high-level homology with HMW1C and has been assigned to the GT41 family, which otherwise contains only O-glycosyltransferases. In this study, we demonstrated that ApHMW1C has N-glycosyltransferase activity and is able to transfer glucose and galactose to known asparagine sites in HMW1. In addition, we found that ApHMW1C is able to complement a deficiency of HMW1C and mediate HMW1 glycosylation and adhesive activity in whole bacteria. Initial structure-function studies suggested that ApHMW1C consists of two domains, including a 15-kDa N-terminal domain and a 55-kDa C-terminal domain harboring glycosyltransferase activity. These findings suggest a new subfamily of HMW1C-like glycosyltransferases distinct from other GT41 family O-glycosyltransferases.	[Choi, Kyoung-Jae; Paek, Seonghee; Yeo, Hye-Jeong] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Grass, Susan; St. Geme, Joseph W., III] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Grass, Susan; St. Geme, Joseph W., III] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	University of Houston System; University of Houston; Duke University; Duke University	Choi, KJ (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.	hyeo@uh.edu		Choi, Kyoungjae/0000-0001-9541-4182	National Institutes of Health (NIH) [RO1-AI068943, RO1-DC02873]; Welch Foundation [E-1616]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002873] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health (NIH) grant RO1-AI068943 and Grant E-1616 from the Welch Foundation to HJY and by NIH grant RO1-DC02873 to JWS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARENKAMP SJ, 1994, INFECT IMMUN, V62, P3320, DOI 10.1128/IAI.62.8.3320-3328.1994; BARENKAMP SJ, 1992, INFECT IMMUN, V60, P1302, DOI 10.1128/IAI.60.4.1302-1313.1992; Brazier-Hicks M, 2007, P NATL ACAD SCI USA, V104, P20238, DOI 10.1073/pnas.0706421104; Buscher AZ, 2006, MOL MICROBIOL, V61, P470, DOI 10.1111/j.1365-2958.2006.05236.x; Buscher AZ, 2004, J BACTERIOL, V186, P4209, DOI 10.1128/JB.186.13.4209-4217.2004; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Charbonneau ME, 2007, J BACTERIOL, V189, P8880, DOI 10.1128/JB.00969-07; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Geme JWS, 2009, TRENDS MICROBIOL, V17, P355, DOI 10.1016/j.tim.2009.06.002; Goon S, 2003, MOL MICROBIOL, V50, P659, DOI 10.1046/j.1365-2958.2003.03725.x; GOSSELIN S, 1994, ANAL BIOCHEM, V220, P92, DOI 10.1006/abio.1994.1303; Grass S, 2003, MOL MICROBIOL, V48, P737, DOI 10.1046/j.1365-2958.2003.03450.x; Grass S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000919; Grizot S, 2006, J MOL BIOL, V363, P383, DOI 10.1016/j.jmb.2006.07.057; Gross J, 2008, J BIOL CHEM, V283, P26010, DOI 10.1074/jbc.M801819200; Guerry P, 2008, TRENDS MICROBIOL, V16, P428, DOI 10.1016/j.tim.2008.07.002; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Herrmann JL, 1996, EMBO J, V15, P3547, DOI 10.1002/j.1460-2075.1996.tb00724.x; Hu YN, 2003, P NATL ACAD SCI USA, V100, P845, DOI 10.1073/pnas.0235749100; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Kirkpatrick AS, 2009, BIOCHEM BIOPH RES CO, V380, P407, DOI 10.1016/j.bbrc.2009.01.115; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Kuo CC, 1996, J CLIN INVEST, V98, P2813, DOI 10.1172/JCI119109; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lindenthal C, 1999, INFECT IMMUN, V67, P4084, DOI 10.1128/IAI.67.8.4084-4091.1999; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Marceau M, 1999, J BACTERIOL, V181, P656, DOI 10.1128/JB.181.2.656-661.1999; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Morera S, 1999, J MOL BIOL, V292, P717, DOI 10.1006/jmbi.1999.3094; Mulichak AM, 2001, STRUCTURE, V9, P547, DOI 10.1016/S0969-2126(01)00616-5; Romain F, 1999, INFECT IMMUN, V67, P5567, DOI 10.1128/IAI.67.11.5567-5572.1999; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Schmidt MA, 2003, TRENDS MICROBIOL, V11, P554, DOI 10.1016/j.tim.2003.10.004; SEBUNYA TNK, 1983, J AM VET MED ASSOC, V182, P1331; St Geme JW, 1998, INFECT IMMUN, V66, P364; STGEME JW, 1993, P NATL ACAD SCI USA, V90, P2875, DOI 10.1073/pnas.90.7.2875; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Yokoyama T, 2008, J MOL BIOL, V384, P364, DOI 10.1016/j.jmb.2008.09.036; Zhou MX, 2009, MICROBIOL-SGM, V155, P317, DOI 10.1099/mic.0.025221-0	44	54	55	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15888	10.1371/journal.pone.0015888	http://dx.doi.org/10.1371/journal.pone.0015888			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209858	Green Published, Green Submitted, gold			2022-12-27	WOS:000285793600049
J	Youngsteadt, E; Bustios, PG; Schal, C				Youngsteadt, Elsa; Guerra Bustios, Patricia; Schal, Coby			Divergent Chemical Cues Elicit Seed Collecting by Ants in an Obligate Multi-Species Mutualism in Lowland Amazonia	PLOS ONE			English	Article							ESSENTIAL OIL; DUFOUR GLAND; GARDENS; PHEROMONE; EPIPHYTES; HYMENOPTERA; ELAIOSOMES; SECRETIONS; DISPERSAL; BEHAVIOR	In lowland Amazonian rainforests, specific ants collect seeds of several plant species and cultivate them in arboreal carton nests, forming species-specific symbioses called ant-gardens (AGs). In this obligate mutualism, ants depend on the plants for nest stability and the plants depend on ant nests for substrate and nutrients. AG ants and plants are abundant, dominant members of lowland Amazonian ecosystems, but the cues ants use to recognize the seeds are poorly understood. To address the chemical basis of the ant-seed interaction, we surveyed seed chemistry in nine AG species and eight non-AG congeners. We detected seven phenolic and terpenoid volatiles common to seeds of all or most of the AG species, but a blend of the shared compounds was not attractive to the AG ant Camponotus femoratus. We also analyzed seeds of three AG species (Anthurium gracile, Codonanthe uleana, and Peperomia macrostachya) using behavior-guided fractionation. At least one chromatographic fraction of each seed extract elicited retrieval behavior in C. femoratus, but the active fractions of the three plant species differed in polarity and chemical composition, indicating that shared compounds alone did not explain seed-carrying behavior. We suggest that the various AG seed species must elicit seed-carrying with different chemical cues.	[Youngsteadt, Elsa; Schal, Coby] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Youngsteadt, Elsa; Schal, Coby] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Guerra Bustios, Patricia] Univ Nacl San Antonio Abad Cusco, Fac Ciencias Biol, Cuzco, Peru	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Universidad Nacional de San Antonio Abad del Cusco	Youngsteadt, E (corresponding author), Sigma Xi, Durham, NC USA.	coby_schal@ncsu.edu	Schal, Coby/A-8717-2010	Schal, Coby/0000-0001-7195-6358; Youngsteadt, Elsa/0000-0003-2032-9674	Amazon Conservation Association; National Science Foundation; United States Department of Education Graduate Assistance in Areas of National Need (GAANN); North Carolina State University; Blanton J. Whitmire Endowment	Amazon Conservation Association; National Science Foundation(National Science Foundation (NSF)); United States Department of Education Graduate Assistance in Areas of National Need (GAANN)(US Department of Education); North Carolina State University; Blanton J. Whitmire Endowment	This work was funded by an Amazon Conservation Association graduate research fellowship, a National Science Foundation predoctoral fellowship, a United States Department of Education Graduate Assistance in Areas of National Need (GAANN) biotechnology fellowship, a North Carolina State University Internationalization Seed Grant, and the Blanton J. Whitmire Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beattie Andrew J., 2002, P211; Belin-Depoux M., 1987, Revue de Cytologie et de Biologie Vegetales le Botaniste, V10, P185; BENZING DH, 1991, ANT - PLANT INTERACTIONS, P353; Bertsch A, 2004, Z NATURFORSCH C, V59, P701; BESTMANN HJ, 1995, NATURWISSENSCHAFTEN, V82, P334; Blum MS, 1987, COMP BIOCH PHYSL B; Bluthgen N, 2004, ECOLOGY, V85, P1479, DOI 10.1890/03-0430; Bluthgen N, 2001, J TROP ECOL, V17, P887, DOI 10.1017/S0266467401001651; BOOS DD, 1995, STAT PROBABIL LETT, V23, P183, DOI 10.1016/0167-7152(94)00112-L; BREW CR, 1989, OECOLOGIA, V80, P490, DOI 10.1007/BF00380071; DAVIDSON DW, 1988, ECOLOGY, V69, P1138, DOI 10.2307/1941268; DAVIDSON DW, 1990, J CHEM ECOL, V16, P2993, DOI 10.1007/BF00979490; Fischer RC, 2008, OECOLOGIA, V155, P539, DOI 10.1007/s00442-007-0931-8; Gammans N, 2005, OECOLOGIA, V146, P43, DOI 10.1007/s00442-005-0154-9; Greenberg L, 2007, J CHEM ECOL, V33, P935, DOI 10.1007/s10886-007-9269-2; Heil M, 2005, SCIENCE, V308, P560, DOI 10.1126/science.1107536; Howard RW, 2003, ARCH INSECT BIOCHEM, V54, P95, DOI 10.1002/arch.10104; HUGHES L, 1994, FUNCT ECOL, V8, P358, DOI 10.2307/2389829; Javidnia K, 2007, J ESSENT OIL RES, V19, P430, DOI 10.1080/10412905.2007.9699944; JEANNE RL, 1979, ECOLOGY, V60, P1211, DOI 10.2307/1936968; Kaufmann E, 2002, SE ASIAN ANT GARDENS; Kaufmann E, 2006, NATURWISSENSCHAFTEN, V93, P216, DOI 10.1007/s00114-005-0081-y; Kleinfeldt S.E., 1986, P283; Kohl E, 2000, NATURWISSENSCHAFTEN, V87, P320, DOI 10.1007/s001140050730; Limberger RP, 2003, FLAVOUR FRAG J, V18, P144, DOI 10.1002/ffj.1122; Longhurst C, 1980, J INSECT PHYSL, V26; Madison M., 1979, SELBYANA, V5, P107; Nieder J, 2000, BIOTROPICA, V32, P385, DOI 10.1111/j.1744-7429.2000.tb00485.x; Orivel J, 1997, BEHAV ECOL SOCIOBIOL, V40, P87, DOI 10.1007/s002650050319; Orivel J, 1999, ECOSCIENCE, V6, P51, DOI 10.1080/11956860.1999.11952205; Orivel J, 1998, BIOTROPICA, V30, P487, DOI 10.1111/j.1744-7429.1998.tb00085.x; Quintana A, 2003, J CHEM ECOL, V29, P639, DOI 10.1023/A:1022868603108; Raina VK, 2006, FLAVOUR FRAG J, V21, P140, DOI 10.1002/ffj.1547; *SAS I, 2002, SAS ONL DOC VERS 9 1; Schmit-Neuerburg Viviane, 2007, Ecotropica-Bonn, V13, P93; SEIDEL JL, 1990, J CHEM ECOL, V16, P1791, DOI 10.1007/BF01020495; Ule E, 1901, ENGLERS BOT JB, V68, P45; WILSON EO, 1987, BIOTROPICA, V19, P245, DOI 10.2307/2388342; Youngsteadt E, 2008, THESIS N CAROLINA ST; Youngsteadt E, 2008, P NATL ACAD SCI USA, V105, P4571, DOI 10.1073/pnas.0708643105; Youngsteadt E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004335; YU DW, 1994, BIOTROPICA, V26, P222, DOI 10.2307/2388813; Zrira S, 2008, J ESSENT OIL BEAR PL, V11, P30, DOI 10.1080/0972060X.2008.10643593	43	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15822	10.1371/journal.pone.0015822	http://dx.doi.org/10.1371/journal.pone.0015822			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209898	Green Submitted, Green Published, gold			2022-12-27	WOS:000285793600043
J	Bashiri, G; Rehan, AM; Greenwood, DR; Dickson, JMJ; Baker, EN				Bashiri, Ghader; Rehan, Aisyah M.; Greenwood, David R.; Dickson, James M. J.; Baker, Edward N.			Metabolic Engineering of Cofactor F-420 Production in Mycobacterium smegmatis	PLOS ONE			English	Article							SECONDARY ALCOHOL-DEHYDROGENASE; REDUCED COENZYME F-420; F-420-DEPENDENT GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; PHOTOREACTIVATING ENZYME; ARCHAEOGLOBUS-FULGIDUS; CRYSTAL-STRUCTURES; PURIFICATION; TUBERCULOSIS; SYSTEM; EXPRESSION	Cofactor F-420 is a unique electron carrier in a number of microorganisms including Archaea and Mycobacteria. It has been shown that F-420 has a direct and important role in archaeal energy metabolism whereas the role of F-420 in mycobacterial metabolism has only begun to be uncovered in the last few years. It has been suggested that cofactor F-420 has a role in the pathogenesis of M. tuberculosis, the causative agent of tuberculosis. In the absence of a commercial source for F-420, M. smegmatis has previously been used to provide this cofactor for studies of the F-420-dependent proteins from mycobacterial species. Three proteins have been shown to be involved in the F420 biosynthesis in Mycobacteria and three other proteins have been demonstrated to be involved in F-420 metabolism. Here we report the over-expression of all of these proteins in M. smegmatis and testing of their importance for F-420 production. The results indicate that co-expression of the F-420 biosynthetic proteins can give rise to a much higher F-420 production level. This was achieved by designing and preparing a new T7 promoter-based co-expression shuttle vector. A combination of co-expression of the F-420 biosynthetic proteins and fine-tuning of the culture media has enabled us to achieve F-420 production levels of up to 10 times higher compared with the wild type M. smegmatis strain. The high levels of the F-420 produced in this study provide a suitable source of this cofactor for studies of F-420-dependent proteins from other microorganisms and for possible biotechnological applications.	[Bashiri, Ghader; Rehan, Aisyah M.; Dickson, James M. J.; Baker, Edward N.] Univ Auckland, Struct Biol Lab, Sch Biol Sci, Auckland 1, New Zealand; [Bashiri, Ghader; Rehan, Aisyah M.; Greenwood, David R.; Dickson, James M. J.; Baker, Edward N.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Sch Biol Sci, Auckland 1, New Zealand; [Greenwood, David R.] Univ Auckland, Ctr Genom & Prote, Sch Biol Sci, Auckland 1, New Zealand	University of Auckland; University of Auckland; University of Auckland	Bashiri, G (corresponding author), Univ Auckland, Struct Biol Lab, Sch Biol Sci, Auckland 1, New Zealand.	g.bashiri@auckland.ac.nz	Rehan, Aisyah/A-9495-2011; Greenwood, David R/D-2375-2016; Rehan, Aisyah Mohamed/N-6806-2019; Bashiri, Ghader/R-4957-2017	Greenwood, David R/0000-0001-5280-042X; Rehan, Aisyah Mohamed/0000-0001-7841-1705; Bashiri, Ghader/0000-0002-5092-3749; Baker, Edward/0000-0003-2456-7661	New Zealand Lottery Grants Board (Health); Maurice & Phyllis Paykel Trust; Allan Wilson Centre for Molecular Ecology and Evolution; Health research Council of New Zealand; Foundation for Research, Science and Technology of New Zealand; Ministry of Higher Education, Malaysia; International Islamic University Malaysia	New Zealand Lottery Grants Board (Health); Maurice & Phyllis Paykel Trust; Allan Wilson Centre for Molecular Ecology and Evolution; Health research Council of New Zealand(Health Research Council of New Zealand); Foundation for Research, Science and Technology of New Zealand(New Zealand Foundation for Research, Science and Technology); Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia); International Islamic University Malaysia	The authors would like to thank New Zealand Lottery Grants Board (Health), the Maurice & Phyllis Paykel Trust and the Allan Wilson Centre for Molecular Ecology and Evolution for funding to purchase the EnVision Multilabel plate reader. This research was supported by the Health research Council of New Zealand, the Foundation for Research, Science and Technology of New Zealand. A. M. R. is a recipient of a PhD scholarship from the IPTA Academic Training Scheme from The Ministry of Higher Education, Malaysia and International Islamic University Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aufhammer SW, 2005, PROTEIN SCI, V14, P1840, DOI 10.1110/ps.041289805; Aufhammer SW, 2004, STRUCTURE, V12, P361, DOI 10.1016/j.str.2004.02.010; Bair TB, 2001, ARCH MICROBIOL, V176, P37, DOI 10.1007/s002030100290; Bashiri G, 2008, J BIOL CHEM, V283, P17531, DOI 10.1074/jbc.M801854200; Bashiri G, 2007, PROTEIN EXPRES PURIF, V54, P38, DOI 10.1016/j.pep.2007.01.014; Ceh K, 2009, BIOCHEMISTRY-US, V48, P10098, DOI 10.1021/bi901104d; Chang Y, 2009, PROTEIN SCI, V18, P2316, DOI 10.1002/pro.242; CHEESEMAN P, 1972, J BACTERIOL, V112, P527, DOI 10.1128/JB.112.1.527-531.1972; Choi KP, 2002, J BACTERIOL, V184, P2420, DOI 10.1128/JB.184.9.2420-2428.2002; Choi KP, 2001, J BACTERIOL, V183, P7058, DOI 10.1128/JB.183.24.7058-7066.2001; Cirillo JD, 1993, EFFICIENT ELECTROTRA; COATS JH, 1989, J ANTIBIOT, V42, P472, DOI 10.7164/antibiotics.42.472; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COUSINS FB, 1960, BIOCHIM BIOPHYS ACTA, V40, P532, DOI 10.1016/0006-3002(60)91396-2; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; DEPPENMEIER U, 1990, FEBS LETT, V261, P199, DOI 10.1016/0014-5793(90)80670-E; DEPPENMEIER U, 1990, P NATL ACAD SCI USA, V87, P9449, DOI 10.1073/pnas.87.23.9449; DIMARCO AA, 1990, ANNU REV BIOCHEM, V59, P355, DOI 10.1146/annurev.biochem.59.1.355; Ebert S, 1999, J BACTERIOL, V181, P2669, DOI 10.1128/JB.181.9.2669-2674.1999; EIRICH LD, 1978, BIOCHEMISTRY-US, V17, P4583, DOI 10.1021/bi00615a002; EIRICH LD, 1979, J BACTERIOL, V140, P20, DOI 10.1128/JB.140.1.20-27.1979; EKER AP, 1988, BIOCHEMISTRY-US, V27, P1758, DOI 10.1021/bi00405a056; EKER APM, 1990, J BIOL CHEM, V265, P8009; FUCHS G, 1982, ZBL BAKT MIK HYG I C, V3, P277, DOI 10.1016/S0721-9571(82)80041-0; GEORGE KM, 1995, J BIOL CHEM, V270, P27292, DOI 10.1074/jbc.270.45.27292; Glas AF, 2009, P NATL ACAD SCI USA, V106, P11540, DOI 10.1073/pnas.0812665106; Goldstone RM, 2008, PROTEIN EXPRES PURIF, V57, P81, DOI 10.1016/j.pep.2007.08.015; Graham DE, 2003, ARCH MICROBIOL, V180, P455, DOI 10.1007/s00203-003-0614-8; Graupner M, 2003, J BACTERIOL, V185, P4662, DOI 10.1128/JB.185.15.4662-4665.2003; Guerra-Lopez D, 2007, MICROBIOL-SGM, V153, P2724, DOI 10.1099/mic.0.2006/009241-0; Harth G, 2004, MICROBIOL-SGM, V150, P2143, DOI 10.1099/mic.0.27113-0; HARTZELL PL, 1985, BIOCHEM BIOPH RES CO, V133, P884, DOI 10.1016/0006-291X(85)91218-5; Huang CYF, 2002, J BIOL CHEM, V277, P34367, DOI 10.1074/jbc.M202468200; Isabelle D, 2002, APPL ENVIRON MICROB, V68, P5750, DOI 10.1128/AEM.68.11.5750-5755.2002; JACOBSON FS, 1982, J BIOL CHEM, V257, P3385; Johnson EF, 2005, J BIOL CHEM, V280, P38776, DOI 10.1074/jbc.M503492200; Kaps I, 2001, GENE, V278, P115, DOI 10.1016/S0378-1119(01)00712-0; KIENER A, 1985, ARCH MICROBIOL, V143, P147, DOI 10.1007/BF00411038; KUNOW J, 1994, EUR J BIOCHEM, V223, P503, DOI 10.1111/j.1432-1033.1994.tb19019.x; Luo Y, 2000, MOL IMMUNOL, V37, P527, DOI 10.1016/S0161-5890(00)00077-8; MA K, 1990, EUR J BIOCHEM, V191, P187, DOI 10.1111/j.1432-1033.1990.tb19109.x; MCCORMICK JRD, 1982, J AM CHEM SOC, V104, P4014, DOI 10.1021/ja00378a044; Nocek B, 2007, J MOL BIOL, V372, P456, DOI 10.1016/j.jmb.2007.06.063; Purwantini E, 1996, J BACTERIOL, V178, P2861, DOI 10.1128/jb.178.10.2861-2866.1996; Purwantini E, 2009, P NATL ACAD SCI USA, V106, P6333, DOI 10.1073/pnas.0812883106; RHODES PM, 1981, J GEN MICROBIOL, V124, P329; Robson J, 2009, J MOL BIOL, V390, P353, DOI 10.1016/j.jmb.2009.05.006; Seedorf H, 2004, ARCH MICROBIOL, V182, P126, DOI 10.1007/s00203-004-0675-3; Selengut JD, 2010, J BACTERIOL, V192, P5788, DOI 10.1128/JB.00425-10; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; Slayden RA, 2000, MOL MICROBIOL, V38, P514, DOI 10.1046/j.1365-2958.2000.02145.x; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SUTTON WB, 1964, BIOCHEM BIOPH RES CO, V15, P414, DOI 10.1016/0006-291X(64)90477-2; Taylor MC, 2010, MOL MICROBIOL, V78, P561, DOI 10.1111/j.1365-2958.2010.07356.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TZENG SF, 1975, J BACTERIOL, V121, P184, DOI 10.1128/JB.121.1.184-191.1975; TZENG SF, 1975, J BACTERIOL, V121, P192, DOI 10.1128/JB.121.1.192-196.1975; VERMEIJ P, 1994, EUR J BIOCHEM, V226, P185, DOI 10.1111/j.1432-1033.1994.tb20040.x; VERMEIJ P, 1995, EUR J BIOCHEM, V234, P592, DOI 10.1111/j.1432-1033.1995.592_b.x; Warkentin E, 2001, EMBO J, V20, P6561, DOI 10.1093/emboj/20.23.6561; WIDDEL F, 1989, ARCH MICROBIOL, V152, P322, DOI 10.1007/BF00425168; ZEIKUS JG, 1977, J BACTERIOL, V132, P604, DOI 10.1128/JB.132.2.604-613.1977	62	95	99	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15803	10.1371/journal.pone.0015803	http://dx.doi.org/10.1371/journal.pone.0015803			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209917	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793200057
J	Hong, SB; Oh, H; Valera, VA; Baba, M; Schmidt, LS; Linehan, WM				Hong, Seung-Beom; Oh, HyoungBin; Valera, Vladimir A.; Baba, Masaya; Schmidt, Laura S.; Linehan, W. Marston			Inactivation of the FLCN Tumor Suppressor Gene Induces TFE3 Transcriptional Activity by Increasing Its Nuclear Localization	PLOS ONE			English	Article							HOGG-DUBE-SYNDROME; RENAL-CELL CARCINOMA; MELANOMA PROTEIN-B; BHD GENE; THERAPEUTIC TARGET; MTOR ACTIVATION; BREAST-CANCER; AURISTATIN-E; MITF; MICROPHTHALMIA	Background: Germline mutations in a tumor suppressor gene FLCN lead to development of fibrofolliculomas, lung cysts and renal cell carcinoma (RCC) in Birt-Hogg-Dube syndrome. TFE3 is a member of the MiTF/TFE transcription factor family and Xp11.2 translocations found in sporadic RCC involving TFE3 result in gene fusions and overexpression of chimeric fusion proteins that retain the C-terminal DNA binding domain of TFE3. We found that GPNMB expression, which is regulated by MiTF, was greatly elevated in renal cancer cells harboring either TFE3 translocations or FLCN inactivation. Since TFE3 is implicated in RCC, we hypothesized that elevated GPNMB expression was due to increased TFE3 activity resulting from the inactivation of FLCN. Methodology/Principal Findings: TFE3 knockdown reduced GPNMB expression in renal cancer cells harboring either TFE3 translocations or FLCN inactivation. Moreover, FLCN knockdown induced GPNMB expression in FLCN-restored renal cancer cells. Conversely, wildtype FLCN suppressed GPNMB expression in FLCN-null cells. FLCN inactivation was correlated with increased TFE3 transcriptional activity accompanied by its nuclear localization as revealed by elevated GPNMB mRNA and protein expression, and predominantly nuclear immunostaining of TFE3 in renal cancer cells, mouse embryo fibroblast cells, mouse kidneys and mouse and human renal tumors. Nuclear localization of TFE3 was associated with TFE3 post-translational modifications including decreased phosphorylation. Conclusions/Significance: Increased TFE3 activity is a downstream event induced by FLCN inactivation and is likely to be important for renal tumor development. This study provides an important novel mechanism for induction of TFE3 activity in addition to TFE3 overexpression resulting from Xp11.2 translocations, suggesting that TFE3 may be more broadly involved in tumorigenesis.	[Hong, Seung-Beom; Oh, HyoungBin; Valera, Vladimir A.; Baba, Masaya; Schmidt, Laura S.; Linehan, W. Marston] NCI, Urol Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Schmidt, Laura S.] NCI, Basic Sci Program, SAIC Frederick Inc, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Hong, SB (corresponding author), NCI, Urol Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA.	linehanm@mail.nih.gov	Baba, Masaya/ABE-4893-2020; Baba, Masaya/L-7490-2013	Baba, Masaya/0000-0002-5308-6683; Hong, Seung-Beom/0000-0002-4928-2091	National Institutes of Health, National Cancer Institute, Center for Cancer Research; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NCI-Frederick; NATIONAL CANCER INSTITUTE [ZIABC011028, Z01BC011043, Z01BC011023, ZIABC011043, Z01BC011028] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI-Frederick; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. This project has been funded with federal funds from the National Cancer Institute, National Institutes of Health, under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Heath and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SAIC-Frederick is the Operation and Technical Support contractor to the National Cancer Institute at Frederick (NCI-Frederick), a federal laboratory. SAIC-Frederick, as the contractor, is the recipient of NCI-Frederick funding and has not independently funded this research.	Aksan I, 1998, MOL CELL BIOL, V18, P6930, DOI 10.1128/MCB.18.12.6930; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Armah HB, 2010, ARCH PATHOL LAB MED, V134, P124, DOI 10.1043/2008-0391-RSR.1; Baba M, 2008, JNCI-J NATL CANCER I, V100, P140, DOI 10.1093/jnci/djm288; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; BIRT AR, 1977, ARCH DERMATOL, V113, P1674, DOI 10.1001/archderm.113.12.1674; Bronisz A, 2006, MOL BIOL CELL, V17, P3897, DOI 10.1091/mbc.E06-05-0470; Chen JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003581; Davis IJ, 2006, CANCER CELL, V9, P473, DOI 10.1016/j.ccr.2006.04.021; Davis IJ, 2003, P NATL ACAD SCI USA, V100, P6051, DOI 10.1073/pnas.0931430100; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Hartman TR, 2009, ONCOGENE, V28, P1594, DOI 10.1038/onc.2009.14; Hasumi H, 2008, GENE, V415, P60, DOI 10.1016/j.gene.2008.02.022; Hasumi Y, 2009, P NATL ACAD SCI USA, V106, P18722, DOI 10.1073/pnas.0908853106; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Hong SB, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-160; Hudon V, 2010, J MED GENET, V47, P182, DOI 10.1136/jmg.2009.072009; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Kuan CT, 2006, CLIN CANCER RES, V12, P1970, DOI 10.1158/1078-0432.CCR-05-2797; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; Lingaas F, 2003, HUM MOL GENET, V12, P3043, DOI 10.1093/hmg/ddg336; Loftus SK, 2009, PIGM CELL MELANOMA R, V22, P99, DOI 10.1111/j.1755-148X.2008.00518.x; Mathur M, 2007, ONCOGENE, V26, P277, DOI 10.1038/sj.onc.1209783; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Miller AJ, 2005, J BIOL CHEM, V280, P146, DOI 10.1074/jbc.M411757200; Nakagawa Y, 2006, NAT MED, V12, P107, DOI 10.1038/nm1334; Naumovski L, 2010, CURR OPIN MOL THER, V12, P248; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Okimoto K, 2004, P NATL ACAD SCI USA, V101, P2023, DOI 10.1073/pnas.0308071100; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Qian XZ, 2008, MOL ONCOL, V2, P81, DOI 10.1016/j.molonc.2008.02.002; Ripoll VM, 2008, GENE, V413, P32, DOI 10.1016/j.gene.2008.01.014; Rose AAN, 2010, CLIN CANCER RES, V16, P2147, DOI 10.1158/1078-0432.CCR-09-1611; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schmidt LS, 2005, AM J HUM GENET, V76, P1023, DOI 10.1086/430842; Schwarz T, 2010, BIOCHEM BIOPH RES CO, V394, P890, DOI 10.1016/j.bbrc.2010.03.034; Selim AA, 2009, MED SCI MONITOR, V15, pMT19; Sidhar SK, 1996, HUM MOL GENET, V5, P1333, DOI 10.1093/hmg/5.9.1333; Tse KF, 2006, CLIN CANCER RES, V12, P1373, DOI 10.1158/1078-0432.CCR-05-2018; Verastegui C, 2000, MOL ENDOCRINOL, V14, P449, DOI 10.1210/me.14.3.449; Weilbaecher KN, 2001, MOL CELL, V8, P749, DOI 10.1016/S1097-2765(01)00360-4; Yang Y, 2008, CANCER GENET CYTOGEN, V180, P100, DOI 10.1016/j.cancergencyto.2007.10.010	43	100	104	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15793	10.1371/journal.pone.0015793	http://dx.doi.org/10.1371/journal.pone.0015793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209915	gold, Green Submitted, Green Published			2022-12-27	WOS:000285793200054
J	Lambert, TJ; Storm, DR; Sullivan, JM				Lambert, Talley J.; Storm, Daniel R.; Sullivan, Jane M.			MicroRNA132 Modulates Short-Term Synaptic Plasticity but Not Basal Release Probability in Hippocampal Neurons	PLOS ONE			English	Article							ASYNCHRONOUS RELEASE; TRANSMISSION; SYNAPSES; EXPRESSION; VESICLES; BRAIN; CALYX; MICE; POOL; CREB	MicroRNAs play important regulatory roles in a broad range of cellular processes including neuronal morphology and long-term synaptic plasticity. MicroRNA-132 (miR132) is a CREB-regulated miRNA that is induced by neuronal activity and neurotrophins, and plays a role in regulating neuronal morphology and cellular excitability. Little is known about the effects of miR132 expression on synaptic function. Here we show that overexpression of miR132 increases the paired-pulse ratio and decreases synaptic depression in cultured mouse hippocampal neurons without affecting the initial probability of neurotransmitter release, the calcium sensitivity of release, the amplitude of excitatory postsynaptic currents or the size of the readily releasable pool of synaptic vesicles. These findings are the first to demonstrate that microRNAs can regulate short-term plasticity in neurons.	[Lambert, Talley J.; Storm, Daniel R.; Sullivan, Jane M.] Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA; [Storm, Daniel R.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Sullivan, Jane M.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Lambert, TJ (corresponding author), Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Pullman, WA 99164 USA.	jmsull@u.washington.edu	Lambert, Talley/B-4024-2015; Lambert, Talley/V-7602-2019	Lambert, Talley/0000-0002-2409-0181; Lambert, Talley/0000-0002-2409-0181	National Institutes of Health [MH073601, NS020498, PHS NRSA T32-GM07270]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (www.nih.gov) grants MH073601 and NS020498 (Daniel R. Storm). Talley J. Lambert was supported in part by NIH grant PHS NRSA T32-GM07270. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional funding that supported this study.	Barry SC, 2001, HUM GENE THER, V12, P1103, DOI 10.1089/104303401750214311; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Hagler DJ, 2001, J NEUROPHYSIOL, V85, P2324, DOI 10.1152/jn.2001.85.6.2324; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Ishikawa T, 2005, J PHYSIOL-LONDON, V568, P199, DOI 10.1113/jphysiol.2005.089912; Jun K, 1999, P NATL ACAD SCI USA, V96, P15245, DOI 10.1073/pnas.96.26.15245; Lugli G, 2005, J NEUROCHEM, V94, P896, DOI 10.1111/j.1471-4159.2005.03224.x; Lugli G, 2008, J NEUROCHEM, V106, P650, DOI 10.1111/j.1471-4159.2008.05413.x; Moulder KL, 2005, J NEUROSCI, V25, P3842, DOI 10.1523/JNEUROSCI.5231-04.2005; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; Otsu Y, 2004, J NEUROSCI, V24, P420, DOI 10.1523/JNEUROSCI.4452-03.2004; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Scheuber A, 2004, J NEUROSCI, V24, P10402, DOI 10.1523/JNEUROSCI.1664-04.2004; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sippy T, 2003, NAT NEUROSCI, V6, P1031, DOI 10.1038/nn1117; Smalheiser NR, 2009, NEUROMOL MED, V11, P133, DOI 10.1007/s12017-009-8065-2; Stevens CF, 2003, NEURON, V39, P299, DOI 10.1016/S0896-6273(03)00432-X; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	24	64	68	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15182	10.1371/journal.pone.0015182	http://dx.doi.org/10.1371/journal.pone.0015182			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206919	Green Submitted, Green Published, gold			2022-12-27	WOS:000285793200019
J	Mai, Y; Gao, GX				Mai, Yun; Gao, Guangxia			Expression of IMP1 Enhances Production of Murine Leukemia Virus Vector by Facilitating Viral Genomic RNA Packaging	PLOS ONE			English	Article							GROWTH-FACTOR-II; MESSENGER-RNA; RETROVIRAL VECTORS; BINDING PROTEINS; REVERSE-TRANSCRIPTASE; ENVELOPE PROTEIN; ACTINOMYCIN-D; GENE-THERAPY; IN-VITRO; CELLS	Murine leukemia virus (MLV)-based retroviral vector is widely used for gene transfer. Efficient packaging of the genomic RNA is critical for production of high-titer virus. Here, we report that expression of the insulin-like growth factor II mRNA binding protein 1 (IMP1) enhanced the production of infectious MLV vector. Overexpression of IMP1 increased the stability of viral genomic RNA in virus producer cells and packaging of the RNA into progeny virus in a dose-dependent manner. Downregulation of IMP1 in virus producer cells resulted in reduced production of the retroviral vector. These results indicate that IMP1 plays a role in regulating the packaging of MLV genomic RNA and can be used for improving production of retroviral vectors.	[Mai, Yun; Gao, Guangxia] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS	Mai, Y (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China.	gaogx@moon.ibp.ac.cn			Ministry of Science and Technology of China [2006CB504302]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants (to G. G.) from Ministry of Science and Technology of China (973 Program 2006CB504302). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNSTEIN PL, 1992, GENE DEV, V6, P642, DOI 10.1101/gad.6.4.642; Butsch M, 2002, J VIROL, V76, P3089, DOI 10.1128/jvi.76.7.3089-3094.2002; Carmo M, 2009, J GENE MED, V11, P670, DOI 10.1002/jgm.1353; Coroadinha AS, 2006, BIOTECHNOL BIOENG, V94, P24, DOI 10.1002/bit.20778; Dorman N, 2000, J VIROL, V74, P11413, DOI 10.1128/JVI.74.23.11413-11417.2000; Douaisi M, 2004, BIOCHEM BIOPH RES CO, V321, P566, DOI 10.1016/j.bbrc.2004.07.005; Doyle GAR, 1998, NUCLEIC ACIDS RES, V26, P5036, DOI 10.1093/nar/26.22.5036; DUESBERG PH, 1968, P NATL ACAD SCI USA, V59, P930, DOI 10.1073/pnas.59.3.930; Flynn JA, 2006, VIROLOGY, V344, P391, DOI 10.1016/j.virol.2005.09.002; Flynn JA, 2004, J VIROL, V78, P12129, DOI 10.1128/JVI.78.22.12129-12139.2004; Gao GX, 1999, MOL BIOL CELL, V10, P1705, DOI 10.1091/mbc.10.6.1705; Gao GX, 1998, J VIROL, V72, P5905, DOI 10.1128/JVI.72.7.5905-5911.1998; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Guo XM, 2004, J VIROL, V78, P12781, DOI 10.1128/JVI.78.23.12781-12787.2004; Guo XM, 2007, P NATL ACAD SCI USA, V104, P151, DOI 10.1073/pnas.0607063104; Higashikawa F, 2001, VIROLOGY, V280, P124, DOI 10.1006/viro.2000.0743; HUANG AS, 1970, NATURE, V226, P325, DOI 10.1038/226325a0; KOTANI H, 1994, HUM GENE THER, V5, P19, DOI 10.1089/hum.1994.5.1-19; Kuznetsov YG, 2004, VIROLOGY, V323, P189, DOI 10.1016/j.virol.2004.02.023; Lavillette D, 2002, J VIROL, V76, P6442, DOI 10.1128/JVI.76.13.6442-6452.2002; Le Doux JM, 1999, BIOTECHNOL BIOENG, V63, P654, DOI 10.1002/(SICI)1097-0290(19990620)63:6<654::AID-BIT3>3.0.CO;2-1; Leeds P, 1997, ONCOGENE, V14, P1279, DOI 10.1038/sj.onc.1201093; Lei P, 2005, BIOTECHNOL BIOENG, V90, P781, DOI 10.1002/bit.20468; Lemm I, 2002, MOL CELL BIOL, V22, P3959, DOI 10.1128/MCB.22.12.3959-3969.2002; LEVIN JG, 1974, J VIROL, V14, P152, DOI 10.1128/JVI.14.1.152-161.1974; LEVIN JG, 1976, P NATL ACAD SCI USA, V73, P1154, DOI 10.1073/pnas.73.4.1154; McTaggart S, 2001, BIOTECHNOL BIOENG, V76, P52, DOI 10.1002/bit.1025; MESSER LI, 1981, J VIROL, V40, P683, DOI 10.1128/JVI.40.3.683-690.1981; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nielsen FC, 2001, SCAND J CLIN LAB INV, V61, P93; NIELSEN FC, 1990, J BIOL CHEM, V265, P13431; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Ogert RA, 1996, J VIROL, V70, P3834, DOI 10.1128/JVI.70.6.3834-3843.1996; OLSEN JC, 1995, HUM GENE THER, V6, P1195, DOI 10.1089/hum.1995.6.9-1195; PAGES JC, 1995, GENE THER, V2, P547; PASKIND MP, 1975, VIROLOGY, V67, P242, DOI 10.1016/0042-6822(75)90421-3; Rodrigues T, 2008, J SEP SCI, V31, P3509, DOI 10.1002/jssc.200800195; Runge S, 2000, J BIOL CHEM, V275, P29562, DOI 10.1074/jbc.M001156200; Shen BQCM, 1996, CYTOTECHNOLOGY, V22; SHIELDS A, 1978, CELL, V14, P601, DOI 10.1016/0092-8674(78)90245-3; Smith CM, 1997, VIROLOGY, V229, P437, DOI 10.1006/viro.1997.8454; Telesnitsky A, 1995, METHOD ENZYMOL, V262, P347; Yisraeli JK, 2005, BIOL CELL, V97, P87; Zhou YD, 2008, J VIROL, V82, P5683, DOI 10.1128/JVI.00189-08	44	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15881	10.1371/journal.pone.0015881	http://dx.doi.org/10.1371/journal.pone.0015881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209918	gold, Green Published, Green Submitted			2022-12-27	WOS:000285793200062
J	Ramgolam, VS; DeGregorio, SD; Rao, GK; Collinge, M; Subaran, SS; Markovic-Plese, S; Pardi, R; Bender, JR				Ramgolam, Vinod S.; DeGregorio, Scott D.; Rao, Gautham K.; Collinge, Mark; Subaran, Sharmila S.; Markovic-Plese, Silva; Pardi, Ruggero; Bender, Jeffrey R.			T Cell LFA-1 Engagement Induces HuR-Dependent Cytokine mRNA Stabilization through a Vav-1, Rac1/2, p38MAPK and MKK3 Signaling Cascade	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; TYROSINE KINASE; BINDING-PROTEIN; INTEGRIN LFA-1; ADHESION; RAC2; UROKINASE; PHOSPHORYLATION; INHIBITOR; STABILITY	Background: Engagement of the beta 2 integrin, lymphocyte function-associated antigen-1 (LFA-1), results in stabilization of T cell mRNA transcripts containing AU-rich elements (AREs) by inducing rapid nuclear-to-cytosolic translocation of the RNA-stabilizing protein, HuR. However, little is known regarding integrin-induced signaling cascades that affect mRNA catabolism. This study examines the role of the GTPases, Rac 1 and Rac 2, and their downstream effectors, in the LFA-1-induced effects on mRNA. Methodology/Principal Findings: Engagement of LFA-1 to its ligand, ICAM-1, in human peripheral T cells resulted in rapid activation of Rac1 and Rac2. siRNA-mediated knockdown of either Rac1 or Rac2 prevented LFA-1-stimulated stabilization of the labile transcripts encoding IFN-gamma and TNF-alpha, and integrin mediated IFN-gamma mRNA stabilization was absent in T cells obtained from Rac2 gene-deleted mice. LFA-1 engagement-induced translocation of HuR and stabilization of TNF-alpha mRNA was lost in Jurkat cells deficient in the Rac guanine nucleotide exchange factor Vav-1 (J.Vav1). The transfection of J.Vav1 cells with constitutively active Rac1 or Rac2 stabilized a labile beta-globin reporter mRNA, in a HuR-dependent manner. Furthermore, LFA-1-mediated mRNA stabilization and HuR translocation in mouse splenic T cells was dependent on the phosphorylation of the mitogen-activated protein kinase kinase, MKK3, and its target MAP kinase p38MAPK, and lost in T cells obtained from MKK3 gene-deleted mice. Conclusions/Significance: Collectively, these results demonstrate that LFA-1-induced stabilization of ARE-containing mRNAs in T cells is dependent on HuR, and occurs through the Vav-1, Rac1/2, MKK3 and p38MAPK signaling cascade. This pathway constitutes a molecular switch that enhances immune and pro-inflammatory gene expression in T cells undergoing adhesion at sites of activation and effector function.	[Ramgolam, Vinod S.; DeGregorio, Scott D.; Rao, Gautham K.; Collinge, Mark; Subaran, Sharmila S.; Bender, Jeffrey R.] Yale Univ, Sch Med, Raymond & Beverly Sackler Fdn, Cardiovasc Lab,Dept Med Cardiovasc Med, New Haven, CT 06520 USA; [Ramgolam, Vinod S.; DeGregorio, Scott D.; Rao, Gautham K.; Collinge, Mark; Subaran, Sharmila S.; Bender, Jeffrey R.] Yale Univ, Sch Med, Dept Immunobiol, Vasc Biol & Therapeut Program, New Haven, CT USA; [Markovic-Plese, Silva] Univ N Carolina, Dept Neurol, Chapel Hill, NC USA; [Pardi, Ruggero] Univ Vita Salute, Sch Med, Dept Mol Pathol, San Raffaele Sci Inst, Milan, Italy	Yale University; Yale University; University of North Carolina; University of North Carolina Chapel Hill; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Ramgolam, VS (corresponding author), Yale Univ, Sch Med, Raymond & Beverly Sackler Fdn, Cardiovasc Lab,Dept Med Cardiovasc Med, New Haven, CT 06520 USA.	jeffrey.bender@yale.edu			National Institutes of Health [HL43331]; Raymond and Beverly Sackler Foundation; Associazione Italiana per la Ricerca sul Cancro; Telethon; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Raymond and Beverly Sackler Foundation; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Telethon(Fondazione Telethon); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health Grant HL43331 and a Raymond and Beverly Sackler Foundation Award (to J.R.B.) and by grants from Associazione Italiana per la Ricerca sul Cancro and Telethon (to R. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bianchi E, 1996, J CLIN INVEST, V98, P1133, DOI 10.1172/JCI118896; Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; D'Souza-Schorey C, 1998, MOL CELL BIOL, V18, P3936, DOI 10.1128/MCB.18.7.3936; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Diebold I, 2008, THROMB HAEMOSTASIS, V100, P1021, DOI 10.1160/TH08-07-0473; Doller A, 2008, MOL CELL BIOL, V28, P2608, DOI 10.1128/MCB.01530-07; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; Doller A, 2010, MOL CELL BIOL, V30, P1397, DOI 10.1128/MCB.01373-09; Filippi MD, 2004, NAT IMMUNOL, V5, P744, DOI 10.1038/ni1081; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Guo F, 2008, BLOOD, V112, P1767, DOI 10.1182/blood-2008-01-132068; Han QW, 2002, J BIOL CHEM, V277, P48379, DOI 10.1074/jbc.M209542200; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; KANNER SB, 1993, P NATL ACAD SCI USA, V90, P7099, DOI 10.1073/pnas.90.15.7099; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; Lafarga V, 2009, MOL CELL BIOL, V29, P4341, DOI 10.1128/MCB.00210-09; Lores P, 1997, ONCOGENE, V15, P601, DOI 10.1038/sj.onc.1201378; Lu HT, 1999, EMBO J, V18, P1845, DOI 10.1093/emboj/18.7.1845; Movilla N, 2001, ONCOGENE, V20, P8057, DOI 10.1038/sj.onc.1205000; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; PARDI R, 1989, J IMMUNOL, V143, P3157; Porter JC, 2002, J IMMUNOL, V168, P6330, DOI 10.4049/jimmunol.168.12.6330; REIBEL L, 1991, BIOCHEM BIOPH RES CO, V175, P451, DOI 10.1016/0006-291X(91)91585-Z; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Rodriguez-Fernandez JL, 1999, MOL BIOL CELL, V10, P1891, DOI 10.1091/mbc.10.6.1891; Sanchez-Martin L, 2004, J BIOL CHEM, V279, P16194, DOI 10.1074/jbc.M400905200; Soede RDM, 1999, J IMMUNOL, V163, P4253; Tong L, 1997, NAT STRUCT BIOL, V4, P311, DOI 10.1038/nsb0497-311; Tran H, 2003, MOL CELL BIOL, V23, P7177, DOI 10.1128/MCB.23.20.7177-7188.2003; Wang GJ, 1998, P NATL ACAD SCI USA, V95, P6296, DOI 10.1073/pnas.95.11.6296; Wang JG, 2006, J IMMUNOL, V176, P2105, DOI 10.4049/jimmunol.176.4.2105; WELDER CA, 1993, J IMMUNOL, V150, P2203; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Yu H, 2001, J EXP MED, V194, P915, DOI 10.1084/jem.194.7.915; YUI K, 1990, P NATL ACAD SCI USA, V87, P7135, DOI 10.1073/pnas.87.18.7135	40	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e14450	10.1371/journal.pone.0014450	http://dx.doi.org/10.1371/journal.pone.0014450			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206905	Green Published, Green Submitted, gold			2022-12-27	WOS:000285793200006
J	Sun, F; Cho, H; Jeong, DW; Li, CL; He, CA; Bae, T				Sun, Fei; Cho, Hoonsik; Jeong, Do-Won; Li, Chunling; He, Chuan; Bae, Taeok			Aureusimines in Staphylococcus aureus Are Not Involved in Virulence	PLOS ONE			English	Article							SAE LOCUS; IN-VITRO; SIGNAL-TRANSDUCTION; REGULATORY SYSTEM; GLOBAL REGULATOR; AGR DYSFUNCTION; EXPRESSION; GENE; MUTATION; SEQUENCE	Background: Recently, dipeptide aureusimines were reported to activate expression of staphylococcal virulence genes, such as alpha-hemolysin, and increase S. aureus virulence. Surprisingly, most of the virulence genes affected by aureusimines form part of the regulon of the SaeRS two component system (TCS), raising the possibility that SaeRS might be directly or indirectly involved in the aureusimine-dependent signaling process. Methodology/Principal Findings: Using HPLC analyses, we confirmed that a transposon mutant of ausA, the gene encoding the aureusimine dipeptide synthesis enzyme, does not produce dipeptides. However, the transposon mutant showed normal hemolysis activity and alpha-hemolysin/SaeP production. Furthermore, the P1 promoter of the sae operon, one of the targets of the SaeRS TCS, showed normal transcription activity. Moreover, in contrast to the original report, the ausA transposon mutant did not exhibit attenuated virulence in an animal infection model. DNA sequencing revealed that the ausA deletion mutant used in the original study has an 83 nt-duplication in saeS. Hemolysis activity of the original mutant was restored by a plasmid carrying the sae operon. A mutant of the sae operon showed elevated resistance to chloramphenicol and erythromycin, two antibiotics widely used during staphylococcal mutagenesis. At 43 degrees C in the presence of erythromycin and aeration, the conditions typically employed for staphylococcal mutagenesis, an saeR transposon mutant grew much faster than a control mutant and the saeR mutant was highly enriched in a mixed culture experiment. Conclusions/Significance: Our results show that the previously reported roles of aureusimines in staphylococcal gene regulation and virulence were due to an unintended mutation in saeS, which was likely selected due to elevated resistance of the mutant to environmental stresses. Thus, there is no evidence indicating that the dipeptide aureusimines play a role in sae-mediated virulence factor production or contribute to staphylococcal virulence.	[Sun, Fei; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Sun, Fei; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Cho, Hoonsik; Jeong, Do-Won; Li, Chunling; Bae, Taeok] Indiana Univ Sch Med NW, Dept Microbiol & Immunol, Gary, IN USA	University of Chicago; University of Chicago; Indiana University System; Indiana University Northwest	Sun, F (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.	chuanhe@uchicago.edu; tbae@iun.edu		Bae, Taeok/0000-0002-0576-2851; Jeong, Do-Won/0000-0001-6586-748X	American Heart Association [0835158N]; National Institute of Allergy and Infectious Diseases [AI077564, AI074658]; Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077564, R01AI074658] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study is supported by a Scientist Development Grant 0835158N from the American Heart Association (T. B.), AI077564 from the National Institute of Allergy and Infectious Diseases (T. B), AI074658 (C. H.), and a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award (C. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari RP, 2008, MICROBIOL-SGM, V154, P949, DOI 10.1099/mic.0.2007/012245-0; Adhikari RP, 2007, INFECT IMMUN, V75, P4534, DOI 10.1128/IAI.00679-07; Archer GL, 1998, CLIN INFECT DIS, V26, P1179, DOI 10.1086/520289; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Balaban N, 2001, J BIOL CHEM, V276, P2658, DOI 10.1074/jbc.M005446200; Chen J, 2007, MICROBIOL-SGM, V153, P1604, DOI 10.1099/mic.0.2007/006247-0; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Fowler VG, 2004, J INFECT DIS, V190, P1140, DOI 10.1086/423145; Garvis S, 2002, MICROBIOL-SGM, V148, P3235, DOI 10.1099/00221287-148-10-3235; Geiger T, 2008, J BACTERIOL, V190, P3419, DOI 10.1128/JB.01927-07; Giraudo AT, 1999, FEMS MICROBIOL LETT, V177, P15, DOI 10.1016/S0378-1097(99)00282-7; Giraudo AT, 1997, ARCH MICROBIOL, V168, P53, DOI 10.1007/s002030050469; GIRAUDO AT, 1994, CAN J MICROBIOL, V40, P677, DOI 10.1139/m94-107; Giraudo AT, 2003, CURR MICROBIOL, V46, P246, DOI 10.1007/s00284-002-3853-z; Goerke C, 2005, INFECT IMMUN, V73, P3415, DOI 10.1128/IAI.73.6.3415-3421.2005; JOHNSON M, 2010, INT J MED M IN PRESS; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; LEE CY, 1991, GENE, V103, P101, DOI 10.1016/0378-1119(91)90399-V; Li CL, 2010, J BACTERIOL, V192, P3883, DOI 10.1128/JB.00237-10; Li DM, 2008, INFECT IMMUN, V76, P1068, DOI 10.1128/IAI.01069-07; Liang XD, 2006, INFECT IMMUN, V74, P4655, DOI 10.1128/IAI.00322-06; Lovmar M, 2009, EMBO J, V28, P736, DOI 10.1038/emboj.2009.17; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; McNamara PJ, 1998, J BACTERIOL, V180, P2609, DOI 10.1128/JB.180.10.2609-2615.1998; Mei JM, 1997, MOL MICROBIOL, V26, P399, DOI 10.1046/j.1365-2958.1997.5911966.x; MOAZED D, 1987, BIOCHIMIE, V69, P879, DOI 10.1016/0300-9084(87)90215-X; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Shopsin B, 2008, J INFECT DIS, V198, P1171, DOI 10.1086/592051; SMELTZER MS, 1993, INFECT IMMUN, V61, P919, DOI 10.1128/IAI.61.3.919-925.1993; Somerville GA, 2002, J BACTERIOL, V184, P1430, DOI 10.1128/JB.184.5.1430-1437.2002; Sun F, 2010, J BACTERIOL, V192, P2111, DOI 10.1128/JB.01524-09; Traber K, 2006, MOL MICROBIOL, V59, P1519, DOI 10.1111/j.1365-2958.2006.04986.x; Villaruz AE, 2009, J INFECT DIS, V200, P724, DOI 10.1086/604728; Voyich JM, 2009, J INFECT DIS, V199, P1698, DOI 10.1086/598967; Wyatt MA, 2010, SCIENCE, V329, P294, DOI 10.1126/science.1188888; Xiong YQ, 2006, J INFECT DIS, V194, P1267, DOI 10.1086/508210; Zeng YB, 2005, BIOORG MED CHEM LETT, V15, P3034, DOI 10.1016/j.bmcl.2005.04.031	40	37	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15703	10.1371/journal.pone.0015703	http://dx.doi.org/10.1371/journal.pone.0015703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209955	Green Submitted, Green Published, gold			2022-12-27	WOS:000285793200039
J	Marro, KI; Lee, D; Shankland, EG; Mathis, CM; Hayes, CE; Friedman, SD; Kushmerick, MJ				Marro, Kenneth I.; Lee, Donghoon; Shankland, Eric G.; Mathis, C. Mark; Hayes, Cecil E.; Friedman, Seth D.; Kushmerick, Martin J.			Quantitative In Vivo Magnetic Resonance Spectroscopy Using Synthetic Signal Injection	PLOS ONE			English	Article							ABSOLUTE METABOLITE CONCENTRATIONS; C-13 NMR-SPECTROSCOPY; HR-MAS SPECTROSCOPY; SOLID-STATE NMR; ERETIC METHOD; HUMAN BRAIN; P-31 MRS; PROTON NMR; SKELETAL-MUSCLE; NONINVASIVE MEASUREMENT	Accurate conversion of magnetic resonance spectra to quantitative units of concentration generally requires compensation for differences in coil loading conditions, the gains of the various receiver amplifiers, and rescaling that occurs during post-processing manipulations. This can be efficiently achieved by injecting a precalibrated, artificial reference signal, or pseudo-signal into the data. We have previously demonstrated, using in vitro measurements, that robust pseudo-signal injection can be accomplished using a second coil, called the injector coil, properly designed and oriented so that it couples inductively with the receive coil used to acquire the data. In this work, we acquired nonlocalized phosphorous magnetic resonance spectroscopy measurements from resting human tibialis anterior muscles and used pseudo-signal injection to calculate the Pi, PCr, and ATP concentrations. We compared these results to parallel estimates of concentrations obtained using the more established phantom replacement method. Our results demonstrate that pseudo-signal injection using inductive coupling provides a robust calibration factor that is immune to coil loading conditions and suitable for use in human measurements. Having benefits in terms of ease of use and quantitative accuracy, this method is feasible for clinical use. The protocol we describe could be readily translated for use in patients with mitochondrial disease, where sensitive assessment of metabolite content could improve diagnosis and treatment.	[Marro, Kenneth I.; Lee, Donghoon; Shankland, Eric G.; Mathis, C. Mark; Hayes, Cecil E.; Kushmerick, Martin J.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Kushmerick, Martin J.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Marro, Kenneth I.; Friedman, Seth D.] Seattle Childrens Hosp, Dept Radiol, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital	Marro, KI (corresponding author), Univ Washington, Dept Radiol, Seattle, WA 98195 USA.	marro@u.washington.edu		friedman, seth/0000-0001-8785-7215	NIH (NIBIB) [R21EB009438, R21EB008166]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB009438, R21EB008166] Funding Source: NIH RePORTER	NIH (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by NIH grants R21EB009438 (NIBIB, www.nibib.nih.gov) and R21EB008166 (NIBIB, www.nibib.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoka S, 1999, ANAL CHEM, V71, P2554, DOI 10.1021/ac981422i; Akoka S, 2002, INSTRUM SCI TECHNOL, V30, P21, DOI 10.1081/CI-100108768; Albers MJ, 2009, MAGN RESON MED, V61, P525, DOI 10.1002/mrm.21808; Barantin L, 1997, MAGN RESON MED, V38, P179, DOI 10.1002/mrm.1910380203; Billault I, 2002, ANAL CHEM, V74, P5902, DOI 10.1021/ac025867p; BUCHLI R, 1993, MAGN RESON MED, V30, P552, DOI 10.1002/mrm.1910300505; BUCHLI R, 1994, NMR BIOMED, V7, P225, DOI 10.1002/nbm.1940070505; BUCHLI R, 1994, MAGN RESON MED, V32, P453, DOI 10.1002/mrm.1910320405; BUCHLI R, 1994, MAGNET RESON MED, V32, P447, DOI 10.1002/mrm.1910320404; Martinez-Bisbal MC, 2009, NMR BIOMED, V22, P199, DOI 10.1002/nbm.1304; Caytan E, 2007, ANAL CHEM, V79, P8266, DOI 10.1021/ac070826k; Caytan E, 2007, TALANTA, V71, P1016, DOI 10.1016/j.talanta.2006.05.075; Chang L, 1997, NEUROLOGY, V48, P836, DOI 10.1212/WNL.48.4.836; DANIELSEN ER, 1994, NMR BIOMED, V7, P311, DOI 10.1002/nbm.1940070704; DEBISSCHOP E, 1992, NMR BIOMED, V5, P341, DOI 10.1002/nbm.1940050604; Dreher W, 2005, MAGN RESON MED, V54, P190, DOI 10.1002/mrm.20549; Franconi F, 2002, MAGN RESON IMAGING, V20, P587, DOI 10.1016/S0730-725X(02)00593-3; GARD JK, 1985, BIOPHYS J, V48, P803, DOI 10.1016/S0006-3495(85)83839-X; HAYES CE, 1985, MED PHYS, V12, P604, DOI 10.1118/1.595682; HeimanPatterson TD, 1997, MUSCLE NERVE, V20, P1219, DOI 10.1002/(SICI)1097-4598(199710)20:10<1219::AID-MUS2>3.0.CO;2-F; Heinzer-Schweizer S, 2010, NMR BIOMED, V23, P406, DOI 10.1002/nbm.1476; Henriksen O, 1995, NMR BIOMED, V8, P139, DOI 10.1002/nbm.1940080402; Hetherington HP, 2001, MAGNET RESON MED, V45, P46, DOI 10.1002/1522-2594(200101)45:1<46::AID-MRM1008>3.0.CO;2-N; HOULT DI, 1976, J MAGN RESON, V24, P71, DOI 10.1016/0022-2364(76)90233-X; Hoult DI, 2000, CONCEPT MAGNETIC RES, V12, P173, DOI 10.1002/1099-0534(2000)12:4<173::AID-CMR1>3.0.CO;2-Q; HUSTED CA, 1994, MAGN RESON IMAGING, V12, P661, DOI 10.1016/0730-725X(94)92461-9; Jansen JFA, 2006, RADIOLOGY, V240, P318, DOI 10.1148/radiol.2402050314; Kelsey CR, 2010, NEURO-ONCOLOGY, V12, P145, DOI 10.1093/neuonc/nop040; Kemp GJ, 2007, NMR BIOMED, V20, P555, DOI 10.1002/nbm.1192; Kreis R, 2005, MAGN RESON MED, V54, P761, DOI 10.1002/mrm.20673; Kreis R, 2001, J MAGN RESON, V149, P245, DOI 10.1006/jmre.2001.2301; KREIS R, 1993, J MAGN RESON SER B, V102, P9, DOI 10.1006/jmrb.1993.1056; KREIS R, 1993, MAGNET RESON MED, V30, P424, DOI 10.1002/mrm.1910300405; KREIS R, 1997, J PROG NMR SPECTROSC, V31, P155; Lane S, 2005, ANAL CHEM, V77, P4354, DOI 10.1021/ac050257l; LAWRY TJ, 1990, MAGNET RESON MED, V16, P294, DOI 10.1002/mrm.1910160210; Le Grand F, 2005, J AGR FOOD CHEM, V53, P5125, DOI 10.1021/jf050385a; Le Grand F, 2005, J MAGN RESON, V174, P171, DOI 10.1016/j.jmr.2005.01.010; Lee D, 2010, MAGN RESON MED, V63, P570, DOI 10.1002/mrm.22298; Lodi R, 1997, ANN NEUROL, V42, P573, DOI 10.1002/ana.410420407; Maintz D, 2002, NMR BIOMED, V15, P18, DOI 10.1002/nbm.735; Marro KI, 2008, J MAGN RESON, V194, P67, DOI 10.1016/j.jmr.2008.05.022; MATHEWS VP, 1995, AM J ROENTGENOL, V165, P633, DOI 10.2214/ajr.165.3.7645484; Michel N, 2004, J MAGN RESON, V168, P118, DOI 10.1016/j.jmr.2004.02.006; Mikkola R, 2007, TOXICON, V49, P1158, DOI 10.1016/j.toxicon.2007.02.010; Molinier V, 2005, J COLLOID INTERF SCI, V286, P360, DOI 10.1016/j.jcis.2004.12.010; Molinier V, 2006, CARBOHYD RES, V341, P1890, DOI 10.1016/j.carres.2006.04.034; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; Ratel S, 2008, APPL PHYSIOL NUTR ME, V33, P720, DOI 10.1139/H08-039; Risa O, 2009, NMR BIOMED, V22, P266, DOI 10.1002/nbm.1317; Schunk K, 1999, INVEST RADIOL, V34, P116, DOI 10.1097/00004424-199902000-00004; Server A, 2010, ACTA RADIOL, V51, P316, DOI 10.3109/02841850903482901; Silvestre V, 2001, ANAL CHEM, V73, P1862, DOI 10.1021/ac0013204; SITTER B, 2010, NMR BIOMED; Subramanian A, 2005, NMR BIOMED, V18, P213, DOI 10.1002/nbm.944; TAYLOR DJ, 1994, J NEUROL SCI, V125, P77, DOI 10.1016/0022-510X(94)90245-3; Tessem MB, 2008, MAGN RESON MED, V60, P510, DOI 10.1002/mrm.21694; THULBORN KR, 1983, J MAGN RESON, V55, P357, DOI 10.1016/0022-2364(83)90118-X; Tofts P S, 1988, NMR Biomed, V1, P1, DOI 10.1002/nbm.1940010103; TOFTS PS, 1988, MAGNET RESON MED, V6, P84, DOI 10.1002/mrm.1910060109; TOFTS PS, 1988, J MAGN RESON, V80, P84, DOI 10.1016/0022-2364(88)90059-5; TOSCANO A, 1995, J NEUROL, V242, P203, DOI 10.1007/BF00919592; Van Lokeren L, 2008, MAGN RESON CHEM, V46, pS63, DOI 10.1002/mrc.2315; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; WRAY S, 1986, BIOCHIM BIOPHYS ACTA, V886, P399, DOI 10.1016/0167-4889(86)90175-8; Ziarelli F, 2006, SOLID STATE NUCL MAG, V29, P214, DOI 10.1016/j.ssnmr.2005.08.013; Ziarelli F, 2008, J MAGN RESON, V194, P307, DOI 10.1016/j.jmr.2008.07.013; Ziarelli F, 2007, J MAGN RESON, V188, P260, DOI 10.1016/j.jmr.2007.07.006	68	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15166	10.1371/journal.pone.0015166	http://dx.doi.org/10.1371/journal.pone.0015166			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203385	gold, Green Published, Green Submitted			2022-12-27	WOS:000285792500024
J	Pilon, G; Charbonneau, A; White, PJ; Dallaire, P; Perreault, M; Kapur, S; Marette, A				Pilon, Genevieve; Charbonneau, Alexandre; White, Phillip J.; Dallaire, Patrice; Perreault, Mylene; Kapur, Sonia; Marette, Andre			Endotoxin Mediated-iNOS Induction Causes Insulin Resistance via ONOO- Induced Tyrosine Nitration of IRS-1 in Skeletal Muscle	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PROSTACYCLIN SYNTHASE; RECEPTOR SUBSTRATE-1; TARGETED DISRUPTION; OXIDATIVE STRESS; S-NITROSYLATION; CARBON-DIOXIDE; PROTEIN-KINASE; PEROXYNITRITE; MECHANISM	Background: It is believed that the endotoxin lipopolysaccharide (LPS) is implicated in the metabolic perturbations associated with both sepsis and obesity (metabolic endotoxemia). Here we examined the role of inducible nitric oxide synthase (iNOS) in skeletal muscle insulin resistance using LPS challenge in rats and mice as in vivo models of endotoxemia. Methodology/Principal Findings: Pharmacological (aminoguanidine) and genetic strategies (iNOS(-/-) mice) were used to counter iNOS induction in vivo. In vitro studies using peroxynitrite (ONOO 2) or inhibitors of the iNOS pathway, 1400 W and EGCG were conducted in L6 myocytes to determine the mechanism by which iNOS mediates LPS-dependent insulin resistance. In vivo, both pharmacological and genetic invalidation of iNOS prevented LPS-induced muscle insulin resistance. Inhibition of iNOS also prevented insulin resistance in myocytes exposed to cytokine/LPS while exposure of myocytes to ONOO 2 fully reproduced the inhibitory effect of cytokine/LPS on both insulin-stimulated glucose uptake and PI3K activity. Importantly, LPS treatment in vivo and iNOS induction and ONOO 2 treatment in vitro promoted tyrosine nitration of IRS-1 and reduced insulin-dependent tyrosine phosphorylation. Conclusions/Significance: Our work demonstrates that iNOS-mediated tyrosine nitration of IRS-1 is a key mechanism of skeletal muscle insulin resistance in endotoxemia, and presents nitrosative modification of insulin signaling proteins as a novel therapeutic target for combating muscle insulin resistance in inflammatory settings.	[Pilon, Genevieve; Charbonneau, Alexandre; White, Phillip J.; Dallaire, Patrice; Perreault, Mylene; Kapur, Sonia; Marette, Andre] Laval Hosp, Dept Med, Quebec Heart & Lung Inst, Ste Foy, PQ, Canada; [Pilon, Genevieve; Charbonneau, Alexandre; White, Phillip J.; Dallaire, Patrice; Perreault, Mylene; Kapur, Sonia; Marette, Andre] Laval Univ Hosp, Res Ctr, Ste Foy, PQ, Canada	Quebec Heart & Lung Institute; Laval University	Pilon, G (corresponding author), Laval Hosp, Dept Med, Quebec Heart & Lung Inst, Ste Foy, PQ, Canada.	andre.marette@criucpq.ulaval.ca	White, Phillip J/H-3048-2019; Marette, Andre/E-9342-2013	White, Phillip J/0000-0002-0957-425X; Marette, Andre/0000-0003-3950-5973	Canadian Institute of Health Research (CIHR); Canadian Diabetes Association; CIHR; Fonds de la Recherche en Sante du Quebec	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association; CIHR(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by a grant (no. 151431 to A.M.) from the Canadian Institute of Health Research (CIHR) and by postdoctoral fellowships to A.C. from the Canadian Diabetes Association and the CIHR obesity training grant. P.J.W. is the recipient of a PhD studentship from the Fonds de la Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686; Bedard S, 1997, BIOCHEM J, V325, P487, DOI 10.1042/bj3250487; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Carvalho MA, 2005, DIABETES, V54, P959, DOI 10.2337/diabetes.54.4.959; Carvalho MA, 2009, DIABETOLOGIA, V52, P2425, DOI 10.1007/s00125-009-1498-1; Carvalho-Filho MA, 2006, AM J PHYSIOL-ENDOC M, V291, pE476, DOI 10.1152/ajpendo.00422.2005; Ceriello A, 2001, DIABETOLOGIA, V44, P834; Charbonneau A, 2010, DIABETES, V59, P861, DOI 10.2337/db09-1238; Frayn KN, 2008, DIABETOLOGIA, V51, P394, DOI 10.1007/s00125-007-0901-z; Geller DA, 1998, CANCER METAST REV, V17, P7, DOI 10.1023/A:1005940202801; Gorg B, 2007, FEBS LETT, V581, P84, DOI 10.1016/j.febslet.2006.11.081; Goldstein S, 2008, METHOD ENZYMOL, V436, P49, DOI 10.1016/S0076-6879(08)36004-2; Gow AJ, 1996, FEBS LETT, V385, P63, DOI 10.1016/0014-5793(96)00347-X; Greenacre SAB, 2001, FREE RADICAL RES, V34, P541, DOI 10.1080/10715760100300471; HAUSCHILDT S, 1990, BIOCHEM J, V270, P351, DOI 10.1042/bj2700351; He CY, 2010, AM J PATHOL, V176, P2542, DOI 10.2353/ajpath.2010.090783; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Ischiropoulos H, 2003, BIOCHEM BIOPH RES CO, V305, P776, DOI 10.1016/S0006-291X(03)00814-3; Ischiropoulos H, 1998, ARCH BIOCHEM BIOPHYS, V356, P1, DOI 10.1006/abbi.1998.0755; Kapur S, 1997, DIABETES, V46, P1691, DOI 10.2337/diabetes.46.11.1691; Kapur S, 1999, AM J PHYSIOL-ENDOC M, V276, pE635, DOI 10.1152/ajpendo.1999.276.4.E635; Lin YL, 1997, MOL PHARMACOL, V52, P465, DOI 10.1124/mol.52.3.465; MARI A, 1992, AM J PHYSIOL, V263, pE400, DOI 10.1152/ajpendo.1992.263.2.E400; Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Nie H, 2006, DIABETES, V55, P3133, DOI 10.2337/db06-0505; Nomiyama T, 2004, BIOCHEM BIOPH RES CO, V320, P639, DOI 10.1016/j.bbrc.2004.06.019; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Pilon G, 2004, J BIOL CHEM, V279, P20767, DOI 10.1074/jbc.M401390200; Pilon G, 2000, HORM METAB RES, V32, P480, DOI 10.1055/s-2007-978674; Roberts ES, 1998, CHEM RES TOXICOL, V11, P1067, DOI 10.1021/tx980099b; Squadrito GL, 1998, FREE RADICAL BIO MED, V25, P392, DOI 10.1016/S0891-5849(98)00095-1; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Suschek CV, 2004, CURR MOL MED, V4, P763, DOI 10.2174/1566524043359908; Thornalley PJ, 2003, ARCH BIOCHEM BIOPHYS, V419, P31, DOI 10.1016/j.abb.2003.08.013; Tien M, 1999, P NATL ACAD SCI USA, V96, P7809, DOI 10.1073/pnas.96.14.7809; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Wahl SM, 2003, CELLS TISSUES ORGANS, V174, P26, DOI 10.1159/000070572; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Xu SQ, 2006, AM J PHYSIOL-HEART C, V290, pH2220, DOI 10.1152/ajpheart.01293.2005; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200	41	49	56	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15912	10.1371/journal.pone.0015912	http://dx.doi.org/10.1371/journal.pone.0015912			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21206533	Green Published, gold, Green Submitted			2022-12-27	WOS:000285792500043
J	Ngamskulrungroj, P; Price, J; Sorrell, T; Perfect, JR; Meyer, W				Ngamskulrungroj, Popchai; Price, Jennifer; Sorrell, Tania; Perfect, John R.; Meyer, Wieland			Cryptococcus gattii Virulence Composite: Candidate Genes Revealed by Microarray Analysis of High and Less Virulent Vancouver Island Outbreak Strains	PLOS ONE			English	Article							NEOFORMANS VAR. GATTII; CELL-WALL INTEGRITY; BRITISH-COLUMBIA; MOLECULAR ANALYSIS; FUNGAL PATHOGEN; USTILAGO-MAYDIS; DISTINCT ROLES; CAPSULE; YEAST; GROWTH	Human and animal cryptococcosis due to an unusual molecular type of Cryptococcus gattii (VGII) emerged recently on Vancouver Island, Canada. Unlike C. neoformans, C. gattii causes disease mainly in immunocompetent hosts, despite producing a similar suite of virulence determinants. To investigate a potential relationship between the regulation of expression of a virulence gene composite and virulence, we took advantage of two subtypes of VGII (a and b), one highly virulent (R265) and one less virulent (R272), that were identified from the Vancouver outbreak. By expression microarray analysis, 202 genes showed at least a 2-fold difference in expression with 108 being up-and 94 being down-regulated in strain R265 compared with strain R272. Specifically, expression levels of genes encoding putative virulence factors (e. g. LAC1, LAC2, CAS3 and MPK1) and genes encoding proteins involved in cell wall assembly, carbohydrate and lipid metabolism were increased in strain R265, whereas genes involved in the regulation of mitosis and ergosterol biosynthesis were suppressed. In vitro phenotypic studies and transcription analysis confirmed the microarray results. Gene disruption of LAC1 and MPK1 revealed defects in melanin synthesis and cell wall integrity, respectively, where CAS3 was not essential for capsule production. Moreover, MPK1 also controls melanin and capsule production and causes a severe attenuation of the virulence in a murine inhalational model. Overall, this study provides the basis for further genetic studies to characterize the differences in the virulence composite of strains with minor evolutionary divergences in gene expression in the primary pathogen C. gattii, that have led to a major invasive fungal infection outbreak.	[Ngamskulrungroj, Popchai; Sorrell, Tania; Meyer, Wieland] Univ Sydney, Westmead Hosp,Mol Mycol Res Lab, Westmead Millennium Inst,Sydney Emerging Infect &, Ctr Infect Dis & Microbiol,Sydney Med Sch Westmed, Westmead, NSW 2145, Australia; [Ngamskulrungroj, Popchai; Price, Jennifer] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Ngamskulrungroj, Popchai; Perfect, John R.] Mahidol Univ, Fac Med, Siriraj Hosp, Bangkok, Thailand	University of Sydney; Westmead Institute for Medical Research; Duke University; Mahidol University	Ngamskulrungroj, P (corresponding author), Univ Sydney, Westmead Hosp,Mol Mycol Res Lab, Westmead Millennium Inst,Sydney Emerging Infect &, Ctr Infect Dis & Microbiol,Sydney Med Sch Westmed, Westmead, NSW 2145, Australia.	w.meyer@usyd.edu.au	Meyer, Wieland/G-1204-2015; Sorrell, Tania/AAZ-5286-2020; Ngamskulrungroj, Popchai/ABE-7699-2021; Ngamskulrungroj, Popchai/N-8545-2019	Meyer, Wieland/0000-0001-9933-8340; Ngamskulrungroj, Popchai/0000-0001-5162-5498; Sorrell, Tania/0000-0001-9460-0960	Endeavour International Postgraduate Research Scholarship (EIPRS); University of Sydney; National Institute of Allergy and Infectious Diseases (NIAID) Public Heath Service [AI28388, AI73896]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028388, R01AI073896, R56AI028388] Funding Source: NIH RePORTER	Endeavour International Postgraduate Research Scholarship (EIPRS)(Australian Government); University of Sydney(University of Sydney); National Institute of Allergy and Infectious Diseases (NIAID) Public Heath Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by Endeavour International Postgraduate Research Scholarship (EIPRS) and International Postgraduate Award (IPA) of the University of Sydney scholarship to PN and a bridging grant of University of Sydney to WM. Also National Institute of Allergy and Infectious Diseases (NIAID) Public Heath Service AI28388 and AI73896 for JRP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2004, MICROBIOL-SGM, V150, P2029, DOI 10.1099/mic.0.26980-0; Alspaugh JA, 1998, FUNGAL GENET BIOL, V25, P1, DOI 10.1006/fgbi.1998.1079; Bahler J, 2005, ANNU REV GENET, V39, P69, DOI 10.1146/annurev.genet.39.110304.095808; Banuett F, 1995, ANNU REV GENET, V29, P179, DOI 10.1146/annurev.ge.29.120195.001143; Boekhout T, 1997, INT J SYST BACTERIOL, V47, P432, DOI 10.1099/00207713-47-2-432; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; Carrillo-Munoz A J, 2006, Rev Esp Quimioter, V19, P130; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; CHANG YC, 1994, MOL CELL BIOL, V14, P4912, DOI 10.1128/MCB.14.7.4912; Chayakulkeeree M, 2007, ANTIMICROB AGENTS CH, V51, P3537, DOI 10.1128/AAC.00442-07; Cheng PY, 2009, INFECT IMMUN, V77, P4284, DOI 10.1128/IAI.00628-09; Chow ED, 2007, CURR GENET, V52, P137, DOI 10.1007/s00294-007-0147-9; Christodoulidou A, 1996, J BIOL CHEM, V271, P31420, DOI 10.1074/jbc.271.49.31420; Chung SY, 2002, EUKARYOT CELL, V1, P432, DOI 10.1128/EC.1.3.432-439.2002; Cox GM, 2003, INFECT IMMUN, V71, P173, DOI 10.1128/IAI.71.1.173-180.2003; Cox GM, 2000, INFECT IMMUN, V68, P443, DOI 10.1128/IAI.68.2.443-448.2000; Cramer KL, 2006, EUKARYOT CELL, V5, P1147, DOI 10.1128/EC.00145-06; Datta K, 2009, INTERDISCIP PERSPECT, DOI DOI 10.1155/2009/176532; Dromer F, 1996, CLIN INFECT DIS, V23, P82, DOI 10.1093/clinids/23.1.82; Escandon P, 2006, FEMS YEAST RES, V6, P625, DOI 10.1111/j.1567-1364.2006.00055.x; Ferrer C, 2001, J CLIN MICROBIOL, V39, P2873, DOI 10.1128/JCM.39.8.2873-2879.2001; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Garcia-Muse T, 2004, J CELL SCI, V117, P487, DOI 10.1242/jcs.00877; Gerik KJ, 2005, MOL MICROBIOL, V58, P393, DOI 10.1111/j.1365-2958.2005.04843.x; GRANGER DL, 1985, J CLIN INVEST, V76, P508, DOI 10.1172/JCI112000; Hicks JK, 2007, EUKARYOT CELL, V6, P413, DOI 10.1128/EC.00213-06; Hull CM, 2002, ANNU REV GENET, V36, P557, DOI 10.1146/annurev.genet.36.052402.152652; Idnurm A, 2007, EUKARYOT CELL, V6, P60, DOI 10.1128/EC.00214-06; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; Kidd SE, 2005, EUKARYOT CELL, V4, P1629, DOI 10.1128/EC.4.10.1629-1638.2005; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Kraus PR, 2004, EUKARYOT CELL, V3, P1249, DOI 10.1128/EC.3.5.1249-1260.2004; Kraus PR, 2003, MOL MICROBIOL, V48, P1377, DOI 10.1046/j.1365-2958.2003.03508.x; KWONCHUNG JK, 1992, MED MYCOL, P397; KWONCHUNG KJ, 1982, A VAN LEEUW J MICROB, V48, P25, DOI 10.1007/BF00399484; KWONCHUNG KJ, 1976, MYCOLOGIA, V68, P942, DOI 10.2307/3758813; KWONCHUNG KJ, 1984, AM J EPIDEMIOL, V120, P123, DOI 10.1093/oxfordjournals.aje.a113861; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602, DOI 10.1128/IAI.60.2.602-605.1992; Latouche GN, 2002, FEMS YEAST RES, V2, P551, DOI 10.1016/S1567-1356(02)00130-7; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Leuthner B, 2005, MOL GENET GENOMICS, V272, P639, DOI 10.1007/s00438-004-1085-6; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Ma HS, 2009, P NATL ACAD SCI USA, V106, P12980, DOI 10.1073/pnas.0902963106; MacDougall L, 2007, EMERG INFECT DIS, V13, P42, DOI 10.3201/eid1301.060827; Meyer W, 2003, EMERG INFECT DIS, V9, P189; Moyrand F, 2004, EUKARYOT CELL, V3, P1513, DOI 10.1128/EC.3.6.1513-1524.2004; Narasipura SD, 2005, MOL MICROBIOL, V55, P1782, DOI 10.1111/j.1365-2958.2005.04503.x; NCCLS, 2002, REF METH BROTH DIL A, V22; NGAMSKULRUNGROJ P, 2010, CLIN MICROBIOL INFEC, DOI DOI 10.1111/J.1469-0691.2010.03222.X; Ngamskulrungroj P, 2008, MED MYCOL, V46, P665, DOI 10.1080/13693780802210734; Ngamskulrungroj P, 2009, INFECT IMMUN, V77, P4584, DOI 10.1128/IAI.00565-09; Ngamskulrungroj Popchai, 2009, Australasian Mycologist, V28, P9; Nosanchuk JD, 1999, ANTIMICROB AGENTS CH, V43, P233, DOI 10.1093/jac/43.2.233; Pardini G, 2006, J BIOL CHEM, V281, P40399, DOI 10.1074/jbc.M606361200; PARKS LW, 1995, LIPIDS, V30, P227, DOI 10.1007/BF02537825; Perfect JR, 2005, FEMS IMMUNOL MED MIC, V45, P395, DOI 10.1016/j.femsim.2005.06.005; PLEMPEL M, 1984, DERMATOLOGICA, V169, P11, DOI 10.1159/000249635; Pukkila-Worley R, 2005, EUKARYOT CELL, V4, P190, DOI 10.1128/EC.4.1.190-201.2005; Ren P, 2006, EUKARYOT CELL, V5, P1065, DOI 10.1128/EC.00009-06; ROEMER T, 1991, P NATL ACAD SCI USA, V88, P11295, DOI 10.1073/pnas.88.24.11295; Shea JM, 2006, FEMS YEAST RES, V6, P469, DOI 10.1111/j.1567-1364.2006.00080.x; Sorrell TC, 2001, MED MYCOL, V39, P155, DOI 10.1080/mmy.39.2.155.168; Stephen C, 2002, CAN VET J, V43, P792; Takeo K, 2004, FEMS YEAST RES, V4, P737, DOI 10.1016/j.femsyr.2004.01.005; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Trilles L, 2008, MEM I OSWALDO CRUZ, V103, P455, DOI 10.1590/S0074-02762008000500008; Velegraki A, 2001, MED MYCOL, V39, P419, DOI 10.1080/mmy.39.5.419.422; Viviani MA, 2006, FEMS YEAST RES, V6, P614, DOI 10.1111/j.1567-1364.2006.00081.x; Volkman JK, 2003, APPL MICROBIOL BIOT, V60, P495, DOI 10.1007/s00253-002-1172-8; Walton FJ, 2005, MOL MICROBIOL, V57, P1381, DOI 10.1111/j.1365-2958.2005.04779.x; WILLIAMSON PR, 1994, J BACTERIOL, V176, P656, DOI 10.1128/jb.176.3.656-664.1994; Wright LC, 2004, BIOCHEM J, V384, P377, DOI 10.1042/BJ20041079; Zaragoza O, 2003, INFECT IMMUN, V71, P6155, DOI 10.1128/IAI.71.11.6155-6164.2003	74	47	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16076	10.1371/journal.pone.0016076	http://dx.doi.org/10.1371/journal.pone.0016076			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249145	Green Submitted, gold, Green Published			2022-12-27	WOS:000286515000015
J	Kulathila, R; Kulathila, R; Indic, M; van den Berg, B				Kulathila, Rithika; Kulathila, Ragini; Indic, Mridhu; van den Berg, Bert			Crystal Structure of Escherichia coli CusC, the Outer Membrane Component of a Heavy Metal Efflux Pump	PLOS ONE			English	Article							PROTEIN; MECHANISMS; EXPRESSION; RESISTANCE	Background: While copper has essential functions as an enzymatic co-factor, excess copper ions are toxic for cells, necessitating mechanisms for regulating its levels. The cusCBFA operon of E. coli encodes a four-component efflux pump dedicated to the extrusion of Cu(I) and Ag(I) ions. Methodology/Principal Findings: We have solved the X-ray crystal structure of CusC, the outer membrane component of the Cus heavy metal efflux pump, to 2.3 A resolution. The structure has the largest extracellular opening of any outer membrane factor (OMF) protein and suggests, for the first time, the presence of a tri-acylated N-terminal lipid anchor. Conclusions/Significance: The CusC protein does not have any obvious features that would make it specific for metal ions, suggesting that the narrow substrate specificity of the pump is provided by other components of the pump, most likely by the inner membrane component CusA.	[Kulathila, Rithika; Kulathila, Ragini; Indic, Mridhu; van den Berg, Bert] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Kulathila, R (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	bert.vandenberg@umassmed.edu		van den Berg, Bert/0000-0003-1966-8804	National Institutes of Health (NIGMS) [R01 GM085785]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085785] Funding Source: NIH RePORTER	National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research in the lab is supported by the National Institutes of Health (NIGMS grant R01 GM085785 to BvdB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama H, 2004, J BIOL CHEM, V279, P52816, DOI 10.1074/jbc.C400445200; [Anonymous], PYMOL MOL GRAPH SYST; Bagai I, 2008, BIOCHEMISTRY-US, V47, P11408, DOI 10.1021/bi801638m; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bavro VN, 2008, MOL CELL, V30, P114, DOI 10.1016/j.molcel.2008.02.015; Conroy O, 2010, FEMS MICROBIOL LETT, V308, P115, DOI 10.1111/j.1574-6968.2010.02006.x; Deniaud A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006214; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HAUN RS, 1992, GENE, V112, P37, DOI 10.1016/0378-1119(92)90300-E; Kittleson JT, 2006, BIOCHEMISTRY-US, V45, P11096, DOI 10.1021/bi0612622; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Loftin IR, 2007, PROTEIN SCI, V16, P2287, DOI 10.1110/ps.073021307; Long F, 2010, NATURE, V467, P484, DOI 10.1038/nature09395; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Neilsen PO, 2001, J IMMUNOL, V167, P5231, DOI 10.4049/jimmunol.167.9.5231; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Nikaido H, 2009, BBA-PROTEINS PROTEOM, V1794, P769, DOI 10.1016/j.bbapap.2008.10.004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paulsen IT, 1997, FEMS MICROBIOL LETT, V156, P1, DOI 10.1111/j.1574-6968.1997.tb12697.x; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; SU CC, 2010, PROTEIN SCI     1027; Su CC, 2009, J MOL BIOL, V393, P342, DOI 10.1016/j.jmb.2009.08.029; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Xue Y, 2008, NAT CHEM BIOL, V4, P107, DOI 10.1038/nchembio.2007.57; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	29	72	75	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e15610	10.1371/journal.pone.0015610	http://dx.doi.org/10.1371/journal.pone.0015610			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249122	Green Submitted, gold, Green Published			2022-12-27	WOS:000286512900008
J	Sullivan, MJ; Curson, ARJ; Shearer, N; Todd, JD; Green, RT; Johnston, AWB				Sullivan, Matthew J.; Curson, Andrew R. J.; Shearer, Neil; Todd, Jonathan D.; Green, Robert T.; Johnston, Andrew W. B.			Unusual Regulation of a Leaderless Operon Involved in the Catabolism of Dimethylsulfoniopropionate in Rhodobacter sphaeroides	PLOS ONE			English	Article							DIMETHYL SULFIDE; ESCHERICHIA-COLI; RHIZOBIUM-LEGUMINOSARUM; CLONING VECTORS; HIGHER-PLANTS; DDDP GENE; BACTERIA; DMSP; OCEAN; SULFUR	Rhodobacter sphaeroides strain 2.4.1 is a widely studied bacterium that has recently been shown to cleave the abundant marine anti-stress molecule dimethylsulfoniopropionate (DMSP) into acrylate plus gaseous dimethyl sulfide. It does so by using a lyase encoded by dddL, the promoter-distal gene of a three-gene operon, acuR-acuI-dddL. Transcription of the operon was enhanced when cells were pre-grown with the substrate DMSP, but this induction is indirect, and requires the conversion of DMSP to the product acrylate, the bona fide co-inducer. This regulation is mediated by the product of the promoter-proximal gene acuR, a transcriptional regulator in the TetR family. AcuR represses the operon in the absence of acrylate, but this is relieved by the presence of the co-inducer. Another unusual regulatory feature is that the acuR-acuI-dddL mRNA transcript is leaderless, such that acuR lacks a Shine-Dalgarno ribosomal binding site and 59-UTR, and is translated at a lower level compared to the downstream genes. This regulatory unit may be quite widespread in bacteria, since several other taxonomically diverse lineages have adjacent acuR-like and acuI-like genes; these operons also have no 59 leader sequences or ribosomal binding sites and their predicted cis-acting regulatory sequences resemble those of R. sphaeroides acuR-acuI-dddL.	[Sullivan, Matthew J.; Curson, Andrew R. J.; Todd, Jonathan D.; Green, Robert T.; Johnston, Andrew W. B.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Shearer, Neil; Green, Robert T.] Inst Food Res, Norwich NR4 7UA, Norfolk, England	University of East Anglia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia	Sullivan, MJ (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	a.johnston@uea.ac.uk	Johnston, Andrew W B/D-1859-2009; Todd, Jonathan/B-8967-2009; Sullivan, Matthew J/C-3857-2009; Curson, Andrew RJ/B-8964-2009	Todd, Jonathan/0000-0003-0777-9312; Sullivan, Matthew J/0000-0003-2276-3132; 	NERC [BBE01688X1, NE/E018033/1]; BBSRC [BBE01688X1, NE/E018033/1]; Natural Environment Research Council [NE/E018033/1, NE/F001339/1, NE/F001312/1] Funding Source: researchfish; NERC [NE/F001339/1, NE/F001312/1] Funding Source: UKRI	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by a PhD studentship to MJS from the NERC (http://www.nerc.ac.uk/) and by grants BBE01688X1 and NE/E018033/1 to AWBJ from the NERC and BBSRC (http://www.bbsrc.ac.uk/) respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaway D, 2001, ENVIRON MICROBIOL, V3, P397, DOI 10.1046/j.1462-2920.2001.00205.x; BAGDASARIAN M, 1981, GENE, V16, P237, DOI 10.1016/0378-1119(81)90080-9; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bensing BA, 1996, P NATL ACAD SCI USA, V93, P7794, DOI 10.1073/pnas.93.15.7794; CANTONI GL, 1956, J BIOL CHEM, V222, P171; Choudhary M, 2007, J BACTERIOL, V189, P1914, DOI 10.1128/JB.01498-06; Cunningham GB, 2008, J EXP BIOL, V211, P3123, DOI 10.1242/jeb.018325; Curson ARJ, 2008, ENVIRON MICROBIOL, V10, P757, DOI 10.1111/j.1462-2920.2007.01499.x; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Howard EC, 2008, ENVIRON MICROBIOL, V10, P2397, DOI 10.1111/j.1462-2920.2008.01665.x; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; Kaberdina AC, 2009, MOL CELL, V33, P227, DOI 10.1016/j.molcel.2008.12.014; Kiene RP, 2000, J SEA RES, V43, P209, DOI 10.1016/S1385-1101(00)00023-X; Kiene RP, 1999, APPL ENVIRON MICROB, V65, P4549; Kirkwood M, 2010, MICROBIOL-SGM, V156, P1900, DOI 10.1099/mic.0.038927-0; KLOCK G, 1986, J MOL BIOL, V189, P633, DOI 10.1016/0022-2836(86)90493-6; Kowalewsky S, 2006, BIOL LETT-UK, V2, P106, DOI 10.1098/rsbl.2005.0380; Kurata A, 2005, J BIOL CHEM, V280, P20286, DOI 10.1074/jbc.M414605200; LOVELOCK JE, 1972, NATURE, V237, P452, DOI 10.1038/237452a0; Ma D, 1996, MOL MICROBIOL, V19, P101, DOI 10.1046/j.1365-2958.1996.357881.x; Malmstrom RR, 2004, APPL ENVIRON MICROB, V70, P4129, DOI 10.1128/AEM.70.7.4129-4135.2004; Messing J, 1979, RECOMBINANT DNA TECH, V2, P43; Moll I, 2002, MOL MICROBIOL, V43, P239, DOI 10.1046/j.1365-2958.2002.02739.x; Nevitt GA, 2008, J EXP BIOL, V211, P1706, DOI 10.1242/jeb.015412; O'Donnell SM, 2001, J BACTERIOL, V183, P1277, DOI 10.1128/JB.183.4.1277-1283.2001; Otte ML, 2004, J EXP BOT, V55, P1919, DOI 10.1093/jxb/erh178; Raina JB, 2010, TRENDS MICROBIOL, V18, P101, DOI 10.1016/j.tim.2009.12.002; ROSSEN L, 1985, EMBO J, V4, P3369, DOI 10.1002/j.1460-2075.1985.tb04092.x; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sambrook J, 1989, MOL CLONING LABORATO; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; SPAINK HP, 1987, PLANT MOL BIOL, V9, P27, DOI 10.1007/BF00017984; Stefels J, 2000, J SEA RES, V43, P183, DOI 10.1016/S1385-1101(00)00030-7; Steinke M, 1998, MAR ECOL PROG SER, V175, P215, DOI 10.3354/meps175215; Steinke M, 2002, J PHYCOL, V38, P630, DOI 10.1046/j.1529-8817.2002.02057.x; Tapiolas DM, 2010, CORAL REEFS, V29, P621, DOI 10.1007/s00338-010-0608-3; Todd JD, 2009, ENVIRON MICROBIOL, V11, P1376, DOI 10.1111/j.1462-2920.2009.01864.x; TODD JD, 2010, ENV MICROBIOL; Todd JD, 2007, SCIENCE, V315, P666, DOI 10.1126/science.1135370; Todd JD, 2010, ENVIRON MICROBIOL, V12, P327, DOI 10.1111/j.1462-2920.2009.02071.x; Vallina SM, 2007, SCIENCE, V315, P506, DOI 10.1126/science.1133680; van Niel CB, 1944, BACTERIOL REV, V8, P1; WALZ A, 1976, NATURE, V262, P665, DOI 10.1038/262665a0; Wexler M, 2001, MOL MICROBIOL, V41, P801, DOI 10.1046/j.1365-2958.2001.02556.x; WOOD WB, 1966, J MOL BIOL, V16, P118, DOI 10.1016/S0022-2836(66)80267-X; Yoch DC, 2002, APPL ENVIRON MICROB, V68, P5804, DOI 10.1128/AEM.68.12.5804-5815.2002	48	26	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e15972	10.1371/journal.pone.0015972	http://dx.doi.org/10.1371/journal.pone.0015972			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249136	Green Published, gold			2022-12-27	WOS:000286512900016
J	Guabiraba, R; Marques, RE; Besnard, AG; Fagundes, CT; Souza, DG; Ryffel, B; Teixeira, MM				Guabiraba, Rodrigo; Marques, Rafael Elias; Besnard, Anne-Gaelle; Fagundes, Caio T.; Souza, Danielle G.; Ryffel, Bernhard; Teixeira, Mauro M.			Role of the Chemokine Receptors CCR1, CCR2 and CCR4 in the Pathogenesis of Experimental Dengue Infection in Mice	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; VIRUS-INFECTION; ANTIBODY-RESPONSE; PLASMA LEAKAGE; INFLAMMATION; EXPRESSION; DISEASE; SYSTEM; CLASSIFICATION; INTERLEUKIN-8	Dengue virus (DENV), a mosquito-borne flavivirus, is a public health problem in many tropical countries. Recent clinical data have shown an association between levels of different chemokines in plasma and severity of dengue. We evaluated the role of CC chemokine receptors CCR1, CCR2 and CCR4 in an experimental model of DENV-2 infection in mice. Infection of mice induced evident clinical disease and tissue damage, including thrombocytopenia, hemoconcentration, lymphopenia, increased levels of transaminases and pro-inflammatory cytokines, and lethality in WT mice. Importantly, infected WT mice presented increased levels of chemokines CCL2/JE, CCL3/MIP-1 alpha and CCL5/RANTES in spleen and liver. CCR1(-/-) mice had a mild phenotype with disease presentation and lethality similar to those of WT mice. In CCR2(-/-) mice, lethality, liver damage, levels of IL-6 and IFN-gamma, and leukocyte activation were attenuated. However, thrombocytopenia, hemoconcentration and systemic TNF-alpha levels were similar to infected WT mice. Infection enhanced levels of CCL17/TARC, a CCR4 ligand. In CCR4(-/-) mice, lethality, tissue injury and systemic inflammation were markedly decreased. Despite differences in disease presentation in CCR-deficient mice, there was no significant difference in viral load. In conclusion, activation of chemokine receptors has discrete roles in the pathogenesis of dengue infection. These studies suggest that the chemokine storm that follows severe primary dengue infection associates mostly to development of disease rather than protection.	[Guabiraba, Rodrigo; Marques, Rafael Elias; Fagundes, Caio T.; Teixeira, Mauro M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Guabiraba, Rodrigo; Besnard, Anne-Gaelle; Ryffel, Bernhard] Univ Orleans, Orleans, France; [Guabiraba, Rodrigo; Besnard, Anne-Gaelle; Ryffel, Bernhard] CNRS, UMR 6218, F-45071 Orleans, France; [Souza, Danielle G.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universite de Orleans; Centre National de la Recherche Scientifique (CNRS); Universidade Federal de Minas Gerais	Guabiraba, R (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.	mmtex@icb.ufmg.br	souza, danielle/D-3378-2014; Fagundes, Caio/AAK-9336-2020; Marques, Rafael Elias/R-4890-2016; R, Guabiraba/F-1396-2010; Teixeira, Mauro M/A-4587-2008	Fagundes, Caio/0000-0002-6747-5233; Marques, Rafael Elias/0000-0002-6949-0947; R, Guabiraba/0000-0003-4005-1753; Teixeira, Mauro M/0000-0002-6944-3008	Fondation pour la Recherche Medicale en France (FRM); Centre Nationale de la Recherche Scientifique (CNRS, France); Conselho Nacional de Deselvovimento Cientifico e Tecnologico (CNPq, Brazil)	Fondation pour la Recherche Medicale en France (FRM)(Fondation pour la Recherche Medicale); Centre Nationale de la Recherche Scientifique (CNRS, France)(Centre National de la Recherche Scientifique (CNRS)); Conselho Nacional de Deselvovimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study received financial support from Fondation pour la Recherche Medicale en France (FRM), Centre Nationale de la Recherche Scientifique (CNRS, France) and Conselho Nacional de Deselvovimento Cientifico e Tecnologico (CNPq, Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assuncao-Miranda I, 2010, FASEB J, V24, P218, DOI 10.1096/fj.09-139469; Atrasheuskaya A, 2003, FEMS IMMUNOL MED MIC, V35, P33, DOI 10.1111/j.1574-695X.2003.tb00646.x; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Balmaseda A, 2006, AM J TROP MED HYG, V74, P449, DOI 10.4269/ajtmh.2006.74.449; Balmaseda A, 2008, J CLIN VIROL, V43, P287, DOI 10.1016/j.jcv.2008.07.016; Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86; Brown KL, 2007, TRENDS IMMUNOL, V28, P260, DOI 10.1016/j.it.2007.04.005; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; Cardona AE, 2008, BLOOD, V112, P256, DOI 10.1182/blood-2007-10-118497; Chvatchko Y, 2000, J EXP MED, V191, P1755, DOI 10.1084/jem.191.10.1755; Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06; Conceicao TM, J INFECT, V60, P65; Couvelard A, 1999, HUM PATHOL, V30, P1106, DOI 10.1016/S0046-8177(99)90230-7; Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5; Di Stasi A, 2009, BLOOD, V113, P6392, DOI 10.1182/blood-2009-03-209650; Fink K, 2009, EUR J IMMUNOL, V39, P2809, DOI 10.1002/eji.200939389; Gibbons RV, 2002, BMJ-BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563; Glass WG, 2003, CURR OPIN ALLERGY CL, V3, P467, DOI 10.1097/01.all.0000104448.09202.91; Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Guzmán María G., 2002, Rev Panam Salud Publica, V11, P223, DOI 10.1590/S1020-49892002000400003; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; HALSTEAD SB, 1970, YALE J BIOL MED, V42, P311; Halstead SB, 2001, AM J TROP MED HYG, V65, P180, DOI 10.4269/ajtmh.2001.65.180; Horuk Richard, 2009, Front Biosci (Elite Ed), V1, P209; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; Johnston B, 1999, J CLIN INVEST, V103, P1269, DOI 10.1172/JCI5208; Juffrie M, 2000, INFECT IMMUN, V68, P702, DOI 10.1128/IAI.68.2.702-707.2000; Kalayanarooj S, 1997, J INFECT DIS, V176, P313, DOI 10.1086/514047; Kim CH, 2002, BLOOD, V100, P11, DOI 10.1182/blood-2001-12-0196; King CA, 2002, J VIROL, V76, P8408, DOI 10.1128/JVI.76.16.8408-8419.2002; Kyle JL, 2008, VIROLOGY, V380, P296, DOI 10.1016/j.virol.2008.08.008; Lee YR, 2006, J GEN VIROL, V87, P3623, DOI 10.1099/vir.0.82093-0; Lin YL, 2000, VIROLOGY, V276, P114, DOI 10.1006/viro.2000.0524; Locati M, 1999, ANNU REV MED, V50, P425, DOI 10.1146/annurev.med.50.1.425; Locati M, 2002, ALLERGY, V57, P972, DOI 10.1034/j.1398-9995.2002.02166.x; Luster AD, 2001, CURR OPIN ALLERGY CL, V1, P561, DOI 10.1097/00130832-200112000-00012; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Mantovani A, 1999, Chem Immunol, V72, P1, DOI 10.1159/000058734; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09; Matsukawa A, 2000, J IMMUNOL, V164, P5362, DOI 10.4049/jimmunol.164.10.5362; Medin CL, 2005, J VIROL, V79, P11053, DOI 10.1128/JVI.79.17.11053-11061.2005; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Navarro-Sanchez E, 2005, ARCH MED RES, V36, P425, DOI 10.1016/j.arcmed.2005.04.007; Nisalak A, 2003, AM J TROP MED HYG, V68, P191, DOI 10.4269/ajtmh.2003.68.191; Nouri-Aria KT, 2002, EUR J IMMUNOL, V32, P1933, DOI 10.1002/1521-4141(200207)32:7<1933::AID-IMMU1933>3.0.CO;2-R; Pham TB, 2009, J CLIN VIROL, V45, P276, DOI 10.1016/j.jcv.2009.04.004; Rodriguez-Madoz JR, 2010, J VIROL, V84, P4845, DOI 10.1128/JVI.02514-09; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Russo RC, 2010, CURR OPIN DRUG DISC, V13, P414; Schnittler HJ, 2003, THROMB HAEMOSTASIS, V89, P967; Schuh JM, 2002, FASEB J, V16, pA331; Semmling V, 2010, NAT IMMUNOL, V11, P313, DOI 10.1038/ni.1848; Shresta S, 2004, VIROLOGY, V319, P262, DOI 10.1016/j.virol.2003.09.048; Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004; Sierra B, CYTOKINE; Souza DG, 2009, P NATL ACAD SCI USA, V106, P14138, DOI 10.1073/pnas.0906467106; Souza DG, 2003, J IMMUNOL, V170, P4759, DOI 10.4049/jimmunol.170.9.4759; Spain-Santana TA, 2001, J MED VIROL, V65, P324, DOI 10.1002/jmv.2037; Speyer CL, 2004, AM J PATHOL, V165, P2187, DOI 10.1016/S0002-9440(10)63268-3; Srikiatkhachorn A, 2007, PEDIATR INFECT DIS J, V26, P283, DOI 10.1097/01.inf.0000258612.26743.10; Srikiatkhachorn A, 2009, THROMB HAEMOSTASIS, V102, P1042, DOI 10.1160/TH09-03-0208; Suksanpaisan L, 2007, J MED VIROL, V79, P300, DOI 10.1002/jmv.20798; Thein S, 1997, AM J TROP MED HYG, V56, P566, DOI 10.4269/ajtmh.1997.56.566; Traeger T, 2008, INFECT IMMUN, V76, P5285, DOI 10.1128/IAI.00310-08; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Vijayanand P, 2010, J IMMUNOL, V184, P4568, DOI 10.4049/jimmunol.0901342; Yuan Q, 2007, J EXP MED, V204, P1327, DOI 10.1084/jem.20062076; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	70	50	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15680	10.1371/journal.pone.0015680	http://dx.doi.org/10.1371/journal.pone.0015680			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206747	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000285793200036
J	Huang, ES; Strate, LL; Ho, WW; Lee, SS; Chan, AT				Huang, Edward S.; Strate, Lisa L.; Ho, Wendy W.; Lee, Salina S.; Chan, Andrew T.			A Prospective Study of Aspirin Use and the Risk of Gastrointestinal Bleeding in Men	PLOS ONE			English	Article							LOW-DOSE ASPIRIN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; COLORECTAL-CANCER; URGENT COLONOSCOPY; PRIMARY PREVENTION; PHYSICAL-ACTIVITY; BLOOD-FLOW; OMEPRAZOLE; ULCERS; COMPLICATIONS	Background and Aims: Data regarding the influence of dose and duration of aspirin use on risk of gastrointestinal bleeding are conflicting. Methods: We conducted a prospective cohort study of 32,989 men enrolled in the Health Professionals Follow-up Study (HPFS) in 1994 who provided biennial aspirin data. We estimated relative risk of major gastrointestinal bleeding requiring hospitalization or a blood transfusion. Results: During 14 years of follow-up, 707 men reported an episode of major gastrointestinal bleeding over 377,231 person-years. After adjusting for risk factors, regular aspirin use (>= 2 times/week) had a multivariate relative risk (RR) of gastrointestinal bleeding of 1.32 (95% confidence interval [CI], 1.12-1.55) compared to non-regular use. The association was particularly evident for upper gastrointestinal bleeding (multivariate RR, 1.49; 95% CI, 1.16-1.92). Compared to men who denied any aspirin use, multivariate RRs of upper gastrointestinal bleeding were 1.05 (95% CI 0.71-1.52) for men who used 0.5-1.5 standard tablets/week, 1.31 (95% CI 0.88-1.95) for 2-5 aspirin/week, 1.63 (95% CI, 1.15-2.32) for 6-14 aspirin/week and 2.40 (95% CI, 1.10-5.22) for >14 aspirin/week (P-trend < 0.001). The relative risk also appeared to be dose-dependent among short-term users (>= 5 years; P-trend<.001) and long-term users (>= 5 years; P-trend = 0.015). In contrast, after controlling for dose, increasing duration of use did not appear to be associated with risk (P-trend = 0.749). Conclusions: Regular aspirin use increases the risk of gastrointestinal bleeding, especially from the upper tract. However, risk of bleeding appears to be more strongly related to dose than to duration of use. Risk of bleeding should be minimized by using the lowest effective dose among short-term and long-term aspirin users.	[Huang, Edward S.; Chan, Andrew T.] Massachusetts Gen Hosp, Dept Med, Div Gastroenterol & Hepatol, Boston, MA 02114 USA; [Huang, Edward S.; Chan, Andrew T.] Harvard Univ, Sch Med, Boston, MA USA; [Strate, Lisa L.] Univ Washington, Dept Med, Div Gastroenterol, Seattle, WA USA; [Ho, Wendy W.] Univ Calif Los Angeles, Dept Med, Div Digest Dis, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Lee, Salina S.] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Chan, Andrew T.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Northwestern University; Feinberg School of Medicine; Harvard University; Brigham & Women's Hospital	Huang, ES (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Gastroenterol & Hepatol, Boston, MA 02114 USA.	eshuang@partners.org	Chan, Andrew T/P-8293-2014	Chan, Andrew T/0000-0001-7284-6767	Foundation for Digestive Health and Nutrition; American Gastroenterology Association; NATIONAL CANCER INSTITUTE [R01CA137178, P01CA055075, K07CA107412, P01CA087969] Funding Source: NIH RePORTER	Foundation for Digestive Health and Nutrition; American Gastroenterology Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Foundation for Digestive Health and Nutrition Pilot Research Award for this work. Dr. Chan is a Damon Runyon Clinical Investigator. Dr. Huang is supported by the American Gastroenterology Association Fellow to Faculty Transition Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen IB, 2000, EPIDEMIOLOGY, V11, P434; Arora G, 2009, CLIN GASTROENTEROL H, V7, P725, DOI 10.1016/j.cgh.2009.03.015; Ascherio A, 1999, ANN INTERN MED, V130, P963, DOI 10.7326/0003-4819-130-12-199906150-00003; Bhatt DL, 2008, CIRCULATION, V118, P1894, DOI 10.1161/CIRCULATIONAHA.108.191087; Brzozowski T, 2008, J PHYSIOL PHARMACOL, V59, P89; Chan AT, 2008, GASTROENTEROLOGY, V134, P21, DOI 10.1053/j.gastro.2007.09.035; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Cole AT, 1999, ALIMENT PHARM THERAP, V13, P187; de Abajo F J, 2001, BMC Clin Pharmacol, V1, P1, DOI 10.1186/1472-6904-1-1; Derry S, 2000, BMJ-BRIT MED J, V321, P1183, DOI 10.1136/bmj.321.7270.1183; EASTWOOD GL, 1982, GASTROENTEROLOGY, V82, P852; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; Green BT, 2005, AM J GASTROENTEROL, V100, P2395, DOI 10.1111/j.1572-0241.2005.00306.x; GRIFFIN MR, 1991, ANN INTERN MED, V114, P257, DOI 10.7326/0003-4819-114-4-257; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hawkey CJ, 1998, NEW ENGL J MED, V338, P727, DOI 10.1056/NEJM199803123381105; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; HENRY D, 1993, GASTROENTEROLOGY, V105, P1078, DOI 10.1016/0016-5085(93)90952-9; Huang ES, 2010, LONG TERM USE ASPIRI; Javid G, 2001, AM J MED, V111, P280, DOI 10.1016/S0002-9343(01)00812-9; Jensen DM, 2000, NEW ENGL J MED, V342, P78, DOI 10.1056/NEJM200001133420202; JUULMOLLER S, 1992, LANCET, V340, P1421, DOI 10.1016/0140-6736(92)92619-Q; Khuroo MS, 1997, NEW ENGL J MED, V336, P1054, DOI 10.1056/NEJM199704103361503; KONTUREK JW, 1994, GUT, V35, P1197, DOI 10.1136/gut.35.9.1197; KONTUREK SJ, 1994, GUT, V35, P1189, DOI 10.1136/gut.35.9.1189; Lanas A, 2000, NEW ENGL J MED, V343, P834, DOI 10.1056/NEJM200009213431202; Lanas A, 2007, AM J GASTROENTEROL, V102, P507, DOI 10.1111/j.1572-0241.2006.01062.x; LANGMAN MJS, 1994, LANCET, V343, P1075, DOI 10.1016/S0140-6736(94)90185-6; McQuaid KR, 2006, AM J MED, V119, P624, DOI 10.1016/j.amjmed.2005.10.039; Meade TW, 1998, LANCET, V351, P233; NELSON RL, 1994, JNCI-J NATL CANCER I, V86, P455, DOI 10.1093/jnci/86.6.455; OLIVERO JJ, 1992, SCAND J GASTROENTERO, V27, P53, DOI 10.3109/00365529209096006; PAHOR M, 1994, JAMA-J AM MED ASSOC, V272, P595, DOI 10.1001/jama.272.8.595; Penglis PS, 2000, J IMMUNOL, V165, P1605, DOI 10.4049/jimmunol.165.3.1605; PENSTON JG, 1992, ALIMENT PHARM THERAP, V6, P629; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rodriguez LAG, 2001, BRIT J CLIN PHARMACO, V52, P563, DOI 10.1046/j.0306-5251.2001.01476.x; Rostom A, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002296, DOI 10.1002/14651858.CD002296]; Scheiman JM, 2006, AM J GASTROENTEROL, V101, P701, DOI 10.1111/j.1572-0241.2006.00499.x; Serebruany VL, 2005, AM J CARDIOL, V95, P1218, DOI 10.1016/j.amjcard.2005.01.049; Serrano P, 2002, ALIMENT PHARM THER, V16, P1945, DOI 10.1046/j.1365-2036.2002.01355.x; SLATTERY J, 1995, GUT, V37, P509, DOI 10.1136/gut.37.4.509; Sorensen HT, 2000, AM J GASTROENTEROL, V95, P2218; Strate LL, 2009, AM J GASTROENTEROL, V104, P1221, DOI 10.1038/ajg.2009.121; Strate LL, 2009, GASTROENTEROLOGY, V136, P115, DOI 10.1053/j.gastro.2008.09.025; Strate LL, 2003, ARCH INTERN MED, V163, P838, DOI 10.1001/archinte.163.7.838; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; WEIL J, 1995, BMJ-BRIT MED J, V310, P827, DOI 10.1136/bmj.310.6983.827; Yeomans ND, 1998, NEW ENGL J MED, V338, P719, DOI 10.1056/NEJM199803123381104; Zanchetti A, 1999, LANCET, V353, P149, DOI 10.1016/S0140-6736(05)76187-0	50	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15721	10.1371/journal.pone.0015721	http://dx.doi.org/10.1371/journal.pone.0015721			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209949	gold, Green Submitted, Green Published			2022-12-27	WOS:000285793200042
J	Stigall, AL				Stigall, Alycia L.			Invasive Species and Biodiversity Crises: Testing the Link in the Late Devonian	PLOS ONE			English	Article							EXTINCTION COMPONENTS; TAXONOMIC DIVERSITY; BIOGEOGRAPHY; ORIGINATION; SPECIATION; DISPERSAL; EVOLUTION; HISTORY; MODELS; MIDDLE	During the Late Devonian Biodiversity Crisis, the primary driver of biodiversity decline was the dramatic reduction in speciation rates, not elevated extinction rates; however, the causes of speciation decline have been previously unstudied. Speciation, the formation of new species from ancestral populations, occurs by two primary allopatric mechanisms: vicariance, where the ancestral population is passively divided into two large subpopulations that later diverge and form two daughter species, and dispersal, in which a small subset of the ancestral population actively migrates then diverges to form a new species. Studies of modern and fossil clades typically document speciation by vicariance in much higher frequencies than speciation by dispersal. To assess the mechanism behind Late Devonian speciation reduction, speciation rates were calculated within stratigraphically constrained species-level phylogenetic hypotheses for three representative clades and mode of speciation at cladogenetic events was assessed across four clades in three phyla: Arthropoda, Brachiopoda, and Mollusca. In all cases, Devonian taxa exhibited a congruent reduction in speciation rate between the Middle Devonian pre-crisis interval and the Late Devonian crisis interval. Furthermore, speciation via vicariance is almost entirely absent during the crisis interval; most episodes of speciation during this time were due to dispersal. The shutdown of speciation by vicariance during this interval was related to widespread interbasinal species invasions. The lack of Late Devonian vicariance is diametrically opposed to the pattern observed in other geologic intervals, which suggests the loss of vicariant speciation attributable to species invasions during the Late Devonian was a causal factor in the biodiversity crisis. Similarly, modern ecosystems, in which invasive species are rampant, may be expected to exhibit similar shutdown of speciation by vicariance as an outcome of the modern biodiversity crisis.	[Stigall, Alycia L.] Ohio Univ, Dept Geol Sci, Athens, OH 45701 USA; [Stigall, Alycia L.] Ohio Univ, OHIO Ctr Ecol & Evolutionary Studies, Athens, OH 45701 USA	University System of Ohio; Ohio University; University System of Ohio; Ohio University	Stigall, AL (corresponding author), Ohio Univ, Dept Geol Sci, Athens, OH 45701 USA.	stigall@ohio.edu	Stigall, Alycia/C-7989-2013	Stigall, Alycia/0000-0002-4722-3303	National Science Foundation (NSF) [EAR-0922067]; American Chemical Society; Ohio University; Directorate For Geosciences [0922067] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); American Chemical Society(American Chemical Society); Ohio University; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding was provided by the National Science Foundation (NSF) EAR-0922067, a grant from the American Chemical Society's Petroleum Research Fund, and Ohio University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe FR, 2009, EVOL BIOL, V36, P225, DOI 10.1007/s11692-009-9060-0; Alroy J, 2001, P NATL ACAD SCI USA, V98, P6261, DOI 10.1073/pnas.111144698; Alroy J, 2008, P NATL ACAD SCI USA, V105, P11536, DOI 10.1073/pnas.0802597105; Ausich WI, 2005, PALEOBIOLOGY, V31, P538, DOI 10.1666/0094-8373(2005)031[0538:ARMHFO]2.0.CO;2; Bambach RK, 2004, PALEOBIOLOGY, V30, P522, DOI 10.1666/0094-8373(2004)030<0522:OEAMDO>2.0.CO;2; Brooks D.R., 2002, NATURE DIVERSITY; BROOKS DR, 2005, PALEONTOLOGICAL SOC, V11, P15; Brooks DR, 1991, PHYLOGENY ECOLOGY BE; Congreve CR, 2010, J PALEONTOL, V84, P128, DOI 10.1666/09-026.1; Congreve Curtis R., 2008, Open Paleontology Journal, V1, P24, DOI 10.2174/1874425700801010024; Cowie RH, 2006, J BIOGEOGR, V33, P193, DOI 10.1111/j.1365-2699.2005.01383.x; Dawson MN, 2005, J BIOGEOGR, V32, P515, DOI 10.1111/j.1365-2699.2004.01193.x; Droser ML, 2000, GEOLOGY, V28, P675, DOI 10.1130/0091-7613(2000)028<0675:DOTAES>2.3.CO;2; Enserink M, 1999, SCIENCE, V285, P1834, DOI 10.1126/science.285.5435.1834; Foote M, 2005, PALEOBIOLOGY, V31, P6, DOI 10.1666/0094-8373(2005)031<0006:POAEIT>2.0.CO;2; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Foote M, 2000, PALEOBIOLOGY, V26, P578, DOI 10.1666/0094-8373(2000)026<0578:OAECOT>2.0.CO;2; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; HULBERT RC, 1993, PALEOBIOLOGY, V19, P216, DOI 10.1017/S0094837300015888; JOHNSON JG, 1985, GEOL SOC AM BULL, V96, P567, DOI 10.1130/0016-7606(1985)96<567:DEFIE>2.0.CO;2; Kaufmann B, 2006, EARTH-SCI REV, V76, P175, DOI 10.1016/j.earscirev.2006.01.001; Kelly DW, 2006, EVOLUTION, V60, P257; KLAPPER G, 1980, J PALEONTOL, V54, P400; Klapper Gilbert, 1995, Historical Biology, V10, P103; Lane A, 2005, PALEOBIOLOGY, V31, P21, DOI 10.1666/0094-8373(2005)031<0021:EPATOT>2.0.CO;2; Lieberman, 2000, PALEOBIOGEOGRAPHY US; Lieberman Bruce S., 2001, Topics in Geobiology, V19, P323; Lieberman BS, 2003, SPEC PAP PALAEONTOL, P59; Lieberman BS, 1997, GEOLOGY, V25, P1039, DOI 10.1130/0091-7613(1997)025<1039:ECPATH>2.3.CO;2; Lieberman BS, 1996, PALEOBIOLOGY, V22, P66, DOI 10.1017/S009483730001602X; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Mayr E, 1942, SYSTEMATICS ORIGIN S; McCartney MA, 2000, MOL ECOL, V9, P1391, DOI 10.1046/j.1365-294x.2000.01022.x; McGhee G.R., 1996, LATE DEVONIAN MASS E; McGhee G.R. Jr, 1989, P133; Nee S, 2001, EVOLUTION, V55, P661, DOI 10.1554/0014-3820(2001)055[0661:ISRFP]2.0.CO;2; Nee S, 2004, PALEOBIOLOGY, V30, P172, DOI 10.1666/0094-8373(2004)030<0172:EMESMI>2.0.CO;2; Nee S, 2006, ANNU REV ECOL EVOL S, V37, P1, DOI 10.1146/annurev.ecolsys.37.091305.110035; OLIVER WA, 1976, J PALEONTOL, V50, P365; Peters SE, 2002, NATURE, V416, P420, DOI 10.1038/416420a; Rode AL, 2005, J PALEONTOL, V79, P267, DOI 10.1666/0022-3360(2005)079<0267:IEABAC>2.0.CO;2; Rode AL, 2004, PALAEOGEOGR PALAEOCL, V211, P345, DOI 10.1016/j.palaeo.2004.05.013; Rode AL, 2002, J PALEONTOL, V76, P271, DOI 10.1666/0022-3360(2002)076<0271:PABAOD>2.0.CO;2; Rode Alycia L., 2004, Postilla, V229, P1; Rode Alycia L. Stigall, 2005, Journal of Systematic Palaeontology, V3, P133, DOI 10.1017/S1477201905001537; Sanderson MJ, 1996, TRENDS ECOL EVOL, V11, P15, DOI 10.1016/0169-5347(96)81059-7; SMITH AB, 1994, SYSTEMATICS FOSSIL R; Stanley S. M., 1979, MACROEVOLUTION PATTE; Stanley SM, 2007, PALEOBIOLOGY, V33, P1, DOI 10.1666/06020.1; Stigall AL, 2010, PALAEONTOL ELECTRON, V13; Stigall Rode AL, 2005, UNDERSTANDING LATE D; Wagner PJ, 2000, SYST BIOL, V49, P65, DOI 10.1080/10635150050207393; WILEY EO, 1985, ANN MO BOT GARD, V72, P596, DOI 10.2307/2399217; Williamson M., 1996, BIOL INVASIONS; Wojcicki M, 2005, J BIOGEOGR, V32, P755, DOI 10.1111/j.1365-2699.2004.01148.x	55	53	54	25	506	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15584	10.1371/journal.pone.0015584	http://dx.doi.org/10.1371/journal.pone.0015584			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206907	Green Submitted, gold, Green Published			2022-12-27	WOS:000285793200029
J	Yuan, HP; Zhang, XY; Huang, XQ; Lu, YG; Tang, WQ; Man, Y; Wang, S; Xi, JZ; Li, JA				Yuan, Huiping; Zhang, Xiaoyong; Huang, Xiuqing; Lu, Yonggang; Tang, Weiqing; Man, Yong; Wang, Shu; Xi, Jianzhong; Li, Jian			NADPH Oxidase 2-Derived Reactive Oxygen Species Mediate FFAs-Induced Dysfunction and Apoptosis of beta-Cells via JNK, p38 MAPK and p53 Pathways	PLOS ONE			English	Article							INDUCED INSULIN-SECRETION; HUMAN PANCREATIC-ISLETS; LONG-TERM EXPOSURE; FREE FATTY-ACIDS; ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTION FACTOR PDX-1; OXIDATIVE STRESS; GENE-EXPRESSION; DIABETES-MELLITUS; RAT ISLETS	Dysfunction of beta-cell is one of major characteristics in the pathogenesis of type 2 diabetes. The combination of obesity and type 2 diabetes, characterized as 'diabesity', is associated with elevated plasma free fatty acids (FFAs). Oxidative stress has been implicated in the pathogenesis of FFA-induced beta-cell dysfunction. However, molecular mechanisms linking between reactive oxygen species (ROS) and FFA-induced beta-cell dysfunction and apoptosis are less clear. In the present study, we test the hypothesis that NOX2-derived ROS may play a critical role in dysfunction and apoptosis of beta-cells induced by FFA. Our results show that palmitate and oleate (0.5 mmol/L, 48 h) induced JNK activation and AKT inhibition which resulted in decreased phosphorylation of FOXO1 following nuclear localization and the nucleocytoplasmic translocation of PDX-1, leading to the reducing of insulin and ultimately dysfunction of pancreatic NIT-1 cells. We also found that palmitate and oleate stimulated apoptosis of NIT-1 cells through p38MAPK, p53 and NF-kappa B pathway. More interestingly, our data suggest that suppression of NOX2 may restore FFA-induced dysfunction and apoptosis of NIT-1 cells. Our findings provide a new insight of the NOX2 as a potential new therapeutic target for preservation of beta-cell mass and function.	[Yuan, Huiping; Xi, Jianzhong] Peking Univ, Dept Biomed Engn, Coll Engn, Beijing 100871, Peoples R China; [Yuan, Huiping; Huang, Xiuqing; Tang, Weiqing; Man, Yong; Wang, Shu; Li, Jian] Peking Univ, Sch Clin Med 5, Beijing Hosp, Beijing 100871, Peoples R China; [Zhang, Xiaoyong; Lu, Yonggang; Li, Jian] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China; [Zhang, Xiaoyong; Lu, Yonggang; Li, Jian] Chinese Acad Med Sci, Beijing 100037, Peoples R China	Peking University; Beijing Hospital; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Yuan, HP (corresponding author), Peking Univ, Dept Biomed Engn, Coll Engn, Beijing 100871, Peoples R China.	jzxi@pku.edu.cn; lijian@bjhmoh.cn	LI, RUIJIAN/GYJ-0470-2022; Xi, Jianzhong/J-1420-2014		National Basic Research Program of China [2006CB503910]; National Natural Science Foundation of China [81070634]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Basic Research Program of China (2006CB503910) and National Natural Science Foundation of China (81070634). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bikopoulos G, 2008, J ENDOCRINOL, V196, P455, DOI 10.1677/JOE-07-0174; Briaud I, 2001, DIABETES, V50, P315, DOI 10.2337/diabetes.50.2.315; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Cnop M, 2007, J BIOL CHEM, V282, P3989, DOI 10.1074/jbc.M607627200; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; ELKS ML, 1993, ENDOCRINOLOGY, V133, P208, DOI 10.1210/en.133.1.208; Gremlich S, 1997, J BIOL CHEM, V272, P30261, DOI 10.1074/jbc.272.48.30261; Guillausseau PJ, 2008, DIABETES METAB, V34, pS43, DOI 10.1016/S1262-3636(08)73394-9; Haber EP, 2006, INT REV CYTOL, V248, P1, DOI 10.1016/S0074-7696(06)48001-3; Hagman DK, 2005, J BIOL CHEM, V280, P32413, DOI 10.1074/jbc.M506000200; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Jacqueminet S, 2000, METABOLISM, V49, P532, DOI 10.1016/S0026-0495(00)80021-9; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kajimoto Y, 2004, ANN NY ACAD SCI, V1011, P168, DOI 10.1196/annals.1293.017; Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200; Kawamori D, 2003, DIABETES, V52, P2896, DOI 10.2337/diabetes.52.12.2896; Kelpe CL, 2003, J BIOL CHEM, V278, P30015, DOI 10.1074/jbc.M302548200; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Klaunig JE, 2010, TOXICOL PATHOL, V38, P96, DOI 10.1177/0192623309356453; Koshkin V, 2003, J BIOL CHEM, V278, P19709, DOI 10.1074/jbc.M209709200; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Manna P, 2010, TOXICOL APPL PHARM, V244, P114, DOI 10.1016/j.taap.2009.12.024; Martinez SC, 2008, DIABETES, V57, P846, DOI 10.2337/db07-0595; Mason TM, 1999, DIABETES, V48, P524, DOI 10.2337/diabetes.48.3.524; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Oliveira HR, 2003, DIABETES, V52, P1457, DOI 10.2337/diabetes.52.6.1457; Oprescu AI, 2007, DIABETES, V56, P2927, DOI 10.2337/db07-0075; PAOLISSO G, 1995, DIABETOLOGIA, V38, P1295; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; RANDLE PJ, 1963, LANCET, V1, P785; Ritz-Laser B, 1999, ENDOCRINOLOGY, V140, P4005, DOI 10.1210/en.140.9.4005; Roggli E, 2010, DIABETES, V59, P978, DOI 10.2337/db09-0881; SAKO Y, 1990, ENDOCRINOLOGY, V127, P1580, DOI 10.1210/endo-127-4-1580; Song P, 2007, CIRCULATION, V116, P1585, DOI 10.1161/CIRCULATIONAHA.107.716498; Talior I, 2003, AM J PHYSIOL-ENDOC M, V285, pE295, DOI 10.1152/ajpendo.00044.2003; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Wrede CE, 2002, J BIOL CHEM, V277, P49676, DOI 10.1074/jbc.M208756200; Yang JY, 2005, J BIOL CHEM, V280, P32835, DOI 10.1074/jbc.M504058200; Zhang Y, 2007, J MOL ENDOCRINOL, V38, P651, DOI 10.1677/JME-06-0048; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042; ZHOU YP, 1995, J CLIN ENDOCR METAB, V80, P1584, DOI 10.1210/jc.80.5.1584	42	92	101	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15726	10.1371/journal.pone.0015726	http://dx.doi.org/10.1371/journal.pone.0015726			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209957	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793200043
J	Moulay, G; Boutin, S; Masurier, C; Scherman, D; Kichler, A				Moulay, Gilles; Boutin, Sylvie; Masurier, Carole; Scherman, Daniel; Kichler, Antoine			Polymers for Improving the In Vivo Transduction Efficiency of AAV2 Vectors	PLOS ONE			English	Article							RECOMBINANT ADENOASSOCIATED VIRUS; HEPARAN-SULFATE PROTEOGLYCAN; GENE-TRANSFER; SYSTEMIC DELIVERY; POINT MUTATIONS; VIRAL VECTORS; EXPRESSION; TROPISM; MUSCLE; ADENOVIRUS	Background: Adeno-associated virus has attracted great attention as vehicle for body-wide gene delivery. However, for the successful treatment of a disease such as Duchenne muscular dystrophy infusion of very large amounts of vectors is required. This not only raises questions about the technical feasibility of the large scale production but also about the overall safety of the approach. One way to overcome these problems would be to find strategies able to increase the in vivo efficiency. Methodology: Here, we investigated whether polymers can act as adjuvants to increase the in vivo efficiency of AAV2. Our strategy consisted in the pre-injection of polymers before intravenous administration of mice with AAV2 encoding a murine secreted alkaline phosphatase (mSeAP). The transgene expression, vector biodistribution and tissue transduction were studied by quantification of the mSeAP protein and real time PCR. The injection of polyinosinic acid and polylysine resulted in an increase of plasmatic mSeAP of 2- and 12-fold, respectively. Interestingly, polyinosinic acid pre-injection significantly reduced the neutralizing antibody titer raised against AAV2. Conclusions: Our results show that the pre-injection of polymers can improve the overall transduction efficiency of systemically administered AAV2 and reduce the humoral response against the capsid proteins.	[Moulay, Gilles; Boutin, Sylvie; Masurier, Carole; Kichler, Antoine] Genethon, Res Dept, Evry, France; [Scherman, Daniel; Kichler, Antoine] Univ Paris 05, CNRS, U1022, UMR 8151,INSERM, F-75270 Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Moulay, G (corresponding author), Genethon, Res Dept, Evry, France.	akich@genethon.fr		Scherman, Daniel/0000-0003-1207-1298; Kichler, Antoine/0000-0003-0593-2424; MOULAY, Gilles/0000-0002-4913-9893	Association Francaise contre les Myopathies	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This work was funded by the Association Francaise contre les Myopathies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD LJ, 1979, P NATL ACAD SCI USA, V76, P3246, DOI 10.1073/pnas.76.7.3246; Bartlett JS, 2000, J VIROL, V74, P2777, DOI 10.1128/JVI.74.6.2777-2785.2000; Baskar JF, 1996, J VIROL, V70, P3207, DOI 10.1128/JVI.70.5.3207-3214.1996; Boucas J, 2009, J GENE MED, V11, P1103, DOI 10.1002/jgm.1392; Carlisle RC, 2008, J GENE MED, V10, P400, DOI 10.1002/jgm.1161; Cecchini S, 2008, GENE THER, V15, P823, DOI 10.1038/gt.2008.61; Douar AM, 2001, J VIROL, V75, P1824, DOI 10.1128/JVI.75.4.1824-1833.2001; Fein DE, 2009, MOL THER, V17, P2078, DOI 10.1038/mt.2009.173; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Haisma HJ, 2008, J GEN VIROL, V89, P1097, DOI 10.1099/vir.0.83495-0; Henderson JP, 2001, BIOCHEMISTRY-US, V40, P2052, DOI 10.1021/bi002015f; KAY MA, 1992, P NATL ACAD SCI USA, V89, P89, DOI 10.1073/pnas.89.1.89; Lee GK, 2005, BIOTECHNOL BIOENG, V92, P24, DOI 10.1002/bit.20562; MARKUSIC DM, 2010, MOL THER; Mislick KA, 1996, P NATL ACAD SCI USA, V93, P12349, DOI 10.1073/pnas.93.22.12349; Opie SR, 2003, J VIROL, V77, P6995, DOI 10.1128/JVI.77.12.6995-7006.2003; Perabo L, 2006, J VIROL, V80, P7265, DOI 10.1128/JVI.00076-06; Petrs-Silva H, 2009, MOL THER, V17, P463, DOI 10.1038/mt.2008.269; Salva MZ, 2007, MOL THER, V15, P320, DOI 10.1038/sj.mt.6300027; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Walters RW, 2000, J VIROL, V74, P535, DOI 10.1128/JVI.74.1.535-540.2000; Wang MP, 2001, GENE, V279, P99, DOI 10.1016/S0378-1119(01)00754-5; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998; Yang L, 2009, P NATL ACAD SCI USA, V106, P3946, DOI 10.1073/pnas.0813207106; Yang YW, 2001, PHARMACEUT RES, V18, P922, DOI 10.1023/A:1010923924844; Yeung SN, 1999, GENE THER, V6, P1536, DOI 10.1038/sj.gt.3300980; Yu CY, 2009, GENE THER, V16, P953, DOI 10.1038/gt.2009.59; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105; Zhu T, 2005, CIRCULATION, V112, P2650, DOI 10.1161/CIRCULATIONAHA.105.565598	29	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15576	10.1371/journal.pone.0015576	http://dx.doi.org/10.1371/journal.pone.0015576			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203395	Green Published, Green Submitted, gold			2022-12-27	WOS:000285792500031
J	Petersen, K; Qiu, JL; Lutje, J; Fiil, BK; Hansen, S; Mundy, J; Petersen, M				Petersen, Klaus; Qiu, Jin-Long; Lutje, Juri; Fiil, Berthe Katrine; Hansen, Sidsel; Mundy, John; Petersen, Morten			Arabidopsis MKS1 Is Involved in Basal Immunity and Requires an Intact N-terminal Domain for Proper Function	PLOS ONE			English	Article							PROTEIN-KINASES; BINDING PROTEIN; SALICYLIC-ACID; DOCKING-SITE; EDS1; SPECIFICITY; RESISTANCE; REGULATOR; PATHWAYS	Background: Innate immune signaling pathways in animals and plants are regulated by mitogen-activated protein kinase (MAPK) cascades. MAP kinase 4 (MPK4) functions downstream of innate immune receptors via a nuclear substrate MKS1 to regulate the activity of the WRKY33 transcription factor, which in turn controls the production of anti-microbial phytoalexins. Methodology/Principal Findings: We investigate the role of MKS1 in basal resistance and the importance of its N- and C-terminal domains for MKS1 function. We used the information that mks1 loss-of-function partially suppresses the mpk4 loss-of-function phenotype, and that transgenic expression of functional MKS1 in mpk4/mks1 double mutants reverted the mpk4 dwarf phenotype. Transformation of mks1/mpk4 with mutant versions of MKS1 constructs showed that a single amino acid substitution in a putative MAP kinase docking domain, MKS1-L32A, or a truncated MKS1 version unable to interact with WRKY33, were deficient in reverting the double mutant to the mpk4 phenotype. These results demonstrate functional requirement in MKS1 for the interaction with MPK4 and WRKY33. In addition, nuclear localization of MKS1 was shown to depend on an intact N-terminal domain. Furthermore, loss-of-function mks1 mutants exhibited increased susceptibility to strains of Pseudomonas syringae and Hyaloperonospora arabidopsidis, indicating that MKS1 plays a role in basal defense responses. Conclusions: Taken together, our results indicate that MKS1 function and subcellular location requires an intact N-terminus important for both MPK4 and WRKY33 interactions.	[Petersen, Klaus; Qiu, Jin-Long; Lutje, Juri; Fiil, Berthe Katrine; Hansen, Sidsel; Mundy, John; Petersen, Morten] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	University of Copenhagen	Petersen, K (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	shutko@bio.ku.dk	Petersen, Morten/J-5023-2014; mundy, john/A-2361-2013	Petersen, Morten/0000-0002-3035-5991; mundy, john/0000-0001-7490-4588; Fiil, Berthe Katrine/0000-0002-9499-4848; Qiu, Jin-Long/0000-0001-8054-2552	Danish Research Councils [23020101, 23030076, 272050367, 272060049]	Danish Research Councils(Det Frie Forskningsrad (DFF))	This work was supported by the Danish Research Councils to MP (23020101) and JM (23030076, 272050367 and 272060049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Andreasson E, 2005, EMBO J, V24, P2579, DOI 10.1038/sj.emboj.7600737; Bardwell AJ, 2001, J BIOL CHEM, V276, P10374, DOI 10.1074/jbc.M010271200; Bi DL, 2010, PLANT PHYSIOL, V153, P1771, DOI 10.1104/pp.110.158501; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Brodersen P, 2006, PLANT J, V47, P532, DOI 10.1111/j.1365-313X.2006.02806.x; Caspersen MB, 2007, BBA-PROTEINS PROTEOM, V1774, P1156, DOI 10.1016/j.bbapap.2007.07.002; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Jonak C, 2002, CURR OPIN PLANT BIOL, V5, P415, DOI 10.1016/S1369-5266(02)00285-6; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Morikawa K, 2002, FEBS LETT, V514, P300, DOI 10.1016/S0014-5793(02)02388-8; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Narusaka M, 2008, J GEN PLANT PATHOL, V74, P345, DOI 10.1007/s10327-008-0117-1; Parker JE, 1996, PLANT CELL, V8, P2033, DOI 10.1105/tpc.8.11.2033; Perruc E, 2004, PLANT J, V38, P410, DOI 10.1111/j.1365-313X.2004.02062.x; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Qiu JL, 2008, EMBO J, V27, P2214, DOI 10.1038/emboj.2008.147; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Rushton PJ, 1998, CURR OPIN PLANT BIOL, V1, P311, DOI 10.1016/1369-5266(88)80052-9; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Xiang CB, 1999, PLANT MOL BIOL, V40, P711, DOI 10.1023/A:1006201910593; Xie YD, 2010, PLANT CELL ENVIRON, V33, P828, DOI 10.1111/j.1365-3040.2009.02109.x; Yang SH, 1999, MOL CELL BIOL, V19, P4028	26	52	58	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14364	10.1371/journal.pone.0014364	http://dx.doi.org/10.1371/journal.pone.0014364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203436	Green Published, gold, Green Submitted			2022-12-27	WOS:000285792500002
J	Garske, T; Ghani, AC				Garske, Tini; Ghani, Azra C.			Uncertainty in the Tail of the Variant Creutzfeldt-Jakob Disease Epidemic in the UK	PLOS ONE			English	Article							TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES; BLOOD-TRANSFUSION; VCJD EPIDEMIC; PROJECTIONS; INFECTIVITY; RISK; CJD	Despite low case numbers the variant Creutzfeldt-Jakob disease epidemic poses many challenges for public health planning due to remaining uncertainties in disease biology and transmission routes. We develop a stochastic model for variant CJD transmission, taking into account the known transmission routes (food and red-cell transfusion) to assess the remaining uncertainty in the epidemic. We use Bayesian methods to obtain scenarios consistent with current data. Our results show a potentially long but uncertain tail in the epidemic, with a peak annual incidence of around 11 cases, but the 95% credibility interval between 1 and 65 cases. These cases are predicted to be due to past food-borne transmissions occurring in previously mostly unaffected genotypes and to transmissions via blood transfusion in all genotypes. However, we also show that the latter are unlikely to be identifiable as transfusion-associated cases by case-linking. Regardless of the numbers of future cases, even in the absence of any further control measures, we do not find any self-sustaining epidemics.	[Garske, Tini; Ghani, Azra C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Med Res Council, Ctr Outbreak Anal & Modelling, London, England	Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Garske, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Med Res Council, Ctr Outbreak Anal & Modelling, London, England.	t.garske@imperial.ac.uk	Ghani, Azra/B-8560-2009	Ghani, Azra/0000-0002-0007-4910	Medical Research Council Centre	Medical Research Council Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Centre funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperovitch A, 1999, LANCET, V353, P1673, DOI 10.1016/S0140-6736(99)01342-2; CARLIN BP, 2000, C&H TEXT STAT SCI, P1; Chohan G, 2010, TRANSFUSION, V50, P1003, DOI 10.1111/j.1537-2995.2010.02614.x; Clarke P, 2005, J R SOC INTERFACE, V2, P19, DOI 10.1098/rsif.2004.0017; Clarke P, 2007, J R SOC INTERFACE, V4, P675, DOI 10.1098/rsif.2007.0216; Clewley JP, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1442; Collins SJ, 2004, LANCET, V363, P51, DOI 10.1016/S0140-6736(03)15171-9; Cooper J D, 2002, J Cancer Epidemiol Prev, V7, P49, DOI 10.1080/147666502321082719; Cousens SN, 1997, NATURE, V385, P197, DOI 10.1038/385197a0; *DEFRA, 2010, BOV SPONG ENC BSE; Dietz K, 2007, EMERG INFECT DIS, V13, P89, DOI 10.3201/eid1301.060396; Dobra SA, 2006, TRANSFUS CLIN BIOL, V13, P307, DOI 10.1016/j.tracli.2006.11.007; Flechsig E, 2001, MOL MED, V7, P679, DOI 10.1007/BF03401958; Garske T, 2006, J R SOC INTERFACE, V3, P757, DOI 10.1098/rsif.2006.0142; Ghani AC, 2003, STAT METHODS MED RES, V12, P191, DOI 10.1191/0962280203sm327ra; Ghani AC, 1998, P ROY SOC B-BIOL SCI, V265, P2443, DOI 10.1098/rspb.1998.0596; GHANI AC, 2003, BMC INFECT DIS, V3; Gregori L, 2004, LANCET, V364, P529, DOI 10.1016/S0140-6736(04)16812-8; Heath CA, 2010, ANN NEUROL, V67, P761, DOI 10.1002/ana.21987; Hewitt PE, 2006, VOX SANG, V91, P221, DOI 10.1111/j.1423-0410.2006.00833.x; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; *HPA, 2007, HLTH PROT REP; Kaski D, 2009, LANCET, V374, P2128, DOI 10.1016/S0140-6736(09)61568-3; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; *NAT CJD SURV UN, 2010, CJD STAT; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; *SEAC, 2008, POS STAT PREV SUBCL; St Rose SG, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-5; Turner ML, 2009, BRIT J HAEMATOL, V144, P14, DOI 10.1111/j.1365-2141.2008.07376.x; Valleron AJ, 2001, SCIENCE, V294, P1726, DOI 10.1126/science.1066838; Wallis JP, 2004, TRANSFUSION, V44, P1025, DOI 10.1111/j.1537-2995.2004.03400.x; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8; Yan ZX, 2004, INFECT CONT HOSP EP, V25, P280, DOI 10.1086/502392	35	41	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15626	10.1371/journal.pone.0015626	http://dx.doi.org/10.1371/journal.pone.0015626			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203419	Green Submitted, Green Published, gold			2022-12-27	WOS:000285579200027
J	Wakida, NM; Botvinick, EL; Lin, J; Berns, MW				Wakida, Nicole M.; Botvinick, Elliot L.; Lin, Justin; Berns, Michael W.			An Intact Centrosome Is Required for the Maintenance of Polarization during Directional Cell Migration	PLOS ONE			English	Article							MOTILE CELLS; CYCLE PROGRESSION; MICROTUBULES; FIBROBLASTS; LASER; ADHESIONS; POLARITY	Background: Establishing and maintaining polarization is critical during cell migration. It is known that the centrosome contains numerous proteins whose roles of organizing the microtubule network range include nucleation, stabilization and severing. It is not known whether the centrosome is necessary to maintain polarization. Due to its role as the microtubule organizing center, we hypothesize that the centrosome is necessary to maintain polarization in a migrating cell. Although there have been implications of its role in cell migration, there is no direct study of the centrosome's role in maintaining polarization. In this study we ablate the centrosome by intracellular laser irradiation to understand the role of the centrosome in two vastly different cell types, human osteosarcoma (U2OS) and rat kangaroo kidney epithelial cells (PtK). The PtK cell line has been extensively used as a model for cytoskeletal dynamics during cell migration. The U2OS cell line serves as a model for a complex, single migrating cell. Methodology/Principal Findings: In this study we use femtosecond near-infrared laser irradiation to remove the centrosome in migrating U2OS and PtK2 cells. Immunofluorescence staining for centrosomal markers verified successful irradiation with 94% success. A loss of cell polarization is observed between 30 and 90 minutes following removal of the centrosome. Changes in cell shape are correlated with modifications in microtubule and actin organization. Changes in cell morphology and microtubule organization were quantified revealing significant depolarization resulting from centrosome irradiation. Conclusions/Significance: This study demonstrates that the centrosome is necessary for the maintenance of polarization during directed cell migration in two widely different cell types. Removal of the centrosome from a polarized cell results in the reorganization of the microtubule network into a symmetric non-polarized phenotype. These results demonstrate that the centrosome plays a critical role in the maintenance of cytoskeletal asymmetry during cell migration.	[Wakida, Nicole M.; Botvinick, Elliot L.; Berns, Michael W.] Univ Calif Irvine, Beckman Laser Inst, Irvine, CA 92623 USA; [Botvinick, Elliot L.; Lin, Justin; Berns, Michael W.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Wakida, NM (corresponding author), Univ Calif Irvine, Beckman Laser Inst, Irvine, CA 92623 USA.	mwberns@uci.edu		Berns, Michael/0000-0002-9640-2885	Air Force Office of Scientific Research; National Institutes of Health, National Center for Research Resources [P41RR001192]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001192] Funding Source: NIH RePORTER	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The project described was supported by grants from the Air Force Office of Scientific Research and from the National Institutes of Health, National Center for Research Resources, grant # P41RR001192. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHTBUEHLER G, 1979, EXP CELL RES, V120, P111, DOI 10.1016/0014-4827(79)90542-1; Badano JL, 2005, NAT REV GENET, V6, P194, DOI 10.1038/nrg1557; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Botvinick EL, 2004, BIOPHYS J, V87, P4203, DOI 10.1529/biophysj.104.049528; Botvinick EL, 2005, MICROSC RES TECHNIQ, V68, P65, DOI 10.1002/jemt.20216; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; EUTENEUER U, 1984, NATURE, V310, P58, DOI 10.1038/310058a0; Grigoriev I, 2006, CELL MOTIL CYTOSKEL, V63, P29, DOI 10.1002/cm.20107; Khodjakov A, 1997, CELL MOTIL CYTOSKEL, V38, P311, DOI 10.1002/(SICI)1097-0169(1997)38:4<311::AID-CM1>3.3.CO;2-M; Kong X, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp221; KOONCE MP, 1984, J CELL BIOL, V98, P1999, DOI 10.1083/jcb.98.6.1999; La Terra S, 2005, J CELL BIOL, V168, P713, DOI 10.1083/jcb.200411126; Miller PM, 2009, NAT CELL BIOL, V11, P1069, DOI 10.1038/ncb1920; Mogilner A, 2009, CURR BIOL, V19, pR762, DOI 10.1016/j.cub.2009.06.053; SCHUTZE K, 1991, P NATL ACAD SCI USA, V88, P8367, DOI 10.1073/pnas.88.19.8367; Small JV, 2003, CURR OPIN CELL BIOL, V15, P40, DOI 10.1016/S0955-0674(02)00008-X; Takesono A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008774; Ueda M, 1997, P NATL ACAD SCI USA, V94, P9674, DOI 10.1073/pnas.94.18.9674; Uetake Y, 2007, J CELL BIOL, V176, P173, DOI 10.1083/jcb.200607073; VASILIEV JM, 1970, J EMBRYOL EXP MORPH, V24, P625; Wakida NM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2718920; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Xu JS, 2007, P NATL ACAD SCI USA, V104, P9296, DOI 10.1073/pnas.0703153104; Yvon AMC, 2002, MOL BIOL CELL, V13, P1871, DOI 10.1091/mbc.01-11-0539	25	24	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15462	10.1371/journal.pone.0015462	http://dx.doi.org/10.1371/journal.pone.0015462			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203421	Green Submitted, gold, Green Published			2022-12-27	WOS:000285579200022
J	Neff, CP; Ndolo, T; Tandon, A; Habu, Y; Akkina, R				Neff, C. Preston; Ndolo, Thomas; Tandon, Apurva; Habu, Yuichiro; Akkina, Ramesh			Oral Pre-Exposure Prophylaxis by Anti-Retrovirals Raltegravir and Maraviroc Protects against HIV-1 Vaginal Transmission in a Humanized Mouse Model	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TENOFOVIR DISOPROXIL FUMARATE; IMMUNE-RESPONSES; MICE; INFECTION; MACAQUES; CHALLENGES; INHIBITOR; ANTAGONIST; PREVENTION	Sexual HIV-1 transmission by vaginal route is the most predominant mode of viral transmission, resulting in millions of new infections every year. In the absence of an effective vaccine, there is an urgent need to develop other alternative methods of pre-exposure prophylaxis (PrEP). Many novel drugs that are currently approved for clinical use also show great potential to prevent viral sexual transmission when administered systemically. A small animal model that permits rapid preclinical evaluation of potential candidates for their systemic PrEP efficacy will greatly enhance progress in this area of investigation. We have previously shown that RAG-hu humanized mouse model permits HIV-1 mucosal transmission via both vaginal and rectal routes and displays CD4 T cell loss typical to that seen in the human. Thus far systemic PrEP studies have been primarily limited to RT inhibitors exemplified by tenofovir and emtricitabine. In these proof-of-concept studies we evaluated two new classes of clinically approved drugs with different modes of action namely, an integrase inhibitor raltegravir and a CCR5 inhibitor maraviroc as potential systemically administered chemo-prophylactics. Our results showed that oral administration of either of these drugs fully protects against vaginal HIV-1 challenge in the RAG-hu mouse model. Based on these results both these drugs show great promise for further development as orally administered PrEPs.	[Neff, C. Preston; Ndolo, Thomas; Tandon, Apurva; Habu, Yuichiro; Akkina, Ramesh] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Colorado State University	Neff, CP (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	akkina@colostate.edu			National Institutes of Health [AI057066, AI073255]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057066, R01AI073255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work reported here was supported by National Institutes of Health RO1 grants AI057066 and AI073255 to RA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas UL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000875; An DS, 2007, CLIN VACCINE IMMUNOL, V14, P391, DOI 10.1128/CVI.00403-06; Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Berges BK, 2008, VIROLOGY, V373, P342, DOI 10.1016/j.virol.2007.11.020; Berges BK, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-76; Berges BK, 2010, VIROLOGY, V397, P100, DOI 10.1016/j.virol.2009.10.034; Broder S, 2010, ANTIVIR RES, V85, P1, DOI 10.1016/j.antiviral.2009.10.002; *CLIN, FEM PREP TRU STUD AS; D'Cruz OJ, 2007, AM J REPROD IMMUNOL, V57, P353, DOI 10.1111/j.1600-0897.2007.00478.x; Denton PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008829; Denton Paul W, 2009, Curr HIV/AIDS Rep, V6, P13, DOI 10.1007/s11904-009-0003-2; Denton PW, 2008, PLOS MED, V5, P79, DOI 10.1371/journal.pmed.0050016; Di Fabio S, 2003, AIDS, V17, P1597, DOI 10.1097/00002030-200307250-00003; Di Fabio S, 2001, AIDS, V15, pS19, DOI 10.1097/00002030-200102001-00020; FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219; Garcia-Lerma JG, 2008, PLOS MED, V5, P291, DOI 10.1371/journal.pmed.0050028; Garcia-Lerma JG, 2010, TRENDS PHARMACOL SCI, V31, P74, DOI 10.1016/j.tips.2009.10.009; Gorantla S, 2007, J VIROL, V81, P2700, DOI 10.1128/JVI.02010-06; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; *JOINT UN HIV AIDS, 2008, REP GLOB AIDS EP; Khanna KV, 2002, J CLIN INVEST, V109, P205; Kromdijk W, 2010, EXPERT OPIN PHARMACO, V11, P1215, DOI 10.1517/14656561003801081; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Legrand N, 2009, CELL HOST MICROBE, V6, P5, DOI 10.1016/j.chom.2009.06.006; Lieberman-Blum SS, 2008, CLIN THER, V30, P1228, DOI 10.1016/S0149-2918(08)80048-3; MacArthur RD, 2008, CLIN INFECT DIS, V47, P236, DOI 10.1086/589289; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Polhemus ME, 2008, ANTIMICROB AGENTS CH, V52, P1493, DOI 10.1128/AAC.01367-07; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Subbarao S, 2006, J INFECT DIS, V194, P904, DOI 10.1086/507306; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; TSAI CC, 1995, SCIENCE, V270, P1197, DOI 10.1126/science.270.5239.1197; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV; *US FDA, 2009, ANT DRUGS US TREATM; Van Duyne R, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-76; Van Rompay KKA, 1998, AIDS, V12, pF79, DOI 10.1097/00002030-199809000-00001; Van Rompay KKA, 2006, JAIDS-J ACQ IMM DEF, V43, P6, DOI 10.1097/01.qai.0000224972.60339.7c; Veazey RS, 2010, J INFECT DIS, V202, P739, DOI 10.1086/655661; Veazey RS, 2005, NATURE, V438, P99, DOI 10.1038/nature04055; Volmink J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub2; Watanabe S, 2007, BLOOD, V109, P212, DOI 10.1182/blood-2006-04-017681; Zhang LG, 2007, BLOOD, V109, P2978, DOI 10.1182/blood-2006-07-033159	45	87	91	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15257	10.1371/journal.pone.0015257	http://dx.doi.org/10.1371/journal.pone.0015257			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203568	Green Published, gold, Green Submitted			2022-12-27	WOS:000285576900024
J	Park, E; Lee, GJ; Choi, S; Choi, SK; Chae, SJ; Kang, SW; Pak, YK; Park, HK				Park, Eunkuk; Lee, Gi-Ja; Choi, Samjin; Choi, Seok-Keun; Chae, Su-Jin; Kang, Sung-Wook; Pak, Youngmi Kim; Park, Hun-Kuk			The Role of Glutamate Release on Voltage-Dependent Anion Channels (VDAC)-Mediated Apoptosis in an Eleven Vessel Occlusion Model in Rats	PLOS ONE			English	Article							BILATERAL HEMISPHERIC ISCHEMIA; NEURONAL CELL-DEATH; CEREBRAL-ISCHEMIA; GLOBAL-ISCHEMIA; MICRODIALYSIS; BRAIN; VDAC; PROTEINS; INJURY; DAMAGE	Voltage-dependent anion channel (VDAC) is the main protein in mitochondria-mediated apoptosis, and the modulation of VDAC may be induced by the excessive release of extracellular glutamate. This study examined the role of glutamate release on VDAC-mediated apoptosis in an eleven vessel occlusion model in rats. Male Sprague-Dawley rats (250-350 g) were used for the 11 vessel occlusion ischemic model, which were induced for a 10-min transient occlusion. During the ischemic and initial reperfusion episode, the real-time monitoring of the extracellular glutamate concentration was measured using an amperometric microdialysis biosensor and the cerebral blood flow (CBF) was monitored by laser-Doppler flowmetry. To confirm neuronal apoptosis, the brains were removed 72 h after ischemia to detect the neuron-specific nuclear protein and pro-apoptotic proteins (cleaved caspase-3, VDAC, p53 and BAX). The changes in the mitochondrial morphology were measured by atomic force microscopy. A decrease in the % of CBF was observed, and an increase in glutamate release was detected after the onset of ischemia, which continued to increase during the ischemic period. A significantly higher level of glutamate release was observed in the ischemia group. The increased glutamate levels in the ischemia group resulted in the activation of VDAC and pro-apoptotic proteins in the hippocampus with morphological alterations to the mitochondria. This study suggests that an increase in glutamate release promotes VDAC-mediated apoptosis in an 11 vessel occlusion ischemic model.	[Park, Eunkuk; Lee, Gi-Ja; Choi, Samjin; Chae, Su-Jin; Kang, Sung-Wook; Park, Hun-Kuk] Kyung Hee Univ, Dept Biomed Engn, Coll Med, Seoul, South Korea; [Park, Eunkuk; Lee, Gi-Ja; Choi, Samjin; Chae, Su-Jin; Kang, Sung-Wook; Park, Hun-Kuk] Kyung Hee Univ, Healthcare Ind Res Inst, Coll Med, Seoul, South Korea; [Park, Eunkuk] Kyung Hee Univ, Dept Med Zool, Coll Med, Seoul, South Korea; [Choi, Seok-Keun] Kyung Hee Univ, Dept Neurosurg, Med Ctr, Seoul, South Korea; [Pak, Youngmi Kim] Kyung Hee Univ, Dept Physiol, Coll Med, Seoul, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University	Park, E (corresponding author), Kyung Hee Univ, Dept Biomed Engn, Coll Med, Seoul, South Korea.	sigmoidus@khu.ac.kr	Pak, Youngmi Kim/AAI-1091-2020; Lee, Gi-Ja/AAH-9998-2020	Pak, Youngmi Kim/0000-0001-7424-3484; Choi, Samjin/0000-0003-3498-0652	Korea government (MEST) [2009-0092562]	Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2009-0092562). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Hamad S, 2008, J BIOL CHEM, V283, P13482, DOI 10.1074/jbc.M708216200; Abu-Hamad S, 2009, J CELL SCI, V122, P1906, DOI 10.1242/jcs.040188; Arbel N, 2010, J BIOL CHEM, V285, P6053, DOI 10.1074/jbc.M109.082990; Arzoine L, 2009, J BIOL CHEM, V284, P3946, DOI 10.1074/jbc.M803614200; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BENVENISTE H, 1989, J CEREBR BLOOD F MET, V9, P629, DOI 10.1038/jcbfm.1989.90; Benveniste H, 2009, ANESTHESIOLOGY, V110, P422, DOI 10.1097/ALN.0b013e318194b620; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Caragine LP, 1998, BRAIN RES, V793, P255, DOI 10.1016/S0006-8993(98)00182-6; Chi OZ, 2009, NEUROCHEM RES, V34, P1249, DOI 10.1007/s11064-008-9902-7; CHOI SK, 2008, KOR J INTEGRA MED, V3, P11; Choi YS, 2005, ANN NY ACAD SCI, V1042, P88, DOI 10.1196/annals.1338.009; Ferecatu I, 2009, BIOCHEM BIOPH RES CO, V387, P772, DOI 10.1016/j.bbrc.2009.07.111; Gincel D, 2000, J BIOENERG BIOMEMBR, V32, P571, DOI 10.1023/A:1005670527340; Goncalves RP, 2007, J MOL BIOL, V369, P413, DOI 10.1016/j.jmb.2007.03.063; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Groebe K, 2010, EXP GERONTOL, V45, P632, DOI 10.1016/j.exger.2010.02.006; Hoogenboom BW, 2007, J MOL BIOL, V370, P246, DOI 10.1016/j.jmb.2007.04.073; Jonas EA, 2009, EXP NEUROL, V218, P203, DOI 10.1016/j.expneurol.2009.03.025; Kirino T, 1989, Rinsho Shinkeigaku, V29, P1522; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Landolt H, 1998, J CLIN NEUROSCI, V5, P193, DOI 10.1016/S0967-5868(98)90037-6; Lee GJ, 2009, CURR APPL PHYS, V9, pS25, DOI 10.1016/j.cap.2008.08.031; Lee GJ, 2008, NEUROL RES, V30, P661, DOI 10.1179/174313208X289570; Lee GJ, 2009, BIOCHIP J, V3, P82; Lee GJ, 2009, KOREAN J PHYSIOL PHA, V13, P23, DOI 10.4196/kjpp.2009.13.1.23; LONNROTH P, 1987, AM J PHYSIOL, V253, pE228, DOI 10.1152/ajpendo.1987.253.2.E228; Ogawa S, 2007, ANTIOXID REDOX SIGN, V9, P573, DOI 10.1089/ars.2006.1516; Ott M, 2009, CELL DEATH DIFFER, V16, P1075, DOI 10.1038/cdd.2009.61; Park E, 2010, BRAIN RES, V1342, P160, DOI 10.1016/j.brainres.2010.04.054; Poleszak E, 2008, PHARMACOL REP, V60, P655; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; Shi Y, 2003, BIOCHEM BIOPH RES CO, V305, P989, DOI 10.1016/S0006-291X(03)00871-4; Shoshan-Barmatz V, 2008, J BIOENERG BIOMEMBR, V40, P183, DOI 10.1007/s10863-008-9147-9; SUGIO K, 1988, STROKE, V19, P922, DOI 10.1161/str.19.7.922a; Takagi N, 2010, EUR J PHARMACOL, V644, P96, DOI 10.1016/j.ejphar.2010.07.026; Taoufik E, 2008, CURR PHARM DESIGN, V14, P3565, DOI 10.2174/138161208786848748; TODD NV, 1986, ACTA NEUROL SCAND, V74, P269; TOSSMAN U, 1986, ACTA PHYSIOL SCAND, V128, P9, DOI 10.1111/j.1748-1716.1986.tb07943.x; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Yao T, 2001, ANAL SCI, V17, P703, DOI 10.2116/analsci.17.703; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; Zhao H, 1998, NEUROREPORT, V9, P3183, DOI 10.1097/00001756-199810050-00011	43	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15192	10.1371/journal.pone.0015192	http://dx.doi.org/10.1371/journal.pone.0015192			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203570	gold, Green Published, Green Submitted			2022-12-27	WOS:000285576900019
J	Sytnikova, YA; Kubarenko, AV; Schafer, A; Weber, ANR; Niehrs, C				Sytnikova, Yuliya A.; Kubarenko, Andriy V.; Schaefer, Andrea; Weber, Alexander N. R.; Niehrs, Christof			Gadd45a Is an RNA Binding Protein and Is Localized in Nuclear Speckles	PLOS ONE			English	Article							NEGATIVE GROWTH-CONTROL; CELL-CYCLE CHECKPOINTS; DNA DEMETHYLATION; RIBOSOMAL-PROTEINS; CRYSTAL-STRUCTURE; CHICKEN-EMBRYO; U4 SNRNA; COMPLEX; GLYCOSYLASE; DOMAINS	Background: The Gadd45 proteins play important roles in growth control, maintenance of genomic stability, DNA repair, and apoptosis. Recently, Gadd45 proteins have also been implicated in epigenetic gene regulation by promoting active DNA demethylation. Gadd45 proteins have sequence homology with the L7Ae/L30e/S12e RNA binding superfamily of ribosomal proteins, which raises the question if they may interact directly with nucleic acids. Principal Findings: Here we show that Gadd45a binds RNA but not single-or double stranded DNA or methylated DNA in vitro. Sucrose density gradient centrifugation experiments demonstrate that Gadd45a is present in high molecular weight particles, which are RNase sensitive. Gadd45a displays RNase-sensitive colocalization in nuclear speckles with the RNA helicase p68 and the RNA binding protein SC35. A K45A point mutation defective in RNA binding was still active in DNA demethylation. This suggests that RNA binding is not absolutely essential for demethylation of an artificial substrate. A point mutation at G39 impared RNA binding, nuclear speckle localization and DNA demethylation, emphasizing its relevance for Gadd45a function. Significance: The results implicate RNA in Gadd45a function and suggest that Gadd45a is associated with a ribonucleoprotein particle.	[Sytnikova, Yuliya A.; Schaefer, Andrea; Niehrs, Christof] Krebsforschungszentrum, DKFZ ZMBH Alliance, Div Mol Embryol, Heidelberg, Germany; [Kubarenko, Andriy V.; Weber, Alexander N. R.] Deutsch Krebsforschungszentrum, Div Toll Like Receptors & Canc, D-6900 Heidelberg, Germany; [Niehrs, Christof] Inst Mol Biol, Mainz, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Institute of Molecular Biology (IMB)	Sytnikova, YA (corresponding author), Krebsforschungszentrum, DKFZ ZMBH Alliance, Div Mol Embryol, Heidelberg, Germany.	Niehrs@DKFZ-Heidelberg.de	Sytnikova, Yuliya/J-6118-2017	Weber, Alexander/0000-0002-8627-7056; Sytnikova, Yuliya/0000-0002-8468-5101	Deutsche Forschungsgemeinschaft [NI 286/12-1, WE-4295/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft, Grant NI 286/12-1 to Christof Niehrs, and WE-4295/1-1 to Alexander Weber. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman MJ, 2005, P NATL ACAD SCI USA, V102, P12765, DOI 10.1073/pnas.0505484102; Allmang C, 2002, RNA, V8, P1308, DOI 10.1017/S1355838202020034; Azam N, 2001, J BIOL CHEM, V276, P2766, DOI 10.1074/jbc.M005626200; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Brown JM, 2008, J CELL BIOL, V182, P1083, DOI 10.1083/jcb.200803174; Carrier F, 1999, MOL CELL BIOL, V19, P1673; Chao JA, 2004, STRUCTURE, V12, P1165, DOI 10.1016/j.str.2004.04.023; Chi HB, 2004, EMBO J, V23, P1576, DOI 10.1038/sj.emboj.7600173; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; DREYFUSS G, 1988, J CELL BIOL, V106, P1419, DOI 10.1083/jcb.106.5.1419; Fayolle C, 2006, CELL CYCLE, V5, P1859, DOI 10.4161/cc.5.16.3119; Fremont M, 1997, NUCLEIC ACIDS RES, V25, P2375, DOI 10.1093/nar/25.12.2375; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hoffman B, 2009, J CELL PHYSIOL, V218, P26, DOI 10.1002/jcp.21582; Hollander MC, 2002, ONCOGENE, V21, P6228, DOI 10.1038/sj.onc.1205774; Imamura T, 2004, BIOCHEM BIOPH RES CO, V322, P593, DOI 10.1016/j.bbrc.2004.07.159; Jost JP, 1999, FEBS LETT, V449, P251, DOI 10.1016/S0014-5793(99)00454-8; Jost JP, 1997, NUCLEIC ACIDS RES, V25, P4545, DOI 10.1093/nar/25.22.4545; Jost JP, 1999, NUCLEIC ACIDS RES, V27, P3245, DOI 10.1093/nar/27.16.3245; KEARSEY JM, 1995, ONCOGENE, V11, P1675; KELLEY RL, 1993, GENE DEV, V7, P948, DOI 10.1101/gad.7.6.948; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; KOONIN EV, 1994, NUCLEIC ACIDS RES, V22, P2166, DOI 10.1093/nar/22.11.2166; Kovalsky O, 2001, J BIOL CHEM, V276, P39330, DOI 10.1074/jbc.M105115200; Kubarenko A, 2007, BIOCHEM SOC T, V35, P1515, DOI 10.1042/BST0351515; Kubarenko AV, 2010, PROTEIN SCI, V19, P558, DOI 10.1002/pro.333; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 2005, ACTA CRYSTALLOGR E, V61, pM761, DOI 10.1107/S1600536805009098; Lin IG, 2001, EMBO REP, V2, P108, DOI 10.1093/embo-reports/kve023; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Mayer C, 2006, MOL CELL, V22, P351, DOI 10.1016/j.molcel.2006.03.028; MELO F, 1997, P INT C INTELL SYST, V5, P187; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; Nottrott S, 1999, EMBO J, V18, P6119, DOI 10.1093/emboj/18.21.6119; Ogilvie VC, 2003, NUCLEIC ACIDS RES, V31, P1470, DOI 10.1093/nar/gkg236; Oruganti SV, 2005, BIOCHEM BIOPH RES CO, V333, P550, DOI 10.1016/j.bbrc.2005.05.141; Peretz G, 2007, GENETICS, V177, P1691, DOI 10.1534/genetics.107.079517; Pettit FK, 2007, J MOL BIOL, V369, P863, DOI 10.1016/j.jmb.2007.03.036; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; SALI A, 1994, PROTEIN SCI, V3, P1582, DOI 10.1002/pro.5560030923; Sambrook J, 1989, MOL CLONING LABORATO; Schafer A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014060; Schmitz KM, 2009, MOL CELL, V33, P344, DOI 10.1016/j.molcel.2009.01.015; Schrag JD, 2008, P NATL ACAD SCI USA, V105, P6566, DOI 10.1073/pnas.0800086105; Schwarz S, 2000, EUR J CELL BIOL, V79, P488, DOI 10.1078/0171-9335-00070; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Shopland LS, 2003, J CELL BIOL, V162, P981, DOI 10.1083/jcb.200303131; Staley JP, 2009, CURR OPIN CELL BIOL, V21, P109, DOI 10.1016/j.ceb.2009.01.003; STEPANOV AS, 1971, FEBS LETT, V18, P13, DOI 10.1016/0014-5793(71)80395-2; Swisher JFA, 1998, NUCLEIC ACIDS RES, V26, P5573, DOI 10.1093/nar/26.24.5573; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Tornatore L, 2008, J MOL BIOL, V378, P97, DOI 10.1016/j.jmb.2008.01.074; Trotter Kevin W, 2008, Nucl Recept Signal, V6, pe004, DOI 10.1621/nrs.06004; Vairapandi M, 2002, J CELL PHYSIOL, V192, P327, DOI 10.1002/jcp.10140; Vairapandi M, 2000, J BIOL CHEM, V275, P16810, DOI 10.1074/jbc.275.22.16810; Vairapandi M, 2000, J CELL BIOCHEM, V79, P249, DOI 10.1002/1097-4644(20001101)79:2<249::AID-JCB80>3.0.CO;2-Z; VAKSER IA, 1994, PROTEINS, V20, P320, DOI 10.1002/prot.340200405; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vidovic I, 2000, MOL CELL, V6, P1331, DOI 10.1016/S1097-2765(00)00131-3; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Weiss A, 1996, CELL, V86, P709, DOI 10.1016/S0092-8674(00)80146-4; Yi YW, 2000, BIOCHEM BIOPH RES CO, V272, P193; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667; Zheng XW, 2008, NATURE, V455, P1259, DOI 10.1038/nature07305	68	35	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e14500	10.1371/journal.pone.0014500	http://dx.doi.org/10.1371/journal.pone.0014500			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249130	gold, Green Published, Green Submitted			2022-12-27	WOS:000286512900005
J	Lu, H; Zhu, ZY; Dong, LL; Jia, XM; Sun, XR; Yan, L; Chai, YF; Jiang, YY; Cao, YY				Lu, Hui; Zhu, ZhenYu; Dong, LingLing; Jia, XinMing; Sun, XuanRong; Yan, Lan; Chai, YiFeng; Jiang, YuanYing; Cao, YingYing			Lack of Trehalose Accelerates H2O2-Induced Candida albicans Apoptosis through Regulating Ca2+ Signaling Pathway and Caspase Activity	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; GENE; CALCINEURIN; STRESS; DISRUPTION; RESISTANCE; TOLERANCE; MORPHOGENESIS; EPIDEMIOLOGY; MITOCHONDRIA	Trehalose is a non-reducing disaccharide and can be accumulated in response to heat or oxidative stresses in Candida albicans. Here we showed that a C. albicans tps1 Delta mutant, which is deficient in trehalose synthesis, exhibited increased apoptosis rate upon H2O2 treatment together with an increase of intracellular Ca2+ level and caspase activity. When the intracellular Ca2+ level was stimulated by adding CaCl2 or A23187, both the apoptosis rate and caspase activity were increased. In contrast, the presence of two calcium chelators, EGTA and BAPTA, could attenuate these effects. Moreover, we investigated the role of Ca2+ pathway in C. albicans apoptosis and found that both calcineurin and the calcineurin-dependent transcription factor, Crz1p, mutants showed decreased apoptosis and caspase activity upon H2O2 treatment compared to the wild-type cells. Expression of CaMCA1, the only gene found encoding a C. albicans metacaspase, in calcineurin-deleted or Crz1p-deleted cells restored the cell sensitivity to H2O2. Our results suggest that Ca2+ and its downstream calcineurin/Crz1p/CaMCA1 pathway are involved in H2O2 -induced C. albicans apoptosis. Inhibition of this pathway might be the mechanism for the protective role of trehalose in C. albicans.	[Lu, Hui; Zhu, ZhenYu; Dong, LingLing; Jia, XinMing; Sun, XuanRong; Yan, Lan; Chai, YiFeng; Jiang, YuanYing; Cao, YingYing] Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China	Naval Medical University	Lu, H (corresponding author), Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China.	caoyingying608@yahoo.com.cn	jiang, anyi/GPT-0379-2022	Lu, Hui/0000-0002-8422-0427	National Natural Science Foundation of China [30630071, 30870105]; Shanghai Rising-Star Program [08QA14001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program	This work was supported by the National Natural Science Foundation of China (No. 30630071, 30870105) and Shanghai Rising-Star Program (08QA14001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dhaheri RS, 2010, J MED MICROBIOL, V59, P149, DOI 10.1099/jmm.0.015784-0; ALVAREZ P, 2002, MICROBIOLOGY, V148, P2599; Arguelles JC, 2000, ARCH MICROBIOL, V174, P217, DOI 10.1007/s002030000192; Bader T, 2006, INFECT IMMUN, V74, P4366, DOI 10.1128/IAI.00142-06; Bozhkov PV, 2005, P NATL ACAD SCI USA, V102, P14463, DOI 10.1073/pnas.0506948102; Cannon RD, 2007, MICROBIOL-SGM, V153, P3211, DOI 10.1099/mic.0.2007/010405-0; Cao YY, 2009, FUNGAL GENET BIOL, V46, P183, DOI 10.1016/j.fgb.2008.11.001; Care RS, 1999, MOL MICROBIOL, V34, P792, DOI 10.1046/j.1365-2958.1999.01641.x; Chen W, 2009, EXP EYE RES, V89, P311, DOI 10.1016/j.exer.2009.03.015; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Fidel P L Jr, 2006, Adv Dent Res, V19, P80; Hemenway Charles S., 1999, Cell Biochemistry and Biophysics, V30, P115, DOI 10.1007/BF02737887; Hoeberichts FA, 2003, PLANTA, V217, P517, DOI 10.1007/s00425-003-1049-9; Karababa M, 2006, MOL MICROBIOL, V59, P1429, DOI 10.1111/j.1365-2958.2005.05037.x; Khan MAS, 2005, P NATL ACAD SCI USA, V102, P17326, DOI 10.1073/pnas.0508120102; Liu Q, 2009, TRANSFUSION, V49, P2158, DOI 10.1111/j.1537-2995.2009.02254.x; Madeo F, 2004, CURR OPIN MICROBIOL, V7, P655, DOI 10.1016/j.mib.2004.10.012; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Martinez-Esparza M, 2007, CLIN MICROBIOL INFEC, V13, P384, DOI 10.1111/j.1469-0691.2007.01663.x; Onyewu Chiatogu, 2004, Infection and Immunity, V72, P7330, DOI 10.1128/IAI.72.12.7330-7333.2004; Perlroth J, 2007, MED MYCOL, V45, P321, DOI 10.1080/13693780701218689; Phillips AJ, 2006, P NATL ACAD SCI USA, V103, P726, DOI 10.1073/pnas.0506405103; Phillips AJ, 2003, P NATL ACAD SCI USA, V100, P14327, DOI 10.1073/pnas.2332326100; Pozniakovsky AI, 2005, J CELL BIOL, V168, P257, DOI 10.1083/jcb.200408145; Redding SW, 1999, J CLIN MICROBIOL, V37, P3896, DOI 10.1128/JCM.37.12.3896-3900.1999; Richards AB, 2002, FOOD CHEM TOXICOL, V40, P871, DOI 10.1016/S0278-6915(02)00011-X; Sanglard D, 2003, MOL MICROBIOL, V48, P959, DOI 10.1046/j.1365-2958.2003.03495.x; Sen Gupta S, 2003, J BIOL CHEM, V278, P28831, DOI 10.1074/jbc.M303300200; Silva RD, 2005, MOL MICROBIOL, V58, P824, DOI 10.1111/j.1365-2958.2005.04868.x; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; STEINBACH WJ, 2000, PHYSIOL REV, V80, P1483; Suarez MF, 2004, CURR BIOL, V14, pR339, DOI 10.1016/j.cub.2004.04.019; THEVELEIN JM, 1995, TRENDS BIOCHEM SCI, V20, P3, DOI 10.1016/S0968-0004(00)88938-0; Vachova L, 2005, J CELL BIOL, V169, P711, DOI 10.1083/jcb.200410064; Van Dijck P, 2002, INFECT IMMUN, V70, P1772, DOI 10.1128/IAI.70.4.1772-1782.2002; Wadskog I, 2004, MOL BIOL CELL, V15, P1436, DOI 10.1091/mbc.E03-02-0114; Wang Y, 2006, FREE RADICAL BIO MED, V40, P1201, DOI 10.1016/j.freeradbiomed.2005.11.019; Watanabe N, 2005, J BIOL CHEM, V280, P14691, DOI 10.1074/jbc.M413527200; Zaragoza O, 1998, J BACTERIOL, V180, P3809, DOI 10.1128/JB.180.15.3809-3815.1998; Zaragoza O, 2002, MICROBIOL-SGM, V148, P1281, DOI 10.1099/00221287-148-5-1281	42	42	46	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15808	10.1371/journal.pone.0015808	http://dx.doi.org/10.1371/journal.pone.0015808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246042	Green Published, Green Submitted, gold			2022-12-27	WOS:000286511200015
J	Fisher, MA; McKinley, KL; Bradley, LH; Viola, SR; Hecht, MH				Fisher, Michael A.; McKinley, Kara L.; Bradley, Luke H.; Viola, Sara R.; Hecht, Michael H.			De Novo Designed Proteins from a Library of Artificial Sequences Function in Escherichia Coli and Enable Cell Growth	PLOS ONE			English	Article							NONPOLAR AMINO-ACIDS; COMBINATORIAL LIBRARY; GENOME; SUPERFAMILY; POLAR; K-12	A central challenge of synthetic biology is to enable the growth of living systems using parts that are not derived from nature, but designed and synthesized in the laboratory. As an initial step toward achieving this goal, we probed the ability of a collection of > 10(6) de novo designed proteins to provide biological functions necessary to sustain cell growth. Our collection of proteins was drawn from a combinatorial library of 102-residue sequences, designed by binary patterning of polar and nonpolar residues to fold into stable 4-helix bundles. We probed the capacity of proteins from this library to function in vivo by testing their abilities to rescue 27 different knockout strains of Escherichia coli, each deleted for a conditionally essential gene. Four different strains - Delta serB, Delta gltA, Delta ilvA, and Delta fes - were rescued by specific sequences from our library. Further experiments demonstrated that a strain simultaneously deleted for all four genes was rescued by co-expression of four novel sequences. Thus, cells deleted for similar to 0.1% of the E. coli genome (and similar to 1% of the genes required for growth under nutrient-poor conditions) can be sustained by sequences designed de novo.	Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University	Fisher, MA (corresponding author), Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA.	hecht@princeton.edu		Bradley, Luke/0000-0003-1870-0796; Hecht, Michael/0000-0002-5538-9813; McKinley, Kara/0000-0001-6283-9168	NSF [MCB-0817651]; Direct For Biological Sciences [0817651, 1050510] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by NSF grant MCB-0817651 (URL: http://www.nsf.gov/div/index.jsp?div = MCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Beasley JR, 1997, J BIOL CHEM, V272, P2031, DOI 10.1074/jbc.272.4.2031; Bradley LH, 2005, PROTEIN ENG DES SEL, V18, P201, DOI 10.1093/protein/gzi020; BRADLEY LH, DESIGNED ARTIF UNPUB; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Go A, 2008, PROTEIN SCI, V17, P821, DOI 10.1110/ps.073377908; Hecht MH, 2004, PROTEIN SCI, V13, P1711, DOI 10.1110/ps.04690804; KAMTEKAR S, 1993, SCIENCE, V262, P1680, DOI 10.1126/science.8259512; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Morett E, 2008, J MOL BIOL, V376, P839, DOI 10.1016/j.jmb.2007.12.017; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; Patel SC, 2009, PROTEIN SCI, V18, P1388, DOI 10.1002/pro.147; Patrick WM, 2008, J MOL BIOL, V377, P323, DOI 10.1016/j.jmb.2008.01.043; Patrick WM, 2007, MOL BIOL EVOL, V24, P2716, DOI 10.1093/molbev/msm204; Pereto Juli, 2007, Biology Theory, V2, P128, DOI 10.1162/biot.2007.2.2.128; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Rudd KE, 2000, NUCLEIC ACIDS RES, V28, P60, DOI 10.1093/nar/28.1.60; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; UMBARGER HE, 1957, J BACTERIOL, V73, P105, DOI 10.1128/JB.73.1.105-112.1957; Wei YN, 2003, P NATL ACAD SCI USA, V100, P13270, DOI 10.1073/pnas.1835644100; Wei YN, 2003, PROTEIN SCI, V12, P92, DOI 10.1110/ps.0228003; XIONG HY, 1995, P NATL ACAD SCI USA, V92, P6349, DOI 10.1073/pnas.92.14.6349	25	76	76	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2011	6	1							e15364	10.1371/journal.pone.0015364	http://dx.doi.org/10.1371/journal.pone.0015364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KM	21245923	gold, Green Published, Green Submitted			2022-12-27	WOS:000286510500006
J	Azzi, S; Parissi, V; Maroun, RG; Eid, P; Mauffret, O; Fermandjian, S				Azzi, Sandy; Parissi, Vincent; Maroun, Richard G.; Eid, Pierre; Mauffret, Olivier; Fermandjian, Serge			The HIV-1 Integrase alpha 4-Helix Involved in LTR-DNA Recognition Is also a Highly Antigenic Peptide Element	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PHOTO-CROSS-LINKING; C-TERMINAL DOMAIN; IN-VITRO; TYPE-1 INTEGRASE; VIRAL-DNA; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; ACTIVE-SITE; MONOCLONAL-ANTIBODY	Monoclonal antibodies (MAbas) constitute remarkable tools to analyze the relationship between the structure and the function of a protein. By immunizing a mouse with a 29mer peptide (K159) formed by residues 147 to 175 of the HIV-1 integrase (IN), we obtained a monoclonal antibody (MAba4) recognizing an epitope lying in the N-terminal portion of K159 (residues 147-166 of IN). The boundaries of the epitope were determined in ELISA assays using peptide truncation and amino acid substitutions. The epitope in K159 or as a free peptide (pep-a4) was mostly a random coil in solution, while in the CCD (catalytic core domain) crystal, the homologous segment displayed an amphipathic helix structure (alpha 4-helix) at the protein surface. Despite this conformational difference, a strong antigenic crossreactivity was observed between pep-a4 and the protein segment, as well as K156, a stabilized analogue of pep-a4 constrained into helix by seven helicogenic mutations, most of them involving hydrophobic residues. We concluded that the epitope is freely accessible to the antibody inside the protein and that its recognition by the antibody is not influenced by the conformation of its backbone and the chemistry of amino acids submitted to helicogenic mutations. In contrast, the AA -> Glu mutations of the hydrophilic residues Gln148, Lys156 and Lys159, known for their interactions with LTRs (long terminal repeats) and inhibitors (5 CITEP, for instance), significantly impaired the binding of K156 to the antibody. Moreover, we found that in competition ELISAs, the processed and unprocessed LTR oligonucleotides interfered with the binding of MAba4 to IN and K156, confirming that the IN alpha 4-helix uses common residues to interact with the DNA target and the MAba4 antibody. This also explains why, in our standard in vitro concerted integration assays, MAba4 strongly impaired the IN enzymatic activity.	[Azzi, Sandy; Mauffret, Olivier; Fermandjian, Serge] CNRS, ENS Cachan, LBPA, Cachan, France; [Azzi, Sandy; Eid, Pierre] Univ Paris 11, INSERM, U1014, Villejuif, France; [Parissi, Vincent] Univ Bordeaux 2, CNRS, UMR 5234, Lab Microbiol Cellulaire & Mol & Pathogenicite, F-33076 Bordeaux, France; [Maroun, Richard G.] Univ St Joseph, Fac Sci, Dept Sci Vie & Terre, CST Mar Roukoz, Beirut, Lebanon	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Saint Joseph University Beirut	Azzi, S (corresponding author), CNRS, ENS Cachan, LBPA, Cachan, France.	serge.fermandjian@lbpa.ens-cachan.fr	Maroun, Richard/ABG-6613-2020	Maroun, Richard/0000-0002-0697-2535	Centre National de la Recherche Scientifique (CNRS)-France [A/18-1/01251]; Conseil National de la Recherche Scientifique (CNRS)-Lebanon; Conseil de la Recherche de l'Universite Saint Joseph [09 S F 24/L 45]; Association Arc en ciel-Lebanon	Centre National de la Recherche Scientifique (CNRS)-France(Centre National de la Recherche Scientifique (CNRS)); Conseil National de la Recherche Scientifique (CNRS)-Lebanon(Centre National de la Recherche Scientifique (CNRS)); Conseil de la Recherche de l'Universite Saint Joseph; Association Arc en ciel-Lebanon	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The project was funded by the Centre National de la Recherche Scientifique (CNRS)-France, Sidaction (Ref: A/18-1/01251), the Conseil National de la Recherche Scientifique (CNRS)-Lebanon, the Conseil de la Recherche de l'Universite Saint Joseph and the Program CEDRE (09 S F 24/L 45). S.A. was supported by Association Arc en ciel-Lebanon.	Adamson CS, 2007, ADV PHARMACOL, V55, P347, DOI 10.1016/S1054-3589(07)55010-6; Agapkina J, 2006, J BIOL CHEM, V281, P11530, DOI 10.1074/jbc.M512271200; Asante-Appiah E, 1997, ANTIVIR RES, V36, P139, DOI 10.1016/S0166-3542(97)00046-6; Bao KK, 2003, J BIOL CHEM, V278, P1323, DOI 10.1074/jbc.C200550200; Bujacz G, 1996, FEBS LETT, V398, P175, DOI 10.1016/S0014-5793(96)01236-7; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; Camacho LH, 2008, EXPERT OPIN INV DRUG, V17, P371, DOI [10.1517/13543784.17.3.371, 10.1517/13543784.17.3.371 ]; Caumont A, 1999, FEBS LETT, V455, P154, DOI 10.1016/S0014-5793(99)00859-5; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Cooper DA, 2008, NEW ENGL J MED, V359, P355, DOI 10.1056/NEJMoa0708978; DAVIES JF, 1991, SCIENCE, V252, P88, DOI 10.1126/science.1707186; Dirac AMG, 2001, EUR J BIOCHEM, V268, P743, DOI 10.1046/j.1432-1327.2001.01932.x; Drake RR, 1998, P NATL ACAD SCI USA, V95, P4170, DOI 10.1073/pnas.95.8.4170; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; ENGELMAN A, 1994, J VIROL, V68, P5911, DOI 10.1128/JVI.68.9.5911-5917.1994; ENGELMAN A, 1992, J VIROL, V66, P6361, DOI 10.1128/JVI.66.11.6361-6369.1992; Engelman A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000046; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; Gerton JL, 1998, J VIROL, V72, P5046, DOI 10.1128/JVI.72.6.5046-5055.1998; Goethals O, 2008, J VIROL, V82, P10366, DOI 10.1128/JVI.00470-08; Goldgur Y, 1999, P NATL ACAD SCI USA, V96, P13040, DOI 10.1073/pnas.96.23.13040; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000515; Heuer TS, 1998, BIOCHEMISTRY-US, V37, P6667, DOI 10.1021/bi972949c; Hobaika Z, 2010, NEUROCHEM RES, V35, P888, DOI 10.1007/s11064-009-0098-2; Hobaika Z, 2009, NUCLEIC ACIDS RES, V37, P7691, DOI 10.1093/nar/gkp824; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Jaskolski M, 2009, FEBS J, V276, P2926, DOI 10.1111/j.1742-4658.2009.07009.x; Jenkins TM, 1997, EMBO J, V16, P6849, DOI 10.1093/emboj/16.22.6849; Johnson AA, 2006, J BIOL CHEM, V281, P461, DOI 10.1074/jbc.M511348200; Johnson AA, 2006, J BIOL CHEM, V281, P32428, DOI 10.1074/jbc.M605101200; KATAYANAGI K, 1993, J BIOL CHEM, V268, P22092; KOSHLAND ME, 1966, BIOCHEMISTRY-US, V5, P641, DOI 10.1021/bi00866a034; KULKOSKY J, 1992, MOL CELL BIOL, V12, P2331, DOI 10.1128/MCB.12.5.2331; Lataillade M, 2007, ANTIVIR THER, V12, P563; LEAVITT AD, 1993, J BIOL CHEM, V268, P2113; Lesbats P, 2008, NUCLEIC ACIDS RES, V36, P7043, DOI 10.1093/nar/gkn796; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Li M, 2005, J BIOL CHEM, V280, P29334, DOI 10.1074/jbc.M505367200; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; Lu R, 2005, J VIROL, V79, P2493, DOI 10.1128/JVI.79.4.2493-2505.2005; LUTZKE RAP, 1994, NUCLEIC ACIDS RES, V22, P4125, DOI 10.1093/nar/22.20.4125; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Mahler M, 2003, J MOL MED-JMM, V81, P194, DOI 10.1007/s00109-003-0423-1; Maignan S, 1998, J MOL BIOL, V282, P359, DOI 10.1006/jmbi.1998.2002; Malet I, 2008, ANTIMICROB AGENTS CH, V52, P1351, DOI 10.1128/AAC.01228-07; Maroun RG, 1999, EUR J BIOCHEM, V260, P145, DOI 10.1046/j.1432-1327.1999.00130.x; Maroun RG, 1999, J BIOL CHEM, V274, P34174, DOI 10.1074/jbc.274.48.34174; Merad H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004081; Moreau K, 2003, EUR J BIOCHEM, V270, P4426, DOI 10.1046/j.1432-1033.2003.03833.x; Moreau K, 2009, VIROLOGY, V392, P94, DOI 10.1016/j.virol.2009.06.031; Mould DR, 2007, CURR OPIN DRUG DISC, V10, P84; MUSACCHIO A, 1992, NATURE, V359, P851, DOI 10.1038/359851a0; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; Queffelec C, 2008, EUR J MED CHEM, V43, P2268, DOI 10.1016/j.ejmech.2007.12.013; Ramcharan J, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-34; Ren G, 2007, J MOL BIOL, V366, P286, DOI 10.1016/j.jmb.2006.11.029; Rhee SY, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-74; Routsias JG, 2006, CRIT REV CL LAB SCI, V43, P203, DOI 10.1080/10408360500523837; SHERMAN PA, 1990, P NATL ACAD SCI USA, V87, P5119, DOI 10.1073/pnas.87.13.5119; Sourgen F, 1996, EUR J BIOCHEM, V240, P765, DOI 10.1111/j.1432-1033.1996.0765h.x; Suzuki Y, 2002, J VIROL, V76, P12376, DOI 10.1128/JVI.76.23.12376-12380.2002; TANESE N, 1988, DNA-J MOLEC CELL BIO, V7, P407, DOI 10.1089/dna.1.1988.7.407; Yi JZ, 2000, J BIOL CHEM, V275, P38739, DOI 10.1074/jbc.M005499200; Zargarian L, 2003, J BIOL CHEM, V278, P19966, DOI 10.1074/jbc.M211711200	67	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e16001	10.1371/journal.pone.0016001	http://dx.doi.org/10.1371/journal.pone.0016001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209864	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793600056
J	Drake, LL; Boudko, DY; Marinotti, O; Carpenter, VK; Dawe, AL; Hansen, IA				Drake, Lisa L.; Boudko, Dmitri Y.; Marinotti, Osvaldo; Carpenter, Victoria K.; Dawe, Angus L.; Hansen, Immo A.			The Aquaporin Gene Family of the Yellow Fever Mosquito, Aedes aegypti	PLOS ONE			English	Article							GENOME SEQUENCE; WATER CHANNEL; BEETLEBASE; GLYCEROL; BRAIN	Background: The mosquito, Aedes aegypti, is the principal vector of the Dengue and yellow fever viruses. During feeding, an adult female can take up more than its own body weight in vertebrate blood. After a blood meal females excrete large amounts of urine through their excretion system, the Malpighian tubules (MT). Diuresis starts within seconds after the mosquito starts feeding. Aquaporins (AQPs) are a family of membrane transporters that regulate the flow of water, glycerol and other small molecules across cellular membranes in both prokaryotic and eukaryotic cells. Our aim was to identify aquaporins that function as water channels, mediating transcellular water transport in MTs of adult female Ae. aegypti. Methodology/Principal Findings: Using a bioinformatics approach we screened genome databases and identified six putative AQPs in the genome of Ae. aegypti. Phylogenetic analysis showed that five of the six Ae. aegypti AQPs have high similarity to classical water-transporting AQPs of vertebrates. Using microarray, reverse transcription and real time PCR analysis we found that all six AQPs are expressed in distinct patterns in mosquito tissues/body parts. AaAQP1, 4, and 5 are strongly expressed in the adult female MT. RNAi-mediated knockdown of the MT-expressed mosquito AQPs resulted in significantly reduced diuresis. Conclusions/Significance: Our results support the notion that AQP1, 4, and 5 function as water transporters in the MTs of adult female Ae. aegypti mosquitoes. Our results demonstrate the importance of these AQPs for mosquito diuresis after blood ingestion and highlight their potential as targets for the development of novel vector control strategies.	[Drake, Lisa L.; Carpenter, Victoria K.; Dawe, Angus L.; Hansen, Immo A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Hansen, Immo A.] New Mexico State Univ, Inst Appl Biosci, Las Cruces, NM 88003 USA; [Dawe, Angus L.; Hansen, Immo A.] New Mexico State Univ, Program Mol Biol, Las Cruces, NM 88003 USA; [Boudko, Dmitri Y.] Rosalind Franklin Univ, Chicago Med Sch, N Chicago, IL USA; [Marinotti, Osvaldo] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA	New Mexico State University; New Mexico State University; New Mexico State University; Chicago Medical School; Rosalind Franklin University Medical & Science; University of California System; University of California Irvine	Drake, LL (corresponding author), New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.	immoh@nmsu.edu		Marinotti, Osvaldo/0000-0002-7173-7160; Boudko, Dmitri/0000-0002-1899-044X	Howard Hughes Medical Institute [52005881]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI030464] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project had two funding sources. First, start-up money given to Immo Hansen by the vice president for research of New Mexico State University. Secondly, this project was supported in part by grant #52005881 to NMSU from the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Attardo GM, 2006, J EXP BIOL, V209, P3071, DOI 10.1242/jeb.02349; BOORMAN J. P. T., 1960, ANN TROP MED ANDPARASITOL, V54, P8; Chou CL, 2000, J BIOL CHEM, V275, P36839, DOI 10.1074/jbc.M005552200; Clements A.N., 1992, BIOL MOSQUITOES, V1; Dissanayake Sumudu N, 2010, BMC Res Notes, V3, P248, DOI 10.1186/1756-0500-3-248; Efron B, 1996, P NATL ACAD SCI USA, V93, P13429, DOI 10.1073/pnas.93.23.13429; EMBL-EBI, 2010, ENS AED AEG; Furukawa K, 2009, MOL MICROBIOL, V74, P1272, DOI 10.1111/j.1365-2958.2009.06933.x; Gonen T, 2006, Q REV BIOPHYS, V39, P361, DOI 10.1017/S0033583506004458; HAYS AR, 1990, ROUX ARCH DEV BIOL, V199, P114, DOI 10.1007/BF02029559; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Ikeguchi M, 2009, FRONT BIOSCI-LANDMRK, V14, P1283, DOI 10.2741/3308; Jagge CL, 2008, INSECT MOL BIOL, V17, P413, DOI 10.1111/j.1365-2583.2008.00817.x; Jensen MO, 2001, STRUCTURE, V9, P1083, DOI 10.1016/S0969-2126(01)00668-2; JUNG JS, 1994, J BIOL CHEM, V269, P14648; Kaufmann N, 2005, AM J PHYSIOL-CELL PH, V289, pC397, DOI 10.1152/ajpcell.00612.2004; Kim HS, 2010, NUCLEIC ACIDS RES, V38, pD437, DOI 10.1093/nar/gkp807; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu KCTH, 2010, CLON CHAR AN GAMB AQ; NCBI, 2009, PRIMERBLAST; NCBI, 2010, GENB; Nedvetsky Pavel I, 2009, Handb Exp Pharmacol, P133, DOI 10.1007/978-3-540-79885-9_6; Nejsum LN, 2002, P NATL ACAD SCI USA, V99, P511, DOI 10.1073/pnas.012588099; NIAID, 2010, VECT; Nishihara E, 2008, BIOL CELL, V100, P179, DOI 10.1042/BC20070091; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pettersson N, 2005, BIOL CELL, V97, P487, DOI 10.1042/BC20040144; Pietrantonio PV, 2000, INSECT MOL BIOL, V9, P407, DOI 10.1046/j.1365-2583.2000.00201.x; Pittendrigh BR, 2006, J MED ENTOMOL, V43, P1103, DOI 10.1603/0022-2585(2006)43[1103:SOANTG]2.0.CO;2; Predel R, 2006, CELL MOL LIFE SCI, V63, P2477, DOI 10.1007/s00018-006-6187-3; Rambaut A., FIGTREE; REDINGTON BC, 1976, J INSECT PHYSIOL, V22, P961, DOI 10.1016/0022-1910(76)90079-2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schepel SA, 2010, AM J PHYSL REGUL INT; Shepard AR, 2005, ANAL BIOCHEM, V344, P287, DOI 10.1016/j.ab.2005.06.005; Spring JH, 2009, J EXP BIOL, V212, P358, DOI 10.1242/jeb.024794; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatsumi K, 2009, FEBS LETT, V583, P2077, DOI 10.1016/j.febslet.2009.05.035; Tornroth-Horsefield S, 2010, FEBS LETT, V584, P2580, DOI 10.1016/j.febslet.2010.04.037; van den Berg H, 2009, ENVIRON HEALTH PERSP, V117, P1656, DOI 10.1289/ehp.0900785; Wang LJ, 2007, NUCLEIC ACIDS RES, V35, pD476, DOI 10.1093/nar/gkl776; Wang S, 1996, J EXP BIOL, V199, P2537; Yoder JA, 2006, J INSECT PHYSIOL, V52, P202, DOI 10.1016/j.jinsphys.2005.10.005; ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4	46	71	74	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15578	10.1371/journal.pone.0015578	http://dx.doi.org/10.1371/journal.pone.0015578			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21249121	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793200028
J	Gu, B; Zhang, JR; Wang, W; Mo, LJ; Zhou, Y; Chen, LB; Liu, YS; Zhang, M				Gu, Bin; Zhang, Jiarong; Wang, Wei; Mo, Lijuan; Zhou, Yang; Chen, Liangbiao; Liu, Yusen; Zhang, Ming			Global Expression of Cell Surface Proteins in Embryonic Stem Cells	PLOS ONE			English	Article							SELF-RENEWAL; HEMATOPOIETIC STEM; MEMBRANE-PROTEINS; MOUSE; DIFFERENTIATION; CHROMATIN; TRANSCRIPTION; LIF; PROLIFERATION; GENES	Background: Recent studies have shown that embryonic stem (ES) cells globally express most genes in the genome at the mRNA level; however, it is unclear whether this global expression is propagated to the protein level. Cell surface proteins could perform critical functions in ES cells, so determining whether ES cells globally express cell surface proteins would have significant implications for ES cell biology. Methods and Principal Findings: The surface proteins of mouse ES cells were purified by biotin labeling and subjected to proteomics analysis. About 1000 transmembrane or secreted cell surface proteins were identified. These proteins covered a large variety if functional categories including signal transduction, adhesion and transporting. More over, mES cells promiscuously expressed a wide variety of tissue specific surface proteins. And many surface proteins were expressed heterogeneously on mES cells. We also find that human ES cells express a wide variety of tissue specific surface proteins. Conclusions/Significance: Our results indicate that global gene expression is not simply a result of leaky gene expression, which could be attributed to the loose chromatin structure of ES cells; it is also propagated to the functional level. ES cells may use diverse surface proteins to receive signals from the diverse extracellular stimuli that initiate differentiation. Moreover, the promiscuous expression of tissue specific surface proteins illuminate new insights into the strategies of cell surface marker screening.	[Gu, Bin; Zhang, Jiarong; Wang, Wei; Mo, Lijuan; Zhou, Yang; Zhang, Ming] Zhejiang Univ, Inst Cell Biol & Genet, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Liangbiao] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China; [Liu, Yusen] Ohio State Univ, Dept Pediat, Ctr Perinatal Res, Res Inst,Nationwide Childrens Hosp,Coll Med, Columbus, OH 43210 USA	Zhejiang University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Gu, B (corresponding author), Zhejiang Univ, Inst Cell Biol & Genet, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	zhangming_ls@zju.edu.cn	Liu, Yusen/E-3527-2011	Liu, Yusen/0000-0002-0994-0109; Gu, Bin/0000-0002-5594-2463; , liangbiao/0000-0002-0717-8536	Ministry of Science and Technology of China; National Key Scientific Research Program of China [2007947804]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Key Scientific Research Program of China	This work was supported by the Ministry of Science and Technology of China and the National Key Scientific Research Program of China (2007947804, http://www.973.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Choo AB, 2008, STEM CELLS, V26, P1454, DOI 10.1634/stemcells.2007-0576; Davey RE, 2007, FASEB J, V21, P2020, DOI 10.1096/fj.06-7852com; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Gu B, 2010, BIOCHEM BIOPH RES CO, V394, P418, DOI 10.1016/j.bbrc.2010.03.042; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hansson M, 2009, DEV BIOL, V330, P286, DOI 10.1016/j.ydbio.2009.03.026; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang Y, 2007, J INFRARED MILLIM W, V26, P26; [姜祖韵 Jiang Zuyun], 2005, [浙江大学学报. 理学版, Journal of Zhejiang University], V32, P574; Josic D, 2007, PROTEOMICS, V7, P3010, DOI 10.1002/pmic.200700139; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim MH, 2008, APOPTOSIS, V13, P295, DOI 10.1007/s10495-007-0160-y; King FW, 2009, STEM CELLS DEV, V18, P1441, DOI 10.1089/scd.2009.0012; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Nagano K, 2008, PROTEOMICS, V8, P4025, DOI 10.1002/pmic.200800073; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nishikawa Y, 2010, J EXP MED, V207, P963, DOI 10.1084/jem.20092144; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Rao M, 2004, DEV BIOL, V275, P269, DOI 10.1016/j.ydbio.2004.08.013; Schwirtlich M, 2010, FASEB J, V24, P1218, DOI 10.1096/fj.09-143586; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Soh BS, 2007, STEM CELLS, V25, P3029, DOI 10.1634/stemcells.2007-0372; Son YS, 2005, STEM CELLS, V23, P1502, DOI 10.1634/stemcells.2004-0307; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SPANGRUDE GJ, 1991, BLOOD, V78, P1395; Speers AE, 2007, CHEM REV, V107, P3687, DOI 10.1021/cr068286z; Spencer HL, 2007, MOL BIOL CELL, V18, P2838, DOI 10.1091/mbc.E06-09-0875; Taylor T, 2010, STEM CELLS DEV, V19, P1333, DOI 10.1089/scd.2009.0484; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; UCHIDA N, 1992, J EXP MED, V175, P175, DOI 10.1084/jem.175.1.175; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Wang J, 2009, SCIENCE, V325, P435, DOI 10.1126/science.1173288; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zandstra PW, 2000, BIOTECHNOL BIOENG, V69, P607, DOI 10.1002/1097-0290(20000920)69:6<607::AID-BIT4>3.3.CO;2-6; Zhao YX, 2004, ANAL CHEM, V76, P1817, DOI 10.1021/ac0354037	52	28	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15795	10.1371/journal.pone.0015795	http://dx.doi.org/10.1371/journal.pone.0015795			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209962	Green Published, Green Submitted, gold			2022-12-27	WOS:000285793200055
J	Ott, PA; Hamilton, A; Min, C; Safarzadeh-Amiri, S; Goldberg, L; Yoon, J; Yee, H; Buckley, M; Christos, PJ; Wright, JJ; Polsky, D; Osman, I; Liebes, L; Pavlick, AC				Ott, Patrick A.; Hamilton, Anne; Min, Christina; Safarzadeh-Amiri, Sara; Goldberg, Lauren; Yoon, Joanne; Yee, Herman; Buckley, Michael; Christos, Paul J.; Wright, John J.; Polsky, David; Osman, Iman; Liebes, Leonard; Pavlick, Anna C.			A Phase II Trial of Sorafenib in Metastatic Melanoma with Tissue Correlates	PLOS ONE			English	Article							B-RAF; BRAF; MUTATIONS; DACARBAZINE; PROGRESSION; IMATINIB; KIT; ASSOCIATION; CARBOPLATIN; COMBINATION	Background: Sorafenib monotherapy in patients with metastatic melanoma was explored in this multi-institutional phase II study. In correlative studies the impact of sorafenib on cyclin D1 and Ki67 was assessed. Methodology/Principal Findings: Thirty-six patients treatment-naive advanced melanoma patients received sorafenib 400 mg p.o. twice daily continuously. Tumor BRAF V600E mutational status was determined by routine DNA sequencing and mutation-specific PCR (MSPCR). Immunohistochemistry (IHC) staining for cyclin D1 and Ki67 was performed on available pre- and post treatment tumor samples. The main toxicities included diarrhea, alopecia, rash, mucositis, nausea, hand-foot syndrome, and intestinal perforation. One patient had a RECIST partial response (PR) lasting 175 days. Three patients experienced stable disease (SD) with a mean duration of 37 weeks. Routine BRAF V600E sequencing yielded 27 wild-type (wt) and 6 mutant tumors, whereas MSPCR identified 12 wt and 18 mutant tumors. No correlation was seen between BRAF V600E mutational status and clinical activity. No significant changes in expression of cyclin D1 or Ki67 with sorafenib treatment were demonstrable in the 15 patients with pre-and post-treatment tumor samples. Conclusions/Significance: Sorafenib monotherapy has limited activity in advanced melanoma patients. BRAF V600E mutational status of the tumor was not associated with clinical activity and no significant effect of sorafenib on cyclin D1 or Ki67 was seen, suggesting that sorafenib is not an effective BRAF inhibitor or that additional signaling pathways are equally important in the patients who benefit from sorafenib. registration:	[Ott, Patrick A.; Min, Christina; Safarzadeh-Amiri, Sara; Goldberg, Lauren; Buckley, Michael; Osman, Iman; Liebes, Leonard; Pavlick, Anna C.] NYU, Sch Med, Dept Med Oncol, New York, NY 10003 USA; [Yee, Herman; Polsky, David] NYU, Sch Med, Dept Pathol, New York, NY USA; [Yoon, Joanne; Polsky, David; Osman, Iman; Pavlick, Anna C.] NYU, Sch Med, Dept Dermatol, New York, NY USA; [Hamilton, Anne] Royal Prince Alfred Hosp, Sydney Canc Ctr, Sydney, NSW, Australia; [Hamilton, Anne] Univ Sydney, Sydney, NSW 2006, Australia; [Hamilton, Anne] Sydney Melanoma Unit, Sydney, NSW, Australia; [Christos, Paul J.] Weill Cornell Med Coll, Div Biostat & Epidemiol, New York, NY USA; [Wright, John J.] NCI, Invest Drug Branch, Bethesda, MD 20892 USA	New York University; New York University; New York University; University of Sydney; University of Sydney; Melanoma Institute Australia; Cornell University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ott, PA (corresponding author), NYU, Sch Med, Dept Med Oncol, New York, NY 10003 USA.	anna.pavlick@nyumc.org	Polsky, David/AAO-6254-2020	Polsky, David/0000-0001-9554-5289	United States Department of Health and Human Service [N01-CM-17103, N01-CM-62204]	United States Department of Health and Human Service	This work was supported by the United States Department of Health and Human Service contracts [N01-CM-17103 and N01-CM-62204]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albino AP, 2000, CANCER RES, V60, P4139; Bedikian AY, 2006, J CLIN ONCOL, V24, P4738, DOI 10.1200/JCO.2006.06.0483; Bukur Juergen, 2010, Cancer Immunol Immunother, V59, P955, DOI 10.1007/s00262-008-0580-8; Carlomagno F, 2006, JNCI-J NATL CANCER I, V98, P326, DOI 10.1093/jnci/djj069; Chapman PB, 1999, J CLIN ONCOL, V17, P2745, DOI 10.1200/JCO.1999.17.9.2745; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dong JL, 2003, CANCER RES, V63, P3883; Eisen T, 2006, BRIT J CANCER, V95, P581, DOI 10.1038/sj.bjc.6603291; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Gorden A, 2003, CANCER RES, V63, P3955; Handolias D, 2010, BRIT J CANCER, V102, P1219, DOI 10.1038/sj.bjc.6605635; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Hauschild A, 2009, J CLIN ONCOL, V27, P2823, DOI 10.1200/JCO.2007.15.7636; Hingorani SR, 2003, CANCER RES, V63, P5198; Hodi FS, 2008, J CLIN ONCOL, V26, P2046, DOI 10.1200/JCO.2007.14.0707; Hoeflich MP, 2006, CANCER RES, V66, P999, DOI 10.1158/0008-5472.CAN-05-2720; Jilaveanu L, 2009, CLIN CANCER RES, V15, P1076, DOI 10.1158/1078-0432.CCR-08-2280; Karasarides M, 2004, ONCOGENE, V23, P6292, DOI 10.1038/sj.onc.1207785; Karreth FA, 2009, MOL CELL, V36, P477, DOI 10.1016/j.molcel.2009.10.017; Korn EL, 2008, J CLIN ONCOL, V26, P527, DOI 10.1200/JCO.2007.12.7837; Kumar R, 2003, CLIN CANCER RES, V9, P3362; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Lutzky J, 2008, PIGM CELL MELANOMA R, V21, P492, DOI 10.1111/j.1755-148X.2008.00475.x; McDermott DF, 2008, J CLIN ONCOL, V26, P2178, DOI 10.1200/JCO.2007.14.8288; Middleton MR, 2000, J CLIN ONCOL, V18, P158, DOI 10.1200/JCO.2000.18.1.158; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Sala E, 2008, MOL CANCER RES, V6, P751, DOI 10.1158/1541-7786.MCR-07-2001; Sharma A, 2005, CANCER RES, V65, P2412, DOI 10.1158/0008-5472.CAN-04-2423; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Viros A, 2008, PLOS MED, V5, P941, DOI 10.1371/journal.pmed.0050120; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Yancovitz M, 2007, J MOL DIAGN, V9, P178, DOI 10.2353/jmoldx.2007.060135	38	76	78	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15588	10.1371/journal.pone.0015588	http://dx.doi.org/10.1371/journal.pone.0015588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206909	Green Published, Green Submitted, gold			2022-12-27	WOS:000285793200030
J	Reynolds, AM; Reynolds, DR; Smith, AD; Chapman, JW				Reynolds, Andy M.; Reynolds, Don R.; Smith, Alan D.; Chapman, Jason W.			Orientation Cues for High-Flying Nocturnal Insect Migrants: Do Turbulence-Induced Temperature and Velocity Fluctuations Indicate the Mean Wind Flow?	PLOS ONE			English	Article							HIGH-ALTITUDE; PARTICLE ACCELERATIONS; VERTICAL-DISTRIBUTION; PASSIVE SCALARS; LOCAL ISOTROPY; FLIGHT; RADAR; MIGRATION; LAYER; MOTION	Migratory insects flying at high altitude at night often show a degree of common alignment, sometimes with quite small angular dispersions around the mean. The observed orientation directions are often close to the downwind direction and this would seemingly be adaptive in that large insects could add their self-propelled speed to the wind speed, thus maximising their displacement in a given time. There are increasing indications that high-altitude orientation may be maintained by some intrinsic property of the wind rather than by visual perception of relative ground movement. Therefore, we first examined whether migrating insects could deduce the mean wind direction from the turbulent fluctuations in temperature. Within the atmospheric boundary-layer, temperature records show characteristic ramp-cliff structures, and insects flying downwind would move through these ramps whilst those flying crosswind would not. However, analysis of vertical-looking radar data on the common orientations of nocturnally migrating insects in the UK produced no evidence that the migrants actually use temperature ramps as orientation cues. This suggests that insects rely on turbulent velocity and acceleration cues, and refocuses attention on how these can be detected, especially as small-scale turbulence is usually held to be directionally invariant (isotropic). In the second part of the paper we present a theoretical analysis and simulations showing that velocity fluctuations and accelerations felt by an insect are predicted to be anisotropic even when the small-scale turbulence (measured at a fixed point or along the trajectory of a fluid-particle) is isotropic. Our results thus provide further evidence that insects do indeed use turbulent velocity and acceleration cues as indicators of the mean wind direction.	[Reynolds, Andy M.; Reynolds, Don R.; Smith, Alan D.; Chapman, Jason W.] Rothamsted Res, Harpenden, Herts, England; [Reynolds, Don R.] Univ Greenwich, Nat Resources Inst, Chatham, Kent, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Greenwich	Reynolds, AM (corresponding author), Rothamsted Res, Harpenden, Herts, England.	andy.reynolds@bbsrc.ac.uk	Reynolds, Donald R/C-7361-2013; Chapman, Jason/H-8236-2012	Chapman, Jason/0000-0002-7475-4441; Reynolds, Donald/0000-0001-8749-7491	Biotechnology and Biological Sciences Research Council	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Rothamsted Research receives grant aided support from the Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONIA RA, 1982, BOUND-LAY METEOROL, V23, P395, DOI 10.1007/BF00116268; Ayyalasomayajula S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.144507; Chapman JW, 2008, CURR BIOL, V18, pR908, DOI 10.1016/j.cub.2008.08.014; Chapman JW, 2008, CURR BIOL, V18, P514, DOI 10.1016/j.cub.2008.02.080; Chapman JW, 2006, ECOL ENTOMOL, V31, P378, DOI 10.1111/j.1365-2311.2006.00797.x; Chapman JW, 2010, SCIENCE, V327, P682, DOI 10.1126/science.1182990; Chapman JW, 2004, INT J PEST MANAGE, V50, P225, DOI 10.1080/09670870410001731961; Chapman JW, 2004, B ENTOMOL RES, V94, P123, DOI 10.1079/BER2004287; Chapman JW, 2003, BIOSCIENCE, V53, P503, DOI 10.1641/0006-3568(2003)053[0503:VRANTF]2.0.CO;2; Chapman JW, 2002, ECOL ENTOMOL, V27, P641, DOI 10.1046/j.1365-2311.2002.00472.x; Fung JCH, 2003, P ROY SOC A-MATH PHY, V459, P445, DOI 10.1098/rspa.2002.1023; FUNG JCH, 1992, J FLUID MECH, V236, P281, DOI 10.1017/S0022112092001423; GIBSON CH, 1977, PHYS FLUIDS, V20, pS156, DOI 10.1063/1.861725; Kamikouchi A, 2009, NATURE, V458, P165, DOI 10.1038/nature07810; KENNEDY JS, 1951, PHILOS T ROY SOC B, V235, P163, DOI 10.1098/rstb.1951.0003; La Porta A, 2001, NATURE, V409, P1017, DOI 10.1038/35059027; MAXEY MR, 1987, PHYS FLUIDS, V30, P1915, DOI 10.1063/1.866206; MESTAYER PG, 1976, PHYS FLUIDS, V19, P1279, DOI 10.1063/1.861649; PHONGANANT D, 1980, J GEOPHYS RES-OCEANS, V85, P424, DOI 10.1029/JC085iC01p00424; Reynolds AM, 2009, J R SOC INTERFACE, V6, P87, DOI 10.1098/rsif.2008.0173; Reynolds AM, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/058; Reynolds AM, 2010, P R SOC B, V277, P765, DOI 10.1098/rspb.2009.1221; Reynolds DR, 2008, B ENTOMOL RES, V98, P35, DOI 10.1017/S0007485307005470; Reynolds DR, 2005, B ENTOMOL RES, V95, P259, DOI 10.1079/BER2004358; Riley J.R., 1986, P71; RILEY JR, 1975, NATURE, V253, P113, DOI 10.1038/253113a0; RILEY JR, 1989, C ROYAL I NAV CARD 6; Sane SP, 2007, SCIENCE, V315, P863, DOI 10.1126/science.1133598; Schaefer G.W., 1976, Symposia Royal Ent Soc Lond, V7, P157; Schaefer G.W., 1969, P ROYAL ENTOMOLOGICA, V34, P39; SCHAEFER GW, 1969, P ROY ENTOMOL SOC  C, V34, P33; SREENIVASAN KR, 1979, J FLUID MECH, V94, P745, DOI 10.1017/S0022112079001270; SREENIVASAN KR, 1991, P ROY SOC LOND A MAT, V434, P165, DOI 10.1098/rspa.1991.0087; Taylor GK, 2007, ADV INSECT PHYSIOL, V34, P231, DOI 10.1016/S0065-2806(07)34005-8; Voth GA, 2002, J FLUID MECH, V469, P121, DOI 10.1017/S0022112002001842; Warhaft Z, 2000, ANNU REV FLUID MECH, V32, P203, DOI 10.1146/annurev.fluid.32.1.203; Webb B, 2007, CURR BIOL, V17, pR124, DOI 10.1016/j.cub.2006.12.008; Wood CR, 2009, B ENTOMOL RES, V99, P525, DOI 10.1017/S0007485308006548; Wood CR, 2006, INT J BIOMETEOROL, V50, P193, DOI 10.1007/s00484-005-0014-7; Yorozu S, 2009, NATURE, V458, P201, DOI 10.1038/nature07843	40	15	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15758	10.1371/journal.pone.0015758	http://dx.doi.org/10.1371/journal.pone.0015758			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209956	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000285793200052
J	Swetnam, J; Shmelkov, E; Zolla-Pazner, S; Cardozo, T				Swetnam, James; Shmelkov, Evgeny; Zolla-Pazner, Susan; Cardozo, Timothy			Comparative Magnitude of Cross-Strain Conservation of HIV Variable Loop Neutralization Epitopes	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODY; PBL-SCID MICE; V3 LOOP; PASSIVE-IMMUNIZATION; CD4-BINDING SITE; TYPE-1 NEUTRALIZATION; GENETIC SUBTYPES; IMMUNE-RESPONSE; SOLUBLE CD4	Although the sequence variable loops of the human immunodeficiency virus' (HIV-1) surface envelope glycoprotein (gp120) can exhibit good immunogenicity, characterizing conserved (invariant) cross-strain neutralization epitopes within these loops has proven difficult. We recently developed a method to derive sensitive and specific signature motifs for the three-dimensional (3D) shapes of the HIV-1 neutralization epitopes in the third variable (V3) loop of gp120 that are recognized by human monoclonal antibodies (mAbs). We used the signature motif method to estimate the conservation of these epitopes across circulating worldwide HIV-1 strains. The epitope targeted by the anti-V3 loop neutralizing mAb 3074 is present in 87% of circulating strains, distributed nearly evenly among all subtypes. The results for other anti-V3 Abs are: 3791, present in 63% of primarily non-B subtypes; 2219, present in 56% of strains across all subtypes; 2557, present in 52% across all subtypes; 447-52D, present in 11% of primarily subtype B strains; 537-10D, present in 9% of primarily subtype B strains; and 268-D, present in 5% of primarily subtype B strains. The estimates correlate with in vitro tests of these mAbs against diverse viral panels. The mAb 3074 thus targets an epitope that is nearly completely conserved among circulating HIV-1 strains, demonstrating the presence of an invariant structure hidden in the dynamic and sequence-variable V3 loop in gp120. Since some variable loop regions are naturally immunogenic, designing immunogens to mimic their conserved epitopes may be a promising vaccine discovery approach. Our results suggest one way to quantify and compare the magnitude of the conservation.	[Swetnam, James; Shmelkov, Evgeny; Cardozo, Timothy] New York Univ Sch Med, Dept Pharmacol, New York, NY USA; [Zolla-Pazner, Susan] New York Univ Sch Med, Dept Pathol, New York, NY USA; [Zolla-Pazner, Susan] New York Vet Affairs Med Ctr, New York, NY USA	New York University; New York University	Swetnam, J (corresponding author), New York Univ Sch Med, Dept Pharmacol, New York, NY USA.	cardot01@nyumc.org	Zolla-Pazner, Susan/S-1864-2019	Zolla-Pazner, Susan/0000-0002-0750-2666	Bill and Melinda Gates Foundation [38631]; National Institutes of Health [DPOD004631]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grant from the Bill and Melinda Gates Foundation (#38631 to SZP; http://www.gatesfoundation.org/Pages/home.aspx) and the National Institutes of Health (DPOD004631 to TC; http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT J, 1990, AIDS, V4, P107, DOI 10.1097/00002030-199002000-00002; Andrus L, 1998, J INFECT DIS, V177, P889, DOI 10.1086/515251; Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Burke V, 2009, STRUCTURE, V17, P1538, DOI 10.1016/j.str.2009.09.012; Cardozo T, 2009, AIDS RES HUM RETROV, V25, P441, DOI 10.1089/aid.2008.0188; Cavacini LA, 2002, AIDS, V16, P2409, DOI 10.1097/00002030-200212060-00005; CONLEY AJ, 1994, J VIROL, V68, P6994, DOI 10.1128/JVI.68.11.6994-7000.1994; EMINI EA, 1992, NATURE, V355, P728, DOI 10.1038/355728a0; Ferrantelli F, 2004, J INFECT DIS, V189, P2167, DOI 10.1086/420833; Gauduin MC, 1997, NAT MED, V3, P1389, DOI 10.1038/nm1297-1389; Gorny MK, 2004, J VIROL, V78, P2394, DOI 10.1128/JVI.78.5.2394-2404.2004; Gorny MK, 1997, J IMMUNOL, V159, P5114; Gorny MK, 2002, J VIROL, V76, P9035, DOI 10.1128/JVI.76.18.9035-9045.2002; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Hioe CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010254; HO DD, 1991, J VIROL, V65, P489, DOI 10.1128/JVI.65.1.489-493.1991; Honnen WJ, 2007, J VIROL, V81, P1424, DOI 10.1128/JVI.02054-06; Israel ZR, 1997, AIDS, V11, P128; Jiang XQ, 2010, NAT STRUCT MOL BIOL, V17, P955, DOI 10.1038/nsmb.1861; Krachmarov C, 2005, J VIROL, V79, P780, DOI 10.1128/JVI.79.2.780-790.2005; Krachmarov CP, 2001, AIDS RES HUM RETROV, V17, P1737, DOI 10.1089/08892220152741432; Mbah HA, 2001, J VIROL, V75, P7785, DOI 10.1128/JVI.75.16.7785-7788.2001; MCKEATING JA, 1993, J VIROL, V67, P4932, DOI 10.1128/JVI.67.8.4932-4944.1993; Moog C, 1997, J VIROL, V71, P3734, DOI 10.1128/JVI.71.5.3734-3741.1997; Osmanov S, 2002, J ACQ IMMUN DEF SYND, V29, P184, DOI 10.1097/00042560-200202010-00013; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; PINTER A, 1993, AIDS RES HUM RETROV, V9, P985, DOI 10.1089/aid.1993.9.985; Ruprecht Ruth M., 2009, V525, P559, DOI 10.1007/978-1-59745-554-1_31; SAFRIT JT, 1993, AIDS, V7, P15, DOI 10.1097/00002030-199301000-00002; SATTENTAU QJ, 1995, J EXP MED, V182, P185, DOI 10.1084/jem.182.1.185; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Stanfield RL, 2006, J VIROL, V80, P6093, DOI 10.1128/JVI.00205-06; VijhWarrier S, 1996, J VIROL, V70, P4466, DOI 10.1128/JVI.70.7.4466-4473.1996; Visciano ML, 2008, VIROLOGY, V372, P409, DOI 10.1016/j.virol.2007.10.044; VOGEL T, 1994, J IMMUNOL, V153, P1895; Wang CY, 1999, P NATL ACAD SCI USA, V96, P10367, DOI 10.1073/pnas.96.18.10367; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wu XL, 2008, VIROLOGY, V380, P285, DOI 10.1016/j.virol.2008.07.007; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307; Zolla-Pazner S, 2004, AIDS RES HUM RETROV, V20, P1254, DOI 10.1089/aid.2004.20.1254; Zolla-Pazner S, 2008, VIROLOGY, V372, P233, DOI 10.1016/j.virol.2007.09.024; Zolla-Pazner Susan, 2005, Human Antibodies, V14, P69; Zolla-Pazner S, 2009, VIROLOGY, V392, P82, DOI 10.1016/j.virol.2009.05.039; ZOLLAPAZNER S, 2009, VIROLOGY; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	48	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15994	10.1371/journal.pone.0015994	http://dx.doi.org/10.1371/journal.pone.0015994			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209919	gold, Green Published, Green Submitted			2022-12-27	WOS:000285793200078
J	Fan, YP; Chong, YS; Choolani, MA; Cregan, MD; Chan, JKY				Fan, Yiping; Chong, Yap Seng; Choolani, Mahesh A.; Cregan, Mark D.; Chan, Jerry K. Y.			Unravelling the Mystery of Stem/Progenitor Cells in Human Breast Milk	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; EPITHELIAL STEM-CELLS; IN-VITRO PROPAGATION; ADULT HUMAN BREAST; PROGENITOR CELLS; MAMMARY-GLAND; CANCER CELLS; HEMATOPOIETIC STEM; ENDOTHELIAL-CELLS; MOUSE ENDOMETRIUM	Background: Mammary stem cells have been extensively studied as a system to delineate the pathogenesis and treatment of breast cancer. However, research on mammary stem cells requires tissue biopsies which limit the quantity of samples available. We have previously identified putative mammary stem cells in human breast milk, and here, we further characterised the cellular component of human breast milk. Methodology/Principal Findings: We identified markers associated with haemopoietic, mesenchymal and neuro-epithelial lineages in the cellular component of human breast milk. We found 2.6+/-0.8% (mean+/-SEM) and 0.7+/-0.2% of the whole cell population (WCP) were found to be CD133+ and CD34+ respectively, 27.8+/-9.1% of the WCP to be positive for Stro-1 through flow-cytometry. Expressions of neuro-ectodermal stem cell markers such as nestin and cytokeratin 5 were found through reverse-transcription polymerase chain reaction (RT-PCR), and in 4.17+/-0.2% and 0.9+/-0.2% of the WCP on flow-cytometry. We also established the presence of a side-population (SP) (1.8+/-0.4% of WCP) as well as CD133+ cells (1.7+/-0.5% of the WCP). Characterisation of the sorted SP and non-SP, CD133+ and CD133-cells carried out showed enrichment of CD326 (EPCAM) in the SP cells (50.6+/-8.6 vs 18.1+/-6.0, P-value = 0.02). However, culture in a wide range of in vitro conditions revealed the atypical behaviour of stem/progenitor cells in human breast milk; in that if they are present, they do not respond to established culture protocols of stem/progenitor cells. Conclusions/Significance: The identification of primitive cell types within human breast milk may provide a non-invasive source of relevant mammary cells for a wide-range of applications; even the possibility of banking one's own stem cell for every breastfeeding woman.	[Fan, Yiping; Chong, Yap Seng; Choolani, Mahesh A.; Chan, Jerry K. Y.] Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Expt Fetal Med Grp, Singapore, Singapore; [Cregan, Mark D.] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Perth, WA 6009, Australia; [Chan, Jerry K. Y.] KK Womens & Childrens Hosp, Dept Reprod Med, Singapore, Singapore; [Chan, Jerry K. Y.] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore, Singapore	National University of Singapore; University of Western Australia; KK Women's & Children's Hospital; National University of Singapore	Fan, YP (corresponding author), Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Expt Fetal Med Grp, Singapore, Singapore.	yiping@nus.edu.sg; jerrychan@nus.edu.sg		Chong, Yap Seng/0000-0002-7232-8473	National Healthcare Group, Singapore [SIG07057]; National University of Singapore; National Medical Research Council, Singapore [CSA/012/2009, CSA/007/2009]	National Healthcare Group, Singapore; National University of Singapore(National University of Singapore); National Medical Research Council, Singapore(National Medical Research Council, Singapore)	This work was funded by National Healthcare Group, Singapore (SIG07057) and also National University of Singapore through a research scholarship to Y. Fan. J. Chan and M. Choolani received support from the Clinician Scientist Award, National Medical Research Council, Singapore (CSA/012/2009 and CSA/007/2009). The funding bodies have supported the authors' research ideas, with no role in study design, data collection and analysis, decision to publish and preparation of manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alvi AJ, 2003, BREAST CANCER RES, V5, DOI 10.1186/bcr563; Bjerknes M, 2006, METHOD ENZYMOL, V419, P337, DOI 10.1016/S0076-6879(06)19014-X; Bocker W, 2002, LAB INVEST, V82, P737, DOI 10.1097/01.LAB.0000017371.72714.C5; BROOKER BE, 1980, CELL TISSUE RES, V210, P321, DOI 10.1007/BF00237619; Calvanese V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003294; Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396; Cervello I, 2007, HUM REPROD, V22, P45, DOI 10.1093/humrep/del332; Chan RWS, 2006, STEM CELLS, V24, P1529, DOI 10.1634/stemcells.2005-0411; Chen CP, 2008, STEM CELLS, V26, P550, DOI 10.1634/stemcells.2007-0406; Clarke RB, 2005, DEV BIOL, V277, P443, DOI 10.1016/j.ydbio.2004.07.044; Clayton H, 2004, EXP CELL RES, V297, P444, DOI 10.1016/j.yexcr.2004.03.029; CRAGO SS, 1979, CLIN EXP IMMUNOL, V38, P585; Cregan MD, 2007, CELL TISSUE RES, V329, P129, DOI 10.1007/s00441-007-0390-x; DEOME KB, 1959, CANCER RES, V19, P515; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; FINA L, 1990, BLOOD, V75, P2417; Gargett CE, 2007, HUM REPROD UPDATE, V13, P87, DOI 10.1093/humupd/dml045; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; GRONTHOS S, 1994, BLOOD, V84, P4164, DOI 10.1182/blood.V84.12.4164.bloodjournal84124164; Gudjonsson T, 2002, GENE DEV, V16, P693, DOI 10.1101/gad.952602; HARRIS J, 1991, J NEUROSCI RES, V30, P47, DOI 10.1002/jnr.490300107; Hida N, 2008, STEM CELLS, V26, P1695, DOI 10.1634/stemcells.2007-0826; HO FCS, 1979, ACTA PAEDIATR SCAND, V68, P389, DOI 10.1111/j.1651-2227.1979.tb05025.x; Kanof ME, 2001, CURR PROTOC IMMUNOL; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Musina RA, 2008, B EXP BIOL MED+, V145, P539, DOI 10.1007/s10517-008-0136-0; Petersen OW, 2001, BREAST CANCER RES, V3, P213; Piechaczek C, 2001, J BIOL REG HOMEOS AG, V15, P101; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Qi HL, 2003, P NATL ACAD SCI USA, V100, P3305, DOI 10.1073/pnas.0532693100; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Satish P, 2010, HUM CELL, V23, P6; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; SMITH CW, 1968, PEDIATR RES, V2, P103, DOI 10.1203/00006450-196803000-00005; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Villadsen R, 2007, J CELL BIOL, V177, P87, DOI 10.1083/jcb.200611114; WATT SM, 1995, LEUKEMIA LYMPHOMA, V17, P229, DOI 10.3109/10428199509056827; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zhang YY, 2008, J UROLOGY, V180, P2226, DOI 10.1016/j.juro.2008.07.023; Zhang ZY, 2009, STEM CELLS	49	53	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14421	10.1371/journal.pone.0014421	http://dx.doi.org/10.1371/journal.pone.0014421			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203434	Green Published, gold, Green Submitted			2022-12-27	WOS:000285792500006
J	Al-Moundhri, MS; Al-Nabhani, M; Tarantini, L; Baccarelli, A; Rusiecki, JA				Al-Moundhri, Mansour S.; Al-Nabhani, Maryam; Tarantini, Letizia; Baccarelli, Andrea; Rusiecki, Jennifer A.			The Prognostic Significance of Whole Blood Global and Specific DNA Methylation Levels in Gastric Adenocarcinoma	PLOS ONE			English	Article							GENE PROMOTER HYPERMETHYLATION; HELICOBACTER-PYLORI; MICROSATELLITE INSTABILITY; LINE-1 HYPOMETHYLATION; ABERRANT METHYLATION; E-CADHERIN; CANCER; TUMOR; RISK; AGE	Background: Epigenetics, particularly DNA methylation, has recently been elucidated as important in gastric cancer (GC) initiation and progression. We investigated the clinical and prognostic importance of whole blood global and site-specific DNA methylation in GC. Methods: Genomic DNA was extracted from the peripheral blood of 105 Omani GC patients at diagnosis. DNA methylation was quantified by pyrosequencing of global DNA and specific gene promoter regions at 5 CpG sites for CDH1, 7 CpG sites for p16, 4 CpG sites for p53, and 3 CpG sites for RUNX3. DNA methylation levels in patients were categorized into low, medium, and high tertiles. Associations between methylation level category and clinicopathological features were evaluated using chi(2) tests. Survival analyses were carried out using the Kaplan-Meier method and log rank test. A backward conditional Cox proportional hazards regression model was used to identify independent predictors of survival. Results: Older GC patients had increased methylation levels at specific CpG sites within the CDH1, p53, and RUNX-3 promoters. Male gender was significantly associated with reduced global and increased site-specific DNA methylation levels in CDH1, p16, and p53 promoters. Global DNA low methylation level was associated with better survival on univariate analysis. Patients with high and medium methylation vs. low methylation levels across p16 promoter CpG sites, site 2 in particular, had better survival. Multivariate analysis showed that global DNA hypermethylation was a significant independent predictor of worse survival (hazard ratio (HR) = 2.0, 95% CI: 1.1-3.8; p = 0.02) and high methylation mean values across p16 promoter sites 1-7 were associated with better survival with HR of 0.3 (95% CI, 0.1-0.8; p = 0.02) respectively. Conclusions: Analysis of global and site-specific DNA methylation in peripheral blood by pyrosequencing provides quantitative DNA methylation values that may serve as important prognostic indicators.	[Al-Moundhri, Mansour S.] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Med, Med Oncol Unit, Muscat, Oman; [Al-Nabhani, Maryam] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Genet, Muscat, Oman; [Tarantini, Letizia; Baccarelli, Andrea] Univ Milan, Milan, Italy; [Tarantini, Letizia; Baccarelli, Andrea] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Environm & Occupat Hlth, Ctr Mol & Genet Epidemiol, Milan, Italy; [Rusiecki, Jennifer A.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD USA	Sultan Qaboos University; Sultan Qaboos University; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Uniformed Services University of the Health Sciences - USA	Al-Moundhri, MS (corresponding author), Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Med, Med Oncol Unit, Muscat, Oman.	mansours@squ.edu.om		Baccarelli, Andrea/0000-0002-3436-0640; Rusiecki, Jennifer/0000-0003-3881-8695; Al-Moundhri, Mansour/0000-0003-3963-1232	Sultan Qaboos university	Sultan Qaboos university	Sultan Qaboos university Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ally MS, 2009, CANCER EPIDEM BIOMAR, V18, P922, DOI 10.1158/1055-9965.EPI-08-0703; An CH, 2005, CLIN CANCER RES, V11, P656; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Chan AOO, 2003, AM J PATHOL, V163, P370, DOI 10.1016/S0002-9440(10)63663-2; Choi JY, 2009, CARCINOGENESIS, V30, P1889, DOI 10.1093/carcin/bgp143; Correa P, 2005, CANCER EPIDEM BIOMAR, V14, P1865, DOI 10.1158/1055-9965.EPI-05-0029; Correa P, 2005, J SURG ONCOL, V90, P134, DOI 10.1002/jso.20216; Correa Pelayo, 2004, IARC Sci Publ, P301; Cravo M, 1996, GUT, V39, P434, DOI 10.1136/gut.39.3.434; Dominguez G, 2003, MUTAT RES-FUND MOL M, V530, P9, DOI 10.1016/S0027-5107(03)00133-7; El-Omar EM, 2001, GASTROENTEROLOGY, V121, P1002, DOI 10.1016/S0016-5085(01)93000-8; Fang JY, 1997, J GASTROENTEROL, V32, P171, DOI 10.1007/BF02936363; Gonzalez C A, 2002, IARC Sci Publ, V156, P79; Gonzalez CA, 2003, INT J CANCER, V107, P629, DOI 10.1002/ijc.11426; Gonzalez CA, 2002, INT J CANCER, V100, P249, DOI 10.1002/ijc.10466; Graziano F, 2004, ANN ONCOL, V15, P489, DOI 10.1093/annonc/mdh108; Gupta A, 2003, CANCER RES, V63, P664; Hou LF, 2010, INT J CANCER, V127, P1866, DOI 10.1002/ijc.25190; Hsiung DT, 2007, CANCER EPIDEM BIOMAR, V16, P108, DOI 10.1158/1055-9965.EPI-06-0636; Ichikawa D, 2004, ANTICANCER RES, V24, P2477; Irahara N, 2010, J MOL DIAGN, V12, P177, DOI 10.2353/jmoldx.2010.090106; Jang SJ, 2001, CANCER RES, V61, P7959; Kim DH, 2003, CANCER RES, V63, P3743; Ksiaa F, 2009, CLIN CHIM ACTA, V404, P128, DOI 10.1016/j.cca.2009.03.044; Lai JC, 2005, INT J CANCER, V117, P974, DOI 10.1002/ijc.21278; Lee TL, 2002, CLIN CANCER RES, V8, P1761; Leung WK, 2005, BRIT J CANCER, V92, P2190, DOI 10.1038/sj.bjc.6602636; Lin CH, 2001, CANCER RES, V61, P4238; Marsit CJ, 2008, CANCER-AM CANCER SOC, V113, P1566, DOI 10.1002/cncr.23770; Marsit CJ, 2007, CARCINOGENESIS, V28, P1745, DOI 10.1093/carcin/bgm116; Moore LE, 2008, LANCET ONCOL, V9, P359, DOI 10.1016/S1470-2045(08)70038-X; Nakajima T, 2001, INT J CANCER, V94, P208, DOI 10.1002/ijc.1454; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Pattamadilok J, 2008, INT J GYNECOL CANCER, V18, P711, DOI 10.1111/j.1525-1438.2007.01117.x; Rosty C, 2002, AM J PATHOL, V160, P45, DOI 10.1016/S0002-9440(10)64347-7; Sato N, 2003, CANCER RES, V63, P4158; SAUER J, 2010, BR J NUTR, P24; Shiozawa E, 2006, LEUKEMIA RES, V30, P859, DOI 10.1016/j.leukres.2005.11.004; Tamura G, 2004, HISTOL HISTOPATHOL, V19, P221, DOI 10.14670/HH-19.221; Tang XM, 2000, JNCI-J NATL CANCER I, V92, P1511, DOI 10.1093/jnci/92.18.1511; Widschwendter M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002656; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Zazula M, 2006, DIAGN MOL PATHOL, V15, P24, DOI 10.1097/00019606-200603000-00004	43	26	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15585	10.1371/journal.pone.0015585	http://dx.doi.org/10.1371/journal.pone.0015585			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203466	gold, Green Published, Green Submitted			2022-12-27	WOS:000285579200024
J	Coppieters, K; Martinic, MM; Kiosses, WB; Amirian, N; von Herrath, M				Coppieters, Ken; Martinic, Marianne M.; Kiosses, William B.; Amirian, Natalie; von Herrath, Matthias			A Novel Technique for the In Vivo Imaging of Autoimmune Diabetes Development in the Pancreas by Two-Photon Microscopy	PLOS ONE			English	Article							DENDRITIC CELLS; TRANSGENIC MICE; IMMUNE-SYSTEM; REAL-TIME; TOLERANCE; MOUSE; ACCELERATION; INDUCTION; INFECTION; ISLETS	Type 1 diabetes (T1D) is characterized by the immune-mediated destruction of beta cells in the pancreas. Little is known about the in vivo dynamic interactions between T cells and beta cells or the kinetic behavior of other immune cell subsets in the pancreatic islets. Utilizing multiphoton microscopy we have designed a technique that allows for the real-time visualization of diabetogenic T cells and dendritic cells in pancreatic islets in a live animal, including their interplay with beta cells and the vasculature. Using a custom designed stage, the pancreas was surgically exposed under live conditions so that imaging of islets under intact blood pressure and oxygen supply became possible. We demonstrate here that this approach allows for the tracking of diabetogenic leukocytes as well as vascularization phenotype of islets and accumulation of dendritic cells in islets during diabetes pathogenesis. This technique should be useful in mapping crucial kinetic events in T1D pathogenesis and in testing the impact of immune based interventions on T cell migration, extravasation and islet destruction.	[Coppieters, Ken; Martinic, Marianne M.; Amirian, Natalie; von Herrath, Matthias] Ctr La Jolla Inst Allergy & Immunol, Type Diabet 1, La Jolla, CA USA; [Kiosses, William B.] Scripps Res Inst, Core Microscopy Facil, La Jolla, CA 92037 USA	Scripps Research Institute	Coppieters, K (corresponding author), Ctr La Jolla Inst Allergy & Immunol, Type Diabet 1, La Jolla, CA USA.	matthias@liai.org		Martinic, Marianne/0000-0003-4407-3423	Juvenile Diabetes Research Foundation [16-2007-370]	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	Juvenile Diabetes Research Foundation Scholar Award #16-2007-370. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanentalo T, 2010, DIABETES, V59, P1756, DOI 10.2337/db09-1400; Bertera S, 2003, BIOTECHNIQUES, V35, P718, DOI 10.2144/03354st01; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Bullen A, 2009, CURR TOP MICROBIOL, V334, P1, DOI 10.1007/978-3-540-93864-4_1; Cahalan MD, 2002, NAT REV IMMUNOL, V2, P872, DOI 10.1038/nri935; Calderon B, 2008, P NATL ACAD SCI USA, V105, P6121, DOI 10.1073/pnas.0801973105; Coppieters K, 2008, DIABETOLOGIA, V51, P2145, DOI 10.1007/s00125-008-1181-y; Coppieters Ken T, 2009, Rev Diabet Stud, V6, P85, DOI 10.1900/RDS.2009.6.85; Deguine J, 2010, IMMUNITY, V33, P632, DOI 10.1016/j.immuni.2010.09.016; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; HARADA M, 1984, DIABETOLOGIA, V27, P604, DOI 10.1007/BF00276978; HASKINS K, 1990, SCIENCE, V249, P1433, DOI 10.1126/science.2205920; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Martinic MM, 2008, IMMUNOL REV, V221, P200, DOI 10.1111/j.1600-065X.2008.00581.x; Martinic MM, 2010, J AUTOIMMUN, V35, P404, DOI 10.1016/j.jaut.2010.08.006; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Nyman LR, 2008, J CLIN INVEST, V118, P3790, DOI 10.1172/JCI36209; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Seewaldt S, 2000, DIABETES, V49, P1801, DOI 10.2337/diabetes.49.11.1801; Serreze DV, 2000, DIABETES, V49, P708, DOI 10.2337/diabetes.49.5.708; Speier S, 2008, NAT MED, V14, P574, DOI 10.1038/nm1701; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Villiger M, 2009, DIABETOLOGIA, V52, P1599, DOI 10.1007/s00125-009-1383-y; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; von Herrath M, 2009, NAT IMMUNOL, V10, P129, DOI 10.1038/ni0209-129; Willcox A, 2009, CLIN EXP IMMUNOL, V155, P173, DOI 10.1111/j.1365-2249.2008.03860.x	33	38	39	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15732	10.1371/journal.pone.0015732	http://dx.doi.org/10.1371/journal.pone.0015732			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203413	Green Submitted, Green Published, gold			2022-12-27	WOS:000285579200033
J	Voss, HU; Salgado-Commissariat, D; Helekar, SA				Voss, Henning U.; Salgado-Commissariat, Delanthi; Helekar, Santosh A.			Altered Auditory BOLD Response to Conspecific Birdsong in Zebra Finches with Stuttered Syllables	PLOS ONE			English	Article							WHITE-CROWNED SPARROW; GENE-EXPRESSION; BENGALESE FINCHES; CONTROL-SYSTEM; SONG; BRAIN; FOREBRAIN; NEURONS; SPEECH; ACTIVATION	How well a songbird learns a song appears to depend on the formation of a robust auditory template of its tutor's song. Using functional magnetic resonance neuroimaging we examine auditory responses in two groups of zebra finches that differ in the type of song they sing after being tutored by birds producing stuttering-like syllable repetitions in their songs. We find that birds that learn to produce the stuttered syntax show attenuated blood oxygenation level-dependent (BOLD) responses to tutor's song, and more pronounced responses to conspecific song primarily in the auditory area field L of the avian forebrain, when compared to birds that produce normal song. These findings are consistent with the presence of a sensory song template critical for song learning in auditory areas of the zebra finch forebrain. In addition, they suggest a relationship between an altered response related to familiarity and/or saliency of song stimuli and the production of variant songs with stuttered syllables.	[Voss, Henning U.] Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Voss, Henning U.] Weill Cornell Med Coll, Biomed Imaging Ctr, Citigrp, New York, NY USA; [Salgado-Commissariat, Delanthi; Helekar, Santosh A.] Methodist Hosp, Res Inst, Dept Neurol, Speech & Language Ctr, Houston, TX 77030 USA; [Helekar, Santosh A.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Cornell University; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston; Baylor College of Medicine	Voss, HU (corresponding author), Weill Cornell Med Coll, Dept Radiol, New York, NY USA.	sahelekar@tmhs.org	Voss, Henning/C-2194-2009	Voss, Henning/0000-0003-2811-2074	M. R. Bauer Foundation; NIH [DC04778-01A1, MH073900-01]; Institute for Biomedical Imaging Sciences (IBIS), Houston, Texas; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH073900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC004778] Funding Source: NIH RePORTER	M. R. Bauer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Biomedical Imaging Sciences (IBIS), Houston, Texas; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the M. R. Bauer Foundation, NIH Grant DC04778-01A1 (SAH), NIH Grant MH073900-01 (SAH), and the Institute for Biomedical Imaging Sciences (IBIS), Houston, Texas (HUV and SAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARDILA A, 1986, BRAIN LANG, V27, P239, DOI 10.1016/0093-934X(86)90018-0; BIJLEVELD H, 1994, FOLIA PHONIATR LOGO, V46, P250, DOI 10.1159/000266323; Bolhuis JJ, 2001, EUR J NEUROSCI, V13, P2165, DOI 10.1046/j.0953-816x.2001.01588.x; Bolhuis JJ, 2000, P NATL ACAD SCI USA, V97, P2282, DOI 10.1073/pnas.030539097; BONKE BA, 1979, CELL TISSUE RES, V200, P101; Brown S, 2005, HUM BRAIN MAPP, V25, P105, DOI 10.1002/hbm.20140; Cardin JA, 2003, J NEUROPHYSIOL, V90, P2884, DOI 10.1152/jn.00391.2003; Chang SE, 2009, NEUROIMAGE, V46, P201, DOI 10.1016/j.neuroimage.2009.01.066; Cosyns M, 2010, J FLUENCY DISORD, V35, P235, DOI 10.1016/j.jfludis.2010.05.001; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; De Nil LF, 2008, BRAIN LANG, V107, P114, DOI 10.1016/j.bandl.2008.07.003; Deregnaucourt S, 2005, NATURE, V433, P710, DOI 10.1038/nature03275; DOUPE AJ, 1991, P NATL ACAD SCI USA, V88, P11339, DOI 10.1073/pnas.88.24.11339; Doupe AJ, 1997, J NEUROSCI, V17, P1147; Espino GG, 2003, NEUROSCIENCE, V122, P521, DOI 10.1016/S0306-4522(03)00549-9; Fox PT, 2000, BRAIN, V123, P1985, DOI 10.1093/brain/123.10.1985; Funabiki Y, 2003, J NEUROSCI, V23, P6928; Gentner TQ, 2006, NATURE, V440, P1204, DOI 10.1038/nature04675; Gobes SMH, 2007, CURR BIOL, V17, P789, DOI 10.1016/j.cub.2007.03.059; Helekar SA, 2003, BEHAV NEUROSCI, V117, P939, DOI 10.1037/0735-7044.117.5.939; Hosino T, 2000, NEUROREPORT, V11, P2091, DOI 10.1097/00001756-200007140-00007; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Jin H, 1997, NEURON, V19, P1049, DOI 10.1016/S0896-6273(00)80396-7; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9645, DOI 10.1073/pnas.1733998100; LEBRUN Y, 1990, J FLUENCY DISORD, V15, P251, DOI 10.1016/0094-730X(90)90040-Y; Lee J.H., 2010, NATURE; Liotti M, 2010, BRAIN LANG, V115, P141, DOI 10.1016/j.bandl.2010.07.007; Logothetis NK, 2003, J NEUROSCI, V23, P3963; MARGOLIASH D, 1992, J NEUROSCI, V12, P4309; MARGOLIASH D, 1986, J NEUROSCI, V6, P1643; Maul KK, 2010, DEV NEUROBIOL, V70, P28, DOI 10.1002/dneu.20751; MELLO CV, 1994, J NEUROSCI, V14, P6652; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; MULLER CM, 1985, EXP BRAIN RES, V59, P587; Northoff G, 2007, NAT NEUROSCI, V10, P1515, DOI 10.1038/nn2001; Okanoya K, 1997, J NEUROBIOL, V33, P343; Periaswamy S, 2003, IEEE T MED IMAGING, V22, P865, DOI 10.1109/TMI.2003.815069; Phan ML, 2006, P NATL ACAD SCI USA, V103, P1088, DOI 10.1073/pnas.0510136103; Pinaud R, 2008, J NEUROPHYSIOL; Poirier C, 2008, NEUROIMAGE, V41, P1, DOI 10.1016/j.neuroimage.2008.01.069; Ribeiro S, 1998, NEURON, V21, P359, DOI 10.1016/S0896-6273(00)80545-0; ROSENFIELD DB, 1991, SPEECH MOTOR CONTROL; Soha JA, 2001, J COMP PSYCHOL, V115, P172, DOI 10.1037//0735-7036.115.2.172; Tabelow K, 2006, NEUROIMAGE, V33, P55, DOI 10.1016/j.neuroimage.2006.06.029; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Terleph TA, 2006, J NEUROBIOL, V66, P281, DOI 10.1002/neu.20219; Van Meir V, 2005, NEUROIMAGE, V25, P1242, DOI 10.1016/j.neuroimage.2004.12.058; VICARIO DS, 1993, J NEUROBIOL, V24, P488, DOI 10.1002/neu.480240407; Voss HU, 2007, P NATL ACAD SCI USA, V104, P10667, DOI 10.1073/pnas.0611515104; Voss HU, 2006, MAGN RESON IMAGING, V24, P231, DOI 10.1016/j.mri.2005.12.007; Watkins KE, 2008, BRAIN, V131, P50, DOI 10.1093/brain/awm241; WILLIAMS H, 1985, SCIENCE, V229, P279, DOI 10.1126/science.4012321; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	53	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e14415	10.1371/journal.pone.0014415	http://dx.doi.org/10.1371/journal.pone.0014415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203446	Green Published, Green Submitted, gold			2022-12-27	WOS:000285579200003
J	Lee, PS; Wilhelmson, ASK; Hubner, AP; Reynolds, SB; Gallacchi, DA; Chiou, TT; Kwiatkowski, DJ				Lee, Po-Shun; Wilhelmson, Anna S. K.; Hubner, Anton P.; Reynolds, Samuel B.; Gallacchi, Dana A.; Chiou, Terry T.; Kwiatkowski, David J.			mTORC1-S6K Activation by Endotoxin Contributes to Cytokine Up-Regulation and Early Lethality in Animals	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MAMMALIAN TARGET; TUBEROUS SCLEROSIS; MTOR; RAPAMYCIN; PATHWAY; INHIBITION; CANCER; TSC1; INFLAMMATION	Background: mTORC1 (mammalian target of rapamycin complex 1) activation has been demonstrated in response to endotoxin challenge, but the mechanism and significance are unclear. We investigated the effect of mTORC1 suppression in an animal model of endotoxemia and in a cellular model of endotoxin signaling. Methodology/Principal Findings: Mice were treated with the mTORC1 inhibitor rapamycin or vehicle prior to lethal endotoxin challenge. Mortality and cytokine levels were assessed. Cultured macrophage-like cells were challenged with endotoxin with or without inhibitors of various pathways known to be upstream of mTORC1. Activated pathways, including downstream S6K pathway, were assessed by immunoblots. We found that mTORC1-S6K suppression by rapamycin delayed mortality of mice challenged with lethal endotoxin, and was associated with dampened circulating levels of VEGF, IL-1 beta, IFN-gamma and IL-5. Furthermore, in vitro cellular studies demonstrated that LPS (lipopolysaccharide) activation of mTORC1-S6K still occurs in the presence of PI3K-Akt inhibition alone, but can be suppressed by concurrent inhibition of PI3K-Akt and MEKERK pathways. Conclusions/Significance: We conclude that cellular activation of mTORC1-S6K contributes to cytokine up-regulation and mortality in response to endotoxin, and may occur via multiple pathways.	[Lee, Po-Shun; Reynolds, Samuel B.; Gallacchi, Dana A.; Chiou, Terry T.; Kwiatkowski, David J.] Brigham & Womens Hosp, Translat Med Div, Boston, MA 02115 USA; [Lee, Po-Shun; Kwiatkowski, David J.] Harvard Univ, Sch Med, Boston, MA USA; [Wilhelmson, Anna S. K.] Univ Gothenburg, Wallenberg Lab Cardiovasc Res, Gothenburg, Sweden; [Wilhelmson, Anna S. K.; Hubner, Anton P.] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Gothenburg; University of Gothenburg	Lee, PS (corresponding author), Brigham & Womens Hosp, Translat Med Div, 75 Francis St, Boston, MA 02115 USA.	plee@rics.bwh.harvard.edu	Wilhelmson, Anna S/HCI-9867-2022	Wilhelmson, Anna S/0000-0003-0640-0251	American Heart Association [0735620N]; National Institutes of Health/National Cancer Institute (NIH/NCI) [1P01CA120964]; NATIONAL CANCER INSTITUTE [P01CA120964] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health/National Cancer Institute (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by American Heart Association Scientist Development Grant 0735620N (PSL) and National Institutes of Health/National Cancer Institute (NIH/NCI) 1P01CA120964 (DJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballou Lisa M, 2008, J Chem Biol, V1, P27, DOI 10.1007/s12154-008-0003-5; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Delgoffe GM, 2009, IMMUNOLOGY, V127, P459, DOI 10.1111/j.1365-2567.2009.03125.x; DUNNE A, 2003, SCI STKE, pRE3, DOI DOI 10.1126/STKE.2003.171.RE3; El-Hashemite N, 2003, CANCER RES, V63, P5173; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Kimball SR, 2003, AM J PHYSIOL-ENDOC M, V285, pE637, DOI 10.1152/ajpendo.00340.2002; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Lorne E, 2009, AM J RESP CELL MOL, V41, P237, DOI 10.1165/rcmb.2008-0290OC; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Ohtani M, 2008, BLOOD, V112, P635, DOI 10.1182/blood-2008-02-137430; Peschon JJ, 1998, J IMMUNOL, V160, P943; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Schmitz F, 2008, EUR J IMMUNOL, V38, P2981, DOI 10.1002/eji.200838761; Thickett DR, 2001, AM J RESP CRIT CARE, V164, P1601, DOI 10.1164/ajrccm.164.9.2011071; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Weichhart T, 2009, TRENDS IMMUNOL, V30, P218, DOI 10.1016/j.it.2009.02.002; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yano K, 2006, J EXP MED, V203, P1447, DOI 10.1084/jem.20060375; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222	27	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e14399	10.1371/journal.pone.0014399	http://dx.doi.org/10.1371/journal.pone.0014399			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21200439	gold, Green Published, Green Submitted			2022-12-27	WOS:000285576900013
J	Vento, MT; Zazzu, V; Loffreda, A; Cross, JR; Downward, J; Stoppelli, MP; Iaccarino, I				Vento, Maria Teresa; Zazzu, Valeria; Loffreda, Alessia; Cross, Justin R.; Downward, Julian; Stoppelli, Maria Patrizia; Iaccarino, Ingram			Praf2 Is a Novel Bcl-xL/Bcl-2 Interacting Protein with the Ability to Modulate Survival of Cancer Cells	PLOS ONE			English	Article							BCL-X-L; ANTI-APOPTOTIC ACTIVITY; ENDOPLASMIC-RETICULUM; MAMMALIAN OLIGOSACCHARYLTRANSFERASE; MITOCHONDRIAL-MEMBRANE; REGULATES APOPTOSIS; FAMILY PROTEINS; MEMBER-2 PRAF2; DOMAIN FAMILY; CYTOCHROME-C	Increased expression of Bcl-xL in cancer has been shown to confer resistance to a broad range of apoptotic stimuli and to modulate a number of other aspects of cellular physiology, including energy metabolism, cell cycle, autophagy, mitochondrial fission/fusion and cellular adhesion. However, only few of these activities have a mechanistic explanation. Here we used Tandem Affinity purification to identify novel Bcl-xL interacting proteins that could explain the pleiotropic effects of Bcl-xL overexpression. Among the several proteins co-purifying with Bcl-xL, we focused on Praf2, a protein with a predicted role in trafficking. The interaction of Praf2 with Bcl-xL was found to be dependent on the transmembrane domain of Bcl-xL. We found that Bcl-2 also interacts with Praf2 and that Bcl-xL and Bcl-2 can interact also with Arl6IP5, an homologue of Praf2. Interestingly, overexpression of Praf2 results in the translocation of Bax to mitochondria and the induction of apoptotic cell death. Praf2 dependent cell death is prevented by the co-transfection of Bcl-xL but not by its transmembrane domain deleted mutant. Accordingly, knock-down of Praf2 increases clonogenicity of U2OS cells following etoposide treatment by reducing cell death. In conclusion a screen for Bcl-xL-interacting membrane proteins let us identify a novel proapoptotic protein whose activity is strongly counteracted exclusively by membrane targeted Bcl-xL.	[Vento, Maria Teresa; Zazzu, Valeria; Loffreda, Alessia; Stoppelli, Maria Patrizia; Iaccarino, Ingram] CNR, Inst Genet & Biophys Adriano Buzzati Traverso, I-80125 Naples, Italy; [Cross, Justin R.; Downward, Julian] London Res Inst, Signal Transduct Lab, London, England	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR)	Vento, MT (corresponding author), CNR, Inst Genet & Biophys Adriano Buzzati Traverso, I-80125 Naples, Italy.	ingram@igb.cnr.it	Downward, Julian/A-3251-2012; Iaccarino, Ingram/B-9086-2015	Iaccarino, Ingram/0000-0001-7324-993X; Cross, Justin/0000-0002-6356-057X; Zazzu, Valeria/0000-0003-0528-8472; Downward, Julian/0000-0002-2331-4729; Loffreda, Alessia/0000-0003-4523-5666	Association for International Cancer Research [05-0416]; European Science Foundation (ESF), Eurocore Network on Membrane Architecture and Dynamics [LSHC-CT-2003-503297]	Association for International Cancer Research; European Science Foundation (ESF), Eurocore Network on Membrane Architecture and Dynamics(European Science Foundation (ESF))	This work was supported by the Association for International Cancer Research, Grant Ref.: 05-0416 (http://www.aicr.org.uk/index.stm), and the European Science Foundation (ESF), Eurocore Network on Membrane Architecture and Dynamics, Contract n.LSHC-CT-2003-503297, to M. P. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani M, 2001, J BIOL CHEM, V276, P6225, DOI 10.1074/jbc.M009073200; Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Amundson SA, 2000, CANCER RES, V60, P6101; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Berman SB, 2009, J CELL BIOL, V184, P707, DOI 10.1083/jcb.200809060; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Cross JR, 2008, CELL DEATH DIFFER, V15, P997, DOI 10.1038/cdd.2008.14; Denis GV, 2003, J BIOL CHEM, V278, P5775, DOI 10.1074/jbc.M210202200; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Dong Z, 2004, J BIOL CHEM, V279, P9215, DOI 10.1074/jbc.M312225200; Du YCN, 2007, PLOS BIOL, V5, P2255, DOI 10.1371/journal.pbio.0050276; Edinger AL, 2003, DEV CELL, V5, P571, DOI 10.1016/S1534-5807(03)00291-0; Feral CC, 2005, P NATL ACAD SCI USA, V102, P355, DOI 10.1073/pnas.0404852102; Fernandez Y, 2000, CELL DEATH DIFFER, V7, P350, DOI 10.1038/sj.cdd.4400662; Fo CS, 2006, GENE, V371, P154, DOI 10.1016/j.gene.2005.12.009; Geerts D, 2007, CLIN CANCER RES, V13, P6312, DOI 10.1158/1078-0432.CCR-07-0829; Geng JM, 2005, EUKARYOT CELL, V4, P1166, DOI 10.1128/EC.4.7.1166-1174.2005; Hajek P, 2007, J BIOL CHEM, V282, P5670, DOI 10.1074/jbc.M608168200; Hauptmann P, 2006, MOL MICROBIOL, V59, P765, DOI 10.1111/j.1365-2958.2005.04981.x; Heiden MGV, 2001, J BIOL CHEM, V276, P19414, DOI 10.1074/jbc.M101590200; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Iaccarino I, 2003, CELL DEATH DIFFER, V10, P599, DOI 10.1038/sj.cdd.4401211; Jeong SY, 2004, EMBO J, V23, P2146, DOI 10.1038/sj.emboj.7600225; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Kelleher DJ, 1997, P NATL ACAD SCI USA, V94, P4994, DOI 10.1073/pnas.94.10.4994; Kuo TH, 1998, ONCOGENE, V17, P1903, DOI 10.1038/sj.onc.1202110; Li C, 2002, P NATL ACAD SCI USA, V99, P9830, DOI 10.1073/pnas.152571899; Li H, 2008, P NATL ACAD SCI USA, V105, P2169, DOI 10.1073/pnas.0711647105; Li LY, 2001, J BIOL CHEM, V276, P27354, DOI 10.1074/jbc.M103821200; Makishima T, 2000, J BIOCHEM-TOKYO, V128, P399, DOI 10.1093/oxfordjournals.jbchem.a022767; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; Martin SS, 2004, ONCOGENE, V23, P4641, DOI 10.1038/sj.onc.1207595; Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200; Minn AJ, 1999, EMBO J, V18, P632, DOI 10.1093/emboj/18.3.632; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; OReilly LA, 1996, EMBO J, V15, P6979, DOI 10.1002/j.1460-2075.1996.tb01090.x; Priault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008755; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rong YP, 2009, P NATL ACAD SCI USA, V106, P14397, DOI 10.1073/pnas.0907555106; Ruggiero AM, 2008, J BIOL CHEM, V283, P6175, DOI 10.1074/jbc.M701008200; Schweneker M, 2005, FEBS LETT, V579, P1751, DOI 10.1016/j.febslet.2005.02.037; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Simpson CD, 2009, CANCER RES, V69, P2739, DOI 10.1158/0008-5472.CAN-08-2530; Sivars U, 2003, NATURE, V425, P856, DOI 10.1038/nature02057; Tagami S, 2000, ONCOGENE, V19, P5736, DOI 10.1038/sj.onc.1203948; Vander Heiden MG, 2002, J BIOL CHEM, V277, P44870, DOI 10.1074/jbc.M204888200; Wan QW, 2007, APOPTOSIS, V12, P319, DOI 10.1007/s10495-006-0574-y; Wang GL, 2008, EXP CELL RES, V314, P1626, DOI 10.1016/j.yexcr.2008.01.028; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhu L, 2007, CELL BIOL INT, V31, P825, DOI 10.1016/j.cellbi.2007.01.032	56	33	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15636	10.1371/journal.pone.0015636	http://dx.doi.org/10.1371/journal.pone.0015636			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21203533	Green Submitted, gold, Green Published			2022-12-27	WOS:000285575200053
J	Mutnal, MB; Cheeran, MCJ; Hu, SX; Lokensgard, JR				Mutnal, Manohar B.; Cheeran, Maxim C-J.; Hu, Shuxian; Lokensgard, James R.			Murine Cytomegalovirus Infection of Neural Stem Cells Alters Neurogenesis in the Developing Brain	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; FLOW-CYTOMETRIC ANALYSIS; PROGENITOR CELLS; MOUSE-BRAIN; CEREBELLAR DEVELOPMENT; ADULT NEUROGENESIS; SIGNALING PROTEIN; EXPRESSION; DIFFERENTIATION; PRECURSORS	Background: Congenital cytomegalovirus (CMV) brain infection causes serious neuro-developmental sequelae including: mental retardation, cerebral palsy, and sensorineural hearing loss. But, the mechanisms of injury and pathogenesis to the fetal brain are not completely understood. The present study addresses potential pathogenic mechanisms by which this virus injures the CNS using a neonatal mouse model that mirrors congenital brain infection. This investigation focused on, analysis of cell types infected with mouse cytomegalovirus (MCMV) and the pattern of injury to the developing brain. Methodology/Principal Findings: We used our MCMV infection model and a multi-color flow cytometry approach to quantify the effect of viral infection on the developing brain, identifying specific target cells and the consequent effect on neurogenesis. In this study, we show that neural stem cells (NSCs) and neuronal precursor cells are the principal target cells for MCMV in the developing brain. In addition, viral infection was demonstrated to cause a loss of NSCs expressing CD133 and nestin. We also showed that infection of neonates leads to subsequent abnormal brain development as indicated by loss of CD24(hi) cells that incorporated BrdU. This neonatal brain infection was also associated with altered expression of Oct4, a multipotency marker; as well as down regulation of the neurotrophins BDNF and NT3, which are essential to regulate the birth and differentiation of neurons during normal brain development. Finally, we report decreased expression of doublecortin, a marker to identify young neurons, following viral brain infection. Conclusions: MCMV brain infection of newborn mice causes significant loss of NSCs, decreased proliferation of neuronal precursor cells, and marked loss of young neurons.	[Mutnal, Manohar B.; Hu, Shuxian; Lokensgard, James R.] Univ Minnesota, Dept Med, Neuroimmunol Lab, Ctr Infect Dis & Microbiol Translat Res, Minneapolis, MN 55455 USA; [Cheeran, Maxim C-J.] Univ Minnesota, Dept Vet Populat Med, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Mutnal, MB (corresponding author), Univ Minnesota, Dept Med, Neuroimmunol Lab, Ctr Infect Dis & Microbiol Translat Res, Box 736 UMHC, Minneapolis, MN 55455 USA.	loken006@umn.edu	Mutnal, Manohar B/K-4744-2012; Cheeran, Maxim C-J/C-2135-2009	Cheeran, Maxim C-J/0000-0002-5331-4746	National Institute of Neurological Disorders and Stroke [R01 NS-038836]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038836] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by Award Number R01 NS-038836 from the National Institute of Neurological Disorders and Stroke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; BALE JF, 1984, ARCH NEUROL-CHICAGO, V41, P310, DOI 10.1001/archneur.1984.04050150092023; Barraud P, 2007, J NEUROSCI RES, V85, P250, DOI 10.1002/jnr.21116; Bates B, 1999, NAT NEUROSCI, V2, P115, DOI 10.1038/5669; Becroft D M, 1981, Perspect Pediatr Pathol, V6, P203; Belvindrah R, 2002, J NEUROSCI, V22, P3594; Brazel CY, 2005, AGING CELL, V4, P197, DOI 10.1111/j.1474-9726.2005.00158.x; Breau MA, 2006, DEVELOPMENT, V133, P1725, DOI 10.1242/dev.02346; Calaora V, 1996, NEUROSCIENCE, V73, P581, DOI 10.1016/0306-4522(96)00042-5; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Carson CT, 2006, NAT MED, V12, P1237, DOI 10.1038/nm1106-1237; Carter AR, 2002, J NEUROSCI, V22, P1316, DOI 10.1523/JNEUROSCI.22-04-01316.2002; Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08; Cheeran MCJ, 2008, J NEUROVIROL, V14, P437, DOI 10.1080/13550280802356845; Das S, 2008, J NEUROCHEM, V106, P1624, DOI 10.1111/j.1471-4159.2008.05511.x; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Fuchs BC, 2008, CANCER RES, V68, P2391, DOI 10.1158/0008-5472.CAN-07-2460; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Hall PE, 2006, STEM CELLS, V24, P2078, DOI 10.1634/stemcells.2005-0595; Herzenberg LA, 2002, CLIN CHEM, V48, P1819; HORAN PK, 1986, P NATL ACAD SCI USA, V83, P8361, DOI 10.1073/pnas.83.21.8361; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Koontz T, 2008, J EXP MED, V205, P423, DOI 10.1084/jem.20071489; Kosugi I, 2000, LAB INVEST, V80, P1373, DOI 10.1038/labinvest.3780145; Krathwohl MD, 2004, J INFECT DIS, V190, P216, DOI 10.1086/422008; Lawrence DMP, 2004, J VIROL, V78, P7319, DOI 10.1128/JVI.78.14.7319-7328.2004; Li JY, 2008, TRENDS NEUROSCI, V31, P146, DOI 10.1016/j.tins.2007.12.001; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; LUO MH, J VIROL, V84, P3528; Maric D, 2004, MOL NEUROBIOL, V30, P49, DOI 10.1385/MN:30:1:049; Murayama A, 2002, J NEUROSCI RES, V69, P837, DOI 10.1002/jnr.10339; Nieoullon V, 2005, MOL CELL NEUROSCI, V28, P462, DOI 10.1016/j.mcn.2004.10.007; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Panchision DM, 2007, STEM CELLS, V25, P1560, DOI 10.1634/stemcells.2006-0260; Peh GSL, 2009, STEM CELLS DEV, V18, P269, DOI 10.1089/scd.2008.0124; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Pruszak J, 2009, STEM CELLS, V27, P2928, DOI 10.1002/stem.211; Reuter JD, 2005, J VIROL, V79, P9527, DOI 10.1128/JVI.79.15.9527-9539.2005; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; Shinmura Y, 1997, ACTA NEUROPATHOL, V93, P551, DOI 10.1007/s004010050651; Sossey-Alaoui K, 1998, HUM MOL GENET, V7, P1327, DOI 10.1093/hmg/7.8.1327; STAGNO S, 1986, JAMA-J AM MED ASSOC, V256, P1904, DOI 10.1001/jama.256.14.1904; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Tirino V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003469; TSUTSUI Y, 1995, PATHOL INT, V45, P91, DOI 10.1111/j.1440-1827.1995.tb03428.x; Tsutsui Yoshihiro, 2009, Congenital Anomalies, V49, P47, DOI 10.1111/j.1741-4520.2009.00222.x; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; van den Pol AN, 1999, J NEUROSCI, V19, P10948, DOI 10.1523/JNEUROSCI.19-24-10948.1999; van den Pol AN, 2002, J VIROL, V76, P8842, DOI 10.1128/JVI.76.17.8842-8854.2002; Wiesner SM, 2009, CANCER RES, V69, P431, DOI 10.1158/0008-5472.CAN-08-1800	53	51	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16211	10.1371/journal.pone.0016211	http://dx.doi.org/10.1371/journal.pone.0016211			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249143	Green Submitted, gold, Green Published			2022-12-27	WOS:000286515000032
J	Lange, C; Brunswig-Spickenheier, B; Cappallo-Obermann, H; Eggert, K; Gehling, UM; Rudolph, C; Schlegelberger, B; Cornils, K; Zustin, J; Spiess, AN; Zander, AR				Lange, Claudia; Brunswig-Spickenheier, Baerbel; Cappallo-Obermann, Heike; Eggert, Katharina; Gehling, Ursula M.; Rudolph, Cornelia; Schlegelberger, Brigitte; Cornils, Kerstin; Zustin, Jozef; Spiess, Andrej-Nikolai; Zander, Axel R.			Radiation Rescue: Mesenchymal Stromal Cells Protect from Lethal Irradiation	PLOS ONE			English	Article							STEM-CELLS; BONE-MARROW; HEMATOPOIETIC RECONSTITUTION; MULTIORGAN FAILURE; THERAPY; MURINE; TRANSPLANTATION; RECOVERY; TISSUES; DISEASE	Background: Successful treatment of acute radiation syndromes relies on immediate supportive care. In patients with limited hematopoietic recovery potential, hematopoietic stem cell (HSC) transplantation is the only curative treatment option. Because of time consuming donor search and uncertain outcome we propose MSC treatment as an alternative treatment for severely radiation-affected individuals. Methods and Findings: Mouse mesenchymal stromal cells (mMSCs) were expanded from bone marrow, retrovirally labeled with eGFP (bulk cultures) and cloned. Bulk and five selected clonal mMSCs populations were characterized in vitro for their multilineage differentiation potential and phenotype showing no contamination with hematopoietic cells. Lethally irradiated recipients were i.v. transplanted with bulk or clonal mMSCs. We found a long-term survival of recipients with fast hematopoietic recovery after the transplantation of MSCs exclusively without support by HSCs. Quantitative PCR based chimerism analysis detected eGFP-positive donor cells in peripheral blood immediately after injection and in lungs within 24 hours. However, no donor cells in any investigated tissue remained long-term. Despite the rapidly disappearing donor cells, microarray and quantitative RT-PCR gene expression analysis in the bone marrow of MSC-transplanted animals displayed enhanced regenerative features characterized by (i) decreased proinflammatory, ECM formation and adhesion properties and (ii) boosted anti-inflammation, detoxification, cell cycle and anti-oxidative stress control as compared to HSC-transplanted animals. Conclusions: Our data revealed that systemically administered MSCs provoke a protective mechanism counteracting the inflammatory events and also supporting detoxification and stress management after radiation exposure. Further our results suggest that MSCs, their release of trophic factors and their HSC-niche modulating activity rescue endogenous hematopoiesis thereby serving as fast and effective first-line treatment to combat radiation-induced hematopoietic failure.	[Lange, Claudia; Brunswig-Spickenheier, Baerbel; Eggert, Katharina; Cornils, Kerstin; Zander, Axel R.] Univ Med Ctr Hamburg Eppendorf, Clin Stem Cell Transplantat, Dept Cell & Gene Therapy, Hamburg, Germany; [Cappallo-Obermann, Heike; Spiess, Andrej-Nikolai] Univ Med Ctr Hamburg Eppendorf, Dept Androl, Hamburg, Germany; [Gehling, Ursula M.] Univ Med Ctr Hamburg Eppendorf, Dept Hepatobiliary & Transplant Surg, Hamburg, Germany; [Rudolph, Cornelia; Schlegelberger, Brigitte] Hannover Med Sch, Inst Cell & Mol Pathol, D-3000 Hannover, Germany; [Zustin, Jozef] Univ Med Ctr Hamburg Eppendorf, Inst Osteopathol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf	Lange, C (corresponding author), Univ Med Ctr Hamburg Eppendorf, Clin Stem Cell Transplantat, Dept Cell & Gene Therapy, Hamburg, Germany.	cllange@uke.uni-hamburg.de	Spiess, Andrej-Nikolai/A-2941-2015	Spiess, Andrej-Nikolai/0000-0002-9630-4724	Federal Ministry of Education and Research, Germany [13N8904 (HyCelex)]; German Research Foundation (DFG)	Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the Federal Ministry of Education and Research, Germany (http://www.bmbf.de/en/index.php), grant number 13N8904 (HyCelex) and German Research Foundation (DFG, http://www.dfg.de/index.jsp) for the Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar S, 2007, STEM CELLS, V25, P1586, DOI 10.1634/stemcells.2006-0762; Anderson DJ, 2001, NAT MED, V7, P393, DOI 10.1038/86439; Bey E, 2010, WOUND REPAIR REGEN, V18, P50, DOI 10.1111/j.1524-475X.2009.00562.x; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chao NJ, 2007, EXP HEMATOL, V35, P24, DOI 10.1016/j.exphem.2007.01.008; Chapel A, 2003, J GENE MED, V5, P1028, DOI 10.1002/jgm.452; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Cornils K, 2009, MOL THER, V17, P131, DOI 10.1038/mt.2008.238; Dallas NA, 2008, CLIN CANCER RES, V14, P1931, DOI 10.1158/1078-0432.CCR-07-4478; DEXTER M, 1992, NATURE, V360, P709, DOI 10.1038/360709a0; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Drouet M, 2005, BONE MARROW TRANSPL, V35, P1201, DOI 10.1038/sj.bmt.1704970; Drouet M, 2010, INT J RADIAT BIOL, V86, P636, DOI 10.3109/09553001003789604; Ferrara J L, 1999, Biol Blood Marrow Transplant, V5, P347, DOI 10.1016/S1083-8791(99)70011-X; Fliedner TM, 2009, STEM CELLS, V27, P1205, DOI 10.1002/stem.16; Fliedner TM., 2001, MED MANAGEMENT RAD A; Fonsatti Ester, 2004, J Transl Med, V2, P18, DOI 10.1186/1479-5876-2-18; Francois S, 2006, STEM CELLS, V24, P1020, DOI 10.1634/stemcells.2005-0260; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Hayashi T, 2005, AM J MED, V118, P83, DOI 10.1016/j.amjmed.2004.06.045; Herodin F, 2005, EXP HEMATOL, V33, P1071, DOI 10.1016/j.exphem.2005.04.007; Huss R, 2000, STEM CELLS, V18, P252, DOI 10.1634/stemcells.18-4-252; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Koc ON, 2000, J CLIN ONCOL, V18, P307, DOI 10.1200/JCO.2000.18.2.307; Lange C, 1999, J HEMATOTH STEM CELL, V8, P335, DOI 10.1089/152581699320090; Lange C, 2007, J CELL PHYSIOL, V213, P18, DOI 10.1002/jcp.21081; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Li ZX, 2003, EXP HEMATOL, V31, P1206, DOI 10.1016/j.exphem.2003.08.008; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Remberger M, 2004, HAEMATOLOGICA, V89, P710; Rombouts WJC, 2003, LEUKEMIA, V17, P160, DOI 10.1038/sj.leu.2402763; Rudolph Cornelia, 2009, V506, P453, DOI 10.1007/978-1-59745-409-4_30; Serafini M, 2007, J EXP MED, V204, P129, DOI 10.1084/jem.20061115; SIMMONS PJ, 1987, NATURE, V328, P429, DOI 10.1038/328429a0; Togel FE, 2010, NAT REV NEPHROL, V6, P179, DOI 10.1038/nrneph.2009.229; Togel F, 2007, AM J PHYSIOL-RENAL, V292, pF1626, DOI 10.1152/ajprenal.00339.2006; Tolar J, 2007, STEM CELLS, V25, P371, DOI 10.1634/stemcells.2005-0620; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779	48	78	99	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e14486	10.1371/journal.pone.0014486	http://dx.doi.org/10.1371/journal.pone.0014486			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21245929	Green Published, gold, Green Submitted			2022-12-27	WOS:000286511200001
J	Singhal, R; Deng, XT; Chenchik, AA; Kandel, ES				Singhal, Ruchi; Deng, Xiaotao; Chenchik, Alex A.; Kandel, Eugene S.			Long-Distance Effects of Insertional Mutagenesis	PLOS ONE			English	Article							NF-KAPPA-B; RNA-POLYMERASE-II; GENE-THERAPY; HUMAN-CELLS; C-MYC; ACTIVATION; SYSTEM; VECTORS; SCID-X1; PROTEIN	Background: Most common systems of genetic engineering of mammalian cells are associated with insertional mutagenesis of the modified cells. Insertional mutagenesis is also a popular approach to generate random alterations for gene discovery projects. A better understanding of the interaction of the structural elements within an insertional mutagen and the ability of such elements to influence host genes at various distances away from the insertion site is a matter of considerable practical importance. Methodology/Principal Findings: We observed that, in the context of a lentiviral construct, a transcript, which is initiated at an internal CMV promoter/enhancer region and incorporates a splice donor site, is able to extend past a collinear viral LTR and trap exons of host genes, while the polyadenylation signal, which is naturally present in the LTR, is spliced out. Unexpectedly, when a vector, which utilizes this phenomenon, was used to produce mutants with elevated activity of NF-kappa B, we found mutants, which owed their phenotype to the effect of the insert on a gene located tens or even hundreds of kilobases away from the insertion site. This effect did not result from a CMV-driven transcript, but was sensitive to functional suppression of the insert. Interestingly, despite the long-distance effect, expression of loci most closely positioned to the insert appeared unaffected. Conclusions/Significance: We concluded that a polyadenylation signal in a retroviral LTR, when occurring within an intron, is an inefficient barrier against the formation of a hybrid transcript, and that a vector containing a strong enhancer may selectively affect the function of genes far away from its insertion site. These phenomena have to be considered when experimental or therapeutic transduction is performed. In particular, the long-distance effects of insertional mutagenesis bring into question the relevance of the lists of disease-associated retroviral integration targets, which did not undergo functional validation.	[Singhal, Ruchi; Kandel, Eugene S.] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA; [Deng, Xiaotao; Chenchik, Alex A.] Cellecta Inc, Mountain View, CA USA	Roswell Park Cancer Institute	Singhal, R (corresponding author), Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA.	eugenekandel@yahoo.com			National Cancer Institute [CA098176, CA137708, CA116060, CA132841]; NATIONAL CANCER INSTITUTE [R21CA116060, R21CA137708, K01CA098176, R43CA132841] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by the following grants from the National Cancer Institute: CA098176, CA137708, CA116060 and CA132841. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. XD and AAC are employees of Cellecta, Inc. and as such Cellecta, Inc. played a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Beck-Engeser GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-4; Dasgupta M, 2008, CELL CYCLE, V7, P2249, DOI 10.4161/cc.7.14.6310; Dong BH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003144; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Dye MJ, 2006, MOL CELL, V21, P849, DOI 10.1016/j.molcel.2006.01.032; Freundlieb S, 1999, J GENE MED, V1, P4, DOI 10.1002/(SICI)1521-2254(199901/02)1:1<4::AID-JGM4>3.0.CO;2-Y; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Kandel ES, 2005, P NATL ACAD SCI USA, V102, P6425, DOI 10.1073/pnas.0502463102; Kandel ES, 2002, MOL CELL, V10, P1495, DOI 10.1016/S1097-2765(02)00777-3; KANDEL ES, 2003, SIGNAL TRANSDUCERS A; Kichina JV, 2008, CELL CYCLE, V7, P2081, DOI 10.4161/cc.7.14.6598; Lengler J, 2005, ANAL BIOCHEM, V343, P116, DOI 10.1016/j.ab.2005.05.004; Li XX, 2000, P NATL ACAD SCI USA, V97, P10489, DOI 10.1073/pnas.160265197; Li XX, 1999, MOL CELL BIOL, V19, P4643; Lu T, 2009, P NATL ACAD SCI USA, V106, P16339, DOI 10.1073/pnas.0908560106; Matz Mikhail V, 2003, Methods Mol Biol, V221, P41; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Neugebauer KM, 2006, NAT STRUCT MOL BIOL, V13, P385, DOI 10.1038/nsmb0506-385; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Sathe SS, 2004, P NATL ACAD SCI USA, V101, P192, DOI 10.1073/pnas.0306812101; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; SWAIN A, 1993, J VIROL, V67, P6265, DOI 10.1128/JVI.67.10.6265-6269.1993; SWAIN A, 1992, SCIENCE, V255, P841, DOI 10.1126/science.1371365; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Zhang F, 2007, BLOOD, V110, P1448, DOI 10.1182/blood-2006-12-060814	29	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15832	10.1371/journal.pone.0015832	http://dx.doi.org/10.1371/journal.pone.0015832			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246045	gold, Green Published, Green Submitted			2022-12-27	WOS:000286511200017
J	Liu, SJ; Yao, L; Ding, DL; Zhu, HZ				Liu, Sijie; Yao, Lei; Ding, DongLin; Zhu, HuanZhang			CCL3L1 Copy Number Variation and Susceptibility to HIV-1 Infection: A Meta-Analysis	PLOS ONE			English	Article							GENETIC-VARIATION; AIDS SUSCEPTIBILITY; TRANSMISSION; PATHOGENESIS; FALSE; CCR5	Background: Although several studies have investigated whether CCL3L1 copy number variation (CNV) influences the risk of HIV-1 infection, there are still no clear conclusions. Therefore, we performed a meta-analysis using two models to generate a more robust estimate of the association between CCL3L1 CNV and susceptibility to HIV-1 infection. Methods: We divided the cases and controls into two parts as individuals with CCL3L1 gene copy number (GCN) above the population specific median copy number (PMN) and individuals with CCL3L1 GCN below PMN, respectively. Odds ratios (ORs) with 95% confidence intervals (95% CIs) were given for the main analysis. We also conducted stratified analyses by ethnicity, age group and sample size. Relevant literatures were searched through PubMed and ISI Web of Knowledge up to March 2010. Results: In total, 9 studies with 2434 cases and 4029 controls were included. ORs for the main analysis were 1.35 (95% CI, 1.02-1.78, model: GCN <= PMN Vs. GCN > PMN) and 1.70 (95% CI, 1.30-2.23, model: GCN < PMN Vs. GCN >= PMN), respectively. Either in stratified analysis, statistically significant results can be detected in some subgroups. Conclusions: Our analyses indicate that CCL3L1 CNV is associated with susceptibility to HIV-1 infection. A lower copy number is associated with an increased risk of HIV-1 infection, while a higher copy number is associated with reduced risk for acquiring HIV-1.	[Liu, Sijie; Yao, Lei; Ding, DongLin; Zhu, HuanZhang] Fudan Univ, State Key Lab Genet Engn, Inst Genet, Sch Life Sci, Shanghai 200433, Peoples R China	Fudan University	Liu, SJ (corresponding author), Fudan Univ, State Key Lab Genet Engn, Inst Genet, Sch Life Sci, Shanghai 200433, Peoples R China.	hzzhu@fudan.edu.cn			National Grand Program on Key Infectious Disease [2008ZX10001-006]; National Natural Science Funding of China [30972609]; Basic Science Key Program of Shanghai [08JC1401300]; National Talent Training Fund in Basic Research of China [J1030627]	National Grand Program on Key Infectious Disease; National Natural Science Funding of China(National Natural Science Foundation of China (NSFC)); Basic Science Key Program of Shanghai; National Talent Training Fund in Basic Research of China	This work was supported by National Grand Program on Key Infectious Disease (2008ZX10001-006), National Natural Science Funding of China (No. 30972609), Basic Science Key Program of Shanghai (No. 08JC1401300) and National Talent Training Fund in Basic Research of China (No. J1030627). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], DEATH TOLL AIDS HAS; Arenzana-Seisdedos F, 2006, SEMIN IMMUNOL, V18, P387, DOI 10.1016/j.smim.2006.07.007; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bhattacharya T, 2009, NAT MED, V15, P1112, DOI 10.1038/nm1009-1112; Bugeja MJ, 2004, AIDS, V18, P1069, DOI 10.1097/00002030-200404300-00017; Cochran WG, 1954, BIOMETRICS, V10, P29, DOI DOI 10.2307/3001666; Colobran R, 2010, CLIN EXP IMMUNOL, V162, P41, DOI 10.1111/j.1365-2249.2010.04224.x; Degenhardt JD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000346; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dolan MJ, 2007, NAT IMMUNOL, V8, P1324, DOI 10.1038/ni1521; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Gonzalez E, 2001, P NATL ACAD SCI USA, V98, P5199, DOI 10.1073/pnas.091056898; He WJ, 2009, NAT MED, V15, P1117, DOI 10.1038/nm1009-1117; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Huik K, 2010, J INFECT DIS, V201, P730, DOI 10.1086/650491; Ioannidis JPA, 2002, AM J EPIDEMIOL, V156, P204, DOI 10.1093/aje/kwf031; Ioannidis JPA, 2003, TRENDS MOL MED, V9, P135, DOI 10.1016/S1471-4914(03)00030-3; Julg B, 2005, INFECTION, V33, P160, DOI 10.1007/s15010-005-6305-4; Kaslow RA, 2005, J INFECT DIS, V191, pS68, DOI 10.1086/425269; Kaur G, 2009, TISSUE ANTIGENS, V73, P289, DOI 10.1111/j.1399-0039.2009.01220.x; Kuhn L, 2007, AIDS, V21, P1753, DOI 10.1097/QAD.0b013e3282ba553a; Kulkarni H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003165; Mackay CR, 2005, TRENDS MOL MED, V11, P203, DOI 10.1016/j.molmed.2005.03.003; MANTEL N, 1959, J NATL CANCER I, V22, P719; Meddows-Taylor S, 2006, J GEN VIROL, V87, P2055, DOI 10.1099/vir.0.81709-0; Modi WS, 2006, AM J HUM GENET, V79, P120, DOI 10.1086/505331; Moore JP, 2007, CELL HOST MICROBE, V2, P281, DOI 10.1016/j.chom.2007.10.005; Nakajima T, 2008, CYTOGENET GENOME RES, V123, P156, DOI 10.1159/000184703; Nakajima T, 2007, IMMUNOGENETICS, V59, P793, DOI 10.1007/s00251-007-0252-4; NCBI - Entrez Gene, CCL3L1 CHEM C C MOT; Rathore A, 2009, AIDS RES HUM RETROV, V25, P1149, DOI 10.1089/aid.2008.0019; Shalekoff S, 2008, JAIDS-J ACQ IMM DEF, V48, P245, DOI 10.1097/QAI.0b013e31816fdc77; Shao W, 2007, GENES IMMUN, V8, P224, DOI 10.1038/sj.gene.6364378; Shostakovich-Koretskaya L, 2009, AIDS, V23, P679, DOI 10.1097/QAD.0b013e3283270b3f; Shrestha S, 2009, NAT MED, V15, P1127, DOI 10.1038/nm1009-1127; Telenti A, 2006, NAT REV MICROBIOL, V4, P865, DOI 10.1038/nrmicro1532; Tobias A., 1999, STATA TECH B, V8; Urban TJ, 2009, NAT MED, V15, P1110, DOI 10.1038/nm1009-1110; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075	40	20	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15778	10.1371/journal.pone.0015778	http://dx.doi.org/10.1371/journal.pone.0015778			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209899	gold, Green Submitted, Green Published			2022-12-27	WOS:000285793600038
J	Maniti, O; Alves, I; Trugnan, G; Ayala-Sanmartin, J				Maniti, Ofelia; Alves, Isabel; Trugnan, Germain; Ayala-Sanmartin, Jesus			Distinct Behaviour of the Homeodomain Derived Cell Penetrating Peptide Penetratin in Interaction with Different Phospholipids	PLOS ONE			English	Article							POLYMORPHIC PHASE-BEHAVIOR; WAVE-GUIDE RESONANCE; SOLID-STATE NMR; LIPID-BILAYERS; ANTENNAPEDIA HOMEODOMAIN; MODEL MEMBRANES; 3RD HELIX; TRYPTOPHAN FLUORESCENCE; DEPENDENT TRANSLOCATION; ANTIMICROBIAL PEPTIDES	Background: Penetratin is a protein transduction domain derived from the homeoprotein Antennapedia. Thereby it is currently used as a cell penetrating peptide to introduce diverse molecules into eukaryotic cells, and it could also be involved in the cellular export of transcription factors. Moreover, it has been shown that it is able to act as an antimicrobial agent. The mechanisms involved in all these processes are quite controversial. Methodology/Principal Findings: In this article, we report spectroscopic, calorimetric and biochemical data on the penetratin interaction with three different phospholipids: phosphatidylcholine (PC) and phosphatidylethanolamine (PE) to mimic respectively the outer and the inner leaflets of the eukaryotic plasma membrane and phosphatidylglycerol (PG) to mimic the bacterial membrane. We demonstrate that with PC, penetratin is able to form vesicle aggregates with no major change in membrane fluidity and presents no well defined secondary structure organization. With PE, penetratin aggregates vesicles, increases membrane rigidity and acquires an alpha-helical structure. With PG membranes, penetratin does not aggregate vesicles but decreases membrane fluidity and acquires a structure with both alpha-helical and beta-sheet contributions. Conclusions/Significance: These data from membrane models suggest that the different penetratin actions in eukaryotic cells (membrane translocation during export and import) and on prokaryotes may result from different peptide and lipid structural arrangements. The data suggest that, for eukaryotic cell penetration, penetratin does not acquire classical secondary structure but requires a different conformation compared to that in solution.	[Maniti, Ofelia; Alves, Isabel; Ayala-Sanmartin, Jesus] CNRS, UMR 7203, Lab Biomol, Grp NJ Conte, Paris, France; [Maniti, Ofelia; Alves, Isabel; Trugnan, Germain; Ayala-Sanmartin, Jesus] Univ Paris 06, Paris, France; [Maniti, Ofelia; Alves, Isabel; Ayala-Sanmartin, Jesus] Ecole Normale Super, Dept Chim, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Maniti, O (corresponding author), CNRS, UMR 7203, Lab Biomol, Grp NJ Conte, Paris, France.	jesus.ayala-sanmartin@upmc.fr	Maniti, Ofélia/AAQ-5624-2021; Alves, Isabel D/R-9613-2016	Alves, Isabel D/0000-0003-3193-2436	ANR/Probdom; CNRS	ANR/Probdom(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	Funding was provided by ANR/Probdom and CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves ID, 2009, J PEPT SCI, V15, P200, DOI 10.1002/psc.1070; Andrushchenko VV, 2007, BBA-BIOMEMBRANES, V1768, P2447, DOI 10.1016/j.bbamem.2007.05.015; AYALA J, 1990, NEURON, V4, P797, DOI 10.1016/0896-6273(90)90206-U; Ayala-Sanmartin J, 2000, BIOCHEMISTRY-US, V39, P15179, DOI 10.1021/bi000501x; Bagatolli LA, 1999, PHOTOCHEM PHOTOBIOL, V70, P557, DOI 10.1562/0031-8655(1999)070<0557:AMFTIO>2.3.CO;2; Barcelo F, 2007, BIOPHYS J, V93, P2530, DOI 10.1529/biophysj.106.101196; Bellet-Amalric E, 2000, BBA-BIOMEMBRANES, V1467, P131, DOI 10.1016/S0005-2736(00)00218-2; Binder H, 2004, BIOPHYS J, V87, P332, DOI 10.1529/biophysj.103.034025; Binder H, 2003, BIOPHYS J, V85, P982, DOI 10.1016/S0006-3495(03)74537-8; Caesar CEB, 2006, BIOCHEMISTRY-US, V45, P7682, DOI 10.1021/bi052095t; CASAL HL, 1984, BIOCHIM BIOPHYS ACTA, V779, P381, DOI 10.1016/0304-4157(84)90017-0; Christiaens B, 2002, EUR J BIOCHEM, V269, P2918, DOI 10.1046/j.1432-1033.2002.02963.x; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Deshayes S, 2004, BIOCHEMISTRY-US, V43, P1449, DOI 10.1021/bi035682s; Dietz GPH, 2004, MOL CELL NEUROSCI, V27, P85, DOI 10.1016/j.mcn.2004.03.005; Drin G, 2003, J BIOL CHEM, V278, P31192, DOI 10.1074/jbc.M303938200; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Epand RM, 2009, BBA-BIOMEMBRANES, V1788, P289, DOI 10.1016/j.bbamem.2008.08.023; Fischer R, 2005, CHEMBIOCHEM, V6, P2126, DOI 10.1002/cbic.200500044; Granjon T, 2001, BIOCHEMISTRY-US, V40, P6016, DOI 10.1021/bi002293e; Gray C, 1996, BIOPHYS J, V70, pWP269; Henriques ST, 2007, MOL MEMBR BIOL, V24, P282, DOI 10.1080/09687860601142936; Illien F, 2010, BBA-BIOMEMBRANES, V1798, P1790, DOI 10.1016/j.bbamem.2010.05.001; Jean-Francois F, 2008, BIOCHEMISTRY-US, V47, P6394, DOI 10.1021/bi800448h; Joanne P, 2009, BBA-BIOMEMBRANES, V1788, P1772, DOI 10.1016/j.bbamem.2009.05.001; JOLIOT A, 1991, P NATL ACAD SCI USA, V88, P1864, DOI 10.1073/pnas.88.5.1864; Laird DJ, 2009, BIOPHYS CHEM, V145, P72, DOI 10.1016/j.bpc.2009.09.002; Lamaziere A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001938; Lamaziere A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000201; Lamaziere A, 2010, BBA-BIOMEMBRANES, V1798, P2223, DOI 10.1016/j.bbamem.2009.12.024; Lamaziere Antonin, 2009, Commun Integr Biol, V2, P223; LEWIS RNAH, 1993, BIOPHYS J, V64, P1081, DOI 10.1016/S0006-3495(93)81474-7; LEWIS RNAH, 1994, BIOPHYS J, V67, P2367, DOI 10.1016/S0006-3495(94)80723-4; LONG FA, 1960, ANN NY ACAD SCI, V84, P596, DOI 10.1111/j.1749-6632.1960.tb39092.x; Mae M, 2006, CURR OPIN PHARMACOL, V6, P509, DOI 10.1016/j.coph.2006.04.004; Magzoub M, 2002, BBA-BIOMEMBRANES, V1563, P53, DOI 10.1016/S0005-2736(02)00373-5; Magzoub M, 2001, BBA-BIOMEMBRANES, V1512, P77, DOI 10.1016/S0005-2736(01)00304-2; Murriel Christopher L, 2006, Expert Opin Drug Deliv, V3, P739, DOI 10.1517/17425247.3.6.739; PARASASSI T, 1990, BIOPHYS J, V57, pA272; PARASASSI T, 1986, CELL MOL BIOL, V32, P103; PEREZ F, 1994, MOL ENDOCRINOL, V8, P1278, DOI 10.1210/me.8.9.1278; Persson D, 2004, BBA-BIOMEMBRANES, V1665, P142, DOI 10.1016/j.bbamem.2004.07.008; Persson D, 2004, BIOCHEMISTRY-US, V43, P11045, DOI 10.1021/bi036054d; Persson D, 2001, FEBS LETT, V505, P307, DOI 10.1016/S0014-5793(01)02843-5; Prochiantz A, 2000, CURR OPIN CELL BIOL, V12, P400, DOI 10.1016/S0955-0674(00)00108-3; Rothbard JB, 2004, J AM CHEM SOC, V126, P9506, DOI 10.1021/ja0482536; Salamon Z, 1997, BIOPHYS J, V73, P2791, DOI 10.1016/S0006-3495(97)78308-5; Salamon Z, 2004, BIOPHYS J, V86, P2508, DOI 10.1016/S0006-3495(04)74306-4; Salamon Z, 2003, BIOPHYS J, V84, P1796, DOI 10.1016/S0006-3495(03)74987-X; Shanmukh S, 2005, BIOPHYS CHEM, V113, P233, DOI 10.1016/j.bpc.2004.09.009; Su YC, 2008, J MOL BIOL, V381, P1133, DOI 10.1016/j.jmb.2008.06.007; Su Y, 2008, J AM CHEM SOC, V130, P8856, DOI 10.1021/ja802383t; Terrone D, 2003, BIOCHEMISTRY-US, V42, P13787, DOI 10.1021/bi035293y; Thoren PEG, 2000, FEBS LETT, V482, P265, DOI 10.1016/S0014-5793(00)02072-X; ZHANG YP, 1995, BIOPHYS J, V68, P847, DOI 10.1016/S0006-3495(95)80261-4; Zhu WL, 2009, CHEM BIOL DRUG DES, V73, P209, DOI 10.1111/j.1747-0285.2008.00769.x; Zibouche M, 2008, J BIOL CHEM, V283, P22121, DOI 10.1074/jbc.M801000200; Ziegler A, 2008, ADV DRUG DELIVER REV, V60, P580, DOI 10.1016/j.addr.2007.10.005	59	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15819	10.1371/journal.pone.0015819	http://dx.doi.org/10.1371/journal.pone.0015819			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209890	Green Submitted, Green Published, gold			2022-12-27	WOS:000285793600042
J	Sobotnik, J; Bourguignon, T; Hanus, R; Sillam-Dusses, D; Pflegerova, J; Weyda, F; Kutalova, K; Vytiskova, B; Roisin, Y				Sobotnik, Jan; Bourguignon, Thomas; Hanus, Robert; Sillam-Dusses, David; Pflegerova, Jitka; Weyda, Frantisek; Kutalova, Katerina; Vytiskova, Blahoslava; Roisin, Yves			Not Only Soldiers Have Weapons: Evolution of the Frontal Gland in Imagoes of the Termite Families Rhinotermitidae and Serritermitidae	PLOS ONE			English	Article							PRORHINOTERMES-SIMPLEX; MOLECULAR PHYLOGENY; ISOPTERA; MITOCHONDRIAL; SECRETIONS	Background: The frontal gland is a unique adaptation of advanced termite families. It has been intensively studied in soldiers with respect to its anatomy and chemistry, with numerous novel compounds being discovered within the tremendous richness of identified products. At the same time, the presence of the frontal gland in non-soldier castes received only negligible attention in the past. Principal Findings: Here, we report on the development of the frontal gland in alate imagoes of 10 genera and 13 species of Rhinotermitidae and Serritermitidae, in order to shed light on the evolution and function of this gland in imagoes. All investigated species possess a frontal gland. In most cases, it is well-developed and equipped with a sac-like reservoir, located in the postero-dorsal part of cranium, but reaching as far as the seventh abdominal segment in some Rhinotermitinae. The only exception is the genus Psammotermes, in which the gland is very small and devoid of the reservoir. Conclusions: Our direct observations and comparisons with soldiers suggest a defensive role of the gland in imagoes of all studied species. This functional analogy, along with the anatomic homology between the frontal gland in soldiers and imagoes, make it likely that the gland appeared once during the early evolution of rhinotermitid ancestors, and remained as a defensive organ of prime importance in both, soldiers and imagoes.	[Sobotnik, Jan; Hanus, Robert; Sillam-Dusses, David; Kutalova, Katerina] Acad Sci Czech Republic, Inst Organ Chem & Biochem, Res Team Infochem, Prague, Czech Republic; [Bourguignon, Thomas; Roisin, Yves] Univ Libre Bruxelles, Brussels, Belgium; [Pflegerova, Jitka; Weyda, Frantisek] Acad Sci Czech Republic, Inst Entomol, Ctr Biol, Dept Physiol, CR-37005 Ceske Budejovice, Czech Republic; [Kutalova, Katerina] Charles Univ Prague, Fac Sci, Prague, Czech Republic; [Vytiskova, Blahoslava] Univ Life Sci, Fac Forestry & Wood Sci, Dept Forest Protect & Game Management, Prague, Czech Republic	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Universite Libre de Bruxelles; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Charles University Prague; Czech University of Life Sciences Prague	Sobotnik, J (corresponding author), Acad Sci Czech Republic, Inst Organ Chem & Biochem, Res Team Infochem, Prague, Czech Republic.	robert@uochb.cas.cz	Hanus, Robert/D-4765-2013; Sillam-Dussès, David/AAI-5942-2021	Hanus, Robert/0000-0002-7054-1975; Roisin, Yves/0000-0001-6635-3552; Sobotnik, Jan/0000-0002-8581-637X; Bourguignon, Thomas/0000-0002-4035-8977; Sillam-Dusses, David/0000-0001-5027-8703	Czech Science Foundation [P506/10/1570]; Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague [Z4 055 0506]; National Fund for Scientific Research (F.R.S.-FNRS, Belgium); FRIA; French "Centre National de la Recherche Scientifique" [2ID]	Czech Science Foundation(Grant Agency of the Czech Republic); Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague(Czech Academy of Sciences); National Fund for Scientific Research (F.R.S.-FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); FRIA(Fonds de la Recherche Scientifique - FNRS); French "Centre National de la Recherche Scientifique"(Centre National de la Recherche Scientifique (CNRS))	This research was funded by the Czech Science Foundation (project No. P506/10/1570, www.gacr.cz), by the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague (project No. Z4 055 0506, www.uochb.cas.cz), by the National Fund for Scientific Research (F.R.S.-FNRS, Belgium, www.fnrs.be) through several travelling grants and a FRIA predoctoral fellowship to TB, and by the "Programme Amazonie II" of the French "Centre National de la Recherche Scientifique" (project 2ID, www.cnrs.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bordereau C, 1997, INSECT SOC, V44, P289, DOI 10.1007/s000400050049; Bugnion E., 1913, Revue Suisse de Zoologie, V21; Deligne J., 1981, SOCIAL INSECTS, VII, P1; Eggleton P, 1996, PHILOS T R SOC B, V351, P51, DOI 10.1098/rstb.1996.0004; EVANS DA, 1976, CHEM ECOLOGY ODOUR C, P213; Feytaud J., 1912, Archives d'Anatomie Microscopique, V13; HARE L, 1937, ANN ENTOMOLOGICAL SO, V30, P459; Holmgren N., 1909, KUNGLIGA SVENSKA VET, V44, P1; Inward DJG, 2007, MOL PHYLOGENET EVOL, V44, P953, DOI 10.1016/j.ympev.2007.05.014; Kuldova J, 1999, J CHEM ECOL, V25, P657, DOI 10.1023/A:1020918323678; Legendre F, 2008, MOL PHYLOGENET EVOL, V48, P615, DOI 10.1016/j.ympev.2008.04.017; LELIS AT, 1993, J MORPHOL, V217, P239, DOI 10.1002/jmor.1052170211; Lo N, 2004, INSECT SOC, V51, P365, DOI 10.1007/s00040-004-0759-8; MILL AE, 1983, PHYSIOL ENTOMOL, V8, P413, DOI 10.1111/j.1365-3032.1983.tb00375.x; Noirot C, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P121; NOIROT C, 1974, ANNU REV ENTOMOL, V19, P61, DOI 10.1146/annurev.en.19.010174.000425; Noirot Ch., 1969, P89; Nutting WL, 1969, BIOLOGY TERMITES, VI, P233; Ohkuma M, 2004, MOL PHYLOGENET EVOL, V31, P701, DOI 10.1016/j.ympev.2003.09.009; Piskorski R, 2009, BIOL J LINN SOC, V98, P384, DOI 10.1111/j.1095-8312.2009.01286.x; PRESTWICH GD, 1984, J CHEM ECOL, V10, P1219, DOI 10.1007/BF00988550; PRESTWICH GD, 1984, ANNU REV ENTOMOL, V29, P201, DOI 10.1146/annurev.en.29.010184.001221; Quennedy A., 1984, P151; Seid MA, 2008, CURR BIOL, V18, pR1049, DOI 10.1016/j.cub.2008.09.033; Sobotnik J, 2004, EUR J ENTOMOL, V101, P153, DOI 10.14411/eje.2004.020; Sobotnik Jan, 2003, Acta Societatis Zoologicae Bohemicae, V67, P83; Sobotnik J, 2010, J INSECT PHYSIOL, V56, P1012, DOI 10.1016/j.jinsphys.2010.02.012; Sobotnik J, 2010, NATURWISSENSCHAFTEN, V97, P495, DOI 10.1007/s00114-010-0664-0; Sobotnik J, 2010, BIOL J LINN SOC, V99, P839, DOI 10.1111/j.1095-8312.2010.01392.x	29	16	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15761	10.1371/journal.pone.0015761	http://dx.doi.org/10.1371/journal.pone.0015761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209882	gold, Green Published, Green Submitted			2022-12-27	WOS:000285793600034
J	Buchanan, J; Mihaylova, B; Gray, A; White, N				Buchanan, James; Mihaylova, Borislava; Gray, Alastair; White, Nicholas			Cost-Effectiveness of Pre-Referral Antimalarial, Antibacterial, and Combined Rectal Formulations for Severe Febrile Illness	PLOS ONE			English	Article							SEVERE FALCIPARUM-MALARIA; SEVERE PNEUMONIA; RANDOMIZED-TRIAL; NEUROLOGICAL SEQUELAE; CEREBRAL MALARIA; RISK-FACTORS; CHILDREN; MORTALITY; AFRICA; ARTESUNATE	Background: Malaria and bacterial infections account for most infectious disease deaths in developing countries. Prompt treatment saves lives, but rapid deterioration often prevents the use of oral therapies; delays in reaching health facilities providing parenteral interventions are common. Rapidly and reliably absorbed antimalarial/antibacterial rectal formulations used in the community could prevent deaths and disabilities. Rectal antimalarial treatments are currently available; rectal antibacterial treatments are yet to be developed. Assessment of the likely cost-effectiveness of these interventions will inform research priorities and implementation. Methods and Findings: The burden of malaria and bacterial infections worldwide and in Sub-Saharan and Southern Africa (SSA) and South and South-East Asia (SEA) was summarised using published data. The additional healthcare costs (US$) per death and per Disability Adjusted Life Year (DALY) avoided following pre-referral treatment of severe febrile illness with rectal antimalarials, antibacterials or combined antimalarial/antibacterials in populations at malaria risk in SSA/SEA were assessed. 46 million severe malaria and bacterial infections and 5 million deaths occur worldwide each year, mostly in SSA/SEA. At annual delivery costs of $0.02/capita and 100% coverage, rectal antimalarials ($2 per dose) would avert 240,000 deaths in SSA and 7,000 deaths in SEA at $5 and $177 per DALY avoided, respectively; rectal antibacterials ($2 per dose) would avert 130,000 deaths in SSA and 27,000 deaths in SEA at $19 and $97 per DALY avoided, respectively. Combined rectal formulations ($2.50 per dose) would avert 370,000 deaths in SSA and 33,000 deaths in SEA at $8 and $79 per DALY avoided, respectively, and are a cost-effective alternative to rectal antimalarials or antibacterials alone. Conclusions: Antimalarial, antibacterial and combined rectal formulations are likely to be cost-effective interventions for severe febrile illness in the community. Attention should focus on developing effective rectal antibacterials and ensuring that these lifesaving treatments are used in a cost-effective manner.	[Buchanan, James; Mihaylova, Borislava; Gray, Alastair] Univ Oxford, Dept Publ Hlth, Hlth Econ Res Ctr, Oxford, England; [White, Nicholas] Mahidol Univ, Fac Trop Med, Oxford, England; [White, Nicholas] Churchill Hosp, Ctr Trop Med, Oxford OX3 7LJ, England	University of Oxford; University of Oxford; University of Oxford	Buchanan, J (corresponding author), Univ Oxford, Dept Publ Hlth, Hlth Econ Res Ctr, Oxford, England.	boby.mihaylova@dphpc.ox.ac.uk	White, Nick/AAC-6527-2019; White, Nicholas J/I-4629-2012; Buchanan, James/H-7157-2019	White, Nick/0000-0002-1897-1978; Buchanan, James/0000-0003-2528-0638; Mihaylova, Borislava/0000-0002-0951-1304	Wellcome Trust [085242]; National Institute for Health Research [NF-SI-0509-10206] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This research was funded by a technology transfer grant (085242) from the Wellcome Trust: Reducing childhood mortality in the tropics; development of a combined antimalarial-antibacterial rectal formulation for community use. Preliminary scoping excercise. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GLOB BURD DIS 2004 U; [Anonymous], SECR WORLD POP PROSP; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Beyrer C, 2006, PLOS MED, V3, P1733, DOI 10.1371/journal.pmed.0030393; BREWSTER DR, 1990, LANCET, V336, P1039, DOI 10.1016/0140-6736(90)92498-7; Dash AP, 2008, J BIOSCIENCES, V33, P583, DOI 10.1007/s12038-008-0076-x; Department of Economic and Social Affairs, 2006, DEM YB; Dondorp AM, 2008, CLIN INFECT DIS, V47, P151, DOI 10.1086/589287; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Duke T, 2002, LANCET, V359, P474, DOI 10.1016/S0140-6736(02)07677-8; Faiz MA, 2005, LANCET, V366, P717; Gomes MF, 2009, LANCET, V373, P557, DOI 10.1016/S0140-6736(08)61734-1; Goodman C, 2000, EC ANAL MALARIA CONT; Goodman CA, 1999, LANCET, V354, P378, DOI 10.1016/S0140-6736(99)02141-8; Goodman CA, 2001, HEALTH ECON, V10, P731, DOI 10.1002/hec.621; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Hazir T, 2008, LANCET, V371, P49, DOI 10.1016/S0140-6736(08)60071-9; International Monetary Fund, 2009, WORLD EC OUTL SURV S; Jeena P, 2006, B WORLD HEALTH ORGAN, V84, P269; Kallander K, 2004, ACTA TROP, V90, P211, DOI 10.1016/j.actatropica.2003.11.013; Karyana M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-148; Kenya Medical Supplies Agency, 2008, TEND PRIC; Lim Y-W, 2006, TECHNICAL SUPPLEMENT; Lim Yee-Wei, 2006, Nature, V444 Suppl 1, P9, DOI 10.1038/nature05442; Lubell Y, 2008, BMJ-BRIT MED J, V336, P202, DOI 10.1136/bmj.39395.696065.47; Manzi F, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-165; Morel CM, 2005, BMJ-BRIT MED J, V331, P1299, DOI 10.1136/bmj.38639.702384.AE; Mulligan JA, 2006, TROP MED INT HEALTH, V11, P452, DOI 10.1111/j.1365-3156.2006.01590.x; Murphy SC, 2001, AM J TROP MED HYG, V64, P57, DOI 10.4269/ajtmh.2001.64.57; Neeraj D, 2010, LANCET; Njau JD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-4; Noedl H, 2009, TRENDS PARASITOL, V25, P540, DOI 10.1016/j.pt.2009.09.001; PrayGod G, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-210; Rudan I, 2004, B WORLD HEALTH ORGAN, V82, P895; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Scott JAG, 2000, LANCET, V355, P1225, DOI 10.1016/S0140-6736(00)02089-4; Shillcutt S, 2008, B WORLD HEALTH ORGAN, V86, P81; Shillcutt SD, 2009, PHARMACOECONOMICS, V27, P903, DOI 10.2165/10899580-000000000-00000; Sigauque B, 2009, J TROP PEDIATRICS, V55, P379, DOI 10.1093/tropej/fmp030; Sinha A, LANCET, V369, P389; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; Tediosi F, 2006, AM J TROP MED HYG, V75, P131, DOI 10.4269/ajtmh.2006.75.131; UNICEF W. H. O, 2006, PNEUM FORG KILL CHIL; United Nations Children's Fund (UNICEF), 2014, STATE WORLDS CHILDRE; *US DEP LAB, 2009, CONS PRIC IND; WHO, 2010, GUID TREATM MAL, V2nd; WHO, 2008, INT MAN CHILDH ILLN; WHO, 2012, MAN SEV MAL PRACT HD, V3; 2004, SOURC PRIC SEL PROD; WHO UNICEF, 2004, MAN PNEUM COMM SETT; *WORLD BANK, 1993, WORLD DEV REP; World Health Organisation, 2009, AC RESP INF CHILDR; World Health Organisation, 2009, WHO CHOICE; World Health Organization, 2008, WHO STAT INF SYST WH; World Health Organization, 2000, MAN CHILD SER INF SE; World Health Organization, 1996, INV HLTH RES DEV REP; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, 2008, WORLD MAL REP	58	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e14446	10.1371/journal.pone.0014446	http://dx.doi.org/10.1371/journal.pone.0014446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206901	Green Submitted, Green Published, gold			2022-12-27	WOS:000285793200004
J	Lieber, DS; Elemento, O; Tavazoie, S				Lieber, Daniel S.; Elemento, Olivier; Tavazoie, Saeed			Large-Scale Discovery and Characterization of Protein Regulatory Motifs in Eukaryotes	PLOS ONE			English	Article							LINEAR MOTIFS; GLOBAL ANALYSIS; SEQUENCE REQUIREMENTS; SYSTEMATIC DISCOVERY; INTERACTION NETWORKS; MASS-SPECTROMETRY; BUDDING YEAST; SITES; PHOSPHORYLATION; PEPTIDES	The increasing ability to generate large-scale, quantitative proteomic data has brought with it the challenge of analyzing such data to discover the sequence elements that underlie systems-level protein behavior. Here we show that short, linear protein motifs can be efficiently recovered from proteome-scale datasets such as sub-cellular localization, molecular function, half-life, and protein abundance data using an information theoretic approach. Using this approach, we have identified many known protein motifs, such as phosphorylation sites and localization signals, and discovered a large number of candidate elements. We estimate that similar to 80% of these are novel predictions in that they do not match a known motif in both sequence and biological context, suggesting that post-translational regulation of protein behavior is still largely unexplored. These predicted motifs, many of which display preferential association with specific biological pathways and non-random positioning in the linear protein sequence, provide focused hypotheses for experimental validation.	[Lieber, Daniel S.; Elemento, Olivier; Tavazoie, Saeed] Princeton Univ, Dept Mol Biol, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Princeton University	Lieber, DS (corresponding author), Princeton Univ, Dept Mol Biol, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	ole2001@med.cornell.edu; tavazoie@genomics.princeton.edu			NSF [2R01HG003219]; NIGMS [P50 GM071508]; NIH [1DP10D003787-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	ST was supported by grants from the NSF Career Award NHGRI (2R01HG003219), NIGMS (P50 GM071508), and the NIH Director's Pioneer Award (1DP10D003787-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN A, 1990, IDENTIFICATION PROTE; Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Benham AM, 2000, EMBO J, V19, P4493, DOI 10.1093/emboj/19.17.4493; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blobel G, 1979, Symp Soc Exp Biol, V33, P9; CHELSKY D, 1989, MOL CELL BIOL, V9, P2487, DOI 10.1128/MCB.9.6.2487; Cover T. M., 2006, ELEMENTS INFORM THEO, p[xxiii, 74]; Davey NE, 2006, NUCLEIC ACIDS RES, V34, P3546, DOI 10.1093/nar/gkl486; DENIS CL, 1991, J BIOL CHEM, V266, P17932; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Diella F, 2009, BIOINFORMATICS, V25, P1, DOI 10.1093/bioinformatics/btn594; Dinkel H, 2007, BIOINFORMATICS, V23, P3297, DOI 10.1093/bioinformatics/btm524; Edwards RJ, 2008, BIOINFORMATICS, V24, P1307, DOI 10.1093/bioinformatics/btn105; Edwards RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000967; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; GAVEL Y, 1990, PROTEIN ENG, V4, P33, DOI 10.1093/protein/4.1.33; Goodarzi H, 2009, MOL CELL, V36, P900, DOI 10.1016/j.molcel.2009.11.016; Gstaiger M, 2009, NAT REV GENET, V10, P617, DOI 10.1038/nrg2633; HALL MN, 1984, CELL, V36, P1057, DOI 10.1016/0092-8674(84)90055-2; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; HURT EC, 1987, J BIOL CHEM, V262, P1420; JONASSEN I, 1995, PROTEIN SCI, V4, P1587, DOI 10.1002/pro.5560040817; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; LAWRENCE CE, 1990, PROTEINS, V7, P41, DOI 10.1002/prot.340070105; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Neduva V, 2005, FEBS LETT, V579, P3342, DOI 10.1016/j.febslet.2005.04.005; Neduva V, 2006, CURR OPIN BIOTECH, V17, P465, DOI 10.1016/j.copbio.2006.08.002; Neduva V, 2006, NUCLEIC ACIDS RES, V34, pW350, DOI 10.1093/nar/gkl159; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Rao VD, 1998, CELL, V94, P829, DOI 10.1016/S0092-8674(00)81741-9; Remenyi A, 2006, CURR OPIN STRUC BIOL, V16, P676, DOI 10.1016/j.sbi.2006.10.008; Rigoutsos I, 1998, BIOINFORMATICS, V14, P55, DOI 10.1093/bioinformatics/14.1.55; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Russell RB, 2008, FEBS LETT, V582, P1271, DOI 10.1016/j.febslet.2008.02.027; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; Slonim N, 2005, P NATL ACAD SCI USA, V102, P18297, DOI 10.1073/pnas.0507432102; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; SUBRAMANI S, 1992, J MEMBRANE BIOL, V125, P99; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	50	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e14444	10.1371/journal.pone.0014444	http://dx.doi.org/10.1371/journal.pone.0014444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206902	Green Submitted, Green Published, gold			2022-12-27	WOS:000285793200002
J	Morgan, SG; Cunningham, CM; Hanley, GE				Morgan, Steven G.; Cunningham, Colleen M.; Hanley, Gillian E.			Individual and Contextual Determinants of Regional Variation in Prescription Drug Use: An Analysis of Administrative Data from British Columbia	PLOS ONE			English	Article							HEALTH-CARE; GEOGRAPHIC-VARIATION; BEHAVIORAL-MODEL; UNITED-STATES; MEDICAL-CARE; CANADA	Background: Increasing attention is being paid to variations in the use of prescription drugs because their role in health care has grown to the point where their use can be considered a proxy for health system performance. Studies have shown that prescription drug use varies across regions in the US, UK, and Canada by more than would be predicted based on age and health status alone. In this paper, we explore the determinants of variations in the use of prescription drugs, drawing on health services theories of access to care. Methods: We conducted a cross-sectional analysis using population-based administrative health care data for British Columbia (BC), Canada. We used logistic and hierarchical regressions to analyze the effects of individual-and area-level determinants of use of prescriptions overall and rates of purchase of prescriptions from five therapeutic categories representing a range of indications: antihypertensives, statins, acid reducing drugs, opioid drugs, and antidepressants. To indicate the relative scale of regional variations and the importance of individual-and area-level variables in explaining them, we computed standardized rates of utilization for 49 local health areas in BC. Results: We found that characteristics of individuals and the areas in which they live affect likelihood of prescription drug purchase. Individual-level factors influenced prescription drug purchases in ways generally consistent with behavioral models of health services use. Contextual variables exerted influences that differed by type of drug studied. Population health, education levels, and ethnic composition of local areas were associated with significant differences in the likelihood of purchasing medications. Relatively modest regional variations remained after both individual-level and area-level determinants were taken into account. Conclusions: The results of this study suggest that individual-and area-level factors should be considered when studying variations in the use of prescription drugs. Some sources of such variations, including individual-and area-level socioeconomic status, warrant further investigation and possible intervention to address inequities.	[Morgan, Steven G.; Cunningham, Colleen M.; Hanley, Gillian E.] Univ British Columbia, Ctr Hlth Serv & Policy Res, Vancouver, BC V5Z 1M9, Canada; [Morgan, Steven G.; Hanley, Gillian E.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Morgan, SG (corresponding author), Univ British Columbia, Ctr Hlth Serv & Policy Res, Vancouver, BC V5Z 1M9, Canada.	morgan@chspr.ubc.ca	Cunningham, Colleen/AAY-4357-2021; Morgan, Steven/J-8814-2015	Hanley, Gillian/0000-0001-9594-0545; Morgan, Steven/0000-0002-7529-0028	British Columbia Ministry of Health Services; Canadian Institutes of Health Research	British Columbia Ministry of Health Services; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This project was made possible through the financial support of the British Columbia Ministry of Health Services and an operating research grant from the Canadian Institutes of Health Research (www.CIHR.ca). The construction of the research database was supported, in part, by contributions of the Ministry of Health Services to the University of British Columbia Centre for Health Services and Policy Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aday L A, 1974, Health Serv Res, V9, P208; ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; *BC STATS, 2010, BC GDP IND; *BC STATS, 2009, PROF IMM; Birch S, 1993, Health Econ, V2, P87, DOI 10.1002/hec.4730020203; CHASSIN MR, 1987, JAMA-J AM MED ASSOC, V258, P2533, DOI 10.1001/jama.258.18.2533; *CIHI, 2010, DRUG EXP CAN 1985 20; Cox ER, 2003, PEDIATRICS, V111, P237, DOI 10.1542/peds.111.2.237; Dubois RW, 2002, HEALTH AFFAIR, V21, P240, DOI 10.1377/hlthaff.21.1.240; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Goyder Elizabeth, 2006, Int J Equity Health, V5, P4, DOI 10.1186/1475-9276-5-4; Hanley GE, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-79; LIPSITZ SR, 1994, BIOMETRICS, V50, P270, DOI 10.2307/2533218; Morgan S, 2004, CAN MED ASSOC J, V170, P329; Morgan S., 2005, CANADIAN RX ATLAS; MORGAN S, 2008, CANADIAN RX ATLAS; MORGAN S, 2005, BC RX ATLAS; MORGAN S, 2009, BC RX ATLAS; NEWBOLD KB, 1995, SOC SCI MED, V40, P1181, DOI 10.1016/0277-9536(94)00229-M; Phillips KA, 1998, HEALTH SERV RES, V33, P571; ROOS NP, 1986, AM J PUBLIC HEALTH, V76, P45, DOI 10.2105/AJPH.76.1.45; Sutherland JM, 2009, NEW ENGL J MED, V361, P1227, DOI 10.1056/NEJMp0907172; Ward Paul R, 2007, Int J Equity Health, V6, P2, DOI 10.1186/1475-9276-6-2; Watson D, 2009, ROAD RENEWAL MAPPING; WEINER JP, 1991, MED CARE, V29, P452, DOI 10.1097/00005650-199105000-00006; WENNBERG J, 1973, SCIENCE, V182, P1102, DOI 10.1126/science.182.4117.1102; ZHANG Y, 2010, NEW ENGLAND J MED	29	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15883	10.1371/journal.pone.0015883	http://dx.doi.org/10.1371/journal.pone.0015883			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	701CZ	21209960	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793200064
J	Conrady, DG; Flagler, MJ; Friedmann, DR; Wielen, BDV; Kovall, RA; Weiss, AA; Herr, AB				Conrady, Deborah G.; Flagler, Michael J.; Friedmann, David R.; Wielen, Bradley D. Vander; Kovall, Rhett A.; Weiss, Alison A.; Herr, Andrew B.			Molecular Basis of Differential B-Pentamer Stability of Shiga Toxins 1 and 2	PLOS ONE			English	Article							HEMOLYTIC-UREMIC-SYNDROME; ESCHERICHIA-COLI O157-H7; SECONDARY STRUCTURE; SHIGELLA DIARRHEA; MASS-SPECTROMETRY; HYBRID TOXINS; SUBUNIT; BINDING; PATHOGENESIS; SEDIMENTATION	Escherichia coli strain O157:H7 is a major cause of food poisoning that can result in severe diarrhea and, in some cases, renal failure. The pathogenesis of E. coli O157: H7 is in large part due to the production of Shiga toxin (Stx), an AB5 toxin that consists of a ribosomal RNA-cleaving A-subunit surrounded by a pentamer of receptor-binding B subunits. There are two major isoforms, Stx1 and Stx2, which differ dramatically in potency despite having 57% sequence identity. Animal studies and epidemiological studies show Stx2 is associated with more severe disease. Although the molecular basis of this difference is unknown, data suggest it is associated with the B-subunit. Mass spectrometry studies have suggested differential B-pentamer stability between Stx1 and Stx2. We have examined the relative stability of the B-pentamers in solution. Analytical ultracentrifugation using purified B-subunits demonstrates that Stx2B, the more deadly isoform, shows decreased pentamer stability compared to Stx1B (EC50 = 2.3 mu M vs. EC50 = 0.043 mu M for Stx1B). X-ray crystal structures of Stx1B and Stx2B identified a glutamine in Stx2 (versus leucine in Stx1) within the otherwise strongly hydrophobic interface between B-subunits. Interchanging these residues switches the stability phenotype of the B-pentamers of Stx1 and Stx2, as demonstrated by analytical ultracentrifugation and circular dichroism. These studies demonstrate a profound difference in stability of the B-pentamers in Stx1 and Stx2, illustrate the mechanistic basis for this differential stability, and provide novel reagents to test the basis for differential pathogenicity of these toxins.	[Conrady, Deborah G.; Flagler, Michael J.; Friedmann, David R.; Wielen, Bradley D. Vander; Kovall, Rhett A.; Weiss, Alison A.; Herr, Andrew B.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Conrady, DG (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA.	Rhett.Kovall@UC.edu; Alison.Weiss@UC.edu; Andrew.Herr@UC.edu	Herr, Andrew/R-3049-2019	Herr, Andrew/0000-0002-3598-3399; Weiss, Alison/0000-0002-4726-8376	NIH-NIAID [ROI-AI064893, U01-AI075498]; State of Ohio; Midwest Center for Emerging Infectious Diseases at the University of Cincinnati; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064893, U01AI075498] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); State of Ohio; Midwest Center for Emerging Infectious Diseases at the University of Cincinnati; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH-NIAID ROI-AI064893 and U01-AI075498 (AAW), funds from the State of Ohio Eminent Scholar Program (ABH), and a pilot grant from the Midwest Center for Emerging Infectious Diseases at the University of Cincinnati. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Asakura H, 2001, EPIDEMIOL INFECT, V127, P27, DOI 10.1017/S0950268801005635; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; BOYCE TG, 1995, NEW ENGL J MED, V333, P364, DOI 10.1056/NEJM199508103330608; Centers for Disease Control and Prevention, 2005, DIS LIST ENT E COLI; Conrady DG, 2008, P NATL ACAD SCI USA, V105, P19456, DOI 10.1073/pnas.0807717105; Correia JJ, 2009, METHOD ENZYMOL, V467, P135, DOI 10.1016/S0076-6879(09)67006-3; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DONOHUEROLFE A, 1984, J EXP MED, V160, P1767, DOI 10.1084/jem.160.6.1767; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; FRASER ME, 1994, NAT STRUCT BIOL, V1, P59, DOI 10.1038/nsb0194-59; Fraser ME, 2004, J BIOL CHEM, V279, P27511, DOI 10.1074/jbc.M401939200; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GILBERT GA, 1959, PROC R SOC LON SER-A, V250, P377, DOI 10.1098/rspa.1959.0070; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; HEAD SC, 1991, J BIOL CHEM, V266, P3617; JACEWICZ M, 1986, J EXP MED, V163, P1391, DOI 10.1084/jem.163.6.1391; Kitova EN, 2009, BIOCHEMISTRY-US, V48, P5365, DOI 10.1021/bi9003155; Kitova EN, 2005, J AM SOC MASS SPECTR, V16, P1957, DOI 10.1016/j.jasms.2005.07.016; KLEANTHOUS H, 1990, ARCH DIS CHILD, V65, P722, DOI 10.1136/adc.65.7.722; Kulkarni AA, 2010, BIOCONJUGATE CHEM, V21, P1486, DOI 10.1021/bc100095w; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JT, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-42; Ling H, 2000, STRUCTURE, V8, P253, DOI 10.1016/S0969-2126(00)00103-9; Lingwood CA, 1996, TRENDS MICROBIOL, V4, P147, DOI 10.1016/0966-842X(96)10017-2; Marcato P, 2003, INFECT IMMUN, V71, P6075, DOI 10.1128/IAI.71.10.6075-6078.2003; Mead PS, 1998, LANCET, V352, P1207, DOI 10.1016/S0140-6736(98)01267-7; MERRITT EA, 1995, CURR OPIN STRUC BIOL, V5, P165, DOI 10.1016/0959-440X(95)80071-9; Miyake M, 2000, ANAL BIOCHEM, V281, P202, DOI 10.1006/abio.2000.4559; NELSON S, 1994, INT CONGR SER, V1072, P245; Orth D, 2007, DIAGN MICR INFEC DIS, V59, P235, DOI 10.1016/j.diagmicrobio.2007.04.013; OSTROFF SM, 1989, J INFECT DIS, V160, P994, DOI 10.1093/infdis/160.6.994; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pina DG, 2008, FEBS LETT, V582, P185, DOI 10.1016/j.febslet.2007.11.086; Pina DG, 2006, BIOCHIMIE, V88, P1199, DOI 10.1016/j.biochi.2006.03.010; Pina DG, 2003, BIOCHEMISTRY-US, V42, P9498, DOI 10.1021/bi034591s; Proulx F, 2001, PEDIATR RES, V50, P163, DOI 10.1203/00006450-200108000-00002; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Siegler RL, 1995, PEDIATR CLIN N AM, V42, P1505; Siegler RL, 2003, PEDIATR NEPHROL, V18, P92, DOI 10.1007/s00467-002-1035-7; Slutsker L, 1997, ANN INTERN MED, V126, P505, DOI 10.7326/0003-4819-126-7-199704010-00002; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; TESH VL, 1993, INFECT IMMUN, V61, P3392, DOI 10.1128/IAI.61.8.3392-3402.1993; Tilden J, 1996, AM J PUBLIC HEALTH, V86, P1142, DOI 10.2105/AJPH.86.8_Pt_1.1142; Tomoda H, 2002, ANAL BIOCHEM, V311, P50, DOI 10.1016/S0003-2697(02)00380-9; WEINSTEIN DL, 1989, INFECT IMMUN, V57, P3743, DOI 10.1128/IAI.57.12.3743-3750.1989; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601	51	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15153	10.1371/journal.pone.0015153	http://dx.doi.org/10.1371/journal.pone.0015153			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203383	Green Submitted, Green Published, gold			2022-12-27	WOS:000285792500023
J	Kotchoni, SO; Jimenez-Lopez, JC; Gachomo, EW; Seufferheld, MJ				Kotchoni, Simeon O.; Jimenez-Lopez, Jose C.; Gachomo, Emma W.; Seufferheld, Manfredo J.			A New and Unified Nomenclature for Male Fertility Restorer (RF) Proteins in Higher Plants	PLOS ONE			English	Article							CYTOPLASMIC MALE-STERILITY; PENTATRICOPEPTIDE REPEAT PROTEIN; T-CYTOPLASM; GENE SUPERFAMILY; SWISS-MODEL; MITOCHONDRIAL; RNA; ACCUMULATION; ENVIRONMENT; DATABASE	The male fertility restorer (RF) proteins belong to extended protein families associated with the cytoplasmic male sterility in higher plants. Up till now, there is no devised nomenclature for naming the RF proteins. The systematic sequencing of new plant species in recent years has uncovered the existence of several novel RF genes and their encoded proteins. Their naming has been simply arbitrary and could not be adequately handled in the context of comparative functional genomics. We propose in this study a unified nomenclature for the RF extended protein families across all plant species. This new and unified nomenclature relies upon previously developed nomenclature for the first ever characterized RF gene, RF2A/ALDH2B2, a member of ALDH gene superfamily, and adheres to the guidelines issued by the ALDH Genome Nomenclature Committees. The proposed nomenclature reveals that RF gene superfamily encodes currently members of 51 families. This unified nomenclature accommodates functional RF genes and pseudogenes, and offers the flexibility needed to incorporate additional RFs as they become available in future. In addition, we provide a phylogenetic relationship between the RF extended families and use computational protein modeling to demonstrate the high divergence of RF functional specializations through specific structural features of selected members of RF superfamily.	[Kotchoni, Simeon O.] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA; [Jimenez-Lopez, Jose C.] CSIC, EEZ, Dept Biochem Cell & Mol Biol Plants, Granada, Spain; [Gachomo, Emma W.] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA; [Seufferheld, Manfredo J.] Univ Illinois UC, Dept Crop Sci, Urbana, IL USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Illinois System; University of Illinois Urbana-Champaign	Kotchoni, SO (corresponding author), Purdue Univ, Dept Agron, Lilly Hall, W Lafayette, IN 47907 USA.	skotchon@purdue.edu	Jimenez-Lopez, Jose C./H-5896-2011	Jimenez-Lopez, Jose C./0000-0002-1470-360X				Akagi H, 2004, THEOR APPL GENET, V108, P1449, DOI 10.1007/s00122-004-1591-2; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2004, CURR OPIN CHEM BIOL, V8, P76, DOI 10.1016/j.cbpa.2003.12.004; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bentolila S, 2002, P NATL ACAD SCI USA, V99, P10887, DOI 10.1073/pnas.102301599; Chase CD, 2004, MOLECULAR BIOLOGY AND BIOTECHNOLOGY OF PLANT ORGANELLES: CHLOROPLASTS AND MITOCHONDRIA, P593, DOI 10.1007/978-1-4020-3166-3_22; Chase CD, 2007, TRENDS GENET, V23, P81, DOI 10.1016/j.tig.2006.12.004; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Christen M, 2005, J COMPUT CHEM, V26, P1719, DOI 10.1002/jcc.20303; Cui XQ, 1996, SCIENCE, V272, P1334, DOI 10.1126/science.272.5266.1334; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; DEWEY RE, 1987, P NATL ACAD SCI USA, V84, P5374, DOI 10.1073/pnas.84.15.5374; Dill CL, 1997, GENETICS, V147, P1367; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gonzalez-Melendi P, 2008, J EXP BOT, V59, P827, DOI 10.1093/jxb/erm365; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; Kazama T, 2003, FEBS LETT, V544, P99, DOI 10.1016/S0014-5793(03)00480-0; KENNELL JC, 1987, MOL GEN GENET, V210, P399, DOI 10.1007/BF00327189; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; Kirch HH, 2004, TRENDS PLANT SCI, V9, P371, DOI 10.1016/j.tplants.2004.06.004; Kotchoni SO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011516; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; LASER KD, 1972, BOT REV, V38, P425, DOI 10.1007/BF02860010; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu F, 2001, PLANT CELL, V13, P1063, DOI 10.1105/tpc.13.5.1063; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Perozich J, 1999, PROTEIN SCI, V8, P137, DOI 10.1110/ps.8.1.137; PRING DR, 1989, ANNU REV PHYTOPATHOL, V27, P483; Schmitz-Linneweber C, 2005, PLANT CELL, V17, P2791, DOI 10.1105/tpc.105.034454; Schnable PS, 1998, TRENDS PLANT SCI, V3, P175, DOI 10.1016/S1360-1385(98)01235-7; Shi SL, 2010, PROTOPLASMA, V241, P37, DOI 10.1007/s00709-009-0100-5; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Skibbe David S., 2002, Plant Molecular Biology, V48, P751, DOI 10.1023/A:1014870429630; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Sophos NA, 2003, CHEM-BIOL INTERACT, V143, P5, DOI 10.1016/S0009-2797(02)00163-1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; ULLSTRUP AJ, 1972, ANNU REV PHYTOPATHOL, V10, P37, DOI 10.1146/annurev.py.10.090172.000345; Vasiliou V, 1999, PHARMACOGENETICS, V9, P421, DOI 10.1097/00008571-199910000-00004; Wise RP, 1996, GENETICS, V143, P1383; Wise RP, 1999, ADV AGRON, V65, P79, DOI 10.1016/S0065-2113(08)60911-6; Yoshida A, 1998, EUR J BIOCHEM, V251, P549, DOI 10.1046/j.1432-1327.1998.2510549.x	46	10	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15906	10.1371/journal.pone.0015906	http://dx.doi.org/10.1371/journal.pone.0015906			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203394	Green Published, gold, Green Submitted			2022-12-27	WOS:000285792500042
J	Qureshi, A; Subathra, M; Grey, A; Schey, K; Del Poeta, M; Luberto, C				Qureshi, Asfia; Subathra, Marimuthu; Grey, Angus; Schey, Kevin; Del Poeta, Maurizio; Luberto, Chiara			Role of Sphingomyelin Synthase in Controlling the Antimicrobial Activity of Neutrophils against Cryptococcus neoformans	PLOS ONE			English	Article							NF-KAPPA-B; PROTEIN-KINASE-D; TANDEM MASS-SPECTROMETRY; EARLY HOST-DEFENSE; QUANTITATIVE-ANALYSIS; CANDIDA-ALBICANS; BIOACTIVE SPHINGOLIPIDS; PHOSPHOLIPASE-C; IMMUNE-SYSTEM; IN-VITRO	The key host cellular pathway(s) necessary to control the infection caused by inhalation of the environmental fungal pathogen Cryptococcus neoformans are still largely unknown. Here we have identified that the sphingolipid pathway in neutrophils is required for them to exert their killing activity on the fungus. In particular, using both pharmacological and genetic approaches, we show that inhibition of sphingomyelin synthase (SMS) activity profoundly impairs the killing ability of neutrophils by preventing the extracellular release of an antifungal factor(s). We next found that inhibition of protein kinase D (PKD), which controls vesicular sorting and secretion and is regulated by diacylglycerol (DAG) produced by SMS, totally blocks the extracellular killing activity of neutrophils against C. neoformans. The expression of SMS genes, SMS activity and the levels of the lipids regulated by SMS (namely sphingomyelin (SM) and DAG) are up-regulated during neutrophil differentiation. Finally, tissue imaging of lungs infected with C. neoformans using matrix-assisted laser desorption-ionization mass spectrometry (MALDI-MS), revealed that specific SM species are associated with neutrophil infiltration at the site of the infection. This study establishes a key role for SMS in the regulation of the killing activity of neutrophils against C. neoformans through a DAG-PKD dependent mechanism, and provides, for the first time, new insights into the protective role of host sphingolipids against a fungal infection.	[Qureshi, Asfia; Subathra, Marimuthu; Del Poeta, Maurizio; Luberto, Chiara] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Grey, Angus; Schey, Kevin] Vanderbilt Univ, Dept Biochem, Mass Spectrometry Res Ctr, Nashville, TN 37232 USA; [Del Poeta, Maurizio] Med Univ S Carolina, Dept Microbiol, Charleston, SC 29425 USA; [Del Poeta, Maurizio] Med Univ S Carolina, Dept Immunol, Charleston, SC 29425 USA; [Del Poeta, Maurizio] Med Univ S Carolina, Div Infect Dis, Charleston, SC 29425 USA	Medical University of South Carolina; Vanderbilt University; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Qureshi, A (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	delpoeta@musc.edu	Grey, Angus/O-3473-2019	Grey, Angus/0000-0002-1540-1080	Burroughs Wellcome Fund; National Institutes of Health (NIH) [AI56168, AI72142, AI78493]; National Center for Research Resources [RR17677, C06 RR015455]; National Science Foundation/EPSCoR [EPS-0132573]; American Cancer Society [IRG 97-219-08]; National Heart, Lung and Blood Institute Cardiovascular Proteomics Center [N01-HV-28282]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455, P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078493, R01AI056168, R01AI072142] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Foundation/EPSCoR(National Science Foundation (NSF)); American Cancer Society(American Cancer Society); National Heart, Lung and Blood Institute Cardiovascular Proteomics Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Burroughs Wellcome Fund, in part by Grants AI56168, AI72142, and AI78493 (to MDP) from the National Institutes of Health (NIH), in part by RR17677 Project 2 (to MDP) and Project 6 (to CL) from the Centers of Biomedical Research Excellence Program of the National Center for Research Resources, in part by the National Science Foundation/EPSCoR Grant EPS-0132573 to CL, in part by IRG 97-219-08 from the American Cancer Society (to CL), in part by National Heart, Lung and Blood Institute Cardiovascular Proteomics Center Contract N01-HV-28282, and in part by NIH C06 RR015455 from the Extramural Research Facilities Program of the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCOULOUMRE MS, 1993, ANTIMICROB AGENTS CH, V37, P2628, DOI 10.1128/AAC.37.12.2628; Alvarez M, 2006, CURR BIOL, V16, P2161, DOI 10.1016/j.cub.2006.09.061; Aratani Y, 2002, MED MYCOL, V40, P557, DOI 10.1080/mmy.40.6.557.563; Aratani Y, 2002, J INFECT DIS, V185, P1833, DOI 10.1086/340635; Aratani Y, 1999, INFECT IMMUN, V67, P1828; Aratani Y, 2006, J MED MICROBIOL, V55, P1291, DOI 10.1099/jmm.0.46620-0; Azoitei N, 2010, GUT, V59, P1316, DOI 10.1136/gut.2009.206813; Bielawska A, 2000, METHOD ENZYMOL, V311, P518; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bielawski J, 2009, METHODS MOL BIOL, V579, P443, DOI 10.1007/978-1-60761-322-0_22; Biswas MHU, 2010, CANCER RES, V70, P2095, DOI 10.1158/0008-5472.CAN-09-4155; Bollinger CR, 2005, BBA-MOL CELL RES, V1746, P284, DOI 10.1016/j.bbamcr.2005.09.001; Buschke A., 1895, DEUT MED WOCHENSCHR, V21, P14; Busse O., 1894, ZENTRALBL BAKTERIOL, V16, P175; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM, P351; Chen LA, 2009, J BIOL CHEM, V284, P2459, DOI 10.1074/jbc.M801697200; Chretien F, 2002, J INFECT DIS, V186, P522, DOI 10.1086/341564; Culpitt SV, 2001, METH MOLEC MED, V56, P177, DOI 10.1385/1-59259-151-5:177; DIAMOND RD, 1972, J INFECT DIS, V125, P367, DOI 10.1093/infdis/125.4.367; EISENHAUER PB, 1992, INFECT IMMUN, V60, P3446, DOI 10.1128/IAI.60.8.3446-3447.1992; Fan WH, 2005, EUKARYOT CELL, V4, P1420, DOI 10.1128/EC.4.8.1420-1433.2005; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Feldmesser M, 2001, TRENDS MICROBIOL, V9, P273, DOI 10.1016/S0966-842X(01)02035-2; FITZGERALD V, 1995, LIPIDS, V30, P805, DOI 10.1007/BF02533955; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Garcia J, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.17; GOLDMAN D, 1994, INFECT IMMUN, V62, P4755, DOI 10.1128/IAI.62.11.4755-4761.1994; Graham DB, 2007, J CLIN INVEST, V117, P3445, DOI 10.1172/JCI32729; Gutierrez MG, 2009, CELL MICROBIOL, V11, P406, DOI 10.1111/j.1462-5822.2008.01263.x; Hailemariam TK, 2008, ARTERIOSCL THROM VAS, V28, P1519, DOI 10.1161/ATVBAHA.108.168682; Hanada K, 2005, JPN J INFECT DIS, V58, P131; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Heung LJ, 2006, INFECT IMMUN, V74, P28, DOI 10.1128/IAI.74.1.28-39.2006; HUFFNAGLE GB, 1991, INFECT IMMUN, V59, P1423, DOI 10.1128/IAI.59.4.1423-1433.1991; HUFFNAGLE GB, 1991, J EXP MED, V173, P793, DOI 10.1084/jem.173.4.793; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Iorio E, 2010, CANCER RES, V70, P2126, DOI 10.1158/0008-5472.CAN-09-3833; Jin JF, 2008, J BIOL CHEM, V283, P26509, DOI 10.1074/jbc.M801597200; Kono M, 2006, J BIOL CHEM, V281, P7324, DOI 10.1074/jbc.M508382200; Levitz SM, 1999, INFECT IMMUN, V67, P885, DOI 10.1128/IAI.67.2.885-890.1999; Li ZQ, 2007, BBA-MOL CELL BIOL L, V1771, P1186, DOI 10.1016/j.bbalip.2007.05.007; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Lin L, 2010, J INFECT DIS, V201, P1708, DOI 10.1086/652496; Liu DZ, 2007, BBA-MOL CELL RES, V1773, P869, DOI 10.1016/j.bbamcr.2007.03.018; Luberto C, 2003, J CLIN INVEST, V112, P1080, DOI 10.1172/JCI200318309; Luberto C, 1998, J BIOL CHEM, V273, P14550, DOI 10.1074/jbc.273.23.14550; Luberto C, 2000, J BIOL CHEM, V275, P14760, DOI 10.1074/jbc.275.19.14760; Ma HS, 2006, CURR BIOL, V16, P2156, DOI 10.1016/j.cub.2006.09.032; Mednick AJ, 2003, EUR J IMMUNOL, V33, P1744, DOI 10.1002/eji.200323626; Meng AM, 2004, EXP CELL RES, V292, P385, DOI 10.1016/j.yexcr.2003.10.001; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; MILLER MF, 1991, INFECT IMMUN, V59, P24, DOI 10.1128/IAI.59.1.24-28.1991; Miskolci V, 2003, ARCH BIOCHEM BIOPHYS, V417, P44, DOI 10.1016/S0003-9861(03)00336-9; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Ritter M, 2009, EXPERT OPIN PHARMACO, V10, P2433, DOI 10.1517/14656560903200642; Rittershaus PC, 2006, J CLIN INVEST, V116, P1651, DOI 10.1172/JCI27890; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; Sanfelice F, 1894, ANN IGIEN, V4, P463; Shao XP, 2005, J IMMUNOL, V175, P3244, DOI 10.4049/jimmunol.175.5.3244; Sharlow ER, 2008, J BIOL CHEM, V283, P33516, DOI 10.1074/jbc.M805358200; Silva MT, 2010, J LEUKOCYTE BIOL, V87, P805, DOI 10.1189/jlb.1109767; Spellberg BJ, 2005, J LEUKOCYTE BIOL, V78, P338, DOI 10.1189/jlb.0205072; Spellberg BJ, 2007, J LEUKOCYTE BIOL, V81, P632, DOI 10.1189/jlb.0906549; Spitsin SV, 1997, MOL MED, V3, P315, DOI 10.1007/BF03401810; Stano P, 2009, J IMMUNOL, V182, P84, DOI 10.4049/jimmunol.182.1.84; Sumara G, 2009, CELL, V136, P235, DOI 10.1016/j.cell.2008.11.018; Tafesse FG, 2007, J BIOL CHEM, V282, P17537, DOI 10.1074/jbc.M702423200; Tafesse FG, 2006, J BIOL CHEM, V281, P29421, DOI 10.1074/jbc.R600021200; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Valsecchi M, 2007, J LIPID RES, V48, P417, DOI 10.1194/jlr.M600344-JLR200; van der Luit AH, 2007, BIOCHEM J, V401, P541, DOI 10.1042/BJ20061178; Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701; Villani M, 2008, BIOCHEM J, V414, P31, DOI 10.1042/BJ20071240; von Wicher G, 2008, CELL SIGNAL, V20, P925, DOI 10.1016/j.cellsig.2008.01.003; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Wang YL, 2010, APPL BIOCHEM BIOTECH, V160, P213, DOI 10.1007/s12010-009-8566-3; Yamamoto H, 1997, BIOCHEM J, V325, P223, DOI 10.1042/bj3250223	77	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15587	10.1371/journal.pone.0015587	http://dx.doi.org/10.1371/journal.pone.0015587			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203393	Green Published, Green Submitted, gold			2022-12-27	WOS:000285792500032
J	Castiglione, F; Paci, P				Castiglione, Filippo; Paci, Paola			Criticality of Timing for Anti-HIV Therapy Initiation	PLOS ONE			English	Article							INFECTION; MODELS; TIME	The time of initiation of antiretroviral therapy in HIV-1 infected patients has a determinant effect on the viral dynamics. The question is, how far can the therapy be delayed? Is sooner always better? We resort to clinical data and to microsimulations to forecast the dynamics of the viral load at therapy interruption after prolonged antiretroviral treatment. A computational model previously evaluated, produces results that are statistically adherent to clinical data. In addition, it allows a finer grain analysis of the impact of the therapy initiation point to the disease course. We find a swift increase of the viral density as a function of the time of initiation of the therapy measured when the therapy is stopped. In particular there is a critical time delay with respect to the infection instant beyond which the therapy does not affect the viral rebound. Initiation of the treatment is beneficial because it can down-regulate the immune activation, hence limiting viral replication and spread.	[Castiglione, Filippo; Paci, Paola] Natl Res Council Italy, Inst Comp Applicat Mauro Picone, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per le Applicazioni del Calcolo "Mauro Picone" (IAC-CNR)	Castiglione, F (corresponding author), Natl Res Council Italy, Inst Comp Applicat Mauro Picone, Rome, Italy.	paolapaci08@gmail.com	Castiglione, Filippo/B-1366-2010	Castiglione, Filippo/0000-0002-1442-3552				Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Bernaschi M, 2002, IMMUNOL CELL BIOL, V80, P307, DOI 10.1046/j.1440-1711.2002.01082.x; Bernaschi M, 2001, COMPUT BIOL MED, V31, P303, DOI 10.1016/S0010-4825(01)00011-7; Castiglione F, 2007, BIOINFORMATICS, V23, P3350, DOI 10.1093/bioinformatics/btm408; Castiglione F, 2004, AIDS RES HUM RETROV, V20, P1314, DOI 10.1089/aid.2004.20.1314; Castiglione F, 2007, BIOINFORMATICS, V23, P1371, DOI 10.1093/bioinformatics/btm044; CELADA F, 1992, IMMUNOL TODAY, V13, P56, DOI 10.1016/0167-5699(92)90135-T; Cox DR, 1974, THEORETICAL STAT; Department of Health and Human Services (DHHS), 2008, GUID US ANT AG HIV 1; FARMER JD, 1986, PHYSICA D, V22, pR7, DOI 10.1016/0167-2789(86)90227-7; Francis K, 1997, P NATL ACAD SCI USA, V94, P12258, DOI 10.1073/pnas.94.23.12258; GARDNER MB, 1989, FASEB J, V3, P2593, DOI 10.1096/fasebj.3.14.2556312; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Paci P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-172; Pappalardo F, 2006, CELL IMMUNOL, V244, P137, DOI 10.1016/j.cellimm.2007.03.002; Pappalardo F, 2005, BIOINFORMATICS, V21, P2891, DOI 10.1093/bioinformatics/bti426; Pappalardo F, 2009, BRIEF BIOINFORM, V10, P330, DOI 10.1093/bib/bbp014; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Segovia-Juarez JL, 2004, J THEOR BIOL, V231, P357, DOI 10.1016/j.jtbi.2004.06.031; Steingrover R, 2008, AIDS, V22, P1583, DOI 10.1097/QAD.0b013e328305bd77; *UNAIDS, 2007, AIDS EP UPD	23	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15294	10.1371/journal.pone.0015294	http://dx.doi.org/10.1371/journal.pone.0015294			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203461	gold, Green Published, Green Submitted			2022-12-27	WOS:000285579200016
J	Karschuk, N; Tepe, Y; Gerlach, S; Pape, W; Wenck, H; Schmucker, R; Wittern, KP; Schepky, A; Reuter, H				Karschuk, Nadine; Tepe, Yeliz; Gerlach, Silke; Pape, Wolfgang; Wenck, Horst; Schmucker, Robert; Wittern, Klaus-Peter; Schepky, Andreas; Reuter, Hendrik			A Novel In Vitro Method for the Detection and Characterization of Photosensitizers	PLOS ONE			English	Article							PHOTOALLERGIC CONTACT-DERMATITIS; LYMPH-NODE ASSAY; DENDRITIC CELLS; PHOTOCONTACT ALLERGY; PHOTOTOXICITY TEST; EXOGENOUS AGENTS; MUSK-AMBRETTE; PHASE-II; SENSITIZATION; VALIDATION	Photoactivation and binding of photoactive chemicals to proteins is a known prerequisite for the formation of immunogenic photoantigens and the induction of photoallergy. The intensive use of products and the availability of new chemicals, along with an increasing exposure to sun light contribute to the risk of photosensitizing adverse reactions. Dendritic cells (DC) play a pivotal role in the induction of allergic contact dermatitis. Human peripheral blood monocyte derived dendritic cells (PBMDC) were thus perceived as an obvious choice for the development of a novel in vitro photosensitization assay using the modulation of cell surface protein expression in response to photosensitizing agents. In this new protocol, known chemicals with photosensitizing, allergenic or non-allergenic potential were pre-incubated with PBMDCs prior to UVA irradiation (1 J/cm(2)). Following a 48 h incubation, the expression of the cell surface molecules CD86, HLA-DR and CD83 was measured by flow cytometry. All tested photosensitizers induced a significant and dose-dependent increase of CD86 expression after irradiation compared to non-irradiated controls. Moreover, the phototoxicity of the chemicals could also be determined. In contrast, (i) CD86 expression was not affected by the chosen irradiation conditions, (ii) increased CD86 expression induced by allergens was independent of irradiation and (iii) no PBMDC activation was observed with the non-allergenic control. The assay proposed here for the evaluation of the photoallergenic potential of chemicals includes the assessment of their allergenic, phototoxic and toxic potential in a single and robust test system and is filling a gap in the in vitro photoallergenicity test battery.	[Karschuk, Nadine; Tepe, Yeliz; Gerlach, Silke; Pape, Wolfgang; Wenck, Horst; Schmucker, Robert; Wittern, Klaus-Peter; Schepky, Andreas; Reuter, Hendrik] Beiersdorf AG, Res & Dev, Hamburg, Germany	Beiersdorf AG	Karschuk, N (corresponding author), Beiersdorf AG, Res & Dev, Hamburg, Germany.	Andreas.Schepky@beiersdorf.com						AEBY P, 2006, ALTEX S, V23, P226; Aiba S, 1997, EUR J IMMUNOL, V27, P3031, DOI 10.1002/eji.1830271141; Allen SK, 1997, BIOCHEM BIOPH RES CO, V235, P615, DOI 10.1006/bbrc.1997.6848; Basketter D, 2007, CUTAN OCUL TOXICOL, V26, P359, DOI 10.1080/15569520701622993; Bosca F, 1998, J PHOTOCH PHOTOBIO B, V43, P1, DOI 10.1016/S1011-1344(98)00062-1; BUEHLER EV, 1985, FOOD CHEM TOXICOL, V23, P689, DOI 10.1016/0278-6915(85)90158-9; Casati S, 2005, ATLA-ALTERN LAB ANIM, V33, P47, DOI 10.1177/026119290503300108; Coutant KD, 1999, TOXICOL SCI, V52, P189, DOI 10.1093/toxsci/52.2.189; Dearman RJ, 2001, CONTACT DERMATITIS, V44, P357, DOI 10.1034/j.1600-0536.2001.044006357.x; DELEO VA, 1992, ARCH DERMATOL, V128, P1513, DOI 10.1001/archderm.128.11.1513; Diaz RL, 2006, CONTACT DERMATITIS, V54, P239, DOI 10.1111/j.0105-1873.2006.00797.x; dos Santos GG, 2009, TOXICOL APPL PHARM, V236, P372, DOI 10.1016/j.taap.2009.02.004; Forte Giovanni, 2008, Inflammation & Allergy Drug Targets, V7, P145, DOI 10.2174/187152808785748146; GERBERICK GF, 1990, FOOD CHEM TOXICOL, V28, P361, DOI 10.1016/0278-6915(90)90110-9; Goossens A, 2004, PHOTODERMATOL PHOTO, V20, P121, DOI 10.1111/j.1600-0781.2004.00092.x; GOULD JW, 1995, J AM ACAD DERMATOL, V33, P551, DOI 10.1016/0190-9622(95)91271-1; Hino R, 2008, J DERMATOL SCI, V52, P140, DOI 10.1016/j.jdermsci.2008.06.002; Hoya M, 2009, TOXICOL IN VITRO, V23, P911, DOI 10.1016/j.tiv.2009.03.010; KATO S, 1985, TOXICOL APPL PHARM, V81, P295, DOI 10.1016/0041-008X(85)90166-8; KROON S, 1979, CONTACT DERMATITIS, V5, P337, DOI 10.1111/j.1600-0536.1979.tb04896.x; Lovell WW, 2000, ATLA-ALTERN LAB ANIM, V28, P707, DOI 10.1177/026119290002800506; Mang R., 2006, CONTACT DERMATITIS, P97; Mittelbrunn M, 2005, J INVEST DERMATOL, V125, P334, DOI 10.1111/j.0022-202X.2005.23824.x; Neumann NJ, 2005, J PHOTOCH PHOTOBIO B, V79, P25, DOI 10.1016/j.jphotobiol.2004.11.014; OECD (Organization for Economic Co-operation and Development), 2004, OECD GUID TEST CHEM, V432; Palmer RA, 2006, CONTACT DERMATITIS, P433; Pape WJW, 2001, ATLA-ALTERN LAB ANIM, V29, P145, DOI 10.1177/026119290102900208; PENDLINGTON RU, 1990, INT J COSMETIC SCI, V12, P91, DOI 10.1111/j.1467-2494.1990.tb00524.x; Placzek M, 2007, ACTA DERM-VENEREOL, V87, P312, DOI 10.2340/00015555-0251; Reuter H., 2010, TOXICOL IN VITRO; Rustemeyer T, 2004, CLIN EXP ALLERGY, V34, P1458, DOI 10.1111/j.1365-2222.2004.02045.x; Ryan CA, 2001, TOXICOL IN VITRO, V15, P43, DOI 10.1016/S0887-2333(00)00059-X; Sakaguchi H, 2009, CELL BIOL TOXICOL, V25, P109, DOI 10.1007/s10565-008-9059-9; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schauder S, 1996, CONTACT DERMATITIS, V35, P344, DOI 10.1111/j.1600-0536.1996.tb02415.x; Schnuch A, 2003, HAUTARZT, V54, P626, DOI 10.1007/s00105-003-0510-9; SCHOLES EW, 1992, J APPL TOXICOL, V12, P217, DOI 10.1002/jat.2550120312; Spielmann H, 1998, TOXICOL IN VITRO, V12, P305, DOI 10.1016/S0887-2333(98)00006-X; Spielmann H, 1995, Curr Probl Dermatol, V23, P256; Spielmann H, 2000, ATLA-ALTERN LAB ANIM, V28, P777, DOI 10.1177/026119290002800603; STEPHENS TJ, 1985, J TOXICOL-CUTAN OCUL, V4, P193, DOI 10.3109/15569528509033546; Timares L, 2008, PHOTOCHEM PHOTOBIOL, V84, P422, DOI 10.1111/j.1751-1097.2007.00284.x; Toebak MJ, 2009, CONTACT DERMATITIS, V60, P2, DOI 10.1111/j.1600-0536.2008.01443.x; Tokura Y, 1996, PHOTOCHEM PHOTOBIOL, V64, P838, DOI 10.1111/j.1751-1097.1996.tb01844.x; Tokura Y, 2000, J DERMATOL SCI, V23, pS6, DOI 10.1016/S0923-1811(99)00071-7; Tuschl H, 2000, TOXICOL IN VITRO, V14, P541, DOI 10.1016/S0887-2333(00)00051-5; WOJNAROWSKA F, 1986, BRIT J DERMATOL, V114, P667, DOI 10.1111/j.1365-2133.1986.tb04874.x	47	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15221	10.1371/journal.pone.0015221	http://dx.doi.org/10.1371/journal.pone.0015221			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203464	Green Published, Green Submitted, gold			2022-12-27	WOS:000285579200014
J	Umbrasaite, J; Schweighofer, A; Kazanaviciute, V; Magyar, Z; Ayatollahi, Z; Unterwurzacher, V; Choopayak, C; Boniecka, J; Murray, JAH; Bogre, L; Meskiene, I				Umbrasaite, Julija; Schweighofer, Alois; Kazanaviciute, Vaiva; Magyar, Zoltan; Ayatollahi, Zahra; Unterwurzacher, Verena; Choopayak, Chonnanit; Boniecka, Justyna; Murray, James A. H.; Bogre, Laszlo; Meskiene, Irute			MAPK Phosphatase AP2C3 Induces Ectopic Proliferation of Epidermal Cells Leading to Stomata Development in Arabidopsis	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASES; TRANSCRIPTION FACTOR; NEGATIVE REGULATOR; EMERGING FUNCTIONS; SECRETORY PEPTIDE; HYPOCOTYL GROWTH; PROTEIN; ACID; DIFFERENTIATION; 2C	In plant post-embryonic epidermis mitogen-activated protein kinase (MAPK) signaling promotes differentiation of pavement cells and inhibits initiation of stomata. Stomata are cells specialized to modulate gas exchange and water loss. Arabidopsis MAPKs MPK3 and MPK6 are at the core of the signaling cascade; however, it is not well understood how the activity of these pleiotropic MAPKs is constrained spatially so that pavement cell differentiation is promoted only outside the stomata lineage. Here we identified a PP2C-type phosphatase termed AP2C3 (Arabidopsis protein phosphatase 2C) that is expressed distinctively during stomata development as well as interacts and inactivates MPK3, MPK4 and MPK6. AP2C3 co-localizes with MAPKs within the nucleus and this localization depends on its N-terminal extension. We show that other closely related phosphatases AP2C2 and AP2C4 are also MAPK phosphatases acting on MPK6, but have a distinct expression pattern from AP2C3. In accordance with this, only AP2C3 ectopic expression is able to stimulate cell proliferation leading to excess stomata development. This function of AP2C3 relies on the domains required for MAPK docking and intracellular localization. Concomitantly, the constitutive and inducible AP2C3 expression deregulates E2F-RB pathway, promotes the abundance and activity of CDKA, as well as changes of CDKB1;1 forms. We suggest that AP2C3 downregulates the MAPK signaling activity to help maintain the balance between differentiation of stomata and pavement cells.	[Umbrasaite, Julija; Schweighofer, Alois; Kazanaviciute, Vaiva; Ayatollahi, Zahra; Unterwurzacher, Verena; Choopayak, Chonnanit; Boniecka, Justyna; Meskiene, Irute] Univ Vienna, Vienna Bioctr, Max F Perutz Labs, Vienna, Austria; [Schweighofer, Alois] Max Planck Inst Mol Plant Physiol, Potsdam, Germany; [Kazanaviciute, Vaiva; Meskiene, Irute] Univ Vilnius, Inst Biotechnol, Vilnius, Lithuania; [Magyar, Zoltan; Bogre, Laszlo] Royal Holloway Univ London, Sch Biol Sci, Egham, Surrey, England; [Magyar, Zoltan] Inst Plant Biol, Biol Res Ctr, Szeged, Hungary; [Murray, James A. H.] Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Max Planck Society; Vilnius University; University of London; Royal Holloway University London; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Cardiff University	Umbrasaite, J (corresponding author), Univ Vienna, Vienna Bioctr, Max F Perutz Labs, Vienna, Austria.	irute.meskiene@univie.ac.at	Murray, James AH/D-3399-2009; Boniecka, Justyna/B-3160-2016	Murray, James AH/0000-0002-2282-3839; Schweighofer, Alois/0000-0002-8466-0924; Magyar, Zoltan/0000-0001-8376-7220; Ayatollahi, Zahra Sepideh/0000-0002-8022-1051; Unterwurzacher, Verena/0000-0002-5897-4620; Boniecka, Justyna/0000-0002-1753-9892	Austrian Exchange Service (OeAD); European Union (EU); Vienna University; Naresuan University; Austrian Erwin Schroedinger; Biotechnology and Biological Sciences Research Council [BBS/B/13268, BBS/B/13314]; Austrian Science Fund (FWF) [P16409, P19005, I255]; British Council; Lithuanian Science Fund; Austrian Science Fund (FWF) [I 255] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/F00964X/1, BBS/B/13268/2] Funding Source: researchfish; BBSRC [BB/F00964X/1] Funding Source: UKRI	Austrian Exchange Service (OeAD); European Union (EU)(CGIAREuropean Commission); Vienna University; Naresuan University; Austrian Erwin Schroedinger(Austrian Science Fund (FWF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); British Council(The British Council in India); Lithuanian Science Fund; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by fellowships from Austrian Exchange Service (OeAD) (for JU), European Union (EU) and Vienna University (for JU and ZA), Naresuan University (for CC), Austrian Erwin Schroedinger and EU Marie Curie fellowships for AS, and grants from the Biotechnology and Biological Sciences Research Council BBS/B/13268 and BBS/B/13314 to JAHM and LB respectively, and from Austrian Science Fund (FWF) Doctoral program "Molecular Mechanisms in Cell Signaling", P16409, P19005, I255, British Council and Lithuanian Science Fund to IM.	Abrash EB, 2009, DEV CELL, V16, P783, DOI 10.1016/j.devcel.2009.05.014; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Andreasson E, 2010, TRENDS PLANT SCI, V15, P106, DOI 10.1016/j.tplants.2009.12.001; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; Bartels S, 2010, TRENDS PLANT SCI, V15, P322, DOI 10.1016/j.tplants.2010.04.003; Bartels S, 2009, PLANT CELL, V21, P2884, DOI 10.1105/tpc.109.067678; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Borghi L, 2010, PLANT CELL, V22, P1792, DOI 10.1105/tpc.110.074591; Boudolf V, 2004, PLANT CELL, V16, P2683, DOI 10.1105/tpc.104.024398; Boudolf V, 2004, PLANT CELL, V16, P945, DOI 10.1105/tpc.021774; Boudolf V, 2001, J EXP BOT, V52, P1381, DOI 10.1093/jexbot/52.359.1381; Brock AK, 2010, PLANT PHYSIOL, V153, P1098, DOI 10.1104/pp.110.156109; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Casson S, 2008, NEW PHYTOL, V178, P9, DOI 10.1111/j.1469-8137.2007.02351.x; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Dai Y, 2006, PLANT CELL, V18, P308, DOI 10.1105/tpc.105.037846; De Veylder L, 2003, CURR OPIN PLANT BIOL, V6, P536, DOI 10.1016/j.pbi.2003.09.001; De Veylder L, 2002, EMBO J, V21, P1360, DOI 10.1093/emboj/21.6.1360; del Pozo JC, 2006, PLANT CELL, V18, P2224, DOI 10.1105/tpc.105.039651; Desvoyes B, 2006, PLANT PHYSIOL, V140, P67, DOI 10.1104/pp.105.071027; Ebel C, 2004, NATURE, V429, P776, DOI 10.1038/nature02637; Gendreau E, 1997, PLANT PHYSIOL, V114, P295, DOI 10.1104/pp.114.1.295; Gray JE, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.149pe53; Gudesblat GE, 2009, PLANT SIGNAL BEHAV, V4, P1114, DOI 10.4161/psb.4.12.10062; Gudesblat GE, 2007, PLANT SIGNAL BEHAV, V2, P271, DOI 10.4161/psb.2.4.3896; Hara K, 2007, GENE DEV, V21, P1720, DOI 10.1101/gad.1550707; Hara K, 2009, PLANT CELL PHYSIOL, V50, P1019, DOI 10.1093/pcp/pcp068; Holtorf S, 1995, PLANT MOL BIOL, V29, P637, DOI 10.1007/BF00041155; Hunt L, 2010, NEW PHYTOL, V186, P609, DOI 10.1111/j.1469-8137.2010.03200.x; Hunt L, 2009, CURR BIOL, V19, P864, DOI 10.1016/j.cub.2009.03.069; Inze D, 2006, ANNU REV GENET, V40, P77, DOI 10.1146/annurev.genet.40.110405.090431; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kanaoka MM, 2008, PLANT CELL, V20, P1775, DOI 10.1105/tpc.108.060848; Kang CY, 2009, PLANT CELL, V21, P2624, DOI 10.1105/tpc.109.069765; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Kiegerl S, 2000, PLANT CELL, V12, P2247, DOI 10.1105/tpc.12.11.2247; Kondo T, 2010, PLANT CELL PHYSIOL, V51, P1, DOI 10.1093/pcp/pcp180; Krysan PJ, 2002, PLANT CELL, V14, P1109, DOI 10.1105/tpc.001164; Lai LB, 2005, PLANT CELL, V17, P2754, DOI 10.1105/tpc.105.034116; LAMPARD GR, 2009, PLANT CELL; Lampard GR, 2008, SCIENCE, V322, P1113, DOI 10.1126/science.1162263; Lee JS, 2007, J BIOL CHEM, V282, P25020, DOI 10.1074/jbc.M701888200; Lee JS, 2009, PLANT J, V57, P975, DOI 10.1111/j.1365-313X.2008.03741.x; Legewie S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.29; Leung J, 2006, PLANT SCI, V171, P596, DOI 10.1016/j.plantsci.2006.06.009; Lopez-Juez E, 2008, PLANT CELL, V20, P947, DOI 10.1105/tpc.107.057075; LOPEZJUEZ E, 1995, PLANT PHYSIOL, V107, P131, DOI 10.1104/pp.107.1.131; MacAlister CA, 2007, NATURE, V445, P537, DOI 10.1038/nature05491; Magyar Z, 2005, PLANT CELL, V17, P2527, DOI 10.1105/tpc.105.033761; Magyar Z, 1997, PLANT CELL, V9, P223, DOI 10.1105/tpc.9.2.223; Magyar Zoltan, 2008, V10, P89, DOI 10.1007/7089_2007_156; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Meskiene I, 1998, P NATL ACAD SCI USA, V95, P1938, DOI 10.1073/pnas.95.4.1938; Meskiene I, 2003, J BIOL CHEM, V278, P18945, DOI 10.1074/jbc.M300878200; Meszaros T, 2006, PLANT J, V48, P485, DOI 10.1111/j.1365-313X.2006.02888.x; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; NADEAU JA, 2008, STOMATAL DEV ARABIDO, P1; Nadeau JA, 2009, CURR OPIN PLANT BIOL, V12, P29, DOI 10.1016/j.pbi.2008.10.006; Ohashi-Ito K, 2006, PLANT CELL, V18, P2493, DOI 10.1105/tpc.106.046136; Park JA, 2005, PLANT J, V42, P153, DOI 10.1111/j.1365-313X.2005.02361.x; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Peterson KM, 2010, PLANT CELL, V22, P296, DOI 10.1105/tpc.109.072777; Pillitteri LJ, 2007, NATURE, V445, P501, DOI 10.1038/nature05467; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Saez A, 2004, PLANT J, V37, P354, DOI 10.1046/j.1365-313X.2003.01966.x; Saez A, 2008, PLANT CELL, V20, P2972, DOI 10.1105/tpc.107.056705; Schweighofer A, 2004, TRENDS PLANT SCI, V9, P236, DOI 10.1016/j.tplants.2004.03.007; Schweighofer A, 2007, PLANT CELL, V19, P2213, DOI 10.1105/tpc.106.049585; Schweighofer Alois, 2009, V479, P247, DOI 10.1007/978-1-59745-289-2_16; Schweighofer Alois, 2008, V10, P277, DOI 10.1007/7089_2007_155; Serna L, 2009, BIOESSAYS, V31, P865, DOI 10.1002/bies.200800231; Sheen J, 1998, P NATL ACAD SCI USA, V95, P975, DOI 10.1073/pnas.95.3.975; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Soyano T, 2003, GENE DEV, V17, P1055, DOI 10.1101/gad.1071103; Stals H, 2000, PLANT MOL BIOL, V43, P583, DOI 10.1023/A:1006409907831; Sugano SS, 2010, NATURE, V463, P241, DOI 10.1038/nature08682; Takahashi Y, 2010, PLANT CELL PHYSIOL, V51, P1766, DOI 10.1093/pcp/pcq135; Tsuchisaka A, 2009, GENETICS, V183, P979, DOI 10.1534/genetics.109.107102; Ulm R, 2002, EMBO J, V21, P6483, DOI 10.1093/emboj/cdf646; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wang ML, 1999, GENOME RES, V9, P325; Wildwater M, 2005, CELL, V123, P1337, DOI 10.1016/j.cell.2005.09.042; Yoo SD, 2008, NATURE, V451, P789, DOI 10.1038/nature06543	87	56	63	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15357	10.1371/journal.pone.0015357	http://dx.doi.org/10.1371/journal.pone.0015357			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203456	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000285579200020
J	Lin, CW; Yen, ST; Chang, HT; Chen, SJ; Lai, SL; Liu, YC; Chan, TH; Liao, WL; Lee, SJ				Lin, Chun-Wei; Yen, Shuo-Ting; Chang, Hui-Ting; Chen, Shiang-Jiuun; Lai, Shih-Lei; Liu, Yi-Ching; Chan, Tun-Hao; Liao, Wen-Lian; Lee, Shyh-Jye			Loss of Cofilin 1 Disturbs Actin Dynamics, Adhesion between Enveloping and Deep Cell Layers and Cell Movements during Gastrulation in Zebrafish	PLOS ONE			English	Article							FILAMENT TURNOVER; IN-VIVO; ARP2/3 COMPLEX; E-CADHERIN; F-ACTIN; ADF/COFILIN; CYTOSKELETON; POLARITY; DROSOPHILA; EXTENSION	During gastrulation, cohesive migration drives associated cell layers to the completion of epiboly in zebrafish. The association of different layers relies on E-cadherin based cellular junctions, whose stability can be affected by actin turnover. Here, we examined the effect of malfunctioning actin turnover on the epibolic movement by knocking down an actin depolymerizing factor, cofilin 1, using antisense morpholino oligos (MO). Knockdown of cfl1 interfered with epibolic movement of deep cell layer (DEL) but not in the enveloping layer (EVL) and the defect could be specifically rescued by overexpression of cfl1. It appeared that the uncoordinated movements of DEL and EVL were regulated by the differential expression of cfl1 in the DEL, but not EVL as shown by in situ hybridization. The dissociation of DEL and EVL was further evident by the loss of adhesion between layers by using transmission electronic and confocal microscopy analyses. cfl1 morphants also exhibited abnormal convergent extension, cellular migration and actin filaments, but not involution of hypoblast. The cfl1 MO-induced cell migration defect was found to be cell-autonomous in cell transplantation assays. These results suggest that proper actin turnover mediated by Cfl1 is essential for adhesion between DEL and EVL and cell movements during gastrulation in zebrafish.	[Lin, Chun-Wei; Chang, Hui-Ting; Lai, Shih-Lei; Liu, Yi-Ching; Chan, Tun-Hao; Lee, Shyh-Jye] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan; [Yen, Shuo-Ting; Chen, Shiang-Jiuun; Lee, Shyh-Jye] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan; [Liao, Wen-Lian] Natl Taiwan Univ, Inst Fisheries Sci, Taipei 10764, Taiwan; [Lee, Shyh-Jye] Natl Taiwan Univ, Ctr Biotechnol, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Lin, CW (corresponding author), Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan.	jefflee@ntu.edu.tw	Lee, Shyh-Jye/C-6092-2008; Lai, Shih-Lei/O-1562-2018; Lai, Ben/AAD-1628-2019	Lee, Shyh-Jye/0000-0001-8452-9152; Lai, Shih-Lei/0000-0002-1409-4701; Yen, Shuo-Ting/0000-0003-4277-1965	National Science Council of Taiwan, R.O.C. [NSC94-2311-B-002-019]	National Science Council of Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This work was supported by a grant (NSC94-2311-B-002-019) from the National Science Council of Taiwan, R.O.C. The NSC played no role in the study and the preparation of the manuscript.	Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Babb SG, 2004, DEV DYNAM, V230, P263, DOI 10.1002/dvdy.20057; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Carlier MF, 1999, J BIOL CHEM, V274, P33827, DOI 10.1074/jbc.274.48.33827; Chan C, 2009, CURR BIOL, V19, P537, DOI 10.1016/j.cub.2009.02.060; Chua BT, 2003, NAT CELL BIOL, V5, P1083, DOI 10.1038/ncb1070; Dedova IV, 2004, BIOPHYS CHEM, V110, P119, DOI 10.1016/j.bpc.2004.01.009; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Gee KR, 2001, BIOORG MED CHEM LETT, V11, P2181, DOI 10.1016/S0960-894X(01)00421-8; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Hable WE, 2005, CELL MOTIL CYTOSKEL, V61, P9, DOI 10.1002/cm.20059; Han L, 2007, EMBO J, V26, P4189, DOI 10.1038/sj.emboj.7601852; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Huber F, 2008, BIOPHYS J, V95, P5508, DOI 10.1529/biophysj.108.134817; Ivanov AI, 2004, MOL BIOL CELL, V15, P2639, DOI 10.1091/mbc.E04-02-0163; Kane DA, 2005, DEVELOPMENT, V132, P1105, DOI 10.1242/dev.01668; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klamt F, 2009, NAT CELL BIOL, V11, P1241, DOI 10.1038/ncb1968; Koppen M, 2006, DEVELOPMENT, V133, P2671, DOI 10.1242/dev.02439; Lachnit M, 2008, DEV BIOL, V315, P1, DOI 10.1016/j.ydbio.2007.10.008; Lai SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003439; Lai SL, 2005, MOL REPROD DEV, V71, P186, DOI 10.1002/mrd.20290; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Lehman N, 2006, BLOOD, V108, P3564, DOI 10.1182/blood-2006-02-005959; McCullough BR, 2008, J MOL BIOL, V381, P550, DOI 10.1016/j.jmb.2008.05.055; McFarland KN, 2005, DEV DYNAM, V233, P390, DOI 10.1002/dvdy.20325; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Montero JA, 2005, DEVELOPMENT, V132, P1187, DOI 10.1242/dev.01667; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; Ohashi K, 2000, BIOCHEM BIOPH RES CO, V276, P1178, DOI 10.1006/bbrc.2000.3599; Pavlov D, 2007, J MOL BIOL, V365, P1350, DOI 10.1016/j.jmb.2006.10.102; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Roh-Johnson M, 2009, J CELL SCI, V122, P3983, DOI 10.1242/jcs.057562; Sawa M, 2003, J CELL SCI, V116, P1505, DOI 10.1242/jcs.00362; Sepich DS, 2000, GENESIS, V27, P159, DOI 10.1002/1526-968X(200008)27:4<159::AID-GENE50>3.0.CO;2-T; Shimizu T, 2005, MECH DEVELOP, V122, P747, DOI 10.1016/j.mod.2005.03.008; Small J. Victor, 1994, Seminars in Cell Biology, V5, P157, DOI 10.1006/scel.1994.1020; Solnica-Krezel L, 2006, CURR OPIN GENET DEV, V16, P433, DOI 10.1016/j.gde.2006.06.009; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; Tanaka K, 2005, ZOOL SCI, V22, P971, DOI 10.2108/zsj.22.971; THERIOT JA, 1994, ADV EXP MED BIOL, V358, P133; Theriot Julie A., 1994, Seminars in Cell Biology, V5, P193, DOI 10.1006/scel.1994.1024; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Wang CH, 2008, J CELL SCI, V121, P2913, DOI 10.1242/jcs.023911; WARGA RM, 1990, DEVELOPMENT, V108, P569; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Welch MD, 1997, CURR OPIN CELL BIOL, V9, P54, DOI 10.1016/S0955-0674(97)80152-4; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yap AS, 2007, CURR OPIN CELL BIOL, V19, P508, DOI 10.1016/j.ceb.2007.09.008; Yu D, 2005, SCI CHINA SER C, V48, P601, DOI 10.1360/062004-111; Yu D, 2010, EXP CELL RES, V316, P848, DOI 10.1016/j.yexcr.2009.11.018; Zalik SE, 1999, BIOCHEM CELL BIOL, V77, P527, DOI 10.1139/bcb-77-6-527	54	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15331	10.1371/journal.pone.0015331	http://dx.doi.org/10.1371/journal.pone.0015331			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203473	gold, Green Published, Green Submitted			2022-12-27	WOS:000285578000030
J	Schwend, T; Loucks, EJ; Ahlgren, SC				Schwend, Tyler; Loucks, Evyn J.; Ahlgren, Sara C.			Visualization of Gli Activity in Craniofacial Tissues of Hedgehog-Pathway Reporter Transgenic Zebrafish	PLOS ONE			English	Article							DROSOPHILA CUBITUS INTERRUPTUS; FINGER TRANSCRIPTION FACTOR; CRANIAL NEURAL CREST; SONIC HEDGEHOG; INDIAN-HEDGEHOG; FLOOR PLATE; KRUPPEL FAMILY; GENE ENCODES; PROTEIN; EXPRESSION	Background: The Hedgehog (Hh)-signaling pathway plays a crucial role in the development and maintenance of multiple vertebrate and invertebrate organ systems. Gli transcription factors are regulated by Hh-signaling and act as downstream effectors of the pathway to activate Hh-target genes. Understanding the requirements for Hh-signaling in organisms can be gained by assessing Gli activity in a spatial and temporal fashion. Methodology/Principal Findings: We have generated a Gli-dependent (Gli-d) transgenic line, Tg(Gli-d: mCherry), that allows for rapid and simple detection of Hh-responding cell populations in both live and fixed zebrafish. This transgenic line expresses a mCherry reporter under the control of a Gli responsive promoter, which can be followed by using fluorescent microscopy and in situ hybridization. Expression of the mCherry transgene reporter during embryogenesis and early larval development faithfully replicated known expression domains of Hh-signaling in zebrafish, and abrogating Hh-signaling in transgenic fish resulted in the suppression of reporter expression. Moreover, ectopic shh expression in Tg(Glid: mCherry) fish led to increased transgene production. Using this transgenic line we investigated the nature of Hh-pathway response during early craniofacial development and determined that the neural crest skeletal precursors do not directly respond to Hh-signaling prior to 48 hours post fertilization, suggesting that earlier requirements for pathway activation in this population of facial skeleton precursors are indirect. Conclusion/Significance: We have determined that early Hh-signaling requirements in craniofacial development are indirect. We further demonstrate the Tg(Gli-d: mCherry) fish are a highly useful tool for studying Hh-signaling dependent processes during embryogenesis and larval stages.	[Schwend, Tyler] Northwestern Univ, Feinberg Sch Med, Integrated Grad Program, Chicago, IL 60611 USA; [Ahlgren, Sara C.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Schwend, Tyler; Loucks, Evyn J.; Ahlgren, Sara C.] Childrens Mem Res Ctr, Dev Biol Program, Chicago, IL USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Schwend, T (corresponding author), Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA.	s-ahlgren@northwestern.edu			NRSA (NIH-NIDCR) [F31DE019604]; National Institutes of Health [AA13596]; State of Illinois; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F31DE019604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA013596] Funding Source: NIH RePORTER	NRSA (NIH-NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Illinois; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by a Ruth L. Kirschtein predoctoral NRSA F31DE019604 (NIH-NIDCR) to T. S. as well as grants from National Institutes of Health (AA13596) and the State of Illinois to S. C. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Altaba ARI, 1998, DEVELOPMENT, V125, P2203; Avaron F, 2006, DEV DYNAM, V235, P478, DOI 10.1002/dvdy.20619; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Bai CB, 2002, DEVELOPMENT, V129, P4753; Brand M, 1996, DEVELOPMENT, V123, P129; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen WB, 2001, DEVELOPMENT, V128, P2385; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Colnot C, 2005, DEVELOPMENT, V132, P1057, DOI 10.1242/dev.01649; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Cortes M, 2009, DEVELOPMENT, V136, P1697, DOI 10.1242/dev.030742; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Dellovade T, 2006, ANNU REV NEUROSCI, V29, P539, DOI 10.1146/annurev.neuro.29.051605.112858; Devine CA, 2009, DEV BIOL, V326, P143, DOI 10.1016/j.ydbio.2008.11.006; Ding Q, 1998, DEVELOPMENT, V125, P2533; Eames BF, 2010, DEV BIOL, V341, P400, DOI 10.1016/j.ydbio.2010.02.035; Eberhart JK, 2006, DEVELOPMENT, V133, P1069, DOI 10.1242/dev.02281; EKKER SC, 1995, DEVELOPMENT, V121, P2337; Epstein DJ, 1996, DEVELOPMENT, V122, P2885; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Hammond CL, 2009, DEVELOPMENT, V136, P3991, DOI 10.1242/dev.042150; HOOPER JE, 1989, CELL, V59, P751, DOI 10.1016/0092-8674(89)90021-4; Hynes M, 1997, NEURON, V19, P15, DOI 10.1016/S0896-6273(00)80344-X; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Karlstrom RO, 2003, DEVELOPMENT, V130, P1549, DOI 10.1242/dev.00364; Karlstrom RO, 1999, GENE DEV, V13, P388, DOI 10.1101/gad.13.4.388; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Ke ZY, 2008, MOL CELL NEUROSCI, V37, P388, DOI 10.1016/j.mcn.2007.10.013; Ke ZY, 2005, DEV DYNAM, V232, P479, DOI 10.1002/dvdy.20242; Kimmel CB, 1998, DEV BIOL, V203, P245, DOI 10.1006/dbio.1998.9016; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; KINZLER KW, 1988, NATURE, V332, P371, DOI 10.1038/332371a0; Knight RD, 2006, ADV EXP MED BIOL, V589, P120; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lauth M, 2007, CELL CYCLE, V6, P2458, DOI 10.4161/cc.6.20.4808; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Le Douarin NM, 2007, BRAIN RES REV, V55, P237, DOI 10.1016/j.brainresrev.2007.06.023; Lee J, 1997, DEVELOPMENT, V124, P2537; Lewis KE, 1999, DEVELOPMENT, V126, P2397; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Matise MP, 1998, DEVELOPMENT, V125, P2759; Methot N, 2001, DEVELOPMENT, V128, P733; Mo R, 1997, DEVELOPMENT, V124, P113; Motoyama J, 2003, DEV BIOL, V259, P150, DOI 10.1016/S0012-1606(03)00159-3; Muenke M, 2000, CURR OPIN GENET DEV, V10, P262, DOI 10.1016/S0959-437X(00)00084-8; Mullor JL, 2002, TRENDS CELL BIOL, V12, P562, DOI 10.1016/S0962-8924(02)02405-4; Nguyen V, 2005, DEVELOPMENT, V132, P3267, DOI 10.1242/dev.01905; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; RUPPERT JM, 1988, MOL CELL BIOL, V8, P3104, DOI 10.1128/MCB.8.8.3104; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Schwend T, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-59; Shin SH, 1999, P NATL ACAD SCI USA, V96, P2880, DOI 10.1073/pnas.96.6.2880; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; THISSE C, 1993, DEVELOPMENT, V119, P1203; Tyurina OV, 2005, DEV BIOL, V277, P537, DOI 10.1016/j.ydbio.2004.10.003; Vanderlaan G, 2005, DEV BIOL, V282, P550, DOI 10.1016/j.ydbio.2005.04.010; Varga ZM, 2001, DEVELOPMENT, V128, P3497; von Mering C, 1999, CURR BIOL, V9, P1319, DOI 10.1016/S0960-9822(00)80054-8; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wada N, 2005, DEVELOPMENT, V132, P3977, DOI 10.1242/dev.01943; WALTERHOUSE D, 1993, DEV DYNAM, V196, P91, DOI 10.1002/aja.1001960203; Wang QT, 1999, DEVELOPMENT, V126, P5097; Yan YL, 2002, DEVELOPMENT, V129, P5065; Yang HB, 2009, J BIOL CHEM, V284, P20876, DOI 10.1074/jbc.M807648200	73	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e14396	10.1371/journal.pone.0014396	http://dx.doi.org/10.1371/journal.pone.0014396			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203590	Green Published, Green Submitted, gold			2022-12-27	WOS:000285576900011
J	Cox, RL; Underwood, EC				Cox, Robin L.; Underwood, Emma C.			The Importance of Conserving Biodiversity Outside of Protected Areas in Mediterranean Ecosystems	PLOS ONE			English	Article							CAPE FLORISTIC REGION; TERRESTRIAL VERTEBRATES; PLANT DIVERSITY; CLIMATE-CHANGE; CONSERVATION; CALIFORNIA; PATTERNS; ECOREGIONS; MANAGEMENT	Mediterranean-type ecosystems constitute one of the rarest terrestrial biomes and yet they are extraordinarily biodiverse. Home to over 250 million people, the five regions where these ecosystems are found have climate and coastal conditions that make them highly desirable human habitats. The current conservation landscape does not reflect the mediterranean biome's rarity and its importance for plant endemism. Habitat conversion will clearly outpace expansion of formal protected-area networks, and conservationists must augment this traditional strategy with new approaches to sustain the mediterranean biota. Using regional scale datasets, we determine the area of land in each of the five regions that is protected, converted (e. g., to urban or industrial), impacted (e. g., intensive, cultivated agriculture), or lands that we consider to have conservation potential. The latter are natural and semi-natural lands that are unprotected (e. g., private range lands) but sustain numerous native species and associated habitats. Chile has the greatest proportion of its land (75%) in this category and California-Mexico the least (48%). To illustrate the potential for achieving mediterranean biodiversity conservation on these lands, we use species-area curves generated from ecoregion scale data on native plant species richness and vertebrate species richness. For example, if biodiversity could be sustained on even 25% of existing unprotected, natural and semi-natural lands, we estimate that the habitat of more than 6,000 species could be represented. This analysis suggests that if unprotected natural and semi-natural lands are managed in a manner that allows for persistence of native species, we can realize significant additional biodiversity gains. Lasting biodiversity protection at the scale needed requires unprecedented collaboration among stakeholders to promote conservation both inside and outside of traditional protected areas, including on lands where people live and work.	[Cox, Robin L.] Nature Conservancy, San Francisco, CA USA; [Underwood, Emma C.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA	Nature Conservancy; University of California System; University of California Davis	Cox, RL (corresponding author), Nature Conservancy, San Francisco, CA USA.	rcox@tnc.org			Nature Conservancy of California; Rodney Johnson/Katherine Ordway	Nature Conservancy of California; Rodney Johnson/Katherine Ordway	This research was funded by The Nature Conservancy of California and the Rodney Johnson/Katherine Ordway Stewardship Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blondel J., 1999, Biology and wildlife of the Mediterranean region.; Bode M, 2008, P NATL ACAD SCI USA, V105, P6498, DOI 10.1073/pnas.0710705105; Center for International Earth Science Information Network (CIESIN) Columbia University Centro Internacional de Agricultura Tropical (CIAT), 2005, GRIDD POP WORLD GPW; Cowling RM, 1996, TRENDS ECOL EVOL, V11, P362, DOI 10.1016/0169-5347(96)10044-6; COWLING RM, 1999, PARKS, V9, P17; COX N, 2006, STATUS DISTRIBUTION; GREUTER W, 1994, PHILOS T ROY SOC B, V344, P41, DOI 10.1098/rstb.1994.0049; HARRIS W, 2008, EXT NAT FARM BILL TR; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; HOBBS RJ, 1991, CONSERV BIOL, V15, P1522; Huntsinger Lynn, 2004, V37, P309; Kark S, 2009, P NATL ACAD SCI USA, V106, P15368, DOI 10.1073/pnas.0901001106; Kemper J, 1999, BIOL CONSERV, V90, P103, DOI 10.1016/S0006-3207(99)00021-X; Kier G, 2005, J BIOGEOGR, V32, P1107, DOI 10.1111/j.1365-2699.2005.01272.x; Klausmeyer KR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006392; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Low A.R., 1996, VEGETATION S AFRICA; LUMBRERAS EL, 2001, CONV CONS EUR WILDL; LUNT ID, 1990, AUST J ECOL, V15, P155, DOI 10.1111/j.1442-9993.1990.tb01524.x; Maiorano L, 2006, BIOL CONSERV, V133, P455, DOI 10.1016/j.biocon.2006.07.015; Mawdsley JR, 2009, CONSERV BIOL, V23, P1080, DOI 10.1111/j.1523-1739.2009.01264.x; MCCREARY D, 2004, OAK WOODLAND CONSERV; Medail F, 1997, ANN MO BOT GARD, V84, P112, DOI 10.2307/2399957; Merenlender A. M., 2000, California Agriculture, V54, P7, DOI 10.3733/ca.v054n03p7; Merenlender AM, 2008, CALIF AGR, V62, P148, DOI 10.3733/ca.v062n04p148; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; Miller JR, 2002, CONSERV BIOL, V16, P330, DOI 10.1046/j.1523-1739.2002.00420.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; *NRCS, 2008, NEW FARM BILL CONS R; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Onate JJ, 1998, J ENVIRON MANAGE, V52, P227, DOI 10.1006/jema.1997.0173; Pauchard A, 2002, NAT AREA J, V22, P318; RIELY SP, 2003, CONSERV BIOL, V17, P566; Rouget M, 2003, BIOL CONSERV, V112, P129, DOI 10.1016/S0006-3207(02)00396-8; Rouget M, 2003, BIOL CONSERV, V112, P63, DOI 10.1016/S0006-3207(02)00395-6; Simonetti JA, 1999, REV CHIL HIST NAT, V72, P493; Sirami C, 2010, LANDSCAPE URBAN PLAN, V96, P214, DOI 10.1016/j.landurbplan.2010.03.007; Stattersfield Alison J., 1998, Birdlife Conservation Series, V7, P1; Thorne JH, 2006, NAT AREA J, V26, P137, DOI 10.3375/0885-8608(2006)26[137:ACDFTC]2.0.CO;2; Tognelli MF, 2008, DIVERS DISTRIB, V14, P148, DOI 10.1111/j.1472-4642.2007.00437.x; Underwood EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001515; Underwood EC, 2009, CONSERV BIOL, V23, P43, DOI 10.1111/j.1523-1739.2008.01072.x; United Nations Environment Programme, 2002, 6 M C PART CONV BIOL; Watson JEM, 2009, DIVERS DISTRIB, V15, P1028, DOI 10.1111/j.1472-4642.2009.00601.x; WESTMAN WE, 1983, VEGETATIO, V52, P3; White C, 2008, CONSERV BIOL, V22, P1380, DOI 10.1111/j.1523-1739.2008.01103.x; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366; *WORLD WILDL FUND, 2006, WILDFINDER ONL DAT S; Zavaleta ES, 2007, DIVERS DISTRIB, V13, P735, DOI 10.1111/j.1472-4642.2007.00384.x	50	99	102	3	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e14508	10.1371/journal.pone.0014508	http://dx.doi.org/10.1371/journal.pone.0014508			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249126	Green Published, Green Submitted, gold			2022-12-27	WOS:000286512900006
J	Linhares, A; Chada, DM; Aranha, CN				Linhares, Alexandre; Chada, Daniel M.; Aranha, Christian N.			The Emergence of Miller's Magic Number on a Sparse Distributed Memory	PLOS ONE			English	Article								Human memory is limited in the number of items held in one's mind-a limit known as "Miller's magic number". We study the emergence of such limits as a result of the statistics of large bitvectors used to represent items in memory, given two postulates: i) the Sparse Distributed Memory; and ii) chunking through averaging. Potential implications for theoretical neuroscience are discussed.	[Linhares, Alexandre; Chada, Daniel M.] EBAPE, Getulio Vargas Fdn, Rio De Janeiro, Brazil; [Aranha, Christian N.] Cortex Intelligence, Rio De Janeiro, Brazil	Getulio Vargas Foundation	Linhares, A (corresponding author), EBAPE, Getulio Vargas Fdn, Rio De Janeiro, Brazil.	alexandre.linhares@fgv.br	Linhares, Alexandre/A-4810-2009	Linhares, Alexandre/0000-0002-4227-6879	Federacao de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/110.790/2009]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) of the Brazilian Ministry of Science Technology [470341/2009-2, 301207/2009-7]; Getulio Vargas Foundation; Cortex Intelligence	Federacao de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) of the Brazilian Ministry of Science Technology(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Getulio Vargas Foundation; Cortex Intelligence	This work has been supported by grant E-26/110.790/2009 from the Federacao de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ-www.faperj.br), grants 470341/2009-2 and 301207/2009-7 from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-www.cnpq.br) of the Brazilian Ministry of Science & Technology, the Programa de Apoio a Pesquisa (PROPESQUISA) of the Getulio Vargas Foundation (www.fgv.br), and Cortex Intelligence (www.cortex-intelligence.com), due to the employment of its CTO, Dr. C.N. Aranha. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assisi C, 2007, NAT NEUROSCI, V10, P1176, DOI 10.1038/nn1947; BOLAND PJ, 1989, STATISTICIAN, V38, P181, DOI 10.2307/2348873; Borisyuk R, 2000, BIOSYSTEMS, V58, P265, DOI 10.1016/S0303-2647(00)00131-3; Cancho RFI, 2001, P ROY SOC B-BIOL SCI, V268, P2261, DOI 10.1098/rspb.2001.1800; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; French RM, 1999, UNDERSTANDING REPRESENTATION IN THE COGNITIVE SCIENCES, P93; GAYLER RW, 2003, ICCS ASCS INT C COGN, P133; Gobet F, 2001, TRENDS COGN SCI, V5, P236, DOI 10.1016/S1364-6613(00)01662-4; Gobet F, 2000, COGNITIVE SCI, V24, P651, DOI 10.1207/s15516709cog2404_4; Hofstadter D., 1985, METAMAGICAL THEMAS Q; KANERVA P, 1994, ICANN 94 P INT C ART, V1, P226; Kanerva P., 1988, SPARSE DISTRIBUTED M; KANERVA P, 1996, ICANN96 ART NEUR NET, P896; KANERVA P, 1998, WORKSH P NIPS98 NEUR; Kanerva P., 1993, ASS NEURAL MEMORIES, P50; Kanerva P, 2009, COGN COMPUT, V1, P139, DOI 10.1007/s12559-009-9009-8; Linhares A, 2000, ARTIF INTELL, V121, P251, DOI 10.1016/S0004-3702(00)00042-4; Linhares A, 2007, COGNITIVE SCI, V31, P989, DOI 10.1080/03640210701703725; Linhares A, 2010, NEW IDEAS PSYCHOL, V28, P64, DOI 10.1016/j.newideapsych.2009.07.008; Lloyd S, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.237901; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Plate TA, 2003, HOLOGRAPHIC REDUCED; STEWART TC, 2009, COMPOSITIONALITY BIO; [No title captured], DOI DOI 10.1016/S1389-0417(03)00015-9	24	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15592	10.1371/journal.pone.0015592	http://dx.doi.org/10.1371/journal.pone.0015592			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246049	gold, Green Published, Green Submitted			2022-12-27	WOS:000286511200008
J	Luo, YZ; Zhang, MH				Luo, Yuzhou; Zhang, Minghua			Environmental Modeling and Exposure Assessment of Sediment-Associated Pyrethroids in an Agricultural Watershed	PLOS ONE			English	Article							SAN-JOAQUIN VALLEY; CALIFORNIA; PESTICIDES; TOXICITY; SYSTEMS; RUNOFF; USA	Synthetic pyrethroid insecticides have generated public concerns due to their increasing use and potential effects on aquatic ecosystems. A modeling system was developed in this study for simulating the transport processes and associated sediment toxicity of pyrethroids at coupled field/watershed scales. The model was tested in the Orestimba Creek watershed, an agriculturally intensive area in California' Central Valley. Model predictions were satisfactory when compared with measured suspended solid concentration (R-2 = 0.536), pyrethroid toxic unit (0.576), and cumulative mortality of Hyalella azteca (0.570). The results indicated that sediment toxicity in the study area was strongly related to the concentration of pyrethroids in bed sediment. Bifenthrin was identified as the dominant contributor to the sediment toxicity in recent years, accounting for 50-85% of predicted toxicity units. In addition, more than 90% of the variation on the annual maximum toxic unit of pyrethroids was attributed to precipitation and prior application of bifenthrin in the late irrigation season. As one of the first studies simulating the dynamics and spatial variability of pyrethroids in fields and instreams, the modeling results provided useful information on new policies to be considered with respect to pyrethroid regulation. This study suggested two potential measures to efficiently reduce sediment toxicity by pyrethroids in the study area: [1] limiting bifenthrin use immediately before rainfall season; and [2] implementing conservation practices to retain soil on cropland.	[Luo, Yuzhou; Zhang, Minghua] Wenzhou Med Coll, Wenzhou, Peoples R China; [Luo, Yuzhou; Zhang, Minghua] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA	Wenzhou Medical University; University of California System; University of California Davis	Luo, YZ (corresponding author), Wenzhou Med Coll, Wenzhou, Peoples R China.	yzluo@ucdavis.edu; mhzhang@ucdavis.edu	Luo, Yuzhou/A-7223-2010	Luo, Yuzhou/0000-0003-0879-9622	Coalition for Urban/Rural Environmental Stewardship; California State Water Quality Control Board; Zhejiang and Wenzhou [2008C03009, 20082780125]	Coalition for Urban/Rural Environmental Stewardship; California State Water Quality Control Board; Zhejiang and Wenzhou	The authors would like to acknowledge funding support from the Coalition for Urban/Rural Environmental Stewardship and California State Water Quality Control Board. This work was also supported by the 2005 to 2006 Consolidate Grants-Proposition 50 Agricultural Water Quality Grant Program, State of California, as well as the support from Zhejiang and Wenzhou (2008C03009, 20082780125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amweg EL, 2005, ENVIRON TOXICOL CHEM, V24, P966, DOI 10.1897/04-146R1.1; *CDWR, 2010, CAL LAND WAT US SURV; *CEPA, 2010, PEST US REP PUR; Chapra S. C., 2008, QUAL2K MODELING FRAM; *CVRWQCB, 2005, COND WAIV IRR AGR MO; Domagalski JL, 2010, ENVIRON TOXICOL CHEM, V29, P813, DOI 10.1002/etc.106; ENSMINGER M, 2009, PESTICIDE CONCENTRAT; Epstein L, 2003, ANNU REV PHYTOPATHOL, V41, P351, DOI 10.1146/annurev.phyto.41.052002.095612; *FOOTPRINT, 2010, FOOTPRINT PEST PROP; Hladik ML, 2009, J AGR FOOD CHEM, V57, P9079, DOI 10.1021/jf9020448; Laskowski Dennis A., 2002, V174, P49; LEONARD RA, 1987, T ASAE, V30, P1403; Luo YZ, 2007, J ENVIRON MANAGE, V83, P44, DOI 10.1016/j.jenvman.2006.01.017; Luo YZ, 2009, ENVIRON POLLUT, V157, P3370, DOI 10.1016/j.envpol.2009.06.024; Luo YZ, 2009, J ENVIRON QUAL, V38, P664, DOI 10.2134/jeq2008.0216; Luo YZ, 2008, ENVIRON POLLUT, V156, P1171, DOI 10.1016/j.envpol.2008.04.005; Ma QL, 2004, PEST MANAG SCI, V60, P267, DOI 10.1002/ps.846; MCKONE TE, 2003, CALTOX 4 0 MULTIMEDI; MEADOWS R, 2005, CALIF AGR, V59, P5; Moriasi DN, 2007, T ASABE, V50, P885, DOI 10.13031/2013.23153; Neitsch S.L., 2005, SOIL WATER ASSESSMEN; Olivera F, 1999, WATER RESOUR RES, V35, P1155, DOI 10.1029/1998WR900104; OLIVERA F, 1996, SPATIALLY DISTRIBUTE; Scholze M, 2001, ENVIRON TOXICOL CHEM, V20, P448, DOI 10.1002/etc.5620200228; Spencer J, 2006, REV ENVIRON CONTAM T, V186, P57, DOI 10.1007/0-387-32883-1_2; United States Environmental Protection Agency (US EPA), 2006, ORG PEST REV CUM RIS; *USEPA, 2006, EPA600R05111 CTR EXP; *USEPA, 2008, USEPA TIER 2 CROP SC; *USEPA, 2000, EPA600R99064 OFF RES; *USEPA, 2010, PEST ROOT ZON MOD PR; USGS, 2010, NAT WAT INF SYST WEB; Weston DP, 2008, ENVIRON TOXICOL CHEM, V27, P953, DOI 10.1897/07-449.1; Weston DP, 2004, ENVIRON SCI TECHNOL, V38, P2752, DOI 10.1021/es0352193; WILLIAMS WM, 2004, RIVWQ CHEM TRANSPORT	34	17	20	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15794	10.1371/journal.pone.0015794	http://dx.doi.org/10.1371/journal.pone.0015794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246035	Green Submitted, Green Published, gold			2022-12-27	WOS:000286511200014
J	de Mendonca, VRR; Andrade, BB; Almeida, A; Barral-Netto, M				Ramos de Mendonca, Vitor Rosa; Andrade, Bruno Bezerril; Almeida, Alessandro; Barral-Netto, Manoel			Can Score Databanks Help Teaching?	PLOS ONE			English	Article							COLLEGE ADMISSION TEST; MEDICAL-SCHOOL; EXAMINATION PERFORMANCE; LEARNING STYLES; PREDICTING PERFORMANCE; ACADEMIC-PERFORMANCE; LONGITUDINAL DATA; STUDENTS; VALIDITY; UNIVERSITY	Background: Basic courses in most medical schools assess students' performance by conferring scores. The objective of this work is to use a large score databank for the early identification of students with low performance and to identify course trends based on the mean of students' grades. Methodology/Principal Findings: We studied scores from 2,398 medical students registered in courses over a period of 10 years. Students in the first semester were grouped into those whose ratings remained in the lower quartile in two or more courses (low-performance) and students who had up to one course in the lower quartile (high-performance). ROC curves were built, aimed at the identification of a cut-off average score in the first semesters that would be able to predict low performances in future semesters. Moreover, to follow the long-term pattern of each course, the mean of all scores conferred in a semester was compared to the overall course mean obtained by averaging 10 years of data. Individuals in the low-performance group had a higher risk of being in the lower quartile of at least one course in the second semester (relative risk 3.907; 95% CI: 3.378-4.519) and in the eighth semester (relative risk 2.873; 95% CI: 2.495-3.308). The prediction analysis revealed that an average score of 7.188 in the first semester could identify students that presented scores below the lower quartiles in both the second and eighth semesters (p < 0.0001 for both AUC). When scores conferred by single courses were compared over time, three time-trend patterns emerged: low variation, upward trend and erratic pattern. Conclusion/Significance: An early identification of students with low performance may be useful in promoting pedagogical strategies for these individuals. Evaluation of the time trend of scores conferred by courses may help departments monitoring changes in personnel and methodology that may affect a student's performance.	[Ramos de Mendonca, Vitor Rosa; Andrade, Bruno Bezerril; Almeida, Alessandro; Barral-Netto, Manoel] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil; [Ramos de Mendonca, Vitor Rosa; Andrade, Bruno Bezerril; Barral-Netto, Manoel] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil; [Barral-Netto, Manoel] Inst Nacl Ciencia & Tecnol, Inst Invest Imunol, Sao Paulo, Brazil	Universidade Federal da Bahia; Fundacao Oswaldo Cruz	de Mendonca, VRR (corresponding author), Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.	mbarral@bahia.fiocruz.br	Andrade, Bruno/J-9111-2012; Almeida, Alessandro/A-1869-2010; Barral-Netto, Manoel/B-3904-2009; Andrade, Bruno/AAI-2248-2020	Andrade, Bruno/0000-0001-6833-3811; Almeida, Alessandro/0000-0001-9289-9727; Barral-Netto, Manoel/0000-0002-5823-7903; 	Brazilian National Research Council (CNPq)	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	VRRdM, BBA and AA received fellowships from the Brazilian National Research Council (CNPq). MB-N is a senior investigator from CNPq. This work was supported by CNPq, which had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	ARNOLD L, 1995, ACAD MED, V70, P715, DOI 10.1097/00001888-199508000-00016; Callahan CA, 2000, ACAD MED, V75, pS71, DOI 10.1097/00001888-200010001-00023; COLLIVER JA, 1989, ACAD MED, V64, P482, DOI 10.1097/00001888-198908000-00014; Ferguson E, 2002, BMJ-BRIT MED J, V324, P952, DOI 10.1136/bmj.324.7343.952; Gonnella JS, 2004, MED EDUC, V38, P425, DOI 10.1111/j.1365-2923.2004.01774.x; Hojat M, 2007, MED EDUC, V41, P982, DOI 10.1111/j.1365-2923.2007.02841.x; Iputo JE, 1999, S AFR MED J, V89, P550; Julian ER, 2005, ACAD MED, V80, P910, DOI 10.1097/00001888-200510000-00010; Kanna B, 2009, BMC MED EDUC, V9, DOI 10.1186/1472-6920-9-42; Kosower E, 1996, AM J MED SCI, V312, P214, DOI 10.1097/00000441-199611000-00004; LLOYD DA, 1992, ACAD MED, V67, P583, DOI 10.1097/00001888-199209000-00005; Lynch TG, 1998, AM J SURG, V176, P62, DOI 10.1016/S0002-9610(98)00107-X; McManus IC, 1998, BRIT MED J, V316, P345, DOI 10.1136/bmj.316.7128.345; McManus IC, 1999, BRIT MED J, V319, P542, DOI 10.1136/bmj.319.7209.542; Millis RM, 2009, ADV PHYSIOL EDUC, V33, P139, DOI 10.1152/advan.00028.2009; Rahbar MH, 2001, MED EDUC, V35, P374, DOI 10.1046/j.1365-2923.2001.00760.x; TOOTH D, 1989, MED EDUC, V23, P416, DOI 10.1111/j.1365-2923.1989.tb00896.x; Wiley A, 1996, ACAD MED, V71, pS83, DOI 10.1097/00001888-199610000-00052; Wilkinson D, 2008, MED J AUSTRALIA, V188, P349, DOI 10.5694/j.1326-5377.2008.tb01653.x; Wong JG, 2007, TEACH LEARN MED, V19, P216, DOI 10.1080/10401330701364551	20	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15695	10.1371/journal.pone.0015695	http://dx.doi.org/10.1371/journal.pone.0015695			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246033	Green Published, gold, Green Submitted			2022-12-27	WOS:000286511200011
J	Piepho, M; Martin-Creuzburg, D; Wacker, A				Piepho, Maike; Martin-Creuzburg, Dominik; Wacker, Alexander			Simultaneous Effects of Light Intensity and Phosphorus Supply on the Sterol Content of Phytoplankton	PLOS ONE			English	Article							KEYSTONE SPECIES DAPHNIA; ESSENTIAL LIPIDS; ISOPRENOID BIOSYNTHESIS; PLANT STEROLS; FOOD QUALITY; GROWTH; MAGNA; AVAILABILITY; CONSEQUENCES; ALLOCATION	Sterol profiles of microalgae and their change with environmental conditions are of great interest in ecological food web research and taxonomic studies alike. Here, we investigated effects of light intensity and phosphorus supply on the sterol content of phytoplankton and assessed potential interactive effects of these important environmental factors on the sterol composition of algae. We identified sterol contents of four common phytoplankton genera, Scenedesmus, Chlamydomonas, Cryptomonas and Cyclotella, and analysed the change in sterol content with varying light intensities in both a high-phosphorus and a low-phosphorus approach. Sterol contents increased significantly with increasing light in three out of four species. Phosphorus-limitation reversed the change of sterol content with light intensity, i.e., sterol content decreased with increasing light at low phosphorus supply. Generally sterol contents were lower in low-phosphorus cultures. In conclusion, both light and phosphorus conditions strongly affect the sterol composition of algae and hence should be considered in ecological and taxonomic studies investigating the biochemical composition of algae. Data suggest a possible sterol limitation of growth and reproduction of herbivorous crustacean zooplankton during summer when high light intensities and low phosphorus supply decrease sterol contents of algae.	[Piepho, Maike; Wacker, Alexander] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Martin-Creuzburg, Dominik] Univ Constance, Inst Limnol, D-7750 Constance, Germany	University of Potsdam; University of Konstanz	Piepho, M (corresponding author), Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany.	piepho@uni-potsdam.de	Wacker, Alexander/I-8277-2012; Martin-Creuzburg, Dominik/C-6361-2011	Wacker, Alexander/0000-0001-9687-6477; Martin-Creuzburg, Dominik/0000-0002-4248-0730	German Research Foundation (DFG) [WA 2445/4-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This study was supported by the German Research Foundation (DFG WA 2445/4-1, www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behmer S. T., 2003, INSECT STEROL NUTR P; Breteler WCMK, 1999, MAR BIOL, V135, P191, DOI 10.1007/s002270050616; Breteler WCMK, 2005, MAR ECOL PROG SER, V291, P125; Disch A, 1998, BIOCHEM J, V333, P381, DOI 10.1042/bj3330381; GESSNER MO, 1993, APPL ENVIRON MICROB, V59, P502, DOI 10.1128/AEM.59.2.502-507.1993; GLADU PK, 1990, COMP BIOCHEM PHYS B, V97, P491, DOI 10.1016/0305-0491(90)90149-N; GLADU PK, 1991, PHYTOCHEMISTRY, V30, P2301, DOI 10.1016/0031-9422(91)83634-W; GOAD LJ, 1981, PURE APPL CHEM, V53, P837, DOI 10.1351/pac198153040837; GOAD LJ, 1983, PHYTOCHEMISTRY, V22, P475, DOI 10.1016/0031-9422(83)83028-3; Gordillo FJL, 1998, J APPL PHYCOL, V10, P135, DOI 10.1023/A:1008067022973; GrandmouginFerjani A, 1997, PLANT PHYSIOL, V113, P163, DOI 10.1104/pp.113.1.163; Guschina IA, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P1, DOI 10.1007/978-0-387-89366-2_1; Hartmann MA, 1998, TRENDS PLANT SCI, V3, P170, DOI 10.1016/S1360-1385(98)01233-3; Martin-Creuzburg D, 2005, AQUAT MICROB ECOL, V41, P271, DOI 10.3354/ame041271; Martin-Creuzburg D, 2005, OECOLOGIA, V144, P362, DOI 10.1007/s00442-005-0090-8; Martin-Creuzburg D, 2004, J CHEM ECOL, V30, P483, DOI 10.1023/B:JOEC.0000018624.94689.95; Martin-Creuzburg D, 2010, LIMNOL OCEANOGR, V55, P2597, DOI 10.4319/lo.2010.55.6.2597; Martin-Creuzburg D, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P43, DOI 10.1007/978-0-387-89366-2_3; Martin-Creuzburg D, 2009, P R SOC B, V276, P1805, DOI 10.1098/rspb.2008.1540; Masse G, 2004, P NATL ACAD SCI USA, V101, P4413, DOI 10.1073/pnas.0400902101; Nichols HW., 1975, HDB PHYCOLOGICAL MET, P7; PARRISH CC, 1994, MAR CHEM, V48, P71, DOI 10.1016/0304-4203(94)90063-9; Patterson G. W., 1991, PHYSL BIOCH STEROLS, V5, P118; PATTERSON GW, 1994, PHYTOCHEMISTRY, V35, P1233, DOI 10.1016/S0031-9422(00)94826-X; PRAHL FG, 1984, SCIENCE, V224, P1235, DOI 10.1126/science.224.4654.1235; SCHULER I, 1991, P NATL ACAD SCI USA, V88, P6926, DOI 10.1073/pnas.88.16.6926; Sperfeld E, 2009, J EXP BIOL, V212, P3051, DOI 10.1242/jeb.031401; Thompson GA, 1996, BBA-LIPID LIPID MET, V1302, P17, DOI 10.1016/0005-2760(96)00045-8; Volkman JK, 2003, APPL MICROBIOL BIOT, V60, P495, DOI 10.1007/s00253-002-1172-8; Volkman JK, 1998, ORG GEOCHEM, V29, P1163, DOI 10.1016/S0146-6380(98)00062-X; Wacker A, 2007, FUNCT ECOL, V21, P738, DOI 10.1111/j.1365-2435.2007.01274.x	31	43	45	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15828	10.1371/journal.pone.0015828	http://dx.doi.org/10.1371/journal.pone.0015828			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209879	gold, Green Submitted, Green Published			2022-12-27	WOS:000285838900039
J	Bohr, W; Kupper, M; Hoffmann, K; Weiskirchen, R				Bohr, Wilhelm; Kupper, Michael; Hoffmann, Kurt; Weiskirchen, Ralf			Recombinant Expression, Purification, and Functional Characterisation of Connective Tissue Growth Factor and Nephroblastoma-Overexpressed Protein	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; TGF-BETA; FACTOR CTGF/CCN2; LIVER FIBROSIS; CCN3 NOV; SCLERODERMA FIBROBLASTS; GENE-EXPRESSION; CTGF EXPRESSION; FAMILY; PROLIFERATION	The CCN family of proteins, especially its prominent member, the Connective tissue growth factor (CTGF/CCN2) has been identified as a possible biomarker for the diagnosis of fibrotic diseases. As a downstream mediator of TGF-beta 1 signalling, it is involved in tissue scarring, stimulates interstitial deposition of extracellular matrix proteins, and promotes proliferation of several cell types. Another member of this family, the Nephroblastoma-Overexpressed protein (NOV/CCN3), has growth-inhibiting properties. First reports further suggest that these two CCN family members act opposite to each other in regulating extracellular matrix protein expression and reciprocally influence their own expression when over-expressed. We have established stable HEK and Flp-In-293 clones as productive sources for recombinant human CCN2/CTGF. In addition, we generated an adenoviral vector for recombinant expression of rat NOV and established protocols to purify large quantities of these CCN proteins. The identity of purified human CCN2/CTGF and rat CCN3/NOV was proven by In-gel digest followed by ESI-TOF/MS mass spectrometry. The biological activity of purified proteins was demonstrated using a Smad3-sensitive reporter gene and BrdU proliferation assay in permanent cell line EA.hy 926 cells. We further demonstrate for the first time that both recombinant CCN proteins are N-glycosylated.	[Bohr, Wilhelm; Weiskirchen, Ralf] RWTH Univ Hosp Aachen, Inst Clin Chem & Pathobiochem, Aachen, Germany; [Kupper, Michael; Hoffmann, Kurt] Rhein Westfal TH Aachen, Inst Mol Biotechnol, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University	Bohr, W (corresponding author), RWTH Univ Hosp Aachen, Inst Clin Chem & Pathobiochem, Aachen, Germany.	rweiskirchen@ukaachen.de	Kupper, Michael/AAW-1780-2021; Hoffmann, Kurt/P-2539-2014; Weiskirchen, Ralf/O-1734-2018	Hoffmann, Kurt/0000-0002-7991-423X; Weiskirchen, Ralf/0000-0003-3888-0931; Kupper, Michael/0000-0002-0010-9570	Deutsche Forschungsgemeinschaft [SFB/TRR57 P13]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by a grant from the Deutsche Forschungsgemeinschaft (SFB/TRR57 P13). This is the official German support foundation for German science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham DJ, 2000, J BIOL CHEM, V275, P15220, DOI 10.1074/jbc.275.20.15220; Arnott JA, 2008, BONE, V42, P871, DOI 10.1016/j.bone.2008.01.006; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; Borkham-Kamphorst E, 2004, BIOCHEM BIOPH RES CO, V317, P451, DOI 10.1016/j.bbrc.2004.03.064; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Chen MM, 2000, J MOL CELL CARDIOL, V32, P1805, DOI 10.1006/jmcc.2000.1215; Chen QA, 2010, AM J PHYSIOL-ENDOC M, V299, pE62, DOI 10.1152/ajpendo.00067.2010; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x; Gressner Olav A, 2007, Comp Hepatol, V6, P7, DOI 10.1186/1476-5926-6-7; Gressner OA, 2007, J HEPATOL, V47, P699, DOI 10.1016/j.jhep.2007.05.015; Grotendorst GR, 2005, FASEB J, V19, P729, DOI 10.1096/fj.04-3217com; Gupta N, 2001, J CLIN PATHOL-MOL PA, V54, P293, DOI 10.1136/mp.54.5.293; HIROSAWA M, 1993, COMPUT APPL BIOSCI, V9, P161; Holmes A, 2001, J BIOL CHEM, V276, P10594, DOI 10.1074/jbc.M010149200; IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637; JOLIOT V, 1992, MOL CELL BIOL, V12, P10, DOI 10.1128/MCB.12.1.10; Kang DH, 2002, B KOREAN CHEM SOC, V23, P1511; Karger A, 2008, CELL SIGNAL, V20, P1865, DOI 10.1016/j.cellsig.2008.06.016; Kovalenko E, 2009, J VIRAL HEPATITIS, V16, P612, DOI 10.1111/j.1365-2893.2009.01110.x; Kunzmann S, 2008, INT ARCH ALLERGY IMM, V147, P152, DOI 10.1159/000137284; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Leask A, 2001, J CLIN PATHOL-MOL PA, V54, P180, DOI 10.1136/mp.54.3.180; Lin CG, 2005, J BIOL CHEM, V280, P8229, DOI 10.1074/jbc.M404903200; Lin CG, 2003, J BIOL CHEM, V278, P24200, DOI 10.1074/jbc.M302028200; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P57, DOI 10.1136/mp.54.2.57; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Phanish MK, 2010, NEPHRON EXP NEPHROL, V114, pE83, DOI 10.1159/000262316; Rachfal AW, 2003, HEPATOL RES, V26, P1, DOI 10.1016/S1386-6346(03)00115-3; Rietsch A, 1998, ANNU REV GENET, V32, P163, DOI 10.1146/annurev.genet.32.1.163; Riser BL, 2009, AM J PATHOL, V174, P1725, DOI 10.2353/ajpath.2009.080241; Secker GA, 2008, EXP CELL RES, V314, P131, DOI 10.1016/j.yexcr.2007.09.001; Sin WC, 2009, J BIOL CHEM, V284, P29935, DOI 10.1074/jbc.M109.042630; SORET J, 1989, J VIROL, V63, P1803, DOI 10.1128/JVI.63.4.1803-1807.1989; Tong ZY, 2009, HEPATOLOGY, V50, P939, DOI 10.1002/hep.23102; van Roeyen CRC, 2008, KIDNEY INT, V73, P86, DOI 10.1038/sj.ki.5002584; Weiskirchen R, 2011, FRONT BIOSCI-LANDMRK, V16, P1939, DOI 10.2741/3832; Xu SW, 2009, J CELL COMMUN SIGNAL, V3, P61, DOI 10.1007/s12079-009-0053-7	41	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e16000	10.1371/journal.pone.0016000	http://dx.doi.org/10.1371/journal.pone.0016000			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209863	Green Submitted, gold, Green Published			2022-12-27	WOS:000285793600055
J	Keasey, S; Pugh, C; Tikhonov, A; Chen, GX; Schweitzer, B; Nalca, A; Ulrich, RG				Keasey, Sarah; Pugh, Christine; Tikhonov, Alexander; Chen, Gengxin; Schweitzer, Barry; Nalca, Aysegul; Ulrich, Robert G.			Proteomic Basis of the Antibody Response to Monkeypox Virus Infection Examined in Cynomolgus Macaques and a Comparison to Human Smallpox Vaccination	PLOS ONE			English	Article							HUMAN IMMUNE-RESPONSE; VACCINIA VIRUS; INTRACELLULAR MATURE; PROTECTION; PROTEINS; ANTIGENS; VIRION; CONGO	Monkeypox is a zoonotic viral disease that occurs primarily in Central and West Africa. A recent outbreak in the United States heightened public health concerns for susceptible human populations. Vaccinating with vaccinia virus to prevent smallpox is also effective for monkeypox due to a high degree of sequence conservation. Yet, the identity of antigens within the monkeypox virus proteome contributing to immune responses has not been described in detail. We compared antibody responses to monkeypox virus infection and human smallpox vaccination by using a protein microarray covering 92-95% (166-192 proteins) of representative proteomes from monkeypox viral clades of Central and West Africa, including 92% coverage (250 proteins) of the vaccinia virus proteome as a reference orthopox vaccine. All viral gene clones were verified by sequencing and purified recombinant proteins were used to construct the microarray. Serum IgG of cynomolgus macaques that recovered from monkeypox recognized at least 23 separate proteins within the orthopox proteome, while only 14 of these proteins were recognized by IgG from vaccinated humans. There were 12 of 14 antigens detected by sera of human vaccinees that were also recognized by IgG from convalescent macaques. The greatest level of IgG binding for macaques occurred with the structural proteins F13L and A33R, and the membrane scaffold protein D13L. Significant IgM responses directed towards A44R, F13L and A33R of monkeypox virus were detected before onset of clinical symptoms in macaques. Thus, antibodies from vaccination recognized a small number of proteins shared with pathogenic virus strains, while recovery from infection also involved humoral responses to antigens uniquely recognized within the monkeypox virus proteome.	[Keasey, Sarah; Pugh, Christine; Nalca, Aysegul; Ulrich, Robert G.] USA, Med Res Inst Infect Dis, Frederick, MD USA; [Tikhonov, Alexander; Chen, Gengxin; Schweitzer, Barry] Life Technol, Carlsbad, CA USA	Thermo Fisher Scientific	Keasey, S (corresponding author), USA, Med Res Inst Infect Dis, Frederick, MD USA.	rulrich@bioanalysis.org	Tikhonov, Alexander/I-1453-2012; Nalca, Aysegul/L-8149-2019	Tikhonov, Alexander/0000-0003-3808-9701; Nalca, Aysegul/0000-0001-8581-7535	Joint Science and Technology Office [4.10017_06_RD, W81XWH-05-2-0077]	Joint Science and Technology Office	Financial support was provided by funding from the Joint Science and Technology Office (4.10017_06_RD and W81XWH-05-2-0077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benhnia MREI, 2008, J VIROL, V82, P3751, DOI 10.1128/JVI.02244-07; CDC (Centers for Disease Control and Prevention), 2004, UPD INT CAS DEF HUM; Chen NH, 2005, VIROLOGY, V340, P46, DOI 10.1016/j.virol.2005.05.030; Chung CS, 2006, J VIROL, V80, P2127, DOI 10.1128/JVI.80.5.2127-2140.2006; Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331; Edghill-Smith Y, 2005, NAT MED, V11, P740, DOI 10.1038/nm1261; Fenner F, 1988, SMALLPOX ITS ERADICA, P1287; Hammarlund E, 2005, NAT MED, V11, P1005, DOI 10.1038/nm1273; Heimburg-Molinaro Jamie, 2009, V534, P341, DOI 10.1007/978-1-59745-022-5_24; Davies DH, 2007, PROTEOMICS, V7, P1678, DOI 10.1002/pmic.200600926; Jarvis DL, 2003, VIROLOGY, V310, P1, DOI 10.1016/S0042-6822(03)00120-X; JEZEK Z, 1988, B WORLD HEALTH ORGAN, V66, P459; Karem KL, 2007, CLIN VACCINE IMMUNOL, V14, P1318, DOI 10.1128/CVI.00148-07; Karem KL, 2005, CLIN DIAGN LAB IMMUN, V12, P867, DOI 10.1128/CDLI.12.7.867-872.2005; Keasey SL, 2009, MOL CELL PROTEOMICS, V8, P924, DOI 10.1074/mcp.M800213-MCP200; KHODAKEVICH L, 1988, B WORLD HEALTH ORGAN, V66, P747; Learned LA, 2005, AM J TROP MED HYG, V73, P428, DOI 10.4269/ajtmh.2005.73.428; Likos AM, 2005, J GEN VIROL, V86, P2661, DOI 10.1099/vir.0.81215-0; Manes NP, 2008, J PROTEOME RES, V7, P960, DOI 10.1021/pr070432+; Nalca A, 2005, CLIN INFECT DIS, V41, P1765, DOI 10.1086/498155; Parker S, 2007, FUTURE MICROBIOL, V2, P17, DOI 10.2217/17460913.2.1.17; Putz MM, 2006, NAT MED, V12, P1310, DOI 10.1038/nm1457; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Resch W, 2007, VIROLOGY, V358, P233, DOI 10.1016/j.virol.2006.08.025; Schmid K, 2008, PROTEOM CLIN APPL, V2, P1528, DOI 10.1002/prca.200780113; Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018; Smith GL, 2004, VIRUS RES, V106, P189, DOI 10.1016/j.virusres.2004.08.015; Weaver JR, 2008, IMMUNOL REV, V225, P96, DOI 10.1111/j.1600-065X.2008.00691.x; Yoder JD, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-10	29	25	25	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15547	10.1371/journal.pone.0015547	http://dx.doi.org/10.1371/journal.pone.0015547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209900	gold, Green Submitted, Green Published			2022-12-27	WOS:000285793600019
J	Wei, CL; Rowe, GT; Escobar-Briones, E; Boetius, A; Soltwedel, T; Caley, MJ; Soliman, Y; Huettmann, F; Qu, FY; Yu, ZS; Pitcher, CR; Haedrich, RL; Wicksten, MK; Rex, MA; Baguley, JG; Sharma, J; Danovaro, R; MacDonald, IR; Nunnally, CC; Deming, JW; Montagna, P; Levesque, M; Weslawski, JM; Wlodarska-Kowalczuk, M; Ingole, BS; Bett, BJ; Billett, DSM; Yool, A; Bluhm, BA; Iken, K; Narayanaswamy, BE				Wei, Chih-Lin; Rowe, Gilbert T.; Escobar-Briones, Elva; Boetius, Antje; Soltwedel, Thomas; Caley, M. Julian; Soliman, Yousria; Huettmann, Falk; Qu, Fangyuan; Yu, Zishan; Pitcher, C. Roland; Haedrich, Richard L.; Wicksten, Mary K.; Rex, Michael A.; Baguley, Jeffrey G.; Sharma, Jyotsna; Danovaro, Roberto; MacDonald, Ian R.; Nunnally, Clifton C.; Deming, Jody W.; Montagna, Paul; Levesque, Melanie; Weslawski, Jan Marcin; Wlodarska-Kowalczuk, Maria; Ingole, Baban S.; Bett, Brian J.; Billett, David S. M.; Yool, Andrew; Bluhm, Bodil A.; Iken, Katrin; Narayanaswamy, Bhavani E.			Global Patterns and Predictions of Seafloor Biomass Using Random Forests	PLOS ONE			English	Article							OXYGEN MINIMUM ZONE; COMMUNITY STRUCTURE; CONTINENTAL-MARGIN; BACTERIAL BIOMASS; ORGANIC-MATTER; STANDING STOCK; WATER DEPTH; NE ATLANTIC; DEEP; SEDIMENT	A comprehensive seafloor biomass and abundance database has been constructed from 24 oceanographic institutions worldwide within the Census of Marine Life (CoML) field projects. The machine-learning algorithm, Random Forests, was employed to model and predict seafloor standing stocks from surface primary production, water-column integrated and export particulate organic matter (POM), seafloor relief, and bottom water properties. The predictive models explain 63% to 88% of stock variance among the major size groups. Individual and composite maps of predicted global seafloor biomass and abundance are generated for bacteria, meiofauna, macrofauna, and megafauna (invertebrates and fishes). Patterns of benthic standing stocks were positive functions of surface primary production and delivery of the particulate organic carbon (POC) flux to the seafloor. At a regional scale, the census maps illustrate that integrated biomass is highest at the poles, on continental margins associated with coastal upwelling and with broad zones associated with equatorial divergence. Lowest values are consistently encountered on the central abyssal plains of major ocean basins The shift of biomass dominance groups with depth is shown to be affected by the decrease in average body size rather than abundance, presumably due to decrease in quantity and quality of food supply. This biomass census and associated maps are vital components of mechanistic deep-sea food web models and global carbon cycling, and as such provide fundamental information that can be incorporated into evidence-based management.	[Wei, Chih-Lin; Qu, Fangyuan; Nunnally, Clifton C.] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; [Rowe, Gilbert T.] Univ Texas Galveston, Dept Marine Biol, Galveston, TX 77555 USA; [Escobar-Briones, Elva] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Mexico City 04510, DF, Mexico; [Boetius, Antje; Soltwedel, Thomas] Alfred Wegener Inst Polar & Marine Res, D-2850 Bremerhaven, Germany; [Caley, M. Julian] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Soliman, Yousria] Qatar Univ, Doha, Qatar; [Huettmann, Falk] Univ Alaska Fairbanks, Dept Biol & Wildlife, Inst Arctic Biol, Fairbanks, AK USA; [Qu, Fangyuan; Yu, Zishan] Ocean Univ Qingdao, Coll Marine Life Sci, Qingdao 266003, Peoples R China; [Pitcher, C. Roland] CSIRO Marine & Atmospher Res, Cleveland, Qld, Australia; [Haedrich, Richard L.] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada; [Wicksten, Mary K.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Rex, Michael A.] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA; [Baguley, Jeffrey G.] Univ Nevada, Dept Biol, Reno, NV 89557 USA; [Sharma, Jyotsna] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA; [Danovaro, Roberto] Polytech Univ Marche, Dept Marine Sci, Ancona, Italy; [MacDonald, Ian R.] Florida State Univ, Dept Oceanog, Tallahassee, FL 32306 USA; [Deming, Jody W.] Univ Washington, Dept Oceanog, Seattle, WA 98195 USA; [Montagna, Paul] Texas A&M Univ Corpus Christi, Harte Res Inst, Corpus Christi, TX USA; [Levesque, Melanie] Univ Quebec, Inst Sci Mer Rimouski, Rimouski, PQ G5L 3A1, Canada; [Weslawski, Jan Marcin; Wlodarska-Kowalczuk, Maria] Polish Acad Sci, Inst Oceanol, Sopot, Poland; [Ingole, Baban S.] Natl Inst Oceanog, Panaji, Goa, India; [Bett, Brian J.; Billett, David S. M.; Yool, Andrew] Natl Oceanog Ctr, Southampton, Hants, England; [Bluhm, Bodil A.; Iken, Katrin] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK USA; [Narayanaswamy, Bhavani E.] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban, Argyll, Scotland	Texas A&M University System; Texas A&M University College Station; University of Texas System; University of Texas Medical Branch Galveston; Universidad Nacional Autonoma de Mexico; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Australian Institute of Marine Science; Qatar University; University of Alaska System; University of Alaska Fairbanks; Ocean University of China; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Memorial University Newfoundland; Texas A&M University System; Texas A&M University College Station; University of Massachusetts System; University of Massachusetts Boston; Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Texas System; University of Texas at San Antonio (UTSA); Marche Polytechnic University; State University System of Florida; Florida State University; University of Washington; University of Washington Seattle; Texas A&M University System; Texas A&M University Corpus Christi; University of Quebec; Polish Academy of Sciences; Institute of Oceanology of the Polish Academy of Sciences; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO); NERC National Oceanography Centre; University of Alaska System; University of Alaska Fairbanks; UHI Millennium Institute	Wei, CL (corresponding author), Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA.	weic@tamug.edu	Boetius, Antje/D-5459-2013; Weslawski, Jan M/F-4075-2012; Montagna, Paul A./J-8208-2017; Ingole, Baban Shravan/GLR-9722-2022; Yool, Andrew/B-4799-2012; Pitcher, C. Roland/A-2368-2012; Wlodarska-kowalczuk, Maria/K-4325-2012; Soltwedel, Thomas/P-1852-2016; Bluhm, Bodil/E-7165-2015; Caley, Julian/A-4042-2008	Boetius, Antje/0000-0003-2117-4176; Montagna, Paul A./0000-0003-4199-3312; Yool, Andrew/0000-0002-9879-2776; Soltwedel, Thomas/0000-0002-8214-5937; Bluhm, Bodil/0000-0002-4584-7796; Caley, Julian/0000-0001-5739-749X; Narayanaswamy, Bhavani/0000-0002-5810-9127; MacDonald, Ian R/0000-0001-9717-7926; Ingole, Baban/0000-0001-6096-6980; Weslawski, Jan-Marcin/0000-0001-8434-5927; WEI, CHIH-LIN/0000-0001-9430-0060; Escobar Briones, Elva/0000-0002-8485-7495; Soliman, Yousria/0000-0001-5062-6640	Census of Marine Life (CoML); Sloan Foundation; NERC [dml010007, noc010010, noc010009] Funding Source: UKRI; Natural Environment Research Council [dml010007, noc010009, noc010010] Funding Source: researchfish	Census of Marine Life (CoML); Sloan Foundation(Alfred P. Sloan Foundation); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by a grant from the Census of Marine Life (CoML) and the Sloan Foundation to G. T. Rowe and E. Escobar-Briones. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amante C., 2009, ETOPO1 ARC MINUTE GL, DOI DOI 10.7289/V5C8276M; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; BETT BJ, 1994, MAR ECOL PROG SER, V104, P197, DOI 10.3354/meps104197; Billett DSM, 2010, DEEP-SEA RES PT II, V57, P1406, DOI 10.1016/j.dsr2.2009.02.001; Bivand RS, 2008, USE R, P1; Boehlert G.W., 1987, WILEY, V43, P319, DOI [DOI 10.1029/GM043P0319, 10.1029/GM043P0319]; BOETIUS A, 1994, MAR ECOL PROG SER, V104, P299, DOI 10.3354/meps104299; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; BROOKS JM, 1987, SCIENCE, V238, P1138, DOI 10.1126/science.238.4830.1138; Clough LM, 2005, CAN J FISH AQUAT SCI, V62, P1756, DOI 10.1139/F05-102; Clough LM, 1997, DEEP-SEA RES PT II, V44, P1683, DOI 10.1016/S0967-0645(97)00052-0; Cutler A, 2006, METHOD ENZYMOL, V411, P422, DOI 10.1016/S0076-6879(06)11023-X; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Danovaro R, 2002, DEEP-SEA RES PT I, V49, P843, DOI 10.1016/S0967-0637(01)00084-X; Danovaro R, 2008, NATURE, V454, P1084, DOI 10.1038/nature07268; Danovaro R, 1995, PROG OCEANOGR, V36, P329, DOI 10.1016/0079-6611(96)00002-X; De Leo FC, 2010, P ROYAL S B IN PRESS; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Deming J. W., 1993, ORGANIC GEOCHEMISTRY, P119; Deming JW, 2008, DEEP-SEA RES PT II, V55, P2597, DOI 10.1016/j.dsr2.2008.07.009; Deming JW, 2000, NONCULTURABLE MICROORGANISMS IN THE ENVIRONMENT, P147; DEMING JW, 1992, NATO ADV SCI I C-MAT, V360, P11; DEMING JW, 1985, APPL ENVIRON MICROB, V50, P1002, DOI 10.1128/AEM.50.4.1002-1006.1985; Dixon JL, 2000, HYDROBIOLOGIA, V440, P217, DOI 10.1023/A:1004127312756; Dunne JP, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002907; Flach E, 2002, PROG OCEANOGR, V52, P433, DOI 10.1016/S0079-6611(02)00018-6; Gage J.D., 2005, P273, DOI 10.1002/9780470995129.ch7; Gage J. D., 1991, DEEP SEA BIOL NATURA; Gage JD, 2002, MAR ECOL PROG SER, V225, P97, DOI 10.3354/meps225097; GOODAY AJ, 1992, NATO ADV SCI I C-MAT, V360, P63; Grebmeier JM, 2007, ELSEV OCEANOGR SERIE, V74, P363, DOI 10.1016/S0422-9894(06)74011-9; Grebmeier JM, 2006, PROG OCEANOGR, V71, P331, DOI 10.1016/j.pocean.2006.10.001; Heip CHR, 2001, DEEP-SEA RES PT II, V48, P3223, DOI 10.1016/S0967-0645(01)00038-8; Ho CK, 2010, AM NAT, V175, P269, DOI 10.1086/649583; Holme N, 1971, IBP HDB; Ingels J, 2010, MAR ECOL PROG SER, V406, P121, DOI 10.3354/meps08535; Johnson NA, 2007, DEEP-SEA RES PT I, V54, P1350, DOI 10.1016/j.dsr.2007.04.011; Kirchman DL, 2009, NAT REV MICROBIOL, V7, P451, DOI 10.1038/nrmicro2115; Levin LA, 2000, DEEP-SEA RES PT II, V47, P189, DOI 10.1016/S0967-0645(99)00103-4; LOCHTE K, 1988, NATURE, V333, P67, DOI 10.1038/333067a0; LOCHTE K, 1992, NATO ADV SCI I C-MAT, V360, P1; Narayanaswamy BE, 2010, MAR ECOL-EVOL PERSP, V31, P237, DOI 10.1111/j.1439-0485.2010.00360.x; Oppel S, 2010, SPATIAL COMPLEXITY, INFORMATICS, AND WILDLIFE CONSERVATION, P151, DOI 10.1007/978-4-431-87771-4_8; PACE ML, 1987, NATURE, V325, P803, DOI 10.1038/325803a0; Patching JW, 1997, DEEP-SEA RES PT I, V44, P1655, DOI 10.1016/S0967-0637(97)00040-X; Petersen CG., 1913, REPORT DANISH BIOL S, V21, P1; PETERSEN CGJ, 1918, REP DAN BIOL STN, V25, P1; Pfannkuche O, 2000, DEEP-SEA RES PT II, V47, P2615, DOI 10.1016/S0967-0645(00)00041-2; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Pitcher CR, EXPLORING ROLE UNPUB; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Queric NV, 2004, J MICROBIOL METH, V57, P351, DOI 10.1016/j.mimet.2004.02.005; Quiroga E, 2005, ESTUAR COAST SHELF S, V62, P217, DOI 10.1016/j.ecss.2004.08.020; R Core Team, 2021, R LANGUAGE ENV STAT; Rex M.A., 2010, BIOSCIENCE; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; ROWE G, 1991, MAR ECOL PROG SER, V79, P99, DOI 10.3354/meps079099; Rowe G.T., 1979, Ambio Special Report, P19, DOI 10.2307/25099603; Rowe GT, 2008, DEEP-SEA RES PT II, V55, P2699, DOI 10.1016/j.dsr2.2008.07.020; Rowe GT, 2008, DEEP-SEA RES PT II, V55, P2686, DOI 10.1016/j.dsr2.2008.07.018; ROWE GT, 1994, DEEP-SEA RES PT II, V41, P657, DOI 10.1016/0967-0645(94)90039-6; Rowe GT, 1997, J MARINE SYST, V10, P497, DOI 10.1016/S0924-7963(96)00065-6; ROWE GT, 1982, DEEP-SEA RES, V29, P257, DOI 10.1016/0198-0149(82)90113-3; Rowe GT, MARINE BIOL RE UNPUB; ROWE GT, 1992, DEEP SEA FOOD CHAINS; Rowe GT, BIODIVERSITY D UNPUB; Rowe GT, 1983, SEA, P97; SMITH CR, 1992, NATO ADV SCI I C-MAT, V360, P375; Smith CR, 1997, DEEP-SEA RES PT II, V44, P2295, DOI 10.1016/S0967-0645(97)00022-2; Smith CR, 1998, DEEP-SEA RES PT II, V45, P335, DOI 10.1016/S0967-0645(97)00043-X; Smith K. L., 1983, SEA, P331; Smith KL, 2009, P NATL ACAD SCI USA, V106, P19211, DOI 10.1073/pnas.0908322106; Soliman Y, 2007, ZOOTAXA, P45, DOI 10.11646/zootaxa.1389.3; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Soltwedel T, 2000, PROG OCEANOGR, V46, P59, DOI 10.1016/S0079-6611(00)00030-6; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; Sweetman AK, 2008, MAR ECOL PROG SER, V355, P73, DOI 10.3354/meps07240; THIEL H, 1975, Internationale Revue der Gesamten Hydrobiologie, V60, P575; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; van Nugteren P, 2009, LIMNOL OCEANOGR, V54, P1413, DOI 10.4319/lo.2009.54.5.1413; Vetter YA, 1998, MICROBIAL ECOL, V36, P75, DOI 10.1007/s002489900095; Vinogradov M.E., 1983, DEEP SEA BIOL, V8, P123; Wei CL, 2010, MAR ECOL PROG SER, V399, P1, DOI 10.3354/meps08388; Westberry T, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003078; Williams RG, 2003, GLO CH IGBP, P19; Witte U, 2003, NATURE, V424, P763, DOI 10.1038/nature01799; Xu P., 2004, P 2004 C EMP METH NA; Yool A, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004792	90	244	250	1	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15323	10.1371/journal.pone.0015323	http://dx.doi.org/10.1371/journal.pone.0015323			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209928	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000285793600017
J	Buchold, GM; Coarfa, C; Kim, J; Milosavljevic, A; Gunaratne, PH; Matzuk, MM				Buchold, Gregory M.; Coarfa, Cristian; Kim, Jong; Milosavljevic, Aleksandar; Gunaratne, Preethi H.; Matzuk, Martin M.			Analysis of MicroRNA Expression in the Prepubertal Testis	PLOS ONE			English	Article							GERM-CELL TUMORS; EMBRYONIC STEM-CELLS; RNA-BINDING PROTEIN; MESSENGER-RNA; CHROMATOID BODY; GENE-EXPRESSION; ADAR DEAMINASES; EDITING SITES; LIN28; PRECURSOR	Only thirteen microRNAs are conserved between D. melanogaster and the mouse; however, conditional loss of miRNA function through mutation of Dicer causes defects in proliferation of premeiotic germ cells in both species. This highlights the potentially important, but uncharacterized, role of miRNAs during early spermatogenesis. The goal of this study was to characterize on postnatal day 7, 10, and 14 the content and editing of murine testicular miRNAs, which predominantly arise from spermatogonia and spermatocytes, in contrast to prior descriptions of miRNAs in the adult mouse testis which largely reflects the content of spermatids. Previous studies have shown miRNAs to be abundant in the mouse testis by postnatal day 14; however, through Next Generation Sequencing of testes from a B6;129 background we found abundant earlier expression of miRNAs and describe shifts in the miRNA signature during this period. We detected robust expression of miRNAs encoded on the X chromosome in postnatal day 14 testes, consistent with prior studies showing their resistance to meiotic sex chromosome inactivation. Unexpectedly, we also found a similar positional enrichment for most miRNAs on chromosome 2 at postnatal day 14 and for those on chromosome 12 at postnatal day 7. We quantified in vivo developmental changes in three types of miRNA variation including 5' heterogeneity, editing, and 3' nucleotide addition. We identified eleven putative novel pubertal testis miRNAs whose developmental expression suggests a possible role in early male germ cell development. These studies provide a foundation for interpretation of miRNA changes associated with testicular pathology and identification of novel components of the miRNA editing machinery in the testis.	[Buchold, Gregory M.; Gunaratne, Preethi H.; Matzuk, Martin M.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Buchold, Gregory M.; Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Coarfa, Cristian; Milosavljevic, Aleksandar] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Kim, Jong; Gunaratne, Preethi H.] Univ Houston, Dept Biol & Biochem, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Houston System; University of Houston	Buchold, GM (corresponding author), Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA.	mmatzuk@tmc.bcm.edu		Buchold, Greg/0000-0003-0710-7866	National Institutes of Health, National Institute of Child Health and Human Development (NIH-NICHD) [5R01HD057880, 5T32HD007165]; National Institutes of Health, Epigenomics Roadmap Initiative from National Institute on Drug Abuse (NIH-NIDA) [5U01DA025956]; National Institutes of Health, Epigenomics Roadmap Initiative from National Human Genome Research Institute (NIH-NHGRI) [5R01HG4009]	National Institutes of Health, National Institute of Child Health and Human Development (NIH-NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health, Epigenomics Roadmap Initiative from National Institute on Drug Abuse (NIH-NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Health, Epigenomics Roadmap Initiative from National Human Genome Research Institute (NIH-NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported in part by National Institutes of Health, National Institute of Child Health and Human Development (NIH-NICHD) 5R01HD057880 (to M. M. M); National Institutes of Health, Epigenomics Roadmap Initiative grant from National Institute on Drug Abuse (NIH-NIDA) 5U01DA025956 and National Human Genome Research Institute (NIH-NHGRI) 5R01HG4009 (to A. M.), and National Institutes of Health, National Institute of Child Health and Human Development (NIH-NICHD) 5T32HD007165 (to G. M. B.). The authors also thank the Cullen Foundation for their generous support of the University of Houston's Institute for Molecular Design (IMD) Illumina/Solexa Sequencer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HW, 2010, MOL HUM REPROD; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Blow MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r27; Carthew RW, 2006, SCIENCE, V313, P305, DOI 10.1126/science.1131186; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Creighton CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009637; de Hoon MJL, 2010, GENOME RES, V20, P257, DOI 10.1101/gr.095273.109; Eisenberg E, 2005, NUCLEIC ACIDS RES, V33, P4612, DOI 10.1093/nar/gki771; Ferras C, 2007, FERTIL STERIL, V88, P1681, DOI 10.1016/j.fertnstert.2007.01.063; Gillis AJM, 2007, J PATHOL, V213, P319, DOI 10.1002/path.2230; Gottwein E, 2006, J VIROL, V80, P5321, DOI 10.1128/JVI.02734-05; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gu P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002548; Habig JW, 2007, MOL CELL, V25, P792, DOI 10.1016/j.molcel.2007.03.010; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Huang J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705116200; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; Kleene KC, 2003, CYTOGENET GENOME RES, V103, P217, DOI 10.1159/000076807; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kotaja N, 2007, NAT REV MOL CELL BIO, V8, P85, DOI 10.1038/nrm2081; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Linsen SEV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-249; Looijenga LHJ, 2007, INT J ANDROL, V30, P304, DOI 10.1111/j.1365-2605.2007.00765.x; Luciano DJ, 2004, RNA, V10, P1174, DOI 10.1261/rna.7350304; Ma L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000635; Mishima T, 2008, REPRODUCTION, V136, P811, DOI 10.1530/REP-08-0349; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Novotny GW, 2007, INT J ANDROL, V30, P316, DOI 10.1111/j.1365-2605.2007.00773.x; Ohman M, 2007, BIOCHIMIE, V89, P1171, DOI 10.1016/j.biochi.2007.06.002; Pfeffer Sebastien, 2005, Curr Protoc Mol Biol, VChapter 26, DOI 10.1002/0471142727.mb2604s72; Pires-daSilva A, 2001, DEV BIOL, V233, P319, DOI 10.1006/dbio.2001.0169; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Reid JG, 2008, GENOME RES, V18, P1571, DOI 10.1101/gr.078246.108; Reuter VE, 2005, MODERN PATHOL, V18, pS51, DOI 10.1038/modpathol.3800309; Ro S, 2007, DEV BIOL, V311, P592, DOI 10.1016/j.ydbio.2007.09.009; SCHUMACHER JM, 1995, J CELL BIOL, V129, P1023, DOI 10.1083/jcb.129.4.1023; Slezak-Prochazka I, 2010, RNA, V16, P1087, DOI 10.1261/rna.1804410; Song R, 2009, NAT GENET, V41, P488, DOI 10.1038/ng.338; Tanaka K, 2009, ONCOGENE, V28, P2142, DOI 10.1038/onc.2009.89; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang PJ, 2004, TRENDS ENDOCRIN MET, V15, P79, DOI 10.1016/j.tem.2004.01.007; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yu ZR, 2005, BIOL REPROD, V73, P427, DOI 10.1095/biolreprod.105.040998	53	79	82	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15317	10.1371/journal.pone.0015317	http://dx.doi.org/10.1371/journal.pone.0015317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206922	Green Submitted, gold, Green Published			2022-12-27	WOS:000285793200024
J	Burdet, J; Zotta, E; Cella, M; Franchi, AM; Ibarra, C				Burdet, Juliana; Zotta, Elsa; Cella, Maximiliano; Franchi, Ana M.; Ibarra, Cristina			Role of Nitric Oxide in Shiga Toxin-2-Induced Premature Delivery of Dead Fetuses in Rats	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; ENDOTHELIAL-CELLS; ESCHERICHIA-COLI; TOXIN; MODEL	Shiga toxin-producing Escherichia coli (STEC) infections could be one of the causes of fetal morbimortality in pregnant women. The main virulence factors of STEC are Shiga toxin type 1 and/or 2 (Stx1, Stx2). We previously reported that intraperitoneal (i.p.) injection of rats in the late stage of pregnancy with culture supernatant from recombinant E. coli expressing Stx2 and containing lipopolysaccharide (LPS) induces premature delivery of dead fetuses. It has been reported that LPS may combine with Stx2 to facilitate vascular injury, which may in turn lead to an overproduction of nitric oxide (NO). The aim of this study was to evaluate whether NO is involved in the effects of Stx2 on pregnancy. Pregnant rats were i.p. injected with culture supernatant from recombinant E. coli containing Stx2 and LPS (sStx2) on day 15 of gestation. In addition, some rats were injected with aminoguanidine (AG), an inducible isoform inhibitor of NO synthase (iNOS), 24 h before and 4 h after sStx2 injection. NO production was measured by NOS activity and iNOS expression by Western blot analysis. A significant increase in NO production and a high iNOS expression was observed in placental tissues from rats injected with sStx2 containing 0.7 ng and 2 ng Stx2/g body weight and killed 12 h after injection. AG caused a significant reduction of sStx2 effects on the feto-maternal unit, but did not prevent premature delivery. Placental tissues from rats treated with AG and sStx2 presented normal histology that was indistinguishable from the controls. Our results reveal that Stx2-induced placental damage and fetus mortality is mediated by an increase in NO production and that AG is able to completely reverse the Stx2 damages in placental tissues, but not to prevent premature delivery, thus suggesting other mechanisms not yet determined could be involved.	[Burdet, Juliana; Zotta, Elsa; Ibarra, Cristina] Univ Buenos Aires, Fac Med, Dept Fisiol, Lab Fisiopatogenia, RA-1425 Buenos Aires, DF, Argentina; [Cella, Maximiliano; Franchi, Ana M.] Univ Buenos Aires, CEFYBO CONICET, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Burdet, J (corresponding author), Univ Buenos Aires, Fac Med, Dept Fisiol, Lab Fisiopatogenia, RA-1425 Buenos Aires, DF, Argentina.	ibarra@fmed.uba.ar	Ibarra, Cristina/D-6242-2016	zotta, elsa/0000-0002-8763-5046	Buenos Aires University; CONICET;  [UBACYT-M030];  [CONICET-PIP 5587];  [ANPCYT-PICT 26224]	Buenos Aires University(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ; ; 	This study received financial support from Buenos Aires University, UBACYT-M030, CONICET-PIP 5587, ANPCYT-PICT 26224. J Burdet has a scholarship from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisemberg J, 2007, P NATL ACAD SCI USA, V104, P7534, DOI 10.1073/pnas.0702279104; Alvarez B, 2003, AMINO ACIDS, V25, P295, DOI 10.1007/s00726-003-0018-8; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; Burdet J, 2009, PLACENTA, V30, P491, DOI 10.1016/j.placenta.2009.03.012; Cella M, 2010, BRIT J PHARMACOL, V161, P844, DOI 10.1111/j.1476-5381.2010.00911.x; Dedeoglu IO, 1996, PEDIATR NEPHROL, V10, P812; Dran GI, 2002, KIDNEY INT, V62, P1338, DOI 10.1046/j.1523-1755.2002.00554.x; Goldstein J, 2007, BRAIN RES, V1161, P106, DOI 10.1016/j.brainres.2007.05.067; Gordjani N, 1997, SEMIN THROMB HEMOST, V23, P281, DOI 10.1055/s-2007-996101; Gravett MG, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.064; HADDAD EK, 1995, J EXP MED, V182, P1143, DOI 10.1084/jem.182.4.1143; Kaper JB, 1998, CURR OPIN MICROBIOL, V1, P103, DOI 10.1016/S1369-5274(98)80149-5; KARMALI MA, 1983, LANCET, V1, P619, DOI 10.1016/s0140-6736(83)91795-6; Keelan JA, 2003, PLACENTA, V24, pS33, DOI 10.1053/plac.2002.0948; LOUISE CB, 1992, INFECT IMMUN, V60, P1536, DOI 10.1128/IAI.60.4.1536-1543.1992; LOUISE CB, 1995, INFECT IMMUN, V63, P2766, DOI 10.1128/IAI.63.7.2766-2769.1995; LOUISE CB, 1991, INFECT IMMUN, V59, P4173, DOI 10.1128/IAI.59.11.4173-4179.1991; Matsunaga T, 1999, BIOCHEM BIOPH RES CO, V260, P813, DOI 10.1006/bbrc.1999.0990; MISKO TP, 1993, EUR J PHARMACOL, V233, P119, DOI 10.1016/0014-2999(93)90357-N; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Noris M, 1996, AM J KIDNEY DIS, V27, P790, DOI 10.1016/S0272-6386(96)90515-6; Ogando DG, 2003, REPRODUCTION, V125, P95, DOI 10.1530/rep.0.1250095; Peltier Morgan R, 2003, Reprod Biol Endocrinol, V1, P122; Repetto HA, 1997, KIDNEY INT, V52, P1708, DOI 10.1038/ki.1997.508; Repetto HA, 2005, KIDNEY INT, V68, pS102, DOI 10.1111/j.1523-1755.2005.09717.x; Rivas M, 2008, EMERG INFECT DIS, V14, P763, DOI 10.3201/eid1405.071050; Rivas M, 2006, MEDICINA-BUENOS AIRE, V66, P27; Siegler RL, 2005, RENAL FAILURE, V27, P635, DOI 10.1080/08860220500200841; te Loo DM, 2006, PEDIATR NEPHROL, V21, P1815, DOI 10.1007/s00467-006-0232-1; TESH VL, 1994, INFECT IMMUN, V62, P5085, DOI 10.1128/IAI.62.11.5085-5094.1994; Zotta E, 2008, PEDIATR NEPHROL, V23, P559, DOI 10.1007/s00467-007-0727-4	31	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15127	10.1371/journal.pone.0015127	http://dx.doi.org/10.1371/journal.pone.0015127			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206910	Green Published, Green Submitted, gold			2022-12-27	WOS:000285793200016
J	Head, BP; Peart, JN; Panneerselvam, M; Yokoyama, T; Pearn, ML; Niesman, IR; Bonds, JA; Schilling, JM; Miyanohara, A; Headrick, J; Ali, SS; Roth, DM; Patel, PM; Patel, HH				Head, Brian P.; Peart, Jason N.; Panneerselvam, Mathivadhani; Yokoyama, Takaakira; Pearn, Matthew L.; Niesman, Ingrid R.; Bonds, Jacqueline A.; Schilling, Jan M.; Miyanohara, Atsushi; Headrick, John; Ali, Sameh S.; Roth, David M.; Patel, Piyush M.; Patel, Hemal H.			Loss of Caveolin-1 Accelerates Neurodegeneration and Aging	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; RICH MEMBRANE DOMAINS; AGE-RELATED-CHANGES; SPINAL-CORD-INJURY; ALZHEIMERS-DISEASE; LIPID RAFTS; RAT-BRAIN; ISCHEMIC TOLERANCE; NEUROBLASTOMA-CELLS; NEUROTROPHIC FACTOR	Background: The aged brain exhibits a loss in gray matter and a decrease in spines and synaptic densities that may represent a sequela for neurodegenerative diseases such as Alzheimer's. Membrane/lipid rafts (MLR), discrete regions of the plasmalemma enriched in cholesterol, glycosphingolipids, and sphingomyelin, are essential for the development and stabilization of synapses. Caveolin-1 (Cav-1), a cholesterol binding protein organizes synaptic signaling components within MLR. It is unknown whether loss of synapses is dependent on an age-related loss of Cav-1 expression and whether this has implications for neurodegenerative diseases such as Alzheimer's disease. Methodology/Principal Findings: We analyzed brains from young (Yg, 3-6 months), middle age (Md, 12 months), aged (Ag, >18 months), and young Cav-1 KO mice and show that localization of PSD-95, NR2A, NR2B, TrkBR, AMPAR, and Cav-1 to MLR is decreased in aged hippocampi. Young Cav-1 KO mice showed signs of premature neuronal aging and degeneration. Hippocampi synaptosomes from Cav-1 KO mice showed reduced PSD-95, NR2A, NR2B, and Cav-1, an inability to be protected against cerebral ischemia-reperfusion injury compared to young WT mice, increased Ab, P-Tau, and astrogliosis, decreased cerebrovascular volume compared to young WT mice. As with aged hippocampi, Cav-1 KO brains showed significantly reduced synapses. Neuron-targeted re-expression of Cav-1 in Cav-1 KO neurons in vitro decreased Ab expression. Conclusions: Therefore, Cav-1 represents a novel control point for healthy neuronal aging and loss of Cav-1 represents a non-mutational model for Alzheimer's disease.	[Head, Brian P.; Panneerselvam, Mathivadhani; Yokoyama, Takaakira; Pearn, Matthew L.; Niesman, Ingrid R.; Bonds, Jacqueline A.; Schilling, Jan M.; Roth, David M.; Patel, Piyush M.; Patel, Hemal H.] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Head, Brian P.; Schilling, Jan M.; Roth, David M.; Patel, Piyush M.; Patel, Hemal H.] VA San Diego Healthcare Syst, San Diego, CA USA; [Ali, Sameh S.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Peart, Jason N.; Headrick, John] Griffith Univ, Heart Fdn Res Ctr, Gold Coast, Qld, Australia; [Miyanohara, Atsushi] Univ Calif San Diego, Gene Therapy Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; Griffith University; University of California System; University of California San Diego	Head, BP (corresponding author), Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA.	bhead@ucsd.edu	Patel, Hemal/C-7325-2019	Patel, Hemal/0000-0001-6722-9625; Ali, Sameh Saad/0000-0002-0339-6106; Niesman, Ingrid/0000-0001-9767-6629	Veteran Affairs; National Institutes of Health, Bethesda, MD, U.S.A.; National Institute on Aging Affairs [K25 AG026379]; UCSD; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K25AG026379] Funding Source: NIH RePORTER	Veteran Affairs; National Institutes of Health, Bethesda, MD, U.S.A.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging Affairs; UCSD; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by Veteran Affairs Career Development Award-2 (B.P. Head), National Institutes of Health, Bethesda, MD, U.S.A., UCSD Start-up funds (H. H. Patel), and National Institute on Aging K25 AG026379 Affairs (S.Ali). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto LT, 2009, NAT NEUROSCI, V12, P1106, DOI 10.1038/nn.2365; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Behrens MM, 2007, SCIENCE, V318, P1645, DOI 10.1126/science.1148045; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Besshoh S, 2005, J NEUROCHEM, V93, P186, DOI 10.1111/j.1471-4159.2004.03009.x; Bilderback TR, 1999, J BIOL CHEM, V274, P257, DOI 10.1074/jbc.274.1.257; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Bist A, 2000, BIOCHEMISTRY-US, V39, P1966, DOI 10.1021/bi991721h; Bist A, 1997, P NATL ACAD SCI USA, V94, P10693, DOI 10.1073/pnas.94.20.10693; Bourasset F, 2009, NEUROPHARMACOLOGY, V56, P808, DOI 10.1016/j.neuropharm.2009.01.006; Bouwman J, 2004, NEUROSCIENCE, V126, P115, DOI 10.1016/j.neuroscience.2004.03.027; Bulloj A, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-22; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Calabrese B, 2006, PHYSIOLOGY, V21, P38, DOI 10.1152/physiol.00042.2005; Cecchi C, 2008, J CELL MOL MED, V12, P1990, DOI 10.1111/j.1582-4934.2008.00216.x; Cerezo-Guisado MI, 2007, BIOCHEM J, V401, P175, DOI 10.1042/BJ20060731; Crameri A, 2006, EMBO J, V25, P432, DOI 10.1038/sj.emboj.7600938; Denny JB, 2006, CURR NEUROPHARMACOL, V4, P293, DOI 10.2174/157015906778520782; Dickstein DL, 2010, MT SINAI J MED, V77, P82, DOI 10.1002/msj.20155; Elder GA, 2010, BRAIN STRUCT FUNCT, V214, P127, DOI 10.1007/s00429-009-0227-3; Elia LP, 2006, NEURON, V51, P43, DOI 10.1016/j.neuron.2006.05.018; FERRER I, 2009, J BIOENERG BIOMEMBR; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Francesconi A, 2009, J NEUROSCI, V29, P3590, DOI 10.1523/JNEUROSCI.5824-08.2009; Gabbita SP, 1997, FREE RADICAL BIO MED, V23, P191, DOI 10.1016/S0891-5849(97)00043-9; Gabbita SP, 1998, BBA-BIOMEMBRANES, V1372, P163, DOI 10.1016/S0005-2736(98)00040-6; Gaudreault SB, 2005, J NEUROCHEM, V92, P831, DOI 10.1111/j.1471-4159.2004.02917.x; Gidday JM, 1999, J CEREBR BLOOD F MET, V19, P331, DOI 10.1097/00004647-199903000-00011; Gioiosa L, 2008, BEHAV BRAIN RES, V188, P255, DOI 10.1016/j.bbr.2007.11.002; GONZALES RA, 1991, NEUROBIOL AGING, V12, P219, DOI 10.1016/0197-4580(91)90100-X; GRIDER MH, 2009, J NEUROSCI RES; Guirland C, 2007, ADV EXP MED BIOL, V621, P144, DOI 10.1007/978-0-387-76715-4_11; Harris B, 2009, BRAIN RES, V1296, P203, DOI 10.1016/j.brainres.2009.07.105; Hattiangady B, 2005, EXP NEUROL, V195, P353, DOI 10.1016/j.expneurol.2005.05.014; Hattori C, 2006, J NEUROSCI RES, V84, P912, DOI 10.1002/jnr.20981; Head BP, 2008, FASEB J, V22, P828, DOI 10.1096/fj.07-9299com; Head BP, 2009, ANESTHESIOLOGY, V110, P813, DOI 10.1097/ALN.0b013e31819b602b; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Hering H, 2003, J NEUROSCI, V23, P3262; HEURTEAUX C, 1995, P NATL ACAD SCI USA, V92, P4666, DOI 10.1073/pnas.92.10.4666; Hibbert AP, 2006, MOL CELL NEUROSCI, V32, P387, DOI 10.1016/j.mcn.2006.06.001; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jasmin JF, 2007, CIRC RES, V100, P721, DOI 10.1161/01.RES.0000260180.42709.29; KANNAN M, 2008, NEUROBIOL AGING; Kerr DS, 2002, NEUROPHARMACOLOGY, V43, P357, DOI 10.1016/S0028-3908(02)00088-6; Kumar B, 2002, J NEUROSCI RES, V68, P627, DOI 10.1002/jnr.10241; Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Magnusson KR, 2002, MOL BRAIN RES, V99, P40, DOI 10.1016/S0169-328X(01)00344-8; MATEOS MV, 2009, BIOCH BIOPHYS ACTA; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Monti B, 2004, NEUROCHEM INT, V44, P579, DOI 10.1016/j.neuint.2003.10.007; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Nishio S, 2000, J NEUROSURG, V93, P845, DOI 10.3171/jns.2000.93.5.0845; Norris CM, 1998, J NEUROSCI, V18, P3171; Park DS, 2003, BIOCHEMISTRY-US, V42, P15124, DOI 10.1021/bi0356348; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Peri A, 2008, J MOL ENDOCRINOL, V41, P251, DOI 10.1677/JME-08-0071; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Renner M, 2009, J NEUROSCI, V29, P2926, DOI 10.1523/JNEUROSCI.4445-08.2009; Rubino A, 2000, TRENDS PHARMACOL SCI, V21, P225, DOI 10.1016/S0165-6147(00)01483-8; Samhan-Arias AK, 2009, MOL CELL NEUROSCI, V40, P14, DOI 10.1016/j.mcn.2008.08.013; Schaller BJ, 2007, EXP NEUROL, V205, P9, DOI 10.1016/j.expneurol.2006.01.017; Shapira S, 2002, BRAIN RES, V925, P148, DOI 10.1016/S0006-8993(01)03270-X; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Sosa MAG, 2010, AM J PATHOL, V176, P353, DOI 10.2353/ajpath.2010.090482; Stefani M, 2009, CURR ALZHEIMER RES, V6, P15, DOI 10.2174/156720509787313899; Suzuki S, 2004, J CELL BIOL, V167, P1205, DOI 10.1083/jcb.200404106; Suzuki S, 2007, J NEUROSCI, V27, P6417, DOI 10.1523/JNEUROSCI.0690-07.2007; TAMARU M, 1991, BRAIN RES, V542, P83, DOI 10.1016/0006-8993(91)91001-H; Thibault O, 1998, CELL CALCIUM, V24, P417, DOI 10.1016/S0143-4160(98)90064-1; Toescu EC, 2004, TRENDS NEUROSCI, V27, P614, DOI 10.1016/j.tins.2004.07.010; Trushina E, 2006, BEHAV BRAIN RES, V172, P24, DOI 10.1016/j.bbr.2006.04.024; VANMIERLO T, 2009, J ALZHEIMERS DIS; Willmann R, 2006, EMBO J, V25, P4050, DOI 10.1038/sj.emboj.7601288; Yam PY, 2002, MOL THER, V5, P479, DOI 10.1006/mthe.2002.0558; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Yoon IS, 2007, FASEB J, V21, P2742, DOI 10.1096/fj.07-8114com; ZHAO H, 2009, NEUROCHEM RES; Zhu MJ, 2008, FREE RADICAL BIO MED, V45, P1493, DOI 10.1016/j.freeradbiomed.2008.08.027	83	120	124	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15697	10.1371/journal.pone.0015697	http://dx.doi.org/10.1371/journal.pone.0015697			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203469	Green Published, Green Submitted, gold			2022-12-27	WOS:000285579200030
J	Pelczar, H; Woisard, A; Lemaitre, JM; Chachou, M; Andeol, Y				Pelczar, Helene; Woisard, Anne; Lemaitre, Jean Marc; Chachou, Mohamed; Andeol, Yannick			Evidence for an RNA Polymerization Activity in Axolotl and Xenopus Egg Extracts	PLOS ONE			English	Article							HEPATITIS-DELTA-VIRUS; DNA-REPLICATION; GENE-EXPRESSION; POLYMERASE-II; AMPHIBIAN OOCYTES; MESSENGER-RNAS; EXOGENOUS RNA; GLOBIN RNA; MAJOR LATE; IN-VITRO	We have previously reported a post-transcriptional RNA amplification observed in vivo following injection of in vitro synthesized transcripts into axolotl oocytes, unfertilized (UFE) or fertilized eggs. To further characterize this phenomenon, low speed extracts (LSE) from axolotl and Xenopus UFE were prepared and tested in an RNA polymerization assay. The major conclusions are: i) the amphibian extracts catalyze the incorporation of radioactive ribonucleotide in RNase but not DNase sensitive products showing that these products correspond to RNA; ii) the phenomenon is resistant to alpha-amanitin, an inhibitor of RNA polymerases II and III and to cordycepin (3'dAMP), but sensitive to cordycepin 5'-triphosphate, an RNA elongation inhibitor, which supports the existence of an RNA polymerase activity different from polymerases II and III; the detection of radiolabelled RNA comigrating at the same length as the exogenous transcript added to the extracts allowed us to show that iii) the RNA polymerization is not a 3' end labelling and that iv) the radiolabelled RNA is single rather than double stranded. In vitro cell-free systems derived from amphibian UFE therefore validate our previous in vivo results hypothesizing the existence of an evolutionary conserved enzymatic activity with the properties of an RNA dependent RNA polymerase (RdRp).	[Pelczar, Helene; Chachou, Mohamed; Andeol, Yannick] Univ Paris 06, UMR 7622, Paris, France; [Pelczar, Helene; Chachou, Mohamed; Andeol, Yannick] CNRS, UMR 7622, Paris, France; [Woisard, Anne] Univ Paris 06, Equipe Photobiol Mol, Paris, France; [Lemaitre, Jean Marc] INSERM, Inst Genom Fonct, U661, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Pelczar, H (corresponding author), Univ Paris 06, UMR 7622, Paris, France.	yannick.andeol@snv.jussieu.fr	LEMAITRE, Jean-Marc/I-4989-2016	LEMAITRE, Jean-Marc/0000-0002-6492-5219	Association pour la Recherche sur le Cancer [ARC 3387]	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by a grant from the Association pour la Recherche sur le Cancer (ARC 3387). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOUZNI G, 1990, EMBO J, V9, P573, DOI 10.1002/j.1460-2075.1990.tb08145.x; Andeol Y, 1998, DIFFERENTIATION, V63, P69, DOI 10.1046/j.1432-0436.1998.6320069.x; Audic Y, 1997, MOL CELL BIOL, V17, P209, DOI 10.1128/MCB.17.1.209; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BALLANTYNE S, 1995, RNA, V1, P64; BARTON DJ, 1995, J VIROL, V69, P5516, DOI 10.1128/JVI.69.9.5516-5527.1995; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; Bosher JM, 2000, NAT CELL BIOL, V2, pE31, DOI 10.1038/35000102; CHAMBON P, 1975, ANNU REV BIOCHEM, V44, P613, DOI 10.1146/annurev.bi.44.070175.003145; Chang JH, 2008, J VIROL, V82, P1118, DOI 10.1128/JVI.01758-07; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Cogoni C, 2000, CURR OPIN GENET DEV, V10, P638, DOI 10.1016/S0959-437X(00)00134-9; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; EDMONDS M, 1960, J BIOL CHEM, V235, P1142; FESENFELD G, 1992, NATURE, V355, P219; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; GURDON JB, 1983, USE XENOPUS OOCYTES, P370; Halbeisen RE, 2008, CELL MOL LIFE SCI, V65, P798, DOI 10.1007/s00018-007-7447-6; HUTCHISON CJ, 1987, EMBO J, V6, P3002; KING MW, 1986, MOL CELL BIOL, V6, P4499, DOI 10.1128/MCB.6.12.4499; Lai MMC, 2005, J VIROL, V79, P7951, DOI 10.1128/JVI.79.13.7951-7958.2005; Lehmann E, 2007, NATURE, V450, P445, DOI 10.1038/nature06290; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Lipardi C, 2009, P NATL ACAD SCI USA, V106, P15645, DOI 10.1073/pnas.0904984106; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Martin G, 2007, RNA, V13, P1834, DOI 10.1261/rna.652807; MATSUI T, 1987, MOL CELL BIOL, V7, P1401, DOI 10.1128/MCB.7.4.1401; MECHALI M, 1982, CELL, V30, P93, DOI 10.1016/0092-8674(82)90015-0; Mendez J, 2003, BIOESSAYS, V25, P1158, DOI 10.1002/bies.10370; Menut S, 1999, ADV MOLEC BIOL, P196; Modahl LE, 2000, MOL CELL BIOL, V20, P6030, DOI 10.1128/MCB.20.16.6030-6039.2000; Montreau N, 2004, NUCLEIC ACIDS RES, V32, P2957, DOI 10.1093/nar/gkh620; Montreau N, 2003, CR BIOL, V326, P1135, DOI 10.1016/j.crvi.2003.10.002; Moraleda G, 2001, J VIROL, V75, P10161, DOI 10.1128/JVI.75.21.10161-10169.2001; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Nakano H, 2000, BIOCHEM BIOPH RES CO, V274, P434, DOI 10.1006/bbrc.2000.3178; Nishikura K, 2001, CELL, V107, P415, DOI 10.1016/S0092-8674(01)00581-5; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Pelczar H, 2007, DEV GROWTH DIFFER, V49, P407, DOI 10.1111/j.1440-169x.2007.00934.x; PRIOLEAU MN, 1994, CELL, V77, P439, DOI 10.1016/0092-8674(94)90158-9; Sambrook J, 1989, MOL CLONING LABORATO; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11851; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Slomovic S, 2006, NUCLEIC ACIDS RES, V34, P2966, DOI 10.1093/nar/gkl357; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Stein P, 2003, RNA, V9, P187, DOI 10.1261/rna.2860603; Vaur S, 2004, DEV BIOL, V267, P265, DOI 10.1016/j.ydbio.2003.12.002; VOLLOCH V, 1987, J CELL BIOL, V105, P137, DOI 10.1083/jcb.105.1.137; Volloch V, 1996, P NATL ACAD SCI USA, V93, P2476, DOI 10.1073/pnas.93.6.2476; Walter SA, 2000, MOL BIOL CELL, V11, P887, DOI 10.1091/mbc.11.3.887; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; WOLFFE AP, 1987, CELL, V355, P733; WORKMAN JL, 1987, CELL, V51, P613, DOI 10.1016/0092-8674(87)90130-9	58	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e14411	10.1371/journal.pone.0014411	http://dx.doi.org/10.1371/journal.pone.0014411			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203452	Green Published, gold, Green Submitted			2022-12-27	WOS:000285579200002
J	Roy, V; Ghani, K; Caruso, M				Roy, Vincent; Ghani, Karim; Caruso, Manuel			A Dominant-Negative Approach That Prevents Diphthamide Formation Confers Resistance to Pseudomonas Exotoxin A and Diphtheria Toxin	PLOS ONE			English	Article							ADP-RIBOSYLATING TOXINS; ELONGATION FACTOR-II; SACCHAROMYCES-CEREVISIAE; TRANSLATION ELONGATION-FACTOR-2; POSTTRANSLATIONAL MODIFICATION; CORYNEBACTERIUM-DIPHTHERIAE; AERUGINOSA INFECTION; HYDROLYSIS PRODUCTS; GENE-THERAPY; HUMAN-CELLS	Diphtheria toxin (DT), Pseudomonas aeruginosa Exotoxin A (ETA) and cholix toxin from Vibrio cholerae share the same mechanism of toxicity; these enzymes ADP-rybosylate elongation factor-2 (EF-2) on a modified histidine residue called diphthamide, leading to a block in protein synthesis. Mutant Chinese hamster ovary cells that are defective in the formation of diphthamide have no distinct phenotype except their resistance to DT and ETA. These observations led us to predict that a strategy that prevents the formation of diphthamide to confer DT and ETA resistance is likely to be safe. It is well documented that Dph1 and Dph2 are involved in the first biochemical step of diphthamide formation and that these two proteins interact with each other. We hypothesized that we could block diphthamide formation with a dominant negative mutant of either Dph1 or Dph2. We report in this study the first cellular-targeted strategy that protects against DT and ETA toxicity. We have generated Dph2(C-), a dominant-negative mutant of Dph2, that could block very efficiently the formation of diphthamide. Cells expressing Dph2(C-) were 1000-fold more resistant to DT than parental cells, and a similar protection against Pseudomonas exotoxin A was also obtained. The targeting of a cellular component with this approach should have a reduced risk of generating resistance as it is commonly seen with antibiotic treatments.	[Roy, Vincent; Ghani, Karim; Caruso, Manuel] Univ Laval, Ctr Rech Canc, Hotel Dieu Quebec, CHU Quebec, Quebec City, PQ, Canada	Laval University	Roy, V (corresponding author), Univ Laval, Ctr Rech Canc, Hotel Dieu Quebec, CHU Quebec, Quebec City, PQ, Canada.	manuel.caruso@crhdq.ulaval.ca		Caruso, Manuel/0000-0002-7609-2015	Canadian Institute of Health Research (CIHR) [MOP-57833]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was supported by a grant from the Canadian Institute of Health Research (CIHR) (MOP-57833). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar C, 2008, MOL MICROBIOL, V69, P1221, DOI 10.1111/j.1365-2958.2008.06350.x; BJORN MJ, 1977, INFECT IMMUN, V16, P362, DOI 10.1128/IAI.16.1.362-366.1977; BROWN BA, 1979, FEBS LETT, V103, P253, DOI 10.1016/0014-5793(79)81339-3; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Chen CM, 2005, CURR OPIN GENET DEV, V15, P49, DOI 10.1016/j.gde.2004.12.006; CHEN JYC, 1985, MOL CELL BIOL, V5, P3357, DOI 10.1128/MCB.5.12.3357; CHEN JYC, 1988, J BIOL CHEM, V263, P11692; Collier RJ, 2001, TOXICON, V39, P1793, DOI 10.1016/S0041-0101(01)00165-9; Danilova E, 2006, CLIN VACCINE IMMUNOL, V13, P627, DOI 10.1128/CVI.00026-06; Deng Q, 2008, ANNU REV MICROBIOL, V62, P271, DOI 10.1146/annurev.micro.62.081307.162848; Densmore Charles L., 2006, Current Drug Delivery, V3, P55, DOI 10.2174/156720106775197547; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; El-Zaim HS, 1998, INFECT IMMUN, V66, P5551, DOI 10.1128/IAI.66.11.5551-5554.1998; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; FARIZO KM, 1993, CLIN INFECT DIS, V16, P59, DOI 10.1093/clinids/16.1.59; Fichtner L, 2003, MOL MICROBIOL, V49, P1297, DOI 10.1046/j.1365-2958.2003.03632.x; Fichtner L, 2002, MOL MICROBIOL, V44, P865, DOI 10.1046/j.1365-2958.2002.02928.x; Fogle MR, 2002, J SURG RES, V106, P86, DOI 10.1006/jsre.2002.6433; Galazka A, 2000, J INFECT DIS, V181, pS2, DOI 10.1086/315533; Ghani K, 2007, GENE THER, V14, P1705, DOI 10.1038/sj.gt.3303039; Jacobsen F, 2005, GENE THER, V12, P1494, DOI 10.1038/sj.gt.3302568; Jorgensen R, 2005, NATURE, V436, P979, DOI 10.1038/nature03871; Jorgensen R, 2008, J BIOL CHEM, V283, P10671, DOI 10.1074/jbc.M710008200; Kipnis E, 2006, MED MALADIES INFECT, V36, P78, DOI 10.1016/j.medmal.2005.10.007; Liu SH, 2004, MOL CELL BIOL, V24, P9487, DOI 10.1128/MCB.24.21.9487-9497.2004; Liu SH, 2003, MOL CELL, V12, P603, DOI 10.1016/j.molcel.2003.08.003; Liu SH, 2006, MOL CELL BIOL, V26, P3835, DOI 10.1128/MCB.26.10.3835-3841.2006; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Manafi A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-23; Matsumoto T, 1999, J MED MICROBIOL, V48, P765, DOI 10.1099/00222615-48-8-765; Matsumoto T, 1998, J MED MICROBIOL, V47, P303, DOI 10.1099/00222615-47-4-303; MATTHEAKIS LC, 1992, MOL CELL BIOL, V12, P4026, DOI 10.1128/MCB.12.9.4026; MATTHEAKIS LC, 1993, GENE, V132, P149, DOI 10.1016/0378-1119(93)90528-B; Mattos-Guaraldi AL, 2003, MEM I OSWALDO CRUZ, V98, P987, DOI 10.1590/S0074-02762003000800001; MIYAZAKI S, 1995, J MED MICROBIOL, V43, P169, DOI 10.1099/00222615-43-3-169; MOEHRING JM, 1980, P NATL ACAD SCI-BIOL, V77, P1010, DOI 10.1073/pnas.77.2.1010; MOEHRING TJ, 1984, MOL CELL BIOL, V4, P642, DOI 10.1128/MCB.4.4.642; Mohan RR, 2005, PROG RETIN EYE RES, V24, P537, DOI 10.1016/j.preteyeres.2005.04.001; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NICAS TI, 1985, CAN J MICROBIOL, V31, P387, DOI 10.1139/m85-074; OHMAN DE, 1980, J INFECT DIS, V142, P547, DOI 10.1093/infdis/142.4.547; Ortiz PA, 2006, J BIOL CHEM, V281, P32639, DOI 10.1074/jbc.M607076200; PAPPENHEIMER AM, 1983, J BACTERIOL, V153, P1342, DOI 10.1128/JB.153.3.1342-1347.1983; PAVLOVSKIS OR, 1977, INFECT IMMUN, V18, P596, DOI 10.1128/IAI.18.3.596-602.1977; Pillar CM, 2002, INVEST OPHTH VIS SCI, V43, P1437; ROBINSON EA, 1974, J BIOL CHEM, V249, P5088; Roy V, 2005, GENE THER, V12, P169, DOI 10.1038/sj.gt.3302394; Sellman BR, 2001, SCIENCE, V292, P695, DOI 10.1126/science.109563; Speranza FAB, 2010, BRAZ J MED BIOL RES, V43, P120, DOI 10.1590/S0100-879X2009007500032; VANNESS BG, 1980, J BIOL CHEM, V255, P710; VANNESS BG, 1980, J BIOL CHEM, V255, P717; Webb TR, 2008, J CELL SCI, V121, P3140, DOI 10.1242/jcs.035550; Yates SP, 2006, TRENDS BIOCHEM SCI, V31, P123, DOI 10.1016/j.tibs.2005.12.007	54	16	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15753	10.1371/journal.pone.0015753	http://dx.doi.org/10.1371/journal.pone.0015753			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203470	Green Submitted, Green Published, gold			2022-12-27	WOS:000285579200038
J	Dowling, AJ; Wilkinson, PA; Holden, MTG; Quail, MA; Bentley, SD; Reger, J; Waterfield, NR; Titball, RW; Ffrench-Constant, RH				Dowling, Andrea J.; Wilkinson, Paul A.; Holden, Matthew T. G.; Quail, Michael A.; Bentley, Stephen D.; Reger, Julia; Waterfield, Nicholas R.; Titball, Richard W.; Ffrench-Constant, Richard H.			Genome-Wide Analysis Reveals Loci Encoding Anti-Macrophage Factors in the Human Pathogen Burkholderia pseudomallei K96243	PLOS ONE			English	Article							PERTUSSIS FILAMENTOUS HEMAGGLUTININ; SYRINGAE PV. SYRINGAE; SECRETION SYSTEM; PHOSPHOLIPASE-D; CORYNEBACTERIUM-PSEUDOTUBERCULOSIS; VIRULENCE PLASMID; MACROPHAGE DEATH; PLANT PATHOGEN; MELIOIDOSIS; EXPRESSION	Burkholderia pseudomallei is an important human pathogen whose infection biology is still poorly understood. The bacterium is endemic to tropical regions, including South East Asia and Northern Australia, where it causes melioidosis, a serious disease associated with both high mortality and antibiotic resistance. B. pseudomallei is a Gram-negative facultative intracellular pathogen that is able to replicate in macrophages. However despite the critical nature of its interaction with macrophages, few anti-macrophage factors have been characterized to date. Here we perform a genome-wide gain of function screen of B. pseudomallei strain K96243 to identify loci encoding factors with anti-macrophage activity. We identify a total of 113 such loci scattered across both chromosomes, with positive gene clusters encoding transporters and secretion systems, enzymes/toxins, secondary metabolite, biofilm, adhesion and signal response related factors. Further phenotypic analysis of four of these regions shows that the encoded factors cause striking cellular phenotypes relevant to infection biology, including apoptosis, formation of actin 'tails' and multi-nucleation within treated macrophages. The detailed analysis of the remaining host of loci will facilitate genetic dissection of the interaction of this important pathogen with host macrophages and thus further elucidate this critical part of its infection cycle.	[Holden, Matthew T. G.; Quail, Michael A.; Bentley, Stephen D.] Wellcome Trust Sanger Inst, Cambridge, England; [Waterfield, Nicholas R.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Titball, Richard W.] Univ Exeter, Sch Biosci, Exeter, Devon, England	Wellcome Trust Sanger Institute; University of Bath; University of Exeter		ajd211@exeter.ac.uk	Quail, michael/ABE-6131-2020; Holden, Matthew TG/K-6449-2014	Holden, Matthew TG/0000-0002-4958-2166; Waterfield, Nicholas/0000-0002-8044-7763; ffrench-Constant, Richard/0000-0001-5385-9888; Dowling, Andrea/0000-0003-0818-6092	BBSRC [BB/E021182/1, BB/E021328/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E021182/1, BB/E021328/1] Funding Source: Medline; Wellcome Trust Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Abramson T, 2001, INFECT IMMUN, V69, P2650, DOI 10.1128/IAI.69.4.2650-2658.2001; Adler NRL, 2009, FEMS MICROBIOL REV, V33, P1079, DOI 10.1111/j.1574-6976.2009.00189.x; Arjcharoen S, 2007, INFECT IMMUN, V75, P4298, DOI 10.1128/IAI.00285-07; Burtnick MN, 2008, INFECT IMMUN, V76, P2991, DOI 10.1128/IAI.00263-08; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Coleman CS, 2006, CELL PROLIFERAT, V39, P599, DOI 10.1111/j.1365-2184.2006.00402.x; Dance DAB, 2002, CURR OPIN INFECT DIS, V15, P127, DOI 10.1097/00001432-200204000-00005; Driskell LO, 2009, INFECT IMMUN, V77, P3244, DOI 10.1128/IAI.00395-09; Ffrench-Constant R, 2006, ADV APPL MICROBIOL, V58, P169, DOI 10.1016/S0065-2164(06)58005-5; GALYOV EE, ANN REV MICROBIOL; Groll M, 2008, NATURE, V452, P755, DOI 10.1038/nature06782; Haase A, 1997, J MED MICROBIOL, V46, P557, DOI 10.1099/00222615-46-7-557; Harland DN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-83; Hodgson ALM, 1999, VACCINE, V17, P802, DOI 10.1016/S0264-410X(98)00264-3; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; JacobDubuisson F, 1996, MOL MICROBIOL, V19, P65, DOI 10.1046/j.1365-2958.1996.349883.x; Kespichayawattana W, 2000, INFECT IMMUN, V68, P5377, DOI 10.1128/IAI.68.9.5377-5384.2000; Libby SJ, 2000, CELL MICROBIOL, V2, P49, DOI 10.1046/j.1462-5822.2000.00030.x; Matsuura M, 1996, FEMS MICROBIOL LETT, V137, P79, DOI 10.1111/j.1574-6968.1996.tb08086.x; McKean SC, 2007, MICROBIOL-SGM, V153, P2203, DOI 10.1099/mic.0.2007/005926-0; Muangsombut V, 2008, ARCH MICROBIOL, V190, P623, DOI 10.1007/s00203-008-0413-3; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Otto H, 2000, MOL MICROBIOL, V37, P1106, DOI 10.1046/j.1365-2958.2000.02064.x; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Shalom G, 2007, MICROBIOL-SGM, V153, P2689, DOI 10.1099/mic.0.2007/006585-0; Sim SH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000178; Stevens MP, 2005, MOL MICROBIOL, V56, P40, DOI 10.1111/j.1365-2958.2004.04528.x; Stevens MP, 2004, MICROBIOL-SGM, V150, P2669, DOI 10.1099/mic.0.27146-0; Stevens MP, 2003, J BACTERIOL, V185, P4992, DOI 10.1128/JB.185.16.4992-4996.2003; Stevens MP, 2002, MOL MICROBIOL, V46, P649, DOI 10.1046/j.1365-2958.2002.03190.x; Suarez G, 2010, J BACTERIOL, V192, P155, DOI 10.1128/JB.01260-09; Sui SJH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008094; Sun GW, 2005, CELL MICROBIOL, V7, P1447, DOI 10.1111/j.1462-5822.2005.00569.x; Tuanyok A, 2006, INFECT IMMUN, V74, P5465, DOI 10.1128/IAI.00737-06; Waspi U, 1998, MOL PLANT MICROBE IN, V11, P727, DOI 10.1094/MPMI.1998.11.8.727; Waterfield NR, 2003, FEMS MICROBIOL LETT, V229, P265, DOI 10.1016/S0378-1097(03)00846-2; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0	39	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15693	10.1371/journal.pone.0015693	http://dx.doi.org/10.1371/journal.pone.0015693			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203527	Green Published, Green Submitted, gold			2022-12-27	WOS:000285578000047
J	Rea, G; Lambreva, M; Polticelli, F; Bertalan, I; Antonacci, A; Pastorelli, S; Damasso, M; Johanningmeier, U; Giardi, MT				Rea, Giuseppina; Lambreva, Maya; Polticelli, Fabio; Bertalan, Ivo; Antonacci, Amina; Pastorelli, Sandro; Damasso, Mario; Johanningmeier, Udo; Giardi, Maria Teresa			Directed Evolution and In Silico Analysis of Reaction Centre Proteins Reveal Molecular Signatures of Photosynthesis Adaptation to Radiation Pressure	PLOS ONE			English	Article							PHOTOSYSTEM-II; CHLAMYDOMONAS-REINHARDTII; D1 PROTEIN; RHODOBACTER-SPHAEROIDES; SINGLET OXYGEN; HIGH LIGHT; MUTANTS; WATER; CYANOBACTERIA; DEGRADATION	Evolutionary mechanisms adopted by the photosynthetic apparatus to modifications in the Earth's atmosphere on a geological time-scale remain a focus of intense research. The photosynthetic machinery has had to cope with continuously changing environmental conditions and particularly with the complex ionizing radiation emitted by solar flares. The photosynthetic D1 protein, being the site of electron tunneling-mediated charge separation and solar energy transduction, is a hot spot for the generation of radiation-induced radical injuries. We explored the possibility to produce D1 variants tolerant to ionizing radiation in Chlamydomonas reinhardtii and clarified the effect of radiation-induced oxidative damage on the photosynthetic proteins evolution. In vitro directed evolution strategies targeted at the D1 protein were adopted to create libraries of chlamydomonas random mutants, subsequently selected by exposures to radical-generating proton or neutron sources. The common trend observed in the D1 aminoacidic substitutions was the replacement of less polar by more polar amino acids. The applied selection pressure forced replacement of residues more sensitive to oxidative damage with less sensitive ones, suggesting that ionizing radiation may have been one of the driving forces in the evolution of the eukaryotic photosynthetic apparatus. A set of the identified aminoacidic substitutions, close to the secondary plastoquinone binding niche and oxygen evolving complex, were introduced by site-directed mutagenesis in untransformed strains, and their sensitivity to free radicals attack analyzed. Mutants displayed reduced electron transport efficiency in physiological conditions, and increased photosynthetic performance stability and oxygen evolution capacity in stressful high-light conditions. Finally, comparative in silico analyses of D1 aminoacidic sequences of organisms differently located in the evolution chain, revealed a higher ratio of residues more sensitive to oxidative damage in the eukaryotic/cyanobacterial proteins compared to their bacterial orthologs. These results led us to hypothesize an archaean atmosphere less challenging in terms of ionizing radiation than the present one.	[Rea, Giuseppina; Lambreva, Maya; Antonacci, Amina; Pastorelli, Sandro; Damasso, Mario; Giardi, Maria Teresa] CNR, Inst Crystallog, Monterotondo, Italy; [Polticelli, Fabio] Univ Roma Tre, Dept Biol, Rome, Italy; [Bertalan, Ivo] Univ Halle Wittenberg, Inst Plant Physiol, Halle, Saale, Germany	Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR); Roma Tre University; Martin Luther University Halle Wittenberg	Rea, G (corresponding author), CNR, Inst Crystallog, Monterotondo, Italy.	giuseppina.rea@mlib.ic.cnr.it	Polticelli, Fabio/A-4573-2009; Lambreva, Maya Dimova/D-6917-2017; Antonacci, Amina/I-4374-2012; REA, GIUSEPPINA/B-9479-2015	Polticelli, Fabio/0000-0002-7657-2019; Lambreva, Maya Dimova/0000-0001-5750-0899; Antonacci, Amina/0000-0002-3245-3739; REA, GIUSEPPINA/0000-0001-7353-727X; Giardi, Maria Teresa/0000-0002-7401-5905; Damasso, Mario/0000-0001-9984-4278	Italian Space Agency; European Space Agency [ESA-RA-LS-01-Flight/BN-004, ILSRA-2009-1001, ASI N I/021/10/0]	Italian Space Agency(Agenzia Spaziale Italiana (ASI)); European Space Agency(European Space AgencyEuropean Commission)	This work was supported from 2005 to 2010 by the Italian Space Agency (http://www.asi.it/en) and the European Space Agency (http://www.esa.int/esaCP/index.html) (call_ideas_nov2004-2006 mod, HME-GA/2005-037 registration code ESA-RA-LS-01-Flight/BN-004, ILSRA-2009-1001, ASI N I/021/10/0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barber J, 2006, BIOCHEM SOC T, V34, P619, DOI 10.1042/BST0340619; Benton ER, 2001, NUCL INSTRUM METH B, V184, P255, DOI 10.1016/S0168-583X(01)00748-0; Berger T, 2008, Z MED PHYS, V18, P265, DOI 10.1016/j.zemedi.2008.06.014; COCKELL CS, 2001, LECT NOTES ASTROBIOL, P219; Damasso M, 2009, RADIAT MEAS, V44, P263, DOI 10.1016/j.radmeas.2009.03.007; Dauvillee D, 2004, PHOTOSYNTH RES, V79, P219, DOI 10.1023/B:PRES.0000015384.24958.a9; Dillon JG, 2003, ENVIRON MICROBIOL, V5, P473, DOI 10.1046/j.1462-2920.2003.00435.x; Draganic IG, 2005, RADIAT PHYS CHEM, V72, P181, DOI 10.1016/j.radphyschem.2004.09.012; Edelman M, 2008, PHOTOSYNTH RES, V98, P609, DOI 10.1007/s11120-008-9342-x; Eriksson KM, 2009, APPL ENVIRON MICROB, V75, P897, DOI 10.1128/AEM.01830-08; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; FINER JJ, 1992, MOL GEN GENET, V251, P373; Forster B, 2001, PHOTOSYNTH RES, V67, P5, DOI 10.1023/A:1010611509209; GARRISON WM, 1987, CHEM REV, V87, P381, DOI 10.1021/cr00078a006; Giardi MT, 2005, TRENDS BIOTECHNOL, V23, P257, DOI 10.1016/j.tibtech.2005.03.003; GM Cooper, 2004, CELL MOL APPROACH; Gupta RS, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-167; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hall D. O., 1999, PHOTOSYNTHESIS; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Heathcote P, 2002, TRENDS BIOCHEM SCI, V27, P79, DOI 10.1016/S0968-0004(01)02034-5; Hideg E, 2000, METHOD ENZYMOL, V319, P77; Immeln D, 2007, J BIOL CHEM, V282, P21720, DOI 10.1074/jbc.M700849200; JOHANNINGMEIER U, 1993, PLANT MOL BIOL, V22, P91, DOI 10.1007/BF00038998; Kern J, 2007, PHOTOSYNTH RES, V94, P183, DOI 10.1007/s11120-007-9201-1; Kiang NY, 2007, ASTROBIOLOGY, V7, P252, DOI 10.1089/ast.2006.0108; Koepke J, 2007, J MOL BIOL, V371, P396, DOI 10.1016/j.jmb.2007.04.082; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lakatos M, 2001, EUR J PHYCOL, V36, P367, DOI 10.1080/09670260110001735518; Lardans A, 1998, J BIOL CHEM, V273, P11082, DOI 10.1074/jbc.273.18.11082; Ledford HK, 2005, PLANT CELL ENVIRON, V28, P1037, DOI 10.1111/j.1365-3040.2005.01374.x; Leslie M, 2009, SCIENCE, V323, P1286, DOI 10.1126/science.323.5919.1286; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Loll B, 2008, BIOL CHEM, V389, P609, DOI 10.1515/BC.2008.058; MATTOO AK, 1984, P NATL ACAD SCI-BIOL, V81, P1380, DOI 10.1073/pnas.81.5.1380; Melis A, 1998, J APPL PHYCOL, V10, P515, DOI 10.1023/A:1008076231267; Merchant S, 2005, PLANT CELL, V17, P648, DOI 10.1105/tpc.105.030676; NEWMAN SM, 1990, GENETICS, V126, P875; Nishiyama Y, 2006, BBA-BIOENERGETICS, V1757, P742, DOI 10.1016/j.bbabio.2006.05.013; Olsson LC, 2000, J EXP BOT, V51, P265, DOI 10.1093/jexbot/51.343.265; Pospisil P, 2004, BIOCHEMISTRY-US, V43, P6783, DOI 10.1021/bi036219i; Potter JA, 2005, J BIOL CHEM, V280, P27155, DOI 10.1074/jbc.M501961200; Preiss S, 2001, EUR J BIOCHEM, V268, P4562, DOI 10.1046/j.1432-1327.2001.02383.x; Rea G, 2008, INT J RADIAT BIOL, V84, P867, DOI 10.1080/09553000802460149; Scognamiglio V, 2009, ANAL BIOANAL CHEM, V394, P1081, DOI 10.1007/s00216-009-2668-1; Sicora CI, 2008, BBA-BIOENERGETICS, V1777, P130, DOI 10.1016/j.bbabio.2007.09.001; Singh SP, 2010, AGEING RES REV, V9, P79, DOI 10.1016/j.arr.2009.05.004; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Strasser R.J., 2000, PROBING PHOTOSYNTHES, P445; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Tekaia F, 2002, GENE, V297, P51, DOI 10.1016/S0378-1119(02)00871-5; Wilski S, 2006, PESTIC BIOCHEM PHYS, V84, P157, DOI 10.1016/j.pestbp.2005.07.001; Xiong J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-245; Yoshioka M, 2006, J BIOL CHEM, V281, P21660, DOI 10.1074/jbc.M602896200; Zeng XQ, 2010, PHYSIOL PLANTARUM, V138, P215, DOI 10.1111/j.1399-3054.2009.01316.x; Zeugner A, 2005, J BIOL CHEM, V280, P19437, DOI 10.1074/jbc.C500077200	57	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16216	10.1371/journal.pone.0016216	http://dx.doi.org/10.1371/journal.pone.0016216			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249156	Green Submitted, Green Published, gold			2022-12-27	WOS:000286515000034
J	Secondini, C; Wetterwald, A; Schwaninger, R; Thalmann, GN; Cecchini, MG				Secondini, Chiara; Wetterwald, Antoinette; Schwaninger, Ruth; Thalmann, George N.; Cecchini, Marco G.			The Role of the BMP Signaling Antagonist Noggin in the Development of Prostate Cancer Osteolytic Bone Metastasis	PLOS ONE			English	Article							MORPHOGENETIC PROTEIN-6; OSTEOBLAST DIFFERENTIATION; TGF-BETA; EXPRESSION; WNT; CELLS; MECHANISMS; RESORPTION; DISEASE; DKK1	Members of the BMP and Wnt protein families play a relevant role in physiologic and pathologic bone turnover. Extracellular antagonists are crucial for the modulation of their activity. Lack of expression of the BMP antagonist noggin by osteoinductive, carcinoma-derived cell lines is a determinant of the osteoblast response induced by their bone metastases. In contrast, osteolytic, carcinoma-derived cell lines express noggin constitutively. We hypothesized that cancer cell-derived noggin may contribute to the pathogenesis of osteolytic bone metastasis of solid cancers by repressing bone formation. Intra-osseous xenografts of PC-3 prostate cancer cells induced osteolytic lesions characterized not only by enhanced osteoclast-mediated bone resorption, but also by decreased osteoblast-mediated bone formation. Therefore, in this model, uncoupling of the bone remodeling process contributes to osteolysis. Bone formation was preserved in the osteolytic lesions induced by noggin-silenced PC-3 cells, suggesting that cancer cell-derived noggin interferes with physiologic bone coupling. Furthermore, intra-osseous tumor growth of noggin-silenced PC-3 cells was limited, most probably as a result of the persisting osteoblast activity. This investigation provides new evidence for a model of osteolytic bone metastasis where constitutive secretion of noggin by cancer cells mediates inhibition of bone formation, thereby preventing repair of osteolytic lesions generated by an excess of osteoclast-mediated bone resorption. Therefore, noggin suppression may be a novel strategy for the treatment of osteolytic bone metastases.	[Secondini, Chiara] Univ Bern, Dept Urol, Urol Res Lab, Bern, Switzerland; Univ Bern, Dept Clin Res, Bern, Switzerland	University of Bern; University of Bern	Secondini, C (corresponding author), Univ Bern, Dept Urol, Urol Res Lab, Bern, Switzerland.	marco.cecchini@dkf.unibe.ch			European Commission [CANCURE-2006-020970, PRIMA-504587]; Swiss National Foundation [3200-068409.02]	European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was supported by grants from the European Commission (CANCURE-2006-020970 and PRIMA-504587) and from the Swiss National Foundation (3200-068409.02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes J, 1995, WORLD J UROL, V13, P337; BATAILLE R, 1986, BRIT J CANCER, V53, P805, DOI 10.1038/bjc.1986.136; Bendre MS, 2003, BONE, V33, P28, DOI 10.1016/S8756-3282(03)00086-3; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Bu GJ, 2008, INT J CANCER, V123, P1034, DOI 10.1002/ijc.23625; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; BUCKLE CH, 2010, CURR PHARM DES; Buijs JT, 2007, CLIN EXP METASTAS, V24, P609, DOI 10.1007/s10585-007-9118-2; Buijs JT, 2007, AM J PATHOL, V171, P1047, DOI 10.2353/ajpath.2007.070168; Canalis E, 2009, J CELL BIOCHEM, V108, P769, DOI 10.1002/jcb.22322; Chanda D, 2009, CLIN CANCER RES, V15, P7175, DOI 10.1158/1078-0432.CCR-09-1938; Chirgwin JM, 2000, CRIT REV EUKAR GENE, V10, P159; Clines GA, 2007, MOL ENDOCRINOL, V21, P486, DOI 10.1210/me.2006-0346; Dai JL, 2008, CANCER RES, V68, P5785, DOI 10.1158/0008-5472.CAN-07-6541; Dai JL, 2005, CANCER RES, V65, P8274, DOI 10.1158/0008-5472.CAN-05-1891; Devlin RD, 2003, ENDOCRINOLOGY, V144, P1972, DOI 10.1210/en.2002-220918; Dougall WC, 2006, CANCER METAST REV, V25, P541, DOI 10.1007/s10555-006-9021-3; Feeley BT, 2006, BONE, V38, P154, DOI 10.1016/j.bone.2005.07.015; Gazzerro E, 2003, BONE, V32, P111, DOI 10.1016/S8756-3282(02)00948-1; Gazzerro E, 1998, J CLIN INVEST, V102, P2106, DOI 10.1172/JCI3459; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Hall CL, 2006, J CELL BIOCHEM, V97, P661, DOI 10.1002/jcb.20735; Hall CL, 2005, CANCER RES, V65, P7554, DOI 10.1158/0008-5472.CAN-05-1317; Hamdy FC, 1997, CANCER RES, V57, P4427; HARRIS SE, 1994, PROSTATE, V24, P204, DOI 10.1002/pros.2990240406; Hartmann C, 2006, TRENDS CELL BIOL, V16, P151, DOI 10.1016/j.tcb.2006.01.001; Haudenschild DR, 2004, CANCER RES, V64, P8276, DOI 10.1158/0008-5472.CAN-04-2251; Heath DJ, 2008, CALCIFIED TISSUE INT, V83, P6; Heath DJ, 2009, J BONE MINER RES, V24, P425, DOI 10.1359/JBMR.081104; Kozlow W, 2005, J MAMMARY GLAND BIOL, V10, P169, DOI 10.1007/s10911-005-5399-8; KULENKAMPFF HA, 1986, VIRCHOWS ARCH A, V409, P817, DOI 10.1007/BF00710766; Lage MJ, 2008, AM J MANAG CARE, V14, P317; Lintern KB, 2009, J BIOL CHEM, V284, P23159, DOI 10.1074/jbc.M109.025478; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; Mastro AM, 2004, J CELL BIOCHEM, V91, P265, DOI 10.1002/jcb.10746; Mercer RR, 2004, CLIN EXP METASTAS, V21, P427, DOI 10.1007/s10585-004-1867-6; Morrissey C, 2010, PROSTATE, V70, P412, DOI 10.1002/pros.21075; Mundy GR, 1997, CANCER-AM CANCER SOC, V80, P1546, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.3.CO;2-R; MUNDY GR, 2008, PRIMER NETABOLIC BON, P374; NERI B, 1989, CANCER INVEST, V7, P551, DOI 10.3109/07357908909017529; Ohazama A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004092; Oshima T, 2005, BLOOD, V106, P3160, DOI 10.1182/blood-2004-12-4940; Parfitt A M, 1995, Can J Oncol, V5 Suppl 1, P1; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pearse RN, 2001, P NATL ACAD SCI USA, V98, P11581, DOI 10.1073/pnas.201394498; Qiang YW, 2008, BLOOD, V112, P196, DOI 10.1182/blood-2008-01-132134; Qiang YW, 2008, BONE, V42, P669, DOI 10.1016/j.bone.2007.12.006; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; ROODMAN GD, 2010, J BONE MINER METAB; Roudier MP, 2003, HUM PATHOL, V34, P646, DOI 10.1016/S0046-8177(03)00190-4; SASAKI A, 1995, CANCER RES, V55, P3551; Schwaninger R, 2007, AM J PATHOL, V170, P160, DOI 10.2353/ajpath.2007.051276; SUNDQUIST KT, 1995, BONE, V16, P39, DOI 10.1016/S8756-3282(94)00005-0; Suva LJ, 2009, ENDOCR-RELAT CANCER, V16, P703, DOI 10.1677/ERC-09-0012; Swan CH, 2006, GENE THER, V13, P1480, DOI 10.1038/sj.gt.3302801; TAUBE T, 1992, EUR J HAEMATOL, V49, P192; TAUBE T, 1994, BONE, V15, P161, DOI 10.1016/8756-3282(94)90703-X; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; van der Pluijm G, 2005, CANCER RES, V65, P7682, DOI 10.1158/0008-5472.CAN-04-4188; Voorzanger-Rousselot N, 2007, BRIT J CANCER, V97, P964, DOI 10.1038/sj.bjc.6603959; Vukmirovic-Popovic S, 2002, BONE, V31, P529, DOI 10.1016/S8756-3282(02)00847-5; Wetterwald A, 2002, AM J PATHOL, V160, P1143, DOI 10.1016/S0002-9440(10)64934-6; Wu XB, 2003, J CLIN INVEST, V112, P924, DOI 10.1172/JCI200315543; Yaccoby S, 2006, HAEMATOL-HEMATOL J, V91, P192; Yaccoby S, 2007, BLOOD, V109, P2106, DOI 10.1182/blood-2006-09-047712; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523	66	45	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16078	10.1371/journal.pone.0016078	http://dx.doi.org/10.1371/journal.pone.0016078			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249149	Green Published, Green Submitted, gold			2022-12-27	WOS:000286515000016
J	Fakiola, M; Mishra, A; Rai, M; Singh, SP; O'Leary, RA; Ball, S; Francis, RW; Firth, MJ; Radford, BT; Miller, EN; Sundar, S; Blackwell, JM				Fakiola, Michaela; Mishra, Anshuman; Rai, Madhukar; Singh, Shri Prakash; O'Leary, Rebecca A.; Ball, Stephen; Francis, Richard W.; Firth, Martin J.; Radford, Ben T.; Miller, E. Nancy; Sundar, Shyam; Blackwell, Jenefer M.			Classification and Regression Tree and Spatial Analyses Reveal Geographic Heterogeneity in Genome Wide Linkage Study of Indian Visceral Leishmaniasis	PLOS ONE			English	Article							SIB-PAIR METHOD; KALA-AZAR; GENETIC SUSCEPTIBILITY; CELL-DIFFERENTIATION; NORTHEASTERN BRAZIL; DONOVANI INFECTION; MUSLIM POPULATIONS; MAJOR INFECTION; EASTERN SUDAN; ENDEMIC AREA	Background: Genome wide linkage studies (GWLS) have provided evidence for loci controlling visceral leishmaniasis on Chromosomes 1p22, 6q27, 22q12 in Sudan and 6q27, 9p21, 17q11-q21 in Brazil. Genome wide studies from the major focus of disease in India have not previously been reported. Methods and Findings: We undertook a GWLS in India in which a primary similar to 10 cM (515 microsatellites) scan was carried out in 58 multicase pedigrees (74 nuclear families; 176 affected, 353 total individuals) and replication sought in 79 pedigrees (102 nuclear families; 218 affected, 473 total individuals). The primary scan provided evidence (>= 2 adjacent markers allele-sharing LOD >= 0.59; nominal P <= 0.05) for linkage on Chromosomes 2, 5, 6, 7, 8, 10, 11, 20 and X, with peaks at 6p25.3-p24.3 and 8p23.1-p21.3 contributed to largely by 31 Hindu families and at Xq21.1-q26.1 by 27 Muslim families. Refined mapping confirmed linkage across all primary scan families at 2q12.2-q14.1 and 11q13.2-q23.3, but only 11q13.2-q23.3 replicated (combined LOD = 1.59; P = 0.0034). Linkage at 6p25.3-p24.3 and 8p23.1-p21.3, and at Xq21.1-q26.1, was confirmed by refined mapping for primary Hindu and Muslim families, respectively, but only Xq21.1-q26.1 replicated across all Muslim families (combined LOD 1.49; P = 0.0045). STRUCTURE and SMARTPCA did not identify population genetic substructure related to religious group. Classification and regression tree, and spatial interpolation, analyses confirm geographical heterogeneity for linkages at 6p25.3-p24.3, 8p23.1-p21.3 and Xq21.1-q26.1, with specific clusters of families contributing LOD scores of 2.13 (P = 0.0009), 1.75 (P = 0.002) and 1.84 (P = 0.001), respectively. Conclusions: GWLS has identified novel loci that show geographical heterogeneity in their influence on susceptibility to VL in India.	[Fakiola, Michaela; Francis, Richard W.; Miller, E. Nancy; Blackwell, Jenefer M.] Univ Cambridge, Sch Clin Med, Cambridge Inst Med Res, Cambridge, England; [Fakiola, Michaela; Francis, Richard W.; Miller, E. Nancy; Blackwell, Jenefer M.] Univ Cambridge, Sch Clin Med, Dept Med, Cambridge, England; [Mishra, Anshuman; Rai, Madhukar; Singh, Shri Prakash; Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [O'Leary, Rebecca A.; Ball, Stephen; Francis, Richard W.; Firth, Martin J.] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Subiaco, WA, Australia; [Radford, Ben T.] Univ Western Australia, UWA Oceans Inst, Australian Inst Marine Sci, Crawley, Australia	University of Cambridge; University of Cambridge; Banaras Hindu University (BHU); Telethon Kids Institute; University of Western Australia; Australian Institute of Marine Science; University of Western Australia	Fakiola, M (corresponding author), Univ Cambridge, Sch Clin Med, Cambridge Inst Med Res, Cambridge, England.	jblackwell@ichr.uwa.edu.au	trivedi, kruti/H-5242-2011; Francis, Richard/K-2812-2019; Blackwell, Jenefer M/H-3015-2015	Francis, Richard/0000-0003-1580-7934; Firth, Martin/0000-0002-7471-0860; Mishra, Anshuman/0000-0002-9390-9971; Fakiola, Michaela/0000-0001-9071-4709	Wellcome Trust, United Kingdom; National Institutes for Health, United States of America, Tropical Medicine Research Centre [1P50AI074321-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076233, P50AI074321] Funding Source: NIH RePORTER	Wellcome Trust, United Kingdom(Wellcome Trust); National Institutes for Health, United States of America, Tropical Medicine Research Centre; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by The Wellcome Trust, United Kingdom, and the National Institutes for Health, United States of America, Tropical Medicine Research Centre grant 1P50AI074321-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artis D, 2003, J IMMUNOL, V170, P1995, DOI 10.4049/jimmunol.170.4.1995; BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639; BADARO R, 1986, J INFECT DIS, V154, P1003, DOI 10.1093/infdis/154.6.1003; BALGIR RS, 1988, AM J PHYS ANTHROPOL, V75, P391, DOI 10.1002/ajpa.1330750310; Basu A, 2003, GENOME RES, V13, P2277, DOI 10.1101/gr.1413403; Bhattacharyya NP, 1999, GENOME RES, V9, P711; Bittles AH, 2000, ANN HUM BIOL, V27, P163; Blackwell JM, 1996, PARASITOLOGY, V112, pS67, DOI 10.1017/S0031182000076678; Breiman L., 1984, CLASSIFICATION REGRE; BROWN DL, 1994, AM J HUM GENET, V54, P544; Bucheton B, 2003, AM J HUM GENET, V73, P1052, DOI 10.1086/379084; Bucheton B, 2003, GENES IMMUN, V4, P104, DOI 10.1038/sj.gene.6363927; CABELLO PH, 1995, AM J TROP MED HYG, V52, P364, DOI 10.4269/ajtmh.1995.52.364; CHATTERJEE M, 1995, INDIAN J MED RES, V102, P165; Eaaswarkhanth M, 2009, HUM BIOL, V81, P427, DOI 10.3378/027.081.0403; Eaaswarkhanth M, 2010, EUR J HUM GENET, V18, P354, DOI 10.1038/ejhg.2009.168; Feng XS, 2002, P NATL ACAD SCI USA, V99, P14212, DOI 10.1073/pnas.212306199; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; FRANKENBURG S, 1990, J IMMUNOL, V145, P4284; Gauzzi MC, 2005, J LEUKOCYTE BIOL, V77, P944, DOI 10.1189/jlb.0205090; Genin E, 1996, AM J HUM GENET, V59, P1149; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Gutala R, 2006, HUM GENET, V120, P543, DOI 10.1007/s00439-006-0234-x; Hatzigeorgiou DE, 1996, P NATL ACAD SCI USA, V93, P14708, DOI 10.1073/pnas.93.25.14708; HO M, 1982, T ROY SOC TROP MED H, V76, P741, DOI 10.1016/0035-9203(82)90095-5; HOLMANS P, 1995, AM J HUM GENET, V57, P1221; Hu CM, 2002, J BIOL CHEM, V277, P49238, DOI 10.1074/jbc.M205895200; Ibrahim ME, 1999, AM J TROP MED HYG, V61, P941, DOI 10.4269/ajtmh.1999.61.941; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Jamieson SE, 2007, GENES IMMUN, V8, P84, DOI 10.1038/sj.gene.6364357; Jeronimo SMB, 2007, J INFECT DIS, V196, P1261, DOI 10.1086/521682; Khalil EAG, 2002, TROP MED INT HEALTH, V7, P35, DOI 10.1046/j.1365-3156.2002.00832.x; Kumar R, 1999, B WORLD HEALTH ORGAN, V77, P371; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lehtonen A, 2003, CYTOKINE, V24, P81, DOI 10.1016/j.cyto.2003.07.001; Leutenegger AL, 2002, GENET EPIDEMIOL, V23, P413, DOI 10.1002/gepi.10190; Lohoff M, 2004, J EXP MED, V200, P247, DOI 10.1084/jem.20040182; Malhotra KC, 1993, HUMAN POPULATION GEN; Manna M, 2005, MED SCI MONITOR, V11, pBR220; Mason NJ, 2004, IMMUNOL REV, V201, P48, DOI 10.1111/j.0105-2896.2004.00189.x; Matthews DJ, 2000, J IMMUNOL, V164, P1458, DOI 10.4049/jimmunol.164.3.1458; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Miller EN, 2007, PLOS GENET, V3, P679, DOI 10.1371/journal.pgen.0030071; Mohamed HS, 2004, EUR J HUM GENET, V12, P66, DOI 10.1038/sj.ejhg.5201089; Mohamed HS, 2003, GENES IMMUN, V4, P351, DOI 10.1038/sj.gene.6363977; Mullen AB, 2006, IMMUNOLOGY, V119, P348, DOI 10.1111/j.1365-2567.2006.02438.x; Murray HW, 2006, INFECT IMMUN, V74, P4370, DOI 10.1128/IAI.00422-06; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; O'sullivan D., 2003, GEOGRAPHIC INFORM AN; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Peacock CS, 2001, GENET EPIDEMIOL, V20, P383, DOI 10.1002/gepi.8; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; REINER NE, 1990, J CLIN INVEST, V85, P1914, DOI 10.1172/JCI114654; SACKS DL, 1987, J IMMUNOL, V138, P908; Salotra P, 2001, BRIT J DERMATOL, V145, P630, DOI 10.1046/j.1365-2133.2001.04434.x; Singh SP, 2006, TROP MED INT HEALTH, V11, P899, DOI 10.1111/j.1365-3156.2006.01647.x; Singh SP, 2006, AM J TROP MED HYG, V75, P505, DOI 10.4269/ajtmh.2006.75.505; Singh SP, 2010, TROP MED INT HEALTH, V15, P12, DOI 10.1111/j.1365-3156.2010.02519.x; Speirs K, 2002, J IMMUNOL, V168, P4406, DOI 10.4049/jimmunol.168.9.4406; Sundar S, 2001, AM J TROP MED HYG, V65, P193, DOI 10.4269/ajtmh.2001.65.193; Sundar Shyam, 2003, J Assoc Physicians India, V51, P195; Thakur CP, 2000, T ROY SOC TROP MED H, V94, P156, DOI 10.1016/S0035-9203(00)90255-4; Thakur CP, 2001, T ROY SOC TROP MED H, V95, P187, DOI 10.1016/S0035-9203(01)90160-9; Therneau T. M., 1997, 61 DEP HLTH SCI RES; Voronov E, 2010, INT IMMUNOL, V22, P245, DOI 10.1093/intimm/dxq006; WEEKS DE, 1995, AM J HUM GENET, V56, P1506; Wei XQ, 2004, IMMUNOL LETT, V94, P35, DOI 10.1016/j.imlet.2004.04.001; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Xu DM, 2000, EUR J IMMUNOL, V30, P3147, DOI 10.1002/1521-4141(200011)30:11<3147::AID-IMMU3147>3.0.CO;2-J; ZIJLSTRA EE, 1994, AM J TROP MED HYG, V51, P826, DOI 10.4269/ajtmh.1994.51.826	73	15	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15807	10.1371/journal.pone.0015807	http://dx.doi.org/10.1371/journal.pone.0015807			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209823	gold, Green Submitted, Green Published			2022-12-27	WOS:000285838900037
J	Padhukasahasram, B; Halperin, E; Wessel, J; Thomas, DJ; Silver, E; Trumbower, H; Cargill, M; Stephan, DA				Padhukasahasram, Badri; Halperin, Eran; Wessel, Jennifer; Thomas, Daryl J.; Silver, Elana; Trumbower, Heather; Cargill, Michele; Stephan, Dietrich A.			Presymptomatic Risk Assessment for Chronic Non-Communicable Diseases	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; RHEUMATOID-ARTHRITIS; ULCERATIVE-COLITIS; COMPLEX DISEASES; GENETIC RISK; SUSCEPTIBILITY; VARIANTS; POLYMORPHISMS; POPULATION	The prevalence of common chronic non-communicable diseases (CNCDs) far overshadows the prevalence of both monogenic and infectious diseases combined. All CNCDs, also called complex genetic diseases, have a heritable genetic component that can be used for pre-symptomatic risk assessment. Common single nucleotide polymorphisms (SNPs) that tag risk haplotypes across the genome currently account for a non-trivial portion of the germ-line genetic risk and we will likely continue to identify the remaining missing heritability in the form of rare variants, copy number variants and epigenetic modifications. Here, we describe a novel measure for calculating the lifetime risk of a disease, called the genetic composite index (GCI), and demonstrate its predictive value as a clinical classifier. The GCI only considers summary statistics of the effects of genetic variation and hence does not require the results of large-scale studies simultaneously assessing multiple risk factors. Combining GCI scores with environmental risk information provides an additional tool for clinical decision-making. The GCI can be populated with heritable risk information of any type, and thus represents a framework for CNCD pre-symptomatic risk assessment that can be populated as additional risk information is identified through next-generation technologies.	[Padhukasahasram, Badri; Halperin, Eran; Wessel, Jennifer; Thomas, Daryl J.; Silver, Elana; Trumbower, Heather; Cargill, Michele; Stephan, Dietrich A.] Navigenics, Foster City, CA USA; [Stephan, Dietrich A.] Inst Individualized Hlth, Palo Alto, CA USA; [Stephan, Dietrich A.] Canc Genome Inst, Philadelphia, PA USA; [Stephan, Dietrich A.] Childrens Hosp Boston, Childrens Hosp Informat Program, Boston, MA USA	Harvard University; Boston Children's Hospital	Padhukasahasram, B (corresponding author), Univ Calif Davis, Sect Ecol & Evolut, Davis, CA 95616 USA.	bpadhuka@ucdavis.edu		Wessel, Jennifer/0000-0002-7031-0085	Navigenics Inc.	Navigenics Inc.	This project was funded by only in that all the authors were employees of Navigenics when this study was carried out. No other company funded this study. The study was carried out at Navigenics Inc. and the methodology used in this paper was initially developed for genetic risk calculations for customers using their genotype data in the product that is offered by Navigenics Inc. The research in this article was conducted to validate this methodology and its assumptions using real and simulated data. The funders had a role in study design, data collection and in the decision to publish this manuscript.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; Doran MF, 2002, ARTHRITIS RHEUM-US, V46, P625, DOI 10.1002/art.509; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kempthorne O, 1957, INTRO GENETIC STAT; King R. A., 2002, GENETIC BASIS COMMON, V2; Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790; Loftus CG, 2007, INFLAMM BOWEL DIS, V13, P254, DOI 10.1002/ibd.20029; Lu Q, 2008, AM J HUM GENET, V82, P641, DOI 10.1016/j.ajhg.2007.12.025; LUSTED LB, 1971, SCIENCE, V171, P1217, DOI 10.1126/science.171.3977.1217; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P2410, DOI 10.1002/1529-0131(200011)43:11<2410::AID-ANR6>3.0.CO;2-E; Morrison AC, 2007, AM J EPIDEMIOL, V166, P28, DOI 10.1093/aje/kwm060; Narayan KMV, 2003, JAMA-J AM MED ASSOC, V290, P1884, DOI 10.1001/jama.290.14.1884; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Salonen JT, 2007, AM J HUM GENET, V81, P338, DOI 10.1086/520599; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Small KM, 2002, NEW ENGL J MED, V347, P1135, DOI 10.1056/NEJMoa020803; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Yang QH, 2005, INT J EPIDEMIOL, V34, P1129, DOI 10.1093/ije/dyi130; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; 2001, NATURE, V409, P934; 2007, NATURE, V449, P851	28	10	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e14338	10.1371/journal.pone.0014338	http://dx.doi.org/10.1371/journal.pone.0014338			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217814	Green Published, gold, Green Submitted			2022-12-27	WOS:000285838900001
J	Robert-Moreno, A; Naranjo, S; de la Calle-Mustienes, E; Gomez-Skarmeta, JL; Alsina, B				Robert-Moreno, Alex; Naranjo, Silvia; de la Calle-Mustienes, Elisa; Luis Gomez-Skarmeta, Jose; Alsina, Berta			Characterization of New Otic Enhancers of the Pou3f4 Gene Reveal Distinct Signaling Pathway Regulation and Spatio-Temporal Patterns	PLOS ONE			English	Article							X-LINKED DEAFNESS; INNER-EAR DEVELOPMENT; PLACODE INDUCTION; PROSENSORY PATCHES; SONIC HEDGEHOG; HEARING-LOSS; HAIR-CELLS; FGF3; ZEBRAFISH; EXPRESSION	POU3F4 is a member of the POU-homedomain transcription factor family with a prominent role in inner ear development. Mutations in the human POU3F4 coding unit leads to X-linked deafness type 3 (DFN3), characterized by conductive hearing loss and progressive sensorineural deafness. Microdeletions found 1 Mb 5' upstream of the coding region also displayed the same phenotype, suggesting that cis-regulatory elements might be present in that region. Indeed, we and others have recently identified several enhancers at the 1 Mb 59 upstream interval of the pou3f4 locus. Here we characterize the spatio-temporal patterns of these regulatory elements in zebrafish transgenic lines. We show that the most distal enhancer (HCNR 81675) is activated earlier and drives GFP reporter expression initially to a broad ear domain to progressively restrict to the sensory patches. The proximal enhancer (HCNR 82478) is switched later during development and promotes expression, among in other tissues, in sensory patches from its onset. The third enhancer (HCNR 81728) is also active at later stages in the otic mesenchyme and in the otic epithelium. We also characterize the signaling pathways regulating these enhancers. While HCNR 81675 is regulated by very early signals of retinoic acid, HCNR 82478 is regulated by Fgf activity at a later stage and the HCNR 81728 enhancer is under the control of Hh signaling. Finally, we show that Sox2 and Pax2 transcription factors are bound to HCNR 81675 genomic region during otic development and specific mutations to these transcription factor binding sites abrogates HCNR 81675 enhancer activity. Altogether, our results suggest that pou3f4 expression in inner ear might be under the control of distinct regulatory elements that fine-tune the spatio-temporal activity of this gene and provides novel data on the signaling mechanisms controlling pou3f4 function.	[Robert-Moreno, Alex; Alsina, Berta] Univ Pompeu Fabra Parc Recerca Biomed Barcelona, Dept Expt & Hlth Sci, Barcelona, Spain; [Naranjo, Silvia; de la Calle-Mustienes, Elisa; Luis Gomez-Skarmeta, Jose] Univ Pablo Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Seville, Spain	Pompeu Fabra University; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD)	Robert-Moreno, A (corresponding author), Univ Pompeu Fabra Parc Recerca Biomed Barcelona, Dept Expt & Hlth Sci, Barcelona, Spain.	berta.alsina@upf.edu	Robert-Moreno, Alex/K-8640-2014; Naranjo, Silvia/P-9845-2016; Alsina, Berta/A-2632-2010; Gomez-Skarmeta, Jose Luis/B-5268-2014	Robert-Moreno, Alex/0000-0001-9042-1316; Naranjo, Silvia/0000-0002-4529-3332; Alsina, Berta/0000-0002-6997-1249; Gomez-Skarmeta, Jose Luis/0000-0001-5125-4332; de la Calle-Mustienes, Elisa/0000-0002-8975-6503	MICINN [BFU 2008-00714, BFU2007-60042/BMC, Petri PET2007_0158, CSD2007-00008]; Junta de Andalucia [CVI-3488]; Juan de la Cierva postdoctoral fellowship	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Junta de Andalucia(Junta de Andalucia); Juan de la Cierva postdoctoral fellowship(Instituto de Salud Carlos III)	This work has been supported by grants from MICINN to BA (BFU 2008-00714) and JLG-S (BFU2007-60042/BMC, Petri PET2007_0158, CSD2007-00008), a grant from the Junta de Andalucia to JLG-S (Proyecto de Excelencia CVI-3488) and a Juan de la Cierva postdoctoral fellowship to ARM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abello G, 2010, DEV BIOL, V339, P166, DOI 10.1016/j.ydbio.2009.12.027; Aguilera C, 2004, P NATL ACAD SCI USA, V101, P16537, DOI 10.1073/pnas.0404429101; Alsina B, 2004, DEV BIOL, V267, P119, DOI 10.1016/j.ydbio.2003.11.012; Alvarez Y, 2003, DEVELOPMENT, V130, P6329, DOI 10.1242/dev.00881; Ann KJ, 2009, GENESIS, V47, P137, DOI 10.1002/dvg.20454; Arnold JS, 2006, HUM MOL GENET, V15, P1629, DOI 10.1093/hmg/ddl084; Begemann G, 2001, DEVELOPMENT, V128, P3081; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bessa J, 2009, DEV DYNAM, V238, P2409, DOI 10.1002/dvdy.22051; BITNERGLINDZICZ M, 1995, HUM MOL GENET, V4, P1467, DOI 10.1093/hmg/4.8.1467; Braunstein EM, 2008, JARO-J ASSOC RES OTO, V9, P33, DOI 10.1007/s10162-008-0110-6; Brown KK, 2010, HUM GENET, V127, P19, DOI 10.1007/s00439-009-0736-4; Chang W, 2002, DEV BIOL, V251, P380, DOI 10.1006/dbio.2002.0822; Cole LK, 2000, J COMP NEUROL, V424, P509, DOI 10.1002/1096-9861(20000828)424:3<509::AID-CNE8>3.0.CO;2-Q; Conte I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r137; Cremers FPM, 2000, ADV OTO-RHINO-LARYNG, V56, P184; Daudet N, 2005, DEVELOPMENT, V132, P541, DOI 10.1242/dev.01589; Daudet N, 2007, DEVELOPMENT, V134, P2369, DOI 10.1242/dev.001842; de la Calle-Mustienes E, 2005, GENOME RES, V15, P1061, DOI 10.1101/gr.4004805; deKok YJM, 1996, HUM MOL GENET, V5, P1229, DOI 10.1093/hmg/5.9.1229; DEKOK YJM, 1995, HUM MOL GENET, V4, P2145; DEKOK YJM, 1995, SCIENCE, V267, P685, DOI 10.1126/science.7839145; Dror AA, 2009, ANNU REV GENET, V43, P411, DOI 10.1146/annurev-genet-102108-134135; Dupe V, 1999, DEVELOPMENT, V126, P5051; Gale E, 1999, MECH DEVELOP, V89, P43, DOI 10.1016/S0925-4773(99)00202-6; Gomez-Skarmeta JL, 2006, DEV DYNAM, V235, P870, DOI 10.1002/dvdy.20659; Guerrero L, 2010, DEV BIOL, V337, P16, DOI 10.1016/j.ydbio.2009.10.006; Hans S, 2007, DEVELOPMENT, V134, P2449, DOI 10.1242/dev.000448; Inoue M, 2007, GENES CELLS, V12, P1049, DOI 10.1111/j.1365-2443.2007.01114.x; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Ladher RK, 2000, SCIENCE, V290, P1965, DOI 10.1126/science.290.5498.1965; LEFEBVRE PP, 1993, SCIENCE, V260, P692, DOI 10.1126/science.8480180; Leger S, 2002, MECH DEVELOP, V119, P91, DOI 10.1016/S0925-4773(02)00343-X; LEMOINE C, 1992, P NATL ACAD SCI USA, V89, P3285, DOI 10.1073/pnas.89.8.3285; Liu W, 2003, DEV DYNAM, V226, P427, DOI 10.1002/dvdy.10258; Maroon H, 2002, DEVELOPMENT, V129, P2099; Naranjo S, 2010, HUM GENET, V128, P411, DOI 10.1007/s00439-010-0864-x; Navratilova Pavla, 2009, Briefings in Functional Genomics & Proteomics, V8, P333, DOI 10.1093/bfgp/elp019; Papatsenko D, 2009, NUCLEIC ACIDS RES, V37, P5665, DOI 10.1093/nar/gkp619; Pauley S, 2003, DEV DYNAM, V227, P203, DOI 10.1002/dvdy.10297; Petit C, 1996, NAT GENET, V14, P385, DOI 10.1038/ng1296-385; Phillips BT, 2004, DEVELOPMENT, V131, P923, DOI 10.1242/dev.00978; Phillips BT, 2001, DEV BIOL, V235, P351, DOI 10.1006/dbio.2001.0297; Phippard D, 1999, J NEUROSCI, V19, P5980, DOI 10.1523/JNEUROSCI.19-14-05980.1999; Phippard D, 2000, HUM MOL GENET, V9, P79, DOI 10.1093/hmg/9.1.79; Pirvola U, 2000, J NEUROSCI, V20, P6125, DOI 10.1523/JNEUROSCI.20-16-06125.2000; Pujades C, 2006, DEV BIOL, V292, P55, DOI 10.1016/j.ydbio.2006.01.001; Raz Y, 1997, SEMIN CELL DEV BIOL, V8, P257, DOI 10.1006/scdb.1997.0148; Riccomagno MM, 2002, GENE DEV, V16, P2365, DOI 10.1101/gad.1013302; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Spitz F, 2001, GENE DEV, V15, P2209, DOI 10.1101/gad.205701; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Torres M, 1998, MECH DEVELOP, V71, P5, DOI 10.1016/S0925-4773(97)00155-X; Vahava O, 1998, SCIENCE, V279, P1950, DOI 10.1126/science.279.5358.1950; Vendrell V, 2000, DEVELOPMENT, V127, P2011; Visel A, 2007, SEMIN CELL DEV BIOL, V18, P140, DOI 10.1016/j.semcdb.2006.12.014; Wright TJ, 2003, DEVELOPMENT, V130, P3379, DOI 10.1242/dev.00555; Yamagishi H, 2003, GENE DEV, V17, P269, DOI 10.1101/gad.1048903	58	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15907	10.1371/journal.pone.0015907	http://dx.doi.org/10.1371/journal.pone.0015907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209840	Green Published, gold, Green Submitted			2022-12-27	WOS:000285838900048
J	Fuentes, JL; Strayer, MS; Matera, AG				Fuentes, Jennifer L.; Strayer, Molly S.; Matera, A. Gregory			Molecular Determinants of Survival Motor Neuron (SMN) Protein Cleavage by the Calcium-Activated Protease, Calpain	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; DETERMINING GENE-PRODUCT; MYOBLAST FUSION; TUDOR DOMAIN; MU-CALPAIN; CELL-DEATH; RIBONUCLEOPROTEIN BIOGENESIS; NEUROMUSCULAR-JUNCTIONS; SKELETAL-MUSCLE; SNRNP PROTEINS	Spinal muscular atrophy (SMA) is a leading genetic cause of childhood mortality, caused by reduced levels of survival motor neuron (SMN) protein. SMN functions as part of a large complex in the biogenesis of small nuclear ribonucleoproteins (snRNPs). It is not clear if defects in snRNP biogenesis cause SMA or if loss of some tissue-specific function causes disease. We recently demonstrated that the SMN complex localizes to the Z-discs of skeletal and cardiac muscle sarcomeres, and that SMN is a proteolytic target of calpain. Calpains are implicated in muscle and neurodegenerative disorders, although their relationship to SMA is unclear. Using mass spectrometry, we identified two adjacent calpain cleavage sites in SMN, S192 and F193. Deletion of small motifs in the region surrounding these sites inhibited cleavage. Patient-derived SMA mutations within SMN reduced calpain cleavage. SMN(D44V), reported to impair Gemin2 binding and amino-terminal SMN association, drastically inhibited cleavage, suggesting a role for these interactions in regulating calpain cleavage. Deletion of A188, a residue mutated in SMA type I (A188S), abrogated calpain cleavage, highlighting the importance of this region. Conversely, SMA mutations that interfere with self-oligomerization of SMN, Y272C and SMN Delta 7, had no effect on cleavage. Removal of the recently-identified SMN degron (Delta 268-294) resulted in increased calpain sensitivity, suggesting that the C-terminus of SMN is important in dictating availability of the cleavage site. Investigation into the spatial determinants of SMN cleavage revealed that endogenous calpains can cleave cytosolic, but not nuclear, SMN. Collectively, the results provide insight into a novel aspect of the post-translation regulation of SMN.	[Fuentes, Jennifer L.] Univ N Carolina, Program Mol Biol & Biotechnol, Dept Biol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Program Mol Biol & Biotechnol, Dept Genet, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Fuentes, JL (corresponding author), Univ N Carolina, Program Mol Biol & Biotechnol, Dept Biol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	matera@unc.edu	, Proteomics Core UNC/AFQ-7201-2022; , Proteomics Core UNC/AAH-3777-2022	Matera, A. Gregory/0000-0002-6406-0630	National Institutes of Health (USA) [R01-NS41617]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041617] Funding Source: NIH RePORTER	National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funds from the National Institutes of Health (USA), grant number R01-NS41617. URL: http://projectreporter.nih.gov/reporter.cfm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold AS, 2004, LAB INVEST, V84, P1271, DOI 10.1038/labinvest.3700163; Baki A, 1996, BIOCHEM J, V318, P897, DOI 10.1042/bj3180897; BALCERZAK D, 1995, J CELL SCI, V108, P2077; Barnoy S, 2005, BIOCHEM BIOPH RES CO, V332, P697, DOI 10.1016/j.bbrc.2005.05.010; Barth S, 2003, J VIROL, V77, P5008, DOI 10.1128/JVI.77.8.5008-5013.2003; Bartoli M, 2005, INT J BIOCHEM CELL B, V37, P2115, DOI 10.1016/j.biocel.2004.12.012; Beckmann JS, 2008, NEUROMUSCULAR DISORD, V18, P913, DOI 10.1016/j.nmd.2008.08.005; Bertoli C, 2009, ONCOGENE, V28, P721, DOI 10.1038/onc.2008.425; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; Buhler D, 1999, HUM MOL GENET, V8, P2351, DOI 10.1093/hmg/8.13.2351; Burghes AHM, 1997, AM J HUM GENET, V61, P9, DOI 10.1086/513913; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Burnett BG, 2008, MOL CELL BIOL; Carissimi C, 2006, J BIOL CHEM, V281, P37009, DOI 10.1074/jbc.M607505200; Carrel TL, 2006, J NEUROSCI, V26, P11014, DOI 10.1523/JNEUROSCI.1637-06.2006; Chan YB, 2003, HUM MOL GENET, V12, P1367, DOI 10.1093/hmg/ddg157; Chang HC, 2004, NEUROCHEM INT, V45, P1107, DOI 10.1016/j.neuint.2004.04.005; Chen F, 2007, NEURON, V55, P247, DOI 10.1016/j.neuron.2007.06.031; Cho SC, 2010, GENE DEV, V24, P438, DOI 10.1101/gad.1884910; Cifuentes-Diaz C, 2002, HUM MOL GENET, V11, P1439, DOI 10.1093/hmg/11.12.1439; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; Dourdin N, 1999, EXP CELL RES, V246, P433, DOI 10.1006/excr.1998.4325; duVerle David, 2010, V22, P202; EBISUI C, 1994, BIOCHEM MOL BIOL INT, V32, P515; Eggert C, 2006, TRENDS MOL MED, V12, P113, DOI 10.1016/j.molmed.2006.01.005; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Gafni J, 2009, J BIOL CHEM, V284, P25441, DOI 10.1074/jbc.M109.038174; GENNARELLI M, 1995, BIOCHEM BIOPH RES CO, V213, P342, DOI 10.1006/bbrc.1995.2135; Giesemann T, 1999, J BIOL CHEM, V274, P37908, DOI 10.1074/jbc.274.53.37908; Gil-Parrado S, 2003, J BIOL CHEM, V278, P16336, DOI 10.1074/jbc.M208657200; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; GREENWOOD JA, 1993, J NEUROCHEM, V61, P191, DOI 10.1111/j.1471-4159.1993.tb03555.x; Grimmler M, 2005, EMBO REP, V6, P70, DOI 10.1038/sj.embor.7400301; HAHNEN E, 1995, HUM MOL GENET, V4, P1927, DOI 10.1093/hmg/4.10.1927; Hanna RA, 2008, NATURE, V456, P409, DOI 10.1038/nature07451; Harwood SM, 2005, ANN CLIN BIOCHEM, V42, P415, DOI 10.1258/000456305774538238; Hasselgren PO, 2001, ANN SURG, V233, P9, DOI 10.1097/00000658-200101000-00003; Hebert MD, 2001, GENE DEV, V15, P2720, DOI 10.1101/gad.908401; HIRAO T, 1984, J BIOCHEM-TOKYO, V96, P775, DOI 10.1093/oxfordjournals.jbchem.a134895; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Ibrahim RM, 2008, J ANIM SCI, V86, P1426, DOI 10.2527/jas.2007-0618; Jablonka S, 2007, J CELL BIOL, V179, P139, DOI 10.1083/jcb.200703187; Jansen Katie M., 2008, V475, P115, DOI 10.1007/978-1-59745-250-2_7; Jones KW, 2001, J BIOL CHEM, V276, P38645, DOI 10.1074/jbc.M106161200; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; Kerr DA, 2000, P NATL ACAD SCI USA, V97, P13312, DOI 10.1073/pnas.230364197; Kim S, 2000, J NEUROBIOL, V42, P22, DOI 10.1002/(SICI)1097-4695(200001)42:1<22::AID-NEU3>3.0.CO;2-#; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; KWAK KB, 1993, FEBS LETT, V323, P151, DOI 10.1016/0014-5793(93)81468-F; Laing NG, 2005, BIOESSAYS, V27, P809, DOI 10.1002/bies.20269; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 1998, NAT GENET, V19, P63, DOI 10.1038/ng0598-63; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Ma H, 2001, J BIOL CHEM, V276, P28525, DOI 10.1074/jbc.M100603200; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Matera AG, 2009, DEV CELL, V17, P639, DOI 10.1016/j.devcel.2009.10.017; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Melki J, 1997, CURR OPIN NEUROL, V10, P381, DOI 10.1097/00019052-199710000-00005; MELKI J, 1990, NATURE, V344, P767, DOI 10.1038/344767a0; Michaud M, 2010, NEUROBIOL DIS, V38, P125, DOI 10.1016/j.nbd.2010.01.006; Moldoveanu T, 2008, NATURE, V456, P404, DOI 10.1038/nature07353; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; Murachi T, 1980, Adv Enzyme Regul, V19, P407; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Narayanan U, 2004, MOL CELL, V16, P223, DOI 10.1016/j.molcel.2004.09.024; Nicole S, 2003, J CELL BIOL, V161, P571, DOI 10.1083/jcb.200210117; Ogawa C, 2007, J BIOL CHEM, V282, P11122, DOI 10.1074/jbc.M609297200; Ono F, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.12pe3; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Otter S, 2007, J BIOL CHEM, V282, P5825, DOI 10.1074/jbc.M608528200; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Pellizzoni L, 1999, P NATL ACAD SCI USA, V96, P11167, DOI 10.1073/pnas.96.20.11167; Pellizzoni L, 2002, J BIOL CHEM, V277, P7540, DOI 10.1074/jbc.M110141200; Pellizzoni L, 2007, EMBO REP, V8, P340, DOI 10.1038/sj.embor.7400941; Petri S, 2007, J CELL BIOL, V179, P451, DOI 10.1083/jcb.200704163; Ponting CP, 1997, TRENDS BIOCHEM SCI, V22, P51, DOI 10.1016/S0968-0004(96)30049-2; Rajendra TK, 2007, J CELL BIOL, V176, P831, DOI 10.1083/jcb.200610053; Raynaud F, 2004, EXP CELL RES, V298, P48, DOI 10.1016/j.yexcr.2004.03.053; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Renvoise B, 2006, J CELL SCI, V119, P680, DOI 10.1242/jcs.02782; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Rossoll W, 2002, HUM MOL GENET, V11, P93, DOI 10.1093/hmg/11.1.93; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Rossoll W, 2009, RESULTS PROBL CELL D, V48, P289, DOI 10.1007/400_2009_4; Ruiz R, 2010, J NEUROSCI, V30, P849, DOI 10.1523/JNEUROSCI.4496-09.2010; Sandoval A, 2006, EUR J NEUROSCI, V23, P2311, DOI 10.1111/j.1460-9568.2006.04749.x; SASAKI T, 1984, J BIOL CHEM, V259, P2489; Scheffer H, 2001, EUR J HUM GENET, V9, P484, DOI 10.1038/sj.ejhg.5200667; Selenko P, 2001, NAT STRUCT BIOL, V8, P27; Shafey D, 2005, EXP CELL RES, V311, P49, DOI 10.1016/j.yexcr.2005.08.019; Sharma A, 2005, EXP CELL RES, V309, P185, DOI 10.1016/j.yexcr.2005.05.014; Shpargel KB, 2005, P NATL ACAD SCI USA, V102, P17372, DOI 10.1073/pnas.0508947102; Solomon V, 1996, J BIOL CHEM, V271, P26690, DOI 10.1074/jbc.271.43.26690; Sun Y, 2005, HUM MUTAT, V25, P64, DOI 10.1002/humu.20111; Tadesse H, 2008, HUM MOL GENET, V17, P506, DOI 10.1093/hmg/ddm327; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Tremper-Wells B, 2005, J BIOL CHEM, V280, P2165, DOI 10.1074/jbc.M410591200; Vaisid T, 2008, J NEUROSCI RES, V86, P2314, DOI 10.1002/jnr.21670; Vaisid T, 2009, INT J BIOCHEM CELL B, V41, P2450, DOI 10.1016/j.biocel.2009.07.010; van Bergeijk J, 2007, FASEB J, V21, P1492, DOI 10.1096/fj.06-7136com; Vitte J, 2007, AM J PATHOL, V171, P1269, DOI 10.2353/ajpath.2007.070399; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Vyas S, 2002, HUM MOL GENET, V11, P2751, DOI 10.1093/hmg/11.22.2751; Walker MP, 2008, HUM MOL GENET, V17, P3399, DOI 10.1093/hmg/ddn234; Wang J, 2001, J BIOL CHEM, V276, P45387, DOI 10.1074/jbc.M105059200; Wendt A, 2004, BIOL CHEM, V385, P465, DOI 10.1515/BC.2004.054; Whitehead SE, 2002, J BIOL CHEM, V277, P48087, DOI 10.1074/jbc.M204551200; Wirth B, 2006, PROG MOLEC, V44, P109; Wu HV, 2006, MOL NEUROBIOL, V33, P215, DOI 10.1385/MN:33:3:215; Young PJ, 2000, HUM MOL GENET, V9, P2869, DOI 10.1093/hmg/9.19.2869; Young PJ, 2003, MOL BRAIN RES, V119, P37, DOI 10.1016/j.molbrainres.2003.08.011; Zapletalova E, 2007, NEUROMUSCULAR DISORD, V17, P476, DOI 10.1016/j.nmd.2007.03.003; ZERRES K, 1995, ARCH NEUROL-CHICAGO, V52, P518, DOI 10.1001/archneur.1995.00540290108025	125	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15769	10.1371/journal.pone.0015769	http://dx.doi.org/10.1371/journal.pone.0015769			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209906	Green Published, Green Submitted, gold			2022-12-27	WOS:000285793600035
J	Kadiyala, CSR; Tomechko, SE; Miyagi, M				Kadiyala, Chandra Sekhar Rao; Tomechko, Sara E.; Miyagi, Masaru			Perfluorooctanoic Acid for Shotgun Proteomics	PLOS ONE			English	Article							MASS-SPECTROMETRY; ENZYMATIC DIGESTION; MEMBRANE-PROTEINS; OUTER SEGMENT; SURFACTANT; DETERGENTS; STRATEGIES; EXCHANGE; REMOVAL; TRYPSIN	Here, we describe the novel use of a volatile surfactant, perfluorooctanoic acid (PFOA), for shotgun proteomics. PFOA was found to solubilize membrane proteins as effectively as sodium dodecyl sulfate (SDS). PFOA concentrations up to 0.5% (w/v) did not significantly inhibit trypsin activity. The unique features of PFOA allowed us to develop a single-tube shotgun proteomics method that used all volatile chemicals that could easily be removed by evaporation prior to mass spectrometry analysis. The experimental procedures involved: 1) extraction of proteins in 2% PFOA; 2) reduction of cystine residues with triethyl phosphine and their S-alkylation with iodoethanol; 3) trypsin digestion of proteins in 0.5% PFOA; 4) removal of PFOA by evaporation; and 5) LC-MS/MS analysis of the resulting peptides. The general applicability of the method was demonstrated with the membrane preparation of photoreceptor outer segments. We identified 75 proteins from 1 mu g of the tryptic peptides in a single, 1-hour, LC-MS/MS run. About 67% of the proteins identified were classified as membrane proteins. We also demonstrate that a proteolytic (18)O labeling procedure can be incorporated after the PFOA removal step for quantitative proteomic experiments. The present method does not require sample clean-up devices such as solid-phase extractions and membrane filters, so no proteins/peptides are lost in any experimental steps. Thus, this single-tube shotgun proteomics method overcomes the major drawbacks of surfactant use in proteomic experiments.	[Kadiyala, Chandra Sekhar Rao; Tomechko, Sara E.; Miyagi, Masaru] Case Western Reserve Univ, Case Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Miyagi, Masaru] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Miyagi, Masaru] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Kadiyala, CSR (corresponding author), Case Western Reserve Univ, Case Ctr Prote & Bioinformat, Cleveland, OH 44106 USA.	masaru.miyagi@case.edu			National Institutes of Health [P30EY-11373]; Juvenile Diabetes Research Foundation [39-2009-643]; NATIONAL EYE INSTITUTE [P30EY011373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by National Institutes of Health grant P30EY-11373 (Visual Sciences Research Center of Case Western Reserve University) and Juvenile Diabetes Research Foundation grant 39-2009-643. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burns DC, 2008, ENVIRON SCI TECHNOL, V42, P9283, DOI 10.1021/es802047v; Capelo JL, 2010, TALANTA, V80, P1476, DOI 10.1016/j.talanta.2009.04.053; Eckel-Passow JE, 2006, BIOINFORMATICS, V22, P2739, DOI 10.1093/bioinformatics/btl464; Fenselau C, 2009, J PROTEOME RES, V8, P2140, DOI 10.1021/pr8009879; Hajkova D, 2010, J PROTEOME RES, V9, P1173, DOI 10.1021/pr900819k; Hale JE, 2004, ANAL BIOCHEM, V333, P174, DOI 10.1016/j.ab.2004.04.013; Ishihama Y, 2000, ANAL BIOCHEM, V287, P45, DOI 10.1006/abio.2000.4836; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kiser JZ, 2009, J PROTEOME RES, V8, P1810, DOI 10.1021/pr8004919; Loo RRO, 2007, ANAL CHEM, V79, P1115, DOI 10.1021/ac061916c; Masuda T, 2008, J PROTEOME RES, V7, P731, DOI 10.1021/pr700658q; Miyagi M, 2007, MASS SPECTROM REV, V26, P121, DOI 10.1002/mas.20116; Negri S, 2008, G Ital Med Lav Ergon, V30, P61; Norris JL, 2003, ANAL CHEM, V75, P6642, DOI 10.1021/ac034802z; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; Pezeshki A, 2009, J PHARMACEUT BIOMED, V49, P607, DOI 10.1016/j.jpba.2008.12.003; Rey M, 2010, ANAL CHEM, V82, P5107, DOI 10.1021/ac100171m; SHEPHERD FH, 1995, ANAL BIOCHEM, V224, P21, DOI 10.1006/abio.1995.1003; Vissers JPC, 1996, J CHROMATOGR B, V686, P119, DOI 10.1016/S0378-4347(96)00213-7; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yao XD, 2003, J PROTEOME RES, V2, P147, DOI 10.1021/pr025572s; Yu YQ, 2004, RAPID COMMUN MASS SP, V18, P711, DOI 10.1002/rcm.1374; Yu YQ, 2003, ANAL CHEM, V75, P6023, DOI 10.1021/ac0346196; Zaikin VG, 2005, EUR J MASS SPECTROM, V11, P611, DOI 10.1255/ejms.773	24	27	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15332	10.1371/journal.pone.0015332	http://dx.doi.org/10.1371/journal.pone.0015332			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209883	Green Published, Green Submitted, gold			2022-12-27	WOS:000285793600018
J	de Una-Alvarez, J; Carvajal-Rodriguez, A				de Una-Alvarez, Jacobo; Carvajal-Rodriguez, Antonio			'SGoFicance Trace': Assessing Significance in High Dimensional Testing Problems	PLOS ONE			English	Article							FALSE DISCOVERY RATE	Recently, an exact binomial test called SGoF (Sequential Goodness-of-Fit) has been introduced as a new method for handling high dimensional testing problems. SGoF looks for statistical significance when comparing the amount of null hypotheses individually rejected at level gamma = 0.05 with the expected amount under the intersection null, and then proceeds to declare a number of effects accordingly. SGoF detects an increasing proportion of true effects with the number of tests, unlike other methods for which the opposite is true. It is worth mentioning that the choice gamma = 0.05 is not essential to the SGoF procedure, and more power may be reached at other values of gamma depending on the situation. In this paper we enhance the possibilities of SGoF by letting the gamma vary on the whole interval (0,1). In this way, we introduce the 'SGoFicance Trace' (from SGoF's significance trace), a graphical complement to SGoF which can help to make decisions in multiple-testing problems. A script has been written for the computation in R of the SGoFicance Trace. This script is available from the web site http://webs.uvigo.es/acraaj/SGoFicance.htm.	[de Una-Alvarez, Jacobo] Univ Vigo, Dept Estadist & Invest Operat, Fac Ciencias Econ & Empresariales, Vigo 36310, Spain; [Carvajal-Rodriguez, Antonio] Univ Vigo, Dept Bioquim Genet & Inmunol, Fac Biol, Vigo 36310, Spain	Universidade de Vigo; Universidade de Vigo	de Una-Alvarez, J (corresponding author), Univ Vigo, Dept Estadist & Invest Operat, Fac Ciencias Econ & Empresariales, Vigo 36310, Spain.	acraaj@uvigo.es	, ACR/A-7676-2012; de Uña-Álvarez, Jacobo/K-5667-2014	, ACR/0000-0002-6242-3581; de Uña-Álvarez, Jacobo/0000-0002-4686-8417	Ministerio de Ciencia e Innovacion [CGL2008-00135/BOS, CGL2009-13278/C02-01, MTM2008-03129]; Xunta de Galicia [INCITE 09 310006PR, PGIDIT07PXIB300191PR, 2009/063]; Xunta de Galicia (Spain)	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Xunta de Galicia (Spain)(Xunta de Galicia)	The authors thank the following institutions for general funding: Ministerio de Ciencia e Innovacion (code CGL2008-00135/BOS, code CGL2009-13278/C02-01 and code MTM2008-03129), Xunta de Galicia (code INCITE 09 310006PR and code PGIDIT07PXIB300191PR). AC-R is currently funded by an Isidro Parga Pondal research fellowship from Xunta de Galicia (Spain). Jacobo de Una-Alvarez is also grateful to the Xunta de Galicia for financial support under the INBIOMED project (DXPCTSUG, Ref. 2009/063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carvajal-Rodriguez A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-209; Dalmasso C, 2005, BIOINFORMATICS, V21, P660, DOI 10.1093/bioinformatics/bti063; Dudoit S, 2008, SPRINGER SER STAT, P1; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Nguyen DV, 2004, COMPUT STAT DATA AN, V47, P611, DOI 10.1016/j.csda.2004.01.006; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; *R DEV COR TEAM, 2006, COMP RFFS; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100	10	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15930	10.1371/journal.pone.0015930	http://dx.doi.org/10.1371/journal.pone.0015930			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209966	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793200073
J	Xu, JH; Yang, ZY; Tsien, JZ				Xu, Jinhua; Yang, Zhiyong; Tsien, Joe Z.			Emergence of Visual Saliency from Natural Scenes via Context-Mediated Probability Distributions Coding	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; CELL RECEPTIVE-FIELDS; CORTEX; ATTENTION; MODEL; STATISTICS; PERCEPTION; ELEMENTS; NEURONS; FILTERS	Visual saliency is the perceptual quality that makes some items in visual scenes stand out from their immediate contexts. Visual saliency plays important roles in natural vision in that saliency can direct eye movements, deploy attention, and facilitate tasks like object detection and scene understanding. A central unsolved issue is: What features should be encoded in the early visual cortex for detecting salient features in natural scenes? To explore this important issue, we propose a hypothesis that visual saliency is based on efficient encoding of the probability distributions (PDs) of visual variables in specific contexts in natural scenes, referred to as context-mediated PDs in natural scenes. In this concept, computational units in the model of the early visual system do not act as feature detectors but rather as estimators of the context-mediated PDs of a full range of visual variables in natural scenes, which directly give rise to a measure of visual saliency of any input stimulus. To test this hypothesis, we developed a model of the context-mediated PDs in natural scenes using a modified algorithm for independent component analysis (ICA) and derived a measure of visual saliency based on these PDs estimated from a set of natural scenes. We demonstrated that visual saliency based on the context-mediated PDs in natural scenes effectively predicts human gaze in free-viewing of both static and dynamic natural scenes. This study suggests that the computation based on the context-mediated PDs of visual variables in natural scenes may underlie the neural mechanism in the early visual cortex for detecting salient features in natural scenes.	[Xu, Jinhua; Yang, Zhiyong; Tsien, Joe Z.] Georgia Hlth Sci Univ, Brain & Behav Discovery Inst, Augusta, GA USA; [Xu, Jinhua] E China Normal Univ, Dept Comp Sci & Technol, Shanghai 200062, Peoples R China; [Yang, Zhiyong] Georgia Hlth Sci Univ, Dept Ophthalmol, Augusta, GA USA; [Tsien, Joe Z.] Georgia Hlth Sci Univ, Dept Neurol, Augusta, GA USA	University System of Georgia; Augusta University; East China Normal University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Xu, JH (corresponding author), Georgia Hlth Sci Univ, Brain & Behav Discovery Inst, Augusta, GA USA.	zhyang@mcg.edu; jtsien@mcg.edu			National Institute of Mental Health (NIMH); National Institute of Aging (NIA); MCG fund; Georgia Research Alliance	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MCG fund; Georgia Research Alliance	This research was supported by funds from National Institute of Mental Health (NIMH), National Institute of Aging (NIA), MCG fund, and Georgia Research Alliance (All to JZT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright TD, 2002, ANNU REV NEUROSCI, V25, P339, DOI 10.1146/annurev.neuro.25.112701.142900; [Anonymous], 2006, NIPS; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Bruce NDB, 2009, J VISION, V9, DOI 10.1167/9.3.5; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Caywood MS, 2004, J NEUROPHYSIOL, V91, P2859, DOI 10.1152/jn.00775.2003; Chen XD, 2007, P NATL ACAD SCI USA, V104, P19120, DOI 10.1073/pnas.0706938104; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1091, DOI 10.1152/jn.1993.69.4.1091; Felsen G, 2005, NAT NEUROSCI, V8, P1643, DOI 10.1038/nn1608; FIELD DJ, 1994, NEURAL COMPUT, V6, P559, DOI 10.1162/neco.1994.6.4.559; Gao D, 2007, BOTTOM UP SALIENCY D; Gao DS, 2009, IEEE T PATTERN ANAL, V31, P989, DOI 10.1109/TPAMI.2009.27; Gao DS, 2009, NEURAL COMPUT, V21, P239, DOI 10.1162/neco.2009.11-06-391; Geisler WS, 2008, ANNU REV PSYCHOL, V59, P167, DOI 10.1146/annurev.psych.58.110405.085632; Hoyer PO, 2000, NETWORK-COMP NEURAL, V11, P191, DOI 10.1088/0954-898X/11/3/302; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 2001, VISION RES, V41, P2413, DOI 10.1016/S0042-6989(01)00114-6; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Itti L, 2009, VISION RES, V49, P1295, DOI 10.1016/j.visres.2008.09.007; JULESZ B, 1981, NATURE, V290, P91, DOI 10.1038/290091a0; Karklin Y, 2009, NATURE, V457, P83, DOI 10.1038/nature07481; Kayser C, 2003, NEURAL COMPUT, V15, P1751, DOI 10.1162/08997660360675026; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Le Meur O, 2006, IEEE T PATTERN ANAL, V28, P802, DOI 10.1109/TPAMI.2006.86; Li ZP, 2002, TRENDS COGN SCI, V6, P9, DOI 10.1016/S1364-6613(00)01817-9; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Olmos A., 2004, MCGILL CALIBRATED CO; Olshausen BA, 2005, NEURAL COMPUT, V17, P1665, DOI 10.1162/0899766054026639; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Rao RPN, 2004, NEURAL COMPUT, V16, P1, DOI 10.1162/08997660460733976; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; Seo HJ, 2009, J VISION, V9, DOI 10.1167/9.12.15; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Simoncelli EP, 2003, CURR OPIN NEUROBIOL, V13, P144, DOI 10.1016/S0959-4388(03)00047-3; Tatler BW, 2005, VISION RES, V45, P643, DOI 10.1016/j.visres.2004.09.017; Torralba A, 2006, PSYCHOL REV, V113, P766, DOI 10.1037/0033-295X.113.4.766; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P359, DOI 10.1098/rspb.1998.0303; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P2315, DOI 10.1098/rspb.1998.0577; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wachtler T, 2001, J OPT SOC AM A, V18, P65, DOI 10.1364/JOSAA.18.000065; Wolfe J. M., 2007, INTEGRATED MODELS CO, V10, P99, DOI [DOI 10.1093/ACPROF:OSO/9780195189193.003.0008, 10.1093/acprof:oso/9780195189193.003.0008]; Zhang L., 2009, P 31 ANN COGN SCI C, P2944; Zhang LY, 2008, J VISION, V8, DOI 10.1167/8.7.32; Zhaoping L, 2007, PLOS COMPUT BIOL, V3, P616, DOI 10.1371/journal.pcbi.0030062	51	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15796	10.1371/journal.pone.0015796	http://dx.doi.org/10.1371/journal.pone.0015796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	701CZ	21209963	gold, Green Published, Green Submitted			2022-12-27	WOS:000285793200056
J	Zhang, T; Black, S; Hao, CL; Ding, YF; Ji, W; Chen, R; Lin, YZ; Eskola, J; Shinefield, H; Knoll, MD; Zhao, GM				Zhang, Tao; Black, Steven; Hao, Chuangli; Ding, Yunfang; Ji, Wei; Chen, Rong; Lin, Yuzun; Eskola, Juhani; Shinefield, Henry; Knoll, Maria Delorian; Zhao, Genming			The Blind NasoTracheal Aspiration Method Is Not a Useful Tool for Pathogen Detection of Pneumonia in Children	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; STREPTOCOCCUS-PNEUMONIAE; ANTIMICROBIAL RESISTANCE; PEDIATRIC-PATIENTS; URINE SAMPLES; ANTIGEN; CULTURE; CATARRHALIS; INFECTIONS; DIAGNOSIS	Background: Acute lower respiratory infection (ALRI) is a major cause of hospitalization for children in China, while the etiological diagnosis of ALRI remains a challenge. This study was performed to evaluate the utility of the blind Nasotracheal aspiration (NTA) in the pathogen detection in ALRI through an evaluation of the test's specificity. Methodology/Principal Findings: A hospital-based study of children <= 3 years was carried out from March 2006 through March 2007 in Suzhou University Affiliated Children's Hospital, including 379 cases with ALRI from the respiratory wards, and 394 controls receiving elective surgery. Nasopharyngeal swabs (NPS) and NTA specimens were taken on admission. S. pneumoniae was isolated from 10.3% of NTA samples from ALRI children, H. influenzae from 15.3%, and M. catarrhalis from 4.7%. The false positive rate-the strains from NTA in control group children-was 8.4% (95% CI: 5.8%-11.4%) for S. pneumoniae, 27.2% (95% CI: 22.7-31.5%) for H. influenzae, and 22.1% (95% CI: 18.0%-26.2%) for M. catarrhalis. The agreement between NPS and NTA in the control group was over 70%. Conclusion/Significance: The blind NTA test is not a useful test for etiologic diagnosis of ALRI.	[Zhang, Tao; Chen, Rong; Lin, Yuzun; Zhao, Genming] Fudan Univ, Dept Epidemiol, Sch Publ Hlth, Key Lab Publ Hlth Safety,Minist Educ, Shanghai 200433, Peoples R China; [Black, Steven] Cincinnati Childrens Hosp, Ctr Global Hlth, Cincinnati, OH USA; [Hao, Chuangli; Ding, Yunfang; Ji, Wei] Suzhou Univ, Childrens Hosp, Suzhou 215006, Peoples R China; [Eskola, Juhani] Natl Inst Hlth & Welf THL, Helsinki, Finland; [Shinefield, Henry] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Knoll, Maria Delorian] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Fudan University; Cincinnati Children's Hospital Medical Center; Soochow University - China; Finland National Institute for Health & Welfare; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zhang, T (corresponding author), Fudan Univ, Dept Epidemiol, Sch Publ Hlth, Key Lab Publ Hlth Safety,Minist Educ, Shanghai 200433, Peoples R China.	gmzhao@shmu.edu.cn		Deloria Knoll, Maria/0000-0001-9041-2671	Johns Hopkins University; Glaxo Smith Kline; Shanghai Leading Academic Discipline Project [B118]	Johns Hopkins University(Johns Hopkins University); Glaxo Smith Kline(GlaxoSmithKline); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This research was funded by a grant from the Pneumo ADIP program of Johns Hopkins University and by an unrestricted grant from Glaxo Smith Kline. This research was supported by Shanghai Leading Academic Discipline Project as well, the Project Number: B118. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beekmann SE, 2005, INT J ANTIMICROB AG, V25, P148, DOI 10.1016/j.ijantimicag.2004.09.016; Che DD., 2004, CHIN J CONT PEDIAT, V6, P136; Clements H, 1996, BRIT MED J, V313, P757; Dowell SF, 2001, CLIN INFECT DIS, V32, P824, DOI 10.1086/319205; HUA CZ, 2006, CHIN J CONT PEDIAT, V8, P365; LENTINO JR, 1987, J CLIN MICROBIOL, V25, P758, DOI 10.1128/JCM.25.5.758-762.1987; LI H, 2006, J CHINESE PHYS, V18; Michelow IC, 2002, CLIN INFECT DIS, V34, pE1, DOI 10.1086/324358; Murdoch DR, 2009, J CLIN MICROBIOL, V47, P3405, DOI 10.1128/JCM.01685-09; Murdoch DR, 2001, J CLIN MICROBIOL, V39, P3495, DOI 10.1128/JCM.39.10.3495-3498.2001; Perera Antoinette, 1998, Ceylon Medical Journal, V43, P200; QIN M, 2005, JIANGSU MED J, V35, P330; Roson B, 2004, CLIN INFECT DIS, V38, P222, DOI 10.1086/380639; Ruiz M, 1999, AM J RESP CRIT CARE, V160, P397, DOI 10.1164/ajrccm.160.2.9808045; SHENG CK, 2004, J CLIN PEDIAT, V22, P94; TANG LX, 2006, GUANGXI MED J, V28, P1926; VONGRAEVENITZ A, 1981, SOUTHERN MED J, V74, P1095, DOI 10.1097/00007611-198109000-00021; ZHAO GC, 2003, CHIN J INFECT CHEMOT, V3, P134; Zhao GM, 2003, PEDIATR INFECT DIS J, V22, P739, DOI 10.1097/01.inf.0000078373.54515.40; ZHAO GM, 2006, 5 INT S PNEUM PNEUM	20	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15885	10.1371/journal.pone.0015885	http://dx.doi.org/10.1371/journal.pone.0015885			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209964	Green Published, Green Submitted, gold			2022-12-27	WOS:000285793200066
J	Magarinos, M; Aburto, MR; Sanchez-Calderon, H; Munoz-Agudo, C; Rapp, UR; Varela-Nieto, I				Magarinos, Marta; Aburto, Maria R.; Sanchez-Calderon, Hortensia; Munoz-Agudo, Carmen; Rapp, Ulf R.; Varela-Nieto, Isabel			RAF Kinase Activity Regulates Neuroepithelial Cell Proliferation and Neuronal Progenitor Cell Differentiation during Early Inner Ear Development	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; B-RAF; SUBCELLULAR-LOCALIZATION; INDEPENDENT MECHANISM; TRANSCRIPTION FACTORS; SYSTEM DEVELOPMENT; CYCLE REGULATION; C-RAF-1 GENE; AXON GROWTH; MEK-ERK	Background: Early inner ear development requires the strict regulation of cell proliferation, survival, migration and differentiation, coordinated by the concerted action of extrinsic and intrinsic factors. Deregulation of these processes is associated with embryonic malformations and deafness. We have shown that insulin-like growth factor I (IGF-I) plays a key role in embryonic and postnatal otic development by triggering the activation of intracellular lipid and protein kinases. RAF kinases are serine/threonine kinases that regulate the highly conserved RAS-RAF-MEK-ERK signaling cascade involved in transducing the signals from extracellular growth factors to the nucleus. However, the regulation of RAF kinase activity by growth factors during development is complex and still not fully understood. Methodology/Principal Findings: By using a combination of qRT-PCR, Western blotting, immunohistochemistry and in situ hybridization, we show that C-RAF and B-RAF are expressed during the early development of the chicken inner ear in specific spatiotemporal patterns. Moreover, later in development B-RAF expression is associated to hair cells in the sensory patches. Experiments in ex vivo cultures of otic vesicle explants demonstrate that the influence of IGF-I on proliferation but not survival depends on RAF kinase activating the MEK-ERK phosphorylation cascade. With the specific RAF inhibitor Sorafenib, we show that blocking RAF activity in organotypic cultures increases apoptosis and diminishes the rate of cell proliferation in the otic epithelia, as well as severely impairing neurogenesis of the acoustic-vestibular ganglion (AVG) and neuron maturation. Conclusions/Significance: We conclude that RAF kinase activity is essential to establish the balance between cell proliferation and death in neuroepithelial otic precursors, and for otic neuron differentiation and axonal growth at the AVG.	[Magarinos, Marta; Aburto, Maria R.; Sanchez-Calderon, Hortensia; Munoz-Agudo, Carmen; Varela-Nieto, Isabel] CSIC UAM, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Magarinos, Marta] Univ Autonoma Madrid, Dept Biol, Madrid, Spain; [Magarinos, Marta; Aburto, Maria R.; Sanchez-Calderon, Hortensia; Varela-Nieto, Isabel] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Unit 761, Madrid, Spain; [Rapp, Ulf R.] Max Planck Inst Biochem, Dept Mol Biol, D-8000 Munich, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Max Planck Society	Magarinos, M (corresponding author), CSIC UAM, Inst Invest Biomed Alberto Sols, Madrid, Spain.	mmagarinos@iib.uam.es	Rodriguez Aburto, Maria/ABG-7492-2021; SÁNCHEZ, MARTA MAGARIÑOS/ABG-7748-2020; Varela-Nieto, Isabel/G-5289-2015	SÁNCHEZ, MARTA MAGARIÑOS/0000-0003-4592-9377; Varela-Nieto, Isabel/0000-0003-3077-0500	Integrated Action [HA2004-0096]; Ministerio de Ciencia e Innovacion [SAF2008-00470]; Fundacion Mutua Madrilea; Consejo Superior de Investigaciones Cientificas-FSE I3	Integrated Action; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Mutua Madrilea; Consejo Superior de Investigaciones Cientificas-FSE I3	This work was supported by the Integrated Action HA2004-0096 to IVN and URR, Ministerio de Ciencia e Innovacion (SAF2008-00470) and Fundacion Mutua Madrilea to IVN. Maria R. Aburto and Hortensia Sanchez-Calderon hold contracts from Consejo Superior de Investigaciones Cientificas-FSE I3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejandro EU, 2008, J BIOL CHEM, V283, P2407, DOI 10.1074/jbc.M703612200; ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; Camarero G, 2003, DEV BIOL, V262, P242, DOI 10.1016/S0012-1606(03)00387-7; Camarero G, 2001, J NEUROSCI, V21, P7630, DOI 10.1523/JNEUROSCI.21-19-07630.2001; Camarero G, 2006, MOL CELL BIOL, V26, P7103, DOI 10.1128/MCB.00424-06; Carnahan J, 2010, MOL CANCER THER, V9, P2399, DOI 10.1158/1535-7163.MCT-10-0181; Cediel R, 2006, EUR J NEUROSCI, V23, P587, DOI 10.1111/j.1460-9568.2005.04584.x; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Chen J, 2001, P NATL ACAD SCI USA, V98, P7783, DOI 10.1073/pnas.141224398; Chin PC, 2004, J NEUROCHEM, V90, P595, DOI 10.1111/j.1471-4159.2004.02530.x; Chong H, 2003, CELL SIGNAL, V15, P463, DOI 10.1016/S0898-6568(02)00139-0; Craig EA, 2008, DEV DYNAM, V237, P3102, DOI 10.1002/dvdy.21750; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; Davies D, 2007, J COMP NEUROL, V502, P673, DOI 10.1002/cne.21302; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Ehrenreiter K, 2005, J CELL BIOL, V168, P955, DOI 10.1083/jcb.200409162; Espinosa AV, 2007, BRIT J CANCER, V96, P16, DOI 10.1038/sj.bjc.6603520; Frago LM, 2003, J CELL SCI, V116, P475, DOI 10.1242/jcs.00223; Frago LM, 1998, J CELL SCI, V111, P549; Galabova-Kovacs G, 2006, P NATL ACAD SCI USA, V103, P1325, DOI 10.1073/pnas.0507399103; Galabova-Kovacs G, 2008, J CELL BIOL, V180, P947, DOI 10.1083/jcb.200709069; GALAKTIONOV K, 1995, GENE DEV, V9, P1046, DOI 10.1101/gad.9.9.1046; Galmiche A, 2007, BBA-MOL CELL RES, V1773, P1256, DOI 10.1016/j.bbamcr.2006.10.012; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hausott B, 2009, MOL CELL NEUROSCI, V42, P328, DOI 10.1016/j.mcn.2009.08.005; Jilaveanu LB, 2009, CLIN CANCER RES, V15, P5704, DOI 10.1158/1078-0432.CCR-09-0198; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kong D, 2008, CANCER SCI, V99, P1734, DOI 10.1111/j.1349-7006.2008.00891.x; Lackey K, 2000, BIOORG MED CHEM LETT, V10, P223, DOI 10.1016/S0960-894X(99)00668-X; Ladher RK, 2005, GENE DEV, V19, P603, DOI 10.1101/gad.1273605; Leon Y, 2004, APOPTOSIS, V9, P255, DOI 10.1023/B:APPT.0000025802.07676.a5; LEON Y, 1995, ENDOCRINOLOGY, V136, P3494, DOI 10.1210/en.136.8.3494; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; Millimaki BB, 2010, DEV BIOL, V338, P262, DOI 10.1016/j.ydbio.2009.12.011; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; Morice C, 1999, EUR J NEUROSCI, V11, P1995, DOI 10.1046/j.1460-9568.1999.00609.x; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Panka DJ, 2006, CANCER RES, V66, P1611, DOI 10.1158/0008-5472.CAN-05-0808; Pimentel B, 2000, J NEUROSCI, V20, P3254, DOI 10.1523/JNEUROSCI.20-09-03254.2000; Polzien L, 2010, ADV ENZYME REGUL, V50, P147, DOI 10.1016/j.advenzreg.2009.10.025; Puligilla C, 2010, J NEUROSCI, V30, P714, DOI 10.1523/JNEUROSCI.3852-09.2010; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Sanchez-Calderon H, 2007, INT J DEV BIOL, V51, P557, DOI 10.1387/ijdb.072373hs; Sanchez-Calderon H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008699; Sanz C, 1999, J CELL SCI, V112, P3967; Sanz C, 1999, ONCOGENE, V18, P429, DOI 10.1038/sj.onc.1202312; Schreck R, 2006, INT J CANCER, V119, P2261, DOI 10.1002/ijc.22144; Sienknecht UJ, 2009, J COMP NEUROL, V517, P751, DOI 10.1002/cne.22169; Troppmair J, 2003, BIOCHEM PHARMACOL, V66, P1341, DOI 10.1016/S0006-2952(03)00483-0; Tsukamoto H, 2008, EUR J IMMUNOL, V38, P518, DOI 10.1002/eji.200737430; Walenkamp MJE, 2006, HORM RES, V66, P221, DOI 10.1159/000095161; Wang S, 1998, MOL CELL BIOL, V18, P7487, DOI 10.1128/MCB.18.12.7487; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Yamaguchi O, 2004, J CLIN INVEST, V114, P937, DOI 10.1172/JCI200420317; Zhong J, 2007, NAT NEUROSCI, V10, P598, DOI 10.1038/nn1898	60	31	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14435	10.1371/journal.pone.0014435	http://dx.doi.org/10.1371/journal.pone.0014435			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203386	Green Published, gold, Green Submitted			2022-12-27	WOS:000285792500012
J	von Dassow, M; Strother, JA; Davidson, LA				von Dassow, Michelangelo; Strother, James A.; Davidson, Lance A.			Surprisingly Simple Mechanical Behavior of a Complex Embryonic Tissue	PLOS ONE			English	Article							ASPIRATION CONTACT PROBLEM; BOUNDARY INTEGRAL MODEL; NEURAL-TUBE CLOSURE; MICROPIPETTE ASPIRATION; XENOPUS-LAEVIS; LIVING CELL; MORPHOGENETIC MOVEMENTS; DROSOPHILA EMBRYOS; RESIDUAL-STRESS; POISSONS RATIO	Background: Previous studies suggest that mechanical feedback could coordinate morphogenetic events in embryos. Furthermore, embryonic tissues have complex structure and composition and undergo large deformations during morphogenesis. Hence we expect highly non-linear and loading-rate dependent tissue mechanical properties in embryos. Methodology/Principal Findings: We used micro-aspiration to test whether a simple linear viscoelastic model was sufficient to describe the mechanical behavior of gastrula stage Xenopus laevis embryonic tissue in vivo. We tested whether these embryonic tissues change their mechanical properties in response to mechanical stimuli but found no evidence of changes in the viscoelastic properties of the tissue in response to stress or stress application rate. We used this model to test hypotheses about the pattern of force generation during electrically induced tissue contractions. The dependence of contractions on suction pressure was most consistent with apical tension, and was inconsistent with isotropic contraction. Finally, stiffer clutches generated stronger contractions, suggesting that force generation and stiffness may be coupled in the embryo. Conclusions/Significance: The mechanical behavior of a complex, active embryonic tissue can be surprisingly well described by a simple linear viscoelastic model with power law creep compliance, even at high deformations. We found no evidence of mechanical feedback in this system. Together these results show that very simple mechanical models can be useful in describing embryo mechanics.	[von Dassow, Michelangelo; Davidson, Lance A.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Strother, James A.] Howard Hughes Med Inst, Ashburn, VA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Howard Hughes Medical Institute	von Dassow, M (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.	mvondass@yahoo.com		Strother, James/0000-0001-6871-5561	National Institutes of Health [R01-HD044750]; National Science Foundation [IOS-0845775]; Hartwell Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Hartwell Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health, Grant number R01-HD044750 (www.nih.gov); National Science Foundation, Grant No. IOS-0845775 (www.nsf.gov); The Hartwell Foundation (www.thehartwellfoundation.org), post-doctoral fellowship to M. von Dassow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DS, 1990, DEVELOPMENT, V110, P115; Aoki T, 1997, ANN BIOMED ENG, V25, P581, DOI 10.1007/BF02684197; Baaijens FPT, 2005, ANN BIOMED ENG, V33, P494, DOI 10.1007/s10439-005-2506-3; Beloussov LV, 2006, INT J DEV BIOL, V50, P113, DOI 10.1387/ijdb.052057lb; Boudou T, 2006, J BIOMECH, V39, P1677, DOI 10.1016/j.jbiomech.2005.04.026; Chen XG, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015003; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Clark AG, 2009, CURR BIOL, V19, P1389, DOI 10.1016/j.cub.2009.06.044; Davidson LA, 1999, DEV BIOL, V209, P221, DOI 10.1006/dbio.1999.9249; Davidson L, 2009, INT J BIOCHEM CELL B, V41, P2147, DOI 10.1016/j.biocel.2009.04.015; Davidson LA, 2008, DEV DYNAM, V237, P2684, DOI 10.1002/dvdy.21600; Desprat N, 2008, DEV CELL, V15, P470, DOI 10.1016/j.devcel.2008.07.009; Drury JL, 2001, BIOPHYS J, V81, P3166, DOI 10.1016/S0006-3495(01)75953-X; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fabry B, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.041914; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Farge E, 2003, CURR BIOL, V13, P1365, DOI 10.1016/S0960-9822(03)00576-1; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; Findley J.S., 1976, MAT INTRO LINEAR VIS; Haider MA, 2002, J BIOMECH ENG-T ASME, V124, P586, DOI 10.1115/1.1504444; Haider MA, 2000, J BIOMECH ENG-T ASME, V122, P236, DOI 10.1115/1.429654; Hochmuth RM, 2000, J BIOMECH, V33, P15, DOI 10.1016/S0021-9290(99)00175-X; Holzapfel G., 2000, NONLINEAR SOLID MECH; Horgan CO, 2009, INT J SOLIDS STRUCT, V46, P3078, DOI 10.1016/j.ijsolstr.2009.04.007; Joshi SD, 2010, EXP CELL RES, V316, P103, DOI 10.1016/j.yexcr.2009.08.005; Kalantarian A, 2009, BIOPHYS J, V96, P1606, DOI 10.1016/j.bpj.2008.10.064; Kasza KE, 2009, BIOPHYS J, V96, P4326, DOI 10.1016/j.bpj.2009.02.035; Kay B. K., 1991, XENOPUS LAEVIS PRACT; Keller R., 2004, P171; Koehl M.A.R., 1990, Seminars in Developmental Biology, V1, P367; Koenderink GH, 2009, P NATL ACAD SCI USA, V106, P15192, DOI 10.1073/pnas.0903974106; Lee JY, 2010, CURR BIOL, V20, P253, DOI 10.1016/j.cub.2009.12.021; Lenormand G, 2006, BIORHEOLOGY, V43, P1; Lenormand G, 2004, J R SOC INTERFACE, V1, P91, DOI 10.1098/rsif.2004.0010; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Ma XY, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/3/036004; Marion S, 2005, EUR BIOPHYS J BIOPHY, V34, P262, DOI 10.1007/s00249-004-0449-5; Merryman WD, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3049821; MITCHISON JM, 1954, J EXP BIOL, V31, P443; Nerurkar NL, 2006, DEV DYNAM, V235, P1822, DOI 10.1002/dvdy.20813; Nieuwkoop PD, 1967, NORMAL TABLES XENOPU; ODELL GM, 1981, DEV BIOL, V85, P446, DOI 10.1016/0012-1606(81)90276-1; Ofek G, 2009, BIOPHYS J, V97, P1873, DOI 10.1016/j.bpj.2009.07.050; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Pouille PA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000098; Rasband W., 2006, IMAGEJ; Rogers SS, 2008, BIOPHYS J, V94, P3313, DOI 10.1529/biophysj.107.123851; Rolo A, 2009, DEV BIOL, V327, P327, DOI 10.1016/j.ydbio.2008.12.009; SATO M, 1983, J CELL BIOL, V97, pA267; SATO M, 1990, J BIOMECH ENG-T ASME, V112, P263, DOI 10.1115/1.2891183; Shindo A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008897; Skoglund P, 2008, DEVELOPMENT, V135, P2435, DOI 10.1242/dev.014704; Solon J, 2009, CELL, V137, P1331, DOI 10.1016/j.cell.2009.03.050; Supatto W, 2005, P NATL ACAD SCI USA, V102, P1047, DOI 10.1073/pnas.0405316102; Taber LA, 2008, BIOMECH MODEL MECHAN, V7, P427, DOI 10.1007/s10237-007-0106-x; THERET DP, 1988, J BIOMECH ENG-T ASME, V110, P190, DOI 10.1115/1.3108430; TOYOIZUMI R, 1995, J CELL SCI, V108, P557; Trepat X, 2007, NATURE, V447, P592, DOI 10.1038/nature05824; Trickey WR, 2006, J BIOMECH, V39, P78, DOI 10.1016/j.jbiomech.2004.11.006; von Dassow M, 2009, DEV DYNAM, V238, P2, DOI 10.1002/dvdy.21809; von Dassow Michelangelo, 2007, Birth Defects Research, V81, P253, DOI 10.1002/bdrc.20108; Wallingford JB, 2001, CURR BIOL, V11, P652, DOI 10.1016/S0960-9822(01)00201-9; Wang J, 2003, AM J PHYSIOL-HEART C, V285, pH1871, DOI 10.1152/ajpheart.00387.2003; Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606, DOI 10.1152/ajpcell.00269.2001; Wiebe C, 2005, J BIOMECH, V38, P2087, DOI 10.1016/j.jbiomech.2004.09.005; Zamir EA, 2004, J BIOMECH ENG-T ASME, V126, P823, DOI 10.1115/1.1824129; Zamir EA, 2004, J BIOMECH ENG-T ASME, V126, P276, DOI 10.1115/1.1695573; Zhou EH, 2010, BIOMECH MODEL MECHAN, V9, P563, DOI 10.1007/s10237-010-0197-7; Zhou EH, 2005, MECH ADV MATER STRUC, V12, P501, DOI 10.1080/15376490500259335; Zhou JA, 2010, DEVELOPMENT, V137, P2785, DOI 10.1242/dev.045997; Zhou J, 2009, DEVELOPMENT, V136, P677, DOI 10.1242/dev.026211; [No title captured]	73	46	46	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15359	10.1371/journal.pone.0015359	http://dx.doi.org/10.1371/journal.pone.0015359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203396	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000285792500029
J	Globisch, D; Munzel, M; Muller, M; Michalakis, S; Wagner, M; Koch, S; Bruckl, T; Biel, M; Carell, T				Globisch, Daniel; Muenzel, Martin; Mueller, Markus; Michalakis, Stylianos; Wagner, Mirko; Koch, Susanne; Brueckl, Tobias; Biel, Martin; Carell, Thomas			Tissue Distribution of 5-Hydroxymethylcytosine and Search for Active Demethylation Intermediates	PLOS ONE			English	Article							DNA METHYLATION; GLYCOSYLASE ACTIVITY; QUANTIFICATION; 5-METHYLCYTOSINE; CONVERSION; DEAMINATION; METABOLISM; NEURONS; REPAIR; DAMAGE	5-Hydroxymethylcytosine (hmC) was recently detected as the sixth base in mammalian tissue at so far controversial levels. The function of the modified base is currently unknown, but it is certain that the base is generated from 5-methylcytosine (mC). This fuels the hypothesis that it represents an intermediate of an active demethylation process, which could involve further oxidation of the hydroxymethyl group to a formyl or carboxyl group followed by either deformylation or decarboxylation. Here, we use an ultra-sensitive and accurate isotope based LC-MS method to precisely determine the levels of hmC in various mouse tissues and we searched for 5-formylcytosine (fC), 5-carboxylcytosine (caC), and 5-hydroxymethyluracil (hmU) as putative active demethylation intermediates. Our data suggest that an active oxidative mC demethylation pathway is unlikely to occur. Additionally, we show using HPLC-MS analysis and immunohistochemistry that hmC is present in all tissues and cell types with highest concentrations in neuronal cells of the CNS.	[Globisch, Daniel; Muenzel, Martin; Mueller, Markus; Wagner, Mirko; Brueckl, Tobias; Carell, Thomas] Univ Munich, Ctr Integrated Prot Sci CiPSM, Dept Chem, Munich, Germany; [Michalakis, Stylianos; Koch, Susanne; Biel, Martin] Univ Munich, Ctr Integrated Prot Sci CiPSM, Dept Pharm, Munich, Germany	University of Munich; University of Munich	Globisch, D (corresponding author), Univ Munich, Ctr Integrated Prot Sci CiPSM, Dept Chem, Marchioninistr 15, Munich, Germany.	Thomas.carell@cup.uni-muenchen.de	Biel, Martin/G-1175-2014; Michalakis, Stylianos/W-2094-2018; Michalakis, Stylianos/M-4677-2019; Carell, Thomas/G-4799-2012; Globisch, Daniel/C-7307-2011; Muenzel, Martin/B-3360-2011	Biel, Martin/0000-0002-9974-3052; Michalakis, Stylianos/0000-0001-5092-9238; Michalakis, Stylianos/0000-0001-5092-9238; Carell, Thomas/0000-0001-7898-2831; Globisch, Daniel/0000-0002-4526-5788; Muller, Markus/0000-0002-3579-3317; Koch, Susanne/0000-0001-9966-113X; Muenzel, Martin/0000-0002-4504-8281	excellence cluster CiPSM; SFBs [646, 749]; Fond der Chemischen Industrie; Bayer Schering Pharma AG	excellence cluster CiPSM; SFBs; Fond der Chemischen Industrie(Fonds der Chemischen Industrie); Bayer Schering Pharma AG(Bayer AG)	Funding was received from the following sources: the excellence cluster CiPSM, the SFBs 646 and 749, the Fond der Chemischen Industrie and Bayer Schering Pharma AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boorstein RJ, 2001, J BIOL CHEM, V276, P41991, DOI 10.1074/jbc.M106953200; Bruckl T, 2009, ANGEW CHEM INT EDIT, V48, P7932, DOI 10.1002/anie.200902740; CANNON SV, 1988, BIOCHEM BIOPH RES CO, V151, P1173, DOI 10.1016/S0006-291X(88)80489-3; Cooke MS, 2008, CANCER EPIDEM BIOMAR, V17, P3, DOI 10.1158/1055-9965.EPI-07-0751; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GAMASOSA MA, 1983, BIOCHIM BIOPHYS ACTA, V740, P212, DOI 10.1016/0167-4781(83)90079-9; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Houk KN, 2001, CHEMBIOCHEM, V2, P113, DOI 10.1002/1439-7633(20010202)2:2<113::AID-CBIC113>3.3.CO;2-K; Hwang C. H., 1992, ARCH PHARMACAL RES, V15, P69, DOI DOI 10.1007/BF02973987; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Liutkeviciute Z, 2009, NAT CHEM BIOL, V5, P400, DOI 10.1038/nchembio.172; Loenarz C, 2009, CHEM BIOL, V16, P580, DOI 10.1016/j.chembiol.2009.06.002; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; PALMATIER RD, 1970, J BIOL CHEM, V245, P6706; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Privat E, 1996, CHEM RES TOXICOL, V9, P745, DOI 10.1021/tx950182o; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rusmintratip V, 2000, P NATL ACAD SCI USA, V97, P14183, DOI 10.1073/pnas.97.26.14183; SHAFFER PM, 1975, J BACTERIOL, V121, P648, DOI 10.1128/JB.121.2.648-655.1975; Simmons JM, 2008, DALTON T, P5132, DOI 10.1039/b803512a; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Taghizadeh K, 2008, NAT PROTOC, V3, P1287, DOI 10.1038/nprot.2008.119; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Vanyushin BF, 1998, EUR J BIOCHEM, V256, P518, DOI 10.1046/j.1432-1327.1998.2560518.x; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Yang YN, 2002, ANAL CHEM, V74, P5376, DOI 10.1021/ac020235o; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205	34	621	649	1	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15367	10.1371/journal.pone.0015367	http://dx.doi.org/10.1371/journal.pone.0015367			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203455	gold, Green Published, Green Submitted			2022-12-27	WOS:000285579200021
J	Kathrani, A; House, A; Catchpole, B; Murphy, A; German, A; Werling, D; Allenspach, K				Kathrani, Aarti; House, Arthur; Catchpole, Brian; Murphy, Angela; German, Alex; Werling, Dirk; Allenspach, Karin			Polymorphisms in the Tlr4 and Tlr5 Gene Are Significantly Associated with Inflammatory Bowel Disease in German Shepherd Dogs	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COPY NUMBER VARIATION; TOLL-LIKE RECEPTOR-5; CROHNS-DISEASE; ULCERATIVE-COLITIS; EPITHELIAL BARRIER; SEQUENCE VARIANTS; ADAPTIVE IMMUNITY; LOCI CONTRIBUTE; SUSCEPTIBILITY	Inflammatory bowel disease (IBD) is considered to be the most common cause of vomiting and diarrhoea in dogs, and the German shepherd dog (GSD) is particularly susceptible. The exact aetiology of IBD is unknown, however associations have been identified between specific single-nucleotide polymorphisms (SNPs) in Toll-like receptors (TLRs) and human IBD. However, to date, no genetic studies have been undertaken in canine IBD. The aim of this study was to investigate whether polymorphisms in canine TLR 2, 4 and 5 genes are associated with IBD in GSDs. Mutational analysis of TLR2, TLR4 and TLR5 was performed in 10 unrelated GSDs with IBD. Four non-synonymous SNPs (T23C, G1039A, A1571T and G1807A) were identified in the TLR4 gene, and three non-synonymous SNPs (G22A, C100T and T1844C) were identified in the TLR5 gene. The non-synonymous SNPs identified in TLR4 and TLR5 were evaluated further in a case-control study using a SNaPSHOT multiplex reaction. Sequencing information from 55 unrelated GSDs with IBD were compared to a control group consisting of 61 unrelated GSDs. The G22A SNP in TLR5 was significantly associated with IBD in GSDs, whereas the remaining two SNPs were found to be significantly protective for IBD. Furthermore, the two SNPs in TLR4 (A1571T and G1807A) were in complete linkage disequilibrium, and were also significantly associated with IBD. The TLR5 risk haplotype (ACC) without the two associated TLR4 SNP alleles was significantly associated with IBD, however the presence of the two TLR4 SNP risk alleles without the TLR5 risk haplotype was not statistically associated with IBD. Our study suggests that the three TLR5 SNPs and two TLR4 SNPs; A1571T and G1807A could play a role in the pathogenesis of IBD in GSDs. Further studies are required to confirm the functional importance of these polymorphisms in the pathogenesis of this disease.	[Kathrani, Aarti; House, Arthur; Allenspach, Karin] Univ London, Dept Vet Clin Sci, Royal Vet Coll, Hatfield, Herts, England; [Catchpole, Brian; Werling, Dirk] Univ London, Dept Pathol & Infect Dis, Royal Vet Coll, Hatfield, Herts, England; [Murphy, Angela] Univ London, Dept Vet Basic Sci, Royal Vet Coll, Hatfield, Herts, England; [German, Alex] Univ Liverpool, Sch Vet Sci, Liverpool L69 3BX, Merseyside, England	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; University of Liverpool	Kathrani, A (corresponding author), Univ London, Dept Vet Clin Sci, Royal Vet Coll, Hatfield, Herts, England.	akathrani@rvc.ac.uk	Werling, Dirk/F-5555-2013	Werling, Dirk/0000-0001-5411-4044; German, Alexander/0000-0002-3017-7988	Biotechnology and Biological Sciences Research Council (BBSRC); Pfizer; Petsavers	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Pfizer(Pfizer); Petsavers	This research was funded by Biotechnology and Biological Sciences Research Council (BBSRC), Pfizer and Petsavers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; ALLENSPACH K, 2010, VET MICROBIOL; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Austen B M, 1981, Biochem Soc Symp, P235; Blumberg RS, 1999, CURR OPIN IMMUNOL, V11, P648, DOI 10.1016/S0952-7915(99)00032-1; Browning BL, 2007, AM J GASTROENTEROL, V102, P2504, DOI 10.1111/j.1572-0241.2007.01463.x; Burgener IA, 2008, J VET INTERN MED, V22, P553, DOI 10.1111/j.1939-1676.2008.0093.x; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Fritz JH, 2008, TRENDS IMMUNOL, V29, P41, DOI 10.1016/j.it.2007.10.002; FROLOVA L, 2007, J HISTOCHEM CYTOCHEM; Gewirtz AT, 2006, AM J PHYSIOL-GASTR L, V290, pG1157, DOI 10.1152/ajpgi.00544.2005; Groth M, 2008, HUM MUTAT, V29, P1247, DOI 10.1002/humu.20751; Guilford W. G., 1996, Strombeck's small animal gastroenterology, by W. G. Guilford et al., P451; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hendrickson BA, 2002, CLIN MICROBIOL REV, V15, P79, DOI 10.1128/CMR.15.1.79-94.2002; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Honko AN, 2005, IMMUNOL RES, V33, P83, DOI 10.1385/IR:33:1:083; House AK, 2009, TISSUE ANTIGENS, V73, P250, DOI 10.1111/j.1399-0039.2008.01190.x; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kennedy LJ, 1999, VET IMMUNOL IMMUNOP, V69, P101, DOI 10.1016/S0165-2427(99)00046-X; Kocsis AK, 2008, SCAND J GASTROENTERO, V43, P299, DOI 10.1080/00365520701682615; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Magalhaes JG, 2007, SEMIN IMMUNOL, V19, P106, DOI 10.1016/j.smim.2006.12.006; McEwan PA, 2006, J STRUCT BIOL, V155, P294, DOI 10.1016/j.jsb.2006.01.016; McMahon LA, 2010, VET IMMUNOL IMMUNOP, V135, P158, DOI 10.1016/j.vetimm.2009.11.012; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogushi K, 2004, J BIOL CHEM, V279, P12213, DOI 10.1074/jbc.M307944200; Ortega-Cava CF, 2006, CLIN VACCINE IMMUNOL, V13, P132, DOI 10.1128/CVI.13.1.132-138.2006; Palazzo M, 2007, J IMMUNOL, V178, P4296, DOI 10.4049/jimmunol.178.7.4296; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Pierik M, 2006, INFLAMM BOWEL DIS, V12, P1, DOI 10.1097/01.MIB.0000195389.11645.ab; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Stanislawowski M, 2009, J PHYSIOL PHARMACOL, V60, P71; Sutter NB, 2004, GENOME RES, V14, P2388, DOI 10.1101/gr.3147604; Szebeni B, 2008, CLIN EXP IMMUNOL, V151, P34, DOI 10.1111/j.1365-2249.2007.03531.x; Torok HP, 2004, CLIN IMMUNOL, V112, P85, DOI 10.1016/j.clim.2004.03.002; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	48	89	90	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15740	10.1371/journal.pone.0015740	http://dx.doi.org/10.1371/journal.pone.0015740			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203467	Green Submitted, Green Published, gold			2022-12-27	WOS:000285579200035
J	Livolsi, A; Niederhoffer, N; Dali-Youcef, N; Mokni, W; Olexa-Zorn, C; Gies, JP; Marcellin, L; Feldman, J; Bousquet, P				Livolsi, Angelo; Niederhoffer, Nathalie; Dali-Youcef, Nassim; Mokni, Walid; Olexa-Zorn, Catherine; Gies, Jean-Pierre; Marcellin, Luc; Feldman, Josiane; Bousquet, Pascal			Constitutive Overexpression of Muscarinic Receptors Leads to Vagal Hyperreactivity	PLOS ONE			English	Article							EXONIC SPLICING ENHANCERS; VASOVAGAL SYNCOPE; HUMAN HEART; ACETYLCHOLINE-RECEPTORS; MULTIPLE SUBTYPES; GENE-EXPRESSION; SUDDEN-DEATH; GUINEA-PIG; VARIABILITY; SPECIFICITY	Background: Alterations in muscarinic receptor expression and acetylcholinesterase (AchE) activity have been observed in tissues from Sudden Infant Death Syndrome (SIDS). Vagal overactivity has been proposed as a possible cause of SIDS as well as of vasovagal syncopes. The aim of the present study was to seek whether muscarinic receptor overexpression may be the underlying mechanism of vagal hyperreactivity. Rabbits with marked vagal pauses following injection of phenylephrine were selected and crossed to obtain a vagal hyperreactive strain. The density of cardiac muscarinic receptors and acetylcholinesterase (AchE) gene expression were assessed. Blood markers of the observed cardiac abnormalities were also sought. Methodology/Principal Findings: Cardiac muscarinic M(2) and M(3) receptors were overexpressed in hyperreactive rabbits compared to control animals (2.3-fold and 2.5-fold, respectively) and the severity of the phenylephrine-induced bradycardia was correlated with their densities. A similar overexpression of M(2) receptors was observed in peripheral mononuclear white blood cells, suggesting that cardiac M(2) receptor expression can be inferred with high confidence from measurements in blood cells. Sequencing of the coding fragment of the M(2) receptor gene revealed a single nucleotide mutation in 83% of hyperreactive animals, possibly contributing for the transcript overexpression. Significant increases in AchE expression and activity were also assessed (AchE mRNA amplification ratio of 3.6 versus normal rabbits). This phenomenon might represent a compensatory consequence of muscarinic receptors overexpression. Alterations in M(2) receptor and AchE expression occurred between the 5th and the 7th week of age, a critical period also characterized by a higher mortality rate of hyperreactive rabbits (52% in H rabbits versus 13% in normal rabbits) and preceeded the appearance of functional disorders. Conclusions/Significance: The results suggest that cardiac muscarinic receptor overexpression plays a critical role in the development of vagal hyperreactivity, whereas AchE hyperactivity appears as a compensatory consequence of it. Since similar vagal disorders were observed recently by us in SIDS, muscarinic receptor overexpression could become a marker of risk of vasovagal syncopes and SIDS.	[Livolsi, Angelo; Niederhoffer, Nathalie; Mokni, Walid; Olexa-Zorn, Catherine; Feldman, Josiane; Bousquet, Pascal] Univ Strasbourg, Lab Neurobiol & Pharmacol Cardiovasc EA 4438, Strasbourg, France; [Livolsi, Angelo; Mokni, Walid; Olexa-Zorn, Catherine; Bousquet, Pascal] Hop Univ Strasbourg, Strasbourg, France; [Mokni, Walid; Gies, Jean-Pierre; Bousquet, Pascal] Univ Strasbourg, CNRS, Lab Biophoton & Pharmacol, UMR 7213, Strasbourg, France; [Dali-Youcef, Nassim; Mokni, Walid; Bousquet, Pascal] Univ Strasbourg, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire Strasbourg IGB, Illkirch Graffenstaden, France; [Dali-Youcef, Nassim; Mokni, Walid; Bousquet, Pascal] Hop Univ, Lab Biochim Gen & Specialisee, Strasbourg, France; [Mokni, Walid; Bousquet, Pascal] Hop Univ, INSERM, Ctr Invest Clin, Strasbourg, France; [Marcellin, Luc] Hop Univ, Dept Anat Pathol, Strasbourg, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg	Livolsi, A (corresponding author), Univ Strasbourg, Lab Neurobiol & Pharmacol Cardiovasc EA 4438, Strasbourg, France.	pascal.bousquet@unistra.fr	Niederhoffer, Nathalie/AAF-1343-2020; DALI-YOUCEF, Nassim/O-2549-2016	DALI-YOUCEF, Nassim/0000-0001-6958-1331	French Ministry of Research	French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was supported by the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamia S, 2008, BLOOD, V112, P5111, DOI 10.1182/blood-2008-02-141770; Alexander SPH, 2004, BRIT J PHARMACOL, V141, pS1; Bechir M, 2003, CIRCULATION, V107, P1620, DOI 10.1161/01.CIR.0000056105.87040.2B; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Carvalho FA, 2004, J APPL TOXICOL, V24, P419, DOI 10.1002/jat.993; Chemnitius JM, 1997, GEN PHARMACOL, V28, P567, DOI 10.1016/S0306-3623(96)00287-X; Dalefield RR, 1999, GEN PHARMACOL, V32, P341, DOI 10.1016/S0306-3623(98)00229-8; Edner A, 2000, ACTA PAEDIATR, V89, P1326, DOI 10.1080/080352500300002516; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; ENGEL GL, 1978, ANN INTERN MED, V89, P403, DOI 10.7326/0003-4819-89-3-403; Ganzeboom KS, 2006, J CARDIOVASC ELECTR, V17, P1172, DOI 10.1111/j.1540-8167.2006.00595.x; Ganzeboom KS, 2003, AM J CARDIOL, V91, P1006, DOI 10.1016/S0002-9149(03)00127-9; GIES JP, 1989, J PHARMACOL EXP THER, V250, P309; HADDAD EB, 1991, AM J PHYSIOL, V261, pL327, DOI 10.1152/ajplung.1991.261.4.L327; Hellgren I, 2000, CELL MOL LIFE SCI, V57, P175, DOI 10.1007/s000180050507; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livolsi A, 2002, CIRCULATION, V106, P2301, DOI 10.1161/01.CIR.0000039155.49920.1F; Livolsi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009464; Maron BJ, 2003, NEW ENGL J MED, V349, P1064, DOI 10.1056/NEJMra022783; Piccirillo G, 2004, CLIN SCI, V107, P55, DOI 10.1042/CS20030327; Shi H, 2004, J BIOL CHEM, V279, P21774, DOI 10.1074/jbc.C400100200; Shi H, 1999, MOL PHARMACOL, V55, P497; Shojaei-Brosseau T, 2003, ARCH DIS CHILD, V88, P88, DOI 10.1136/adc.88.1.88; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Vaddadi G, 2007, MED J AUSTRALIA, V187, P299, DOI 10.5694/j.1326-5377.2007.tb01248.x; Wang HZ, 2001, MOL PHARMACOL, V59, P1029, DOI 10.1124/mol.59.5.1029; Wang ZG, 2004, BRIT J PHARMACOL, V142, P395, DOI 10.1038/sj.bjp.0705787; WEI JW, 1978, EUR J PHARMACOL, V52, P235; Wilde AAM, 2007, CLIN AUTON RES, V17, P203, DOI 10.1007/s10286-007-0432-1; Willmy-Matthes P, 2003, N-S ARCH PHARMACOL, V368, P316, DOI 10.1007/s00210-003-0796-2	32	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15618	10.1371/journal.pone.0015618	http://dx.doi.org/10.1371/journal.pone.0015618			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203511	Green Submitted, gold, Green Published			2022-12-27	WOS:000285578000038
J	Miao, AJ; Luo, ZP; Chen, CS; Chin, WC; Santschi, PH; Quigg, A				Miao, Ai-Jun; Luo, Zhiping; Chen, Chi-Shuo; Chin, Wei-Chun; Santschi, Peter H.; Quigg, Antonietta			Intracellular Uptake: A Possible Mechanism for Silver Engineered Nanoparticle Toxicity to a Freshwater Alga Ochromonas danica	PLOS ONE			English	Article							CHLAMYDOMONAS-REINHARDTII; CHELATING-AGENTS; NANOMATERIALS; DISSOLUTION; KINETICS; RISK	The behavior and toxicity of silver engineered nanoparticles (Ag-ENs) to the mixotrophic freshwater alga Ochromonas danica were examined in the present study to determine whether any other mechanisms are involved in their algal toxicity besides Ag(+) liberation outside the cells. Despite their good dispersability, the Ag-ENs were found to continuously aggregate and dissolve rapidly. When the initial nanoparticle concentration was lower than 10 mu M, the total dissolved Ag(+) concentration ([ Ag(+)] T) in the suspending media reached its maximum after 1 d and then decreased suggesting that Ag(+) release might be limited by the nanoparticle surface area under these conditions. Furthermore, Ag-EN dissolution extent remarkably increased in the presence of glutathione. In the Ag-EN toxicity experiment, glutathione was also used to eliminate the indirect effects of Ag(+) that was released. However, remarkable toxicity was still observed although the free Ag(+) concentration in the media was orders of magnitude lower than the non-observed effect concentration of Ag(+) itself. Such inhibitive effects were mitigated when more glutathione was added, but could never be completely eliminated. Most importantly, we demonstrate, for the first time, that Ag-ENs can be taken in and accumulated inside the algal cells, where they exerted their toxic effects. Therefore, nanoparticle internalization may be an alternative pathway through which algal growth can be influenced.	[Miao, Ai-Jun] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing 210008, Jiangsu Prov, Peoples R China; [Miao, Ai-Jun; Santschi, Peter H.; Quigg, Antonietta] Texas A&M Univ, Dept Marine Sci, Galveston, TX 77553 USA; [Miao, Ai-Jun; Quigg, Antonietta] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Luo, Zhiping] Texas A&M Univ, Microscopy & Imaging Ctr, College Stn, TX USA; [Chen, Chi-Shuo; Chin, Wei-Chun] Univ Calif Merced, Sch Engn, Merced, CA USA; [Santschi, Peter H.; Quigg, Antonietta] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA	Nanjing University; Texas A&M University System; Texas A&M University System; Texas A&M University System; Texas A&M University College Station; University of California System; University of California Merced; Texas A&M University System; Texas A&M University College Station	Miao, AJ (corresponding author), Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing 210008, Jiangsu Prov, Peoples R China.	miaoaj@nju.edu.cn	Quigg, Antonietta S/A-9345-2010; Santschi, Peter H/D-5712-2012; Luo, Zhiping/C-4435-2014; Chin, Wei-Chun/A-6068-2008	Santschi, Peter H/0000-0001-8188-7691; Luo, Zhiping/0000-0002-8264-6424; Chin, Wei-Chun/0000-0003-4881-9085	Texas Institute of Oceanography; National Natural Science Foundation of China [41001338]; Natural Science Foundation of Jiangsu Province [BK2010371]; National Science Foundation [NSF-0351559, NSF-0210865, NSF-CBET-0933137, NSF-CBET-0932404]; National Oceanic and Atmospheric Administration [NAO5NOS4191064]	Texas Institute of Oceanography; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Science Foundation(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	This work was supported, in parts, by the Texas Institute of Oceanography Postdoctoral Fellowship to Ai-Jun Miao, the National Natural Science Foundation of China (41001338) to Ai-Jun Miao, the Natural Science Foundation of Jiangsu Province (BK2010371) to Ai-Jun Miao, the National Science Foundation (NSF-0351559 and NSF-0210865) to Peter Santschi, (NSF-CBET-0933137) to Peter Santschi and Antonietta Quigg, (NSF-CBET-0932404) to Wei-Chun Chin and the National Oceanic and Atmospheric Administration (NAO5NOS4191064) to Antonietta Quigg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NWH, 1999, ENVIRON TOXICOL CHEM, V18, P2674, DOI 10.1002/etc.5620181204; ANDERSSON LO, 1972, J POLYM SCI A1, V10, P1963, DOI 10.1002/pol.1972.150100707; [Anonymous], 2010, PROJECT EMERGING NAN; Bell RA, 1999, ENVIRON TOXICOL CHEM, V18, P9, DOI [10.1897/1551-5028(1999)018&lt;0009:SCAGOS&gt;2.3.CO;2, 10.1002/etc.5620180103]; BELL RA, 1997, SILVER COMPLEXES ENV, P10; Borm P, 2006, TOXICOL SCI, V90, P23, DOI 10.1093/toxsci/kfj084; Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m; CHANG HC, 1983, J COLLOID INTERF SCI, V92, P479, DOI 10.1016/0021-9797(83)90169-8; Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334; Fabrega J, 2009, ENVIRON SCI TECHNOL, V43, P7285, DOI 10.1021/es803259g; Fredd CN, 1998, J COLLOID INTERF SCI, V204, P187, DOI 10.1006/jcis.1998.5535; GREEN JB, 1977, J INORG NUCL CHEM, V39, P1023, DOI 10.1016/0022-1902(77)80257-1; Griffitt RJ, 2008, ENVIRON TOXICOL CHEM, V27, P1972, DOI 10.1897/08-002.1; Guillard R.R.L., 1975, CULTURE PHYTOPLANKTO; Han X, 2006, J COLLOID INTERF SCI, V303, P365, DOI 10.1016/j.jcis.2006.08.028; Johnston HJ, 2010, CRIT REV TOXICOL, V40, P328, DOI 10.3109/10408440903453074; Laban G, 2010, ECOTOXICOLOGY, V19, P185, DOI 10.1007/s10646-009-0404-4; Lee DY, 2005, AQUAT TOXICOL, V75, P127, DOI 10.1016/j.aquatox.2005.06.011; Li ZQ, 2010, ENVIRON SCI TECHNOL, V44, P3462, DOI 10.1021/es9031198; Lu WT, 2010, CHEM PHYS LETT, V487, P92, DOI 10.1016/j.cplett.2010.01.027; Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y; Martinez-Castanon GA, 2008, J NANOPART RES, V10, P1343, DOI 10.1007/s11051-008-9428-6; MEYERS CN, 1921, J LAB CLIN MED, V6, P359; Miao AJ, 2009, ENVIRON POLLUT, V157, P3034, DOI 10.1016/j.envpol.2009.05.047; Navarro E, 2008, ENVIRON SCI TECHNOL, V42, P8959, DOI 10.1021/es801785m; Ratte HT, 1999, ENVIRON TOXICOL CHEM, V18, P89, DOI [10.1897/1551-5028(1999)018&lt;0089:BATOSC&gt;2.3.CO;2, 10.1002/etc.5620180112]; Rothhaupt KO, 1996, ECOLOGY, V77, P706, DOI 10.2307/2265495; SCHINDLER P, 1964, HELV CHIM ACTA, V47, P982, DOI 10.1002/hlca.19640470409; SCHINDLER P, 1965, HELV CHIM ACTA, V48, P1204, DOI 10.1002/hlca.19650480528; Stampoulis D, 2009, ENVIRON SCI TECHNOL, V43, P9473, DOI 10.1021/es901695c; Wen LS, 1997, ENVIRON SCI TECHNOL, V31, P723, DOI 10.1021/es9603057; Wiesner MR, 2009, ENVIRON SCI TECHNOL, V43, P6458, DOI 10.1021/es803621k; Wijnhoven SWP, 2009, NANOTOXICOLOGY, V3, P109, DOI 10.1080/17435390902725914	33	144	150	7	168	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15196	10.1371/journal.pone.0015196	http://dx.doi.org/10.1371/journal.pone.0015196			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203552	Green Published, Green Submitted, gold			2022-12-27	WOS:000285578000022
J	Taghizadeh, R; Noh, M; Huh, YH; Ciusani, E; Sigalotti, L; Maio, M; Arosio, B; Nicotra, MR; Natali, P; Sherley, JL; La Porta, CAM				Taghizadeh, Rouzbeh; Noh, Minsoo; Huh, Yang Hoon; Ciusani, Emilio; Sigalotti, Luca; Maio, Michele; Arosio, Beatrice; Nicotra, Maria R.; Natali, PierGiorgio; Sherley, James L.; La Porta, Caterina A. M.			CXCR6, a Newly Defined Biomarker of Tissue-Specific Stem Cell Asymmetric Self-Renewal, Identifies More Aggressive Human Melanoma Cancer Stem Cells	PLOS ONE			English	Article							CLASS-I; EXPRESSION; VARIANTS; DNA; DEHYDROGENASE; COSEGREGATION; RESISTANCE; RECEPTORS; ANTIGENS; ABCG2	Background: A fundamental problem in cancer research is identifying the cell type that is capable of sustaining neoplastic growth and its origin from normal tissue cells. Recent investigations of a variety of tumor types have shown that phenotypically identifiable and isolable subfractions of cells possess the tumor-forming ability. In the present paper, using two lineage-related human melanoma cell lines, primary melanoma line IGR39 and its metastatic derivative line IGR37, two main observations are reported. The first one is the first phenotypic evidence to support the origin of melanoma cancer stem cells (CSCs) from mutated tissue-specific stem cells; and the second one is the identification of a more aggressive subpopulation of CSCs in melanoma that are CXCR6+. Methods/Findings: We defined CXCR6 as a new biomarker for tissue-specific stem cell asymmetric self-renewal. Thus, the relationship between melanoma formation and ABCG2 and CXCR6 expression was investigated. Consistent with their non-metastatic character, unsorted IGR39 cells formed significantly smaller tumors than unsorted IGR37 cells. In addition, ABCG2+ cells produced tumors that had a 2-fold greater mass than tumors produced by unsorted cells or ABCG2-cells. CXCR6+ cells produced more aggressive tumors. CXCR6 identifies a more discrete subpopulation of cultured human melanoma cells with a more aggressive MCSC phenotype than cells selected on the basis of the ABCG2+ phenotype alone. Conclusions/Significance: The association of a more aggressive tumor phenotype with asymmetric self-renewal phenotype reveals a previously unrecognized aspect of tumor cell physiology. Namely, the retention of some tissue-specific stem cell attributes, like the ability to asymmetrically self-renew, impacts the natural history of human tumor development. Knowledge of this new aspect of tumor development and progression may provide new targets for cancer prevention and treatment.	[Taghizadeh, Rouzbeh; Huh, Yang Hoon; Sherley, James L.] Boston Biomed Res Inst, Adult Stem Cell Technol Ctr, Program Canc Biol, Watertown, MA USA; [Noh, Minsoo] Ajou Univ, Coll Pharm, Suwon 441749, South Korea; [Ciusani, Emilio] Ist Neurol Carlo Besta, Milan, Italy; [Sigalotti, Luca; Maio, Michele] Ist Ricovero Cura Carattere Sci, Ctr Riferimento Oncol, Dept Med Oncol, Canc Bioimmunotherapy Unit, Aviano, Italy; [Arosio, Beatrice] Univ Milan, Dept Internal Med, Milan, Italy; [Nicotra, Maria R.] CNR, Mol Biol & Pathol Inst, Rome, Italy; [Natali, PierGiorgio] Univ G dAnnunzio, CINBO Lab, Chieti, Italy; [La Porta, Caterina A. M.] Univ Milan, Dept Biomol Sci & Biotechnol, Milan, Italy	Boston Biomedical Research Institute; Ajou University; IRCCS Istituto Neurologico Besta; IRCCS Aviano (CRO); University of Milan; Consiglio Nazionale delle Ricerche (CNR); G d'Annunzio University of Chieti-Pescara; University of Milan		caterina.laporta@unimi.it	Ciusani, Emilio/J-9822-2016; Sigalotti, Luca/A-5893-2013; Sigalotti, Luca/AAC-2926-2020; Taghizadeh, Rouzbeh R./AAO-6669-2021; la porta, caterina/K-7345-2013	Ciusani, Emilio/0000-0002-7285-123X; Sigalotti, Luca/0000-0003-3362-5026; Sigalotti, Luca/0000-0002-1436-2358; Taghizadeh, Rouzbeh R./0000-0002-3437-7530; Arosio, Beatrice/0000-0002-0615-3580; la porta, caterina/0000-0002-3010-8966; coral, sandra/0000-0002-1308-3082; Maio, Michele/0000-0002-0323-6321; NOH, MINSOO/0000-0002-4020-5372	National Institues of Health [5DP1OD000805]; National Italian grant; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000805] Funding Source: NIH RePORTER	National Institues of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Italian grant; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by the National Institues of Health Director's Pioneer Award #5DP1OD000805 and by National Italian grant COFIN 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Calabro L, 2005, J CELL PHYSIOL, V202, P474, DOI 10.1002/jcp.20133; Coral S, 1999, J IMMUNOTHER, V22, P16, DOI 10.1097/00002371-199901000-00003; Darzynkiewicz Z, 1996, CYTOMETRY, V25, P1; Deng HK, 1997, NATURE, V388, P296, DOI 10.1038/40894; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; HANNES B, 2007, HUM PATHOL, V38, P768; Jager E, 1997, INT J CANCER, V71, P142, DOI 10.1002/(SICI)1097-0215(19970410)71:2<142::AID-IJC3>3.0.CO;2-0; Kim CH, 2001, J CLIN INVEST, V107, P595, DOI 10.1172/JCI11902; Kondo C, 2004, PHARM RES-DORDR, V21, P1895, DOI 10.1023/B:PHAM.0000045245.21637.d4; La Porta C, 2009, STEM CELL REV REP, V5, P61, DOI 10.1007/s12015-008-9048-7; La Porta CAM, 2009, CURR CANCER DRUG TAR, V9, P391, DOI 10.2174/156800909788166574; Lee HS, 2003, BIOTECHNOL BIOENG, V83, P760, DOI 10.1002/bit.10727; Liu Y, 1998, J CELL PHYSIOL, V177, P364, DOI 10.1002/(SICI)1097-4652(199811)177:2<364::AID-JCP18>3.0.CO;2-9; Liu YA, 1998, MOL BIOL CELL, V9, P15, DOI 10.1091/mbc.9.1.15; Loeffler Markus, 1997, P1, DOI 10.1016/B978-012563455-7/50002-7; Meijer J, 2008, CANCER RES, V68, P4701, DOI 10.1158/0008-5472.CAN-08-0482; Merok JR, 2002, CANCER RES, V62, P6791; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Nakagawa H, 2008, BIOCHEM J, V411, P623, DOI 10.1042/BJ20071229; Rambhatla L, 2005, CANCER RES, V65, P3155, DOI 10.1158/0008-5472.CAN-04-3161; Rambhatla L., 2001, J BIOMED BIOTECHNOL, V1, P28, DOI DOI 10.1155/S1110724301000079; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Seidl H, 2007, HUM PATHOL, V38, P768, DOI 10.1016/j.humpath.2006.11.013; Sherley James L., 2005, P21, DOI 10.1142/9781860949296_0002; Sigalotti L, 2002, BRIT J CANCER, V86, P979, DOI 10.1038/sj.bjc.6600174; Tamura A, 2006, MOL PHARMACOL, V70, P287, DOI 10.1124/mol.106.023556; Zamber CP, 2003, PHARMACOGENETICS, V13, P19, DOI 10.1097/00008571-200301000-00004	29	62	66	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15183	10.1371/journal.pone.0015183	http://dx.doi.org/10.1371/journal.pone.0015183			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203549	Green Published, Green Submitted, gold			2022-12-27	WOS:000285578000021
J	Trager, MD; Bhotika, S; Hostetler, JA; Andrade, GV; Rodriguez-Cabal, MA; McKeon, CS; Osenberg, CW; Bolker, BM				Trager, Matthew D.; Bhotika, Smriti; Hostetler, Jeffrey A.; Andrade, Gilda V.; Rodriguez-Cabal, Mariano A.; McKeon, C. Seabir; Osenberg, Craig W.; Bolker, Benjamin M.			Benefits for Plants in Ant-Plant Protective Mutualisms: A Meta-Analysis	PLOS ONE			English	Article							ANTIHERBIVORE DEFENSES; MYRMECOPHYTIC CECROPIA; SPECIES COEXISTENCE; TROPHIC CASCADES; HERBIVORY; PATTERNS; ACACIA; CASTRATION; COMMUNITY; FITNESS	Costs and benefits for partners in mutualistic interactions can vary greatly, but surprisingly little is known about the factors that drive this variation across systems. We conducted a meta-analysis of ant-plant protective mutualisms to quantify the effects of ant defenders on plant reproductive output, to evaluate if reproductive effects were predicted from reductions in herbivory and to identify characteristics of the plants, ants and environment that explained variation in ant protection. We also compared our approach with two other recent meta-analyses on ant-plant mutualisms, emphasizing differences in our methodology (using a weighted linear mixed effects model) and our focus on plant reproduction rather than herbivore damage. Based on 59 ant and plant species pairs, ant presence increased plant reproductive output by 49% and reduced herbivory by 62%. The effects on herbivory and reproduction within systems were positively correlated, but the slope of this relationship (0.75) indicated that tolerance to foliar herbivory may be a common plant response to absence of ant guards. Furthermore, the relationship between foliar damage and reproduction varied substantially among systems, suggesting that herbivore damage is not a reliable surrogate for fitness consequences of ant protection. Studies that experimentally excluded ants reported a smaller effect of ant protection on plant reproduction than studies that relied upon natural variation in ant presence, suggesting that study methods can affect results in these systems. Of the ecological variables included in our analysis, only plant life history (i.e., annual or perennial) explained variation in the protective benefit of mutualistic ants: presence of ants benefitted reproduction of perennials significantly more than that of annuals. These results contrast with other quantitative reviews of these relationships that did not include plant life history as an explanatory factor and raise several questions to guide future research on ant-plant protection mutualisms.	[Trager, Matthew D.; McKeon, C. Seabir] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Trager, Matthew D.; Bhotika, Smriti] Univ Florida, Sch Nat Resources & Environm, Gainesville, FL USA; [Bhotika, Smriti; McKeon, C. Seabir; Osenberg, Craig W.; Bolker, Benjamin M.] Univ Florida, Dept Biol, Gainesville, FL USA; [Hostetler, Jeffrey A.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA; [Andrade, Gilda V.] Univ Fed Maranhao, Dept Biol, Sao Luis, Maranhao, Brazil; [Rodriguez-Cabal, Mariano A.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Universidade Federal do Maranhao; University of Tennessee System; University of Tennessee Knoxville	Trager, MD (corresponding author), Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA.	mtrager@ufl.edu	Trager, Matthew/AAM-7627-2020; Osenberg, Craig/M-9904-2013; Hostetler, Jeffrey A./A-3345-2011; ANDRADE, GILDA V/G-4067-2012; andrade, gilda v/I-7088-2017	Hostetler, Jeffrey A./0000-0003-3669-1758; andrade, gilda v/0000-0003-0113-0782; Osenberg, Craig/0000-0003-1918-7904; Bolker, Benjamin/0000-0002-2127-0443; McKeon, Seabird/0000-0001-7261-8094; Trager, Matthew/0000-0003-0145-4568	National Science Foundation (NSF); Foundation of Support to the Research and the Scientific and Technological Development of Maranhao (FAPEMA); National Council for Scientific and Technological Development (CNPq) [proc. 304987/2009-3]	National Science Foundation (NSF)(National Science Foundation (NSF)); Foundation of Support to the Research and the Scientific and Technological Development of Maranhao (FAPEMA); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Matthew D. Trager was supported by a National Science Foundation (NSF) Graduate Fellowship. Gilda V. Andrade's participation in this research was supported by the Foundation of Support to the Research and the Scientific and Technological Development of Maranhao (FAPEMA) and a research fellowship from National Council for Scientific and Technological Development (CNPq - proc. #304987/2009-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 1998, OIKOS, V83, P227, DOI 10.2307/3546834; BOLKER B, 2008, BBMLE TOOLS GEN MAX; Bolker B, 2008, ECOLOGICAL MODELS DA; Bronstein JL, 1998, BIOTROPICA, V30, P150, DOI 10.1111/j.1744-7429.1998.tb00050.x; Chamberlain SA, 2009, ECOLOGY, V90, P2384, DOI 10.1890/08-1490.1; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; COLEY PD, 1980, NATURE, V284, P545, DOI 10.1038/284545a0; Dyer LA, 1999, P NATL ACAD SCI USA, V96, P5072, DOI 10.1073/pnas.96.9.5072; Edwards DP, 2009, NATURWISSENSCHAFTEN, V96, P1137, DOI 10.1007/s00114-009-0559-0; Englund G, 1999, ECOLOGY, V80, P1132, DOI 10.1890/0012-9658(1999)080[1132:TIODSC]2.0.CO;2; Ferriere R, 2002, P ROY SOC B-BIOL SCI, V269, P773, DOI 10.1098/rspb.2001.1900; FISHER BL, 1992, J TROP ECOL, V8, P109, DOI 10.1017/S0266467400006179; FOLGARAIT PJ, 1994, OIKOS, V71, P305, DOI 10.2307/3546279; FOLGARAIT PJ, 1995, OECOLOGIA, V104, P189, DOI 10.1007/BF00328584; Freitas L, 2001, BOT J LINN SOC, V136, P267, DOI 10.1006/bojl.2000.0437; Gaume L, 2005, OECOLOGIA, V145, P76, DOI 10.1007/s00442-005-0107-3; Gaume L, 2005, EVOL ECOL RES, V7, P435; Gaume L, 1997, OECOLOGIA, V112, P209, DOI 10.1007/s004420050302; Gurevitch J, 1999, ECOLOGY, V80, P1142, DOI 10.1890/0012-9658(1999)080[1142:SIIEMA]2.0.CO;2; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.2307/177062; Heil M, 2004, J TROP ECOL, V20, P573, DOI 10.1017/S0266467404001567; Heil M, 2002, OIKOS, V99, P457, DOI 10.1034/j.1600-0706.2002.11954.x; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; HORVITZ CC, 1984, ECOLOGY, V65, P1369, DOI 10.2307/1939117; Hungate BA, 2009, GLOBAL CHANGE BIOL, V15, P2020, DOI 10.1111/j.1365-2486.2009.01866.x; Huntzinger M, 2004, ECOLOGY, V85, P609, DOI 10.1890/03-3056; Itino T, 2001, ECOL RES, V16, P775, DOI 10.1046/j.1440-1703.2001.00433.x; Izzo TJ, 2002, OECOLOGIA, V133, P200, DOI 10.1007/s00442-002-1027-0; JANZEN DH, 1966, EVOLUTION, V20, P249, DOI 10.1111/j.1558-5646.1966.tb03364.x; Kersch MF, 2005, ECOLOGY, V86, P2117, DOI 10.1890/04-1916; Lapola DM, 2005, SOCIOBIOLOGY, V46, P433; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; LONGINO JT, 1989, BIOTROPICA, V21, P126, DOI 10.2307/2388703; MASCHINSKI J, 1989, AM NAT, V134, P1, DOI 10.1086/284962; Miller TEX, 2007, OIKOS, V116, P500, DOI 10.1111/j.2007.0030-1299.15317.x; ODOWD DJ, 1983, OECOLOGIA, V59, P191, DOI 10.1007/BF00378837; Oliver TH, 2009, OIKOS, V118, P346, DOI 10.1111/j.1600-0706.2008.17045.x; Osenberg CW, 1997, AM NAT, V150, P798, DOI 10.1086/286095; Osenberg CW, 1999, ECOLOGY, V80, P1105, DOI 10.2307/177058; Palmer TM, 2000, OECOLOGIA, V123, P425, DOI 10.1007/s004420051030; Palmer TM, 2007, ECOLOGY, V88, P3004, DOI 10.1890/07-0133.1; Palmer TM, 2008, SCIENCE, V319, P192, DOI 10.1126/science.1151579; PINHEIRO J, 2009, NLME LINCAR NONLINEA; Pinheiro J. C., 2002, MIXED EFFECTS MODELS; PRIMACK RB, 1989, ANNU REV ECOL SYST, V20, P367, DOI 10.1146/annurev.es.20.110189.002055; R Core Team, 2020, R LANG ENV STAT COMP; Raine NE, 2004, ECOL ENTOMOL, V29, P345, DOI 10.1111/j.0307-6946.2004.00608.x; Raine NE, 2002, ECOLOGY, V83, P3086, DOI 10.1890/0012-9658(2002)083[3086:SSAFAB]2.0.CO;2; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; RICOGRAY V, 1989, J TROP ECOL, V5, P109, DOI 10.1017/S0266467400003266; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; Rosumek FB, 2009, OECOLOGIA, V160, P537, DOI 10.1007/s00442-009-1309-x; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; Shima JS, 2003, ECOLOGY, V84, P46, DOI 10.1890/0012-9658(2003)084[0046:CDDEOC]2.0.CO;2; Stanton ML, 1999, NATURE, V401, P578, DOI 10.1038/44119; Stanton ML, 2003, AM NAT, V162, pS10, DOI 10.1086/378646; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Tillberg CV, 2004, OECOLOGIA, V140, P506, DOI 10.1007/s00442-004-1601-8; Trager MD, 2006, J ECOL, V94, P1156, DOI 10.1111/j.1365-2745.2006.01165.x; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Willmer PG, 2009, FUNCT ECOL, V23, P888, DOI 10.1111/j.1365-2435.2009.01632.x; Willmer PG, 1997, NATURE, V388, P165, DOI 10.1038/40610; Wilson J, 2002, OECOLOGIA, V130, P205, DOI 10.1007/s004420100784; Young TP, 1997, OECOLOGIA, V109, P98, DOI 10.1007/s004420050063; Yu DW, 2004, J ANIM ECOL, V73, P1102, DOI 10.1111/j.0021-8790.2004.00877.x; Yu DW, 2001, BIOL J LINN SOC, V72, P529, DOI [10.1006/bijl.2000.0514, 10.1111/j.1095-8312.2001.tb01336.x]; Yu DW, 1998, P ROY SOC B-BIOL SCI, V265, P375, DOI 10.1098/rspb.1998.0305	68	122	124	5	152	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14308	10.1371/journal.pone.0014308	http://dx.doi.org/10.1371/journal.pone.0014308			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203550	Green Submitted, gold, Green Published			2022-12-27	WOS:000285578000002
J	Martin, CW; Valentine, MM; Valentine, JF				Martin, Charles W.; Valentine, Marla M.; Valentine, John F.			Competitive Interactions between Invasive Nile Tilapia and Native Fish: The Potential for Altered Trophic Exchange and Modification of Food Webs	PLOS ONE			English	Article							COASTAL MISSISSIPPI WATERSHEDS; OREOCHROMIS-NILOTICUS; SALINITY TOLERANCE; NONNATIVE ENVIRONMENTS; SPECIES INVASIONS; COLD TOLERANCE; INVASIBILITY; AQUACULTURE; COMMUNITY; EXTINCTION	Recent studies have highlighted both the positive and negative impacts of species invasions. Most of these studies have been conducted on either immobile invasive plants or sessile fauna found at the base of food webs. Fewer studies have examined the impacts of vagile invasive consumers on native competitors. This is an issue of some importance given the controlling influence that consumers have on lower order plants and animals. Here, we present results of laboratory experiments designed to assess the impacts of unintended aquaculture releases of the Nile tilapia (Oreochromis niloticus), in estuaries of the Gulf of Mexico, on the functionally similar redspotted sunfish (Lepomis miniatus). Laboratory choice tests showed that tilapia prefer the same structured habitat that native sunfish prefer. In subsequent interspecific competition experiments, agonistic tilapia displaced sunfish from their preferred structured habitats. When a piscivore (largemouth bass) was present in the tank with both species, the survival of sunfish decreased. Based on these findings, if left unchecked, we predict that the proliferation of tilapia (and perhaps other aggressive aquaculture fishes) will have important detrimental effects on the structure of native food webs in shallow, structured coastal habitats. While it is likely that the impacts of higher trophic level invasive competitors will vary among species, these results show that consequences of unintended releases of invasive higher order consumers can be important.	[Martin, Charles W.; Valentine, Marla M.; Valentine, John F.] Dauphin Isl Sea Lab, Dauphin Isl, AL USA; [Martin, Charles W.; Valentine, John F.] Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA	Dauphin Island Sea Lab; University of South Alabama	Martin, CW (corresponding author), Dauphin Isl Sea Lab, Dauphin Isl, AL USA.	cwm301@jaguar1.usouthal.edu		Martin, Charles/0000-0001-9240-3824	Northern Gulf Institute; Dauphin Island Sea Lab; Department of Marine Sciences at the University of South Alabama	Northern Gulf Institute; Dauphin Island Sea Lab; Department of Marine Sciences at the University of South Alabama	Support for this project was provided through funding from the Northern Gulf Institute, Dauphin Island Sea Lab, and the Department of Marine Sciences at the University of South Alabama. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVELLA M, 1993, J FISH BIOL, V42, P243, DOI 10.1111/j.1095-8649.1993.tb00325.x; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Blanchet S, 2007, ECOL FRESHW FISH, V16, P133, DOI 10.1111/j.1600-0633.2006.00205.x; Bologna PAX, 2000, ESTUARIES, V23, P449, DOI 10.2307/1353138; Boschung HT, 2004, FISHES A SMITHSONIAN; Braaten B, 1983, ICES COASTAL MANAGEM, V26, P11; Buria L, 2007, FUND APPL LIMNOL, V168, P145, DOI 10.1127/1863-9135/2007/0168-0145; Capers RS, 2007, ECOLOGY, V88, P3135, DOI 10.1890/06-1911.1; Charo-Karisa H, 2005, AQUACULTURE, V249, P115, DOI 10.1016/j.aquaculture.2005.04.029; CHERVINSKI J, 1971, Bamidgeh, V23, P125; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Cleland EE, 2004, ECOL LETT, V7, P947, DOI 10.1111/j.1461-0248.2004.00655.x; Cohen AN, 1998, SCIENCE, V279, P555, DOI 10.1126/science.279.5350.555; Cohen JE, 2003, SCIENCE, V302, P1172, DOI 10.1126/science.1088665; CONNELL JH, 1961, ECOLOGY, V42, P710, DOI 10.2307/1933500; CONRY PJ, 1988, CONDOR, V90, P478, DOI 10.2307/1368576; Costa-Pierce BA, 2003, BIOL INVASIONS, V5, P71, DOI 10.1023/A:1024094606326; Courtenay Jr WR, 1991, BIOL POLLUTION CONTR, P35; Courtenay Jr WR, 1997, TILAPIA AQUACULTURE, V1, P18; Courtenay W.R. Jr, 1984, P41; COURTENAY WR, 1973, T AM FISH SOC, V102, P1, DOI 10.1577/1548-8659(1973)102<1:EAOIFW>2.0.CO;2; CRUTCHFIELD JU, 1995, AM FISH S S, V15, P452; Davis M. A., 2009, INVASION BIOL; Davis MA, 2003, BIOSCIENCE, V53, P481, DOI 10.1641/0006-3568(2003)053[0481:BGDCFI]2.0.CO;2; DEFUR PL, 1995, ESTUARIES, V18, P2, DOI 10.2307/1352278; DIAL R S, 1983, Florida Scientist, V46, P8; Dukes JS, 2004, REV CHIL HIST NAT, V77, P411; Duponchelle F, 1998, AQUAT LIVING RESOUR, V11, P137, DOI 10.1016/S0990-7440(98)80110-1; Edyvane K.S., 1999, Wetlands Ecology and Management, V7, P83, DOI 10.1023/A:1008481228129; El-Sayed AFM, 1999, AQUACULTURE, V179, P149, DOI 10.1016/S0044-8486(99)00159-3; Elton C. S., 1958, ECOLOGY INVASIONS AN; ESTES JA, 1978, ECOLOGY, V59, P822, DOI 10.2307/1938786; FAO Fisheries Department, 1997, FAO TECHN GUID RESP; FARMER GJ, 1969, J FISH RES BOARD CAN, V26, P2807, DOI 10.1139/f69-277; Faunce CH, 1999, WETLANDS, V19, P126, DOI 10.1007/BF03161741; Febry R, 1987, J EXP BIOL, V128, P60; Fodrie FJ, 2009, GLOBAL CHANGE BIOL; GOWEN RJ, 1987, OCEANOGR MAR BIOL, V25, P563; Grosholz E, 2002, TRENDS ECOL EVOL, V17, P22, DOI 10.1016/S0169-5347(01)02358-8; Grosholz ED, 2000, ECOLOGY, V81, P1206, DOI 10.2307/177202; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Hargreaves JA, 2000, TILAPIA AQUACULTURE, V2, P60; HAUSER WJ, 1977, CALIF FISH GAME, V63, P228; Heck KL, 2007, ESTUAR COAST, V30, P371, DOI 10.1007/BF02819384; Hofer Scott C., 2002, World Aquaculture, V33, P19; Howells RG, 1992, TEXAS PARKS WILDLIFE, V78; Jennings Dawn P., 1992, Northeast Gulf Science, V12, P111; Krakowiak PJ, 2008, J GREAT LAKES RES, V34, P675, DOI 10.3394/0380-1330-34.4.675; KREBS CJ, 1995, OECOLOGIA, V103, P481, DOI 10.1007/BF00328687; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Lightner DV, 1997, REV SCI TECH OIE, V16, P146, DOI 10.20506/rst.16.1.1010; Liti D, 2005, AQUAC RES, V36, P746, DOI 10.1111/j.1365-2109.2005.01265.x; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; LOTAN RUTH, 1960, BAMIDGEH, V12, P96; Lowe MR, 2008, MS AL SEAGR BAYS BAY; LYDEARD C, 1995, CONSERV BIOL, V9, P800, DOI 10.1046/j.1523-1739.1995.09040800.x; Mack RN, 2000, ECOLOGICAL APPL, V10; Mair GC, 2000, P TIL 2001 INT TECHN, P136; Martin CW, 2011, ESTUAR COAST, V34, P364, DOI 10.1007/s12237-010-9274-5; McBay L. G., 1961, P 15 ANN C SE ASS GA, P208; McDonald JL, 2006, THESIS U SO MISSISSI; McVicar AH, 1997, ICES J MAR SCI, V54, P1093, DOI 10.1016/S1054-3139(97)80014-8; Miller SA, 2006, FRESHWATER BIOL, V51, P85, DOI 10.1111/j.1365-2427.2005.01477.x; Muir JF, 1998, J NW ATL FISH SCI, V23, P157; National Research Council, 1995, UND MAR BIOD; Naylor RL, 2001, SCIENCE, V294, P1655, DOI 10.1126/science.1064875; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Nico LG, 2010, USGS NONINDIGENOUS A; Nugon RW, 2003, THESIS SCH RENEWABLE; Nunan LM, 1998, AQUACULTURE, V160, P19, DOI 10.1016/S0044-8486(97)00222-6; OGUTUOHWAYO R, 1991, CAN J FISH AQUAT SCI, V48, P8, DOI 10.1139/f91-299; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Park K, 2007, J COASTAL RES, V23, P1332, DOI 10.2112/06-0686.1; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; PERRY WG, 1972, PROG FISH CULT, V34, P229, DOI 10.1577/1548-8659(1972)34[229:COSMAT]2.0.CO;2; PETERSON CH, 1989, OECOLOGIA, V80, P82, DOI 10.1007/BF00789935; Peterson MS, 2006, ENVIRON BIOL FISH, V76, P283, DOI 10.1007/s10641-006-9033-4; Peterson MS, 2005, WETLANDS, V25, P112, DOI 10.1672/0277-5212(2005)025[0112:TOONNT]2.0.CO;2; Peterson MS, 2004, COPEIA, P842; Peterson MS, 2002, 206 MISS DEP WILDL F; POPPER D, 1975, AQUACULTURE, V5, P213, DOI 10.1016/0044-8486(75)90101-5; POTTS WTW, 1967, J EXP BIOL, V47, P461; Pysek P, 2008, TRENDS ECOL EVOL, V23, P237, DOI 10.1016/j.tree.2008.02.002; Ricciardi A, 2004, TRENDS ECOL EVOL, V19, P619, DOI 10.1016/j.tree.2004.09.021; Sax DF, 2008, P NATL ACAD SCI USA, V105, P11490, DOI 10.1073/pnas.0802290105; Schiermeier Q, 2002, NATURE, V419, P662, DOI 10.1038/419662a; SELVIN HC, 1966, AM STAT, V20, P20, DOI 10.2307/2681493; Shafland Paul L., 1996, Reviews in Fisheries Science, V4, P101; Smith MD, 2004, OIKOS, V106, P253, DOI 10.1111/j.0030-1299.2004.13057.x; Springer V. G., 1963, Transactions of the American Fisheries Society, V92, P317, DOI 10.1577/1548-8659(1963)92[317:TACTHD]2.0.CO;2; Stickney RR, 2002, RESPONSIBLE MARINE AQUACULTURE, P205, DOI 10.1079/9780851996042.0205; TAYLOR JN, 1986, COPEIA, P903, DOI 10.2307/1445286; WATANABE WO, 1985, AQUACULTURE, V47, P353, DOI 10.1016/0044-8486(85)90220-0; WATANABE WO, 1985, AQUACULTURE, V48, P159, DOI 10.1016/0044-8486(85)90102-4; Wiles GJ, 2003, CONSERV BIOL, V17, P1350, DOI 10.1046/j.1523-1739.2003.01526.x; Williams MJ, 1997, AQUACULTURE SUSTAINA, P16; WILSON EO, 2006, CREATION APPEAL SAVE; ZALE AV, 1989, T AM FISH SOC, V118, P718, DOI 10.1577/1548-8659(1989)118<0718:EOSOCT>2.3.CO;2	99	78	89	5	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e14395	10.1371/journal.pone.0014395	http://dx.doi.org/10.1371/journal.pone.0014395			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21200433	gold, Green Submitted, Green Published			2022-12-27	WOS:000285576900010
J	Fisher, DO; Blomberg, SP				Fisher, Diana O.; Blomberg, Simon P.			Costs of Reproduction and Terminal Investment by Females in a Semelparous Marsupial	PLOS ONE			English	Article							ANTECHINUS-STUARTII MARSUPIALIA; NATURAL-SELECTION; SENESCENCE; ALLOCATION; SUCCESS; FITNESS; POPULATIONS; SURVIVAL	Evolutionary explanations for life history diversity are based on the idea of costs of reproduction, particularly on the concept of a trade-off between age-specific reproduction and parental survival, and between expenditure on current and future offspring. Such trade-offs are often difficult to detect in population studies of wild mammals. Terminal investment theory predicts that reproductive effort by older parents should increase, because individual offspring become more valuable to parents as the conflict between current versus potential future offspring declines with age. In order to demonstrate this phenomenon in females, there must be an increase in maternal expenditure on offspring with age, imposing a fitness cost on the mother. Clear evidence of both the expenditure and fitness cost components has rarely been found. In this study, we quantify costs of reproduction throughout the lifespan of female antechinuses. Antechinuses are nocturnal, insectivorous, forest-dwelling small (20-40 g) marsupials, which nest in tree hollows. They have a single synchronized mating season of around three weeks, which occurs on predictable dates each year in a population. Females produce only one litter per year. Unlike almost all other mammals, all males, and in the smaller species, most females are semelparous. We show that increased allocation to current reproduction reduces maternal survival, and that offspring growth and survival in the first breeding season is traded-off with performance of the second litter in iteroparous females. In iteroparous females, increased allocation to second litters is associated with severe weight loss in late lactation and post-lactation death of mothers, but increased offspring growth in late lactation and survival to weaning. These findings are consistent with terminal investment. Iteroparity did not increase lifetime reproductive success, indicating that terminal investment in the first breeding season at the expense of maternal survival (i.e. semelparity) is likely to be advantageous for females.	[Fisher, Diana O.; Blomberg, Simon P.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Fisher, Diana O.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia	University of Queensland; Australian National University	Fisher, DO (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.	d.fisher@uq.edu.au	Blomberg, Simone P/B-7613-2008; Fisher, Diana O/C-1324-2010	Blomberg, Simone P/0000-0003-1062-0839; Fisher, Diana O/0000-0002-4017-3710	Australian Research Council	Australian Research Council(Australian Research Council)	This study was supported by the Australian Research Council (an Australian Postdoctoral Fellowship and an ARF fellowship to DOF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardsen BJ, 2010, OECOLOGIA, V162, P627, DOI 10.1007/s00442-009-1537-0; Bates D., 2010, IME4 LINEAR MIXED EF; Berube CH, 1999, ECOLOGY, V80, P2555, DOI 10.1890/0012-9658(1999)080[2555:IDLARS]2.0.CO;2; BRAITHWAITE RW, 1979, AM NAT, V113, P151, DOI 10.1086/283372; Broussard DR, 2003, J ANIM ECOL, V72, P212, DOI 10.1046/j.1365-2656.2003.00691.x; Cameron EZ, 2000, BEHAV ECOL SOCIOBIOL, V47, P243, DOI 10.1007/s002650050661; CHARNOV EL, 1973, AM NAT, V107, P791, DOI 10.1086/282877; CLUTTONBROCK TH, 1983, J ANIM ECOL, V52, P367, DOI 10.2307/4560; COCKBURN A, 1994, BEHAV ECOL SOCIOBIOL, V35, P53, DOI 10.1007/BF00167060; COCKBURN A, 1992, AUST J ZOOL, V40, P195, DOI 10.1071/ZO9920195; DICKMAN CR, 1989, AUST J ECOL, V14, P387, DOI 10.1111/j.1442-9993.1989.tb01449.x; Fisher DO, 2009, AUSTRAL ECOL, V34, P858, DOI 10.1111/j.1442-9993.2009.01991.x; Fisher DO, 2006, NATURE, V444, P89, DOI 10.1038/nature05206; Fisher DO, 2011, BEHAV ECOL SOCIOBIOL, V65, P593, DOI 10.1007/s00265-010-1060-7; Fisher DO, 2005, AUST J ZOOL, V53, P103, DOI 10.1071/ZO04068; Fisher DO, 2001, ECOLOGY, V82, P3531, DOI 10.1890/0012-9658(2001)082[3531:TEBOLH]2.0.CO;2; Gendreau Y, 2005, BEHAV ECOL SOCIOBIOL, V58, P237, DOI 10.1007/s00265-005-0938-2; GREEN B, 1991, AUST J ZOOL, V39, P539, DOI 10.1071/ZO9910539; Hamel S, 2010, ECOL LETT, V13, P915, DOI 10.1111/j.1461-0248.2010.01478.x; Harshman LG, 2007, TRENDS ECOL EVOL, V22, P80, DOI 10.1016/j.tree.2006.10.008; Holleley CE, 2006, MOL ECOL, V15, P3439, DOI 10.1111/j.1365-294X.2006.03001.x; Isaac JL, 2005, BIOL LETTERS, V1, P271, DOI 10.1098/rsbl.2005.0326; Le Galliard JF, 2004, NATURE, V432, P502, DOI 10.1038/nature03057; McAdam AG, 2003, J EVOLUTION BIOL, V16, P1249, DOI 10.1046/j.1420-9101.2003.00630.x; Nussey DH, 2008, FUNCT ECOL, V22, P393, DOI 10.1111/j.1365-2435.2008.01408.x; Parrott ML, 2007, WILDLIFE RES, V34, P437, DOI 10.1071/WR07071; Pianka, 1988, EVOL ECOL; Pinheiro J, 2001, MIXED EFFECTS MODELS; PROMISLOW DEL, 1991, ACTA OECOL, V12, P119; R Core Team, 2020, R LANG ENV STAT COMP; Rebke M, 2010, P NATL ACAD SCI USA, V107, P7841, DOI 10.1073/pnas.1002645107; Reznick D, 2000, TRENDS ECOL EVOL, V15, P421, DOI 10.1016/S0169-5347(00)01941-8; Ruppert D, 2003, SEMIPARAMETRIC REGRE; Seamons TR, 2010, BEHAV ECOL SOCIOBIOL, V64, P505, DOI 10.1007/s00265-009-0866-7; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; Statham H.L., 1982, P165; Stearns S.C., 1992, pi; Tavecchia G, 2005, J ANIM ECOL, V74, P201, DOI 10.1111/j.1365-2656.2005.00916.x; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Weladji RB, 2006, P ROY SOC B-BIOL SCI, V273, P1239, DOI 10.1098/rspb.2005.3393; Weladji RB, 2010, OECOLOGIA, V162, P261, DOI 10.1007/s00442-009-1443-5; Westman W, 2002, J MAMMAL, V83, P81, DOI 10.1644/1545-1542(2002)083<0081:DTOTDM>2.0.CO;2; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wilson AJ, 2006, AM NAT, V167, pE23, DOI 10.1086/498138; [No title captured]	46	36	36	1	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e15226	10.1371/journal.pone.0015226	http://dx.doi.org/10.1371/journal.pone.0015226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249185	Green Published, gold			2022-12-27	WOS:000286515000003
J	Maitah, MY; Ali, S; Ahmad, A; Gadgeel, S; Sarkar, FH				Maitah, Ma'in Y.; Ali, Shadan; Ahmad, Aamir; Gadgeel, Shirish; Sarkar, Fazlul H.			Up-Regulation of Sonic Hedgehog Contributes to TGF-beta 1-Induced Epithelial to Mesenchymal Transition in NSCLC Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; LUNG-CANCER; PANCREATIC-CANCER; GASTRIC-CANCER; STEM-CELLS; E-CADHERIN; TGF-BETA; IN-VITRO; ACTIVATION; METASTASIS	Background: Lung cancer, especially non-small cell lung cancer (NSCLC) is the major cause of cancer-related deaths in the United States. The aggressiveness of NSCLC has been shown to be associated with the acquisition of epithelial-to-mesenchymal transition (EMT). The acquisition of EMT phenotype induced by TGF-beta 1in several cancer cells has been implicated in tumor aggressiveness and resistance to conventional therapeutics; however, the molecular mechanism of EMT and tumor aggressiveness in NSCLC remains unknown. Methodology/Principal Findings: In this study we found for the first time that the induction of EMT by chronic exposure of A549 NSCLC cells to TGF-beta 1 (A549-M cells) led to the up-regulation of sonic hedgehog (Shh) both at the mRNA and protein levels causing activation of hedgehog signaling. These results were also reproduced in another NSCLC cell line (H2030). Induction of EMT was found to be consistent with aggressive characteristics such as increased clonogenic growth, cell motility and invasion. The aggressiveness of these cells was attenuated by the treatment of A549-M cells with pharmacological inhibitors of Hh signaling in addition to Shh knock-down by siRNA. The inhibition of Hh signaling by pharmacological inhibitors led to the reversal of EMT phenotype as confirmed by the reduction of mesenchymal markers such as ZEB1 and Fibronectin, and induction of epithelial marker E-cadherin. In addition, knock-down of Shh by siRNA significantly attenuated EMT induction by TGF-beta 1. Conclusions/Significance: Our results show for the first time the transcriptional up-regulation of Shh by TGF-beta 1, which is mechanistically associated with TGF-beta 1 induced EMT phenotype and aggressive behavior of NSCLC cells. Thus the inhibitors of Shh signaling could be useful for the reversal of EMT phenotype, which would inhibit the metastatic potential of NSCLC cells and also make these tumors more sensitive to conventional therapeutics.	[Maitah, Ma'in Y.; Ahmad, Aamir; Sarkar, Fazlul H.] Wayne State Univ, Dept Pathol, Karmanos Canc Inst, Detroit, MI 48202 USA; [Ali, Shadan; Gadgeel, Shirish] Wayne State Univ, Dept Internal Med, Div Hematol Oncol, Karmanos Canc Inst, Detroit, MI 48202 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Maitah, MY (corresponding author), Wayne State Univ, Dept Pathol, Karmanos Canc Inst, Detroit, MI 48202 USA.	fsarkar@med.wayne.edu						Bailey JM, 2009, ONCOGENE, V28, P3513, DOI 10.1038/onc.2009.220; Bailey JM, 2007, J CELL BIOCHEM, V102, P829, DOI 10.1002/jcb.21509; BECKETT WS, 1993, CLIN CHEST MED, V14, P1; Bethea CL, 2009, GENE EXPR PATTERNS, V9, P94, DOI 10.1016/j.gep.2008.10.002; DE SF, 2007, B MEM ACAD R MED BEL, V162, P219; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Fendrich V, 2007, ENDOCR-RELAT CANCER, V14, P865, DOI 10.1677/ERC-07-0108; Fukaya M, 2006, GASTROENTEROLOGY, V131, P14, DOI 10.1053/j.gastro.2006.05.008; Gunhaga L, 2000, DEVELOPMENT, V127, P3283; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hogan BLM, 1999, CELL, V96, P225, DOI 10.1016/S0092-8674(00)80562-0; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Johansson D, 2010, BRIT J CANCER, V102, P383, DOI 10.1038/sj.bjc.6605467; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Katoh Y, 2008, INT J MOL MED, V22, P271, DOI 10.3892/ijmm_00000019; Kim JH, 2007, J KOREAN MED SCI, V22, P898, DOI 10.3346/jkms.2007.22.5.898; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Ohta H, 2009, BRIT J CANCER, V100, P389, DOI 10.1038/sj.bjc.6604846; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Sabbah M, 2008, DRUG RESIST UPDATE, V11, P123, DOI 10.1016/j.drup.2008.07.001; Saito RA, 2009, CANCER RES, V69, P2783, DOI 10.1158/0008-5472.CAN-08-3490; Sanchez-Tillo E, 2010, ONCOGENE, V29, P3490, DOI 10.1038/onc.2010.102; Sato N, 1999, J CLIN INVEST, V104, P855, DOI 10.1172/JCI7691; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; SINGH A, 2010, ONCOGENE; Syn WK, 2009, GASTROENTEROLOGY, V137, P1478, DOI 10.1053/j.gastro.2009.06.051; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Teraishi F, 2005, FEBS LETT, V579, P6681, DOI 10.1016/j.febslet.2005.10.064; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; TRAVIS WD, 1995, CANCER-AM CANCER SOC, V75, P191, DOI 10.1002/1097-0142(19950101)75:1+<191::AID-CNCR2820751307>3.0.CO;2-Y; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; Turley EA, 2008, NAT CLIN PRACT ONCOL, V5, P280, DOI 10.1038/ncponc1089; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492; Yilmaz M, 2007, TRENDS MOL MED, V13, P535, DOI 10.1016/j.molmed.2007.10.004; Yoo YA, 2008, CARCINOGENESIS, V29, P480, DOI 10.1093/carcin/bgm281; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yuan Z, 2007, ONCOGENE, V26, P1046, DOI 10.1038/sj.onc.1209860; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737	48	111	123	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16068	10.1371/journal.pone.0016068	http://dx.doi.org/10.1371/journal.pone.0016068			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249152	Green Published, gold			2022-12-27	WOS:000286515000012
J	Lasher, CD; Rajagopalan, P; Murali, TM				Lasher, Christopher D.; Rajagopalan, Padmavathy; Murali, T. M.			Discovering Networks of Perturbed Biological Processes in Hepatocyte Cultures	PLOS ONE			English	Article							BILE-ACID SYNTHESIS; IDENTIFYING FUNCTIONAL MODULES; COA DESATURASE 1; GENE-EXPRESSION; X-RECEPTOR; CHOLESTEROL 7-ALPHA-HYDROXYLASE; LXR-ALPHA; TRANSCRIPTIONAL ACTIVATION; LIPOPROTEIN METABOLISM; SANDWICH CONFIGURATION	The liver plays a vital role in glucose homeostasis, the synthesis of bile acids and the detoxification of foreign substances. Liver culture systems are widely used to test adverse effects of drugs and environmental toxicants. The two most prevalent liver culture systems are hepatocyte monolayers (HMs) and collagen sandwiches (CS). Despite their wide use, comprehensive transcriptional programs and interaction networks in these culture systems have not been systematically investigated. We integrated an existing temporal transcriptional dataset for HM and CS cultures of rat hepatocytes with a functional interaction network of rat genes. We aimed to exploit the functional interactions to identify statistically significant linkages between perturbed biological processes. To this end, we developed a novel approach to compute Contextual Biological Process Linkage Networks (CBPLNs). CBPLNs revealed numerous meaningful connections between different biological processes and gene sets, which we were successful in interpreting within the context of liver metabolism. Multiple phenomena captured by CBPLNs at the process level such as regulation, downstream effects, and feedback loops have well described counterparts at the gene and protein level. CBPLNs reveal high-level linkages between pathways and processes, making the identification of important biological trends more tractable than through interactions between individual genes and molecules alone. Our approach may provide a new route to explore, analyze, and understand cellular responses to internal and external cues within the context of the intricate networks of molecular interactions that control cellular behavior.	[Lasher, Christopher D.] Virginia Polytech Inst & State Univ, Genet Bioinformat & Computat Biol PhD Program, Blacksburg, VA 24061 USA; [Rajagopalan, Padmavathy] Virginia Polytech Inst & State Univ, Dept Chem Engn, Blacksburg, VA 24061 USA; [Murali, T. M.] Virginia Polytech Inst & State Univ, Dept Comp Sci, Blacksburg, VA 24061 USA; [Rajagopalan, Padmavathy; Murali, T. M.] Virginia Polytech Inst & State Univ, ICTAS Ctr Syst Biol Engineered Tissues, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Lasher, CD (corresponding author), Virginia Polytech Inst & State Univ, Genet Bioinformat & Computat Biol PhD Program, Blacksburg, VA 24061 USA.	murali@cs.vt.edu			National Science Foundation [CBET-0933225]; Institute for Critical Technology and Applied Sciences at Virginia Polytechnic Institute and State University; Virginia Polytechnic Institute and State University; Div Of Chem, Bioeng, Env, & Transp Sys [0933225] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Institute for Critical Technology and Applied Sciences at Virginia Polytechnic Institute and State University; Virginia Polytechnic Institute and State University; Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	The authors gratefully acknowledge financial support from the National Science Foundation (CBET-0933225, PR and TMM) and the Institute for Critical Technology and Applied Sciences (PR and TMM) at Virginia Polytechnic Institute and State University. CDL was partly supported by a 2010 Fellowship from Virginia Polytechnic Institute and State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051; Amara U, 2008, ADV EXP MED BIOL, V632, P71, DOI 10.1007/978-0-387-78952-1_6; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; ARIAS IM, 2001, LIVER BIOL PATHOBIOL; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOLOTIN E, 2010, HEPATOLOGY; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Chu K, 2006, MOL CELL BIOL, V26, P6786, DOI 10.1128/MCB.00077-06; Crestani M, 1998, J LIPID RES, V39, P2192; Dey A, 2006, HEPATOLOGY, V43, pS63, DOI 10.1002/hep.20957; Dittrich MT, 2008, BIOINFORMATICS, V24, pI223, DOI 10.1093/bioinformatics/btn161; Dotan-Cohen D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005313; DREYER C, 1993, BIOL CELL, V77, P67, DOI 10.1016/S0248-4900(05)80176-5; DUNN JCY, 1989, FASEB J, V3, P174, DOI 10.1096/fasebj.3.2.2914628; DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007; DUNN JCY, 1992, J CELL BIOL, V116, P1043, DOI 10.1083/jcb.116.4.1043; ENOCH HG, 1978, BIOCHEMISTRY-US, V17, P4927, DOI 10.1021/bi00616a011; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Groot PHE, 2005, J LIPID RES, V46, P2182, DOI 10.1194/jlr.M500116-JLR200; Guillou Herve, 2008, V49, P3, DOI 10.1007/978-1-4020-8831-5_1; Gupta S, 2002, BIOCHEM BIOPH RES CO, V293, P338, DOI 10.1016/S0006-291X(02)00229-2; Haugen BR, 2004, ENDOCRINOLOGY, V145, P3679, DOI 10.1210/en.2003-1401; Hostetler HA, 2009, J LIPID RES, V50, P1663, DOI 10.1194/jlr.M900058-JLR200; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Huang SSC, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000350; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Inoue Y, 2006, J LIPID RES, V47, P215, DOI 10.1194/jlr.M500430-JLR200; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361; KIM Y, 2010, TISSUE ENG C; KIM Y, 2010, TISSUE ENG A; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Lee SST, 1996, J BIOL CHEM, V271, P12063, DOI 10.1074/jbc.271.20.12063; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lee YK, 2008, MOL ENDOCRINOL, V22, P1345, DOI 10.1210/me.2007-0565; LIU Q, 1993, MOL ENDOCRINOL, V7, P651, DOI 10.1210/me.7.5.651; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; Marrapodi M, 2000, J LIPID RES, V41, P514; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; McDermott NB, 2002, J BIOL CHEM, V277, P36839, DOI 10.1074/jbc.M203689200; Miller CW, 1996, P NATL ACAD SCI USA, V93, P9443, DOI 10.1073/pnas.93.18.9443; Milo R., 2003, CONDMAT0312028 ARXIV; MIURA N, 1993, NUCLEIC ACIDS RES, V21, P3731, DOI 10.1093/nar/21.16.3731; Murali TM, 2008, J COMPUT BIOL, V15, P829, DOI 10.1089/cmb.2007.0139; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Pandey J, 2007, BIOINFORMATICS, V23, pI377, DOI 10.1093/bioinformatics/btm203; Pandey Jayesh, 2008, Pac Symp Biocomput, P153; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Peters JM, 1997, J BIOL CHEM, V272, P27307, DOI 10.1074/jbc.272.43.27307; Post SM, 2001, ARTERIOSCL THROM VAS, V21, P1840, DOI 10.1161/hq1101.098228; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Rajagopalan P, 2006, TISSUE ENG, V12, P1553, DOI 10.1089/ten.2006.12.1553; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Rhee J, 2006, J BIOL CHEM, V281, P14683, DOI 10.1074/jbc.M512636200; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; SMYTH GK, BIOINFORMATICS COMPU, P397; Spath GF, 1997, MOL CELL BIOL, V17, P1913; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Subramanian A., 2005, P NATL ACAD SCI US; Tabor DE, 1999, J BIOL CHEM, V274, P20603, DOI 10.1074/jbc.274.29.20603; Tabor DE, 1998, J BIOL CHEM, V273, P22052, DOI 10.1074/jbc.273.34.22052; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Tirona RG, 2003, NAT MED, V9, P220, DOI 10.1038/nm815; Torra IP, 2003, MOL ENDOCRINOL, V17, P259, DOI 10.1210/me.2002-0120; Ulitsky I, 2009, BIOINFORMATICS, V25, P1158, DOI 10.1093/bioinformatics/btp118; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898; WU KJ, 1994, J BIOL CHEM, V269, P1177; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441	74	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15247	10.1371/journal.pone.0015247	http://dx.doi.org/10.1371/journal.pone.0015247			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21245926	Green Published, Green Submitted, gold			2022-12-27	WOS:000286511200005
J	Brown, MTC; Bellone, C; Mameli, M; Labouebe, G; Bocklisch, C; Balland, B; Dahan, L; Lujan, R; Deisseroth, K; Luscher, C				Brown, Matthew T. C.; Bellone, Camilla; Mameli, Manuel; Labouebe, Gwenael; Bocklisch, Christina; Balland, Benedicte; Dahan, Lionel; Lujan, Rafael; Deisseroth, Karl; Luescher, Christian			Drug-Driven AMPA Receptor Redistribution Mimicked by Selective Dopamine Neuron Stimulation	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; LONG-TERM POTENTIATION; NUCLEUS-ACCUMBENS; IN-VIVO; EXTRACELLULAR DOPAMINE; SYNAPTIC PLASTICITY; SUBSTANTIA-NIGRA; COCAINE REWARD; TRANSPORTER; MIDBRAIN	Background: Addictive drugs have in common that they cause surges in dopamine (DA) concentration in the mesolimbic reward system and elicit synaptic plasticity in DA neurons of the ventral tegmental area (VTA). Cocaine for example drives insertion of GluA2-lacking AMPA receptors (AMPARs) at glutamatergic synapes in DA neurons. However it remains elusive which molecular target of cocaine drives such AMPAR redistribution and whether other addictive drugs (morphine and nicotine) cause similar changes through their effects on the mesolimbic DA system. Methodology/Principal Findings: We used in vitro electrophysiological techniques in wild-type and transgenic mice to observe the modulation of excitatory inputs onto DA neurons by addictive drugs. To observe AMPAR redistribution, post-embedding immunohistochemistry for GluA2 AMPAR subunit was combined with electron microscopy. We also used a double-floxed AAV virus expressing channelrhodopsin together with a DAT Cre mouse line to selectively express ChR2 in VTA DA neurons. We find that in mice where the effect of cocaine on the dopamine transporter (DAT) is specifically blocked, AMPAR redistribution was absent following administration of the drug. Furthermore, addictive drugs known to increase dopamine levels cause a similar AMPAR redistribution. Finally, activating DA VTA neurons optogenetically is sufficient to drive insertion of GluA2-lacking AMPARs, mimicking the changes observed after a single injection of morphine, nicotine or cocaine. Conclusions/Significance: We propose the mesolimbic dopamine system as a point of convergence at which addictive drugs can alter neural circuits. We also show that direct activation of DA neurons is sufficient to drive AMPAR redistribution, which may be a mechanism associated with early steps of non-substance related addictions.	[Brown, Matthew T. C.; Bellone, Camilla; Mameli, Manuel; Labouebe, Gwenael; Bocklisch, Christina; Balland, Benedicte; Dahan, Lionel; Luescher, Christian] Univ Geneva, Fac Med, Dept Basic Neurosci, Geneva, Switzerland; [Lujan, Rafael] Univ Castilla La Mancha, Fac Med, Dept Ciencias Med, Albacete, Spain; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Luescher, Christian] Univ Hosp Geneva, Dept Clin Neurosci, Neurol Clin, Geneva, Switzerland	University of Geneva; Universidad de Castilla-La Mancha; Stanford University; Stanford University; University of Geneva	Brown, MTC (corresponding author), Univ Geneva, Fac Med, Dept Basic Neurosci, Geneva, Switzerland.	christian.luscher@unige.ch	Core, Vector/CAF-4832-2022; Lüscher, Christian/A-2496-2011; Dahan, Lionel/C-2760-2009; Lujan, Rafael/G-2555-2015	Lüscher, Christian/0000-0001-7917-4596; Mameli, Manuel/0000-0002-0570-6964; Brown, Matthew/0000-0001-6983-962X; Dahan, Lionel/0000-0001-7810-6233; Lujan Miras, Rafael/0000-0003-2001-9545; bellone, camilla/0000-0002-6774-6275	National Institute on Drug Abuse [DA019022]; Swiss National Science Foundation; Systems X Initiative (NeuroChoice); Ministerio de Ciencia e Innovacion; Junta de Comunidades de Castilla-La Mancha; NIH; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019022] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Systems X Initiative (NeuroChoice); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Comunidades de Castilla-La Mancha(Junta de Comunidades de Castilla-La Mancha); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported by the National Institute on Drug Abuse (DA019022; C. L., P. S.), the Swiss National Science Foundation, the Systems X Initiative (NeuroChoice), the Ministerio de Ciencia e Innovacion and Junta de Comunidades de Castilla-La Mancha and the NIH Pioneer Award program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argilli E, 2008, J NEUROSCI, V28, P9092, DOI 10.1523/JNEUROSCI.1001-08.2008; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; BJORKLUND A, 1975, BRAIN RES, V83, P531, DOI 10.1016/0006-8993(75)90849-5; BRADBERRY CW, 1989, NEUROSCI LETT, V103, P97, DOI 10.1016/0304-3940(89)90492-8; Caine SB, 2007, J NEUROSCI, V27, P13140, DOI 10.1523/JNEUROSCI.2284-07.2007; CHEN NH, 1994, J PHARMACOL EXP THER, V271, P1597; Chen R, 2006, P NATL ACAD SCI USA, V103, P9333, DOI 10.1073/pnas.0600905103; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Di Chiara G, 2004, NEUROPHARMACOLOGY, V47, P227, DOI 10.1016/j.neuropharm.2004.06.032; Dong Y, 2009, J MOL NEUROSCI; Engblom D, 2008, NEURON, V59, P497, DOI 10.1016/j.neuron.2008.07.010; Frank ST, 2008, SYNAPSE, V62, P243, DOI 10.1002/syn.20489; Gao M, 2010, J NEUROSCI, V30, P13814, DOI 10.1523/JNEUROSCI.1943-10.2010; GRACE AA, 1984, J NEUROSCI, V4, P2877; GRACE AA, 1984, J NEUROSCI, V4, P2866; GROVES PM, 1975, SCIENCE, V190, P522, DOI 10.1126/science.242074; Hall FS, 2009, NEUROSCIENCE, V162, P870, DOI 10.1016/j.neuroscience.2009.05.058; Han Dawn D., 2006, BMC Pharmacology, V6, P6, DOI 10.1186/1471-2210-6-6; Hnasko TS, 2005, NATURE, V438, P854, DOI 10.1038/nature04172; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Lodge DJ, 2005, J PHARMACOL EXP THER, V314, P201, DOI 10.1124/jpet.105.084913; Luscher C, 2006, PLOS MED, V3, P2005, DOI 10.1371/journal.pmed.0030437; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; Mameli-Engvall M, 2006, NEURON, V50, P911, DOI 10.1016/j.neuron.2006.05.007; McBride WJ, 1999, BEHAV BRAIN RES, V101, P129, DOI 10.1016/S0166-4328(99)00022-4; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Napolitano F, 2010, J NEUROSCI, V30, P11043, DOI 10.1523/JNEUROSCI.1682-10.2010; Rice ME, 1997, J NEUROPHYSIOL, V77, P853, DOI 10.1152/jn.1997.77.2.853; Rocha BA, 1998, NAT NEUROSCI, V1, P132, DOI 10.1038/381; Rouge-Pont F, 2002, J NEUROSCI, V22, P3293, DOI 10.1523/JNEUROSCI.22-08-03293.2002; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Schilstrom B, 2006, J NEUROSCI, V26, P8549, DOI 10.1523/JNEUROSCI.5179-05.2006; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Sora I, 1998, P NATL ACAD SCI USA, V95, P7699, DOI 10.1073/pnas.95.13.7699; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Tan KR, 2010, NATURE, V463, P769, DOI 10.1038/nature08758; Tecuapetla F, 2010, J NEUROSCI, V30, P7105, DOI 10.1523/JNEUROSCI.0265-10.2010; Thomsen M, 2009, J PHARMACOL EXP THER, V331, P204, DOI 10.1124/jpet.109.156265; Tilley MR, 2009, NEUROREPORT, V20, P9, DOI 10.1097/WNR.0b013e32831b9ce4; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Turiault M, 2007, FEBS J, V274, P3568, DOI 10.1111/j.1742-4658.2007.05886.x; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Zhang D, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-57; Zweifel LS, 2008, NEURON, V59, P486, DOI 10.1016/j.neuron.2008.05.028	47	94	96	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15870	10.1371/journal.pone.0015870	http://dx.doi.org/10.1371/journal.pone.0015870			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209835	gold, Green Published			2022-12-27	WOS:000285838900044
J	Sendagire, I; Van der Loeff, MS; Mubiru, M; Konde-Lule, J; Cobelens, F				Sendagire, Ibrahim; Van der Loeff, Maarten Schim; Mubiru, Mesach; Konde-Lule, Joseph; Cobelens, Frank			Long Delays and Missed Opportunities in Diagnosing Smear-Positive Pulmonary Tuberculosis in Kampala, Uganda: A Cross-Sectional Study	PLOS ONE			English	Article							HEALTH-SERVICE DELAY; PATIENT; SPUTUM; MICROSCOPY	Background: Early detection and treatment of tuberculosis cases are the hallmark of successful tuberculosis control. We conducted a cross-sectional study at public primary health facilities in Kampala city, Uganda to quantify diagnostic delay among pulmonary tuberculosis (PTB) patients, assess associated factors, and describe trajectories of patients' health care seeking. Methodology/Principal Findings: Semi-structured interviews with new smear-positive PTB patients (>= 15 years) registered for treatment. Between April 2007 and April 2008, 253 patients were studied. The median total delay was 8 weeks (IQR 4-12), median patient delay was 4 weeks (inter-quartile range [IQR] 1-8) and median health service delay was 4 weeks (IQR 2-8). Long total delay (>14 weeks) was observed for 61/253 (24.1%) of patients, long health service delay (>6 weeks) for 71/242 (29.3%) and long patient delay (>8 weeks) for 47/242 (19.4%). Patients who knew that TB was curable were less likely to have long total delay (adjusted Odds Ratio [aOR] 0.28; 95%CI 0.11-0.73) and long patient delay (aOR 0.36; 95%CI 0.13-0.97). Being female (aOR 1.98; 95%CI 1.06-3.71), staying for more than 5 years at current residence (aOR 2.24 95%CI 1.18-4.27) and having been tested for HIV before (aOR 3.72; 95%CI 1.42-9.75) was associated with long health service delay. Health service delay contributed 50% of the total delay. Ninety-one percent (231) of patients had visited one or more health care providers before they were diagnosed, for an average (median) of 4 visits (range 1-30). All but four patients had systemic symptoms by the time the diagnosis of TB was made. Conclusions/Significance: Diagnostic delay among tuberculosis patients in Kampala is common and long. This reflects patients waiting too long before seeking care and health services waiting until systemic symptoms are present before examining sputum smears; this results in missed opportunities for diagnosis.	[Sendagire, Ibrahim; Mubiru, Mesach] Kampala City Council, Dept Publ Hlth, Kampala, Uganda; [Van der Loeff, Maarten Schim; Cobelens, Frank] Univ Amsterdam, Acad Med Ctr, Ctr Poverty Related Communicable Dis, NL-1105 AZ Amsterdam, Netherlands; [Van der Loeff, Maarten Schim] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [Van der Loeff, Maarten Schim] Municipal Hlth Serv, Dept Res, Amsterdam, Netherlands; [Konde-Lule, Joseph] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda; [Cobelens, Frank] Amsterdam Inst Global Hlth & Dev, Dept Res, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Makerere University	Sendagire, I (corresponding author), Kampala City Council, Dept Publ Hlth, Kampala, Uganda.	f.cobelens@amc-cpcd.org		Cobelens, Frank/0000-0002-4367-1133	Netherlands Organization for Scientific Research - WOTRO Science for Global Development [NACCAP W 07.05.20100]	Netherlands Organization for Scientific Research - WOTRO Science for Global Development	This work was done as part of the Infectious Diseases Network for Treatment and Research in Africa (INTERACT), and financially supported by the Netherlands Organization for Scientific Research - WOTRO Science for Global Development (www.nwo.nl), grant NACCAP W 07.05.20100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayuo P O, 2008, East Afr Med J, V85, P263; Bonnet M, 2007, INT J TUBERC LUNG D, V11, P953; Bustamante-Montes LP, 2000, INT J TUBERC LUNG D, V4, P208; Currie CSM, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-130; Demissie M, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-23; Keeler Emmett, 2006, Nature, V444 Suppl 1, P49, DOI 10.1038/nature05446; Kiwuwa MS, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-122; Lawn SD, 1998, INT J TUBERC LUNG D, V2, P635; Lienhardt C, 2001, INT J TUBERC LUNG D, V5, P233; Lonnroth K, 1999, INT J TUBERC LUNG D, V3, P992; Lorent N, 2008, INT J TUBERC LUNG D, V12, P392; Marais BJ, 2008, CLIN INFECT DIS, V47, P203, DOI 10.1086/589248; Meintjes G, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-72; Mesfin MM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-173; Mfinanga G S, 2007, Tanzan Health Res Bull, V9, P164; Ministry of Health [Uganda], 1999, UG NAT HLTH POL; Ozkutuk A, 2007, JPN J INFECT DIS, V60, P73; Pronyk PM, 2001, INT J TUBERC LUNG D, V5, P619; Ramsay A, 2009, J TROP MED-US, V2009, DOI 10.1155/2009/398767; Ward HA, 2004, INT J TUBERC LUNG D, V8, P593; Wei XL, 2009, INT J TUBERC LUNG D, V13, P514; World Bank, 2007, SOC DIFF HLTH NUTR P; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; World Health Organization, 2009, GLOB TUB CONTR EP ST; MERK MANUALS ONLINE	25	41	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e14459	10.1371/journal.pone.0014459	http://dx.doi.org/10.1371/journal.pone.0014459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206746	gold, Green Submitted, Green Published			2022-12-27	WOS:000285793200012
J	Tagbor, H; Bruce, J; Agbo, M; Greenwood, B; Chandramohan, D				Tagbor, Harry; Bruce, Jane; Agbo, Mitchell; Greenwood, Brian; Chandramohan, Daniel			Intermittent Screening and Treatment versus Intermittent Preventive Treatment of Malaria in Pregnancy: A Randomised Controlled Non-Inferiority Trial	PLOS ONE			English	Article							SULFADOXINE-PYRIMETHAMINE RESISTANCE; WOMEN; DIAGNOSIS; EFFICACY; THERAPY; BURDEN; KENYA	Background: The effectiveness of intermittent preventive treatment of malaria in pregnancy (IPTp) may be compromised by the spread of resistance to sulphadoxine/pyrimethamine (SP) across Africa. But little informtion exists on alternative drugs for IPTp or alternative strategies for the prevention of malaria in pregnancy. Therefore, we have investigated whether screening with a rapid diagnostic test and treatment of those who are positive (IST) at routine antenatal clinic attendances is as effective and as safe as SP-IPTp in pregnant women. Methods and Findings: During antenatal clinic sessions in six health facilities in Ghana held between March 2007 and September 2007, 3333 pregnant women who satisfied inclusion criteria were randomised into three intervention arms (1) standard SP-IPTp, (2) IST and treatment with SP or (3) IST and treatment with amodiaquine+artesunate (AQ+AS). All women received a long-lasting insecticide treated net. Study women had a maximum of three scheduled follow-up visits following enrolment. Haemoglobin concentration and peripheral parasitaemia were assessed between 36 and 40 weeks of gestation. Birth weight was measured at delivery or within 72 hours for babies delivered at home. Parasite prevalence at enrolment in primigravidae and in multigravidae was 29.6% and 10.2% respectively. At 36-40 weeks of gestation the prevalence of asymptomatic parasitaemia was 12.1% in study women overall and was very similar in all treatment groups. The risk of third trimester severe anaemia or low birth weight did not differ significantly between the three treatment groups regardless of gravidity. IST with AQ+AS or SP was not inferior to SP-IPTp in reducing the risk of low birth weight (RD = -1.17[95% CI; -4.39-1.02] for IST-SP vs. SP-IPTp and RD = 0.78[95% CI; -2.11-3.68] for IST-AQAS vs. SP-IPTp); third trimester severe anaemia (RD = 0.29[95% CI; -0.69-1.30] for IST-SP vs. SP-IPTp and RD = -0.36[95% CI;-1.12-0.44] for IST-AQAS vs. SP-IPTp). Conclusion: The results of this study suggest that in an area of moderately high malaria transmission, IST with SP or AS+AQ may be a safe and effective strategy for the control of malaria in pregnancy. However, it is important that these encouraging findings are confirmed in other geographical areas and that the impact of IST on placental malaria is investigated.	[Tagbor, Harry] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Dept Community Hlth, Kumasi, Ghana; [Agbo, Mitchell] Juaben Govt Hosp, Juaben, Ashanti, Ghana; [Bruce, Jane; Greenwood, Brian; Chandramohan, Daniel] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England	Kwame Nkrumah University Science & Technology; University of London; London School of Hygiene & Tropical Medicine	Tagbor, H (corresponding author), Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Dept Community Hlth, Kumasi, Ghana.	Harry.Tagbor@lshtm.ac.uk	Tagbor, Harry/B-9312-2018	Tagbor, Harry/0000-0002-9300-665X	London School of Hygiene & Tropical Medicine, UK; Bill and Melinda Gates Foundation	London School of Hygiene & Tropical Medicine, UK; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by a re-entry grant from the Gates Malaria Partnership (GMP), London School of Hygiene & Tropical Medicine, UK, which received support from the Bill and Melinda Gates Foundation. The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	[Anonymous], 2009, MAL RAP DIAGN TEST P; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Crawley J, 2007, LANCET INFECT DIS, V7, P145, DOI 10.1016/S1473-3099(07)70026-9; Gamble C, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003755.pub2, 10.1002/14651858.CD001031.pub2]; Harrington WE, 2009, P NATL ACAD SCI USA, V106, P9027, DOI 10.1073/pnas.0901415106; Kilian AHD, 1999, ACTA TROP, V72, P281, DOI 10.1016/S0001-706X(99)00003-0; Leke RFG, 1999, J CLIN MICROBIOL, V37, P2992, DOI 10.1128/JCM.37.9.2992-2996.1999; Mankhambo L, 2002, J CLIN MICROBIOL, V40, P155, DOI 10.1128/JCM.40.1.155-158.2002; Mbaye A, 2006, TROP MED INT HEALTH, V11, P992, DOI 10.1111/j.1365-3156.2006.01649.x; Mockenhaupt FP, 2002, J CLIN MICROBIOL, V40, P306, DOI 10.1128/JCM.40.1.306-308.2002; Mockenhaupt FP, 2008, J INFECT DIS, V198, P1545, DOI 10.1086/592455; Newman RD, 2003, TROP MED INT HEALTH, V8, P488, DOI 10.1046/j.1365-3156.2003.01066.x; Njagi JK, 2003, T ROY SOC TROP MED H, V97, P277, DOI 10.1016/S0035-9203(03)90141-6; Owusu-Agyei S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-220; Singer LM, 2004, AM J TROP MED HYG, V70, P481; Smith LA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-18; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Tagbor Harry, 2008, Ther Clin Risk Manag, V4, P631; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; Trung HD, 2004, TROP MED INT HEALTH, V9, P230, DOI 10.1046/j.1365-3156.2003.01179.x; Vallely A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-16; van Eijk AM, 2004, TROP MED INT HEALTH, V9, P351, DOI 10.1111/j.1365-3156.2004.01196.x; VanderJagt TA, 2005, TROP MED INT HEALTH, V10, P39, DOI 10.1111/j.1365-3156.2004.01349.x; WHO, 2004, AFRMAL0401P WHO REG; *WHO, 2009, WORLD MAL REP	27	88	88	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14425	10.1371/journal.pone.0014425	http://dx.doi.org/10.1371/journal.pone.0014425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203389	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000285792500007
J	Fowler, CJ; Hammarsten, P; Bergh, A				Fowler, Christopher J.; Hammarsten, Peter; Bergh, Anders			Tumour Cannabinoid CB1 Receptor and Phosphorylated Epidermal Growth Factor Receptor Expression Are Additive Prognostic Markers for Prostate Cancer	PLOS ONE			English	Article							INDUCED APOPTOSIS; CELLS; 2-ARACHIDONOYLGLYCEROL; INHIBITION; INVASION	Background: In cultured prostate cancer cells, down-regulation of epidermal growth factor receptor (EGFR) has been implicated in mediating the antiproliferative effect of the endogenous cannabinoid (CB) ligand anandamide. Using a well-characterised cohort of prostate cancer patients, we have previously reported that expression levels of phosphorylated EGFR (pEGFR-IR) and CB1 receptor (CB1IR) in tumour tissue at diagnosis are markers of disease-specific survival, but it is not known whether the two markers interact in terms of their influence on disease severity at diagnosis and disease outcome. Methodology/Principal Findings: Data from a cohort of 419 patients who were diagnosed with prostate cancer at transurethral resection for voiding difficulties was used. Scores for both tumour CB1IR and pEGFR-IR were available in the database. Of these, 235 had been followed by expectancy until the appearance of metastases. For patients scored for both parameters, Cox proportional-hazards regression analyses using optimal cut-off scores indicated that the two measures provided additional diagnostic information not only to each other, but to that provided by the tumour stage and the Gleason score. When the cases were divided into subgroups on the basis of these cut-off scores, the patients with both CB1IR and pEGFR-IR scores above their cut-off had a poorer disease-specific survival and showed a more severe pathology at diagnosis than patients with high pEGFR-IR scores but with CB1IR scores below the cut-off. Conclusions/Significance: These data indicate that a high tumour CB1 receptor expression at diagnosis augments the deleterious effects of a high pEGFR expression upon disease-specific survival.	[Fowler, Christopher J.] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Hammarsten, Peter; Bergh, Anders] Umea Univ, Dept Med Biosci, Umea, Sweden	Umea University; Umea University	Fowler, CJ (corresponding author), Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden.	cf@pharm.umu.se	Fowler, Christopher J./M-6313-2019	Fowler, Christopher J./0000-0002-6658-7874	Swedish Science Council [12158]; Swedish Cancer Society [CAN 2007/712]; Medical Faculty, Umea University	Swedish Science Council; Swedish Cancer Society(Swedish Cancer Society); Medical Faculty, Umea University	The authors thank the Swedish Science Council (Grant no. 12158, medicine, C.J. Fowler); the Swedish Cancer Society (Grant no. CAN 2007/712, Anders Bergh); and the Research Funds of the Medical Faculty, Umea University (C.J. Fowler) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Alkaitis MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010891; Ayala G, 2004, CLIN CANCER RES, V10, P6572, DOI 10.1158/1078-0432.CCR-04-0477; Chung SC, 2009, EUR J CANCER, V45, P174, DOI 10.1016/j.ejca.2008.10.010; Cudaback E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008702; De Miguel MP, 1999, CYTOKINE, V11, P722, DOI 10.1006/cyto.1998.0443; Egevad L, 2002, BJU INT, V89, P538, DOI 10.1046/j.1464-410X.2002.02669.x; Endsley MP, 2008, INT J CANCER, V123, P1318, DOI 10.1002/ijc.23674; Fowler CJ, 2010, CURR TOP MED CHEM, V10, P814; Freimuth N, 2010, J PHARMACOL EXP THER, V332, P336, DOI 10.1124/jpet.109.157735; Hammarsten P, 2010, CLIN CANCER RES, V16, P1245, DOI 10.1158/1078-0432.CCR-09-0103; Lorente M, 2009, GLIA, V57, P1374, DOI 10.1002/glia.20856; Lurje G, 2009, ONCOLOGY-BASEL, V77, P400, DOI 10.1159/000279388; Melck D, 2000, ENDOCRINOLOGY, V141, P118, DOI 10.1210/en.141.1.118; Michalski CW, 2008, INT J CANCER, V122, P742, DOI 10.1002/ijc.23114; Mimeault M, 2006, CARCINOGENESIS, V27, P1, DOI 10.1093/carcin/bgi229; Mimeault M, 2003, PROSTATE, V56, P1, DOI 10.1002/pros.10190; Nithipatikom K, 2005, BIOCHEM BIOPH RES CO, V332, P1028, DOI 10.1016/j.bbrc.2005.05.049; Nithipatikom K, 2004, CANCER RES, V64, P8826, DOI 10.1158/0008-5472.CAN-04-3136; Olea-Herrero N, 2009, BRIT J CANCER, V101, P940, DOI 10.1038/sj.bjc.6605248; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Pisanti S, 2009, BEST PRACT RES CL EN, V23, P117, DOI 10.1016/j.beem.2009.02.001; Sanchez MG, 2003, FEBS LETT, V555, P561, DOI 10.1016/S0014-5793(03)01349-8; Sarfaraz S, 2005, CANCER RES, V65, P1635, DOI 10.1158/0008-5472.CAN-04-3410; SARFARAZ S, 2008, CANCER RES, V68, P239; Sarfaraz S, 2006, J BIOL CHEM, V281, P39480, DOI 10.1074/jbc.M603495200; Thors L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012275; Velasco G, 2007, MOL NEUROBIOL, V36, P60, DOI 10.1007/s12035-007-0002-5; Wang DZ, 2008, CANCER RES, V68, P6468, DOI 10.1158/0008-5472.CAN-08-0896; Xu XD, 2006, CANCER GENET CYTOGEN, V171, P31, DOI 10.1016/j.cancergencyto.2006.06.014; ZWEIG MH, 1993, CLIN CHEM, V39, P561	31	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15205	10.1371/journal.pone.0015205	http://dx.doi.org/10.1371/journal.pone.0015205			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203460	gold, Green Submitted, Green Published			2022-12-27	WOS:000285579200013
J	Di Camillo, B; Sanavia, T; Iori, E; Bronte, V; Roncaglia, E; Maran, A; Avogaro, A; Toffolo, G; Cobelli, C				Di Camillo, Barbara; Sanavia, Tiziana; Iori, Elisabetta; Bronte, Vincenzo; Roncaglia, Enrica; Maran, Alberto; Avogaro, Angelo; Toffolo, Gianna; Cobelli, Claudio			The Transcriptional Response in Human Umbilical Vein Endothelial Cells Exposed to Insulin: A Dynamic Gene Expression Approach	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; HUMAN SKELETAL-MUSCLE; STIMULATED PRODUCTION; METABOLIC SYNDROME; AKT; PHOSPHORYLATION; ACTIVATION; RESISTANCE; TISSUE; RISK	Background: In diabetes chronic hyperinsulinemia contributes to the instability of the atherosclerotic plaque and stimulates cellular proliferation through the activation of the MAP kinases, which in turn regulate cellular proliferation. However, it is not known whether insulin itself could increase the transcription of specific genes for cellular proliferation in the endothelium. Hence, the characterization of transcriptional modifications in endothelium is an important step for a better understanding of the mechanism of insulin action and the relationship between endothelial cell dysfunction and insulin resistance. Methodology and principal findings: The transcriptional response of endothelial cells in the 440 minutes following insulin stimulation was monitored using microarrays and compared to a control condition. About 1700 genes were selected as differentially expressed based on their treated minus control profile, thus allowing the detection of even small but systematic changes in gene expression. Genes were clustered in 7 groups according to their time expression profile and classified into 15 functional categories that can support the biological effects of insulin, based on Gene Ontology enrichment analysis. In terms of endothelial function, the most prominent processes affected were NADH dehydrogenase activity, N-terminal myristoylation domain binding, nitric-oxide synthase regulator activity and growth factor binding. Pathway-based enrichment analysis revealed "Electron Transport Chain" significantly enriched. Results were validated on genes belonging to "Electron Transport Chain" pathway, using quantitative RT-PCR. Conclusions: As far as we know, this is the first systematic study in the literature monitoring transcriptional response to insulin in endothelial cells, in a time series microarray experiment. Since chronic hyperinsulinemia contributes to the instability of the atherosclerotic plaque and stimulates cellular proliferation, some of the genes identified in the present work are potential novel candidates in diabetes complications related to endothelial dysfunction.	[Di Camillo, Barbara; Sanavia, Tiziana; Toffolo, Gianna; Cobelli, Claudio] Univ Padua, Dept Informat Engn, Padua, Italy; [Iori, Elisabetta; Maran, Alberto; Avogaro, Angelo] Univ Padua, Dept Clin & Expt Med, Div Metab Dis, Padua, Italy; [Bronte, Vincenzo] Ist Ricovero & Cura Carattere Sci, IOV, Padua, Italy; [Roncaglia, Enrica] Univ Modena & Reggio Emilia, Dept Biomed Sci, Modena, Italy; [Roncaglia, Enrica] BioPharmaNet Inc, Emilia Romagna High Tech Network, Ferrara, Italy; [Avogaro, Angelo] VIMM, Padua, Italy	University of Padua; University of Padua; IRCCS Istituto Oncologico Veneto (IOV); Universita di Modena e Reggio Emilia; Veneto Institute Molecular Medicine	Di Camillo, B (corresponding author), Univ Padua, Dept Informat Engn, Padua, Italy.	cobelli@dei.unipd.it	Di Camillo, Barbara/L-3202-2013; Bronte, Vincenzo/K-7902-2016; Avogaro, Angelo/S-3808-2016; Sanavia, Tiziana/F-9446-2015	Di Camillo, Barbara/0000-0001-8415-4688; Bronte, Vincenzo/0000-0002-3741-5141; Sanavia, Tiziana/0000-0003-3288-0631; AVOGARO, ANGELO/0000-0002-1177-0516; MARAN, ALBERTO/0000-0002-7266-8486	PRIN; CARIPARO	PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); CARIPARO(Fondazione Cariparo)	This work was supported by PRIN 2005-2006 "Dynamic models of gene and protein expression in endothelial progenitor cells in evolution of diabetes" and CARIPARO 2008/2010 "Systems biology approaches to infer gene regulation from gene and protein time series data". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett EJ, 2009, DIABETOLOGIA, V52, P752, DOI 10.1007/s00125-009-1313-z; Boden G, 2008, AM J PHYSIOL-ENDOC M, V295, pE692, DOI 10.1152/ajpendo.90370.2008; Boo YC, 2006, FREE RADICAL BIO MED, V41, P144, DOI 10.1016/j.freeradbiomed.2006.03.024; CHENG Z, 2010, TRENDS ENDO IN PRESS; Consoli C, 2008, ARTERIOSCL THROM VAS, V28, pE7, DOI 10.1161/ATVBAHA.107.152264; dela Paz NG, 2009, CELL TISSUE RES, V335, P5, DOI 10.1007/s00441-008-0706-5; Di Camillo B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S11; Di Camillo B, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S10; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Ducluzeau PH, 2001, DIABETES, V50, P1134, DOI 10.2337/diabetes.50.5.1134; Fisslthaler B, 2003, NITRIC OXIDE-BIOL CH, V8, P253, DOI 10.1016/S1089-8603(03)00042-9; Fonseca VA, 2007, ENDOCRIN METAB CLIN, V36, P20, DOI 10.1016/S0889-8529(07)80009-0; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Hiden U, 2006, DIABETOLOGIA, V49, P123, DOI 10.1007/s00125-005-0054-x; Hirashima M, 2006, ENDOTHELIUM-J ENDOTH, V13, P137, DOI 10.1080/10623320600698078; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kashiwagi A, 1999, AM J PHYSIOL-ENDOC M, V277, pE976, DOI 10.1152/ajpendo.1999.277.6.E976; Kuboki K, 2000, CIRCULATION, V101, P676, DOI 10.1161/01.CIR.101.6.676; Luo ZY, 2000, J CLIN INVEST, V106, P493, DOI 10.1172/JCI9419; MATTHEWS VB, 2010, DIABETOLOGI IN PRESS; Montagnani M, 2002, MOL ENDOCRINOL, V16, P1931, DOI 10.1210/me.2002-0074; Moon CT, 2001, NEUROSURGERY, V48, P1328, DOI 10.1097/00006123-200106000-00030; Muniyappa R, 2008, ENDOCRIN METAB CLIN, V37, P685, DOI 10.1016/j.ecl.2008.06.001; POLLOCK JS, 1992, FEBS LETT, V309, P402, DOI 10.1016/0014-5793(92)80816-Y; Ritchie SA, 2010, BIOCHEM J, V426, P85, DOI 10.1042/BJ20091580; Ritov VB, 2010, AM J PHYSIOL-ENDOC M, V298, pE49, DOI 10.1152/ajpendo.00317.2009; Rome S, 2003, J BIOL CHEM, V278, P18063, DOI 10.1074/jbc.M300293200; Sata M, 2002, CIRC RES, V91, P273, DOI 10.1161/01.RES.0000031956.29928.62; SESSA WC, 1992, J BIOL CHEM, V267, P15274; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Sreekumar R, 2002, DIABETES, V51, P1913, DOI 10.2337/diabetes.51.6.1913; Tai SC, 2004, ARTERIOSCL THROM VAS, V24, P405, DOI 10.1161/01.ATV.0000109171.50229.33; Tanner FC, 2000, CIRCULATION, V101, P1982, DOI 10.1161/01.CIR.101.16.1982; Zeng GY, 1996, J CLIN INVEST, V98, P894, DOI 10.1172/JCI118871	38	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14390	10.1371/journal.pone.0014390	http://dx.doi.org/10.1371/journal.pone.0014390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203503	Green Published, Green Submitted, gold			2022-12-27	WOS:000285578000006
J	Hohn, O; Strohschein, K; Brandt, AU; Seeher, S; Klein, S; Kurth, R; Paul, F; Meisel, C; Scheibenbogen, C; Bannert, N				Hohn, Oliver; Strohschein, Kristin; Brandt, Alexander U.; Seeher, Sandra; Klein, Sandra; Kurth, Reinhard; Paul, Friedemann; Meisel, Christian; Scheibenbogen, Carmen; Bannert, Norbert			No Evidence for XMRV in German CFS and MS Patients with Fatigue Despite the Ability of the Virus to Infect Human Blood Cells In Vitro	PLOS ONE			English	Article							PROSTATE CARCINOMA-CELLS; MULTIPLE-SCLEROSIS; GAMMARETROVIRUS XMRV; RETROVIRUS; CANCER; INTEGRATION; DEFINITION; DIAGNOSIS; TUMORS; SCALE	Background: Xenotropic murine leukemia virus-related virus (XMRV), a novel human retrovirus originally identified in prostate cancer tissues, has recently been associated with chronic fatigue syndrome (CFS), a disabling disease of unknown etiology affecting millions of people worldwide. However, several subsequent studies failed to detect the virus in patients suffering from these illnesses or in healthy subjects. Here we report the results of efforts to detect antibody responses and viral sequences in samples from a cohort of German CFS and relapsing remitting multiple sclerosis (MS) patients with fatigue symptoms. Methodology: Blood samples were taken from a cohort of 39 patients fulfilling the Fukuda/CDC criteria (CFS), from 112 patients with an established MS diagnosis and from 40 healthy donors. Fatigue severity in MS patients was assessed using the Fatigue Severity Scale (FSS). Validated Gag-and Env-ELISA assays were used to screen sera for XMRV antibodies. PHA-activated PBMC were cultured for seven days in the presence of IL-2 and DNA isolated from these cultures as well as from co-cultures of PBMC and highly permissive LNCaP cells was analyzed by nested PCR for the presence of the XMRV gag gene. In addition, PBMC cultures were exposed to 22Rv1-derived XMRV to assess infectivity and virus production. Conclusion: None of the screened sera from CFS and MS patients or healthy blood donors tested positive for XMRV specific antibodies and all PBMC (and PBMC plus LNCaP) cultures remained negative for XMRV sequences by nested PCR. These results argue against an association between XMRV infection and CFS and MS in Germany. However, we could confirm that PBMC cultures from healthy donors and from CFS patients can be experimentally infected by XMRV, resulting in the release of low levels of transmittable virus.	[Hohn, Oliver; Seeher, Sandra; Klein, Sandra; Bannert, Norbert] Robert Koch Inst, Ctr Biol Secur 4, D-1000 Berlin, Germany; [Strohschein, Kristin; Meisel, Christian; Scheibenbogen, Carmen] Charite, Inst Med Immunol, D-13353 Berlin, Germany; [Brandt, Alexander U.; Paul, Friedemann] Charite, NCRC, D-13353 Berlin, Germany; [Hohn, Oliver; Bannert, Norbert] Robert Koch Inst, Ctr Retrovirol, D-1000 Berlin, Germany	Robert Koch Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Robert Koch Institute	Hohn, O (corresponding author), Robert Koch Inst, Ctr Biol Secur 4, D-1000 Berlin, Germany.	bannertn@rki.de	Paul, Friedemann/ABF-9415-2020	Scheibenbogen, Carmen/0000-0002-8554-9638; Meisel, Christian/0000-0003-0222-991X; paul, friedemann/0000-0002-6378-0070	Fatigatio	Fatigatio	CS was supported by Fatigatio, the German patients self-help group for CFS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony JM, 2010, BIOCH BIOPHYS ACTA; Arnold RS, 2010, UROLOGY, V75, P755, DOI 10.1016/j.urology.2010.01.038; Bakshi R, 2003, MULT SCLER J, V9, P219, DOI 10.1191/1352458503ms904oa; Behrendt R, 2009, J VIROL METHODS, V159, P40, DOI 10.1016/j.jviromet.2009.02.024; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; D'Arcy F, 2008, EUR UROL SUPPL, V7, P271, DOI 10.1016/S1569-9056(08)60798-8; DEFREITAS E, 1991, P NATL ACAD SCI USA, V88, P2922, DOI 10.1073/pnas.88.7.2922; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Groom HCT, 2010, P NATL ACAD SCI USA, V107, P5166, DOI 10.1073/pnas.0913650107; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Maric R, 2010, J CLIN VIROL, V49, P227, DOI 10.1016/j.jcv.2010.08.003; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Paprotka T, 2010, J VIROL, V84, P5719, DOI 10.1128/JVI.00134-10; PERRON H, 1991, LANCET, V337, P862, DOI 10.1016/0140-6736(91)92579-Q; Prins JB, 2006, LANCET, V367, P346, DOI 10.1016/S0140-6736(06)68073-2; Qiu XX, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-68; Reeves WC, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-25; Rodriguez JJ, 2010, J VIROL, V84, P2556, DOI 10.1128/JVI.01969-09; ROE TY, 1993, EMBO J, V12, P2099, DOI 10.1002/j.1460-2075.1993.tb05858.x; SAITO M, 2010, INTERDISCIP PERSPECT; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Smith MM, 2005, MULT SCLER J, V11, P602, DOI 10.1191/1352458505ms1204oa; Stieler K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011738; Stieler K, 2010, VIROLOGY, V399, P23, DOI 10.1016/j.virol.2009.12.028; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018; Voisset C, 2008, MICROBIOL MOL BIOL R, V72, P157, DOI 10.1128/MMBR.00033-07; Yamashita M, 2006, VIROLOGY, V344, P88, DOI 10.1016/j.virol.2005.09.012	38	49	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15632	10.1371/journal.pone.0015632	http://dx.doi.org/10.1371/journal.pone.0015632			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203514	Green Accepted, Green Published, gold			2022-12-27	WOS:000285578000041
J	Venticinque, L; Jamieson, KV; Meruelo, D				Venticinque, Lisa; Jamieson, Kelly V.; Meruelo, Daniel			Interactions Between Laminin Receptor and the Cytoskeleton During Translation and Cell Motility	PLOS ONE			English	Article							RIBOSOMAL-PROTEIN GENES; BINDING PROTEIN; INTERMEDIATE-FILAMENTS; MESSENGER-RNA; HELA-CELLS; MICROFILAMENT BUNDLES; EMBRYO FIBROBLASTS; SURFACE RECEPTOR; MAMMALIAN-CELLS; ACTIN	Human laminin receptor acts as both a component of the 40S ribosomal subunit to mediate cellular translation and as a cell surface receptor that interacts with components of the extracellular matrix. Due to its role as the cell surface receptor for several viruses and its overexpression in several types of cancer, laminin receptor is a pathologically significant protein. Previous studies have determined that ribosomes are associated with components of the cytoskeleton, however the specific ribosomal component(s) responsible has not been determined. Our studies show that laminin receptor binds directly to tubulin. Through the use of siRNA and cytoskeletal inhibitors we demonstrate that laminin receptor acts as a tethering protein, holding the ribosome to tubulin, which is integral to cellular translation. Our studies also show that laminin receptor is capable of binding directly to actin. Through the use of siRNA and cytoskeletal inhibitors we have shown that this laminin receptor-actin interaction is critical for cell migration. These data indicate that interactions between laminin receptor and the cytoskeleton are vital in mediating two processes that are intimately linked to cancer, cellular translation and migration.	[Venticinque, Lisa] NYU, Sch Med, Inst Canc, Gene Therapy Ctr, New York, NY 10003 USA; NYU, Sch Med, Dept Pathol, New York, NY USA	New York University; New York University	Venticinque, L (corresponding author), NYU, Sch Med, Inst Canc, Gene Therapy Ctr, New York, NY 10003 USA.	DM01@mac.com			Litwin foundation; National Cancer Institute, National Institutes of Health [CA100687]; Department of Health and Human Services; NATIONAL CANCER INSTITUTE [R01CA100687] Funding Source: NIH RePORTER	Litwin foundation; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Health and Human Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by a generous donation from the Litwin foundation and the U.S. Public Health grant CA100687 from the National Cancer Institute, National Institutes of Health, and Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoumianaki T, 2009, J CELL SCI, V122, P1111, DOI 10.1242/jcs.043034; Ardini E, 1998, MOL BIOL EVOL, V15, P1017, DOI 10.1093/oxfordjournals.molbev.a026000; AUTH D, 1992, P NATL ACAD SCI USA, V89, P4368, DOI 10.1073/pnas.89.10.4368; Basolo F, 1996, CLIN CANCER RES, V2, P1777; Berno V, 2005, ENDOCR-RELAT CANCER, V12, P393, DOI 10.1677/erc.1.00870; BROWN S, 1976, J SUPRAMOL STR CELL, V5, P119, DOI 10.1002/jss.400050203; BROWN SS, 1983, P NATL ACAD SCI-BIOL, V80, P5927, DOI 10.1073/pnas.80.19.5927; Buto S, 1998, J CELL BIOCHEM, V69, P244, DOI 10.1002/(SICI)1097-4644(19980601)69:3<244::AID-JCB2>3.0.CO;2-R; CERVERA M, 1981, CELL, V23, P113, DOI 10.1016/0092-8674(81)90276-2; Chuong SDX, 2004, MOL CELL PROTEOMICS, V3, P970, DOI 10.1074/mcp.M400053-MCP200; CODY RL, 1986, EXP CELL RES, V165, P107, DOI 10.1016/0014-4827(86)90536-7; Demianova M, 1996, J BIOL CHEM, V271, P11383, DOI 10.1074/jbc.271.19.11383; FERRARI S, 1990, CANCER RES, V50, P5825; Ford CL, 1999, CANCER RES, V59, P704; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Goldberg MB, 2001, MICROBIOL MOL BIOL R, V65, P595, DOI 10.1128/MMBR.65.4.595-626.2001; GOLDMAN RD, 1975, EXP CELL RES, V90, P333, DOI 10.1016/0014-4827(75)90323-7; Gross SR, 2007, MOL CELL BIOL, V27, P1974, DOI 10.1128/MCB.00832-06; HAMILL D, 1994, J CELL BIOL, V127, P973, DOI 10.1083/jcb.127.4.973; HESKETH J, 1994, MOL BIOL REP, V19, P233, DOI 10.1007/BF00986965; HESKETH JE, 1991, CELL BIOL INT REP, V15, P141, DOI 10.1016/0309-1651(91)90105-R; HUGLE B, 1985, J CELL BIOL, V100, P873, DOI 10.1083/jcb.100.3.873; Hundt C, 2001, EMBO J, V20, P5876, DOI 10.1093/emboj/20.21.5876; Jamieson KV, 2008, J BIOL CHEM, V283, P3002, DOI 10.1074/jbc.C700206200; JAMIESON KV, 2010, J MOL BIOL; Kaneda Y, 1998, CELL DEATH DIFFER, V5, P20, DOI 10.1038/sj.cdd.4400315; Kim S, 2010, NAT REV MOL CELL BIO, V11, P75, DOI 10.1038/nrm2818; Kondoh N, 2001, ANTICANCER RES, V21, P2429; LANDOWSKI TH, 1995, BIOCHEMISTRY-US, V34, P11276, DOI 10.1021/bi00035a037; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LAZARIDES E, 1980, NATURE, V283, P249, DOI 10.1038/283249a0; LENK R, 1977, CELL, V10, P67, DOI 10.1016/0092-8674(77)90141-6; LESOT H, 1983, EMBO J, V2, P861, DOI 10.1002/j.1460-2075.1983.tb01514.x; Loging WT, 1999, CANCER EPIDEM BIOMAR, V8, P1011; Ludwig GV, 1996, J VIROL, V70, P5592, DOI 10.1128/JVI.70.8.5592-5599.1996; MAFUNE K, 1992, J SURG RES, V52, P340, DOI 10.1016/0022-4804(92)90113-E; MALINOFF HL, 1983, J CELL BIOL, V96, P1475, DOI 10.1083/jcb.96.5.1475; Menard S, 1998, BREAST CANCER RES TR, V52, P137, DOI 10.1023/A:1006171403765; MITCHISON TJ, 1995, PHILOS T ROY SOC B, V349, P299, DOI 10.1098/rstb.1995.0117; ORNELLES DA, 1986, MOL CELL BIOL, V6, P1650, DOI 10.1128/MCB.6.5.1650; OSBORN M, 1977, EXP CELL RES, V106, P339, DOI 10.1016/0014-4827(77)90179-3; Pelosi G, 1997, J PATHOL, V183, P62, DOI 10.1002/(SICI)1096-9896(199709)183:1<62::AID-PATH1095>3.0.CO;2-A; PINEIRO D, 2010, MOL CELL BIOCH; Pineiro D, 2007, EXP CELL RES, V313, P3694, DOI 10.1016/j.yexcr.2007.07.025; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; RAO NC, 1983, BIOCHEM BIOPH RES CO, V111, P804, DOI 10.1016/0006-291X(83)91370-0; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sanjuan X, 1996, J PATHOL, V179, P376, DOI 10.1002/(SICI)1096-9896(199608)179:4<376::AID-PATH591>3.0.CO;2-V; Scheiman J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.19; SCHEIMAN J, MOL THER, V18, P63; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Susantad T, 2008, CELL MOL BIOL LETT, V13, P452, DOI 10.2478/s11658-008-0017-6; Thepparit C, 2004, J VIROL, V78, P12647, DOI 10.1128/JVI.78.22.12647-12656.2004; Tio PH, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-25; TOH BH, 1980, CELL TISSUE RES, V211, P163; Traub P, 1998, BIOL CELL, V90, P319, DOI 10.1016/S0248-4900(98)80013-0; vandenBrule FA, 1996, EUR J CANCER, V32A, P1598, DOI 10.1016/0959-8049(96)00119-0; VANVENROOIJ WJ, 1981, EXP CELL RES, V135, P79, DOI 10.1016/0014-4827(81)90301-3; VEDELER A, 1991, MOL CELL BIOCHEM, V100, P183; WANG KS, 1992, J VIROL, V66, P4992, DOI 10.1128/JVI.66.8.4992-5001.1992; WEWER UM, 1987, CANCER RES, V47, P5691; WOLOSEWICK JJ, 1976, AM J ANAT, V147, P303, DOI 10.1002/aja.1001470305; YANNARIELLOBROWN J, 1988, J CELL BIOL, V106, P1773, DOI 10.1083/jcb.106.5.1773	63	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e15895	10.1371/journal.pone.0015895	http://dx.doi.org/10.1371/journal.pone.0015895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249134	Green Published, gold, Green Submitted			2022-12-27	WOS:000286512900011
J	Slove, J; Janz, N				Slove, Jessica; Janz, Niklas			The Relationship between Diet Breadth and Geographic Range Size in the Butterfly Subfamily Nymphalinae - A Study of Global Scale	PLOS ONE			English	Article							HOST-PLANT SPECIALIZATION; PHYLOGENETIC-RELATIONSHIPS; LEPIDOPTERA; DIVERSIFICATION; HERITABILITY; EVOLUTION; COLONIZATION; EXPANSIONS; SPECIATION; RESOLUTION	The "oscillation hypothesis" has been proposed as a general explanation for the exceptional diversification of herbivorous insect species. The hypothesis states that speciation rates are elevated through repeated correlated changes - oscillations - in degree of host plant specificity and geographic range. The aim of this study is to test one of the predictions from the oscillation hypothesis: a positive correlation between diet breadth (number of host plants used) and geographic range size, using the globally distributed butterfly subfamily Nymphalinae. Data on diet breadth and global geographic range were collected for 182 Nymphalinae butterflies species and the size of the geographic range was measured using a GIS. We tested both diet breadth and geographic range size for phylogenetic signal to see if species are independent of each other with respect to these characters. As this test gave inconclusive results, data was analysed both using cross-species comparisons and taking phylogeny into account using generalised estimating equations as applied in the APE package in R. Irrespective of which method was used, we found a significant positive correlation between diet breadth and geographic range size. These results are consistent for two different measures of diet breadth and removal of outliers. We conclude that the global range sizes of Nymphalinae butterflies are correlated to diet breadth. That is, butterflies that feed on a large number of host plants tend to have larger geographic ranges than do butterflies that feed on fewer plants. These results lend support for an important step in the oscillation hypothesis of plant-driven diversification, in that it can provide the necessary fuel for future population fragmentation and speciation.	[Slove, Jessica; Janz, Niklas] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden	Stockholm University	Slove, J (corresponding author), Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden.	jessica.slove@zoologi.su.se	Janz, Niklas/B-1756-2010	Janz, Niklas/0000-0002-6379-7905	Swedish National Science Research Council	Swedish National Science Research Council	This work was supported by a grant from the Swedish National Science Research Council to NJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta SJ, 2008, ECOL LETT, V11, P1123, DOI 10.1111/j.1461-0248.2008.01237.x; Agosta SJ, 2010, ZOOLOGIA-CURITIBA, V27, P151, DOI 10.1590/S1984-46702010000200001; Beck J, 2006, GLOBAL ECOL BIOGEOGR, V15, P339, DOI 10.1111/j.1466-822x.2006.00230.x; Benkman CW, 1999, AM NAT, V153, pS75, DOI 10.1086/303213; Blackburn TM, 2004, J BIOGEOGR, V31, P285, DOI 10.1046/j.0305-0270.2003.01018.x; Braby MF, 2000, BUTTERFLIES AUSTR TH; Brandle M, 2002, EVOL ECOL RES, V4, P993; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Corbet A.S., 1992, BUTTERFLIES MALAY PE; Dennis RLH, 2000, BIODIVERS CONSERV, V9, P343, DOI 10.1023/A:1008924329854; DeVries PJ, 1987, BUTTERFLIES COSTA RI; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Erwin T.L., 1979, P539; Erwin T.L., 1981, P159; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; Fordyce JA, 2010, P ROY SOC B-BIOL SCI, V277, P3735, DOI 10.1098/rspb.2010.0211; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hoberg EP, 2008, J BIOGEOGR, V35, P1533, DOI 10.1111/j.1365-2699.2008.01951.x; IGARASHI S, 1997, LIFE HIST ASIAN BUTT; JABLONSKI D, 1987, SCIENCE, V238, P360, DOI 10.1126/science.238.4825.360; Janz N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-4; Janz N, 2001, EVOLUTION, V55, P783, DOI 10.1554/0014-3820(2001)055[0783:EDOHPS]2.0.CO;2; Janz N, 1998, EVOLUTION, V52, P486, DOI [10.2307/2411084, 10.1111/j.1558-5646.1998.tb01648.x]; Janz N, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P203; Kodandaramaiah U, 2007, J EVOLUTION BIOL, V20, P2181, DOI 10.1111/j.1420-9101.2007.01425.x; LARSEN TB, 1992, BUTTERFLIES KENYA TH; Larsen TB, 2005, BUTTERFLIES W AFRICA; Leneveu J, 2009, BIOL J LINN SOC, V97, P346, DOI 10.1111/j.1095-8312.2009.01208.x; Miller M. A., 2010, CIPRES PORTALS; MITTER C, 1988, AM NAT, V132, P107, DOI 10.1086/284840; Mouillot D, 2007, GLOBAL ECOL BIOGEOGR, V16, P367, DOI 10.1111/j.1466-8238.2007.00292.x; Nosil P, 2002, EVOLUTION, V56, P1701, DOI 10.1111/j.0014-3820.2002.tb01482.x; Nylin S, 2009, EVOL ECOL, V23, P137, DOI 10.1007/s10682-007-9205-5; Nyman T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-266; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Paivinen J, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-5; Paradis E, 2002, J THEOR BIOL, V218, P175, DOI 10.1006/jtbi.2002.3066; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PARSONS M, 1992, WAU ECOLOGY I HDB, V12; Parsons MJ., 1998, BUTTERFLIES PAPUA NE; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Posada D, 2006, NUCLEIC ACIDS RES, V34, pW700, DOI 10.1093/nar/gkl042; Quinn RM, 1998, ECOGRAPHY, V21, P279, DOI 10.1111/j.1600-0587.1998.tb00565.x; R Core Team, 2020, R LANG ENV STAT COMP; SAVELA M, 2007, LEPIDOPTERA SOME OTH; Scott J. A., 1986, BUTTERFLIES N AM NAT; Smith D. S., 1994, BUTTERFLIES W INDIES; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; STEVENS PF, 2001, ANGIOSPERM PHYLOGENY; Stireman JO, 2005, J EVOLUTION BIOL, V18, P325, DOI 10.1111/j.1420-9101.2004.00850.x; Strong D., 1984, INSECTS PLANTS COMMU; Swofford DL., 2001, PAUP PHYLOGENETIC AN; Tennent W.J., 2002, BUTTERFLIES SOLOMON; Thompson J. N., 2005, INTERSPEC INTERACT; Thompson JD., 1994, COEVOLUTIONARY PROCE; Wahlberg N, 2005, BIOL J LINN SOC, V86, P227, DOI 10.1111/j.1095-8312.2005.00531.x; Wahlberg N, 2003, MOL PHYLOGENET EVOL, V28, P473, DOI 10.1016/S1055-7903(03)00052-6; Wahlberg N, 2001, EVOLUTION, V55, P522, DOI 10.1554/0014-3820(2001)055[0522:TPABOH]2.0.CO;2; Wahlberg N, 2000, CLADISTICS, V16, P347, DOI 10.1111/j.1096-0031.2000.tb00355.x; Wahlberg N, 2007, MOL PHYLOGENET EVOL, V44, P1257, DOI 10.1016/j.ympev.2007.04.012; Wahlberg N, 2009, P ROY SOC B-BIOL SCI, V276, P4295, DOI 10.1098/rspb.2009.1303; Wahlberg N, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-92; Webb TJ, 2003, AM NAT, V161, P553, DOI 10.1086/368296; Weingartner E, 2006, J EVOLUTION BIOL, V19, P483, DOI 10.1111/j.1420-9101.2005.01009.x; West-Eberhard Mary Jane, 2003, pi; Winkler IS, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P240; Zimmermann M, 2000, ANN ENTOMOL SOC AM, V93, P347, DOI 10.1603/0013-8746(2000)093[0347:POECBL]2.0.CO;2	69	37	37	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e16057	10.1371/journal.pone.0016057	http://dx.doi.org/10.1371/journal.pone.0016057			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246054	Green Published, gold, Green Submitted			2022-12-27	WOS:000286511200032
J	Carnahan, RH; Rokas, A; Gaucher, EA; Reynolds, AB				Carnahan, Robert H.; Rokas, Antonis; Gaucher, Eric A.; Reynolds, Albert B.			The Molecular Evolution of the p120-Catenin Subfamily and Its Functional Associations	PLOS ONE			English	Article							RHO-FAMILY GTPASES; BAYESIAN PHYLOGENETIC INFERENCE; CELL-ADHESION MOLECULES; E-CADHERIN FUNCTION; P120 CATENIN; DELTA-CATENIN; BETA-CATENIN; ADHERENS JUNCTION; DNA METHYLATION; TRANSCRIPTIONAL REPRESSOR	Background: p120-catenin (p120) is the prototypical member of a subclass of armadillo-related proteins that includes delta-catenin/NPRAP, ARVCF, p0071, and the more distantly related plakophilins 1-3. In vertebrates, p120 is essential in regulating surface expression and stability of all classical cadherins, and directly interacts with Kaiso, a BTB/ZF family transcription factor. Methodology/Principal Findings: To clarify functional relationships between these proteins and how they relate to the classical cadherins, we have examined the proteomes of 14 diverse vertebrate and metazoan species. The data reveal a single ancient delta-catenin-like p120 family member present in the earliest metazoans and conserved throughout metazoan evolution. This single p120 family protein is present in all protostomes, and in certain early-branching chordate lineages. Phylogenetic analyses suggest that gene duplication and functional diversification into "p120-like" and "delta-catenin-like" proteins occurred in the urochordate-vertebrate ancestor. Additional gene duplications during early vertebrate evolution gave rise to the seven vertebrate p120 family members. Kaiso family members (i.e., Kaiso, ZBTB38 and ZBTB4) are found only in vertebrates, their origin following that of the p120-like gene lineage and coinciding with the evolution of vertebrate-specific mechanisms of epigenetic gene regulation by CpG island methylation. Conclusions/Significance: The p120 protein family evolved from a common delta-catenin-like ancestor present in all metazoans. Through several rounds of gene duplication and diversification, however, p120 evolved in vertebrates into an essential, ubiquitously expressed protein, whereas loss of the more selectively expressed delta-catenin, p0071 and ARVCF are tolerated in most species. Together with phylogenetic studies of the vertebrate cadherins, our data suggest that the p120-like and delta-catenin-like genes co-evolved separately with non-neural (E-and P-cadherin) and neural (N-and R-cadherin) cadherin lineages, respectively. The expansion of p120 relative to delta-catenin during vertebrate evolution may reflect the pivotal and largely disproportionate role of the non-neural cadherins with respect to evolution of the wide range of somatic morphology present in vertebrates today.	[Carnahan, Robert H.; Reynolds, Albert B.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37203 USA; [Rokas, Antonis] Vanderbilt Univ, Dept Biol Sci, Nashville, TN USA; [Gaucher, Eric A.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	Vanderbilt University; Vanderbilt University; University System of Georgia; Georgia Institute of Technology	Carnahan, RH (corresponding author), Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37203 USA.	al.reynolds@vanderbilt.edu	Gaucher, Eric/I-7313-2013; Carnahan, Robert H/N-7429-2013; Rokas, Antonis/A-9775-2008	Carnahan, Robert H/0000-0001-5230-1532; Rokas, Antonis/0000-0002-7248-6551	Searle Scholars Program; National Science Foundation [DEB-0844968]; Vanderbilt Antibody and Protein Resource; Vanderbilt Cancer Center Support Grant [P30 CA068485]; Vanderbilt GI SPORE [50 CA95103];  [RO1 CA055724];  [RO1 CA111947]; NATIONAL CANCER INSTITUTE [R01CA111947, P50CA095103, R01CA055724, P30CA068485] Funding Source: NIH RePORTER	Searle Scholars Program; National Science Foundation(National Science Foundation (NSF)); Vanderbilt Antibody and Protein Resource; Vanderbilt Cancer Center Support Grant; Vanderbilt GI SPORE; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research in Antonis Rokas' laboratory is supported by the Searle Scholars Program and the National Science Foundation (DEB-0844968). Robert Carnahan is supported by the Vanderbilt Antibody and Protein Resource and RO1 CA055724 to Albert Reynolds. This work is supported in part by the Vanderbilt Cancer Center Support Grant (P30 CA068485), RO1 CA111947 (Albert Reynolds), and the Vanderbilt GI SPORE 50 CA95103 (Robert Coffey/Albert Reynolds). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin M, 2008, SCIENCE, V319, P946, DOI 10.1126/science.1151084; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Arikkath J, 2009, J NEUROSCI, V29, P5435, DOI 10.1523/JNEUROSCI.0835-09.2009; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Chen XY, 2002, J BIOL CHEM, V277, P10512, DOI 10.1074/jbc.M108765200; Daniel JM, 2002, NUCLEIC ACIDS RES, V30, P2911, DOI 10.1093/nar/gkf398; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; DANIEL JM, 1995, MOL CELL BIOL, V15, P4819; Davis MA, 2006, DEV CELL, V10, P21, DOI 10.1016/j.devcel.2005.12.004; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Elia LP, 2006, NEURON, V51, P43, DOI 10.1016/j.neuron.2006.05.018; Filion GJP, 2006, MOL CELL BIOL, V26, P169, DOI 10.1128/MCB.26.1.169-181.2006; Gallin WJ, 1998, MOL BIOL EVOL, V15, P1099, DOI 10.1093/oxfordjournals.molbev.a026017; Grimson MJ, 2000, NATURE, V408, P727, DOI 10.1038/35047099; Grosheva I, 2001, J CELL SCI, V114, P695; Grossmann KS, 2004, J CELL BIOL, V167, P149, DOI 10.1083/jcb.200402096; Gu DM, 2009, J CELL SCI, V122, P4049, DOI 10.1242/jcs.031948; Hatzfeld M, 2005, EUR J CELL BIOL, V84, P205, DOI 10.1016/j.ejcb.2004.12.016; Hatzfeld M, 1996, J CELL SCI, V109, P2767; Hatzfeld M, 2000, J CELL BIOL, V149, P209, DOI 10.1083/jcb.149.1.209; Hatzfeld M, 2007, BBA-MOL CELL RES, V1773, P69, DOI 10.1016/j.bbamcr.2006.04.009; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; Ho C, 2000, J COMP NEUROL, V420, P261; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hulpiau P, 2009, INT J BIOCHEM CELL B, V41, P349, DOI 10.1016/j.biocel.2008.09.027; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Keirsebilck A, 1998, GENOMICS, V50, P129, DOI 10.1006/geno.1998.5325; Kelly KF, 2004, J CELL SCI, V117, P2675, DOI 10.1242/jcs.01101; Kim SW, 2004, NAT CELL BIOL, V6, P1212, DOI 10.1038/ncb1191; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kowalczyk AP, 1999, J BIOL CHEM, V274, P18145, DOI 10.1074/jbc.274.26.18145; Lopes EC, 2008, CANCER RES, V68, P7258, DOI 10.1158/0008-5472.CAN-08-0344; Lu Q, 2005, HUM PATHOL, V36, P1037, DOI 10.1016/j.humpath.2005.07.012; Lu Q, 1999, J CELL BIOL, V144, P519, DOI 10.1083/jcb.144.3.519; Magie Craig R., 2002, Development (Cambridge), V129, P3771; Mariner DJ, 2000, J CELL SCI, V113, P1481; McGrath JA, 1999, BRIT J DERMATOL, V140, P297; Medina M, 2000, GENOMICS, V63, P157, DOI 10.1006/geno.1999.6090; Mertens C, 1996, J CELL BIOL, V135, P1009, DOI 10.1083/jcb.135.4.1009; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Mo YY, 1996, CANCER RES, V56, P2633; Morgenstern B, 1999, BIOINFORMATICS, V15, P211, DOI 10.1093/bioinformatics/15.3.211; Myster SH, 2003, J CELL BIOL, V160, P433, DOI 10.1083/jcb.200211083; Natarajan L, 2001, GENETICS, V159, P159; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; OAS RG, 2010, CIRCULATION RES; OHKUBO T, 2004, J CELL SCI PT; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; Park JI, 2005, DEV CELL, V8, P843, DOI 10.1016/j.devcel.2005.04.010; Pettitt J, 2003, J CELL BIOL, V162, P15, DOI 10.1083/jcb.200212136; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roura S, 2004, BIOCHEM BIOPH RES CO, V320, P435, DOI 10.1016/j.bbrc.2004.05.186; RUZOV A, 2009, INTERACTION XKAISO X; SALEMI M, 2009, PHYLOGENETIC HDB PRA, pR16; Schmidt A, 1997, CELL TISSUE RES, V290, P481, DOI 10.1007/s004410050956; Schneider SQ, 2003, J EXP ZOOL PART B, V295B, P25, DOI 10.1002/jez.b.00006; SMALLEYFREED WG, J CLIN INVEST, V120, P1824; SOBOLIKDELMAIRE T, J INVEST DERMATOL; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Taylor JS, 2001, PHILOS T R SOC B, V356, P1661, DOI 10.1098/rstb.2001.0975; van Hengel J, 1999, P NATL ACAD SCI USA, V96, P7980, DOI 10.1073/pnas.96.14.7980; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; YANAGISAWA M, 2008, J BIOL CHEM; Zhou JH, 1997, NEUROREPORT, V8, P2085, DOI 10.1097/00001756-199705260-00054	72	51	54	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15747	10.1371/journal.pone.0015747	http://dx.doi.org/10.1371/journal.pone.0015747			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209830	Green Published, Green Submitted, gold			2022-12-27	WOS:000285838900029
J	Portillo, JAC; Okenka, G; Reed, E; Subauste, A; Van Grol, J; Gentil, K; Komatsu, M; Tanaka, K; Landreth, G; Levine, B; Subauste, CS				Portillo, Jose-Andres C.; Okenka, Genevieve; Reed, Erin; Subauste, Angela; Van Grol, Jennifer; Gentil, Katrin; Komatsu, Masaaki; Tanaka, Keiji; Landreth, Gary; Levine, Beth; Subauste, Carlos S.			The CD40-Autophagy Pathway Is Needed for Host Protection Despite IFN-Gamma-Dependent Immunity and CD40 Induces Autophagy via Control of P21 Levels	PLOS ONE			English	Article							INDUCIBLE NITRIC-OXIDE; TOXOPLASMA-GONDII; TNF-ALPHA; IN-VIVO; T-CELLS; ANTIMICROBIAL ACTIVITY; LIGAND INTERACTION; MAMMALIAN-CELLS; UP-REGULATION; INFECTION	Autophagy degrades pathogens in vitro. The autophagy gene Atg5 has been reported to be required for IFN-gamma-dependent host protection in vivo. However, these protective effects occur independently of autophagosome formation. Thus, the in vivo role of classic autophagy in protection conferred by adaptive immunity and how adaptive immunity triggers autophagy are incompletely understood. Employing biochemical, genetic and morphological studies, we found that CD40 upregulates the autophagy molecule Beclin 1 in microglia and triggers killing of Toxoplasma gondii dependent on the autophagy machinery. Infected CD40(-/-) mice failed to upregulate Beclin 1 in microglia/macrophages in vivo. Autophagy-deficient Beclin 1(+/-) mice, mice with deficiency of the autophagy protein Atg7 targeted to microglia/macrophages as well as CD40(-/-) mice exhibited impaired killing of T. gondii and were susceptible to cerebral and ocular toxoplasmosis. Susceptibility to toxoplasmosis occurred despite upregulation of IFN-gamma, TNF-alpha and NOS2, preservation of IFN-gamma-induced microglia/macrophage anti-T. gondii activity and the generation of anti-T. gondii T cell immunity. CD40 upregulated Beclin 1 and triggered killing of T. gondii by decreasing protein levels of p21, a molecule that degrades Beclin 1. These studies identified CD40-p21-Beclin 1 as a pathway by which adaptive immunity stimulates autophagy. In addition, they support that autophagy is a mechanism through which CD40-dependent immunity mediates in vivo protection and that the CD40-autophagic machinery is needed for host resistance despite IFN-gamma.	[Portillo, Jose-Andres C.; Okenka, Genevieve; Van Grol, Jennifer; Gentil, Katrin; Subauste, Carlos S.] Case Western Reserve Univ, Sch Med, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Portillo, Jose-Andres C.; Okenka, Genevieve; Van Grol, Jennifer; Subauste, Carlos S.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Reed, Erin; Landreth, Gary] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; [Subauste, Angela] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Van Grol, Jennifer; Subauste, Carlos S.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Komatsu, Masaaki; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Tokyo 113, Japan; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Microbiol, Dept Internal Med, Dallas, TX 75390 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of Michigan System; University of Michigan; Case Western Reserve University; Tokyo Metropolitan Institute of Medical Science; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Portillo, JAC (corresponding author), Case Western Reserve Univ, Sch Med, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA.	carlos.subauste@case.edu	Komatsu, Masaaki/B-8321-2011	Komatsu, Masaaki/0000-0001-7672-7722; Subauste, Carlos/0000-0002-5602-1439	National Institutes of Health (NIH) [EY018341, AI48406]; American Heart Association Ohio Valley Affiliate, NIH [P30 EY11373]; Case/University Hospitals of Cleveland (UHC) Center for AIDS Research NIH [AI36219]; Ohio Lions Eye Research Foundation; Prevent Blindness Ohio;  [T32 EY007157-07]; NATIONAL EYE INSTITUTE [T32EY007157, P30EY011373, R01EY018341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048406, P30AI036219] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Ohio Valley Affiliate, NIH(American Heart AssociationUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case/University Hospitals of Cleveland (UHC) Center for AIDS Research NIH; Ohio Lions Eye Research Foundation; Prevent Blindness Ohio; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants EY018341 (C. S. S) and AI48406 (C. S. S), the American Heart Association Ohio Valley Affiliate (C. S. S), NIH grant P30 EY11373, and Case/University Hospitals of Cleveland (UHC) Center for AIDS Research NIH grant AI36219. J-A.P. is a recipient of a post-doctoral fellowship from the Ohio Lions Eye Research Foundation. J.V.G. is a recipient of a pre-doctoral fellowship from Prevent Blindness Ohio. J.V.G. was supported by T32 EY007157-07. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade RM, 2005, INFECT IMMUN, V73, P3115, DOI 10.1128/IAI.73.5.3115-3123.2005; Andrade RM, 2003, J IMMUNOL, V171, P6750, DOI 10.4049/jimmunol.171.12.6750; Andrade RM, 2006, J CLIN INVEST, V116, P2366, DOI 10.1172/JCI28796; Bekpen C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r92; Bot I, 2005, BLOOD, V106, P1147, DOI 10.1182/blood-2004-12-4839; BRETAGNE S, 1993, J INFECT DIS, V168, P1585, DOI 10.1093/infdis/168.6.1585; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Deckert-Schluter M, 1998, J IMMUNOL, V160, P3427; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; ELDEIRY WS, 1995, CANCER RES, V55, P2910; Fujiwara K, 2008, J BIOL CHEM, V283, P388, DOI 10.1074/jbc.M611043200; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Gannage M, 2009, CELL HOST MICROBE, V6, P367, DOI 10.1016/j.chom.2009.09.005; Gavrilescu LC, 2004, INFECT IMMUN, V72, P1257, DOI 10.1128/IAI.72.3.1257-1264.2004; GAZZINELLI RT, 1994, EXP PARASITOL, V78, P217, DOI 10.1006/expr.1994.1022; GAZZINELLI RT, 1993, J IMMUNOL, V151, P3672; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hollmann CA, 2002, EXP CELL RES, V280, P201, DOI 10.1006/excr.2002.5640; Janssen R, 2002, J IMMUNOL, V169, P3900, DOI 10.4049/jimmunol.169.7.3900; Jia KL, 2009, P NATL ACAD SCI USA, V106, P14564, DOI 10.1073/pnas.0813319106; Johnson LL, 2004, VACCINE, V22, P4054, DOI 10.1016/j.vaccine.2004.03.056; Kaur K, 2007, BLOOD, V110, P2948, DOI 10.1182/blood-2007-01-069245; Khaminets A, 2010, CELL MICROBIOL, V12, P939, DOI 10.1111/j.1462-5822.2010.01443.x; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kyei GB, 2009, J CELL BIOL, V186, P255, DOI 10.1083/jcb.200903070; Lazarevic V, 2003, IMMUNITY, V19, P823, DOI 10.1016/S1074-7613(03)00324-8; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Leib DA, 2009, J VIROL, V83, P12164, DOI 10.1128/JVI.01676-09; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li CY, 2006, J IMMUNOL, V177, P5163, DOI 10.4049/jimmunol.177.8.5163; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lieberman LA, 2004, J IMMUNOL, V172, P457, DOI 10.4049/jimmunol.172.1.457; Ling YM, 2006, J EXP MED, V203, P2063, DOI 10.1084/jem.20061318; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nelson DE, 2005, P NATL ACAD SCI USA, V102, P10658, DOI 10.1073/pnas.0504198102; NONOYAMA S, 1995, J CLIN INVEST, V95, P66, DOI 10.1172/JCI117677; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Park EM, 2004, STROKE, V35, P2896, DOI 10.1161/01.STR.0000147042.53659.6c; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Reichmann G, 2000, INFECT IMMUN, V68, P1312, DOI 10.1128/IAI.68.3.1312-1318.2000; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; SchartonKersten TM, 1997, J EXP MED, V185, P1261, DOI 10.1084/jem.185.7.1261; Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Subauste CS, 2007, AUTOPHAGY, V3, P245, DOI 10.4161/auto.3717; Subauste CS, 2007, J IMMUNOL, V178, P1645, DOI 10.4049/jimmunol.178.3.1645; Subauste CS, 2006, INFECT IMMUN, V74, P1573, DOI 10.1128/IAI.74.3.1573-1579.2006; Subauste CS, 1999, J IMMUNOL, V162, P6690; SUZUKI Y, 1989, J IMMUNOL, V143, P2045; Wu M, 1998, J EXP MED, V187, P1671, DOI 10.1084/jem.187.10.1671; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Yap GS, 1998, J IMMUNOL, V160, P1340; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zhang R, 2004, J IMMUNOL, V172, P2678, DOI 10.4049/jimmunol.172.4.2678; Zhao YO, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000288; Zhao YL, 2007, INFECT IMMUN, V75, P4799, DOI 10.1128/IAI.00738-07; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003	65	53	58	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e14472	10.1371/journal.pone.0014472	http://dx.doi.org/10.1371/journal.pone.0014472			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217818	gold, Green Published, Green Submitted			2022-12-27	WOS:000285838900003
J	Zeki, S; Romaya, JP				Zeki, Semir; Romaya, John Paul			The Brain Reaction to Viewing Faces of Opposite- and Same-Sex Romantic Partners	PLOS ONE			English	Article							DOPAMINE; ACTIVATION; SEROTONIN; NOREPINEPHRINE; CEREBELLUM; STIMULI; AROUSAL; REWARD; LOVE	We pursued our functional magnetic resonance imaging (fMRI) studies of the neural correlates of romantic love in 24 subjects, half of whom were female (6 heterosexual and 6 homosexual) and half male (6 heterosexual and 6 homosexual). We compared the pattern of activity produced in their brains when they viewed the faces of their loved partners with that produced when they viewed the faces of friends of the same sex to whom they were romantically indifferent. The pattern of activation and de-activation was very similar in the brains of males and females, and heterosexuals and homosexuals. We could therefore detect no difference in activation patterns between these groups.	[Zeki, Semir; Romaya, John Paul] UCL, Wellcome Lab Neurobiol, London, England	University of London; University College London	Zeki, S (corresponding author), UCL, Wellcome Lab Neurobiol, London, England.	zeki.pa@ucl.ac.uk	Zeki, Semir/AAA-1789-2020	Romaya, John/0000-0002-4857-3997	Wellcome Trust, London	Wellcome Trust, London(Wellcome Trust)	This work was supported by the Wellcome Trust, London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN LS, 1992, P NATL ACAD SCI USA, V89, P7199, DOI 10.1073/pnas.89.15.7199; Anderson CM, 2006, NEUROPSYCHOPHARMACOL, V31, P1318, DOI 10.1038/sj.npp.1300937; Aron A, 2005, J NEUROPHYSIOL, V94, P327, DOI 10.1152/jn.00838.2004; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Bartels A, 2000, NEUROREPORT, V11, P3829, DOI 10.1097/00001756-200011270-00046; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; CORTES R, 1989, NEUROSCIENCE, V28, P263, DOI 10.1016/0306-4522(89)90178-4; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fisher H, 2005, J COMP NEUROL, V493, P58, DOI 10.1002/cne.20772; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Guiard BP, 2008, INT J NEUROPSYCHOPH, V11, P625, DOI 10.1017/S1461145707008383; HATFIELD E, 1986, J ADOLESCENCE, V9, P383, DOI 10.1016/S0140-1971(86)80043-4; Hu SH, 2008, AM J NEURORADIOL, V29, P1890, DOI 10.3174/ajnr.A1260; Karama S, 2002, HUM BRAIN MAPP, V16, P1, DOI 10.1002/hbm.10014; Kim W, 2009, PSYCHIAT INVEST, V6, P19, DOI 10.4306/pi.2009.6.1.19; Kinsey AC, SEXUAL BEHAV HUMAN M; Lauzon NM, 2010, BEHAV BRAIN RES, V208, P12, DOI 10.1016/j.bbr.2009.11.037; LEVAY S, 1991, SCIENCE, V253, P1034, DOI 10.1126/science.1887219; Marazziti D, 1999, PSYCHOL MED, V29, P741, DOI 10.1017/S0033291798007946; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Messer K, 1999, P 2 C AUD VID BIOM P; Parsons LM, 2000, P NATL ACAD SCI USA, V97, P2332, DOI 10.1073/pnas.040555497; Paul T, 2008, HUM BRAIN MAPP, V29, P726, DOI 10.1002/hbm.20435; Penny W, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P166, DOI 10.1016/B978-012372560-8/50013-9; Penny WD, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P156, DOI 10.1016/B978-012372560-8/50012-7; Ruhe HG, 2007, MOL PSYCHIATR, V12, P331, DOI 10.1038/sj.mp.4001949; Rupp HA, 2009, EVOL HUM BEHAV, V30, P1, DOI 10.1016/j.evolhumbehav.2008.08.006; Sacchetti B, 2009, NEUROSCIENCE, V162, P756, DOI 10.1016/j.neuroscience.2009.01.064; Safron A, 2007, BEHAV NEUROSCI, V121, P237, DOI 10.1037/0735-7044.121.2.237; Savic I, 2008, P NATL ACAD SCI USA, V105, P9403, DOI 10.1073/pnas.0801566105; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Smith AT, 2000, NEUROREPORT, V11, P271, DOI 10.1097/00001756-200002070-00010; SWAAB DF, 1990, BRAIN RES, V537, P141, DOI 10.1016/0006-8993(90)90350-K; Weiskopf N, 2006, NEUROIMAGE, V33, P493, DOI 10.1016/j.neuroimage.2006.07.029; Zeki S, SPLENDORS MISERIES B; Zeki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003556	37	56	58	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15802	10.1371/journal.pone.0015802	http://dx.doi.org/10.1371/journal.pone.0015802			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209829	Green Submitted, Green Published, gold			2022-12-27	WOS:000285838900035
J	Glas, J; Seiderer, J; Tillack, C; Pfennig, S; Beigel, F; Jurgens, M; Olszak, T; Laubender, RP; Weidinger, M; Muller-Myhsok, B; Goke, B; Ochsenkuhn, T; Lohse, P; Diegelmann, J; Czamara, D; Brand, S				Glas, Juergen; Seiderer, Julia; Tillack, Cornelia; Pfennig, Simone; Beigel, Florian; Juergens, Matthias; Olszak, Torsten; Laubender, Ruediger P.; Weidinger, Maria; Mueller-Myhsok, Bertram; Goeke, Burkhard; Ochsenkuehn, Thomas; Lohse, Peter; Diegelmann, Julia; Czamara, Darina; Brand, Stephan			The NOD2 Single Nucleotide Polymorphisms rs2066843 and rs2076756 Are Novel and Common Crohn's Disease Susceptibility Gene Variants	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ALPHA-DEFENSIN EXPRESSION; GENOME-WIDE ASSOCIATION; CARD15/NOD2 MUTATIONS; FRAMESHIFT MUTATION; DENDRITIC CELLS; PATHOGENESIS; TOLL; PHENOTYPE; ATG16L1	Background: The aims were to analyze two novel NOD2 variants (rs2066843 and rs2076756) in a large cohort of patients with inflammatory bowel disease and to elucidate phenotypic consequences. Methodology/Principal Findings: Genomic DNA from 2700 Caucasians including 812 patients with Crohn's disease (CD), 442 patients with ulcerative colitis (UC), and 1446 healthy controls was analyzed for the NOD2 SNPs rs2066843 and rs2076756 and the three main CD-associated NOD2 variants p. Arg702Trp (rs2066844), p. Gly908Arg (rs2066847), and p.Leu1007fsX1008 (rs2066847). Haplotype and genotype-phenotype analyses were performed. The SNPs rs2066843 (p = 3.01x10(-5), OR 1.48, [95% CI 1.23-1.78]) and rs2076756 (p = 4.01x10(-6); OR 1.54, [95% CI 1.28-1.86]) were significantly associated with CD but not with UC susceptibility. Haplotype analysis revealed a number of significant associations with CD susceptibility with omnibus p values <10(-10). The SNPs rs2066843 and rs2076756 were in linkage disequilibrium with each other and with the three main CD-associated NOD2 mutations (D'>0.9). However, in CD, SNPs rs2066843 and rs2076756 were more frequently observed than the other three common NOD2 mutations (minor allele frequencies for rs2066843 and rs2076756: 0.390 and 0.380, respectively). In CD patients homozygous for these novel NOD2 variants, genotype-phenotype analysis revealed higher rates of a penetrating phenotype (rs2076756: p = 0.015) and fistulas (rs2076756: p = 0.015) and significant associations with CD-related surgery (rs2076756: p = 0.003; rs2066843: p = 0.015). However, in multivariate analysis only disease localization (p<2x10(-16)) and behaviour (p = 0.02) were significantly associated with the need for surgery. Conclusion/Significance: The NOD2 variants rs2066843 and rs2076756 are novel and common CD susceptibility gene variants.	[Glas, Juergen; Seiderer, Julia; Tillack, Cornelia; Pfennig, Simone; Beigel, Florian; Juergens, Matthias; Olszak, Torsten; Weidinger, Maria; Goeke, Burkhard; Ochsenkuehn, Thomas; Diegelmann, Julia; Brand, Stephan] Univ Munich, Dept Med Grosshadern 2, Munich, Germany; [Glas, Juergen; Diegelmann, Julia] Univ Munich, Dept Prevent Dent & Periodontol, Munich, Germany; [Glas, Juergen] Rhein Westfal TH Aachen, Dept Human Genet, Aachen, Germany; [Juergens, Matthias] Katholieke Univ Leuven, Div Gastroenterol, Louvain, Belgium; [Olszak, Torsten] Harvard Univ, Brigham & Womens Hosp, Div Gastroenterol Hepatol & Endoscopy, Sch Med, Boston, MA 02115 USA; [Laubender, Ruediger P.] Univ Munich, Inst Med Informat Biometry & Epidemiol IBE, Munich, Germany; [Mueller-Myhsok, Bertram; Czamara, Darina] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Lohse, Peter] Univ Munich, Inst Clin Chem Grosshadern, Munich, Germany	University of Munich; University of Munich; RWTH Aachen University; KU Leuven; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Munich; Max Planck Society; University of Munich	Glas, J (corresponding author), Univ Munich, Dept Med Grosshadern 2, Munich, Germany.	stephan.brand@med.uni-muenchen.de	Müller-Myhsok, Bertram/A-3289-2013		Broad Medical Foundation [IBD-0126R2]; Ludwig-Maximilians-University Munich [422]; Robert-Bosch-Foundation; Else Kroener-Fresenius-Stiftung [81/08//EKMS08/01, P50/05/EKMS05/62]; German Research Council (Deutsche Forschungsgemeinschaft, DFG); DFG [BR 1912/5-1]; DCCV e.V.; Ludwig-Maximilians-University Munich (Excellence Initiative); Else Kroener-Exzellenzstipendium [2010_EKES.32]	Broad Medical Foundation; Ludwig-Maximilians-University Munich; Robert-Bosch-Foundation; Else Kroener-Fresenius-Stiftung; German Research Council (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); DCCV e.V.; Ludwig-Maximilians-University Munich (Excellence Initiative); Else Kroener-Exzellenzstipendium	J. Glas was supported by a grant from the Broad Medical Foundation (IBD-0126R2). J. Seiderer and J. Diegelmann were supported by grants from the Ludwig-Maximilians-University Munich (FoLe Nr. 422; Habilitationsstipendium, LMUExcellent to J.S. and Promotionsstipendium to J.D.); J. Seiderer was also supported by the Robert-Bosch-Foundation and the Else Kroener-Fresenius-Stiftung (81/08//EKMS08/01). T. Olszak was supported by a grant from the German Research Council (Deutsche Forschungsgemeinschaft, DFG). S. Brand was supported by grants from the DFG (BR 1912/5-1), the Else Kroener-Fresenius-Stiftung (Else Kroener Fresenius Memorial Stipendium 2005; P50/05/EKMS05/62 and the Else Kroener-Exzellenzstipendium 2010_EKES.32), by the Ludwig-Demling Grant 2007 from DCCV e.V., and by grants of Ludwig-Maximilians-University Munich (Excellence Initiative, Investment Funds 2008 and FoeFoLe program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2005, GASTROENTEROLOGY, V129, P1302, DOI 10.1053/j.gastro.2005.08.028; Aldhous MC, 2003, GUT, V52, P1533, DOI 10.1136/gut.52.11.1533; Alvarez-Lobos M, 2005, ANN SURG, V242, P693, DOI 10.1097/01.sla.0000186173.14696.ea; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Bonen DK, 2003, GASTROENTEROLOGY, V124, P140, DOI 10.1053/gast.2003.50019; Brand S, 2005, INFLAMM BOWEL DIS, V11, P645, DOI 10.1097/01.MIB.0000168372.94907.d2; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Cho Judy, 2006, Curr Treat Options Gastroenterol, V9, P191, DOI 10.1007/s11938-006-0038-z; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Cummings JRF, 2007, INFLAMM BOWEL DIS, V13, P941, DOI 10.1002/ibd.20162; Cuthbert AP, 2002, GASTROENTEROLOGY, V122, P867, DOI 10.1053/gast.2002.32415; Dambacher J, 2007, INFLAMM BOWEL DIS, V13, P71, DOI 10.1002/ibd.20008; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Economou M, 2004, AM J GASTROENTEROL, V99, P2393, DOI 10.1111/j.1572-0241.2004.40304.x; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Glas J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000819; Glas J, 2008, AM J GASTROENTEROL, V103, P682, DOI 10.1111/j.1572-0241.2007.01694.x; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hanauer SB, 2006, INFLAMM BOWEL DIS, V12, pS1, DOI 10.1097/01.MIB.0000195388.04021.56; Hugot JP, 2006, ANN NY ACAD SCI, V1072, P9, DOI 10.1196/annals.1326.011; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kim YG, 2008, J IMMUNOL, V181, P4340, DOI 10.4049/jimmunol.181.6.4340; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kramer M, 2006, J LEUKOCYTE BIOL, V79, P860, DOI 10.1189/jlb.0805484; Kucharzik T, 2006, INFLAMM BOWEL DIS, V12, P1068, DOI 10.1097/01.mib.0000235827.21778.d5; Lakatos PL, 2006, WORLD J GASTROENTERO, V12, P1829, DOI 10.3748/wjg.v12.i12.1829; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Leon F, 2006, ADV EXP MED BIOL, V579, P117; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Schnitzler F, 2006, IMMUNOGENETICS, V58, P99, DOI 10.1007/s00251-005-0073-2; Seiderer J, 2006, SCAND J GASTROENTERO, V41, P1421, DOI 10.1080/00365520600703900; Seiderer J, 2006, INFLAMM BOWEL DIS, V12, P1114, DOI 10.1097/01.mib.0000235836.32176.5e; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Simms LA, 2008, GUT, V57, P903, DOI 10.1136/gut.2007.142588; Torok HP, 2005, GUT, V54, P1421, DOI 10.1136/gut.2005.066340; Torok HP, 2004, GASTROENTEROLOGY, V127, P365, DOI 10.1053/j.gastro.2004.05.051; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; van Heel DA, 2005, GUT, V54, P1553, DOI 10.1136/gut.2005.065888; Wang YF, 2007, J DIGEST DIS, V8, P121, DOI 10.1111/j.1443-9573.2007.00296.x; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yamazaki K, 2004, J HUM GENET, V49, P664, DOI 10.1007/s10038-004-0204-x	46	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e14466	10.1371/journal.pone.0014466	http://dx.doi.org/10.1371/journal.pone.0014466			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209938	Green Submitted, Green Published, gold			2022-12-27	WOS:000285793600009
J	Rauch, DA; Hurchla, MA; Harding, JC; Deng, HJ; Shea, LK; Eagleton, MC; Niewiesk, S; Lairmore, MD; Piwnica-Worms, D; Rosol, TJ; Weber, JD; Ratner, L; Weilbaecher, KN				Rauch, Daniel A.; Hurchla, Michelle A.; Harding, John C.; Deng, Hongju; Shea, Lauren K.; Eagleton, Mark C.; Niewiesk, Stefan; Lairmore, Michael D.; Piwnica-Worms, David; Rosol, Thomas J.; Weber, Jason D.; Ratner, Lee; Weilbaecher, Katherine N.			The ARF Tumor Suppressor Regulates Bone Remodeling and Osteosarcoma Development in Mice	PLOS ONE			English	Article							CONTAINING BISPHOSPHONATES INHIBIT; ZOLEDRONIC ACID; IN-VIVO; NEUROFIBROMATOSIS TYPE-1; DEFICIENT MICE; GENE; P53; RETINOBLASTOMA; OSTEOCLAST; PATHWAY	The ARF tumor suppressor regulates p53 as well as basic developmental processes independent of p53, including osteoclast activation, by controlling ribosomal biogenesis. Here we provide evidence that ARF is a master regulator of bone remodeling and osteosarcoma (OS) development in mice. Arf(-/-) mice displayed increased osteoblast (OB) and osteoclast (OC) activity with a significant net increase in trabecular bone volume. The long bones of Arf(-/-) mice had increased expression of OB genes while Arf(-/-) OB showed enhanced differentiation in vitro. Mice transgenic for the Tax oncogene develop lymphocytic tumors with associated osteolytic lesions, while Tax+Arf(-/-) mice uniformly developed spontaneous OS by 7 months of age. Tax+Arf(-/-) tumors were well differentiated OS characterized by an abundance of new bone with OC recruitment, expressed OB markers and displayed intact levels of p53 mRNA and reduced Rb transcript levels. Cell lines established from OS recapitulated characteristics of the primary tumor, including the expression of mature OB markers and ability to form mineralized tumors when transplanted. Loss of heterozygosity in OS tumors arising in Tax+Arf(+/-) mice emphasized the necessity of ARF-loss in OS development. Hypothesizing that inhibition of ARF-regulated bone remodeling would repress development of OS, we demonstrated that treatment of Tax+Arf(-/-) mice with zoledronic acid, a bisphosphonate inhibitor of OC activity and repressor of bone turnover, prevented or delayed the onset of OS. These data describe a novel role for ARF as a regulator of bone remodeling through effects on both OB and OC. Finally, these data underscore the potential of targeting bone remodeling as adjuvant therapy or in patients with genetic predispositions to prevent the development of OS.	[Rauch, Daniel A.; Hurchla, Michelle A.; Harding, John C.; Deng, Hongju; Shea, Lauren K.; Eagleton, Mark C.; Weber, Jason D.; Ratner, Lee; Weilbaecher, Katherine N.] Washington Univ, Sch Med, Dept Med, Div Mol Oncol, St Louis, MO 63110 USA; [Niewiesk, Stefan; Lairmore, Michael D.; Rosol, Thomas J.] Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA; [Niewiesk, Stefan; Lairmore, Michael D.] Ohio State Univ, Ctr Retrovirus Res, Dept Vet Biosci, Columbus, OH 43210 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Mol Imaging Ctr, Mallinckrodt Inst Radiol,Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Washington University (WUSTL)	Rauch, DA (corresponding author), Washington Univ, Sch Med, Dept Med, Div Mol Oncol, St Louis, MO 63110 USA.	KWEILBAE@WUSTL.EDU	Rosol, Thomas/G-9585-2011	Rosol, Thomas/0000-0003-3737-1190; Ratner, Lee/0000-0003-2744-7294; Weber, Jason/0000-0002-1069-6983	National Institutes of Health [T32 CA113275, P01 CA100730, P50 CA94056, R01 CA120436, CA10521, CA63417]; St. Louis Mens' Group Against Cancer; NATIONAL CANCER INSTITUTE [P01CA100730, R01CA120436, T32CA113275, P50CA094056, R01CA063417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Louis Mens' Group Against Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by grants from the National Institutes of Health to MAH (T32 CA113275), MDL (P01 CA100730), DP-W (P50 CA94056), TJR (P01 CA100730), JDW (R01 CA120436), LR (CA10521, CA63417, P01 CA100730), KNW, MAH, HD, LKS, MCE (P01 CA100730) and from the St. Louis Mens' Group Against Cancer to KNW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFT R, LANCET ONCOL, V11, P421; Akiyama T, 2008, MOL CANCER THER, V7, P3461, DOI 10.1158/1535-7163.MCT-08-0530; Apicelli AJ, 2008, MOL CELL BIOL, V28, P1068, DOI 10.1128/MCB.00484-07; Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; Birch JM, 2001, ONCOGENE, V20, P4621, DOI 10.1038/sj.onc.1204621; Brady SN, 2009, ONCOGENE, V28, P3209, DOI 10.1038/onc.2009.178; Brown HK, 2009, CURR CANCER DRUG TAR, V9, P807, DOI 10.2174/156800909789760339; Campbell KJ, 2006, CANCER RES, V66, P929, DOI 10.1158/0008-5472.CAN-05-2234; Chirgwin JM, 2007, J CELL BIOCHEM, V102, P1333, DOI 10.1002/jcb.21556; Chowdhry M, 2009, J BONE JOINT SURG BR, V91B, P1223, DOI 10.1302/0301-620X.91B9.22299; Christiansen BA, 2006, ANN BIOMED ENG, V34, P1149, DOI 10.1007/s10439-006-9133-5; Cinamon U, 2002, EUR ARCH OTO-RHINO-L, V259, P540, DOI 10.1007/s00405-002-0497-3; Edwards CM, 2008, BONE, V42, P1007, DOI 10.1016/j.bone.2008.01.027; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Eischen CM, 2002, CANCER RES, V62, P2184; Gao L, 2005, BLOOD, V106, P4294, DOI 10.1182/blood-2005-04-1730; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; GROSSMAN WJ, 1995, P NATL ACAD SCI USA, V92, P1057, DOI 10.1073/pnas.92.4.1057; Guise TA, 1998, ENDOCR REV, V19, P18, DOI 10.1210/er.19.1.18; Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035; HANSEN MF, 1985, P NATL ACAD SCI USA, V82, P6216, DOI 10.1073/pnas.82.18.6216; Hapidin H, 2007, J BONE MINER METAB, V25, P93, DOI 10.1007/s00774-006-0733-9; Hirbe AC, 2009, BONE, V44, P908, DOI 10.1016/j.bone.2009.01.010; Horiuchi K, 2003, J RHEUMATOL, V30, P1799; Huang CY, 2009, J CELL PHYSIOL, V221, P204, DOI 10.1002/jcp.21846; Kamijo T, 1999, CANCER RES, V59, P2217; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kansara M, 2007, DNA CELL BIOL, V26, P1, DOI 10.1089/dna.2006.0505; Lamoureux F, 2007, CANCER RES, V67, P7308, DOI 10.1158/0008-5472.CAN-06-4130; Lane NE, 2005, J BONE MINER RES, V20, P58, DOI 10.1359/JBMR.041017; LeRoy BE, 2006, PROSTATE, V66, P1213, DOI 10.1002/pros.20408; Lipton A, 2008, CANCER TREAT REV, V34, pS25, DOI 10.1016/j.ctrv.2008.03.008; Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581; Luo H, 2005, BLOOD, V106, P2452, DOI 10.1182/blood-2005-02-0734; McKeller RN, 2002, P NATL ACAD SCI USA, V99, P3848, DOI 10.1073/pnas.052484199; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; O'Day K, 2009, EXPERT REV ANTICANC, V9, P511, DOI [10.1586/era.09.7, 10.1586/ERA.09.7]; Oh JH, 2006, CLIN ORTHOP RELAT R, P216, DOI 10.1097/01.blo.0000188063.56091.69; PICARDA G, CLIN CANC RES, V16, P2363; Portis T, 2001, J VIROL, V75, P2185, DOI 10.1128/JVI.75.5.2185-2193.2001; Rauch D, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-116; Rauch D, 2009, BLOOD, V113, P1493, DOI 10.1182/blood-2008-07-166462; Reid IR, 2005, NEW ENGL J MED, V353, P898, DOI 10.1056/NEJMoa044241; Roelofs AJ, 2006, CLIN CANCER RES, V12, p6222S, DOI 10.1158/1078-0432.CCR-06-0843; Saporita AJ, 2007, CURR MED CHEM, V14, P1815; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Sdek P, 2004, J BIOL CHEM, V279, P53317, DOI 10.1074/jbc.M406062200; Tiffee JC, 1999, CALCIFIED TISSUE INT, V65, P53, DOI 10.1007/s002239900657; van Beek E, 1999, BIOCHEM BIOPH RES CO, V255, P491, DOI 10.1006/bbrc.1999.0224; WADAYAMA B, 1994, CANCER RES, V54, P3042; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; Wan XL, 2005, CANCER RES, V65, P2406, DOI 10.1158/0008-5472.CAN-04-3135; Wang XY, 2006, J CELL BIOL, V172, P115, DOI 10.1083/jcb.200507106; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Weber JD, 2000, GENE DEV, V14, P2358, DOI 10.1101/gad.827300; Xu ZQ, 2009, J BIOL CHEM, V284, P4658, DOI 10.1074/jbc.M804812200; Zaidi SK, 2007, P NATL ACAD SCI USA, V104, P19861, DOI 10.1073/pnas.0709650104; Zhou ZC, 2005, CANCER-AM CANCER SOC, V104, P1713, DOI 10.1002/cncr.21383; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424; Zucchini C, 2008, INT J ONCOL, V32, P17	61	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15755	10.1371/journal.pone.0015755	http://dx.doi.org/10.1371/journal.pone.0015755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209895	Green Published, Green Submitted, gold			2022-12-27	WOS:000285793600032
J	Wardlaw, JM; von Kummer, R; Farrall, AJ; Chappell, FM; Hill, M; Perry, D				Wardlaw, Joanna M.; von Kummer, Ruediger; Farrall, Andrew J.; Chappell, Francesca M.; Hill, Michael; Perry, David			A Large Web-Based Observer Reliability Study of Early Ischaemic Signs on Computed Tomography. The Acute Cerebral CT Evaluation of Stroke Study (ACCESS)	PLOS ONE			English	Article							ARTERY OCCLUSION; BRAIN; MR; THROMBOLYSIS; INFARCTION; DIFFUSION	Background: Early signs of ischaemic stroke on computerised tomography (CT) scanning are subtle but CT is the most widely available diagnostic test for stroke. Scoring methods that code for the extent of brain ischaemia may improve stroke diagnosis and quantification of the impact of ischaemia. Methodology and Principal Findings: We showed CT scans from patients with acute ischaemic stroke (n = 32, with different patient characteristics and ischaemia signs) to doctors in stroke-related specialties world-wide over the web. CT scans were shown twice, randomly and blindly. Observers entered their scan readings, including early ischaemic signs by three scoring methods, into the web database. We compared observers' scorings to a reference standard neuroradiologist using area under receiver operator characteristic curve (AUC) analysis, Cronbach's alpha and logistic regression to determine the effect of scales, patient, scan and observer variables on detection of early ischaemic changes. Amongst 258 readers representing 33 nationalities and six specialties, the AUCs comparing readers with the reference standard detection of ischaemic signs were similar for all scales and both occasions. Being a neuroradiologist, slower scan reading, more pronounced ischaemic signs and later time to CT all improved detection of early ischaemic signs and agreement on the rating scales. Scan quality, stroke severity and number of years of training did not affect agreement. Conclusions: Large-scale observer reliability studies are possible using web-based tools and inform routine practice. Slower scan reading and use of CT infarct rating scales improve detection of acute ischaemic signs and should be encouraged to improve stroke diagnosis.	[Wardlaw, Joanna M.; Farrall, Andrew J.; Chappell, Francesca M.; Perry, David] Univ Edinburgh, SINAPSE Collaborat, Div Clin Neurosci, Edinburgh, Midlothian, Scotland; [von Kummer, Ruediger] Tech Univ Dresden, Univ Hosp, Dept Neuroradiol, Dresden, Germany; [Hill, Michael] Univ Calgary, Stroke Unit, Dept Neurosci, Foothills Med Ctr, Calgary, AB, Canada	University of Edinburgh; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Calgary	Wardlaw, JM (corresponding author), Univ Edinburgh, SINAPSE Collaborat, Div Clin Neurosci, Edinburgh, Midlothian, Scotland.	Joanna.wardlaw@ed.ac.uk	von Kummer, Rüdiger/AAA-4478-2019; Hernandez, María/GYU-3543-2022; Hill, Michael D/C-9073-2012; Wardlaw, Joanna M/Y-3456-2019	von Kummer, Rüdiger/0000-0003-0119-4604; Hill, Michael D/0000-0002-6269-1543; Wardlaw, Joanna M/0000-0002-9812-6642	Scottish Funding Council (SFC); Chief Scientist Office of the Scottish Executive through the Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE); Chest Heart Stroke Scotland [RES000/7]; Royal College of Radiologists; DesAcc, Inc, 801 W Adams St, Chicago, IL; Health Foundation [2268/1282]; Chest Heart Stroke Scotland	Scottish Funding Council (SFC); Chief Scientist Office of the Scottish Executive through the Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE); Chest Heart Stroke Scotland; Royal College of Radiologists; DesAcc, Inc, 801 W Adams St, Chicago, IL; Health Foundation; Chest Heart Stroke Scotland	Scottish Funding Council (SFC, http://www.sfc.ac.uk/) and Chief Scientist Office of the Scottish Executive (http://www.cso.scot.nhs.uk/) for JMW through the Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration (www.sinapse.ac.uk); Chest Heart Stroke Scotland (RES000/7) (http://www.chss.org.uk/) and Royal College of Radiologists (www.rcr.ac.uk) for AJF; DesAcc, Inc, 801 W Adams St, Chicago, IL 60607 for scan management software Digital Jacket (http://www.desacc.com/); The Health Foundation (2268/1282) (this agency no longer exists) supported IST-3 and with Chest Heart Stroke Scotland, also supported a scan management technician for the study; The Stroke Association (TSA 93) supported MAST-I from which some CT scans were obtained (http://www.stroke.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber PA, 2005, J NEUROL NEUROSUR PS, V76, P1528, DOI 10.1136/jnnp.2004.059261; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Bossuyt PM, 2003, CLIN RADIOL, V58, P575, DOI 10.1016/S0009-9260(03)00258-7; CANDELISE L, 1995, LANCET, V346, P1509; Dorfman DD, 1998, ACAD RADIOL, V5, P591, DOI 10.1016/S1076-6332(98)80294-8; DORFMAN DD, 1992, INVEST RADIOL, V27, P723, DOI 10.1097/00004424-199209000-00015; Dzialowski I, 2004, J NEUROIMAGING, V14, P42, DOI 10.1177/1051228403258135; Dzialowski I, 2007, RADIOLOGY, V243, P720, DOI 10.1148/radiol.2432060137; HOSSMANN KA, 1980, STROKE, V11, P583, DOI 10.1161/01.STR.11.6.583; Kane I, 2008, CEREBROVASC DIS, V25, P375, DOI 10.1159/000120688; Kharitonova T, 2009, CEREBROVASC DIS, V27, P51, DOI 10.1159/000172634; Leys D, 2007, STROKE, V38, P2985, DOI 10.1161/STROKEAHA.107.487967; Na DG, 2005, RADIOLOGY, V235, P992, DOI 10.1148/radiol.2353040571; SANDERCOCK P, 2008, 3 INT STROKE TRIAL I; Silver B, 2001, CAN J NEUROL SCI, V28, P113, DOI 10.1017/S031716710005277X; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; von Kummer R, 1998, NEUROLOGY, V51, pS50, DOI 10.1212/WNL.51.3_Suppl_3.S50; von Kummer R, 2009, CLIN NEURORADIOL, V19, P105, DOI 10.1007/s00062-009-1002-9; vonKummer R, 1996, AM J NEURORADIOL, V17, P1743; Wardlaw JM, 2005, RADIOLOGY, V235, P444, DOI 10.1148/radiol.2352040262; WARDLAW JM, 1994, AM J NEURORADIOL, V15, P1933; Wardlaw JM, 2007, STROKE, V38, P1250, DOI 10.1161/01.STR.0000259715.53166.25; Warren RML, 2005, RADIOLOGY, V236, P779, DOI 10.1148/radiol.2363040735	23	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15757	10.1371/journal.pone.0015757	http://dx.doi.org/10.1371/journal.pone.0015757			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209901	Green Published, Green Submitted, gold			2022-12-27	WOS:000285793600033
J	Franklin, J; Steadman, DW				Franklin, Janet; Steadman, David W.			Forest Plant and Bird Communities in the Lau Group, Fiji	PLOS ONE			English	Article							IGUANA BRACHYLOPHUS-VITIENSIS; TROPICAL RAIN-FOREST; HABITAT RELATIONSHIPS; SPECIES COMPOSITION; AMERICAN-SAMOA; NEW-GUINEA; VEGETATION; ISLAND; DIVERSITY; ABUNDANCE	Background: We examined species composition of forest and bird communities in relation to environmental and human disturbance gradients on Lakeba (55.9 km(2)), Nayau (18.4 km(2)), and Aiwa Levu (1.2 km(2)), islands in the Lau Group of Fiji, West Polynesia. The unique avifauna of West Polynesia (Fiji, Tonga, Samoa) has been subjected to prehistoric human-caused extinctions but little was previously known about this topic in the Lau Group. We expected that the degree of human disturbance would be a strong determinant of tree species composition and habitat quality for surviving landbirds, while island area would be unrelated to bird diversity. Methodology/Principal Findings: All trees >5 cm diameter were measured and identified in 23 forest plots of 500 m(2) each. We recognized four forest species assemblages differentiated by composition and structure: coastal forest, dominated by widely distributed species, and three forest types with differences related more to disturbance history (stages of secondary succession following clearing or selective logging) than to environmental gradients (elevation, slope, rockiness). Our point counts (73 locations in 1 or 2 seasons) recorded 18 of the 24 species of landbirds that exist on the three islands. The relative abundance and species richness of birds were greatest in the forested habitats least disturbed by people. These differences were due mostly to increased numbers of columbid frugivores and passerine insectivores in forests on Lakeba and Aiwa Levu. Considering only forested habitats, the relative abundance and species richness of birds were greater on the small but completely forested (and uninhabited) island of Aiwa Levu than on the much larger island of Lakeba. Conclusions/Significance: Forest disturbance history is more important than island area in structuring both tree and landbird communities on remote Pacific islands. Even very small islands may be suitable for conservation reserves if they are protected from human disturbance.	[Franklin, Janet] Arizona State Univ, Sch Geog Sci & Urban Planning, Tempe, AZ 85287 USA; [Franklin, Janet] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Steadman, David W.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; State University System of Florida; University of Florida	Franklin, J (corresponding author), Arizona State Univ, Sch Geog Sci & Urban Planning, Tempe, AZ 85287 USA.	Janet.Franklin@asu.edu			San Diego State University Research Foundation; U.S. National Science Foundation [EAR-9714819]	San Diego State University Research Foundation; U.S. National Science Foundation(National Science Foundation (NSF))	This work was supported by San Diego State University Research Foundation (JF) and U.S. National Science Foundation grant EAR-9714819 (DWS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no other funding for this research.	Athens J. S., 1997, HIST ECOLOGY PACIFIC, P248; Best SB, 2002, NZ ARCHAEOLOGICAL SO, P24; Burley DV, 2001, P NATL ACAD SCI USA, V98, P11829, DOI 10.1073/pnas.181335398; Burslem DFRP, 2000, J ECOL, V88, P1063, DOI 10.1046/j.1365-2745.2000.00517.x; Clunie F, 1984, BIRDS FIJI BUSH; Coblentz BE, 1978, BIOL CONSERV, V41, P253; Drake DR, 1996, NEW ZEAL J BOT, V34, P65; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Fall PL, 2005, QUATERNARY RES, V64, P451, DOI 10.1016/j.yqres.2005.08.003; FLENLEY JR, 1969, J ECOL, V57, P465, DOI 10.2307/2258393; FRANKLIN J, 1992, J VEG SCI, V3, P3, DOI 10.2307/3235991; Franklin J, 1999, J VEG SCI, V10, P51, DOI 10.2307/3237160; Franklin J, 2006, J VEG SCI, V17, P233, DOI 10.1111/j.1654-1103.2006.tb02442.x; Franklin J, 2003, NEW ZEAL J BOT, V41, P669, DOI 10.1080/0028825X.2003.9512877; Franklin J, 2004, J TROP ECOL, V20, P409, DOI 10.1017/S0266467404001543; FRANKLIN J, 1991, CONSERV BIOL, V5, P506, DOI 10.1111/j.1523-1739.1991.tb00358.x; Franklin J, 2007, AUSTRAL ECOL, V32, P789, DOI 10.1111/j.1442-9993.2007.01766.x; Franklin Janet, 2008, Micronesica, V40, P169; Franklin J, 2008, OIKOS, V117, P1885, DOI 10.1111/j.1600-0706.2008.16922.x; Freifeld HB, 1999, J BIOGEOGR, V26, P1191, DOI 10.1046/j.1365-2699.1999.00349.x; Garnock-Jones PJ, 1978, ROYAL SOC NZ B, V17, P95; Greig-Smith P., 1983, QUANTITATIVE PLANT E; Grubb PJ, 1996, FUNCT ECOL, V10, P512, DOI 10.2307/2389944; Harlow PS, 2007, ORYX, V41, P44, DOI 10.1017/S0030605307001639; Harlow PS, 2001, BIOL CONSERV, V98, P223, DOI 10.1016/S0006-3207(00)00157-9; HECK KL, 1975, ECOLOGY, V56, P1459, DOI 10.2307/1934716; Hjerpe J, 2001, BIOTROPICA, V33, P249, DOI 10.1111/j.1744-7429.2001.tb00176.x; HOPKINS MS, 1983, BIOTROPICA, V15, P90, DOI 10.2307/2387950; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; HYNDMAN DC, 1990, J BIOGEOGR, V17, P241, DOI 10.2307/2845122; Jones S, 2007, J ISL COAST ARCHAEOL, V2, P72, DOI DOI 10.1080/15564890701219966; Keppel G, 2007, NEW ZEAL J BOT, V45, P545, DOI 10.1080/00288250709509738; Keppel G, 2006, NEW ZEAL J BOT, V44, P273, DOI 10.1080/0028825X.2006.9513024; Keppel Gunnar, 2005, Pacific Science, V59, P175, DOI 10.1353/psc.2005.0021; Keppel G, 2010, J ECOL, V98, P87, DOI 10.1111/j.1365-2745.2009.01595.x; KIRCH PV, 1994, ANTIQUITY, V68, P310, DOI 10.1017/S0003598X00046615; KIRCH PV, 2000, ROAD WINDS ARCHAEOLO; Koopman Karl F., 1995, American Museum Novitates, V3125, P1; Kuehler C., 1997, Bird Conservation International, V7, P69; Ladd HS, 1945, BERNICE P BISH MUS B, V181, p2N; Lasky JR, 2010, J TROP ECOL, V26, P67, DOI 10.1017/S0266467409990368; Latham M, 1983, 3 UNESCOUNFPA; Lawrence D, 2004, ECOL APPL, V14, P1855, DOI 10.1890/03-5321; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; McConkey KR, 2004, EMU, V104, P369, DOI 10.1071/MU03060; Mielke P.W., 1984, HDB STAT, V4, P813, DOI DOI 10.1016/S0169-7161(84)04036-0; Morrison C, 2007, AUST J ZOOL, V55, P341, DOI 10.1071/ZO07062; Morrison C, 2009, PAC SCI, V63, P223, DOI 10.2984/049.063.0205; Mueller-Dombois D, 1998, VEGETATION TROPICAL; Nichols JD, 2000, AUK, V117, P393, DOI 10.1642/0004-8038(2000)117[0393:ADOAFE]2.0.CO;2; Nunn P., 1994, OCEANIC ISLANDS; O'Day SJ, 2004, NZ J ARCHAEOLOGY, V25, P31; Palmer MW, 1991, ECOLOGY, V71, P1195; Pratt H. D., 1987, FIELD GUIDE BIRDS HA; Pregill Gregory K., 1993, Pacific Science, V47, P101; R Development Core Team, 2007, R LANG ENV STAT COMP; RICHARDS P. W., 1952, The tropical rain forest. An ecological study.; Robertson HA, 2006, BIRD CONSERV INT, V16, P197, DOI 10.1017/S0959270906000268; Simons TR, 2007, AUK, V124, P986, DOI 10.1642/0004-8038(2007)124[986:EAOTAD]2.0.CO;2; Steadman David W., 1999, Pacific Conservation Biology, V5, P191; Steadman David W., 1998, Pacific Science, V52, P14; Steadman David W., 1999, Ecotropica, V5, P13; Steadman DW, 1998, CONDOR, V100, P609, DOI 10.2307/1369743; Steadman DW, 2000, EMU, V100, P227, DOI 10.1071/MU9934; STEADMAN DW, 1995, SCIENCE, V267, P1123, DOI 10.1126/science.267.5201.1123; Steadman DW, 2002, P NATL ACAD SCI USA, V99, P3673, DOI 10.1073/pnas.072079299; STEADMAN DW, 2006, EXT BIOG TROP PAC, pR9; Straatmans W, 1964, MICRONESICA, V1, P113; Ter Braak C. J. F., 1995, P91; TER BRAAK CJF, 1987, VEGETATIO, V69, P69, DOI 10.1007/BF00038688; Van Tongeren O. F. R., 1995, P174; Watling D, 2001, GUIDE BIRDS FIJI W P; Watling D, 1982, BIRDS FIJI TONGA SAM; Webb EL, 2006, PAC SCI, V60, P333, DOI 10.1353/psc.2006.0019; Webb EL, 1999, PLANT ECOL, V144, P257, DOI 10.1023/A:1009862618250; Webb EL, 1999, J BIOGEOGR, V26, P887, DOI 10.1046/j.1365-2699.1999.00326.x; Whistler WA, 1980, ALLERTONIA, V2, P45; Wiser SK, 2002, J BIOGEOGR, V29, P767, DOI 10.1046/j.1365-2699.2002.00723.x	78	11	14	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15685	10.1371/journal.pone.0015685	http://dx.doi.org/10.1371/journal.pone.0015685			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206753	Green Published, Green Submitted, gold			2022-12-27	WOS:000285793200037
J	Wernery, U; Liu, CH; Baskar, V; Guerineche, Z; Khazanehdari, KA; Saleem, S; Kinne, J; Wernery, R; Griffin, DK; Chang, IK				Wernery, Ulrich; Liu, Chunhai; Baskar, Vijay; Guerineche, Zhor; Khazanehdari, Kamal A.; Saleem, Shazia; Kinne, Joerg; Wernery, Renate; Griffin, Darren K.; Chang, Il-Kuk			Primordial Germ Cell-Mediated Chimera Technology Produces Viable Pure-Line Houbara Bustard Offspring: Potential for Repopulating an Endangered Species	PLOS ONE			English	Article							CHICKEN; QUAIL; GENERATION; BIRDS	Background: The Houbara bustard (Chlamydotis undulata) is a wild seasonal breeding bird populating arid sandy semi-desert habitats in North Africa and the Middle East. Its population has declined drastically during the last two decades and it is classified as vulnerable. Captive breeding programmes have, hitherto, been unsuccessful in reviving population numbers and thus radical technological solutions are essential for the long term survival of this species. The purpose of this study was to investigate the use of primordial germ cell-mediated chimera technology to produce viable Houbara bustard offspring. Methodology/Principal Findings: Embryonic gonadal tissue was dissected from Houbara bustard embryos at eight days post-incubation. Subsequently, Houbara tissue containing gonadal primordial germ cells (gPGCs) was injected into White Leghorn chicken (Gallus gallus domesticus) embryos, producing 83/138 surviving male chimeric embryos, of which 35 chimeric roosters reached sexual maturity after 5 months. The incorporation and differentiation of Houbara gPGCs in chimeric chicken testis were assessed by PCR with Houbara-specific primers and 31.3% (5/16) gonads collected from the injected chicken embryos showed the presence of donor Houbara cells. A total of 302 semen samples from 34 chimeric roosters were analyzed and eight were confirmed as germline chimeras. Semen samples from these eight roosters were used to artificially inseminate three female Houbara bustards. Subsequently, 45 Houbara eggs were obtained and incubated, two of which were fertile. One egg hatched as a male live born Houbara; the other was female but died before hatching. Genotyping confirmed that the male chick was a pure-line Houbara derived from a chimeric rooster. Conclusion: This study demonstrates for the first time that Houbara gPGCs can migrate, differentiate and eventually give rise to functional sperm in the chimeric chicken testis. This approach may provide a promising tool for propagation and conservation of endangered avian species that cannot breed in captivity.	[Wernery, Ulrich; Liu, Chunhai; Baskar, Vijay; Guerineche, Zhor; Khazanehdari, Kamal A.; Saleem, Shazia; Kinne, Joerg; Wernery, Renate; Chang, Il-Kuk] Cent Vet Res Lab, Dubai, U Arab Emirates; [Griffin, Darren K.] Univ Kent, Sch Biosci, Canterbury, Kent, England	University of Kent	Wernery, U (corresponding author), Cent Vet Res Lab, Dubai, U Arab Emirates.	d.k.griffin@kent.ac.uk	Khazanehdari, Kamal/AAN-1572-2021		Biotechnology and Biological Sciences Research Council [BB/E024211/1]; International Foundation for Conservation & Development of Wildlife (IFCDW) in Agadir, the Kingdom of Morocco; Houbara bustard Breeding Centre; BBSRC [BB/E024211/1, BB/E010652/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E010652/1, G19438/2] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); International Foundation for Conservation & Development of Wildlife (IFCDW) in Agadir, the Kingdom of Morocco; Houbara bustard Breeding Centre; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was supported by H.H. Sheikh Mohammed bin Rashid Al Maktoum, the Ruler of Dubai and Vice President of the United Arab Emirates, and Dr. Ali Redha, Administrative Director of Central Veterinary Research Laboratory. DKG is supported by Biotechnology and Biological Sciences Research Council Career Development Fellowship BB/E024211/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the International Foundation for Conservation & Development of Wildlife (IFCDW) in Agadir, the Kingdom of Morocco for their support. Many thanks go to Dr. Jurgen Sasse, Mr. Jahabar Ali, Mr. Lahcen Ben Kamel, Mr. Chris Dumatol and Dr. Fatima Hakimuddin for their excellent work. Furthermore we thank the staff of CVRL's chicken house as well as the Houbara bustard Breeding Centre for their support.	[Anonymous], 1914, AM J ANAT, V15, P483; CHANG IK, 1995, CELL BIOL INT, V19, P143, DOI 10.1006/cbir.1995.1055; Chang IK, 1997, CELL BIOL INT, V21, P495, DOI 10.1006/cbir.1997.0173; CITES, CONV INT TRAD END SP; EYALGILADI H, 1981, J EMBRYOL EXP MORPH, V65, P139; GINSBURG M, 1986, J EMBRYOL EXP MORPH, V95, P53; Griffiths R, 1996, P ROY SOC B-BIOL SCI, V263, P1251, DOI 10.1098/rspb.1996.0184; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Kang SJ, 2008, BIOL REPROD, V79, P931, DOI 10.1095/biolreprod.108.069989; Kim JN, 2010, BIOL REPROD, V82, P257, DOI 10.1095/biolreprod.109.079723; Li Hai-Chang, 2001, Journal of Poultry Science, V38, P308, DOI 10.2141/jpsa.38.308; Li ZD, 2002, POULTRY SCI, V81, P1360, DOI 10.1093/ps/81.9.1360; Liu CH, 2007, ANIM REPROD SCI, V101, P344, DOI 10.1016/j.anireprosci.2006.12.021; Nakamura Y, 2008, REPROD FERT DEVELOP, V20, P900, DOI 10.1071/RD08138; Ogawa A, 1997, CHROMOSOME RES, V5, P93, DOI 10.1023/A:1018461906913; Park TS, 2008, MOL REPROD DEV, V75, P274, DOI 10.1002/mrd.20821; Pitra C, 2000, MOL ECOL, V9, P1165, DOI 10.1046/j.1365-294x.2000.00983.x; Saint-Jalme M, 1995, PROPAGATION HOUBARA, P70; Shin SS, 2008, FASEB J, V22, P2435, DOI 10.1096/fj.07-101485; Tajima A, 1998, J EXP ZOOL, V280, P265, DOI 10.1002/(SICI)1097-010X(19980215)280:3&lt;265::AID-JEZ8&gt;3.0.CO;2-L; TAJIMA A, 1993, THERIOGENOLOGY, V40, P509, DOI 10.1016/0093-691X(93)90404-S; The IUCN Red List,, IUCN RED LIST THREAT; van de Lavoir MC, 2006, NATURE, V441, P766, DOI 10.1038/nature04831; Yamamoto Y, 2007, BIOL REPROD, V77, P115, DOI 10.1095/biolreprod.107.061200; YASUDA Y, 1992, J REPROD FERTIL, V96, P521, DOI 10.1530/jrf.0.0960521; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	26	38	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15824	10.1371/journal.pone.0015824	http://dx.doi.org/10.1371/journal.pone.0015824			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209914	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000285793200060
J	DeSilva, JM; Throckmorton, ZJ				DeSilva, Jeremy M.; Throckmorton, Zachary J.			Lucy's Flat Feet: The Relationship between the Ankle and Rearfoot Arching in Early Hominins	PLOS ONE			English	Article							HADAR FORMATION; FUNCTIONAL-MORPHOLOGY; FLEXIBLE FLATFOOT; LOCOMOTOR ANATOMY; FOOT; PREVALENCE; HOMO; FOOTPRINTS; EVOLUTION; PATTERNS	Background: In the Plio-Pleistocene, the hominin foot evolved from a grasping appendage to a stiff, propulsive lever. Central to this transition was the development of the longitudinal arch, a structure that helps store elastic energy and stiffen the foot during bipedal locomotion. Direct evidence for arch evolution, however, has been somewhat elusive given the failure of soft-tissue to fossilize. Paleoanthropologists have relied on footprints and bony correlates of arch development, though little consensus has emerged as to when the arch evolved. Methodology/Principal Findings: Here, we present evidence from radiographs of modern humans (n = 261) that the set of the distal tibia in the sagittal plane, henceforth referred to as the tibial arch angle, is related to rearfoot arching. Non-human primates have a posteriorly directed tibial arch angle, while most humans have an anteriorly directed tibial arch angle. Those humans with a posteriorly directed tibial arch angle (8%) have significantly lower talocalcaneal and talar declination angles, both measures of an asymptomatic flatfoot. Application of these results to the hominin fossil record reveals that a well developed rearfoot arch had evolved in Australopithecus afarensis. However, as in humans today, Australopithecus populations exhibited individual variation in foot morphology and arch development, and "Lucy" (A.L. 288-1), a 3.18 Myrold female Australopithecus, likely possessed asymptomatic flat feet. Additional distal tibiae from the Plio-Pleistocene show variation in tibial arch angles, including two early Homo tibiae that also have slightly posteriorly directed tibial arch angles. Conclusions/Significance: This study finds that the rearfoot arch was present in the genus Australopithecus. However, the female Australopithecus afarensis "Lucy" has an ankle morphology consistent with non-pathological flat-footedness. This study suggests that, as in humans today, there was variation in arch development in Plio-Pleistocene hominins.	[DeSilva, Jeremy M.] Boston Univ, Dept Anthropol, Boston, MA 02215 USA; [Throckmorton, Zachary J.] Univ Wisconsin, Dept Anthropol, Madison, WI 53706 USA	Boston University; University of Wisconsin System; University of Wisconsin Madison	DeSilva, JM (corresponding author), Boston Univ, Dept Anthropol, Boston, MA 02215 USA.	jdesilva@bu.edu			Leakey Foundation	Leakey Foundation	This work was funded by the Leakey Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Fattah M. M., 2006, Eastern Mediterranean Health Journal, V12, P211; Akcali O, 2000, FOOT ANKLE INT, V21, P772, DOI 10.1177/107110070002100910; Bennett MR, 2009, SCIENCE, V323, P1197, DOI 10.1126/science.1168132; Berillon G., 2003, Human Evolution, V18, P113, DOI 10.1007/BF02436280; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; COOK DC, 1983, AM J PHYS ANTHROPOL, V60, P83, DOI 10.1002/ajpa.1330600113; Cowan D N, 1993, Arch Fam Med, V2, P773, DOI 10.1001/archfami.2.7.773; Curnoe D, 2006, J HUM EVOL, V50, P36, DOI 10.1016/j.jhevol.2005.07.008; Curnoe D, 2010, HOMO, V61, P151, DOI 10.1016/j.jchb.2010.04.002; DAVIS PR, 1964, NATURE, V201, P967, DOI 10.1038/201967a0; DAY MH, 1964, NATURE, V201, P969, DOI 10.1038/201969a0; Deloison Yvette, 2003, Biometrie Humaine et Anthropologie, V21, P189; DeSilva JM, 2010, AM J PHYS ANTHROPOL, V141, P245, DOI 10.1002/ajpa.21140; DeSilva JM, 2010, INT J OSTEO IN PRESS; Dunn JE, 2004, AM J EPIDEMIOL, V159, P491, DOI 10.1093/aje/kwh071; Feibel Craig S., 1995, Evolutionary Anthropology, V4, P149, DOI 10.1002/evan.1360040502; FEIBEL CS, 1989, AM J PHYS ANTHROPOL, V78, P595, DOI 10.1002/ajpa.1330780412; GRAUSZ HM, 1988, FOUND HUM B, P127; Harcourt-Smith W.E., 2002, THESIS U COLL LONDON; Harris Edwin J, 2010, Clin Podiatr Med Surg, V27, P1, DOI 10.1016/j.cpm.2009.09.002; HICKS JH, 1954, J ANAT, V88, P25; Hogan MT, 2002, FOOT ANKLE INT, V23, P43, DOI 10.1177/107110070202300108; Jennings MM, 2008, J FOOT ANKLE SURG, V47, P219, DOI 10.1053/j.jfas.2008.02.002; JOHANSON DC, 1982, AM J PHYS ANTHROPOL, V57, P403, DOI 10.1002/ajpa.1330570403; KENNEDY GE, 1983, AM J PHYS ANTHROPOL, V61, P429, DOI 10.1002/ajpa.1330610405; KER RF, 1987, NATURE, V325, P147, DOI 10.1038/325147a0; Kidd RS, 1996, J HUM EVOL, V31, P269, DOI 10.1006/jhev.1996.0061; Kuman K, 2000, J HUM EVOL, V38, pA16; LAMY P, 1986, J HUM EVOL, V15, P31, DOI 10.1016/S0047-2484(86)80063-X; LATIMER B, 1987, AM J PHYS ANTHROPOL, V74, P155, DOI 10.1002/ajpa.1330740204; LATIMER B, 1990, AM J PHYS ANTHROPOL, V83, P13, DOI 10.1002/ajpa.1330830103; Leakey MG, 1998, NATURE, V393, P62, DOI 10.1038/29972; Lieberman DE, 2010, NATURE, V463, P531, DOI 10.1038/nature08723; LOVEJOY CO, 1982, AM J PHYS ANTHROPOL, V57, P679, DOI 10.1002/ajpa.1330570411; Morag E, 1999, J BIOMECH, V32, P359, DOI 10.1016/S0021-9290(98)00188-2; Morton DJ, 1935, HUMAN FOOT; Pehlivan O, 2009, INT ORTHOP, V33, P447, DOI 10.1007/s00264-007-0508-5; Pfeiffer M, 2006, PEDIATRICS, V118, P634, DOI 10.1542/peds.2005-2126; Pickering R, 2010, J HUM EVOL, V59, P70, DOI 10.1016/j.jhevol.2010.03.014; Pickering TR, 2004, AM J PHYS ANTHROPOL, V125, P1, DOI 10.1002/ajpa.10278; Pontzer H, 2010, J HUM EVOL, V58, P492, DOI 10.1016/j.jhevol.2010.03.006; Preuschoft H., 1970, THE CHIMPANZEE, V3, P221; SARRAFIAN SK, 1987, FOOT ANKLE, V8, P4, DOI 10.1177/107110078700800103; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; SUSMAN RL, 1982, SCIENCE, V217, P931, DOI 10.1126/science.217.4563.931; SUSMAN RL, 1983, FOOT ANKLE, V3, P365, DOI 10.1177/107110078300300605; Teyhen DS, 2009, CLIN BIOMECH, V24, P391, DOI 10.1016/j.clinbiomech.2009.01.006; Thorpe SKS, 2006, AM J PHYS ANTHROPOL, V131, P384, DOI 10.1002/ajpa.20422; TRINKAUS E, 1984, AM J PHYS ANTHROPOL, V64, P137, DOI 10.1002/ajpa.1330640206; Tudor A, 2009, PEDIATRICS, V123, pe386, DOI 10.1542/peds.2008-2262; TUTTLE R, 1990, J ARCHAEOL SCI, V17, P347, DOI 10.1016/0305-4403(90)90028-4; Villemure I, 2009, J BIOMECH, V42, P1793, DOI 10.1016/j.jbiomech.2009.05.021; Walker A., 1993, NARIOKOTOME HOMO ERE; WALTER RC, 1994, GEOLOGY, V22, P6, DOI 10.1130/0091-7613(1994)022<0006:AOLATF>2.3.CO;2; WHITE TD, 1980, SCIENCE, V208, P175, DOI 10.1126/science.208.4440.175; WHITE TD, 1987, AM J PHYS ANTHROPOL, V72, P485, DOI 10.1002/ajpa.1330720409; Williams DS, 2001, CLIN BIOMECH, V16, P341, DOI 10.1016/S0268-0033(01)00005-5	57	33	33	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14432	10.1371/journal.pone.0014432	http://dx.doi.org/10.1371/journal.pone.0014432			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	701CS	21203433	Green Published, gold			2022-12-27	WOS:000285792500009
J	Whelan, KF; Lu, JP; Fridman, E; Wolf, A; Honig, A; Paulin, G; Klotz, L; Pinthus, JH				Whelan, Kaitlyn F.; Lu, Jian-Ping; Fridman, Eduard; Wolf, Alex; Honig, Alon; Paulin, Gregory; Klotz, Laurence; Pinthus, Jehonathan H.			What Can Surrogate Tissues Tell Us about the Oxidative Stress Status of the Prostate? A Hypothesis-Generating In-Vivo Study	PLOS ONE			English	Article							DERMAL PAPILLA CELLS; HUMAN HAIR FOLLICLE; ANDROGEN RECEPTOR; SUBMANDIBULAR-GLAND; SEXUAL-DIMORPHISM; CANCER; MOUSE; SERUM; PREVENTION; EXPRESSION	Background: Prostatic oxidative stress (OS) is androgen-regulated and a key event in the development of prostate cancer (PC). Thus, reducing prostatic OS is an attractive target for PC prevention strategies. We sought to determine if the individual's prostatic OS status can be determined by examining the OS in surrogate androgen regulated tissues from the same host. Methodology/Principal Findings: Adult male rats were divided equally into three groups: (A-) underwent bilateral orchiectomy, (A+) received continuous testosterone supplementation or (C) were eugonadal. Serum testosterone, 8hydroxy-2-deoxyguanosine (8-OHdG) and anti-oxidative capacity (AOC) were determined after 72 hrs and the prostate, salivary glands and the hair follicles' Dermal Papillary Cells (DPC) from each animal were harvested, embedded into tissue microarray and examined for the expression of 8-OHdG by immuno-staining. Multi-variate regression was used to analyze inter-individual differences in OS staining within each androgen group and if there was a correlation between serum testosterone, 8-OHdG or AOC and Prostatic OS in tissues of same host. At the group level, 8-OHdG staining intensity directly correlated with serum testosterone levels in all three target tissues (p>0.01, Mann-Whitney Test). Although different levels of prostatic OS were noted between rats with similar serum testosterone levels and similar systemic OS measurements (p<0.01), there were no intra-individual differences between the OS status of the prostate and DPC (p<0.05). Conclusions/Significance: The level of prostatic OS is correlated with the OS of hair follicles and salivary glands, but not systemic OS. Moreover, systemic AOC negatively correlates with both prostatic and hair follicle OS. This suggests that hair follicle and salivary gland OS can serve as surrogate markers for the efficiency of OS reduction. This has tremendous potential for the rational evaluation of patient response to prevention strategies.	[Whelan, Kaitlyn F.; Lu, Jian-Ping; Fridman, Eduard; Wolf, Alex; Honig, Alon; Paulin, Gregory; Pinthus, Jehonathan H.] McMaster Univ, Dept Surg, Hamilton, ON L8S 4L8, Canada; [Klotz, Laurence] Univ Toronto, Dept Surg, Toronto, ON, Canada	McMaster University; University of Toronto	Whelan, KF (corresponding author), McMaster Univ, Dept Surg, Hamilton, ON L8S 4L8, Canada.	Jehonathan.pinthus@jcc.hhsc.ca	Pinthus, Jehonathan/AAQ-1667-2021	Paulin, Gregory/0000-0001-8752-0102; Fridman, Eddie/0000-0002-0317-7085				ANDREWS EJ, 1972, ANAT REC, V174, P361, DOI 10.1002/ar.1091740307; Arck PC, 2006, FASEB J, V20, P1567, DOI 10.1096/fj.05-4039fje; Arsova-Sarafinovska Z, 2009, CLIN BIOCHEM, V42, P1228, DOI 10.1016/j.clinbiochem.2009.05.009; Behrend L, 2003, BIOCHEM SOC T, V31, P1441; Canakci CF, 2009, ARCH IMMUNOL THER EX, V57, P205, DOI 10.1007/s00005-009-0026-9; CEFALU WT, 1986, J CLIN ENDOCR METAB, V63, P20, DOI 10.1210/jcem-63-1-20; Cerbon MA, 1996, J COMP PHYSIOL A, V178, P351; Chen WC, 2004, ARCH DERMATOL RES, V296, P245, DOI 10.1007/s00403-004-0514-z; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; DeWeese TL, 2001, UROLOGY, V57, P137, DOI 10.1016/S0090-4295(00)00959-6; FLOYD RA, 1990, CARCINOGENESIS, V11, P1447, DOI 10.1093/carcin/11.9.1447; Gaziano JM, 2009, JAMA-J AM MED ASSOC, V301, P52, DOI 10.1001/jama.2008.862; George J, 2001, J CLIN PHARM THER, V26, P231, DOI 10.1046/j.1365-2710.2001.00354.x; Hoque A, 2010, CANCER PREV RES, V3, P478, DOI 10.1158/1940-6207.CAPR-09-0201; Inui S, 2007, J INVEST DERMATOL, V127, P2302, DOI 10.1038/sj.jid.5700883; Jave-Suarez LF, 2004, J INVEST DERMATOL, V122, P555, DOI 10.1111/j.0022-202X.2004.22336.x; JAYASINGHE NR, 1990, J ANAT, V172, P115; Khandrika L, 2009, CANCER LETT, V282, P125, DOI 10.1016/j.canlet.2008.12.011; Klein EA, 2006, UROLOGY, V68, P1145, DOI 10.1016/j.urology.2006.08.1074; Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259; KYAKUMOTO S, 1986, J ENDOCRINOL, V108, P267, DOI 10.1677/joe.0.1080267; LAINE M, 1993, ARCH ORAL BIOL, V38, P299, DOI 10.1016/0003-9969(93)90136-A; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Lu JP, 2010, PROSTATE CANCER P D, V13, P39, DOI 10.1038/pcan.2009.24; MIN KW, 1980, UROLOGY, V16, P95, DOI 10.1016/0090-4295(80)90346-5; Minelli A, 2009, BBA-REV CANCER, V1795, P83, DOI 10.1016/j.bbcan.2008.11.001; Miyake H, 2004, J UROLOGY, V171, P1533, DOI 10.1097/01.ju.0000116617.32728.ca; MIZUKI N, 1992, MOL CELL ENDOCRINOL, V89, P25, DOI 10.1016/0303-7207(92)90207-M; Pinthus JH, 2007, NEOPLASIA, V9, P68, DOI 10.1593/neo.06739; Pinthus JH, 2004, J UROLOGY, V172, P1644, DOI 10.1097/01.ju.0000140139.91993.a0; RANDALL VA, 1994, SKIN PHARMACOL, V7, P20; Reznick AZ, 2006, ARCH ORAL BIOL, V51, P640, DOI 10.1016/j.archoralbio.2006.02.004; Ripple MO, 1997, JNCI-J NATL CANCER I, V89, P40, DOI 10.1093/jnci/89.1.40; Ryo K, 2006, PATHOBIOLOGY, V73, P252, DOI 10.1159/000098211; SAWADA K, 1991, ACTA ANAT, V140, P97; Shigemura K, 2007, PROSTATE, V67, P722, DOI 10.1002/pros.20565; SIMSSAMPSON G, 1984, ANAT RECORD, V210, P53, DOI 10.1002/ar.1092100109; Sung SY, 2006, CANCER RES, V66, P9519, DOI 10.1158/0008-5472.CAN-05-4375; Yasuda M, 2008, J SEX MED, V5, P1482, DOI 10.1111/j.1743-6109.2008.00821.x; YOSSEPOWITCH O, 2007, J UROLOGY, V178, P1243; Zitzmann M, 2009, FRONT HORM RES, V37, P52, DOI 10.1159/000175843	41	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15880	10.1371/journal.pone.0015880	http://dx.doi.org/10.1371/journal.pone.0015880			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21209941	Green Submitted, Green Published, gold			2022-12-27	WOS:000285792500040
J	Gies, E; Wilde, I; Winget, JM; Brack, M; Rotblat, B; Novoa, CA; Balgi, AD; Sorensen, PH; Roberge, M; Mayor, T				Gies, Esther; Wilde, Inga; Winget, Jason M.; Brack, Maria; Rotblat, Barak; Novoa, Carolina Arias; Balgi, Aruna D.; Sorensen, Poul H.; Roberge, Michel; Mayor, Thibault			Niclosamide Prevents the Formation of Large Ubiquitin-Containing Aggregates Caused by Proteasome Inhibition	PLOS ONE			English	Article							PROTEIN AGGREGATION; HUNTINGTONS-DISEASE; AUTOPHAGY PATHWAY; BODY FORMATION; DEGRADATION; SYSTEM; INCLUSIONS; CELLS; AGGRESOMES; BINDING	Background: Protein aggregation is a hallmark of many neurodegenerative diseases and has been linked to the failure to degrade misfolded and damaged proteins. In the cell, aberrant proteins are degraded by the ubiquitin proteasome system that mainly targets short-lived proteins, or by the lysosomes that mostly clear long-lived and poorly soluble proteins. Both systems are interconnected and, in some instances, autophagy can redirect proteasome substrates to the lysosomes. Principal Findings: To better understand the interplay between these two systems, we established a neuroblastoma cell population stably expressing the GFP-ubiquitin fusion protein. We show that inhibition of the proteasome leads to the formation of large ubiquitin-containing inclusions accompanied by lower solubility of the ubiquitin conjugates. Strikingly, the formation of the ubiquitin-containing aggregates does not require ectopic expression of disease-specific proteins. Moreover, formation of these focused inclusions caused by proteasome inhibition requires the lysine 63 (K63) of ubiquitin. We then assessed selected compounds that stimulate autophagy and found that the antihelmintic chemical niclosamide prevents large aggregate formation induced by proteasome inhibition, while the prototypical mTORC1 inhibitor rapamycin had no apparent effect. Niclosamide also precludes the accumulation of poly-ubiquitinated proteins and of p62 upon proteasome inhibition. Moreover, niclosamide induces a change in lysosome distribution in the cell that, in the absence of proteasome activity, may favor the uptake into lysosomes of ubiquitinated proteins before they form large aggregates. Conclusions: Our results indicate that proteasome inhibition provokes the formation of large ubiquitin containing aggregates in tissue culture cells, even in the absence of disease specific proteins. Furthermore our study suggests that the autophagy-inducing compound niclosamide may promote the selective clearance of ubiquitinated proteins in the absence of proteasome activity.	[Gies, Esther; Wilde, Inga; Winget, Jason M.; Brack, Maria; Novoa, Carolina Arias; Balgi, Aruna D.; Roberge, Michel; Mayor, Thibault] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Gies, Esther; Wilde, Inga; Winget, Jason M.; Brack, Maria; Novoa, Carolina Arias; Mayor, Thibault] Univ British Columbia, Ctr Highthroughput Biol, Vancouver, BC V5Z 1M9, Canada; [Rotblat, Barak; Sorensen, Poul H.] British Columbia Canc Res Ctr, Dept Mol Oncol, Vancouver, BC V5Z 1L3, Canada; [Rotblat, Barak; Sorensen, Poul H.] Univ British Columbia, Dept Pathol, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia	Gies, E (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada.	mayor@interchange.ubc.ca	Rotblat, Barak/H-5970-2019	Rotblat, Barak/0000-0003-2985-7115	Parkinson Society Canada; Canadian Institute of Health Research (CIHR); Canadian Breast Cancer Foundation	Parkinson Society Canada; Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS))	This work was supported by a Parkinson Society Canada New Investigator Award and a Canadian Institute of Health Research (CIHR) Pilot Project Grant to T.M. and a Canadian Breast Cancer Foundation Grant to M.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANAND N, 1997, APPROACHES DESIGN SY, P239; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; BOTERO D, 1978, ANNU REV PHARMACOL, V18, P1; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Douglas PM, 2008, P NATL ACAD SCI USA, V105, P7206, DOI 10.1073/pnas.0802593105; Hands S, 2008, BBA-GENE REGUL MECH, V1779, P507, DOI 10.1016/j.bbagrm.2008.05.008; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Johnston JA, 2002, CELL MOTIL CYTOSKEL, V53, P26, DOI 10.1002/cm.10057; KAISER P, 2010, MOL CELL PROTEOMICS; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kolodziejska KE, 2005, P NATL ACAD SCI USA, V102, P4854, DOI 10.1073/pnas.0500485102; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Kuusisto E, 2001, BIOCHEM BIOPH RES CO, V280, P223, DOI 10.1006/bbrc.2000.4107; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lehman NL, 2009, ACTA NEUROPATHOL, V118, P329, DOI 10.1007/s00401-009-0560-x; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Liu C, 2007, J BIOL CHEM, V282, P14558, DOI 10.1074/jbc.M700422200; MATTEONI R, 1987, J CELL BIOL, V105, P1253, DOI 10.1083/jcb.105.3.1253; Mayor T, 2007, MOL CELL PROTEOMICS, V6, P1885, DOI 10.1074/mcp.M700264-MCP200; McLean PJ, 2001, NEUROSCIENCE, V104, P901, DOI 10.1016/S0306-4522(01)00113-0; McNaught KSP, 2004, ANN NEUROL, V56, P149, DOI 10.1002/ana.20186; Mimnaugh EG, 1997, BIOCHEMISTRY-US, V36, P14418, DOI 10.1021/bi970998j; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Navab M, 2009, J LIPID RES, V50, P1538, DOI 10.1194/jlr.M800539-JLR200; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Outeiro Tiago Fleming, 2007, Semin Pediatr Neurol, V14, P15, DOI 10.1016/j.spen.2006.11.005; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Richter-Landsberg C, 2008, J MOL NEUROSCI, V35, P55, DOI 10.1007/s12031-007-9017-7; Rideout HJ, 2001, J NEUROCHEM, V78, P899, DOI 10.1046/j.1471-4159.2001.00474.x; Riedel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008753; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Sin N, 1999, BIOORG MED CHEM LETT, V9, P2283, DOI 10.1016/S0960-894X(99)00376-5; Stenoien DL, 2002, NAT CELL BIOL, V4, P806, DOI 10.1038/ncb859; Sun F, 2006, NEUROTOXICOLOGY, V27, P807, DOI 10.1016/j.neuro.2006.06.006; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Tan JM, 2007, AUTOPHAGY, V4; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wade RH, 2009, MOL BIOTECHNOL, V43, P177, DOI 10.1007/s12033-009-9193-5; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Zeng BY, 2006, ANN NEUROL, V60, P248, DOI 10.1002/ana.20932	62	17	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e14410	10.1371/journal.pone.0014410	http://dx.doi.org/10.1371/journal.pone.0014410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203451	Green Published, gold, Green Submitted			2022-12-27	WOS:000285579200001
J	Landry, N; Ward, BJ; Trepanier, S; Montomoli, E; Dargis, M; Lapini, G; Vezina, LP				Landry, Nathalie; Ward, Brian J.; Trepanier, Sonia; Montomoli, Emanuele; Dargis, Michele; Lapini, Giulia; Vezina, Louis-P.			Preclinical and Clinical Development of Plant-Made Virus-Like Particle Vaccine against Avian H5N1 Influenza	PLOS ONE			English	Article							PHASE-I; SPLIT-VIRION; IMMUNOGENICITY; ANTIBODY; SAFETY; REASSORTMENT	The recent swine H1N1 influenza outbreak demonstrated that egg-based vaccine manufacturing has an Achille's heel: its inability to provide a large number of doses quickly. Using a novel manufacturing platform based on transient expression of influenza surface glycoproteins in Nicotiana benthamiana, we have recently demonstrated that a candidate Virus-Like Particle (VLP) vaccine can be generated within 3 weeks of release of sequence information. Herein we report that alum-adjuvanted plant-made VLPs containing the hemagglutinin (HA) protein of H5N1 influenza (A/Indonesia/5/05) can induce cross-reactive antibodies in ferrets. Even low doses of this vaccine prevented pathology and reduced viral loads following heterotypic lethal challenge. We further report on safety and immunogenicity from a Phase I clinical study of the plant-made H5 VLP vaccine in healthy adults 18-60 years of age who received 2 doses 21 days apart of 5, 10 or 20 mu g of alum-adjuvanted H5 VLP vaccine or placebo (alum). The vaccine was well tolerated at all doses. Adverse events (AE) were mild-to-moderate and self-limited. Pain at the injection site was the most frequent AE, reported in 70% of vaccinated subjects versus 50% of the placebo recipients. No allergic reactions were reported and the plant-made vaccine did not significantly increase the level of naturally occurring serum antibodies to plant-specific sugar moieties. The immunogenicity of the H5 VLP vaccine was evaluated by Hemagglutination-Inhibition (HI), Single Radial Hemolysis (SRH) and MicroNeutralisation (MN). Results from these three assays were highly correlated and showed similar trends across doses. There was a clear dose-response in all measures of immunogenicity and almost 96% of those in the higher dose groups (2 x 10 or 20 mu g) mounted detectable MN responses. Evidence of striking cross-protection in ferrets combined with a good safety profile and promising immunogenicity in humans suggest that plant-based VLP vaccines should be further evaluated for use in pre-pandemic or pandemic situations.	[Landry, Nathalie; Trepanier, Sonia; Dargis, Michele; Vezina, Louis-P.] Medicago Inc, Quebec City, PQ, Canada; [Ward, Brian J.] McGill Univ, Montreal Gen Hosp, Ctr Hlth, Res Inst, Montreal, PQ H3G 1A4, Canada; [Montomoli, Emanuele; Lapini, Giulia] Univ Siena, Dept Physiopathol Expt Med & Publ Hlth, Mol Epidemiol Res Div, I-53100 Siena, Italy	McGill University; University of Siena	Landry, N (corresponding author), Medicago Inc, Quebec City, PQ, Canada.	landryn@medicago.com	MONTOMOLI, EMANUELE/Q-2122-2015	MONTOMOLI, EMANUELE/0000-0001-7595-4974	Medicago Inc.	Medicago Inc.	Medicago Inc. was the sponsor of the clinical trial: NL participated in study design, data collection and analysis, decision to publish and preparation of the manuscript. ST participated in study design, data collection and analysis and preparation of the manuscript. MD participated in data collection and analysis. L-PV participated in decision to publish and preparation of the manuscript.	Altmann F, 2007, INT ARCH ALLERGY IMM, V142, P99, DOI 10.1159/000096114; Banzhoff A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004384; Bardor M, 2003, GLYCOBIOLOGY, V13, P427, DOI 10.1093/glycob/cwg024; BERSTEIN DI, 2008, JID, V197, P667; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Carter NJ, 2008, BIODRUGS, V22, P279, DOI 10.2165/00063030-200822050-00001; *CHMP, 2008, EMEACPMPVEG471703REV; Coudeville L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-18; D'Aoust MA, 2010, PLANT BIOTECHNOL J, V8, P607, DOI 10.1111/j.1467-7652.2009.00496.x; DAOUST MA, 2010, PLANT BIOTECHNOLOGY, V6, P930; Ehrlich HJ, 2008, NEW ENGL J MED, V358, P2573, DOI 10.1056/NEJMoa073121; Feng JQ, 2009, VACCINE, V27, P6358, DOI 10.1016/j.vaccine.2009.06.090; Hannoun C, 2004, VIRUS RES, V103, P133, DOI 10.1016/j.virusres.2004.02.025; Heininger U, 2009, VACCINE, V27, pG9, DOI 10.1016/j.vaccine.2009.10.010; Jackson S, 2009, J VIROL, V83, P8131, DOI 10.1128/JVI.00534-09; Keitel WA, 2008, J INFECT DIS, V198, P1309, DOI 10.1086/592172; Levie K, 2008, J INFECT DIS, V198, P642, DOI 10.1086/590913; Li CJ, 2010, P NATL ACAD SCI USA, V107, P4687, DOI 10.1073/pnas.0912807107; Lin JT, 2006, LANCET, V368, P991, DOI 10.1016/S0140-6736(06)69294-5; LU BL, 1982, INFECT IMMUN, V38, P530, DOI 10.1128/IAI.38.2.530-535.1982; Nolan TM, 2008, VACCINE, V26, P4160, DOI 10.1016/j.vaccine.2008.05.077; *O WYM PATH, 2007, INFL STRAT BROAD GLO; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; SCHILD GC, 1975, B WORLD HEALTH ORGAN, V52, P43; WOOD J, 1997, DEV BIOL STAND, V39, P193; World Health Organization, 2009, AV CAND REASS VACC V; World Health Organization (WHO), 2002, MAN AN INFL DIAGN SU	28	191	213	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15559	10.1371/journal.pone.0015559	http://dx.doi.org/10.1371/journal.pone.0015559			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203523	gold, Green Published, Green Submitted			2022-12-27	WOS:000285578000034
J	Koparde, VN; Scarsdale, JN; Kellogg, GE				Koparde, Vishal N.; Scarsdale, J. Neel; Kellogg, Glen E.			Applying an Empirical Hydropathic Forcefield in Refinement May Improve Low-Resolution Protein X-Ray Crystal Structures	PLOS ONE			English	Article							FREE-ENERGY; CRYSTALLOGRAPHY; BINDING; DOMAIN; WATER; SITE; PARAMETERS; COLCHICINE; COMPLEXES; TUBULIN	Background: The quality of X-ray crystallographic models for biomacromolecules refined from data obtained at high-resolution is assured by the data itself. However, at low-resolution, >3.0 angstrom, additional information is supplied by a forcefield coupled with an associated refinement protocol. These resulting structures are often of lower quality and thus unsuitable for downstream activities like structure-based drug discovery. Methodology: An X-ray crystallography refinement protocol that enhances standard methodology by incorporating energy terms from the HINT (Hydropathic INTeractions) empirical forcefield is described. This protocol was tested by refining synthetic low-resolution structural data derived from 25 diverse high-resolution structures, and referencing the resulting models to these structures. The models were also evaluated with global structural quality metrics, e. g., Ramachandran score and MolProbity clashscore. Three additional structures, for which only low-resolution data are available, were also re-refined with this methodology. Results: The enhanced refinement protocol is most beneficial for reflection data at resolutions of 3.0 angstrom or worse. At the low-resolution limit, >= 4.0 angstrom, the new protocol generated models with C alpha positions that have RMSDs that are 0.18 angstrom more similar to the reference high-resolution structure, Ramachandran scores improved by 13%, and clashscores improved by 51%, all in comparison to models generated with the standard refinement protocol. The hydropathic forcefield terms are at least as effective as Coulombic electrostatic terms in maintaining polar interaction networks, and significantly more effective in maintaining hydrophobic networks, as synthetic resolution is decremented. Even at resolutions >= 4.0 angstrom, these latter networks are generally native-like, as measured with a hydropathic interactions scoring tool.	[Koparde, Vishal N.; Scarsdale, J. Neel; Kellogg, Glen E.] Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Richmond, VA 23284 USA; [Koparde, Vishal N.; Kellogg, Glen E.] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA; [Scarsdale, J. Neel] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Koparde, VN (corresponding author), Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Richmond, VA 23284 USA.	jscarsda@vcu.edu; glen.kellogg@vcu.edu		Koparde, Vishal/0000-0001-8978-8495; Kellogg, Glen/0000-0002-6282-6794	United States National Institutes of Health (NIH) [R01 GM071894]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071894] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the United States National Institutes of Health (NIH, www.nih.gov) grant R01 GM071894 to G. E. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham DJ, 1997, J MOL BIOL, V272, P613, DOI 10.1006/jmbi.1997.1249; Amadasi A, 2006, J MOL BIOL, V358, P289, DOI 10.1016/j.jmb.2006.01.053; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Bai RL, 2000, J BIOL CHEM, V275, P40443, DOI 10.1074/jbc.M005299200; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUNGER AT, ANNOUNCING CNS VERSI; Carugo O, 1999, ACTA CRYSTALLOGR D, V55, P479, DOI 10.1107/S0907444998012086; Cozzini P, 2002, J MED CHEM, V45, P2469, DOI 10.1021/jm0200299; Cozzini P, 2008, J MED CHEM, V51, P6237, DOI 10.1021/jm800562d; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; DePristo MA, 2004, STRUCTURE, V12, P831, DOI 10.1016/j.str.2004.02.031; Deshpande N, 2005, NUCLEIC ACIDS RES, V33, pD233; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Fermani S, 2005, J STRUCT BIOL, V149, P204, DOI 10.1016/j.jsb.2004.11.007; HANSCH C, 1968, J ORG CHEM, V33, P347, DOI 10.1021/jo01265a071; Hennig S, 2009, PLOS BIOL, V7, P836, DOI 10.1371/journal.pbio.1000094; Karmali AM, 2009, ACTA CRYSTALLOGR D, V65, P121, DOI 10.1107/S0907444908040006; Kellogg GE, 2000, EUR J MED CHEM, V35, P651, DOI 10.1016/S0223-5234(00)00167-7; LEVITT M, 1988, J MOL BIOL, V201, P751, DOI 10.1016/0022-2836(88)90471-8; Li YH, 2005, J MOL BIOL, V352, P151, DOI 10.1016/j.jmb.2005.07.017; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marabotti A, 2008, J COMPUT CHEM, V29, P1955, DOI 10.1002/jcc.20954; Montelione GT, 2000, NAT STRUCT BIOL, V7, P982, DOI 10.1038/80768; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen TL, 2005, J MED CHEM, V48, P6107, DOI 10.1021/jm050502t; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Spyrakis F, 2004, J AM CHEM SOC, V126, P11764, DOI 10.1021/ja0465754; TAKAHASHI H, CRYSTAL STR IN PRESS; Tripathi A, 2008, BIOORGAN MED CHEM, V16, P2235, DOI 10.1016/j.bmc.2007.11.076; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Wilson MA, 2000, J MOL BIOL, V301, P1237, DOI 10.1006/jmbi.2000.4029; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	36	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15920	10.1371/journal.pone.0015920	http://dx.doi.org/10.1371/journal.pone.0015920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246043	Green Published, Green Submitted, gold			2022-12-27	WOS:000286511200024
J	Liao, YL; Kristiansen, AM; Oksvold, CP; Tuvnes, FA; Gu, N; Runden-Pran, E; Ruth, P; Sausbier, M; Storm, JF				Liao, Yiliu; Kristiansen, Ase-Marit; Oksvold, Cecilie P.; Tuvnes, Frode A.; Gu, Ning; Runden-Pran, Elise; Ruth, Peter; Sausbier, Matthias; Storm, Johan F.			Neuronal Ca2+-Activated K+ Channels Limit Brain Infarction and Promote Survival	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNELS; HIPPOCAMPAL PYRAMIDAL CELLS; CEREBRAL-ARTERY OCCLUSION; TRANSMITTER RELEASE; SLICE CULTURES; SPIKE REPOLARIZATION; DNA FRAGMENTATION; GLUTAMATE RELEASE; LARGE-CONDUCTANCE; NERVE-TERMINALS	Neuronal calcium-activated potassium channels of the BK type are activated by membrane depolarization and intracellular Ca2+ ions. It has been suggested that these channels may play a key neuroprotective role during and after brain ischemia, but this hypothesis has so far not been tested by selective BK-channel manipulations in vivo. To elucidate the in vivo contribution of neuronal BK channels in acute focal cerebral ischemia, we performed middle cerebral artery occlusion (MCAO) in mice lacking BK channels (homozygous mice lacking the BK channel alpha subunit, BK-/-). MCAO was performed in BK-/- and WT mice for 90 minutes followed by a 7-hour-reperfusion period. Coronal 1 mm thick sections were stained with 2,3,5-triphenyltetrazolium chloride to reveal the infarction area. We found that transient focal cerebral ischemia by MCAO produced larger infarct volume, more severe neurological deficits, and higher post-ischemic mortality in BK-/- mice compared to WT littermates. However, the regional cerebral blood flow was not significantly different between genotypes as measured by Laser Doppler (LD) flowmetry pre-ischemically, intra-ischemically, and post-ischemically, suggesting that the different impact of MCAO in BK-/- vs. WT was not due to vascular BK channels. Furthermore, when NMDA was injected intracerebrally in non-ischemic mice, NMDA-induced neurotoxicity was found to be larger in BK-/- mice compared to WT. Whole-cell patch clamp recordings from CA1 pyramidal cells in organotypic hippocampal slice cultures revealed that BK channels contribute to rapid action potential repolarization, as previously found in acute slices. When these cultures were exposed to ischemia-like conditions this induced significantly more neuronal death in BK-/- than in WT cultures. These results indicate that neuronal BK channels are important for protection against ischemic brain damage.	[Liao, Yiliu; Ruth, Peter; Sausbier, Matthias] Univ Tubingen, Inst Pharm, Tubingen, Germany; [Kristiansen, Ase-Marit; Oksvold, Cecilie P.; Tuvnes, Frode A.; Gu, Ning; Runden-Pran, Elise; Storm, Johan F.] Univ Oslo, Ctr Mol Biol & Neurosci, Oslo, Norway; [Kristiansen, Ase-Marit; Oksvold, Cecilie P.; Tuvnes, Frode A.; Gu, Ning; Runden-Pran, Elise; Storm, Johan F.] Univ Oslo, Inst Basal Med Sci, Oslo, Norway	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Oslo; University of Oslo	Liao, YL (corresponding author), Huazhong Univ Sci & Technol, Div Trauma, Dept Surg, Tongji Hosp,Tongji Med Coll, Wuhan 430074, Peoples R China.	Hmatthias.sausbier@uni-tuebingen.de; Hjstorm@basalmed.uio.no	Rundén-Pran, Elise/AAN-2490-2020; Rundén-Pran, Elise/AAE-6290-2019	Rundén-Pran, Elise/0000-0002-5541-4513; 	European Union; Deutsche Forschungsgemeinschaft [SFB773]; Norwegian Research Council	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by the European Union Biomed Project, Glutamate Receptor Interacting Proteins as Neuroprotective Targets, Deutsche Forschungsgemeinschaft (SFB773), and the Norwegian Research Council (Norwegian Centre of Excellence Program/Funksjonell Genomforsking). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber PA, 2004, STROKE, V35, P1720, DOI 10.1161/01.STR.0000129653.22241.d7; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; BIELEFELDT K, 1992, J PHYSIOL-LONDON, V458, P41, DOI 10.1113/jphysiol.1992.sp019405; COWAN AI, 1992, J PHYSIOL-LONDON, V455, P89, DOI 10.1113/jphysiol.1992.sp019292; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DESHPANDE JK, 1987, J CEREBR BLOOD F MET, V7, P89, DOI 10.1038/jcbfm.1987.13; Diez-Sampedro A, 2006, J NEUROPHYSIOL, V96, P1507, DOI 10.1152/jn.00461.2006; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Dupuis DS, 2002, EUR J PHARMACOL, V437, P129, DOI 10.1016/S0014-2999(02)01287-6; Faber ESL, 2003, NEUROSCIENTIST, V9, P181, DOI 10.1177/1073858403009003011; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Gribkoff VK, 2001, NAT MED, V7, P471, DOI 10.1038/86546; Gribkoff VK, 1996, MOL PHARMACOL, V50, P206; Gu N, 2006, SOC NEUR ABSTR; Gu N, 2007, ANN M SCAND PHYS SOC; Gu N, 2002, SOC NEUR ABSTR, P35; Gu N, 2007, J PHYSIOL-LONDON, V580, P859, DOI 10.1113/jphysiol.2006.126367; Haddad JJ, 2005, PROG NEUROBIOL, V77, P252, DOI 10.1016/j.pneurobio.2005.10.008; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Knaus HG, 1996, J NEUROSCI, V16, P955; Laake JH, 1999, BRAIN RES PROTOC, V4, P173, DOI 10.1016/S1385-299X(99)00021-5; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; Lawson K, 1996, CLIN SCI, V91, P651, DOI 10.1042/cs0910651; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Liao Y, 2009, SOC NEUR ABSTR; Liu HJ, 1999, J CLIN INVEST, V104, P577, DOI 10.1172/JCI7291; MACMANUS JP, 1993, NEUROSCI LETT, V164, P89, DOI 10.1016/0304-3940(93)90864-H; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; MENZIES SA, 1992, NEUROSURGERY, V31, P100, DOI 10.1227/00006123-199207000-00014; Michaelis EK, 1998, PROG NEUROBIOL, V54, P369, DOI 10.1016/S0301-0082(97)00055-5; Nishizawa Y, 2001, LIFE SCI, V69, P369, DOI 10.1016/S0024-3205(01)01142-0; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; OJCIUS DM, 1991, EXP CELL RES, V197, P43, DOI 10.1016/0014-4827(91)90477-C; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Parmentier-Batteur S, 2002, J NEUROSCI, V22, P9771, DOI 10.1523/jneurosci.22-22-09771.2002; Popescu G, 2005, CELL MOL LIFE SCI, V62, P2100, DOI 10.1007/s00018-005-5227-8; Raffaelli G, 2004, J PHYSIOL-LONDON, V557, P147, DOI 10.1113/jphysiol.2004.062661; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; ROBITAILLE R, 1992, J NEUROSCI, V12, P297; Roeper J, 1996, CURR OPIN NEUROBIOL, V6, P338, DOI 10.1016/S0959-4388(96)80117-6; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Runden-Pran E, 2002, NEUROSCIENCE, V112, P277, DOI 10.1016/S0306-4522(02)00092-1; Rytter A, 2003, J CEREBR BLOOD F MET, V23, P23, DOI 10.1097/01.WCB.0000034361.37277.1B; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Sausbier M, 2005, CIRCULATION, V112, P60, DOI 10.1161/01.CIR.0000156448.74296.FE; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Sausbier U, 2006, HISTOCHEM CELL BIOL, V125, P725, DOI 10.1007/s00418-005-0124-7; Schabitz WR, 2001, STROKE, V32, P1226, DOI 10.1161/01.STR.32.5.1226; Schroder RL, 2003, PFLUG ARCH EUR J PHY, V446, P607, DOI 10.1007/s00424-003-1116-x; Schroder RL, 2001, NEUROPHARMACOLOGY, V40, P888, DOI 10.1016/S0028-3908(01)00029-6; Shao LR, 1999, J PHYSIOL-LONDON, V521, P135, DOI 10.1111/j.1469-7793.1999.00135.x; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; STORM JF, 1990, PROG BRAIN RES, V83, P161; STORM JF, 1987, J PHYSIOL-LONDON, V385, P733, DOI 10.1113/jphysiol.1987.sp016517; STORM JF, 1987, BRAIN RES, V435, P387, DOI 10.1016/0006-8993(87)91631-3; Traystman RJ, 2003, ILAR J, V44, P85, DOI 10.1093/ilar.44.2.85; Wieloch T, 2001, IUBMB LIFE, V52, P247, DOI 10.1080/15216540152846064; Zhang ZG, 1997, J CEREBR BLOOD F MET, V17, P1081, DOI 10.1097/00004647-199710000-00010	62	37	39	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15601	10.1371/journal.pone.0015601	http://dx.doi.org/10.1371/journal.pone.0015601			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209897	gold, Green Submitted, Green Published			2022-12-27	WOS:000285793600022
J	Tsuang, DW; Millard, SP; Ely, B; Chi, P; Wang, KN; Raskind, WH; Kim, S; Brkanac, Z; Yu, CE				Tsuang, Debby W.; Millard, Steven P.; Ely, Benjamin; Chi, Peter; Wang, Kenneth; Raskind, Wendy H.; Kim, Sulgi; Brkanac, Zoran; Yu, Chang-En			The Effect of Algorithms on Copy Number Variant Detection	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HIDDEN-MARKOV MODEL; SNP GENOTYPING DATA; GENETIC-VARIATION; SCHIZOPHRENIA; RISK; MAP	Background: The detection of copy number variants (CNVs) and the results of CNV-disease association studies rely on how CNVs are defined, and because array-based technologies can only infer CNVs, CNV-calling algorithms can produce vastly different findings. Several authors have noted the large-scale variability between CNV-detection methods, as well as the substantial false positive and false negative rates associated with those methods. In this study, we use variations of four common algorithms for CNV detection (PennCNV, QuantiSNP, HMMSeg, and cnvPartition) and two definitions of overlap (any overlap and an overlap of at least 40% of the smaller CNV) to illustrate the effects of varying algorithms and definitions of overlap on CNV discovery. Methodology and Principal Findings: We used a 56 K Illumina genotyping array enriched for CNV regions to generate hybridization intensities and allele frequencies for 48 Caucasian schizophrenia cases and 48 age-, ethnicity-, and gender-matched control subjects. No algorithm found a difference in CNV burden between the two groups. However, the total number of CNVs called ranged from 102 to 3,765 across algorithms. The mean CNV size ranged from 46 kb to 787 kb, and the average number of CNVs per subject ranged from 1 to 39. The number of novel CNVs not previously reported in normal subjects ranged from 0 to 212. Conclusions and Significance: Motivated by the availability of multiple publicly available genome-wide SNP arrays, investigators are conducting numerous analyses to identify putative additional CNVs in complex genetic disorders. However, the number of CNVs identified in array-based studies, and whether these CNVs are novel or valid, will depend on the algorithm(s) used. Thus, given the variety of methods used, there will be many false positives and false negatives. Both guidelines for the identification of CNVs inferred from high-density arrays and the establishment of a gold standard for validation of CNVs are needed.	[Tsuang, Debby W.; Wang, Kenneth; Raskind, Wendy H.; Brkanac, Zoran] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Tsuang, Debby W.; Millard, Steven P.; Ely, Benjamin; Chi, Peter; Raskind, Wendy H.] VISN 20 Mental Illness Res Educ & Clin Ctr, Dept Vet Affairs, Seattle, WA USA; [Raskind, Wendy H.; Kim, Sulgi; Yu, Chang-En] Univ Washington, Dept Med, Sch Med, Seattle, WA 98195 USA; [Yu, Chang-En] Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Tsuang, DW (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.	dwt1@uw.edu	Tsuang, Debby/L-7234-2016	Tsuang, Debby/0000-0002-4716-1894	VA Puget Sound Health Care System, Seattle, Washington; NIH/NIMH [RO1 MH065558]; VA Merit Review [VISN-20 MIRECC]; University of Washington Alzheimer's Disease Research Center NIH/NIA [P50 AG05136]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005136] Funding Source: NIH RePORTER	VA Puget Sound Health Care System, Seattle, Washington; NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); VA Merit Review(US Department of Veterans Affairs); University of Washington Alzheimer's Disease Research Center NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This material is the result of work supported by resources from the VA Puget Sound Health Care System, Seattle, Washington. Funding provided by NIH/NIMH RO1 MH065558 (www.nimh.nih.gov), VA Merit Review, VISN-20 MIRECC (www.va.gov), and University of Washington Alzheimer's Disease Research Center NIH/NIA P50 AG05136 (www.nia.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calkins ME, 2007, SCHIZOPHRENIA BULL, V33, P33, DOI 10.1093/schbul/sbl044; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; Carvalho CMB, 2010, P NATL ACAD SCI USA, V107, P1765, DOI 10.1073/pnas.0906222107; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Cooper GM, 2008, NAT GENET, V40, P1199, DOI 10.1038/ng.236; Day N, 2007, BIOINFORMATICS, V23, P1424, DOI 10.1093/bioinformatics/btm096; Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; *ILL, 2010, DNA COP NUMB LOSS HE; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Khoury MJ, 2009, AM J EPIDEMIOL, V170, P269, DOI 10.1093/aje/kwp119; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Manolio TA, 2009, ANNU REV MED, V60, P443, DOI 10.1146/annurev.med.60.061907.093117; Maxwell M., 1992, FAMILY INTERVIEW GEN; McCarroll SA, 2008, HUM MOL GENET, V17, pR135, DOI 10.1093/hmg/ddn282; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; PEIFFER DA, 2006, ANAL COPY NUMBER VAR; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Pique-Regi R, 2008, BIOINFORMATICS, V24, P309, DOI 10.1093/bioinformatics/btm601; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Team RDC, 2019, R LANG ENV STAT COMP; *TOR U, DAT GEN VAR; Tsuang D, 1996, J AM GERIATR SOC, V44, P704, DOI 10.1111/j.1532-5415.1996.tb01836.x; Wain LV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008175; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Winchester Laura, 2009, Briefings in Functional Genomics & Proteomics, V8, P353, DOI 10.1093/bfgp/elp017; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; ZHANG D, 2009, 17 WORLD C PSYCH GEN	33	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e14456	10.1371/journal.pone.0014456	http://dx.doi.org/10.1371/journal.pone.0014456			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209939	Green Published, Green Submitted, gold			2022-12-27	WOS:000285793600003
J	Friedli, M; Barde, I; Arcangeli, M; Verp, S; Quazzola, A; Zakany, J; Lin-Marq, N; Robyr, D; Attanasio, C; Spitz, F; Duboule, D; Trono, D; Antonarakis, SE				Friedli, Marc; Barde, Isabelle; Arcangeli, Melanie; Verp, Sonia; Quazzola, Alexandra; Zakany, Jozsef; Lin-Marq, Nathalie; Robyr, Daniel; Attanasio, Catia; Spitz, Francois; Duboule, Denis; Trono, Didier; Antonarakis, Stylianos E.			A Systematic Enhancer Screen Using Lentivector Transgenesis Identifies Conserved and Non-Conserved Functional Elements at the Olig1 and Olig2 Locus	PLOS ONE			English	Article							NON-GENIC SEQUENCES; HUMAN GENOME; IN-VIVO; EXPRESSION ATLAS; HUMAN-CHROMOSOME-21; TRANSCRIPTION; CELLS; CHROMATIN; SCHIZOPHRENIA; ORGANIZATION	Finding sequences that control expression of genes is central to understanding genome function. Previous studies have used evolutionary conservation as an indicator of regulatory potential. Here, we present a method for the unbiased in vivo screen of putative enhancers in large DNA regions, using the mouse as a model. We cloned a library of 142 overlapping fragments from a 200 kb-long murine BAC in a lentiviral vector expressing LacZ from a minimal promoter, and used the resulting vectors to infect fertilized murine oocytes. LacZ staining of E11 embryos obtained by first using the vectors in pools and then testing individual candidates led to the identification of 3 enhancers, only one of which shows significant evolutionary conservation. In situ hybridization and 3C/4C experiments suggest that this enhancer, which is active in the neural tube and posterior diencephalon, influences the expression of the Olig1 and/or Olig2 genes. This work provides a new approach for the large-scale in vivo screening of transcriptional regulatory sequences, and further demonstrates that evolutionary conservation alone seems too limiting a criterion for the identification of enhancers.	[Friedli, Marc; Arcangeli, Melanie; Lin-Marq, Nathalie; Robyr, Daniel; Attanasio, Catia; Antonarakis, Stylianos E.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Friedli, Marc; Arcangeli, Melanie; Lin-Marq, Nathalie; Robyr, Daniel; Attanasio, Catia; Antonarakis, Stylianos E.] Univ Hosp Geneva, Geneva, Switzerland; [Barde, Isabelle; Verp, Sonia; Quazzola, Alexandra; Duboule, Denis; Trono, Didier] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland; [Zakany, Jozsef; Spitz, Francois; Duboule, Denis] Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva, Switzerland; [Friedli, Marc; Barde, Isabelle; Arcangeli, Melanie; Verp, Sonia; Quazzola, Alexandra; Zakany, Jozsef; Lin-Marq, Nathalie; Robyr, Daniel; Attanasio, Catia; Spitz, Francois; Duboule, Denis; Trono, Didier; Antonarakis, Stylianos E.] Frontiers Genet Natl Ctr Competence Res, Bern, Switzerland	University of Geneva; University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva	Friedli, M (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	denis.duboule@unige.ch; didier.trono@epfl.ch; stylianos.antonarakis@unige.ch	attanasio, catia/D-5042-2017; Antonarakis, Stylianos E/N-8866-2014	attanasio, catia/0000-0001-8077-5719; Antonarakis, Stylianos E/0000-0001-8907-5823; duboule, denis/0000-0001-9961-2960	National Centre For Competence in Research (NCCR) "Frontiers in Genetics" doctoral school; NCCR; Swiss National Science Foundation; Childcare Foundation; European program "Crescendo"; European program "CONSERT"; European program "AnEUploidy"	National Centre For Competence in Research (NCCR) "Frontiers in Genetics" doctoral school(Swiss National Science Foundation (SNSF)); NCCR(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Childcare Foundation; European program "Crescendo"; European program "CONSERT"; European program "AnEUploidy"	MF is supported by a fellowship from the National Centre For Competence in Research (NCCR) "Frontiers in Genetics" doctoral school. This work was supported by grants from the NCCR "Frontiers in Genetics" (to DD, DT, SEA), the Swiss National Science Foundation (to DD, DT, SEA), the Childcare Foundation (to SEA), and the European programs "Crescendo" (to DD), "CONSERT" (to DT) and "AnEUploidy" (to SEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahituv N, 2004, HUM MOL GENET, V13, pR261, DOI 10.1093/hmg/ddh229; Attanasio C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r168; Benko S, 2009, NAT GENET, V41, P359, DOI 10.1038/ng.329; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Chakrabarti L, 2010, NAT NEUROSCI, V13, P927, DOI 10.1038/nn.2600; Chen CTL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003946; Dermitzakis ET, 2005, NAT REV GENET, V6, P151, DOI 10.1038/nrg1527; Dermitzakis ET, 2003, SCIENCE, V302, P1033, DOI 10.1126/science.1087047; Dermitzakis ET, 2002, NATURE, V420, P578, DOI 10.1038/nature01251; Frazer KA, 2001, GENOME RES, V11, P1651, DOI 10.1101/gr.198201; Georgieva L, 2006, P NATL ACAD SCI USA, V103, P12469, DOI 10.1073/pnas.0603029103; Heintzman N. D, 2009, NATURE; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hofmann A, 2006, MOL THER, V13, P59, DOI 10.1016/j.ymthe.2005.07.685; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; Huang K, 2008, HUM GENET, V122, P659, DOI 10.1007/s00439-007-0434-z; Jeong Y, 2008, NAT GENET, V40, P1348, DOI 10.1038/ng.230; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lin YW, 2005, CANCER RES, V65, P7151, DOI 10.1158/0008-5472.CAN-05-1400; Loeuillet C, 2008, PLOS BIOL, V6, P319, DOI 10.1371/journal.pbio.0060032; Loots GG, 2005, GENOME RES, V15, P928, DOI 10.1101/gr.3437105; McGaughey DM, 2008, GENOME RES, V18, P252, DOI 10.1101/gr.6929408; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Parker SC, 2009, SCIENCE; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Prabhakar S, 2008, SCIENCE, V321, P1346, DOI 10.1126/science.1159974; Prabhakar S, 2006, GENOME RES, V16, P855, DOI 10.1101/gr.4717506; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; Reymond A, 2002, NATURE, V420, P582, DOI 10.1038/nature01178; Sauvain MO, 2008, J VIROL, V82, P7111, DOI 10.1128/JVI.00623-08; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Spitz F, 2008, ADV GENET, V61, P175, DOI 10.1016/S0065-2660(07)00006-5; Splinter E, 2004, METHOD ENZYMOL, V375, P493; Uchida Y, 2007, J BIOL CHEM, V282, P19700, DOI 10.1074/jbc.M703099200; van den Brandt J, 2004, GENESIS, V39, P94, DOI 10.1002/gene.20037; Visel A, 2009, NATURE; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Visel A, 2007, SEMIN CELL DEV BIOL, V18, P140, DOI 10.1016/j.semcdb.2006.12.014; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wang QF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r1; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Xian HQ, 2005, BIOCHEM BIOPH RES CO, V327, P155, DOI 10.1016/j.bbrc.2004.11.149; Yaylaoglu MB, 2005, DEV DYNAM, V234, P371, DOI 10.1002/dvdy.20441; Zhang X, 2008, STEM CELLS, V26, P1841, DOI 10.1634/stemcells.2007-0902; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3	50	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15741	10.1371/journal.pone.0015741	http://dx.doi.org/10.1371/journal.pone.0015741			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206754	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793200048
J	Lei, HY; Fukushige, T; Niu, W; Sarov, M; Reinke, V; Krause, M				Lei, Haiyan; Fukushige, Tetsunari; Niu, Wei; Sarov, Mihail; Reinke, Valerie; Krause, Michael			A Widespread Distribution of Genomic CeMyoD Binding Sites Revealed and Cross Validated by ChIP-Chip and ChIP-Seq Techniques	PLOS ONE			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; MUSCLE DEVELOPMENT; GENE-EXPRESSION; PROTEIN; MYOD; TRANSCRIPTION; REGULATOR; FAMILY; HLH-1	Identifying transcription factor binding sites genome-wide using chromatin immunoprecipitation (ChIP)-based technology is becoming an increasingly important tool in addressing developmental questions. However, technical problems associated with factor abundance and suitable ChIP reagents are common obstacles to these studies in many biological systems. We have used two completely different, widely applicable methods to determine by ChIP the genome-wide binding sites of the master myogenic regulatory transcription factor HLH-1 (CeMyoD) in C. elegans embryos. The two approaches, ChIP-seq and ChIP-chip, yield strongly overlapping results revealing that HLH-1 preferentially binds to promoter regions of genes enriched for E-box sequences (CANNTG), known binding sites for this well-studied class of transcription factors. HLH-1 binding sites were enriched upstream of genes known to be expressed in muscle, consistent with its role as a direct transcriptional regulator. HLH-1 binding was also detected at numerous sites unassociated with muscle gene expression, as has been previously described for its mouse homolog MyoD. These binding sites may reflect several additional functions for HLH-1, including its interactions with one or more co-factors to activate (or repress) gene expression or a role in chromatin organization distinct from direct transcriptional regulation of target genes. Our results also provide a comparison of ChIP methodologies that can overcome limitations commonly encountered in these types of studies while highlighting the complications of assigning in vivo functions to identified target sites.	[Lei, Haiyan; Fukushige, Tetsunari; Krause, Michael] NIDDK, NIH, Bethesda, MD 20892 USA; [Niu, Wei] Yale Univ, Dept Mol, New Haven, CT USA; [Sarov, Mihail] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Reinke, Valerie] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Yale University; Max Planck Society; Yale University	Lei, HY (corresponding author), NIDDK, NIH, Bethesda, MD 20892 USA.	mwkrause@helix.nih.gov	NUI, WEI/B-8300-2011	Krause, Michael/0000-0001-6127-3940	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; National Human Genome Research Institute [U01HG004267]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036131] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in part, by the Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Support also came from the Model Organism Encylopedia of DNA Elements (modENCODE) project funded by grant U01HG004267 from the National Human Genome Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Cesaroni M, 2008, BIOINFORMATICS, V24, P2918, DOI 10.1093/bioinformatics/btn542; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chowdhuri SR, 2006, DEV BIOL, V295, P664, DOI 10.1016/j.ydbio.2006.04.001; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dent JA, 1998, MECH DEVELOP, V72, P179, DOI 10.1016/S0925-4773(98)00026-4; Fox RM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r188; Fukushige T, 2005, DEVELOPMENT, V132, P1795, DOI 10.1242/dev.01774; Fukushige T, 2006, GENE DEV, V20, P3395, DOI 10.1101/gad.1481706; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Graham PL, 1997, J CELL BIOL, V137, P1171, DOI 10.1083/jcb.137.5.1171; Halevi S, 2002, EMBO J, V21, P1012, DOI 10.1093/emboj/21.5.1012; Hikita T, 2005, BIOCHEM BIOPH RES CO, V335, P139, DOI 10.1016/j.bbrc.2005.07.068; Huang CG, 2007, AM J PHYSIOL-CELL PH, V292, pC1867, DOI 10.1152/ajpcell.00514.2006; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Kophengnavong T, 2000, MOL CELL BIOL, V20, P261, DOI 10.1128/MCB.20.1.261-272.2000; Krause M, 1997, DEVELOPMENT, V124, P2179; Lei H, 2009, DEVELOPMENT, V136, P1241, DOI 10.1242/dev.030668; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; McGhee JD, 2007, DEV BIOL, V302, P627, DOI 10.1016/j.ydbio.2006.10.024; McGhee James D, 2007, WormBook, P1; McGhee JD, 2009, DEV BIOL, V327, P551, DOI 10.1016/j.ydbio.2008.11.034; Meissner B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000537; Milne CA, 1999, CURR BIOL, V9, P1243, DOI 10.1016/S0960-9822(99)80504-1; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pD175, DOI 10.1093/nar/gkn815; OKKEMA PG, 1993, GENETICS, V135, P385; Ono S, 1999, J CELL BIOL, V145, P491, DOI 10.1083/jcb.145.3.491; Praitis V, 2001, GENETICS, V157, P1217; Reece-Hoyes JS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2168-8-27; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Rozen S, 2000, Methods Mol Biol, V132, P365; Sarov M, 2006, NAT METHODS, V3, P839, DOI 10.1038/nmeth933; Steven R, 2005, GENE DEV, V19, P2016, DOI 10.1101/gad.1319905; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Wang X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-213; Wang Y, 2006, P NATL ACAD SCI USA, V103, P10450, DOI 10.1073/pnas.0602073103; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607; Zhong M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000848	45	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15898	10.1371/journal.pone.0015898	http://dx.doi.org/10.1371/journal.pone.0015898			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209968	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793200070
J	Morato, T; Hoyle, SD; Allain, V; Nicol, SJ				Morato, Telmo; Hoyle, Simon D.; Allain, Valerie; Nicol, Simon J.			Tuna Longline Fishing around West and Central Pacific Seamounts	PLOS ONE			English	Article							THUNNUS-ALBACARES; YELLOWFIN TUNA; STANDARDIZING CATCH; BIGEYE TUNA; BEHAVIOR; FISHERY; OBESUS; OCEAN; RATES; FADS	Background: Seamounts have been identified as aggregating locations for pelagic biodiversity including tuna; however the topography and prevailing oceanography differ between seamounts and not all are important for tuna. Although a relatively common feature in oceanic ecosystems, little information is available that identifies those that are biologically important. Improved knowledge offers opportunities for unique management of these areas, which may advance the sustainable management of oceanic resources. In this study, we evaluate the existence of an association between seamounts and tuna longline fisheries at the ocean basin scale, identify significant seamounts for tuna in the western and central Pacific Ocean, and quantify the seamount contribution to the tuna longline catch. Methodology/Principal Findings: We use data collected for the Western and Central Pacific Ocean for bigeye, yellowfin, and albacore tuna at the ocean basin scale. GLMs were applied to a coupled dataset of longline fisheries catch and effort, and seamount location information. The analyses show that seamounts may be associated with an annual longline combined catch of 35 thousand tonnes, with higher catch apparent for yellowfin, bigeye, and albacore tuna on 17%, 14%, and 14% of seamounts respectively. In contrast 14%, 18%, and 20% of seamounts had significantly lower catches for yellowfin, bigeye and albacore tuna respectively. Studying catch data in relation to seamount positions presents several challenges such as bias in location of seamounts, or lack of spatial resolution of fisheries data. Whilst we recognize these limitations the criteria used for detecting significant seamounts were conservative and the error in identification is likely to be low albeit unknown. Conclusions/Significance: Seamounts throughout the study area were found to either enhance or reduce tuna catch. This indicates that management of seamounts is important Pacific-wide, but management approaches must take account of local conditions. Management of tuna and biodiversity resources in the region would benefit from considering such effects.	[Morato, Telmo; Hoyle, Simon D.; Allain, Valerie; Nicol, Simon J.] Secretariat Pacific Commun, Ocean Fisheries Programme, Noumea, New Caledonia; [Morato, Telmo] Univ Acores, Dept Oceanog & Pescas, Horta, Portugal	Universidade dos Acores	Morato, T (corresponding author), Secretariat Pacific Commun, Ocean Fisheries Programme, Noumea, New Caledonia.	telmo@uac.pt	Allain, Valerie/AAE-1449-2019; Hoyle, Simon D/G-1201-2015; Morato, Telmo/A-4548-2009	Allain, Valerie/0000-0002-9874-3077; Hoyle, Simon D/0000-0002-1787-6565; Morato, Telmo/0000-0003-2393-4773; Nicol, Simon/0000-0001-8193-8719	Global Environment Facility (GEF)	Global Environment Facility (GEF)	This research is part of the Pacific Islands 327 Oceanic Fisheries Management Project supported by Global Environment Facility (GEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain V, 2008, DEEP-SEA RES PT I, V55, P1035, DOI 10.1016/j.dsr.2008.04.004; BEVERLY S, 2004, FTWG7 SEC PAC COMM S; Etnoyer PJ, 2010, OCEANOGRAPHY, V23, P206, DOI 10.5670/oceanog.2010.96; FAO, 2009, STAT WORLD FISH AQ 2; Fonteneau A, 1991, AQUAT LIVING RESOUR, V4, P13, DOI 10.1051/alr:1991001; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; HARLEY S, 2009, SC5SAWP04 WCPFC, P98; HILBORN R, 1992; Holland KN, 1999, FISH B-NOAA, V97, P392; HOLLAND KN, 2007, SEAMOUNTS ECOLOGY FI, P189; Itano DG, 2000, AQUAT LIVING RESOUR, V13, P213, DOI 10.1016/S0990-7440(00)01062-7; Kitchingman A., 2007, SEAMOUNTS ECOLOGY FI, V12, P26, DOI DOI 10.1002/9780470691953.CH2; Kitchingman A., 2004, INFERENCES POTENTIAL, V12, P7; Klimley AP, 2003, FISH B-NOAA, V101, P684; LANGLEY A, 2009, SC5SAWP03 WCPEC, P121; LAWSON TA, 2008, TUNA FISHERY YB 2007; Lowry M, 2007, FISH RES, V88, P15, DOI 10.1016/j.fishres.2007.07.011; Mackinson S, 1997, FISH RES, V31, P11, DOI 10.1016/S0165-7836(97)00020-9; Maunder MN, 2004, FISH RES, V70, P141, DOI 10.1016/j.fishres.2004.08.002; Morato T, 2008, MAR ECOL PROG SER, V357, P23, DOI 10.3354/meps07269; Morato T, 2010, P NATL ACAD SCI USA, V107, P9707, DOI 10.1073/pnas.0910290107; Morato T, 2010, OCEANOGRAPHY, V23, P190, DOI 10.5670/oceanog.2010.71; Musyl MK, 2003, FISH OCEANOGR, V12, P152, DOI 10.1046/j.1365-2419.2003.00229.x; PITCHER TJ, 1995, SCI MAR, V59, P295; Pitcher TJ, 2010, OCEANOGRAPHY, V23, P134, DOI 10.5670/oceanog.2010.66; PROBERT PK, 2007, SEAMOUNTS ECOLOGY FI, P442, DOI DOI 10.1002/9780470691953.CH20; Santos RS, 2009, DEEP-SEA RES PT II, V56, P2720, DOI 10.1016/j.dsr2.2008.12.031; Sibert J, 2000, AQUAT LIVING RESOUR, V13, P225, DOI 10.1016/S0990-7440(00)01057-3; Su NJ, 2008, FISH RES, V90, P235, DOI 10.1016/j.fishres.2007.10.024; Sumaila U. Rashid, 2007, Journal of Bioeconomics, V9, P39, DOI 10.1007/s10818-007-9015-4; Walters C, 2003, CAN J FISH AQUAT SCI, V60, P1433, DOI 10.1139/F03-152; Watson R., 2007, SEAMOUNTS ECOLOGY FI, P400; Wessel P, 2010, OCEANOGRAPHY, V23, P24, DOI 10.5670/oceanog.2010.60; WILLIAMS P, 2009, WCPFCSC52009GNWP01; YASUI M, 1986, NOAA TECHNICAL REPOR, V43, P37; 1994, TONGA SMALL SCALE TU	36	29	32	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e14453	10.1371/journal.pone.0014453	http://dx.doi.org/10.1371/journal.pone.0014453			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206913	Green Submitted, Green Published, gold			2022-12-27	WOS:000285793200009
J	Oonincx, DGAB; van Itterbeeck, J; Heetkamp, MJW; van den Brand, H; van Loon, JJA; van Huis, A				Oonincx, Dennis G. A. B.; van Itterbeeck, Joost; Heetkamp, Marcel J. W.; van den Brand, Henry; van Loon, Joop J. A.; van Huis, Arnold			An Exploration on Greenhouse Gas and Ammonia Production by Insect Species Suitable for Animal or Human Consumption	PLOS ONE			English	Article							PACHNODA-EPHIPPIATA COLEOPTERA; NITROUS-OXIDE; OXYGEN-CONSUMPTION; METABOLIC-RATE; CARBON-DIOXIDE; WEANED PIGS; EMISSIONS; METHANE; RESPIRATION; BUILDINGS	Background: Greenhouse gas (GHG) production, as a cause of climate change, is considered as one of the biggest problems society is currently facing. The livestock sector is one of the large contributors of anthropogenic GHG emissions. Also, large amounts of ammonia (NH3), leading to soil nitrification and acidification, are produced by livestock. Therefore other sources of animal protein, like edible insects, are currently being considered. Methodology/Principal Findings: An experiment was conducted to quantify production of carbon dioxide (CO2) and average daily gain (ADG) as a measure of feed conversion efficiency, and to quantify the production of the greenhouse gases methane (CH4) and nitrous oxide (N2O) as well as NH3 by five insect species of which the first three are considered edible: Tenebrio molitor, Acheta domesticus, Locusta migratoria, Pachnoda marginata, and Blaptica dubia. Large differences were found among the species regarding their production of CO2 and GHGs. The insects in this study had a higher relative growth rate and emitted comparable or lower amounts of GHG than described in literature for pigs and much lower amounts of GHG than cattle. The same was true for CO2 production per kg of metabolic weight and per kg of mass gain. Furthermore, also the production of NH3 by insects was lower than for conventional livestock. Conclusions/Significance: This study therefore indicates that insects could serve as a more environmentally friendly alternative for the production of animal protein with respect to GHG and NH3 emissions. The results of this study can be used as basic information to compare the production of insects with conventional livestock by means of a life cycle analysis.	[Oonincx, Dennis G. A. B.; van Itterbeeck, Joost; van Loon, Joop J. A.; van Huis, Arnold] Wageningen Univ, Dept Plant Sci, Entomol Lab, Wageningen, Netherlands; [Heetkamp, Marcel J. W.; van den Brand, Henry] Wageningen Univ, Wageningen Inst Anim Sci, Adaptat Physiol Grp, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Oonincx, DGAB (corresponding author), Wageningen Univ, Dept Plant Sci, Entomol Lab, Wageningen, Netherlands.	dennis.oonincx@wur.nl	van Loon, Joop J.A./B-3744-2009	van Loon, Joop J.A./0000-0002-4260-0501; Van Itterbeeck, Joost/0000-0002-0431-001X; Oonincx, Dennis/0000-0002-6728-4859	Wageningen University, Wageningen, The Netherlands	Wageningen University, Wageningen, The Netherlands(Netherlands Government)	This study was directly funded by Wageningen University, Wageningen, The Netherlands (www.wur.nl) as part of a PhD program. Wageningen University had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, than can be expected with the academic supervision of a PhD candidate.	AARNINK AJA, 1995, J AGR ENG RES, V62, P105, DOI 10.1006/jaer.1995.1069; Agutter P. S., 2004, THEORETICAL BIOL MED, V1; AIDLEY DJ, 1976, PHYSIOL ENTOMOL, V1, P73, DOI 10.1111/j.1365-3032.1976.tb00890.x; ARMSTRONG G, 1985, PHYSIOL ENTOMOL, V10, P353, DOI 10.1111/j.1365-3032.1985.tb00057.x; AXELSSON B, 1979, ENTOMOL EXP APPL, V25, P260, DOI 10.1111/j.1570-7458.1979.tb02878.x; BAILEY CG, 1977, CAN ENTOMOL, V109, P687, DOI 10.4039/Ent109687-5; Beauchemin KA, 2005, J ANIM SCI, V83, P653; Beets WC, 1997, ECOL FOOD NUTR, V36, P237, DOI 10.1080/03670244.1997.9991518; Blanes-Vidal V, 2008, AGR ECOSYST ENVIRON, V124, P237, DOI 10.1016/j.agee.2007.10.002; Bruins E., 2001, GEILLUSTREERDE TERRA; Cabaraux JF, 2009, AGR ECOSYST ENVIRON, V130, P86, DOI 10.1016/j.agee.2008.11.016; Casey JW, 2006, J ENVIRON QUAL, V35, P231, DOI 10.2134/jeq2005.0121; Chadwick DR, 1999, ATMOS ENVIRON, V33, P3345, DOI 10.1016/S1352-2310(98)00379-3; Chown SL, 2007, FUNCT ECOL, V21, P282, DOI 10.1111/j.1365-2435.2007.01245.x; Cole NA, 2005, J ANIM SCI, V83, P722; Collavo A, 2004, ECOLOGICAL IMPLICATIONS OF MINLIVESTOCK: POTENTIAL OF INSECTS RODENTS FROGS AND SNAILS, P519; da Silva JKL, 2006, PHYS LIFE REV, V3, P229, DOI 10.1016/j.plrev.2006.08.001; De Boer IJM, 2008, COMMUNICATION; de Vries M, 2010, LIVEST SCI, V128, P1, DOI 10.1016/j.livsci.2009.11.007; Demmers TGM, 1999, ATMOS ENVIRON, V33, P217, DOI 10.1016/S1352-2310(98)00150-2; Demmers TGM, 2001, J AGR ENG RES, V79, P107, DOI 10.1006/jaer.2000.0678; Duncan FD, 2002, J EXP BIOL, V205, P791; Egert M, 2003, APPL ENVIRON MICROB, V69, P6659, DOI 10.1128/AEM.69.11.6659-6668.2003; Emekci M, 2004, J STORED PROD RES, V40, P27, DOI 10.1016/S0022-474X(02)00076-0; Emekci M, 2002, J STORED PROD RES, V38, P413, DOI 10.1016/S0022-474X(01)00045-5; Fabbri C, 2007, BIOSYST ENG, V97, P441, DOI 10.1016/j.biosystemseng.2007.03.036; Faulkner WB, 2008, ATMOS ENVIRON, V42, P6567, DOI 10.1016/j.atmosenv.2008.04.021; Friedrich U., 2004, BREEDING FOOD ANIMAL; Gouveia SM, 2000, PHYSIOL ENTOMOL, V25, P88, DOI 10.1046/j.1365-3032.2000.00168.x; Greenlee KJ, 2004, J EXP BIOL, V207, P497, DOI 10.1242/jeb.00767; Guiziou F, 2005, BIORESOURCE TECHNOL, V96, P203, DOI 10.1016/j.biortech.2004.05.009; Gullan PJ, 2005, INSECTS OUTLINE ENTO, P10; HACKSTEIN JHP, 1994, P NATL ACAD SCI USA, V91, P5441, DOI 10.1073/pnas.91.12.5441; Harper LA, 2009, J DAIRY SCI, V92, P2326, DOI 10.3168/jds.2008-1753; HEUSNER AA, 1982, RESP PHYSIOL, V48, P1, DOI 10.1016/0034-5687(82)90046-9; IPCC, 2007, CLIM CHANG 2007 PHYS; Kleiber M., 1961, FIRE LIFE INTRO ANIM; Koerkamp PWGG, 1998, J AGR ENG RES, V70, P79, DOI 10.1006/jaer.1998.0275; Kroon LJM, 2009, INLEIDING ATMOSFEER; Lacey RE, 2002, 2002 ASAE ANN INT M; Lemke R, 2002, COMMUN SOIL SCI PLAN, V33, P2705, DOI 10.1081/CSS-120014474; Li XZ, 2007, PLANT SOIL, V301, P233, DOI 10.1007/s11104-007-9440-0; LIGHTON JRB, 1995, PHYSIOL ZOOL, V68, P43, DOI 10.1086/physzool.68.1.30163917; MAY ML, 1986, PHYSIOL ENTOMOL, V11, P171, DOI 10.1111/j.1365-3032.1986.tb00403.x; NAKAGAKI BJ, 1991, J ECON ENTOMOL, V84, P891, DOI 10.1093/jee/84.3.891; Nicks B, 2003, ANIM RES, V52, P299, DOI 10.1051/animres:2003017; PROTHERO JW, 1979, COMP BIOCHEM PHYS A, V64, P463, DOI 10.1016/0300-9629(79)90572-3; Ramos-Elorduy J, 2008, ECOL FOOD NUTR, V47, P280, DOI 10.1080/03670240701805074; SLANSKY F, 1985, ENTOMOL EXP APPL, V39, P47, DOI 10.1007/BF00338524; Steinfeld H., 2006, LIVESTOCKS LONG SHAD, DOI [10.1890/1540-9295(2007)5[4:D]2.0.CO;2, DOI 10.1890/1540-9295(2007)5[4:D]2.0.CO;2]; Terblanche JS, 2007, PHYSIOL ENTOMOL, V32, P175, DOI 10.1111/j.1365-3032.2006.00549.x; Thorne PS, 2007, ENVIRON HEALTH PERSP, V115, P296, DOI 10.1289/ehp.8831; Van Loon JJA, 2005, OIKOS, V108, P194, DOI 10.1111/j.0030-1299.2005.13079.x; Verstegen M.W.A., 1987, ENERGY METABOLISM FA, P21; Volkova VV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006403; Waldbauer G. P., 1968, P229, DOI 10.1016/S0065-2806(08)60230-1; Wathes CM, 1997, BRIT POULTRY SCI, V38, P14, DOI 10.1080/00071669708417936; Wheeler EF, 2003, AMMONIA EMISSIONS 3; Wrage N, 2001, SOIL BIOL BIOCHEM, V33, P1723, DOI 10.1016/S0038-0717(01)00096-7	59	363	378	11	197	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e14445	10.1371/journal.pone.0014445	http://dx.doi.org/10.1371/journal.pone.0014445			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206900	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793200003
J	Patel, GB; Zhou, HY; Ponce, A; Harris, G; Chen, WX				Patel, Girishchandra B.; Zhou, Hongyan; Ponce, Amalia; Harris, Greg; Chen, Wangxue			Intranasal Immunization with an Archaeal Lipid Mucosal Vaccine Adjuvant and Delivery Formulation Protects against a Respiratory Pathogen Challenge	PLOS ONE			English	Article							FRANCISELLA-TULARENSIS; T-CELLS; GAMMA-INTERFERON; IMMUNE-RESPONSES; IMMUNOGLOBULIN-A; INFECTION; MICE; ANTIBODIES; TULAREMIA; NEUTROPHILS	Archaeal lipid mucosal vaccine adjuvant and delivery (AMVAD) is a safe mucosal adjuvant that elicits long lasting and memory boostable mucosal and systemic immune responses to model antigens such as ovalbumin. In this study, we evaluated the potential of the AMVAD system for eliciting protective immunity against mucosal bacterial infections, using a mouse model of intranasal Francisella tularensis LVS (LVS) challenge. Intranasal immunization of mice with cell free extract of LVS (LVSCE) adjuvanted with the AMVAD system (LVSCE/AMVAD) induced F. tularensis-specific antibody responses in sera and bronchoalveolar lavage fluids, as well as antigen-specific splenocyte proliferation and IL-17 production. More importantly, the AMVAD vaccine partially protected the mice against a lethal intranasal challenge with LVS. Compared to LVSCE immunized and naive mice, the LVSCE/AMVAD immunized mice showed substantial to significant reduction in pathogen burdens in the lungs and spleens, reduced serum and pulmonary levels of proinflammatory cytokines/chemokines, and longer mean time to death as well as significantly higher survival rates (p<0.05). These results suggest that the AMVAD system is a promising mucosal adjuvant and vaccine delivery technology, and should be explored further for its applications in combating mucosal infectious diseases.	[Patel, Girishchandra B.; Zhou, Hongyan; Ponce, Amalia; Harris, Greg; Chen, Wangxue] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	National Research Council Canada	Patel, GB (corresponding author), Natl Res Council Canada, Inst Biol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	girish.patel@nrc-cnrc.gc.ca			Institute for Biological Sciences, National Research Council Canada (a Crown corporation of the Government of Canada)	Institute for Biological Sciences, National Research Council Canada (a Crown corporation of the Government of Canada)	This research was funded from the A-base budget of the Institute for Biological Sciences, National Research Council Canada (a Crown corporation of the Government of Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron SD, 2007, INFECT IMMUN, V75, P2152, DOI 10.1128/IAI.01606-06; Bitsaktsis C, 2009, J IMMUNOL, V182, P4899, DOI 10.4049/jimmunol.0803242; Brandtzaeg P, 2007, VACCINE, V25, P5467, DOI 10.1016/j.vaccine.2006.12.001; CHOQUET CG, 1994, APPL MICROBIOL BIOT, V42, P375, DOI 10.1007/s002530050266; Conlan JW, 2002, MICROB PATHOGENESIS, V32, P127, DOI 10.1006/mpat.2001.0489; Giudice EL, 2006, ADV DRUG DELIVER REV, V58, P68, DOI 10.1016/j.addr.2005.12.003; Holmgren J, 2003, VACCINE, V21, pS89, DOI 10.1016/S0264-410X(03)00206-8; Jakobsen H, 2003, SCAND J IMMUNOL, V58, P119, DOI 10.1046/j.1365-3083.2003.01292.x; Kemble G, 2003, VACCINE, V21, P1789, DOI 10.1016/S0264-410X(03)00074-4; KuoLee R, 2007, VACCINE, V25, P3781, DOI 10.1016/j.vaccine.2007.02.014; KuoLee R, 2007, EXPERT OPIN THER PAT, V17, P267, DOI 10.1517/13543776.17.3.267; Lemoine D, 1998, STP PHARMA SCI, V8, P5; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; Markel G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011176; Mestecky J, 1997, J CONTROL RELEASE, V48, P243, DOI 10.1016/S0168-3659(97)00036-9; Mitragotri S, 2005, NAT REV IMMUNOL, V5, P905, DOI 10.1038/nri1728; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Ogra PL, 2001, CLIN MICROBIOL REV, V14, P430, DOI 10.1128/CMR.14.2.430-445.2001; Patel GB, 2008, INT J TOXICOL, V27, P329, DOI 10.1080/10915810802352703; Patel GB, 2008, J LIPOSOME RES, V18, P127, DOI [10.1080/08982100802129232, 10.1080/08982100802129232 ]; Patel GB, 2007, VACCINE, V25, P8622, DOI 10.1016/j.vaccine.2007.09.042; Ray HJ, 2009, CLIN VACCINE IMMUNOL, V16, P444, DOI 10.1128/CVI.00405-08; RHINEHARTJONES TR, 1994, INFECT IMMUN, V62, P3129, DOI 10.1128/IAI.62.8.3129-3137.1994; Ryan EJ, 2001, TRENDS BIOTECHNOL, V19, P293, DOI 10.1016/S0167-7799(01)01670-5; Singh M, 2002, PHARM RES-DORDR, V19, P715, DOI 10.1023/A:1016104910582; Sjostedt A, 1996, MICROBIOL-UK, V142, P1369, DOI 10.1099/13500872-142-6-1369; Sprott GD, 2003, METHOD ENZYMOL, V373, P155; Stenmark S, 2004, J MED MICROBIOL, V53, P501, DOI 10.1099/jmm.0.05352-0; Stenmark S, 2003, MICROB PATHOGENESIS, V35, P73, DOI 10.1016/S0882-4010(03)00095-0; UNKELESS JC, 1988, ANNU REV IMMUNOL, V6, P251, DOI 10.1146/annurev.iy.06.040188.001343; Van Faassen H, 2007, INFECT IMMUN, V75, P5597, DOI 10.1128/IAI.00762-07; Woolard MD, 2008, INFECT IMMUN, V76, P2651, DOI 10.1128/IAI.01412-07	32	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15574	10.1371/journal.pone.0015574	http://dx.doi.org/10.1371/journal.pone.0015574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206916	Green Submitted, Green Published, gold			2022-12-27	WOS:000285793200027
J	Taves, MD; Schmidt, KL; Ruhr, IM; Kapusta, K; Prior, NH; Soma, KK				Taves, Matthew D.; Schmidt, Kim L.; Ruhr, Ilan M.; Kapusta, Katarzyna; Prior, Nora H.; Soma, Kiran K.			Steroid Concentrations in Plasma, Whole Blood and Brain: Effects of Saline Perfusion to Remove Blood Contamination from Brain	PLOS ONE			English	Article							ACUTE STRESS; RAT-BRAIN; CEREBRAL-ISCHEMIA; SONGBIRD PLASMA; IMMUNE ORGANS; ZEBRA FINCHES; CORTICOSTERONE; CORTISOL; DEHYDROEPIANDROSTERONE; ESTRADIOL	The brain and other organs locally synthesize steroids. Local synthesis is suggested when steroid levels are higher in tissue than in the circulation. However, measurement of both circulating and tissue steroid levels are subject to methodological considerations. For example, plasma samples are commonly used to estimate circulating steroid levels in whole blood, but steroid levels in plasma and whole blood could differ. In addition, tissue steroid measurements might be affected by blood contamination, which can be addressed experimentally by using saline perfusion to remove blood. In Study 1, we measured corticosterone and testosterone (T) levels in zebra finch (Taeniopygia guttata) plasma, whole blood, and red blood cells (RBC). We also compared corticosterone in plasma, whole blood, and RBC at baseline and after 60 min restraint stress. In Study 2, we quantified corticosterone, dehydroepiandrosterone (DHEA), T, and 17 beta-estradiol (E-2) levels in the brains of sham-perfused or saline-perfused subjects. In Study 1, corticosterone and T concentrations were highest in plasma, significantly lower in whole blood, and lowest in RBC. In Study 2, saline perfusion unexpectedly increased corticosterone levels in the rostral telencephalon but not other regions. In contrast, saline perfusion decreased DHEA levels in caudal telencephalon and diencephalon. Saline perfusion also increased E-2 levels in caudal telencephalon. In summary, when comparing local and systemic steroid levels, the inclusion of whole blood samples should prove useful. Moreover, blood contamination has little or no effect on measurement of brain steroid levels, suggesting that saline perfusion is not necessary prior to brain collection. Indeed, saline perfusion itself may elevate and lower steroid concentrations in a rapid, region-specific manner.	[Taves, Matthew D.; Schmidt, Kim L.; Prior, Nora H.; Soma, Kiran K.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Taves, Matthew D.; Ruhr, Ilan M.; Prior, Nora H.; Soma, Kiran K.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Schmidt, Kim L.; Soma, Kiran K.] Univ British Columbia, Grad Program Neurosci, Vancouver, BC V5Z 1M9, Canada; [Kapusta, Katarzyna] Univ Strasbourg, Dept Life Sci, Strasbourg, France	University of British Columbia; University of British Columbia; University of British Columbia; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Taves, MD (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	taves@zoology.ubc.ca	ruhr, ilan/U-4266-2019; Taves, Matthew Donald/AAW-3148-2020; Soma, Kiran K/B-9772-2012	ruhr, ilan/0000-0001-9243-7055; Taves, Matthew Donald/0000-0002-4841-059X; Soma, Kiran K/0000-0003-2169-8092; Schmidt, Kim/0000-0003-2311-9285; Prior, Nora/0000-0002-3271-4409	Canadian Institutes of Health Research (CIHR); Michael Smith Foundation for Health Research; CIHR Frederick Banting and Charles Best Canada Graduate Scholarship; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); CIHR Frederick Banting and Charles Best Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by grants from the Canadian Institutes of Health Research (CIHR) and the Michael Smith Foundation for Health Research to K. K. S. M. D. T. received a CIHR Frederick Banting and Charles Best Canada Graduate Scholarship, and K. L. S. received Natural Sciences and Engineering Research Council of Canada CGS-M and CGS-D Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amateau SK, 2004, ENDOCRINOLOGY, V145, P2906, DOI 10.1210/en.2003-1363; Balthazart J, 2001, J NEUROENDOCRINOL, V13, P63, DOI 10.1046/j.1365-2826.2001.00598.x; Balthazart J, 2006, TRENDS NEUROSCI, V29, P241, DOI 10.1016/j.tins.2006.03.004; BARKS JDE, 1991, PEDIATR RES, V29, P558, DOI 10.1203/00006450-199106010-00008; BELANGER A, 1990, ANN NY ACAD SCI, V595, P251, DOI 10.1111/j.1749-6632.1990.tb34299.x; Bradbury MWB, 1979, CONCEPT BLOOD BRAIN; Breuner CW, 2006, HORM METAB RES, V38, P260, DOI 10.1055/s-2006-925347; Brummelte S, 2010, DEV NEUROBIOL, V70, P714, DOI 10.1002/dneu.20805; Charlier TD, 2010, GEN COMP ENDOCR, V167, P18, DOI 10.1016/j.ygcen.2010.02.002; Charlier TD, 2009, HORM BEHAV, V56, P339, DOI 10.1016/j.yhbeh.2009.06.012; Cohen J., 1988, STAT POWER ANAL BEHA; Do Rego JL, 2009, FRONT NEUROENDOCRIN, V30, P259, DOI 10.1016/j.yfrne.2009.05.006; Drabkin DL, 1932, J BIOL CHEM, V98, P719; Dubal DB, 1999, J NEUROSCI, V19, P6385; Dunlap WP, 1996, PSYCHOL METHODS, V1, P170, DOI 10.1037/1082-989X.1.2.170; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gomez-Sanchez EP, 2005, AM J PHYSIOL-ENDOC M, V288, pE342, DOI 10.1152/ajpendo.00355.2004; GomezSanchez CE, 1997, ENDOCRINOLOGY, V138, P3369, DOI 10.1210/en.138.8.3369; Goodson JL, 2005, HORM BEHAV, V48, P461, DOI 10.1016/j.yhbeh.2005.04.005; Granger DA, 1999, PSYCHONEUROENDOCRINO, V24, P567, DOI 10.1016/S0306-4530(99)00013-X; Granger DA, 1999, HORM BEHAV, V35, P18, DOI 10.1006/hbeh.1998.1492; HIRAMATSU R, 1983, CLIN CHIM ACTA, V134, P143; HIRAMATSU R, 1987, J CLIN ENDOCR METAB, V64, P1224, DOI 10.1210/jcem-64-6-1224; HIRAMATSU R, 1991, J STEROID BIOCHEM, V38, P383, DOI 10.1016/0960-0760(91)90111-H; Hojo Y, 2009, ENDOCRINOLOGY, V150, P5106, DOI 10.1210/en.2009-0305; HOLTKAMP HC, 1975, CLIN CHIM ACTA, V59, P41, DOI 10.1016/0009-8981(75)90216-8; Ito N, 2005, FASEB J, V19, P1332, DOI 10.1096/fj.04-1968fje; Little HJ, 2008, NEUROSCIENCE, V156, P1017, DOI 10.1016/j.neuroscience.2008.08.029; Newman AEM, 2008, GEN COMP ENDOCR, V155, P503, DOI 10.1016/j.ygcen.2007.08.007; Newman AEM, 2008, ENDOCRINOLOGY, V149, P2537, DOI 10.1210/en.2007-1363; Newman AEM, 2010, J COMP NEUROL, V518, P3662, DOI 10.1002/cne.22395; Newman AEM, 2009, EUR J NEUROSCI, V29, P1905, DOI 10.1111/j.1460-9568.2009.06748.x; Payne RS, 2003, BRAIN RES, V971, P9, DOI 10.1016/S0006-8993(03)02276-5; Pradhan DS, 2008, J NEUROCHEM, V104, P244, DOI 10.1111/j.1471-4159.2007.04953.x; Pradhan DS, 2010, J NEUROCHEM, V115, P667, DOI 10.1111/j.1471-4159.2010.06954.x; Pradhan DS, 2010, HORM BEHAV, V57, P381, DOI 10.1016/j.yhbeh.2010.01.008; Remage-Healey L, 2008, NAT NEUROSCI, V11, P1327, DOI 10.1038/nn.2200; Remage-Healey L, 2010, J CHEM NEUROANAT, V39, P72, DOI 10.1016/j.jchemneu.2009.06.009; Roberts JR, 1998, J COMP PHYSIOL B, V168, P25, DOI 10.1007/s003600050117; Romero LM, 1998, AM J PHYSIOL-REG I, V274, pR1338; Saldanha CJ, 2000, J COMP NEUROL, V423, P619, DOI 10.1002/1096-9861(20000807)423:4<619::AID-CNE7>3.0.CO;2-U; Saleh Tarek M, 2004, J Stroke Cerebrovasc Dis, V13, P24, DOI 10.1016/j.jstrokecerebrovasdis.2004.01.003; SAPOLSKY RM, 1985, SCIENCE, V229, P1397, DOI 10.1126/science.4035356; Schmidt KL, 2008, GEN COMP ENDOCR, V157, P266, DOI 10.1016/j.ygcen.2008.03.025; Schmidt KL, 2008, AM J PHYSIOL-REG I, V295, pR103, DOI 10.1152/ajpregu.00002.2008; Schmidt KL, 2010, BRAIN BEHAV IMMUN, V24, P908, DOI 10.1016/j.bbi.2010.02.008; Schmidt KL, 2009, AM J PHYSIOL-REG I, V297, pR42, DOI 10.1152/ajpregu.90964.2008; Soma KK, 2004, ENDOCRINOLOGY, V145, P1668, DOI 10.1210/en.2003-0883; VACCHIO MS, 1994, J EXP MED, V179, P1835, DOI 10.1084/jem.179.6.1835; Wagner EC, 2008, J EXP BIOL, V211, P400, DOI 10.1242/jeb.011205; Wang MD, 1997, J STEROID BIOCHEM, V62, P299, DOI 10.1016/S0960-0760(97)00041-1; Washburn BE, 2002, CONDOR, V104, P558, DOI 10.1650/0010-5422(2002)104[0558:UACART]2.0.CO;2; Ye P, 2003, ENDOCRINOLOGY, V144, P3321, DOI 10.1210/en.2003-0109	53	44	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15727	10.1371/journal.pone.0015727	http://dx.doi.org/10.1371/journal.pone.0015727			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206751	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793200044
J	Berrocal-Lobo, M; Stone, S; Yang, X; Antico, J; Callis, J; Ramonell, KM; Somerville, S				Berrocal-Lobo, Marta; Stone, Sophia; Yang, Xin; Antico, Jay; Callis, Judy; Ramonell, Katrina M.; Somerville, Shauna			ATL9, a RING Zinc Finger Protein with E3 Ubiquitin Ligase Activity Implicated in Chitin- and NADPH Oxidase-Mediated Defense Responses	PLOS ONE			English	Article							RECEPTOR-LIKE KINASE; MILDEW DISEASE RESISTANCE; INNATE IMMUNE-RESPONSE; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; PLANT-DEFENSE; SACCHAROMYCES-CEREVISIAE; CONSTITUTIVE EXPRESSION; BACTERIAL PATHOGENESIS; ENDOPLASMIC-RETICULUM	Pathogen associated molecular patterns (PAMPs) are signals detected by plants that activate basal defenses. One of these PAMPs is chitin, a carbohydrate present in the cell walls of fungi and in insect exoskeletons. Previous work has shown that chitin treatment of Arabidopsis thaliana induced defense-related genes in the absence of a pathogen and that the response was independent of the salicylic acid (SA), jasmonic acid (JA) and ethylene (ET) signaling pathways. One of these genes is ATL9 (=ATL2G), which encodes a RING zinc-finger like protein. In the current work we demonstrate that ATL9 has E3 ubiquitin ligase activity and is localized to the endoplasmic reticulum. The expression pattern of ATL9 is positively correlated with basal defense responses against Golovinomyces cichoracearum, a biotrophic fungal pathogen. The basal levels of expression and the induction of ATL9 by chitin, in wild type plants, depends on the activity of NADPH oxidases suggesting that chitin-mediated defense response is NADPH oxidase dependent. Although ATL9 expression is not induced by treatment with known defense hormones (SA, JA or ET), full expression in response to chitin is compromised slightly in mutants where ET-or SA-dependent signaling is suppressed. Microarray analysis of the atl9 mutant revealed candidate genes that appear to act downstream of ATL9 in chitin-mediated defenses. These results hint at the complexity of chitin-mediated signaling and the potential interplay between elicitor-mediated signaling, signaling via known defense pathways and the oxidative burst.	[Berrocal-Lobo, Marta; Somerville, Shauna] Carnegie Inst, Dept Plant Biol, Stanford, CA USA; [Yang, Xin; Antico, Jay; Ramonell, Katrina M.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL USA; [Stone, Sophia; Callis, Judy] Univ Calif Davis, Sect Mol & Cellular Biol, Davis, CA 95616 USA	Carnegie Institution for Science; University of Alabama System; University of Alabama Tuscaloosa; University of California System; University of California Davis	Berrocal-Lobo, M (corresponding author), Univ Politecn Madrid, UPM INIA, CBGP, Campus Montegancedo, Madrid, Spain.	kramonel@bama.ua.edu	Berrocal-Lobo, Marta/B-3482-2018	Berrocal-Lobo, Marta/0000-0002-4711-9338; Callis, Judy/0000-0002-0622-078X; Stone, Sophia/0000-0003-2140-6037	Carnegie Institution of Washington; Secretaria de Estado de Educacion y Universidades; Fondo Social Europeo, MECD/Fullbright (Spain); University of Alabama; National Institutes of Health [1-R15-GM073630-01]; U.S. Department of Agriculture [2007-01652]; National Science Foundation; Carnegie Institution; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM073630] Funding Source: NIH RePORTER	Carnegie Institution of Washington; Secretaria de Estado de Educacion y Universidades; Fondo Social Europeo, MECD/Fullbright (Spain)(European Social Fund (ESF)); University of Alabama; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF)); Carnegie Institution; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Marta Berrocal-Lobo was supported by the Carnegie Institution of Washington and a postdoctoral fellowship from the Secretaria de Estado de Educacion y Universidades and Fondo Social Europeo, MECD/Fullbright (Spain). Katrina M. Ramonell was supported by the University of Alabama and by grants from the National Institutes of Health (grant no. 1-R15-GM073630-01) and the U.S. Department of Agriculture (grant no. 2007-01652 to K.M.R.). This work was supported in part by the National Science Foundation and the Carnegie Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam L, 1996, PLANT J, V9, P341, DOI 10.1046/j.1365-313X.1996.09030341.x; Aguilar-Henonin L, 2006, CURR GENET, V50, P257, DOI 10.1007/s00294-006-0093-y; Albert P, 2005, PLANT CELL PHYSIOL, V46, pS122; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Torres MA, 2010, PHYSIOL PLANTARUM, V138, P414, DOI 10.1111/j.1399-3054.2009.01326.x; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; Berrocal-Lobo M, 2002, PLANT J, V29, P23, DOI 10.1046/j.1365-313x.2002.01191.x; Bopopi JM, 2010, J EXP BOT, V61, P297, DOI 10.1093/jxb/erp305; Chinchilla D, 2009, TRENDS PLANT SCI, V14, P535, DOI 10.1016/j.tplants.2009.08.002; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; DEBLAERE R, 1987, METHOD ENZYMOL, V153, P277; Delaure SL, 2008, PLANT SCI, V174, P375, DOI 10.1016/j.plantsci.2008.01.008; Durrant WE, 2000, PLANT CELL, V12, P963, DOI 10.1105/tpc.12.6.963; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Gomez-Gomez L, 2004, MOL IMMUNOL, V41, P1055, DOI 10.1016/j.molimm.2004.06.008; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; Hammond-Kosack KE, 1998, PLANT CELL, V10, P1251, DOI 10.1105/tpc.10.8.1251; Hardtke CS, 2002, PLANT J, V30, P385, DOI 10.1046/j.1365-313X.2002.01298.x; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hondo D, 2007, MOL PLANT MICROBE IN, V20, P72, DOI 10.1094/MPMI-20-0072; Hong JK, 2007, PLANT MOL BIOL, V63, P571, DOI 10.1007/s11103-006-9110-2; Ingvardsen C, 2001, PHYSIOL PLANTARUM, V112, P451, DOI 10.1034/j.1399-3054.2001.1120401.x; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Katoh S, 2003, J BIOL CHEM, V278, P15341, DOI 10.1074/jbc.M210531200; Kawchuk LM, 2001, P NATL ACAD SCI USA, V98, P6511, DOI 10.1073/pnas.091114198; KG KMR, 2007, GENE REGULATION SYST, V1, P167; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Libault M, 2007, MOL PLANT MICROBE IN, V20, P900, DOI 10.1094/MPMI-20-8-0900; Liu Y, 2002, PLANT CELL, V14, P1483, DOI 10.1105/tpc.002493; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; MartinezGarcia M, 1996, MOL GEN GENET, V252, P587, DOI 10.1007/s004380050266; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Michels J, 2005, INT J BIOCHEM CELL B, V37, P267, DOI 10.1016/j.biocel.2004.04.007; Miller G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000448; Mudgett MB, 1999, MOL MICROBIOL, V32, P927, DOI 10.1046/j.1365-2958.1999.01403.x; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Nishimura MT, 2003, SCIENCE, V301, P969, DOI 10.1126/science.1086716; Osbourn AE, 1996, PLANT CELL, V8, P1821, DOI 10.1105/tpc.8.10.1821; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramonell K, 2005, PLANT PHYSIOL, V138, P1027, DOI 10.1104/pp.105.060947; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Roden J, 2004, MOL PLANT MICROBE IN, V17, P633, DOI 10.1094/MPMI.2004.17.6.633; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Rowland O, 2005, PLANT CELL, V17, P295, DOI 10.1105/tpc.104.026013; Salinas-Mondragon RE, 1999, PLANT MOL BIOL, V40, P579, DOI 10.1023/A:1006267201855; SCHIEFELBEIN JW, 1990, PLANT CELL, V2, P235, DOI 10.1105/tpc.2.3.235; Serrano M, 2006, J MOL EVOL, V62, P434, DOI 10.1007/s00239-005-0038-y; Serrano M, 2004, GENETICS, V167, P919, DOI 10.1534/genetics.104.028043; Serrano M, 2007, J BIOL CHEM, V282, P6803, DOI 10.1074/jbc.M608792200; Shirasu K, 2003, TRENDS PLANT SCI, V8, P252, DOI 10.1016/S1360-1385(03)00104-3; Solano R, 1998, CURR OPIN PLANT BIOL, V1, P393, DOI 10.1016/S1369-5266(98)80262-8; Spoel SH, 2007, P NATL ACAD SCI USA, V104, P18842, DOI 10.1073/pnas.0708139104; Takai R, 2002, PLANT CELL PHYSIOL, V43, pS154; Takai R, 2002, PLANT J, V30, P447, DOI 10.1046/j.1365-313X.2002.01299.x; Takemoto D, 2003, PLANT J, V33, P775, DOI 10.1046/j.1365-313X.2003.01673.x; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Vogel J, 2000, P NATL ACAD SCI USA, V97, P1897, DOI 10.1073/pnas.030531997; WALTHERLARSEN H, 1993, PLANT MOL BIOL, V21, P1097, DOI 10.1007/BF00023606; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Wang YS, 2006, PLANT CELL, V18, P3635, DOI 10.1105/tpc.106.046730; Wilson IW, 2001, GENETICS, V158, P1301; Xu WH, 2006, PLANT J, V45, P740, DOI 10.1111/j.1365-313X.2005.02638.x; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Zeng LR, 2006, CELL RES, V16, P413, DOI 10.1038/sj.cr.7310053; Zhang B, 2002, MOL PLANT MICROBE IN, V15, P963, DOI 10.1094/MPMI.2002.15.9.963; Zimmerli L, 2004, PLANT J, V40, P633, DOI 10.1111/j.1365-313X.2004.02236.x; Zipfel C, 2008, CURR OPIN IMMUNOL, V20, P10, DOI 10.1016/j.coi.2007.11.003; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	81	68	74	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							14426	10.1371/journal.pone.0014426	http://dx.doi.org/10.1371/journal.pone.0014426			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203445	Green Published, Green Submitted, gold			2022-12-27	WOS:000285579200008
J	Agrillo, C; Piffer, L; Bisazza, A				Agrillo, Christian; Piffer, Laura; Bisazza, Angelo			Large Number Discrimination by Mosquitofish	PLOS ONE			English	Article							COTTON-TOP TAMARINS; NUMERICAL COMPETENCE; QUANTITY DISCRIMINATION; PERCEIVED NUMEROSITY; FEMALE MOSQUITOFISH; ANALOG MAGNITUDES; RHESUS-MONKEYS; INFANTS; REPRESENTATIONS; JUDGMENTS	0Background: Recent studies have demonstrated that fish display rudimentary numerical abilities similar to those observed in mammals and birds. The mechanisms underlying the discrimination of small quantities (, 4) were recently investigated while, to date, no study has examined the discrimination of large numerosities in fish. Methodology/Principal Findings: Subjects were trained to discriminate between two sets of small geometric figures using social reinforcement. In the first experiment mosquitofish were required to discriminate 4 from 8 objects with or without experimental control of the continuous variables that co-vary with number (area, space, density, total luminance). Results showed that fish can use the sole numerical information to compare quantities but that they preferentially use cumulative surface area as a proxy of the number when this information is available. A second experiment investigated the influence of the total number of elements to discriminate large quantities. Fish proved to be able to discriminate up to 100 vs. 200 objects, without showing any significant decrease in accuracy compared with the 4 vs. 8 discrimination. The third experiment investigated the influence of the ratio between the numerosities. Performance was found to decrease when decreasing the numerical distance. Fish were able to discriminate numbers when ratios were 1: 2 or 2: 3 but not when the ratio was 3: 4. The performance of a sample of undergraduate students, tested non-verbally using the same sets of stimuli, largely overlapped that of fish. Conclusions/Significance: Fish are able to use pure numerical information when discriminating between quantities larger than 4 units. As observed in human and non-human primates, the numerical system of fish appears to have virtually no upper limit while the numerical ratio has a clear effect on performance. These similarities further reinforce the view of a common origin of non-verbal numerical systems in all vertebrates.	[Agrillo, Christian; Piffer, Laura; Bisazza, Angelo] Univ Padua, Dept Gen Psychol, Padua, Italy	University of Padua	Agrillo, C (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	christian.agrillo@unipd.it		Bisazza, Angelo/0000-0003-0209-7638; Agrillo, Christian/0000-0002-7391-8934	University of Padova to Angelo Bisazza	University of Padova to Angelo Bisazza	Research Grant "Progetto di Ateneo" from University of Padova to Angelo Bisazza. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrillo C, 2007, ETHOL ECOL EVOL, V19, P145, DOI 10.1080/08927014.2007.9522574; Agrillo C, 2008, ANIM COGN, V11, P495, DOI 10.1007/s10071-008-0140-9; Agrillo C, 2007, ANIM COGN, V10, P63, DOI 10.1007/s10071-006-0036-5; Agrillo C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004786; Al Ain S, 2009, ANIM COGN, V12, P145, DOI 10.1007/s10071-008-0178-8; Barth H, 2003, COGNITION, V86, P201, DOI 10.1016/S0010-0277(02)00178-6; Beran MJ, 2008, PLOS BIOL, V6, P221, DOI 10.1371/journal.pbio.0060019; Beran MJ, 2008, AM J PRIMATOL, V70, P191, DOI 10.1002/ajp.20474; BISAZZA A, 1995, ETHOL ECOL EVOL, V7, P169, DOI 10.1080/08927014.1995.9522963; Bisazza A, 2010, ECOLOGY EVOLUTION PO; Bonanni R, 2011, ANIM COGN, V14, P103, DOI 10.1007/s10071-010-0348-3; Brannon EM, 2001, PSYCHOL SCI, V12, P238, DOI 10.1111/1467-9280.00342; Brown C, 2003, FISH FISH, V4, P280, DOI 10.1046/j.1467-2979.2003.00122.x; Bshary R, 2002, ANIM COGN, V5, P1, DOI 10.1007/s10071-001-0116-5; Buckingham JN, 2007, BEHAVIOUR, V144, P1333, DOI 10.1163/156853907782418196; Cantlon JF, 2007, PLOS BIOL, V5, P2912, DOI 10.1371/journal.pbio.0050328; Cantlon JF, 2006, PSYCHOL SCI, V17, P401, DOI 10.1111/j.1467-9280.2006.01719.x; Chiandetti C, 2008, ANIM COGN, V11, P139, DOI 10.1007/s10071-007-0099-y; Chittka L, 2009, CURR BIOL, V19, pR995, DOI 10.1016/j.cub.2009.08.023; Clearfield MW, 1999, PSYCHOL SCI, V10, P408, DOI 10.1111/1467-9280.00177; Dadda M, 2009, COGNITION, V112, P343, DOI 10.1016/j.cognition.2009.05.009; DAVIS H, 1988, BEHAV BRAIN SCI, V11, P561, DOI 10.1017/S0140525X00053437; DURGIN FH, 1995, J EXP PSYCHOL HUMAN, V21, P149, DOI 10.1037/0096-1523.21.1.149; Emmerton J, 2009, ANIM COGN, V12, P511, DOI 10.1007/s10071-009-0212-5; Feigenson L, 2002, PSYCHOL SCI, V13, P150, DOI 10.1111/1467-9280.00427; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Flombaum JI, 2005, COGNITION, V97, P315, DOI 10.1016/j.cognition.2004.09.004; Gomez-Laplaza LM, 2011, ANIM COGN, V14, P1, DOI 10.1007/s10071-010-0337-6; Gross HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004263; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Halberda J, 2008, DEV PSYCHOL, V44, P1457, DOI 10.1037/a0012682; Hauser MD, 2000, P ROY SOC B-BIOL SCI, V267, P829, DOI 10.1098/rspb.2000.1078; Hauser MD, 2003, P ROY SOC B-BIOL SCI, V270, P1441, DOI 10.1098/rspb.2003.2414; HOLLINGSWORTH WH, 1991, B PSYCHONOMIC SOC, V29, P448; Hope T, 2010, COGNITIVE SCI, V34, P406, DOI 10.1111/j.1551-6709.2009.01079.x; Hunt S, 2008, P ROY SOC B-BIOL SCI, V275, P2373, DOI 10.1098/rspb.2008.0702; Izard V, 2009, P NATL ACAD SCI USA, V106, P10382, DOI 10.1073/pnas.0812142106; Jordan KE, 2006, J EXP CHILD PSYCHOL, V95, P215, DOI 10.1016/j.jecp.2006.05.004; Kilian A, 2003, LEARN BEHAV, V31, P133; Koehler O., 1950, B ANIMAL BEHAVIOUR, V9, P41, DOI [10.1037/0033-2909.92.3.547, DOI 10.1037/0033-2909.92.3.547]; Lipton JS, 2003, PSYCHOL SCI, V14, P396, DOI 10.1111/1467-9280.01453; Lyon BE, 2003, NATURE, V422, P495, DOI 10.1038/nature01505; Matsuzawa T, 2009, CURR OPIN NEUROBIOL, V19, P92, DOI 10.1016/j.conb.2009.04.007; MCCOMB K, 1994, ANIM BEHAV, V47, P379, DOI 10.1006/anbe.1994.1052; Pisa P, 2009, J ETHOL, V27, P289, DOI 10.1007/s10164-008-0121-0; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Revkin SK, 2008, PSYCHOL SCI, V19, P607, DOI 10.1111/j.1467-9280.2008.02130.x; Rugani R, 2009, P ROY SOC B-BIOL SCI, V276, P2451, DOI 10.1098/rspb.2009.0044; Stevens JR, 2007, ANIM COGN, V10, P429, DOI 10.1007/s10071-007-0081-8; Suzuki K, 2000, J COMP PSYCHOL, V114, P73, DOI 10.1037//0735-7036.114.1.73; Tomonaga M, 2002, ANIM LEARN BEHAV, V30, P143, DOI 10.3758/BF03192916; TRICK LM, 1994, PSYCHOL REV, V101, P80, DOI 10.1037/0033-295X.101.1.80; Uller C, 1999, COGNITIVE DEV, V14, P1, DOI 10.1016/S0885-2014(99)80016-1; Uller C, 2003, ANIM COGN, V6, P105, DOI 10.1007/s10071-003-0167-x; vanMarle K, 2009, COGNITION, V111, P302, DOI 10.1016/j.cognition.2009.01.011; Ward C, 2007, ANIM COGN, V10, P71, DOI 10.1007/s10071-006-0042-7; West RE, 2002, ANIM COGN, V5, P183, DOI 10.1007/s10071-002-0140-0; White DJ, 2009, PSYCHOL SCI, V20, P1140, DOI 10.1111/j.1467-9280.2009.02418.x; Xu F, 2007, BRIT J DEV PSYCHOL, V25, P103, DOI 10.1348/026151005X90704	59	64	64	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15232	10.1371/journal.pone.0015232	http://dx.doi.org/10.1371/journal.pone.0015232			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	698FG	21203508	Green Published, Green Submitted, gold			2022-12-27	WOS:000285578000024
J	Anafi, RC; Bates, JHT				Anafi, Ron C.; Bates, Jason H. T.			Balancing Robustness against the Dangers of Multiple Attractors in a Hopfield-Type Model of Biological Attractors	PLOS ONE			English	Article							NETWORKS; COMPLEX	Background: Many chronic human diseases are of unclear origin, and persist long beyond any known insult or instigating factor. These diseases may represent a structurally normal biologic network that has become trapped within the basin of an abnormal attractor. Methodology/Principal Findings: We used the Hopfield net as the archetypical example of a dynamic biological network. By progressively removing the links of fully connected Hopfield nets, we found that a designated attractor of the nets could still be supported until only slightly more than 1 link per node remained. As the number of links approached this minimum value, the rate of convergence to this attractor from an arbitrary starting state increased dramatically. Furthermore, with more than about twice the minimum of links, the net became increasingly able to support a second attractor. Conclusions/Significance: We speculate that homeostatic biological networks may have evolved to assume a degree of connectivity that balances robustness and agility against the dangers of becoming trapped in an abnormal attractor.	[Anafi, Ron C.] Univ Penn, Div Sleep Med, Philadelphia, PA 19104 USA; [Bates, Jason H. T.] Univ Vermont, Dept Med, Burlington, VT USA	University of Pennsylvania; University of Vermont	Anafi, RC (corresponding author), Univ Penn, Div Sleep Med, Philadelphia, PA 19104 USA.	jason.h.bates@uvm.edu			American Sleep Medicine Physician Scientist grant; NIH (NCRR COBRE) [RR15557HL87788]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015557] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL087788] Funding Source: NIH RePORTER	American Sleep Medicine Physician Scientist grant; NIH (NCRR COBRE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors acknowledge the financial support of an American Sleep Medicine Physician Scientist grant and the NIH (NCRR COBRE RR15557 and HL87788). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini Carlo, 2006, Proc Am Thorac Soc, V3, P357, DOI 10.1513/pats.200601-010TK; Bar-Yam Y, 2004, P NATL ACAD SCI USA, V101, P4341, DOI 10.1073/pnas.0400673101; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bray D, 2003, SCIENCE, V301, P1864, DOI 10.1126/science.1089118; Castillo IP, 2004, J PHYS A-MATH GEN, V37, P8789, DOI 10.1088/0305-4470/37/37/002; Cavalcante FSA, 2005, J APPL PHYSIOL, V98, P672, DOI 10.1152/japplphysiol.00619.2004; DERRIDA B, 1988, J PHYS A, V22, P2069; Detours V, 1996, J THEOR BIOL, V183, P409, DOI 10.1006/jtbi.1996.0231; Haykin S, NEURAL NETWORKS LEAR; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; KAUFFMAN S, 1971, J THEOR BIOL, V31, P429, DOI 10.1016/0022-5193(71)90020-8; Li X, 2007, J BIOMED INFORM, V40, P453, DOI 10.1016/j.jbi.2007.01.001; Macklem PT, 2008, J APPL PHYSIOL, V104, P1844, DOI 10.1152/japplphysiol.00942.2007; MORIN CM, 2005, PRINCIPLES PRACTICE; Oshima H, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036114; Paris L, 2008, MOL BIOL CELL, V19, P5409, DOI 10.1091/mbc.E08-05-0477; PERLIS ML, 2005, PRINCIPLES PRACTICE, P726; Prigogine I., 1984, ORDER OUT CHAOS; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Ribeiro AS, 2007, J THEOR BIOL, V247, P743, DOI 10.1016/j.jtbi.2007.04.020; Segel LA, 1998, BIOPHYS CHEM, V72, P223, DOI 10.1016/S0301-4622(98)00136-7; Stauffer D, 2003, EUR PHYS J B, V32, P395, DOI 10.1140/epjb/e2003-00114-7; Sul JY, 2009, P NATL ACAD SCI USA, V106, P7624, DOI 10.1073/pnas.0902161106	24	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14413	10.1371/journal.pone.0014413	http://dx.doi.org/10.1371/journal.pone.0014413			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203505	Green Published, Green Submitted, gold			2022-12-27	WOS:000285578000016
J	Zhang, DD; Qian, YD; Akula, N; Alliey-Rodriguez, N; Tang, JS; Gershon, ES; Liu, CY				Zhang, Dandan; Qian, Yudong; Akula, Nirmala; Alliey-Rodriguez, Ney; Tang, Jinsong; Gershon, Elliot S.; Liu, Chunyu		Bipolar Genome Study	Accuracy of CNV Detection from GWAS Data	PLOS ONE			English	Article							COPY-NUMBER VARIATION; HIDDEN-MARKOV MODEL; SNP GENOTYPING DATA; HUMAN GENOME; BIPOLAR DISORDER; INCREASE RISK; SCHIZOPHRENIA; POLYMORPHISM; ASSOCIATION; ABERRATIONS	Several computer programs are available for detecting copy number variants (CNVs) using genome-wide SNP arrays. We evaluated the performance of four CNV detection software suites-Birdsuite, Partek, HelixTree, and PennCNV-Affy-in the identification of both rare and common CNVs. Each program's performance was assessed in two ways. The first was its recovery rate, i.e., its ability to call 893 CNVs previously identified in eight HapMap samples by paired-end sequencing of whole-genome fosmid clones, and 51,440 CNVs identified by array Comparative Genome Hybridization (aCGH) followed by validation procedures, in 90 HapMap CEU samples. The second evaluation was program performance calling rare and common CNVs in the Bipolar Genome Study (BiGS) data set (1001 bipolar cases and 1033 controls, all of European ancestry) as measured by the Affymetrix SNP 6.0 array. Accuracy in calling rare CNVs was assessed by positive predictive value, based on the proportion of rare CNVs validated by quantitative real-time PCR (qPCR), while accuracy in calling common CNVs was assessed by false positive/false negative rates based on qPCR validation results from a subset of common CNVs. Birdsuite recovered the highest percentages of known HapMap CNVs containing >20 markers in two reference CNV datasets. The recovery rate increased with decreased CNV frequency. In the tested rare CNV data, Birdsuite and Partek had higher positive predictive values than the other software suites. In a test of three common CNVs in the BiGS dataset, Birdsuite's call was 98.8% consistent with qPCR quantification in one CNV region, but the other two regions showed an unacceptable degree of accuracy. We found relatively poor consistency between the two "gold standards,'' the sequence data of Kidd et al., and aCGH data of Conrad et al. Algorithms for calling CNVs especially common ones need substantial improvement, and a "gold standard'' for detection of CNVs remains to be established.	[Zhang, Dandan] Zhejiang Univ, Sch Med, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Dandan; Qian, Yudong; Alliey-Rodriguez, Ney; Gershon, Elliot S.; Liu, Chunyu] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Akula, Nirmala] NIMH, Intramural Res Programs, Bethesda, MD 20892 USA; [Tang, Jinsong] Cent S Univ, Xiangya Hosp 2, Inst Mental Hlth, Changsha, Hunan, Peoples R China	Zhejiang University; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Central South University	Zhang, DD (corresponding author), Zhejiang Univ, Sch Med, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China.	egershon@yoda.bsd.uchicago.edu; cliu@yoda.bsd.uchicago.edu	Liu, chunyu/Q-3901-2017; Greenwood, Tiffany/F-6356-2012; Liu, Chunyu/G-7561-2012; Smith, Erin/E-5933-2011; Zhang, Dandan/ABA-9747-2020; Mahon, Pamela Belmonte/O-9806-2018; McMahon, Francis J/A-7290-2009	Greenwood, Tiffany/0000-0002-6080-6503; Liu, Chunyu/0000-0002-5986-4415; Mahon, Pamela Belmonte/0000-0002-3947-441X; McMahon, Francis J/0000-0002-9469-305X; Alliey-Rodriguez, Ney/0000-0001-8594-5676; zhang, dandan/0000-0001-5305-9856	National Institute of Mental Health [R01MH080425, 1R01MH081804]; National Alliance for Research on Schizophrenia and Depression [R01MH081804]; Eklund family; Geraldi Norton Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081804, R01MH080425, ZIAMH002843] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Alliance for Research on Schizophrenia and Depression(NARSAD); Eklund family; Geraldi Norton Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from The National Institute of Mental Health, R01MH080425 and 1R01MH081804, The National Alliance for Research on Schizophrenia and Depression, R01MH081804, the Eklund family, and the Geraldi Norton Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baross A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-368; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cooper GM, 2008, NAT GENET, V40, P1199, DOI 10.1038/ng.236; Diskin SJ, 2006, GENOME RES, V16, P1149, DOI 10.1101/gr.5076506; Henrichsen CN, 2009, HUM MOL GENET, V18, pR1, DOI 10.1093/hmg/ddp011; Huang Jing, 2004, Human Genomics, V1, P287; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; MARENNE G, 2010, HUM MUTAT IN PRESS; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Mei TS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-147; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pique-Regi R, 2008, BIOINFORMATICS, V24, P309, DOI 10.1093/bioinformatics/btm601; Pradervand S, 2009, RNA, V15, P493, DOI 10.1261/rna.1295509; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Winchester Laura, 2009, Briefings in Functional Genomics & Proteomics, V8, P353, DOI 10.1093/bfgp/elp017; Zhang D, 2009, MOL PSYCHIATR, V14, P376, DOI 10.1038/mp.2008.144; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308	33	47	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e14511	10.1371/journal.pone.0014511	http://dx.doi.org/10.1371/journal.pone.0014511			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249187	Green Published, gold, Green Submitted			2022-12-27	WOS:000286515000001
J	Tam, JM; Castro, CE; Heath, RJW; Cardenas, ML; Xavier, RJ; Lang, MJ; Vyas, JM				Tam, Jenny M.; Castro, Carlos E.; Heath, Robert J. W.; Cardenas, Michael L.; Xavier, Ramnik J.; Lang, Matthew J.; Vyas, Jatin M.			Control and Manipulation of Pathogens with an Optical Trap for Live Cell Imaging of Intercellular Interactions	PLOS ONE			English	Article							ATTRIBUTABLE MORTALITY; T-CELLS; PHAGOCYTOSIS; PARTICLES; TWEEZERS; FORCE; ACTIVATION; CANDIDEMIA; MICROSCOPY; SYNAPSES	The application of live cell imaging allows direct visualization of the dynamic interactions between cells of the immune system. Some preliminary observations challenge long-held beliefs about immune responses to microorganisms; however, the lack of spatial and temporal control between the phagocytic cell and microbe has rendered focused observations into the initial interactions of host response to pathogens difficult. This paper outlines a method that advances live cell imaging by integrating a spinning disk confocal microscope with an optical trap, also known as an optical tweezer, in order to provide exquisite spatial and temporal control of pathogenic organisms and place them in proximity to host cells, as determined by the operator. Polymeric beads and live, pathogenic organisms (Candida albicans and Aspergillus fumigatus) were optically trapped using non-destructive forces and moved adjacent to living cells, which subsequently phagocytosed the trapped particle. High resolution, transmitted light and fluorescence-based movies established the ability to observe early events of phagocytosis in living cells. To demonstrate the broad applicability of this method to immunological studies, anti-CD3 polymeric beads were also trapped and manipulated to form synapses with T cells in vivo, and time-lapse imaging of synapse formation was also obtained. By providing a method to exert fine control of live pathogens with respect to immune cells, cellular interactions can be captured by fluorescence microscopy with minimal perturbation to cells and can yield powerful insight into early responses of innate and adaptive immunity.	[Tam, Jenny M.; Cardenas, Michael L.; Vyas, Jatin M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Infect Dis, Boston, MA 02115 USA; [Castro, Carlos E.; Lang, Matthew J.] MIT, Cambridge, MA 02139 USA; [Heath, Robert J. W.; Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Computat & Integrat Biol, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts General Hospital	Tam, JM (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Infect Dis, Boston, MA 02115 USA.	jvyas@partners.org	Vyas, Jatin/Q-1627-2016; Castro, Carlos E/D-8756-2016	Vyas, Jatin/0000-0002-9985-9565; Castro, Carlos E/0000-0001-7023-6105; Heath, Robert/0000-0001-6675-7573	Massachusetts General Hospital Department of Medicine; National Institute of Biomedical Imaging and Bioengineering [T32EB006348]; Massachusetts General Hospital's Center for Computational and Integrative Biology [AI062773]; National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) [AI057999];  [DK83756];  [DK 043351]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI057999, R01AI092084, R01AI062773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB006348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, P30DK040561, R01DK083756] Funding Source: NIH RePORTER	Massachusetts General Hospital Department of Medicine; National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Massachusetts General Hospital's Center for Computational and Integrative Biology; National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Massachusetts General Hospital Department of Medicine Internal Funds (J.M.T. and J.M.V.), National Institute of Biomedical Imaging and Bioengineering grant T32EB006348 (C. E. C.), Massachusetts General Hospital's Center for Computational and Integrative Biology development fund and AI062773 (R.J.H.). grants AI062773, DK83756 and DK 043351 (R.J.X.), and National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) AI057999 (J.M.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas K, 2006, P NATL ACAD SCI USA, V103, P15945, DOI 10.1073/pnas.0607528103; Ashkin A, 1997, P NATL ACAD SCI USA, V94, P4853, DOI 10.1073/pnas.94.10.4853; ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; ASHKIN A, 1987, SCIENCE, V235, P1517, DOI 10.1126/science.3547653; ASHKIN A, 1970, PHYS REV LETT, V24, P156, DOI 10.1103/PhysRevLett.24.156; Batchelor G.K., 2000, INTRO FLUID DYNAMICS, DOI DOI 10.1017/CBO9780511800955; Blander JM, 2008, ANN RHEUM DIS, V67, P44, DOI 10.1136/ard.2008.097964; Brau RR, 2006, BIOPHYS J, V91, P1069, DOI 10.1529/biophysj.106.082602; Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103; Desjardins M, 2003, CURR OPIN CELL BIOL, V15, P498, DOI 10.1016/S0955-0674(03)00083-8; Goksor M, 2004, APPL OPTICS, V43, P4831, DOI 10.1364/AO.43.004831; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Han SW, 2005, BIOSENS BIOELECTRON, V20, P2120, DOI 10.1016/j.bios.2004.08.023; Heinrich M, 2010, P NATL ACAD SCI US; Hoffmann A, 2000, APPL PHYS B-LASERS O, V71, P747, DOI 10.1007/s003400000454; Hultgren A, 2003, J APPL PHYS, V93, P7554, DOI 10.1063/1.1556204; Ionescu-Zanetti C, 2005, P NATL ACAD SCI USA, V102, P9112, DOI 10.1073/pnas.0503418102; Ke PC, 1999, APPL OPTICS, V38, P160, DOI 10.1364/AO.38.000160; Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102; Khalil AS, 2007, P NATL ACAD SCI USA, V104, P4892, DOI 10.1073/pnas.0605727104; Khalil AS, 2008, P NATL ACAD SCI USA, V105, P19247, DOI 10.1073/pnas.0805147105; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; Kress H, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061927; Kress H, 2007, P NATL ACAD SCI USA, V104, P11633, DOI 10.1073/pnas.0702449104; Li ZW, 2002, BIOPHYS J, V82, P1386, DOI 10.1016/S0006-3495(02)75493-3; Lin SJ, 2001, CLIN INFECT DIS, V32, P358, DOI 10.1086/318483; McNerney GP, 2010, J BIOPHOTONICS, V3, P216, DOI 10.1002/jbio.200900102; Mohanty SK, 2005, OPT EXPRESS, V13, P4745, DOI 10.1364/OPEX.13.004745; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Neuman KC, 1999, BIOPHYS J, V77, P2856, DOI 10.1016/S0006-3495(99)77117-1; Oddos S, 2008, BIOPHYS J, V95, pL66, DOI 10.1529/biophysj.108.143198; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; SCHROEDER F, 1983, J BIOCHEM BIOPH METH, V8, P15, DOI 10.1016/0165-022X(83)90017-9; Stuart LM, 2008, NAT REV IMMUNOL, V8, P131, DOI 10.1038/nri2240; SVOBODA K, 1994, OPT LETT, V19, P930, DOI 10.1364/OL.19.000930; Tsai HF, 1998, J BACTERIOL, V180, P3031, DOI 10.1128/JB.180.12.3031-3038.1998; Voldman J, 1999, ANNU REV BIOMED ENG, V1, P401, DOI 10.1146/annurev.bioeng.1.1.401; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; WEY SB, 1988, ARCH INTERN MED, V148, P2642, DOI 10.1001/archinte.148.12.2642; Yamada S, 2007, ANNU REV BIOCHEM, V76, P267, DOI 10.1146/annurev.biochem.75.103004.142811	43	20	22	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15215	10.1371/journal.pone.0015215	http://dx.doi.org/10.1371/journal.pone.0015215			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217821	Green Published, gold, Green Submitted			2022-12-27	WOS:000285838900016
J	French, DA; Badamdorj, D; Kleene, SJ				French, Donald A.; Badamdorj, Dorjsuren; Kleene, Steven J.			Spatial Distribution of Calcium-Gated Chloride Channels in Olfactory Cilia	PLOS ONE			English	Article							FROG; TRANSDUCTION; RAT; LOCALIZATION; CONDUCTANCE; MECHANISM; MOUSE; CA	Background: In vertebrate olfactory receptor neurons, sensory cilia transduce odor stimuli into changes in neuronal membrane potential. The voltage changes are primarily caused by the sequential openings of two types of channel: a cyclic-nucleotide-gated (CNG) cationic channel and a calcium-gated chloride channel. In frog, the cilia are 25 to 200 mu m in length, so the spatial distributions of the channels may be an important determinant of odor sensitivity. Principal Findings: To determine the spatial distribution of the chloride channels, we recorded from single cilia as calcium was allowed to diffuse down the length of the cilium and activate the channels. A computational model of this experiment allowed an estimate of the spatial distribution of the chloride channels. On average, the channels were concentrated in a narrow band centered at a distance of 29% of the ciliary length, measured from the base of the cilium. This matches the location of the CNG channels determined previously. This non-uniform distribution of transduction proteins is consistent with similar findings in other cilia. Conclusions: On average, the two types of olfactory transduction channel are concentrated in the same region of the cilium. This may contribute to the efficient detection of weak stimuli.	[French, Donald A.; Badamdorj, Dorjsuren] Univ Cincinnati, Dept Math Sci, Cincinnati, OH 45221 USA; [Kleene, Steven J.] Univ Cincinnati, Dept Canc & Cell Biol, Cincinnati, OH 45221 USA	University of Cincinnati; University of Cincinnati	French, DA (corresponding author), Univ Cincinnati, Dept Math Sci, Cincinnati, OH 45221 USA.	steve@syrano.acb.uc.edu			National Science Foundation (Division of Mathematical Sciences) [DMS-0515989]; College of Medicine Dean's Bridge Funding Program; University Research Council of the University of Cincinnati	National Science Foundation (Division of Mathematical Sciences)(National Science Foundation (NSF)); College of Medicine Dean's Bridge Funding Program; University Research Council of the University of Cincinnati	This work was supported by research grant DMS-0515989 from the National Science Foundation (Division of Mathematical Sciences), the College of Medicine Dean's Bridge Funding Program, and the University Research Council of the University of Cincinnati. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMEK GD, 1984, BRAIN RES, V310, P87, DOI 10.1016/0006-8993(84)90012-X; Antolin S, 2007, J PHYSIOL-LONDON, V581, P495, DOI 10.1113/jphysiol.2007.131094; Badamdorj D, 2008, MATH METHOD APPL SCI, V31, P1860, DOI 10.1002/mma.1007; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Berezhkovskii AM, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3271998; BERS DM, 1982, AM J PHYSIOL, V242, pC404, DOI 10.1152/ajpcell.1982.242.5.C404; Bloodgood RA, 2010, J CELL SCI, V123, P505, DOI 10.1242/jcs.066308; Flannery RJ, 2006, BIOPHYS J, V91, P179, DOI 10.1529/biophysj.105.079046; French DA, 2006, MATH COMPUT MODEL, V43, P945, DOI 10.1016/j.mcm.2005.11.010; FRINGS S, 1992, J GEN PHYSIOL, V100, P45, DOI 10.1085/jgp.100.1.45; Frings S, 2009, PHYSIOLOGY AND PATHOLOGY OF CHLORIDE TRANSPORTERS AND CHANNELS IN THE NERVOUS SYSTEM: FROM MOLECULES TO DISEASES, P413; Fujiu K, 2009, CURR BIOL, V19, P133, DOI 10.1016/j.cub.2008.11.068; GETCHELL TV, 1980, BIOPHYS J, V29, P397, DOI 10.1016/S0006-3495(80)85142-3; Green JA, 2010, CELL MOL LIFE SCI, V67, P3287, DOI 10.1007/s00018-010-0425-4; HARTZELL LB, 1993, EXP CELL RES, V208, P148, DOI 10.1006/excr.1993.1232; Higgins MK, 2002, EMBO J, V21, P2087, DOI 10.1093/emboj/21.9.2087; Jack JJB, 1983, ELECTRIC CURRENT FLO, P518; Kalinay P, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.031143; kandel, 1977, NERVOUS SYSTEM, V1; KLEENE SJ, 1994, BRIT J PHARMACOL, V111, P469, DOI 10.1111/j.1476-5381.1994.tb14760.x; KLEENE SJ, 1992, PFLUG ARCH EUR J PHY, V421, P374, DOI 10.1007/BF00374226; KLEENE SJ, 1991, J MEMBRANE BIOL, V120, P75, DOI 10.1007/BF01868593; KLEENE SJ, 1993, NEURON, V11, P123, DOI 10.1016/0896-6273(93)90276-W; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; Kleene SJ, 2008, CHEM SENSES, V33, P839, DOI 10.1093/chemse/bjn048; Larsson HP, 1997, BIOPHYS J, V72, P1193, DOI 10.1016/S0006-3495(97)78767-8; Lee J, 2010, PLOS ONE, V8; LIDOW MS, 1984, J ULTRA MOL STRUCT R, V86, P18, DOI 10.1016/S0022-5320(84)90092-3; Lohret TA, 1998, MOL BIOL CELL, V9, P1195, DOI 10.1091/mbc.9.5.1195; Matsuzaki O, 1999, NEUROSCIENCE, V94, P131, DOI 10.1016/S0306-4522(99)00228-6; Menco BPM, 1997, CHEM SENSES, V22, P295, DOI 10.1093/chemse/22.3.295; MENCO BPM, 1992, NEURON, V8, P441, DOI 10.1016/0896-6273(92)90272-F; MENCO BPM, 1980, CELL TISSUE RES, V207, P183; Menco BPM, 1997, J NEUROCYTOL, V26, P691, DOI 10.1023/A:1018554029186; Pifferi S, 2009, NEUROBIOLOGY OLFACTI, P203; Quarmby L, 2009, CURR BIOL, V19, pR158, DOI 10.1016/j.cub.2008.12.038; REESE TS, 1965, J CELL BIOL, V25, P209, DOI 10.1083/jcb.25.2.209; Reisert J, 2005, NEURON, V45, P553, DOI 10.1016/j.neuron.2005.01.012; Reisert J, 2003, J GEN PHYSIOL, V122, P349, DOI 10.1085/jgp.200308888; Reisert J, 1998, J GEN PHYSIOL, V112, P529, DOI 10.1085/jgp.112.5.529; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Schwarzenbacher K, 2005, HISTOCHEM CELL BIOL, V123, P419, DOI 10.1007/s00418-005-0790-5; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Takeuchi H, 2008, J NEUROSCI, V28, P766, DOI 10.1523/JNEUROSCI.3531-07.2008; Takeuchi H, 2009, J GEN PHYSIOL, V133, P583, DOI 10.1085/jgp.200810085	45	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15676	10.1371/journal.pone.0015676	http://dx.doi.org/10.1371/journal.pone.0015676			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209888	Green Submitted, gold, Green Published			2022-12-27	WOS:000285793600026
J	Akgul, B; Lin, KW; Yang, HMO; Chen, YH; Lu, TH; Chen, CH; Kikuchi, T; Chen, YT; Tu, CPD				Akgul, Bunyamin; Lin, Kai-Wei; Yang, Hui-Mei Ou; Chen, Yen-Hui; Lu, Tzu-Huan; Chen, Chien-Hsiun; Kikuchi, Tateki; Chen, Yuan-Tsong; Tu, Chen-Pei D.			Garlic Accelerates Red Blood Cell Turnover and Splenic Erythropoietic Gene Expression in Mice: Evidence for Erythropoietin-Independent Erythropoiesis	PLOS ONE			English	Article							CARBON-MONOXIDE; HEME OXYGENASE; BILIRUBIN; ENZYME; ANTIOXIDANT; INDUCTION; PROMOTER; SULFUR; MAPK	Garlic (Allium sativum) has been valued in many cultures both for its health effects and as a culinary flavor enhancer. Garlic's chemical complexity is widely thought to be the source of its many health benefits, which include, but are not limited to, anti-platelet, procirculatory, anti-inflammatory, anti-apoptotic, neuro-protective, and anti-cancer effects. While a growing body of scientific evidence strongly upholds the herb's broad and potent capacity to influence health, the common mechanisms underlying these diverse effects remain disjointed and relatively poorly understood. We adopted a phenotype-driven approach to investigate the effects of garlic in a mouse model. We examined RBC indices and morphologies, spleen histochemistry, RBC half-lives and gene expression profiles, followed up by qPCR and immunoblot validation. The RBCs of garlic-fed mice register shorter half-lives than the control. But they have normal blood chemistry and RBC indices. Their spleens manifest increased heme oxygenase 1, higher levels of iron and bilirubin, and presumably higher CO, a pleiotropic gasotransmitter. Heat shock genes and those critical for erythropoiesis are elevated in spleens but not in bone marrow. The garlic-fed mice have lower plasma erythropoietin than the controls, however. Chronic exposure to CO of mice on garlic-free diet was sufficient to cause increased RBC indices but again with a lower plasma erythropoietin level than air-treated controls. Furthermore, dietary garlic supplementation and CO treatment showed additive effects on reducing plasma erythropoietin levels in mice. Thus, garlic consumption not only causes increased energy demand from the faster RBC turnover but also increases the production of CO, which in turn stimulates splenic erythropoiesis by an erythropoietin-independent mechanism, thus completing the sequence of feedback regulation for RBC metabolism. Being a pleiotropic gasotransmitter, CO may be a second messenger for garlic's other physiological effects.	[Akgul, Bunyamin; Lin, Kai-Wei; Yang, Hui-Mei Ou; Chen, Yen-Hui; Lu, Tzu-Huan; Chen, Chien-Hsiun; Kikuchi, Tateki; Chen, Yuan-Tsong; Tu, Chen-Pei D.] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Akgul, Bunyamin] Izmir Inst Technol, Dept Mol Biol & Genet, Izmir, Turkey; [Yang, Hui-Mei Ou; Lu, Tzu-Huan; Chen, Chien-Hsiun; Chen, Yuan-Tsong] Acad Sinica, Natl Genotyping Ctr, Taipei 115, Taiwan; [Chen, Yen-Hui; Kikuchi, Tateki] Acad Sinica, Taiwan Mouse Clin, Natl Phenotyping Ctr, Taipei 115, Taiwan; [Tu, Chen-Pei D.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Academia Sinica - Taiwan; Izmir Institute of Technology; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Akgul, B (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	unh@psu.edu	Akgül, Bünyamin/AAY-2958-2020; Chen, Chien Hsiun/Q-3826-2018	Akgül, Bünyamin/0000-0001-9877-9689; 	National Research Program for Genomic Medicine, Taiwan Authority (National Genotyping Core) [NSC-95-3112-B-001-011]; Academia Sinica; National Science Council (Taiwan Authority)	National Research Program for Genomic Medicine, Taiwan Authority (National Genotyping Core)(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan); National Science Council (Taiwan Authority)(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Research Program for Genomic Medicine, Taiwan Authority (National Genotyping Core, NSC-95-3112-B-001-011 to YTC), and the Genomics and Proteomics Program, Academia Sinica. C-PDT was supported by Academia Sinica and the National Science Council (Taiwan Authority) during residence in Academia Sinica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amagase H, 2006, J NUTR, V136, p716S; Benavides GA, 2007, P NATL ACAD SCI USA, V104, P17977, DOI 10.1073/pnas.0705710104; Coburn RF, 1965, J CLIN INVEST, V43, P1098; CROSSLEY M, 1994, J BIOL CHEM, V269, P15440; Dehari H, 2009, MOL REPROD DEV, V76, P379, DOI 10.1002/mrd.20976; Dinkova-Kostova AT, 2008, MOL NUTR FOOD RES, V52, pS128, DOI 10.1002/mnfr.200700195; Drissen R, 2005, MOL CELL BIOL, V25, P5205, DOI 10.1128/MCB.25.12.5205-5214.2005; Dumitriu B, 2006, BLOOD, V108, P1198, DOI 10.1182/blood-2006-02-004184; El-Bayoumy K, 2006, J NUTR, V136, p864S, DOI 10.1093/jn/136.3.864S; Elagib KE, 2004, MOL CELL BIOL, V24, P7779, DOI 10.1128/MCB.24.17.7779-7794.2004; Gibbons JD, 1992, NONPARAMETRIC STAT I; Gill PR, 1981, PRACTICAL OPTIMIZATI, P136, DOI DOI 10.1137/1025065; Gomori G, 1952, MICROSCOPIC HISTOCHE, P189; Guihard S, 2010, BLOOD, V115, P3686, DOI 10.1182/blood-2009-09-242487; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; HOFFMANNFEZER G, 1991, ANN HEMATOL, V63, P214, DOI 10.1007/BF01703446; Kikuchi T, 1998, J CLIN INVEST, V101, P827, DOI 10.1172/JCI1722; Kim HP, 2005, J IMMUNOL, V175, P2622, DOI 10.4049/jimmunol.175.4.2622; Kovtunovych G, 2010, BLOOD, V116, P6054, DOI 10.1182/blood-2010-03-272138; Landaw S, 1991, HEMATOLOGY BASIC PRI, P274; LANDAW SA, 1970, J CLIN INVEST, V49, P914, DOI 10.1172/JCI106311; MAINES MD, 1986, J BIOL CHEM, V261, P411; Matsuura H, 2001, J NUTR, V131, p1000S, DOI 10.1093/jn/131.3.1000S; Miron T, 2008, J NUTR BIOCHEM, V19, P524, DOI 10.1016/j.jnutbio.2007.06.009; Munday R, 2003, FREE RADICAL BIO MED, V34, P1200, DOI 10.1016/S0891-5849(03)00144-8; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; Oboh G, 2004, J MED FOOD, V7, P498, DOI 10.1089/jmf.2004.7.498; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; PARMLEY RT, 1988, J HISTOCHEM CYTOCHEM, V36, P433, DOI 10.1177/36.4.2450121; Penney DP, 2002, BIOTECH HISTOCHEM, V77, P237, DOI 10.1080/714028210; Ribeil JA, 2007, NATURE, V445, P102, DOI 10.1038/nature05378; Rodriguez P, 2005, EMBO J, V24, P2354, DOI 10.1038/sj.emboj.7600702; Shalon D, 1996, GENOME RES, V6, P639, DOI 10.1101/gr.6.7.639; SHERPA AK, 1989, J APPL PHYSIOL, V67, P1383, DOI 10.1152/jappl.1989.67.4.1383; Sherrod PH, 2000, NONLINEAR REGRESSION; SHIBAHARA S, 1978, ARCH BIOCHEM BIOPHYS, V188, P243, DOI 10.1016/S0003-9861(78)80006-X; Simpson LO, 2001, J ORTHOMOL MED, V16, P157; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; TOOHEY JI, 1989, BIOCHEM J, V264, P625, DOI 10.1042/bj2640625; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Wu LY, 2005, PHARMACOL REV, V57, P585, DOI 10.1124/pr.57.4.3; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; YEH YY, 1994, LIPIDS, V29, P189, DOI 10.1007/BF02536728	45	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15358	10.1371/journal.pone.0015358	http://dx.doi.org/10.1371/journal.pone.0015358			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206920	gold, Green Published, Green Submitted			2022-12-27	WOS:000285793200025
J	Mandle, L; Warren, DL; Hoffmann, MH; Peterson, AT; Schmitt, J; von Wettberg, EJ				Mandle, Lisa; Warren, Dan L.; Hoffmann, Matthias H.; Peterson, A. Townsend; Schmitt, Johanna; von Wettberg, Eric J.			Conclusions about Niche Expansion in Introduced Impatiens walleriana Populations Depend on Method of Analysis	PLOS ONE			English	Article							POTENTIAL DISTRIBUTION; NORTH-AMERICA; ALIEN PLANT; SPECIES INVASIONS; CLIMATE-CHANGE; DISTRIBUTIONS; CONSERVATISM; RANGES; SHIFT; RISK	Determining the degree to which climate niches are conserved across plant species' native and introduced ranges is valuable to developing successful strategies to limit the introduction and spread of invasive plants, and also has important ecological and evolutionary implications. Here, we test whether climate niches differ between native and introduced populations of Impatiens walleriana, globally one of the most popular horticultural species. We use approaches based on both raw climate data associated with occurrence points and ecological niche models (ENMs) developed with Maxent. We include comparisons of climate niche breadth in both geographic and environmental spaces, taking into account differences in available habitats between the distributional areas. We find significant differences in climate envelopes between native and introduced populations when comparing raw climate variables, with introduced populations appearing to expand into wetter and cooler climates. However, analyses controlling for differences in available habitat in each region do not indicate expansion of climate niches. We therefore cannot reject the hypothesis that observed differences in climate envelopes reflect only the limited environments available within the species' native range in East Africa. Our results suggest that models built from only native range occurrence data will not provide an accurate prediction of the potential for invasiveness if applied to areas containing a greater range of environmental combinations, and that tests of niche expansion may overestimate shifts in climate niches if they do not control carefully for environmental differences between distributional areas.	[Mandle, Lisa; Schmitt, Johanna] Brown Univ, Providence, RI 02912 USA; [Mandle, Lisa] Univ Hawaii, Dept Bot, Honolulu, HI 96822 USA; [Warren, Dan L.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Hoffmann, Matthias H.] Univ Halle Wittenberg, Inst Geobot & Bot Garten, Halle, Saale, Germany; [Peterson, A. Townsend] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [von Wettberg, Eric J.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [von Wettberg, Eric J.] Fairchild Trop Bot Garden, Ctr Trop Plant Conservat, Coral Gables, FL USA	Brown University; University of Hawaii System; University of Texas System; University of Texas Austin; Martin Luther University Halle Wittenberg; University of Kansas; State University System of Florida; Florida International University	Mandle, L (corresponding author), Brown Univ, Providence, RI 02912 USA.	evonwettberg@fairchildgarden.org	Peterson, A. Townsend/I-5697-2013; Warren, Dan/B-3821-2010; Mandle, Lisa/G-6380-2011; von Wettberg, Eric/C-1115-2016	Peterson, A. Townsend/0000-0003-0243-2379; Warren, Dan/0000-0002-8747-2451; von Wettberg, Eric/0000-0002-2724-0317; Mandle, Lisa/0000-0002-1420-8529	US Environmental Protection Agency; US National Science Foundation [0408015]; US NSF Division of Environmental Biology [0129018]; NSF; Microsoft Research; Microsoft Research Foundation	US Environmental Protection Agency(United States Environmental Protection Agency); US National Science Foundation(National Science Foundation (NSF)); US NSF Division of Environmental Biology; NSF(National Science Foundation (NSF)); Microsoft Research(Microsoft); Microsoft Research Foundation(Microsoft)	This work was funded by an US Environmental Protection Agency Science To Achieve Results graduate fellowship (to EVW, http://www.epa.gov/ncerqa/fellow/), US National Science Foundation Doctoral Dissertation Improvement Grant 0408015 (to EVW and JS, www.nsf.gov), US NSF Division of Environmental Biology 0129018 (to JS, including an REU supplement to LM, www.nsf.gov), and NSF Graduate Research Fellowship Program (to LM, www.nsf.gov), and Microsoft Research (to ATP, http://research.microsoft.com/en-us/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding received did not entail employment, consultation, patents, marketing or commercial software development, or any other financial obligation. Funding does not alter the authors' adherence to PLOS ONE data sharing and materials guidelines.; The authors have declared that no competing interests exist. ATP has received academic grants from the Microsoft Research Foundation. These awards are for basic research, and come with no commercial or finanacial dimensions. They do not involve employment, consultation on microsoft products, commercial software development, patents, or advocacy for microsoft. They also do not affect our adherence to PLOS ONE policies on data sharing or materials.	ADREER H, 1890, SEED CATALOG 1 N WAT; *AGR USDO, 1998, 1998 CENS HORT SPEC; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; BirdLife International, 2009, IMP BIRD AR FACTSH; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Cain S.A., 1944, FDN PLANT GEOGRAPHY; CARNES BA, 1982, ECOLOGY, V63, P888, DOI 10.2307/1937227; Curnutt JL, 2000, BIOL CONSERV, V94, P341, DOI 10.1016/S0006-3207(99)00186-X; Daehler CC, 2004, CONSERV BIOL, V18, P360, DOI 10.1111/j.1523-1739.2004.00066.x; ESPENAK F, 1999, TOTAL SOLAR ECLIPSE; Fitzpatrick MC, 2007, GLOBAL ECOL BIOGEOGR, V16, P24, DOI 10.1111/j.1466-8238.2006.00258.x; Grey-Wilson C., 1982, FLORA TROPICAL E AFR; Grey-Wilson C, 1980, IMPATIENS AFRICA MOR; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoffmann MH, 2002, J BIOGEOGR, V29, P125, DOI 10.1046/j.1365-2699.2002.00647.x; Hoffmann MH, 2001, FLORA, V196, P395, DOI 10.1016/S0367-2530(17)30076-2; Hutchinson G.E., 1978, INTRO POPULATION ECO; KRAMER IN, 2000, SEED CATALOG, P225; Kriticos DJ, 2005, WEED RES, V45, P246, DOI 10.1111/j.1365-3180.2005.00458.x; Kriticos DJ, 2003, J APPL ECOL, V40, P111, DOI 10.1046/j.1365-2664.2003.00777.x; LAUNERT E, 1963, FLORA ZAMBESIACA; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; LEVINS RICHARD, 1968; *LIV SEED CO, 1900, SEED CAT COLUMBUSOH; Loo SE, 2007, ECOL APPL, V17, P181, DOI 10.1890/1051-0761(2007)017[0181:FNZMIR]2.0.CO;2; PANETTA FD, 1991, WEED RES, V31, P273, DOI 10.1111/j.1365-3180.1991.tb01767.x; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; PERRINS J, 1993, J BIOGEOGR, V20, P33, DOI 10.2307/2845737; Peterson AT, 2008, GLOBAL ECOL BIOGEOGR, V17, P135, DOI 10.1111/j.1466-8238.2007.00347.x; Peterson AT, 2003, WEED SCI, V51, P863, DOI 10.1614/P2002-081; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; PETERSON AT, 2010, ECOLOGICAL NICHES GE; Pheloung PC, 1999, J ENVIRON MANAGE, V57, P239, DOI 10.1006/jema.1999.0297; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; *PLANTS DAT, 2010, NAT RES CONS SERV US; Polhill D, 1988, FLORA TROPICAL E AFR; R Core Team, 2020, R LANG ENV STAT COMP; Reichard SH, 1997, CONSERV BIOL, V11, P193, DOI 10.1046/j.1523-1739.1997.95473.x; Rodder D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007843; Rodder D, 2009, GLOBAL ECOL BIOGEOGR, V18, P674, DOI 10.1111/j.1466-8238.2009.00477.x; Rogg H., 2003, EXPERIENCES LIMITATI, P117; Ron SR, 2005, BIOTROPICA, V37, P209, DOI 10.1111/j.1744-7429.2005.00028.x; SCOTT JK, 1993, J BIOGEOGR, V20, P87, DOI 10.2307/2845742; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; STOKES J, 1890, SEED CATALOG MARKET; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; *US BUR CENS, 2002, CENS 2000 US GAZ; *US BUR CENS, 2001, HYDR EL DER DAT; *USDA, 1995, IMP BAL REP HERB ORN; VICKERY RK, 1974, ECOLOGY, V55, P796, DOI 10.2307/1934415; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; WARREN DL, ECOLOGICAL IN PRESS; Welk E, 2002, DIVERS DISTRIB, V8, P219, DOI 10.1046/j.1472-4642.2002.00144.x; WIENS JJ, 2005, NICHE CONSERVATISM I; WILLIAMSON MH, BIOL INVASIONS; Woodward F.I., 1987, CLIMATE PLANT DISTRI	61	58	58	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15297	10.1371/journal.pone.0015297	http://dx.doi.org/10.1371/journal.pone.0015297			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206912	Green Published, Green Submitted, gold			2022-12-27	WOS:000285793200023
J	Nelson, DM; Cann, IKO; Mackie, RI				Nelson, David M.; Cann, Isaac K. O.; Mackie, Roderick I.			Response of Archaeal Communities in the Rhizosphere of Maize and Soybean to Elevated Atmospheric CO2 Concentrations	PLOS ONE			English	Article							CARBON-DIOXIDE CONCENTRATION; MULTIPLE SEQUENCE ALIGNMENT; SOIL MICROBIAL COMMUNITIES; AMMONIA-OXIDIZING ARCHAEA; ENRICHMENT FACE; ZEA-MAYS; HYDROGEN EVOLUTION; NITROGEN-FIXATION; DIVERSITY; PHOTOSYNTHESIS	Background: Archaea are important to the carbon and nitrogen cycles, but it remains uncertain how rising atmospheric carbon dioxide concentrations ([CO2]) will influence the structure and function of soil archaeal communities. Methodology/Principal Findings: We measured abundances of archaeal and bacterial 16S rRNA and amoA genes, phylogenies of archaeal 16S rRNA and amoA genes, concentrations of KCl-extractable soil ammonium and nitrite, and potential ammonia oxidation rates in rhizosphere soil samples from maize and soybean exposed to ambient (similar to 385 ppm) and elevated (550 ppm) [CO2] in a replicated and field-based study. There was no influence of elevated [CO2] on copy numbers of archaeal or bacterial 16S rRNA or amoA genes, archaeal community composition, KCl-extractable soil ammonium or nitrite, or potential ammonia oxidation rates for samples from maize, a model C-4 plant. Phylogenetic evidence indicated decreased relative abundance of crenarchaeal sequences in the rhizosphere of soybean, a model leguminous-C-3 plant, at elevated [CO2], whereas quantitative PCR data indicated no changes in the absolute abundance of archaea. There were no changes in potential ammonia oxidation rates at elevated [CO2] for soybean. Ammonia oxidation rates were lower in the rhizosphere of maize than soybean, likely because of lower soil pH and/or abundance of archaea. KCl-extractable ammonium and nitrite concentrations were lower at elevated than ambient [CO2] for soybean. Conclusion: Plant-driven shifts in soil biogeochemical processes in response to elevated [CO2] affected archaeal community composition, but not copy numbers of archaeal genes, in the rhizosphere of soybean. The lack of a treatment effect for maize is consistent with the fact that the photosynthesis and productivity of maize are not stimulated by elevated [CO2] in the absence of drought.	[Nelson, David M.] Univ Maryland, Appalachian Lab, Ctr Environm Sci, Frostburg, MD USA; [Nelson, David M.; Cann, Isaac K. O.; Mackie, Roderick I.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Cann, Isaac K. O.; Mackie, Roderick I.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Cann, Isaac K. O.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University System of Maryland; University of Maryland Center for Environmental Science; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Nelson, DM (corresponding author), Univ Maryland, Appalachian Lab, Ctr Environm Sci, Frostburg, MD USA.	dmnelson@al.umces.edu	Nelson, David/AAP-9412-2020; Nelson, David M/D-5596-2009	Nelson, David/0000-0003-2755-5535; Nelson, David M/0000-0003-2755-5535	United States Department of Agriculture National Institute of Food and Agriculture [2008-35107-05854]; U.S. Department of Energy; Illinois Council for Food and Agricultural Research; Archer Daniels Midland Company; U.S. Department of Agriculture Agricultural Research Service; Office of Science (BER) Midwestern Regional Center of the National Institute for Climatic Change Research at Michigan Technological University [DE-FC02-06ER64158]	United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); U.S. Department of Energy(United States Department of Energy (DOE)); Illinois Council for Food and Agricultural Research; Archer Daniels Midland Company; U.S. Department of Agriculture Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Office of Science (BER) Midwestern Regional Center of the National Institute for Climatic Change Research at Michigan Technological University(United States Department of Energy (DOE))	This project was supported by competitive grant no. 2008-35107-05854 from the United States Department of Agriculture National Institute of Food and Agriculture (D.M.N.). Funding for SoyFACE was provided by the U.S. Department of Energy, Illinois Council for Food and Agricultural Research, Archer Daniels Midland Company, and U.S. Department of Agriculture Agricultural Research Service. Department of Energy support was through the Office of Science (BER) Midwestern Regional Center of the National Institute for Climatic Change Research at Michigan Technological University, under Award Number DE-FC02-06ER64158. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Ainsworth EA, 2008, NEW PHYTOL, V179, P5, DOI 10.1111/j.1469-8137.2008.02500.x; Austin EE, 2009, SOIL BIOL BIOCHEM, V41, P514, DOI 10.1016/j.soilbio.2008.12.010; Balser TC, 2005, BIOGEOCHEMISTRY, V73, P395, DOI 10.1007/s10533-004-0372-y; Bernacchi CJ, 2005, PLANTA, V220, P434, DOI 10.1007/s00425-004-1320-8; Castro HF, 2010, APPL ENVIRON MICROB, V76, P999, DOI 10.1128/AEM.02874-09; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; CRUSH JR, 1993, NEW ZEAL J AGR RES, V36, P177; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Drigo B, 2008, BIOL FERT SOILS, V44, P667, DOI 10.1007/s00374-008-0277-3; Drigo B, 2009, ISME J, V3, P1204, DOI 10.1038/ismej.2009.65; Endres TJ, 2001, SOIL SURVEY CHAMPAIG; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Francis CA, 2007, ISME J, V1, P19, DOI 10.1038/ismej.2007.8; Grosskopf R, 1998, APPL ENVIRON MICROB, V64, P960; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hansel CM, 2008, APPL ENVIRON MICROB, V74, P1620, DOI 10.1128/AEM.01787-07; He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x; Hendershot W.H., 1993, SOIL SAMPLING METHOD, P141; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Ineson P, 1998, PLANT SOIL, V198, P89, DOI 10.1023/A:1004298309606; Inubushi K, 2003, GLOBAL CHANGE BIOL, V9, P1458, DOI 10.1046/j.1365-2486.2003.00665.x; IPCC Apndice, 2007, AR4 CLIMATE CHANGE 2; Janus LR, 2005, MICROB ECOL, V50, P102, DOI 10.1007/s00248-004-0120-9; Jossi M, 2006, FEMS MICROBIOL ECOL, V55, P339, DOI 10.1111/j.1574-6941.2005.00040.x; Kassem II, 2008, J INTEGR PLANT BIOL, V50, P1406, DOI 10.1111/j.1744-7909.2008.00752.x; Klamer M, 2002, APPL ENVIRON MICROB, V68, P4370, DOI 10.1128/AEM.68.9.4370-4376.2002; Koike S, 2007, APPL ENVIRON MICROB, V73, P4813, DOI 10.1128/AEM.00665-07; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Leakey ADB, 2006, PLANT PHYSIOL, V140, P779, DOI 10.1104/pp.105.073957; Leakey ADB, 2004, GLOBAL CHANGE BIOL, V10, P951, DOI 10.1111/j.1529-8817.2003.00767.x; Leakey ADB, 2009, P ROY SOC B-BIOL SCI, V276, P2333, DOI 10.1098/rspb.2008.1517; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Lesaulnier C, 2008, ENVIRON MICROBIOL, V10, P926, DOI 10.1111/j.1462-2920.2007.01512.x; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lu YH, 2005, SCIENCE, V309, P1088, DOI 10.1126/science.1113435; Morgan PB, 2005, GLOBAL CHANGE BIOL, V11, P1856, DOI 10.1111/j.1365-2486.2005.001017.x; Nadelhoffer KJ, 2004, FOREST ECOL MANAG, V196, P89, DOI 10.1016/j.foreco.2004.03.014; Nawrocki EP, 2007, PLOS COMPUT BIOL, V3, P540, DOI 10.1371/journal.pcbi.0030056; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Nicol GW, 2005, ENVIRON MICROBIOL, V7, P337, DOI 10.1111/j.1462-2920.2005.00698.x; Peoples MB, 2008, PLANT SOIL, V307, P67, DOI 10.1007/s11104-008-9582-8; Peralta AL, 2008, PLANT SOIL, V303, P69, DOI 10.1007/s11104-007-9474-3; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Prosser JI, 2008, ENVIRON MICROBIOL, V10, P2931, DOI 10.1111/j.1462-2920.2008.01775.x; Rodriguez V, 2004, SOYBEAN ROOT PRODUCT; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rogers A, 2006, PLANT CELL ENVIRON, V29, P1651, DOI 10.1111/j.1365-3040.2006.01549.x; Rogers A, 2009, PLANT PHYSIOL, V151, P1009, DOI 10.1104/pp.109.144113; Schinner F., 1996, METHODS SOIL BIOL; SCHUBERT KR, 1976, P NATL ACAD SCI USA, V73, P1207, DOI 10.1073/pnas.73.4.1207; Simon HM, 2005, APPL ENVIRON MICROB, V71, P4751, DOI 10.1128/AEM.71.8.4751-4760.2005; Sliwinski MK, 2004, APPL ENVIRON MICROB, V70, P1821, DOI 10.1128/AEM.70.3.1821-1826.2004; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; UEDA T, 1995, EUR J SOIL SCI, V46, P415, DOI 10.1111/j.1365-2389.1995.tb01337.x; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yu YN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-57; Zheng XH, 2006, GLOBAL CHANGE BIOL, V12, P1717, DOI 10.1111/j.1365-2486.2006.01199.x	69	15	18	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15897	10.1371/journal.pone.0015897	http://dx.doi.org/10.1371/journal.pone.0015897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209969	Green Submitted, gold, Green Published			2022-12-27	WOS:000285793200069
J	Tapirdamaz, O; Mancham, S; van der Laan, LJW; Kazemier, G; Thielemans, K; Metselaar, HJ; Kwekkeboom, J				Tapirdamaz, Ozlem; Mancham, Shanta; van der Laan, Luc J. W.; Kazemier, Geert; Thielemans, Kris; Metselaar, Herold J.; Kwekkeboom, Jaap			Detailed Kinetics of the Direct Allo-Response in Human Liver Transplant Recipients: New Insights from an Optimized Assay	PLOS ONE			English	Article							ALLOREACTIVE T-CELLS; IMMUNOSORBENT SPOT ASSAY; ANTIGEN-PRESENTING CELLS; CD40-ACTIVATED B-CELLS; DENDRITIC CELLS; PRECURSOR FREQUENCIES; GRAFT FUNCTION; IN-VIVO; ENDOTHELIAL-CELLS; CLONAL EXPANSION	Conventional assays for quantification of allo-reactive T-cell precursor frequencies (PF) are relatively insensitive. We present a robust assay for quantification of PF of T-cells with direct donor-specificity, and establish the kinetics of circulating donor-specific T cells after liver transplantation (LTx). B cells from donor splenocytes were differentiated into professional antigen-presenting cells by CD40-engagement (CD40-B cells). CFSE-labelled PBMC from LTx-recipients obtained before and at several time points after LTx, were stimulated with donor-derived or 3(rd) party CD40-B cells. PF of donor-specific T cells were calculated from CFSE-dilution patterns, and intracellular IFN-gamma was determined after re-stimulation with CD40-B cells. Compared to splenocytes, stimulations with CD40-B cells resulted in 3 to 5-fold higher responding T-cell PF. Memory and naive T-cell subsets responded equally to allogeneic CD40-B cell stimulation. Donor-specific CD4(+) and CD8(+) T-cell PF ranged from 0.5 to 19% (median: 5.2%). One week after LTx, PF of circulating donor-specific CD4(+) and CD8(+) T cells increased significantly, while only a minor increase in numbers of T cells reacting to 3(rd) party allo-antigens was observed. One year after LTx numbers of CD4(+) and CD8(+) T cells reacting to donor antigens, as well as those reacting to 3(rd) party allo-antigens, were slightly lower compared to pre-transplant values. Moreover, CD4(+) and CD8(+) T cells responding to donor-derived, as well as those reacting to 3(rd) party CD40-B cells, produced less IFN-gamma. In conclusion, our alternative approach enables detection of allo-reactive human T cells at high frequencies, and after application we conclude that donor-specific T-cell PF increase immediately after LTx. However, no evidence for a specific loss of circulating T-cells recognizing donor allo-antigens via the direct pathway up to 1 year after LTx was obtained, underscoring the relative insensitiveness of previous assays.	[Tapirdamaz, Ozlem; Mancham, Shanta; Metselaar, Herold J.; Kwekkeboom, Jaap] Erasmus MC Univ, Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [van der Laan, Luc J. W.; Kazemier, Geert] Erasmus MC Univ, Dept Surg, Med Ctr, Rotterdam, Netherlands; [Thielemans, Kris] Vrije Univ Brussel, Lab Mol & Cellular Therapy, Brussels, Belgium	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Brussel	Tapirdamaz, O (corresponding author), Erasmus MC Univ, Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands.	j.kwekkeboom@erasmusmc.nl		van der Laan, Luc/0000-0002-0651-5334	Dutch Organization of Scientific Research (NWO) [017.003.031]	Dutch Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was financially supported by a Mozaiek Grant of the Dutch Organization of Scientific Research (NWO, 017.003.031 to O.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archbold JK, 2008, TRENDS IMMUNOL, V29, P220, DOI 10.1016/j.it.2008.02.005; ATKINS RC, 1975, J EXP MED, V141, P664, DOI 10.1084/jem.141.3.664; Baker RJ, 2001, J IMMUNOL, V167, P7199, DOI 10.4049/jimmunol.167.12.7199; Baker RJ, 2001, TRANSPLANTATION, V72, P480, DOI 10.1097/00007890-200108150-00020; Benichou G, 1999, J IMMUNOL, V162, P352; Bercovici N, 2003, J IMMUNOL METHODS, V276, P5, DOI 10.1016/S0022-1759(03)00059-0; Bestard O, 2008, J AM SOC NEPHROL, V19, P1419, DOI 10.1681/ASN.2007050539; Bosma BM, 2010, LIVER TRANSPLANT, V16, P12, DOI 10.1002/lt.21961; Brennan TV, 2009, AM J TRANSPLANT, V9, P709, DOI 10.1111/j.1600-6143.2009.02578.x; Coughlin CM, 2004, BLOOD, V103, P2046, DOI 10.1182/blood-2003-07-2379; de Haan A, 2000, TRANSPLANTATION, V69, P1434, DOI 10.1097/00007890-200004150-00038; de Haan A, 2002, TRANSPLANTATION, V74, P562, DOI 10.1097/00007890-200208270-00023; de Haan A, 2001, TRANSPLANTATION, V71, P785, DOI 10.1097/00007890-200103270-00017; de Haan A, 2000, TRANSPLANTATION, V69, P1637; Dengler TJ, 2001, J IMMUNOL, V166, P3846, DOI 10.4049/jimmunol.166.6.3846; Game DS, 2003, J AM SOC NEPHROL, V14, P1652, DOI 10.1097/01.ASN.0000067411.03024.A9; Gebauer BS, 2002, AM J TRANSPLANT, V2, P857, DOI 10.1034/j.1600-6143.2002.20908.x; Givan AL, 1999, J IMMUNOL METHODS, V230, P99, DOI 10.1016/S0022-1759(99)00136-2; Givan Alice L, 2004, Methods Mol Biol, V263, P109; Godoy-Ramirez K, 2005, CYTOM PART A, V68A, P71, DOI 10.1002/cyto.a.20189; Hasbold J, 1999, IMMUNOL CELL BIOL, V77, P516, DOI 10.1046/j.1440-1711.1999.00874.x; Heeger PS, 2003, AM J TRANSPLANT, V3, P525, DOI 10.1034/j.1600-6143.2003.00123.x; Kusaka S, 2000, J IMMUNOL, V164, P2240, DOI 10.4049/jimmunol.164.4.2240; LARSEN CP, 1990, TRANSPLANTATION, V50, P294, DOI 10.1097/00007890-199008000-00025; Lechler RI, 2005, NAT MED, V11, P605, DOI 10.1038/nm1251; LINDAHL KF, 1977, J EXP MED, V145, P508, DOI 10.1084/jem.145.3.508; LINDAHL KF, 1977, J EXP MED, V145, P500, DOI 10.1084/jem.145.3.500; LOMBARDI G, 1990, INT IMMUNOL, V2, P9, DOI 10.1093/intimm/2.1.9; Macedo C, 2009, AM J TRANSPLANT, V9, P2057, DOI 10.1111/j.1600-6143.2009.02742.x; Mannering SI, 2003, J IMMUNOL METHODS, V283, P173, DOI 10.1016/j.jim.2003.09.004; Matesic D, 1998, TRANSPLANTATION, V65, P906, DOI 10.1097/00007890-199804150-00008; McMichael AJ, 1998, J EXP MED, V187, P1367, DOI 10.1084/jem.187.9.1367; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Nather BJ, 2006, TRANSPL IMMUNOL, V16, P232, DOI 10.1016/j.trim.2006.09.026; Ng WF, 2002, J AM SOC NEPHROL, V13, P2983, DOI 10.1097/01.ASN.0000042163.73539.D4; Nickel P, 2004, TRANSPLANTATION, V78, P1640, DOI 10.1097/01.TP.0000144057.31799.6A; NISBET NW, 1969, J EXP MED, V129, P459, DOI 10.1084/jem.129.3.459; Noorchashm H, 1999, TRANSPLANTATION, V67, P1281, DOI 10.1097/00007890-199905150-00015; Rodriguez-Pinto D, 2005, EUR J IMMUNOL, V35, P1097, DOI 10.1002/eji.200425732; Saiki T, 2001, TRANSPLANTATION, V71, P1806, DOI 10.1097/00007890-200106270-00017; Saiki T, 2001, J LEUKOCYTE BIOL, V69, P705; Schultze JL, 1997, J CLIN INVEST, V100, P2757, DOI 10.1172/JCI119822; Schultze JL, 2004, TRENDS IMMUNOL, V25, P659, DOI 10.1016/j.it.2004.09.016; Smyth LA, 2006, TRANSPLANTATION, V82, pS15, DOI 10.1097/01.tp.0000231347.06149.ca; Song HK, 1999, TRANSPLANTATION, V68, P297, DOI 10.1097/00007890-199907270-00024; Stax AM, 2008, J IMMUNOL METHODS, V335, P46, DOI 10.1016/j.jim.2008.02.013; Suchin EJ, 2001, J IMMUNOL, V166, P973, DOI 10.4049/jimmunol.166.2.973; Ueta H, 2008, HEPATOLOGY, V47, P1352, DOI 10.1002/hep.22161; van Besouw NM, 2000, TRANSPLANTATION, V70, P136; van Besouw NM, 2005, TRANSPLANTATION, V79, P1062, DOI 10.1097/01.TP.0000161222.03635.86; van der Mast BJ, 2001, TRANSPLANTATION, V72, P873, DOI 10.1097/00007890-200109150-00023; Velthuis JHL, 2006, AM J TRANSPLANT, V6, P2955, DOI 10.1111/j.1600-6143.2006.01566.x; von Bergwelt-Baildon M, 2006, BLOOD, V107, P2786, DOI 10.1182/blood-2004-01-0113; von Bergwelt-Baildon M, 2004, ANN ONCOL, V15, P853, DOI 10.1093/annonc/mdh213; von Bergwelt-Baildon M, 2007, EXPERT REV VACCINES, V6, P667, DOI 10.1586/14760584.6.5.667; von Bergwelt-Baildon MS, 2002, BLOOD, V99, P3319, DOI 10.1182/blood.V99.9.3319; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; Zand MS, 2005, AM J TRANSPLANT, V5, P76, DOI 10.1111/j.1600-6143.2003.00637.x	58	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e14452	10.1371/journal.pone.0014452	http://dx.doi.org/10.1371/journal.pone.0014452			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206923	Green Published, Green Submitted, gold			2022-12-27	WOS:000285793200008
J	Waters, J				Waters, Jack			The Concentration of Soluble Extracellular Amyloid-beta Protein in Acute Brain Slices from CRND8 Mice	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; IN-VIVO; INTERSTITIAL FLUID; SECRETED OLIGOMERS; PEPTIDE; DEPOSITION; DISRUPTION; CLEARANCE	Background: Many recent studies of the effects of amyloid-beta protein (A beta) on brain tissue from amyloid precursor protein (APP) overexpressing mice have concluded that A beta oligomers in the extracellular space can profoundly affect synaptic structure and function. As soluble proteins, oliomers of A beta can diffuse through brain tissue and can presumably exit acute slices, but the rate of loss of A beta species by diffusion from brain slices and the resulting reduced concentrations of A beta species in brain slices are unknown. Methodology/Principal Findings: Here I combine measurements of A beta 1-42 diffusion and release from acute slices and simple numerical models to measure the concentration of A beta 1-42 in intact mice (in vivo) and in acute slices from CRND8 mice. The in vivo concentration of diffusible A beta 1-42 in CRND8 mice was 250 pM at 6 months of age and 425 pM at 12 months of age. The concentration of A beta 1-42 declined rapidly after slice preparation, reaching a steady-state concentration within one hour. 50 mm from the surface of an acute slice the steady-state concentration of A beta was 15-30% of the concentration in intact mice. In more superficial regions of the slice, where synaptic physiology is generally studied, the remaining A beta is less than 15%. Hence the concentration of A beta 1-42 in acute slices from CRND8 mice is less than 150 pM. Conclusions/Significance: A beta affects synaptic plasticity in the picomolar concentration range. Some of the effects of A beta may therefore be lost or altered after slice preparation, as the extracellular A beta concentration declines from the high picomolar to the low picomolar range. Hence loss of A beta by diffusion may complicate interpretation of the effects of A beta in experiments on acute slices from APP overexpressing mice.	Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Waters, J (corresponding author), Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA.	jackwaters@northwestern.edu			Alzheimer's Association [NIRG-06-25509]; National Institute on Aging [AG029282]; NATIONAL INSTITUTE ON AGING [R21AG029282] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Alzheimer's Association (NIRG-06-25509) and the National Institute on Aging (AG029282).	Abramowski D, 2008, J PHARMACOL EXP THER, V327, P411, DOI 10.1124/jpet.108.140327; Ambree O, 2006, NEUROBIOL AGING, V27, P955, DOI 10.1016/j.neurobiolaging.2005.05.009; ARRIAGADA PV, 1992, NEUROLOGY, V42, P1681, DOI 10.1212/WNL.42.9.1681; Randall JB, 2006, NAT MED, V12, P856, DOI 10.1038/nm1438; Bharadwaj PR, 2009, J CELL MOL MED, V13, P412, DOI 10.1111/j.1582-4934.2009.00609.x; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; CRYSTAL H, 1988, NEUROLOGY, V38, P1682, DOI 10.1212/WNL.38.11.1682; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; DeMattos RB, 2002, J NEUROCHEM, V81, P229, DOI 10.1046/j.1471-4159.2002.00889.x; DICKSON DW, 1992, NEUROBIOL AGING, V13, P179, DOI 10.1016/0197-4580(92)90027-U; GhersiEgea JF, 1996, J NEUROCHEM, V67, P880; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hyde LA, 2005, BEHAV BRAIN RES, V160, P344, DOI 10.1016/j.bbr.2004.12.017; Jolas T, 2002, NEUROBIOL DIS, V11, P394, DOI 10.1006/nbdi.2002.0557; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; KATZMAN R, 1988, ANN NEUROL, V23, P138, DOI 10.1002/ana.410230206; Klein WL, 2002, NEUROBIOL AGING, V23, P231, DOI 10.1016/S0197-4580(01)00312-8; Koch Christof, 1999, P1; Larson J, 1999, BRAIN RES, V840, P23, DOI 10.1016/S0006-8993(99)01698-4; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Massi F, 2001, BIOPHYS J, V80, P31, DOI 10.1016/S0006-3495(01)75993-0; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Phinney AL, 2003, P NATL ACAD SCI USA, V100, P14193, DOI 10.1073/pnas.2332851100; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Saxton Michael J., 2007, V400, P295; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Small DH, 2001, NAT REV NEUROSCI, V2, P595, DOI 10.1038/35086072; Stern EA, 2004, J NEUROSCI, V24, P4535, DOI 10.1523/JNEUROSCI.0462-04.2004; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Tseng BP, 1999, BIOCHEMISTRY-US, V38, P10424, DOI 10.1021/bi990718v; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Zaman SH, 2000, NEUROBIOL DIS, V7, P54, DOI 10.1006/nbdi.1999.0271	43	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15709	10.1371/journal.pone.0015709	http://dx.doi.org/10.1371/journal.pone.0015709			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209950	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793200040
J	Cai, ML; Huang, Y; Craigie, R; Clore, GM				Cai, Mengli; Huang, Ying; Craigie, Robert; Clore, G. Marius			Structural Basis of the Association of HIV-1 Matrix Protein with DNA	PLOS ONE			English	Article							PARAMAGNETIC RELAXATION ENHANCEMENT; VIRUS TYPE-1 MATRIX; NUCLEAR-LOCALIZATION SIGNAL; DIPOLAR COUPLINGS; CRYSTAL-STRUCTURES; NONDIVIDING CELLS; MACROMOLECULES; INFECTION; BINDING; DOMAIN	HIV-1 matrix (MA) is a multifunctional protein that is synthesized as a polyprotein that is cleaved by protease during viral maturation. MA contains a cluster of basic residues whose role is controversial. Proposed functions include membrane anchoring, facilitating viral assembly, and directing nuclear import of the viral DNA. Since MA has been reported to be a component of the preintegration complex (PIC), we have used NMR to probe its interaction with other PIC components. We show that MA interacts with DNA and this is likely sufficient to account for its association with the PIC.	[Cai, Mengli; Clore, G. Marius] NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; [Huang, Ying; Craigie, Robert] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Cai, ML (corresponding author), NIDDKD, Chem Phys Lab, NIH, Bldg 2, Bethesda, MD 20892 USA.	robertc@mail.nih.gov; mariusc@mail.nih.gov	Clore, G Marius/L-2546-2018; Clore, G. Marius/A-3511-2008	Clore, G Marius/0000-0003-3809-1027; Clore, G. Marius/0000-0003-3809-1027	NIDDK; NIH; Office of the Director of the NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029038, ZIADK029023, ZIADK036171] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Director of the NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Program of NIDDK, NIH and by the AIDS Targeted Antiviral Program of the Office of the Director of the NIH (to G.M.C. and R.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bax A, 2001, METHOD ENZYMOL, V339, P127, DOI 10.1016/S0076-6879(01)39313-8; BUKRINSKY MI, 1993, NATURE, V365, P666, DOI 10.1038/365666a0; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; Clore GM, 1998, J AM CHEM SOC, V120, P10571, DOI 10.1021/ja982592f; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; FREED EO, 1995, J VIROL, V69, P3949, DOI 10.1128/JVI.69.6.3949-3954.1995; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Hearps AC, 2008, BIOCHEMISTRY-US, V47, P2199, DOI 10.1021/bi701360j; Hearps AC, 2007, AIDS RES HUM RETROV, V23, P341, DOI 10.1089/aid.2006.0108; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Iwahara J, 2004, J AM CHEM SOC, V126, P12800, DOI 10.1021/ja046246b; Iwahara J, 2004, J AM CHEM SOC, V126, P5879, DOI 10.1021/ja031580d; Iwahara J, 2003, J AM CHEM SOC, V125, P6634, DOI 10.1021/ja034488q; Iwahara J, 2007, J MAGN RESON, V184, P185, DOI 10.1016/j.jmr.2006.10.003; Iwahara J, 2006, P NATL ACAD SCI USA, V103, P15062, DOI 10.1073/pnas.0605868103; Legler PM, 2004, J BIOL CHEM, V279, P39115, DOI 10.1074/jbc.M406764200; Mannioui A, 2005, VIROLOGY, V339, P21, DOI 10.1016/j.virol.2005.05.023; MASSIAH MA, 1994, J MOL BIOL, V244, P198, DOI 10.1006/jmbi.1994.1719; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Reil H, 1998, EMBO J, V17, P2699, DOI 10.1093/emboj/17.9.2699; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; VONSCHWEDLER U, 1994, P NATL ACAD SCI USA, V91, P6992, DOI 10.1073/pnas.91.15.6992; Warrilow D, 2007, CURR HIV RES, V5, P293, DOI 10.2174/157016207780636579; Williams DC, 2005, J BIOL CHEM, V280, P29269, DOI 10.1074/jbc.M504642200; Williams DC, 2004, J BIOL CHEM, V279, P1449, DOI 10.1074/jbc.M309790200	28	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15675	10.1371/journal.pone.0015675	http://dx.doi.org/10.1371/journal.pone.0015675			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203471	Green Published, gold, Green Submitted			2022-12-27	WOS:000285579200028
J	Jensen, F; Woudwyk, M; Teles, A; Woidacki, K; Taran, F; Costa, S; Malfertheiner, SF; Zenclussen, AC				Jensen, Federico; Woudwyk, Mariana; Teles, Ana; Woidacki, Katja; Taran, Florin; Costa, Serban; Malfertheiner, Sara Fill; Zenclussen, Ana Claudia			Estradiol and Progesterone Regulate the Migration of Mast Cells from the Periphery to the Uterus and Induce Their Maturation and Degranulation	PLOS ONE			English	Article							HISTAMINE-RELEASING FACTOR; RAT UTERINE CERVIX; T-CELLS; EXTRACELLULAR-MATRIX; ESTRUS CYCLE; MOUSE UTERUS; EXPRESSION; TRYPTASE; METALLOPROTEINASES; IMPLANTATION	Background: Mast cells (MCs) have long been suspected as important players for implantation based on the fact that their degranulation causes the release of pivotal factors, e. g., histamine, MMPs, tryptase and VEGF, which are known to be involved in the attachment and posterior invasion of the embryo into the uterus. Moreover, MC degranulation correlates with angiogenesis during pregnancy. The number of MCs in the uterus has been shown to fluctuate during menstrual cycle in human and estrus cycle in rat and mouse indicating a hormonal influence on their recruitment from the periphery to the uterus. However, the mechanisms behind MC migration to the uterus are still unknown. Methodology/Principal Findings: We first utilized migration assays to show that MCs are able to migrate to the uterus and to the fetal-maternal interface upon up-regulation of the expression of chemokine receptors by hormonal changes. By using a model of ovariectomized animals, we provide clear evidences that also in vivo, estradiol and progesterone attract MC to the uterus and further provoke their maturation and degranulation. Conclusion/Significance: We propose that estradiol and progesterone modulate the migration of MCs from the periphery to the uterus and their degranulation, which may prepare the uterus for implantation.	[Jensen, Federico; Woudwyk, Mariana; Teles, Ana; Woidacki, Katja; Zenclussen, Ana Claudia] Otto Von Guericke Univ, Fac Med, Magdeburg, Germany; [Woudwyk, Mariana] Natl Univ La Plata, Sch Vet Sci, Lab Histol & Embryol, Buenos Aires, DF, Argentina; [Teles, Ana] Univ Coimbra, Ctr Neurosci & Cell Biol, Doctoral Program Expt Biol & Biomed, Coimbra, Portugal; [Taran, Florin; Costa, Serban; Malfertheiner, Sara Fill] Otto Von Guericke Univ, Univ Womens Clin, Magdeburg, Germany	Otto von Guericke University; National University of La Plata; Universidade de Coimbra; Otto von Guericke University	Jensen, F (corresponding author), Otto Von Guericke Univ, Fac Med, Magdeburg, Germany.	federico.jensen@med.ovgu.de; ana.zenclussen@med.ovgu.de	Zenclussen, Ana/AAE-8760-2020; Zenclussen, Ana C/G-2186-2013; Malfertheiner, Sara Fill/AAW-3419-2021; Taran, Florin-Andrei/GLV-3748-2022	Zenclussen, Ana/0000-0003-3544-4552; Zenclussen, Ana C/0000-0003-3544-4552; Malfertheiner, Sara Fill/0000-0002-4274-2526; 	Fritz-Thyssen Foundation [AZ. 10.08.2.179]; German Research Foundation [DFG ZE 526/6-1, SFB 854 TP7, DFG SPP 1394]	Fritz-Thyssen Foundation; German Research Foundation(German Research Foundation (DFG))	The present work was funded by grants from the Fritz-Thyssen Foundation (AZ. 10.08.2.179) and by the German Research Foundation (DFG ZE 526/6- 1 and SFB 854 TP7) to ACZ. ACZ, KW and FJ are members of the Priority Research Program "Mast cells-promoters of health and modulators of disease" from the German Research Foundation (DFG SPP 1394). ACZ is a member of the SFB 854 from the German Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accorsi-Mendonca D, 2002, PHARMACOLOGY, V64, P208, DOI 10.1159/000056173; Achache H, 2006, HUM REPROD UPDATE, V12, P731, DOI 10.1093/humupd/dml004; Baram D, 2001, J IMMUNOL, V167, P4008, DOI 10.4049/jimmunol.167.7.4008; Batth BK, 2000, EUR J MORPHOL, V38, P17, DOI 10.1076/0924-3860(200002)38:01;1-#;FT017; Belot MP, 2007, AM J PHYSIOL-ENDOC M, V292, pE1410, DOI 10.1152/ajpendo.00286.2006; Bischof P, 1995, Early Pregnancy, V1, P263; BISCHOF P, 1991, AM J OBSTET GYNECOL, V165, P1791, DOI 10.1016/0002-9378(91)90034-O; Bosquiazzo VL, 2007, REPRODUCTION, V133, P1045, DOI 10.1530/REP-06-0168; Brightling CE, 2003, CLIN EXP ALLERGY, V33, P550, DOI 10.1046/j.1365-2222.2003.01636.x; BUTTERFIELD JH, 1988, LEUKEMIA RES, V12, P345, DOI 10.1016/0145-2126(88)90050-1; Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; COCCHIARA R, 1986, HUM REPROD, V1, P445, DOI 10.1093/oxfordjournals.humrep.a136452; COCCHIARA R, 1992, HUM REPROD, V7, P1036, DOI 10.1093/oxfordjournals.humrep.a137790; Cohen M, 2006, PLACENTA, V27, P783, DOI 10.1016/j.placenta.2005.08.006; Cohen M, 2007, GYNECOL OBSTET INVES, V64, P126, DOI 10.1159/000101734; de Marco R, 2002, J ALLERGY CLIN IMMUN, V110, P228, DOI 10.1067/mai.2002.125600; Fang KC, 1996, J CLIN INVEST, V97, P1589, DOI 10.1172/JCI118583; FISHER SJ, 1989, J CELL BIOL, V109, P891, DOI 10.1083/jcb.109.2.891; FISHER SJ, 1985, J CELL BIOCHEM, V27, P31, DOI 10.1002/jcb.240270105; GRUBER BL, 1989, J CLIN INVEST, V84, P1657, DOI 10.1172/JCI114344; HARVEY EB, 1964, ANAT REC, V148, P507, DOI 10.1002/ar.1091480309; Hirota Y, 2006, J IMMUNOL, V177, P8813, DOI 10.4049/jimmunol.177.12.8813; JOHNSON DC, 1980, BIOL REPROD, V22, P1136, DOI 10.1093/biolreprod/22.5.1136; Jones RL, 2006, REPRODUCTION, V132, P217, DOI 10.1530/rep.1.01076; Jones RL, 2004, J CLIN ENDOCR METAB, V89, P6155, DOI 10.1210/jc.2004-0507; Karaca T, 2009, VET RES COMMUN, V33, P545, DOI 10.1007/s11259-009-9203-x; KIELTY CM, 1993, BIOCHEM BIOPH RES CO, V191, P1230, DOI 10.1006/bbrc.1993.1349; Lambert KC, 2005, J IMMUNOL, V175, P5716, DOI 10.4049/jimmunol.175.9.5716; LEES M, 1994, EUR J BIOCHEM, V223, P171, DOI 10.1111/j.1432-1033.1994.tb18980.x; Liu ZT, 2004, MOL REPROD DEV, V68, P345, DOI 10.1002/mrd.20082; LOHI J, 1992, J CELL BIOCHEM, V50, P337, DOI 10.1002/jcb.240500402; MANNINO DM, 2002, MMWR SURVEILL SUMM, V29, P1; Narita S, 2007, ENVIRON HEALTH PERSP, V115, P48, DOI 10.1289/ehp.9378; NELSON JF, 1981, BIOL REPROD, V24, P784, DOI 10.1095/biolreprod24.4.784; Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382; Orsi NM, 2007, ANIM REPROD SCI, V100, P301, DOI 10.1016/j.anireprosci.2006.08.016; Ozen A, 2002, DEUT TIERARZTL WOCH, V109, P412; PADILLA L, 1990, CELL MOL BIOL, V36, P93; Schatz M, 2003, ANN ALLERG ASTHMA IM, V91, P553, DOI 10.1016/S1081-1206(10)61533-5; Schumacher A, 2009, J IMMUNOL, V182, P5488, DOI 10.4049/jimmunol.0803177; SHIMONOVITZ S, 1994, AM J OBSTET GYNECOL, V171, P832, DOI 10.1016/0002-9378(94)90107-4; STACK MS, 1994, J BIOL CHEM, V269, P9416; TSUJI A, 1994, BIOCHEM J, V298, P79, DOI 10.1042/bj2980079; Varayoud J, 2004, REPRODUCTION, V127, P379, DOI 10.1530/rep.1.00018; Vrieze A, 2003, J ALLERGY CLIN IMMUN, V112, P271, DOI 10.1067/mai.2003.1676; Wood GW, 1999, CYTOKINE, V11, P1038, DOI 10.1006/cyto.1999.0513; WORDINGER RJ, 1985, J REPROD FERTIL, V73, P451, DOI 10.1530/jrf.0.0730451; Zaitsu M, 2007, MOL IMMUNOL, V44, P1977, DOI 10.1016/j.molimm.2006.09.030; Zenclussen AC, 2005, AM J PATHOL, V166, P811, DOI 10.1016/S0002-9440(10)62302-4; Zhang J, 1998, BIOL REPROD, V59, P693, DOI 10.1095/biolreprod59.3.693; Zysow BR, 1997, ARTERIOSCL THROM VAS, V17, P1741, DOI 10.1161/01.ATV.17.9.1741	51	81	85	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14409	10.1371/journal.pone.0014409	http://dx.doi.org/10.1371/journal.pone.0014409			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203555	Green Published, Green Submitted, gold			2022-12-27	WOS:000285578000014
J	Mundinano, J; Berguer, PM; Cabrera, G; Lorenzo, D; Nepomnaschy, I; Piazzon, I				Mundinano, Juliana; Berguer, Paula M.; Cabrera, Gabriel; Lorenzo, Daniela; Nepomnaschy, Irene; Piazzon, Isabel			Superantigens Increase the Survival of Mice Bearing T Cell Lymphomas by Inducing Apoptosis of Neoplastic Cells	PLOS ONE			English	Article							STAPHYLOCOCCAL-ENTEROTOXIN-B; MAMMARY-TUMOR VIRUS; IN-VIVO; BACTERIAL SUPERANTIGEN; FUSION PROTEIN; FAS LIGAND; ACTIVATION; IMMUNOTHERAPY; DEATH; STIMULATION	Superantigens bind to major histocompatibility complex class II molecules and interact with T cells expressing a particular T cell receptor V beta inducing a strong proliferation/deletion response of the superantigen-reactive T cells. However, there have been no attempts to investigate the ability of Sags to induce apoptosis in neoplastic T cells by signaling through the V beta region of their TCR. In the present study we show that bacterial and MMTV-encoded superantigens induce the apoptosis of AKR/J cognate lymphoma T cells both in vitro and in vivo. The Fas-Fas-L pathway was shown to be involved in the apoptosis of lymphoma T cells induced by bacterial superantigens. In vivo exposure to bacterial superantigens was able to improve the survival of lymphoma bearing mice. Moreover, the permanent expression of a retroviral encoded superantigen induced the complete remission of an aggressive lymphoma in a high percentage of mice. The possibility of a therapeutic use of superantigens in lymphoma/leukemia T cell malignancies is discussed.	[Mundinano, Juliana; Cabrera, Gabriel; Lorenzo, Daniela; Nepomnaschy, Irene; Piazzon, Isabel] Acad Nacl Med Buenos Aires, Inst Invest Hematol, Div Med Expt, ILEX CONICET, Buenos Aires, DF, Argentina; [Berguer, Paula M.] Fundac Inst Leloir, Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina	Buenos Aires National Academy of Medicine; IIHEMA - Instituto de Investigaciones Hematologicas; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute	Mundinano, J (corresponding author), Acad Nacl Med Buenos Aires, Inst Invest Hematol, Div Med Expt, ILEX CONICET, Buenos Aires, DF, Argentina.	ipiazzon@hematologia.anm.edu.ar	Berguer, Paula/AAI-6353-2020		Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 506305]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 20080102494]; FUNDALEU; Fundacion A.J. Roemmers	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FUNDALEU; Fundacion A.J. Roemmers	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica PICT 506305, Consejo Nacional de Investigaciones Cientificas y Tecnicas PIP 20080102494, FUNDALEU, and Fundacion A.J. Roemmers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHAORBEA H, 1995, ANNU REV IMMUNOL, V13, P459, DOI 10.1146/annurev.iy.13.040195.002331; ALBER G, 1990, J IMMUNOL, V144, P4501; Arnold R, 2006, EUR J IMMUNOL, V36, P1654, DOI 10.1002/eji.200636197; Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; Bittner JJ, 1936, SCIENCE, V84, P162, DOI 10.1126/science.84.2172.162; BRANDTCARLSON C, 1993, VIROLOGY, V193, P171, DOI 10.1006/viro.1993.1113; Brenner D, 2008, CRIT REV ONCOL HEMAT, V66, P52, DOI 10.1016/j.critrevonc.2008.01.002; Buggiano V, 1999, SCAND J IMMUNOL, V49, P269; Cabrera G, 2008, J VIROL, V82, P7422, DOI 10.1128/JVI.00102-08; CALLAHAN JE, 1990, J IMMUNOL, V144, P2473; Callahan R, 2000, ONCOGENE, V19, P992, DOI 10.1038/sj.onc.1203276; CHOI YW, 1991, NATURE, V350, P203, DOI 10.1038/350203a0; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; ETTINGER R, 1995, J IMMUNOL, V154, P4302; Fernandez MM, 2006, MOL IMMUNOL, V43, P927, DOI 10.1016/j.molimm.2005.06.029; FLEMING SD, 1991, INFECT IMMUN, V59, P4049, DOI 10.1128/IAI.59.11.4049-4055.1991; Forsberg G, 2001, BRIT J CANCER, V85, P129, DOI 10.1054/bjoc.2001.1891; FRANKEL WN, 1991, NATURE, V349, P526, DOI 10.1038/349526a0; Fraser JD, 2008, IMMUNOL REV, V225, P226, DOI 10.1111/j.1600-065X.2008.00681.x; Gidlof C, 1997, BLOOD, V89, P2089, DOI 10.1182/blood.V89.6.2089; Golovkina TV, 1997, J VIROL, V71, P3895, DOI 10.1128/JVI.71.5.3895-3903.1997; Gomez G, 2000, INT IMMUNOL, V12, P263, DOI 10.1093/intimm/12.3.263; GONZALO JA, 1993, J EXP MED, V177, P1239, DOI 10.1084/jem.177.5.1239; Hildeman DA, 1999, IMMUNITY, V10, P735, DOI 10.1016/S1074-7613(00)80072-2; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Jackow CM, 1997, BLOOD, V89, P32, DOI 10.1182/blood.V89.1.32; JANEWAY CA, 1989, IMMUNOL REV, V107, P61, DOI 10.1111/j.1600-065X.1989.tb00003.x; Kominsky SL, 2001, INT J CANCER, V94, P834, DOI 10.1002/ijc.1551; Linnemann T, 2004, BRIT J DERMATOL, V150, P1013, DOI 10.1111/j.1365-2133.2004.05970.x; Litton MJ, 1999, BRIT J CANCER, V81, P359, DOI 10.1038/sj.bjc.6690701; Lombardi G, 2005, J IMMUNOL, V174, P7022, DOI 10.4049/jimmunol.174.11.7022; MACDONALD HR, 1991, EUR J IMMUNOL, V21, P1963, DOI 10.1002/eji.1830210827; MARRACK P, 1990, J EXP MED, V171, P455, DOI 10.1084/jem.171.2.455; METZGER R, 1993, SCAND J IMMUNOL, V37, P245, DOI 10.1111/j.1365-3083.1993.tb01762.x; NEWELL KA, 1991, P NATL ACAD SCI USA, V88, P1074, DOI 10.1073/pnas.88.3.1074; Ogata M, 1998, BRIT J HAEMATOL, V100, P490, DOI 10.1046/j.1365-2141.1998.00605.x; Perabo FG, 2005, INT J CANCER, V115, P591, DOI 10.1002/ijc.20941; Ragnarsson L, 2001, CANCER IMMUNOL IMMUN, V50, P382, DOI 10.1007/s002620100211; Renno T, 1996, J EXP MED, V183, P431, DOI 10.1084/jem.183.2.431; Renno T, 1999, J IMMUNOL, V162, P6312; Shurin G, 1997, NEUROENDOCRINOLOGY, V65, P18, DOI 10.1159/000127161; SIMPSON E, 1993, EUR J IMMUNOGENET, V20, P137; Sundberg EJ, 2002, CURR OPIN IMMUNOL, V14, P36, DOI 10.1016/S0952-7915(01)00296-5; Sundstedt A, 2009, INT IMMUNOPHARMACOL, V9, P1063, DOI 10.1016/j.intimp.2009.04.013; Terman DS, 2006, CLIN CHEST MED, V27, P321, DOI 10.1016/j.ccm.2006.01.001; TOKURA Y, 1992, J INVEST DERMATOL, V98, P33, DOI 10.1111/1523-1747.ep12494184; Tordsson JM, 2000, CANCER IMMUNOL IMMUN, V48, P691, DOI 10.1007/s002620050018; Ueno A, 2002, ANTICANCER RES, V22, P769; Vonderheid EC, 2005, J INVEST DERMATOL, V124, P651, DOI 10.1111/j.0022-202X.2004.23586.x; YAZDANBAKHSH K, 1993, J EXP MED, V178, P737, DOI 10.1084/jem.178.2.737	50	4	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15694	10.1371/journal.pone.0015694	http://dx.doi.org/10.1371/journal.pone.0015694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203530	Green Published, gold, Green Submitted			2022-12-27	WOS:000285578000048
J	Estey, T; Chen, Y; Carpenter, JF; Vasiliou, V				Estey, Tia; Chen, Ying; Carpenter, John F.; Vasiliou, Vasilis			Structural and Functional Modifications of Corneal Crystallin ALDH3A1 by UVB Light	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE; ULTRAVIOLET-LIGHT; OXIDATIVE STRESS; CATALYTIC MECHANISM; ALPHA-CRYSTALLIN; CROSS-LINK; PROTEIN; TRYPTOPHAN; DITYROSINE; EXPRESSION	As one of the most abundantly expressed proteins in the mammalian corneal epithelium, aldehyde dehydrogenase 3A1 (ALDH3A1) plays critical and multifaceted roles in protecting the cornea from oxidative stress. Recent studies have demonstrated that one protective mechanism of ALDH3A1 is the direct absorption of UV-energy, which reduces damage to other corneal proteins such as glucose-6-phosphate dehydrogenase through a competition mechanism. UV-exposure, however, leads to the inactivation of ALDH3A1 in such cases. In the current study, we demonstrate that UV-light caused soluble, non-native aggregation of ALDH3A1 due to both covalent and non-covalent interactions, and that the formation of the aggregates was responsible for the loss of ALDH3A1 enzymatic activity. Spectroscopic studies revealed that as a result of aggregation, the secondary and tertiary structure of ALDH3A1 were perturbed. LysC peptide mapping using MALDI-TOF mass spectrometry shows that UV-induced damage to ALDH3A1 also includes chemical modifications to Trp, Met, and Cys residues. Surprisingly, the conserved active site Cys of ALDH3A1 does not appear to be affected by UV-exposure; this residue remained intact after exposure to UV-light that rendered the enzyme completely inactive. Collectively, our data suggest that the UV-induced inactivation of ALDH3A1 is a result of non-native aggregation and associated structural changes rather than specific damage to the active site Cys.	[Estey, Tia; Carpenter, John F.; Vasiliou, Vasilis] Univ Colorado Denver, Ctr Pharmaceut Biotechnol, Dept Pharmaceut Sci, Aurora, CO USA; [Chen, Ying; Vasiliou, Vasilis] Univ Colorado Denver, Mol Toxicol & Environm Hlth Sci Program, Dept Pharmaceut Sci, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Estey, T (corresponding author), Univ Colorado Denver, Ctr Pharmaceut Biotechnol, Dept Pharmaceut Sci, Aurora, CO USA.	vasiliou@ucdenver.edu		vasiliou, vasilis/0000-0003-2552-3118	NIH [R01 EY17963]; NATIONAL EYE INSTITUTE [R01EY017963] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The research was supported by NIH grant R01 EY17963. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEDINIA M, 1990, EXP EYE RES, V51, P419, DOI 10.1016/0014-4835(90)90154-M; ALEXANDER RJ, 1981, EXP EYE RES, V32, P205, DOI 10.1016/0014-4835(81)90009-9; Atherton SJ, 1999, PHOTOCHEM PHOTOBIOL, V70, P823, DOI 10.1111/j.1751-1097.1999.tb08289.x; Bhaskar B, 2003, J MOL BIOL, V328, P157, DOI 10.1016/S0022-2836(03)00179-7; Cobessi D, 2000, J MOL BIOL, V300, P141, DOI 10.1006/jmbi.2000.3824; D'Ambrosio K, 2006, BIOCHEMISTRY-US, V45, P2978, DOI 10.1021/bi0515117; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; DAVIES K J A, 1986, Journal of Free Radicals in Biology and Medicine, V2, P155, DOI 10.1016/S0748-5514(86)80066-6; Davies MJ, 2004, PHOTOCH PHOTOBIO SCI, V3, P17, DOI 10.1039/b307576c; Davies MJ, 2001, J PHOTOCH PHOTOBIO B, V63, P114, DOI 10.1016/S1011-1344(01)00208-1; DOWNES JE, 1993, CORNEA, V12, P241, DOI 10.1097/00003226-199305000-00010; Estey T, 2007, J BIOL CHEM, V282, P4382, DOI 10.1074/jbc.M607546200; Estey T, 2007, EXP EYE RES, V84, P3, DOI 10.1016/j.exer.2006.04.010; Estey T, 2009, J PHARM SCI-US, V98, P2994, DOI 10.1002/jps.21543; GUPTASARMA P, 1992, CURR EYE RES, V11, P1121, DOI 10.3109/02713689209015084; Hempel J, 1999, ADV EXP MED BIOL, V463, P53; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; HOTT JL, 1993, PHOTOCHEM PHOTOBIOL, V57, P312; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kerwin BA, 2007, J PHARM SCI-US, V96, P1468, DOI 10.1002/jps.20815; Kueltzo LA, 2003, J BIOL CHEM, V278, P2792, DOI 10.1074/jbc.M208383200; Lassen N, 2005, DRUG METAB DISPOS, V33, P649, DOI 10.1124/dmd.104.002964; Lassen N, 2007, J BIOL CHEM, V282, P25668, DOI 10.1074/jbc.M702076200; Liu ZJ, 1997, NAT STRUCT BIOL, V4, P317, DOI 10.1038/nsb0497-317; MACH H, 1994, ANAL BIOCHEM, V222, P323, DOI 10.1006/abio.1994.1499; Malencik DA, 2003, AMINO ACIDS, V25, P233, DOI 10.1007/s00726-003-0014-z; Manzer R, 2003, CHEM-BIOL INTERACT, V143, P45, DOI 10.1016/S0009-2797(02)00171-0; MITCHELL J, 1995, CORNEA, V14, P266, DOI 10.1097/00003226-199505000-00007; Onorato JM, 1998, ANN NY ACAD SCI, V854, P277, DOI 10.1111/j.1749-6632.1998.tb09909.x; Osapay K, 2000, J BIOL CHEM, V275, P12017, DOI 10.1074/jbc.275.16.12017; Pappa A, 2003, BIOCHEM J, V376, P615, DOI 10.1042/BJ20030810; Pappa A, 2001, CHEM-BIOL INTERACT, V130, P181, DOI 10.1016/S0009-2797(00)00233-7; Piatigorsky J, 2000, J OCUL PHARMACOL TH, V16, P173, DOI 10.1089/jop.2000.16.173; Piatigorsky J, 1998, PROG RETIN EYE RES, V17, P145, DOI 10.1016/S1350-9462(97)00004-9; Requena JR, 2003, AMINO ACIDS, V25, P221, DOI 10.1007/s00726-003-0012-1; Reshetnyak YK, 2001, BIOPHYS J, V81, P1735, DOI 10.1016/S0006-3495(01)75825-0; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Stiuso P, 1999, EUR J BIOCHEM, V266, P1029, DOI 10.1046/j.1432-1327.1999.00944.x; VANKUIJK FJGM, 1991, ENVIRON HEALTH PERSP, V96, P177, DOI 10.2307/3431229; Vasiliou V, 1999, PHARMACOGENETICS, V9, P421, DOI 10.1097/00008571-199910000-00004; WALRANT P, 1974, PHOTOCHEM PHOTOBIOL, V19, P411, DOI 10.1111/j.1751-1097.1974.tb06533.x; ZIGMAN S, 1988, CURR EYE RES, V7, P531, DOI 10.3109/02713688809031808	44	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15218	10.1371/journal.pone.0015218	http://dx.doi.org/10.1371/journal.pone.0015218			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203538	Green Published, Green Submitted, gold			2022-12-27	WOS:000285576900022
J	Johnston, APW; Baker, J; Bellamy, LM; McKay, BR; De Lisio, M; Parise, G				Johnston, Adam P. W.; Baker, Jeff; Bellamy, Leeann M.; McKay, Bryon R.; De Lisio, Michael; Parise, Gianni			Regulation of Muscle Satellite Cell Activation and Chemotaxis by Angiotensin II	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; ADULT SKELETAL-MUSCLE; GENE-EXPRESSION; INDUCED MIGRATION; LEADING-EDGE; STEM-CELLS; TGF-BETA; IN-VITRO; HYPERTENSION; MYOBLASTS	The role of angiotensin II (Ang II) in skeletal muscle is poorly understood. We report that pharmacological inhibition of Ang II signaling or ablation of the AT1a receptor significantly impaired skeletal muscle growth following myotrauma, in vivo, likely due to impaired satellite cell activation and chemotaxis. In vitro experiments demonstrated that Ang II treatment activated quiescent myoblasts as evidenced by the upregulation of myogenic regulatory factors, increased number of beta-gal+, Myf5-LacZ myoblasts and the acquisition of cellular motility. Furthermore, exogenous treatment with Ang II significantly increased the chemotactic capacity of C2C12 and primary cells while AT1a(-/-) myoblasts demonstrated a severe impairment in basal migration and were not responsive to Ang II treatment. Additionally, Ang II interacted with myoblasts in a paracrine-mediated fashion as 4 h of cyclic mechanical stimulation resulted in Ang II-induced migration of cocultured myoblasts. Ang II-induced chemotaxis appeared to be regulated by multiple mechanisms including reorganization of the actin cytoskeleton and augmentation of MMP2 activity. Collectively, these results highlight a novel role for Ang II and ACE inhibitors in the regulation of skeletal muscle growth and satellite cell function.	[Johnston, Adam P. W.; Baker, Jeff; Bellamy, Leeann M.; McKay, Bryon R.; De Lisio, Michael; Parise, Gianni] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada; [Parise, Gianni] McMaster Univ, Dept Med Phys & Appl Radiat Sci, Hamilton, ON, Canada	McMaster University; McMaster University	Johnston, APW (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada.	pariseg@mcmaster.ca			Natural Science and Engineering Research Council [327071-06]	Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Natural Science and Engineering Research Council Discovery Grant (# 327071-06) awarded to GP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RE, 1995, J CELL PHYSIOL, V165, P307, DOI 10.1002/jcp.1041650211; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; CHEN Y, 2010, PHYSL GENOMICS; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; Deato MDE, 2008, MOL CELL, V32, P96, DOI 10.1016/j.molcel.2008.09.009; Dinh DT, 2001, CLIN SCI, V100, P481, DOI 10.1042/CS20000263; El Fahime E, 2000, EXP CELL RES, V258, P279, DOI 10.1006/excr.2000.4962; ESTREICHER A, 1990, J CELL BIOL, V111, P783, DOI 10.1083/jcb.111.2.783; Fields LE, 2004, HYPERTENSION, V44, P398, DOI 10.1161/01.HYP.0000142248.54761.56; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gordon SE, 2001, AM J PHYSIOL-ENDOC M, V280, pE150, DOI 10.1152/ajpendo.2001.280.1.E150; Gu QP, 2006, CIRCULATION, V113, P213, DOI 10.1161/CIRCULATIONAHA.105.542290; Hawke TJ, 2005, EXERC SPORT SCI REV, V33, P63, DOI 10.1097/00003677-200504000-00002; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; HEIT B, 2003, SCI STKE, pPL5; Hlaing M, 2002, J BIOL CHEM, V277, P23794, DOI 10.1074/jbc.M201980200; Hsu HH, 2008, J MOL MED, V86, P1379, DOI 10.1007/s00109-008-0399-y; Inagami T, 2000, BRAZ J MED BIOL RES, V33, P619, DOI 10.1590/S0100-879X2000000600002; Ispanovic E, 2008, AM J PHYSIOL-CELL PH, V295, pC600, DOI 10.1152/ajpcell.00460.2007; JOHNSTON A, 2010, J RENIN ANG IN PRESS; KAMI K, 1995, CELL TISSUE RES, V280, P11, DOI 10.1007/BF00304506; Kawamura K, 2004, J BIOL CHEM, V279, P54862, DOI 10.1074/jbc.M408057200; Kay RR, 2008, NAT REV MOL CELL BIO, V9, P455, DOI 10.1038/nrm2419; Lafreniere JF, 2006, EXP CELL RES, V312, P1127, DOI 10.1016/j.yexcr.2006.01.002; Lijnen P, 1999, J MOL CELL CARDIOL, V31, P949, DOI 10.1006/jmcc.1999.0934; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Milasincic DJ, 1996, IN VITRO CELL DEV-AN, V32, P90; Milasincic DJ, 1996, MOL CELL BIOL, V16, P5964; Montiel M, 2005, BIOCHEM BIOPH RES CO, V327, P971, DOI 10.1016/j.bbrc.2004.12.110; Muralikrishna B, 2001, J CELL SCI, V114, P4001; Nadal JA, 2002, AM J PHYSIOL-HEART C, V282, pH739, DOI 10.1152/ajpheart.00656.2001; Nieto M, 1997, J EXP MED, V186, P153, DOI 10.1084/jem.186.1.153; Onder G, 2002, LANCET, V359, P926, DOI 10.1016/S0140-6736(02)08024-8; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Pisconti A, 2010, J CELL BIOL, V190, P427, DOI 10.1083/jcb.201003081; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Saito S, 2002, BIOCHEM BIOPH RES CO, V294, P1023, DOI 10.1016/S0006-291X(02)00595-8; Schabort EJ, 2009, EXP CELL RES, V315, P373, DOI 10.1016/j.yexcr.2008.10.037; SCHULTZ E, 1985, MUSCLE NERVE, V8, P217, DOI 10.1002/mus.880080307; Shin EY, 2009, EXP MOL MED, V41, P387, DOI 10.3858/emm.2009.41.6.044; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Tatsumi R, 1998, DEV BIOL, V194, P114, DOI 10.1006/dbio.1997.8803; Westerkamp CM, 2005, AM J PHYSIOL-REG I, V289, pR1223, DOI 10.1152/ajpregu.00730.2004; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006	49	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15212	10.1371/journal.pone.0015212	http://dx.doi.org/10.1371/journal.pone.0015212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203566	gold, Green Published, Green Submitted			2022-12-27	WOS:000285576900020
J	Chait, R; Shrestha, S; Shah, AK; Michel, JB; Kishony, R				Chait, Remy; Shrestha, Shreya; Shah, Aakash Kaushik; Michel, Jean-Baptiste; Kishony, Roy			A Differential Drug Screen for Compounds That Select Against Antibiotic Resistance	PLOS ONE			English	Article							TETRACYCLINE RESISTANCE; BACTERIAL-RESISTANCE; NATURAL ENVIRONMENTS; GENES	Antibiotics increase the frequency of resistant bacteria by providing them a competitive advantage over sensitive strains. Here, we develop a versatile assay for differential chemical inhibition of competing microbial strains, and use it to identify compounds that preferentially inhibit tetracycline-resistant relative to sensitive bacteria, thus "inverting" selection for resistance. Our assay distinguishes compounds selecting directly against specific resistance mechanisms and compounds whose selection against resistance is based on their physiological interaction with tetracycline and is more general with respect to resistance mechanism. We find that both types of selection-inverting compounds are secreted by soil microbes, indicating that nature has evolved a repertoire of chemicals that counteracts antibiotic resistance. Finally, we show that our assay can more generally permit simple, direct screening for drugs based on their differential activity against different strains or targets.	[Chait, Remy; Michel, Jean-Baptiste; Kishony, Roy] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Shrestha, Shreya; Shah, Aakash Kaushik] Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA; [Kishony, Roy] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University	Chait, R (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	roy_kishony@hms.harvard.edu	Michel, Jean-Baptiste/AAH-9336-2020	Chait, Remy/0000-0003-0876-3187	Bill and Melinda Gates Foundation through the Grand Challenges Explorations Initiative; National Institutes of Health [R01 GM081617]; FAS (Faculty of Arts and Sciences) Center for Systems Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081617, P50GM068763] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation through the Grand Challenges Explorations Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAS (Faculty of Arts and Sciences) Center for Systems Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Bill and Melinda Gates Foundation through the Grand Challenges Explorations Initiative, National Institutes of Health grant R01 GM081617, and the FAS (Faculty of Arts and Sciences) Center for Systems Biology Undergraduate Summer Research Internship program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Bacon CW, 1996, APPL ENVIRON MICROB, V62, P4039, DOI 10.1128/AEM.62.11.4039-4043.1996; BOCHNER BR, 1980, J BACTERIOL, V143, P926, DOI 10.1128/JB.143.2.926-933.1980; Bollenbach T, 2009, CELL, V139, P707, DOI 10.1016/j.cell.2009.10.025; CAMPBELL AH, 1960, BRIT MED BULL, V16, P82, DOI 10.1093/oxfordjournals.bmb.a069798; Chait R, 2007, NATURE, V446, P668, DOI 10.1038/nature05685; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; COLEMAN K, 1994, J ANTIMICROB CHEMOTH, V33, P1091, DOI 10.1093/jac/33.6.1091; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Djapa LY, 2007, MOL BIOCHEM PARASIT, V156, P89, DOI 10.1016/j.molbiopara.2007.07.009; Li Q, 2002, ANTIMICROB AGENTS CH, V46, P1262, DOI 10.1128/AAC.46.5.1262-1268.2002; Li XZ, 2009, DRUGS, V69, P1555, DOI 10.2165/11317030-000000000-00000; Lorian V., 2005, ANTIBIOTICS LAB MED; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Palmer AC, 2010, NAT CHEM BIOL, V6, P105, DOI [10.1038/NCHEMBIO.289, 10.1038/nchembio.289]; SZYBALSKI W, 1952, J BACTERIOL, V64, P489, DOI 10.1128/JB.64.4.489-499.1952; Taubes G, 2008, SCIENCE, V321, P356, DOI 10.1126/science.321.5887.356; WAKSMAN SA, 1961, PERSPECT BIOL MED, V4, P271; Whittle G, 2003, APPL ENVIRON MICROB, V69, P4151, DOI 10.1128/AEM.69.7.4151-4158.2003; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755	20	36	36	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15179	10.1371/journal.pone.0015179	http://dx.doi.org/10.1371/journal.pone.0015179			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21209699	Green Published, gold, Green Submitted			2022-12-27	WOS:000285084100025
J	Kim, D; Yu, H				Kim, Daehyun; Yu, Hong			Figure Text Extraction in Biomedical Literature	PLOS ONE			English	Article							SEARCH; IMAGES; RECOGNITION; ENGINE	Background: Figures are ubiquitous in biomedical full-text articles, and they represent important biomedical knowledge. However, the sheer volume of biomedical publications has made it necessary to develop computational approaches for accessing figures. Therefore, we are developing the Biomedical Figure Search engine (http://figuresearch.askHERMES.org) to allow bioscientists to access figures efficiently. Since text frequently appears in figures, automatically extracting such text may assist the task of mining information from figures. Little research, however, has been conducted exploring text extraction from biomedical figures. Methodology: We first evaluated an off-the-shelf Optical Character Recognition (OCR) tool on its ability to extract text from figures appearing in biomedical full-text articles. We then developed a Figure Text Extraction Tool (FigTExT) to improve the performance of the OCR tool for figure text extraction through the use of three innovative components: image preprocessing, character recognition, and text correction. We first developed image preprocessing to enhance image quality and to improve text localization. Then we adapted the off-the-shelf OCR tool on the improved text localization for character recognition. Finally, we developed and evaluated a novel text correction framework by taking advantage of figure-specific lexicons. Results/Conclusions: The evaluation on 382 figures (9,643 figure texts in total) randomly selected from PubMed Central full-text articles shows that FigTExT performed with 84% precision, 98% recall, and 90% F1-score for text localization and with 62.5% precision, 51.0% recall and 56.2% F1-score for figure text extraction. When limiting figure texts to those judged by domain experts to be important content, FigTExT performed with 87.3% precision, 68.8% recall, and 77% F1-score. FigTExT significantly improved the performance of the off-the-shelf OCR tool we used, which on its own performed with 36.6% precision, 19.3% recall, and 25.3% F1-score for text extraction. In addition, our results show that FigTExT can extract texts that do not appear in figure captions or other associated text, further suggesting the potential utility of FigTExT for improving figure search.	[Kim, Daehyun; Yu, Hong] Univ Wisconsin, Dept Hlth Sci, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee	Kim, D (corresponding author), Univ Wisconsin, Dept Hlth Sci, Milwaukee, WI 53201 USA.	kim48@uwm.edu			National Institutes of Health [1R21RR024933]; University of Wisconsin-Milwaukee; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR024933] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin-Milwaukee; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors acknowledge that this work was supported in part by National Institutes of Health 1R21RR024933 and the Research Growth Initiative grant by University of Wisconsin-Milwaukee. Any opinions, findings, or recommendations are those of the authors and do not necessarily reflect the views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL S, 2009, AMIA ANN S; Agarwal S, 2009, BIOINFORMATICS, V25, P3174, DOI 10.1093/bioinformatics/btp548; Ahmed A, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P39; Anthimopoulos M, 2008, PROCEEDINGS OF THE 8TH IAPR INTERNATIONAL WORKSHOP ON DOCUMENT ANALYSIS SYSTEMS, P286, DOI 10.1109/DAS.2008.72; Chen DT, 2004, SIGNAL PROCESS-IMAGE, V19, P205, DOI 10.1016/S0923-5965(03)00075-4; Chen DT, 2004, PATTERN RECOGN, V37, P595, DOI 10.1016/j.patcog.2003.06.001; Chen XL, 2004, IEEE T IMAGE PROCESS, V13, P87, DOI 10.1109/TIP.2003.819223; Chen XR, 2004, PROC CVPR IEEE, P366; DAMERAU FJ, 1964, COMMUN ACM, V7, P171, DOI 10.1145/363958.363994; Donoser M., 2009, INT C PATT REC; Fattal R, 2007, ACM T GRAPHIC, V26, DOI 10.1145/1276377.1276441; GATOS B, 2005, INT WORKSH CAM BAS D, P127; GLASNER D, 2009, INT C COMP VIS ICCV2; Gonzalez R.C., 2002, DIGIT IMAGE PROCESS, V2, P75; Hearst MA, 2007, BIOINFORMATICS, V23, P2196, DOI 10.1093/bioinformatics/btm301; Hodge VJ, 2001, LECT NOTES COMPUT SC, V2130, P1199; HOU HS, 1978, IEEE T ACOUST SPEECH, V26, P508; Jones M., 1997, P 5 C APPL NATURAL L, P166; Kahn CE, 2007, AM J ROENTGENOL, V188, P1475, DOI 10.2214/AJR.06.1740; KASHYAP RL, 1984, PATTERN RECOGN LETT, V2, P147, DOI 10.1016/0167-8655(84)90038-2; KIM D, 2009, AMIA ANN S; KIM DH, 2008, INT C PATT REC; KOU Z, 2003, ACM SIGKDD WORKSH DA; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Li M, 2006, COLING/ACL 2006, VOLS 1 AND 2, PROCEEDINGS OF THE CONFERENCE, P1025; LIU Z, 2008, INT C PATTERN RECOGN; Lucas S, 2003, INT C DOC AN REC; Martins B, 2004, LECT NOTES ARTIF INT, V3230, P372; Murphy RF, 2001, 2ND ANNUAL IEEE INTERNATIONAL SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, PROCEEDINGS, P119, DOI 10.1109/BIBE.2001.974420; PATERSON M, 1994, INT S MATH FDN COMP, V841, P127; Qian YT, 2008, BIOINFORMATICS, V24, P569, DOI 10.1093/bioinformatics/btm561; Rafkind B., 2006, P BIONLP WORKSH LINK, P73; Ringlstetter Christoph, 2007, ACM T SPEECH LANG PR, V4, P9; RISEMAN EM, 1974, IEEE T COMPUT, VC 23, P480, DOI 10.1109/T-C.1974.223971; Ruch Patrick, 2002, P 19 INT C COMP LING, P1; SCHAMBACH MP, 2005, INT C DOC AN REC; Shatkay H, 2008, BIOINFORMATICS, V24, P2086, DOI 10.1093/bioinformatics/btn381; Shatkay H, 2006, BIOINFORMATICS, V22, pE446, DOI 10.1093/bioinformatics/btl235; SHIVAKUMARA P, 2008, INT C PATT REC; STEHOUWER H, 2009, P EACL 2009 WORKSH C, P41; Thillou C, 2005, EURASIP J APPL SIG P, V2005, P2127, DOI 10.1155/ASP.2005.2127; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TONG X, 1996, P 4 WORKSH VER LARG; WAGNER RA, 1974, J ACM, V21, P168, DOI 10.1145/321796.321811; WEINMAN JJ, 2007, INT C DOC AN REC; Xu SH, 2008, BIOINFORMATICS, V24, P1968, DOI 10.1093/bioinformatics/btn340; Yu H., 2006, BIOEX NOVEL USER INT; YU H, 2009, J BIOMEDICAL DISCOVE, V4; YU H, 2010, PLOS ONE IN PRESS; Yu H, 2006, BIOINFORMATICS, V22, pE547, DOI 10.1093/bioinformatics/btl261; ZAMORA EM, 1981, INFORM PROCESS MANAG, V17, P305, DOI 10.1016/0306-4573(81)90044-3	51	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e15338	10.1371/journal.pone.0015338	http://dx.doi.org/10.1371/journal.pone.0015338			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249186	Green Published, gold, Green Submitted			2022-12-27	WOS:000286515000005
J	Overstreet, MG; Chen, YC; Cockburn, IA; Tse, SW; Zavala, F				Overstreet, Michael G.; Chen, Yun-Chi; Cockburn, Ian A.; Tse, Sze-Wah; Zavala, Fidel			CD4(+) T Cells Modulate Expansion and Survival but Not Functional Properties of Effector and Memory CD8(+) T Cells Induced by Malaria Sporozoites	PLOS ONE			English	Article							LIVER-STAGES; CD8-T-CELL MEMORY; HIV-1 INFECTION; CD4-T-CELL HELP; DENDRITIC CELL; LYMPHOCYTES-T; IN-VIVO; RESPONSES; GENERATION; VIRUS	CD4(+) helper T cells are critical orchestrators of immune responses to infection and vaccination. During primary responses, naive CD8(+) T cells may need "CD4 help'' for optimal development of memory populations. The immunological factors attributed to CD4 help depend on the context of immunization and vary depending on the priming system. In response to immunization with radiation-attenuated Plasmodium yoelii sporozoites, CD8(+) T cells in BALB/c mice fail to generate large numbers of effector cells without help from CD4(+) T cells - a defect not observed in most systems. Given this unique early dependence on CD4 help, we evaluated the effects of CD4(+) cells on the development of functional properties of CD8(+) T cells and on their ability to abolish infection. First, we determined that this effect was not mediated by CD4(+) non-T cells and did not involve CD1d-restricted NKT cells. We found that CD8(+) T cells induced by sporozoites without CD4 help formed memory populations severely reduced in magnitude that could not limit parasite development in the liver. The inability of these "helpless'' memory T cells to protect is not a result of defects in effector function, as their capacity to produce cytokines and undergo cytotoxic degranulation was indistinguishable from control memory T cells. These data indicate that CD4(+) T help may not be necessary to develop the functional attributes of CD8(+) T cells; however they are crucial to ensure the survival of effector and memory cells induced in primary responses.	[Overstreet, Michael G.; Chen, Yun-Chi; Cockburn, Ian A.; Tse, Sze-Wah; Zavala, Fidel] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Malaria Res Inst, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Overstreet, MG (corresponding author), Univ Rochester, Med Ctr, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA.	fzavala@jhsph.edu		Cockburn, Ian/0000-0001-8220-9294; Overstreet, Michael/0000-0001-7450-7929; Chen, Yun-Chi/0000-0003-2787-1247	NIH [AI44375]; Malaria Research Institute; Bloomberg Family Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI044375, R01AI044375] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Malaria Research Institute; Bloomberg Family Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant number AI44375 to FZ (http://www.nih.gov). MGO and IAC were supported by fellowships from the Malaria Research Institute. The authors are grateful for the support of the Bloomberg Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bennett SRM, 1997, J EXP MED, V186, P65, DOI 10.1084/jem.186.1.65; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2004, METHOD CELL BIOL, V75, P497; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Boaz MJ, 2002, J IMMUNOL, V169, P6376, DOI 10.4049/jimmunol.169.11.6376; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Bruna-Romero O, 2001, INT J PARASITOL, V31, P1499, DOI 10.1016/S0020-7519(01)00265-X; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Carvalho LH, 2002, NAT MED, V8, P166, DOI 10.1038/nm0202-166; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Castellino F, 2007, J IMMUNOL, V178, P778, DOI 10.4049/jimmunol.178.2.778; Chakravarty S, 2007, NAT MED, V13, P1035, DOI 10.1038/nm1628; De Rosa SC, 2004, J IMMUNOL, V173, P5372, DOI 10.4049/jimmunol.173.9.5372; Duvall MG, 2008, EUR J IMMUNOL, V38, P350, DOI 10.1002/eji.200737768; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; JENNINGS SR, 1991, CELL IMMUNOL, V133, P234, DOI 10.1016/0008-8749(91)90194-G; KEENE JA, 1982, J EXP MED, V155, P768, DOI 10.1084/jem.155.3.768; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; Lichterfeld M, 2004, J EXP MED, V200, P701, DOI 10.1084/jem.20041270; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Obar JJ, 2010, P NATL ACAD SCI USA, V107, P193, DOI 10.1073/pnas.0909945107; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; Sano G, 2001, J EXP MED, V194, P173, DOI 10.1084/jem.194.2.173; SCHMIDT N, 2008, P NATL ACAD SCI US; Schmidt NW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000998; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Shedlock DJ, 2003, J IMMUNOL, V170, P2053, DOI 10.4049/jimmunol.170.4.2053; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Stock AT, 2007, IMMUNOL CELL BIOL, V85, P394, DOI 10.1038/sj.icb.7100076; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; vonHerrath MG, 1996, J VIROL, V70, P1072, DOI 10.1128/JVI.70.2.1072-1079.1996; Wang JCE, 2003, J IMMUNOL, V171, P6339, DOI 10.4049/jimmunol.171.12.6339; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	42	36	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2011	6	1							e15948	10.1371/journal.pone.0015948	http://dx.doi.org/10.1371/journal.pone.0015948			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KM	21245909	Green Submitted, Green Published, gold			2022-12-27	WOS:000286510500007
J	Erlandsson, L; Nielsen, LP; Fomsgaard, A				Erlandsson, Lena; Nielsen, Lars Peter; Fomsgaard, Anders			Amp-PCR: Combining a Random Unbiased Phi29-Amplification with a Specific Real-Time PCR, Performed in One Tube to Increase PCR Sensitivity	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; WHOLE-GENOME AMPLIFICATION; PHI-29 DNA-POLYMERASE; VIRUS; SAMPLES; FLUID; JC	In clinical situations where a diagnostic real-time PCR assay is not sensitive enough, leading to low or falsely negative results, or where detection earlier in a disease progression would benefit the patient, an unbiased pre-amplification prior to the real-time PCR could be beneficial. In Amp-PCR, an unbiased random Phi29 pre-amplification is combined with a specific real-time PCR reaction. The two reactions are separated physically by a wax-layer (AmpliWax (R)) and are run in sequel in the same sealed tube. Amp-PCR can increase the specific PCR signal at least 100x10(6)-fold and make it possible to detect positive samples normally under the detection limit of the specific real-time PCR. The risk of contamination is eliminated and Amp-PCR could replace nested-PCR in situations where increased sensitivity is needed e. g. in routine PCR diagnostic analysis. We show Amp-PCR to work on clinical samples containing circular and linear viral dsDNA genomes, but can work well on DNA of any origin, both from non-cellular (virus) and cellular sources (bacteria, archae, eukaryotes).	[Erlandsson, Lena; Nielsen, Lars Peter] Statens Serum Inst, Dept Virol, Influenza Lab, DK-2300 Copenhagen, Denmark	Statens Serum Institut	Erlandsson, L (corresponding author), Statens Serum Inst, Dept Virol, Influenza Lab, DK-2300 Copenhagen, Denmark.	lao@ssi.dk		Erlandsson, Lena/0000-0003-4350-5909; Fomsgaard, Anders/0000-0003-4304-0603				Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Berthet N, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-77; BLANCO L, 1989, J BIOL CHEM, V264, P8935; Bustin SA, 2004, A Z QUANTITATIVE PCR; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; ESTEBAN JA, 1993, J BIOL CHEM, V268, P2719; Giardina E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-159; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; KARRER EE, 1995, P NATL ACAD SCI USA, V92, P3814, DOI 10.1073/pnas.92.9.3814; Koralnik IJ, 2004, CURR OPIN NEUROL, V17, P365, DOI 10.1097/00019052-200406000-00019; Landry ML, 2008, J CLIN VIROL, V43, P247, DOI 10.1016/j.jcv.2008.07.003; Lasken RS, 2003, TRENDS BIOTECHNOL, V21, P531, DOI 10.1016/j.tibtech.2003.09.010; Linda H, 2009, NEW ENGL J MED, V361, P1081, DOI 10.1056/NEJMoa0810316; MacKenzie J, 2003, J NATL CANCER I, V95, P1001, DOI 10.1093/jnci/95.13.1001; Perrott P, 2009, J APPL MICROBIOL, V106, P1438, DOI 10.1111/j.1365-2672.2008.04119.x; Ryschkewitsch C, 2004, J VIROL METHODS, V121, P217, DOI 10.1016/j.jviromet.2004.06.021; Schloss L, 2003, J CLIN VIROL, V28, P175, DOI 10.1016/S1386-6532(03)00003-9; VOSBERG HP, 1989, HUM GENET, V83, P1, DOI 10.1007/BF00274139	19	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15719	10.1371/journal.pone.0015719	http://dx.doi.org/10.1371/journal.pone.0015719			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209824	Green Published, gold, Green Submitted			2022-12-27	WOS:000285838900028
J	Feng, QP; Jiang, L; Berg, RL; Antonik, M; MacKinney, E; Gunnell-Santoro, J; McCarty, CA; Wilke, RA				Feng, Qiping; Jiang, Lan; Berg, Richard L.; Antonik, Melissa; MacKinney, Erin; Gunnell-Santoro, Jennifer; McCarty, Catherine A.; Wilke, Russell A.			A Common CNR1 (Cannabinoid Receptor 1) Haplotype Attenuates the Decrease in HDL Cholesterol That Typically Accompanies Weight Gain	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; FOOD FREQUENCY QUESTIONNAIRES; DIET HISTORY QUESTIONNAIRE; BODY-MASS INDEX; PHYSICAL-ACTIVITY; GENETIC-VARIATION; CB1 RECEPTOR; RISK-FACTORS; ASSOCIATION; POPULATION	We have previously shown that genetic variability in CNR1 is associated with low HDL dyslipidemia in a multigenerational obesity study cohort of Northern European descent (209 families, median = 10 individuals per pedigree). In order to assess the impact of CNR1 variability on the development of dyslipidemia in the community, we genotyped this locus in all subjects with class III obesity (body mass index.40 kg/m(2)) participating in a population-based biobank of similar ancestry. Twenty-two haplotype tagging SNPs, capturing the entire CNR1 gene locus plus 15 kb upstream and 5 kb downstream, were genotyped and tested for association with clinical lipid data. This biobank contains data from 645 morbidly obese study subjects. In these subjects, a common CNR1 haplotype (H3, frequency 21.1%) is associated with fasting TG and HDL cholesterol levels (p = 0.031 for logTG; p = 0.038 for HDL-C; p = 0.00376 for log[TG/HDL-C]). The strength of this relationship increases when the data are adjusted for age, gender, body mass index, diet and physical activity. Mean TG levels were 160 +/- 70, 155 +/- 70, and 120 +/- 60 mg/dL for subjects with 0, 1, and 2 copies of the H3 haplotype. Mean HDL-C levels were 45 +/- 10, 47 +/- 10, and 48 +/- 9 mg/dL, respectively. The H3 CNR1 haplotype appears to exert a protective effect against development of obesity-related dyslipidemia.	[Feng, Qiping; Wilke, Russell A.] Vanderbilt Univ, Med Ctr, Dept Med, Div Clin Pharmacol, Nashville, TN 37203 USA; [Jiang, Lan] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Dept Mol Physiol & Biophys, Nashville, TN USA; [Berg, Richard L.] Marshfield Clin Res Fdn, Biomed Informat Res Ctr, Marshfield, WI USA; [Antonik, Melissa; MacKinney, Erin; Gunnell-Santoro, Jennifer] Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA; [McCarty, Catherine A.] Marshfield Clin Res Fdn, Ctr Human Genet, Marshfield, WI USA	Vanderbilt University; Vanderbilt University; Medical College of Wisconsin	Feng, QP (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Clin Pharmacol, Nashville, TN 37203 USA.	russell.a.wilke@Vanderbilt.Edu	Feng, Qiping/F-7941-2013	McCarty, Catherine/0000-0003-1089-0142	Eagles Max Bauer Heart Fund;  [U01HG004608];  [R01DK080007]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080007] Funding Source: NIH RePORTER	Eagles Max Bauer Heart Fund; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was partly funded by U01HG004608 (McCarty) (http://www.genome.gov/) and R01DK080007 (Wilke)(http://www2.niddk.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; We thank all PMRP participants, and the Eagles Max Bauer Heart Fund (C.A. McCarty).	Ashen MD, 2005, NEW ENGL J MED, V353, P1252, DOI 10.1056/NEJMcp044370; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baye TM, 2008, PHARMACOGENOMICS, V9, P1647, DOI 10.2217/14622416.9.11.1647; Colombo G, 1998, LIFE SCI, V63, pPL113, DOI 10.1016/S0024-3205(98)00322-1; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; DEGOTTARDI A, 2010, LIVER INT; Delahoy PJ, 2009, CLIN THER, V31, P236, DOI 10.1016/j.clinthera.2009.02.017; *DHHS, 2000, BOD MASS IND; Flood A, 2006, J AM DIET ASSOC, V106, P393, DOI 10.1016/j.jada.2005.12.008; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gazzerro P, 2007, INT J OBESITY, V31, P908, DOI 10.1038/sj.ijo.0803510; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; GREENBERG I, 1976, PSYCHOPHARMACOLOGY, V49, P79; Greenlee RT, 2005, J AGRIC SAF HEALTH, V11, P211, DOI 10.13031/2013.18188; Greenlee Robert T, 2002, WMJ, V101, P46; Hegele RA, 2009, NAT REV GENET, V10, P109, DOI 10.1038/nrg2481; Hillman MA, 2004, PHARMACOGENETICS, V14, P539, DOI 10.1097/01.fpc.0000114760.08559.dc; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Howlett AC, 2002, PROSTAG OTH LIPID M, V68-9, P619, DOI 10.1016/S0090-6980(02)00060-6; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Jaeger JP, 2008, DIS MARKERS, V25, P67, DOI 10.1155/2008/841490; Jourdan T, 2010, DIABETES, V59, P926, DOI 10.2337/db09-1482; Juhasz G, 2009, NEUROPSYCHOPHARMACOL, V34, P2019, DOI 10.1038/npp.2009.19; Kaiser J, 2002, SCIENCE, V298, P1158, DOI 10.1126/science.298.5596.1158; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Lieb W, 2009, OBESITY, V17, P755, DOI 10.1038/oby.2008.608; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Margetts BM, 1991, DESIGN CONCEPTS NUTR; MCCARTY CA, 2005, PERSONALIZED MED, V2; McCarty CA, 2008, PERS MED, V5, P529, DOI 10.2217/17410541.5.5.529; McCarty CA, 2010, PHARMACOGENOMICS, V11, P637, DOI [10.2217/pgs.10.13, 10.2217/PGS.10.13]; Millen AE, 2006, AM J EPIDEMIOL, V163, P279, DOI 10.1093/aje/kwj031; Miller M, 2008, J AM COLL CARDIOL, V51, P724, DOI 10.1016/j.jacc.2007.10.038; Neufeld EB, 1996, J BIOL CHEM, V271, P21604, DOI 10.1074/jbc.271.35.21604; Osei-Hyiaman D, 2006, INT J OBESITY, V30, pS33, DOI 10.1038/sj.ijo.0803276; Osei-Hyiaman D, 2008, J CLIN INVEST, V118, P3160, DOI 10.1172/JCI34827; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi L, 2008, CURR MOL MED, V8, P519, DOI 10.2174/156652408785747915; RICHARDSON MT, 1995, INT J EPIDEMIOL, V24, P685, DOI 10.1093/ije/24.4.685; Ruby MA, 2008, P NATL ACAD SCI USA, V105, P14561, DOI 10.1073/pnas.0807232105; Scheen AJ, 2009, BEST PRACT RES CL EN, V23, P103, DOI 10.1016/j.beem.2008.09.001; Schleinitz D, 2010, PHARMACOGENOMICS, V11, P693, DOI [10.2217/pgs.10.42, 10.2217/PGS.10.42]; Subar AF, 2001, AM J EPIDEMIOL, V154, P1089, DOI 10.1093/aje/154.12.1089; SUBAR AF, 1995, J AM DIET ASSOC, V95, P781, DOI 10.1016/S0002-8223(95)00217-0; Subar AF, 2000, AM J EPIDEMIOL, V152, P279, DOI 10.1093/aje/152.3.279; Subar AF, 2001, AM J EPIDEMIOL, V153, P404, DOI 10.1093/aje/153.4.404; Sugamura K, 2010, J ATHEROSCLER THROMB, V17, P141, DOI 10.5551/jat.2865; Thompson FE, 2002, J AM DIET ASSOC, V102, P212, DOI 10.1016/S0002-8223(02)90050-7; *US NIH, 2007, DIET HIST QUEST DIET; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; Wilke Russell A, 2010, Prev Cardiol, V13, P63, DOI 10.1111/j.1751-7141.2009.00055.x; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; WILLET WC, 1990, NUTR EPIDEMIOLOGY; Zhang PW, 2004, MOL PSYCHIATR, V9, P916, DOI 10.1038/sj.mp.4001560; Zhang Y, 2009, PHARMACOGENOMICS, V10, P1929, DOI [10.2217/pgs.09.122, 10.2217/PGS.09.122]	58	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15779	10.1371/journal.pone.0015779	http://dx.doi.org/10.1371/journal.pone.0015779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209828	Green Published, gold, Green Submitted			2022-12-27	WOS:000285838900032
J	Hartman, NW; Carpentino, JE; LaMonica, K; Mor, DE; Naegele, JR; Grabel, L				Hartman, Nathaniel W.; Carpentino, Joseph E.; LaMonica, Kristi; Mor, Danielle E.; Naegele, Janice R.; Grabel, Laura			CXCL12-Mediated Guidance of Migrating Embryonic Stem Cell-Derived Neural Progenitors Transplanted into the Hippocampus	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; GENERATED GRANULE CELLS; ACID-INDUCED SEIZURES; ADULT-RAT BRAIN; DENTATE GYRUS; KAINIC ACID; MESSENGER-RNA; PRECURSOR CELLS; IN-VITRO; NEUROGENESIS	Stem cell therapies for neurodegenerative disorders require accurate delivery of the transplanted cells to the sites of damage. Numerous studies have established that fluid injections to the hippocampus can induce lesions in the dentate gyrus (DG) that lead to cell death within the upper blade. Using a mouse model of temporal lobe epilepsy, we previously observed that embryonic stem cell-derived neural progenitors (ESNPs) survive and differentiate within the granule cell layer after stereotaxic delivery to the DG, replacing the endogenous cells of the upper blade. To investigate the mechanisms for ESNP migration and repair in the DG, we examined the role of the chemokine CXCL12 in mice subjected to kainic acid-induced seizures. We now show that ESNPs transplanted into the DG show extensive migration through the upper blade, along the septotemporal axis of the hippocampus. Seizures upregulate CXCL12 and infusion of the CXCR4 antagonist AMD3100 by osmotic minipump attenuated ESNP migration. We also demonstrate that seizures promote the differentiation of transplanted ESNPs toward neuronal rather than astrocyte fates. These findings suggest that ESNPs transplanted into the adult rodent hippocampus migrate in response to cytokine-mediated signals.	[Hartman, Nathaniel W.; Carpentino, Joseph E.; LaMonica, Kristi; Mor, Danielle E.; Naegele, Janice R.; Grabel, Laura] Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA; [Naegele, Janice R.] Wesleyan Univ, Neurosci & Behav Program, Middletown, CT 06459 USA	Wesleyan University; Wesleyan University	Hartman, NW (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA.	nathaniel.hartman@yale.edu	; Hartman, Nathaniel/P-7654-2014	Naegele, Janice Rae/0000-0001-5151-0543; Mor, Danielle/0000-0003-3851-5010; Hartman, Nathaniel/0000-0003-4976-5525	Connecticut Stem Cell Initiative; McKnight Foundation	Connecticut Stem Cell Initiative; McKnight Foundation	Connecticut Stem Cell Initiative (Grabel). McKnight Foundation Brain Disorders Award (Naegele). Connecticut Stem Cell Initiative ( Naegele). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharonowiz M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003145; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bagri A, 2002, DEVELOPMENT, V129, P4249; Belmadani A, 2005, J NEUROSCI, V25, P3995, DOI 10.1523/JNEUROSCI.4631-04.2005; Bhattacharyya BJ, 2008, J NEUROSCI, V28, P6720, DOI 10.1523/JNEUROSCI.1677-08.2008; Cai C, 2008, STEM CELLS, V26, P1097, DOI 10.1634/stemcells.2007-0684; Carbajal KS, 2010, P NATL ACAD SCI USA, V107, P11068, DOI 10.1073/pnas.1006375107; Carpentino JE, 2008, J NEUROSCI RES, V86, P512, DOI 10.1002/jnr.21514; CASSEL JC, 1993, NEUROSCI LETT, V150, P89, DOI 10.1016/0304-3940(93)90115-2; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Crespel A, 2005, NEUROBIOL DIS, V19, P436, DOI 10.1016/j.nbd.2005.01.020; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; DUGICHDJORDJEVIC MM, 1992, NEUROSCIENCE, V47, P303, DOI 10.1016/0306-4522(92)90246-X; Einstein O, 2009, J NEUROSCI, V29, P15694, DOI 10.1523/JNEUROSCI.3364-09.2009; Elliott RC, 2003, J NEUROSCI, V23, P2218; Englund U, 2002, DEV BRAIN RES, V134, P123, DOI 10.1016/S0165-3806(01)00330-3; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Gabriel S, 2004, J NEUROSCI, V24, P10416, DOI 10.1523/JNEUROSCI.2074-04.2004; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Gong C, 2007, J NEUROSCI, V27, P1803, DOI 10.1523/JNEUROSCI.3111-06.2007; Hodge RD, 2008, J NEUROSCI, V28, P3707, DOI 10.1523/JNEUROSCI.4280-07.2008; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; Jessberger S, 2005, EXP NEUROL, V196, P342, DOI 10.1016/j.expneurol.2005.08.010; Juarez J, 2003, LEUKEMIA, V17, P1294, DOI 10.1038/sj.leu.2402998; Jung KH, 2009, EPILEPSIA, V50, P537, DOI 10.1111/j.1528-1167.2008.01718.x; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; Kolodziej A, 2008, J NEUROSCI, V28, P4488, DOI 10.1523/JNEUROSCI.4721-07.2008; Kuruba R, 2009, EPILEPSY BEHAV, V14, P65, DOI 10.1016/j.yebeh.2008.08.020; Li L, 2010, J NEUROSCI, V30, P9038, DOI 10.1523/JNEUROSCI.5691-09.2010; Li Y, 2009, CURR TOP DEV BIOL, V87, P149, DOI 10.1016/S0070-2153(09)01205-8; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Maisano X, 2009, NEUROTHERAPEUTICS, V6, P263, DOI 10.1016/j.nurt.2009.01.011; Mathern GW, 2002, PROG BRAIN RES, V135, P237; MORGAN TE, 1993, EXP NEUROL, V120, P291, DOI 10.1006/exnr.1993.1063; Naegele JR, 2010, NEUROPHARMACOLOGY, V58, P855, DOI 10.1016/j.neuropharm.2010.01.019; Neema M, 2005, HIPPOCAMPUS, V15, P1057, DOI 10.1002/hipo.20123; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P2326, DOI 10.1523/JNEUROSCI.4111-05.2006; Parent JM, 1997, J NEUROSCI, V17, P3727; Pickering M, 2007, PROG BRAIN RES, V163, P339, DOI 10.1016/S0079-6123(07)63020-9; Pierce JP, 2007, NEUROSCI LETT, V422, P136, DOI 10.1016/j.neulet.2007.06.016; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Ruschenschmidt T, 2005, EPILEPSIA, V46, P174, DOI 10.1111/j.1528-1167.2005.01028.x; Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016; Scharfman HE, 2000, J NEUROSCI, V20, P6144, DOI 10.1523/JNEUROSCI.20-16-06144.2000; Schauwecker PE, 2003, EPILEPSY RES, V55, P201, DOI 10.1016/S0920-1211(03)00115-3; Schonemeier B, 2008, J NEUROIMMUNOL, V198, P39, DOI 10.1016/j.jneuroim.2008.04.010; Steiner B, 2008, NEUROSCIENCE, V154, P521, DOI 10.1016/j.neuroscience.2008.04.023; Stumm R, 2007, J COMP NEUROL, V502, P382, DOI 10.1002/cne.21336; Stumm RK, 2003, J NEUROSCI, V23, P5123; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Tabar V, 2005, NAT BIOTECHNOL, V23, P601, DOI 10.1038/nbt1088; Tham TN, 2001, EUR J NEUROSCI, V13, P845, DOI 10.1046/j.0953-816x.2000.01451.x; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Tran PB, 2007, J COMP NEUROL, V500, P1007, DOI 10.1002/cne.21229; VIETJE BP, 1989, EXP NEUROL, V106, P275, DOI 10.1016/0014-4886(89)90160-X; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zhang HX, 2003, J CELL BIOL, V163, P1375, DOI 10.1083/jcb.200308040; Zhang S, 2009, J NEUROSCI RES, V87, P1135, DOI 10.1002/jnr.21941	64	28	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15856	10.1371/journal.pone.0015856	http://dx.doi.org/10.1371/journal.pone.0015856			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209827	Green Submitted, Green Published, gold			2022-12-27	WOS:000285838900042
J	Seemanapalli, SV; Xu, QL; McShan, K; Liang, FT				Seemanapalli, Sunita V.; Xu, Qilong; McShan, Kristy; Liang, Fang Ting			Outer Surface Protein C Is a Dissemination-Facilitating Factor of Borrelia burgdorferi during Mammalian Infection	PLOS ONE			English	Article							LYME-DISEASE SPIROCHETE; IMMUNE EVASION; OSPC; LIPOPOLYSACCHARIDE; LIPOPROTEINS; EXPRESSION; TICKS	Background: The Lyme disease spirochete Borrelia burgdorferi dramatically upregulates outer surface protein C (OspC) in response to fresh bloodmeal during transmission from the tick vector to a mammal, and abundantly produces the antigen during early infection. As OspC is an effective immune target, to evade the immune system B. burgdorferi downregulates the antigen once the anti-OspC humoral response has developed, suggesting an important role for OspC during early infection. Methodology/Principal Findings: In this study, a borrelial mutant producing an OspC antigen with a 5-amino-acid deletion was generated. The deletion didn't significantly increase the 50% infectious dose or reduce the tissue bacterial burden during infection of the murine host, indicating that the truncated OspC can effectively protect B. burgdorferi against innate elimination. However, the deletion greatly impaired the ability of B. burgdorferi to disseminate to remote tissues after inoculation into mice. Conclusions/Significance: The study indicates that OspC plays an important role in dissemination of B. burgdorferi during mammalian infection.	[Seemanapalli, Sunita V.; Xu, Qilong; McShan, Kristy; Liang, Fang Ting] Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Seemanapalli, SV (corresponding author), Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.	fliang@vetmed.lsu.edu			National Institutes of Health [AI077733, AR053338, RR020159]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR053338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by AI077733, AR053338, and RR020159 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Crother TR, 2004, INFECT IMMUN, V72, P5063, DOI 10.1128/IAI.72.9.5063-5072.2004; Cullen PA, 2004, FEMS MICROBIOL REV, V28, P291, DOI 10.1016/j.femsre.2003.10.004; deSilva AM, 1996, J EXP MED, V183, P271, DOI 10.1084/jem.183.1.271; Downie AB, 2004, J EXP BOT, V55, P961, DOI 10.1093/jxb/erh112; Eicken C, 2001, J BIOL CHEM, V276, P10010, DOI 10.1074/jbc.M010062200; Fingerle V, 2007, INT J MED MICROBIOL, V297, P97, DOI 10.1016/j.ijmm.2006.11.003; FUNG BP, 1994, INFECT IMMUN, V62, P3213, DOI 10.1128/IAI.62.8.3213-3221.1994; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; Kumaran D, 2001, ACTA CRYSTALLOGR D, V57, P298, DOI 10.1107/S0907444900017546; Liang FT, 2004, INFECT IMMUN, V72, P5759, DOI 10.1128/IAI.72.10.5759-5767.2004; Liang FT, 2004, AM J PATHOL, V165, P977, DOI 10.1016/S0002-9440(10)63359-7; Liang FT, 2002, J EXP MED, V195, P415, DOI 10.1084/jem.20011870; Liang FT, 2002, J EXP MED, V196, P275, DOI 10.1084/jem.20020770; Ohnishi J, 2001, P NATL ACAD SCI USA, V98, P670, DOI 10.1073/pnas.98.2.670; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; Purser JE, 2003, MOL MICROBIOL, V48, P753, DOI 10.1046/j.1365-2958.2003.03452.x; RADOLF JD, 1994, J BACTERIOL, V176, P21, DOI 10.1128/JB.176.1.21-31.1994; Radolf JD, 2008, MOL MICROBIOL, V69, P1, DOI 10.1111/j.1365-2958.2008.06226.x; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; REED L. J., 1938, AMER JOUR HYG, V27, P493; Schulze RJ, 2006, MOL MICROBIOL, V59, P1473, DOI 10.1111/j.1365-2958.2006.05039.x; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Schwan TG, 2000, J CLIN MICROBIOL, V38, P382; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Stewart PE, 2006, INFECT IMMUN, V74, P3547, DOI 10.1128/IAI.00158-06; TAKAYAMA K, 1987, INFECT IMMUN, V55, P2311, DOI 10.1128/IAI.55.9.2311-2313.1987; Tilly K, 2007, INFECT IMMUN, V75, P1517, DOI 10.1128/IAI.01725-06; Tilly K, 2006, INFECT IMMUN, V74, P3554, DOI 10.1128/IAI.01950-05; Tilly K, 2009, INFECT IMMUN, V77, P2672, DOI 10.1128/IAI.01193-08; Xu QL, 2008, MOL MICROBIOL, V69, P15, DOI 10.1111/j.1365-2958.2008.06264.x; Xu QL, 2007, MOL MICROBIOL, V64, P220, DOI 10.1111/j.1365-2958.2007.05636.x; Xu QL, 2006, INFECT IMMUN, V74, P5177, DOI 10.1128/IAI.00713-06; Xu QL, 2005, INFECT IMMUN, V73, P7208, DOI 10.1128/IAI.73.11.7208-7215.2005	34	26	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15830	10.1371/journal.pone.0015830	http://dx.doi.org/10.1371/journal.pone.0015830			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209822	Green Submitted, Green Published, gold			2022-12-27	WOS:000285838900040
J	van der Helden, J; van Schie, HT; Rombouts, C				van der Helden, Jurjen; van Schie, Hein T.; Rombouts, Christiaan			Observational Learning of New Movement Sequences Is Reflected in Fronto-Parietal Coherence	PLOS ONE			English	Article							PARIETAL AREAS; HAND ACTIONS; MU-RHYTHM; MOTOR; EEG; IMITATION; MODULATION; MECHANISMS; PREMOTOR; DESYNCHRONIZATION	Mankind is unique in her ability for observational learning, i.e. the transmission of acquired knowledge and behavioral repertoire through observation of others' actions. In the present study we used electrophysiological measures to investigate brain mechanisms of observational learning. Analysis investigated the possible functional coupling between occipital (alpha) and motor (mu) rhythms operating in the 10Hz frequency range for translating "seeing" into "doing". Subjects observed movement sequences consisting of six consecutive left or right hand button presses directed at one of two target-buttons for subsequent imitation. Each movement sequence was presented four times, intervened by short pause intervals for sequence rehearsal. During a control task subjects observed the same movement sequences without a requirement for subsequent reproduction. Although both alpha and mu rhythms desynchronized during the imitation task relative to the control task, modulations in alpha and mu power were found to be largely independent from each other over time, arguing against a functional coupling of alpha and mu generators during observational learning. This independence was furthermore reflected in the absence of coherence between occipital and motor electrodes overlaying alpha and mu generators. Instead, coherence analysis revealed a pair of symmetric fronto-parietal networks, one over the left and one over the right hemisphere, reflecting stronger coherence during observation of movements than during pauses. Individual differences in fronto-parietal coherence were furthermore found to predict imitation accuracy. The properties of these networks, i.e. their fronto-parietal distribution, their ipsilateral organization and their sensitivity to the observation of movements, match closely with the known properties of the mirror neuron system (MNS) as studied in the macaque brain. These results indicate a functional dissociation between higher order areas for observational learning (i.e. parts of the MNS as reflected in 10Hz coherence measures) and peripheral structures (i.e. lateral occipital gyrus for alpha; central sulcus for mu) that provide low-level support for observation and motor imagery of action sequences.	[van der Helden, Jurjen] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [van der Helden, Jurjen; Rombouts, Christiaan] Univ Twente, Dept Cognit Psychol & Ergon, NL-7500 AE Enschede, Netherlands; [van Schie, Hein T.] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; University of Twente; Radboud University Nijmegen	van der Helden, J (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	J.vanderHelden@donders.ru.nl	van Schie, Hein T/D-2281-2010		European Union [FP6-IST2-003747]	European Union(European Commission)	HvS was supported by the European Union Integrated Project JAST (Joint Action Science and Technology), grant FP6-IST2-003747. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew C, 1996, MED BIOL ENG COMPUT, V34, P232, DOI 10.1007/BF02520079; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Aziz-Zadeh L, 2006, J NEUROSCI, V26, P2964, DOI 10.1523/JNEUROSCI.2921-05.2006; Babiloni C, 2002, NEUROIMAGE, V17, P559, DOI 10.1006/nimg.2002.1192; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; Byrne R. W., 2005, PERSPECTIVES IMITATI, V1, P225; Byrne RW, 1998, BEHAV BRAIN SCI, V21, P667, DOI 10.1017/S0140525X98001745; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Classen J, 1998, J NEUROPHYSIOL, V79, P1567, DOI 10.1152/jn.1998.79.3.1567; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Frey SH, 2006, J NEUROSCI, V26, P13194, DOI 10.1523/JNEUROSCI.3914-06.2006; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V., 2005, PHENOMENOLOGY COGNIT, V4, P23, DOI [10.1007/s11097-005-4737-z, DOI 10.1007/S11097-005-4737-Z]; Gomarus HK, 2006, CLIN NEUROPHYSIOL, V117, P871, DOI 10.1016/j.clinph.2005.12.008; Hamilton AFD, 2006, J NEUROSCI, V26, P1133, DOI 10.1523/JNEUROSCI.4551-05.2006; Hummel F, 2005, CEREB CORTEX, V15, P670, DOI 10.1093/cercor/bhh170; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2005, CURR OPIN NEUROBIOL, V15, P632, DOI 10.1016/j.conb.2005.10.010; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Johnson SH, 2002, NEUROIMAGE, V17, P1693, DOI 10.1006/nimg.2002.1265; Kayser J, 2006, CLIN NEUROPHYSIOL, V117, P348, DOI 10.1016/j.clinph.2005.08.034; Kilner JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004925; Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P61, DOI 10.1016/S0167-8760(96)00057-8; Koelewijn T, 2008, NEUROIMAGE, V40, P767, DOI 10.1016/j.neuroimage.2007.12.018; Koski L, 2002, CEREB CORTEX, V12, P847, DOI 10.1093/cercor/12.8.847; Molnar-Szakacs I, 2006, NEUROIMAGE, V33, P923, DOI 10.1016/j.neuroimage.2006.07.035; Muthukumaraswamy SD, 2006, BRAIN RES, V1071, P105, DOI 10.1016/j.brainres.2005.11.053; Muthukumaraswamy SD, 2004, COGNITIVE BRAIN RES, V19, P195, DOI 10.1016/j.cogbrainres.2003.12.001; Muthukumaraswamy SD, 2004, PSYCHOPHYSIOLOGY, V41, P152, DOI 10.1046/j.1469-8986.2003.00129.x; Neuper C, 2001, INT J PSYCHOPHYSIOL, V43, P41, DOI 10.1016/S0167-8760(01)00178-7; Newman-Norlund R, 2010, BRAIN RES, V1315, P63, DOI 10.1016/j.brainres.2009.11.065; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; Orgs G, 2008, EUR J NEUROSCI, V27, P3380, DOI 10.1111/j.1460-9568.2008.06271.x; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pfurtscheller G, 1997, NEUROSCI LETT, V239, P65, DOI 10.1016/S0304-3940(97)00889-6; Pineda JA, 2005, BRAIN RES REV, V50, P57, DOI 10.1016/j.brainresrev.2005.04.005; PIVIK RT, 1993, PSYCHOPHYSIOLOGY, V30, P547, DOI 10.1111/j.1469-8986.1993.tb02081.x; Rihs TA, 2007, EUR J NEUROSCI, V25, P603, DOI 10.1111/j.1460-9568.2007.05278.x; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G., 2005, PERSPECTIVES IMITATI, V1, P55, DOI DOI 10.1146/ANNUREV.NEURO.27.070203.144230; SMYTH MM, 1990, Q J EXP PSYCHOL-A, V42, P291, DOI 10.1080/14640749008401223; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; van Elk M, 2008, NEUROIMAGE, V43, P808, DOI 10.1016/j.neuroimage.2008.07.057; van Schie HT, 2008, SOC NEUROSCI-UK, V3, P213, DOI 10.1080/17470910701414364; van Schie HT, 2004, NAT NEUROSCI, V7, P549, DOI 10.1038/nn1239; Vogt S, 2007, NEUROIMAGE, V37, P1371, DOI 10.1016/j.neuroimage.2007.07.005	51	33	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e14482	10.1371/journal.pone.0014482	http://dx.doi.org/10.1371/journal.pone.0014482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	701RA	21217815	Green Published, gold			2022-12-27	WOS:000285838900011
J	Wu, J; Xia, J; Lei, W; Wang, BP				Wu, Jun; Xia, Jun; Lei, Wei; Wang, Baoping			Superhydrophobic Surface Based on a Coral-Like Hierarchical Structure of ZnO	PLOS ONE			English	Article							SUPER-HYDROPHOBIC SURFACE; LOTUS; FILMS; CONTACT	Background: Fabrication of superhydrophobic surfaces has attracted much interest in the past decade. The fabrication methods that have been studied are chemical vapour deposition, the sol-gel method, etching technique, electrochemical deposition, the layer-by-layer deposition, and so on. Simple and inexpensive methods for manufacturing environmentally stable superhydrophobic surfaces have also been proposed lately. However, work referring to the influence of special structures on the wettability, such as hierarchical ZnO nanostructures, is rare. Methodology: This study presents a simple and reproducible method to fabricate a superhydrophobic surface with micro-scale roughness based on zinc oxide (ZnO) hierarchical structure, which is grown by the hydrothermal method with an alkaline aqueous solution. Coral-like structures of ZnO were fabricated on a glass substrate with a micro-scale roughness, while the antennas of the coral formed the nano-scale roughness. The fresh ZnO films exhibited excellent superhydrophilicity (the apparent contact angle for water droplet was about 0 degrees), while the ability to be wet could be changed to superhydrophobicity after spin-coating Teflon (the apparent contact angle greater than 168 degrees). The procedure reported here can be applied to substrates consisting of other materials and having various shapes. Results: The new process is convenient and environmentally friendly compared to conventional methods. Furthermore, the hierarchical structure generates the extraordinary solid/gas/liquid three-phase contact interface, which is the essential characteristic for a superhydrophobic surface.	[Wu, Jun; Xia, Jun; Lei, Wei; Wang, Baoping] Southeast Univ, Sch Elect Sci & Engn, Nanjing, Peoples R China	Southeast University - China	Wu, J (corresponding author), Southeast Univ, Sch Elect Sci & Engn, Nanjing, Peoples R China.	xiajun@seu.edu.cn	Xia, Jun/A-1240-2011		National High Technology Research and Development Program of China [2007AA01Z303]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work is supported by the National High Technology Research and Development Program of China (2007AA01Z303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki T, 2000, APPL PHYS LETT, V76, P3257, DOI 10.1063/1.126599; Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Bormashenko E, 2006, LANGMUIR, V22, P9982, DOI 10.1021/la061622m; Erbil HY, 2003, SCIENCE, V299, P1377, DOI 10.1126/science.1078365; Feng XJ, 2004, J AM CHEM SOC, V126, P62, DOI 10.1021/ja038636o; Han JT, 2005, J PHYS CHEM B, V109, P20773, DOI 10.1021/jp052691x; Hikita M, 2005, LANGMUIR, V21, P7299, DOI 10.1021/la050901r; Huang L, 2005, J PHYS CHEM B, V109, P7746, DOI 10.1021/jp046549s; Kim H, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/9/095002; Lafuma A, 2003, NAT MATER, V2, P457, DOI 10.1038/nmat924; Li GP, 2008, APPL PHYS LETT, V17, P92; Li XH, 2006, POLYMER, V47, P506, DOI 10.1016/j.polymer.2005.08.097; Li XM, 2007, CHEM SOC REV, V36, P1350, DOI 10.1039/b602486f; Ma M, 2008, J ADHES SCI TECHNOL, V11, P193; Marmur A, 2004, LANGMUIR, V20, P3517, DOI 10.1021/la036369u; Marmur A, 2006, SOFT MATTER, V2, P12, DOI 10.1039/b514811c; Marmur A, 2003, LANGMUIR, V19, P8343, DOI 10.1021/la0344682; Ming W, 2005, NANO LETT, V5, P2298, DOI 10.1021/nl0517363; Nakajima A, 2001, MONATSH CHEM, V132, P31, DOI 10.1007/s007060170142; Niu JJ, 2009, J PHYS CHEM B, V113, P2909, DOI 10.1021/jp808322e; Okamoto K, 2004, NANO LETT, V4, P233, DOI 10.1021/nl034954+; Patankar NA, 2004, LANGMUIR, V20, P8209, DOI 10.1021/la048629t; Qu AL, 2007, APPL SURF SCI, V253, P9430, DOI 10.1016/j.apsusc.2007.06.002; Rosario R, 2004, J PHYS CHEM B, V108, P12640, DOI 10.1021/jp0473568; Sarkar DK, 2008, MATER LETT, V62, P1226, DOI 10.1016/j.matlet.2007.08.051; SCHMIDT DL, 1994, NATURE, V368, P39, DOI 10.1038/368039a0; Service RE, 1997, SCIENCE, V276, P895, DOI 10.1126/science.276.5314.895; Shibuichi S, 1996, J PHYS CHEM-US, V100, P19512, DOI 10.1021/jp9616728; Su CH, 2006, APPL SURF SCI, V253, P2633, DOI 10.1016/j.apsusc.2006.05.038; Wang CH, 2006, SURF SCI, V600, pL38, DOI 10.1016/j.susc.2005.12.013; Wang J, 2009, MATER CHEM PHYS, V117, P183, DOI 10.1016/j.matchemphys.2009.05.033; Wang R, 1997, NATURE, V388, P431, DOI 10.1038/41233; Xi JM, 2008, APPL PHYS LETT, V5, P92; Zhang X, 2008, J MATER CHEM, V18, P621, DOI 10.1039/b711226b; Zhang Z, 2007, J ELECTRON MATER, V36, P895, DOI 10.1007/s11664-007-0126-4	35	24	26	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e14475	10.1371/journal.pone.0014475	http://dx.doi.org/10.1371/journal.pone.0014475			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209931	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793600013
J	Raman, R; Rajanikanth, V; Palaniappan, RUM; Lin, YP; He, HX; McDonough, SP; Sharma, Y; Chang, YF				Raman, Rajeev; Rajanikanth, V.; Palaniappan, Raghavan U. M.; Lin, Yi-Pin; He, Hongxuan; McDonough, Sean P.; Sharma, Yogendra; Chang, Yung-Fu			Big Domains Are Novel Ca2+-Binding Modules: Evidences from Big Domains of Leptospira Immunoglobulin-Like (Lig) Proteins	PLOS ONE			English	Article							PATHOGENIC LEPTOSPIRA; CALCIUM-BINDING; SURFACE PROTEIN; INTERROGANS; SUPERFAMILY; CRYSTALLINS; MUTAGENESIS; EXPRESSION; LIPL32; MOTIF	Background: Many bacterial surface exposed proteins mediate the host-pathogen interaction more effectively in the presence of Ca2+. Leptospiral immunoglobulin-like (Lig) proteins, LigA and LigB, are surface exposed proteins containing Bacterial immunoglobulin like (Big) domains. The function of proteins which contain Big fold is not known. Based on the possible similarities of immunoglobulin and beta gamma-crystallin folds, we here explore the important question whether Ca2+ binds to a Big domains, which would provide a novel functional role of the proteins containing Big fold. Principal Findings: We selected six individual Big domains for this study (three from the conserved part of LigA and LigB, denoted as Lig A3, Lig A4, and LigBCon5; two from the variable region of LigA, i.e., 9(th) (Lig A9) and 10(th) repeats (Lig A10); and one from the variable region of LigB, i.e., LigBCen2. We have also studied the conserved region covering the three and six repeats (LigBCon1-3 and LigCon). All these proteins bind the calcium-mimic dye Stains-all. All the selected four domains bind Ca2+ with dissociation constants of 2-4 mu M. Lig A9 and Lig A10 domains fold well with moderate thermal stability, have beta-sheet conformation and form homodimers. Fluorescence spectra of Big domains show a specific doublet (at 317 and 330 nm), probably due to Trp interaction with a Phe residue. Equilibrium unfolding of selected Big domains is similar and follows a two-state model, suggesting the similarity in their fold. Conclusions: We demonstrate that the Lig are Ca2+-binding proteins, with Big domains harbouring the binding motif. We conclude that despite differences in sequence, a Big motif binds Ca2+. This work thus sets up a strong possibility for classifying the proteins containing Big domains as a novel family of Ca2+-binding proteins. Since Big domain is a part of many proteins in bacterial kingdom, we suggest a possible function these proteins via Ca2+ binding.	[Raman, Rajeev; Rajanikanth, V.; Sharma, Yogendra] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India; [Palaniappan, Raghavan U. M.; Lin, Yi-Pin; He, Hongxuan; Chang, Yung-Fu] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [McDonough, Sean P.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [He, Hongxuan] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Cornell University; Cornell University; Chinese Academy of Sciences; Institute of Zoology, CAS	Raman, R (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	yogendra@ccmb.res.in; yc42@cornell.edu	Vangipurapu, Rajanikanth/AAM-6841-2020	Vangipurapu, Rajanikanth/0000-0003-0676-3140	Biotechnology Research and Development Corporation (BRDC); Harry M. Zweig Memorial Fund for Equine Research; New York State Science and Technology Foundation (CAT); Government of India; Council of Scientific and Industrial Research (CSIR), Government of India; Department of Biotechnology, Government of India	Biotechnology Research and Development Corporation (BRDC); Harry M. Zweig Memorial Fund for Equine Research; New York State Science and Technology Foundation (CAT); Government of India; Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported in part by the Biotechnology Research and Development Corporation (BRDC), the Harry M. Zweig Memorial Fund for Equine Research, the New York State Science and Technology Foundation (CAT). DBT as well as DST are supported by the Government of India. RR is supported by a senior research fellowship from the Council of Scientific and Industrial Research (CSIR), Government of India. VR acknowledges Department of Biotechnology, Government of India, for a post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind P, 2008, J MOL BIOL, V376, P1100, DOI 10.1016/j.jmb.2007.12.033; Aravind P, 2009, BIOCHEMISTRY-US, V48, P12180, DOI 10.1021/bi9017076; CADAY CG, 1985, J BIOL CHEM, V260, P5985; CHANG YF, 1993, DNA CELL BIOL, V12, P351, DOI 10.1089/dna.1993.12.351; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; CRABBE MJC, 1995, COMPUT CHEM, V19, P343, DOI 10.1016/0097-8485(95)90316-X; Croda J, 2008, INFECT IMMUN, V76, P5826, DOI 10.1128/IAI.00989-08; CRUZ WT, 1990, MOL MICROBIOL, V4, P1933, DOI 10.1111/j.1365-2958.1990.tb02042.x; Dardanelli M, 2003, CAN J MICROBIOL, V49, P399, DOI 10.1139/w03-054; Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x; Gopalan V, 1997, J MOL BIOL, V267, P765, DOI 10.1006/jmbi.1997.0907; Halaby DM, 1998, J MOL EVOL, V46, P389, DOI 10.1007/PL00006318; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; Hauk P, 2009, J MOL BIOL, V390, P722, DOI 10.1016/j.jmb.2009.05.034; Hung HC, 2003, B MATH BIOL, V65, P553, DOI 10.1016/S0092-8240(03)00024-7; Izutsu KT, 1996, FEMS MICROBIOL LETT, V144, P145, DOI 10.1111/j.1574-6968.1996.tb08521.x; Josefsson E, 1998, J BIOL CHEM, V273, P31145, DOI 10.1074/jbc.273.47.31145; KLEE CB, 1982, ADV PROTEIN CHEM, V35, P213, DOI 10.1016/S0065-3233(08)60470-2; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; Lappalainen I, 2008, J MOL BIOL, V375, P547, DOI 10.1016/j.jmb.2007.09.088; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lin XP, 2008, J VET SCI, V9, P133; Lin YP, 2008, J BIOL CHEM, V283, P25140, DOI 10.1074/jbc.M801350200; Lin YP, 2007, BIOCHEM BIOPH RES CO, V362, P443, DOI 10.1016/j.bbrc.2007.07.196; Lin YP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011301; Lin YP, 2009, BIOCHEM BIOPH RES CO, V389, P57, DOI 10.1016/j.bbrc.2009.08.089; Lin YP, 2009, J BIOL CHEM, V284, P23547, DOI 10.1074/jbc.M109.031369; Lin YP, 2009, J BIOL CHEM, V284, P19380, DOI 10.1074/jbc.M109.004531; Matsunaga J, 2005, INFECT IMMUN, V73, P70, DOI 10.1128/IAI.73.1.70-78.2005; Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x; McBride AJA, 2009, INFECT GENET EVOL, V9, P196, DOI 10.1016/j.meegid.2008.10.012; Michiels J, 2002, TRENDS MICROBIOL, V10, P87, DOI 10.1016/S0966-842X(01)02284-3; Murray GL, 2009, INFECT IMMUN, V77, P810, DOI 10.1128/IAI.01293-08; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Palaniappan RUM, 2007, CURR OPIN INFECT DIS, V20, P284, DOI 10.1097/QCO.0b013e32814a5729; Palaniappan RUM, 2006, INFECT IMMUN, V74, P1745, DOI 10.1128/IAI.74.3.1745-1750.2006; Palaniappan RUM, 2004, J MED MICROBIOL, V53, P975, DOI 10.1099/jmm.0.45568-0; Palaniappan RUM, 2002, INFECT IMMUN, V70, P5924, DOI 10.1128/IAI.70.11.5924-5930.2002; Rajini B, 2001, J BIOL CHEM, V276, P38464, DOI 10.1074/jbc.M102164200; Reshetnyak YK, 2001, BIOPHYS J, V81, P1710, DOI 10.1016/S0006-3495(01)75824-9; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; SHARMA Y, 1989, J BIOL CHEM, V264, P20923; SHARMA Y, 1989, J BIOL CHEM, V264, P12794; Sharma Y, 1991, NOVEL CALCIUM BINDIN, P51; Torres AG, 2002, MOL MICROBIOL, V45, P951, DOI 10.1046/j.1365-2958.2002.03094.x; Tung JY, 2010, J BIOL CHEM, V285, P3245, DOI 10.1074/jbc.M109.006320; WARREN JR, 1966, J PHYS CHEM-US, V70, P297, DOI 10.1021/j100873a507; WISTOW G, 1990, J MOL EVOL, V30, P140, DOI 10.1007/BF02099940	48	29	30	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e14377	10.1371/journal.pone.0014377	http://dx.doi.org/10.1371/journal.pone.0014377			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206924	Green Published, Green Submitted, gold			2022-12-27	WOS:000285793200001
J	Wu, LM; Yang, Z; Zhou, L; Zhang, F; Xie, HY; Feng, XW; Wu, JA; Zheng, SS				Wu, Li-Ming; Yang, Zhe; Zhou, Lin; Zhang, Feng; Xie, Hai-Yang; Feng, Xiao-Wen; Wu, Jian; Zheng, Shu-Sen			Identification of Histone Deacetylase 3 as a Biomarker for Tumor Recurrence Following Liver Transplantation in HBV-Associated Hepatocellular Carcinoma	PLOS ONE			English	Article							COLORECTAL-CANCER; HEPATOMA-CELLS; EXPRESSION; INHIBITORS; PROGNOSIS; EPIDEMIOLOGY; APOPTOSIS; HDAC3; ACID; SAHA	Background: Recent studies have shown that high expression levels of class I histone deacetylases (HDACs) correlate with malignant phenotype and poor prognosis in some human tumors. However, the expression patterns and prognostic role of class I HDAC isoforms in hepatocellular carcinoma (HCC) remain unclear. Methodology/Principal Findings: The expression patterns and clinical significance of class I HDAC isoforms were assessed by immunohistochemistry in a cohort of 43 hepatitis B virus-associated HCC patients treated with liver transplantation. In addition, the effects of HDAC inhibition on HCC cell behavior were investigated by knockdown of the HDAC isoform with short interfering RNA. Class I HDACs were highly expressed in a subset of HCCs with positivity for HDAC1 in 51.2%, HDAC2 in 48.8%, and HDAC3 in 32.6% of cases. The expression levels of HDAC isoforms were significantly associated with the proliferation index of HCC. Kaplan-Meier curves showed that a high expression level of HDAC2 or HDAC3 implicated significantly reduced recurrence-free survival. Cox proportional hazards model analysis revealed HDAC3 overexpression was an unfavorable independent prognostic factor (P = 0.002; HR 3.907). In vitro, inhibition of HDAC2 and HDAC3, but not HDAC1, suppressed proliferation and the invasiveness of liver cancer cells. Conclusions/Significance: Our findings demonstrate that HDAC3 plays a significant role in regulating tumor cell proliferation and invasion, and it could be served as a candidate biomarker for predicting the recurrence of hepatitis B virus-associated HCC following liver transplantation and a potential therapeutic target.	[Wu, Li-Ming; Yang, Zhe; Zhou, Lin; Zhang, Feng; Xie, Hai-Yang; Feng, Xiao-Wen; Wu, Jian; Zheng, Shu-Sen] Zhejiang Univ, Sch Med,Div Hepatobiliary & Pancreat Surg, Affiliated Hosp 1,Minist Publ Hlth,Key Lab Organ, Key Lab Combined Multiorgan Transplantat,Dept Sur, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Wu, LM (corresponding author), Zhejiang Univ, Sch Med,Div Hepatobiliary & Pancreat Surg, Affiliated Hosp 1,Minist Publ Hlth,Key Lab Organ, Key Lab Combined Multiorgan Transplantat,Dept Sur, Hangzhou 310003, Zhejiang, Peoples R China.	shusenzheng@zju.edu.cn	Wu, liming/AAH-5415-2019		National Basic Research Program of China (973 program) [2009CB522400]; National Natural Science Foundation of China [30972946]; Science and Technology Fund for Excellent Young Talents of Medical and Health of Zhejiang Province [2009QN007]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Fund for Excellent Young Talents of Medical and Health of Zhejiang Province	This study was supported by National Basic Research Program of China (973 program) (No. 2009CB522400, http://www.most.gov.cn/kjjh/), National Natural Science Foundation of China (No. 30972946, http://www.nsfc.gov.cn/) and Science and Technology Fund for Excellent Young Talents of Medical and Health of Zhejiang Province (2009QN007, http://www.zjwst.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armeanu S, 2005, J HEPATOL, V42, P210, DOI 10.1016/j.jhep.2004.10.020; Bai DS, 2009, HEPATOLOGY, V49, P460, DOI 10.1002/hep.22638; Blaheta RA, 2005, MED RES REV, V25, P383, DOI 10.1002/med.20027; Bosch FX, 1999, SEMIN LIVER DIS, V19, P271, DOI 10.1055/s-2007-1007117; Chan DW, 2008, INT J CANCER, V123, P1043, DOI 10.1002/ijc.23634; Chung YL, 2009, MOL CANCER RES, V7, P1672, DOI 10.1158/1541-7786.MCR-09-0112; Emanuele S, 2007, APOPTOSIS, V12, P1327, DOI 10.1007/s10495-007-0063-y; Fritzsche FR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-381; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; Kew MC, 2002, TOXICOLOGY, V181, P35, DOI 10.1016/S0300-483X(02)00251-2; Krusche CA, 2005, BREAST CANCER RES TR, V90, P15, DOI 10.1007/s10549-004-1668-2; Lu YS, 2007, HEPATOLOGY, V46, P1119, DOI 10.1002/hep.21804; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Richon VM, 2001, BLOOD CELL MOL DIS, V27, P260, DOI 10.1006/bcmd.2000.0376; Rikimaru T, 2007, ONCOLOGY-BASEL, V72, P69, DOI 10.1159/000111106; Spurling CC, 2008, MOL CARCINOGEN, V47, P137, DOI 10.1002/mc.20373; Vinodhkumar R, 2007, CHEM-BIOL INTERACT, V165, P220, DOI 10.1016/j.cbi.2006.12.012; Vogiatzi P, 2007, J CELL PHYSIOL, V211, P287, DOI 10.1002/jcp.20982; Weichert W, 2008, BRIT J CANCER, V98, P604, DOI 10.1038/sj.bjc.6604199; Weichert W, 2008, NEOPLASIA, V10, P1021, DOI 10.1593/neo.08474; Weichert W, 2008, CLIN CANCER RES, V14, P1669, DOI 10.1158/1078-0432.CCR-07-0990; Weichert W, 2008, LANCET ONCOL, V9, P139, DOI 10.1016/S1470-2045(08)70004-4; Weichert W, 2009, CANCER LETT, V280, P168, DOI 10.1016/j.canlet.2008.10.047; Wild CP, 2000, MUTAT RES-REV MUTAT, V462, P381, DOI 10.1016/S1383-5742(00)00027-2; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Wu LM, 2008, CLIN GENET, V73, P273, DOI 10.1111/j.1399-0004.2007.00955.x; Yasui W, 2003, ANN NY ACAD SCI, V983, P220, DOI 10.1111/j.1749-6632.2003.tb05977.x; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Yoo HY, 2003, J CLIN ONCOL, V21, P4329, DOI 10.1200/JCO.2003.11.137; Yoo YG, 2008, ONCOGENE, V27, P3405, DOI 10.1038/sj.onc.1211000; Zhang F, 2008, ANN SURG ONCOL, V15, P3494, DOI 10.1245/s10434-008-0146-1	32	92	93	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e14460	10.1371/journal.pone.0014460	http://dx.doi.org/10.1371/journal.pone.0014460			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206745	gold, Green Published, Green Submitted			2022-12-27	WOS:000285793200013
J	Wang, Q; Frolova, AI; Purcell, S; Adastra, K; Schoeller, E; Chi, MM; Schedl, T; Moley, KH				Wang, Qiang; Frolova, Antonina I.; Purcell, Scott; Adastra, Katie; Schoeller, Erica; Chi, Maggie M.; Schedl, Tim; Moley, Kelle H.			Mitochondrial Dysfunction and Apoptosis in Cumulus Cells of Type I Diabetic Mice	PLOS ONE			English	Article							PREIMPLANTATION MOUSE EMBRYOS; VITRO FERTILIZATION; GRANULOSA-CELLS; PARACRINE REGULATION; GLUCOSE-METABOLISM; MEIOTIC REGULATION; ENERGY-METABOLISM; OXIDATIVE STRESS; SKELETAL-MUSCLE; OOCYTE QUALITY	Impaired oocyte quality has been demonstrated in diabetic mice; however, the potential pathways by which maternal diabetes exerts its effects on the oocyte are poorly understood. Cumulus cells are in direct contact with the oocyte via gap junctions and provide essential nutrients to support oocyte development. In this study, we investigated the effects of maternal diabetes on the mitochondrial status in cumulus cells. We found an increased frequency of fragmented mitochondria, a decreased transmembrane potential and an aggregated distribution of mitochondria in cumulus cells from diabetic mice. Furthermore, while mitochondrial biogenesis in cumulus cells was induced by maternal diabetes, their metabolic function was disrupted as evidenced by lower ATP and citrate levels. Moreover, we present evidence suggesting that the mitochondrial impairments induced by maternal diabetes, at least in part, lead to cumulus cell apoptosis through the release of cytochrome c. Together the deleterious effects on cumulus cells may disrupt trophic and signaling interactions with the oocyte, contributing to oocyte incompetence and thus poor pregnancy outcomes in diabetic females.	[Wang, Qiang; Frolova, Antonina I.; Purcell, Scott; Adastra, Katie; Schoeller, Erica; Chi, Maggie M.; Moley, Kelle H.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; [Wang, Qiang; Schedl, Tim] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Wang, Q (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.	moleyk@wustl.edu	Frolova, Antonina/ABC-1994-2020	Frolova, Antonina/0000-0002-6491-6910	National Institutes of Health [NIH-UO1 HD044691, HD040390, NIH-R01 GM085150]; American Diabetes Association; March of Dimes; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040390] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD044691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085150] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); March of Dimes(March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following agencies: The National Institutes of Health (http://www.nih.gov/), The American Diabetes Association (http://www.diabetes.org/), and the March of Dimes (http://www.marchofdimes.com/). The National Institutes of Health grant numbers and grantees are as follows: NIH-UO1 HD044691 and HD040390 (KHM) and NIH-R01 GM085150 (TS). The funders had no role in study design, data collection and analysis, decision to publish or preparation of this manuscript.	Albertini DF, 2001, REPRODUCTION, V121, P647, DOI 10.1530/rep.0.1210647; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7; BIGGERS JD, 1967, P NATL ACAD SCI USA, V58, P560, DOI 10.1073/pnas.58.2.560; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Boudina S, 2007, DIABETES, V56, P2457, DOI 10.2337/db07-0481; BUCCIONE R, 1990, BIOL REPROD, V43, P543, DOI 10.1095/biolreprod43.4.543; Chan CCW, 2006, FERTIL STERIL, V85, P780, DOI 10.1016/j.fertnstert.2005.08.042; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chang AS, 2005, ENDOCRINOLOGY, V146, P2445, DOI 10.1210/en.2004-1472; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Chi MMY, 2002, AM J PHYSIOL-ENDOC M, V283, pE226, DOI 10.1152/ajpendo.00046.2002; Civitarese AE, 2008, ENDOCRINOLOGY, V149, P950, DOI 10.1210/en.2007-1444; Colton SA, 2003, BIOL REPROD, V69, P761, DOI 10.1095/biolreprod.102.013649; Colton SA, 2002, BIOL REPROD, V67, P220, DOI 10.1095/biolreprod67.1.220; Cotrina ML, 1998, J NEUROSCI, V18, P2520; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; DIAMOND MP, 1989, J REPROD FERTIL, V86, P1; Diaz F, 2008, CELL CALCIUM, V44, P24, DOI 10.1016/j.ceca.2007.12.004; Doblado Manuel, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P488, DOI 10.1097/MED.0b013e3282f1cb92; DOWNS SM, 1995, DEV BIOL, V167, P502, DOI 10.1006/dbio.1995.1044; ETHELL DW, 2002, APOPTOSIS TECHNIQUES, P21; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Frazier AE, 2006, BIOL CHEM, V387, P1551, DOI 10.1515/BC.2006.193; Frolova A, 2009, ENDOCRINOLOGY, V150, P1512, DOI 10.1210/en.2008-1081; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Greene MF, 1999, SEMIN REPROD ENDOCR, V17, P127, DOI 10.1055/s-2007-1016220; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gualtieri R, 2009, FERTIL STERIL, V91, P1023, DOI 10.1016/j.fertnstert.2008.01.076; Hussein TS, 2005, J CELL SCI, V118, P5257, DOI 10.1242/jcs.02644; Hutt KJ, 2007, REPROD BIOMED ONLINE, V14, P758, DOI 10.1016/S1472-6483(10)60679-7; Idil M, 2004, EUR J OBSTET GYN R B, V112, P182, DOI 10.1016/S0301-2115(03)00365-8; Jansen S, 2009, REPRODUCTION, V138, P493, DOI 10.1530/REP-09-0038; Jensen PJ, 2006, J BIOL CHEM, V281, P13382, DOI 10.1074/jbc.M601881200; Kaneko T, 2000, J ASSIST REPROD GEN, V17, P580, DOI 10.1023/A:1026439409584; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Krutovskikh VA, 2002, ONCOGENE, V21, P1989, DOI 10.1038/sj.onc.1205187; Lee KS, 2001, J ASSIST REPROD GEN, V18, P490, DOI 10.1023/A:1016649026353; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Lezza AMS, 2001, FEBS LETT, V501, P74, DOI 10.1016/S0014-5793(01)02628-X; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; Malka F, 2005, EMBO REP, V6, P853, DOI 10.1038/sj.embor.7400488; Miao YL, 2009, HUM REPROD UPDATE, V15, P573, DOI 10.1093/humupd/dmp014; MOLEY KH, 1991, J REPROD FERTIL, V93, P325; Nakahara K, 1997, FERTIL STERIL, V68, P312, DOI 10.1016/S0015-0282(97)81521-X; Neuspiel M, 2005, J BIOL CHEM, V280, P25060, DOI 10.1074/jbc.M501599200; Paramo B, 2010, NEUROSCIENCE, V167, P1057, DOI 10.1016/j.neuroscience.2010.02.074; Park DW, 2003, FERTIL STERIL, V80, P993, DOI 10.1016/S0015-0282(03)01118-X; Pocar P, 2005, REPRODUCTION, V130, P857, DOI 10.1530/rep.1.00761; QUINN P, 1973, J REPROD FERTIL, V35, P301, DOI 10.1530/jrf.0.0350301; Ramalho-Santos J, 2009, HUM REPROD UPDATE, V15, P553, DOI 10.1093/humupd/dmp016; Ratchford AM, 2007, AM J PHYSIOL-ENDOC M, V293, pE1198, DOI 10.1152/ajpendo.00097.2007; Ratchford AM, 2008, MOL ENDOCRINOL, V22, P2643, DOI 10.1210/me.2007-0495; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Seifer DB, 2002, FERTIL STERIL, V78, P1046, DOI 10.1016/S0015-0282(02)04214-0; Shen X, 2004, AM J PHYSIOL-ENDOC M, V287, pE896, DOI 10.1152/ajpendo.00047.2004; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Solaini G, 2007, BIOSCIENCE REP, V27, P11, DOI 10.1007/s10540-007-9033-4; Spinazzi M, 2008, HUM MOL GENET, V17, P3291, DOI 10.1093/hmg/ddn225; Su YQ, 2009, SEMIN REPROD MED, V27, P32, DOI 10.1055/s-0028-1108008; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Sugiura K, 2005, REPROD FERT DEVELOP, V17, P667, DOI 10.1071/RD05071; Udawatte C, 2005, APOPTOSIS, V10, P1019, DOI 10.1007/s10495-005-0776-8; VANBLERKOM J, 1995, HUM REPROD, V10, P415, DOI 10.1093/oxfordjournals.humrep.a135954; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; VERCHEVAL M, 1990, DIABETOLOGIA, V33, P187, DOI 10.1007/BF00404794; Voet D, 2006, FUNDAMENTALS BIOCH; Wadia JS, 1998, J NEUROSCI, V18, P932; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Wang Q, 2009, MOL ENDOCRINOL, V23, P1603, DOI 10.1210/me.2009-0033; Weng SW, 2009, DIABETES RES CLIN PR, V83, P94, DOI 10.1016/j.diabres.2008.10.002; WYLLIE AH, 1981, HISTOCHEM J, V13, P681, DOI 10.1007/BF01002719; Wyman A, 2008, ENDOCRINOLOGY, V149, P466, DOI 10.1210/en.2007-1273; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	83	61	67	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15901	10.1371/journal.pone.0015901	http://dx.doi.org/10.1371/journal.pone.0015901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21209947	Green Submitted, Green Published, gold			2022-12-27	WOS:000285792500041
J	Lin, HX; Dai, T; Xiong, HP; Zhao, XH; Chen, XT; Yu, CP; Li, J; Wang, X; Song, LB				Lin, Huanxin; Dai, Ting; Xiong, Huaping; Zhao, Xiaohui; Chen, Xiuting; Yu, Chunping; Li, Jun; Wang, Xi; Song, Libing			Unregulated miR-96 Induces Cell Proliferation in Human Breast Cancer by Downregulating Transcriptional Factor FOXO3a	PLOS ONE			English	Article							EXPRESSION; SURVIVAL; APOPTOSIS; GROWTH; BIM; INHIBITION; BIOGENESIS; MICRORNAS; MIR-182; LIGAND	FOXO transcription factors are key tumor suppressors in mammalian cells. Until now, suppression of FOXOs in cancer cells was thought to be mainly due to activation of multiple onco-kinases by a phosphorylation-ubiquitylation-mediated cascade. Therefore, it was speculated that inhibition of FOXO proteins would naturally occur through a multiple step post-translational process. However, whether cancer cells may downregulate FOXO protein via an alternative regulatory mechanism is unclear. In the current study, we report that expression of miR-96 was markedly upregulated in breast cancer cells and breast cancer tissues compared with normal breast epithelial cells (NBEC) and normal breast tissues. Ectopic expression of miR-96 induced the proliferation and anchorage-independent growth of breast cancer cells, while inhibition of miR-96 reduced this effect. Furthermore, upregulation of miR-96 in breast cancer cells resulted in modulation of their entry into the G1/S transitional phase, which was caused by downregulation of cyclin-dependent kinase (CDK) inhibitors, p27(Kip1) and p21(Cip1), and upregulation of the cell-cycle regulator cyclin D1. Moreover, we demonstrated that miR-96 downregulated FOXO3a expression by directly targeting the FOXO3a 3 '-untranslated region. Taken together, our results suggest that miR-96 may play an important role in promoting proliferation of human breast cancer cells and present a novel mechanism of miRNA-mediated direct suppression of FOXO3a expression in cancer cells.	[Lin, Huanxin; Zhao, Xiaohui; Chen, Xiuting; Yu, Chunping; Wang, Xi; Song, Libing] Sun Yat Sen Univ, Dept Expt Res, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Huanxin] Sun Yat Sen Univ, Dept Radiotherapy, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Dai, Ting; Li, Jun] Sun Yat Sen Univ, Dept Biochem, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Xiong, Huaping] Sun Yat Sen Univ, Dept Microbiol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Xi] Sun Yat Sen Univ, Dept Breast Surg, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Lin, HX (corresponding author), Sun Yat Sen Univ, Dept Expt Res, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China.	wangxi0521@medmail.com.cn; songlb@sysucc.org.cn	Song, LB/AAL-1968-2020		Natural Science Foundation of China [81071780, 81030048, 30770836, 30771110, 30870963, 30831160517]; Program for New Century Excellent Talents in Universities [NCET-07-0877]; Science and Technology Department of Guangdong Province, China [2009B030801188, 8251008901000006, 2008A030201006]; Ministry of Education of China [(2008) 890, 200805580047]; Department of Health of Guangdong Province [A2009215]; Fundamental Research Funds [10ykzd03]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in Universities(Program for New Century Excellent Talents in University (NCET)); Science and Technology Department of Guangdong Province, China; Ministry of Education of China(Ministry of Education, China); Department of Health of Guangdong Province; Fundamental Research Funds	All grant information: The Natural Science Foundation of China (No. 81071780, 81030048, 30770836, 30771110, 30870963, 30831160517); Program for New Century Excellent Talents in Universities (No. NCET-07-0877); The Science and Technology Department of Guangdong Province, China (No. 2009B030801188, 8251008901000006, 2008A030201006); Ministry of Education of China [No.(2008) 890 and No. 200805580047]; Department of Health of Guangdong Province (No. A2009215); the Fundamental Research Funds for the Central Universities (No. 10ykzd03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Agirre X, 2008, MOL CANCER RES, V6, P1830, DOI 10.1158/1541-7786.MCR-08-0167; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aoki M, 2004, P NATL ACAD SCI USA, V101, P13613, DOI 10.1073/pnas.0405454101; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bouchard C, 2007, GENE DEV, V21, P2775, DOI 10.1101/gad.453107; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; GALEA MH, 1992, BREAST CANCER RES TR, V22, P207, DOI 10.1007/BF01840834; Greene FL, 2002, AJCC CANC STAGING MA, P255; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Gregory RI, 2005, CANCER RES, V65, P3509, DOI 10.1158/0008-5472.CAN-05-0298; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Khatri S, 2010, J BIOL CHEM, V285, P15960, DOI 10.1074/jbc.M110.121871; Kong W, 2010, J BIOL CHEM, V285, P17869, DOI 10.1074/jbc.M110.101055; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Li JC, 2010, PLOS GENET, V6, DOI [10.1371/journal.pgen.1000795, 10.1186/1746-4811-6-1]; Li J, 2008, CLIN CANCER RES, V14, P3319, DOI 10.1158/1078-0432.CCR-07-4054; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Real PJ, 2005, CANCER RES, V65, P8151, DOI 10.1158/0008-5472.CAN-05-1134; ROBBINS P, 1995, HUM PATHOL, V26, P873, DOI 10.1016/0046-8177(95)90010-1; Sakoe Y, 2010, BLOOD, V115, P3787, DOI 10.1182/blood-2009-05-222976; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Tsai WB, 2008, NAT CELL BIOL, V10, P460, DOI 10.1038/ncb1709; Wang K, 2010, J BIOL CHEM, V285, P16958, DOI 10.1074/jbc.M109.093005; Yang JY, 2006, INT J ONCOL, V29, P643; Yang JY, 2010, CANCER RES, V70, P4709, DOI 10.1158/0008-5472.CAN-09-4524; YIYUZOU, 2008, BREAST CANCER RES, V10, pR21; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Yu F, 2010, ONCOGENE, V29, P4194, DOI 10.1038/onc.2010.167	49	149	161	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15797	10.1371/journal.pone.0015797	http://dx.doi.org/10.1371/journal.pone.0015797			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203424	Green Published, Green Submitted, gold			2022-12-27	WOS:000285579200042
J	Xu, Y; Fang, F; Zhang, JY; Josson, S; St Clair, WH; St Clair, DK				Xu, Yong; Fang, Fang; Zhang, Jiayou; Josson, Sajni; St Clair, William H.; St Clair, Daret K.			miR-17*Suppresses Tumorigenicity of Prostate Cancer by Inhibiting Mitochondrial Antioxidant Enzymes	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE GENE; MIR-17-92 CLUSTER; IDENTIFICATION; POLYCISTRON; BIOGENESIS; EXPRESSION; INDUCTION; MICRORNAS; REDUCTASE	Aberrant micro RNA (miRNA) expression has been implicated in the pathogenesis of cancer. Recent studies have shown that the miR-17-92 cluster is overexpressed in many types of cancer. The oncogenic function of mature miRNAs encoded by the miR-17-92 cluster has been identified from the 59 arm of six precursors. However, the function of the miRNAs produced from the 39 arm of these precursors remains unknown. The present study demonstrates that miR-17* is able to suppress critical primary mitochondrial antioxidant enzymes, such as manganese superoxide dismutase (MnSOD), glutathione peroxidase-2 (GPX2) and thioredoxin reductase-2 (TrxR2). Transfection of miR-17* into prostate cancer PC-3 cells significantly reduces levels of the three antioxidant proteins and activity of the luciferase reporter under the control of miR17* binding sequences located in the 3'-untranslated regions of the three target genes. Disulfiram (DSF), a dithiolcarbomate drug shown to have an anticancer effect, induces the level of mature miR-17* and cell death in PCa cells, which can be attenuated by transfection of antisense miR-17*. Increasing miR-17* level in PC-3 cells by a Tet-on based conditional expression system markedly suppresses its tumorigencity. These results suggest that miR-17* may suppress tumorigenicity of prostate cancer through inhibition of mitochondrial antioxidant enzymes.	[Xu, Yong; St Clair, Daret K.] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Fang, Fang; St Clair, William H.] Univ Kentucky, Dept Radiat Med, Lexington, KY USA; [Zhang, Jiayou] Univ Kentucky, Dept Microbiol Immunol & Mol Genet, Lexington, KY USA; [Josson, Sajni] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA	University of Kentucky; University of Kentucky; University of Kentucky; Cedars Sinai Medical Center; University of California System; University of California Los Angeles	Xu, Y (corresponding author), Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA.	dstcl00@uky.edu			National Institutes of Health [CA115801, CA 049797]; NATIONAL CANCER INSTITUTE [R01CA049797, R01CA115801, R29CA049797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant CA115801 to William H. St. Clair and grant CA 049797 to Daret K. St. Clair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boggs RM, 2007, GENE, V404, P25, DOI 10.1016/j.gene.2007.08.015; Chen D, 2006, CANCER RES, V66, P10425, DOI 10.1158/0008-5472.CAN-06-2126; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Ebi H, 2009, ONCOGENE, V28, P3371, DOI 10.1038/onc.2009.201; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Josson S, 2006, ONCOGENE, V25, P1554, DOI 10.1038/sj.onc.1209186; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Niki E, 2010, FREE RADICAL BIO MED, V49, P503, DOI 10.1016/j.freeradbiomed.2010.04.016; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; REYNOLDS AR, 2006, BR J PHARM S2, V2, P144; SPITZ DR, 1989, ANAL BIOCHEM, V179, P8, DOI 10.1016/0003-2697(89)90192-9; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Taguchi A, 2008, CANCER RES, V68, P5540, DOI 10.1158/0008-5472.CAN-07-6460; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Venturini L, 2007, BLOOD, V109, P4399, DOI 10.1182/blood-2006-09-045104; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Weinberg F, 2009, ANN NY ACAD SCI, V1177, P66, DOI 10.1111/j.1749-6632.2009.05039.x; WHEELER CR, 1990, ANAL BIOCHEM, V184, P193, DOI 10.1016/0003-2697(90)90668-Y; Xu Y, 1999, DNA CELL BIOL, V18, P709, DOI 10.1089/104454999314999; Xu Y, 2007, MOL CANCER THER, V6, P2048, DOI 10.1158/1535-7163.MCT-06-0700; Xu Y, 2009, CANCER RES, V69, P3267, DOI 10.1158/0008-5472.CAN-08-4635; Yan HL, 2009, EMBO J, V28, P2719, DOI 10.1038/emboj.2009.214; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang XL, 2009, CHINESE PHYS LETT, V26, DOI 10.1088/0256-307X/26/2/024204	32	57	61	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14356	10.1371/journal.pone.0014356	http://dx.doi.org/10.1371/journal.pone.0014356			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203553	Green Published, gold, Green Submitted			2022-12-27	WOS:000285578000003
J	Brand, A; Smith, ES; Lewin, GR; Park, TJ				Brand, Antje; Smith, Ewan St. J.; Lewin, Gary R.; Park, Thomas J.			Functional Neurokinin and NMDA Receptor Activity in an Animal Naturally Lacking Substance P: The Naked Mole-Rat	PLOS ONE			English	Article							PROTEIN-KINASE-C; DORSAL-HORN NEURONS; NOCICEPTIVE RESPONSES; HYPERALGESIA; GLUTAMATE; NEUROPEPTIDES; POTENTIATION; CHANNELS; BLOCK; PAIN	Naked mole-rats are extremely unusual among mammals in that their cutaneous C-fibers lack the neuropeptide Substance P (SP). In other mammals, SP plays an important role in nociception: it is released from C-fibers onto spinal neurons where it facilitates NMDA receptor activity and causes sensitization that can last for minutes, hours or days. In the present study, we tested the effects of intrathecal application of: 1) SP, 2) an SP antagonist (GR-82334), and 3) an NMDA antagonist (APV) on heat-evoked foot withdrawal. In the naked mole-rat, at a high enough concentration, application of SP caused a large, immediate, and long-lasting sensitization of foot withdrawal latency that was transiently reversed by application of either antagonist. However, neither SP nor NMDA antagonists had an effect when administered alone to naive animals. In contrast, both antagonists induced an increase in basal withdrawal latency in mice. These results indicate that spinal neurons in naked mole-rats have functional SP and NMDA receptors, but that these receptors do not participate in heat-evoked foot withdrawal unless SP is experimentally introduced. We propose that the natural lack of SP in naked mole-rat C-fibers may have resulted during adaptation to living in a chronically high carbon dioxide, high ammonia environment that, in other mammals, would stimulate C-fibers and evoke nocifensive behavior.	[Brand, Antje; Park, Thomas J.] Univ Illinois, Dept Biol Sci, Lab Integrat Neurosci, Chicago, IL 60680 USA; [Smith, Ewan St. J.; Lewin, Gary R.] Max Delbruck Ctr Mol Med, Dept Neurosci, Berlin, Germany	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Brand, A (corresponding author), Univ Illinois, Dept Biol Sci, Lab Integrat Neurosci, Chicago, IL 60680 USA.	TPark@uic.edu	St. John Smith, Ewan/G-1776-2011; Lewin, Gary R/B-8028-2011	St. John Smith, Ewan/0000-0002-2699-1979; Lewin, Gary/0000-0002-2890-6352	National Science Foundation [0744979]; Alexander von Humboldt Foundation;  [Sonderforschungsbereich 665]	National Science Foundation(National Science Foundation (NSF)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); 	This work was supported by National Science Foundation grant 0744979, Sonderforschungsbereich 665, and the Alexander von Humboldt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander SPH, 2009, BRIT J PHARMACOL, V158, pS1, DOI 10.1111/j.1476-5381.2009.00499.x; ANTON F, 1991, NEUROSCI LETT, V123, P208, DOI 10.1016/0304-3940(91)90932-J; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bennett N.C., 2000, AFRICAN MOLE RATS EC; Buffenstein R, 2008, J COMP PHYSIOL B, V178, P439, DOI 10.1007/s00360-007-0237-5; CARPENTER SE, 1981, BRIT J PHARMACOL, V73, P755, DOI 10.1111/j.1476-5381.1981.tb16812.x; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; CHEN L, 1991, NEURON, V7, P319, DOI 10.1016/0896-6273(91)90270-A; Dubin AE, 2010, J CLIN INVEST, V120, P3760, DOI 10.1172/JCI42843; Hua XY, 1999, NEUROSCIENCE, V89, P525, DOI 10.1016/S0306-4522(98)00488-6; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; JARVIS JUM, 1981, SCIENCE, V212, P571, DOI 10.1126/science.7209555; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; LaVinka PC, 2009, J COMP PHYSIOL A, V195, P419, DOI 10.1007/s00359-009-0420-0; Li P, 1999, NAT NEUROSCI, V2, P972, DOI 10.1038/14771; MALMBERG AB, 1992, SCIENCE, V257, P1276, DOI 10.1126/science.1381521; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MJELLEMJOLY N, 1991, NEUROSCI LETT, V133, P121, DOI 10.1016/0304-3940(91)90072-2; Park TJ, 2008, PLOS BIOL, V6, P156, DOI 10.1371/journal.pbio.0060013; Park TJ, 2003, J COMP NEUROL, V465, P104, DOI 10.1002/cne.10824; RUSIN KI, 1993, BRAIN RES BULL, V30, P329, DOI 10.1016/0361-9230(93)90261-9; RUSIN KI, 1992, J NEUROPHYSIOL, V68, P265, DOI 10.1152/jn.1992.68.1.265; SEKIZAWA S, 1994, RESP PHYSIOL, V96, P37, DOI 10.1016/0034-5687(94)90104-X; Seybold V S, 2009, Handb Exp Pharmacol, P451, DOI 10.1007/978-3-540-79090-7_13; SIMONE DA, 1987, BRAIN RES, V418, P201, DOI 10.1016/0006-8993(87)90982-6; Smith ES, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-29; Smith ESJ, 2009, J COMP PHYSIOL A, V195, P1089, DOI 10.1007/s00359-009-0482-z; Stanfa LC, 1999, NEUROSCIENCE, V93, P1391, DOI 10.1016/S0306-4522(99)00310-3; Suzuki R, 2001, PAIN, V91, P101, DOI 10.1016/S0304-3959(00)00423-1; Swanson L. W., 2003, BRAIN ARCHITECTURE U; Wajima Z, 2000, BRAIN RES, V877, P314, DOI 10.1016/S0006-8993(00)02714-1; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Yeomans DC, 1996, PAIN, V68, P141, DOI 10.1016/S0304-3959(96)03177-6; Yeomans DC, 1996, PAIN, V68, P133, DOI 10.1016/S0304-3959(96)03176-4	34	15	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15162	10.1371/journal.pone.0015162	http://dx.doi.org/10.1371/journal.pone.0015162			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21200438	Green Published, Green Accepted, gold			2022-12-27	WOS:000285576900017
J	Jourd'heuil, FL; Lowery, AM; Melton, EM; Mnaimneh, S; Bryan, NS; Fernandez, BO; Park, JH; Ha, CE; Bhagavan, NV; Feelisch, M; Jourd'heuil, D				Jourd'heuil, Frances L.; Lowery, Anthony M.; Melton, Elaina M.; Mnaimneh, Sanie; Bryan, Nathan S.; Fernandez, Bernadette O.; Park, Joo-Ho; Ha, Chung-Eun; Bhagavan, Nadhipuram V.; Feelisch, Martin; Jourd'heuil, David			Redox-Sensitivity and Site-Specificity of S- and N-Denitrosation in Proteins	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; FAMILIAL DYSALBUMINEMIC HYPERTHYROXINEMIA; NITRIC-OXIDE; NITROSOTRYPTOPHAN DERIVATIVES; TRYPTOPHAN DERIVATIVES; SUPEROXIDE-DISMUTASE; THYROXINE-BINDING; THIYL RADICALS; IN-VIVO; NITROSYLATION	Background: S-nitrosation - the formation of S-nitrosothiols (RSNOs) at cysteine residues in proteins - is a posttranslational modification involved in signal transduction and nitric oxide (NO) transport. Recent studies would also suggest the formation of N-nitrosamines (RNNOs) in proteins in vivo, although their biological significance remains obscure. In this study, we characterized a redox-based mechanism by which N-nitroso-tryptophan residues in proteins may be denitrosated. Methodology/Principal Findings: The denitrosation of N-acetyl-nitroso Trp (NANT) by glutathione (GSH) required molecular oxygen and was inhibited by superoxide dismutase (SOD). Transnitrosation to form S-nitrosoglutathione (GSNO) was observed only in the absence of oxygen or presence of SOD. Protein denitrosation by GSH was studied using a set of mutant recombinant human serum albumin (HSA). Trp-214 and Cys-37 were the only two residues nitrosated by NO under aerobic conditions. Nitroso-Trp-214 in HSA was insensitive to denitrosation by GSH or ascorbate while denitrosation at Cys-37 was evident in the presence of GSH but not ascorbate. GSH-dependent denitrosation of Trp-214 was restored in a peptide fragment of helix II containing Trp-214. Finally, incubation of cell lysates with NANT revealed a pattern of protein nitrosation distinct from that observed with GSNO. Conclusions: We propose that the denitrosation of nitrosated Trp by GSH occurs through homolytic cleavage of nitroso Trp to NO and a Trp aminyl radical, driven by the formation of superoxide derived from the oxidation of GSH to GSSG. Overall, the accessibility of Trp residues to redox-active biomolecules determines the stability of protein-associated nitroso species such that in the case of HSA, N-nitroso-Trp-214 is insensitive to denitrosation by low-molecular-weight antioxidants. Moreover, RNNOs can generate free NO and transfer their NO moiety in an oxygen-dependent fashion, albeit site-specificities appear to differ markedly from that of RSNOs.	[Jourd'heuil, Frances L.; Lowery, Anthony M.; Melton, Elaina M.; Jourd'heuil, David] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Mnaimneh, Sanie; Bryan, Nathan S.; Feelisch, Martin] Louisiana State Univ, Dept Mol & Cellular Physiol, Shreveport, LA 71105 USA; [Bryan, Nathan S.; Fernandez, Bernadette O.; Feelisch, Martin] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Park, Joo-Ho] R&D Planning Dept, Inchon, South Korea; [Ha, Chung-Eun] Univ Hawaii Manoa, John A Burns Sch Med, Dept Native Hawaiian Hlth, Honolulu, HI 96822 USA; [Bhagavan, Nadhipuram V.] Univ Hawaii Manoa, Dept Anat Biochem & Physiol, Honolulu, HI 96822 USA	Albany Medical College; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Boston University; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Jourd'heuil, FL (corresponding author), Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA.	jourdhd@mail.amc.edu	Fernandez, Bernadette/AAG-7202-2020; Feelisch, Martin/C-3042-2008	Fernandez, Bernadette/0000-0001-6337-0381; Feelisch, Martin/0000-0003-2320-1158; Jourd'heuil, David/0000-0002-6555-5061; Melton, Elaina/0000-0002-4030-7766	National Institutes of Health [CA89366, HL 69029]; Albany Medical College; NATIONAL CANCER INSTITUTE [R01CA089366] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069029] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albany Medical College; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was made possible by Grants CA89366 (to D.J.) and HL 69029 (to M. F.) from the National Institutes of Health, and support from Albany Medical College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Bhattacharya AA, 2000, J BIOL CHEM, V275, P38731, DOI 10.1074/jbc.M005460200; Bryan NS, 2004, P NATL ACAD SCI USA, V101, P4308, DOI 10.1073/pnas.0306706101; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; De Biase PM, 2005, J ORG CHEM, V70, P5790, DOI 10.1021/jo047720z; Dimmeler S, 1997, J EXP MED, V185, P601, DOI 10.1084/jem.185.4.601; Eu JP, 2000, BIOCHEMISTRY-US, V39, P1040, DOI 10.1021/bi992046e; Feelisch M, 2002, FASEB J, V16, P1775, DOI 10.1096/fj.02-0363com; Harohalli K, 2002, J BIOMED SCI, V9, P47, DOI 10.1007/BF02256578; Hogg N, 1996, FEBS LETT, V382, P223, DOI 10.1016/0014-5793(96)00086-5; Ishima Y, 2007, BIOCHEM BIOPH RES CO, V364, P790, DOI 10.1016/j.bbrc.2007.10.094; Ishima Y, 2008, J BIOL CHEM, V283, P34966, DOI 10.1074/jbc.M807009200; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jourd'heuil D, 1999, ARCH BIOCHEM BIOPHYS, V361, P323, DOI 10.1006/abbi.1998.1010; Jourd'heuil D, 1998, BIOCHEM BIOPH RES CO, V244, P525, DOI 10.1006/bbrc.1998.8227; Jourd'heuil D, 2003, J BIOL CHEM, V278, P15720, DOI 10.1074/jbc.M300203200; Kirsch M, 2003, J BIOL CHEM, V278, P11931, DOI 10.1074/jbc.M300237200; Kirsch M, 2007, ORG BIOMOL CHEM, V5, P3889, DOI 10.1039/b713377b; Kytzia A, 2006, CHEM-EUR J, V12, P8786, DOI 10.1002/chem.200600405; Lander HM, 1996, NATURE, V381, P380, DOI 10.1038/381380a0; Li S, 2003, ARCH BIOCHEM BIOPHYS, V410, P269, DOI 10.1016/S0003-9861(02)00696-3; Madej E, 2008, FREE RADICAL BIO MED, V44, P2013, DOI 10.1016/j.freeradbiomed.2008.02.015; MAGEE PN, 1956, BR J CANC; MEYER TA, 1982, J CHEM SOC PERK T 2, P1383, DOI 10.1039/p29820001383; Nedospasov A, 2000, P NATL ACAD SCI USA, V97, P13543, DOI 10.1073/pnas.250398197; Pelaez D, 2007, J ORG CHEM, V72, P4741, DOI 10.1021/jo070399a; Petersen CE, 1999, CLIN CHEM, V45, P1248; Petersen CE, 1996, J BIOL CHEM, V271, P19110, DOI 10.1074/jbc.271.32.19110; Petersen CE, 1997, BIOCHEMISTRY-US, V36, P7012, DOI 10.1021/bi970225v; Petersen CE, 2000, J BIOL CHEM, V275, P20985, DOI 10.1074/jbc.M001038200; Rassaf T, 2002, FREE RADICAL BIO MED, V33, P1590, DOI 10.1016/S0891-5849(02)01183-8; Reynaert NL, 2004, P NATL ACAD SCI USA, V101, P8945, DOI 10.1073/pnas.0400588101; Romeo AA, 2003, J AM CHEM SOC, V125, P14370, DOI 10.1021/ja0289752; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Simon DI, 1996, P NATL ACAD SCI USA, V93, P4736, DOI 10.1073/pnas.93.10.4736; Sonnenschein K, 2004, J BIOL CHEM, V279, P45433, DOI 10.1074/jbc.M405987200; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Sun JH, 2001, P NATL ACAD SCI USA, V98, P11158, DOI 10.1073/pnas.201289098; Suntsova TP, 2002, IUBMB LIFE, V54, P281, DOI 10.1080/15216540215677; Tsikas D, 2001, J CHROMATOGR A, V915, P107, DOI 10.1016/S0021-9673(01)00634-3; WANG X, 2008, FREE RADIC BIOL MED; WARDMAN P, 1995, METHOD ENZYMOL, V251, P31, DOI 10.1016/0076-6879(95)51108-3; Williams D. L. H., 1988, NITROSATION; Zhang YH, 2004, P NATL ACAD SCI USA, V101, P7891, DOI 10.1073/pnas.0401167101; Zhang YY, 1996, J BIOL CHEM, V271, P14271, DOI 10.1074/jbc.271.24.14271	45	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e14400	10.1371/journal.pone.0014400	http://dx.doi.org/10.1371/journal.pone.0014400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203591	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000285576900014
J	McLean, MH; Murray, GI; Stewart, KN; Norrie, G; Mayer, C; Hold, GL; Thomson, J; Fyfe, N; Hope, M; Mowat, NAG; Drew, JE; El-Omar, EM				McLean, Mairi H.; Murray, Graeme I.; Stewart, Keith N.; Norrie, Gillian; Mayer, Claus; Hold, Georgina L.; Thomson, John; Fyfe, Nicky; Hope, Mairi; Mowat, N. Ashley G.; Drew, Janice E.; El-Omar, Emad M.			The Inflammatory Microenvironment in Colorectal Neoplasia	PLOS ONE			English	Article							MICE LACKING EXPRESSION; CC-CHEMOKINE CCL23; NEUTROPHIL ELASTASE; GENE-EXPRESSION; PROMOTES ANGIOGENESIS; RANDOMIZED-TRIAL; CARCINOMA-CELLS; NITRIC-OXIDE; BONE-MARROW; CANCER	Colorectal cancer (CRC) is a major cause of mortality and morbidity worldwide. Inflammatory activity within the stroma of invasive colorectal tumours is known to be a key predictor of disease activity with type, density and location of immune cells impacting on patient prognosis. To date, there has been no report of inflammatory phenotype within pre-malignant human colonic adenomas. Assessing the stromal microenvironment and particularly, inflammatory activity within colorectal neoplastic lesions is central to understanding early colorectal carcinogenesis. Inflammatory cell infiltrate was assessed by immunohistochemistry in paired colonic adenoma and adjacent normal colonic mucosa samples, and adenomas exhibiting increasing degrees of epithelial cell dysplasia. Macrophage phenotype was assessed using double stain immunohistochemistry incorporating expression of an intracellular enzyme of function. A targeted array of inflammatory cytokine and receptor genes, validated by RT-PCR, was used to assess inflammatory gene expression. Inflammatory cell infiltrates are a key feature of sporadic adenomatous colonic polyps with increased macrophage, neutrophil and T cell (specifically helper and activated subsets) infiltration in adenomatous colonic polyps, that increases in association with characteristics of high malignant potential, namely, increasing degree of cell dysplasia and adenoma size. Macrophages within adenomas express iNOS, suggestive of a pro-inflammatory phenotype. Several inflammatory cytokine genes (CXCL1, CXCL2, CXCL3, CCL20, IL8, CCL23, CCL19, CCL21, CCL5) are dysregulated in adenomas. This study has provided evidence of increased inflammation within pre-malignant colonic adenomas. This may allow potential mechanistic pathways in the initiation and promotion of early colorectal carcinogenesis to be identified.	[McLean, Mairi H.; Hold, Georgina L.; Thomson, John; Hope, Mairi; Mowat, N. Ashley G.; El-Omar, Emad M.] Univ Aberdeen, Sch Med & Dent, Gastrointestinal Res Grp, Aberdeen, Scotland; [Murray, Graeme I.; Stewart, Keith N.; Fyfe, Nicky] Univ Aberdeen, Dept Pathol, Aberdeen, Scotland; [Norrie, Gillian] Western Gen Hosp, Colorectal Surg Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Mayer, Claus; Drew, Janice E.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland	University of Aberdeen; University of Aberdeen; University of Edinburgh; University of Aberdeen	McLean, MH (corresponding author), Univ Aberdeen, Sch Med & Dent, Gastrointestinal Res Grp, Aberdeen, Scotland.	e.el-omar@abdn.ac.uk	El-Omar, Emad/AAT-7780-2021; Hold, Georgina Louise/AAG-9923-2020; Mayer, Claus-Dieter/L-9353-2013	Hold, Georgina Louise/0000-0001-7573-3397; El-Omar, Emad/0000-0002-0011-3924; McLean, Mairi/0000-0002-7443-2653; Mayer, Claus-Dieter/0000-0001-8788-3149	Friends of Anchor, North of Scotland; (UK) cancer charity [SC025332]; Scottish Government Rural and Environment Research & Analysis Directorate (SGRERAD); Rowett Research Institute, Aberdeen, UK	Friends of Anchor, North of Scotland; (UK) cancer charity; Scottish Government Rural and Environment Research & Analysis Directorate (SGRERAD); Rowett Research Institute, Aberdeen, UK	The funders for this study were (1) a personal clinical fellowship for Dr Mairi McLean from Friends of Anchor, a registered North of Scotland, (UK) cancer charity (registered charity number SC025332), www.friendsofanchor.org, and (2) Scottish Government Rural and Environment Research & Analysis Directorate (SGRERAD) who provided core funding for Dr Janice Drew for work carried out within the Rowett Research Institute, Aberdeen, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baier PK, 2005, ANTICANCER RES, V25, P3581; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Benamouzig R, 2003, GASTROENTEROLOGY, V125, P328, DOI 10.1016/S0016-5085(03)00887-4; Campregher C, 2008, GUT, V57, P780, DOI 10.1136/gut.2007.141556; Cancer Research UK, CANC STAT; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Daemen Anneleen, 2008, Pac Symp Biocomput, P166; DeNardo DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1746; DiNapoli MR, 1996, J EXP MED, V183, P1323, DOI 10.1084/jem.183.4.1323; Duncan R, 2008, BRIT J CANCER, V98, P426, DOI 10.1038/sj.bjc.6604128; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Forssmann U, 1997, FEBS LETT, V408, P211, DOI 10.1016/S0014-5793(97)00408-0; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; GRISHAM MB, 1992, GASTROENTEROLOGY, V103, P1260, DOI 10.1016/0016-5085(92)91513-4; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Hwang J, 2005, CYTOKINE, V30, P254, DOI 10.1016/j.cyto.2005.01.018; Ichikawa Y, 2002, BIOCHEM BIOPH RES CO, V296, P497, DOI 10.1016/S0006-291X(02)00732-5; Inada M, 1997, RES COMMUN MOL PATH, V97, P229; Ishiko T, 2003, INT CONGR SER, V1255, P327, DOI 10.1016/S0531-5131(03)00825-2; Jablonska J, 2010, J CLIN INVEST, V120, P4163, DOI 10.1172/JCI37223C1; Jeffery N, 2009, HISTOPATHOLOGY, V54, P820, DOI 10.1111/j.1365-2559.2009.03301.x; Kamohara H, 1997, RES COMMUN MOL PATH, V98, P103; Kita H, 2006, J GASTROENTEROL, V41, P1053, DOI 10.1007/s00535-006-1894-y; Kitadai Y, 1999, BRIT J CANCER, V81, P647, DOI 10.1038/sj.bjc.6690742; Kumarakulasingham M, 2005, CLIN CANCER RES, V11, P3758, DOI 10.1158/1078-0432.CCR-04-1848; Lin YM, 2002, ONCOGENE, V21, P4120, DOI 10.1038/sj.onc.1205518; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Macdonald TT, 2003, PARASITE IMMUNOL, V25, P235, DOI 10.1046/j.1365-3024.2003.00632.x; Mantovani A, 2008, LANCET, V371, P771, DOI 10.1016/S0140-6736(08)60241-X; McLean MH, 2008, HISTOPATHOLOGY, V52, P806, DOI 10.1111/j.1365-2559.2008.03038.x; Mian BM, 2003, CLIN CANCER RES, V9, P3167; Mori S, 2001, J EXP MED, V193, P207, DOI 10.1084/jem.193.2.207; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Munder M, 1999, J IMMUNOL, V163, P3771; Notterman DA, 2001, CANCER RES, V61, P3124; Rubie C, 2006, TUMOR BIOL, V27, P166, DOI 10.1159/000092777; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Shih CH, 2005, EXP HEMATOL, V33, P1101, DOI 10.1016/j.exphem.2005.06.028; Sillars-Hardebol AH, 2010, TUMOR BIOL, V31, P89, DOI 10.1007/s13277-009-0012-1; Son KN, 2006, BIOCHEM BIOPH RES CO, V340, P498, DOI 10.1016/j.bbrc.2005.12.037; Starcher B, 1996, J INVEST DERMATOL, V107, P159, DOI 10.1111/1523-1747.ep12329559; Sun ZF, 2004, LANCET ONCOL, V5, P182, DOI 10.1016/S1470-2045(04)01414-7; Sutton A, 2007, MOL CANCER THER, V6, P2948, DOI 10.1158/1535-7163.MCT-07-0114; Tang ZQ, 2007, CANCER RES, V67, P9996, DOI 10.1158/0008-5472.CAN-07-1601; THUN MJ, 1991, NEW ENGL J MED, V325, P1593, DOI 10.1056/NEJM199112053252301; Vaday GG, 2006, PROSTATE, V66, P124, DOI 10.1002/pros.20306; VERMEER IT, 2004, NEUTROPHIL MEDIATED; Wang DZ, 2006, J EXP MED, V203, P941, DOI 10.1084/jem.20052124; Wen Y, 2006, CLIN CANCER RES, V12, P5951, DOI 10.1158/1078-0432.CCR-06-0736; Wittig BM, 2003, INT J COLORECTAL DIS, V18, P181, DOI 10.1007/s00384-002-0444-1	52	121	125	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e15366	10.1371/journal.pone.0015366	http://dx.doi.org/10.1371/journal.pone.0015366			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249124	Green Published, gold, Green Submitted			2022-12-27	WOS:000286512900007
J	van Zuylen, WJ; Garceau, V; Idris, A; Schroder, K; Irvine, KM; Lattin, JE; Ovchinnikov, DA; Perkins, AC; Cook, AD; Hamilton, JA; Hertzog, PJ; Stacey, KJ; Kellie, S; Hume, DA; Sweet, MJ				van Zuylen, Wendy J.; Garceau, Valerie; Idris, Adi; Schroder, Kate; Irvine, Katharine M.; Lattin, Jane E.; Ovchinnikov, Dmitry A.; Perkins, Andrew C.; Cook, Andrew D.; Hamilton, John A.; Hertzog, Paul J.; Stacey, Katryn J.; Kellie, Stuart; Hume, David A.; Sweet, Matthew J.			Macrophage Activation and Differentiation Signals Regulate Schlafen-4 Gene Expression: Evidence for Schlafen-4 as a Modulator of Myelopoiesis	PLOS ONE			English	Article							MONONUCLEAR PHAGOCYTE SYSTEM; COLLAGEN-INDUCED ARTHRITIS; VIRAL-INFECTION; TRANSGENIC MICE; IN-VITRO; CELLS; GROWTH; CSF-1; RECEPTOR; PROTEIN	Background: The ten mouse and six human members of the Schlafen (Slfn) gene family all contain an AAA domain. Little is known of their function, but previous studies suggest roles in immune cell development. In this report, we assessed Slfn regulation and function in macrophages, which are key cellular regulators of innate immunity. Methodology/Principal Findings: Multiple members of the Slfn family were up-regulated in mouse bone marrow-derived macrophages (BMM) by the Toll-like Receptor (TLR) 4 agonist lipopolysaccharide (LPS), the TLR3 agonist Poly(I:C), and in disease-affected joints in the collagen-induced model of rheumatoid arthritis. Of these, the most inducible was Slfn4. TLR agonists that signal exclusively through the MyD88 adaptor protein had more modest effects on Slfn4 mRNA levels, thus implicating MyD88-independent signalling and autocrine interferon (IFN)-beta in inducible expression. This was supported by the substantial reduction in basal and LPS-induced Slfn4 mRNA expression in IFNAR-1(-/-) BMM. LPS causes growth arrest in macrophages, and other Slfn family genes have been implicated in growth control. Slfn4 mRNA levels were repressed during macrophage colony-stimulating factor (CSF-1)-mediated differentiation of bone marrow progenitors into BMM. To determine the role of Slfn4 in vivo, we over-expressed the gene specifically in macrophages in mice using a csf1r promoter-driven binary expression system. Transgenic over-expression of Slfn4 in myeloid cells did not alter macrophage colony formation or proliferation in vitro. Monocyte numbers, as well as inflammatory macrophages recruited to the peritoneal cavity, were reduced in transgenic mice that specifically over-expressed Slfn4, while macrophage numbers and hematopoietic activity were increased in the livers and spleens. Conclusions: Slfn4 mRNA levels were up-regulated during macrophage activation but down-regulated during differentiation. Constitutive Slfn4 expression in the myeloid lineage in vivo perturbs myelopoiesis. We hypothesise that the down-regulation of Slfn4 gene expression during macrophage differentiation is a necessary step in development of this lineage.	[van Zuylen, Wendy J.; Idris, Adi; Schroder, Kate; Irvine, Katharine M.; Lattin, Jane E.; Ovchinnikov, Dmitry A.; Perkins, Andrew C.; Stacey, Katryn J.; Kellie, Stuart; Sweet, Matthew J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Garceau, Valerie; Hume, David A.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Garceau, Valerie; Hume, David A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland; [Cook, Andrew D.; Hamilton, John A.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia; [Hertzog, Paul J.] Monash Univ, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia; [Stacey, Katryn J.; Kellie, Stuart] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Stacey, Katryn J.; Kellie, Stuart; Sweet, Matthew J.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia	University of Queensland; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Royal Melbourne Hospital; University of Melbourne; Monash University; University of Queensland; University of Queensland	van Zuylen, WJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	david.hume@roslin.ed.ac.uk; m.sweet@imb.uq.edu.au	Idris, Adi/N-3500-2016; Perkins, Andrew C/M-3216-2014; Perkins, Andrew/X-4180-2019; Kellie, Stuart/A-6036-2010; Hertzog, Paul J/G-6734-2013; Sweet, Matthew J/F-2229-2011; Hume, David A/C-7695-2013; Hertzog, Paul J/I-7053-2013; Irvine, Katharine M/A-5559-2011; Perkins, Andrew/AAJ-9696-2020; Schroder, Kate/C-6132-2008; Ovchinnikov, Dmitry/J-7963-2014	Idris, Adi/0000-0002-0562-1549; Perkins, Andrew C/0000-0003-3644-7093; Perkins, Andrew/0000-0003-3644-7093; Hertzog, Paul J/0000-0002-1373-8472; Sweet, Matthew J/0000-0002-0406-8139; Hertzog, Paul J/0000-0002-1373-8472; Irvine, Katharine M/0000-0002-6716-1605; Schroder, Kate/0000-0001-9261-3805; Ovchinnikov, Dmitry/0000-0001-9603-8385; Hamilton, John A/0000-0002-9493-9224; Hume, David/0000-0002-2615-1478; Stacey, Katryn/0000-0002-3992-7802; Kellie, Stuart/0000-0002-8163-1474; Cook, Andrew/0000-0002-7314-924X	Cooperative Research Centre for Chronic Inflammatory Diseases	Cooperative Research Centre for Chronic Inflammatory Diseases(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was supported by funding from the Cooperative Research Centre for Chronic Inflammatory Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreda DR, 2004, DEV COMP IMMUNOL, V28, P509, DOI 10.1016/j.dci.2003.09.010; BARTELMEZ SH, 1985, J CELL PHYSIOL, V122, P362, DOI 10.1002/jcp.1041220305; Berger M, 2010, NAT IMMUNOL, V11, P335, DOI 10.1038/ni.1847; Brady G, 2005, J BIOL CHEM, V280, P30723, DOI 10.1074/jbc.M500435200; BREEN FN, 1990, BRIT J HAEMATOL, V74, P138, DOI 10.1111/j.1365-2141.1990.tb02556.x; Bruno L, 2004, MOL CELL BIOL, V24, P741, DOI 10.1128/MCB.24.2.741-756.2004; Bustos O, 2009, GENE, V447, P1, DOI 10.1016/j.gene.2009.07.006; Campbell IK, 1997, ANN RHEUM DIS, V56, P364, DOI 10.1136/ard.56.6.364; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Caron J, 2006, INFECT IMMUN, V74, P2787, DOI 10.1128/IAI.74.5.2787-2802.2006; Chang MK, 2008, J IMMUNOL, V181, P1232, DOI 10.4049/jimmunol.181.2.1232; Condamine T, 2010, J LEUKOCYTE BIOL, V87, P451, DOI 10.1189/jlb.0609410; Deonarain R, 2003, P NATL ACAD SCI USA, V100, P13453, DOI 10.1073/pnas.2230460100; Engler A, 2005, J NEUROIMMUNOL, V162, P103, DOI 10.1016/j.jneuroim.2005.01.017; Fujikado N, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1985; Geserick P, 2004, INT IMMUNOL, V16, P1535, DOI 10.1093/intimm/dxh155; Gubser C, 2007, J GEN VIROL, V88, P1667, DOI 10.1099/vir.0.82748-0; Hamilton JA, 1996, J IMMUNOL, V156, P2553; Huang YH, 2004, P NATL ACAD SCI USA, V101, P4936, DOI 10.1073/pnas.0401133101; Hume DA, 2006, CURR OPIN IMMUNOL, V18, P49, DOI 10.1016/j.coi.2005.11.008; HUME DA, 2010, GENOMICS; Irvine KM, 2006, FASEB J, V20, P1921, DOI 10.1096/fj.06-5848fje; Irvine KM, 2009, J LEUKOCYTE BIOL, V85, P278, DOI 10.1189/jlb.0808497; Katsoulidis E, 2009, J BIOL CHEM, V284, P25051, DOI 10.1074/jbc.M109.030445; Kinne RW, 2000, ARTHRITIS RES, V2, P189, DOI 10.1186/ar86; Neumann B, 2008, BIOCHEM BIOPH RES CO, V370, P62, DOI 10.1016/j.bbrc.2008.03.032; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Ovchinnikov DA, 2008, J LEUKOCYTE BIOL, V83, P430, DOI 10.1189/jlb.0807585; Ovchinnikov DA, 2010, J LEUKOCYTE BIOL, V87, P815, DOI 10.1189/jlb.0809557; Patel BB, 2009, AM J PHYSIOL-GASTR L, V296, pG955, DOI 10.1152/ajpgi.90726.2008; Patel VB, 2009, BIOCHEM BIOPH RES CO, V388, P752, DOI 10.1016/j.bbrc.2009.08.094; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; ROBERTS TL, 2009, SCIENCE; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; Schurr JR, 2005, INFECT IMMUN, V73, P532, DOI 10.1128/IAI.73.1.532-545.2005; Schwarz DA, 1998, IMMUNITY, V9, P657, DOI 10.1016/S1074-7613(00)80663-9; Starczynowski DT, 2008, BLOOD, V112, P3412, DOI 10.1182/blood-2007-11-122028; Sun DX, 2006, NAT IMMUNOL, V7, P375, DOI 10.1038/ni1308; Sweet MJ, 1998, J INFLAMM, V48, P67; Tyner JW, 2005, NAT MED, V11, P1180, DOI 10.1038/nm1303; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Wells CA, 2005, J LEUKOCYTE BIOL, V78, P9, DOI 10.1189/jlb.1204710; WILLIAMS RO, 1992, P NATL ACAD SCI USA, V89, P9784, DOI 10.1073/pnas.89.20.9784	43	51	51	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e15723	10.1371/journal.pone.0015723	http://dx.doi.org/10.1371/journal.pone.0015723			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249125	Green Published, gold			2022-12-27	WOS:000286512900009
J	Hu, W; Hossain, M; Lux, R; Wang, J; Yang, Z; Li, YZ; Shi, WY				Hu, Wei; Hossain, Muhaiminu; Lux, Renate; Wang, Jing; Yang, Zhe; Li, Yuezhong; Shi, Wenyuan			Exopolysaccharide-Independent Social Motility of Myxococcus xanthus	PLOS ONE			English	Article							FRUITING BODY FORMATION; GLIDING MOTILITY; IV PILUS; MULTICELLULAR DEVELOPMENT; TWITCHING MOTILITY; POLYSACCHARIDE PRODUCTION; PSEUDOMONAS-AERUGINOSA; CHEMOTAXIS HOMOLOGS; O-ANTIGEN; MYXOBACTERIA	Social motility (S motility), the coordinated movement of large cell groups on agar surfaces, of Myxococcus xanthus requires type IV pili (TFP) and exopolysaccharides (EPS). Previous models proposed that this behavior, which only occurred within cell groups, requires cycles of TFP extension and retraction triggered by the close interaction of TFP with EPS. However, the curious observation that M. xanthus can perform TFP-dependent motility at a single-cell level when placed onto polystyrene surfaces in a highly viscous medium containing 1% methylcellulose indicated that "S motility" is not limited to group movements. In an apparent further challenge of the previous findings for S motility, mutants defective in EPS production were found to perform TFP-dependent motility on polystyrene surface in methylcellulose-containing medium. By exploring the interactions between pilin and surface materials, we found that the binding of TFP onto polystyrene surfaces eliminated the requirement for EPS in EPS- cells and thus enabled TFP-dependent motility on a single cell level. However, the presence of a general anchoring surface in a viscous environment could not substitute for the role of cell surface EPS in group movement. Furthermore, EPS was found to serve as a self-produced anchoring substrate that can be shed onto surfaces to enable cells to conduct TFP-dependent motility regardless of surface properties. These results suggested that in certain environments, such as in methylcellulose solution, the cells could bypass the need for EPS to anchor their TPF and conduct single-cell S motility to promote exploratory movement of colonies over new specific surfaces.	[Hu, Wei; Lux, Renate; Wang, Jing; Shi, Wenyuan] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA; [Hossain, Muhaiminu; Yang, Zhe; Shi, Wenyuan] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Hu, Wei; Wang, Jing; Li, Yuezhong] Shandong Univ, State Key Lab Microbial Technol, Sch Life Sci, Jinan 250100, Peoples R China	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Shandong University	Hu, W (corresponding author), Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA.	wenyuan@ucla.edu	SHI, wen/GPW-9531-2022; Li, Yuezhong/ACN-5179-2022	Li, Yuezhong/0000-0001-8336-6638	United States National Institutes of Health [GM54666]; Chinese National Natural Science Foundation [30870020]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054666] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States National Institutes of Health Grant GM54666 (to W.S.) and Chinese National Natural Science Foundation Grant 30870020 (to W.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black WP, 2004, J BACTERIOL, V186, P1001, DOI 10.1128/JB.186.4.1001-1008.2004; Bowden MG, 1998, MOL MICROBIOL, V30, P275, DOI 10.1046/j.1365-2958.1998.01060.x; CAMPOS JM, 1978, J MOL BIOL, V119, P167, DOI 10.1016/0022-2836(78)90431-X; CHANG BY, 1994, J BACTERIOL, V176, P7190, DOI 10.1128/JB.176.23.7190-7196.1994; Chavira M, 2007, J BACTERIOL, V189, P169, DOI 10.1128/JB.00792-06; Clausen M, 2009, J BACTERIOL, V191, P4633, DOI 10.1128/JB.00396-09; Cordelieres F, 2005, MANUAL TRACKING PLUG; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Guo DC, 1996, J BACTERIOL, V178, P1631, DOI 10.1128/jb.178.6.1631-1639.1996; Harlow E., 1988, ANTIBODIES LAB MANUA; HARTZELL P, 2008, GLIDING MOTILITY MYX; HIGGS P, 2008, MYXOCOCCUS XANTHUS C; HODGKIN J, 1979, MOL GEN GENET, V171, P177, DOI 10.1007/BF00270004; HODGKIN J, 1979, MOL GEN GENET, V171, P167, DOI 10.1007/BF00270003; Jelsbak L, 2000, CURR OPIN MICROBIOL, V3, P637, DOI 10.1016/S1369-5274(00)00153-3; Julien B, 2000, P NATL ACAD SCI USA, V97, P9098, DOI 10.1073/pnas.97.16.9098; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; Kaiser D, 2003, NAT REV MICROBIOL, V1, P45, DOI 10.1038/nrmicro733; KAISER D, 1983, CELL MOTILITY, V3, P18; Kaplan HB, 2003, CURR OPIN MICROBIOL, V6, P572, DOI 10.1016/j.mib.2003.10.006; Leonardy S, 2008, MOL BIOSYST, V4, P1009, DOI 10.1039/b806640j; Li YN, 2005, MICROBIOL-SGM, V151, P353, DOI 10.1099/mic.0.27614-0; Li YZ, 2002, J MICROBIOL METH, V50, P205, DOI 10.1016/S0167-7012(02)00029-5; Lu A, 2005, MOL MICROBIOL, V55, P206, DOI 10.1111/j.1365-2958.2004.04369.x; Lux R., 2004, BIOFILMS, V1, P293; MACNEIL SD, 1994, MOL MICROBIOL, V14, P785, DOI 10.1111/j.1365-2958.1994.tb01315.x; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; MCBRIDE M, 1993, MOTILITY TACTIC BEHA; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Merz AJ, 2000, ANNU REV CELL DEV BI, V16, P423, DOI 10.1146/annurev.cellbio.16.1.423; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Rasband W, IMAGEJ; Reichenbach H, 1999, ENVIRON MICROBIOL, V1, P15, DOI 10.1046/j.1462-2920.1999.00016.x; Reichenbach H, 1993, BIOL MYXOBACTERIA EC; Semmler ABT, 1999, MICROBIOL-SGM, V145, P2863, DOI 10.1099/00221287-145-10-2863; Shi WY, 2002, INFECT IMMUN, V70, P1, DOI 10.1128/IAI.70.1.1-4.2002; SHI WY, 1993, P NATL ACAD SCI USA, V90, P3378, DOI 10.1073/pnas.90.8.3378; Shi WY, 1996, P NATL ACAD SCI USA, V93, P4142, DOI 10.1073/pnas.93.9.4142; Shimkets LJ, 1999, ANNU REV MICROBIOL, V53, P525, DOI 10.1146/annurev.micro.53.1.525; SHIMKETS LJ, 1986, J BACTERIOL, V166, P837, DOI 10.1128/jb.166.3.837-841.1986; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; Sun H, 2000, CURR BIOL, V10, P1143, DOI 10.1016/S0960-9822(00)00705-3; Sun H, 1999, P NATL ACAD SCI USA, V96, P15178, DOI 10.1073/pnas.96.26.15178; Wall D, 1999, MOL MICROBIOL, V32, P1, DOI 10.1046/j.1365-2958.1999.01339.x; Ward MJ, 1999, CURR OPIN MICROBIOL, V2, P624, DOI 10.1016/S1369-5274(99)00032-6; Welch R, 2001, P NATL ACAD SCI USA, V98, P14907, DOI 10.1073/pnas.261574598; WU SS, 1995, MOL MICROBIOL, V18, P547, DOI 10.1111/j.1365-2958.1995.mmi_18030547.x; Wu SS, 1997, MOL MICROBIOL, V23, P109, DOI 10.1046/j.1365-2958.1997.1791550.x; Wu SS, 1997, J BACTERIOL, V179, P7748, DOI 10.1128/jb.179.24.7748-7758.1997; Yang RF, 2004, J BACTERIOL, V186, P6168, DOI 10.1128/jb.186.18.6168-6178.2004; Yang Z, 2010, MOL MICROBIOL, V76, P1500, DOI 10.1111/j.1365-2958.2010.07180.x; Yang ZM, 1998, MOL MICROBIOL, V30, P1123, DOI 10.1046/j.1365-2958.1998.01160.x; Youderian P, 2006, GENETICS, V172, P1397, DOI 10.1534/genetics.105.050542	55	19	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e16102	10.1371/journal.pone.0016102	http://dx.doi.org/10.1371/journal.pone.0016102			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21245931	gold, Green Published, Green Submitted			2022-12-27	WOS:000286511200034
J	Berecki, G; Wilders, R; de Jonge, B; van Ginneken, ACG; Verkerk, AO				Berecki, Geza; Wilders, Ronald; de Jonge, Berend; van Ginneken, Antoni C. G.; Verkerk, Arie O.			Re-Evaluation of the Action Potential Upstroke Velocity as a Measure of the Na+ Current in Cardiac Myocytes at Physiological Conditions	PLOS ONE			English	Article							AVAILABLE SODIUM CONDUCTANCE; VOLTAGE CLAMP MEASUREMENTS; RABBIT PURKINJE-FIBERS; BRUGADA-SYNDROME; HEART-FAILURE; VENTRICULAR MYOCYTES; TEMPERATURE-DEPENDENCE; CHANNEL MUTATIONS; PATCH-CLAMP; V-MAX	Background: The SCN5A encoded sodium current (I-Na) generates the action potential (AP) upstroke and is a major determinant of AP characteristics and AP propagation in cardiac myocytes. Unfortunately, in cardiac myocytes, investigation of kinetic properties of I-Na with near-physiological ion concentrations and temperature is technically challenging due to the large amplitude and rapidly activating nature of I-Na, which may seriously hamper the quality of voltage control over the membrane. We hypothesized that the alternating voltage clamp-current clamp (VC/CC) technique might provide an alternative to traditional voltage clamp (VC) technique for the determination of I-Na properties under physiological conditions. Principal Findings: We studied I-Na under close-to-physiological conditions by VC technique in SCN5A cDNA-transfected HEK cells or by alternating VC/CC technique in both SCN5A cDNA-transfected HEK cells and rabbit left ventricular myocytes. In these experiments, peak I-Na during a depolarizing VC step or maximal upstroke velocity, dV/dt(max), during VC/CC served as an indicator of available I-Na. In HEK cells, biophysical properties of I-Na, including current density, voltage dependent (in) activation, development of inactivation, and recovery from inactivation, were highly similar in VC and VC/CC experiments. As an application of the VC/CC technique we studied I-Na in left ventricular myocytes isolated from control or failing rabbit hearts. Conclusions: Our results demonstrate that the alternating VC/CC technique is a valuable experimental tool for I-Na measurements under close-to-physiological conditions in cardiac myocytes.	[Berecki, Geza; Wilders, Ronald; de Jonge, Berend; van Ginneken, Antoni C. G.; Verkerk, Arie O.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, Dept Anat Embryol & Physiol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Berecki, G (corresponding author), Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, Dept Anat Embryol & Physiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	A.O.Verkerk@amc.uva.nl	Berecki, Geza/T-5016-2017	Verkerk, Arie/0000-0003-2140-834X				Abriel H, 2007, CARDIOVASC RES, V76, P381, DOI 10.1016/j.cardiores.2007.07.019; Abriel H, 2010, J MOL CELL CARDIOL, V48, P2, DOI 10.1016/j.yjmcc.2009.08.025; Akar FG, 2004, CIRC RES, V95, P717, DOI 10.1161/01.RES.0000144125.61927.1c; Amin AS, 2005, ACTA PHYSIOL SCAND, V185, P291, DOI 10.1111/j.1365-201X.2005.01496.x; Baartscheer A, 2008, BRIT J PHARMACOL, V154, P1266, DOI 10.1038/bjp.2008.189; Berecki G, 2006, J PHYSIOL-LONDON, V570, P237, DOI 10.1113/jphysiol.2005.096578; CALLEWAERT G, 1984, J PHYSIOL-LONDON, V349, P643, DOI 10.1113/jphysiol.1984.sp015179; CARMELIET E, 1991, EUR J PHARMACOL, V196, P53, DOI 10.1016/0014-2999(91)90408-I; Cascio WE, 2001, J CARDIOVASC ELECTR, V12, P726, DOI 10.1046/j.1540-8167.2001.00726.x; Casini S, 2009, CARDIOVASC RES, V81, P72, DOI 10.1093/cvr/cvn274; CLARKSON CW, 1984, AM J PHYSIOL, V247, pH645, DOI 10.1152/ajpheart.1984.247.4.H645; COHEN CJ, 1984, CIRC RES, V54, P636, DOI 10.1161/01.RES.54.6.636; COHEN IS, 1985, CIRC RES, V57, P482, DOI 10.1161/01.RES.57.3.482; COLATSKY TJ, 1979, NATURE, V278, P265, DOI 10.1038/278265a0; Coronel R, 2005, CIRCULATION, V112, P2769, DOI 10.1161/CIRCULATIONAHA.105.532614; de Groot JR, 2003, CARDIOVASC RES, V59, P705, DOI 10.1016/S0008-6363(03)00460-7; DECARVALHO AP, 1969, J GEN PHYSIOL, V54, P607, DOI 10.1085/jgp.54.5.607; Dumaine R, 1999, CIRC RES, V85, P803, DOI 10.1161/01.RES.85.9.803; Fozzard HA, 2005, CURR PHARM DESIGN, V11, P2671, DOI 10.2174/1381612054546833; GELBAND H, 1972, CIRC RES, V30, P293, DOI 10.1161/01.RES.30.3.293; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Han CY, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-3; HANCK DA, 1992, AM J PHYSIOL, V262, pH1197, DOI 10.1152/ajpheart.1992.262.4.H1197; HONDEGHEM LM, 1985, CIRC RES, V57, P192; HONDEGHEM LM, 1978, BIOPHYS J, V23, P147, DOI 10.1016/S0006-3495(78)85439-3; JOHNS JA, 1989, J CARDIOVASC PHARM, V13, P826, DOI 10.1097/00005344-198906000-00004; Kleber AG, 2005, CIRC RES, V97, P204, DOI 10.1161/01.RES.0000177922.62341.f2; Kleber AG, 1997, BASIC RES CARDIOL, V92, P111, DOI 10.1007/BF00794075; Milburn T, 1995, RECEPTOR CHANNEL, V3, P201; MURRAY KT, 1990, BIOPHYS J, V57, P607, DOI 10.1016/S0006-3495(90)82576-5; Nagatomo T, 1998, AM J PHYSIOL-HEART C, V275, pH2016, DOI 10.1152/ajpheart.1998.275.6.H2016; Petitprez S, 2008, CARDIOVASC RES, V78, P494, DOI 10.1093/cvr/cvn023; Postema PG, 2009, HEART RHYTHM, V6, P1335, DOI 10.1016/j.hrthm.2009.07.002; Remme CA, 2009, BASIC RES CARDIOL, V104, P511, DOI 10.1007/s00395-009-0012-8; Remme CA, 2008, TRENDS CARDIOVAS MED, V18, P78, DOI 10.1016/j.tcm.2008.01.002; Remme CA, 2006, CIRCULATION, V114, P2584, DOI 10.1161/CIRCULATIONAHA.106.653949; Rivolta I, 2001, J BIOL CHEM, V276, P30623, DOI 10.1074/jbc.M104471200; ROBERGE FA, 1987, COMPUT BIOMED RES, V20, P351, DOI 10.1016/0010-4809(87)90049-8; ROSEN MR, 1974, AM HEART J, V88, P380, DOI 10.1016/0002-8703(74)90475-X; Ruan YF, 2009, NAT REV CARDIOL, V6, P337, DOI 10.1038/nrcardio.2009.44; SAIKAWA T, 1982, PFLUG ARCH EUR J PHY, V394, P90, DOI 10.1007/BF01108313; SAKAKIBARA Y, 1993, AM J PHYSIOL, V265, pH1301, DOI 10.1152/ajpheart.1993.265.4.H1301; SHEETS MF, 1988, CIRC RES, V63, P386, DOI 10.1161/01.RES.63.2.386; Sherman AJ, 1999, BIOPHYS J, V77, P2590, DOI 10.1016/S0006-3495(99)77093-1; Sperelakis N, 1968, J Electrocardiol, V1, P31; Tan HL, 2003, CARDIOVASC RES, V57, P961, DOI 10.1016/S0008-6363(02)00714-9; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Tomaselli GF, 2004, CIRC RES, V95, P754, DOI 10.1161/01.RES.0000145047.14691.db; Traynelis SF, 1998, J NEUROSCI METH, V86, P25, DOI 10.1016/S0165-0270(98)00140-X; Verkerk AO, 2005, CARDIOVASC RES, V68, P441, DOI 10.1016/j.cardiores.2005.06.027; Verkerk AO, 2003, CIRCULATION, V108, P760, DOI 10.1161/01.CIR.0000083719.51661.B9; Verkerk AO, 2008, EUROPACE, V10, P257, DOI 10.1093/europace/eum267; Verkerk AO, 2007, EUROPACE, V9, P571, DOI 10.1093/europace/eum121; Verkerk AO, 2011, INT J CARDIOL, V148, P154, DOI 10.1016/j.ijcard.2009.10.047; VERMEULEN JT, 1994, CARDIOVASC RES, V28, P1547, DOI 10.1093/cvr/28.10.1547; Wang DW, 2000, CIRC RES, V87, pE37, DOI 10.1161/01.RES.87.8.e37; WEIDMANN S, 1955, J PHYSIOL-LONDON, V127, P213, DOI 10.1113/jphysiol.1955.sp005250; Wiegerinck RF, 2006, CIRCULATION, V113, P806, DOI 10.1161/CIRCULATIONAHA.105.565804; YAMAOKA K, 1987, JPN J PHYSIOL, V37, P585, DOI 10.2170/jjphysiol.37.585	59	51	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15772	10.1371/journal.pone.0015772	http://dx.doi.org/10.1371/journal.pone.0015772			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217835	Green Published, gold			2022-12-27	WOS:000285838900031
J	Morran, LT; Ohdera, AH; Phillips, PC				Morran, Levi T.; Ohdera, Aki H.; Phillips, Patrick C.			Purging Deleterious Mutations under Self Fertilization: Paradoxical Recovery in Fitness with Increasing Mutation Rate in Caenorhabditis elegans	PLOS ONE			English	Article							EVOLUTIONARY CONSEQUENCES; COMPENSATORY MUTATIONS; INBREEDING DEPRESSION; POPULATIONS; RECOMBINATION; SELECTION; MUTAGENESIS; EXTINCTION; ADVANTAGE; GENETICS	Background: The accumulation of deleterious mutations can drastically reduce population mean fitness. Self-fertilization is thought to be an effective means of purging deleterious mutations. However, widespread linkage disequilibrium generated and maintained by self-fertilization is predicted to reduce the efficacy of purging when mutations are present at multiple loci. Methodology/Principal Findings: We tested the ability of self-fertilizing populations to purge deleterious mutations at multiple loci by exposing obligately self-fertilizing populations of Caenorhabditis elegans to a range of elevated mutation rates and found that mutations accumulated, as evidenced by a reduction in mean fitness, in each population. Therefore, purging in obligate selfing populations is overwhelmed by an increase in mutation rate. Surprisingly, we also found that obligate and predominantly self-fertilizing populations exposed to very high mutation rates exhibited consistently greater fitness than those subject to lesser increases in mutation rate, which contradicts the assumption that increases in mutation rate are negatively correlated with fitness. The high levels of genetic linkage inherent in self-fertilization could drive this fitness increase. Conclusions: Compensatory mutations can be more frequent under high mutation rates and may alleviate a portion of the fitness lost due to the accumulation of deleterious mutations through epistatic interactions with deleterious mutations. The prolonged maintenance of tightly linked compensatory and deleterious mutations facilitated by self-fertilization may be responsible for the fitness increase as linkage disequilibrium between the compensatory and deleterious mutations preserves their epistatic interaction.	[Morran, Levi T.; Ohdera, Aki H.; Phillips, Patrick C.] Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA	University of Oregon	Morran, LT (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	pphil@uoregon.edu			National Science Foundation [DEB-0236180, DEB-0710386, DEB-0641066]; National Institutes of Health; NIH National Center for Research Resources (NCRR)	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was funded by National Science Foundation grants DEB-0236180, DEB-0710386, DEB-0641066, and an National Institutes of Health Genetics Fellowship awarded to LTM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Y.L. Lee, M. Parmenter, S. Scholz, and J. Chiem for logistical help and J. Thornton for use of lab space and equipment. We would also like to thank the members of the Phillips lab and two anonymous reviewers for helpful comments and discussion pertaining to this work. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR).	Anderson P, 1995, METHOD CELL BIOL, V48, P31; Baer CF, 2005, P NATL ACAD SCI USA, V102, P5785, DOI 10.1073/pnas.0406056102; BARTON NH, 1995, GENETICS, V140, P821; BRENNER S, 1974, GENETICS, V77, P71; Burch CL, 1999, GENETICS, V151, P921; Charlesworth B, 1998, GENETICA, V102-3, P3, DOI 10.1023/A:1017066304739; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; CHARLESWORTH D, 1993, GENET RES, V61, P39, DOI 10.1017/S0016672300031086; Charlesworth D, 2001, CURR OPIN GENET DEV, V11, P685, DOI 10.1016/S0959-437X(00)00254-9; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Davies EK, 1999, SCIENCE, V285, P1748, DOI 10.1126/science.285.5434.1748; Davis BH, 2009, P R SOC B, V276, P1823, DOI 10.1098/rspb.2008.1846; Denver DR, 2010, GENOME RES, V20, P1663, DOI 10.1101/gr.108191.110; Drake JW, 1998, GENETICS, V148, P1667; Estes S, 2003, EVOLUTION, V57, P1022, DOI 10.1111/j.0014-3820.2003.tb00313.x; Estes S, 2009, EXPERIMENTAL EVOLUTION: CONCEPTS, METHODS, AND APPLICATIONS OF SELECTION EXPERIMENTS, P135; FELSENSTEIN J, 1974, GENETICS, V78, P737; Flibotte S, 2010, GENETICS, V185, P431, DOI 10.1534/genetics.110.116616; GABRIEL W, 1993, EVOLUTION, V47, P1744, DOI 10.1111/j.1558-5646.1993.tb01266.x; HASTINGS A, 1984, P NATL ACAD SCI-BIOL, V81, P4596, DOI 10.1073/pnas.81.14.4596; HELLER J, 1972, GENET RES, V8, P269; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Howe DK, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-62; JOHNS V, 1978, MOL GEN GENET, V167, P197, DOI 10.1007/BF00266913; Keightley PD, 1999, GENETICS, V153, P515; Kimura M., 1985, J GENET, V64, P7, DOI [10.1007/BF02923549, DOI 10.1007/BF02923549]; Kimura M., 1985, POPULATION GENETICS, P19; KONDRASHOV AS, 1984, GENET RES, V44, P199, DOI 10.1017/S0016672300026392; LANDE R, 1985, EVOLUTION, V39, P24, DOI [10.2307/2408514, 10.1111/j.1558-5646.1985.tb04077.x]; Lande R, 1998, GENETICA, V102-3, P21, DOI 10.1023/A:1017018405648; Lynch M., 1995, EVOLUTION, V47, P1744; Manoel D, 2007, P ROY SOC B-BIOL SCI, V274, P417, DOI 10.1098/rspb.2006.3739; MILLER LM, 1988, CELL, V55, P167, DOI 10.1016/0092-8674(88)90019-0; Morran LT, 2009, NATURE, V462, P350, DOI 10.1038/nature08496; MUKAI T, 1964, GENETICS, V50, P1; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; PARK EC, 1986, GENETICS, V113, P821; Phillips PC, 2000, EPISTATIS EVOLUTIONA; ROSENBLUTH RE, 1983, MUTAT RES, V110, P39, DOI 10.1016/0027-5107(83)90016-7; Sarin S, 2010, GENETICS, V185, P417, DOI 10.1534/genetics.110.116319; Schultz ST, 1997, EVOLUTION, V51, P1363, DOI [10.1111/j.1558-5646.1997.tb01459.x, 10.2307/2411188]; SIDDIQI BA, 1973, HEREDITAS, V73, P311; Silander OK, 2007, PLOS BIOL, V5, P922, DOI 10.1371/journal.pbio.0050094; Stiernagle T, 2006, COMMUNITY TCER; Teotonio H, 2006, EVOLUTION, V60, P1300, DOI 10.1111/j.0014-3820.2006.tb01207.x; Vassilieva LL, 2000, EVOLUTION, V54, P1234, DOI 10.1111/j.0014-3820.2000.tb00557.x; Whitlock MC, 1999, TRENDS ECOL EVOL, V14, P295, DOI 10.1016/S0169-5347(99)01662-6; Wright S, 1931, GENETICS, V16, P0097	48	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e14473	10.1371/journal.pone.0014473	http://dx.doi.org/10.1371/journal.pone.0014473			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217820	Green Submitted, Green Published, gold			2022-12-27	WOS:000285838900004
J	Ramirez, O; Illera, JC; Rando, JC; Gonzalez-Solis, J; Alcover, JA; Lalueza-Fox, C				Ramirez, Oscar; Carlos Illera, Juan; Carlos Rando, Juan; Gonzalez-Solis, Jacob; Antoni Alcover, Josep; Lalueza-Fox, Carles			Ancient DNA of the Extinct Lava Shearwater (Puffinus olsoni) from the Canary Islands Reveals Incipient Differentiation within the P. puffinus Complex	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; NUCLEOTIDE-SEQUENCES; PROCELLARIIFORMES; EVOLUTION; SEABIRD; PHYLOGEOGRAPHY; INFERENCE; MRBAYES; PETREL; AVES	Background: The loss of species during the Holocene was, dramatically more important on islands than on continents. Seabirds from islands are very vulnerable to human-induced alterations such as habitat destruction, hunting and exotic predators. For example, in the genus Puffinus (family Procellariidae) the extinction of at least five species has been recorded during the Holocene, two of them coming from the Canary Islands. Methodology/Principal Findings: We used bones of the two extinct Canary shearwaters (P. olsoni and P. holeae) to obtain genetic data, for use in providing insights into the differentiation process within the genus Puffinus. Although mitochondrial DNA (mtDNA) cytochrome b sequences were successfully retrieved from four Holocene specimens of the extinct Lava shearwater (P. olsoni) from Fuerteventura (Canary Islands), the P. holeae specimens yielded no DNA. Only one haplotype was detected in P. olsoni, suggesting a low genetic diversity within this species. Conclusions: The phylogenetic analyses based on the DNA data reveal that: (i) the "Puffinus puffinus complex'', an assemblage of species defined using osteological characteristics (P. puffinus, P. olsoni, P. mauretanicus, P. yelkouan and probably P. holeae), shows unresolved phylogenetic relationships; (ii) despite the differences in body size and proportions, P. olsoni and the extant P. puffinus are sister species. Several hypotheses can be considered to explain the incipient differentiation between P. olsoni and P. puffinus.	[Ramirez, Oscar; Lalueza-Fox, Carles] Inst Evolutionary Biol CSIC UPF, Barcelona, Spain; [Carlos Illera, Juan] IPNA CSIC, Isl Ecol & Evolut Res Grp, Tenerife, Spain; [Carlos Rando, Juan] Univ La Laguna, Dept Biol Anim UDI Zool, Tenerife, Spain; [Gonzalez-Solis, Jacob] Univ Barcelona, Dept Biol Anim, Barcelona, Spain; [Antoni Alcover, Josep] CSIC UIB, Inst Mediterrani Estudis Avancats, Palma de Mallorca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Naturales y Agrobiologia (IPNA); Universidad de la Laguna; University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Barcelona	Ramirez, O (corresponding author), Inst Evolutionary Biol CSIC UPF, Barcelona, Spain.	carles.lalueza@upf.edu	LALUEZA-FOX, CARLES/AAG-5341-2020; González-Solís, Jacob/AAB-1161-2019; Gonzalez-Solis, Jacob/C-3942-2008; Gonzalez-Solis, Jacob/AAZ-5338-2021; Ramirez, Oscar/E-7293-2012; Illera, Juan Carlos/C-6583-2014; Alcover, Josep Antoni/Y-3796-2018	LALUEZA-FOX, CARLES/0000-0002-1730-5914; Gonzalez-Solis, Jacob/0000-0002-8691-9397; Gonzalez-Solis, Jacob/0000-0002-8691-9397; Ramirez, Oscar/0000-0001-5164-6790; Illera, Juan Carlos/0000-0002-4389-0264; Rando, Juan Carlos/0000-0001-7397-869X; Alcover, Josep Antoni/0000-0001-9905-2588	Spanish Ministry of Education; Ministerio de Ciencia e Innovacion from Spain; Spanish Direccion General de Investigacion Cientifica y Tecnica [CGL2007-62047/BTE, BFU2009-06974]	Spanish Ministry of Education(Spanish Government); Ministerio de Ciencia e Innovacion from Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Direccion General de Investigacion Cientifica y Tecnica(Spanish Government)	J.C.I. was funded by a Ramon y Cajal fellowship (Spanish Ministry of Education). C. L-F. and O.R. were supported by a grant from the Ministerio de Ciencia e Innovacion from Spain. J.A.A. and J.C.R. were partially supported by Spanish Direccion General de Investigacion Cientifica y Tecnica, Research Project CGL2007-62047/BTE. C.L-F. and O.R. were supported by Spanish Direccion General de Investigacion Cientifica y Tecnica, Research Project BFU2009-06974. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson I.A.E., 1985, International Council for Bird Preservation Technical Publication, P35; Austin JJ, 1996, MOL PHYLOGENET EVOL, V6, P77, DOI 10.1006/mpev.1996.0060; Austin JJ, 2004, AUK, V121, P847, DOI 10.1642/0004-8038(2004)121[0847:AGMPOT]2.0.CO;2; AUSTIN JJ, 1994, AUK, V111, P70, DOI 10.2307/4088506; Boyer AG, 2008, DIVERS DISTRIB, V14, P509, DOI 10.1111/j.1472-4642.2007.00459.x; Rando JC, 2010, J ORNITHOL, V151, P365, DOI 10.1007/s10336-009-0463-6; Criado C., 1991, EVOLUCION RELIEVE FU; Duncan RP, 2002, P ROY SOC B-BIOL SCI, V269, P517, DOI 10.1098/rspb.2001.1918; Emerson BC, 2000, EVOLUTION, V54, P911, DOI 10.1111/j.0014-3820.2000.tb00091.x; Friesen VL, 2007, P NATL ACAD SCI USA, V104, P18589, DOI 10.1073/pnas.0700446104; Gaskell J, 2000, WHO KILLED GREAT AUK, P224; Gomez-Diaz E, 2006, MOL PHYLOGENET EVOL, V41, P322, DOI 10.1016/j.ympev.2006.05.006; Heidrich P, 1998, BIOCHEM SYST ECOL, V26, P145, DOI 10.1016/S0305-1978(97)00085-9; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Igual JM, 2007, BIOL CONSERV, V137, P189, DOI 10.1016/j.biocon.2007.02.003; Jesus J, 2009, BIRD CONSERV INT, V19, P199, DOI 10.1017/S0959270909008296; Juste J, 2007, INVESTIGACION PARQUE, P209; Kennedy M, 2002, AUK, V119, P88, DOI 10.1642/0004-8038(2002)119[0088:SSCPEO]2.0.CO;2; Krause J, 2006, NATURE, V439, P724, DOI 10.1038/nature04432; Lalueza-Fox C, 2007, SCIENCE, V318, P1453, DOI 10.1126/science.1147417; Lee K, 1997, PHYLOGENETIC RELATIO; Louzao M, 2006, THESIS U ILLES BALEA; Martin A., 2001, AVES ARCHIPIELAGO CA; McMinn M, 1990, ENDINS, V16, P63; MICHAUX J, 1991, CR ACAD SCI II, V312, P801; Moum T, 2002, MOL BIOL EVOL, V19, P1434, DOI 10.1093/oxfordjournals.molbev.a004206; Nunn GB, 1998, MOL BIOL EVOL, V15, P1360, DOI 10.1093/oxfordjournals.molbev.a025864; Nunn GB, 1996, AUK, V113, P784; OLSON SL, 1982, SCIENCE, V217, P633, DOI 10.1126/science.217.4560.633; Peck DR, 2004, J AVIAN BIOL, V35, P327, DOI 10.1111/j.0908-8857.2004.03303.x; Penhallurick J, 2004, EMU, V104, P125, DOI 10.1071/MU01060; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Quammen David, 1996, P1; Rambaut A, TRACER V1 4; Ramirez O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005670; Rando JC, 2008, IBIS, V150, P188; Rando Juan Carlos, 1994, Archaeofauna, V3, P13; Scofield R. Paul, 2009, P151; Smith AL, 2007, MOL PHYLOGENET EVOL, V43, P755, DOI 10.1016/j.ympev.2007.02.012; Snow DW, 1998, BIRDS W PALEARCTIC, V1, P722; STEADMAN DW, 2006, EXT BIOG TROP PAC, pR9; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tyrberg Tommy, 2009, P63; Walker C.A., 1990, Historical Biology, V3, P203; Warham J., 1990, PETRELS THEIR ECOLOG, DOI [10.1017/S0954102092220514, DOI 10.1017/S0954102092220514]; Worthy TH, 2002, PREHISTORIC LIFE NZ; Zino F, 2008, IBIS, V150, P326, DOI 10.1111/j.1474-919X.2007.00794.x	49	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e16072	10.1371/journal.pone.0016072	http://dx.doi.org/10.1371/journal.pone.0016072			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209838	Green Published, gold, Green Submitted			2022-12-27	WOS:000285838900057
J	Jang, KJ; Kim, MS; Feltrin, D; Jeon, NL; Suh, KY; Pertz, O				Jang, Kyung-Jin; Kim, Min Sung; Feltrin, Daniel; Jeon, Noo Li; Suh, Kahp-Yang; Pertz, Olivier			Two Distinct Filopodia Populations at the Growth Cone Allow to Sense Nanotopographical Extracellular Matrix Cues to Guide Neurite Outgrowth	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; MYOSIN-II; AXONAL OUTGROWTH; TIME-LAPSE; GUIDANCE; ACTIN; DIFFERENTIATION; MECHANISMS; FIBERS; NANOFIBERS	Background: The process of neurite outgrowth is the initial step in producing the neuronal processes that wire the brain. Current models about neurite outgrowth have been derived from classic two-dimensional (2D) cell culture systems, which do not recapitulate the topographical cues that are present in the extracellular matrix (ECM) in vivo. Here, we explore how ECM nanotopography influences neurite outgrowth. Methodology/Principal Findings: We show that, when the ECM protein laminin is presented on a line pattern with nanometric size features, it leads to orientation of neurite outgrowth along the line pattern. This is also coupled with a robust increase in neurite length. The sensing mechanism that allows neurite orientation occurs through a highly stereotypical growth cone behavior involving two filopodia populations. Non-aligned filopodia on the distal part of the growth cone scan the pattern in a lateral back and forth motion and are highly unstable. Filopodia at the growth cone tip align with the line substrate, are stabilized by an F-actin rich cytoskeleton and enable steady neurite extension. This stabilization event most likely occurs by integration of signals emanating from non-aligned and aligned filopodia which sense different extent of adhesion surface on the line pattern. In contrast, on the 2D substrate only unstable filopodia are observed at the growth cone, leading to frequent neurite collapse events and less efficient outgrowth. Conclusions/Significance: We propose that a constant crosstalk between both filopodia populations allows stochastic sensing of nanotopographical ECM cues, leading to oriented and steady neurite outgrowth. Our work provides insight in how neuronal growth cones can sense geometric ECM cues. This has not been accessible previously using routine 2D culture systems.	[Jang, Kyung-Jin; Suh, Kahp-Yang] Seoul Natl Univ, Interdisciplinary Program Nanosci & Technol, Seoul, South Korea; [Kim, Min Sung; Jeon, Noo Li; Suh, Kahp-Yang] Seoul Natl Univ, Sch Mech & Aerosp Engn, Seoul, South Korea; [Feltrin, Daniel; Pertz, Olivier] Univ Basel, Inst Biochem & Genet, Dept Biomed, Basel, Switzerland	Seoul National University (SNU); Seoul National University (SNU); University of Basel	Jang, KJ (corresponding author), Seoul Natl Univ, Interdisciplinary Program Nanosci & Technol, Seoul, South Korea.	sky4u@snu.ac.kr; olivier.pertz@unibas.ch		pertz, olivier/0000-0001-8579-4919	Swiss National Science Foundation [114853]; World Class University [R31-2008-000-10083-0]; Korea Research Foundation [KRF-J03003]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); World Class University; Korea Research Foundation(National Research Foundation of Korea)	This work was supported by a grant from the Swiss National Science Foundation (http://www.snf.ch) to Olivier Pertz (grant 114853). This work was supported in part by a World Class University Program (http://www.mrs.org/s_mrs/doc.asp?CID = 1653&DID = 214385) to Kahp-Yang Suh and Noo Li Jeon (grant R31-2008-000-10083-0) and a Korea Research Foundation Grant (http://hero2.krf.or.kr/KHPapp/eng/maina.jsp) to Kahp-Yang Suh (grant KRF-J03003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Brown J, 2003, J HISTOCHEM CYTOCHEM, V51, P421, DOI 10.1177/002215540305100403; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; CLARK P, 1993, J CELL SCI, V105, P203; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; HARRIS WA, 1987, DEVELOPMENT, V101, P123; Hwang SY, 2010, ANAL CHEM, V82, P3016, DOI 10.1021/ac100107z; Ingber DE, 2006, INT J DEV BIOL, V50, P255, DOI 10.1387/ijdb.052044di; Johansson F, 2006, BIOMATERIALS, V27, P1251, DOI 10.1016/j.biomaterials.2005.07.047; KAETHNER RJ, 1992, J NEUROSCI, V12, P3257, DOI 10.1523/JNEUROSCI.12-08-03257.1992; Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102; Kim DH, 2009, BIOMATERIALS, V30, P5433, DOI 10.1016/j.biomaterials.2009.06.042; Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012; Loudon RR, 2006, J NEUROBIOL, V66, P847, DOI 10.1002/neu.20258; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Mason CA, 1997, J NEUROSCI, V17, P1086; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Mortimer D, 2008, TRENDS NEUROSCI, V31, P90, DOI 10.1016/j.tins.2007.11.008; Ottani V, 2001, MICRON, V32, P251, DOI 10.1016/S0968-4328(00)00042-1; Patel S, 2007, NANO LETT, V7, P2122, DOI 10.1021/nl071182z; Pertz OC, 2008, P NATL ACAD SCI USA, V105, P1931, DOI 10.1073/pnas.0706545105; Reynolds M L, 1993, Curr Opin Neurobiol, V3, P683, DOI 10.1016/0959-4388(93)90139-P; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; SHEETZ MP, 1992, CELL MOTIL CYTOSKEL, V22, P160, DOI 10.1002/cm.970220303; Sniadecki N, 2006, ANN BIOMED ENG, V34, P59, DOI 10.1007/s10439-005-9006-3; Suh KY, 2009, ADV FUNCT MATER, V19, P2699, DOI 10.1002/adfm.200900771; Tsiper MV, 2002, J CELL SCI, V115, P1005; Turney SG, 2005, NAT NEUROSCI, V8, P717, DOI 10.1038/nn1466; Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046; Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051; Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031; Yurchenco PD, 2004, CURR OPIN CELL BIOL, V16, P572, DOI 10.1016/j.ceb.2004.07.013	38	71	71	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15966	10.1371/journal.pone.0015966	http://dx.doi.org/10.1371/journal.pone.0015966			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209862	gold, Green Submitted, Green Published			2022-12-27	WOS:000285793600052
J	Tang, SM; Juusola, M				Tang, Shiming; Juusola, Mikko			Intrinsic Activity in the Fly Brain Gates Visual Information during Behavioral Choices	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; FRUIT-FLY; LOBULA PLATE; BINOCULAR INTERACTION; COROLLARY DISCHARGE; RESPONSE PROPERTIES; FLIGHT ORIENTATION; NEURAL MECHANISMS; FINE-STRUCTURE; YAW TORQUE	The small insect brain is often described as an input/output system that executes reflex-like behaviors. It can also initiate neural activity and behaviors intrinsically, seen as spontaneous behaviors, different arousal states and sleep. However, less is known about how intrinsic activity in neural circuits affects sensory information processing in the insect brain and variability in behavior. Here, by simultaneously monitoring Drosophila's behavioral choices and brain activity in a flight simulator system, we identify intrinsic activity that is associated with the act of selecting between visual stimuli. We recorded neural output (multiunit action potentials and local field potentials) in the left and right optic lobes of a tethered flying Drosophila, while its attempts to follow visual motion (yaw torque) were measured by a torque meter. We show that when facing competing motion stimuli on its left and right, Drosophila typically generate large torque responses that flip from side to side. The delayed onset (0.1-1 s) and spontaneous switch-like dynamics of these responses, and the fact that the flies sometimes oppose the stimuli by flying straight, make this behavior different from the classic steering reflexes. Drosophila, thus, seem to choose one stimulus at a time and attempt to rotate toward its direction. With this behavior, the neural output of the optic lobes alternates; being augmented on the side chosen for body rotation and suppressed on the opposite side, even though the visual input to the fly eyes stays the same. Thus, the flow of information from the fly eyes is gated intrinsically. Such modulation can be noise-induced or intentional; with one possibility being that the fly brain highlights chosen information while ignoring the irrelevant, similar to what we know to occur in higher animals.	[Tang, Shiming; Juusola, Mikko] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Tang, Shiming] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Juusola, Mikko] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	Beijing Normal University; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Sheffield	Tang, SM (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	tangshm@sun5.ibp.ac.cn; m.juusola@sheffield.ac.uk	Juusola, Mikko/E-6948-2011	Juusola, Mikko/0000-0002-4428-5330	NSFC (National Science Foundation of China) [30525016, 90408030, 30810103906]; Chinese Academy of Sciences; Gatsby Foundation; Royal Society; BBSRC [BBF0120711, BBD0019001]; BBSRC [BB/F012071/1, BB/D001900/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F012071/1, BB/D001900/1] Funding Source: researchfish	NSFC (National Science Foundation of China)(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Gatsby Foundation; Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by the NSFC (National Science Foundation of China) Outstanding Young Researcher Award (30525016), the NSFC project (90408030) and the Knowledge Innovation Project of the Chinese Academy of Sciences (S.T.); the NSFC project (30810103906: S.T. & M.J.); the Gatsby Foundation (M.J.), the Royal Society (M.J.) and BBSRC (BBF0120711: M.J. and BBD0019001: M.J. and S.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; Barlow H.B., 1961, SENSORY COMMUNICATIO, V1; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; BLONDEAU J, 1981, J EXP BIOL, V92, P143; Bolzon DM, 2009, J NEUROSCI, V29, P14143, DOI 10.1523/JNEUROSCI.2857-09.2009; Borst A, 2002, J COMP PHYSIOL A, V188, P419, DOI 10.1007/s00359-002-0316-8; Chiappe ME, 2010, CURR BIOL, V20, P1470, DOI 10.1016/j.cub.2010.06.072; Chklovskii DB, 2000, VISION RES, V40, P1765, DOI 10.1016/S0042-6989(00)00023-7; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; EGELHAAF M, 1993, J NEUROSCI, V13, P4563; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; FRANCESCHINI N, 1997, P 25 GOTT NEUR C 199, V2; Frye MA, 2004, CURR OPIN NEUROBIOL, V14, P729, DOI 10.1016/j.conb.2004.10.004; GEIGER G, 1981, NATURE, V293, P398, DOI 10.1038/293398a0; GEIGER G, 1982, BIOL CYBERN, V44, P141, DOI 10.1007/BF00317974; Goodhill GJ, 2007, NEURON, V56, P301, DOI 10.1016/j.neuron.2007.09.027; GOTZ KG, 1964, KYBERNETIK, V2, P77, DOI 10.1007/BF00288561; Haag J, 2004, NAT NEUROSCI, V7, P628, DOI 10.1038/nn1245; Haag J, 1999, J COMPUT NEUROSCI, V7, P213, DOI 10.1023/A:1008950515719; Hardin Paul E, 2003, Novartis Found Symp, V253, P140; HARDIN PE, 2003, NOVART FDN SYMP, V253, P150; HARRIS FJ, 1978, P IEEE, V66, P51, DOI 10.1109/PROC.1978.10837; Hausen K., 1989, P391; HEISENBERG M, 1977, J COMP PHYSIOL, V117, P127, DOI 10.1007/BF00612784; HEISENBERG M, 1978, J COMP PHYSIOL, V124, P287, DOI 10.1007/BF00661379; HEISENBERG M, 1979, J COMP PHYSIOL, V130, P113, DOI 10.1007/BF00611046; HEISENBERG M, 1984, SELECTIVE ATTENTION, P183; HENGSTENBERG R, 1971, BIOL CYBERN, V9, P56; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jefferys JGR, 1996, TRENDS NEUROSCI, V19, P202, DOI 10.1016/S0166-2236(96)10023-0; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Juusola M, 2001, J GEN PHYSIOL, V117, P3, DOI 10.1085/jgp.117.1.3; KARA P, 2009, NATURE; Katsov AY, 2008, NEURON, V59, P322, DOI 10.1016/j.neuron.2008.05.022; Knudsen EI, 2007, ANNU REV NEUROSCI, V30, P57, DOI 10.1146/annurev.neuro.30.051606.094256; Krishnan B, 1999, NATURE, V400, P375, DOI 10.1038/22566; Krishnan B, 2001, NATURE, V411, P313, DOI 10.1038/35077094; LAND MF, 1974, J COMP PHYSIOL, V89, P331, DOI 10.1007/BF00695351; Lebestky T, 2009, NEURON, V64, P522, DOI 10.1016/j.neuron.2009.09.031; LI ZP, 1994, NETWORK-COMP NEURAL, V5, P157, DOI 10.1088/0954-898X/5/2/003; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; LOWNE BT, 1890, ANATOMY PHYSL MORPHO; Maimon G, 2010, NAT NEUROSCI, V13, P393, DOI 10.1038/nn.2492; Maye A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000443; Miller SM, 2000, CURR BIOL, V10, P383, DOI 10.1016/S0960-9822(00)00416-4; Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003; Nordstrom K, 2009, TRENDS NEUROSCI, V32, P383, DOI 10.1016/j.tins.2009.03.004; Osborne LC, 2005, NATURE, V437, P412, DOI 10.1038/nature03961; Otsuna H, 2006, J COMP NEUROL, V497, P928, DOI 10.1002/cne.21015; PATTERSON J, 1973, J EXP BIOL, V58, P565; Pick S, 2005, CURR BIOL, V15, P1473, DOI 10.1016/j.cub.2005.07.022; Poulet JFA, 2007, TRENDS NEUROSCI, V30, P14, DOI 10.1016/j.tins.2006.11.005; Poulet JFA, 2006, SCIENCE, V311, P518, DOI 10.1126/science.1120847; Poulet JFA, 2002, NATURE, V418, P872, DOI 10.1038/nature00919; ROSSEL S, 1983, NATURE, V302, P821, DOI 10.1038/302821a0; Rossel S, 1996, P NATL ACAD SCI USA, V93, P13229, DOI 10.1073/pnas.93.23.13229; Schmidt MF, 2008, PLOS BIOL, V6, P2089, DOI 10.1371/journal.pbio.0060269; Srinivasan MV, 2004, ANNU REV NEUROSCI, V27, P679, DOI 10.1146/annurev.neuro.27.070203.144343; Stavenga DG, 2003, J COMP PHYSIOL A, V189, P189, DOI 10.1007/s00359-003-0390-6; Tammero LF, 2004, J EXP BIOL, V207, P113, DOI 10.1242/jeb.00724; Tammero LF, 2002, J EXP BIOL, V205, P2785; Tammero LF, 2002, J EXP BIOL, V205, P327; Tang SM, 2004, SCIENCE, V305, P1020, DOI 10.1126/science.1099839; Tang SM, 2001, SCIENCE, V294, P1543, DOI 10.1126/science.1058237; Tanoue S, 2004, CURR BIOL, V14, P638, DOI 10.1016/j.cub.2004.04.009; van Swinderen B, 2005, BIOESSAYS, V27, P321, DOI 10.1002/bies.20195; van Swinderen B, 2004, CURR BIOL, V14, P81, DOI 10.1016/j.cub.2003.12.057; van Swinderen B, 2003, NAT NEUROSCI, V6, P579, DOI 10.1038/nn1054; van Swinderen B, 2007, SCIENCE, V315, P1590, DOI 10.1126/science.1137931; van Swinderen B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005989; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wang CZH, 2008, PLOS BIOL, V6, P2154, DOI 10.1371/journal.pbio.0060250; Webb B, 2004, TRENDS NEUROSCI, V27, P278, DOI 10.1016/j.tins.2004.03.004; WOLF R, 1980, J COMP PHYSIOL, V140, P69, DOI 10.1007/BF00613749; Zheng L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004307	81	38	38	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e14455	10.1371/journal.pone.0014455	http://dx.doi.org/10.1371/journal.pone.0014455			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209935	Green Published, Green Accepted, gold			2022-12-27	WOS:000285793600002
J	Noonin, C; Jiravanichpaisal, P; Soderhall, I; Merino, S; Tomas, JM; Soderhall, K				Noonin, Chadanat; Jiravanichpaisal, Pikul; Soderhall, Irene; Merino, Susana; Tomas, Juan M.; Soderhall, Kenneth			Melanization and Pathogenicity in the Insect, Tenebrio molitor, and the Crustacean, Pacifastacus leniusculus, by Aeromonas hydrophila AH-3	PLOS ONE			English	Article							III SECRETION SYSTEM; INDUCED MELANIN SYNTHESIS; CLINICAL ISOLATE; LATERAL FLAGELLA; POLAR FLAGELLUM; CDNA CLONING; LIPOPOLYSACCHARIDE; PHENOLOXIDASE; EXPRESSION; RESISTANCE	Aeromonas hydrophila is the most common Aeromonas species causing infections in human and other animals such as amphibians, reptiles, fish and crustaceans. Pathogenesis of Aeromonas species have been reported to be associated with virulence factors such as lipopolysaccharides (LPS), bacterial toxins, bacterial secretion systems, flagella, and other surface molecules. Several mutant strains of A. hydrophila AH-3 were initially used to study their virulence in two animal species, Pacifastacus leniusculus (crayfish) and Tenebrio molitor larvae (mealworm). The AH-3 strains used in this study have mutations in genes involving the synthesis of flagella, LPS structures, secretion systems, and some other factors, which have been reported to be involved in A. hydrophila pathogenicity. Our study shows that the LPS (O-antigen and external core) is the most determinant A. hydrophila AH-3 virulence factor in both animals. Furthermore, we studied the immune responses of these hosts to infection of virulent or non-virulent strains of A. hydrophila AH-3. The AH-3 wild type (WT) containing the complete LPS core is highly virulent and this bacterium strongly stimulated the prophenoloxidase activating system resulting in melanization in both crayfish and mealworm. In contrast, the Delta waaE mutant which has LPS without O-antigen and external core was non-virulent and lost ability to stimulate this system and melanization in these two animals. The high phenoloxidase activity found in WT infected crayfish appears to result from a low expression of pacifastin, a prophenoloxidase activating enzyme inhibitor, and this gene expression was not changed in the Delta waaE mutant infected animal and consequently phenoloxidase activity was not altered as compared to non-infected animals. Therefore we show that the virulence factors of A. hydrophila are the same regardless whether an insect or a crustacean is infected and the O-antigen and external core is essential for activation of the proPO system and as virulence factors for this bacterium.	[Noonin, Chadanat; Jiravanichpaisal, Pikul; Soderhall, Irene; Soderhall, Kenneth] Uppsala Univ, Dept Comparat Physiol, Uppsala, Sweden; [Jiravanichpaisal, Pikul] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Bangkok, Thailand; [Merino, Susana; Tomas, Juan M.] Univ Barcelona, Dept Microbiol, Fac Biol, Barcelona, Spain	Uppsala University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); University of Barcelona	Noonin, C (corresponding author), Uppsala Univ, Dept Comparat Physiol, Uppsala, Sweden.	kenneth.soderhall@ebc.uu.se	Tomas, Juan M/L-1398-2015; Noonin, Chadanat/AAD-6269-2022; Merino, Susana/D-4342-2014; Soderhall, Irene/AAS-5433-2020	Tomas, Juan M/0000-0002-3575-7113; Merino, Susana/0000-0001-6040-4259; 	Swedish Science Research Council; Swedish Research Council Formas; Swedish Foundation for International Cooperation in Research and Higher Education; Ministerio de Educacion, Ciencia y Deporte and Ministerio de Sanidad, Spain; Generalitat de Catalunya (Centre de Referencia en Biotecnologia)	Swedish Science Research Council; Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish Foundation for International Cooperation in Research and Higher Education; Ministerio de Educacion, Ciencia y Deporte and Ministerio de Sanidad, Spain(Spanish Government); Generalitat de Catalunya (Centre de Referencia en Biotecnologia)(Generalitat de Catalunya)	This work has been supported by the Swedish Science Research Council (K. S.), The Swedish Research Council Formas (K. S.) and The Swedish Foundation for International Cooperation in Research and Higher Education (K. S. and P.J.). Part of this work was supported by Plan Nacional de I+D and FIS grants (Ministerio de Educacion, Ciencia y Deporte and Ministerio de Sanidad, Spain) and from Generalitat de Catalunya (Centre de Referencia en Biotecnologia) to J.M.T.. The funders had no role in study design, data collection and analysis, decision of publish, or preparation of the manuscript.	Akinbowale AL, 2007, INT J ANTIMICROB AG, V30, P177, DOI 10.1016/j.ijantimicag.2007.03.012; Alagappan K.M., 2009, World Journal of Fish and Marine Sciences, V1, P185; ASPAN A, 1995, P NATL ACAD SCI USA, V92, P939, DOI 10.1073/pnas.92.4.939; Austin B., 2012, BACTERIAL FISH PATHO, DOI DOI 10.1007/978-94-007-4884-2; Canals R, 2006, J BACTERIOL, V188, P852, DOI 10.1128/JB.188.3.852-862.2006; Canals R, 2006, J BACTERIOL, V188, P542, DOI 10.1128/JB.188.2.542-555.2006; Daskalov H, 2006, FOOD CONTROL, V17, P474, DOI 10.1016/j.foodcont.2005.02.009; Edberg SC, 2007, CRIT REV MICROBIOL, V33, P89, DOI 10.1080/10408410601172180; Erova TE, 2007, FEMS MICROBIOL LETT, V275, P301, DOI 10.1111/j.1574-6968.2007.00895.x; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Jimenez N, 2008, J BACTERIOL, V190, P4198, DOI 10.1128/JB.00153-08; Jimenez N, 2008, J BACTERIOL, V190, P3176, DOI 10.1128/JB.01874-07; Jiravanichpaisal P, 2007, DEV COMP IMMUNOL, V31, P441, DOI 10.1016/j.dci.2006.08.002; Jiravanichpaisal P, 2009, J INVERTEBR PATHOL, V101, P56, DOI 10.1016/j.jip.2009.02.002; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Kirov SM, 2003, FEMS MICROBIOL LETT, V224, P151, DOI 10.1016/S0378-1097(03)00445-2; Kirov SM, 2002, J BACTERIOL, V184, P547, DOI 10.1128/JB.184.2.547-555.2002; Lee SY, 2000, J BIOL CHEM, V275, P1337, DOI 10.1074/jbc.275.2.1337; Liang ZC, 1997, P NATL ACAD SCI USA, V94, P6682, DOI 10.1073/pnas.94.13.6682; Liu H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706113200; Liu HP, 2006, J VIROL, V80, P10365, DOI 10.1128/JVI.01101-06; MASSAD G, 1991, J GEN MICROBIOL, V137, P237, DOI 10.1099/00221287-137-2-237; Merino S, 1999, INFECT IMMUN, V67, P4008, DOI 10.1128/IAI.67.8.4008-4013.1999; MERINO S, 1991, J GEN MICROBIOL, V137, P1583, DOI 10.1099/00221287-137-7-1583; Merino S, 1995, INT J FOOD MICROBIOL, V28, P157, DOI 10.1016/0168-1605(95)00054-2; MUNN CB, 1982, INFECT IMMUN, V36, P1069, DOI 10.1128/IAI.36.3.1069-1075.1982; Neves JV, 2009, DEV COMP IMMUNOL, V33, P848, DOI 10.1016/j.dci.2009.02.001; Nogueras MM, 2000, INFECT IMMUN, V68, P1849, DOI 10.1128/IAI.68.4.1849-1854.2000; Rabaan AA, 2001, INFECT IMMUN, V69, P4257, DOI 10.1128/IAI.69.7.4257-4267.2001; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rubires X, 1997, J BACTERIOL, V179, P7581, DOI 10.1128/jb.179.23.7581-7586.1997; Sahoo PK, 2008, FISH SHELLFISH IMMUN, V25, P163, DOI 10.1016/j.fsi.2008.04.003; Seshadri R, 2006, J BACTERIOL, V188, P8272, DOI 10.1128/JB.00621-06; Sha J, 2005, INFECT IMMUN, V73, P6446, DOI 10.1128/IAI.73.10.6446-6457.2005; Sha J, 2007, MICROB PATHOGENESIS, V43, P127, DOI 10.1016/j.micpath.2007.05.002; Sierra JC, 2007, MICROB PATHOGENESIS, V43, P147, DOI 10.1016/j.micpath.2007.05.003; Silver AC, 2007, P NATL ACAD SCI USA, V104, P9481, DOI 10.1073/pnas.0700286104; Soderhall I, 2005, J IMMUNOL, V174, P6153, DOI 10.4049/jimmunol.174.10.6153; Soderhall I, 2003, DEV COMP IMMUNOL, V27, P661, DOI 10.1016/S0145-305X(03)00039-9; Stintzi A, 2000, J BIOL INORG CHEM, V5, P57, DOI 10.1007/PL00010655; Suarez G, 2008, MICROB PATHOGENESIS, V44, P344, DOI 10.1016/j.micpath.2007.10.005; van der Marel M, 2008, J FISH DIS, V31, P321, DOI 10.1111/j.1365-2761.2008.00902.x; Vilches S, 2004, APPL ENVIRON MICROB, V70, P6914, DOI 10.1128/AEM.70.11.6914-6919.2004; Vilches S, 2009, APPL ENVIRON MICROB, V75, P6382, DOI 10.1128/AEM.00222-09; Yu HB, 2004, INFECT IMMUN, V72, P1248, DOI 10.1128/IAI.72.3.1248-1256.2004; Zhao MY, 2005, J BIOL CHEM, V280, P24744, DOI 10.1074/jbc.M504173200	46	25	28	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15728	10.1371/journal.pone.0015728	http://dx.doi.org/10.1371/journal.pone.0015728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206752	gold, Green Submitted, Green Published			2022-12-27	WOS:000285793200045
J	Ganapathy, S; Chen, QH; Singh, KP; Shankar, S; Srivastava, RK				Ganapathy, Suthakar; Chen, Qinghe; Singh, Karan P.; Shankar, Sharmila; Srivastava, Rakesh K.			Resveratrol Enhances Antitumor Activity of TRAIL in Prostate Cancer Xenografts through Activation of FOXO Transcription Factor (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							FACTOR-KAPPA-B; CHEMOTHERAPEUTIC DRUGS; MOLECULAR-MECHANISMS; DOWN-REGULATION; CELL-SURVIVAL; IN-VITRO; APOPTOSIS; EXPRESSION; STRESS; LIGAND	Background: Resveratrol (3, 49, 5 tri-hydroxystilbene), a naturally occurring polyphenol, exhibits anti-inflammatory, antioxidant, cardioprotective and antitumor activities. We have recently shown that resveratrol can enhance the apoptosis-inducing potential of TRAIL in prostate cancer cells through multiple mechanisms in vitro. Therefore, the present study was designed to validate whether resveratrol can enhance the apoptosis-inducing potential of TRAIL in a xenograft model of prostate cancer. Methodology/Principal Findings: Resveratrol and TRAIL alone inhibited growth of PC-3 xenografts in nude mice by inhibiting tumor cell proliferation (PCNA and Ki67 staining) and inducing apoptosis (TUNEL staining). The combination of resveratrol and TRAIL was more effective in inhibiting tumor growth than single agent alone. In xenografted tumors, resveratrol upregulated the expressions of TRAIL-R1/DR4, TRAIL-R2/DR5, Bax and p27/(K IP1), and inhibited the expression of Bcl-2 and cyclin D1. Treatment of mice with resveratrol and TRAIL alone inhibited angiogenesis (as demonstrated by reduced number of blood vessels, and VEGF and VEGFR2 positive cells) and markers of metastasis (MMP-2 and MMP-9). The combination of resveratrol with TRAIL further inhibited number of blood vessels in tumors, and circulating endothelial growth factor receptor 2-positive endothelial cells than single agent alone. Furthermore, resveratrol inhibited the cytoplasmic phosphorylation of FKHRL1 resulting in its enhanced activation as demonstrated by increased DNA binding activity. Conclusions/Significance: These data suggest that resveratrol can enhance the apoptosis-inducing potential of TRAIL by activating FKHRL1 and its target genes. The ability of resveratrol to inhibit tumor growth, metastasis and angiogenesis, and enhance the therapeutic potential of TRAIL suggests that resveratrol alone or in combination with TRAIL can be used for the management of prostate cancer.	[Ganapathy, Suthakar] Univ Texas Hlth Sci Ctr San Antonio, Dept Radiat Oncol, Div Radiat Biol, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Chen, Qinghe] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Singh, Karan P.] Univ N Texas, Hlth Sci Ctr Ft Worth, Dept Biostat, Ft Worth, TX USA; [Shankar, Sharmila] Univ Kansas, Med Ctr, Ctr Canc, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Srivastava, Rakesh K.] Univ Kansas, Med Ctr, Ctr Canc, Dept Pharmacol Toxicol & Therapeut & Med, Kansas City, KS 66103 USA	University of Texas System; University of Texas Health San Antonio; Virginia Polytechnic Institute & State University; University of North Texas System; University of North Texas Health Science Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Ganapathy, S (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Radiat Oncol, Div Radiat Biol, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA.	rsrivastava@kumc.edu	Ganapathy, Suthakar/C-1266-2013	Ganapathy, Suthakar/0000-0003-3828-5382				Alex D, 2010, J CELL BIOCHEM, V109, P339, DOI 10.1002/jcb.22405; Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Bakker WJ, 2007, MOL CELL, V28, P941, DOI 10.1016/j.molcel.2007.10.035; Bhardwaj A, 2007, BLOOD, V109, P2293, DOI 10.1182/blood-2006-02-003988; Birkenkamp KU, 2003, J IMMUNOL, V171, P1623, DOI 10.4049/jimmunol.171.4.1623; Brito PM, 2009, ATHEROSCLEROSIS, V205, P126, DOI 10.1016/j.atherosclerosis.2008.11.011; Brosens JJ, 2009, ADV EXP MED BIOL, V665, P227; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burgering B, 2008, ONCOGENE, V27, P2258, DOI 10.1038/onc.2008.29; Calamini B, 2010, BIOCHEM J, V429, P273, DOI 10.1042/BJ20091857; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Chen XF, 2003, CANCER RES, V63, P1059; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Dansen TB, 2008, TRENDS CELL BIOL, V18, P421, DOI 10.1016/j.tcb.2008.07.004; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Fabbrocini G, 2010, EXP DERMATOL; Folkman J, 2003, SEMIN CANCER BIOL, V13, P159, DOI 10.1016/S1044-579X(02)00133-5; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Fukuoka M, 2003, INT J MOL MED, V12, P503; Fulda S, 2010, DRUG DISCOV TODAY, V15, P757, DOI 10.1016/j.drudis.2010.07.005; Hedrick SM, 2009, NAT IMMUNOL, V10, P1057, DOI 10.1038/ni.1784; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jiang Jingting, 2010, Mol Cell Pharmacol, V2, P1, DOI 10.2174/1874467210902010001; Kalantari H, 2010, BIOFACTORS, V36, P401, DOI 10.1002/biof.100; Kim EJ, 2001, INT J ONCOL, V18, P187; Liu XG, 2004, CANCER RES, V64, P5078, DOI 10.1158/0008-5472.CAN-04-1195; Mader I, 2010, FASEB J, V24, P1997, DOI 10.1096/fj.09-142943; Madsen MA, 2006, J BIOL CHEM, V281, P15997, DOI 10.1074/jbc.M601223200; Maiese K, 2009, MED RES REV, V29, P395, DOI 10.1002/med.20139; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Mustafi SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008719; Padayatty SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011414, 10.1371/journal.pone.0015288]; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pal S. K., 2010, EXPERT OPIN INVESTIG; Paul S, 2010, EUR J MED CHEM, V45, P3702, DOI 10.1016/j.ejmech.2010.05.019; Puig O, 2010, ANTIOXID REDOX SIGN; Queen Brannon L, 2010, Curr Aging Sci, V3, P34; Roy Sanjit K, 2010, J Mol Signal, V5, P10, DOI 10.1186/1750-2187-5-10; Shankar S, 2005, INT J MOL MED, V16, P1125; Shankar S, 2004, DRUG RESIST UPDATE, V7, P139, DOI 10.1016/j.drup.2004.03.002; Shankar S, 2004, PROSTATE, V61, P35, DOI 10.1002/pros.20069; Shankar S, 2004, INT J ONCOL, V24, P1133; Shankar S, 2005, PROSTATE, V62, P165, DOI 10.1002/pros.20126; Shankar Sharmila, 2007, J Mol Signal, V2, P7, DOI 10.1186/1750-2187-2-7; Shankar Sharmila, 2007, J Mol Signal, V2, P10, DOI 10.1186/1750-2187-2-10; Shankar S, 2008, FRONT BIOSCI-LANDMRK, V13, P440, DOI 10.2741/2691; Shankar S, 2007, FRONT BIOSCI-LANDMRK, V12, P4839, DOI 10.2741/2432; Shankar S, 2007, MOL CELL BIOCHEM, V304, P273, DOI 10.1007/s11010-007-9510-x; Shankar S, 2007, CARCINOGENESIS, V28, P1277, DOI 10.1093/carcin/bgm024; Shankar S, 2007, INT J ONCOL, V30, P905; Singh TR, 2005, ONCOGENE, V24, P4609, DOI 10.1038/sj.onc.1208585; Singh TR, 2003, CANCER RES, V63, P5390; Slusarz A, 2010, CANCER RES, V70, P3382, DOI 10.1158/0008-5472.CAN-09-3012; Srivastava RK, 2010, MOL CELL BIOCHEM, V337, P201, DOI 10.1007/s11010-009-0300-5; Srivastava RK, 2001, NEOPLASIA, V3, P535, DOI 10.1038/sj.neo.7900203; Szewczuk LM, 2004, J BIOL CHEM, V279, P22727, DOI 10.1074/jbc.M314302200; Urbich C, 2005, FASEB J, V19, P974, DOI 10.1096/fj.04-2727fje; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; van der Vos KE, 2010, ANTIOXID REDOX SIGN; Wang SL, 2004, CANCER RES, V64, P6666, DOI 10.1158/0008-5472.CAN-04-1734; Wang Y, 2010, HUM MOL GENET, V19, P4319, DOI 10.1093/hmg/ddq354; Wu HH, 2010, ONCOGENE, V29, P4330, DOI 10.1038/onc.2010.178; Xie G, 2010, BRIT J PHARMACOL, V159, P689, DOI 10.1111/j.1476-5381.2009.00577.x; Yoshida T, 2004, VITAM HORM, V67, P35; Zykova TA, 2008, MOL CARCINOGEN, V47, P797, DOI 10.1002/mc.20437	71	92	98	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15627	10.1371/journal.pone.0015627	http://dx.doi.org/10.1371/journal.pone.0015627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21209944	Green Published, gold, Green Submitted			2022-12-27	WOS:000285792500033
J	Hong, JA; Hu, YF; Li, CM; Jia, ZC; Xia, B; Jin, CW				Hong, Jiang; Hu, Yunfei; Li, Congmin; Jia, Zongchao; Xia, Bin; Jin, Changwen			NMR Characterizations of the Ice Binding Surface of an Antifreeze Protein	PLOS ONE			English	Article							GROUP HYDROGEN-EXCHANGE; CHEMICAL-SHIFTS; SPRUCE BUDWORM; FREEZING RESISTANCE; TEMPERATURE; DYNAMICS; RELAXATION; WATER; RECOGNITION; POLYPEPTIDE	Antifreeze protein (AFP) has a unique function of reducing solution freezing temperature to protect organisms from ice damage. However, its functional mechanism is not well understood. An intriguing question concerning AFP function is how the high selectivity for ice ligand is achieved in the presence of free water of much higher concentration which likely imposes a large kinetic barrier for protein-ice recognition. In this study, we explore this question by investigating the property of the ice binding surface of an antifreeze protein using NMR spectroscopy. An investigation of the temperature gradient of amide proton chemical shift and its correlation with chemical shift deviation from random coil was performed for CfAFP-501, a hyperactive insect AFP. A good correlation between the two parameters was observed for one of the two Thr rows on the ice binding surface. A significant temperature-dependent protein-solvent interaction is found to be the most probable origin for this correlation, which is consistent with a scenario of hydrophobic hydration on the ice binding surface. In accordance with this finding, rotational correlation time analyses combined with relaxation dispersion measurements reveals a weak dimer formation through ice binding surface at room temperature and a population shift of dimer to monomer at low temperature, suggesting hydrophobic effect involved in dimer formation and hence hydrophobic hydration on the ice binding surface of the protein. Our finding of hydrophobic hydration on the ice binding surface provides a test for existing simulation studies. The occurrence of hydrophobic hydration on the ice binding surface is likely unnecessary for enhancing protein-ice binding affinity which is achieved by a tight H-bonding network. Subsequently, we speculate that the hydrophobic hydration occurring on the ice binding surface plays a role in facilitating protein-ice recognition by lowering the kinetic barrier as suggested by some simulation studies.	[Hong, Jiang; Hu, Yunfei; Li, Congmin; Xia, Bin; Jin, Changwen] Peking Univ, Beijing NMR Ctr, Beijing 100871, Peoples R China; [Hu, Yunfei; Xia, Bin; Jin, Changwen] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Li, Congmin; Xia, Bin; Jin, Changwen] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Jia, Zongchao] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada	Peking University; Peking University; Peking University; Queens University - Canada	Hong, JA (corresponding author), Peking Univ, Beijing NMR Ctr, Beijing 100871, Peoples R China.	changwen@pku.edu.cn		Hong, Jiang/0000-0003-4068-0779	National Natural Science Foundation of China [30325010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant 30325010) to C.J (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen NH, 1997, J AM CHEM SOC, V119, P8547, DOI 10.1021/ja963250h; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079; Chao HM, 1997, BIOCHEMISTRY-US, V36, P14652, DOI 10.1021/bi970817d; CONNELLY GP, 1993, PROTEINS, V17, P87, DOI 10.1002/prot.340170111; Daley ME, 2004, BIOCHEMISTRY-US, V43, P13012, DOI 10.1021/bi0488092; Daley ME, 2004, J BIOMOL NMR, V29, P139, DOI 10.1023/B:JNMR.0000019250.02229.a8; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DEVRIES AL, 1969, SCIENCE, V163, P1073, DOI 10.1126/science.163.3871.1073; Doucet D, 2000, EUR J BIOCHEM, V267, P6082, DOI 10.1046/j.1432-1327.2000.01694.x; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Gauthier SY, 1998, EUR J BIOCHEM, V258, P445, DOI 10.1046/j.1432-1327.1998.2580445.x; Graether SP, 2000, NATURE, V406, P325, DOI 10.1038/35018610; Graether SP, 2003, J MOL BIOL, V327, P1155, DOI 10.1016/S0022-2836(03)00235-3; Haymet ADJ, 1998, FEBS LETT, V430, P301, DOI 10.1016/S0014-5793(98)00652-8; Jia ZC, 2002, TRENDS BIOCHEM SCI, V27, P101, DOI 10.1016/S0968-0004(01)02028-X; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Leinala EK, 2002, J BIOL CHEM, V277, P33349, DOI 10.1074/jbc.M205575200; Li CM, 2005, J BIOMOL NMR, V32, P251, DOI 10.1007/s10858-005-8206-3; Li CM, 2004, J BIOMOL NMR, V30, P101, DOI 10.1023/B:JNMR.0000042949.59771.69; Liou YC, 2000, NATURE, V406, P322, DOI 10.1038/35018604; Loria JP, 1999, J BIOMOL NMR, V15, P151, DOI 10.1023/A:1008355631073; Madura JD, 2000, J MOL RECOGNIT, V13, P101, DOI 10.1002/(SICI)1099-1352(200003/04)13:2<101::AID-JMR493>3.0.CO;2-9; MERUTKA G, 1995, J BIOMOL NMR, V5, P14, DOI 10.1007/BF00227466; Nutt DR, 2008, J AM CHEM SOC, V130, P13066, DOI 10.1021/ja8034027; OHNISHI M, 1969, BIOCHEM BIOPH RES CO, V36, P194, DOI 10.1016/0006-291X(69)90314-3; RAYMOND JA, 1977, P NATL ACAD SCI USA, V74, P2589, DOI 10.1073/pnas.74.6.2589; Smolin N, 2008, J PHYS CHEM B, V112, P6193, DOI 10.1021/jp710546e; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Tjandra N, 1995, J AM CHEM SOC, V117, P12562, DOI 10.1021/ja00155a020; Wierzbicki A, 2007, BIOPHYS J, V93, P1442, DOI 10.1529/biophysj.107.105189; Yang C, 2005, PROTEINS, V59, P266, DOI 10.1002/prot.20429; Yang C, 2004, BIOPHYS CHEM, V109, P137, DOI 10.1016/j.bpc.2003.10.024; Yang ZY, 2003, BIOPHYS J, V85, P2599, DOI 10.1016/S0006-3495(03)74682-7; Yeh Y, 1996, CHEM REV, V96, P601, DOI 10.1021/cr950260c; Zhang W, 1998, J BIOL CHEM, V273, P34806, DOI 10.1074/jbc.273.52.34806	37	6	6	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15682	10.1371/journal.pone.0015682	http://dx.doi.org/10.1371/journal.pone.0015682			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21209943	gold, Green Submitted, Green Published			2022-12-27	WOS:000285792500036
J	Langlois, MJ; Bergeron, S; Bernatchez, G; Boudreau, F; Saucier, C; Perreault, N; Carrier, JC; Rivard, N				Langlois, Marie-Josee; Bergeron, Sebastien; Bernatchez, Gerald; Boudreau, Francois; Saucier, Caroline; Perreault, Nathalie; Carrier, Julie C.; Rivard, Nathalie			The PTEN Phosphatase Controls Intestinal Epithelial Cell Polarity and Barrier Function: Role in Colorectal Cancer Progression	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PTEN; MESENCHYMAL TRANSITION; COLON-CANCER; LIVER METASTASIS; MICROSATELLITE INSTABILITY; ADHERENS-JUNCTION; TIGHT-JUNCTION; GENE-MUTATIONS; KAPPA-B; EXPRESSION	Background: The PTEN phosphatase acts on phosphatidylinositol 3,4,5-triphosphates resulting from phosphatidylinositol 3-kinase (PI3K) activation. PTEN expression has been shown to be decreased in colorectal cancer. Little is known however as to the specific cellular role of PTEN in human intestinal epithelial cells. The aim of this study was to investigate the role of PTEN in human colorectal cancer cells. Methodology/Principal Findings: Caco-2/15, HCT116 and CT26 cells were infected with recombinant lentiviruses expressing a shRNA specifically designed to knock-down PTEN. The impact of PTEN downregulation was analyzed on cell polarization and differentiation, intercellular junction integrity (expression of cell-cell adhesion proteins, barrier function), migration (wound assay), invasion (matrigel-coated transwells) and on tumor and metastasis formation in mice. Electron microscopy analysis showed that lentiviral infection of PTEN shRNA significantly inhibited Caco-2/15 cell polarization, functional differentiation and brush border development. A strong reduction in claudin 1, 3, 4 and 8 was also observed as well as a decrease in transepithelial resistance. Loss of PTEN expression increased the spreading, migration and invasion capacities of colorectal cancer cells in vitro. PTEN downregulation also increased tumor size following subcutaneous injection of colorectal cancer cells in nude mice. Finally, loss of PTEN expression in HCT116 and CT26, but not in Caco-2/15, led to an increase in their metastatic potential following tail-vein injections in mice. Conclusions/Significance: Altogether, these results indicate that PTEN controls cellular polarity, establishment of cell-cell junctions, paracellular permeability, migration and tumorigenic/metastatic potential of human colorectal cancer cells.	[Langlois, Marie-Josee; Bergeron, Sebastien; Boudreau, Francois; Saucier, Caroline; Perreault, Nathalie; Rivard, Nathalie] Univ Sherbrooke, Canadian Inst Hlth Res Team Digest Epithelium, Dept Anat & Biol Cellulaire, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada; [Bernatchez, Gerald; Carrier, Julie C.] Univ Sherbrooke, Canadian Inst Hlth Res Team Digest Epithelium, Dept Med, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke; University of Sherbrooke	Langlois, MJ (corresponding author), Univ Sherbrooke, Canadian Inst Hlth Res Team Digest Epithelium, Dept Anat & Biol Cellulaire, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada.	nathalie.rivard@usherbrooke.ca	Saucier, Caroline/Q-9250-2019	Saucier, Caroline/0000-0001-7678-9886	Canadian Institutes of Health Research (CIHR) [CTP-82942, MT-14405]; Canadian Research Chair in Signaling and Digestive Physiopathology; Canadian Association of Gastroenterology/CIHR/CCFC; FRSQ	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Research Chair in Signaling and Digestive Physiopathology; Canadian Association of Gastroenterology/CIHR/CCFC(Canadian Institutes of Health Research (CIHR)); FRSQ(Fonds de la Recherche en Sante du Quebec)	This research was supported by the Canadian Institutes of Health Research (CIHR: www.cihr-irsc.gc.ca) (CTP-82942) and MT-14405 (to N.R.). N.R. is a recipient of a Canadian Research Chair in Signaling and Digestive Physiopathology. J.C., C.S. and F.B. are scholars from the Fonds de la Recherche en Sante du Quebec. S.B. is a recipient of a post-doctoral fellowship from the Canadian Association of Gastroenterology/CIHR/CCFC. N.R., J.C., C.S., N.P., and F.B. are members of the FRSQ-funded "Centre de Recherche Clinique Etienne LeBel". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, ONCOGENE, V24, P1021, DOI 10.1038/sj.onc.1208296; Boulanger J, 2005, J BIOL CHEM, V280, P18095, DOI 10.1074/jbc.M502184200; Bowen KA, 2009, ANTICANCER RES, V29, P4439; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Calzado MA, 2000, CLIN EXP IMMUNOL, V120, P317, DOI 10.1046/j.1365-2249.2000.01203.x; Colakoglu T, 2008, AM J SURG, V195, P719, DOI 10.1016/j.amjsurg.2007.05.061; Danielsen SA, 2008, HUM MUTAT, V29, pE252, DOI 10.1002/humu.20860; Darsigny M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007609; Dey N, 2008, CANCER RES, V68, P1862, DOI 10.1158/0008-5472.CAN-07-1182; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Gardiol D, 2006, INT J CANCER, V119, P1285, DOI 10.1002/ijc.21982; Garneau H, 2009, J CELL PHYSIOL, V221, P350, DOI 10.1002/jcp.21859; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Haier J, 2002, ONCOGENE, V21, P1450, DOI 10.1038/sj.onc.1205213; Hamada K, 2008, INT J ONCOL, V32, P153; HERMANEK P, 1995, WORLD J SURG, V19, P184, DOI 10.1007/BF00308624; Hu YL, 2007, ARCH BIOCHEM BIOPHYS, V467, P1, DOI 10.1016/j.abb.2007.07.027; Ikenoue T, 2005, CANCER RES, V65, P4562, DOI 10.1158/0008-5472.CAN-04-4114; Ishizu K, 2007, BIOL PHARM BULL, V30, P1779, DOI 10.1248/bpb.30.1779; Jang KS, 2010, HISTOPATHOLOGY, V56, P229, DOI 10.1111/j.1365-2559.2009.03468.x; Jiang YA, 2003, WORLD J GASTROENTERO, V9, P491, DOI 10.3748/wjg.v9.i3.491; Kim S, 2002, GASTROENTEROLOGY, V123, P1163, DOI 10.1053/gast.2002.36043; Kotelevets L, 2004, FASEB J, V18, P115, DOI 10.1096/fj.04-1942fje; Kotelevets L, 2001, J CELL BIOL, V155, P1129, DOI 10.1083/jcb.200105109; Langlois MJ, 2009, FASEB J, V23, P1835, DOI 10.1096/fj.08-123125; Laprise P, 2002, J BIOL CHEM, V277, P8226, DOI 10.1074/jbc.M110235200; Lee MH, 2008, J CELL SCI, V121, P1141, DOI 10.1242/jcs.016634; Lemieux E, 2009, INT J CANCER, V125, P1575, DOI 10.1002/ijc.24485; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; Leslie NR, 2007, CURR BIOL, V17, P115, DOI 10.1016/j.cub.2006.12.026; Li XH, 2009, ONCOL REP, V22, P757, DOI 10.3892/or_00000497; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Marsh V, 2008, NAT GENET, V40, P1436, DOI 10.1038/ng.256; Martin TA, 2009, BBA-BIOMEMBRANES, V1788, P872, DOI 10.1016/j.bbamem.2008.11.005; Martin-Belmonte F, 2007, CELL CYCLE, V6, P1957, DOI 10.4161/cc.6.16.4583; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Menard D, 2006, CELL SIGNALING AND GROWTH FACTORS IN DEVELOPMENT: FROM MOLECULES TO ORGANOGENESIS, P755; Natalwala A, 2008, WORLD J GASTROENTERO, V14, P3792, DOI 10.3748/wjg.14.3792; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; Oikonomou E, 2009, NEOPLASIA, V11, P1116, DOI 10.1593/neo.09514; Pallares J, 2005, MODERN PATHOL, V18, p198A; Pinal N, 2006, CURR BIOL, V16, P140, DOI 10.1016/j.cub.2005.11.068; Raftopoulou M, 2004, SCIENCE, V303, P1179, DOI 10.1126/science.1092089; Rozen S, 2000, Methods Mol Biol, V132, P365; Rychahou PG, 2008, P NATL ACAD SCI USA, V105, P20315, DOI 10.1073/pnas.0810715105; Sakaguchi T, 2002, J BIOL CHEM, V277, P21361, DOI 10.1074/jbc.M110261200; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Satake S, 2008, PATHOL INT, V58, P156, DOI 10.1111/j.1440-1827.2007.02204.x; Satohisa S, 2005, EXP CELL RES, V310, P66, DOI 10.1016/j.yexcr.2005.06.025; Sawai H, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-56; Semba S, 2009, CANCER LETT, V274, P143, DOI 10.1016/j.canlet.2008.09.019; Shao J, 2007, CARCINOGENESIS, V28, P2476, DOI 10.1093/carcin/bgm186; Shin KH, 2001, CANCER LETT, V174, P189, DOI 10.1016/S0304-3835(01)00691-7; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Shulkla S, 2007, INT J CANCER, V121, P1424, DOI 10.1002/ijc.22862; Smakman N, 2005, BBA-REV CANCER, V1756, P103, DOI 10.1016/j.bbcan.2005.07.001; Tamura M, 1999, CANCER RES, V59, P442; Tetreault MP, 2005, EXP CELL RES, V306, P285, DOI 10.1016/j.yexcr.2005.02.019; Thant AA, 2008, ANTICANCER RES, V28, P3579; Tsanou E, 2008, ANTICANCER RES, V28, P3815; VACHON PH, 1992, GASTROENTEROLOGY, V103, P414, DOI 10.1016/0016-5085(92)90829-N; Voisin L, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-337; von Stein W, 2005, DEVELOPMENT, V132, P1675, DOI 10.1242/dev.01720; Wang Z, 2004, BIOCHEM BIOPH RES CO, V322, P609, DOI 10.1016/j.bbrc.2004.07.166; Wang ZJ, 1998, AM J PATHOL, V153, P363, DOI 10.1016/S0002-9440(10)65579-4; Watton SJ, 1999, CURR BIOL, V9, P433, DOI 10.1016/S0960-9822(99)80192-4; Weinstein R S, 1976, Adv Cancer Res, V23, P23, DOI 10.1016/S0065-230X(08)60543-6; Wodarz A, 2007, NAT CELL BIOL, V9, P1016, DOI 10.1038/ncb433; Yamada KM, 2001, J CELL SCI, V114, P2375; Yu W, 2003, MOL BIOL CELL, V14, P748, DOI 10.1091/mbc.E02-06-0350; Zhang BX, 2009, CANCER LETT, V277, P114, DOI 10.1016/j.canlet.2008.11.035; ZHONG W, AM J PHYSL GASTROINT, V299, pG643; Zhou XP, 2002, AM J PATHOL, V161, P439, DOI 10.1016/S0002-9440(10)64200-9; Zweibaum A, 1989, ADAPTATION DEV GASTR, P103	78	58	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15742	10.1371/journal.pone.0015742	http://dx.doi.org/10.1371/journal.pone.0015742			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203412	Green Published, Green Submitted, gold			2022-12-27	WOS:000285579200036
J	Manavalan, B; Basith, S; Choi, YM; Lee, G; Choi, S				Manavalan, Balachandran; Basith, Shaherin; Choi, Yong-Min; Lee, Gwang; Choi, Sangdun			Structure-Function Relationship of Cytoplasmic and Nuclear I kappa B Proteins: An In Silico Analysis	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; ANKYRIN REPEAT; DNA-BINDING; P50 HOMODIMERS; ZETA; BCL-3; SEQUENCE; COMPLEX; SERVER; MEMBER	Cytoplasmic I kappa B proteins are primary regulators that interact with NF-kappa B subunits in the cytoplasm of unstimulated cells. Upon stimulation, these IkB proteins are rapidly degraded, thus allowing NF-kB to translocate into the nucleus and activate the transcription of genes encoding various immune mediators. Subsequent to translocation, nuclear IkB proteins play an important role in the regulation of NF-kB transcriptional activity by acting either as activators or inhibitors. To date, molecular basis for the binding of I kappa B alpha, I kappa B beta and I kappa B zeta along with their partners is known; however, the activation and inhibition mechanism of the remaining I kappa B (I kappa BNS, I kappa Be and Bcl-3) proteins remains elusive. Moreover, even though I kappa B proteins are structurally similar, it is difficult to determine the exact specificities of I kappa B proteins towards their respective binding partners. The three-dimensional structures of I kappa BNS, I kappa B zeta and I kappa B epsilon were modeled. Subsequently, we used an explicit solvent method to perform detailed molecular dynamic simulations of these proteins along with their known crystal structures (I kappa B alpha, I kappa B beta and Bcl-3) in order to investigate the flexibility of the ankyrin repeat domains (ARDs). Furthermore, the refined models of IkBNS, IkBe and Bcl-3 were used for multiple protein-protein docking studies for the identification of I kappa BNS-p50/p50, I kappa B epsilon-p50/p65 and Bcl-3-p50/p50 complexes in order to study the structural basis of their activation and inhibition. The docking experiments revealed that I kappa B epsilon masked the nuclear localization signal (NLS) of the p50/p65 subunits, thereby preventing its translocation into the nucleus. For the Bcl-3-and I kappa BNS-p50/p50 complexes, the results show that Bcl-3 mediated transcription through its transactivation domain (TAD) while I kappa BNS inhibited transcription due to its lack of a TAD, which is consistent with biochemical studies. Additionally, the numbers of identified flexible residues were equal in number among all IkB proteins, although they were not conserved. This could be the primary reason for their binding partner specificities.	[Manavalan, Balachandran; Basith, Shaherin; Choi, Yong-Min; Lee, Gwang; Choi, Sangdun] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Lee, Gwang] Ajou Univ, Inst Med Sci, Sch Med, Suwon 441749, South Korea	Ajou University; Ajou University	Manavalan, B (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea.	sangdunchoi@ajou.ac.kr	Manavalan, Balachandran/Q-8279-2019	Manavalan, Balachandran/0000-0003-0697-9419	Ministry of Education, Science and Technology [2010-0015356]; Korea Food and Drug Administration [10182KFDA992]; NRF of Korea [2009-0093826]; Ajou University	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Food and Drug Administration(Food & Drug Administration (KFDA), Republic of Korea); NRF of Korea; Ajou University	This work was supported by the Basic Science Research Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Education, Science and Technology (2010-0015356). This work was also partly supported by a grant (10182KFDA992) from the Korea Food and Drug Administration, the Priority Research Centers Program through the NRF of Korea (2009-0093826) and the Ajou University Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AK, 2005, J PHARMACEUT BIOMED, V37, P351, DOI 10.1016/j.jpba.2004.10.036; Bundy DL, 1997, J BIOL CHEM, V272, P33132, DOI 10.1074/jbc.272.52.33132; Caamano JH, 1996, MOL CELL BIOL, V16, P1342; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; DA WL, 2002, PYMOL MOL GRAPHICS S; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Forrer P, 2003, FEBS LETT, V539, P2, DOI 10.1016/S0014-5793(03)00177-7; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Hariharan R, 2008, PROTEINS, V71, P1853, DOI 10.1002/prot.21869; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hertlein E, 2005, MOL CELL BIOL, V25, P4956, DOI 10.1128/MCB.25.12.4956-4968.2005; Hirotani T, 2005, J IMMUNOL, V174, P3650, DOI 10.4049/jimmunol.174.6.3650; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Huxford T, 2002, J MOL BIOL, V324, P587, DOI 10.1016/S0022-2836(02)01149-X; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Kuwata H, 2006, IMMUNITY, V24, P41, DOI 10.1016/j.immuni.2005.11.004; Li XC, 2004, P NATL ACAD SCI USA, V101, P2939, DOI 10.1073/pnas.0308691101; Li Z, 1997, MOL CELL BIOL, V17, P6184, DOI 10.1128/MCB.17.10.6184; Main ERG, 2003, CURR OPIN STRUC BIOL, V13, P482, DOI 10.1016/S0959-440X(03)00105-2; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Malek S, 2003, J BIOL CHEM, V278, P23094, DOI 10.1074/jbc.M301022200; Malek S, 1998, J BIOL CHEM, V273, P25427, DOI 10.1074/jbc.273.39.25427; MANAVALAN B, J MOL RECOG IN PRESS; Matsuo S, 2007, BIOCHEM J, V405, P605, DOI 10.1042/BJ20061797; McGuffin LJ, 2008, BIOINFORMATICS, V24, P586, DOI 10.1093/bioinformatics/btn014; Michel F, 2001, EMBO J, V20, P6180, DOI 10.1093/emboj/20.22.6180; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; NOLAN GP, 1993, MOL CELL BIOL, V13, P3557, DOI 10.1128/MCB.13.6.3557; Pawlowski M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-403; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Sue SC, 2009, J MOL BIOL, V388, P824, DOI 10.1016/j.jmb.2009.03.048; Totzke G, 2006, J BIOL CHEM, V281, P12645, DOI 10.1074/jbc.M511956200; Touma M, 2007, J IMMUNOL, V179, P1681, DOI 10.4049/jimmunol.179.3.1681; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Trinh DV, 2008, J MOL BIOL, V379, P122, DOI 10.1016/j.jmb.2008.03.060; Wallner B, 2003, PROTEINS, V53, P534, DOI 10.1002/prot.10536; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wessells J, 2004, J BIOL CHEM, V279, P49995, DOI 10.1074/jbc.M404246200; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Wu ZH, 2009, BIOCHEM BIOPH RES CO, V387, P348, DOI 10.1016/j.bbrc.2009.07.023; Yamamoto Masahiro, 2008, Journal of Infection and Chemotherapy, V14, P265, DOI 10.1007/s10156-008-0619-y; Yamazaki S, 2001, J BIOL CHEM, V276, P27657, DOI 10.1074/jbc.M103426200; Yamazaki S, 2008, J BIOL CHEM, V283, P32404, DOI 10.1074/jbc.M802148200	56	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15782	10.1371/journal.pone.0015782	http://dx.doi.org/10.1371/journal.pone.0015782			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203422	Green Published, gold, Green Submitted			2022-12-27	WOS:000285579200039
J	Donix, M; Petrowski, K; Jurjanz, L; Huebner, T; Herold, U; Baeumler, D; Amanatidis, EC; Poettrich, K; Smolka, MN; Holthoff, VA				Donix, Markus; Petrowski, Katja; Jurjanz, Luisa; Huebner, Thomas; Herold, Ulf; Baeumler, Damaris; Amanatidis, Eva C.; Poettrich, Katrin; Smolka, Michael N.; Holthoff, Vjera A.			Age and the Neural Network of Personal Familiarity	PLOS ONE			English	Article							AUTOBIOGRAPHICAL MEMORY; OLDER-ADULTS; SOCIAL COGNITION; SELF; RECOGNITION; RECOLLECTION; DEACTIVATION; REPRESENTATIONS; SYSTEMS; DEFICIT	Background: Accessing information that defines personally familiar context in real-world situations is essential for the social interactions and the independent functioning of an individual. Personal familiarity is associated with the availability of semantic and episodic information as well as the emotional meaningfulness surrounding a stimulus. These features are known to be associated with neural activity in distinct brain regions across different stimulus conditions (e. g., when perceiving faces, voices, places, objects), which may reflect a shared neural basis. Although perceiving context-rich personal familiarity may appear unchanged in aging on the behavioral level, it has not yet been studied whether this can be supported by neuroimaging data. Methodology/Principal Findings: We used functional magnetic resonance imaging to investigate the neural network associated with personal familiarity during the perception of personally familiar faces and places. Twelve young and twelve elderly cognitively healthy subjects participated in the study. Both age groups showed a similar activation pattern underlying personal familiarity, predominantly in anterior cingulate and posterior cingulate cortices, irrespective of the stimulus type. The young subjects, but not the elderly subjects demonstrated an additional anterior cingulate deactivation when perceiving unfamiliar stimuli. Conclusions/Significance: Although we found evidence for an age-dependent reduction in frontal cortical deactivation, our data show that there is a stimulus-independent neural network associated with personal familiarity of faces and places, which is less susceptible to aging-related changes.	[Donix, Markus; Jurjanz, Luisa; Huebner, Thomas; Baeumler, Damaris; Amanatidis, Eva C.; Poettrich, Katrin; Smolka, Michael N.; Holthoff, Vjera A.] Tech Univ Dresden, Dept Psychiat & Psychotherapy, Univ Clin Carl Gustav Carus, Dresden, Germany; [Donix, Markus; Petrowski, Katja; Herold, Ulf] Tech Univ Dresden, Dept Psychotherapy & Psychosomat Med, Univ Clin Carl Gustav Carus, Dresden, Germany; [Huebner, Thomas; Smolka, Michael N.] Tech Univ Dresden, Dept Psychol, Neuroimaging Ctr, Dresden, Germany; [Donix, Markus; Holthoff, Vjera A.] German Ctr Neurodegenerat Dis, DZNE, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technische Universitat Dresden	Donix, M (corresponding author), Tech Univ Dresden, Dept Psychiat & Psychotherapy, Univ Clin Carl Gustav Carus, Dresden, Germany.	markus.donix@uniklinikum-dresden.de	Smolka, Michael/B-4865-2011	Smolka, Michael/0000-0001-5398-5569; Holthoff, Vjera/0000-0001-7803-1091	Hirnliga e.V.	Hirnliga e.V.	The study was funded by Hirnliga e.V. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Cabeza R, 1997, J NEUROSCI, V17, P391; Clough JS, 2010, SOC NEUROSCI, P1; Conway MA, 2004, SOC COGNITION, V22, P491, DOI 10.1521/soco.22.5.491.50768; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; Donix M, 2010, ARCH CLIN NEUROPSYCH, V25, P383, DOI 10.1093/arclin/acq037; Epstein RA, 2007, J NEUROPHYSIOL, V97, P3670, DOI 10.1152/jn.00003.2007; Fossati P, 2003, AM J PSYCHIAT, V160, P1938, DOI 10.1176/appi.ajp.160.11.1938; Frith CD, 2008, PHILOS T R SOC B, V363, P2033, DOI 10.1098/rstb.2008.0005; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gobbini MI, 2007, NEUROPSYCHOLOGIA, V45, P32, DOI 10.1016/j.neuropsychologia.2006.04.015; Gobbini MI, 2006, BRAIN RES BULL, V71, P76, DOI 10.1016/j.brainresbull.2006.08.003; Gobbini MI, 2004, NEUROIMAGE, V22, P1628, DOI 10.1016/j.neuroimage.2004.03.049; GRADY CL, 1994, J NEUROSCI, V14, P1450, DOI 10.1523/JNEUROSCI.14-03-01450.1994; Grady CL, 2000, CURR OPIN NEUROBIOL, V10, P224, DOI 10.1016/S0959-4388(00)00073-8; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Healey MK, 2008, PROG BRAIN RES, V169, P353, DOI 10.1016/S0079-6123(07)00022-2; Jacoby LL, 1999, J EXP PSYCHOL LEARN, V25, P3, DOI 10.1037/0278-7393.25.1.3; Keightley ML, 2006, PSYCHOL AGING, V21, P558, DOI 10.1037/0882-7974.21.3.558; Kensinger EA, 2009, MEMORY, V17, P208, DOI 10.1080/09658210802221425; Kosaka H, 2003, NEUROIMAGE, V20, P1734, DOI 10.1016/S1053-8119(03)00447-6; Leveroni CL, 2000, J NEUROSCI, V20, P878, DOI 10.1523/JNEUROSCI.20-02-00878.2000; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Maguire EA, 2001, PHILOS T R SOC B, V356, P1441, DOI 10.1098/rstb.2001.0944; Martinelli P, 2009, PSYCHOL NEUROPSYCHIA, V7, P151, DOI 10.1684/pnv.2009.0178; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Miller SL, 2008, P NATL ACAD SCI USA, V105, P2181, DOI 10.1073/pnas.0706818105; Mitchell JP, 2005, J COGNITIVE NEUROSCI, V17, P1306, DOI 10.1162/0898929055002418; Naveh-Benjamin M, 2000, J EXP PSYCHOL LEARN, V26, P1170, DOI 10.1037/0278-7393.26.5.1170; Naveh-Benjamin M, 2007, PSYCHOL AGING, V22, P202, DOI 10.1037/0882-7974.22.1.202; Persson J, 2007, J COGNITIVE NEUROSCI, V19, P1021, DOI 10.1162/jocn.2007.19.6.1021; Piolino P, 2006, PSYCHOL AGING, V21, P510, DOI 10.1037/0882-7974.21.3.510; Piolino P, 2009, NEUROPSYCHOLOGIA, V47, P2314, DOI 10.1016/j.neuropsychologia.2009.01.020; Rhodes MG, 2008, PSYCHOL AGING, V23, P239, DOI 10.1037/0882-7974.23.2.239; Shah NJ, 2001, BRAIN, V124, P804, DOI 10.1093/brain/124.4.804; Sugiura M, 2005, J COGNITIVE NEUROSCI, V17, P183, DOI 10.1162/0898929053124956; SUGIURA M, 2010, J COGN NEUR IN PRESS; Sugiura M, 2009, J COGNITIVE NEUROSCI, V21, P1855, DOI 10.1162/jocn.2008.21150; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Yonelinas AP, 2001, PHILOS T R SOC B, V356, P1363, DOI 10.1098/rstb.2001.0939; Yonelinas AP, 2005, J NEUROSCI, V25, P3002, DOI 10.1523/JNEUROSCI.5295-04.2005; Yovel G, 2004, NEURON, V44, P889, DOI 10.1016/S0896-6273(04)00728-7	44	14	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15790	10.1371/journal.pone.0015790	http://dx.doi.org/10.1371/journal.pone.0015790			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	698FG	21203474	Green Published, gold			2022-12-27	WOS:000285578000053
J	Levkovitz, L; Yosef, N; Gershengorn, MC; Ruppin, E; Sharan, R; Oron, Y				Levkovitz, Liron; Yosef, Nir; Gershengorn, Marvin C.; Ruppin, Eytan; Sharan, Roded; Oron, Yoram			A Novel HMM-Based Method for Detecting Enriched Transcription Factor Binding Sites Reveals RUNX3 as a Potential Target in Pancreatic Cancer Biology	PLOS ONE			English	Article							GENE-EXPRESSION; GROWTH; METASTASIS; INHIBITION; DISCOVERY	Background: Pancreatic adenocarcinoma (PAC) is one of the most intractable malignancies. In order to search for potential new therapeutic targets, we relied on computational methods aimed at identifying transcription factor binding sites (TFBSs) over-represented in the promoter regions of genes differentially expressed in PAC. Though many computational methods have been implemented to accomplish this, none has gained overall acceptance or produced proven novel targets in PAC. To this end we have developed DEMON, a novel method for motif detection. Methodology: DEMON relies on a hidden Markov model to score the appearance of sequence motifs, taking into account all potential sites in a promoter of potentially varying binding affinities. We demonstrate DEMON's accuracy on simulated and real data sets. Applying DEMON to PAC-related data sets identifies the RUNX family as highly enriched in PAC-related genes. Using a novel experimental paradigm to distinguish between normal and PAC cells, we find that RUNX3 mRNA (but not RUNX1 or RUNX2 mRNAs) exhibits time-dependent increases in normal but not in PAC cells. These increases are accompanied by changes in mRNA levels of putative RUNX gene targets. Conclusions: The integrated application of DEMON and a novel differentiation system led to the identification of a single family member, RUNX3, which together with four of its putative targets showed a robust response to a differentiation stimulus in healthy cells, whereas this regulatory mechanism was absent in PAC cells, emphasizing RUNX3 as a promising target for further studies.	[Levkovitz, Liron; Ruppin, Eytan; Oron, Yoram] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Levkovitz, Liron; Yosef, Nir; Ruppin, Eytan; Sharan, Roded] Tel Aviv Univ, Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Gershengorn, Marvin C.] NIDDK, Clin Endocrinol Branch, NIH, Bethesda, MD USA	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Levkovitz, L (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	roded@post.tau.ac.il; medfair@post.tau.ac.il	Ruppin, Eytan/R-9698-2017	Ruppin, Eytan/0000-0002-7862-3940	Era-Net pathogenomics; Israel Cancer Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK011007] Funding Source: NIH RePORTER	Era-Net pathogenomics; Israel Cancer Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an Era-Net pathogenomics grant to ER and RS, and Israel Cancer Association grant to ER, RS and YO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUM LE, 1970, ANN MATH STAT, V41, P164, DOI 10.1214/aoms/1177697196; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brandt R, 2004, PANCREATOLOGY, V4, P587, DOI 10.1159/000082241; Cameron ER, 2004, ONCOGENE, V23, P4308, DOI 10.1038/sj.onc.1207130; Chang LW, 2006, GENOME RES, V16, P405, DOI 10.1101/gr.4303406; Durbin R., 1998, BIOL SEQUENCE ANAL P; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Fujii S, 2008, J BIOL CHEM, V283, P17324, DOI 10.1074/jbc.M800224200; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Hardikar AA, 2003, P NATL ACAD SCI USA, V100, P7117, DOI 10.1073/pnas.1232230100; Hart SM, 2002, HAEMATOLOGICA, V87, P1307; Huang CH, 2007, BIOCHEM PHARMACOL, V73, P990, DOI 10.1016/j.bcp.2006.12.013; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Komori T, 2008, FRONT BIOSCI-LANDMRK, V13, P898, DOI 10.2741/2730; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670; Li J, 2004, J CLIN PATHOL, V57, P294, DOI 10.1136/jcp.2003.013011; Linhart C, 2008, GENOME RES, V18, P1180, DOI 10.1101/gr.076117.108; Naxerova K, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r108; *NCI NIH SEER, NCI NIH SEER STAT FA; Nomoto S, 2008, BRIT J CANCER, V98, P1690, DOI 10.1038/sj.bjc.6604333; OGAWA E, 1993, P NATL ACAD SCI USA, V90, P6859, DOI 10.1073/pnas.90.14.6859; Peng ZH, 2008, INT J ONCOL, V33, P979, DOI 10.3892/ijo_00000085; Peng ZH, 2006, CLIN CANCER RES, V12, P6386, DOI 10.1158/1078-0432.CCR-05-2359; Puig-Kroger A, 2006, J CELL BIOCHEM, V98, P744, DOI 10.1002/jcb.20813; Real FX, 2003, GASTROENTEROLOGY, V124, P1958, DOI 10.1016/S0016-5085(03)00389-5; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Tabach Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000807; Tan SH, 2007, ONCOL REP, V18, P1225; *UCSC, UCSC GEN BROWS DAT; Von Hoff DD, 2005, PANCREATIC CANC; Wada M, 2004, ONCOGENE, V23, P2401, DOI 10.1038/sj.onc.1207395; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Woolf E, 2007, DEV BIOL, V303, P703, DOI 10.1016/j.ydbio.2006.12.005; Zhong JA, 2006, NEURON, V49, P325, DOI 10.1016/j.neuron.2006.01.013	36	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14423	10.1371/journal.pone.0014423	http://dx.doi.org/10.1371/journal.pone.0014423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203558	Green Published, Green Submitted, gold			2022-12-27	WOS:000285578000018
J	Moutsatsou, P; Papoutsi, Z; Kassi, E; Heldring, N; Zhao, CY; Tsiapara, A; Melliou, E; Chrousos, GP; Chinou, I; Karshikoff, A; Nilsson, L; Dahlman-Wright, K				Moutsatsou, Paraskevi; Papoutsi, Zoi; Kassi, Eva; Heldring, Nina; Zhao, Chunyan; Tsiapara, Anna; Melliou, Eleni; Chrousos, George P.; Chinou, Ioanna; Karshikoff, Andrey; Nilsson, Lennart; Dahlman-Wright, Karin			Fatty Acids Derived from Royal Jelly Are Modulators of Estrogen Receptor Functions	PLOS ONE			English	Article							GENE-EXPRESSION; IN-VITRO; ALPHA; MECHANISMS; BINDING; BETA; IDENTIFICATION; PROLIFERATION; SEQUENCE; DYNAMICS	Royal jelly (RJ) excreted by honeybees and used as a nutritional and medicinal agent has estrogen-like effects, yet the compounds mediating these effects remain unidentified. The possible effects of three RJ fatty acids (FAs) (10-hydroxy-2-decenoic-10H2DA, 3,10-dihydroxydecanoic-3,10DDA, sebacic acid-SA) on estrogen signaling was investigated in various cellular systems. In MCF-7 cells, FAs, in absence of estradiol (E-2), modulated the estrogen receptor (ER) recruitment to the pS2 promoter and pS2 mRNA levels via only ER beta but not ER alpha, while in presence of E-2 FAs modulated both ER beta and ER alpha. Moreover, in presence of FAs, the E-2-induced recruitment of the EAB1 co-activator peptide to ER alpha is masked and the E-2-induced estrogen response element (ERE)-mediated transactivation is inhibited. In HeLa cells, in absence of E-2, FAs inhibited the ERE-mediated transactivation by ER beta but not ER alpha, while in presence of E-2, FAs inhibited ERE-activity by both ERb and ER alpha. Molecular modeling revealed favorable binding of FAs to ER alpha at the co-activator-binding site, while binding assays showed that FAs did not bind to the ligand-binding pocket of ER alpha or ER beta. In KS483 osteoblasts, FAs, like E-2, induced mineralization via an ER-dependent way. Our data propose a possible molecular mechanism for the estrogenic activities of RJ's components which, although structurally entirely different from E-2, mediate estrogen signaling, at least in part, by modulating the recruitment of ER alpha, ER beta and co-activators to target genes.	[Moutsatsou, Paraskevi; Papoutsi, Zoi; Kassi, Eva; Tsiapara, Anna] Univ Athens, Sch Med, Dept Biol Chem, GR-11527 Athens, Greece; [Papoutsi, Zoi; Heldring, Nina; Zhao, Chunyan; Karshikoff, Andrey; Nilsson, Lennart; Dahlman-Wright, Karin] Karolinska Inst, Novum, Dept Biosci & Med Nutr, Huddinge, Sweden; [Melliou, Eleni; Chinou, Ioanna] Univ Athens, Fac Pharm, Div Pharmacognosy & Nat Prod, GR-11527 Athens, Greece; [Chrousos, George P.] Univ Athens, Aghia Sophia Childrens Hosp, Sch Med, Dept Pediat 1, GR-11527 Athens, Greece	Athens Medical School; National & Kapodistrian University of Athens; Karolinska Institutet; National & Kapodistrian University of Athens; Athens Medical School; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital	Moutsatsou, P (corresponding author), Univ Athens, Sch Med, Dept Biol Chem, GR-11527 Athens, Greece.	pmoutsatsou@med.uoa.gr	Karshikoff, Andrey D/C-4387-2016; Kassi, Eva N/G-1278-2011; Nilsson, Lennart/B-7208-2009	Kassi, Eva N/0000-0001-7491-2297; Nilsson, Lennart/0000-0002-5067-6397	Greek General Secretariat of Research and Technology; Bodossaki Foundation; Gaea Products SA; Aktina SA; Yiotis SA; Pierre Fabre Hellas; Bee Culturing Co "Attiki" Alex Pittas; Korres SA [EPAN-TP27, PENED-70-3-6340, PAVE-70-3-8966]; Swedish Research Council [08-0573, 621-2006-4470]; Marie Curie Outgoing International Fellowships [MOIF-CT-2006-040428]	Greek General Secretariat of Research and Technology(Greek Ministry of Development-GSRT); Bodossaki Foundation; Gaea Products SA; Aktina SA; Yiotis SA; Pierre Fabre Hellas; Bee Culturing Co "Attiki" Alex Pittas; Korres SA; Swedish Research Council(Swedish Research CouncilEuropean Commission); Marie Curie Outgoing International Fellowships	This research was supported by the Greek General Secretariat of Research and Technology, Bodossaki Foundation, Gaea Products SA, Aktina SA, Yiotis SA, Pierre Fabre Hellas, Bee Culturing Co "Attiki" Alex Pittas, Korres SA (EPAN-TP27, PENED-70-3-6340, PAVE-70-3-8966), the Swedish Research Council (08-0573, 621-2006-4470) and Marie Curie Outgoing International Fellowships (MOIF-CT-2006-040428). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamine R, 2007, J BIOCHEM BIOPH METH, V70, P481, DOI 10.1016/j.jbbm.2006.11.008; Antinelli JF, 2002, J AGR FOOD CHEM, V50, P2227, DOI 10.1021/jf0112466; ATTAWIA MA, 1995, J BIOMED MATER RES, V29, P1233, DOI 10.1002/jbm.820291010; Barkhem T, 1998, MOL PHARMACOL, V54, P105, DOI 10.1124/mol.54.1.105; Berrada M, 2002, INT J RADIAT ONCOL, V54, P1550, DOI 10.1016/S0360-3016(02)03740-9; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Burendahl S, 2009, PROTEINS, V77, P842, DOI 10.1002/prot.22503; Dang ZC, 2002, J BONE MINER RES, V17, P394, DOI 10.1359/jbmr.2002.17.3.394; Davis T, 2000, CLIN CANCER RES, V6, P4334; DEFAZIO A, 1992, J BIOL CHEM, V267, P18008; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; Feller SE, 2002, J AM CHEM SOC, V124, P318, DOI 10.1021/ja0118340; Fiegel J, 2004, J CONTROL RELEASE, V96, P411, DOI 10.1016/j.jconrel.2004.02.018; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; GREENE GL, 1986, SCIENCE, V231, P1150, DOI 10.1126/science.3753802; Heldring N, 2004, MOL CELL BIOL, V24, P3445, DOI 10.1128/MCB.24.8.3445-3459.2004; Henley DV, 2009, ENVIRON HEALTH PERSP, V117, P1702, DOI 10.1289/ehp.0900800; Jansen MS, 2004, P NATL ACAD SCI USA, V101, P7199, DOI 10.1073/pnas.0402014101; Kipper MJ, 2006, J BIOMED MATER RES A, V76A, P798, DOI 10.1002/jbm.a.30545; Kridli RT, 2003, SMALL RUMINANT RES, V49, P25, DOI 10.1016/S0921-4488(03)00057-9; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; LERCKER G, 1981, LIPIDS, V16, P912, DOI 10.1007/BF02534997; Liu Y, 2008, P NATL ACAD SCI USA, V105, P2604, DOI 10.1073/pnas.0712085105; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Malaisse WJ, 2000, BRIT J NUTR, V84, P733; Melliou E, 2005, J AGR FOOD CHEM, V53, P8987, DOI 10.1021/jf051550p; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Mishima S, 2005, J ETHNOPHARMACOL, V101, P215, DOI 10.1016/j.jep.2005.04.012; Mueller SO, 2002, J CHROMATOGR B, V777, P155, DOI 10.1016/S1570-0232(02)00282-9; Narita Y, 2006, BIOSCI BIOTECH BIOCH, V70, P2508, DOI 10.1271/bbb.60240; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Omoto Y, 2001, BIOCHEM BIOPH RES CO, V285, P340, DOI 10.1006/bbrc.2001.5158; Papoutsi Z, 2006, J STEROID BIOCHEM, V98, P63, DOI 10.1016/j.jsbmb.2005.07.005; Papoutsi Z, 2009, J MOL ENDOCRINOL, V43, P65, DOI 10.1677/JME-08-0177; Prossnitz ER, 2009, MOL CELL ENDOCRINOL, V308, P32, DOI 10.1016/j.mce.2009.03.026; Reid G, 2005, ONCOGENE, V24, P4894, DOI 10.1038/sj.onc.1208662; Stauffer SR, 2000, J MED CHEM, V43, P4934, DOI 10.1021/jm000170m; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; Suzuki KM, 2008, EVID-BASED COMPL ALT, V5, P295, DOI 10.1093/ecam/nem036; Thurmond DC, 1998, J BIOL CHEM, V273, P15373, DOI 10.1074/jbc.273.25.15373; TOWNSEND GF, 1959, NATURE, V183, P1270, DOI 10.1038/1831270a0; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Vivar OI, 2010, ENDOCRINOLOGY, V151, P1662, DOI 10.1210/en.2009-1028; Warnmark A, 2002, J BIOL CHEM, V277, P21862, DOI 10.1074/jbc.M200764200; Yamashita T, 1996, BONE, V19, P429, DOI 10.1016/S8756-3282(96)00255-4; Zhao CY, 2007, CANCER RES, V67, P3955, DOI 10.1158/0008-5472.CAN-06-3505; Zhou JH, 2007, J AOAC INT, V90, P244	50	51	55	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15594	10.1371/journal.pone.0015594	http://dx.doi.org/10.1371/journal.pone.0015594			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203528	Green Published, Green Submitted, gold			2022-12-27	WOS:000285578000037
J	Teferedegne, B; Murata, H; Quinones, M; Peden, K; Lewis, AM				Teferedegne, Belete; Murata, Haruhiko; Quinones, Mariam; Peden, Keith; Lewis, Andrew M., Jr.			Patterns of microRNA Expression in Non-Human Primate Cells Correlate with Neoplastic Development In Vitro	PLOS ONE			English	Article							DOWN-REGULATION; BREAST-CANCER; TUMOR INVASION; NKG2D; TRANSFORMATION; PROGRESSION; SIGNATURE; REVEALS; GENE; PROLIFERATION	MicroRNAs (miRNAs) are small noncoding RNAs that negatively regulate gene expression post-transcriptionally. They play a critical role in developmental and physiological processes and have been implicated in the pathogenesis of several diseases including cancer. To identify miRNA signatures associated with different stages of neoplastic development, we examined the expression profile of 776 primate miRNAs in VERO cells (a neoplastically transformed cell line being used for the manufacture of viral vaccines), progenitor primary African green monkey kidney (pAGMK) cells, and VERO cell derivatives: spontaneously immortalized, non-tumorigenic, low-passage VERO cells (10-87 LP); tumorigenic, high-passage VERO cells (10-87 HP); and a cell line (10-87 T) derived from a 10-87 HP cell tumor xenograft in athymic nude mice. When compared with pAGMK cells, the majority of miRNAs were expressed at lower levels in 10-87 LP, 10-87 HP, and 10-87 T cells. We identified 10 up-regulated miRNAs whose level of expression correlated with VERO cell evolution from a non-tumorigenic phenotype to a tumorigenic phenotype. The overexpression of miR-376a and the polycistronic cluster of miR-376a, miR-376b and miR-376c conferred phenotypic changes to the non-tumorigenic 10-87 LP cells that mimic the tumorigenic 10-87 HP cells. Thirty percent of miRNAs that were components of the identified miRNAs in our spontaneously transformed AGMK cell model are also dysregulated in a variety of human tumors. These results may prove to be relevant to the biology of neoplastic development. In addition, one or more of these miRNAs could be biomarkers for the expression of a tumorigenic phenotype.	[Teferedegne, Belete; Murata, Haruhiko; Lewis, Andrew M., Jr.] US FDA, Lab DNA Viruses, Div Viral Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA; [Peden, Keith] US FDA, Lab Retrovirus Res, Div Viral Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA; [Quinones, Mariam] NIH, Bioinformat & Computat Biosci Branch, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA	Teferedegne, B (corresponding author), US FDA, Lab DNA Viruses, Div Viral Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	andrew.lewis@fda.hhs.gov		Quinones, Mariam/0000-0002-8520-5114	Division of Microbiology and Infectious Diseases (DMID); National Institute of Allergy and Infectious Diseases (NIAID) through Biologics Evaluation and Research (CBER); Food and Drug Administration (FDA)	Division of Microbiology and Infectious Diseases (DMID); National Institute of Allergy and Infectious Diseases (NIAID) through Biologics Evaluation and Research (CBER)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Food and Drug Administration (FDA)(United States Department of Health & Human Services)	This work is partially supported by a contract from the Division of Microbiology and Infectious Diseases (DMID), National Institute of Allergy and Infectious Diseases (NIAID) through an interagency agreement with Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brueckner B, 2007, CANCER RES, V67, P1419, DOI 10.1158/0008-5472.CAN-06-4074; Calin GA, 2006, ONCOGENE, V25, P6202, DOI 10.1038/sj.onc.1209910; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chow TFF, 2010, CLIN BIOCHEM, V43, P150, DOI 10.1016/j.clinbiochem.2009.07.020; Cowland JB, 2007, APMIS, V115, P1090, DOI 10.1111/j.1600-0463.2007.apm_775.xml.x; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; Dalmay T, 2008, J INTERN MED, V263, P366, DOI 10.1111/j.1365-2796.2008.01926.x; Dalmay T, 2006, ONCOGENE, V25, P6170, DOI 10.1038/sj.onc.1209911; DAVIS JM, 2002, BASIC CELL CULTURE P; Deng S, 2008, CELL CYCLE, V7, P2643, DOI 10.4161/cc.7.17.6597; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Furesz J, 1989, Dev Biol Stand, V70, P233; Gao CF, 2005, P NATL ACAD SCI USA, V102, P10528, DOI 10.1073/pnas.0504367102; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Gonzalez S, 2006, CURR TOP MICROBIOL, V298, P121; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hayakawa Y, 2006, SEMIN IMMUNOL, V18, P176, DOI 10.1016/j.smim.2006.03.005; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Heneghan HM, 2010, J ONCOL, V2010, DOI 10.1155/2010/950201; Hooth MJ, 1998, AM J PATHOL, V153, P1913, DOI 10.1016/S0002-9440(10)65705-7; HOPPS HE, 1963, J IMMUNOL, V91, P416; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Huang Y, 2009, EJSO-EUR J SURG ONC, V35, P1119, DOI 10.1016/j.ejso.2009.04.010; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; JENSEN FC, 1964, P NATL ACAD SCI USA, V52, P53, DOI 10.1073/pnas.52.1.53; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; LEVENBOOK IS, 1984, J BIOL STAND, V12, P391, DOI 10.1016/S0092-1157(84)80063-3; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Manohar M, 2008, BIOLOGICALS, V36, P65, DOI 10.1016/j.biologicals.2007.06.002; Meng F, 2008, ONCOGENE, V27, P378, DOI 10.1038/sj.onc.1210648; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mueller DW, 2009, J INVEST DERMATOL, V129, P1740, DOI 10.1038/jid.2008.452; Nachmani D, 2010, NAT IMMUNOL, V11, P806, DOI 10.1038/ni.1916; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Olson P, 2009, GENE DEV, V23, P2152, DOI 10.1101/gad.1820109; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Rubin H, 2005, P NATL ACAD SCI USA, V102, P9276, DOI 10.1073/pnas.0503688102; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Slaby O, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-90; Stern-Ginossar N, 2008, NAT IMMUNOL, V9, P1065, DOI 10.1038/ni.1642; Stern-Ginossar N, 2009, IMMUNOLOGY, V128, P1, DOI 10.1111/j.1365-2567.2009.03147.x; Sun YQ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh186; SWANSON SK, 1988, J BIOL STAND, V16, P311, DOI 10.1016/0092-1157(88)90019-4; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tsutsui T, 1997, MOL CARCINOGEN, V18, P7, DOI 10.1002/(SICI)1098-2744(199701)18:1<7::AID-MC2>3.0.CO;2-F; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Weber B, 2007, CELL CYCLE, V6, P1001, DOI 10.4161/cc.6.9.4209; Wu XY, 2006, CANCER RES, V66, P9527, DOI 10.1158/0008-5472.CAN-05-4470; Wylie AA, 2000, GENOME RES, V10, P1711, DOI 10.1101/gr.161600; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yasumura Y., 1963, NIHON RINSHO, V21, P1201; Yi ZJ, 2010, J CANCER RES CLIN, V136, P855, DOI 10.1007/s00432-009-0726-x; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zhao JJ, 2009, CHILD NERV SYST, V25, P13, DOI 10.1007/s00381-008-0701-x	78	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14416	10.1371/journal.pone.0014416	http://dx.doi.org/10.1371/journal.pone.0014416			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203544	Green Published, gold, Green Submitted			2022-12-27	WOS:000285578000017
J	Veenma, D; Beurskens, N; Douben, H; Eussen, B; Noomen, P; Govaerts, L; Grijseels, E; Lequin, M; de Krijger, R; Tibboel, D; de Klein, A; Van Opstal, D				Veenma, Danielle; Beurskens, Niels; Douben, Hannie; Eussen, Bert; Noomen, Petra; Govaerts, Lutgarde; Grijseels, Els; Lequin, Maarten; de Krijger, Ronald; Tibboel, Dick; de Klein, Annelies; Van Opstal, Dian			Comparable Low-Level Mosaicism in Affected and Non Affected Tissue of a Complex CDH Patient	PLOS ONE			English	Article							CONGENITAL DIAPHRAGMATIC-HERNIA; COPY-NUMBER-VARIATION; DEPENDENT PROBE AMPLIFICATION; PRENATAL-DIAGNOSIS; CHROMOSOMAL MOSAICISM; SOMATIC MOSAICISM; ARRAY-CGH; HYBRIDIZATION; FETUSES; GENOME	In this paper we present the detailed clinical and cytogenetic analysis of a prenatally detected complex Congenital Diaphragmatic Hernia (CDH) patient with a mosaic unbalanced translocation (5; 12). High-resolution whole genome SNP array confirmed a low-level mosaicism (20%) in uncultured cells, underlining the value of array technology for identification studies. Subsequently, targeted Fluorescence In-Situ Hybridization in postmortem collected tissues demonstrated a similar low-level mosaicism, independently of the affected status of the tissue. Thus, a higher incidence of the genetic aberration in affected organs as lung and diaphragm cannot explain the severe phenotype of this complex CDH patient. Comparison with other described chromosome 5p and 12p anomalies indicated that half of the features presented in our patient (including the diaphragm defect) could be attributed to both chromosomal areas. In contrast, a few features such as the palpebral downslant, the broad nasal bridge, the micrognathia, microcephaly, abnormal dermatoglyphics and IUGR better fitted the 5p associated syndromes only. This study underlines the fact that low-level mosaicism can be associated with severe birth defects including CDH. The contribution of mosaicism to human diseases and specifically to congenital anomalies and spontaneous abortions becomes more and more accepted, although its phenotypic consequences are poorly described phenomena leading to counseling issues. Therefore, thorough follow-up of mosaic aberrations such as presented here is indicated in order to provide genetic counselors a more evidence based prediction of fetal prognosis in the future.	[Veenma, Danielle; Beurskens, Niels; Tibboel, Dick] Erasmus MC Sophia, Dept Pediat Surg, Rotterdam, Netherlands; [Veenma, Danielle; Douben, Hannie; Eussen, Bert; Noomen, Petra; Govaerts, Lutgarde; de Klein, Annelies; Van Opstal, Dian] Erasmus MC Sophia, Dept Clin Genet, Rotterdam, Netherlands; [Grijseels, Els] Erasmus MC Sophia, Dept Obstet & Gynaecol, Rotterdam, Netherlands; [Lequin, Maarten] Erasmus MC Sophia, Dept Radiol, Rotterdam, Netherlands; [de Krijger, Ronald] Erasmus MC Sophia, Dept Pathol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Veenma, D (corresponding author), Erasmus MC Sophia, Dept Pediat Surg, Rotterdam, Netherlands.	d.veenma@erasmusmc.nl			Sophia's Children's Hospital Foundation for Medical Research, Rotterdam, The Netherlands	Sophia's Children's Hospital Foundation for Medical Research, Rotterdam, The Netherlands(Netherlands Government)	This research was funded by the Sophia's Children's Hospital Foundation for Medical Research, Rotterdam, The Netherlands (SSWO project 551, http://www.vriendensophia.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HY, 2005, J KOREAN MED SCI, V20, P895, DOI 10.3346/jkms.2005.20.5.895; Balliff BC, 2006, AM J MED GENET A, V140A, P2757, DOI 10.1002/ajmg.a.31539; Bergman Y, 1999, SEMIN IMMUNOL, V11, P319, DOI 10.1006/smim.1999.0188; BERGOFFEN J, 1993, J PEDIATR-US, V122, P603, DOI 10.1016/S0022-3476(05)83546-2; Bruder CEG, 2008, AM J HUM GENET, V82, P763, DOI 10.1016/j.ajhg.2007.12.011; Chen CP, 2004, PRENATAL DIAG, V24, P63, DOI 10.1002/pd.796; Cheung SW, 2007, AM J MED GENET A, V143A, P1679, DOI 10.1002/ajmg.a.31740; Conlin LK, 2010, HUM MOL GENET, V19, P1263, DOI 10.1093/hmg/ddq003; DONNENFELD AE, 1993, AM J OBSTET GYNECOL, V169, P1017, DOI 10.1016/0002-9378(93)90046-L; Erickson R, 2010, MUTATION RE IN PRESS; Garne E, 2005, ULTRASOUND OBST GYN, V25, P6, DOI 10.1002/uog.1784; Holder AM, 2007, AM J HUM GENET, V80, P825, DOI 10.1086/513442; Hulinsky R, 2005, AM J MED GENET A, V137A, P336, DOI 10.1002/ajmg.a.30856; Iourov IY, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-26; Iwarsson E, 1999, HUM GENET, V104, P376, DOI 10.1007/s004390050971; Jani J, 2007, ULTRASOUND OBST GYN, V30, P72, DOI 10.1002/uog.4051; Klaassens M, 2009, EUR J MED GENET, V52, P281, DOI 10.1016/j.ejmg.2009.05.005; Kondoh T, 2005, J HUM GENET, V50, P26, DOI 10.1007/s10038-004-0213-9; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Kunz J, 2009, ARCH GYNECOL OBSTET, V280, P1049, DOI 10.1007/s00404-009-1059-3; Laffaire J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-138; Lestou VS, 2000, AM J MED GENET, V92, P281, DOI 10.1002/(SICI)1096-8628(20000605)92:4<281::AID-AJMG12>3.0.CO;2-S; LGSM Shaffer, 2009, ISCN 2009 INT SYSTEM, DOI DOI 10.1007/S00439-009-0726-6; Li CM, 2010, AM J MED GENET A, V152A, P2339, DOI 10.1002/ajmg.a.33588; Mainardi PC, 2001, J MED GENET, V38, P151, DOI 10.1136/jmg.38.3.151; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Notini AJ, 2008, CYTOGENET GENOME RES, V123, P270, DOI 10.1159/000184717; Nowaczyk MJM, 1998, AM J MED GENET, V77, P306, DOI 10.1002/(SICI)1096-8628(19980526)77:4<306::AID-AJMG11>3.0.CO;2-M; Piotrowski A, 2008, HUM MUTAT, V29, P1118, DOI 10.1002/humu.20815; Reymond A, 2002, NATURE, V420, P582, DOI 10.1038/nature01178; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Scott DA, 2007, HUM MOL GENET, V16, P424, DOI 10.1093/hmg/ddl475; Segel R, 2006, AM J MED GENET A, V140A, P695, DOI 10.1002/ajmg.a.31143; Takahashi H, 2010, OBSTET GYNECOL INT, V2010, DOI 10.1155/2010/379534; Valduga M, 2010, PRENATAL DIAG, V30, P333, DOI 10.1002/pd.2460; Van Opstal D, 2001, PRENATAL DIAG, V21, P75, DOI 10.1002/1097-0223(200102)21:2<75::AID-PD990>3.0.CO;2-B; Van Opstal D, 2009, EUR J HUM GENET, V17, P112, DOI 10.1038/ejhg.2008.161; VANDEKKEN H, 1990, CYTOGENET CELL GENET, V54, P103, DOI 10.1159/000132971; VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503; Vorsanova S. G., 2005, Klinicheskaya Laboratornaya Diagnostika, P30; Wells D, 2000, MOL HUM REPROD, V6, P1055, DOI 10.1093/molehr/6.11.1055; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Youssoufian H, 2002, NAT REV GENET, V3, P748, DOI 10.1038/nrg906; Yurov YB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000558; Zhang YX, 2009, CLIN GENET, V75, P133, DOI 10.1111/j.1399-0004.2008.01131.x; Zumkeller W, 2004, AM J MED GENET A, V129A, P261, DOI 10.1002/ajmg.a.30125	46	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15348	10.1371/journal.pone.0015348	http://dx.doi.org/10.1371/journal.pone.0015348			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203572	Green Published, Green Submitted, gold			2022-12-27	WOS:000285576900030
J	Torner, N; Carnicer-Pont, D; Castilla, J; Cayla, J; Godoy, P; Dominguez, A				Torner, Nuria; Carnicer-Pont, Dolors; Castilla, Jesus; Cayla, Joan; Godoy, Pere; Dominguez, Angela		Epidemiol Surveillance Working Grp	Auditing the Management of Vaccine-Preventable Disease Outbreaks: The Need for a Tool	PLOS ONE			English	Article							QUALITY-OF-CARE; PUBLIC-HEALTH; SYSTEM; INTERVENTION; PRESCRIPTION; SURVEILLANCE; PERFORMANCE; RECORD	Public health activities, especially infectious disease control, depend on effective teamwork. We present the results of a pilot audit questionnaire aimed at assessing the quality of public health services in the management of VPD outbreaks. Audit questionnaire with three main areas indicators (structure, process and results) was developed. Guidelines were set and each indicator was assessed by three auditors. Differences in indicator scores according to median size of outbreaks were determined by ANOVA (significance at p <= 0.05). Of 154 outbreaks; eighteen indicators had a satisfactory mean score, indicator "updated guidelines'' and "timely reporting'' had a poor mean score (2.84 +/- 1.06 and 2.44 +/- 1.67, respectively). Statistically significant differences were found according to outbreak size, in the indicators "availability of guidelines/ protocol updated less than 3 years ago'' (p = 0.03) and "days needed for outbreak control'' (p = 0.04). Improving availability of updated guidelines, enhancing timely reporting and adequate recording of control procedures taken is needed to allow for management assessment and improvement.	[Torner, Nuria; Castilla, Jesus; Cayla, Joan; Godoy, Pere; Dominguez, Angela] Gen Catalonia, Dept Hlth, Barcelona, Spain; [Torner, Nuria; Carnicer-Pont, Dolors; Godoy, Pere] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Carnicer-Pont, Dolors; Cayla, Joan] Publ Hlth Agcy Barcelona, Barcelona, Spain; [Castilla, Jesus] Publ Hlth Inst Navarre, Pamplona, Spain; [Dominguez, Angela] Univ Barcelona, Dept Publ Hlth, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Public Health Agency of Barcelona; Public Health Institute of Navarra; University of Barcelona	Torner, N (corresponding author), Gen Catalonia, Dept Hlth, Barcelona, Spain.	nuria.torner@gencat.cat	Castilla, Jesus/B-9048-2008; Etxeberria, Jaione/J-7199-2017; Godoy, Pere/A-7662-2010; , Nuria/AAG-8951-2019; Guevara, Marcela/B-4473-2015	Castilla, Jesus/0000-0002-6396-7265; Godoy, Pere/0000-0002-2896-7286; , Nuria/0000-0003-0143-5295; Guevara, Marcela/0000-0001-9242-6364; Cayla, Joan A./0000-0003-3891-111X; Barrabeig, Irene/0000-0003-4789-7620	CIBER Epidemiologia y Salud Publica (CIBERESP) Institute of Health Carlos III, Madrid, Spain	CIBER Epidemiologia y Salud Publica (CIBERESP) Institute of Health Carlos III, Madrid, Spain(Instituto de Salud Carlos III)	This work was partially funded by CIBER Epidemiologia y Salud Publica (CIBERESP) Institute of Health Carlos III, Madrid, Spain. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auplish S, 1997, J Eval Clin Pract, V3, P77, DOI 10.1111/j.1365-2753.1997.tb00070.x; BAKER EL, 1994, JAMA-J AM MED ASSOC, V272, P1276, DOI 10.1001/jama.272.16.1276; Bjorvell C, 2000, QUAL HEALTH CARE, V9, P6, DOI 10.1136/qhc.9.1.6; Christakis NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012948; Derose SF, 2003, AM J PREV MED, V25, P347, DOI 10.1016/S0749-3797(03)00208-3; Derose SF, 2003, ANNU REV PUBL HEALTH, V24, P363, DOI 10.1146/annurev.publhealth.24.100901.140847; Derose SF, 2002, ANNU REV PUBL HEALTH, V23, P1, DOI 10.1146/annurev.publhealth.23.092601.095644; Donabedian A., 1980, EXPLORATIONS QUALITY; *FAC PUBL HLTH, 2008, GOOD PUBL HLTH PRACT; GAIR R, 1992, J PUBLIC HEALTH MED, V14, P169; HARTLEY LA, 2002, NURS ECON, V20, P248; Hartley Lou Ann, 2002, Nurs Econ, V20, P235; Jayawardena Suriya, 2007, Am J Ther, V14, P336, DOI 10.1097/01.mjt.0000209681.22077.b9; Johnston N H, 1992, Qual Health Care, V1, P225, DOI 10.1136/qshc.1.4.225; Keyhani S, 2008, MED CARE, V46, P1267, DOI 10.1097/MLR.0b013e31817e18ae; Kipping RR, 2006, J PUBLIC HEALTH, V28, P347, DOI 10.1093/pubmed/fdl065; Krause G, 2008, EURO SURVEILL, V13; Krause G, 2008, EMBO REP, V9, pS22, DOI 10.1038/embor.2008.76; Krause G, 2007, EMERG INFECT DIS, V13, P1548, DOI 10.3201/eid1310.070253; Lester WT, 2006, J GEN INTERN MED, V21, P22, DOI 10.1111/j.1525-1497.2005.00268.x; Lowe G, 2000, J PUBLIC HEALTH MED, V22, P129, DOI 10.1093/pubmed/22.2.129; NAZARETH B, 2007, AUDIT OUTBREAK MANAG; Scutchfield FD, 2009, AM J PREV MED, V36, P266, DOI 10.1016/j.amepre.2008.11.007; SMITH R, 1992, BRIT MED J, V305, P905, DOI 10.1136/bmj.305.6859.905; Straetemans M, 2008, EMERG INFECT DIS, V14, P1610, DOI 10.3201/eid1410.071354; Trepka MJ, 2009, EPIDEMIOL INFECT, V137, P22, DOI 10.1017/S0950268808000721; Vaux S, 2009, EUR J EPIDEMIOL, V24, P149, DOI 10.1007/s10654-009-9315-1; Vogt TM, 2004, HEALTH SERV RES, V39, P511, DOI 10.1111/j.1475-6773.2004.00242.x	28	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e15699	10.1371/journal.pone.0015699	http://dx.doi.org/10.1371/journal.pone.0015699			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710ME	21249188	gold, Green Published, Green Submitted			2022-12-27	WOS:000286515000006
J	Hallbook, H; Felth, J; Eriksson, A; Fryknas, M; Bohlin, L; Larsson, R; Gullbo, J				Hallbook, Helene; Felth, Jenny; Eriksson, Anna; Fryknas, Marten; Bohlin, Lars; Larsson, Rolf; Gullbo, Joachim			Ex Vivo Activity of Cardiac Glycosides in Acute Leukaemia	PLOS ONE			English	Article							MICROCULTURE CYTOTOXICITY ASSAY; ACUTE LYMPHOBLASTIC-LEUKEMIA; HUMAN TUMOR-CELLS; BREAST-CANCER; NA+/K+-ATPASE; DIGITALIS; APOPTOSIS; EXPRESSION; DIGITOXIN; BUFALIN	Background: Despite years of interest in the anti-cancerous effects of cardiac glycosides (CGs), and numerous studies in vitro and in animals, it has not yet been possible to utilize this potential clinically. Reports have demonstrated promising in vitro effects on different targets as well as a possible therapeutic index/selectivity in vitro and in experimental animals. Recently, however, general inhibition of protein synthesis was suggested as the main mechanism of the anti-cancerous effects of CGs. In addition, evidence of species differences of a magnitude sufficient to explain the results of many studies called for reconsideration of earlier results. Principal Findings: In this report we identified primary B-precursor and T-ALL cells as being particularly susceptible to the cytotoxic effects of CGs. Digitoxin appeared most potent and IC50 values for several patient samples were at concentrations that may be achieved in the clinic. Significant protein synthesis inhibition at concentrations corresponding to IC50 was demonstrated in colorectal tumour cell lines moderately resistant to the cytotoxic effects of digoxin and digitoxin, but not in highly sensitive leukaemia cell lines. Conclusion: It is suggested that further investigation regarding CGs may be focused on diagnoses like T-and B-precursor ALL.	[Hallbook, Helene] Uppsala Univ, Dept Haematol, Univ Hosp, Uppsala, Sweden; [Felth, Jenny; Bohlin, Lars] Uppsala Univ, Dept Med Chem, Div Pharmacognosy, Biomed Ctr, Uppsala, Sweden; [Eriksson, Anna; Fryknas, Marten; Larsson, Rolf; Gullbo, Joachim] Univ Uppsala Hosp, Dept Med Sci, Div Clin Pharmacol, Uppsala, Sweden	Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University; Uppsala University Hospital	Hallbook, H (corresponding author), Uppsala Univ, Dept Haematol, Univ Hosp, Uppsala, Sweden.	helene.hallbook@medsci.uu.se		Eriksson, Anna/0000-0002-8853-1863	Uppsala University Hospital; Lions cancer research found (in Swedish named: "Lions Cancerforskningsfond i Uppsala Orebro regionen")	Uppsala University Hospital; Lions cancer research found (in Swedish named: "Lions Cancerforskningsfond i Uppsala Orebro regionen")	The work was supported by grants from Uppsala University Hospital and from Lions cancer research found (in Swedish named: "Lions Cancerforskningsfond i Uppsala Orebro regionen"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassan R, 2004, CRIT REV ONCOL HEMAT, V50, P223, DOI 10.1016/j.critrevonc.2003.11.003; BECK WT, 1979, CANCER RES, V39, P2070; Bielawski K, 2006, BIOL PHARM BULL, V29, P1493, DOI 10.1248/bpb.29.1493; Bohmer T, 1998, AGE AGEING, V27, P222, DOI 10.1093/ageing/27.2.222; Felth J, 2009, J NAT PROD, V72, P1969, DOI 10.1021/np900210m; GOLDIN AG, 1984, LANCET, V1, P1134; Graves R, 1997, ANAL BIOCHEM, V248, P251, DOI 10.1006/abio.1997.2088; Harris DW, 1996, ANAL BIOCHEM, V243, P249, DOI 10.1006/abio.1996.0513; Haux J, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-11; Ihenetu K, 2007, CLIN CHEM, V53, P1315, DOI 10.1373/clinchem.2006.082081; JING YK, 1994, JPN J CANCER RES, V85, P645, DOI 10.1111/j.1349-7006.1994.tb02408.x; Kawazoe N, 1999, J BIOCHEM-TOKYO, V126, P278, DOI 10.1093/oxfordjournals.jbchem.a022446; Khan MI, 2009, AM J MED SCI, V337, P355, DOI 10.1097/MAJ.0b013e3181942f57; KHAN MI, 2007, ASCO2007 CHIC; Kometiani P, 2005, MOL PHARMACOL, V67, P929, DOI 10.1124/mol.104.007302; LARSSON R, 1992, INT J CANCER, V50, P177, DOI 10.1002/ijc.2910500204; Lindhagen E, 2008, NAT PROTOC, V3, P1364, DOI 10.1038/nprot.2008.114; Lopez-Lazaro M, 2006, LEUKEMIA RES, V30, P895, DOI 10.1016/j.leukres.2005.11.005; MASUDA Y, 1995, LEUKEMIA RES, V19, P549, DOI 10.1016/0145-2126(95)00031-I; Mekhail T, 2006, INVEST NEW DRUG, V24, P423, DOI 10.1007/s10637-006-7772-x; NAUMOVSKI L, 1988, CANCER RES, V48, P2876; Nesher M, 2007, LIFE SCI, V80, P2093, DOI 10.1016/j.lfs.2007.03.013; Newman RA, 2008, MOL INTERV, V8, P36, DOI 10.1124/mi.8.1.8; Newman RA, 2006, J EXP THER ONCOL, V5, P167; Perne A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008292; Raghavendra PB, 2007, MOL IMMUNOL, V44, P2292, DOI 10.1016/j.molimm.2006.11.009; Schoner W, 2007, AM J PHYSIOL-CELL PH, V293, pC509, DOI 10.1152/ajpcell.00098.2007; Stenkvist B, 1999, ONCOL REP, V6, P493; Stenkvist B, 2001, ANTI-CANCER DRUG, V12, P635, DOI 10.1097/00001813-200108000-00012; STENKVIST B, 1979, LANCET, V1, P563; Turan Nevruz, 2006, J Exp Ther Oncol, V6, P31; Weidemann H, 2005, FRONT BIOSCI-LANDMRK, V10, P2165, DOI 10.2741/1688; Winnicka Katarzyna, 2006, Acta Pol Pharm, V63, P109; Xie ZJ, 2002, EUR J BIOCHEM, V269, P2434, DOI 10.1046/j.1432-1033.2002.02910.x	34	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15718	10.1371/journal.pone.0015718	http://dx.doi.org/10.1371/journal.pone.0015718			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246039	gold, Green Published, Green Submitted			2022-12-27	WOS:000286511200012
J	Schuijt, TJ; Narasimhan, S; Daffre, S; DePonte, K; Hovius, JWR; van't Veer, C; van der Poll, T; Bakhtiari, K; Meijers, JCM; Boder, ET; van Dam, AP; Fikrig, E				Schuijt, Tim J.; Narasimhan, Sukanya; Daffre, Sirlei; DePonte, Kathleen; Hovius, Joppe W. R.; van't Veer, Cornelis; van der Poll, Tom; Bakhtiari, Kamran; Meijers, Joost C. M.; Boder, Eric T.; van Dam, Alje P.; Fikrig, Erol			Identification and Characterization of Ixodes scapularis Antigens That Elicit Tick Immunity Using Yeast Surface Display	PLOS ONE			English	Article							SALIVARY PROTEIN; BORRELIA-BURGDORFERI; RICINUS L; RESISTANCE; COMPLEMENT; SALP15; SERUM; TRANSMISSION; INFESTATION; ANTIBODIES	Repeated exposure of rabbits and other animals to ticks results in acquired resistance or immunity to subsequent tick bites and is partially elicited by antibodies directed against tick antigens. In this study we demonstrate the utility of a yeast surface display approach to identify tick salivary antigens that react with tick-immune serum. We constructed an Ixodes scapularis nymphal salivary gland yeast surface display library and screened the library with nymph-immune rabbit sera and identified five salivary antigens. Four of these proteins, designated P8, P19, P23 and P32, had a predicted signal sequence. We generated recombinant (r) P8, P19 and P23 in a Drosophila expression system for functional and immunization studies. rP8 showed anti-complement activity and rP23 demonstrated anti-coagulant activity. Ixodes scapularis feeding was significantly impaired when nymphs were fed on rabbits immunized with a cocktail of rP8, rP19 and rP23, a hall mark of tick-immunity. These studies also suggest that these antigens may serve as potential vaccine candidates to thwart tick feeding.	[Schuijt, Tim J.; Narasimhan, Sukanya; Daffre, Sirlei; DePonte, Kathleen; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Schuijt, Tim J.; Hovius, Joppe W. R.; van't Veer, Cornelis; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Bakhtiari, Kamran; Meijers, Joost C. M.] Univ Amsterdam, Acad Med Ctr, Dept Expt Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Schuijt, Tim J.] Leiden Univ, Dept Med Microbiol, Med Ctr, Leiden, Netherlands; [Daffre, Sirlei] Univ Sao Paulo, Dept Parasitol, Sao Paulo, Brazil; [Boder, Eric T.] Univ Tennessee, Dept Chem & Biomol Engn, Knoxville, TN USA; [van Dam, Alje P.] Onze Lieve Vrouw Hosp, Dept Med Microbiol, Amsterdam, Netherlands	Yale University; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universidade de Sao Paulo; University of Tennessee System; University of Tennessee Knoxville; Onze Lieve Vrouwe Gasthuis Hospital	Schuijt, TJ (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.	T.J.Schuijt@amc.uva.nl	Meijers, J.C.M./S-5981-2019; Boder, Eric T./E-9635-2015; Schuijt, Tim J/S-6440-2017; Hovius, Joppe/GZL-6894-2022; Daffre, Sirlei/M-4233-2013	Meijers, J.C.M./0000-0002-4198-6780; Boder, Eric T./0000-0003-4095-5680; Schuijt, Tim J/0000-0002-4799-225X; Hovius, Joppe/0000-0003-0066-2437; Daffre, Sirlei/0000-0002-9966-0433; Van Dam, Alje/0000-0003-3967-550X	National Institutes of Health [41440, 49200, 32947]; OLVG (Onze Lieve Vrouwe Gasthuis, Amsterdam); National Institute of Allergy and Infectious Diseases/NIH; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OLVG (Onze Lieve Vrouwe Gasthuis, Amsterdam); National Institute of Allergy and Infectious Diseases/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by grants 41440, 49200 and 32947 from the National Institutes of Health (E. F.). E. F. is an Investigator of the Howard Hughes Medical Institute. T.J.S. is supported by a grant from the OLVG (Onze Lieve Vrouwe Gasthuis, Amsterdam) research fund, and S.N. is supported by an Exploratory Research grant from the National Institute of Allergy and Infectious Diseases/NIH. S. D. is supported by a grant from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2008, TICKS: BIOLOGY, DISEASE AND CONTROL, P92, DOI 10.1017/CBO9780511551802.005; Anguita J, 2002, IMMUNITY, V16, P849, DOI 10.1016/S1074-7613(02)00325-4; ASKENASE PW, 1982, IMMUNOLOGY, V45, P501; BARBOUR AG, 1993, SCIENCE, V260, P1610, DOI 10.1126/science.8503006; BELL JF, 1979, AM J TROP MED HYG, V28, P876, DOI 10.4269/ajtmh.1979.28.876; Bidlingmaier S, 2006, MOL CELL PROTEOMICS, V5, P533, DOI 10.1074/mcp.M500309-MCP200; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; BROSSARD M, 1979, EXPERIENTIA, V35, P1395, DOI 10.1007/BF01964030; BROSSARD M, 1982, PARASITOLOGY, V85, P583, DOI 10.1017/S0031182000056365; Burke GS, 2005, EMERG INFECT DIS, V11, P36; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Daix V, 2007, INSECT MOL BIOL, V16, P155, DOI 10.1111/j.1365-2583.2006.00710.x; Das S, 2001, J INFECT DIS, V184, P1056, DOI 10.1086/323351; Decrem Y, 2008, INT J PARASITOL, V38, P549, DOI 10.1016/j.ijpara.2007.09.003; Decrem Y, 2009, J EXP MED, V206, P2381, DOI 10.1084/jem.20091007; Estrada-Pena A, 1999, EXP APPL ACAROL, V23, P685, DOI 10.1023/A:1006241108739; Francischetti IMB, 2002, BLOOD, V99, P3602, DOI 10.1182/blood-2001-12-0237; Gao JL, 2009, VACCINE, V27, P483, DOI 10.1016/j.vaccine.2008.10.067; Goodman J., 2005, TICK BORNE DIS HUMAN; Hannier S, 2004, IMMUNOLOGY, V113, P401, DOI 10.1111/j.1365-2567.2004.01975.x; HOFFMANN A, 1991, PHARMAZIE, V46, P209; Hovius JWR, 2007, VECTOR-BORNE ZOONOT, V7, P296, DOI 10.1089/vbz.2006.0624; Hovius JWR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040031; Hu RJ, 2000, J MED ENTOMOL, V37, P198, DOI 10.1603/0022-2585-37.1.198; Komachi K, 1997, MOL CELL BIOL, V17, P6023, DOI 10.1128/MCB.17.10.6023; Narasimhan S, 2004, P NATL ACAD SCI USA, V101, P1141, DOI 10.1073/pnas.0307669100; Narasimhan S, 2002, INSECT MOL BIOL, V11, P641, DOI 10.1046/j.1365-2583.2002.00375.x; Narasimhan S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000451; Nazario S, 1998, AM J TROP MED HYG, V58, P780, DOI 10.4269/ajtmh.1998.58.780; Nuttall PA, 2006, PARASITE IMMUNOL, V28, P155, DOI 10.1111/j.1365-3024.2006.00806.x; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Pepper LR, 2008, COMB CHEM HIGH T SCR, V11, P127; Prevot PP, 2006, J BIOL CHEM, V281, P26361, DOI 10.1074/jbc.M604197200; Ramamoorthi N, 2005, NATURE, V436, P573, DOI 10.1038/nature03812; Ribeiro JMC, 2006, INSECT BIOCHEM MOLEC, V36, P111, DOI 10.1016/j.ibmb.2005.11.005; Schroeder H, 2007, MICROBES INFECT, V9, P247, DOI 10.1016/j.micinf.2006.10.020; Schuijt TJ, 2008, INFECT IMMUN, V76, P2888, DOI 10.1128/IAI.00232-08; SCHUIJT TJ, 2010, TRENDS PARASITOL; SHAPIRO SZ, 1987, J MED ENTOMOL, V24, P147, DOI 10.1093/jmedent/24.2.147; TRAGER WILLIAM, 1939, JOUR PARASITOL, V25, P57, DOI 10.2307/3272160; Tyers M, 2000, CURR OPIN GENET DEV, V10, P54, DOI 10.1016/S0959-437X(99)00049-0; Tyson K, 2007, INSECT MOL BIOL, V16, P469, DOI 10.1111/j.1365-2583.2007.00742.x; Valenzuela JG, 2000, J BIOL CHEM, V275, P18717, DOI 10.1074/jbc.M001486200; Vancova I, 2010, VET PARASITOL, V167, P274, DOI 10.1016/j.vetpar.2009.09.029; VanDam AP, 1997, INFECT IMMUN, V65, P1228, DOI 10.1128/IAI.65.4.1228-1236.1997; Wadle A, 2005, INT J CANCER, V117, P104, DOI 10.1002/ijc.21147; Walker LM, 2009, J MOL BIOL, V389, P365, DOI 10.1016/j.jmb.2009.04.019; Walsh C., 2006, POSTTRANSLATIONAL MO; WANG H, 1994, PARASITOLOGY, V109, P525, DOI 10.1017/S0031182000080781; Wikel SK, 1997, INFECT IMMUN, V65, P335, DOI 10.1128/IAI.65.1.335-338.1997; You M, 2001, INSECT BIOCHEM MOLEC, V32, P67, DOI 10.1016/S0965-1748(01)00081-9	51	61	62	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15926	10.1371/journal.pone.0015926	http://dx.doi.org/10.1371/journal.pone.0015926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246036	gold, Green Published, Green Submitted			2022-12-27	WOS:000286511200025
J	Askoxylakis, V; Garcia-Boy, R; Rana, S; Kramer, S; Hebling, U; Mier, W; Altmann, A; Markert, A; Debus, J; Haberkorn, U				Askoxylakis, Vasileios; Garcia-Boy, Regine; Rana, Shoaib; Kraemer, Susanne; Hebling, Ulrike; Mier, Walter; Altmann, Annette; Markert, Annette; Debus, Juergen; Haberkorn, Uwe			A New Peptide Ligand for Targeting Human Carbonic Anhydrase IX, Identified through the Phage Display Technology	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SQUAMOUS-CELL CARCINOMA; TUMOR HYPOXIA; POOR-PROGNOSIS; LUNG-CANCER; NECK-CANCER; EXPRESSION; MARKER; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; THERAPEUTICS	Carbonic anhydrase IX (CAIX) is a transmembrane enzyme found to be overexpressed in various tumors and associated with tumor hypoxia. Ligands binding this target may be used to visualize hypoxia, tumor manifestation or treat tumors by endoradiotherapy. Methods: Phage display was performed with a 12 amino acid phage display library by panning against a recombinant extracellular domain of human carbonic anhydrase IX. The identified peptide CaIX-P1 was chemically synthesized and tested in vitro on various cell lines and in vivo in Balb/c nu/nu mice carrying subcutaneously transplanted tumors. Binding, kinetic and competition studies were performed on the CAIX positive human renal cell carcinoma cell line SKRC 52, the CAIX negative human renal cell carcinoma cell line CaKi 2, the human colorectal carcinoma cell line HCT 116 and on human umbilical vein endothelial cells (HUVEC). Organ distribution studies were carried out in mice, carrying SKRC 52 tumors. RNA expression of CAIX in HCT 116 and HUVEC cells was investigated by quantitative real time PCR. Results: In vitro binding experiments of (125)I-labeled-CaIX-P1 revealed an increased uptake of the radioligand in the CAIX positive renal cell carcinoma cell line SKRC 52. Binding of the radioligand in the colorectal carcinoma cell line HCT 116 increased with increasing cell density and correlated with the mRNA expression of CAIX. Radioligand uptake was inhibited up to 90% by the unlabeled CaIX-P1 peptide, but not by the negative control peptide octreotide at the same concentration. No binding was demonstrated in CAIX negative CaKi 2 and HUVEC cells. Organ distribution studies revealed a higher accumulation in SKRC 52 tumors than in heart, spleen, liver, muscle, intestinum and brain, but a lower uptake compared to blood and kidney. Conclusions: These data indicate that CaIX-P1 is a promising candidate for the development of new ligands targeting human carbonic anhydrase IX.	[Askoxylakis, Vasileios; Debus, Juergen] Univ Heidelberg, Dept Radiooncol & Radiat Therapy, Heidelberg, Germany; [Garcia-Boy, Regine; Rana, Shoaib; Kraemer, Susanne; Hebling, Ulrike; Mier, Walter; Haberkorn, Uwe] Univ Heidelberg, Dept Nucl Med, Heidelberg, Germany; [Altmann, Annette; Markert, Annette; Haberkorn, Uwe] German Canc Res Ctr, Clin Cooperat Unit Nucl Med, D-6900 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Askoxylakis, V (corresponding author), Univ Heidelberg, Dept Radiooncol & Radiat Therapy, Heidelberg, Germany.	vasileios.askoxylakis@med.uni-heidelberg.de			Tumorzentrum Heidelberg/Mannheim; Medical Faculty at the University of Heidelberg	Tumorzentrum Heidelberg/Mannheim; Medical Faculty at the University of Heidelberg	This project has been financially supported by the Tumorzentrum Heidelberg/Mannheim. Vasileios Askoxylakis received support from the PostDoc fellowship of the Medical Faculty at the University of Heidelberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlskog JKJ, 2009, BRIT J CANCER, V101, P645, DOI 10.1038/sj.bjc.6605200; Askoxylakis V, 2005, CLIN CANCER RES, V11, P6705, DOI 10.1158/1078-0432.CCR-05-0432; Askoxylakis V, 2006, J NUCL MED, V47, P981; BAKKER WH, 1990, J NUCL MED, V31, P1501; Boy RG, 2010, MOL IMAGING BIOL, V12, P377, DOI 10.1007/s11307-009-0287-z; Brissette R, 2006, CURR OPIN DRUG DISC, V9, P363; Brouwers AH, 2005, CLIN CANCER RES, V11, p7178S, DOI 10.1158/1078-0432.CCR-1004-0010; Bussink J, 2003, RADIOTHER ONCOL, V67, P3, DOI 10.1016/S0167-8140(03)00011-2; Chrastina A, 2003, INT J CANCER, V105, P873, DOI 10.1002/ijc.11142; Crim JW, 2002, PEPTIDES, V23, P2045, DOI 10.1016/S0196-9781(02)00192-4; Demir R, 2009, PATHOL ONCOL RES, V15, P417, DOI 10.1007/s12253-008-9140-y; Giatromanolaki A, 2003, MELANOMA RES, V13, P493, DOI 10.1097/00008390-200310000-00008; Haapasalo JA, 2006, CLIN CANCER RES, V12, P473, DOI 10.1158/1078-0432.CCR-05-0848; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hulikova A, 2009, FEBS LETT, V583, P3563, DOI 10.1016/j.febslet.2009.10.060; Jubb AM, 2004, J CLIN PATHOL, V57, P504, DOI 10.1136/jcp.2003.012963; Kim SJ, 2005, LUNG CANCER, V49, P325, DOI 10.1016/j.lungcan.2005.03.036; Krause BJ, 2006, Q J NUCL MED MOL IM, V50, P28; Lee SH, 2005, BIOCONJUGATE CHEM, V16, P377, DOI 10.1021/bc049735+; Li GR, 2001, CLIN CANCER RES, V7, P89; McGuire BB, 2009, CURR OPIN UROL, V19, P441, DOI 10.1097/MOU.0b013e32832f0c68; Mees G, 2009, EUR J NUCL MED MOL I, V36, P1674, DOI 10.1007/s00259-009-1195-9; Mier W, 2007, J NUCL MED, V48, P1545, DOI 10.2967/jnumed.106.036707; Niemela AM, 2007, CANCER EPIDEM BIOMAR, V16, P1760, DOI 10.1158/1055-9965.EPI-07-0080; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; RALEIGH JA, 1990, BIOCHEM PHARMACOL, V40, P2457, DOI 10.1016/0006-2952(90)90086-Z; Rofstad EK, 2000, BRIT J CANCER, V83, P354, DOI 10.1054/bjoc.2000.1266; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Skrzypski M, 2008, CLIN CANCER RES, V14, P4794, DOI 10.1158/1078-0432.CCR-08-0576; Sun X, 2006, APPL RADIAT ISOTOPES, V64, P645, DOI 10.1016/j.apradiso.2005.12.019; Swinson DEB, 2003, J CLIN ONCOL, V21, P473, DOI 10.1200/JCO.2003.11.132; Thorwarth D, 2006, RADIOTHER ONCOL, V80, P151, DOI 10.1016/j.radonc.2006.07.033; Winum JY, 2008, MED RES REV, V28, P445, DOI 10.1002/med.20112; Wykoff CC, 2000, CANCER RES, V60, P7075; Zimny M, 2006, EUR J NUCL MED MOL I, V33, P1426, DOI 10.1007/s00259-006-0175-6	35	28	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15962	10.1371/journal.pone.0015962	http://dx.doi.org/10.1371/journal.pone.0015962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209841	Green Published, gold, Green Submitted			2022-12-27	WOS:000285838900053
J	Heinemann, LV; Rahm, B; Kaiser, J; Gaese, BH; Altmann, CF				Heinemann, Linda V.; Rahm, Benjamin; Kaiser, Jochen; Gaese, Bernhard H.; Altmann, Christian F.			Repetition Enhancement for Frequency-Modulated but Not Unmodulated Sounds: A Human MEG Study	PLOS ONE			English	Article							PRIMARY AUDITORY-CORTEX; FORMANT TRANSITIONS; NORMAL READERS; SENSITIVITY; SELECTIVITY; DIRECTION; STIMULI; NEURONS; ADAPTATION; RESPONSES	Background: Decoding of frequency-modulated (FM) sounds is essential for phoneme identification. This study investigates selectivity to FM direction in the human auditory system. Methodology/Principal Findings: Magnetoencephalography was recorded in 10 adults during a two-tone adaptation paradigm with a 200-ms interstimulus-interval. Stimuli were pairs of either same or different frequency modulation direction. To control that FM repetition effects cannot be accounted for by their on-and offset properties, we additionally assessed responses to pairs of unmodulated tones with either same or different frequency composition. For the FM sweeps, N1m event-related magnetic field components were found at 103 and 130 ms after onset of the first (S1) and second stimulus (S2), respectively. This was followed by a sustained component starting at about 200 ms after S2. The sustained response was significantly stronger for stimulation with the same compared to different FM direction. This effect was not observed for the non-modulated control stimuli. Conclusions/Significance: Low-level processing of FM sounds was characterized by repetition enhancement to stimulus pairs with same versus different FM directions. This effect was FM-specific; it did not occur for unmodulated tones. The present findings may reflect specific interactions between frequency separation and temporal distance in the processing of consecutive FM sweeps.	[Heinemann, Linda V.; Rahm, Benjamin; Kaiser, Jochen; Altmann, Christian F.] Goethe Univ Frankfurt, Inst Med Psychol, Frankfurt, Germany; [Rahm, Benjamin] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Mainz, Germany; [Gaese, Bernhard H.] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, Frankfurt, Germany; [Altmann, Christian F.] Kyoto Univ, Grad Sch Med, Int Young Scientists Career Dev Org, Kyoto, Japan; [Altmann, Christian F.] Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Kyoto, Japan	Goethe University Frankfurt; Johannes Gutenberg University of Mainz; Goethe University Frankfurt; Kyoto University; Kyoto University	Heinemann, LV (corresponding author), Goethe Univ Frankfurt, Inst Med Psychol, Frankfurt, Germany.	heinemann@med.uni-frankfurt.de	Kaiser, Jochen/T-9184-2017	Kaiser, Jochen/0000-0001-6740-5000; Gaese, Bernhard/0000-0002-6410-2626; Altmann, Christian/0000-0003-0958-1238	Deutsche Forschungsgemeinschaft (DFG) [AL 1074/2-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Christian Friedrich Altmann and Jochen Kaiser were supported by Deutsche Forschungsgemeinschaft (DFG AL 1074/2-1), http://www.dfg.de/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann CF, 2008, CEREB CORTEX, V18, P1350, DOI 10.1093/cercor/bhm166; Atencio CA, 2007, J NEUROPHYSIOL, V98, P2182, DOI 10.1152/jn.00394.2007; Bartlett EL, 2005, J NEUROPHYSIOL, V94, P83, DOI 10.1152/jn.01124.2004; Behne N, 2005, J NEUROPHYSIOL, V93, P414, DOI 10.1152/jn.00568.2004; Brimijoin WO, 2005, HEARING RES, V210, P63, DOI 10.1016/j.heares.2005.07.005; Brosch M, 2000, CEREB CORTEX, V10, P1155, DOI 10.1093/cercor/10.12.1155; Brosch M, 1999, J NEUROPHYSIOL, V82, P1542, DOI 10.1152/jn.1999.82.3.1542; Brosch M, 2003, NEURAL REPRESENTATIO; Brosch M, 2008, EXP BRAIN RES, V184, P349, DOI 10.1007/s00221-007-1109-7; BUDD TW, 1994, NEUROREPORT, V5, P2513, DOI 10.1097/00001756-199412000-00027; Budd TW, 1998, INT J PSYCHOPHYSIOL, V31, P51, DOI 10.1016/S0167-8760(98)00040-3; Cheung SW, 2005, J NEUROSCI, V25, P2490, DOI 10.1523/JNEUROSCI.5289-04.2005; DAVIS H, 1966, ELECTROEN CLIN NEURO, V21, P105, DOI 10.1016/0013-4694(66)90118-0; Doehrmann O, 2008, NEUROPSYCHOLOGIA, V46, P2776, DOI 10.1016/j.neuropsychologia.2008.05.011; Efron B., 1994, INTRO BOOTSTRAP; GARDNER RB, 1979, J ACOUST SOC AM, V66, P704, DOI 10.1121/1.383220; Godey B, 2005, J NEUROPHYSIOL, V94, P1299, DOI 10.1152/jn.00950.2004; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Hall DA, 2003, AUDIOL NEURO-OTOL, V8, P1, DOI 10.1159/000067894; HARI R, 1982, ELECTROEN CLIN NEURO, V54, pP43; HEIL P, 1992, HEARING RES, V63, P108, DOI 10.1016/0378-5955(92)90080-7; Jaaskelainen IP, 2004, P NATL ACAD SCI USA, V101, P6809, DOI 10.1073/pnas.0303760101; Johnsrude IS, 2002, AUDIOL NEURO-OTOL, V7, P251, DOI 10.1159/000064446; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; LINDBLOM BE, 1967, J ACOUST SOC AM, V42, P830, DOI 10.1121/1.1910655; LOVELESS N, 1989, ELECTROEN CLIN NEURO, V74, P217, DOI 10.1016/0013-4694(89)90008-4; LOVELESS NE, 1993, BIOL PSYCHOL, V35, P1, DOI 10.1016/0301-0511(93)90088-P; Luo H, 2007, HEARING RES, V224, P75, DOI 10.1016/j.heares.2006.11.007; Millman RE, 2010, NEUROIMAGE, V49, P745, DOI 10.1016/j.neuroimage.2009.08.029; MOODY DB, 1984, J ACOUST SOC AM, V76, P1076, DOI 10.1121/1.391399; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Obleser J, 2006, HUM BRAIN MAPP, V27, P562, DOI 10.1002/hbm.20201; PARDO PJ, 1993, NEUROSCI LETT, V159, P43, DOI 10.1016/0304-3940(93)90794-L; Poeppel D, 2004, NEUROPSYCHOLOGIA, V42, P183, DOI 10.1016/j.neuropsychologia.2003.07.010; Razak KA, 2006, J NEUROPHYSIOL, V96, P1303, DOI 10.1152/jn.00020.2006; SHEPARD RN, 1964, J ACOUST SOC AM, V36, P2346, DOI 10.1121/1.1919362; Solis MM, 1997, J NEUROSCI, V17, P6447; STEVENS KN, 1974, J ACOUST SOC AM, V55, P653, DOI 10.1121/1.1914578; Stoodley CJ, 2006, BRAIN RES, V1121, P190, DOI 10.1016/j.brainres.2006.08.095; Tian B, 2004, J NEUROPHYSIOL, V92, P2993, DOI 10.1152/jn.00472.2003; Wang AL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003929; Weisz N, 2004, HEARING RES, V191, P49, DOI 10.1016/j.heares.2004.01.012; Wetzel W, 1998, NEUROSCI LETT, V252, P115, DOI 10.1016/S0304-3940(98)00561-8; Witton C, 1998, CURR BIOL, V8, P791, DOI 10.1016/S0960-9822(98)70320-3; Witton C, 2002, J COGNITIVE NEUROSCI, V14, P866, DOI 10.1162/089892902760191090; WOLDORFF MG, 1993, PSYCHOPHYSIOLOGY, V30, P98, DOI 10.1111/j.1469-8986.1993.tb03209.x	46	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15548	10.1371/journal.pone.0015548	http://dx.doi.org/10.1371/journal.pone.0015548			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	701RA	21217825	Green Published, gold, Green Submitted			2022-12-27	WOS:000285838900021
J	Hu, LL; Niu, S; Huang, T; Wang, K; Shi, XH; Cai, YD				Hu, Le-Le; Niu, Shen; Huang, Tao; Wang, Kai; Shi, Xiao-He; Cai, Yu-Dong			Prediction and Analysis of Protein Hydroxyproline and Hydroxylysine	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE-FACTOR; AMINO-ACID-COMPOSITION; CORE-SPECIFIC LECTIN; INTRINSIC DISORDER; POSTTRANSLATIONAL MODIFICATIONS; FEATURE-SELECTION; PROLINE HYDROXYLATION; LYSINE HYDROXYLATION; CROSS-LINKING; IDENTIFICATION	Background: Hydroxylation is an important post-translational modification and closely related to various diseases. Besides the biotechnology experiments, in silico prediction methods are alternative ways to identify the potential hydroxylation sites. Methodology/Principal Findings: In this study, we developed a novel sequence-based method for identifying the two main types of hydroxylation sites - hydroxyproline and hydroxylysine. First, feature selection was made on three kinds of features consisting of amino acid indices (AAindex) which includes various physicochemical properties and biochemical properties of amino acids, Position-Specific Scoring Matrices (PSSM) which represent evolution information of amino acids and structural disorder of amino acids in the sliding window with length of 13 amino acids, then the prediction model were built using incremental feature selection method. As a result, the prediction accuracies are 76.0% and 82.1%, evaluated by jackknife cross-validation on the hydroxyproline dataset and hydroxylysine dataset, respectively. Feature analysis suggested that physicochemical properties and biochemical properties and evolution information of amino acids contribute much to the identification of the protein hydroxylation sites, while structural disorder had little relation to protein hydroxylation. It was also found that the amino acid adjacent to the hydroxylation site tends to exert more influence than other sites on hydroxylation determination. Conclusions/Significance: These findings may provide useful insights for exploiting the mechanisms of hydroxylation.	[Hu, Le-Le; Wang, Kai; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Hu, Le-Le] Shanghai Univ, Coll Sci, Dept Chem, Shanghai, Peoples R China; [Niu, Shen; Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Shi, Xiao-He] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Shi, Xiao-He] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Cai, Yu-Dong] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China	Shanghai University; Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Fudan University	Hu, LL (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	cai_yud@yahoo.com.cn		WANG, kai/0000-0002-6194-0480; cai, yudong/0000-0001-5664-7979				Ahmad S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-33; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Auer M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-S1-S1; Backlund J, 2002, EUR J IMMUNOL, V32, P3776, DOI 10.1002/1521-4141(200212)32:12<3776::AID-IMMU3776>3.0.CO;2-A; BAXEVANIS AD, 2006, CURR PROTOC BIOINFOR, pCH1; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; Berra E, 2006, EMBO REP, V7, P41, DOI 10.1038/sj.embor.7400598; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Cai YD, 2008, BIOCHEM BIOPH RES CO, V372, P862, DOI 10.1016/j.bbrc.2008.05.143; Cai YD, 2010, PROTEIN PEPTIDE LETT, V17, P464, DOI 10.2174/092986610790963654; CHOPRA RK, 1982, P NATL ACAD SCI-BIOL, V79, P7180, DOI 10.1073/pnas.79.23.7180; Chou KC, 2008, BIOCHEM BIOPH RES CO, V376, P321, DOI 10.1016/j.bbrc.2008.08.125; Chowdhury R, 2009, STRUCTURE, V17, P981, DOI 10.1016/j.str.2009.06.002; Cockman ME, 2009, MOL CELL PROTEOMICS, V8, P535, DOI 10.1074/mcp.M800340-MCP200; COLLEY KJ, 1987, J BIOL CHEM, V262, P10290; COLLEY KJ, 1987, J BIOL CHEM, V262, P10296; Ding Chris, 2005, Journal of Bioinformatics and Computational Biology, V3, P185, DOI 10.1142/S0219720005001004; Ding YS, 2007, PROTEIN PEPTIDE LETT, V14, P811; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Hansen JC, 2006, J BIOL CHEM, V281, P1853, DOI 10.1074/jbc.R500022200; He B, 2009, CELL RES, V19, P929, DOI 10.1038/cr.2009.87; Himly M, 2002, FASEB J, V16, P106, DOI 10.1096/fj.02-0472fje; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; KIVIRIKK.KI, 1967, P NATL ACAD SCI USA, V57, P782, DOI 10.1073/pnas.57.3.782; Li SL, 2009, PROTEIN PEPTIDE LETT, V16, P977, DOI 10.2174/092986609788923338; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Midic U, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S12; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Myllyharju J, 1997, EMBO J, V16, P1173, DOI 10.1093/emboj/16.6.1173; Ostell J M, 2001, Methods Biochem Anal, V43, P19; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Raychaudhuri S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005566; Richards AA, 2006, MOL ENDOCRINOL, V20, P1673, DOI 10.1210/me.2005-0390; Russell RB, 2008, FEBS LETT, V582, P1271, DOI 10.1016/j.febslet.2008.02.027; Salnikow K, 2005, ENVIRON HEALTH PERSP, V113, P577, DOI 10.1289/ehp.7605; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Shi MG, 2008, PROTEIN PEPTIDE LETT, V15, P692, DOI 10.2174/092986608785133627; Sigalov AB, 2010, MOL BIOSYST, V6, P451, DOI 10.1039/b916030m; Tung CW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-310; Uversky VN, 2008, SCIENCE, V322, P1340, DOI 10.1126/science.1167453; Uversky VN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S7; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Uzawa K, 1999, J BONE MINER RES, V14, P1272, DOI 10.1359/jbmr.1999.14.8.1272; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Wu G, 2008, PROTEIN PEPTIDE LETT, V15, P144, DOI 10.2174/092986608783489571; Xiao X, 2007, PROTEIN PEPTIDE LETT, V14, P871, DOI 10.2174/092986607782110293; Xie HB, 2007, J PROTEOME RES, V6, P1917, DOI 10.1021/pr060394e; Yamauchi Mitsuo, 2008, V446, P95, DOI 10.1007/978-1-60327-084-7_7; Yang ZR, 2009, J COMPUT BIOL, V16, P691, DOI 10.1089/cmb.2008.0167; Zhou J, 2007, BIOINFORMATICS, V23, P589, DOI 10.1093/bioinformatics/btl680	61	19	20	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15917	10.1371/journal.pone.0015917	http://dx.doi.org/10.1371/journal.pone.0015917			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209839	Green Submitted, Green Published, gold			2022-12-27	WOS:000285838900050
J	Jensen, VL; Simonsen, KT; Lee, YH; Park, D; Riddle, DL				Jensen, Victor L.; Simonsen, Karina T.; Lee, Yu-Hui; Park, Donha; Riddle, Donald L.			RNAi Screen of DAF-16/FOXO Target Genes in C. elegans Links Pathogenesis and Dauer Formation	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; TRANSCRIPTION FACTOR; LIFE-SPAN; LONGEVITY; RECEPTOR; LARVA; IDENTIFICATION; EXPRESSION; BACTERIA; DIAPAUSE	The DAF-16/FOXO transcription factor is the major downstream output of the insulin/IGF1R signaling pathway controlling C. elegans dauer larva development and aging. To identify novel downstream genes affecting dauer formation, we used RNAi to screen candidate genes previously identified to be regulated by DAF-16. We used a sensitized genetic background [eri-1(mg366); sdf-9(m708)], which enhances both RNAi efficiency and constitutive dauer formation (Daf-c). Among 513 RNAi clones screened, 21 displayed a synthetic Daf-c (SynDaf) phenotype with sdf-9. One of these genes, srh-100, was previously identified to be SynDaf, but twenty have not previously been associated with dauer formation. Two of the latter genes, lys-1 and cpr-1, are known to participate in innate immunity and six more are predicted to do so, suggesting that the immune response may contribute to the dauer decision. Indeed, we show that two of these genes, lys-1 and clc-1, are required for normal resistance to Staphylococcus aureus. clc-1 is predicted to function in epithelial cohesion. Dauer formation exhibited by daf-8(m85), sdf-9(m708), and the wild-type N2 (at 27 degrees C) were all enhanced by exposure to pathogenic bacteria, while not enhanced in a daf-22(m130) background. We conclude that knockdown of the genes required for proper pathogen resistance increases pathogenic infection, leading to increased dauer formation in our screen. We propose that dauer larva formation is a behavioral response to pathogens mediated by increased dauer pheromone production.	[Jensen, Victor L.; Riddle, Donald L.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Jensen, Victor L.; Lee, Yu-Hui; Park, Donha; Riddle, Donald L.] Univ British Columbia, Michael Smith Labs, Vancouver, BC, Canada; [Simonsen, Karina T.] Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark	University of British Columbia; University of British Columbia; University of Southern Denmark	Jensen, VL (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada.	driddle@msl.ubc.ca		Jensen, Victor/0000-0002-9039-4319	Canadian Institute of Health Research [MOP-79458]; Natural Science and Engineering Research Council; Michael Smith Foundation for Health Research; National Institutes of Health - National Center for Research Resources	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); National Institutes of Health - National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Canadian Institute of Health Research Operating Grant to D. L. R. #MOP-79458 (www.cihr.ca), the Natural Science and Engineering Research Council Scholarship to V.L.J. (www.nserc-crsng.gc.ca), and the Michael Smith Foundation for Health Research Scholarship to V.L.J. (www.msfhr.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Caenorhabditis Genetics Center (funded by the National Institutes of Health - National Center for Research Resources) for strains, Dr. Donald Moerman for the RNAi clones, and Nigel O'Neil and Marco Gallo for constructive discussions.	Ailion M, 2000, GENETICS, V156, P1047; Ailion M, 1999, P NATL ACAD SCI USA, V96, P7394, DOI 10.1073/pnas.96.13.7394; Ailion M, 2003, GENETICS, V165, P127; ALBERT PS, 1981, J COMP NEUROL, V198, P435, DOI 10.1002/cne.901980305; Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Antebi A, 2000, GENE DEV, V14, P1512; Asano A, 2003, CURR BIOL, V13, P1042, DOI 10.1016/S0960-9822(03)00395-6; Bell LR, 2006, GENETICS, V173, P1275, DOI 10.1534/genetics.106.056721; Bolz DD, 2010, J BIOL CHEM, V285, P10832, DOI 10.1074/jbc.M109.091629; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; BRENNER S, 1974, GENETICS, V77, P71; Butcher RA, 2009, P NATL ACAD SCI USA, V106, P1875, DOI 10.1073/pnas.0810338106; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Couillault C, 2002, INFECT IMMUN, V70, P4705, DOI 10.1128/IAI.70.8.4705-4707.2002; Darby Creg, 2005, WormBook, P1; Davalli AM, 1996, J ENDOCRINOL, V150, P195, DOI 10.1677/joe.0.1500195; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Garigan D, 2002, GENETICS, V161, P1101; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; GOLDEN JW, 1985, MOL GEN GENET, V198, P534, DOI 10.1007/BF00332953; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Hu P.J., 2007, WORMBOOK, P1, DOI [10.1895/wormbook.1.144.1, DOI 10.1895/WORMBOOK.1.144.1]; Hu PJ, 2006, PLOS GENET, V2, P930, DOI 10.1371/journal.pgen.0020099; Jensen VL, 2007, GENETICS, V177, P661, DOI 10.1534/genetics.107.076703; Jensen VL, 2006, EXP GERONTOL, V41, P922, DOI 10.1016/j.exger.2006.06.058; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kiesecker JM, 1999, P NATL ACAD SCI USA, V96, P9165, DOI 10.1073/pnas.96.16.9165; LARSEN PL, 1995, GENETICS, V139, P1567; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Liu Tao, 2004, BMC Developmental Biology, V4; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Matsuura T, 2005, ZOOL SCI, V22, P1095, DOI 10.2108/zsj.22.1095; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nandakumar M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000273; Narbonne P, 2006, DEVELOPMENT, V133, P611, DOI 10.1242/dev.02232; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Ohkura K, 2003, DEVELOPMENT, V130, P3237, DOI 10.1242/dev.00540; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Patterson GI, 1997, GENE DEV, V11, P2679, DOI 10.1101/gad.11.20.2679; Perens EA, 2005, DEV CELL, V8, P893, DOI 10.1016/j.devcel.2005.03.009; Pinkston-Gosse J, 2007, NAT GENET, V39, P1403, DOI 10.1038/ng.2007.1; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Ren M, 2009, IMMUNITY, V30, P521, DOI 10.1016/j.immuni.2009.03.007; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; Robertson HM, 2000, GENOME RES, V10, P192, DOI 10.1101/gr.10.2.192; Rogers A, 2008, NUCLEIC ACIDS RES, V36, pD612, DOI 10.1093/nar/gkm975; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Shivers RP, 2008, CURR OPIN MICROBIOL, V11, P251, DOI 10.1016/j.mib.2008.05.014; Shostak Y, 2004, GENE DEV, V18, P2529, DOI 10.1101/gad.1218504; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Suzuki Y, 2006, GENE DEV, V20, P423, DOI 10.1101/gad.1378906; Swoboda P, 2000, MOL CELL, V5, P411, DOI 10.1016/S1097-2765(00)80436-0; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tewari M, 2004, MOL CELL, V13, P469, DOI 10.1016/S1097-2765(04)00033-4; Thomas JH, 2006, GENETICS, V172, P127, DOI 10.1534/genetics.104.040030; THOMAS JH, 1993, GENETICS, V134, P1105; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Wong D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r194; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	71	17	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15902	10.1371/journal.pone.0015902	http://dx.doi.org/10.1371/journal.pone.0015902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209831	Green Published, Green Submitted, gold			2022-12-27	WOS:000285838900046
J	McCluney, KE; Sabo, JL				McCluney, Kevin E.; Sabo, John L.			Tracing Water Sources of Terrestrial Animal Populations with Stable Isotopes: Laboratory Tests with Crickets and Spiders	PLOS ONE			English	Article							NATURAL-ABUNDANCE; CARBON-DIOXIDE; FOOD WEBS; HYDROGEN; RATIOS; TEMPERATURE; OXYGEN; DEUTERIUM; STREAM; HAIR	Fluxes of carbon, nitrogen, and water between ecosystem components and organisms have great impacts across levels of biological organization. Although much progress has been made in tracing carbon and nitrogen, difficulty remains in tracing water sources from the ecosystem to animals and among animals (the "water web"). Naturally occurring, non-radioactive isotopes of hydrogen and oxygen in water provide a potential method for tracing water sources. However, using this approach for terrestrial animals is complicated by a change in water isotopes within the body due to differences in activity of heavy and light isotopes during cuticular and transpiratory water losses. Here we present a technique to use stable water isotopes to estimate the mean mix of water sources in a population by sampling a group of sympatric animals over time. Strong correlations between H and O isotopes in the body water of animals collected over time provide linear patterns of enrichment that can be used to predict a mean mix of water sources useful in standard mixing models to determine relative source contribution. Multiple temperature and humidity treatment levels do not greatly alter these relationships, thus having little effect on our ability to estimate this population-level mix of water sources. We show evidence for the validity of using multiple samples of animal body water, collected across time, to estimate the isotopic mix of water sources in a population and more accurately trace water sources. The ability to use isotopes to document patterns of animal water use should be a great asset to biologists globally, especially those studying drylands, droughts, streamside areas, irrigated landscapes, and the effects of climate change.	[McCluney, Kevin E.; Sabo, John L.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe	McCluney, KE (corresponding author), Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA.	Kevin.McCluney@colostate.edu		McCluney, Kevin/0000-0002-3574-0354	EPA [FP-91649201]; National Science Foundation [DEB-0808537]; Brian Daniel Corrigan Foundation; Direct For Biological Sciences [0842410] Funding Source: National Science Foundation	EPA(United States Environmental Protection Agency); National Science Foundation(National Science Foundation (NSF)); Brian Daniel Corrigan Foundation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was funded by EPA STAR grant FP-91649201 and National Science Foundation DDIG grant DEB-0808537 to K. McCluney and by the Brian Daniel Corrigan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowden RD, 1998, SOIL BIOL BIOCHEM, V30, P1591, DOI 10.1016/S0038-0717(97)00228-9; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Cerling TE, 2009, P NATL ACAD SCI USA, V106, P8093, DOI 10.1073/pnas.0902192106; Clark I., 1997, ENV ISOTOPES HYDROLO; CORMIE AB, 1994, GEOCHIM COSMOCHIM AC, V58, P377, DOI 10.1016/0016-7037(94)90471-5; CRAIG H, 1961, SCIENCE, V133, P1702, DOI 10.1126/science.133.3465.1702; CRAIG H, 1963, J GEOPHYS RES, V68, P5079, DOI 10.1029/JZ068i017p05079; Currie WS, 1999, ECOSYSTEMS, V2, P4, DOI 10.1007/s100219900054; Davis JR, 2006, INTEGR COMP BIOL, V46, pE31; DAWSON TE, 1991, NATURE, V350, P335, DOI 10.1038/350335a0; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; DONGMANN G, 1974, RADIAT ENVIRON BIOPH, V11, P41, DOI 10.1007/BF01323099; Ehleringer JR, 2008, P NATL ACAD SCI USA, V105, P2788, DOI 10.1073/pnas.0712228105; EPSTEIN S, 1953, GEOCHIM COSMOCHIM AC, V4, P213, DOI 10.1016/0016-7037(53)90051-9; EPSTEIN S, 1976, EARTH PLANET SC LETT, V30, P241, DOI 10.1016/0012-821X(76)90251-X; ESTEP MF, 1980, SCIENCE, V209, P1537, DOI 10.1126/science.209.4464.1537; FLANAGAN LB, 1991, PLANT PHYSIOL, V97, P298, DOI 10.1104/pp.97.1.298; Gannes LZ, 1998, COMP BIOCHEM PHYS A, V119, P725, DOI 10.1016/S1095-6433(98)01016-2; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hobson KA, 1997, OECOLOGIA, V109, P142, DOI 10.1007/s004420050068; Hobson KA, 1999, P NATL ACAD SCI USA, V96, P8003, DOI 10.1073/pnas.96.14.8003; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Huxman TE, 2004, NATURE, V429, P651, DOI 10.1038/nature02561; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; IPCC, 2007, AR4 SYNTHESIS REPORT; LIFSON N, 1955, J APPL PHYSIOL, V7, P704, DOI 10.1152/jappl.1955.7.6.704; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; McCluney KE, 2010, IMPACTS ALTERED WATE; McCluney KE, 2009, ECOLOGY, V90, P1463, DOI 10.1890/08-1626.1; McKechnie AE, 2004, OECOLOGIA, V140, P191, DOI 10.1007/s00442-004-1564-9; Middleton NJ, WORLD ATLAS DESERTIF; NAGY KA, 1972, J COMP PHYSIOL, V79, P39, DOI 10.1007/BF00693617; Sabo JL, 2008, ECOL MONOGR, V78, P615, DOI 10.1890/07-1382.1; Sanzone DM, 2003, OECOLOGIA, V134, P238, DOI 10.1007/s00442-002-1113-3; SCHOELLER DA, 1986, AM J PHYSIOL, V251, pR1137, DOI 10.1152/ajpregu.1986.251.6.R1137; Soykan C, 2007, THESIS ARIZONA STATE; TATNER P, 1988, J THEOR BIOL, V133, P267, DOI 10.1016/S0022-5193(88)80321-7; West AG, 2006, RAPID COMMUN MASS SP, V20, P1317, DOI 10.1002/rcm.2456; Wolf BO, 2002, ECOLOGY, V83, P1286, DOI 10.1890/0012-9658(2002)083[1286:SIRTSF]2.0.CO;2; Zar JH, 1999, BIOSTATISTICAL ANAL	40	12	12	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15696	10.1371/journal.pone.0015696	http://dx.doi.org/10.1371/journal.pone.0015696			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209877	Green Submitted, Green Published, gold			2022-12-27	WOS:000285838900027
J	Chittenden, TW; Pak, J; Rubio, R; Cheng, HL; Holton, K; Prendergast, N; Glinskii, V; Cai, Y; Culhane, A; Bentink, S; Schwede, M; Mar, JC; Howe, EA; Aryee, M; Sultana, R; Lanahan, AA; Taylor, JM; Holmes, C; Hahn, WC; Zhao, JJ; Iglehart, JD; Quackenbush, J				Chittenden, Thomas W.; Pak, Jane; Rubio, Renee; Cheng, Hailing; Holton, Kristina; Prendergast, Niall; Glinskii, Vladimir; Cai, Yi; Culhane, Aedin; Bentink, Stefan; Schwede, Mathew; Mar, Jessica C.; Howe, Eleanor A.; Aryee, Martin; Sultana, Razvan; Lanahan, Anthony A.; Taylor, Jennifer M.; Holmes, Chris; Hahn, William C.; Zhao, Jean J.; Iglehart, J. Dirk; Quackenbush, John			Therapeutic Implications of GIPC1 Silencing in Cancer	PLOS ONE			English	Article							GENE-EXPRESSION-DATA; PDZ DOMAIN PROTEIN; TGF-BETA RECEPTOR; INTERACTING PROTEIN; MOLECULAR SUBTYPES; CYTOPLASMIC DOMAIN; BREAST-CANCER; SYNECTIN; GROWTH; PATHWAY	GIPC1 is a cytoplasmic scaffold protein that interacts with numerous receptor signaling complexes, and emerging evidence suggests that it plays a role in tumorigenesis. GIPC1 is highly expressed in a number of human malignancies, including breast, ovarian, gastric, and pancreatic cancers. Suppression of GIPC1 in human pancreatic cancer cells inhibits in vivo tumor growth in immunodeficient mice. To better understand GIPC1 function, we suppressed its expression in human breast and colorectal cancer cell lines and human mammary epithelial cells (HMECs) and assayed both gene expression and cellular phenotype. Suppression of GIPC1 promotes apoptosis in MCF-7, MDA-MD231, SKBR-3, SW480, and SW620 cells and impairs anchorage-independent colony formation of HMECs. These observations indicate GIPC1 plays an essential role in oncogenic transformation, and its expression is necessary for the survival of human breast and colorectal cancer cells. Additionally, a GIPC1 knock-down gene signature was used to interrogate publically available breast and ovarian cancer microarray datasets. This GIPC1 signature statistically correlates with a number of breast and ovarian cancer phenotypes and clinical outcomes, including patient survival. Taken together, these data indicate that GIPC1 inhibition may represent a new target for therapeutic development for the treatment of human cancers.	[Chittenden, Thomas W.; Pak, Jane; Rubio, Renee; Holton, Kristina; Prendergast, Niall; Glinskii, Vladimir; Cai, Yi; Culhane, Aedin; Bentink, Stefan; Schwede, Mathew; Mar, Jessica C.; Howe, Eleanor A.; Sultana, Razvan; Quackenbush, John] Dana Farber Canc Inst, Funct Genom & Computat Biol Grp, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Chittenden, Thomas W.; Pak, Jane; Rubio, Renee; Holton, Kristina; Prendergast, Niall; Glinskii, Vladimir; Cai, Yi; Culhane, Aedin; Bentink, Stefan; Schwede, Mathew; Mar, Jessica C.; Howe, Eleanor A.; Sultana, Razvan; Quackenbush, John] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Chittenden, Thomas W.; Culhane, Aedin; Bentink, Stefan; Mar, Jessica C.; Quackenbush, John] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Chittenden, Thomas W.; Howe, Eleanor A.; Holmes, Chris] Univ Oxford, Dept Stat, Oxford Ctr Gene Funct, Oxford OX1 3TG, England; [Cheng, Hailing; Zhao, Jean J.; Iglehart, J. Dirk] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Aryee, Martin] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Aryee, Martin] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Lanahan, Anthony A.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Taylor, Jennifer M.] CSIRO Plant Ind, Canberra, ACT, Australia; [Hahn, William C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Hahn, William C.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA; [Hahn, William C.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; University of Oxford; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Yale University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute	Chittenden, TW (corresponding author), Dana Farber Canc Inst, Funct Genom & Computat Biol Grp, Dept Biostat & Computat Biol, Boston, MA 02115 USA.	johnq@jimmy.harvard.edu	Taylor, Jennifer M/A-1686-2010; Aryee, Martin/AAC-8113-2020; Culhane, Aedin/AAG-8490-2019	Taylor, Jennifer M/0000-0003-4231-0181; Culhane, Aedin/0000-0002-1395-9734; Quackenbush, John/0000-0002-2702-5879; Mar, Jessica/0000-0002-5147-9299	Dana-Farber Strategic Fund Initiative; Claudia Adams Barr Foundation; National Library of Medicine of the United States National Institutes of Health [R01LM010129]; NATIONAL CANCER INSTITUTE [R01CA134502] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010129] Funding Source: NIH RePORTER; MRC [MC_UP_A390_1107, G0500115] Funding Source: UKRI; Medical Research Council [G0500115, MC_UP_A390_1107] Funding Source: researchfish	Dana-Farber Strategic Fund Initiative; Claudia Adams Barr Foundation; National Library of Medicine of the United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	T.W.C, A.C., J.Q., J.P., R.R., K.H., N.P., V.G., Y.C., S.B., M.S., J.C.M., E.A.H., M.A., and R.S. were supported by funds from the Dana-Farber Strategic Fund Initiative and the Claudia Adams Barr Foundation. J.Q. and J.C.M were supported in part by a grant from the National Library of Medicine (R01LM010129) of the United States National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Blobe GC, 2001, J BIOL CHEM, V276, P39608, DOI 10.1074/jbc.M106831200; Cai HB, 1999, J NEUROSCI, V19, P6519; Chittenden TW, 2006, DEV CELL, V10, P783, DOI 10.1016/j.devcel.2006.03.012; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Finger EC, 2008, J BIOL CHEM, V283, P34808, DOI 10.1074/jbc.M804741200; Gao YH, 2000, J CELL PHYSIOL, V184, P373, DOI 10.1002/1097-4652(200009)184:3<373::AID-JCP12>3.0.CO;2-I; Goeman JJ, 2005, BIOINFORMATICS, V21, P1950, DOI 10.1093/bioinformatics/bti267; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Kato H, 2004, FEBS LETT, V572, P123, DOI 10.1016/j.febslet.2004.07.017; Katoh M, 2002, INT J MOL MED, V9, P585; KELLERPINTER A, 2010, CELL MOL LIFE SCI; Kirikoshi H, 2002, INT J MOL MED, V9, P509; Kirikoshi H, 2002, INT J ONCOL, V20, P1183; Lanahan AA, 2006, PHYSIOL GENOMICS, V27, P380, DOI 10.1152/physiolgenomics.00145.2006; Ligensa T, 2001, J BIOL CHEM, V276, P33419, DOI 10.1074/jbc.M104509200; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Lottaz C, 2006, BIOINFORMATICS, V22, P2315, DOI 10.1093/bioinformatics/btl385; Lou XJ, 2001, MOL BIOL CELL, V12, P615, DOI 10.1091/mbc.12.3.615; Muders M H, 2007, Verh Dtsch Ges Pathol, V91, P286; Muders MH, 2006, CANCER RES, V66, P10264, DOI 10.1158/0008-5472.CAN-06-2321; Muders MH, 2009, CLIN CANCER RES, V15, P4095, DOI 10.1158/1078-0432.CCR-08-2837; Rudchenko S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-248; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Tan C, 2001, DEVELOPMENT, V128, P3665; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Yavelsky V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-247; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6	36	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15581	10.1371/journal.pone.0015581	http://dx.doi.org/10.1371/journal.pone.0015581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209904	gold, Green Published, Green Submitted			2022-12-27	WOS:000285793600021
J	Jorgensen, KW; Buus, S; Nielsen, M				Jorgensen, Kasper Winther; Buus, Soren; Nielsen, Morten			Structural Properties of MHC Class II Ligands, Implications for the Prediction of MHC Class II Epitopes	PLOS ONE			English	Article							T-CELL RECOGNITION; ANTIGEN	Major Histocompatibility class II (MHC-II) molecules sample peptides from the extracellular space allowing the immune system to detect the presence of foreign microbes from this compartment. Prediction of MHC class II ligands is complicated by the open binding cleft of the MHC class II molecule, allowing binding of peptides extending out of the binding groove. Furthermore, only a few HLA-DR alleles have been characterized with a sufficient number of peptides (100-200 peptides per allele) to derive accurate description of their binding motif. Little work has been performed characterizing structural properties of MHC class II ligands. Here, we perform one such large-scale analysis. A large set of SYFPEITHI MHC class II ligands covering more than 20 different HLA-DR molecules was analyzed in terms of their secondary structure and surface exposure characteristics in the context of the native structure of the corresponding source protein. We demonstrated that MHC class II ligands are significantly more exposed and have significantly more coil content than other peptides in the same protein with similar predicted binding affinity. We next exploited this observation to derive an improved prediction method for MHC class II ligands by integrating prediction of MHC- peptide binding with prediction of surface exposure and protein secondary structure. This combined prediction method was shown to significantly outperform the state-of-the-art MHC class II peptide binding prediction method when used to identify MHC class II ligands. We also tried to integrate N- and O-glycosylation in our prediction methods but this additional information was found not to improve prediction performance. In summary, these findings strongly suggest that local structural properties influence antigen processing and/or the accessibility of peptides to the MHC class II molecule.	[Jorgensen, Kasper Winther; Nielsen, Morten] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Buus, Soren] Univ Copenhagen, Expt Immunol Lab, Fac Hlth Sci, Copenhagen, Denmark	Technical University of Denmark; University of Copenhagen	Jorgensen, KW (corresponding author), Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark.	mniel@cbs.dtu.dk	Buus, Soren/F-5446-2010; Nielsen, Morten/AAL-8700-2020; Nielsen, Morten/E-7754-2011	Nielsen, Morten/0000-0001-7885-4311; Nielsen, Morten/0000-0001-7885-4311; Buus, Soren/0000-0001-8363-1999	National Institutes of Health [HHSN272200900045C]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a National Institutes of Health grant (contract no. HHSN272200900045C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; BARLOW DJ, 1986, NATURE, V322, P747, DOI 10.1038/322747a0; BERZOFSKY JA, 1983, SURV IMMUNOL RES, V2, P223; Brodsky F M, 1992, Trends Cell Biol, V2, P109, DOI 10.1016/0962-8924(92)90015-F; Carmicle S, 2007, MOL IMMUNOL, V44, P1159, DOI 10.1016/j.molimm.2006.06.014; Dengjel J, 2005, J MASS SPECTROM, V40, P100, DOI 10.1002/jms.780; Doytchinova IA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-131; Faraggi E, 2009, PROTEINS, V74, P847, DOI 10.1002/prot.22193; GalliStampino L, 1997, CANCER RES, V57, P3214; ISHIOKA GY, 1992, J IMMUNOL, V148, P2446; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; LANZAVECCHIA A, 1987, IMMUNOL REV, V99, P39, DOI 10.1111/j.1600-065X.1987.tb01171.x; Nielsen M, 2010, IMMUNOLOGY, V130, P319, DOI 10.1111/j.1365-2567.2010.03268.x; Nielsen M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000107; OZAKI S, 1987, J IMMUNOL, V138, P4133; Paul B, 2008, FUNDAMENTAL IMMUNOLO; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Rao XY, 2009, J IMMUNOL, V182, P1526, DOI 10.4049/jimmunol.182.3.1526; Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018; Stranzl T, 2010, IMMUNOGENETICS, V62, P357, DOI 10.1007/s00251-010-0441-4; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Van Regenmortal Marc H. V., 1996, Methods (Orlando), V9, P465, DOI 10.1006/meth.1996.0054; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51	24	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15877	10.1371/journal.pone.0015877	http://dx.doi.org/10.1371/journal.pone.0015877			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209859	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793600048
J	Khurana, S; Li, WK; Atkinson, NS				Khurana, Sukant; Li, Wen-Ke; Atkinson, Nigel S.			Image Enhancement for Tracking the Translucent Larvae of Drosophila melanogaster	PLOS ONE			English	Article							SENSORY INPUT; REAL-TIME; BEHAVIOR; SYSTEM; MODEL; TASTE	Drosophila melanogaster larvae are model systems for studies of development, synaptic transmission, sensory physiology, locomotion, drug discovery, and learning and memory. A detailed behavioral understanding of larvae can advance all these fields of neuroscience. Automated tracking can expand fine-grained behavioral analysis, yet its full potential remains to be implemented for the larvae. All published methods are unable to track the larvae near high contrast objects, including the petri-dish edges encountered in many behavioral paradigms. To alleviate these issues, we enhanced the larval contrast to obtain complete tracks. Our method employed a dual approach of optical-contrast boosting and post-hoc image processing for contrast enhancement. We reared larvae on black food media to enhance their optical contrast through darkening of their digestive tracts. For image processing we performed Frame Averaging followed by Subtraction then Thresholding (FAST). This algorithm can remove all static objects from the movie, including petri-dish edges prior to processing by the image-tracking module. This dual approach for contrast enhancement also succeeded in overcoming fluctuations in illumination caused by the alternating current power source. Our tracking method yields complete tracks, including at the edges of the behavioral arena and is computationally fast, hence suitable for high-throughput fine-grained behavioral measurements.	[Khurana, Sukant] Univ Texas Austin, Neurobiol Sect, Austin, TX 78712 USA; Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Khurana, S (corresponding author), Univ Texas Austin, Neurobiol Sect, Austin, TX 78712 USA.	sukant@mail.utexas.edu		Khurana, Sukant/0000-0002-6665-6892	NSF [IOS-0641370]	NSF(National Science Foundation (NSF))	NSF grant IOS-0641370 to N.S.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACEVESPINA FO, 1979, SCIENCE, V206, P93, DOI 10.1126/science.206.4414.93; Asahina K, 2008, CURR BIOL, V18, P1153, DOI 10.1016/j.cub.2008.06.075; Bellen HJ, 2010, NAT REV NEUROSCI, V11, P514, DOI 10.1038/nrn2839; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Cole BJ, 1996, AM NAT, V148, P1, DOI 10.1086/285908; Dukas R, 1999, BEHAV ECOL SOCIOBIOL, V45, P195, DOI 10.1007/s002650050553; Fontaine Ebraheem, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P3716; Gerber B, 2009, RESULTS PROBL CELL D, V47, P139, DOI 10.1007/400_2008_9; HASEGAWA K, 1988, PHYSIOL BEHAV, V42, P397, DOI 10.1016/0031-9384(88)90282-X; Hassan J, 2000, BEHAV GENET, V30, P59, DOI 10.1023/A:1002090627601; Heimbeck G, 1999, J NEUROSCI, V19, P6599; Honjo K, 2009, J NEUROSCI, V29, P852, DOI 10.1523/JNEUROSCI.1315-08.2009; Hoy JB, 1996, J NEUROSCI METH, V64, P157, DOI 10.1016/0165-0270(95)00121-2; Hussaini A, 2003, CURR SCI INDIA, V85, P857; Khurana Sukant, 2003, Drosophila Information Service, V86, P151; Khurana S, 2009, J BIOSCIENCES, V34, P621, DOI 10.1007/s12038-009-0080-9; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Kreher SA, 2008, NEURON, V59, P110, DOI 10.1016/j.neuron.2008.06.010; Liu L, 2003, NEURON, V39, P133, DOI 10.1016/S0896-6273(03)00394-5; Louis M, 2008, NAT NEUROSCI, V11, P187, DOI 10.1038/nn2031; Pauls D, 2010, CHEM SENSES, V35, P335, DOI 10.1093/chemse/bjq023; Ramazani RB, 2007, J NEUROSCI METH, V162, P171, DOI 10.1016/j.jneumeth.2007.01.005; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; ROBB JA, 1969, J CELL BIOL, V41, P876, DOI 10.1083/jcb.41.3.876; Selcho M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005897; Shapiro L.G., 2001, COMPUTER VISION, P137; Stilwell GE, 2006, EUR J NEUROSCI, V24, P2211, DOI 10.1111/j.1460-9568.2006.05075.x; Tsechpenakis G, 2008, IEEE T BIO-MED ENG, V55, P1539, DOI 10.1109/TBME.2008.918582; Tsen C, 2008, J MED CHEM, V51, P324, DOI 10.1021/jm701198s	29	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15259	10.1371/journal.pone.0015259	http://dx.doi.org/10.1371/journal.pone.0015259			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209929	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793600016
J	Xi, JF; Wang, YF; Zhang, P; He, LJ; Nan, X; Yue, W; Pei, XT				Xi, Jiafei; Wang, Yunfang; Zhang, Peng; He, Lijuan; Nan, Xue; Yue, Wen; Pei, Xuetao			Human Fetal Liver Stromal Cells That Overexpress bFGF Support Growth and Maintenance of Human Embryonic Stem Cells	PLOS ONE			English	Article							PROLONGED UNDIFFERENTIATED GROWTH; II IGF-II; SELF-RENEWAL; CULTURE-CONDITIONS; FEEDER LAYERS; DEFINED CONDITIONS; HUMAN BLASTOCYSTS; IN-VITRO; DIFFERENTIATION; LINES	In guiding hES cell technology toward the clinic, one key issue to be addressed is to culture and maintain hES cells much more safely and economically in large scale. In order to avoid using mouse embryonic fibroblasts (MEFs) we isolated human fetal liver stromal cells (hFLSCs) from 14 weeks human fetal liver as new human feeder cells. hFLSCs feeders could maintain hES cells for 15 passages (about 100 days). Basic fibroblast growth factor (bFGF) is known to play an important role in promoting self-renewal of human embryonic stem (hES) cells. So, we established transgenic hFLSCs that stably express bFGF by lentiviral vectors. These transgenic human feeder cells - bFGF-hFLSCs maintained the properties of H9 hES cells without supplementing with any exogenous growth factors. H9 hES cells culturing under these conditions maintained all hES cell features after prolonged culture, including the developmental potential to differentiate into representative tissues of all three embryonic germ layers, unlimited and undifferentiated proliferative ability, and maintenance of normal karyotype. Our results demonstrated that bFGF-hFLSCs feeder cells were central to establishing the signaling network among bFGF, insulin-like growth factor 2 (IGF-2), and transforming growth factor beta (TGF-beta), thereby providing the framework in which hES cells were instructed to self-renew or to differentiate. We also found that the conditioned medium of bFGF-hFLSCs could maintain the H9 hES cells under feeder-free conditions without supplementing with bFGF. Taken together, bFGF-hFLSCs had great potential as feeders for maintaining pluripotent hES cell lines more safely and economically.	[Xi, Jiafei; Wang, Yunfang; Zhang, Peng; He, Lijuan; Nan, Xue; Yue, Wen; Pei, Xuetao] Beijing Inst Transfus Med, Stem Cell & Regenerat Med Lab, Beijing, Peoples R China		Xi, JF (corresponding author), Beijing Inst Transfus Med, Stem Cell & Regenerat Med Lab, Beijing, Peoples R China.	wenyue26@yahoo.com; peixt@nic.bmi.ac.cn	Zhang, Peng/B-6898-2014	Zhang, Peng/0000-0001-5574-0899; Yue, Wen/0000-0002-3935-360X	National High Technology Research and Development Program of China [2006AA02A107]; Major State Basic Research Program of China [2009CB941102, 2011CB964804]; Project of Beijing Municipal Science & Technology Commission [D07050701350702]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Major State Basic Research Program of China(National Basic Research Program of China); Project of Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission)	This work was supported by National High Technology Research and Development Program of China (No: 2006AA02A107 to X.T.P.), the Major State Basic Research Program of China (No: 2009CB941102 to W.Y. and No: 2011CB964804 to W.Y.), and the Project of Beijing Municipal Science & Technology Commission (No: D07050701350702 to X.T.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Amit M, 2003, BIOL REPROD, V68, P2150, DOI 10.1095/biolreprod.102.012583; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Braam SR, 2008, NAT PROTOC, V3, P1435, DOI 10.1038/nprot.2008.140; Cai LH, 2007, CELL RES, V17, P62, DOI 10.1038/sj.cr.7310138; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chen HF, 2009, HUM REPROD, V24, P1114, DOI 10.1093/humrep/dep003; Cheng LZ, 2003, STEM CELLS, V21, P131, DOI 10.1634/stemcells.21-2-131; Choo A, 2008, METHOD CELL BIOL, V86, P15, DOI 10.1016/S0091-679X(08)00002-2; Dvorak P, 2005, STEM CELLS, V23, P1200, DOI 10.1634/stemcells.2004-0303; Eiselleova L, 2008, INT J DEV BIOL, V52, P353, DOI 10.1387/ijdb.082590le; Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105; GABBITAS B, 1994, ENDOCRINOLOGY, V135, P284, DOI 10.1210/en.135.1.284; Greber B, 2007, STEM CELLS, V25, P455, DOI 10.1634/stemcells.2006-0476; Ji L, 2009, J CELL PHYSIOL, V221, P54, DOI 10.1002/jcp.21826; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Miyamoto K, 2004, STEM CELLS, V22, P433, DOI 10.1634/stemcells.22-4-433; Montes R, 2009, CELL RES, V19, P698, DOI 10.1038/cr.2009.35; NEWMANSMITH ED, 1995, DEVELOPMENT, V121, P2069; O'Dell SD, 1998, INT J BIOCHEM CELL B, V30, P767, DOI 10.1016/S1357-2725(98)00048-X; Peng H, 2002, J NEUROCHEM, V81, P506, DOI 10.1046/j.1471-4159.2002.00833.x; PONS S, 1992, ENDOCRINOLOGY, V131, P2271, DOI 10.1210/en.131.5.2271; Rajala K, 2007, HUM REPROD, V22, P1231, DOI 10.1093/humrep/del523; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; Richards M, 2003, STEM CELLS, V21, P546, DOI 10.1634/stemcells.21-5-546; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Saxena S, 2008, MOL REPROD DEV, V75, P1523, DOI 10.1002/mrd.20895; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; TAKAHASHI A, 1995, J VET MED SCI, V57, P553, DOI 10.1292/jvms.57.553; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wang GW, 2005, BIOCHEM BIOPH RES CO, V330, P934, DOI 10.1016/j.bbrc.2005.03.058; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Xi JF, 2007, PROG BIOCHEM BIOPHYS, V34, P207; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Zhang CC, 2004, BLOOD, V103, P2513, DOI 10.1182/blood-2003-08-2955; Zhou HS, 2008, DIFFERENTIATION, V76, P923, DOI 10.1111/j.1432-0436.2008.00280.x	46	21	25	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e14457	10.1371/journal.pone.0014457	http://dx.doi.org/10.1371/journal.pone.0014457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209880	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793600004
J	Zhang, HY; Mao, XG; Wang, CS; Jing, RL				Zhang, Hongying; Mao, Xinguo; Wang, Chengshe; Jing, Ruilian			Overexpression of a Common Wheat Gene TaSnRK2.8 Enhances Tolerance to Drought, Salt and Low Temperature in Arabidopsis	PLOS ONE			English	Article							SNF1-RELATED PROTEIN-KINASES; ABSCISIC-ACID; HYPEROSMOTIC STRESS; SIGNAL-TRANSDUCTION; ENCODES; IDENTIFICATION; METABOLISM; ACTIVATION; EXPRESSION; CALCIUM	Drought, salinity and low temperatures are major factors limiting crop productivity and quality. Sucrose non-fermenting1-related protein kinase 2 (SnRK2) plays a key role in abiotic stress signaling in plants. In this study, TaSnRK2.8, a SnRK2 member in wheat, was cloned and its functions under multi-stress conditions were characterized. Subcellular localization showed the presence of TaSnRK2.8 in the cell membrane, cytoplasm and nucleus. Expression pattern analyses in wheat revealed that TaSnRK2.8 was involved in response to PEG, NaCl and cold stresses, and possibly participates in ABA-dependent signal transduction pathways. To investigate its role under various environmental stresses, TaSnRK2.8 was transferred to Arabidopsis under control of the CaMV-35S promoter. Overexpression of TaSnRK2.8 resulted in enhanced tolerance to drought, salt and cold stresses, further confirmed by longer primary roots and various physiological characteristics, including higher relative water content, strengthened cell membrane stability, significantly lower osmotic potential, more chlorophyll content, and enhanced PSII activity. Meanwhile, TaSnRK2.8 plants had significantly lower total soluble sugar levels under normal growing conditions, suggesting that TaSnRK2.8 might be involved in carbohydrate metabolism. Moreover, the transcript levels of ABA biosynthesis (ABA1, ABA2), ABA signaling (ABI3, ABI4, ABI5), stress-responsive genes, including two ABA-dependent genes (RD20A, RD29B) and three ABA-independent genes (CBF1, CBF2, CBF3), were generally higher in TaSnRK2.8 plants than in WT/GFP controls under normal/stress conditions. Our results suggest that TaSnRK2.8 may act as a regulatory factor involved in a multiple stress response pathways.	[Zhang, Hongying; Wang, Chengshe] NW A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China; [Zhang, Hongying; Mao, Xinguo; Jing, Ruilian] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China	Northwest A&F University - China; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Zhang, HY (corresponding author), NW A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China.	jingrl@caas.net.cn	Xinguo, Mao/AAF-3195-2020	Xinguo, Mao/0000-0003-4712-437X	National Key Technologies RD Program [2009ZX08002-012B]; National Science Foundation [NSF31040089]	National Key Technologies RD Program(National Key Technology R&D Program); National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Key Technologies R&D Program (2009ZX08002-012B) and the National Science Foundation (NSF31040089). The funders had no role in study design, data collection and analysis, decision to publish.	ANDERBERG RJ, 1992, P NATL ACAD SCI USA, V89, P10183, DOI 10.1073/pnas.89.21.10183; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Boudsocq M, 2004, J BIOL CHEM, V279, P41758, DOI 10.1074/jbc.M405259200; Boudsocq M, 2007, PLANT MOL BIOL, V63, P491, DOI 10.1007/s11103-006-9103-1; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Claussen W, 2005, PLANT SCI, V168, P241, DOI 10.1016/j.plantsci.2004.07.039; Cullen PJ, 2000, P NATL ACAD SCI USA, V97, P13619, DOI 10.1073/pnas.240345197; Diedhiou CJ, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-49; Ding ZH, 2009, J GENET GENOMICS, V36, P17, DOI 10.1016/S1673-8527(09)60003-5; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; Gong DM, 2002, PLANT PHYSIOL, V130, P256, DOI 10.1104/pp.004507; Granier C, 1999, PLANT PHYSIOL, V119, P609, DOI 10.1104/pp.119.2.609; Guo Y, 2001, PLANT CELL, V13, P1383, DOI 10.1105/tpc.13.6.1383; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Halford NG, 2003, J EXP BOT, V54, P467, DOI 10.1093/jxb/erg038; Halford NG, 1998, PLANT MOL BIOL, V37, P735, DOI 10.1023/A:1006024231305; Halford NG, 2009, BIOCHEM J, V419, P247, DOI 10.1042/BJ20082408; HARMON AC, 1994, BIOCHEMISTRY-US, V33, P7278, DOI 10.1021/bi00189a032; Harmon Alice C, 2003, Gravit Space Biol Bull, V16, P83; HARPER JF, 1994, BIOCHEMISTRY-US, V33, P7267, DOI 10.1021/bi00189a031; Hrabak EM, PLANT PHYSL, V132, P666; HU CAA, 1992, P NATL ACAD SCI USA, V89, P9354, DOI 10.1073/pnas.89.19.9354; Huai JL, 2008, PLANT CELL REP, V27, P1861, DOI 10.1007/s00299-008-0608-8; Huang JF, 1996, BIOCHEMISTRY-US, V35, P13222, DOI 10.1021/bi960498a; Ishitani M, 2000, PLANT CELL, V12, P1667, DOI 10.1105/tpc.12.9.1667; Jonak C, 1996, P NATL ACAD SCI USA, V93, P11274, DOI 10.1073/pnas.93.20.11274; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kim J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9r87; Knight H, 2001, TRENDS PLANT SCI, V6, P262, DOI 10.1016/S1360-1385(01)01946-X; Kobayashi Y, 2005, PLANT J, V44, P939, DOI 10.1111/j.1365-313X.2005.02583.x; Kobayashi Y, 2004, PLANT CELL, V16, P1163, DOI 10.1105/tpc.019943; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Kuchin S, 2000, P NATL ACAD SCI USA, V97, P7916, DOI 10.1073/pnas.140109897; Leung J, 1997, PLANT CELL, V9, P759, DOI 10.1105/tpc.9.5.759; LEUNG J, 1994, SCIENCE, V264, P1448, DOI 10.1126/science.7910981; Liu JP, 2000, P NATL ACAD SCI USA, V97, P3730, DOI 10.1073/pnas.060034197; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig AA, 2004, J EXP BOT, V55, P181, DOI 10.1093/jxb/erh008; Mao XG, 2010, J EXP BOT, V61, P683, DOI 10.1093/jxb/erp331; Pang XiaoBin, 2007, Acta Agronomica Sinica, V33, P333; Podell S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-37; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Shin R, 2007, P NATL ACAD SCI USA, V104, P6460, DOI 10.1073/pnas.0610208104; Strasser R.J., 2000, PROBING PHOTOSYNTHES, P445; Takahashi S, 2001, PLANT CELL PHYSIOL, V42, P214, DOI 10.1093/pcp/pce028; Umezawa T, 2004, P NATL ACAD SCI USA, V101, P17306, DOI 10.1073/pnas.0407758101; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; Wang ZQ, 2007, J PLANT PHYSIOL, V164, P695, DOI 10.1016/j.jplph.2006.05.001; Xiong LM, 2003, PLANT PHYSIOL, V133, P29, DOI 10.1104/pp.103.025395; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xu W, 2000, PLANT BREEDING, V119, P365, DOI 10.1046/j.1439-0523.2000.00506.x; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; YEMM EW, 1954, BIOCHEM J, V57, P508, DOI 10.1042/bj0570508; ZEEVAART JAD, 1988, ANNU REV PLANT PHYS, V39, P439, DOI 10.1146/annurev.pp.39.060188.002255; Zheng ZF, 2010, PLANT PHYSIOL, V153, P99, DOI 10.1104/pp.109.150789; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	58	123	143	4	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e16041	10.1371/journal.pone.0016041	http://dx.doi.org/10.1371/journal.pone.0016041			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209856	Green Published, Green Submitted, gold			2022-12-27	WOS:000285793600059
J	Aki, A; Nair, BG; Morimoto, H; Kumar, DS; Maekawa, T				Aki, Atsushi; Nair, Baiju G.; Morimoto, Hisao; Kumar, D. Sakthi; Maekawa, Toru			Label-Free Determination of the Number of Biomolecules Attached to Cells by Measurement of the Cell's Electrophoretic Mobility in a Microchannel	PLOS ONE			English	Article							BLOOD; PROTEIN	We developed a label-free method for a determination of the number of biomolecules attached to individual cells by measuring the electrophoretic mobility of the cells in a microchannel. The surface of a biological cell, which is dispersed in aqueous solution, is normally electrically charged and the charge quantity at the cell's surface is slightly changed once antibody molecules are attached to the cell, based on which we detect the attachment of antibody molecules to the surface of individual red blood cells by electrophoretic mobility measurement. We also analyzed the number of antibody molecules attached to the cell's surface using a flow cytometer. We found that there is a clear correlation between the number of antibody molecules attached to the individual cells and the electophoretic mobility of the cells. The present technique may well be utilized not only in the field of cell biology but also in the medical and pharmaceutical industries.	[Aki, Atsushi; Nair, Baiju G.; Morimoto, Hisao; Kumar, D. Sakthi; Maekawa, Toru] Toyo Univ, Bionano Elect Res Ctr, Kawagoe, Saitama, Japan	Toyo University	Aki, A (corresponding author), Toyo Univ, Bionano Elect Res Ctr, Kawagoe, Saitama, Japan.	maekawa@toyo.jp	; /M-7880-2013	Kumar, Sakthi/0000-0003-4624-7327; /0000-0002-1616-8807	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the High-Tech Research Centre Fund organized by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AA, 2008, J AM CHEM SOC, V130, P8633, DOI 10.1021/ja8015022; Akagi T, 2008, ANAL BIOANAL CHEM, V391, P2433, DOI 10.1007/s00216-008-2203-9; Aki A, 2008, SENSOR ACTUAT B-CHEM, V131, P285, DOI 10.1016/j.snb.2007.11.046; Alberts B., 2004, MOL BIOL CELL; Baksh MM, 2004, NATURE, V427, P139, DOI 10.1038/nature02209; BAUER J, 1994, CELL ELECTROPHORESIS; Carbonaro A, 2008, LAB CHIP, V8, P1478, DOI 10.1039/b801929k; Chabinyc ML, 2001, ANAL CHEM, V73, P4491, DOI 10.1021/ac010423z; Diaspro A, 2002, LANGMUIR, V18, P5047, DOI 10.1021/la025646e; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Hultin LE, 1998, CYTOMETRY, V33, P123, DOI 10.1002/(SICI)1097-0320(19981001)33:2<123::AID-CYTO6>3.0.CO;2-K; Ichiki T, 2002, ELECTROPHORESIS, V23, P2029, DOI 10.1002/1522-2683(200207)23:13<2029::AID-ELPS2029>3.0.CO;2-R; Mills JP, 2007, P NATL ACAD SCI USA, V104, P9213, DOI 10.1073/pnas.0703433104; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Park YK, 2008, P NATL ACAD SCI USA, V105, P13730, DOI 10.1073/pnas.0806100105; Petty RT, 2007, J AM CHEM SOC, V129, P8966, DOI 10.1021/ja0735709; Puckett CA, 2007, J AM CHEM SOC, V129, P46, DOI 10.1021/ja0677564; Saleh OA, 2003, NANO LETT, V3, P37, DOI 10.1021/nl0255202; Satake D, 2008, SENSOR ACTUAT B-CHEM, V83, P77; Steinem C, 2004, CHEMPHYSCHEM, V5, P1121, DOI 10.1002/cphc.200400092; Takahashi N, 2010, SENS ACTU B IN PRESS; Whitesides GM, 2001, PHYS TODAY, V54, P42, DOI 10.1063/1.1387591; Zhang J, 2004, NANO LETT, V9, P519	24	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15641	10.1371/journal.pone.0015641	http://dx.doi.org/10.1371/journal.pone.0015641			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206908	gold, Green Published, Green Submitted			2022-12-27	WOS:000285793200034
J	Zeng, HQ; Jia, JP; Liu, AM				Zeng, Huiqing; Jia, Jinping; Liu, Aimin			Coordinated Translocation of Mammalian Gli Proteins and Suppressor of Fused to the Primary Cilium	PLOS ONE			English	Article							HEDGEHOG SIGNAL-TRANSDUCTION; INTRAFLAGELLAR TRANSPORT PROTEINS; PALLISTER-HALL SYNDROME; NEGATIVE REGULATOR; REPRESSOR FUNCTIONS; VERTEBRATE LIMB; SENSORY CILIA; DROSOPHILA; MOUSE; ACTIVATOR	Intracellular transduction of Hedgehog (Hh) signals in mammals requires functional primary cilia. The Hh signaling effectors, the Gli family of transcription factors, and their negative regulator, Suppressor of Fused (Sufu), accumulate at the tips of cilia; however, the molecular mechanism regulating this localization remains elusive. In the current study, we show that the ciliary localization of mammalian Gli proteins depends on both their N-terminal domains and a central region lying C-terminal to the zinc-finger DNA-binding domains. Invertebrate Gli homologs Ci and Tra1, when over-expressed in ciliated mouse fibroblasts, fail to localize to the cilia, suggesting the lack of a vertebrate-specific structural feature required for ciliary localization. We further show that activation of protein kinase A (PKA) efficiently inhibits ciliary localization of Gli2 and Gli3, but only moderately affects the ciliary localization of Gli1. Interestingly, variants of Gli2 mimicking the phosphorylated or non-phosphorylated states of Gli2 are both localized to the cilia, and their ciliary localizations are subjected to the inhibitory effect of PKA activation, suggesting a likely indirect mechanism underlying the roles of PKA in Gli ciliary localization. Finally, we show that ciliary localization of Sufu is dependent on ciliary-localized Gli proteins, and is inhibited by PKA activation, suggesting a coordinated mechanism for the ciliary translocation of Sufu and Gli proteins.	[Zeng, Huiqing; Jia, Jinping; Liu, Aimin] Penn State Univ, Dept Biol, Eberly Coll Sci, University Pk, PA 16802 USA; [Liu, Aimin] Penn State Univ, Ctr Cellular Dynam, Huck Inst Life Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Zeng, HQ (corresponding author), Penn State Univ, Dept Biol, Eberly Coll Sci, University Pk, PA 16802 USA.	AXL25@psu.edu		Liu, Aimin/0000-0003-0099-0879	National Science Foundation [0949877]; Penn State University; Direct For Biological Sciences [0949877] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Penn State University; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation 0949877 and The Penn State University start-up fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aza-Blanc P, 2000, DEVELOPMENT, V127, P4293; Bai CB, 2002, DEVELOPMENT, V129, P4753; Bose J, 2002, HUM MOL GENET, V11, P1129, DOI 10.1093/hmg/11.9.1129; Burglin TR., 2006, HOMOLOGS HH SIGNALLI, P1, DOI [10.1895/wormbook.1.76.1, DOI 10.1895/WORMBOOK.1.76.1]; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Cheng SY, 2002, P NATL ACAD SCI USA, V99, P5442, DOI 10.1073/pnas.082096999; Cooper AF, 2005, DEVELOPMENT, V132, P4407, DOI 10.1242/dev.02021; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Ding Q, 1999, CURR BIOL, V9, P1119, DOI 10.1016/S0960-9822(99)80482-5; Dunaeva M, 2003, J BIOL CHEM, V278, P5116, DOI 10.1074/jbc.M209492200; Endoh-Yamagami S, 2009, CURR BIOL, V19, P1320, DOI 10.1016/j.cub.2009.06.046; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Han YG, 2003, CURR BIOL, V13, P1679, DOI 10.1016/j.cub.2003.08.034; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Hoover AN, 2008, DEVELOPMENT, V135, P4049, DOI 10.1242/dev.029835; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Jia JP, 2009, DEV BIOL, V330, P452, DOI 10.1016/j.ydbio.2009.04.009; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kang S, 1997, NAT GENET, V15, P266, DOI 10.1038/ng0397-266; Kim J, 2009, P NATL ACAD SCI USA, V106, P21666, DOI 10.1073/pnas.0912180106; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Lipinski RJ, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-49; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Maynard TM, 2002, MAMM GENOME, V13, P58, DOI 10.1007/s00335-001-2115-X; Methot N, 2000, DEVELOPMENT, V127, P4001; Murone M, 2000, NAT CELL BIOL, V2, P310, DOI 10.1038/35010610; Paces-Fessy M, 2004, BIOCHEM J, V378, P353, DOI 10.1042/BJ20030786; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Pearse RV, 1999, DEV BIOL, V212, P323, DOI 10.1006/dbio.1999.9335; PREAT T, 1992, GENETICS, V132, P725; Rink JC, 2009, SCIENCE, V326, P1406, DOI 10.1126/science.1178712; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Sarpal R, 2003, CURR BIOL, V13, P1687, DOI 10.1016/j.cub.2003.09.025; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Sisson BE, 2006, DEV BIOL, V294, P258, DOI 10.1016/j.ydbio.2006.02.050; Stone DM, 1999, J CELL SCI, V112, P4437; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; von Mering C, 1999, CURR BIOL, V9, P1319, DOI 10.1016/S0960-9822(00)80054-8; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang CB, 2007, DEV BIOL, V305, P460, DOI 10.1016/j.ydbio.2007.02.029; Wang Y, 2009, P NATL ACAD SCI USA, V106, P2623, DOI 10.1073/pnas.0812110106; Wen XH, 2010, MOL CELL BIOL, V30, P1910, DOI 10.1128/MCB.01089-09; Wilson CW, 2010, DEVELOPMENT, V137, P2079, DOI 10.1242/dev.045021; Wilson CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005182	49	38	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15900	10.1371/journal.pone.0015900	http://dx.doi.org/10.1371/journal.pone.0015900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209912	gold, Green Published, Green Submitted			2022-12-27	WOS:000285793200071
J	Zhu, F; Wang, P; Lee, NH; Goldring, MB; Konstantopoulos, K				Zhu, Fei; Wang, Pu; Lee, Norman H.; Goldring, Mary B.; Konstantopoulos, Konstantinos			Prolonged Application of High Fluid Shear to Chondrocytes Recapitulates Gene Expression Profiles Associated with Osteoarthritis	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; NITRIC-OXIDE; IN-VITRO; FUNCTIONAL ANNOTATION; POSSIBLE INVOLVEMENT; MICROARRAY ANALYSIS; SYNOVIAL TISSUE; CANDIDATE GENES; DOWN-REGULATION; CARTILAGE	Background: Excessive mechanical loading of articular cartilage producing hydrostatic stress, tensile strain and fluid flow leads to irreversible cartilage erosion and osteoarthritic (OA) disease. Since application of high fluid shear to chondrocytes recapitulates some of the earmarks of OA, we aimed to screen the gene expression profiles of shear-activated chondrocytes and assess potential similarities with OA chondrocytes. Methodology/Principal Findings: Using a cDNA microarray technology, we screened the differentially-regulated genes in human T/C-28a2 chondrocytes subjected to high fluid shear (20 dyn/cm(2)) for 48 h and 72 h relative to static controls. Confirmation of the expression patterns of select genes was obtained by qRT-PCR. Using significance analysis of microarrays with a 5% false discovery rate, 71 and 60 non-redundant transcripts were identified to be >= 2-fold up-regulated and <= 0.6-fold down-regulated, respectively, in sheared chondrocytes. Published data sets indicate that 42 of these genes, which are related to extracellular matrix/degradation, cell proliferation/differentiation, inflammation and cell survival/death, are differentially-regulated in OA chondrocytes. In view of the pivotal role of cyclooxygenase-2 (COX-2) in the pathogenesis and/or progression of OA in vivo and regulation of shear-induced inflammation and apoptosis in vitro, we identified a collection of genes that are either up-or down-regulated by shear-induced COX-2. COX-2 and L-prostaglandin D synthase (L-PGDS) induce reactive oxygen species production, and negatively regulate genes of the histone and cell cycle families, which may play a critical role in chondrocyte death. Conclusions/Significance: Prolonged application of high fluid shear stress to chondrocytes recapitulates gene expression profiles associated with osteoarthritis. Our data suggest a potential link between exposure of chondrocytes/cartilage to abnormal mechanical loading and the pathogenesis/progression of OA.	[Zhu, Fei; Wang, Pu; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Lee, Norman H.] George Washington Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20037 USA; [Goldring, Mary B.] Hosp Special Surg, New York, NY 10021 USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD USA	Johns Hopkins University; George Washington University; Johns Hopkins University; Johns Hopkins University	Zhu, F (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	kkonsta1@jhu.edu	Konstantopoulos, Konstantinos/A-7045-2011		National Institutes of Health [RO1 AR053358, R01 AG022021]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022021] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health grants RO1 AR053358 (KK)(http://www.niams.nih.gov) and R01 AG022021 (MBG)(http://www.nia.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulencia JP, 2003, J BIOL CHEM, V278, P28388, DOI 10.1074/jbc.M301378200; Aigner T, 2001, ARTHRITIS RHEUM-US, V44, P2777, DOI 10.1002/1529-0131(200112)44:12<2777::AID-ART465>3.0.CO;2-H; Aigner T, 1997, ARTHRITIS RHEUM, V40, P562, DOI 10.1002/art.1780400323; Aigner T, 2006, ARTHRITIS RHEUM-US, V54, P3533, DOI 10.1002/art.22174; Al-Shahrour F, 2005, NUCLEIC ACIDS RES, V33, pW460, DOI 10.1093/nar/gki456; Al-Shahrour F, 2006, NUCLEIC ACIDS RES, V34, pW472, DOI 10.1093/nar/gkl172; Ali K, 2008, ATHEROSCLEROSIS, V196, P201, DOI 10.1016/j.atherosclerosis.2007.03.038; Amin AR, 1997, J CLIN INVEST, V99, P1231, DOI 10.1172/JCI119280; Appleton CTG, 2007, ARTHRITIS RHEUM-US, V56, P1854, DOI 10.1002/art.22711; Backman JT, 1998, VIRCHOWS ARCH, V433, P153, DOI 10.1007/s004280050230; Bramlage CP, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1923; Buckwalter JA, 2006, BIORHEOLOGY, V43, P603; Carter DR, 2003, PHILOS T ROY SOC B, V358, P1461, DOI 10.1098/rstb.2003.1346; Carter DR, 2004, CLIN ORTHOP RELAT R, pS69, DOI 10.1097/01.blo.0000144970.05107.7e; Dai SM, 2006, ARTHRITIS RHEUM-US, V54, P818, DOI 10.1002/art.21639; Dunn S, 2009, MOD RHEUMATOL, V19, P151, DOI 10.1007/s10165-008-0136-y; Fukui N, 2008, ARTHRITIS RHEUM-US, V58, P154, DOI 10.1002/art.23175; Gobezie R, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2172; Goldring MB, 2008, ANN RHEUM DIS, V67, P75, DOI 10.1136/ard.2008.098764; Goldring MB, 2004, METH MOLEC MED, V100, P37; GOLDRING MB, 1988, J CLIN INVEST, V82, P2026, DOI 10.1172/JCI113823; Greim H, 2003, TOXICOL LETT, V138, P1, DOI 10.1016/S0378-4274(02)00408-3; Haas CS, 2006, ARTHRITIS RHEUM-US, V54, P2047, DOI 10.1002/art.21953; Hansen IB, 2006, J RHEUMATOL, V33, P1754; Healy ZR, 2008, AM J PHYSIOL-CELL PH, V294, pC1146, DOI 10.1152/ajpcell.00542.2007; Healy ZR, 2005, P NATL ACAD SCI USA, V102, P14010, DOI 10.1073/pnas.0506620102; Hsieh YS, 2007, J RHEUMATOL, V34, P785; Hu SI, 1998, J BIOL CHEM, V273, P34406, DOI 10.1074/jbc.273.51.34406; Joosten LAB, 2006, P NATL ACAD SCI USA, V103, P3298, DOI 10.1073/pnas.0511233103; Jung N, 2000, SCAND J RHEUMATOL, V29, P222; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Kim CH, 2010, BIOCHEM BIOPH RES CO, V391, P1182, DOI 10.1016/j.bbrc.2009.12.012; Kim HA, 2000, J RHEUMATOL, V27, P455; Kim SR, 2008, MECH AGEING DEV, V129, P706, DOI 10.1016/j.mad.2008.09.003; Kitamura T, 2005, AM J PHYSIOL-CELL PH, V289, pC82, DOI 10.1152/ajpcell.00486.2004; Kobayashi M, 2005, ARTHRITIS RHEUM-US, V52, P128, DOI 10.1002/art.20776; Lee MS, 2003, J CELL BIOCHEM, V90, P80, DOI 10.1002/jcb.10611; Lee MS, 2002, J ORTHOP RES, V20, P556, DOI 10.1016/S0736-0266(01)00149-8; Lin AC, 2009, NAT MED, V15, P1421, DOI 10.1038/nm.2055; Liou JY, 2001, J BIOL CHEM, V276, P34975, DOI 10.1074/jbc.M105946200; Mahr S, 2006, AM J HUM GENET, V78, P793, DOI 10.1086/503849; Mahr Sandra, 2007, Genomic Med, V1, P125, DOI 10.1007/s11568-007-9012-7; Martin JA, 2006, BIORHEOLOGY, V43, P517; Meng JH, 2005, OSTEOARTHR CARTILAGE, V13, P1115, DOI 10.1016/j.joca.2005.03.010; Mohtai M, 1996, J ORTHOP RES, V14, P67, DOI 10.1002/jor.1100140112; Moritani Norifumi H, 2005, Cell Commun Signal, V3, P6, DOI 10.1186/1478-811X-3-6; Nzeako UC, 2002, HEPATOLOGY, V35, P552, DOI 10.1053/jhep.2002.31774; Pattoli MA, 2005, J PHARMACOL EXP THER, V315, P382, DOI 10.1124/jpet.105.087569; Pfander D, 2005, INT ORTHOP, V29, P6, DOI 10.1007/s00264-004-0618-2; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Scanzello CR, 2008, CURR OPIN RHEUMATOL, V20, P565, DOI 10.1097/BOR.0b013e32830aba34; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; Siow HC, 2004, CEPHALALGIA, V24, P414, DOI 10.1111/j.1468-2982.2003.00695.x; Su C, 2004, EMBO J, V23, P1133, DOI 10.1038/sj.emboj.7600120; Tardif G, 2004, ARTHRITIS RHEUM-US, V50, P2521, DOI 10.1002/art.20441; Tiku ML, 2000, J BIOL CHEM, V275, P20069, DOI 10.1074/jbc.M907604199; Trifan OC, 1999, J BIOL CHEM, V274, P34141, DOI 10.1074/jbc.274.48.34141; Ullrich O, 2001, FREE RADICAL BIO MED, V31, P887, DOI 10.1016/S0891-5849(01)00672-4; Valdes AM, 2006, ARTHRITIS RHEUM-US, V54, P533, DOI 10.1002/art.21621; Wang P, 2010, J BIOL CHEM, V285, P24793, DOI 10.1074/jbc.M110.110320; Wang P, 2010, AM J PHYSIOL-CELL PH, V298, pC1445, DOI 10.1152/ajpcell.00508.2009; Wang WZ, 2009, OSTEOARTHR CARTILAGE, V17, P83, DOI 10.1016/j.joca.2008.05.008; Welch ID, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2604; Yamane S, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-5; Yatsugi N, 2000, J Orthop Sci, V5, P150, DOI 10.1007/s007760050142; Yokota H, 2003, J BIOL CHEM, V278, P47275, DOI 10.1074/jbc.M304652200; Zayed N, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2581; Zhang QY, 2009, ARTHRITIS RHEUM-US, V60, P3602, DOI 10.1002/art.24999; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006; Zhu F, 2010, CELL DEATH DIFFER, V17, P1325, DOI 10.1038/cdd.2010.13	70	35	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15174	10.1371/journal.pone.0015174	http://dx.doi.org/10.1371/journal.pone.0015174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209926	Green Published, Green Submitted, gold			2022-12-27	WOS:000285793200018
J	Chu-LaGraff, Q; Blanchette, C; O'Hern, P; Denefrio, C				Chu-LaGraff, Quynh; Blanchette, Cassandra; O'Hern, Patrick; Denefrio, Cassandra			The Batten Disease Palmitoyl Protein Thioesterase 1 Gene Regulates Neural Specification and Axon Connectivity during Drosophila Embryonic Development	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; NERVOUS-SYSTEM LINEAGES; MOLECULAR-CLONING; EXPRESSION; MELANOGASTER; MICE; CNS; NEUROECTODERM; PRECURSOR; ANTIBODY	Palmitoyl Protein Thioesterase 1 (PPT1) is an essential lysosomal protein in the mammalian nervous system whereby defects result in a fatal pediatric disease called Infantile Neuronal Ceroids Lipofuscinosis (INCL). Flies bearing mutations in the Drosophila ortholog Ppt1 exhibit phenotypes similar to the human disease: accumulation of autofluorescence deposits and shortened adult lifespan. Since INCL patients die as young children, early developmental neural defects due to the loss of PPT1 are postulated but have yet to be elucidated. Here we show that Drosophila Ppt1 is required during embryonic neural development. Ppt1 embryos display numerous neural defects ranging from abnormal cell fate specification in a number of identified precursor lineages in the CNS, missing and disorganized neurons, faulty motoneuronal axon trajectory, and discontinuous, misaligned, and incorrect midline crossings of the longitudinal axon bundles of the ventral nerve cord. Defects in the PNS include a decreased number of sensory neurons, disorganized chordotonal neural clusters, and abnormally shaped neurons with aberrant dendritic projections. These results indicate that Ppt1 is essential for proper neuronal cell fates and organization; and to establish the local environment for proper axon guidance and fasciculation. Ppt1 function is well conserved from humans to flies; thus the INCL pathologies may be due, in part, to the accumulation of various embryonic neural defects similar to that of Drosophila. These findings may be relevant for understanding the developmental origin of neural deficiencies in INCL.	[Chu-LaGraff, Quynh; Blanchette, Cassandra; O'Hern, Patrick; Denefrio, Cassandra] Union Coll, Dept Biol, Schenectady, NY 12308 USA	Union College	Chu-LaGraff, Q (corresponding author), Union Coll, Dept Biol, Schenectady, NY 12308 USA.	chulagrq@union.edu	Denefrio, Cassandra/AAV-2261-2021		NIH [NIH-R15 NS046334]; Merck-AAAS; Booth-Ferris; Batten Disease Research and Support Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS046334] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck-AAAS(Merck & Company); Booth-Ferris; Batten Disease Research and Support Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH-R15 NS046334, Merck-AAAS Undergraduate Fellowship, Booth-Ferris Fellowship, and Batten Disease Research and Support Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahtiainen L, 2003, J COMP NEUROL, V455, P368, DOI 10.1002/cne.10492; BODMER R, 1989, NEURON, V3, P21, DOI 10.1016/0896-6273(89)90112-8; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; Broadus J, 1995, DEVELOPMENT, V121, P3989; Buff H, 2007, GENETICS, V176, P209, DOI 10.1534/genetics.106.067983; CAMP LA, 1993, J BIOL CHEM, V268, P22566; CAMP LA, 1994, J BIOL CHEM, V269, P23212; CHULAGRAFF Q, 1995, NEURON, V15, P1041, DOI 10.1016/0896-6273(95)90093-4; CHULAGRAFF Q, 1993, SCIENCE, V261, P1594, DOI 10.1126/science.8372355; Cooper JD, 2003, CURR OPIN NEUROL, V16, P121, DOI 10.1097/00019052-200304000-00001; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Fujioka M, 2003, DEVELOPMENT, V130, P5385, DOI 10.1242/dev.00770; Glaser RL, 2003, GENE, V312, P271, DOI 10.1016/S0378-1119(03)00623-1; Goswami R, 2005, J NEUROSCI RES, V81, P208, DOI 10.1002/jnr.20549; GRENNINGLOH G, 1990, COLD SH Q B, V55, P327; Gupta P, 2001, P NATL ACAD SCI USA, V98, P13566, DOI 10.1073/pnas.251485198; Heinonen O, 2000, MOL GENET METAB, V69, P123, DOI 10.1006/mgme.2000.2961; Hickey AJ, 2006, GENETICS, V172, P2379, DOI 10.1534/genetics.105.053306; Isosomppi J, 1999, DEV BRAIN RES, V118, P1, DOI 10.1016/S0165-3806(99)00115-7; Jalanko A, 2005, NEUROBIOL DIS, V18, P226, DOI 10.1016/j.nbd.2004.08.013; Kielar C, 2009, HUM MOL GENET, V18, P4066, DOI 10.1093/hmg/ddp355; Korey CA, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-30; Landgraf M, 1999, NEURON, V22, P43, DOI 10.1016/S0896-6273(00)80677-7; Lehtovirta M, 2001, HUM MOL GENET, V10, P69, DOI 10.1093/hmg/10.1.69; Little EB, 1998, CELL ADHES COMMUN, V6, P415, DOI 10.3109/15419069809109150; Mole S, 1999, EPILEPSIA, V40, P29, DOI 10.1111/j.1528-1157.1999.tb00896.x; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Soyombo AA, 1997, J BIOL CHEM, V272, P27456, DOI 10.1074/jbc.272.43.27456; Suopanki J, 1999, MOL GENET METAB, V66, P290, DOI 10.1006/mgme.1999.2839; UDOLPH G, 1993, DEVELOPMENT, V118, P765; ZIPURSKY SL, 1985, P NATL ACAD SCI USA, V82, P1855, DOI 10.1073/pnas.82.6.1855	34	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14402	10.1371/journal.pone.0014402	http://dx.doi.org/10.1371/journal.pone.0014402			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203506	gold, Green Published, Green Submitted			2022-12-27	WOS:000285578000009
J	Glover, KA; Kanda, N; Haug, T; Pastene, LA; Oien, N; Goto, M; Seliussen, BB; Skaug, HJ				Glover, Kevin A.; Kanda, Naohisa; Haug, Tore; Pastene, Luis A.; Oien, Nils; Goto, Mutsuo; Seliussen, Bjorghild B.; Skaug, Hans J.			Migration of Antarctic Minke Whales to the Arctic	PLOS ONE			English	Article							ATLANTIC HUMPBACK WHALES; MULTILOCUS GENOTYPE DATA; BALAENOPTERA-ACUTOROSTRATA; POPULATION-STRUCTURE; NORTH-ATLANTIC; MEGAPTERA-NOVAEANGLIAE; MICROSATELLITE LOCI; BALEEN WHALES; FAROE-ISLANDS; INFERENCE	The Antarctic minke whale (Balaenoptera bonaerensis), and the common minke whale found in the North Atlantic (Balaenoptera acutorostrata acutorostrata), undertake synchronized seasonal migrations to feeding areas at their respective poles during spring, and to the tropics in the autumn where they overwinter. Differences in the timing of seasons between hemispheres prevent these species from mixing. Here, based upon analysis of mitochondrial and microsatellite DNA profiles, we report the observation of a single B. bonaerensis in 1996, and a hybrid with maternal contribution from B. bonaerensis in 2007, in the Arctic Northeast Atlantic. Paternal contribution was not conclusively resolved. This is the first documentation of B. bonaerensis north of the tropics, and, the first documentation of hybridization between minke whale species.	[Glover, Kevin A.; Oien, Nils; Seliussen, Bjorghild B.; Skaug, Hans J.] Inst Marine Res, N-5024 Bergen, Norway; [Kanda, Naohisa; Pastene, Luis A.; Goto, Mutsuo] Inst Cetacean Res, Tokyo, Japan; [Haug, Tore] Inst Marine Res, Tromso, Norway; [Skaug, Hans J.] Univ Bergen, Dept Math, N-5007 Bergen, Norway	Institute of Marine Research - Norway; Institute of Marine Research - Norway; University of Bergen	Glover, KA (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	Kevin.glover@imr.no		Breistein, Bjorghild/0000-0002-1805-7190	Institute of Marine Research	Institute of Marine Research	This research was funded by the Institute of Marine Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Als TD, 2006, EUR J HUM GENET, V14, P497, DOI 10.1038/sj.ejhg.5201578; ARNASON U, 1993, MOL BIOL EVOL, V10, P960; Berube M, 1998, MAR MAMMAL SCI, V14, P82, DOI 10.1111/j.1748-7692.1998.tb00692.x; Berube M, 2000, MOL ECOL, V9, P2181; Buchanan FC, 1996, MOL ECOL, V5, P571; BUCKLAND ST, 1989, REP INT WHAL COMMN, V11, P121; CHRISTENSEN I, 1990, MAR MAMMAL SCI, V6, P327, DOI 10.1111/j.1748-7692.1990.tb00362.x; Cornuet JM, 1999, GENETICS, V153, P1989; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Falush D, 2003, GENETICS, V164, P1567; Folkow L.P., 1991, REPORTS INT WHALING, V41, P531; Glover KA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-2; Horwood J., 1990, BIOL EXPLOITATION MI; Jorgensen TH, 2004, HUM GENET, V115, P19, DOI 10.1007/s00439-004-1117-7; Kalinowski ST, 2004, CAN J FISH AQUAT SCI, V61, P1075, DOI 10.1139/F04-060; KASAMATSU F, 1995, MAR ECOL PROG SER, V119, P1, DOI 10.3354/meps119001; Larsen AH, 1996, P ROY SOC B-BIOL SCI, V263, P1611, DOI 10.1098/rspb.1996.0236; MICHELL ED, 1991, REPORT INT WHALING C, V41, P455; Naess A, 1998, SARSIA, V83, P211; Narum SR, 2008, MOL ECOL, V17, P3464, DOI 10.1111/j.1365-294X.2008.03851.x; NEMOTO T, 1980, SCI REP WHALES RES, V32, P97; Nielsen EE, 2006, MOL ECOL NOTES, V6, P971, DOI 10.1111/j.1471-8286.2006.01433.x; Ohsum S., 1973, Scientific Rep Whales Res Inst Tokyo, VNo. 25, P237; Omura H., 1975, Scientific Rep Whales Res Inst Tokyo, VNo. 27, P1; Palsboll Per J., 1998, P426; Palsboll PJ, 1997, MOL ECOL, V6, P893; PALSBOLL PJ, 1995, MAR ECOL PROG SER, V116, P1, DOI 10.3354/meps116001; Pastene L. A., 1994, REP INT WHAL COMMN, V44, P277; Pastene LA, 2007, MOL ECOL, V16, P1481, DOI 10.1111/j.1365-294X.2007.03244.x; Pastene LA, 2010, CONSERV GENET, V11, P1553, DOI 10.1007/s10592-009-9944-7; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pomilla C, 2005, BIOL LETTERS, V1, P476, DOI 10.1098/rsbl.2005.0351; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rice D. W., 1998, SOC MARINE MAMMALOGY, V4, P231; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Skaug HJ, 2004, CAN J FISH AQUAT SCI, V61, P870, DOI 10.1139/F04-020; Valsecchi E, 1996, MOL ECOL, V5, P151, DOI 10.1111/j.1365-294X.1996.tb00301.x; Van Waerebeek Koen, 1999, Journal of Cetacean Research and Management, V1, P223; Wada S., 1991, REP INT WHAL COMMN, V13, P203	41	34	39	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15197	10.1371/journal.pone.0015197	http://dx.doi.org/10.1371/journal.pone.0015197			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203557	gold, Green Published, Green Submitted			2022-12-27	WOS:000285578000023
J	Guggenhuber, S; Monory, K; Lutz, B; Klugmann, M				Guggenhuber, Stephan; Monory, Krisztina; Lutz, Beat; Klugmann, Matthias			AAV Vector-Mediated Overexpression of CB1 Cannabinoid Receptor in Pyramidal Neurons of the Hippocampus Protects against Seizure-Induced Excitoxicity	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; CENTRAL-NERVOUS-SYSTEM; ENDOCANNABINOID SYSTEM; ADENOASSOCIATED VIRUS; SYNAPTIC-TRANSMISSION; PRINCIPAL NEURONS; KAINIC ACID; EXPRESSION; MICE; FOREBRAIN	The CB1 cannabinoid receptor is the most abundant G-protein coupled receptor in the brain and a key regulator of neuronal excitability. There is strong evidence that CB1 receptor on glutamatergic hippocampal neurons is beneficial to alleviate epileptiform seizures in mouse and man. Therefore, we hypothesized that experimentally increased CB1 gene dosage in principal neurons would have therapeutic effects in kainic acid (KA)-induced hippocampal pathogenesis. Here, we show that virus-mediated conditional overexpression of CB1 receptor in pyramidal and mossy cells of the hippocampus is neuroprotective and moderates convulsions in the acute KA seizure model in mice. We introduce a recombinant adeno-associated virus (AAV) genome with a short stop element flanked by loxP sites, for highly efficient attenuation of transgene expression on the transcriptional level. The presence of Cre-recombinase is strictly necessary for expression of reporter proteins or CB1 receptor in vitro and in vivo. Transgenic CB1 receptor immunoreactivity is targeted to glutamatergic neurons after stereotaxic delivery of AAV to the dorsal hippocampus of the driver mice NEX-cre. Increased CB1 receptor protein levels in hippocampal lysates of AAV-treated Cre-mice is paralleled by enhanced cannabinoid-induced G-protein activation. KA-induced seizure severity and mortality is reduced in CB1 receptor overexpressors compared with AAV-treated control animals. Neuronal damage in the hippocampal CA3 field is specifically absent from AAV-treated Cre-transgenics, but evident throughout cortical areas of both treatment groups. Our data provide further evidence for a role of increased CB1 signaling in pyramidal hippocampal neurons as a safeguard against the adverse effects of excessive excitatory network activity.	[Guggenhuber, Stephan; Monory, Krisztina; Lutz, Beat; Klugmann, Matthias] Johannes Gutenberg Univ Mainz, Inst Physiol Chem, Univ Med Ctr, Mainz, Germany	Johannes Gutenberg University of Mainz	Guggenhuber, S (corresponding author), Johannes Gutenberg Univ Mainz, Inst Physiol Chem, Univ Med Ctr, Mainz, Germany.	blutz@uni-mainz.de; m.klugmann@unsw.edu.au	Lutz, Beat/AAG-4538-2022; Lutz, Beat/AFK-6229-2022		Deutsche Forschungsgemeinschaft [LU 775/3-1, LU 775/4-1]; European Leukodystrophy association	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Leukodystrophy association	This work was supported by the Deutsche Forschungsgemeinschaft Grants LU 775/3-1 and LU 775/4-1 (in the context of FOR926) (to B.L. and K.M.) and in part by a project grant of the European Leukodystrophy association (ELA) to M.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Coomber B, 2008, SYNAPSE, V62, P746, DOI 10.1002/syn.20547; Domenici MR, 2006, J NEUROSCI, V26, P5794, DOI 10.1523/JNEUROSCI.0372-06.2006; Dong JY, 1996, HUM GENE THER, V7, P2101, DOI 10.1089/hum.1996.7.17-2101; During Matthew J, 2003, Methods Mol Med, V76, P221; Falenski KW, 2007, NEUROSCIENCE, V146, P1232, DOI 10.1016/j.neuroscience.2007.01.065; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Hopkins KJ, 2000, BRAIN RES, V864, P69, DOI 10.1016/S0006-8993(00)02137-5; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Katona I, 1999, J NEUROSCI, V19, P4544; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Klugmann M, 2006, MOL CELL NEUROSCI, V31, P303, DOI 10.1016/j.mcn.2005.09.019; Klugmann M, 2005, MOL CELL NEUROSCI, V28, P347, DOI 10.1016/j.mcn.2004.10.002; Kuhlman SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002005; Ludanyi A, 2008, J NEUROSCI, V28, P2976, DOI 10.1523/JNEUROSCI.4465-07.2008; Lutz B, 2004, BIOCHEM PHARMACOL, V68, P1691, DOI 10.1016/j.bcp.2004.07.007; Magloczky Z, 2010, EPILEPSIA, V51, P115, DOI 10.1111/j.1528-1167.2010.02624.x; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Massa F, 2010, J NEUROSCI, V30, P6273, DOI 10.1523/JNEUROSCI.2648-09.2010; Mechoulam R, 2003, SCIENCE, V302, P65, DOI 10.1126/science.1091256; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Morozov YM, 2009, CEREB CORTEX, V19, pI78, DOI 10.1093/cercor/bhp028; Naderi N, 2008, J NEURAL TRANSM, V115, P1501, DOI 10.1007/s00702-008-0076-x; Richichi C, 2004, J NEUROSCI, V24, P3051, DOI 10.1523/JNEUROSCI.4056-03.2004; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schneider M, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-105; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Takahashi KA, 2006, NEUROSCIENCE, V139, P795, DOI 10.1016/j.neuroscience.2006.01.024; van der Stelt M, 2002, MOL NEUROBIOL, V26, P317, DOI 10.1385/MN:26:2-3:317; Wallace MJ, 2003, J PHARMACOL EXP THER, V307, P129, DOI 10.1124/jpet.103.051920; Wallace MJ, 2002, EUR J PHARMACOL, V452, P295, DOI 10.1016/S0014-2999(02)02331-2; Wettschureck N, 2006, MOL CELL BIOL, V26, P5888, DOI 10.1128/MCB.00397-06; Wyeth MS, 2010, J NEUROSCI, V30, P8993, DOI 10.1523/JNEUROSCI.1183-10.2010	37	65	66	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15707	10.1371/journal.pone.0015707	http://dx.doi.org/10.1371/journal.pone.0015707			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203567	Green Published, Green Submitted, gold			2022-12-27	WOS:000285576900035
J	Mongan, MA; Dunn, RT; Vonderfecht, S; Everds, N; Chen, GA; Su, C; Higgins-Garn, M; Chen, YA; Afshari, CA; Williamson, TL; Carlock, L; DiPalma, C; Moss, S; Bussiere, J; Qualls, C; He, YD; Hamadeh, HK				Mongan, M. Ann; Dunn, Robert T., II; Vonderfecht, Steven; Everds, Nancy; Chen, Guang; Su, Cheng; Higgins-Garn, Marnie; Chen, Yuan; Afshari, Cynthia A.; Williamson, Toni L.; Carlock, Linda; DiPalma, Christopher; Moss, Suzanne; Bussiere, Jeanine; Qualls, Charles, Jr.; He, Yudong D.; Hamadeh, Hisham K.			A Novel Statistical Algorithm for Gene Expression Analysis Helps Differentiate Pregnane X Receptor-Dependent and Independent Mechanisms of Toxicity	PLOS ONE			English	Article							DRUG DISCOVERY; BETA-SECRETASE; MICROARRAY; REPRODUCIBILITY; ELEMENT; BIOLOGY; STRESS; BACE	Genome-wide gene expression profiling has become standard for assessing potential liabilities as well as for elucidating mechanisms of toxicity of drug candidates under development. Analysis of microarray data is often challenging due to the lack of a statistical model that is amenable to biological variation in a small number of samples. Here we present a novel non-parametric algorithm that requires minimal assumptions about the data distribution. Our method for determining differential expression consists of two steps: 1) We apply a nominal threshold on fold change and platform p-value to designate whether a gene is differentially expressed in each treated and control sample relative to the averaged control pool, and 2) We compared the number of samples satisfying criteria in step 1 between the treated and control groups to estimate the statistical significance based on a null distribution established by sample permutations. The method captures group effect without being too sensitive to anomalies as it allows tolerance for potential non-responders in the treatment group and outliers in the control group. Performance and results of this method were compared with the Significant Analysis of Microarrays (SAM) method. These two methods were applied to investigate hepatic transcriptional responses of wild-type (PXR(+/+)) and pregnane X receptor-knockout (PXR(-/-)) mice after 96 h exposure to CMP013, an inhibitor of beta-secretase (beta-site of amyloid precursor protein cleaving enzyme 1 or BACE1). Our results showed that CMP013 led to transcriptional changes in hallmark PXR-regulated genes and induced a cascade of gene expression changes that explained the hepatomegaly observed only in PXR(+/+) animals. Comparison of concordant expression changes between PXR(+/+) and PXR(-/-) mice also suggested a PXR-independent association between CMP013 and perturbations to cellular stress, lipid metabolism, and biliary transport.	[Mongan, M. Ann; Dunn, Robert T., II; Vonderfecht, Steven; Everds, Nancy; Higgins-Garn, Marnie; Chen, Yuan; Afshari, Cynthia A.; Williamson, Toni L.; Carlock, Linda; DiPalma, Christopher; Moss, Suzanne; Bussiere, Jeanine; Qualls, Charles, Jr.; He, Yudong D.; Hamadeh, Hisham K.] Amgen Inc, Comparat Biol & Safety Sci, Thousand Oaks, CA 91320 USA; [Chen, Guang; Su, Cheng] Amgen Inc, Res & Translat Sci Biostat, Seattle, WA USA	Amgen; Amgen	Mongan, MA (corresponding author), Amgen Inc, Comparat Biol & Safety Sci, Thousand Oaks, CA 91320 USA.	thuyv@amgen.com			Amgen	Amgen(Amgen)	All authors are employed by Amgen. This employment does not alter the authors' adherence to PLoS ONE policies on sharing data and materials. This study is funded by Amgen as part of the company's business. The fund source does not compromise the objectivity or validity of the research, analyses, and interpretations presented in the paper.	Bammler T, 2005, NAT METHODS, V2, P351, DOI 10.1038/nmeth0605-477a; Blomme EAG, 2009, TOXICOL LETT, V186, P22, DOI 10.1016/j.toxlet.2008.09.017; Citron Martin, 2001, Expert Opin Ther Targets, V5, P341, DOI 10.1517/14728222.5.3.341; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Gant TW, 2009, CURR OPIN DRUG DISC, V12, P72; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hamadeh HK, 2002, TOXICOL SCI, V67, P219, DOI 10.1093/toxsci/67.2.219; Hamadeh HK, 2002, TOXICOL SCI, V67, P232, DOI 10.1093/toxsci/67.2.232; He YDD, 2003, BIOINFORMATICS, V19, P956, DOI 10.1093/bioinformatics/btg126; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lee JN, 2004, J BIOL CHEM, V279, P45257, DOI 10.1074/jbc.M408235200; Mongan A, 2008, BIOTECHNIQUES, V45, P283, DOI 10.2144/000112914; Reed SI, 1997, CANCER SURV, V29, P7; Searfoss GH, 2005, CURR MOL MED, V5, P53, DOI 10.2174/1566524053152825; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Trauner M, 2003, PHYSIOL REV, V83, P633, DOI 10.1152/physrev.00027.2002; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vassar R, 2001, J MOL NEUROSCI, V17, P157, DOI 10.1385/JMN:17:2:157; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Walker MS, 2008, INT J MOL MED, V21, P13; WEINTRAUB SJ, 1992, NATURE, V358, P259, DOI 10.1038/358259a0	21	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15595	10.1371/journal.pone.0015595	http://dx.doi.org/10.1371/journal.pone.0015595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203578	gold, Green Published, Green Submitted			2022-12-27	WOS:000285576900034
J	Penfold, S; Hill, Z; Mrisho, M; Manzi, F; Tanner, M; Mshinda, H; Schellenberg, D; Schellenberg, JRMA				Penfold, Suzanne; Hill, Zelee; Mrisho, Mwifadhi; Manzi, Fatuma; Tanner, Marcel; Mshinda, Hassan; Schellenberg, David; Schellenberg, Joanna R. M. Armstrong			A Large Cross-Sectional Community-Based Study of Newborn Care Practices in Southern Tanzania	PLOS ONE			English	Article							NEONATAL-MORTALITY; RURAL GHANA; SURVIVAL; TRANSMISSION; INITIATION; INFECTION; PROGRAM; NEPAL; RISK	Despite recent improvements in child survival in sub-Saharan Africa, neonatal mortality rates remain largely unchanged. This study aimed to determine the frequency of delivery and newborn-care practices in southern Tanzania, where neonatal mortality is higher than the national average. All households in five districts of Southern Tanzania were approached to participate. Of 213,220 female residents aged 13-49 years, 92% participated. Cross-sectional, retrospective data on childbirth and newborn care practices were collected from 22,243 female respondents who had delivered a live baby in the preceding year. Health facility deliveries accounted for 41% of births, with nearly all non-facility deliveries occurring at home (57% of deliveries). Skilled attendants assisted 40% of births. Over half of women reported drying the baby and over a third reported wrapping the baby within 5 minutes of delivery. The majority of mothers delivering at home reported that they had made preparations for delivery, including buying soap (84%) and preparing a cloth for drying the child (85%). Although 95% of these women reported that the cord was cut with a clean razor blade, only half reported that it was tied with a clean thread. Furthermore, out of all respondents 10% reported that their baby was dipped in cold water immediately after delivery, around two-thirds reported bathing their babies within 6 hours of delivery, and 28% reported putting something on the cord to help it dry. Skin-to-skin contact between mother and baby after delivery was rarely practiced. Although 83% of women breastfed within 24 hours of delivery, only 18% did so within an hour. Fewer than half of women exclusively breastfed in the three days after delivery. The findings suggest a need to promote and facilitate health facility deliveries, hygienic delivery practices for home births, delayed bathing and immediate and exclusive breastfeeding in Southern Tanzania to improve newborn health.	[Penfold, Suzanne; Schellenberg, David; Schellenberg, Joanna R. M. Armstrong] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Hill, Zelee] UCL, Inst Child Hlth, London, England; [Mrisho, Mwifadhi; Manzi, Fatuma] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Tanner, Marcel] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Tanner, Marcel] Univ Basel, Basel, Switzerland; [Mshinda, Hassan] COSTECH, Dar Es Salaam, Tanzania	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; Ifakara Health Institute; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Penfold, S (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England.	Suzanne.penfold@lshtm.ac.uk		Schellenberg, David/0000-0001-8222-0186; Schellenberg, Joanna/0000-0002-0708-3676	Bill and Melinda Gates Foundation through the Intermittent Preventative Treatment in Infants (IPTi) consortium; Saving Newborn Lives program of Save the Children [NCT00152204]	Bill and Melinda Gates Foundation through the Intermittent Preventative Treatment in Infants (IPTi) consortium; Saving Newborn Lives program of Save the Children	The study was funded by the Bill and Melinda Gates Foundation through the Intermittent Preventative Treatment in Infants (IPTi) consortium (www.ipti-malaria.org) and the Saving Newborn Lives program of Save the Children (www.savethechildren.org/programs/health/saving-newborn-lives/), clinical trial number NCT00152204. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], TECHN WORK GROUP M N; [Anonymous], 2005, POVERTY HUMAN DEV RE; Baqui AH, 2008, B WORLD HEALTH ORGAN, V86, P796, DOI 10.2471/BLT.07.042226; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Darmstadt GL, 2006, J HEALTH POPUL NUTR, V24, P380; Edmond KM, 2007, AM J CLIN NUTR, V86, P1126, DOI 10.1093/ajcn/86.4.1126; Edmond KM, 2006, PEDIATRICS, V117, pE380, DOI 10.1542/peds.2005-1496; Hill Z., 2009, REPORT FORMATIVE RES; Hill Z, 2010, PEDIATR INFECT DIS J, V29, P1004, DOI 10.1097/INF.0b013e3181f5ddb1; Hill Z, 2010, TROP MED INT HEALTH, V15, P1118, DOI 10.1111/j.1365-3156.2010.02593.x; Iliff PJ, 2005, AIDS, V19, P699, DOI 10.1097/01.aids.0000166093.16446.c9; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, INT J EPIDEMIOL S1, V39, pi144; Manji K., 2009, SITUATION ANAL NEWBO; Masanja H, 2008, LANCET, V371, P1276, DOI 10.1016/S0140-6736(08)60562-0; Mbuyita S, 2008, NEONATAL CARE PRACTI; Mrisho M, 2008, T ROY SOC TROP MED H, V102, P669, DOI 10.1016/j.trstmh.2008.04.029; NBS, TANZ DEM HLTH SURV 2; Osrin D, 2002, BMJ-BRIT MED J, V325, P1063, DOI 10.1136/bmj.325.7372.1063; Rhee V, 2008, ARCH PEDIAT ADOL MED, V162, P603, DOI 10.1001/archpedi.162.7.603; Schellenberg JRA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-194; Shirima K, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-5; *STAT CORP LP, 2007, STAT STAT SOFTW REL; Syed U, 2008, J PERINATOL, V28, pS9, DOI 10.1038/jp.2008.165; Tawiah-Agyemang C, 2008, J PERINATOL, V28, pS46, DOI 10.1038/jp.2008.173; Waiswa P, BMC PREGNANCY CHILDB, V10, P9; White E, 2008, PRINCIPLES EXPOSURE; World Health Organization, 1994, ESS NEWB CAR REP TEC	29	43	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15593	10.1371/journal.pone.0015593	http://dx.doi.org/10.1371/journal.pone.0015593			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203574	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000285576900033
J	Shi, ZD; Wang, H; Tarbell, JM				Shi, Zhong-Dong; Wang, Hui; Tarbell, John M.			Heparan Sulfate Proteoglycans Mediate Interstitial Flow Mechanotransduction Regulating MMP-13 Expression and Cell Motility via FAK-ERK in 3D Collagen	PLOS ONE			English	Article							FOCAL ADHESION KINASE; FLUID SHEAR-STRESS; HUMAN AORTIC MEDIA; ENDOTHELIAL-CELLS; CYTOSKELETAL ORGANIZATION; MATRIX; INTEGRINS; GLYCOCALYX; SYNDECAN-4; MIGRATION	Background: Interstitial flow directly affects cells that reside in tissues and regulates tissue physiology and pathology by modulating important cellular processes including proliferation, differentiation, and migration. However, the structures that cells utilize to sense interstitial flow in a 3-dimensional (3D) environment have not yet been elucidated. Previously, we have shown that interstitial flow upregulates matrix metalloproteinase (MMP) expression in rat vascular smooth muscle cells (SMCs) and fibroblasts/myofibroblasts via activation of an ERK1/2-c-Jun pathway, which in turn promotes cell migration in collagen. Herein, we focused on uncovering the flow-induced mechanotransduction mechanism in 3D. Methodology/Principal Findings: Cleavage of rat vascular SMC surface glycocalyx heparan sulfate (HS) chains from proteoglycan (PG) core proteins by heparinase or disruption of HS biosynthesis by silencing N-deacetylase/N-sulfotransferase 1 (NDST1) suppressed interstitial flow-induced ERK1/2 activation, interstitial collagenase (MMP-13) expression, and SMC motility in 3D collagen. Inhibition or knockdown of focal adhesion kinase (FAK) also attenuated or blocked flow-induced ERK1/2 activation, MMP-13 expression, and cell motility. Interstitial flow induced FAK phosphorylation at Tyr925, and this activation was blocked when heparan sulfate proteoglycans (HSPGs) were disrupted. These data suggest that HSPGs mediate interstitial flow-induced mechanotransduction through FAK-ERK. In addition, we show that integrins are crucial for mechanotransduction through HSPGs as they mediate cell spreading and maintain cytoskeletal rigidity. Conclusions/Significance: We propose a conceptual mechanotransduction model wherein cell surface glycocalyx HSPGs, in the presence of integrin-mediated cell-matrix adhesions and cytoskeleton organization, sense interstitial flow and activate the FAK-ERK signaling axis, leading to upregulation of MMP expression and cell motility in 3D. This is the first study to describe a flow-induced mechanotransduction mechanism via HSPG-mediated FAK activation in 3D. This study will be of interest in understanding the flow-related mechanobiology in vascular lesion formation, tissue morphogenesis, cancer cell metastasis, and stem cell differentiation in 3D, and also has implications in tissue engineering.	[Shi, Zhong-Dong; Wang, Hui; Tarbell, John M.] CUNY, Dept Biomed Engn, City Coll New York, New York, NY 10021 USA	City University of New York (CUNY) System; City College of New York (CUNY)	Shi, ZD (corresponding author), CUNY, Dept Biomed Engn, City Coll New York, New York, NY 10021 USA.	tarbell@ccny.cuny.edu	Shi, Zhong-Dong/A-7212-2012		NIH NHLBI [RO1 HL 57093, RO1 HL 094889]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094889, R01HL057093] Funding Source: NIH RePORTER	NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH NHLBI grants RO1 HL 57093 (JMT) and RO1 HL 094889 ( JMT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie KM, 2005, J APPL PHYSIOL, V98, P242, DOI 10.1152/japplphysiol.01006.2003; Ando J, 2009, CIRC J, V73, P1983, DOI 10.1253/circj.CJ-09-0583; Bellin RM, 2009, P NATL ACAD SCI USA, V106, P22102, DOI 10.1073/pnas.0902639106; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bershadsky A, 2006, CURR OPIN CELL BIOL, V18, P472, DOI 10.1016/j.ceb.2006.08.012; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Boutahar N, 2004, J BIOL CHEM, V279, P30588, DOI 10.1074/jbc.M313244200; Chang SF, 2008, P NATL ACAD SCI USA, V105, P3927, DOI 10.1073/pnas.0712353105; Charni F, 2009, BBA-GEN SUBJECTS, V1790, P1314, DOI 10.1016/j.bbagen.2009.07.015; Chaturvedi LS, 2008, AM J PHYSIOL-CELL PH, V294, pC1350, DOI 10.1152/ajpcell.00027.2008; Chen P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006565; Cheung PFY, 2008, INT IMMUNOL, V20, P353, DOI 10.1093/intimm/dxm146; Couchman JR, 2001, INT REV CYTOL, V207, P113; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Das A, 2009, ARTERIOSCL THROM VAS, V29, P562, DOI 10.1161/ATVBAHA.108.182725; Davies PF, 2009, NAT CLIN PRACT CARD, V6, P16, DOI 10.1038/ncpcardio1397; Denhez F, 2002, J BIOL CHEM, V277, P12270, DOI 10.1074/jbc.M110291200; DINGEMANS KP, 1981, VIRCHOWS ARCH A, V392, P199, DOI 10.1007/BF00430821; Dingemans KP, 2000, ANAT REC, V258, P1; Fleury ME, 2006, BIOPHYS J, V91, P113, DOI 10.1529/biophysj.105.080192; Florian JA, 2003, CIRC RES, V93, pE136, DOI 10.1161/01.RES.0000101744.47866.D5; Garanich JS, 2007, AM J PHYSIOL-HEART C, V292, pH3128, DOI 10.1152/ajpheart.00578.2006; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Harfouche R, 2009, CIRCULATION, V120, P1883, DOI 10.1161/CIRCULATIONAHA.108.837724; Hoshina N, 2007, GENES CELLS, V12, P1245, DOI 10.1111/j.1365-2443.2007.01130.x; Hosseinkhani H, 2005, TISSUE ENG, V11, P1476, DOI 10.1089/ten.2005.11.1476; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Kirkpatrick CA, 2007, J CELL SCI, V120, P1829, DOI 10.1242/jcs.03432; Langholz O, 1995, J CELL BIOL, V131, P1903, DOI 10.1083/jcb.131.6.1903; LEVICK JR, 1987, Q J EXP PHYSIOL CMS, V72, P409, DOI 10.1113/expphysiol.1987.sp003085; Li S, 2002, P NATL ACAD SCI USA, V99, P3546, DOI 10.1073/pnas.052018099; Li S, 1997, J BIOL CHEM, V272, P30455, DOI 10.1074/jbc.272.48.30455; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moon JJ, 2005, J CELL PHYSIOL, V203, P166, DOI 10.1002/jcp.20220; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Okina E, 2009, SCAND J MED SCI SPOR, V19, P479, DOI 10.1111/j.1600-0838.2009.00941.x; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Ramanujan S, 2002, BIOPHYS J, V83, P1650, DOI 10.1016/S0006-3495(02)73933-7; Rizzo V, 2009, AM J PHYSIOL-HEART C, V297, pH1196, DOI 10.1152/ajpheart.00499.2009; Rutkowski JM, 2007, TRENDS CELL BIOL, V17, P44, DOI 10.1016/j.tcb.2006.11.007; SAKU T, 1989, J BIOL CHEM, V264, P3514; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; SCHLAEPFER DD, 1994, NATURE, V372, P786; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Shi ZD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012196; Shi ZD, 2010, AM J PHYSIOL-HEART C, V298, pH127, DOI 10.1152/ajpheart.00732.2009; Shi ZD, 2009, AM J PHYSIOL-HEART C, V297, pH1225, DOI 10.1152/ajpheart.00369.2009; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Swartz MA, 2007, ANNU REV BIOMED ENG, V9, P229, DOI 10.1146/annurev.bioeng.9.060906.151850; Tarbell JM, 2005, ANN BIOMED ENG, V33, P1719, DOI 10.1007/s10439-005-8775-z; Tarbell JM, 2006, J INTERN MED, V259, P339, DOI 10.1111/j.1365-2796.2006.01620.x; Tarbell JM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.140pt8; Vera RH, 2009, TISSUE ENG PT A, V15, P175, DOI 10.1089/ten.tea.2007.0314; Vuoriluoto K, 2008, EXP CELL RES, V314, P3369, DOI 10.1016/j.yexcr.2008.07.005; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Wang S, 2000, ARTERIOSCL THROM VAS, V20, P2220, DOI 10.1161/01.ATV.20.10.2220; Wang YL, 2007, P NATL ACAD SCI USA, V104, P15941, DOI 10.1073/pnas.0707246104; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; Wilcox-Adelman SA, 2002, J BIOL CHEM, V277, P32970, DOI 10.1074/jbc.M201283200; WILLIAMS JL, 1994, BIORHEOLOGY, V31, P163; Woods A, 2001, J CLIN INVEST, V107, P935, DOI 10.1172/JCI12802; Woods A, 1998, TRENDS CELL BIOL, V8, P189, DOI 10.1016/S0962-8924(98)01244-6; Xian XJ, 2010, CELL TISSUE RES, V339, P31, DOI 10.1007/s00441-009-0829-3; Yao Y, 2007, AM J PHYSIOL-HEART C, V293, pH1023, DOI 10.1152/ajpheart.00162.2007; Yoneda A, 2003, MATRIX BIOL, V22, P25, DOI 10.1016/S0945-053X(03)00010-6; Zamir E, 2001, J CELL SCI, V114, P3583	68	58	58	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15956	10.1371/journal.pone.0015956	http://dx.doi.org/10.1371/journal.pone.0015956			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246051	Green Submitted, Green Published, gold			2022-12-27	WOS:000286511200027
J	Zimmermann, E; Skogstrand, K; Hougaard, DM; Astrup, A; Hansen, T; Pedersen, O; Sorensen, TIA; Jess, T				Zimmermann, Esther; Skogstrand, Kristin; Hougaard, David M.; Astrup, Arne; Hansen, Torben; Pedersen, Oluf; Sorensen, Thorkild I. A.; Jess, Tine			Influences of the Common FTO rs9939609 Variant on Inflammatory Markers Throughout a Broad Range of Body Mass Index	PLOS ONE			English	Article							OBESITY; GENE; PREVALENCE; BIOMARKERS; OVERWEIGHT; CHILDHOOD; MORTALITY; DISEASE; RISK	Background: A recent study reported that the fatness associated A-allele of FTO rs9939609 increased plasma high sensitivity C-reactive protein ( hs-CRP) levels independent of fatness. We aimed to investigate if this gene variant had fatness-independent effects on plasma hs-CRP and 10 additional circulating obesity-related adipokines throughout a broad range of body mass index ( BMI) among Danish men. Methodology/Principal Findings: In a population of 362,200 young men, examined for military service between 1943 and 1977, two groups were identified: 1) a random 1% sample and 2) all obese men ( BMI = 31.0 kg/m(2), all of whom were above the 99(th) percentile of this population). At an average age of 49 years ( range: 39 through 65 years), 551 men, hereof 231 of the obese, were re-examined, including genotyping and measurement of the fasting circulating inflammatory markers hs-CRP, IL-1 beta, IL-6, IL-10, IL-18, mip1 alpha, mip1 beta, sTNF alpha-R1, TGF-beta, TNF-alpha and leptin. Men with known disease were excluded from the examination. All the inflammatory markers were log-transformed to approximate a normal distribution. Genotype-phenotype relationships were studied using linear regression analyses with the inflammatory markers as the response variable. Significant positive associations between hs-CRP, leptin and a broad range of BMI were observed, but the associations did not significantly differ across FTO rs9939609 genotype. There were no significant associations between the other inflammatory markers, FTO rs9939609 genotype or BMI, respectively. Conclusion: No fatness-independent effects of the FTO rs9939609 A-allele on a series of inflammatory markers were observed in this cohort of healthy middle-aged men representing a broad range of fatness.	[Zimmermann, Esther; Sorensen, Thorkild I. A.; Jess, Tine] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Zimmermann, Esther] Univ Copenhagen, Inst Biomed Sci, Copenhagen, Denmark; [Skogstrand, Kristin; Hougaard, David M.] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark; [Astrup, Arne] Univ Copenhagen, Dept Human Nutr, Fac Life Sci, Copenhagen, Denmark; [Hansen, Torben; Pedersen, Oluf] Hagedorn Res Inst, Gentofte, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark	University of Copenhagen; University of Copenhagen; Statens Serum Institut; University of Copenhagen; Novo Nordisk; Hagedorn Research Institute; Aarhus University	Zimmermann, E (corresponding author), Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark.	ez@ipm.regionh.dk	Hougaard, David/AAD-6368-2019; Pedersen, Oluf/AAG-8015-2020; Astrup, Arne/B-1407-2015	Skogstrand, Kristin/0000-0002-0026-3711; Astrup, Arne/0000-0001-8968-8996; Zimmermann, Esther/0000-0001-5854-0542	Cluster for Endocrinology and Metabolism, University of Copenhagen, Denmark; European Commission [LSHM-CT-2005-018734]; Danish Obesity Research Centre (DanORC); Danish Council for Strategic Research [2101-06-0005]; Danish Council for Independent Research	Cluster for Endocrinology and Metabolism, University of Copenhagen, Denmark; European Commission(European CommissionEuropean Commission Joint Research Centre); Danish Obesity Research Centre (DanORC); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	The work was supported by grants from the Cluster for Endocrinology and Metabolism, University of Copenhagen, Denmark. The work is also part of the project "Hepatic and adipose tissue and functions in the metabolic syndrome" (HEPADIP, see http://www.hepadip.org/), which is supported by the European Commission as an Integrated Project under the 6th Framework Programme [Contract LSHM-CT-2005-018734], and part of the research program of the Danish Obesity Research Centre (DanORC, see www.danorc.dk). DanORC is supported by the Danish Council for Strategic Research (Grant 2101-06-0005). Also, Dr. Tine Jess is funded by a Female Researcher Leader grant from the Danish Council for Independent Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson P.K., 2010, REGRESSION LINEAR PR, DOI [DOI 10.1007/978-1-4419-7170-8, 10.1007/978-1-4419-7170-8]; APPLEYARD M, 1989, SCAND J SOC MED S41, V70, P1; Black E, 2005, DIABETIC MED, V22, P1199, DOI 10.1111/j.1464-5491.2005.01615.x; CHRISTENSEN U, 1981, HUM BIOL, V53, P403; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Doney ASF, 2009, CIRC-CARDIOVASC GENE, V2, P255, DOI 10.1161/CIRCGENETICS.108.822320; Due P, 2007, OBES REV, V8, P187, DOI 10.1111/j.1467-789X.2006.00291.x; Fawcett KA, 2010, TRENDS GENET, V26, P266, DOI 10.1016/j.tig.2010.02.006; Fisher E, 2009, OBESITY, V17, P330, DOI 10.1038/oby.2008.465; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gnacinska M, 2009, ADV MED SCI-POLAND, V54, P150, DOI 10.2478/v10039-009-0035-2; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kring SII, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002958; Kring SII, 2008, OBESITY FACTS, V1, P138, DOI 10.1159/000137665; Musaad S, 2007, EPIDEMIOL REV, V29, P98, DOI 10.1093/epirev/mxm005; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pischon T, 2009, DIS MARKERS, V26, P247, DOI [10.1155/2009/757683, 10.3233/DMA-2009-0634]; Qi L, 2008, DIABETES, V57, P3145, DOI 10.2337/db08-0006; Schnohr P, 2001, EUR HEART J SUPPL, V3, pH1; Skogstrand K, 2005, CLIN CHEM, V51, P1854, DOI 10.1373/clinchem.2005.052241; Skogstrand K, 2008, J IMMUNOL METHODS, V336, P78, DOI 10.1016/j.jim.2008.04.006; SONNEHOLM S, 1977, J CHRON DIS, V30, P351, DOI 10.1016/0021-9681(77)90029-7; SORENSEN TIA, 1977, J CHRON DIS, V30, P359, DOI 10.1016/0021-9681(77)90030-3; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Zimmermann E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004428	26	27	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15958	10.1371/journal.pone.0015958	http://dx.doi.org/10.1371/journal.pone.0015958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246032	Green Submitted, Green Published, gold			2022-12-27	WOS:000286511200028
J	Sawada, H; Oeda, T; Kuno, S; Nomoto, M; Yamamoto, K; Yamamoto, M; Hisanaga, K; Kawamura, T				Sawada, Hideyuki; Oeda, Tomoko; Kuno, Sadako; Nomoto, Masahiro; Yamamoto, Kenji; Yamamoto, Mitsutoshi; Hisanaga, Kinya; Kawamura, Takashi		Amantadine Study Grp	Amantadine for Dyskinesias in Parkinson's Disease: A Randomized Controlled Trial	PLOS ONE			English	Article							MEDIUM SPINY NEURONS; DOUBLE-BLIND; QUALITY; FLUCTUATIONS; DURATION	Background: Dyskinesias are some of the major motor complications that impair quality of life for patients with Parkinson's disease. The purpose of the present study was to investigate the efficacy of amantadine in Parkinson's disease patients suffering from dyskinesias. Methods: In this multi-center, double-blind, randomized, placebo-controlled, cross-over trial, 36 patients with Parkinson's disease and dyskinesias were randomized, and 62 interventions, which included amantadine (300 mg /day) or placebo treatment for 27 days, were analyzed. At 15 days after washout, the treatments were crossed over. The primary outcome measure was the changes in the Rush Dyskinesia Rating Scale (RDRS) during each treatment period. The secondary outcome measures were changes in the Unified Parkinson's Disease Rating Scale part IVa (UPDRS-IVa, dyskinesias), part IVb (motor fluctuations), and part III (motor function). Results: RDRS improved in 64% and 16% of patients treated with amantadine or placebo, respectively, with significant differences between treatments. The adjusted odds-ratio for improvement by amantadine was 6.7 (95% confidence interval, 1.4 to 31.5). UPDRS-IVa was improved to a significantly greater degree in amantadine-treated patients [mean (SD) of 1.83 (1.56)] compared with placebo-treated patients [0.03 (1.51)]. However, there were no significant effects on UPDRS-IVb or III scores. Conclusions: Results from the present study demonstrated that amantadine exhibited efficacious effects against dyskinesias in 60-70% of patients.	[Sawada, Hideyuki; Oeda, Tomoko; Yamamoto, Kenji] Natl Utano Hosp, Clin Res Ctr, Kyoto, Japan; [Kuno, Sadako] Natl Ctr Neurol & Psychiat Disorders, Kodaira, Tokyo, Japan; [Nomoto, Masahiro] Ehime Univ, Sch Med, Dept Therapeut Med, Toon, Japan; [Yamamoto, Mitsutoshi] Kagawa Prefectural Cent Hosp, Dept Neurol, Takamatsu, Kagawa, Japan; [Hisanaga, Kinya] Miyagi Natl Hosp, Dept Neurol, Sendai, Miyagi, Japan; [Kawamura, Takashi] Kyoto Univ, Student Hlth Ctr, Kyoto, Japan	Ehime University; Kyoto University	Sawada, H (corresponding author), Natl Utano Hosp, Clin Res Ctr, Kyoto, Japan.	sawada@unh.hosp.go.jp	Yamamoto, Kenji/AAD-8766-2019	Yamamoto, Kenji/0000-0003-1240-6369; Sawada, Hideyuki/0000-0002-5909-3366	Minister of Health, Labour, and Welfare [18A-9]; National Hospital Organization	Minister of Health, Labour, and Welfare; National Hospital Organization	This study was supported by The Research Grant (18A-9) for Nervous and Mental Disorders from the Minister of Health, Labour, and Welfare and supported by grants-in-aid from the National Hospital Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Calabresi P, 2008, MOVEMENT DISORD, V23, pS570, DOI 10.1002/mds.22019; Carta M, 2007, BRAIN, V130, P1819, DOI 10.1093/brain/awm082; Chapuis S, 2005, MOVEMENT DISORD, V20, P224, DOI 10.1002/mds.20279; Corvol JC, 2004, J NEUROSCI, V24, P7007, DOI 10.1523/JNEUROSCI.0676-04.2004; Crosby NJ, 2003, COCHRANE DB SYST REV; da Silva-Junior FP, 2005, PARKINSONISM RELAT D, V11, P449, DOI 10.1016/j.parkreldis.2005.05.008; Daniel S E, 1993, J Neural Transm Suppl, V39, P165; deRijk MC, 1997, J NEUROL NEUROSUR PS, V62, P10, DOI 10.1136/jnnp.62.1.10; GOETZ CG, 1994, MOVEMENT DISORD, V9, P390, DOI 10.1002/mds.870090403; Hallett PJ, 2005, NEUROPHARMACOLOGY, V48, P503, DOI 10.1016/j.neuropharm.2004.11.008; KORNHUBER J, 1991, EUR J PHARM-MOLEC PH, V206, P297, DOI 10.1016/0922-4106(91)90113-V; Liang L, 2008, J NEUROSCI, V28, P7537, DOI 10.1523/JNEUROSCI.1176-08.2008; Luginger E, 2000, MOVEMENT DISORD, V15, P873, DOI 10.1002/1531-8257(200009)15:5<873::AID-MDS1017>3.0.CO;2-I; Merello M, 2006, J NEUROL NEUROSUR PS, V77, P172, DOI 10.1136/jnnp.2005.068940; Metman LV, 1998, NEUROLOGY, V50, P1323, DOI 10.1212/WNL.50.5.1323; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; Nishikawa N, 2009, PARKINSONISM RELAT D, V15, P351, DOI 10.1016/j.parkreldis.2008.08.005; Pahwa R, 2006, NEUROLOGY, V66, P983, DOI 10.1212/01.wnl.0000215250.82576.87; Plenz D, 1998, J NEUROSCI, V18, P266; Schindehutte J, 2007, CLIN NEUROL NEUROSUR, V109, P188, DOI 10.1016/j.clineuro.2006.07.003; Snow BJ, 2000, CLIN NEUROPHARMACOL, V23, P82, DOI 10.1097/00002826-200003000-00004; Thomas A, 2004, J NEUROL NEUROSUR PS, V75, P141; Van Gerpen JA, 2006, ARCH NEUROL-CHICAGO, V63, P205, DOI 10.1001/archneur.63.2.205; Wilson CJ, 1996, J NEUROSCI, V16, P2397; Wolf E, MOV DISORD, V25, P1357	26	87	95	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15298	10.1371/journal.pone.0015298	http://dx.doi.org/10.1371/journal.pone.0015298			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217832	Green Submitted, gold, Green Published			2022-12-27	WOS:000285838900018
J	Turque, AS; Batista, D; Silveira, CB; Cardoso, AM; Vieira, RP; Moraes, FC; Clementino, MM; Albano, RM; Paranhos, R; Martins, OB; Muricy, G				Turque, Aline S.; Batista, Daniela; Silveira, Cynthia B.; Cardoso, Alexander M.; Vieira, Ricardo P.; Moraes, Fernando C.; Clementino, Maysa M.; Albano, Rodolpho M.; Paranhos, Rodolfo; Martins, Orlando B.; Muricy, Guilherme			Environmental Shaping of Sponge Associated Archaeal Communities	PLOS ONE			English	Article							AMMONIA-OXIDIZING ARCHAEA; RIO-DE-JANEIRO; GUANABARA BAY; MARINE SPONGES; FLOW-CYTOMETRY; DIVERSITY; BACTERIAL; QUALITY; DNA; MICROORGANISMS	Background: Archaea are ubiquitous symbionts of marine sponges but their ecological roles and the influence of environmental factors on these associations are still poorly understood. Methodology/Principal Findings: We compared the diversity and composition of archaea associated with seawater and with the sponges Hymeniacidon heliophila, Paraleucilla magna and Petromica citrina in two distinct environments: Guanabara Bay, a highly impacted estuary in Rio de Janeiro, Brazil, and the nearby Cagarras Archipelago. For this we used metagenomic analyses of 16S rRNA and ammonia monooxygenase (amoA) gene libraries. Hymeniacidon heliophila was more abundant inside the bay, while P. magna was more abundant outside and P. citrina was only recorded at the Cagarras Archipelago. Principal Component Analysis plots (PCA) generated using pairwise unweighted UniFrac distances showed that the archaeal community structure of inner bay seawater and sponges was different from that of coastal Cagarras Archipelago. Rarefaction analyses showed that inner bay archaeaoplankton were more diverse than those from the Cagarras Archipelago. Only members of Crenarchaeota were found in sponge libraries, while in seawater both Crenarchaeota and Euryarchaeota were observed. Although most amoA archaeal genes detected in this study seem to be novel, some clones were affiliated to known ammonia oxidizers such as Nitrosopumilus maritimus and Cenarchaeum symbiosum. Conclusion/Significance: The composition and diversity of archaeal communities associated with pollution-tolerant sponge species can change in a range of few kilometers, probably influenced by eutrophication. The presence of archaeal amoA genes in Porifera suggests that Archaea are involved in the nitrogen cycle within the sponge holobiont, possibly increasing its resistance to anthropogenic impacts. The higher diversity of Crenarchaeota in the polluted area suggests that some marine sponges are able to change the composition of their associated archaeal communities, thereby improving their fitness in impacted environments.	[Turque, Aline S.; Silveira, Cynthia B.; Vieira, Ricardo P.; Martins, Orlando B.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil; [Batista, Daniela] Pontificia Univ Catolica Rio de Janeiro, Lab Estudos Marinhos & Ambientais, Dept Quim, Rio De Janeiro, Brazil; [Cardoso, Alexander M.] Inst Nacl Metrol Normalizacao & Qualidade Ind, Inmetro Diretoria Programa, Rio De Janeiro, Brazil; [Moraes, Fernando C.; Muricy, Guilherme] Univ Fed Rio de Janeiro, Museu Nacl, Dept Invertebrados, Rio De Janeiro, Brazil; [Clementino, Maysa M.] Fundacao Oswaldo Cruz, INCQS, Lab Microrganismos Referencia, Rio De Janeiro, Brazil; [Albano, Rodolpho M.] Univ Estado Rio de Janeiro, Dept Bioquim, BR-20550011 Rio De Janeiro, Brazil; [Paranhos, Rodolfo] Univ Fed Rio de Janeiro, Dept Biol Marinha, Inst Biol, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Pontificia Universidade Catolica do Rio de Janeiro; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Turque, AS (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil.	muricy@mn.ufrj.br	Muricy, Guilherme/O-2012-2015; Cardoso, Alexander/S-6687-2017; Silveira, Cynthia/D-6829-2013; Paranhos, Rodolfo/F-1927-2011; Clementino, Maysa/C-1944-2009; Cardoso, Alexander/AAX-2505-2021	Muricy, Guilherme/0000-0002-1705-3673; Cardoso, Alexander/0000-0003-2974-0232; Silveira, Cynthia/0000-0002-9533-5588; Albano, Rodolpho/0000-0002-0643-901X; Batista, Daniela/0000-0001-5624-132X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [478925/2007-7]; Fundacao de Amparo a Pesquisa Carlos Chagas Filho (FAPERJ) [E-26/152.841/2006]; Petrobras/UFRJ [21-0050.0023462.06.4]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa Carlos Chagas Filho (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Petrobras/UFRJ	This study benefited from funding by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq Grant Number 478925/2007-7; www.cnpq.br), Fundacao de Amparo a Pesquisa Carlos Chagas Filho (FAPERJ Grant number E-26/152.841/2006; www.faperj.br) and Petrobras/UFRJ (Grant number 21-0050.0023462.06.4; www.petrobras.com.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcolado Pedro M., 2007, V28, P3; Andrade L, 2003, J MICROBIOL METH, V55, P841, DOI 10.1016/j.mimet.2003.08.002; Bayer K, 2008, ENVIRON MICROBIOL, V10, P2942, DOI 10.1111/j.1462-2920.2008.01582.x; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; Britto ER, 1978, MONITORAGEM EMISSARI; Chong SC, 2002, ANTON LEEUW INT J G, V81, P263, DOI 10.1023/A:1020535222281; Clementino MM, 2007, J APPL MICROBIOL, V103, P141, DOI 10.1111/j.1365-2672.2006.03230.x; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Finks RH, 1970, S ZOOL SOC LONDON, V25, P331; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; Godoy JM, 1998, J RADIOANAL NUCL CH, V227, P157, DOI 10.1007/BF02386450; Gonzalez AM, 2000, BRAZ ARCH BIOL TECHN, V43, P493, DOI 10.1590/S1516-89132000000500008; Grasshoff K, 1999, METHODS SEAWATER ANA; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; Hardoim CCP, 2009, APPL ENVIRON MICROB, V75, P3331, DOI 10.1128/AEM.02101-08; HECK KL, 1975, ECOLOGY, V56, P1459, DOI 10.2307/1934716; Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002; Hoffmann F, 2009, ENVIRON MICROBIOL, V11, P2228, DOI 10.1111/j.1462-2920.2009.01944.x; Holmes B, 2007, MAR BIOL, V150, P759, DOI 10.1007/s00227-006-0361-x; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Ionescu D, 2009, FEMS MICROBIOL ECOL, V69, P425, DOI 10.1111/j.1574-6941.2009.00721.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KIRCHMAN D, 1985, APPL ENVIRON MICROB, V49, P599, DOI 10.1128/AEM.49.3.599-607.1985; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Margot H, 2002, MAR BIOL, V140, P739, DOI 10.1007/s00227-001-0740-2; Menezes CBA, 2010, MICROBIOL RES, V165, P466, DOI 10.1016/j.micres.2009.09.005; Meniconi MDG, 2002, ENVIRON FORENSICS, V3, P303, DOI 10.1006/enfo.2002.0101; Muricy G., 2006, SERIE LIVROS, V17; Otto TD, 2008, GENET MOL RES, V7, P861, DOI 10.4238/vol7-3X-Meeting04; PARANHOS R, 1993, ARQ BIOL TECNOL, V36, P685; Paranhos R, 1998, ENVIRON MONIT ASSESS, V50, P131, DOI 10.1023/A:1005855914215; Perez T, 2000, B SOC ZOOL FR, V125, P17; Preston CM, 1996, P NATL ACAD SCI USA, V93, P6241, DOI 10.1073/pnas.93.13.6241; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santos OCS, 2010, RES MICROBIOL, V161, P604, DOI 10.1016/j.resmic.2010.05.013; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; SOMERVILLE CC, 1989, APPL ENVIRON MICROB, V55, P548, DOI 10.1128/AEM.55.3.548-554.1989; Steger D, 2008, ENVIRON MICROBIOL, V10, P1087, DOI 10.1111/j.1462-2920.2007.01515.x; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turque AS, 2008, MAR BIOL, V155, P135, DOI 10.1007/s00227-008-1008-x; VACELET J, 1975, J MICROSC BIOL CELL, V23, P271; Vieira RP, 2007, MICROB ECOL, V54, P460, DOI 10.1007/s00248-007-9261-y; Webster NS, 2004, ENVIRON MICROBIOL, V6, P288, DOI 10.1111/j.1462-2920.2004.00570.x; Webster NS, 2001, MAR BIOTECHNOL, V3, P600, DOI 10.1007/s10126-001-0065-7; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103; Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x	55	63	66	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15774	10.1371/journal.pone.0015774	http://dx.doi.org/10.1371/journal.pone.0015774			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209889	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793600036
J	Weber, MS; Benkhoucha, M; Lehmann-Horn, K; Hertzenberg, D; Sellner, J; Santiago-Raber, ML; Chofflon, M; Hemmer, B; Zamvil, SS; Lalive, PH				Weber, Martin S.; Benkhoucha, Mahdia; Lehmann-Horn, Klaus; Hertzenberg, Deetje; Sellner, Johann; Santiago-Raber, Marie-Laure; Chofflon, Michel; Hemmer, Bernhard; Zamvil, Scott S.; Lalive, Patrice H.			Repetitive Pertussis Toxin Promotes Development of Regulatory T Cells and Prevents Central Nervous System Autoimmune Disease	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; MYCOBACTERIUM-TUBERCULOSIS; GLATIRAMER ACETATE; CROSS-REACTIVITY; IMMUNE-RESPONSES; DENDRITIC CELLS; PROTECTS MICE; INDUCTION; RECEPTOR	Bacterial and viral infections have long been implicated in pathogenesis and progression of multiple sclerosis (MS). Incidence and severity of its animal model experimental autoimmune encephalomyelitis (EAE) can be enhanced by concomitant administration of pertussis toxin (PTx), the major virulence factor of Bordetella pertussis. Its adjuvant effect at the time of immunization with myelin antigen is attributed to an unspecific activation and facilitated migration of immune cells across the blood brain barrier into the central nervous system (CNS). In order to evaluate whether recurring exposure to bacterial antigen may have a differential effect on development of CNS autoimmunity, we repetitively administered PTx prior to immunization. Mice weekly injected with PTx were largely protected from subsequent EAE induction which was reflected by a decreased proliferation and pro-inflammatory differentiation of myelin-reactive T cells. Splenocytes isolated from EAE-resistant mice predominantly produced IL-10 upon re-stimulation with PTx, while non-specific immune responses were unchanged. Longitudinal analyses revealed that repetitive exposure of mice to PTx gradually elevated serum levels for TGF-beta and IL-10 which was associated with an expansion of peripheral CD4(+)CD25(+)FoxP3(+) regulatory T cells (Treg). Increased frequency of Treg persisted upon immunization and thereafter. Collectively, these data suggest a scenario in which repetitive PTx treatment protects mice from development of CNS autoimmune disease through upregulation of regulatory cytokines and expansion of CD4(+)CD25(+)FoxP3(+) Treg. Besides its therapeutic implication, this finding suggests that encounter of the immune system with microbial products may not only be part of CNS autoimmune disease pathogenesis but also of its regulation.	[Weber, Martin S.; Lehmann-Horn, Klaus; Hertzenberg, Deetje; Sellner, Johann; Hemmer, Bernhard] Tech Univ Munich, Dept Neurol, Munich, Germany; [Weber, Martin S.; Zamvil, Scott S.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Benkhoucha, Mahdia; Santiago-Raber, Marie-Laure; Chofflon, Michel; Lalive, Patrice H.] Univ Hosp Geneva, Dept Neurosci, Div Neurol, Geneva, Switzerland; [Benkhoucha, Mahdia; Santiago-Raber, Marie-Laure; Chofflon, Michel; Lalive, Patrice H.] Univ Geneva, Fac Med, Geneva, Switzerland; [Benkhoucha, Mahdia; Lalive, Patrice H.] Univ Hosp Geneva, Dept Pathol & Immunol, Geneva, Switzerland; [Lalive, Patrice H.] Univ Geneva, Univ Hosp Geneva, Fac Med, Dept Genet & Lab Med, Geneva, Switzerland	Technical University of Munich; University of California System; University of California San Francisco; University of Geneva; University of Geneva; University of Geneva; University of Geneva	Weber, MS (corresponding author), Tech Univ Munich, Dept Neurol, Munich, Germany.	m.weber@lrz.tu-muenchen.de; zamvil@ucsf.neuroimmunol.org	Hemmer, Bernhard/GPX-8451-2022; Hemmer, Bernhard/AAT-8388-2021; Selllner, Johann/AAB-1263-2019; Weber, Martin/GPW-6095-2022; Lalive, Patrice/AAM-5861-2020	Hemmer, Bernhard/0000-0001-5985-6784; 	Deutsche Forschungsgemeinschaft (DFG) [WE 3547/4-1]; National Multiple Sclerosis Society (NMSS) [RG 445A1/T, RG 3622, 3913]; Else Kroner Fresenius Stiftung [A69/2010]; TEVA; Kommission fur Klinische Forschung (KKF) of the Technische Universitat Munchen; Novartis; Bayer Schering; Biogen Idec; Merck-Serono; Roche; Micromet; Metanomics; Protagen; National Institutes of Health (NIH [RO1 AI073737, RO1 AI059709, RO1 NS063008]; Maisin Foundation; Swiss National Foundation [310000-132705]; Swiss Multiple Sclerosis Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059709, R01AI073737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063008] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); Else Kroner Fresenius Stiftung; TEVA(Teva Pharmaceutical Industries); Kommission fur Klinische Forschung (KKF) of the Technische Universitat Munchen; Novartis(Novartis); Bayer Schering(Bayer AG); Biogen Idec(Biogen); Merck-Serono(Merck & Company); Roche(Roche Holding); Micromet(Amgen); Metanomics; Protagen; National Institutes of Health (NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maisin Foundation; Swiss National Foundation(Swiss National Science Foundation (SNSF)); Swiss Multiple Sclerosis Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	M.S.W. received grant support from the Deutsche Forschungsgemeinschaft (DFG; WE 3547/4-1), the National Multiple Sclerosis Society (NMSS; RG 445A1/T), the Else Kroner Fresenius Stiftung (A69/2010), TEVA and the Kommission fur Klinische Forschung (KKF) of the Technische Universitat Munchen. K.L-H. and J.S. were supported by fellowships from the KKF of the Technische Universitat Munchen. B.H. has received board membership and/or consulting fees from Novartis, Bayer Schering, Biogen Idec, Merck-Serono, Roche, Micromet and Novartis. B.H. received grant support from Novartis, Bayer Schering, Biogen Idec, Metanomics, Protagen and Merck-Serono. S.S.Z. was supported by the National Institutes of Health (NIH; RO1 AI073737, RO1 AI059709, and RO1 NS063008), the NMSS (RG 3622 and 3913) and the Maisin Foundation. P.H.L. was supported by the Swiss National Foundation (#310000-132705) and the Swiss Multiple Sclerosis Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal RK, 2002, J NEUROIMMUNOL, V129, P133, DOI 10.1016/S0165-5728(02)00203-5; Andreasen C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007079; Arimoto H, 2000, J NEUROIMMUNOL, V104, P15, DOI 10.1016/S0165-5728(99)00242-8; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bager P, 2004, BRAIN, V127, P2491, DOI 10.1093/brain/awh283; BENNUN A, 1995, J IMMUNOL, V154, P2939; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; BROCKE S, 1993, NATURE, V365, P642, DOI 10.1038/365642a0; Bruckener KE, 2003, J CELL SCI, V116, P1837, DOI 10.1242/jcs.00378; Burger D, 2009, P NATL ACAD SCI USA, V106, P4355, DOI 10.1073/pnas.0812183106; Burnette W N, 1997, Behring Inst Mitt, P434; Cassan C, 2006, J IMMUNOL, V177, P1552, DOI 10.4049/jimmunol.177.3.1552; Cermelli C, 2003, J INFECT DIS, V187, P1377, DOI 10.1086/368166; Chen X, 2006, EUR J IMMUNOL, V36, P671, DOI 10.1002/eji.200535353; Chen X, 2007, J IMMUNOL, V178, P6123, DOI 10.4049/jimmunol.178.10.6123; Correale J, 2006, NEUROLOGY, V67, P652, DOI 10.1212/01.wnl.0000233834.09743.3b; Falnes PO, 2000, CURR OPIN CELL BIOL, V12, P407, DOI 10.1016/S0955-0674(00)00109-5; Gardell JL, 2006, J CLIN VIROL, V37, pS11, DOI 10.1016/S1386-6532(06)70005-1; Gilden DH, 2005, LANCET NEUROL, V4, P195, DOI 10.1016/S1474-4422(05)01017-3; HANDEL AE, PLOS ONE, V5; He JP, 2000, J EXP MED, V191, P1605, DOI 10.1084/jem.191.9.1605; Hofstetter HH, 2007, CYTOKINE, V40, P35, DOI 10.1016/j.cyto.2007.07.192; Hong J, 2005, P NATL ACAD SCI USA, V102, P6449, DOI 10.1073/pnas.0502187102; Hou WQ, 2003, J IMMUNOL, V170, P1728, DOI 10.4049/jimmunol.170.4.1728; Kerfoot SM, 2004, J IMMUNOL, V173, P7070, DOI 10.4049/jimmunol.173.11.7070; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605; LEHMANN D, 1992, J AUTOIMMUN, V5, P675, DOI 10.1016/0896-8411(92)90185-S; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; LINTHICUM DS, 1982, IMMUNOBIOLOGY, V162, P211, DOI 10.1016/S0171-2985(11)80001-X; Mahnke K, 2007, CELL IMMUNOL, V250, P1, DOI 10.1016/j.cellimm.2008.01.004; MCFARLIN DE, 1982, NEW ENGL J MED, V307, P1183, DOI 10.1056/NEJM198211043071905; MUNOZ JJ, 1984, CELL IMMUNOL, V83, P92, DOI 10.1016/0008-8749(84)90228-4; O'Connor RA, 2008, J NEUROIMMUNOL, V193, P1, DOI 10.1016/j.jneuroim.2007.11.016; Racke MK, 2005, TRENDS IMMUNOL, V26, P289, DOI 10.1016/j.it.2005.03.012; RADVANYI LG, 1993, J IMMUNOL, V150, P5704; Reddy J, 2004, P NATL ACAD SCI USA, V101, P15434, DOI 10.1073/pnas.0404444101; Robbinson D, 1996, CELL IMMUNOL, V168, P165, DOI 10.1006/cimm.1996.0063; SCHIFFENBAUER J, 1993, P NATL ACAD SCI USA, V90, P8543, DOI 10.1073/pnas.90.18.8543; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Soldan SS, 1997, NAT MED, V3, P1394, DOI 10.1038/nm1297-1394; SOOS JM, 1993, J NEUROIMMUNOL, V43, P39, DOI 10.1016/0165-5728(93)90073-8; Stephens LA, 2005, P NATL ACAD SCI USA, V102, P17418, DOI 10.1073/pnas.0507454102; Stuve O, 2006, J CLIN INVEST, V116, P1037, DOI 10.1172/JCI25805; Su SB, 2001, J IMMUNOL, V167, P250, DOI 10.4049/jimmunol.167.1.250; Tejada-Simon MV, 2003, ANN NEUROL, V53, P189, DOI 10.1002/ana.10425; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; von Herrath MG, 2003, NAT REV MICROBIOL, V1, P151, DOI 10.1038/nrmicro754; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; WESSELBORG S, 1993, J IMMUNOL, V150, P4338; Zhang XM, 2004, INT IMMUNOL, V16, P249, DOI 10.1093/intimm/dxh029	53	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e16009	10.1371/journal.pone.0016009	http://dx.doi.org/10.1371/journal.pone.0016009			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209857	Green Published, Green Submitted, gold			2022-12-27	WOS:000285793600057
J	Yoder, MJ; Miko, I; Seltmann, KC; Bertone, MA; Deans, AR				Yoder, Matthew J.; Miko, Istvan; Seltmann, Katja C.; Bertone, Matthew A.; Deans, Andrew R.			A Gross Anatomy Ontology for Hymenoptera	PLOS ONE			English	Article							GENOMICS; IMAGES	Hymenoptera is an extraordinarily diverse lineage, both in terms of species numbers and morphotypes, that includes sawflies, bees, wasps, and ants. These organisms serve critical roles as herbivores, predators, parasitoids, and pollinators, with several species functioning as models for agricultural, behavioral, and genomic research. The collective anatomical knowledge of these insects, however, has been described or referred to by labels derived from numerous, partially overlapping lexicons. The resulting corpus of information-millions of statements about hymenopteran phenotypes-remains inaccessible due to language discrepancies. The Hymenoptera Anatomy Ontology (HAO) was developed to surmount this challenge and to aid future communication related to hymenopteran anatomy. The HAO was built using newly developed interfaces within mx, a Web-based, open source software package, that enables collaborators to simultaneously contribute to an ontology. Over twenty people contributed to the development of this ontology by adding terms, genus differentia, references, images, relationships, and annotations. The database interface returns an Open Biomedical Ontology (OBO) formatted version of the ontology and includes mechanisms for extracting candidate data and for publishing a searchable ontology to the Web. The application tools are subject-agnostic and may be used by others initiating and developing ontologies. The present core HAO data constitute 2,111 concepts, 6,977 terms (labels for concepts), 3,152 relations, 4,361 sensus (links between terms, concepts, and references) and over 6,000 text and graphical annotations. The HAO is rooted with the Common Anatomy Reference Ontology (CARO), in order to facilitate interoperability with and future alignment to other anatomy ontologies, and is available through the OBO Foundry ontology repository and BioPortal. The HAO provides a foundation through which connections between genomic, evolutionary developmental biology, phylogenetic, taxonomic, and morphological research can be actualized. Inherent mechanisms for feedback and content delivery demonstrate the effectiveness of remote, collaborative ontology development and facilitate future refinement of the HAO.	[Yoder, Matthew J.; Miko, Istvan; Seltmann, Katja C.; Bertone, Matthew A.; Deans, Andrew R.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Yoder, MJ (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	andy_deans@ncsu.edu	Deans, Andrew R./AAG-4166-2021; Seltmann, Katja/AAC-9120-2020	Deans, Andrew R./0000-0002-2119-4663; Seltmann, Katja/0000-0001-5354-6048; Miko, Istvan/0000-0001-9719-0215; Bertone, Matt/0000-0001-7985-1913	National Science Foundation [DBI-0850223, DEB-0328922, EF-0905606]; OBO ontology; International Society of Hymenopterist; Direct For Biological Sciences [1261346] Funding Source: National Science Foundation; Div Of Biological Infrastructure [0850223] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); OBO ontology; International Society of Hymenopterist; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The National Science Foundation funded this research through its Advances in Biological Informatics program (grant DBI-0850223), PEET program (DEB-0328922), and NESCent (EF-0905606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Fredrik Ronquist for encouraging the development of the HAO, Gary Gibson and Lars Vilhelmsen for their feedback on content and the OBO ontology and International Society of Hymenopterist for support and feedback. Ontology development was significantly enhanced by colleagues at the National Evolutionary Synthesis Center (NESCent). Roberto Keller and two anonymous reviewers provided many useful comments and suggestions to improve the manuscript.	Agosti Donat, 2009, BMC Res Notes, V2, P53, DOI 10.1186/1756-0500-2-53; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balhoff JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010500; BARD J, 2008, COMPUT BIOL SER, V6, P3; BECK D. ELDEN, 1933, PROC UTAH ACAD SCI, V10, P89; Bezier A, 2009, SCIENCE, V323, P926, DOI 10.1126/science.1166788; Burger A., 2008, ANATOMY ONTOLOGIES B; Cote RG, 2008, NUCLEIC ACIDS RES, V36, pW372, DOI 10.1093/nar/gkn252; *CREAT COMM, CREAT COMM BY NC SA; Dahdul WM, 2010, SYST BIOL, V59, P369, DOI 10.1093/sysbio/syq013; Day-Richter J, 2007, BIOINFORMATICS, V23, P2198, DOI 10.1093/bioinformatics/btm112; Deans AR, 2008, ZOOTAXA, P28, DOI 10.11646/zootaxa.1787.1.2; Drysdale R, 2001, Brief Bioinform, V2, P68, DOI 10.1093/bib/2.1.68; Gkoutos GV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r8; Grumbling G, 2006, NUCLEIC ACIDS RES, V34, pD484, DOI 10.1093/nar/gkj068; HAENDEL MA, 2008, COMPUT BIOL SER, V6, P327; La Salle J, 2009, ZOOTAXA, P43, DOI 10.11646/zootaxa.2217.1.3; LEOPOLD J, 2009, P WORLD ACAD SCI ENG, V52, P369; Mabee PM, 2007, J EXP ZOOL PART B, V308B, P655, DOI 10.1002/jez.b.21181; Mabee PM, 2007, TRENDS ECOL EVOL, V22, P345, DOI 10.1016/j.tree.2007.03.013; Miko I, 2009, ZOOKEYS, P127, DOI 10.3897/zookeys.20.119; Musen M A, 2008, AMIA Annu Symp Proc, P1223; Ramirez MJ, 2007, SYST BIOL, V56, P283, DOI 10.1080/10635150701313848; Smith B., 2005, 10 INT C LOG METH PH, P505; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; SNODGRASS R. E., 1941, SMITHSONIAN MISC COLL, V99, P1; SNODGRASS R. E., 1957, SMITHSONIAN MISC COLL, V135, P1; Topalis P, 2008, INSECT MOL BIOL, V17, P87, DOI 10.1111/j.1365-2583.2008.00781.x; Verhoeff CW, 1893, ZOOL ANZ, V16, P407; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Wharton RA, 2010, ZOOKEYS, P35, DOI 10.3897/zookeys.37.313; WHEELER WM, 1910, COLUMBIA BIOL SERIES, V9; Yoder M, 2007, ZOOTAXA, P47; Yu AC, 2006, J BIOMED INFORM, V39, P252, DOI 10.1016/j.jbi.2005.11.006; MX COLLABORATIVE WEB	36	236	257	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15991	10.1371/journal.pone.0015991	http://dx.doi.org/10.1371/journal.pone.0015991			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209921	Green Published, Green Submitted, gold			2022-12-27	WOS:000285793200077
J	Bonnot, N; Gaillard, JM; Coulon, A; Galan, M; Cosson, JF; Delorme, D; Klein, F; Hewison, AJM				Bonnot, Nadege; Gaillard, Jean-Michel; Coulon, Aurelie; Galan, Maxime; Cosson, Jean-Francois; Delorme, Daniel; Klein, Francois; Hewison, A. J. Mark			No Difference between the Sexes in Fine-Scale Spatial Genetic Structure of Roe Deer	PLOS ONE			English	Article							FEMALE PHILOPATRY; BIASED DISPERSAL; MATING SYSTEM; RELATEDNESS; POPULATION; UNGULATE; ORGANIZATION; SOFTWARE; PATTERNS	Background: Data on spatial genetic patterns may provide information about the ecological and behavioural mechanisms underlying population structure. Indeed, social organization and dispersal patterns of species may be reflected by the pattern of genetic structure within a population. Methodology/Principal Findings: We investigated the fine-scale spatial genetic structure of a roe deer (Capreolus capreolus) population in Trois-Fontaines (France) using 12 microsatellite loci. The roe deer is weakly polygynous and highly sedentary, and can form matrilineal clans. We show that relatedness among individuals was negatively correlated with geographic distance, indicating that spatially proximate individuals are also genetically close. More unusually for a large mammalian herbivore, the link between relatedness and distance did not differ between the sexes, which is consistent with the lack of sex-biased dispersal and the weakly polygynous mating system of roe deer. Conclusions/Significance: Our results contrast with previous reports on highly polygynous species with male-biased dispersal, such as red deer, where local genetic structure was detected in females only. This divergence between species highlights the importance of socio-spatial organization in determining local genetic structure of vertebrate populations.	[Bonnot, Nadege; Hewison, A. J. Mark] INRA, Lab Comportement & Ecol Faune Sauvage, F-31326 Castanet Tolosan, France; [Gaillard, Jean-Michel] Univ Lyon 1, CNRS, UMR 5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Coulon, Aurelie] CNRS, UMR 7179, Museum Natl Hist Nat, Brunoy, France; [Galan, Maxime; Cosson, Jean-Francois] INRA, Ctr Biol Gest Populat, Montferrier Sur Lez, France; [Delorme, Daniel; Klein, Francois] Ctr Natl Etud & Rech Appl Cervides Sangliers, Off Natl Chasse & Faune Sauvage, Bar Le Duc, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); INRAE; Institut de Recherche pour le Developpement (IRD)	Bonnot, N (corresponding author), INRA, Lab Comportement & Ecol Faune Sauvage, F-31326 Castanet Tolosan, France.	nbonnot@toulouse.inra.fr	Hewison, Aidan J Mark/AGJ-3300-2022; Galan, Maxime/AAB-9511-2019; Bonnot, Nadege/N-1762-2019	Hewison, Aidan J Mark/0000-0002-2276-4154; Galan, Maxime/0000-0001-6981-5732; Bonnot, Nadege/0000-0002-8717-231X; Cosson, Jean Francois/0000-0003-0863-5871	French National Institute for Agricultural Research	French National Institute for Agricultural Research	The study was funded by the French National Institute for Agricultural Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apio A, 2010, J ZOOL, V280, P213, DOI 10.1111/j.1469-7998.2009.00654.x; Campbell V, 2006, CAN J ZOOL, V84, P1112, DOI 10.1139/Z06-099; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; Coltman DW, 2003, MOL ECOL, V12, P733, DOI 10.1046/j.1365-294X.2003.01762.x; Comer CE, 2005, J WILDLIFE MANAGE, V69, P332, DOI 10.2193/0022-541X(2005)069&lt;0332:FGSASO&gt;2.0.CO;2; Coulon A, 2006, P ROY SOC B-BIOL SCI, V273, P341, DOI 10.1098/rspb.2005.3329; Csillery K, 2006, GENETICS, V173, P2091, DOI 10.1534/genetics.106.057331; Cullingham CI, 2011, EVOL APPL, V4, P116, DOI 10.1111/j.1752-4571.2010.00142.x; Cutrera AP, 2005, MOL ECOL, V14, P2511, DOI 10.1111/j.1365-294X.2005.02551.x; Da Silva A, 2009, EVOLUTION, V63, P403, DOI 10.1111/j.1558-5646.2008.00542.x; Frantz AC, 2008, EUR J WILDLIFE RES, V54, P44, DOI 10.1007/s10344-007-0107-1; Gaillard JM, 2008, P ROY SOC B-BIOL SCI, V275, P2025, DOI 10.1098/rspb.2008.0393; GAILLARD JM, 1993, J ANIM ECOL, V62, P778; Galan M, 2003, MOL ECOL NOTES, V3, P142, DOI 10.1046/j.1471-8286.2003.00384.x; Gauffre B, 2009, P R SOC B, V276, P3487, DOI 10.1098/rspb.2009.0881; Grear DA, 2010, J APPL ECOL, V47, P532, DOI 10.1111/j.1365-2664.2010.01813.x; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hardy OJ, 1999, HEREDITY, V83, P145, DOI 10.1046/j.1365-2540.1999.00558.x; Hazlitt SL, 2004, MOL ECOL, V13, P3621, DOI 10.1111/j.1365-294X.2004.02342.x; Hewison AJM, 1998, EUROPEAN ROE DEER: THE BIOLOGY OF SUCCESS, P189; Kurt F, 1968, MAMMALIA DEPICTA, V3; LI CC, 1993, HUM HERED, V43, P45, DOI 10.1159/000154113; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Lynch M, 1999, GENETICS, V152, P1753; Miller BF, 2010, J MAMMAL, V91, P681, DOI 10.1644/09-MAMM-A-258.1; Nituch LA, 2008, ETHOLOGY, V114, P711, DOI 10.1111/j.1439-0310.2008.01522.x; Nussey DH, 2005, MOL ECOL, V14, P3395, DOI 10.1111/j.1365-294X.2005.02692.x; Perez-Espona S, 2010, MOL ECOL, V19, P3101, DOI 10.1111/j.1365-294X.2010.04733.x; Pilot M, 2010, J EVOLUTION BIOL, V23, P20, DOI 10.1111/j.1420-9101.2009.01887.x; Poteaux C, 2009, J ZOOL, V278, P116, DOI 10.1111/j.1469-7998.2009.00553.x; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; R Core Team, 2018, R LANG ENV STAT COMP; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Stoen OG, 2005, BEHAV ECOL SOCIOBIOL, V59, P191, DOI 10.1007/s00265-005-0024-9; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storz JF, 1999, J MAMMAL, V80, P553, DOI 10.2307/1383301; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vanpe C, 2008, BEHAV ECOL, V19, P309, DOI 10.1093/beheco/arm132	40	24	24	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14436	10.1371/journal.pone.0014436	http://dx.doi.org/10.1371/journal.pone.0014436			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203388	gold, Green Published, Green Submitted			2022-12-27	WOS:000285792500013
J	Valeri, A; Alonso-Ferrero, ME; Rio, P; Pujol, MR; Casado, JA; Perez, L; Jacome, A; Agirre, X; Calasanz, MJ; Hanenberg, H; Surralles, J; Prosper, F; Albella, B; Bueren, JA				Valeri, Antonio; Eugenia Alonso-Ferrero, Maria; Rio, Paula; Roser Pujol, Maria; Casado, Jose A.; Perez, Laura; Jacome, Ariana; Agirre, Xabier; Jose Calasanz, Maria; Hanenberg, Helmut; Surralles, Jordi; Prosper, Felipe; Albella, Beatriz; Bueren, Juan A.			Bcr/Abl Interferes with the Fanconi Anemia/BRCA Pathway: Implications in the Chromosomal Instability of Chronic Myeloid Leukemia Cells	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; STRAND BREAK REPAIR; BCR-ABL ONCOGENE; HEMATOPOIETIC-CELLS; DNA-REPAIR; PHOSPHATIDYLINOSITOL 3-KINASE; CENTROSOME AMPLIFICATION; PHILADELPHIA-CHROMOSOME; CYCLE CHECKPOINT; GENOTOXIC STRESS	Chronic myeloid leukemia (CML) is a malignant clonal disorder of the hematopoietic system caused by the expression of the BCR/ABL fusion oncogene. Although it is well known that CML cells are genetically unstable, the mechanisms accounting for this genomic instability are still poorly understood. Because the Fanconi anemia (FA) pathway is believed to control several mechanisms of DNA repair, we investigated whether this pathway was disrupted in CML cells. Our data show that CML cells have a defective capacity to generate FANCD2 nuclear foci, either in dividing cells or after DNA damage. Similarly, human cord blood CD34(+) cells transduced with BCR/ABL retroviral vectors showed impaired FANCD2 foci formation, whereas FANCD2 monoubiquitination in these cells was unaffected. Soon after the transduction of CD34+ cells with BCR/ABL retroviral vectors a high proportion of cells with supernumerary centrosomes was observed. Similarly, BCR/ABL induced a high proportion of chromosomal abnormalities, while mediated a cell survival advantage after exposure to DNA cross-linking agents. Significantly, both the impaired formation of FANCD2 nuclear foci, and also the predisposition of BCR/ABL cells to develop centrosomal and chromosomal aberrations were reverted by the ectopic expression of BRCA1. Taken together, our data show for the first time a disruption of the FA/BRCA pathway in BCR/ABL cells, suggesting that this defective pathway should play an important role in the genomic instability of CML by the co-occurrence of centrosomal amplification and DNA repair deficiencies.	[Valeri, Antonio; Eugenia Alonso-Ferrero, Maria; Rio, Paula; Casado, Jose A.; Perez, Laura; Jacome, Ariana; Albella, Beatriz; Bueren, Juan A.] Ctr Invest Energet Medioambientales & Tecnol CIEM, Madrid, Spain; [Valeri, Antonio; Eugenia Alonso-Ferrero, Maria; Rio, Paula; Casado, Jose A.; Perez, Laura; Jacome, Ariana; Albella, Beatriz; Bueren, Juan A.] CIBERER, Madrid, Spain; [Roser Pujol, Maria; Surralles, Jordi] Univ Autonoma Barcelona, Dept Genet & Microbiol, Bellaterra, Spain; [Roser Pujol, Maria; Surralles, Jordi] CIBERER, Barcelona, Spain; [Agirre, Xabier; Jose Calasanz, Maria; Prosper, Felipe] Univ Navarra Clin, Fdn Invest Med Aplicada CIMA, Pamplona, Spain; [Hanenberg, Helmut] Childrens Hosp, Dept Pediat Oncol Hematol & Immunol, Dusseldorf, Germany; [Hanenberg, Helmut] Riley Hosp Children, Dept Pediat, Wells Ctr Pediat Res, Indianapolis, IN USA	Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Navarra; James Whitcomb Riley Hospital Children	Valeri, A (corresponding author), Ctr Invest Energet Medioambientales & Tecnol CIEM, Madrid, Spain.	juan.bueren@ciemat.es	Surrallés, Jordi/AAE-7667-2020; Prosper, Felipe/H-6859-2017; Rio, Paula/G-8681-2015; Calasanz, MJ/R-5813-2016; Agirre, Xabier/ABE-4110-2020; Bueren, Juan/L-6112-2014; Casado, José Antonio/H-5077-2015	Prosper, Felipe/0000-0001-6115-8790; Rio, Paula/0000-0002-5424-5543; Calasanz, MJ/0000-0002-0374-3008; Bueren, Juan/0000-0002-3228-7013; Casado, José Antonio/0000-0003-2479-1508; Jacome de Azevedo, Ariana/0000-0002-2980-7399; Surralles, Jordi/0000-0002-4041-7519	European Program Life Sciences, Genomics and Biotechnology for Health [LSHB-CT-2004-5242]; Centro de Investigacion en Red de Enfermedades Raras (CIBERER); Comision Interministerial de Ciencia y Tecnologia [SAF2005-00058, SAF 2009-11936, SAF 2009-027]; Genoma Espana (FANCOGENE); NATIONAL CANCER INSTITUTE [R01CA155294] Funding Source: NIH RePORTER	European Program Life Sciences, Genomics and Biotechnology for Health; Centro de Investigacion en Red de Enfermedades Raras (CIBERER); Comision Interministerial de Ciencia y Tecnologia(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Genoma Espana (FANCOGENE); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the European Program "Life Sciences, Genomics and Biotechnology for Health" (CONSERT; Ref LSHB-CT-2004-5242), Centro de Investigacion en Red de Enfermedades Raras (CIBERER), Comision Interministerial de Ciencia y Tecnologia (SAF2005-00058, SAF 2009-11936 and SAF 2009-027) and Genoma Espana (FANCOGENE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichberger KJ, 2005, BLOOD, V105, P3303, DOI 10.1182/blood-2004-02-0749; Altiok S, 1999, J BIOL CHEM, V274, P32274, DOI 10.1074/jbc.274.45.32274; AUERBACH AD, 1976, NATURE, V261, P494, DOI 10.1038/261494a0; BARTRAM CR, 1983, NATURE, V306, P277, DOI 10.1038/306277a0; BEDI A, 1995, BLOOD, V86, P1148, DOI 10.1182/blood.V86.3.1148.bloodjournal8631148; Bogliolo M, 2007, EMBO J, V26, P1340, DOI 10.1038/sj.emboj.7601574; Burke BA, 2010, LEUKEMIA; Cambier N, 1998, ONCOGENE, V16, P335, DOI 10.1038/sj.onc.1201490; Casado JA, 2007, J MED GENET, V44, P241, DOI 10.1136/jmg.2006.044719; Chalandon Y, 2002, BLOOD, V99, P3197, DOI 10.1182/blood.V99.9.3197; Cohn MA, 2008, MOL CELL, V32, P306, DOI 10.1016/j.molcel.2008.10.009; Cramer K, 2008, CANCER RES, V68, P6884, DOI 10.1158/0008-5472.CAN-08-1101; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Deutsch E, 2001, BLOOD, V97, P2084, DOI 10.1182/blood.V97.7.2084; Deutsch E, 2003, BLOOD, V101, P4583, DOI 10.1182/blood-2002-10-3011; Dierov J, 2009, LEUKEMIA, V23, P279, DOI 10.1038/leu.2008.308; Fernandes MS, 2009, BLOOD, V114, P1813, DOI 10.1182/blood-2008-07-172148; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Ghaffari S, 2003, P NATL ACAD SCI USA, V100, P6523, DOI 10.1073/pnas.0731871100; Giehl M, 2005, LEUKEMIA, V19, P1192, DOI 10.1038/sj.leu.2403779; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; Hess CJ, 2008, CELL ONCOL, V30, P299, DOI 10.3233/CLO-2008-0426; Horita M, 2000, J EXP MED, V191, P977, DOI 10.1084/jem.191.6.977; Jacome A, 2006, HUM GENE THER, V17, P245, DOI 10.1089/hum.2006.17.245; Jose-Eneriz ES, 2008, BRIT J HAEMATOL, V142, P571, DOI 10.1111/j.1365-2141.2008.07221.x; Koptyra M, 2008, LEUKEMIA, V22, P1969, DOI 10.1038/leu.2008.78; Koptyra M, 2008, BLOOD, V112, P112; Koptyra M, 2006, BLOOD, V108, P319, DOI 10.1182/blood-2005-07-2815; Levitus M, 2006, CELL ONCOL, V28, P3; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; Lyakhovich A, 2006, CANCER LETT, V232, P99, DOI 10.1016/j.canlet.2005.07.038; MCGAHON A, 1994, BLOOD, V83, P1179, DOI 10.1182/blood.V83.5.1179.bloodjournal8351179; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Narayan G, 2004, CANCER RES, V64, P2994, DOI 10.1158/0008-5472.CAN-04-0245; Neshat MS, 2000, MOL CELL BIOL, V20, P1179, DOI 10.1128/MCB.20.4.1179-1186.2000; Nowicki MO, 2004, BLOOD, V104, P3746, DOI 10.1182/blood-2004-05-1941; Plo I, 2008, CANCER RES, V68, P9404, DOI 10.1158/0008-5472.CAN-08-0861; Quintas-Cardama A, 2009, BLOOD, V113, P1619, DOI 10.1182/blood-2008-03-144790; Sattler M, 2000, J BIOL CHEM, V275, P24273, DOI 10.1074/jbc.M002094200; SEYSCHAB H, 1995, BLOOD, V85, P2233, DOI 10.1182/blood.V85.8.2233.bloodjournal8582233; Starita LM, 2004, MOL CELL BIOL, V24, P8457, DOI 10.1128/MCB.24.19.8457-8466.2004; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Taniguchi T, 2003, NAT MED, V9, P568, DOI 10.1038/nm852; Tischkowitz MD, 2004, LEUKEMIA, V18, P420, DOI 10.1038/sj.leu.2403280; Tonic I, 2010, J BIOL CHEM, V285, P23790, DOI 10.1074/jbc.M110.104372; Van der Heijden MS, 2004, AM J PATHOL, V165, P651, DOI 10.1016/S0002-9440(10)63329-9; Vandenberg CJ, 2003, MOL CELL, V12, P247, DOI 10.1016/S1097-2765(03)00281-8; VARTICOVSKI L, 1991, MOL CELL BIOL, V11, P1107, DOI 10.1128/MCB.11.2.1107; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Zhao RC, 2001, BLOOD, V97, P2406, DOI 10.1182/blood.V97.8.2406	53	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15525	10.1371/journal.pone.0015525	http://dx.doi.org/10.1371/journal.pone.0015525			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203397	gold, Green Published			2022-12-27	WOS:000285792500030
J	Chan, YC; Roos, C; Inoue-Murayama, M; Inoue, E; Shih, CC; Pei, KJC; Vigilant, L				Chan, Yi-Chiao; Roos, Christian; Inoue-Murayama, Miho; Inoue, Eiji; Shih, Chih-Chin; Pei, Kurtis Jai-Chyi; Vigilant, Linda			Mitochondrial Genome Sequences Effectively Reveal the Phylogeny of Hylobates Gibbons	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; DIVERGENCE DATES; UPPER MIOCENE; DNA; BIOGEOGRAPHY; EVOLUTION; DIVERSIFICATION; SOFTWARE; HOMINID; ORIGIN	Background: Uniquely among hominoids, gibbons exist as multiple geographically contiguous taxa exhibiting distinctive behavioral, morphological, and karyotypic characteristics. However, our understanding of the evolutionary relationships of the various gibbons, especially among Hylobates species, is still limited because previous studies used limited taxon sampling or short mitochondrial DNA (mtDNA) sequences. Here we use mtDNA genome sequences to reconstruct gibbon phylogenetic relationships and reveal the pattern and timing of divergence events in gibbon evolutionary history. Methodology/Principal Findings: We sequenced the mitochondrial genomes of 51 individuals representing 11 species belonging to three genera (Hylobates, Nomascus and Symphalangus) using the high-throughput 454 sequencing system with the parallel tagged sequencing approach. Three phylogenetic analyses (maximum likelihood, Bayesian analysis and neighbor-joining) depicted the gibbon phylogenetic relationships congruently and with strong support values. Most notably, we recover a well-supported phylogeny of the Hylobates gibbons. The estimation of divergence times using Bayesian analysis with relaxed clock model suggests a much more rapid speciation process in Hylobates than in Nomascus. Conclusions/Significance: Use of more than 15 kb sequences of the mitochondrial genome provided more informative and robust data than previous studies of short mitochondrial segments (e. g., control region or cytochrome b) as shown by the reliable reconstruction of divergence patterns among Hylobates gibbons. Moreover, molecular dating of the mitogenomic divergence times implied that biogeographic change during the last five million years may be a factor promoting the speciation of Sundaland animals, including Hylobates species.	[Chan, Yi-Chiao; Vigilant, Linda] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Roos, Christian] German Primate Ctr, Gene Bank Primates, Gottingen, Germany; [Roos, Christian] German Primate Ctr, Primate Genet Lab, Gottingen, Germany; [Inoue-Murayama, Miho] Kyoto Univ, Wildlife Res Ctr, Kyoto, Japan; [Inoue, Eiji] Kyoto Univ, Grad Sch Sci, Kyoto, Japan; [Shih, Chih-Chin] Taipei Zoo, Anim Div, Taipei, Taiwan; [Pei, Kurtis Jai-Chyi] Natl Pingtung Univ Sci & Technol, Inst Wildlife Conservat, Pingtung, Taiwan	Max Planck Society; Deutsches Primatenzentrum (DPZ); Deutsches Primatenzentrum (DPZ); Kyoto University; Kyoto University; National Pingtung University Science & Technology	Chan, YC (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany.	yichiao_chan@eva.mpg.de			Leakey Foundation; Deutscher Akademischer Austausch Dienst; Max Planck Society	Leakey Foundation; Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by a grant from the Leakey Foundation (L.V.), the fellowship of the Deutscher Akademischer Austausch Dienst (Y.-C.C.) and the Max Planck Society. Leakey Foundation website: http://www.leakeyfoundation.org/. Deutscher Akademischer Austausch Dienst (DAAD) website: http://www.daad.de/en/index.html. Max Planck Society website: http://www.mpg.de/english/portal/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanuma J, 2000, J HUM GENET, V45, P337, DOI 10.1007/s100380070004; ARNASON U, 1995, J MOL EVOL, V40, P78, DOI 10.1007/BF00166598; Benefit Brenda R., 2002, VVolume 33, P241; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Brandon-Jones D, 2004, INT J PRIMATOL, V25, P97, DOI 10.1023/B:IJOP.0000014647.18720.32; Brunet M, 2005, NATURE, V434, P752, DOI 10.1038/nature03392; Cerling TE, 1998, PHILOS T R SOC B, V353, P159, DOI 10.1098/rstb.1998.0198; Chatterjee HJ, 2006, INT J PRIMATOL, V27, P699, DOI 10.1007/s10764-006-9044-1; Delisle I, 2005, MOL PHYLOGENET EVOL, V37, P192, DOI 10.1016/j.ympev.2005.04.025; den Tex RJ, 2010, MOL PHYLOGENET EVOL, V55, P711, DOI 10.1016/j.ympev.2009.12.023; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fenn JD, 2008, MOL PHYLOGENET EVOL, V49, P59, DOI 10.1016/j.ympev.2008.07.004; Fortelius M, 2006, PALAEOGEOGR PALAEOCL, V238, P219, DOI 10.1016/j.palaeo.2006.03.042; Fulton TL, 2010, J BIOGEOGR, V37, P814, DOI 10.1111/j.1365-2699.2010.02271.x; Garza JC, 1992, MOL PHYLOGENET EVOL, V1, P202, DOI 10.1016/1055-7903(92)90016-A; Geissmann Thomas, 1995, IZN (International Zoo News), V42, P467; Gilbert C, 2006, MOL PHYLOGENET EVOL, V40, P101, DOI 10.1016/j.ympev.2006.02.017; Gladenkov AY, 2002, PALAEOGEOGR PALAEOCL, V183, P321, DOI 10.1016/S0031-0182(02)00249-3; Groves C.P., 2001, PRIMATE TAXONOMY; Hall LM, 1998, MOL PHYLOGENET EVOL, V10, P281, DOI 10.1006/mpev.1998.0539; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HAYASHI S, 1995, J MOL EVOL, V41, P359, DOI 10.1007/BF01215183; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Johnson WE, 2006, SCIENCE, V311, P73, DOI 10.1126/science.1122277; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kelley Jay, 2002, VVolume 33, P369; Krause J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-220; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lebatard AE, 2008, P NATL ACAD SCI USA, V105, P3226, DOI 10.1073/pnas.0708015105; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Matsudaira K, 2010, MOL PHYLOGENET EVOL, V55, P454, DOI 10.1016/j.ympev.2010.01.032; Matsui A, 2009, GENE, V441, P53, DOI 10.1016/j.gene.2008.08.024; Meyer M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm566; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Mittermeier RA., 2005, HOTSPOTS REVISITED E, DOI DOI 10.1111/j.1471-8286.2007.01678.x; Miya M, 2001, MOL BIOL EVOL, V18, P1993, DOI 10.1093/oxfordjournals.molbev.a003741; Monda K, 2007, AM J PRIMATOL, V69, P1285, DOI 10.1002/ajp.20439; Mootnick A, 2005, INT J PRIMATOL, V26, P971, DOI 10.1007/s10764-005-5332-4; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Muller S, 2003, HUM GENET, V113, P493, DOI 10.1007/s00439-003-0997-2; Outlaw DC, 2008, J BIOGEOGR, V35, P739, DOI 10.1111/j.1365-2699.2007.01821.x; Quek SP, 2007, MOL ECOL, V16, P2045, DOI 10.1111/j.1365-294X.2007.03294.x; Raaum RL, 2005, J HUM EVOL, V48, P237, DOI 10.1016/j.jhevol.2004.11.007; Rohland N, 2007, PLOS BIOL, V5, P1663, DOI 10.1371/journal.pbio.0050207; Roos C, 2001, MOL PHYLOGENET EVOL, V19, P486, DOI 10.1006/mpev.2001.0939; Roos Christian, 2007, Vietnamese Journal of Primatology, V1, P41; Schmitz J, 2005, J MOL EVOL, V61, P1, DOI 10.1007/s00239-004-0293-3; Schrago CG, 2003, MOL BIOL EVOL, V20, P1620, DOI 10.1093/molbev/msg172; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Takacs Z, 2005, MOL PHYLOGENET EVOL, V36, P456, DOI 10.1016/j.ympev.2005.03.032; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thalmann O, 2004, MOL ECOL, V13, P321, DOI 10.1046/j.1365-294X.2003.02070.x; Thinh VN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-74; Vignaud P, 2002, NATURE, V418, P152, DOI 10.1038/nature00880; Whittaker DJ, 2007, MOL PHYLOGENET EVOL, V45, P620, DOI 10.1016/j.ympev.2007.08.009; Woodruff DS, 2009, J BIOGEOGR, V36, P803, DOI 10.1111/j.1365-2699.2008.02071.x; Young NM, 2004, J HUM EVOL, V46, P163, DOI 10.1016/j.jhevol.2003.11.002; Yu L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-198; Zhang P, 2008, MOL PHYLOGENET EVOL, V49, P586, DOI 10.1016/j.ympev.2008.08.020	63	60	64	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e14419	10.1371/journal.pone.0014419	http://dx.doi.org/10.1371/journal.pone.0014419			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203450	Green Published, gold			2022-12-27	WOS:000285579200005
J	Gimenez, E; Pineda, B; Capel, J; Anton, MT; Atares, A; Perez-Martin, F; Garcia-Sogo, B; Angosto, T; Moreno, V; Lozano, R				Gimenez, Estela; Pineda, Benito; Capel, Juan; Teresa Anton, Maria; Atares, Alejandro; Perez-Martin, Fernando; Garcia-Sogo, Begona; Angosto, Trinidad; Moreno, Vicente; Lozano, Rafael			Functional Analysis of the Arlequin Mutant Corroborates the Essential Role of the ARLEQUIN/TAGL1 Gene during Reproductive Development of Tomato	PLOS ONE			English	Article							MADS-BOX GENES; FLORAL ORGAN IDENTITY; FRUIT-DEVELOPMENT; ARABIDOPSIS-THALIANA; DIFFERENTIAL EXPRESSION; TRANSGENIC TOMATOES; FLOWER DEVELOPMENT; MOLECULAR-BIOLOGY; OVULE DEVELOPMENT; RIPENING MUTANT	Reproductive development of higher plants comprises successive events of organ differentiation and growth which finally lead to the formation of a mature fruit. However, most of the genetic and molecular mechanisms which coordinate such developmental events are yet to be identified and characterized. Arlequin (Alq), a semi-dominant T-DNA tomato mutant showed developmental changes affecting flower and fruit ripening. Sepals were converted into fleshy organs which ripened as normal fruit organs and fruits displayed altered ripening features. Molecular characterization of the tagged gene demonstrated that it corresponded to the previously reported TOMATO AGAMOUS-LIKE 1 (TAGL1) gene, the tomato ortholog of SHATTERPROOF MADS-box genes of Arabidopsis thaliana, and that the Alq mutation promoted a gain-of-function phenotype caused by the ectopic expression of TAGL1. Ectopic overexpression of TAGL1 resulted in homeotic alterations affecting floral organ identity that were similar to but stronger than those observed in Alq mutant plants. Interestingly, TAGL1 RNAi plants yielded tomato fruits which were unable to ripen. They displayed a yellow-orange color and stiffness appearance which are in accordance with reduced lycopene and ethylene levels, respectively. Moreover, pericarp cells of TAGL1 RNAi fruits showed altered cellular and structural properties which correlated to both decreased expression of genes regulating cell division and lignin biosynthesis. Over-expression of TAGL1 is able to rescue the non-ripening phenotype of rin and nor mutants, which is mediated by the transcriptional activation of several ripening genes. Our results demonstrated that TAGL1 participates in the genetic control of flower and fruit development of tomato plants. Furthermore, gene silencing and over-expression experiments demonstrated that the fruit ripening process requires the regulatory activity of TAGL1. Therefore, TAGL1 could act as a linking factor connecting successive stages of reproductive development, from flower development to fruit maturation, allowing this complex process to be carried out successfully.	[Gimenez, Estela; Capel, Juan; Lozano, Rafael] Univ Almeria, Dept Biol Aplicada, Politecn Super E, Almeria, Spain; [Pineda, Benito; Teresa Anton, Maria; Atares, Alejandro; Garcia-Sogo, Begona; Moreno, Vicente] Univ Politecn Valencia, Inst Biol Mol & Celular Plantas UPV CSIC, E-46071 Valencia, Spain; [Perez-Martin, Fernando; Angosto, Trinidad] Univ Almeria, Dept Biol Vegetal & Ecol, Politecn Super E, Almeria, Spain	Universidad de Almeria; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Universidad de Almeria	Gimenez, E (corresponding author), Univ Almeria, Dept Biol Aplicada, Politecn Super E, Carretera Sacramento S-N, Almeria, Spain.	rlozano@ual.es	Pineda, Benito/ABD-5149-2020; Huerta, Alejandro Atares/M-6870-2019; Huerta, Alejandro Atares/G-9943-2015; Angosto, Trinidad/M-4451-2014; Caminero, Estela Gimenez/H-9198-2015; Capel, Juan/M-3772-2018; Lozano, Rafael/M-2813-2014; Ferrero, Vicente Moreno/C-6613-2016; Lozano, Rafael/AAD-6545-2020	Pineda, Benito/0000-0001-9176-701X; Huerta, Alejandro Atares/0000-0003-1728-5471; Huerta, Alejandro Atares/0000-0003-1728-5471; Angosto, Trinidad/0000-0003-0294-9255; Caminero, Estela Gimenez/0000-0002-7403-5279; Capel, Juan/0000-0002-4327-0604; Lozano, Rafael/0000-0001-5458-2075; Ferrero, Vicente Moreno/0000-0002-0345-7300; Lozano, Rafael/0000-0001-5458-2075; Garcia Sogo, Begona/0000-0001-8819-6711	Spanish Ministry of Science and Innovation [AGL2009-13388, BIO2009-11484]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was funded by the Spanish Ministry of Science and Innovation (grants AGL2009-13388 and BIO2009-11484). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES FB, 1991, PLANT PHYSIOL, V95, P269, DOI 10.1104/pp.95.1.269; Adams-Phillips L, 2004, TRENDS PLANT SCI, V9, P331, DOI 10.1016/j.tplants.2004.05.004; Alba R, 2005, PLANT CELL, V17, P2954, DOI 10.1105/tpc.105.036053; Alexander L, 2002, J EXP BOT, V53, P2039, DOI 10.1093/jxb/erf072; Andrews J, 2002, J EXP BOT, V53, P2393, DOI 10.1093/jxb/erf109; Bargel H, 2005, J EXP BOT, V56, P1049, DOI 10.1093/jxb/eri098; BAULCOMBE DC, 1986, NATURE, V321, P446, DOI 10.1038/321446a0; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Brukhin V, 2003, SEX PLANT REPROD, V15, P311, DOI 10.1007/s00497-003-0167-7; Cara B, 2008, PLANT SCI, V175, P106, DOI 10.1016/j.plantsci.2008.03.021; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Cong B, 2002, P NATL ACAD SCI USA, V99, P13606, DOI 10.1073/pnas.172520999; Dinneny JR, 2005, DEVELOPMENT, V132, P4687, DOI 10.1242/dev.02062; Ellul P, 2003, THEOR APPL GENET, V106, P231, DOI 10.1007/s00122-002-0928-y; Emmanuel E, 2002, CURR OPIN PLANT BIOL, V5, P112, DOI 10.1016/S1369-5266(02)00237-6; Eriksson EM, 2004, PLANT PHYSIOL, V136, P4184, DOI 10.1104/pp.104.045765; Favaro R, 2003, PLANT CELL, V15, P2603, DOI 10.1105/tpc.015123; Ferrandiz C, 2000, SCIENCE, V289, P436, DOI 10.1126/science.289.5478.436; Fornale S, 2006, PLANT MOL BIOL, V62, P809, DOI 10.1007/s11103-006-9058-2; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; FRAY RG, 1993, PLANT MOL BIOL, V22, P589, DOI 10.1007/BF00047400; Gidoni D, 2003, PLANT MOL BIOL, V51, P83, DOI 10.1023/A:1020718520618; GILLASPY G, 1993, PLANT CELL, V5, P1439, DOI 10.1105/tpc.5.10.1439; Giovannoni J, 2001, ANNU REV PLANT PHYS, V52, P725, DOI 10.1146/annurev.arplant.52.1.725; Giovannoni JJ, 2007, CURR OPIN PLANT BIOL, V10, P283, DOI 10.1016/j.pbi.2007.04.008; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Gonzalez N, 2007, PLANT J, V51, P642, DOI 10.1111/j.1365-313X.2007.03167.x; GUSTAFSONBROWN C, 1994, CELL, V76, P131, DOI 10.1016/0092-8674(94)90178-3; HALL LN, 1993, PLANT J, V3, P121, DOI 10.1111/j.1365-313X.1993.tb00015.x; Hileman LC, 2006, MOL BIOL EVOL, V23, P2245, DOI 10.1093/molbev/msl095; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; Itkin M, 2009, PLANT J, V60, P1081, DOI 10.1111/j.1365-313X.2009.04064.x; Ito Y, 2008, PLANT J, V55, P212, DOI 10.1111/j.1365-313X.2008.03491.x; JEFFERSON RA, 1987, EMBO J, V6, P3901; JONES DA, 1994, SCIENCE, V266, P789, DOI 10.1126/science.7973631; Joubes J, 2000, PLANTA, V211, P430, DOI 10.1007/s004250000306; Joubes J, 1999, PLANT PHYSIOL, V121, P857, DOI 10.1104/pp.121.3.857; Kim CM, 2004, PLANT J, V39, P252, DOI 10.1111/j.1365-313X.2004.02116.x; KLANN EM, 1993, PLANT PHYSIOL, V103, P863, DOI 10.1104/pp.103.3.863; Knapp S, 2002, J EXP BOT, V53, P2001, DOI 10.1093/jxb/erf068; Kramer EM, 1998, GENETICS, V149, P765; Lashbrook CC, 1998, PLANT J, V15, P243, DOI 10.1046/j.1365-313X.1998.00202.x; Leseberg CH, 2008, J EXP BOT, V59, P2253, DOI 10.1093/jxb/ern094; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; Lin ZF, 2008, PLANT J, V55, P301, DOI 10.1111/j.1365-313X.2008.03505.x; LINCOLN JE, 1988, PLANT PHYSIOL, V88, P370, DOI 10.1104/pp.88.2.370; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Lozano R, 1998, PLANT PHYSIOL, V117, P91, DOI 10.1104/pp.117.1.91; Lozano R, 2009, INT J DEV BIOL, V53, P1635, DOI 10.1387/ijdb.072440rl; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; MIZUKAMI Y, 1992, CELL, V71, P119, DOI 10.1016/0092-8674(92)90271-D; Moore S, 2002, J EXP BOT, V53, P2023, DOI 10.1093/jxb/erf057; Nakatsuka A, 1998, PLANT PHYSIOL, V118, P1295, DOI 10.1104/pp.118.4.1295; Ng M, 2000, CURR OPIN PLANT BIOL, V3, P47, DOI 10.1016/S1369-5266(99)00036-9; NICKLAS KJ, 1992, PLAN BIOMECHANICS EN; Orfila C, 2001, PLANT PHYSIOL, V126, P210, DOI 10.1104/pp.126.1.210; Pineda B, 2010, PLANT CELL PHYSIOL, V51, P435, DOI 10.1093/pcp/pcq009; Pinyopich A, 2003, NATURE, V424, P85, DOI 10.1038/nature01741; PNUELI L, 1994, PLANT CELL, V6, P163, DOI 10.1105/tpc.6.2.163; Quiroga M, 2000, PLANT PHYSIOL, V122, P1119, DOI 10.1104/pp.122.4.1119; Raes J, 2003, PLANT PHYSIOL, V133, P1051, DOI 10.1104/pp.103.026484; Ronen G, 1999, PLANT J, V17, P341, DOI 10.1046/j.1365-313X.1999.00381.x; Saladie M, 2007, PLANT PHYSIOL, V144, P1012, DOI 10.1104/pp.107.097477; Seymour GB, 2002, J EXP BOT, V53, P2065, DOI 10.1093/jxb/erf087; Seymour G, 2008, CURR OPIN PLANT BIOL, V11, P58, DOI 10.1016/j.pbi.2007.09.003; SHACKEL KA, 1991, PLANT PHYSIOL, V97, P814, DOI 10.1104/pp.97.2.814; SMITH CJS, 1988, NATURE, V334, P724, DOI 10.1038/334724a0; Soto-Zamora G, 2005, LWT-FOOD SCI TECHNOL, V38, P657, DOI 10.1016/j.lwt.2004.08.005; Spence J, 1996, J MICROSC-OXFORD, V181, P195, DOI 10.1046/j.1365-2818.1996.111391.x; Tadiello A, 2009, J EXP BOT, V60, P651, DOI 10.1093/jxb/ern313; Tani E, 2007, TREE PHYSIOL, V27, P649, DOI 10.1093/treephys/27.5.649; Tani Helen, 2004, Functional & Integrative Genomics, V4, P258, DOI 10.1007/s10142-004-0112-3; Theissen G, 2001, CURR OPIN PLANT BIOL, V4, P75, DOI 10.1016/S1369-5266(00)00139-4; Thompson AJ, 1999, PLANT PHYSIOL, V120, P383, DOI 10.1104/pp.120.2.383; Thompson DS, 1998, PLANT CELL ENVIRON, V21, P589, DOI 10.1046/j.1365-3040.1998.00308.x; Tieman DM, 1999, PLANT PHYSIOL, V120, P165, DOI 10.1104/pp.120.1.165; Tieman DV, 2000, P NATL ACAD SCI USA, V97, P5663, DOI 10.1073/pnas.090550597; TIGCHELAAR EC, 1978, HORTSCIENCE, V13, P508; van der Rest B, 2006, J EXP BOT, V57, P1399, DOI 10.1093/jxb/erj120; Victoria BM, 2003, PLANT MOL BIOL, V52, P801, DOI 10.1023/A:1025001402838; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; Vrebalov J, 2009, PLANT CELL, V21, P3041, DOI 10.1105/tpc.109.066936; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; WHITMORE FW, 1978, PHYTOCHEMISTRY, V17, P421, DOI 10.1016/S0031-9422(00)89329-2; WILKINSON JQ, 1995, SCIENCE, V270, P1807, DOI 10.1126/science.270.5243.1807	86	83	88	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e14427	10.1371/journal.pone.0014427	http://dx.doi.org/10.1371/journal.pone.0014427			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203447	gold, Green Published, Green Submitted			2022-12-27	WOS:000285579200009
J	Kuchimaru, T; Kadonosono, T; Tanaka, S; Ushiki, T; Hiraoka, M; Kizaka-Kondoh, S				Kuchimaru, Takahiro; Kadonosono, Tetsuya; Tanaka, Shotaro; Ushiki, Takashi; Hiraoka, Masahiro; Kizaka-Kondoh, Shinae			In Vivo Imaging of HIF-Active Tumors by an Oxygen-Dependent Degradation Protein Probe with an Interchangeable Labeling System	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1; SUPPRESSOR PROTEIN; CANCER; EXPRESSION; CELLS; HIF-1-ALPHA; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; TRANSDUCTION; MECHANISM; DELIVERY	Hypoxia-inducible factor (HIF) functions as a master transcriptional regulator for adaptation to hypoxia by inducing adaptive changes in gene expression for regulation of proliferation, angiogenesis, apoptosis and energy metabolism. Cancers with high expression of the alpha subunit of HIF (HIF alpha) are often malignant and treatment-resistant. Therefore, the development of a molecular probe that can detect HIF activity has great potential value for monitoring tumor hypoxia. HIF prolyl hydroxylases (HPHDs) act as oxygen sensors that regulate the fate of HIF alpha protein through its oxygen-dependent degradation (ODD) domain. We constructed a recombinant protein PTD-ODD-HaloTag (POH) that is under the same ODD regulation as HIF alpha and contains protein transduction domain (PTD) and an interchangeable labeling system. Administration of near-infrared fluorescently labeled POH (POH-N) to mouse models of cancers allowed successful monitoring of HIF-active regions. Immunohistochemical analysis for intratumoral localization of POH probe revealed its specificity to HIF-active cells. Furthermore, lack of the PTD domain or a point mutation in the ODD domain abrogated the specificity of POH-N to HIF-active cells. Overall results indicate that POH is a practical probe specific to HIF-active cell in cancers and suggest its large potential for imaging and targeting of HIF-related diseases.	[Kuchimaru, Takahiro; Kadonosono, Tetsuya; Kizaka-Kondoh, Shinae] Tokyo Inst Technol, Dept Biomol Engn, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan; [Tanaka, Shotaro] Tokyo Womens Med Univ, Dept Biochem, Sch Med, Tokyo, Japan; [Ushiki, Takashi] Niigata Univ, Dept Hematol, Grad Sch Med & Dent Sci, Niigata, Japan; [Hiraoka, Masahiro] Kyoto Univ, Dept Radiat Oncol & Image Appl Therapy, Grad Sch Med, Kyoto, Japan	Tokyo Institute of Technology; Tokyo Women's Medical University; Niigata University; Kyoto University	Kuchimaru, T (corresponding author), Tokyo Inst Technol, Dept Biomol Engn, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 227, Japan.	skondoh@bio.titech.ac.jp	Kadonosono, Tetsuya/D-4651-2019; Kuchimaru, Takahiro/B-9269-2015; Kondoh, Shinae/AAF-8745-2020; Kondoh, Shinae/C-6937-2015	Kuchimaru, Takahiro/0000-0002-5355-3165; Kondoh, Shinae/0000-0003-3085-5782; Kondoh, Shinae/0000-0003-3085-5782				ARTEEL GE, 1995, BRIT J CANCER, V72, P889, DOI 10.1038/bjc.1995.429; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Contag CH, 2007, ANNU REV PATHOL-MECH, V2, P277, DOI 10.1146/annurev.pathol.2.010506.091930; Depping R, 2008, BBA-MOL CELL RES, V1783, P394, DOI 10.1016/j.bbamcr.2007.12.006; Fels DR, 2005, TRENDS BIOCHEM SCI, V30, P426, DOI 10.1016/j.tibs.2005.06.009; Fujibayashi Y, 1999, NUCL MED BIOL, V26, P117, DOI 10.1016/S0969-8051(98)00049-3; Greer LF, 2002, LUMINESCENCE, V17, P43, DOI 10.1002/bio.676; Harada H, 2007, ONCOGENE, V26, P7508, DOI 10.1038/sj.onc.1210556; Harada H, 2002, CANCER RES, V62, P2013; Harada H, 2007, BIOCHEM BIOPH RES CO, V360, P791, DOI 10.1016/j.bbrc.2007.06.149; Harada H, 2005, MOL IMAGING, V4, P182; Harada H, 2006, FEBS LETT, V580, P5718, DOI 10.1016/j.febslet.2006.09.025; Hiraga T, 2007, CANCER RES, V67, P4157, DOI 10.1158/0008-5472.CAN-06-2355; HWANG DR, 1989, APPL RADIAT ISOTOPES, V40, P117, DOI 10.1016/0883-2889(89)90186-X; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kizaka-Kondoh S, 2009, CLIN CANCER RES, V15, P3433, DOI 10.1158/1078-0432.CCR-08-2267; Kosaka N, 2009, BIOCONJUGATE CHEM, V20, P1367, DOI 10.1021/bc9001344; Lehmann S, 2009, P NATL ACAD SCI USA, V106, P14004, DOI 10.1073/pnas.0901194106; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Moroz E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005077; Piert M, 2005, J NUCL MED, V46, P106; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2008, IUBMB LIFE, V60, P591, DOI 10.1002/iub.93; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Shah Khalid, 2005, NeuroRx, V2, P215, DOI 10.1007/BF03206667; Sobhanifar S, 2005, CANCER RES, V65, P7259, DOI 10.1158/0008-5472.CAN-04-4480; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; VAUPEL P, 1989, CANCER RES, V49, P6449; Wadia JS, 2005, ADV DRUG DELIVER REV, V57, P579, DOI 10.1016/j.addr.2004.10.005; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501	35	27	28	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15736	10.1371/journal.pone.0015736	http://dx.doi.org/10.1371/journal.pone.0015736			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203417	Green Published, Green Submitted, gold			2022-12-27	WOS:000285579200034
J	Vallely, A; Page, A; Dias, S; Siba, P; Lupiwa, T; Law, G; Millan, J; Wilson, DP; Murray, JM; Toole, M; Kaldor, JM				Vallely, Andrew; Page, Andrew; Dias, Shannon; Siba, Peter; Lupiwa, Tony; Law, Greg; Millan, John; Wilson, David P.; Murray, John M.; Toole, Michael; Kaldor, John M.			The Prevalence of Sexually Transmitted Infections in Papua New Guinea: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; FEMALE SEX WORKERS; TRICHOMONAS-VAGINALIS; EPIDEMIOLOGIC SYNERGY; CHLAMYDIA-TRACHOMATIS; HIV TRANSMISSION; RISK-FACTORS; RURAL WOMEN; DISEASES; PACIFIC	Background: The potential for an expanded HIV epidemic in Papua New Guinea (PNG) demands an effective, evidence-based and locally-appropriate national response. As sexually transmitted infections (STIs) may be important co-factors in HIV transmission nationally, it is timely to conduct a systematic review of STI prevalences to inform national policy on sexual health and HIV/STI prevention. Methodology/Principal Findings: We undertook a systematic review and meta-analysis of HIV and STI prevalences in PNG, reported in peer-reviewed and non-peer-reviewed publications for the period 1950-2010. Prevalence estimates were stratified by study site (community or clinic-based), geographic area and socio-demographic characteristics. The search strategy identified 105 reports, of which 25 studies (10 community-based; 10 clinic-based; and 5 among self-identified female sex workers) reported STI prevalences and were included in the systematic review. High prevalences of chlamydia, gonorrhoea, syphilis and trichomonas were reported in all settings, particularly among female sex workers, where pooled estimates of 26.1%, 33.6%, 33.1% and 39.3% respectively were observed. Pooled HIV prevalence in community-based studies was 1.8% (95% CI: 1.2-2.4) in men; 2.6% (95% CI: 1.7-3.5) in women; and 11.8% (95% CI: 5.8-17.7) among female sex workers. Conclusions/Significance: The epidemiology of STIs and HIV in PNG shows considerable heterogeneity by geographical setting and sexual risk group. Prevalences from community-based studies in PNG were higher than in many other countries in the Asia-Pacific. A renewed focus on national STI/HIV surveillance priorities and systems for routine and periodic data collection will be essential to building effective culturally-relevant behavioural and biomedical STI/HIV prevention programs in PNG.	[Vallely, Andrew; Wilson, David P.; Murray, John M.; Kaldor, John M.] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia; [Siba, Peter] Papua New Guinea Inst Med Res, Goroka, Papua N Guinea; [Page, Andrew; Dias, Shannon] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Lupiwa, Tony] Natl AIDS Council Secretariat, Port Moresby, Papua N Guinea; [Law, Greg; Millan, John] Natl Dept Hlth, Port Moresby, Papua N Guinea; [Murray, John M.] Univ New S Wales, Sch Math & Stat, Sydney, NSW, Australia; [Toole, Michael] Burnet Inst, Ctr Int Hlth, Melbourne, Vic, Australia	University of New South Wales Sydney; Kirby Institute; PNG Institute Of Medical Research; University of Queensland; University of New South Wales Sydney; Burnet Institute	Vallely, A (corresponding author), Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia.	avallely@nchecr.unsw.edu.au	Murray, John/B-5481-2009; Kaldor, John M/D-4545-2011; Wilson, David P/G-4614-2013	Murray, John/0000-0001-9314-2283; Dias, Shannon/0000-0001-5129-7738; Vallely, Andrew/0000-0003-1558-4822	Australian Government [ADRA HIV_11]	Australian Government(Australian GovernmentCGIAR)	This research was conducted as part of the Male Circumcision Acceptability and Epidemiological Impact Study, PNG a four-year research program funded by an Australian Development Research Award from the Australian Government (Ref No. ADRA HIV_11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NAT RES AG HIV AIDS; [Anonymous], 2006, HLTH SOCIOLOGY REV, DOI DOI 10.5172/HESR.2006.15.3.293; ANTAL GM, 1985, REV INFECT DIS, V7, pS220; ARUWAFU H, 2009, BIOBEHAVIOURAL SENTI; *AUSAID, 2006, IMP HIV AIDS 2005 20; Backhouse JL, 1998, AM J TROP MED HYG, V59, P388, DOI 10.4269/ajtmh.1998.59.388; Berwald N, 2009, ACAD EMERG MED, V16, P360, DOI 10.1111/j.1553-2712.2009.00359.x; Bollen LJM, 2010, SEX TRANSM INFECT, V86, P61, DOI 10.1136/sti.2009.038299; BRADLEY C, 2006, STRENGTHENING GENDER; Bruce E, 2010, SEX HEALTH, V7, P71, DOI 10.1071/SH09093; BUKENYA GB, 1986, PAPUA NEW GUINEA MED, V29, P295; Caldwell JC, 2002, J HEALTH POPUL NUTR, V20, P104; CHANDLER J, 2010, PNG INFECT RATES HIV; Cliffe SJ, 2008, SEX TRANSM DIS, V35, P801, DOI 10.1097/OLQ.0b013e318175d885; CLOTTEY C, 1993, INFECT DIS CLIN N AM, V7, P753; Cohen MS, 1998, LANCET, V351, P5, DOI 10.1016/S0140-6736(98)90002-2; Cohen MS, 1998, LANCET, V352, P2026; Curry Chris, 2005, Emerg Med Australas, V17, P359, DOI 10.1111/j.1742-6723.2005.00757.x; Davies SC, 2007, SEX TRANSM DIS, V34, P132, DOI 10.1097/01.olq.0000230427.01727.80; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dore GJ, 1996, MED J AUSTRALIA, V165, P494, DOI 10.5694/j.1326-5377.1996.tb138615.x; Duke T, 2008, J PAEDIATR CHILD H, V44, P611, DOI 10.1111/j.1440-1754.2008.01396.x; Eves R., 2008, EXPLORING ROLE MEN M; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Fotinatos N, 2008, AUST J RURAL HEALTH, V16, P23, DOI 10.1111/j.1440-1584.2007.00932.x; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gare J, 2005, SEX TRANSM DIS, V32, P466, DOI 10.1097/01.olq.0000161177.21639.96; Gray RH, 2007, LANCET, V370, P200, DOI 10.1016/S0140-6736(07)61058-7; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; GYANESHWAR R, 1987, AUST NZ J OBSTET GYN, V27, P213, DOI 10.1111/j.1479-828X.1987.tb00989.x; Haddow LJ, 2007, SEX TRANSM DIS, V34, P258, DOI 10.1097/01.olq.0000237774.29010.30; HAMMAR L, 2007, ITS EVERY CORNER NOW, V1; HUDSON BJ, 1994, PAPUA NEW GUINEA MED, V37, P152; Hull TH, 2001, REPROD HEALTH MATTER, V9, P60, DOI 10.1016/S0968-8080(01)90091-6; Jenkins C., 1994, KNOWLEDGE EVENTS BEF, P24; JENKINS C, 2007, CULTURES CONTEXT MAT; KELLY A, 2008, YOUNG PEOPLES ATTITI; Kim AA, 2005, SEX TRANSM DIS, V32, P745, DOI 10.1097/01.olq.0000175384.44106.be; Klufio Cecil A., 1995, Papua New Guinea Medical Journal, V38, P163; Knox J, 2002, SEX TRANSM DIS, V29, P647, DOI 10.1097/00007435-200211000-00006; Koczberski G, 2000, Dev Bull, P61; KUBERSKI T, 1979, PAPUA NEW GUINEA MED, V22, P5; Lama JR, 2006, J INFECT DIS, V194, P1459, DOI 10.1086/508548; Lepani K, 2008, AUST J ANTHROPOL, V19, P150, DOI 10.1111/j.1835-9310.2008.tb00119.x; Limpakarnjanarat K, 1999, SEX TRANSM INFECT, V75, P30, DOI 10.1136/sti.75.1.30; LUPIWA T, 2001, 37 ANN S MED SOC PAP; LUPIWA T, 2003, HIGH PREVALENCE TRIC; MADDOCKS I, 1976, BRIT J VENER DIS, V52, P190; MAGNANI R, 2010, SEXUALLY TRANSMITTED; MAJID N, 2010, SEXUALLY TRANSMITTED; Mgone CS, 2002, SEX TRANSM DIS, V29, P775, DOI 10.1097/00007435-200212000-00007; Mgone CS, 2002, SEX TRANSM DIS, V29, P265, DOI 10.1097/00007435-200205000-00003; MGONE CS, 1999, 35 ANN S MED SOC PAP; MGONE CS, 1997, 33 ANN S MED SOC PAP; MILLAN J, 2006, PNG 2006 BSS HIGH RI; *MIN HLTH, 2001, CAMB STI PREV SURV N; *MIN HLTH CENTR ST, 2007, RISK BEH HIV PREV TA; *NACS, 2007, 2007 EST REP HIV EP; *NACS, 2006, PAP NEW GUIN NAT STR; *NAT AIDS COUNC SE, 2002, RTI STI PREV SEL SIT; Ohshige K, 2000, INT J EPIDEMIOL, V29, P344, DOI 10.1093/ije/29.2.344; Over M, 1996, J INFECT DIS, V174, pS162, DOI 10.1093/infdis/174.Supplement_2.S162; Passey M, 1998, B WORLD HEALTH ORGAN, V76, P401; Passey M, 1998, SEX TRANSM INFECT, V74, P120, DOI 10.1136/sti.74.2.120; PASSEY M, 1997, 33 ANN S MED SOC PAP; PASSEY M, 1999, GONOCOCCAL DRUG SENS; PASSEY M, 1998, 34 ANN S MED SOC PAP; Renton AM, 1998, SEX TRANSM INFECT, V74, P339, DOI 10.1136/sti.74.5.339; Rezza G, 2001, EMERG INFECT DIS, V7, P893; RICHENS J, 1985, PAPUA NEW GUINEA MED, V28, P67; Robinson NJ, 1997, INT J EPIDEMIOL, V26, P180, DOI 10.1093/ije/26.1.180; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; SENGUPTA SK, 1984, AM J TROP MED HYG, V33, P632, DOI 10.4269/ajtmh.1984.33.632; Sladden Tim, 2005, Pac Health Dialog, V12, P23; Sopheab H, 2003, SEX TRANSM INFECT, V79, DOI 10.1136/sti.79.4.e2; Sopheab H, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-167; Steen R, 2004, J CLIN VIROL, V29, P143, DOI 10.1016/j.jcv.2003.05.001; SUARKIA D, 1999, 35 ANN S MED SOC PAP; Suligoi B, 2005, AM J TROP MED HYG, V72, P33, DOI 10.4269/ajtmh.2005.72.33; Sullivan EA, 2004, INT J STD AIDS, V15, P116, DOI 10.1258/095646204322764316; Sullivan EA, 2003, SEX TRANSM DIS, V30, P362, DOI 10.1097/00007435-200304000-00017; THEUNISSEN JJH, 1995, GENITOURIN MED, V71, P295; Tiwara Steven, 1996, Papua New Guinea Medical Journal, V39, P234; *UNAIDS WHO, 2008, OC AIDS EP UPD REG S; VACCA A, 1980, Papua New Guinea Medical Journal, V23, P70; Wardlow H, 2007, AM J PUBLIC HEALTH, V97, P1006, DOI 10.2105/AJPH.2006.088559; Wardlow Holly, 2002, Papua New Guinea Medical Journal, V45, P142; WASSERHEIT JN, 1992, SEX TRANSM DIS, V19, P61, DOI 10.1097/00007435-199219020-00001; *WHO, 2007, YAWS FORG DIS; Wi T, 2006, SEX TRANSM INFECT, V82, P386, DOI 10.1136/sti.2005.018283; Wi T, 1998, SEX TRANSM INFECT, V74, pS118; WILLCOX RR, 1980, BRIT J VENER DIS, V56, P277; *WPRO, 2006, 2 GEN SURV SURV HIV; YAPEA N, 1999, COUNSELLING HIV TEST; Zenner Dominik, 2005, N Z Med J, V118, pU1610; ZIGAS V, 1977, SEX TRANSM DIS, V4, P63, DOI 10.1097/00007435-197704000-00008	96	50	53	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15586	10.1371/journal.pone.0015586	http://dx.doi.org/10.1371/journal.pone.0015586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203468	Green Published, gold, Green Submitted			2022-12-27	WOS:000285579200025
J	van Dijk, SJ; Feskens, EJM; Heidema, AG; Bos, MB; van de Rest, O; Geleijnse, JM; de Groot, LCPGM; Muller, M; Afman, LA				van Dijk, Susan J.; Feskens, Edith J. M.; Heidema, A. Geert; Bos, Marieke B.; van de Rest, Ondine; Geleijnse, Johanna M.; de Groot, Lisette C. P. G. M.; Mueller, Michael; Afman, Lydia A.			Plasma Protein Profiling Reveals Protein Clusters Related to BMI and Insulin Levels in Middle-Aged Overweight Subjects	PLOS ONE			English	Article							C-REACTIVE PROTEIN; PLASMINOGEN-ACTIVATOR INHIBITOR-1; COMPLEMENT C3; MULTIMARKER APPROACH; ADIPOSE-TISSUE; SERUM-LEVELS; OLDER MEN; INFLAMMATION; RESISTANCE; RISK	Background: Biomarkers that allow detection of the onset of disease are of high interest since early detection would allow intervening with lifestyle and nutritional changes before the disease is manifested and pharmacological therapy is required. Our study aimed to improve the phenotypic characterization of overweight but apparently healthy subjects and to identify new candidate profiles for early biomarkers of obesity-related diseases such as cardiovascular disease and type 2 diabetes. Methodology/Principal Findings: In a population of 56 healthy, middle-aged overweight subjects Body Mass Index (BMI), fasting concentration of 124 plasma proteins and insulin were determined. The plasma proteins are implicated in chronic diseases, inflammation, endothelial function and metabolic signaling. Random Forest was applied to select proteins associated with BMI and plasma insulin. Subsequently, the selected proteins were analyzed by clustering methods to identify protein clusters associated with BMI and plasma insulin. Similar analyses were performed for a second population of 20 healthy, overweight older subjects to verify associations found in population I. In both populations similar clusters of proteins associated with BMI or insulin were identified. Leptin and a number of pro-inflammatory proteins, previously identified as possible biomarkers for obesity-related disease, e. g. Complement 3, C Reactive Protein, Serum Amyloid P, Vascular Endothelial Growth Factor clustered together and were positively associated with BMI and insulin. IL-3 and IL-13 clustered together with Apolipoprotein A1 and were inversely associated with BMI and might be potential new biomarkers. Conclusion/Significance: We identified clusters of plasma proteins associated with BMI and insulin in healthy populations. These clusters included previously reported biomarkers for obesity-related disease and potential new biomarkers such as IL-3 and IL-13. These plasma protein clusters could have potential applications for improved phenotypic characterization of volunteers in nutritional intervention studies or as biomarkers in the early detection of obesity-linked disease development and progression.	[van Dijk, Susan J.; Feskens, Edith J. M.; Heidema, A. Geert; Bos, Marieke B.; van de Rest, Ondine; Geleijnse, Johanna M.; de Groot, Lisette C. P. G. M.; Mueller, Michael; Afman, Lydia A.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Mueller, Michael] Netherlands Nutrigenom Ctr, TI Food & Nutr, Wageningen, Netherlands	Wageningen University & Research; Top Institute Food & Nutrition	van Dijk, SJ (corresponding author), Wageningen Univ, Div Human Nutr, Wageningen, Netherlands.	lydia.afman@wur.nl	Muller, Michael/B-5795-2008; Muller, Michael/M-5724-2019; Feskens, Edith/ABI-1446-2020; van Dijk, Susan/H-8910-2013; Geleijnse, Johanna Marianna M/B-5749-2012; Feskens, Edith JM/A-3757-2012	Muller, Michael/0000-0002-5930-9905; Muller, Michael/0000-0002-5930-9905; Feskens, Edith/0000-0001-5819-2488; van Dijk, Susan/0000-0001-7019-0418; Geleijnse, Johanna Marianna M/0000-0001-7638-0589; de Groot, Lisette/0000-0003-2778-2789	Dutch Diabetes Research Foundation [20060052]; Netherlands Heart Foundation [2003B068]; Netherlands Genomics Initiative	Dutch Diabetes Research Foundation; Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Genomics Initiative	This study was supported by the Dutch Diabetes Research Foundation (20060052), the Netherlands Heart Foundation (2003B068), and the Netherlands Genomics Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldus S, 2003, CIRCULATION, V108, P1440, DOI 10.1161/01.CIR.0000090690.67322.51; Barrett JH, 2008, STAT APPL GENET MOL, V7; Bastard JP, 2000, DIABETES-METAB RES, V16, P192, DOI 10.1002/1520-7560(200005/06)16:3<192::AID-DMRR114>3.3.CO;2-7; BOS MB, 2009, NUTR METAB CARDIOVAS; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carter AM, 2009, ATHEROSCLEROSIS, V203, P538, DOI 10.1016/j.atherosclerosis.2008.07.007; Cesari M, 2003, CIRCULATION, V108, P2317, DOI 10.1161/01.CIR.0000097109.90783.FC; Chang IH, 2009, J UROLOGY, V181, P567, DOI 10.1016/j.juro.2008.10.030; Cushman M, 2005, CIRCULATION, V112, P25, DOI 10.1161/CIRCULATIONAHA.104.504159; Domenici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009166; Engstrom G, 2005, DIABETES, V54, P570, DOI 10.2337/diabetes.54.2.570; Fenton JI, 2009, DIABETES OBES METAB, V11, P343, DOI 10.1111/j.1463-1326.2008.00974.x; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; Festa A, 2000, CIRCULATION, V102, P42, DOI 10.1161/01.CIR.102.1.42; Haffner SM, 2003, DIABETES RES CLIN PR, V61, pS9, DOI 10.1016/S0168-8227(03)00122-0; Heidema AG, 2007, GENET EPIDEMIOL, V31, P910, DOI 10.1002/gepi.20251; Heidema AG, 2009, J PROTEOME RES, V8, P2640, DOI 10.1021/pr8006182; HUYNH T, 2008, J MACHINE LEARNING R, V4, P60; Ikonomidis I, 2005, EUR HEART J, V26, P1618, DOI 10.1093/eurheartj/ehi192; Ikonomidis I, 2008, ATHEROSCLEROSIS, V199, P3, DOI 10.1016/j.atherosclerosis.2008.02.019; Ikonomidis I, 2009, DIS MARKERS, V26, P273, DOI [10.1155/2009/135423, 10.3233/DMA-2009-0633]; Jenny NS, 2007, ARTERIOSCL THROM VAS, V27, P352, DOI 10.1161/01.ATV.0000254150.97741.fe; Keshishian H, 2009, MOL CELL PROTEOMICS, V8, P2339, DOI 10.1074/mcp.M900140-MCP200; Kim BK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2247; Koenig W, 2007, ARTERIOSCL THROM VAS, V27, P15, DOI 10.1161/01.ATV.0000251503.35795.4f; Kyzer S, 1999, OBES SURG, V9, P229, DOI 10.1381/096089299765553089; Rodenburg W, 2008, PHYSIOL GENOMICS, V33, P78, DOI 10.1152/physiolgenomics.00167.2007; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Singh U, 2009, CLIN CHEM, V55, P361, DOI 10.1373/clinchem.2008.109207; Szeplaki G, 2004, ATHEROSCLEROSIS, V177, P383, DOI 10.1016/j.atherosclerosis.2004.07.022; Tracy RP, 1999, CURR OPIN LIPIDOL, V10, P435, DOI 10.1097/00041433-199910000-00008; Trayhurn P, 2005, BIOCHEM SOC T, V33, P1078, DOI [10.1042/BST0331078, 10.1042/BST20051078]; Trayhurn P, 2001, P NUTR SOC, V60, P329, DOI 10.1079/PNS200194; van de Rest O, 2008, AM J CLIN NUTR, V88, P706, DOI 10.1093/ajcn/88.3.706; Vasudevan AR, 2006, J CLIN ENDOCR METAB, V91, P256, DOI 10.1210/jc.2005-1280; VERMEULEN A, 1990, MATURITAS, V12, P121, DOI 10.1016/0378-5122(90)90090-S; Vozarova B, 2001, OBES RES, V9, P414, DOI 10.1038/oby.2001.54; Warnberg J, 2006, AM J CLIN NUTR, V84, P505; Yang Y, 2006, INT J OBESITY, V30, P439, DOI 10.1038/sj.ijo.0803173; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	41	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e14422	10.1371/journal.pone.0014422	http://dx.doi.org/10.1371/journal.pone.0014422			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203453	Green Published, Green Submitted, gold			2022-12-27	WOS:000285579200007
J	Pietschnig, J; Voracek, M; Formann, AK				Pietschnig, Jakob; Voracek, Martin; Formann, Anton K.			Pervasiveness of the IQ Rise: A Cross-Temporal Meta-Analysis	PLOS ONE			English	Article							FLUID INTELLIGENCE; RECENT DECLINE; GAINS; VOCABULARY; TESTS	Background: Generational IQ gains in the general population (termed the Flynn effect) show an erratic pattern across different nations as well as across different domains of intelligence (fluid vs crystallized). Gains of fluid intelligence in different countries have been subject to extensive research, but less attention was directed towards gains of crystallized intelligence, probably due to evidence from the Anglo-American sphere suggesting only slight gains on this measure. In the present study, development of crystallized intelligence in the German speaking general population is assessed. Methodology/Principal Findings: To investigate whether IQ gains for crystallized intelligence are in progress in German-speaking countries, two independent meta-analyses were performed. By means of a cited reference search in ISI Web of Science, all studies citing test manuals and review articles of two widely-used salient measures of crystallized intelligence were obtained. Additionally, the electronic database for German academic theses was searched to identify unpublished studies employing these tests. All studies reporting participants mean IQ or raw scores of at least one of the two measures were included in the present analyses, yielding over 500 studies (>1,000 samples; >45,000 individuals). We found a significant positive association between years of test performance and intelligence (1971-2007) amounting to about 3.5 IQ points per decade. Conclusions/Significance: This study clearly demonstrates that crystallized IQ gains are substantial and of comparable strength as Flynn effects typically observed for measures of fluid intelligence in Central Europe. Since mean IQ was assessed in a large number of small, non-representative samples, our evidence suggests a remarkable robustness of these gains. Moreover, in both meta-analyses strength of gains was virtually identical. On the whole, results of the present study demonstrate a pervasive and generalizing Flynn effect in German-speaking countries.	[Pietschnig, Jakob; Voracek, Martin; Formann, Anton K.] Univ Vienna, Sch Psychol, Dept Basic Psychol Res, Vienna, Austria	University of Vienna	Pietschnig, J (corresponding author), Univ Vienna, Sch Psychol, Dept Basic Psychol Res, Vienna, Austria.	jakob.pietschnig@univie.ac.at	Voracek, Martin/S-5865-2016; Pietschnig, Jakob/AAE-8913-2020	Voracek, Martin/0000-0001-6109-6155; Pietschnig, Jakob/0000-0003-0222-9557				*AM PSYCH ASS, 1992, AM PSYCH, V0047, P01597, DOI DOI 10.1037/0003-066X.47.12.1597; American Psychological Association, 2002, AM PSYCHOL, V57, P1060, DOI 10.1037/0003-066X.57.12.1060; Cohen J., 2003, APPL MULTIPLE REGRES; Colom R, 2005, INTELLIGENCE, V33, P83, DOI 10.1016/j.intell.2004.07.010; Colom R, 2003, J BIOSOC SCI, V35, P33, DOI 10.1017/S0021932003000336; *DIN, 2002, 33430 DIN; Flynn J R, 2000, Novartis Found Symp, V233, P202, DOI 10.1002/0470870850.ch13; Flynn JR, 2010, J PSYCHOEDUC ASSESS, V28, P412, DOI 10.1177/0734282910373342; Flynn JR, 2008, INT REV RES MENT RET, V35, P121, DOI 10.1016/S0074-7750(07)35004-0; Flynn JR, 2009, WHAT IS INTELLIGENCE: BEYOND THE FLYNN EFFECT, P1; FLYNN JR, 1987, PSYCHOL BULL, V101, P171, DOI 10.1037/0033-2909.101.2.171; FLYNN JR, 1984, PSYCHOL BULL, V95, P29, DOI 10.1037/0033-2909.95.1.29; Gorlicki C, 1997, Z KLIN PSYCH PSYCHIA, V45, P367; Herrnstein RJ, 1996, BELL CURVE INTELLIGE; Jensen A.R., 1998, G FACTOR SCI MENTAL; Lehrl S., 1977, MEHRFACHWAHL WORTSCH; Lynn R, 2009, INTELLIGENCE, V37, P249, DOI 10.1016/j.intell.2008.09.007; Merz J, 1975, Psychiatr Neurol Med Psychol (Leipz), V27, P423; Neisser U, 1996, AM PSYCHOL, V51, P77, DOI 10.1037/0003-066X.51.2.77; ROTH F, 1973, ARZNEIMITTEL-FORSCH, V23, P997; Schmidt K. -H., 1992, WORTSCHATZTEST WST R; Teasdale TW, 2005, PERS INDIV DIFFER, V39, P837, DOI 10.1016/j.paid.2005.01.029; Twenge JM, 2010, CLIN PSYCHOL REV, V30, P145, DOI 10.1016/j.cpr.2009.10.005; Twenge JM, 2000, J PERS SOC PSYCHOL, V79, P1007, DOI 10.1037//0022-3514.79.6.1007; Twenge JM, 2004, PERS SOC PSYCHOL REV, V8, P308, DOI 10.1207/s15327957pspr0803_5; Verhaeghen P, 2003, PSYCHOL AGING, V18, P332, DOI 10.1037/0882-7974.18.2.332; Voracek M, 2006, BEHAV BRAIN SCI, V29, P142, DOI 10.1017/S0140525X06389030; Voracek M, 2008, PSYCHOL REP, V103, P799, DOI 10.2466/PR0.103.3.799-811; Wicherts JM, 2004, INTELLIGENCE, V32, P509, DOI 10.1016/j.intell.2004.07.002	29	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14406	10.1371/journal.pone.0014406	http://dx.doi.org/10.1371/journal.pone.0014406			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	698FG	21203545	Green Published, Green Submitted, gold			2022-12-27	WOS:000285578000012
J	Valluet, A; Hmitou, I; Davis, S; Druillennec, S; Larcher, M; Laroche, S; Eychene, A				Valluet, Agathe; Hmitou, Isabelle; Davis, Sabrina; Druillennec, Sabine; Larcher, Magalie; Laroche, Serge; Eychene, Alain			B-raf Alternative Splicing Is Dispensable for Development but Required for Learning and Memory Associated with the Hippocampus in the Adult Mouse	PLOS ONE			English	Article							LONG-TERM POTENTIATION; FACIO-CUTANEOUS SYNDROME; ELEMENT-BINDING PROTEIN; EARLY GENE ZIF268; SYNAPTIC PLASTICITY; RECOGNITION MEMORY; REGULATED KINASE; MAP KINASE; IN-VIVO; ACTIVATION	The B-raf proto-oncogene exerts essential functions during development and adulthood. It is required for various processes, such as placental development, postnatal nervous system myelination and adult learning and memory. The mouse B-raf gene encodes several isoforms resulting from alternative splicing of exons 8b and 9b located in the hinge region upstream of the kinase domain. These alternative sequences modulate the biochemical and biological properties of B-Raf proteins. To gain insight into the physiological importance of B-raf alternative splicing, we generated two conditional knockout mice of exons 8b and 9b. Homozygous animals with a constitutive deletion of either exon are healthy and fertile, and survive up to 18 months without any visible abnormalities, demonstrating that alternative splicing is not essential for embryonic development and brain myelination. However, behavioural analyses revealed that expression of exon 9b-containing isoforms is required for B-Raf function in hippocampal-dependent learning and memory. In contrast, mice mutated on exon 8b are not impaired in this function. Interestingly, our results suggest that exon 8b is present only in eutherians and its splicing is differentially regulated among species.	[Valluet, Agathe; Hmitou, Isabelle; Druillennec, Sabine; Larcher, Magalie; Eychene, Alain] Inst Curie, F-91405 Orsay, France; [Valluet, Agathe; Hmitou, Isabelle; Druillennec, Sabine; Larcher, Magalie; Eychene, Alain] Ctr Univ Orsay, INSERM, U1021, F-91405 Orsay, France; [Valluet, Agathe; Hmitou, Isabelle; Druillennec, Sabine; Larcher, Magalie; Eychene, Alain] Ctr Univ Orsay, CNRS, UMR 3347, F-91405 Orsay, France; [Davis, Sabrina; Laroche, Serge] Univ Paris 11, Ctr Neurosci Paris Sud, Orsay, France; [Davis, Sabrina; Laroche, Serge] CNRS, UMR 8195, F-91405 Orsay, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet	Valluet, A (corresponding author), Inst Curie, F-91405 Orsay, France.	eychene@curie.fr	DRUILLENNEC, Sabine/B-2572-2019; Eychene, Alain/M-8838-2017; Hmitou, Isabelle/H-8341-2017	DRUILLENNEC, Sabine/0000-0003-0237-1465; Hmitou, Isabelle/0000-0001-7320-6075; EYCHENE, Alain/0000-0002-6818-7225	Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); Ligue Nationale Contre le Cancer (Comite de l'Essonne); Ministere Francais de la Recherche; Association pour la Recherche sur le Cancer (ARC); Ligue Nationale Contre le Cancer (Comites de l'Essonne et de l'Oise); Institut National du Cancer (INCa)	Institut Curie; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ligue Nationale Contre le Cancer (Comite de l'Essonne); Ministere Francais de la Recherche(Ministry of Research, France); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale Contre le Cancer (Comites de l'Essonne et de l'Oise); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France)	This work was funded by the Institut Curie, the Centre National de la Recherche Scientifique (CNRS), the Institut National de la Sante et de la Recherche Medicale (INSERM), and by grants from the Ligue Nationale Contre le Cancer (Comite de l'Essonne). A. V. and I. H. were supported by fellowships from the Ministere Francais de la Recherche, the Association pour la Recherche sur le Cancer (ARC) and the Ligue Nationale Contre le Cancer (Comites de l'Essonne et de l'Oise). M.L. was supported by the Institut National du Cancer (INCa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; BARNIER JV, 1995, J BIOL CHEM, V270, P23381, DOI 10.1074/jbc.270.40.23381; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; Busca R, 2000, EMBO J, V19, P2900, DOI 10.1093/emboj/19.12.2900; Camarero G, 2006, MOL CELL BIOL, V26, P7103, DOI 10.1128/MCB.00424-06; Chen AP, 2006, J NEUROSCI RES, V83, P28, DOI 10.1002/jnr.20703; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davis S, 2006, GENES BRAIN BEHAV, V5, P61, DOI 10.1111/j.1601-183X.2006.00230.x; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; EYCHENE A, 1992, ONCOGENE, V7, P1315; Galabova-Kovacs G, 2006, P NATL ACAD SCI USA, V103, P1325, DOI 10.1073/pnas.0507399103; Galabova-Kovacs G, 2008, J CELL BIOL, V180, P947, DOI 10.1083/jcb.200709069; Hmitou I, 2007, MOL CELL BIOL, V27, P31, DOI 10.1128/MCB.01265-06; IKAWA S, 1988, MOL CELL BIOL, V8, P2651, DOI 10.1128/MCB.8.6.2651; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kelly A, 2003, J NEUROSCI, V23, P5354; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Lecoin L, 2010, DEV NEUROBIOL, V70, P485, DOI 10.1002/dneu.20790; MARX M, 1988, EMBO J, V7, P3369, DOI 10.1002/j.1460-2075.1988.tb03209.x; Mazzucchelli C, 2002, NEURON, V34, P807, DOI 10.1016/S0896-6273(02)00716-X; Newbern J, 2008, P NATL ACAD SCI USA, V105, P17115, DOI 10.1073/pnas.0805239105; Niault TS, 2010, CARCINOGENESIS, V31, P1165, DOI 10.1093/carcin/bgp337; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; Papin C, 1998, J BIOL CHEM, V273, P24939, DOI 10.1074/jbc.273.38.24939; Peyssonnaux C, 2001, BIOL CELL, V93, P53, DOI 10.1016/S0248-4900(01)01125-X; Ritt DA, 2010, MOL CELL BIOL, V30, P806, DOI 10.1128/MCB.00569-09; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Selcher JC, 2002, NEUROSCIENTIST, V8, P122, DOI 10.1177/107385840200800208; THOMAS KL, 1994, NEURON, V13, P737, DOI 10.1016/0896-6273(94)90040-X; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Waltereit R, 2003, MOL NEUROBIOL, V27, P99, DOI 10.1385/MN:27:1:99; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Zhong J, 2007, NAT NEUROSCI, V10, P598, DOI 10.1038/nn1898	36	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15272	10.1371/journal.pone.0015272	http://dx.doi.org/10.1371/journal.pone.0015272			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203559	Green Published, gold, Green Submitted			2022-12-27	WOS:000285578000027
J	Christie, MR; Tissot, BN; Albins, MA; Beets, JP; Jia, YL; Ortiz, DM; Thompson, SE; Hixon, MA				Christie, Mark R.; Tissot, Brian N.; Albins, Mark A.; Beets, James P.; Jia, Yanli; Ortiz, Delisse M.; Thompson, Stephen E.; Hixon, Mark A.			Larval Connectivity in an Effective Network of Marine Protected Areas	PLOS ONE			English	Article							CORAL-REEF FISH; ZEBRASOMA-FLAVESCENS; SELF-RECRUITMENT; YELLOW TANG; POPULATIONS; PATTERNS; RETENTION; ACANTHURIDAE; MANAGEMENT; DISPERSAL	Acceptance of marine protected areas (MPAs) as fishery and conservation tools has been hampered by lack of direct evidence that MPAs successfully seed unprotected areas with larvae of targeted species. For the first time, we present direct evidence of large-scale population connectivity within an existing and effective network of MPAs. A new parentage analysis identified four parent-offspring pairs from a large, exploited population of the coral-reef fish Zebrasoma flavescens in Hawai'i, revealing larval dispersal distances ranging from 15 to 184 km. In two cases, successful dispersal was from an MPA to unprotected sites. Given high adult abundances, the documentation of any parent-offspring pairs demonstrates that ecologically-relevant larval connectivity between reefs is substantial. All offspring settled at sites to the north of where they were spawned. Satellite altimetry and oceanographic models from relevant time periods indicated a cyclonic eddy that created prevailing northward currents between sites where parents and offspring were found. These findings empirically demonstrate the effectiveness of MPAs as useful conservation and management tools and further highlight the importance of coupling oceanographic, genetic, and ecological data to predict, validate and quantify larval connectivity among marine populations.	[Christie, Mark R.; Albins, Mark A.; Hixon, Mark A.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Tissot, Brian N.] Washington State Univ, Sch Earth & Environm Sci, Vancouver, WA USA; [Beets, James P.] Univ Hawaii, Dept Marine Sci, Hilo, HI 96720 USA; [Jia, Yanli] Univ Hawaii, Int Pacific Res Ctr, Honolulu, HI 96822 USA; [Ortiz, Delisse M.] Natl Marine Fisheries Serv, Highly Migratory Species Management Div, Silver Spring, MD USA; [Thompson, Stephen E.] Marine Environm Res, Kailua, HI USA	Oregon State University; Washington State University; University of Hawaii System; University Hawaii Hilo; University of Hawaii System; National Oceanic Atmospheric Admin (NOAA) - USA	Christie, MR (corresponding author), Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA.	christim@science.oregonstate.edu	Langhamer, Olivia/J-3425-2012	Tissot, Brian/0000-0003-0398-2241	Conservation International; Marine Environmental Research; National Science Foundation [05-50709, 08-51162]; National Oceanic and Atmospheric Association	Conservation International; Marine Environmental Research; National Science Foundation(National Science Foundation (NSF)); National Oceanic and Atmospheric Association(National Oceanic Atmospheric Admin (NOAA) - USA)	This work was supported by grants from Conservation International (MAH), Marine Environmental Research (MAH, JPB, and BNT), and Jim and Kayla Paul (MAH), with supplemental funding from the National Science Foundation (05-50709, 08-51162) (MAH). YJ was supported by the National Oceanic and Atmospheric Association through a grant to the International Pacific Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Amos W, 2007, MOL ECOL NOTES, V7, P10, DOI 10.1111/j.1471-8286.2006.01560.x; BELKHIR K, 2002, 5000 CNR SUMR U MONT; Bleck R, 2002, OCEAN MODEL, V4, P55, DOI 10.1016/S1463-5003(01)00012-9; Christie MR, 2010, MOL ECOL, V19, P1042, DOI 10.1111/j.1365-294X.2010.04524.x; Christie MR, 2010, MOL ECOL RESOUR, V10, P115, DOI 10.1111/j.1755-0998.2009.02687.x; Christie MR, 2009, MOL ECOL RESOUR, V9, P544, DOI 10.1111/j.1755-0998.2008.02354.x; Claisse JT, 2009, CORAL REEFS, V28, P95, DOI 10.1007/s00338-008-0447-7; Cudney-Bueno R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004140; Dickey TD, 2008, DEEP-SEA RES PT II, V55, P1195, DOI 10.1016/j.dsr2.2008.01.006; EBLE JA, 2011, MAR ECOL PR IN PRESS; Fisher R, 2005, MAR ECOL PROG SER, V285, P223, DOI 10.3354/meps285223; Francis RC, 2007, FISHERIES, V32, P217, DOI 10.1577/1548-8446(2007)32[217:TCFBFS]2.0.CO;2; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Goudet J., FSTAT PROGRAM ESTIMA; Hedgecock D, 2007, OCEANOGRAPHY, V20, P70, DOI 10.5670/oceanog.2007.30; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Jones GP, 2005, CURR BIOL, V15, P1314, DOI 10.1016/j.cub.2005.06.061; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; Konovalov DA, 2004, MOL ECOL NOTES, V4, P779, DOI 10.1111/j.1471-8286.2004.00796.x; Kritzer JP, 2004, FISH FISH, V5, P131, DOI 10.1111/j.1467-2979.2004.00131.x; Leis JM, 2006, ADV MAR BIOL, V51, P57, DOI 10.1016/S0065-2881(06)51002-8; LEIS JM, 1976, MAR BIOL, V36, P359, DOI 10.1007/BF00389198; LOBEL PS, 1986, DEEP-SEA RES, V33, P483, DOI 10.1016/0198-0149(86)90127-5; Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x; MILLER JM, 1973, EARLY LIFE HIST FISH; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Ortiz DM, 2008, MAR ECOL PROG SER, V365, P217, DOI 10.3354/meps07492; Palumbi SR, 2003, ECOL APPL, V13, pS146; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Russ Garry R., 2002, P421, DOI 10.1016/B978-012615185-5/50024-4; Sancho G, 1997, MAR ECOL PROG SER, V153, P311, DOI 10.3354/meps153311; Selkoe KA, 2010, MOL ECOL, V19, P3708, DOI 10.1111/j.1365-294X.2010.04658.x; STEVENSON TC, ICES J MARI IN PRESS; Stobutzki IC, 1997, MAR ECOL PROG SER, V149, P35, DOI 10.3354/meps149035; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Thorrold SR, 2002, B MAR SCI, V70, P291; Thresher R. E., 1984, REPROD REEF FISHES, P273; WALSH WJ, 1987, ENVIRON BIOL FISH, V18, P257, DOI 10.1007/BF00004879; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; Williams ID, 2009, BIOL CONSERV, V142, P1066, DOI 10.1016/j.biocon.2008.12.029	42	158	159	0	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15715	10.1371/journal.pone.0015715	http://dx.doi.org/10.1371/journal.pone.0015715			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203576	gold, Green Published			2022-12-27	WOS:000285576900036
J	Ma, LG; Xin, HP; Qu, LH; Zhao, J; Yang, LB; Zhao, P; Sun, MX				Ma, Ligang; Xin, Haiping; Qu, Lianghuan; Zhao, Jing; Yang, Libo; Zhao, Peng; Sun, Mengxiang			Transcription Profile Analysis Reveals That Zygotic Division Results in Uneven Distribution of Specific Transcripts in Apical/Basal Cells of Tobacco	PLOS ONE			English	Article							EMBRYONIC PATTERN-FORMATION; ARABIDOPSIS ROOT-MERISTEM; FACTOR FAMILY; EMBRYOGENESIS; EXPRESSION; PROTEIN; PLANTS; GENES; FATE; SUSPENSOR	Background: Asymmetric zygotic division in higher plants results in the formation of an apical cell and a basal cell. These two embryonic cells possess distinct morphologies and cell developmental fates. It has been proposed that unevenly distributed cell fate determinants and/or distinct cell transcript profiles may be the underlying reason for their distinct fates. However, neither of these hypotheses has convincing support due to technical limitations. Methodology/Principal Findings: Using laser-controlled microdissection, we isolated apical and basal cells and constructed cell type-specific cDNA libraries. Transcript profile analysis revealed difference in transcript composition. PCR and qPCR analysis confirmed that transcripts of selected embryogenesis-related genes were cell-type preferentially distributed. Some of the transcripts that existed in zygotes were found distinctly existed in apical or basal cells. The cell type specific de novo transcription was also found after zygotic cell division. Conclusions/Significance: Thus, we found that the transcript diversity occurs between apical and basal cells. Asymmetric zygotic division results in the uneven distribution of some embryogenesis related transcripts in the two-celled proembryos, suggesting that a differential distribution of some specific transcripts in the apical or basal cells may involve in guiding the two cell types to different developmental destinies.	[Ma, Ligang; Xin, Haiping; Qu, Lianghuan; Zhao, Jing; Yang, Libo; Zhao, Peng; Sun, Mengxiang] Wuhan Univ, Coll Life Sci, Minist Educ Plant Dev Biol, Key Lab, Wuhan 430072, Peoples R China	Wuhan University	Ma, LG (corresponding author), Wuhan Univ, Coll Life Sci, Minist Educ Plant Dev Biol, Key Lab, Wuhan 430072, Peoples R China.	mxsun@whu.edu.cn	Ma, Ligang/O-9603-2014	Ma, Ligang/0000-0003-3451-5291	'973' Project [2007CB108700]; National Natural Science Fund of China [30521004, 30771131]	'973' Project(National Basic Research Program of China); National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	The project was supported by the '973' Project (2007CB108700), National Natural Science Fund of China (30521004, 30771131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouget FY, 1998, DEVELOPMENT, V125, P1999; Chandler JW, 2009, PLANT MOL BIOL, V69, P57, DOI 10.1007/s11103-008-9405-6; De Smet I, 2010, PLANT J, V61, P959, DOI 10.1111/j.1365-313X.2010.04143.x; Ding YH, 2006, PLANT CELL, V18, P815, DOI 10.1105/tpc.105.039495; Dresselhaus T, 1999, MOL GEN GENET, V261, P416, DOI 10.1007/s004380050983; Fu ChunMei, 1996, Acta Botanica Sinica, V38, P262; Gallagher K, 1997, CURR OPIN CELL BIOL, V9, P842, DOI 10.1016/S0955-0674(97)80086-5; GURDON JB, 1992, CELL, V68, P185, DOI 10.1016/0092-8674(92)90465-O; Haecker A, 2004, DEVELOPMENT, V131, P657, DOI 10.1242/dev.00963; He YC, 2007, PLANT J, V49, P515, DOI 10.1111/j.1365-313X.2006.02970.x; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Irish VF, 2001, CURR OPIN GENET DEV, V11, P424, DOI 10.1016/S0959-437X(00)00213-6; Jurgens G, 2001, EMBO J, V20, P3609, DOI 10.1093/emboj/20.14.3609; Kumar M, 2009, MOL PLANT, V2, P152, DOI 10.1093/mp/ssn095; Kwong RW, 2003, PLANT CELL, V15, P5, DOI 10.1105/tpc.006973; Laux T, 2004, PLANT CELL, V16, pS190, DOI 10.1105/tpc.016014; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; LINDSEY K, 1993, J EXP BOT, V44, P359, DOI 10.1093/jxb/44.2.359; Lu PZ, 1996, PLANT CELL, V8, P2155, DOI 10.1105/tpc.8.12.2155; Ning J, 2006, FEBS LETT, V580, P1747, DOI 10.1016/j.febslet.2006.02.028; Okamoto T, 2005, PLANT CELL PHYSIOL, V46, P332, DOI 10.1093/pcp/pci032; PRIESS JR, 1987, CELL, V51, P601, DOI 10.1016/0092-8674(87)90129-2; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Scheres B, 1999, ANNU REV PLANT PHYS, V50, P505, DOI 10.1146/annurev.arplant.50.1.505; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; VANDENBERG C, 1995, NATURE, V378, P62, DOI 10.1038/378062a0; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VERNON DM, 1994, DEV BIOL, V165, P566, DOI 10.1006/dbio.1994.1276; Weijers D, 2005, CURR OPIN PLANT BIOL, V8, P32, DOI 10.1016/j.pbi.2004.11.001; Weterings K, 2001, PLANT CELL, V13, P2409, DOI 10.1105/tpc.13.11.2409; Xin HP, 2010, SCI CHINA LIFE SCI, V53, P927, DOI 10.1007/s11427-010-4033-1	32	16	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e15971	10.1371/journal.pone.0015971	http://dx.doi.org/10.1371/journal.pone.0015971			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249132	Green Published, Green Submitted, gold			2022-12-27	WOS:000286512900015
J	Bulow, MH; Aebersold, R; Pankratz, MJ; Junger, MA				Buelow, Margret H.; Aebersold, Ruedi; Pankratz, Michael J.; Juenger, Martin A.			The Drosophila FoxA Ortholog Fork Head Regulates Growth and Gene Expression Downstream of Target of Rapamycin	PLOS ONE			English	Article							LIFE-SPAN; CAENORHABDITIS-ELEGANS; TRANSCRIPTION FACTOR; CELL-GROWTH; C-ELEGANS; INSULIN; RNAI; METABOLISM; MELANOGASTER; RESTRICTION	Forkhead transcription factors of the FoxO subfamily regulate gene expression programs downstream of the insulin signaling network. It is less clear which proteins mediate transcriptional control exerted by Target of rapamycin (TOR) signaling, but recent studies in nematodes suggest a role for FoxA transcription factors downstream of TOR. In this study we present evidence that outlines a similar connection in Drosophila, in which the FoxA protein Fork head (FKH) regulates cellular and organismal size downstream of TOR. We find that ectopic expression and targeted knockdown of FKH in larval tissues elicits different size phenotypes depending on nutrient state and TOR signaling levels. FKH overexpression has a negative effect on growth under fed conditions, and this phenotype is not further exacerbated by inhibition of TOR via rapamycin feeding. Under conditions of starvation or low TOR signaling levels, knockdown of FKH attenuates the size reduction associated with these conditions. Subcellular localization of endogenous FKH protein is shifted from predominantly cytoplasmic on a high-protein diet to a pronounced nuclear accumulation in animals with reduced levels of TOR or fed with rapamycin. Two putative FKH target genes, CG6770 and cabut, are transcriptionally induced by rapamycin or FKH expression, and silenced by FKH knockdown. Induction of both target genes in heterozygous TOR mutant animals is suppressed by mutations in fkh. Furthermore, TOR signaling levels and FKH impact on transcription of the dFOXO target gene d4E-BP, implying a point of crosstalk with the insulin pathway. In summary, our observations show that an alteration of FKH levels has an effect on cellular and organismal size, and that FKH function is required for the growth inhibition and target gene induction caused by low TOR signaling levels.	[Buelow, Margret H.; Aebersold, Ruedi; Juenger, Martin A.] Swiss Fed Inst Technol, Inst Mol Syst Biol, Zurich, Switzerland; [Buelow, Margret H.; Pankratz, Michael J.] Univ Bonn, Dept Mol Brain Physiol & Behav, Life & Med Sci LIMES Inst, D-5300 Bonn, Germany; [Buelow, Margret H.; Aebersold, Ruedi] Swiss Fed Inst Technol, CC SPMD, Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bonn; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Bulow, MH (corresponding author), Swiss Fed Inst Technol, Inst Mol Syst Biol, Zurich, Switzerland.	pankratz@uni-bonn.de; juenger@imsb.biol.ethz.ch	Bülow, Margret/P-3641-2019; Bülow, Margret H/U-8001-2018; Jünger, Martin A./A-8010-2011	Bülow, Margret/0000-0001-6006-8507; Bülow, Margret H/0000-0001-6006-8507; 	Swiss Federal Institute of Technology (ETH) Zurich [TH-17 07-1]; Swiss National Science Foundation (SNF); Deutsche Forschungsgemeinschaft (DFG)	Swiss Federal Institute of Technology (ETH) Zurich(ETH Zurich); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by a research grant of the Swiss Federal Institute of Technology (ETH) Zurich (TH-17 07-1), the Swiss National Science Foundation (SNF) and the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armknecht S, 2005, METHOD ENZYMOL, V392, P55, DOI 10.1016/S0076-6879(04)92004-6; Bjorklund M, 2006, NATURE, V439, P1009, DOI 10.1038/nature04469; Buch S, 2008, CELL METAB, V7, P321, DOI 10.1016/j.cmet.2008.02.012; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Gershman B, 2007, PHYSIOL GENOMICS, V29, P24, DOI 10.1152/physiolgenomics.00061.2006; Giordano E, 2002, GENETICS, V160, P637; Gorski SM, 2003, CURR BIOL, V13, P358, DOI 10.1016/S0960-9822(03)00082-4; Guertin DA, 2006, CURR BIOL, V16, P958, DOI 10.1016/j.cub.2006.03.084; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kraut R, 2001, CURR BIOL, V11, P417, DOI 10.1016/S0960-9822(01)00124-5; Lee HH, 2004, DEV DYNAM, V229, P357, DOI 10.1002/dvdy.10443; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Liu Y, 2008, INSECT MOL BIOL, V17, P91, DOI 10.1111/j.1365-2583.2007.00785.x; Meissner B, 2004, J BIOL CHEM, V279, P36739, DOI 10.1074/jbc.M403415200; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Min KJ, 2006, MECH AGEING DEV, V127, P643, DOI 10.1016/j.mad.2006.02.005; Munoz-Descalzo S, 2005, DEV BIOL, V287, P168, DOI 10.1016/j.ydbio.2005.08.048; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Sheaffer KL, 2008, CURR BIOL, V18, P1355, DOI 10.1016/j.cub.2008.07.097; Silva JP, 2009, NATURE, V462, P646, DOI 10.1038/nature08589; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Teleman AA, 2005, GENE DEV, V19, P1844, DOI 10.1101/gad.341505; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; WEIGEL D, 1989, CELL, V57, P645, DOI 10.1016/0092-8674(89)90133-5; Wolfrum C, 2003, P NATL ACAD SCI USA, V100, P11624, DOI 10.1073/pnas.1931483100; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	42	29	29	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15171	10.1371/journal.pone.0015171	http://dx.doi.org/10.1371/journal.pone.0015171			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217822	Green Published, Green Submitted, gold			2022-12-27	WOS:000285838900015
J	Fenk, LM; Heidlmayr, K; Lindner, P; Schmid, A				Fenk, Lisa M.; Heidlmayr, Karin; Lindner, Philipp; Schmid, Axel			Pupil Size in Spider Eyes Is Linked to Post-Ecdysal Lens Growth	PLOS ONE			English	Article							PRINCIPAL EYES; ARANEAE; SALTICIDAE; OPTICS	In this study we describe a distinctive pigment ring that appears in spider eyes after ecdysis and successively decreases in size in the days thereafter. Although pigment stops in spider eyes are well known, size variability is, to our knowledge, reported here for the first time. Representative species from three families (Ctenidae, Sparassidae and Lycosidae) are investigated and, for one of these species (Cupiennius salei, Ctenidae), the progressive increase in pupil diameter is monitored. In this species the pupil occupies only a fourth of the total projected lens surface after ecdysis and reaches its final size after approximately ten days. MicroCT images suggest that the decrease of the pigment ring is linked to the growth of the corneal lens after ecdysis. The pigment rings might improve vision in the immature eye by shielding light rays that would otherwise enter the eye via peripheral regions of the cornea, beside the growing crystalline lens.	[Fenk, Lisa M.; Heidlmayr, Karin; Lindner, Philipp; Schmid, Axel] Univ Vienna, Fac Life Sci, Dept Neurobiol, Vienna, Austria	University of Vienna	Fenk, LM (corresponding author), Univ Vienna, Fac Life Sci, Dept Neurobiol, Vienna, Austria.	lisa.fenk@univie.ac.at			Austrian Academy of Sciences at the Department of Neurobiology, University of Vienna	Austrian Academy of Sciences at the Department of Neurobiology, University of Vienna	LMF is recipient of a DOC-fFORTE fellowship of the Austrian Academy of Sciences at the Department of Neurobiology, University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLEST AD, 1985, J COMP PHYSIOL A, V157, P391, DOI 10.1007/BF00618129; BLEST AD, 1977, PROC R SOC SER B-BIO, V196, P197, DOI 10.1098/rspb.1977.0037; Browning HC, 1942, PROC R SOC SER B-BIO, V131, P65, DOI 10.1098/rspb.1942.0018; CARRICAB.P, 1970, VISION RES, V10, P943, DOI 10.1016/0042-6989(70)90072-6; CODDINGTON JA, 1991, ANNU REV ECOL SYST, V22, P565, DOI 10.1146/annurev.es.22.110191.003025; Fenk LM, 2010, J EXP BIOL, V213, P3111, DOI 10.1242/jeb.041939; HOMANN H, 1971, Z MORPHOL TIERE, V69, P201, DOI 10.1007/BF00277623; Insausti TC, 2000, MEM I OSWALDO CRUZ, V95, P743, DOI 10.1590/S0074-02762000000500024; Land M.F., 1985, P53; LAND MF, 1969, J EXP BIOL, V51, P443; LAND MF, 1992, J EXP BIOL, V164, P227; Melchers M., 1963, Zoologische Jahrbuecher Systematik, V91, P1; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; Muller J, 1826, VERGLEICHENDEN PHYSI; Neuhofer D, 2009, J EXP BIOL, V212, P2819, DOI 10.1242/jeb.027136; OPELL BD, 1987, J MORPHOL, V192, P87, DOI 10.1002/jmor.1051920202; Paulus H.F., 1979, P299; Wagner W, 1888, ANN SCI NAT, VAnn Sci Nat Zool, p[6, 281]; WILLIAMS DS, 1980, NATURE, V288, P578, DOI 10.1038/288578a0; WILSON M, 1975, NATURE, V258, P603, DOI 10.1038/258603a0	21	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15838	10.1371/journal.pone.0015838	http://dx.doi.org/10.1371/journal.pone.0015838			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209876	Green Submitted, Green Published, gold			2022-12-27	WOS:000285838900041
J	Grad, I; Cederroth, CR; Walicki, J; Grey, C; Barluenga, S; Winssinger, N; De Massy, B; Nef, S; Picard, D				Grad, Iwona; Cederroth, Christopher R.; Walicki, Joel; Grey, Corinne; Barluenga, Sofia; Winssinger, Nicolas; De Massy, Bernard; Nef, Serge; Picard, Didier			The Molecular Chaperone Hsp90 alpha Is Required for Meiotic Progression of Spermatocytes beyond Pachytene in the Mouse	PLOS ONE			English	Article							MALE GERM-CELLS; HSP90 INHIBITORS; MALE-INFERTILITY; IN-VIVO; MEIOSIS; EXPRESSION; CYCLE; MICE; HSP70-2; FKBP52	The molecular chaperone Hsp90 has been found to be essential for viability in all tested eukaryotes, from the budding yeast to Drosophila. In mammals, two genes encode the two highly similar and functionally largely redundant isoforms Hsp90 alpha and Hsp90 beta. Although they are co-expressed in most if not all cells, their relative levels vary between tissues and during development. Since mouse embryos lacking Hsp90 beta die at implantation, and despite the fact that Hsp90 inhibitors being tested as anti-cancer agents are relatively well tolerated, the organismic functions of Hsp90 in mammals remain largely unknown. We have generated mouse lines carrying gene trap insertions in the Hsp90 alpha gene to investigate the global functions of this isoform. Surprisingly, mice without Hsp90 alpha are apparently normal, with one major exception. Mutant male mice, whose Hsp90 beta levels are unchanged, are sterile because of a complete failure to produce sperm. While the development of the male reproductive system appears to be normal, spermatogenesis arrests specifically at the pachytene stage of meiosis I. Over time, the number of spermatocytes and the levels of the meiotic regulators and Hsp90 interactors Hsp70-2, NASP and Cdc2 are reduced. We speculate that Hsp90 alpha may be required to maintain and to activate these regulators and/or to disassemble the synaptonemal complex that holds homologous chromosomes together. The link between fertility and Hsp90 is further supported by our finding that an Hsp90 inhibitor that can cross the blood-testis barrier can partially phenocopy the genetic defects.	[Grad, Iwona; Walicki, Joel; Picard, Didier] Univ Geneva, Dept Biol Cellulaire, Geneva, Switzerland; [Cederroth, Christopher R.; Nef, Serge] Univ Geneva, Dept Med Genet & Dev, Ctr Med Univ, Geneva, Switzerland; [Grey, Corinne; De Massy, Bernard] IGH CNRS, Inst Genet Humaine, Montpellier, France; [Barluenga, Sofia; Winssinger, Nicolas] Univ Strasbourg, Inst Sci & Ingn Supramol, Strasbourg, France	University of Geneva; University of Geneva; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Grad, I (corresponding author), Univ Geneva, Dept Biol Cellulaire, Sci 3, Geneva, Switzerland.	didier.picard@unige.ch	Grad, Iwona/D-1222-2012; Cederroth, Christopher/B-9932-2011; Nef, Serge/AAV-6445-2020; Cederroth, Christopher R./AAO-9501-2020; Winssinger, Nicolas/B-6710-2017	Grad, Iwona/0000-0003-4379-5950; Nef, Serge/0000-0001-5462-0676; Winssinger, Nicolas/0000-0003-1636-7766; Cederroth, Christopher/0000-0001-7267-5136	Swiss National Science Foundation; Canton de Geneve; Centre National de la Recherche Scientifique; Agence Nationale de la Recherche [06-BLAN-0160-01, 09-BLAN-0269-01]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canton de Geneve; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR))	Work in the DP and SN laboratories was supported by the Swiss National Science Foundation and the Canton de Geneve. CG and BdM were supported by the Centre National de la Recherche Scientifique and the Agence Nationale de la Recherche (06-BLAN-0160-01 and 09-BLAN-0269-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseev OM, 2009, BIOL REPROD, V81, P739, DOI 10.1095/biolreprod.109.076497; Alekseev OM, 2005, J BIOL CHEM, V280, P2904, DOI 10.1074/jbc.M410397200; Alekseev OM, 2003, J BIOL CHEM, V278, P8846, DOI 10.1074/jbc.M210352200; Allen JW, 1996, CHROMOSOMA, V104, P414, DOI 10.1007/BF00352265; Barluenga S, 2008, ANGEW CHEM INT EDIT, V47, P4432, DOI 10.1002/anie.200800233; Barluenga S, 2009, CHEMBIOCHEM, V10, P2753, DOI 10.1002/cbic.200900494; Bouchier-Hayes L, 2009, MOL CELL, V35, P830, DOI 10.1016/j.molcel.2009.07.023; Brandeis M, 1998, P NATL ACAD SCI USA, V95, P4344, DOI 10.1073/pnas.95.8.4344; Caldas-Lopes E, 2009, P NATL ACAD SCI USA, V106, P8368, DOI 10.1073/pnas.0903392106; Cederroth CR, 2007, ENDOCRINOLOGY, V148, P5507, DOI 10.1210/en.2007-0689; Cederroth CR, 2010, MOL CELL ENDOCRINOL, V321, P152, DOI 10.1016/j.mce.2010.02.011; Chen SY, 1998, CELL STRESS CHAPERON, V3, P118, DOI 10.1379/1466-1268(1998)003<0118:DIOPAT>2.3.CO;2; Cheung-Flynn J, 2005, MOL ENDOCRINOL, V19, P1654, DOI 10.1210/me.2005-0071; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; Crackower MA, 2003, SCIENCE, V300, P1291, DOI 10.1126/science.1083022; Dix DJ, 1996, P NATL ACAD SCI USA, V93, P3264, DOI 10.1073/pnas.93.8.3264; Dix DJ, 1997, DEVELOPMENT, V124, P4595; Drabent B, 2000, HISTOCHEM CELL BIOL, V113, P433; Echeverria PC, 2010, BBA-MOL CELL RES, V1803, P641, DOI 10.1016/j.bbamcr.2009.11.012; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Glaze ER, 2005, CANCER CHEMOTH PHARM, V56, P637, DOI 10.1007/s00280-005-1000-9; Grad I, 2006, MOL CELL BIOL, V26, P8976, DOI 10.1128/MCB.00734-06; GRUPPI CM, 1993, DEV GENET, V14, P119, DOI 10.1002/dvg.1020140206; Guillon H, 2005, MOL CELL, V20, P563, DOI 10.1016/j.molcel.2005.09.021; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Inoue T, 2006, DEV GROWTH DIFFER, V48, P25, DOI [10.1111/j.1440-169x.2006.00841.x, 10.1111/j.1440-169X.2006.00841.x]; Kim YS, 2009, CURR TOP MED CHEM, V9, P1479, DOI 10.2174/156802609789895728; Kunisawa J, 2006, IMMUNITY, V24, P523, DOI 10.1016/j.immuni.2006.03.015; LABBE JC, 1989, EMBO J, V8, P3053, DOI 10.1002/j.1460-2075.1989.tb08456.x; LEE SJ, 1990, MOL CELL BIOL, V10, P3239, DOI 10.1128/MCB.10.6.3239; Li W, 2007, EMBO J, V26, P1221, DOI 10.1038/sj.emboj.7601579; Liu D, 1998, NAT GENET, V20, P377, DOI 10.1038/3855; Louvion JF, 1996, P NATL ACAD SCI USA, V93, P13937, DOI 10.1073/pnas.93.24.13937; MacLean MJ, 2005, BIOCHEM BIOPH RES CO, V337, P133, DOI 10.1016/j.bbrc.2005.09.025; Metchat A, 2009, J BIOL CHEM, V284, P9521, DOI 10.1074/jbc.M808819200; MINAMI Y, 1994, MOL CELL BIOL, V14, P1459, DOI 10.1128/MCB.14.2.1459; Moens PB, 1997, CHROMOSOMA, V106, P207, DOI 10.1007/s004120050241; Munoz MJ, 1999, MOL GEN GENET, V261, P242, DOI 10.1007/s004380050963; Nakai A, 2001, EMBO J, V20, P2885, DOI 10.1093/emboj/20.11.2885; Nickerson HD, 2007, DEV BIOL, V306, P725, DOI 10.1016/j.ydbio.2007.04.009; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Richardson RT, 2006, J BIOL CHEM, V281, P21526, DOI 10.1074/jbc.M603816200; RUBIN MR, 1986, SCIENCE, V233, P663, DOI 10.1126/science.3726554; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Saribek B, 2006, BIOCHEM BIOPH RES CO, V349, P1190, DOI 10.1016/j.bbrc.2006.08.143; Sreedhar AS, 2004, FEBS LETT, V562, P11; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tash JS, 2008, BIOL REPROD, V78, P1139, DOI 10.1095/biolreprod.107.062679; Vanmuylder N, 2002, ANAT EMBRYOL, V205, P301, DOI 10.1007/s00429-002-0258-5; Voss AK, 2000, DEVELOPMENT, V127, P1; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wang CH, 2009, BIOORG MED CHEM LETT, V19, P3836, DOI 10.1016/j.bmcl.2009.04.030; Wolgemuth DJ, 2008, CELL CYCLE, V7, P3509, DOI 10.4161/cc.7.22.6978; Wolgemuth DJ, 2004, INT J ANDROL, V27, P192, DOI 10.1111/j.1365-2605.2004.00480.x; Yong WD, 2007, J BIOL CHEM, V282, P5026, DOI 10.1074/jbc.M609360200; Yue L, 1999, GENETICS, V151, P1065; Zhu DH, 1997, DEVELOPMENT, V124, P3007	61	115	116	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15770	10.1371/journal.pone.0015770	http://dx.doi.org/10.1371/journal.pone.0015770			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209834	Green Published, gold			2022-12-27	WOS:000285838900030
J	Arinaminpathy, N; Grenfell, B				Arinaminpathy, Nimalan; Grenfell, Bryan			Dynamics of Glycoprotein Charge in the Evolutionary History of Human Influenza	PLOS ONE			English	Article							A VIRUS; LINKED GLYCOSYLATION; RECEPTOR-BINDING; ANTIGENIC DRIFT; HEMAGGLUTININ; PHENOTYPE; TURKEYS; GLYCANS; DOMAIN; SITES	Background: Influenza viruses show a significant capacity to evade host immunity; this is manifest both as large occasional jumps in the antigenic phenotype of viral surface molecules and in gradual antigenic changes leading to annual influenza epidemics in humans. Recent mouse studies show that avidity for host cells can play an important role in polyclonal antibody escape, and further that electrostatic charge of the hemagglutinin glycoprotein can contribute to such avidity. Methodology/Principal Findings: We test the role of glycoprotein charge on sequence data from the three major subtypes of influenza A in humans, using a simple method of calculating net glycoprotein charge. Of all subtypes, H3N2 in humans shows a striking pattern of increasing positive charge since its introduction in 1968. Notably, this trend applies to both hemagglutinin and neuraminidase glycoproteins. In the late 1980s hemagglutinin charge reached a plateau, while neuraminidase charge started to decline. We identify key groups of amino acid sites involved in this charge trend. Conclusions/Significance: To our knowledge these are the first indications that, for human H3N2, net glycoprotein charge covaries strongly with antigenic drift on a global scale. Further work is needed to elucidate how such charge interacts with other immune escape mechanisms, such as glycosylation, and we discuss important questions arising for future study.	[Arinaminpathy, Nimalan; Grenfell, Bryan] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; [Grenfell, Bryan] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Princeton University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Arinaminpathy, N (corresponding author), Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA.	nimpathy@princeton.edu		Arinaminpathy, Nimalan/0000-0001-9502-6876	National Institutes of Health [R01 GM083983-01]; National Science Foundation [EF-0742373]; Department of Homeland Security Science and Technology Directorate; Fogarty International Center, National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083983] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Department of Homeland Security Science and Technology Directorate(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institutes of Health grant R01 GM083983-01 (www.nih.gov). Bryan Grenfell was also supported by the National Science Foundation grant EF-0742373 and the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Department of Homeland Security Science and Technology Directorate and the Fogarty International Center, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNTHSEN A, 2003, NEW AGE INT; Blackburne BP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000058; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Choi YK, 2004, EMERG INFECT DIS, V10, P2156, DOI 10.3201/eid1012.040581; CORNELISSEN M, 1995, AIDS RES HUM RETROV, V11, P1169, DOI 10.1089/aid.1995.11.1169; Cui JK, 2009, P NATL ACAD SCI USA, V106, P13421, DOI 10.1073/pnas.0905818106; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Gambaryan AS, 1998, VIROLOGY, V247, P223, DOI 10.1006/viro.1998.9274; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Holmes EC, 2009, J CLIN INVEST, V119, P2488, DOI 10.1172/JCI38050; MirShekari SY, 1997, J BIOL CHEM, V272, P4027, DOI 10.1074/jbc.272.7.4027; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Schulze IT, 1997, J INFECT DIS S1, V176, P24; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Tang Y, 2005, AVIAN DIS, V49, P207, DOI 10.1637/7288-101304R; Vigerust DJ, 2007, J VIROL, V81, P8593, DOI 10.1128/JVI.00769-07; Wagner R, 2002, J GEN VIROL, V83, P601, DOI 10.1099/0022-1317-83-3-601; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; WEBSTER RG, 1982, NATURE, V296, P115, DOI 10.1038/296115a0; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; 2010, INFLUENZA VIRUS RESO	25	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15674	10.1371/journal.pone.0015674	http://dx.doi.org/10.1371/journal.pone.0015674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209885	Green Published, gold			2022-12-27	WOS:000285793600025
J	Lescault, PJ; Thompson, AB; Patil, V; Lirussi, D; Burton, A; Margarit, J; Bond, J; Matrajt, M				Lescault, Pamela J.; Thompson, Ann B.; Patil, Veerupaxagouda; Lirussi, Dario; Burton, Amanda; Margarit, Juan; Bond, Jeffrey; Matrajt, Mariana			Genomic Data Reveal Toxoplasma gondii Differentiation Mutants Are Also Impaired with Respect to Switching into a Novel Extracellular Tachyzoite State	PLOS ONE			English	Article							DEVELOPMENTALLY-REGULATED GENES; VIRULENCE FACTORS; TISSUE CYSTS; EXPRESSION; IDENTIFICATION; BRADYZOITES; KINASES; BIOLOGY; STAGE; PERSISTENCE	Toxoplasma gondii pathogenesis includes the invasion of host cells by extracellular parasites, replication of intracellular tachyzoites, and differentiation to a latent bradyzoite stage. We present the analysis of seven novel T. gondii insertional mutants that do not undergo normal differentiation to bradyzoites. Microarray quantification of the variation in genome-wide RNA levels for each parasite line and times after induction allowed us to describe states in the normal differentiation process, to analyze mutant lines in the context of these states, and to identify genes that may have roles in initiating the transition from tachyzoite to bradyzoite. Gene expression patterns in wild-type parasites undergoing differentiation suggest a novel extracellular state within the tachyzoite stage. All mutant lines exhibit aberrant regulation of bradyzoite gene expression and notably some of the mutant lines appear to exhibit high proportions of the intracellular tachyzoite state regardless of whether they are intracellular or extracellular. In addition to the genes identified by the insertional mutagenesis screen, mixture model analysis allowed us to identify a small number of genes, in mutants, for which expression patterns could not be accounted for using the three parasite states - genes that may play a mechanistic role in switching from the tachyzoite to bradyzoite stage.	[Lescault, Pamela J.; Thompson, Ann B.; Patil, Veerupaxagouda; Lirussi, Dario; Burton, Amanda; Margarit, Juan; Bond, Jeffrey; Matrajt, Mariana] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA	University of Vermont	Lescault, PJ (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA.	mmatrajt@uvm.edu	Patil, Veerupaxagouda/ACB-8475-2022	Lirussi, Dario/0000-0002-3054-2586; Burton, Amanda/0000-0002-8080-5081	National Center for Research Resources (NCRR) of the NIH [1 P20 RR16462]; American Heart Association [AHA 0535047N]; NIH [P20 RR021905]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016462, P20RR021905] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR) of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Vermont Genetics Network (VGN) through National Institutes of Health grant 1 P20 RR16462 from the BRIN program of the National Center for Research Resources (NCRR) of the NIH; The American Heart Association AHA 0535047N; and the NIH P20 RR021905. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MZ, 2009, EUKARYOT CELL, V8, P398, DOI 10.1128/EC.00329-08; Behnke MS, 2008, MOL MICROBIOL, V68, P1502, DOI 10.1111/j.1365-2958.2008.06249.x; Behnke MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012354; Bengtesson H, 2008, 745 U CAL; BOHNE W, 1995, MOL MICROBIOL, V16, P1221, DOI 10.1111/j.1365-2958.1995.tb02344.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boothroyd JC, 1997, PHILOS T ROY SOC B, V352, P1347, DOI 10.1098/rstb.1997.0119; Bradley PJ, 2007, CURR OPIN MICROBIOL, V10, P582, DOI 10.1016/j.mib.2007.09.013; Calarco JA, 2009, CELL, V138, P898, DOI 10.1016/j.cell.2009.06.012; Cleary MD, 2002, EUKARYOT CELL, V1, P329, DOI 10.1128/EC.1.3.329-340.2002; de Felipe MMC, 2008, MOL BIOCHEM PARASIT, V157, P22, DOI 10.1016/j.molbiopara.2007.09.003; DeChamps C, 1997, J PARASITOL, V83, P152, DOI 10.2307/3284336; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; DUBEY JP, 1994, J AM VET MED ASSOC, V205, P1593; Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267; Dzierszinski F, 2001, J MOL BIOL, V309, P1017, DOI 10.1006/jmbi.2001.4730; Dzierszinski F, 2004, EUKARYOT CELL, V3, P992, DOI 10.1128/EC.3.4.992-1003.2004; FICHERA ME, 1995, ANTIMICROB AGENTS CH, V39, P1530, DOI 10.1128/AAC.39.7.1530; Frankel MB, 2007, P NATL ACAD SCI USA, V104, P10181, DOI 10.1073/pnas.0701893104; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh D, 2004, BIOINFORMATICS, V20, P1663, DOI 10.1093/bioinformatics/bth139; Gissot M, 2007, PLOS PATHOG, V3, P709, DOI 10.1371/journal.ppat.0030077; Gubbels MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040036; Guerardel Y, 2005, MICROBES INFECT, V7, P41, DOI 10.1016/j.micinf.2004.09.007; Hartigan J., 1975, CLUSTERING ALGORITHM; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kim SK, 2005, J IMMUNOL, V174, P8038, DOI 10.4049/jimmunol.174.12.8038; Li L, 2003, GENOME RES, V13, P443, DOI 10.1101/gr.693203; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; Manger ID, 1998, INFECT IMMUN, V66, P1632, DOI 10.1128/IAI.66.4.1632-1637.1998; Matrajt M, 2002, MOL MICROBIOL, V44, P735, DOI 10.1046/j.1365-2958.2002.02904.x; Matrajt M, 2010, MOL BIOCHEM PARASIT, V174, P1, DOI 10.1016/j.molbiopara.2010.06.002; Narasimhan J, 2008, J BIOL CHEM, V283, P16591, DOI 10.1074/jbc.M800681200; PARMLEY SF, 1994, MOL BIOCHEM PARASIT, V66, P283, DOI 10.1016/0166-6851(94)90155-4; Peixoto L, 2010, CELL HOST MICROBE, V8, P208, DOI 10.1016/j.chom.2010.07.004; Pomel S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000188; Possenti A, 2010, INT J PARAS IN PRESS; Radke JR, 2006, PLOS PATHOG, V2, P964, DOI 10.1371/journal.ppat.0020105; Radke JR, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-26; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Roos DS, 1997, METHODS, V13, P112, DOI 10.1006/meth.1997.0504; Lopes FMR, 2007, BRAZ J INFECT DIS, V11, P496, DOI 10.1590/S1413-86702007000500011; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Saeij JPJ, 2008, INFECT IMMUN, V76, P2402, DOI 10.1128/IAI.01494-07; Saksouk N, 2005, MOL CELL BIOL, V25, P10301, DOI 10.1128/MCB.25.23.10301-10314.2005; Singh U, 2002, MOL MICROBIOL, V44, P721, DOI 10.1046/j.1365-2958.2002.02903.x; SOETE M, 1993, EXP PARASITOL, V76, P259, DOI 10.1006/expr.1993.1031; Team RDC, 2009, R LANG ENV STAT COMP; Templeton TJ, 2004, INFECT IMMUN, V72, P980, DOI 10.1128/IAI.72.2.980-987.2004; Weiss LM, 2000, FRONT BIOSCI-LANDMRK, V5, pD391, DOI 10.2741/Weiss; Yang SM, 1997, GENE, V184, P1, DOI 10.1016/S0378-1119(96)00566-5	51	35	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e14463	10.1371/journal.pone.0014463	http://dx.doi.org/10.1371/journal.pone.0014463			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209930	Green Submitted, Green Published, gold			2022-12-27	WOS:000285793600006
J	Lindblade, KA; Arvelo, W; Gray, J; Estevez, A; Frenkel, G; Reyes, L; Moscoso, F; Moir, JC; Fry, AM; Olsen, SJ				Lindblade, Kim A.; Arvelo, Wences; Gray, Jennifer; Estevez, Alejandra; Frenkel, Gal; Reyes, Lissette; Moscoso, Fabiola; Carlos Moir, Juan; Fry, Alicia M.; Olsen, Sonja J.			A Comparison of the Epidemiology and Clinical Presentation of Seasonal Influenza A and 2009 Pandemic Influenza A (H1N1) in Guatemala	PLOS ONE			English	Article							PROTECT PHASE; VIRUS	Background: A new influenza A (H1N1) virus was first found in April 2009 and proceeded to cause a global pandemic. We compare the epidemiology and clinical presentation of seasonal influenza A (H1N1 and H3N2) and 2009 pandemic influenza A (H1N1) (pH1N1) using a prospective surveillance system for acute respiratory disease in Guatemala. Methodology/Findings: Patients admitted to two public hospitals in Guatemala in 2008-2009 who met a pneumonia case definition, and ambulatory patients with influenza-like illness (ILI) at 10 ambulatory clinics were invited to participate. Data were collected through patient interview, chart abstraction and standardized physical and radiological exams. Nasopharyngeal swabs were taken from all enrolled patients for laboratory diagnosis of influenza A virus infection with real-time reverse transcription polymerase chain reaction. We identified 1,744 eligible, hospitalized pneumonia patients, enrolled 1,666 (96%) and tested samples from 1,601 (96%); 138 (9%) had influenza A virus infection. Surveillance for ILI found 899 eligible patients, enrolled 801 (89%) and tested samples from 793 (99%); influenza A virus infection was identified in 246 (31%). The age distribution of hospitalized pneumonia patients was similar between seasonal H1N1 and pH1N1 (P = 0.21); the proportion of pneumonia patients < 1 year old with seasonal H1N1 (39%) and pH1N1 (37%) were similar (P = 0.42). The clinical presentation of pH1N1 and seasonal influenza A was similar for both hospitalized pneumonia and ILI patients. Although signs of severity (admission to an intensive care unit, mechanical ventilation and death) were higher among cases of pH1N1 than seasonal H1N1, none of the differences was statistically significant. Conclusions/Significance: Small sample sizes may limit the power of this study to find significant differences between seasonal influenza A and pH1N1. In Guatemala, influenza, whether seasonal or pH1N1, appears to cause severe disease mainly in infants; targeted vaccination of children should be considered.	[Lindblade, Kim A.; Arvelo, Wences] Ctr Dis Control & Prevent, Div Global Dis Detect & Emergency Response, Atlanta, GA 30333 USA; [Lindblade, Kim A.; Arvelo, Wences] Reg Off Cent Amer & Panama, Ctr Dis Control & Prevent, Guatemala City, Guatemala; [Gray, Jennifer; Estevez, Alejandra; Frenkel, Gal; Moscoso, Fabiola] Univ Valle Guatemala, Ctr Hlth Studies, Guatemala City, Guatemala; [Reyes, Lissette] Minist Publ Hlth & Social Assistance, Field Epidemiol Training Program, Guatemala City, Guatemala; [Carlos Moir, Juan] Minist Publ Hlth & Social Assistance, Guatemala City, Guatemala; [Fry, Alicia M.; Olsen, Sonja J.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Universidad del Valle de Guatemala; Centers for Disease Control & Prevention - USA	Lindblade, KA (corresponding author), Ctr Dis Control & Prevent, Div Global Dis Detect & Emergency Response, Atlanta, GA 30333 USA.	kil2@cdc.gov		Lindblade, Kim/0000-0002-5593-0470	US Centers for Disease Control and Prevention [UO1 GH000028-02]; Universidad del Valle de Guatemala	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Universidad del Valle de Guatemala	Funding for these activities was provided by the US Centers for Disease Control and Prevention, in part through a Cooperative Agreement (UO1 GH000028-02) with the Universidad del Valle de Guatemala. The CDC participated in all aspects of study design, data collection, data analysis and manuscript preparation.	Aberle JH, 2005, PEDIATR INFECT DIS J, V24, P605, DOI 10.1097/01.inf.0000168741.59747.2d; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P173; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P185; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P249; [Anonymous], 2009, CDC PROT REALT RTPCR; Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Boelle PY, 2009, EUROSURVEILLANCE, V14, P10; Brooks WA, 2010, PEDIATR INFECT DIS J, V29, P216, DOI 10.1097/INF.0b013e3181bc23fd; Carcione D, 2010, EMERG INFECT DIS, V16, P1388, DOI 10.3201/eid1609.100076; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P941; Chang YS, 2010, MED J AUSTRALIA, V192, P90, DOI 10.5694/j.1326-5377.2010.tb03426.x; Dalton CB, 2010, MED J AUSTRALIA, V192, P357, DOI 10.5694/j.1326-5377.2010.tb03547.x; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gordon A, 2010, CLIN INFECT DIS, V50, P1462, DOI 10.1086/652647; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Heim A, 2003, J MED VIROL, V70, P228, DOI 10.1002/jmv.10382; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jhung MA, CLIN INFECT IN PRESS; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Morgan OW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009694; Munayco C. V., 2009, EUROSURVEILLANCE, V14; PAHO-CDC, 2006, PAHOHDMCDV41106; Reyes L, 2010, INFLUENZA OTHER RESP, V4, P129, DOI 10.1111/j.1750-2659.2010.00138.x; Shiley KT, 2010, INFECT CONT HOSP EP, V31, P676, DOI 10.1086/653204; Tang JWT, 2010, ARCH INTERN MED, V170, P861, DOI 10.1001/archinternmed.2010.108; To KKW, 2010, POSTGRAD MED J, V86, P515, DOI 10.1136/pgmj.2009.096206; Vaillant L, 2009, EUROSURVEILLANCE, V14, P2; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Yazdanbakhsh M, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000182	29	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15826	10.1371/journal.pone.0015826	http://dx.doi.org/10.1371/journal.pone.0015826			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209850	gold, Green Published			2022-12-27	WOS:000285793600044
J	Simanova, I; van Gerven, M; Oostenveld, R; Hagoort, P				Simanova, Irina; van Gerven, Marcel; Oostenveld, Robert; Hagoort, Peter			Identifying Object Categories from Event-Related EEG: Toward Decoding of Conceptual Representations	PLOS ONE			English	Article							GOOD-ENOUGH REPRESENTATIONS; VISUAL WORD RECOGNITION; SUPPORT VECTOR MACHINES; FUSIFORM FACE AREA; HUMAN BRAIN; TIME-COURSE; FUNCTIONAL-ANATOMY; SEMANTIC DEFICITS; TEMPORAL CORTEX; MENTAL-IMAGERY	Multivariate pattern analysis is a technique that allows the decoding of conceptual information such as the semantic category of a perceived object from neuroimaging data. Impressive single-trial classification results have been reported in studies that used fMRI. Here, we investigate the possibility to identify conceptual representations from event-related EEG based on the presentation of an object in different modalities: its spoken name, its visual representation and its written name. We used Bayesian logistic regression with a multivariate Laplace prior for classification. Marked differences in classification performance were observed for the tested modalities. Highest accuracies (89% correctly classified trials) were attained when classifying object drawings. In auditory and orthographical modalities, results were lower though still significant for some subjects. The employed classification method allowed for a precise temporal localization of the features that contributed to the performance of the classifier for three modalities. These findings could help to further understand the mechanisms underlying conceptual representations. The study also provides a first step towards the use of concept decoding in the context of real-time brain-computer interface applications.	[Simanova, Irina; Hagoort, Peter] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Simanova, Irina; van Gerven, Marcel; Oostenveld, Robert; Hagoort, Peter] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [van Gerven, Marcel] Radboud Univ Nijmegen, Inst Comp & Informat Sci, NL-6525 ED Nijmegen, Netherlands	Max Planck Society; Radboud University Nijmegen; Radboud University Nijmegen	Simanova, I (corresponding author), Max Planck Inst Psycholinguist, Nijmegen, Netherlands.	irina.simanova@mpi.nl	Hagoort, Peter/B-7417-2012; Oostenveld, Robert/D-3259-2009; van Gerven, Marcel A. J./D-7800-2012	Oostenveld, Robert/0000-0002-1974-1293; van Gerven, Marcel A. J./0000-0002-2206-9098	Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science	Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Ministry of Education, Culture and Science	The authors gratefully acknowledge the support of the BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science (http://www.nici.ru.nl/cgi-brain/index.cgi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorni R, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-33; ALCAINI M, 1994, PSYCHOPHYSIOLOGY, V31, P611, DOI 10.1111/j.1469-8986.1994.tb02354.x; Arnott SR, 2001, COGNITIVE BRAIN RES, V12, P383, DOI 10.1016/S0926-6410(01)00066-0; Assadollahi R, 2001, NEUROREPORT, V12, P207, DOI 10.1097/00001756-200102120-00007; Barber HA, 2007, BRAIN RES REV, V53, P98, DOI 10.1016/j.brainresrev.2006.07.002; Barsalou LW, 2003, TRENDS COGN SCI, V7, P84, DOI 10.1016/S1364-6613(02)00029-3; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Bright P, 2004, BRAIN LANG, V89, P417, DOI 10.1016/j.bandl.2004.01.010; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Caramazza A, 2003, TRENDS COGN SCI, V7, P354, DOI 10.1016/S1364-6613(03)00159-1; Caramazza A, 1998, J COGNITIVE NEUROSCI, V10, P1, DOI 10.1162/089892998563752; Chao LL, 2002, CEREB CORTEX, V12, P545, DOI 10.1093/cercor/12.5.545; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Devlin JT, 2006, J COGNITIVE NEUROSCI, V18, P911, DOI 10.1162/jocn.2006.18.6.911; Dien J, 2009, BIOL PSYCHOL, V80, P10, DOI 10.1016/j.biopsycho.2008.04.013; Ferreira F, 2002, CURR DIR PSYCHOL SCI, V11, P11, DOI 10.1111/1467-8721.00158; Fuggetta G, 2009, J COGNITIVE NEUROSCI, V21, P403, DOI 10.1162/jocn.2008.21030; Gerlach C, 2002, J COGNITIVE NEUROSCI, V14, P1230, DOI 10.1162/089892902760807221; Gerlach C, 2007, J COGNITIVE NEUROSCI, V19, P296, DOI 10.1162/jocn.2007.19.2.296; Grainger J, 2009, LANG LINGUIST COMPAS, V3, P128, DOI 10.1111/j.1749-818x.2008.00121.x; Hanson SJ, 2008, NEURAL COMPUT, V20, P486, DOI 10.1162/neco.2007.09-06-340; Hauk O, 2008, J PHYSIOL-PARIS, V102, P50, DOI 10.1016/j.jphysparis.2008.03.013; Hauk O, 2006, NEUROIMAGE, V30, P1383, DOI 10.1016/j.neuroimage.2005.11.048; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Hoenig K, 2008, J COGNITIVE NEUROSCI, V20, P1799, DOI 10.1162/jocn.2008.20123; Humphreys GW, 2001, BEHAV BRAIN SCI, V24, P453, DOI 10.1017/S0140525X01004150; Hyde M, 1997, AUDIOL NEURO-OTOL, V2, P281, DOI 10.1159/000259253; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Kiefer M, 2001, MEM COGNITION, V29, P100, DOI 10.3758/BF03195745; Kiefer M, 2005, J COGNITIVE NEUROSCI, V17, P199, DOI 10.1162/0898929053124938; Kiefer M, 2008, J NEUROSCI, V28, P12224, DOI 10.1523/JNEUROSCI.3579-08.2008; Kircher T, 2009, HUM BRAIN MAPP, V30, P4116, DOI 10.1002/hbm.20833; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Large ME, 2004, COGNITIVE BRAIN RES, V20, P415, DOI 10.1016/j.cogbrainres.2004.03.013; Liu HS, 2009, NEURON, V62, P281, DOI 10.1016/j.neuron.2009.02.025; LloydJones TJ, 1997, MEM COGNITION, V25, P18, DOI 10.3758/BF03197282; Mace MJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005927; Mahon BZ, 2007, NEURON, V55, P507, DOI 10.1016/j.neuron.2007.07.011; Mahon BZ, 2009, ANNU REV PSYCHOL, V60, P27, DOI 10.1146/annurev.psych.60.110707.163532; MANGUN GR, 1991, J EXP PSYCHOL HUMAN, V17, P1057, DOI 10.1037/0096-1523.17.4.1057; Martin A, 2001, CURR OPIN NEUROBIOL, V11, P194, DOI 10.1016/S0959-4388(00)00196-3; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; Mazerolle EL, 2007, INT J PSYCHOPHYSIOL, V66, P81, DOI 10.1016/j.ijpsycho.2007.06.003; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; McRae K, 2002, BRAIN DAM B, P211; Mellet E, 1998, NEUROIMAGE, V8, P129, DOI 10.1006/nimg.1998.0355; Moss HE, 2003, TRENDS COGN SCI, V7, P480, DOI 10.1016/j.tics.2003.09.008; Muller KR, 2008, J NEUROSCI METH, V167, P82, DOI 10.1016/j.jneumeth.2007.09.022; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; New J, 2007, P NATL ACAD SCI USA, V104, P16598, DOI 10.1073/pnas.0703913104; Noppeney U, 2006, CEREB CORTEX, V16, P437, DOI 10.1093/cercor/bhi123; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Paz-Caballero D, 2006, BRAIN RES, V1067, P189, DOI 10.1016/j.brainres.2005.10.046; PERANI D, 1995, NEUROREPORT, V6, P1637, DOI 10.1097/00001756-199508000-00012; Pernet C, 2003, COGNITIVE BRAIN RES, V17, P327, DOI 10.1016/S0926-6410(03)00134-4; Pinto N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040027; Price CJ, 2004, HUMAN BRAIN FUNCTION, P517; Proverbio Alice M, 2007, BMC Neurosci, V8, P24, DOI 10.1186/1471-2202-8-24; Pulvermuller F, 1999, CEREB CORTEX, V9, P497, DOI 10.1093/cercor/9.5.497; Pulvermuller F, 2001, BRAIN LANG, V78, P143, DOI 10.1006/brln.2000.2390; Reddy L, 2010, NEUROIMAGE, V50, P818, DOI 10.1016/j.neuroimage.2009.11.084; ROLAND PE, 1995, CEREB CORTEX, V5, P79, DOI 10.1093/cercor/5.1.79; Sahin NT, 2009, SCIENCE, V326, P445, DOI 10.1126/science.1174481; Sereno SC, 2003, TRENDS COGN SCI, V7, P489, DOI 10.1016/j.tics.2003.09.010; Shinkareva SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001394; Stokes M, 2009, J NEUROSCI, V29, P1565, DOI 10.1523/JNEUROSCI.4657-08.2009; Sturt P, 2004, PSYCHON B REV, V11, P882, DOI 10.3758/BF03196716; Szekely A, 2004, J MEM LANG, V51, P247, DOI 10.1016/j.jml.2004.03.002; Tanaka J, 1999, NEUROREPORT, V10, P829, DOI 10.1097/00001756-199903170-00030; Tarr MJ, 2003, TRENDS COGN SCI, V7, P23, DOI 10.1016/S1364-6613(02)00010-4; Thirion B, 2006, NEUROIMAGE, V33, P1104, DOI 10.1016/j.neuroimage.2006.06.062; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Thrun S, 1996, P NEUR INF PROC SYST, P640; Tyler LK, 2001, TRENDS COGN SCI, V5, P244, DOI 10.1016/S1364-6613(00)01651-X; Tyler LK, 2003, NEUROIMAGE, V18, P542, DOI 10.1016/S1053-8119(02)00047-2; Van Doren L, 2010, NEUROIMAGE, V49, P3295, DOI 10.1016/j.neuroimage.2009.12.005; van Gerven M, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/041001; van Gerven MAJ, 2010, NEUROIMAGE, V50, P150, DOI 10.1016/j.neuroimage.2009.11.064; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; VanRullen R, 2001, J COGNITIVE NEUROSCI, V13, P454, DOI 10.1162/08989290152001880; Vogel EK, 2000, PSYCHOPHYSIOLOGY, V37, P190, DOI 10.1111/1469-8986.3720190; WARRINGTON EK, 1984, BRAIN, V107, P829, DOI 10.1093/brain/107.3.829; WARRINGTON EK, 1987, BRAIN, V110, P1273, DOI 10.1093/brain/110.5.1273; WARRINGTON EK, 1983, BRAIN, V106, P859, DOI 10.1093/brain/106.4.859	88	92	92	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e14465	10.1371/journal.pone.0014465	http://dx.doi.org/10.1371/journal.pone.0014465			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209937	Green Submitted, Green Published, gold			2022-12-27	WOS:000285793600008
J	Gaudet, AD; Ramer, LM; Nakonechny, J; Cragg, JJ; Ramer, MS				Gaudet, Andrew D.; Ramer, Leanne M.; Nakonechny, Joanne; Cragg, Jacquelyn J.; Ramer, Matt S.			Small-Group Learning in an Upper-Level University Biology Class Enhances Academic Performance and Student Attitudes Toward Group Work	PLOS ONE			English	Article							PEER; ACHIEVEMENT; ENGAGEMENT; QUESTIONS; SCIENCE	To improve science learning, science educators' teaching tools need to address two major criteria: teaching practice should mirror our current understanding of the learning process; and science teaching should reflect scientific practice. We designed a small-group learning (SGL) model for a fourth year university neurobiology course using these criteria and studied student achievement and attitude in five course sections encompassing the transition from individual work-based to SGL course design. All students completed daily quizzes/assignments involving analysis of scientific data and the development of scientific models. Students in individual work-based (Individualistic) sections usually worked independently on these assignments, whereas SGL students completed assignments in permanent groups of six. SGL students had significantly higher final exam grades than Individualistic students. The transition to the SGL model was marked by a notable increase in 10th percentile exam grade (Individualistic: 47.5%; Initial SGL: 60%; Refined SGL: 65%), suggesting SGL enhanced achievement among the least prepared students. We also studied student achievement on paired quizzes: quizzes were first completed individually and submitted, and then completed as a group and submitted. The group quiz grade was higher than the individual quiz grade of the highest achiever in each group over the term. All students - even term high achievers -could benefit from the SGL environment. Additionally, entrance and exit surveys demonstrated student attitudes toward SGL were more positive at the end of the Refined SGL course. We assert that SGL is uniquely-positioned to promote effective learning in the science classroom.	[Gaudet, Andrew D.; Ramer, Leanne M.; Ramer, Matt S.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Gaudet, Andrew D.; Ramer, Leanne M.; Cragg, Jacquelyn J.; Ramer, Matt S.] Univ British Columbia, Int Collaborat Repair Discoveries, Vancouver, BC V5Z 1M9, Canada; [Gaudet, Andrew D.; Ramer, Leanne M.; Cragg, Jacquelyn J.; Ramer, Matt S.] Univ British Columbia, Vancouver Coastal Hlth Res Inst, Vancouver, BC V5Z 1M9, Canada; [Nakonechny, Joanne] Univ British Columbia, Sci Ctr Learning & Teaching Skylight, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute; University of British Columbia	Gaudet, AD (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.	adg@icord.org		Gaudet, Andrew/0000-0001-8828-1553	National Sciences Engineering and Research Council of Canada; Michael Smith Foundation; Heart and Stroke Foundation of Canada; Skylight	National Sciences Engineering and Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation(Michael Smith Foundation for Health Research); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Skylight	This work would not have been possible without funding from National Sciences Engineering and Research Council of Canada (MSR, ADG, LMR), Michael Smith Foundation for Health Research/Rick Hansen Man in Motion Fund (MSR, LMR, ADG), Heart and Stroke Foundation of Canada (LMR), and Skylight (MSR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bransford J. D., 2004, PEOPLE LEARN BRAIN M; Carini RM, 2006, RES HIGH EDUC, V47, P1, DOI 10.1007/s11162-005-8150-9; COOPER MM, 1995, J CHEM EDUC, V72, P162, DOI 10.1021/ed072p162; Cortright RN, 2003, ADV PHYSIOL EDUC, V27, P102, DOI 10.1152/advan.00041.2002; DiCarlo SE, 2006, NAT REV MOL CELL BIO, V7, P290, DOI 10.1038/nrm1856; Druckman D., 1994, LEARNING REMEMBERING; Feichtner S. B., 1984, ORG BEHAV TEACHING R, V9, P58, DOI DOI 10.1177/105256298400900409; Giuliodori MJ, 2006, ADV PHYSIOL EDUC, V30, P168, DOI 10.1152/advan.00013.2006; Giuliodori MJ, 2008, ADV PHYSIOL EDUC, V32, P274, DOI 10.1152/advan.00101.2007; Giuliodori MJ, 2009, ADV PHYSIOL EDUC, V33, P24, DOI 10.1152/advan.90161.2008; Gokhale A.A., 1995, J TECHNOLOGY ED, V7, P22, DOI DOI 10.21061/JTE.V7I1.A.2; HELLER P, 1992, AM J PHYS, V60, P627, DOI 10.1119/1.17117; Johnson D. W., 1998, ACTIVE LEARNING COOP; JOHNSON DW, 1981, PSYCHOL BULL, V89, P47, DOI 10.1037/0033-2909.89.1.47; Kouros C, 2006, DO STUDENTS REALLY F; Lord T, 1998, AM BIOL TEACH, V60, P580, DOI 10.2307/4450554; Michael J, 2006, ADV PHYSIOL EDUC, V30, P159, DOI 10.1152/advan.00053.2006; Michaelsen L.K., 2002, GETTING STARTED TEAM; National Research Council Committee on Undergraduate Biology Education to Prepare Research Scientists for the 21st Century, 2003, TRANSF UND ED FUT RE; Rao SP, 2000, ADV PHYSIOL EDUC, V24, P51, DOI 10.1152/advances.2000.24.1.51; Rao SP, 2001, ADV PHYSIOL EDUC, V25, P55, DOI 10.1152/advances.2001.25.2.55; Rutherford F. J., 1991, SCI ALL AM; Slavin RE, 1996, CONTEMP EDUC PSYCHOL, V21, P43, DOI 10.1006/ceps.1996.0004; Smith KA, 2005, J ENG EDUC, V94, P87, DOI 10.1002/j.2168-9830.2005.tb00831.x; Smith MK, 2009, SCIENCE, V323, P122, DOI 10.1126/science.1165919; Springer L, 1999, REV EDUC RES, V69, P21, DOI 10.3102/00346543069001021; Tanner Kimberly, 2003, Cell Biol Educ, V2, P1, DOI 10.1187/cbe.03-03-0010; Volkmann M. J., 2010, SCH SCI MATH, V99, DOI 10.1111/j.1949-8594.1999.tb17462.x.; Wood WB, 2009, SCIENCE, V325, P1627, DOI 10.1126/science.1180821	29	38	38	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15821	10.1371/journal.pone.0015821	http://dx.doi.org/10.1371/journal.pone.0015821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	701CZ	21209910	Green Published, Green Submitted, gold			2022-12-27	WOS:000285793200058
J	Latasa, MU; Gil-Puig, C; Fernandez-Barrena, MG; Rodriguez-Ortigosa, CM; Banales, JM; Urtasun, R; Goni, S; Mendez, M; Arcelus, S; Juanarena, N; Recio, JA; Lotersztajn, S; Prieto, J; Berasain, C; Corrales, FJ; Lecanda, J; Avila, MA				Latasa, M. Ujue; Gil-Puig, Carmen; Fernandez-Barrena, Maite G.; Rodriguez-Ortigosa, Carlos M.; Banales, Jesus M.; Urtasun, Raquel; Goni, Saioa; Mendez, Miriam; Arcelus, Sara; Juanarena, Nerea; Recio, Juan A.; Lotersztajn, Sophie; Prieto, Jesus; Berasain, Carmen; Corrales, Fernando J.; Lecanda, Jon; Avila, Matias A.			Oral Methylthioadenosine Administration Attenuates Fibrosis and Chronic Liver Disease Progression in Mdr2-/- Mice	PLOS ONE			English	Article							N-TERMINAL KINASE; MONOCYTE CHEMOTACTIC PROTEIN-1; HEPATIC STELLATE CELLS; FACTOR-KAPPA-B; S-ADENOSYLMETHIONINE; ADENOSINE RECEPTOR; RAT HEPATOCYTES; MOLECULAR-MECHANISMS; BILIARY FIBROSIS; GENE-EXPRESSION	Background: Inflammation and fibrogenesis are directly related to chronic liver disease progression, including hepatocellular carcinoma (HCC) development. Currently there are few therapeutic options available to inhibit liver fibrosis. We have evaluated the hepatoprotective and anti-fibrotic potential of orally-administered 59-methylthioadenosine (MTA) in Mdr2(-/-) mice, a clinically relevant model of sclerosing cholangitis and spontaneous biliary fibrosis, followed at later stages by HCC development. Methodology: MTA was administered daily by gavage to wild type and Mdr2(-/-) mice for three weeks. MTA anti-inflammatory and anti-fibrotic effects and potential mechanisms of action were examined in the liver of Mdr2(-/-) mice with ongoing fibrogenesis and in cultured liver fibrogenic cells (myofibroblasts). Principal Findings: MTA treatment reduced hepatomegaly and liver injury. alpha-Smooth muscle actin immunoreactivity and collagen deposition were also significantly decreased. Inflammatory infiltrate, the expression of the cytokines IL6 and Mcp-1, pro-fibrogenic factors like TGF beta 2 and tenascin-C, as well as pro-fibrogenic intracellular signalling pathways were reduced by MTA in vivo. MTA inhibited the activation and proliferation of isolated myofibroblasts and down-regulated cyclin D1 gene expression at the transcriptional level. The expression of JunD, a key transcription factor in liver fibrogenesis, was also reduced by MTA in activated myofibroblasts. Conclusions/Significance: Oral MTA administration was well tolerated and proved its efficacy in reducing liver inflammation and fibrosis. MTA may have multiple molecular and cellular targets. These include the inhibition of inflammatory and profibrogenic cytokines, as well as the attenuation of myofibroblast activation and proliferation. Downregulation of JunD and cyclin D1 expression in myofibroblasts may be important regarding the mechanism of action of MTA. This compound could be a good candidate to be tested for the treatment of (biliary) liver fibrosis.	[Latasa, M. Ujue; Gil-Puig, Carmen; Fernandez-Barrena, Maite G.; Rodriguez-Ortigosa, Carlos M.; Banales, Jesus M.; Urtasun, Raquel; Goni, Saioa; Mendez, Miriam; Juanarena, Nerea; Prieto, Jesus; Berasain, Carmen; Corrales, Fernando J.; Lecanda, Jon; Avila, Matias A.] Univ Navarra, Div Hepatol & Gene Therapy, CIMA, E-31080 Pamplona, Spain; [Gil-Puig, Carmen; Lecanda, Jon] Digna Biotech, Madrid, Spain; [Fernandez-Barrena, Maite G.; Rodriguez-Ortigosa, Carlos M.; Banales, Jesus M.; Arcelus, Sara; Prieto, Jesus] Univ Navarra, CIBERehd, Univ Clin, E-31080 Pamplona, Spain; [Recio, Juan A.] Inst Oncol & Hosp, Vall Hebron Res Inst, Barcelona, Spain; [Lotersztajn, Sophie] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France; [Lotersztajn, Sophie] Univ Paris Est, Fac Med, UMR S955, Creteil, France	University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Navarra; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Latasa, MU (corresponding author), Univ Navarra, Div Hepatol & Gene Therapy, CIMA, E-31080 Pamplona, Spain.	maavila@unav.es	Berasain, Carmen/E-4139-2016; Avila, Matias A/Y-6342-2019; Rodriguez-Ortigosa, Carlos/K-9895-2014; Gil, Carmen/K-3759-2017; Fernandez-Barrena, Maite G/J-8040-2014; URTASUN, RAQUEL/AAD-1590-2021; Banales, Jesus M/R-9739-2019; Lotersztajn, Sophie/K-9160-2017; Goñi Irigoyen, Saioa/M-6330-2015; Latasa, Maria Ujue/Z-2178-2019	Berasain, Carmen/0000-0001-7075-2476; Avila, Matias A/0000-0001-6570-3557; Rodriguez-Ortigosa, Carlos/0000-0002-4931-4719; Gil, Carmen/0000-0002-8867-4442; Fernandez-Barrena, Maite G/0000-0003-0375-6236; Goñi Irigoyen, Saioa/0000-0002-2368-7373; Latasa, Maria Ujue/0000-0002-0878-1337; Banales, Jesus/0000-0002-5224-2373; URTASUN, RAQUEL/0000-0003-2332-5361; Corrales, Fernando/0000-0002-0231-5159; lotersztajn, Sophie/0000-0002-0053-7807; Recio, Juan Angel/0000-0002-7320-3832; Prieto, Jesus/0000-0002-1091-9593	FIMA; UTE project CIMA; CiberEhd [FIS-PI070392, PI070402]; Instituto de Salud Carlos III Fellowship; Ramon y Cajal Program; Torres Quevedo Program; INSERM; Universite Paris-Est; Agence Nationale de la Recherche; Fondation pour la Recherche Medicale;  [RTICC-RD06 00200061];  [SAF2008-01540]	FIMA; UTE project CIMA; CiberEhd; Instituto de Salud Carlos III Fellowship; Ramon y Cajal Program(Spanish Government); Torres Quevedo Program; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris-Est; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); ; 	This work was supported by the agreement between FIMA and the "UTE project CIMA"; RTICC-RD06 00200061 (CB, FJC, MAA), CiberEhd (MGF-B, JB, CRO, JP), FIS-PI070392 and PI070402 (CB, MAA); SAF2008-01540 (FJC); Instituto de Salud Carlos III Fellowship (SG); Ramon y Cajal Program (MUL) and Torres Quevedo Program (CG-P, RU); INSERM, Universite Paris-Est, the Agence Nationale de la Recherche and the Fondation pour la Recherche Medicale (SL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHERNE CM, 2010, BIOCHIM BIOPHYS 0527; Andreu-Perez P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-265; Ansorena E, 2002, HEPATOLOGY, V35, P274, DOI 10.1053/jhep.2002.30419; Ansorena E, 2006, AM J PHYSIOL-GASTR L, V290, pG1186, DOI 10.1152/ajpgi.00282.2005; Avila MA, 2004, INT J BIOCHEM CELL B, V36, P2125, DOI 10.1016/j.biocel.2003.11.016; Baghdasaryan A, 2010, GUT, V59, P521, DOI 10.1136/gut.2009.186528; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Berasain C, 2004, BBA-MOL BASIS DIS, V1690, P276, DOI 10.1016/j.bbadis.2004.08.002; Berasain C, 2009, ANN NY ACAD SCI, V1155, P206, DOI 10.1111/j.1749-6632.2009.03704.x; Chen H, 2007, GASTROENTEROLOGY, V133, P207, DOI 10.1053/j.gastro.2007.03.114; Csoka B, 2010, J IMMUNOL, V185, P542, DOI 10.4049/jimmunol.0901295; Dranoff JA, 2010, HEPATOLOGY, V51, P1438, DOI 10.1002/hep.23405; El-Karef A, 2007, J PATHOL, V211, P86, DOI 10.1002/path.2099; El-Karef A, 2007, J HEPATOL, V46, P664, DOI 10.1016/j.jhep.2006.10.011; Elsharkawy AM, 2007, HEPATOLOGY, V46, P590, DOI 10.1002/hep.21802; Eto I, 2000, CELL PROLIFERAT, V33, P167, DOI 10.1046/j.1365-2184.2000.00176.x; Fickert P, 2004, GASTROENTEROLOGY, V127, P261, DOI 10.1053/j.gastro.2004.04.009; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gabele E, 2005, J BIOL CHEM, V280, P13374, DOI 10.1074/jbc.M409444200; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Gunawan BK, 2006, GASTROENTEROLOGY, V131, P165, DOI 10.1053/j.gastro.2006.03.045; Hasko G, 2009, TRENDS IMMUNOL, V30, P263, DOI 10.1016/j.it.2009.04.001; Hevia H, 2004, HEPATOLOGY, V39, P1088, DOI 10.1002/hep.20154; IGLESIAS AA, 2008, HEPATOLOGY, V47, P1655; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Ju MJ, 2009, AM J CLIN PATHOL, V131, P498, DOI 10.1309/AJCP86PPBNGOHNNL; Katzenellenbogen M, 2006, CANCER RES, V66, P4001, DOI 10.1158/0008-5472.CAN-05-2937; Katzenellenbogen M, 2007, MOL CANCER RES, V5, P1159, DOI 10.1158/1541-7786.MCR-07-0172; Kawada N, 1999, J HEPATOL, V30, P1057, DOI 10.1016/S0168-8278(99)80260-8; Kluwe J, 2010, GASTROENTEROLOGY, V138, P347, DOI 10.1053/j.gastro.2009.09.015; Kreckler LM, 2006, J PHARMACOL EXP THER, V317, P172, DOI 10.1124/jpet.105.096016; Kruglov EA, 2006, AM J PHYSIOL-GASTR L, V290, pG765, DOI 10.1152/ajpgi.00308.2005; Li LY, 2003, GASTROENTEROLOGY, V125, P460, DOI 10.1016/S0016-5085(03)00906-5; Lotersztajn S, 2005, ANNU REV PHARMACOL, V45, P605, DOI 10.1146/annurev.pharmtox.45.120403.095906; Mann J, 2010, GASTROENTEROLOGY, V138, P705, DOI 10.1053/j.gastro.2009.10.002; Mann J, 2009, ADV DRUG DELIVER REV, V61, P497, DOI 10.1016/j.addr.2009.03.011; Marderstein EL, 2003, SURGERY, V134, P280, DOI 10.1067/msy.2003.237; MARRA F, 1993, J CLIN INVEST, V92, P1674, DOI 10.1172/JCI116753; Marra F, 1998, AM J PATHOL, V152, P423; Mato JM, 2008, ANNU REV NUTR, V28, P273, DOI 10.1146/annurev.nutr.28.061807.155438; MORATTI E, 1998, Patent No. 5753213; Moreno B, 2006, ANN NEUROL, V60, P323, DOI 10.1002/ana.20895; MUNSHI R, 1988, BIOCHEM PHARMACOL, V37, P2085, DOI 10.1016/0006-2952(88)90560-6; Nakken KE, 2007, SCAND J GASTROENTERO, V42, P1245, DOI 10.1080/00365520701320521; Nemeth ZH, 2005, J IMMUNOL, V175, P8260, DOI 10.4049/jimmunol.175.12.8260; Nemeth ZH, 2003, J PHARMACOL EXP THER, V306, P1042, DOI 10.1124/jpet.103.052944; Nieto N, 2005, J BIOL CHEM, V280, P30963, DOI 10.1074/jbc.M503569200; Pascale RM, 2002, ALCOHOL, V27, P193, DOI 10.1016/S0741-8329(02)00227-6; Patsenker E, 2008, GASTROENTEROLOGY, V135, P660, DOI 10.1053/j.gastro.2008.04.009; Perugorria MJ, 2008, HEPATOLOGY, V48, P1251, DOI 10.1002/hep.22437; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Pinzani M, 2005, J HEPATOL, V42, pS22, DOI 10.1016/j.jhep.2004.12.008; Popov Y, 2005, J HEPATOL, V43, P1045, DOI 10.1016/j.jhep.2005.06.025; Popov Y, 2009, HEPATOLOGY, V50, P1294, DOI 10.1002/hep.23123; Ryzhov S, 2008, J PHARMACOL EXP THER, V324, P694, DOI 10.1124/jpet.107.131540; Schuppan D, 2009, GASTROEN CLIN BIOL, V33, P949, DOI 10.1016/j.gcb.2009.07.021; Siegel AB, 2009, CANCER-AM CANCER SOC, V115, P5651, DOI 10.1002/cncr.24687; Simile MM, 2001, J HEPATOL, V34, P386, DOI 10.1016/S0168-8278(00)00078-7; Sitkovsky MV, 2003, BIOCHEM PHARMACOL, V65, P493, DOI 10.1016/S0006-2952(02)01548-4; Smart DE, 2006, HEPATOLOGY, V44, P1432, DOI 10.1002/hep.21436; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Spirli C, 2003, GASTROENTEROLOGY, V124, P737, DOI 10.1053/gast.2003.50100; Stramentinoli G, 1984, Patent No. [4454122, US4454122A]; Tao JC, 1999, J BIOL CHEM, V274, P23761, DOI 10.1074/jbc.274.34.23761; Uehara T, 2005, J HEPATOL, V42, P850, DOI 10.1016/j.jhep.2005.01.030; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yang HP, 2009, HEPATOLOGY, V49, P1982, DOI 10.1002/hep.22908; Zamara E, 2007, J HEPATOL, V46, P230, DOI 10.1016/j.jhep.2006.09.007	69	21	22	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15690	10.1371/journal.pone.0015690	http://dx.doi.org/10.1371/journal.pone.0015690			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209952	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793200038
J	Shen, L; Spector, DJ				Shen, Li; Spector, David J.			Read-through Activation of Transcription in a Cellular Genomic Context	PLOS ONE			English	Article							RIBOSOMAL-RNA TRANSCRIPTION; MEDIATED GENE-TRANSFER; ADENOVIRUS TYPE-5; DNA TRANSFER; DROSOPHILA-MELANOGASTER; READTHROUGH ACTIVATION; LYMPHOID-CELLS; E1B GENE; EXPRESSION; REGION	Read-through transcription from the adjacent E1a gene region is required for wild-type wt) activity of the downstream adenovirus E1b promoter early after infection read-through activation). However, whether a cellular chromosomal template can support read-through activation is not known. To address this issue, read-through activation was evaluated in the context of stably expressed templates in transfected cells. Inhibition of read-through transcription by insertion of a transcription termination sequence between the E1a and E1b promoters reduced downstream gene expression from stably integrated templates. The results indicate that the mechanism of read-through activation does not depend on the structure of early adenovirus nucleoprotein complexes, a structure that is likely to be different from that of cellular chromatin. Accordingly, this regulatory interaction could participate in the coordinated control of the expression of closely linked cellular genes.	[Shen, Li; Spector, David J.] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Intercoll Grad Degree Program Genet, Hershey, PA USA; [Spector, David J.] Penn State Univ, Coll Med, Program Cell & Mol Biol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Shen, L (corresponding author), Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA.	dspector@psu.edu			National Institute of General Medical Sciences [GM058214]; Public Health Service; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058214] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The initial stages of this work were funded by Public Health Service grant GM058214 from the National Institute of General Medical Sciences. There is no current external funding source for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarrategui I, 2007, EMBO J, V26, P4380, DOI 10.1038/sj.emboj.7601866; ARTELT P, 1991, GENE, V99, P249, DOI 10.1016/0378-1119(91)90134-W; BABISS LE, 1984, J VIROL, V52, P389, DOI 10.1128/JVI.52.2.389-395.1984; BATEMAN E, 1988, CELL, V54, P985, DOI 10.1016/0092-8674(88)90113-4; CASSIDY BG, 1987, MOL CELL BIOL, V7, P2388, DOI 10.1128/MCB.7.7.2388; Cook WJ, 1996, VIROLOGY, V218, P193, DOI 10.1006/viro.1996.0179; CORBIN V, 1989, NATURE, V337, P279, DOI 10.1038/337279a0; Emery DW, 2000, P NATL ACAD SCI USA, V97, P9150, DOI 10.1073/pnas.160159597; Esperet C, 2000, J BIOL CHEM, V275, P25831, DOI 10.1074/jbc.M001757200; FALCKPEDERSEN E, 1985, CELL, V40, P897, DOI 10.1016/0092-8674(85)90349-6; FEDOROFF NV, 1979, CELL, V16, P697, DOI 10.1016/0092-8674(79)90086-2; GRIMALDI G, 1990, MOL CELL BIOL, V10, P4667, DOI 10.1128/MCB.10.9.4667; Han YF, 2008, CELL HOST MICROBE, V4, P134, DOI 10.1016/j.chom.2008.06.008; JASTREBOFF MM, 1987, EXP CELL RES, V171, P513, DOI 10.1016/0014-4827(87)90184-4; Kong SM, 1997, MOL CELL BIOL, V17, P3955, DOI 10.1128/MCB.17.7.3955; Maxfield LF, 1997, J VIROL, V71, P8321, DOI 10.1128/JVI.71.11.8321-8329.1997; MONTELL C, 1983, NATURE, V305, P600, DOI 10.1038/305600a0; MOSS T, 1983, NATURE, V302, P223, DOI 10.1038/302223a0; ORKIN SH, 1990, CELL, V63, P665, DOI 10.1016/0092-8674(90)90133-Y; PAALMAN MH, 1995, MOL CELL BIOL, V15, P4648; PARKS CL, 1988, J VIROL, V62, P54, DOI 10.1128/JVI.62.1.54-67.1988; PARKS CL, 1990, J VIROL, V64, P2780, DOI 10.1128/JVI.64.6.2780-2787.1990; POTTER H, 1984, P NATL ACAD SCI-BIOL, V81, P7161, DOI 10.1073/pnas.81.22.7161; Shen L, 2003, J VIROL, V77, P9266, DOI 10.1128/JVI.77.17.9266-9277.2003; SPECTOR DJ, 1993, VIROLOGY, V194, P128, DOI 10.1006/viro.1993.1242; SPECTOR DJ, 1983, VIROLOGY, V130, P533, DOI 10.1016/0042-6822(83)90107-1; Steinwaerder DS, 2000, GENE THER, V7, P556, DOI 10.1038/sj.gt.3301139; SUSSENBACH JS, 1984, ADENOVIRUSES, P35; THOMAS GP, 1980, CELL, V22, P523; TONEGUZZO F, 1986, P NATL ACAD SCI USA, V83, P3496, DOI 10.1073/pnas.83.10.3496; TONEGUZZO F, 1986, MOL CELL BIOL, V6, P703, DOI 10.1128/MCB.6.2.703; TONEGUZZO F, 1988, NUCLEIC ACIDS RES, V16, P5515, DOI 10.1093/nar/16.12.5515; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; WHYTE P, 1988, J VIROL, V62, P257, DOI 10.1128/JVI.62.1.257-265.1988; WILSON MC, 1981, J MOL BIOL, V148, P231, DOI 10.1016/0022-2836(81)90537-4	35	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15704	10.1371/journal.pone.0015704	http://dx.doi.org/10.1371/journal.pone.0015704			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21209942	Green Published, Green Submitted, gold			2022-12-27	WOS:000285792500037
J	Lai, JF; Zindl, CL; Duffy, LB; Atkinson, TP; Jung, YW; van Rooijen, N; Waites, KB; Krause, DC; Chaplin, DD				Lai, Jen-Feng; Zindl, Carlene L.; Duffy, Lynn B.; Atkinson, T. Prescott; Jung, Yong Woo; van Rooijen, Nico; Waites, Ken B.; Krause, Duncan C.; Chaplin, David D.			Critical Role of Macrophages and Their Activation via MyD88-NF kappa B Signaling in Lung Innate Immunity to Mycoplasma pneumoniae	PLOS ONE			English	Article							NF-KAPPA-B; TOLL-LIKE-RECEPTORS; RESPIRATORY MYCOPLASMOSIS; PULMONARY INFLAMMATION; ALVEOLAR MACROPHAGES; POTENT INHIBITORS; BRONCHIAL-ASTHMA; STRUCTURAL CLASS; DENDRITIC CELLS; MICE	Mycoplasma pneumoniae (Mp), a common cause of pneumonia, is associated with asthma; however, the mechanisms underlying this association remain unclear. We investigated the cellular immune response to Mp in mice. Intranasal inoculation with Mp elicited infiltration of the lungs with neutrophils, monocytes and macrophages. Systemic depletion of macrophages, but not neutrophils, resulted in impaired clearance of Mp from the lungs. Accumulation and activation of macrophages were decreased in the lungs of MyD88(-/-) mice and clearance of Mp was impaired, indicating that MyD88 is a key signaling protein in the anti-Mp response. MyD88-dependent signaling was also required for the Mp-induced activation of NFkB, which was essential for macrophages to eliminate the microbe in vitro. Thus, MyD88-NF kappa B signaling in macrophages is essential for clearance of Mp from the lungs.	[Lai, Jen-Feng; Zindl, Carlene L.; Chaplin, David D.] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; [Zindl, Carlene L.; Duffy, Lynn B.; Jung, Yong Woo; Waites, Ken B.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Atkinson, T. Prescott] Univ Alabama, Dept Pediat, Birmingham, AL USA; [van Rooijen, Nico] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol, Amsterdam, Netherlands; [Krause, Duncan C.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Vrije Universiteit Amsterdam; University System of Georgia; University of Georgia	Lai, JF (corresponding author), Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA.	dchaplin@uab.edu	Van Rooijen, Nico/Z-1578-2019	Zindl, Carlene/0000-0003-4841-3552; Chaplin, David/0000-0002-1354-3069	National Institutes of Health [5P01HL073907, 5R21AI083873, 5R01AI23362]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007051, R01AI023362, R21AI083873] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Portions of this research were supported by National Institutes of Health grants 5P01HL073907 (DDC), 5R21AI083873 (TPA and KBW) and 5R01AI23362 (DCK). The NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; BASEMAN JB, 1982, J BACTERIOL, V151, P1514, DOI 10.1128/JB.151.3.1514-1522.1982; Biscardi S, 2004, CLIN INFECT DIS, V38, P1341, DOI 10.1086/392498; CARTNER SC, 1995, INFECT IMMUN, V63, P4138, DOI 10.1128/IAI.63.10.4138-4142.1995; Chu HW, 2005, J IMMUNOL, V174, P5713, DOI 10.4049/jimmunol.174.9.5713; Chu HW, 2004, J INFECT DIS, V189, P1119, DOI 10.1086/382050; Circolo A, 1999, IMMUNOPHARMACOLOGY, V42, P135, DOI 10.1016/S0162-3109(99)00021-1; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; Craig A, 2009, INFECT IMMUN, V77, P568, DOI 10.1128/IAI.00832-08; Dallo SF, 1996, INFECT IMMUN, V64, P2595, DOI 10.1128/IAI.64.7.2595-2601.1996; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Fayon M, 1999, ACTA PAEDIATR, V88, P1216, DOI 10.1080/080352599750030310; Fonseca-Aten M, 2005, AM J RESP CELL MOL, V32, P201, DOI 10.1165/rcmb.2004-0197OC; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; GALLOWAY CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3334, DOI 10.1073/pnas.80.11.3334; GIL JC, 1993, ANN ALLERGY, V70, P23; Gonzalez-Juarrero M, 2003, J IMMUNOL, V171, P3128, DOI 10.4049/jimmunol.171.6.3128; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; Hasselbring BM, 2006, P NATL ACAD SCI USA, V103, P16478, DOI 10.1073/pnas.0608051103; Hickman-Davis J, 1999, P NATL ACAD SCI USA, V96, P4953, DOI 10.1073/pnas.96.9.4953; Hickman-Davis JM, 2007, AM J RESP CELL MOL, V36, P103, DOI 10.1165/rcmb.2006-0049OC; HickmanDavis JM, 1997, INFECT IMMUN, V65, P2278, DOI 10.1128/IAI.65.6.2278-2282.1997; Hofmann AM, 2009, CURR OPIN IMMUNOL, V21, P679, DOI 10.1016/j.coi.2009.09.007; Jung YW, 2009, EUR J IMMUNOL, V39, P2281, DOI 10.1002/eji.200838985; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Katz B, 2004, CLIN LAB MED, V24, P627, DOI 10.1016/j.cll.2004.05.005; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kormann MSD, 2008, J ALLERGY CLIN IMMUN, V122, P86, DOI 10.1016/j.jaci.2008.04.039; Kraft M, 1998, AM J RESP CRIT CARE, V158, P998, DOI 10.1164/ajrccm.158.3.9711092; Kraft M, 2002, CHEST, V121, P1782, DOI 10.1378/chest.121.6.1782; KRAUSE DC, 1982, INFECT IMMUN, V35, P809, DOI 10.1128/IAI.35.3.809-817.1982; Kuroda E, 2002, J IMMUNOL, V168, P5477, DOI 10.4049/jimmunol.168.11.5477; Lagasse E, 1996, J IMMUNOL METHODS, V197, P139, DOI 10.1016/0022-1759(96)00138-X; Marriott HM, 2007, EXP LUNG RES, V33, P493, DOI 10.1080/01902140701756562; Martin RJ, 2006, CLIN CHEST MED, V27, P87, DOI 10.1016/j.ccm.2005.10.004; Martin RJ, 2001, J ALLERGY CLIN IMMUN, V107, P595, DOI 10.1067/mai.2001.113563; McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; O'Dea KP, 2009, J IMMUNOL, V182, P1155, DOI 10.4049/jimmunol.182.2.1155; O'Dea KP, 2005, AM J RESP CRIT CARE, V172, P1119, DOI 10.1164/rccm.200504-605OC; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; Romero-Arroyo CE, 1999, J BACTERIOL, V181, P1079, DOI 10.1128/JB.181.4.1079-1087.1999; Salvatore CM, 2007, INFECT IMMUN, V75, P236, DOI 10.1128/IAI.01249-06; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; SEGGEV JS, 1986, ANN ALLERGY, V57, P263; Shimizu T, 2008, INFECT IMMUN, V76, P270, DOI 10.1128/IAI.00955-07; SIMBERKOFF MS, 1971, J EXP MED, V134, P1417, DOI 10.1084/jem.134.6.1417; Sleiman PMA, 2010, CURR OPIN PEDIATR, V22, P307, DOI 10.1097/MOP.0b013e328339553d; Strowig T, 2008, J IMMUNOL, V180, P7785, DOI 10.4049/jimmunol.180.12.7785; Sutherland ER, 2007, CHEST, V132, P1962, DOI 10.1378/chest.06-2415; Sutherland ER, 2010, J ALLERGY CLIN IMMUN, V126, P747, DOI 10.1016/j.jaci.2010.07.024; Tang T, 1997, J EXP MED, V186, P1853, DOI 10.1084/jem.186.11.1853; Tobe M, 2003, BIOORGAN MED CHEM, V11, P3869, DOI 10.1016/S0968-0896(03)00438-3; Tobe M, 2003, BIOORGAN MED CHEM, V11, P383, DOI 10.1016/S0968-0896(02)00440-6; Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657; VANKUPPEVELD FJM, 1992, APPL ENVIRON MICROB, V58, P2606, DOI 10.1128/AEM.58.8.2606-2615.1992; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Waldo RH, 2006, J BACTERIOL, V188, P569, DOI 10.1128/JB.188.2.569-575.2006; WIKTORJEDRZEJCZAK W, 1982, J EXP MED, V156, P1516, DOI 10.1084/jem.156.5.1516; WILLIAMSON J, 1992, EPIDEMIOL INFECT, V109, P519, DOI 10.1017/S0950268800050512; Wubbel L, 1998, J INFECT DIS, V178, P1526, DOI 10.1086/314439; Xu X, 2006, AM J RESP CRIT CARE, V173, P219, DOI 10.1164/rccm.200507-1034OC; Yanagisawa S, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-50	67	51	61	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e14417	10.1371/journal.pone.0014417	http://dx.doi.org/10.1371/journal.pone.0014417			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203444	Green Published, Green Submitted, gold			2022-12-27	WOS:000285579200004
J	Proulx, MJ				Proulx, Michael J.			Size Matters: Large Objects Capture Attention in Visual Search	PLOS ONE			English	Article							INTERFERENCE; LUMINANCE; GUIDANCE; SALIENCE; FEATURES; CONTRAST	Can objects or events ever capture one's attention in a purely stimulus-driven manner? A recent review of the literature set out the criteria required to find stimulus-driven attentional capture independent of goal-directed influences, and concluded that no published study has satisfied that criteria. Here visual search experiments assessed whether an irrelevantly large object can capture attention. Capture of attention by this static visual feature was found. The results suggest that a large object can indeed capture attention in a stimulus-driven manner and independent of displaywide features of the task that might encourage a goal-directed bias for large items. It is concluded that these results are either consistent with the stimulus-driven criteria published previously or alternatively consistent with a flexible, goal-directed mechanism of saliency detection.	Queen Mary Univ London, Sch Biol & Chem Sci, Biol & Expt Psychol Grp, London, England	University of London; Queen Mary University London	Proulx, MJ (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Biol & Expt Psychol Grp, London, England.	m.proulx@qmul.ac.uk	Proulx, Michael J/A-1045-2008	Proulx, Michael/0000-0003-4066-3645				BACON WF, 1994, PERCEPT PSYCHOPHYS, V55, P485, DOI 10.3758/BF03205306; Burnham BP, 2007, PSYCHON B REV, V14, P392, DOI 10.3758/BF03194082; Chan LKH, 2009, J EXP PSYCHOL HUMAN, V35, P119, DOI 10.1037/0096-1523.35.1.119; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; Gibson BS, 1998, J EXP PSYCHOL HUMAN, V24, P699, DOI 10.1037/0096-1523.24.3.699; Hubner R, 2001, PERCEPT PSYCHOPHYS, V63, P258, DOI 10.3758/BF03194467; Kumada T, 1999, PERCEPT PSYCHOPHYS, V61, P61, DOI 10.3758/BF03211949; Lamy D, 1999, PSYCHON B REV, V6, P93, DOI 10.3758/BF03210814; Leber AB, 2006, PSYCHON B REV, V13, P132, DOI 10.3758/BF03193824; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Proulx MJ, 2008, PSYCHOL RES-PSYCH FO, V72, P106, DOI 10.1007/s00426-006-0077-z; Proulx MJ, 2007, J NEUROSCI, V27, P13043, DOI 10.1523/JNEUROSCI.4378-07.2007; Proulx MJ, 2007, J EXP PSYCHOL HUMAN, V33, P48, DOI 10.1037/0096-1523.33.1.48; Rauschenberger R, 2003, PSYCHON B REV, V10, P814, DOI 10.3758/BF03196545; THEEUWES J, 1991, PERCEPT PSYCHOPHYS, V50, P184, DOI 10.3758/BF03212219; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Yantis S, 1999, J EXP PSYCHOL HUMAN, V25, P661, DOI 10.1037/0096-1523.25.3.661; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601; Zehetleitner M, 2009, ATTEN PERCEPT PSYCHO, V71, P1760, DOI 10.3758/APP.71.8.1760	20	39	39	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15293	10.1371/journal.pone.0015293	http://dx.doi.org/10.1371/journal.pone.0015293			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	698FO	21203454	gold, Green Published, Green Submitted			2022-12-27	WOS:000285579200015
J	Johnson, TJ; Thorsness, JL; Anderson, CP; Lynne, AM; Foley, SL; Han, J; Fricke, WF; McDermott, PF; White, DG; Khatri, M; Stell, AL; Flores, C; Singer, RS				Johnson, Timothy J.; Thorsness, Jessica L.; Anderson, Cole P.; Lynne, Aaron M.; Foley, Steven L.; Han, Jing; Fricke, W. Florian; McDermott, Patrick F.; White, David G.; Khatri, Mahesh; Stell, Adam L.; Flores, Cristian; Singer, Randall S.			Horizontal Gene Transfer of a ColV Plasmid Has Resulted in a Dominant Avian Clonal Type of Salmonella enterica Serovar Kentucky	PLOS ONE			English	Article							PATHOGENIC ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; DNA-SEQUENCE; VIRULENCE; PREVALENCE; CHICKENS; STRAINS; COLONIZATION; ASSOCIATION; MENINGITIS	Salmonella enterica continues to be a significant cause of foodborne gastrointestinal illness in humans. A wide variety of Salmonella serovars have been isolated from production birds and from retail poultry meat. Recently, though, S. enterica subsp. enterica serovar Kentucky has emerged as one of the prominent Salmonella serovars isolated from broiler chickens. Recent work suggests that its emergence apparently coincides with its acquisition of a ColV virulence plasmid. In the present study, we examined 902 Salmonella isolates belonging to 59 different serovars for the presence of this plasmid. Of the serovars examined, the ColV plasmid was found only among isolates belonging to the serovars Kentucky (72.9%), Typhimurium (15.0%) and Heidelberg (1.7%). We demonstrated that a single PFGE clonal type of S. Kentucky harbors this plasmid, and acquisition of this plasmid by S. Kentucky significantly increased its ability to colonize the chicken cecum and cause extraintestinal disease. Comparison of the completed sequences of three ColV plasmids from S. Kentucky isolated from different geographical locales, timepoints and sources revealed a nearly identical genetic structure with few single nucleotide changes or insertions/deletions. Overall, it appears that the ColV plasmid was recently acquired by a single clonal type S. Kentucky and confers to its host enhanced colonization and fitness capabilities. Thus, the potential for horizontal gene transfer of virulence and fitness factors to Salmonella from other enteric bacteria exists in poultry, representing a potential human health hazard.	[Johnson, Timothy J.; Thorsness, Jessica L.; Khatri, Mahesh; Stell, Adam L.; Flores, Cristian; Singer, Randall S.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Anderson, Cole P.; Lynne, Aaron M.] Sam Houston State Univ, Dept Biol Sci, Huntsville, TX 77340 USA; [Foley, Steven L.; Han, Jing] US FDA, Natl Ctr Toxicol Res, Div Microbiol, Jefferson, AR 72079 USA; [Fricke, W. Florian] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [McDermott, Patrick F.; White, David G.] US FDA, Ctr Vet Med, Res Off, Div Anim & Food Microbiol, Laurel, MD USA	University of Minnesota System; University of Minnesota Twin Cities; Texas State University System; Sam Houston State University; US Food & Drug Administration (FDA); University System of Maryland; University of Maryland Baltimore; US Food & Drug Administration (FDA)	Johnson, TJ (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	joh04207@umn.edu	McDermott, Patrick F./ABE-4374-2021	McDermott, Patrick F./0000-0003-1868-8096; Foley, Steven/0000-0003-3146-4548; Stell, Adam/0000-0001-6810-316X; Fricke, W. Florian/0000-0003-1586-0962; Johnson, Timothy/0000-0001-7556-9347; Anderson, Cole/0000-0002-4366-6166	Minnesota Agricultural Experiment Station [MINV-063-054]; Food Safety Research and Response Network [2005-35212-15287]	Minnesota Agricultural Experiment Station; Food Safety Research and Response Network	This project was funded by the Minnesota Agricultural Experiment Station, grant MINV-063-054 and by the Food Safety Research and Response Network, which is supported by the National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service, grant number # 2005-35212-15287. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUERO ME, 1989, MED MICROBIOL IMMUN, V178, P211, DOI 10.1007/BF00202554; Berrang ME, 2009, J FOOD PROTECT, V72, P1610, DOI 10.4315/0362-028X-72.8.1610; BINNS MM, 1979, NATURE, V279, P778, DOI 10.1038/279778a0; Byrd JA, 1999, AVIAN DIS, V43, P39, DOI 10.2307/1592760; *CDC, 2008, SALM SURV ANN SUMM 2; *CDC, 2006, SALM SURV ANN SUMM 2; Collard JM, 2007, J ANTIMICROB CHEMOTH, V60, P190, DOI 10.1093/jac/dkm114; COOPER GE, 1986, J MED MICROBIOL, V22, P231, DOI 10.1099/00222615-22-3-231; Corder Gregory W, 2009, NONPARAMETRIC STAT N; Dieye Y, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-3; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Fricke WF, 2009, APPL ENVIRON MICROB, V75, P5963, DOI 10.1128/AEM.00786-09; Gutierrez M, 2009, FOODBORNE PATHOG DIS, V6, P111, DOI 10.1089/fpd.2008.0163; Joerger RD, 2009, FOODBORNE PATHOG DIS, V6, P503, DOI 10.1089/fpd.2008.0144; Johnson JR, 2002, J LAB CLIN MED, V139, P155, DOI 10.1067/mlc.2002.121550; Johnson TJ, 2008, APPL ENVIRON MICROB, V74, P7043, DOI 10.1128/AEM.01395-08; Johnson TJ, 2007, J BACTERIOL, V189, P3228, DOI 10.1128/JB.01726-06; Johnson TJ, 2006, J BACTERIOL, V188, P5975, DOI 10.1128/JB.00204-06; Johnson TJ, 2010, INFECT IMMUN, V78, P1931, DOI 10.1128/IAI.01174-09; Johnson TJ, 2008, J CLIN MICROBIOL, V46, P3987, DOI 10.1128/JCM.00816-08; Johnson TJ, 2006, J BACTERIOL, V188, P745, DOI 10.1128/JB.188.2.745-758.2006; JOHNSON TJ, 2009, VET MICROBIOL; Kariyawasam S, 2004, AVIAN DIS, V48, P287, DOI 10.1637/7093; LEONARD EK, 2010, EVALUATION PET RELAT; Lestari SI, 2009, J FOOD PROTECT, V72, P1165, DOI 10.4315/0362-028X-72.6.1165; Li X, 2007, POULTRY SCI, V86, P591, DOI 10.1093/ps/86.3.591; Lo-Ten-Foe JR, 2007, J HOSP INFECT, V67, P105, DOI 10.1016/j.jhin.2007.07.005; Majtan V, 2006, JPN J INFECT DIS, V59, P358; McCrea BA, 2006, J FOOD PROTECT, V69, P2908, DOI 10.4315/0362-028X-69.12.2908; Muhammad M, 2010, VET MICROBIOL, V140, P131, DOI 10.1016/j.vetmic.2009.07.009; *NARMS, 2008, 2006 VET IS FIN REP; *NARMS, 2008, 2006 NARMS ANN MEAT; Parveen S, 2007, J FOOD PROTECT, V70, P2466, DOI 10.4315/0362-028X-70.11.2466; Peighambari SM, 2002, AVIAN DIS, V46, P287, DOI 10.1637/0005-2086(2002)046[0287:SIAEOT]2.0.CO;2; Roy P, 2002, AVIAN DIS, V46, P17, DOI 10.1637/0005-2086(2002)046[0017:ROSIFP]2.0.CO;2; Santos FBO, 2007, J FOOD PROTECT, V70, P1328, DOI 10.4315/0362-028X-70.6.1328; Singer RS, 2009, J FOOD PROTECT, V72, P707, DOI 10.4315/0362-028X-72.4.707; Sivula CP, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-182; Skyberg JA, 2006, INFECT IMMUN, V74, P6287, DOI 10.1128/IAI.00363-06; Skyberg JA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-24; SMITH HW, 1976, J GEN MICROBIOL, V92, P335; SMITH HW, 1980, J GEN MICROBIOL, V121, P387; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; WATERS VL, 1991, MICROBIOL REV, V55, P437, DOI 10.1128/MMBR.55.3.437-450.1991; WOOLEY RE, 1994, AVIAN DIS, V38, P141, DOI 10.2307/1591847; Zhao S, 2006, FOODBORNE PATHOG DIS, V3, P106, DOI 10.1089/fpd.2006.3.106	46	79	80	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15524	10.1371/journal.pone.0015524	http://dx.doi.org/10.1371/journal.pone.0015524			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203520	Green Published, Green Submitted, gold			2022-12-27	WOS:000285578000033
J	Miller, TW; Isenberg, JS; Shih, HB; Wang, YC; Roberts, DD				Miller, Thomas W.; Isenberg, Jeff S.; Shih, Hubert B.; Wang, Yichen; Roberts, David D.			Amyloid-beta Inhibits No-cGMP Signaling in a CD36-and CD47-Dependent Manner	PLOS ONE			English	Article							SOLUBLE GUANYLATE-CYCLASE; ISCHEMIC TISSUE SURVIVAL; LONG-TERM POTENTIATION; NITRIC-OXIDE SYNTHASE; ALZHEIMERS-DISEASE; PLATELET-AGGREGATION; CELL RESPONSES; SMOOTH-MUSCLE; MICROGLIAL PHAGOCYTOSIS; PRECURSOR PROTEIN	Amyloid-beta interacts with two cell surface receptors, CD36 and CD47, through which the matricellular protein thrombospondin-1 inhibits soluble guanylate cyclase activation. Here we examine whether amyloid-beta shares this inhibitory activity. Amyloid-beta inhibited both drug and nitric oxide-mediated activation of soluble guanylate cyclase in several cell types. Known cGMP-dependent functional responses to nitric oxide in platelets and vascular smooth muscle cells were correspondingly inhibited by amyloid-beta. Functional interaction of amyloid-beta with the scavenger receptor CD36 was indicated by inhibition of free fatty acid uptake via this receptor. Both soluble oligomer and fibrillar forms of amyloid-beta were active. In contrast, amyloid-beta did not compete with the known ligand SIRP alpha for binding to CD47. However, both receptors were necessary for amyloid-beta to inhibit cGMP accumulation. These data suggest that amyloid-beta interaction with CD36 induces a CD47-dependent signal that inhibits soluble guanylate cyclase activation. Combined with the pleiotropic effects of inhibiting free fatty acid transport via CD36, these data provides a molecular mechanism through which amyloid-beta can contribute to the nitric oxide signaling deficiencies associated with Alzheimer's disease.	[Miller, Thomas W.; Isenberg, Jeff S.; Shih, Hubert B.; Wang, Yichen; Roberts, David D.] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Isenberg, Jeff S.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA USA; [Shih, Hubert B.] NIH, Howard Hughes Med Inst, Res Scholars Program, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA	Miller, TW (corresponding author), NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	droberts@helix.nih.gov	Roberts, David D./A-9699-2008; Miller, Thomas W/G-1215-2011	Roberts, David D./0000-0002-2481-2981; Miller, Thomas W/0000-0001-8645-2785	National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research [CA128616]; Howard Hughes Medical Institute-NIH; NATIONAL CANCER INSTITUTE [K22CA128616, ZIASC009174] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute-NIH(Howard Hughes Medical InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research (D. D. R.), NIH grant CA128616 (J.S.I.) and by the Howard Hughes Medical Institute-NIH Research Scholars Program (H. B. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arancio O, 1996, CELL, V87, P1025, DOI 10.1016/S0092-8674(00)81797-3; Baltrons MA, 2002, NEUROBIOL DIS, V10, P139, DOI 10.1006/nbdi.2002.0492; Bamberger ME, 2003, J NEUROSCI, V23, P2665; Barazi HO, 2002, J BIOL CHEM, V277, P42859, DOI 10.1074/jbc.M206849200; Bi X, 2002, NEUROSCIENCE, V112, P827, DOI 10.1016/S0306-4522(02)00132-X; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Bon CLM, 2003, J NEUROSCI, V23, P1941; Castellani RJ, 2009, J ALZHEIMERS DIS, V18, P447, DOI 10.3233/JAD-2009-1151; Crawford F, 1998, FEBS LETT, V436, P445, DOI 10.1016/S0014-5793(98)01170-3; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; GILLIS S, 1980, J EXP MED, V152, P1709, DOI 10.1084/jem.152.6.1709; Giokarini T, 1997, Ann N Y Acad Sci, V826, P475, DOI 10.1111/j.1749-6632.1997.tb48507.x; GRUETTER CA, 1981, J PHARMACOL EXP THER, V219, P181; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; IGNARRO LJ, 1986, J PHARMACOL EXP THER, V237, P893; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Isenberg JS, 2008, ANN SURG, V247, P860, DOI 10.1097/SLA.0b013e31816c4006; Isenberg JS, 2008, BLOOD, V111, P613, DOI 10.1182/blood-2007-06-098392; Isenberg JS, 2007, J BIOL CHEM, V282, P15404, DOI 10.1074/jbc.M701638200; Isenberg JS, 2007, BLOOD, V109, P1945, DOI 10.1182/blood-2006-08-041368; Isenberg JS, 2006, CARDIOVASC RES, V71, P785, DOI 10.1016/j.cardiores.2006.05.024; Isenberg JS, 2006, J BIOL CHEM, V281, P26069, DOI 10.1074/jbc.M605040200; Isenberg JS, 2009, J BIOL CHEM, V284, P1116, DOI 10.1074/jbc.M804860200; Isenberg JS, 2005, P NATL ACAD SCI USA, V102, P13141, DOI 10.1073/pnas.0502977102; Jeon YJ, 2008, NEUROREPORT, V19, P1661, DOI 10.1097/WNR.0b013e3283140f10; Koenigsknecht J, 2004, J NEUROSCI, V24, P9838, DOI 10.1523/JNEUROSCI.2557-04.2004; Law A, 2002, NEUROSCIENCE, V112, P267, DOI 10.1016/S0306-4522(02)00082-9; Li QX, 1998, LAB INVEST, V78, P461; Lohmann SM, 1997, TRENDS BIOCHEM SCI, V22, P307, DOI 10.1016/S0968-0004(97)01086-4; Lu YF, 1999, J NEUROSCI, V19, P10250; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; Matter ML, 1998, J CELL BIOL, V141, P1019, DOI 10.1083/jcb.141.4.1019; MELLION BT, 1981, BLOOD, V57, P946; Miller TW, 2010, BRIT J PHARMACOL, V159, P1542, DOI 10.1111/j.1476-5381.2009.00631.x; Niederhoffer N, 2009, INT J IMMUNOPATH PH, V22, P473, DOI 10.1177/039463200902200224; Niwa K, 2001, AM J PHYSIOL-HEART C, V281, pH2417, DOI 10.1152/ajpheart.2001.281.6.H2417; Paris D, 1999, EXP NEUROL, V157, P211, DOI 10.1006/exnr.1999.7055; Paris D, 2000, ANN NY ACAD SCI, V903, P446, DOI 10.1111/j.1749-6632.2000.tb06397.x; Persaud-Sawin DA, 2009, GLIA, V57, P320, DOI 10.1002/glia.20759; Piccio L, 2005, BLOOD, V105, P2421, DOI 10.1182/blood-2004-07-2823; Pimplikar SW, 2009, INT J BIOCHEM CELL B, V41, P1261, DOI 10.1016/j.biocel.2008.12.015; Price JM, 2001, NEUROL RES, V23, P506, DOI 10.1179/016164101101198758; Puzzo D, 2005, J NEUROSCI, V25, P6887, DOI 10.1523/JNEUROSCI.5291-04.2005; Puzzo D, 2006, REV NEUROSCIENCE, V17, P497; SCHINI V, 1988, EUR J CELL BIOL, V47, P53; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; SELKOE DJ, 1994, ANNU REV NEUROSCI, V17, P489, DOI 10.1146/annurev.neuro.17.1.489; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Smith CCT, 2001, BRAIN RES, V896, P161, DOI 10.1016/S0006-8993(01)02080-7; Smith CCT, 2007, CLIN SCI, V113, P427, DOI 10.1042/CS20070082; Tulasne D, 2001, BLOOD, V98, P3346, DOI 10.1182/blood.V98.12.3346; Van Broeck B, 2007, NEURODEGENER DIS, V4, P349, DOI 10.1159/000105156; Verdier Y, 2004, J PEPT SCI, V10, P229, DOI 10.1002/psc.573; Wilcock DM, 2008, J NEUROSCI, V28, P1537, DOI 10.1523/JNEUROSCI.5066-07.2008; Wilkinson B, 2006, J BIOL CHEM, V281, P20842, DOI 10.1074/jbc.M600627200; Wirtz-Brugger F, 2000, NEUROSCIENCE, V99, P737, DOI 10.1016/S0306-4522(00)00243-8; Wright S, 2007, NEUROBIOL AGING, V28, P226, DOI 10.1016/j.neurobiolaging.2005.12.002; Yamashita S, 2007, MOL CELL BIOCHEM, V299, P19, DOI 10.1007/s11010-005-9031-4; Zhu WF, 2005, J BIOL CHEM, V280, P29543, DOI 10.1074/jbc.M501238200	60	37	37	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15686	10.1371/journal.pone.0015686	http://dx.doi.org/10.1371/journal.pone.0015686			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203512	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000285578000045
J	Ohigashi, I; Yamasaki, Y; Hirashima, T; Takahama, Y				Ohigashi, Izumi; Yamasaki, Yuki; Hirashima, Tsukasa; Takahama, Yousuke			Identification of the Transgenic Integration Site in Immunodeficient tg epsilon 26 Human CD3 epsilon Transgenic Mice	PLOS ONE			English	Article							KILLER-CELL DEVELOPMENT; T-LYMPHOCYTE; GENE; REARRANGEMENTS; INDUCTION; MUTANT; DEFECT; GLAND; BLOCK	A strain of human CD3 epsilon transgenic mice, tg epsilon 26, exhibits severe immunodeficiency associated with early arrest of T cell development. Complete loss of T cells is observed in homozygous tg epsilon 26 mice, but not in heterozygotes, suggesting that genomic disruption due to transgenic integration may contribute to the arrest of T cell development. Here we report the identification of the transgenic integration site in tge26 mice. We found that multiple copies of the human CD3 epsilon transgene are inserted between the Sstr5 and Metrn loci on chromosome 17, and that this is accompanied by duplication of the neighboring genomic region spanning 323 kb. However, none of the genes in this region were abrogated. These results suggest that the severe immunodeficiency seen in tg epsilon 26 mice is not due to gene disruption resulting from transgenic integration.	[Ohigashi, Izumi; Takahama, Yousuke] Univ Tokushima, Inst Genom Res, Div Expt Immunol, Tokushima 770, Japan; [Yamasaki, Yuki; Hirashima, Tsukasa] Otsuka Pharmaceut Co Ltd, Tokushima, Japan	Tokushima University; Otsuka Pharmaceutical	Ohigashi, I (corresponding author), Univ Tokushima, Inst Genom Res, Div Expt Immunol, Tokushima 770, Japan.	takahama@genome.tokushima-u.ac.jp	Takahama, Yousuke/A-5863-2010	Takahama, Yousuke/0000-0002-4992-9174	MEXT	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a MEXT Grant-in-Aid for Scientific Research in the Priority Area "Immunological Self" (Y. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Goodrich JA, 2006, NAT REV MOL CELL BIO, V7, P612, DOI 10.1038/nrm1946; Guimond MJ, 1996, AM J REPROD IMMUNOL, V35, P501; HOLLANDER GA, 1995, NATURE, V373, P350, DOI 10.1038/373350a0; Hsu W, 2001, J CELL BIOL, V155, P1055, DOI 10.1083/jcb.200107066; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; Kanemoto N, 1998, MAMM GENOME, V9, P419, DOI 10.1007/s003359900789; LEVELT CN, 1995, EUR J IMMUNOL, V25, P1257, DOI 10.1002/eji.1830250519; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Morgan D, 1998, NAT GENET, V20, P149, DOI 10.1038/2450; Roberts NA, 2009, EUR J IMMUNOL, V39, P2395, DOI 10.1002/eji.200939501; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Smiraglia DJ, 1997, GENOMICS, V45, P572, DOI 10.1006/geno.1997.4976; Tokoro Y, 1998, J IMMUNOL, V161, P4591; van Ewijk W, 2000, DEVELOPMENT, V127, P1583; Vermeire L, 2009, INT J DEV BIOL, V53, P1045, DOI 10.1387/ijdb.092859lv; Wang BP, 1997, IMMUNOL REV, V157, P53, DOI 10.1111/j.1600-065X.1997.tb00973.x; Wang BP, 1996, INT IMMUNOL, V8, P939, DOI 10.1093/intimm/8.6.939; WANG BP, 1994, P NATL ACAD SCI USA, V91, P9402, DOI 10.1073/pnas.91.20.9402; Watanabe TK, 2000, MAMM GENOME, V11, P300, DOI 10.1007/s003350010056; Wen XY, 1998, HUM MOL GENET, V7, P743, DOI 10.1093/hmg/7.4.743	21	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14391	10.1371/journal.pone.0014391	http://dx.doi.org/10.1371/journal.pone.0014391			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203507	Green Published, gold, Green Submitted			2022-12-27	WOS:000285578000007
J	Huang, HC; Mitchison, TJ; Shi, J				Huang, Hsiao-Chun; Mitchison, Timothy J.; Shi, Jue			Stochastic Competition between Mechanistically Independent Slippage and Death Pathways Determines Cell Fate during Mitotic Arrest	PLOS ONE			English	Article							SPINDLE ASSEMBLY CHECKPOINT; CANCER-CELLS; ANTIMITOTIC DRUGS; APOPTOSIS; PACLITAXEL; PROGRESSION; INHIBITORS; KINESIN-5; RESPONSES; MITOSIS	Variability in cell-to-cell behavior within clonal populations can be attributed to the inherent stochasticity of biochemical reactions. Most single-cell studies have examined variation in behavior due to randomness in gene transcription. Here we investigate the mechanism of cell fate choice and the origin of cell-to-cell variation during mitotic arrest, when transcription is silenced. Prolonged mitotic arrest is commonly observed in cells treated with anti-mitotic drugs. Cell fate during mitotic arrest is determined by two alternative pathways, one promoting cell death, the other promoting cyclin B1 degradation, which leads to mitotic slippage and survival. It has been unclear whether these pathways are mechanistically coupled or independent. In this study we experimentally uncoupled these two pathways using zVAD-fmk to block cell death or Cdc20 knockdown to block slippage. We then used time-lapse imaging to score the kinetics of single cells adopting the remaining fate. We also used kinetic simulation to test whether the behaviors of death versus slippage in cell populations where both pathways are active can be quantitatively recapitulated by a model that assumes stochastic competition between the pathways. Our data are well fit by a model where the two pathways are mechanistically independent, and cell fate is determined by a stochastic kinetic competition between them that results in cell-to-cell variation.	[Huang, Hsiao-Chun; Mitchison, Timothy J.; Shi, Jue] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Huang, Hsiao-Chun] Harvard Univ, Sch Med, Grad Program Syst Biol, Boston, MA USA; [Shi, Jue] Hong Kong Baptist Univ, Ctr Quantitat Syst Biol, Kowloon Tong, Hong Kong, Peoples R China; [Shi, Jue] Hong Kong Baptist Univ, Dept Phys, Kowloon Tong, Hong Kong, Peoples R China	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Hong Kong Baptist University; Hong Kong Baptist University	Huang, HC (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	jshi@hkbu.eduk.hk	Shi, Jue/J-9714-2014	Shi, Jue/0000-0003-4061-3496	National Cancer Institute [CA139980]; Hong Kong Research Grant Council [261310]; NATIONAL CANCER INSTITUTE [P01CA139980] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Hong Kong Research Grant Council(Hong Kong Research Grants Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (CA139980) to T.J. Mitchison, and the Hong Kong Research Grant Council(#261310) to J. Shi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Allan LA, 2007, MOL CELL, V26, P301, DOI 10.1016/j.molcel.2007.03.019; Bentley AM, 2007, MOL BIOL CELL, V18, P4847, DOI 10.1091/mbc.E06-06-0539; Blagosklonny MV, 2007, CELL CYCLE, V6, P70, DOI 10.4161/cc.6.1.3682; Blagosklonny MV, 2006, CELL CYCLE, V5, P1574, DOI 10.4161/cc.5.14.3113; Blagosklonny MV, 2002, CANCER BIOL THER, V1, P113, DOI 10.4161/cbt.53; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Demidenko ZN, 2008, ONCOGENE, V27, P4402, DOI 10.1038/onc.2008.82; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Jackson JR, 2007, NAT REV CANCER, V7, P107, DOI 10.1038/nrc2049; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kim M, 2005, MOL CELL BIOL, V25, P9232, DOI 10.1128/MCB.25.21.9232-9248.2005; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; McEleny KR, 2002, PROSTATE, V51, P133, DOI 10.1002/pros.10061; Noguchi S, 2006, CANCER SCI, V97, P813, DOI 10.1111/j.1349-7006.2006.00265.x; Orth JD, 2008, MOL CANCER THER, V7, P3480, DOI 10.1158/1535-7163.MCT-08-0684; Park SJ, 2004, J BIOL CHEM, V279, P51057, DOI 10.1074/jbc.M406543200; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Shi J, 2008, CANCER RES, V68, P3269, DOI 10.1158/0008-5472.CAN-07-6699; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Tao WK, 2005, CANCER CELL, V8, P49, DOI 10.1016/j.ccr.2005.06.003; Wang LG, 1999, CANCER CHEMOTH PHARM, V44, P355, DOI 10.1007/s002800050989; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103	26	48	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15724	10.1371/journal.pone.0015724	http://dx.doi.org/10.1371/journal.pone.0015724			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203573	Green Published, gold, Green Submitted			2022-12-27	WOS:000285576900038
J	Tong, YK; Chiu, RWK; Akolekar, R; Leung, TY; Lau, TK; Nicolaides, KH; Lo, YMD				Tong, Yu K.; Chiu, Rossa W. K.; Akolekar, Ranjit; Leung, Tak Y.; Lau, Tze K.; Nicolaides, Kypros H.; Lo, Y. M. Dennis			Epigenetic-Genetic Chromosome Dosage Approach for Fetal Trisomy 21 Detection Using an Autosomal Genetic Reference Marker	PLOS ONE			English	Article							NONINVASIVE-PRENATAL-DIAGNOSIS; MATERNAL PLASMA; DIGITAL PCR; PLACENTAL ORIGIN; DNA-METHYLATION; MESSENGER-RNA; ALLELIC RATIO; BLOOD; ANEUPLOIDY; 1ST-TRIMESTER	Background: The putative promoter of the holocarboxylase synthetase (HLCS) gene on chromosome 21 is hypermethylated in placental tissues and could be detected as a fetal-specific DNA marker in maternal plasma. Detection of fetal trisomy 21 (T21) has been demonstrated by an epigenetic-genetic chromosome dosage approach where the amount of hypermethylated HLCS in maternal plasma is normalized using a fetal genetic marker on the Y chromosome as a chromosome dosage reference marker. We explore if this method can be applied on both male and female fetuses with the use of a paternally-inherited fetal single nucleotide polymorphism (SNP) allele on a reference chromosome for chromosome dosage normalization. Methodology: We quantified hypermethylated HLCS molecules using methylation-sensitive restriction endonuclease digestion followed by real-time or digital PCR analyses. For chromosome dosage analysis, we compared the amount of digestion-resistant HLCS to that of a SNP allele (rs6636, a C/G SNP) that the fetus has inherited from the father but absent in the pregnant mother. Principal Findings: Using a fetal-specific SNP allele on a reference chromosome, we analyzed 20 euploid and nine T21 placental tissue samples. All samples with the fetal-specific C allele were correctly classified. One sample from each of the euploid and T21 groups were misclassified when the fetal-specific G allele was used as the reference marker. We then analyzed 33 euploid and 14 T21 maternal plasma samples. All but one sample from each of the euploid and T21 groups were correctly classified using the fetal-specific C allele, while correct classification was achieved for all samples using the fetal-specific G allele as the reference marker. Conclusions: As a proof-of-concept study, we have demonstrated that the epigenetic-genetic chromosome dosage approach can be applied to the prenatal diagnosis of trisomy 21 for both male and female fetuses.	[Tong, Yu K.; Chiu, Rossa W. K.; Lo, Y. M. Dennis] Chinese Univ Hong Kong, Ctr Res Circulating Fetal Nucle Acids, Li Ka Shing Inst Hlth Sci, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Tong, Yu K.; Chiu, Rossa W. K.; Lo, Y. M. Dennis] Chinese Univ Hong Kong, Dept Chem Pathol, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Akolekar, Ranjit; Nicolaides, Kypros H.] Kings Coll Hosp London, Harris Birthright Res Ctr Fetal Med, London, England; [Leung, Tak Y.; Lau, Tze K.] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; Chinese University of Hong Kong; Prince of Wales Hospital	Tong, YK (corresponding author), Chinese Univ Hong Kong, Ctr Res Circulating Fetal Nucle Acids, Li Ka Shing Inst Hlth Sci, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China.	loym@cuhk.edu.hk	Lo, Yuk Ming Dennis/D-4468-2011	Lo, Yuk Ming Dennis/0000-0001-8746-0293; Lau, Tze Kin/0000-0002-0242-1410; Nicolaides, Kypros/0000-0003-1266-0711	University Grants Committee of the Government of the Hong Kong Special Administration Region, China [AoE/M-04/06]; Li Ka Shing Foundation	University Grants Committee of the Government of the Hong Kong Special Administration Region, China; Li Ka Shing Foundation	This study was supported by the University Grants Committee of the Government of the Hong Kong Special Administration Region, China - Areas of Excellence Scheme (AoE/M-04/06). YMDL is supported by the Chair Professorship Scheme of the Li Ka Shing Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan KCA, 2006, CLIN CHEM, V52, P2211, DOI 10.1373/clinchem.2006.074997; Chim SSC, 2005, P NATL ACAD SCI USA, V102, P14753, DOI 10.1073/pnas.0503335102; Chim SSC, 2008, CLIN CHEM, V54, P500, DOI 10.1373/clinchem.2007.098731; Chiu RWK, 2007, AM J PATHOL, V170, P941, DOI 10.2353/ajpath.2007.060641; Chiu RWK, 2010, CLIN CHEM, V56, P459, DOI 10.1373/clinchem.2009.136507; Chiu RWK, 2009, TRENDS GENET, V25, P324, DOI 10.1016/j.tig.2009.05.004; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Chow KCK, 2007, CLIN CHEM, V53, P141, DOI 10.1373/clinchem.2007.079335; Costa JM, 2002, NEW ENGL J MED, V346, P1502, DOI 10.1056/NEJM200205093461918; Daniels G, 2009, PRENATAL DIAG, V29, P101, DOI 10.1002/pd.2172; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Heung MMS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005858; Kong CW, 2006, PRENATAL DIAG, V26, P925, DOI 10.1002/pd.1528; Lau TK, 2005, CHINESE MED J-PEKING, V118, P1675; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; Lo YMD, 2007, NAT REV GENET, V8, P71, DOI 10.1038/nrg1982; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lo YMD, 1998, NEW ENGL J MED, V339, P1734, DOI 10.1056/NEJM199812103392402; Lun FMF, 2008, CLIN CHEM, V54, P1664, DOI 10.1373/clinchem.2008.111385; Malone FD, 2005, NEW ENGL J MED, V353, P2001, DOI 10.1056/NEJMoa043693; Ng EKO, 2003, P NATL ACAD SCI USA, V100, P4748, DOI 10.1073/pnas.0637450100; Old RW, 2007, REPROD BIOMED ONLINE, V15, P227, DOI 10.1016/S1472-6483(10)60713-4; Oudejans CBM, 2003, CLIN CHEM, V49, P1445, DOI 10.1373/49.9.1445; Papageorgiou EA, 2009, AM J PATHOL, V174, P1609, DOI 10.2353/ajpath.2009.081038; TABOR A, 1986, LANCET, V1, P1287; Tong YK, 2006, CLIN CHEM, V52, P2194, DOI 10.1373/clinchem.2006.076851; Tong YK, 2010, CLIN CHEM, V56, P90, DOI 10.1373/clinchem.2009.134114; Tsui NBY, 2010, CLIN CHEM, V56, P73, DOI 10.1373/clinchem.2009.132662; Tsui NBY, 2009, PRENATAL DIAG, V29, P1031, DOI 10.1002/pd.2340; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Wapner R, 2003, NEW ENGL J MED, V349, P1405, DOI 10.1056/NEJMoa025273	34	31	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15244	10.1371/journal.pone.0015244	http://dx.doi.org/10.1371/journal.pone.0015244			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21249119	gold, Green Submitted, Green Published			2022-12-27	WOS:000285575200026
J	Domingues, HS; Mues, M; Lassmann, H; Wekerle, H; Krishnamoorthy, G				Domingues, Helena S.; Mues, Marsilius; Lassmann, Hans; Wekerle, Hartmut; Krishnamoorthy, Gurumoorthy			Functional and Pathogenic Differences of Th1 and Th17 Cells in Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; VASCULAR ENDOTHELIAL-CELLS; IFN-GAMMA; T-CELLS; CUTTING EDGE; INDUCTION; MICE; EXPRESSION; CYTOKINE	Background: There is consensus that experimental autoimmune encephalomyelitis (EAE) can be mediated by myelin specific T cells of Th1 as well as of Th17 phenotype, but the contribution of either subset to the pathogenic process has remained controversial. In this report, we compare functional differences and pathogenic potential of "monoclonal" T cell lines that recognize myelin oligodendrocyte glycoprotein (MOG) with the same transgenic TCR but are distinguished by an IFN-gamma producing Th1-like and IL-17 producing Th17-like cytokine signature. Methods and Findings: CD4(+) T cell lines were derived from the transgenic mouse strain 2D2, which expresses a TCR recognizing MOG peptide 35-55 in the context of I-A(b). Adoptive transfer of Th1 cells into lymphopenic (Rag2(-/-)) recipients, predominantly induced "classic" paralytic EAE, whereas Th17 cells mediated "atypical" ataxic EAE in approximately 50% of the recipient animals. Combination of Th1 and Th17 cells potentiated the encephalitogenicity inducing classical EAE exclusively. Th1 and Th17 mediated EAE lesions differed in their composition but not in their localization within the CNS. While Th1 lesions contained IFN-gamma, but no IL-17 producing T cells, the T cells in Th17 lesions showed plasticity, substantially converting to IFN-gamma producing Th1-like cells. Th1 and Th17 cells differed drastically by their lytic potential. Th1 but not Th17 cells lysed autoantigen presenting astrocytes and fibroblasts in vitro in a contact-dependent manner. In contrast, Th17 cells acquired cytotoxic potential only after antigenic stimulation and conversion to IFN-gamma producing Th1 phenotype. Conclusions: Our data demonstrate that both Th1 and Th17 lineages possess the ability to induce CNS autoimmunity but can function with complementary as well as differential pathogenic mechanisms. We propose that Th17-like cells producing IL-17 are required for the generation of atypical EAE whereas IFN-gamma producing Th1 cells induce classical EAE.	[Domingues, Helena S.] Univ Coimbra, PhD Program Expt Biol & Biomed, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Lassmann, Hans] Med Univ Vienna, Ctr Brain Res, Vienna, Austria; [Domingues, Helena S.; Mues, Marsilius; Wekerle, Hartmut; Krishnamoorthy, Gurumoorthy] Max Planck Inst Neurobiol, Dept Neuroimmunol, Martinsried, Germany	Universidade de Coimbra; Medical University of Vienna; Max Planck Society	Domingues, HS (corresponding author), Inst Mol & Cellular Biol IBMC, Div Basic & Clin Neurobiol, Oporto, Portugal.	guru@neuro.mpg.de	Krishnamoorthy, Gurumoorthy/O-1650-2013; Domingues, Sofia/A-9842-2011; Lassmann, Hans/Z-2269-2019	Krishnamoorthy, Gurumoorthy/0000-0002-7798-6707; Domingues, Sofia/0000-0003-1230-2682; Lassmann, Hans/0000-0001-8617-5052	Max Planck society, Deutsche Forschungsgemeinschaft [SFB 571, B6]; ARSEP [AO 2009]; Portuguese Foundation for Science and Tecnology (FCT) [SFRH/BD/15885/2005]	Max Planck society, Deutsche Forschungsgemeinschaft(Max Planck SocietyGerman Research Foundation (DFG)); ARSEP; Portuguese Foundation for Science and Tecnology (FCT)(Portuguese Foundation for Science and Technology)	This work was supported in part by the Max Planck society, Deutsche Forschungsgemeinschaft (SFB 571, Project B6), ARSEP (AO 2009) and by a PhD fellowship to H. S. D. (Portuguese Foundation for Science and Tecnology (FCT), reference SFRH/BD/15885/2005). Funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTEN DM, 1994, J NEUROIMMUNOL, V51, P123, DOI 10.1016/0165-5728(94)90074-4; Becher B, 2002, J CLIN INVEST, V110, P493, DOI 10.1172/JCI200215751; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Carlson T, 2008, J EXP MED, V205, P811, DOI 10.1084/jem.20072404; Constantinescu CS, 1998, J IMMUNOL, V161, P5097; Cox CA, 2008, J IMMUNOL, V180, P7414, DOI 10.4049/jimmunol.180.11.7414; Cruz A, 2006, J IMMUNOL, V177, P1416, DOI 10.4049/jimmunol.177.3.1416; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; FALLIS RJ, 1989, J IMMUNOL, V143, P2160; Ferber IA, 1996, J IMMUNOL, V156, P5; FONTANA A, 1984, NATURE, V307, P273, DOI 10.1038/307273a0; Gran B, 2002, J IMMUNOL, V169, P7104, DOI 10.4049/jimmunol.169.12.7104; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Horwitz MS, 1997, NAT MED, V3, P1037, DOI 10.1038/nm0997-1037; Ichikawa M, 2000, J NEUROIMMUNOL, V102, P56, DOI 10.1016/S0165-5728(99)00153-8; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Krishnamoorthy G, 2006, J CLIN INVEST, V116, P2385, DOI 10.1172/JCI28330; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Lees JR, 2008, J EXP MED, V205, P2633, DOI 10.1084/jem.20080155; Lees JR, 2008, J IMMUNOL, V180, P8066, DOI 10.4049/jimmunol.180.12.8066; LEONARD JP, 1995, J EXP MED, V181, P381, DOI 10.1084/jem.181.1.381; Lexberg MH, 2008, EUR J IMMUNOL, V38, P2654, DOI 10.1002/eji.200838541; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Martin-Orozco N, 2009, EUR J IMMUNOL, V39, P216, DOI 10.1002/eji.200838475; MCCARRON RM, 1991, J IMMUNOL, V147, P503; Nurieva R, 2009, J IMMUNOL, V182, P2565, DOI 10.4049/jimmunol.0803931; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Pollinger B, 2009, J EXP MED, V206, P1303, DOI 10.1084/jem.20090299; RANSOHOFF RM, 1991, ARCH NEUROL-CHICAGO, V48, P1244, DOI 10.1001/archneur.1991.00530240048017; RONCHESE F, 1987, J IMMUNOL, V139, P629; Sabater L, 2009, J NEUROIMMUNOL, V215, P31, DOI 10.1016/j.jneuroim.2009.07.014; SEDGWICK JD, 1990, J IMMUNOL, V145, P2474; Sonderegger I, 2008, J EXP MED, V205, P2281, DOI 10.1084/jem.20071119; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Storch MK, 1998, BRAIN PATHOL, V8, P681, DOI 10.1111/j.1750-3639.1998.tb00194.x; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; SUN D, 1986, NATURE, V320, P70, DOI 10.1038/320070a0; SUZUMURA A, 1987, J NEUROIMMUNOL, V15, P263, DOI 10.1016/0165-5728(87)90121-4; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wang ZJ, 2006, J CLIN INVEST, V116, P2434, DOI 10.1172/JCI25826; Wensky AK, 2005, J IMMUNOL, V174, P1416, DOI 10.4049/jimmunol.174.3.1416; Willenborg DO, 1996, J IMMUNOL, V157, P3223; Yang YH, 2009, J EXP MED, V206, P1549, DOI 10.1084/jem.20082584; Zhang GX, 2003, J IMMUNOL, V170, P2153, DOI 10.4049/jimmunol.170.4.2153	51	159	172	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15531	10.1371/journal.pone.0015531	http://dx.doi.org/10.1371/journal.pone.0015531			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21209700	Green Published, gold, Green Submitted			2022-12-27	WOS:000284686500046
J	Penner, O; Grassberger, P; Paczuski, M				Penner, Orion; Grassberger, Peter; Paczuski, Maya			Sequence Alignment, Mutual Information, and Dissimilarity Measures for Constructing Phylogenies	PLOS ONE			English	Article							EVOLUTIONARY TREES; MULTIPLE ALIGNMENT; DNA; BLAST	Background: Existing sequence alignment algorithms use heuristic scoring schemes based on biological expertise, which cannot be used as objective distance metrics. As a result one relies on crude measures, like the p- or log-det distances, or makes explicit, and often too simplistic, a priori assumptions about sequence evolution. Information theory provides an alternative, in the form of mutual information (MI). MI is, in principle, an objective and model independent similarity measure, but it is not widely used in this context and no algorithm for extracting MI from a given alignment (without assuming an evolutionary model) is known. MI can be estimated without alignments, by concatenating and zipping sequences, but so far this has only produced estimates with uncontrolled errors, despite the fact that the normalized compression distance based on it has shown promising results. Results: We describe a simple approach to get robust estimates of MI from global pairwise alignments. Our main result uses algorithmic (Kolmogorov) information theory, but we show that similar results can also be obtained from Shannon theory. For animal mitochondrial DNA our approach uses the alignments made by popular global alignment algorithms to produce MI estimates that are strikingly close to estimates obtained from the alignment free methods mentioned above. We point out that, due to the fact that it is not additive, normalized compression distance is not an optimal metric for phylogenetics but we propose a simple modification that overcomes the issue of additivity. We test several versions of our MI based distance measures on a large number of randomly chosen quartets and demonstrate that they all perform better than traditional measures like the Kimura or log-det (resp. paralinear) distances. Conclusions: Several versions of MI based distances outperform conventional distances in distance-based phylogeny. Even a simplified version based on single letter Shannon entropies, which can be easily incorporated in existing software packages, gave superior results throughout the entire animal kingdom. But we see the main virtue of our approach in a more general way. For example, it can also help to judge the relative merits of different alignment algorithms, by estimating the significance of specific alignments. It strongly suggests that information theory concepts can be exploited further in sequence analysis.	[Penner, Orion; Grassberger, Peter; Paczuski, Maya] Univ Calgary, Dept Phys & Astron, Complex Sci Grp, Calgary, AB T2N 1N4, Canada; [Grassberger, Peter] Univ Calgary, Dept Biol Sci, Inst Biocomplex & Informat, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary	Penner, O (corresponding author), Univ Calgary, Dept Phys & Astron, Complex Sci Grp, Calgary, AB T2N 1N4, Canada.	openner@phas.ucalgary.ca; pgrassbe@ucalgary.ca	Penner, Orion/E-5071-2012; Grasberger, Peter/ABA-5538-2021	Penner, Orion/0000-0003-3382-9491; Grasberger, Peter/0000-0003-4966-9998	NSERC; iCORE; Advanced Education and Technology	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); iCORE; Advanced Education and Technology	This research was funded by NSERC. OP is funded through scholarships from NSERC, iCORE and Advanced Education and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison L, 1999, COMPUT J, V42, P1, DOI 10.1093/comjnl/42.1.1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aluru S., 2006, HDB COMPUTATIONAL MO; Bray N, 2003, NUCLEIC ACIDS RES, V31, P3525, DOI 10.1093/nar/gkg623; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Brudno M, 2003, BIOINFORMATICS, V19, pi54, DOI 10.1093/bioinformatics/btg1005; Buneman P., 1974, J COMBINAT THEORY B, V17, P48, DOI [DOI 10.1016/0095-8956(74)90047-1, 10.1016/0095-8956(74)90047-1]; Cao MD, 2007, IEEE DATA COMPR CONF, P43; Cilibrasi R, 2005, IEEE T INFORM THEORY, V51, P1523, DOI 10.1109/TIT.2005.844059; Durbin R., 1998, BIOL SEQUENCE ANAL P; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Kraskov A., 2003, QBIO0311039 ARXIV; LAKE JA, 1994, P NATL ACAD SCI USA, V91, P1455, DOI 10.1073/pnas.91.4.1455; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Li M, 2004, IEEE T INFORM THEORY, V50, P3250, DOI 10.1109/TIT.2004.838101; Li M, 2001, BIOINFORMATICS, V17, P149, DOI 10.1093/bioinformatics/17.2.149; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; MILOSAVLJEVIC A, 1995, MACH LEARN, V21, P35, DOI 10.1007/BF00993378; Navarro G, 2001, ACM COMPUT SURV, V33, P31, DOI 10.1145/375360.375365; Nei M., 2000, MOL EVOLUTION PHYLOG; RISSANEN J, 1978, AUTOMATICA, V14, P465, DOI 10.1016/0005-1098(78)90005-5; RISSANEN J, 1986, ANAL OPTIMIZATION SY, P391; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; STEEL MA, 1993, NATURE, V364, P440, DOI 10.1038/364440a0; Thomas MC, 2006, ELEMENTS INFORM THEO; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Varre JS, 1999, BIOINFORMATICS, V15, P194, DOI 10.1093/bioinformatics/15.3.194; Vinga S, 2003, BIOINFORMATICS, V19, P513, DOI 10.1093/bioinformatics/btg005; Viola P, 1997, INT J COMPUT VISION, V24, P137, DOI 10.1023/A:1007958904918; 2006, EMBL EBI; 1999, EMBOSS	34	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2011	6	1							e14373	10.1371/journal.pone.0014373	http://dx.doi.org/10.1371/journal.pone.0014373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KM	21245917	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000286510500001
J	Yadav, P; Tran, H; Ebegbe, R; Gottlieb, P; Wei, H; Lewis, RH; Mumbey-Wafula, A; Kaplan, A; Kholdarova, E; Spatz, L				Yadav, Pragya; Tran, Hoa; Ebegbe, Roland; Gottlieb, Paul; Wei, Hui; Lewis, Rita H.; Mumbey-Wafula, Alice; Kaplan, Atira; Kholdarova, Elina; Spatz, Linda			Antibodies Elicited in Response to EBNA-1 May Cross-React with dsDNA	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ALTERED IMMUNE-RESPONSE; BARR NUCLEAR ANTIGEN-1; ORIGIN-BINDING-PROTEIN; ANTI-DNA ANTIBODIES; DOUBLE-STRANDED DNA; B-CELLS; AUTOANTIBODIES; PEPTIDE; EPITOPE	Background: Several genetic and environmental factors have been linked to Systemic Lupus Erythematosus (SLE). One environmental trigger that has a strong association with SLE is the Epstein Barr Virus (EBV). Our laboratory previously demonstrated that BALB/c mice expressing the complete EBNA-1 protein can develop antibodies to double stranded DNA (dsDNA). The present study was undertaken to understand why anti-dsDNA antibodies arise during the immune response to EBNA-1. Methodology/Principal Findings: In this study, we demonstrated that mouse antibodies elicited in response to EBNA-1 cross-react with dsDNA. First, we showed that adsorption of sera reactive with EBNA-1 and dsDNA, on dsDNA cellulose columns, diminished reactivity with EBNA-1. Next, we generated mononclonal antibodies (MAbs) to EBNA-1 and showed, by several methods, that they also reacted with dsDNA. Examination of two cross-reactive MAbs-3D4, generated in this laboratory, and 0211, a commercial MAb-revealed that 3D4 recognizes the carboxyl region of EBNA-1, while 0211 recognizes both the amino and carboxyl regions. In addition, 0211 binds moderately well to the ribonucleoprotein, Sm, which has been reported by others to elicit a cross-reactive response with EBNA-1, while 3D4 binds only weakly to Sm. This suggests that the epitope in the carboxyl region may be more important for cross-reactivity with dsDNA while the epitope in the amino region may be more important for cross-reactivity with Sm. Conclusions/Significance: In conclusion, our results demonstrate that antibodies to the EBNA-1 protein cross-react with dsDNA. This study is significant because it demonstrates a direct link between the viral antigen and the development of anti-dsDNA antibodies, which are the hallmark of SLE. Furthermore, it illustrates the crucial need to identify the epitopes in EBNA-1 responsible for this cross-reactivity so that therapeutic strategies can be designed to mask these regions from the immune system following EBV exposure.	[Yadav, Pragya] CUNY City Coll, Dept Chem, New York, NY 10031 USA; [Yadav, Pragya; Gottlieb, Paul; Spatz, Linda] CUNY, Grad Ctr, New York, NY USA; [Yadav, Pragya; Gottlieb, Paul; Spatz, Linda] CUNY City Coll, PhD Program Biochem, New York, NY 10031 USA; [Tran, Hoa; Ebegbe, Roland; Gottlieb, Paul; Lewis, Rita H.; Spatz, Linda] CUNY City Coll, Grad Sch Biol, New York, NY 10031 USA; [Gottlieb, Paul; Wei, Hui; Mumbey-Wafula, Alice; Kaplan, Atira; Kholdarova, Elina; Spatz, Linda] CUNY City Coll, Dept Microbiol & Immunol, Sophie Davis Sch Biomed Educ, New York, NY 10031 USA	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City College of New York (CUNY); Sophie Davis School of Biomedical Education	Yadav, P (corresponding author), CUNY City Coll, Dept Chem, New York, NY 10031 USA.	lspatz@med.cuny.edu			National Institute of General Medical Sciences (NIGMS)/Support of Continuous Research Excellence (SCORE) [SO6 GM 08168]; National Center for Research Resources Centers in Minority Institutions [NIH/NCRR/RCMI 5G12 RR03060]; Professional Staff Congress at the City University of New York (PSC-CUNY) foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008168] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)/Support of Continuous Research Excellence (SCORE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources Centers in Minority Institutions(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Professional Staff Congress at the City University of New York (PSC-CUNY) foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by grants SO6 GM 08168 from the National Institute of General Medical Sciences (NIGMS)/Support of Continuous Research Excellence (SCORE), NIH/NCRR/RCMI 5G12 RR03060 from the National Center for Research Resources Centers in Minority Institutions and the Professional Staff Congress at the City University of New York (PSC-CUNY) foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberdi F, 2001, CLIN IMMUNOL, V98, P293, DOI 10.1006/clim.2000.4970; Bochkarev A, 1996, CELL, V84, P791, DOI 10.1016/S0092-8674(00)81056-9; Ceccarelli DFJ, 2000, J VIROL, V74, P4939, DOI 10.1128/JVI.74.11.4939-4948.2000; DeGiorgio LA, 2001, NAT MED, V7, P1189, DOI 10.1038/nm1101-1189; Deocharan B, 2002, J IMMUNOL, V168, P3072, DOI 10.4049/jimmunol.168.6.3072; EVANS AS, 1989, VIRAL INFECT HUMANS, P265; FAWCETT PT, 1990, AUTOIMMUNITY, V6, P249, DOI 10.3109/08916939008998417; FRAPPIER L, 1991, J BIOL CHEM, V266, P7819; Gaynor B, 1997, P NATL ACAD SCI USA, V94, P1955, DOI 10.1073/pnas.94.5.1955; Gottlieb P, 2002, VIROLOGY, V295, P266, DOI 10.1006/viro.2002.1436; Harley JB, 2000, MOLECULAR MIMICRY, MICROBES, AND AUTOIMMUNITY, P109; ILIEV A, 1994, J IMMUNOL, V153, P3551; James JA, 1997, ANN NY ACAD SCI, V815, P124, DOI 10.1111/j.1749-6632.1997.tb52054.x; James JA, 1997, J CLIN INVEST, V100, P3019, DOI 10.1172/JCI119856; James JA, 2001, ARTHRITIS RHEUM-US, V44, P1122, DOI 10.1002/1529-0131(200105)44:5<1122::AID-ANR193>3.0.CO;2-D; Jiang C, 2010, J IMMUNOL, V184, P1085, DOI 10.4049/jimmunol.0902670; LEVITSKAYA J, 1995, NATURE, V375, P685, DOI 10.1038/375685a0; LIMPANASITHIKUL W, 1995, J IMMUNOL, V155, P967; MARCHINI B, 1994, J AUTOIMMUN, V7, P179, DOI 10.1006/jaut.1994.1014; McClain MT, 2006, ARTHRITIS RHEUM-US, V54, P360, DOI 10.1002/art.21682; PETERSEN J, 1990, ARTHRITIS RHEUM, V33, P993, DOI 10.1002/art.1780330711; Poole BD, 2009, AUTOIMMUN REV, V8, P337, DOI 10.1016/j.autrev.2008.12.008; Poole BD, 2008, J AUTOIMMUN, V31, P362, DOI 10.1016/j.jaut.2008.08.007; RANA FR, 1990, FEBS LETT, V261, P464, DOI 10.1016/0014-5793(90)80616-Q; Riemekasten G, 1998, J CLIN INVEST, V102, P754, DOI 10.1172/JCI2749; SABBATINI A, 1993, EUR J IMMUNOL, V23, P1146, DOI 10.1002/eji.1830230525; Sharma A, 2001, J AUTOIMMUN, V16, P479, DOI 10.1006/jaut.2001.0514; SHOENFELD Y, 1986, CLIN EXP IMMUNOL, V66, P255; Summers H, 1996, J VIROL, V70, P1228, DOI 10.1128/JVI.70.2.1228-1231.1996; Sun YJ, 2001, INT IMMUNOL, V13, P223, DOI 10.1093/intimm/13.2.223; Sundar K, 2004, J AUTOIMMUN, V23, P127, DOI 10.1016/j.jaut.2004.06.001; Takeda I, 1999, J AUTOIMMUN, V13, P423, DOI 10.1006/jaut.1999.0330; Taylor DK, 2006, MOL IMMUNOL, V43, P1776, DOI 10.1016/j.molimm.2005.11.003; Workman CJ, 1998, J PROTEIN CHEM, V17, P599, DOI 10.1007/BF02780961; ZACK DJ, 1995, J IMMUNOL, V154, P1987; Zhang J, 2009, J AUTOIMMUN, V33, P270, DOI 10.1016/j.jaut.2009.03.011; Zhang W, 2008, CLIN DEV IMMUNOL, DOI 10.1155/2008/683489	37	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2011	6	1							e14488	10.1371/journal.pone.0014488	http://dx.doi.org/10.1371/journal.pone.0014488			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KM	21245919	Green Published, gold			2022-12-27	WOS:000286510500005
J	Corbi, N; Batassa, EM; Pisani, C; Onori, A; Di Certo, MG; Strimpakos, G; Fanciulli, M; Mattei, E; Passananti, C				Corbi, Nicoletta; Batassa, Enrico Maria; Pisani, Cinzia; Onori, Annalisa; Di Certo, Maria Grazia; Strimpakos, Georgios; Fanciulli, Maurizio; Mattei, Elisabetta; Passananti, Claudio			The eEF1 gamma Subunit Contacts RNA Polymerase II and Binds Vimentin Promoter Region	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATION; YEAST; INTERACTS; MEDIATOR; RPB3; IDENTIFICATION; LOCALIZATION; ARCHITECTURE; DOXORUBICIN; ACTIVATION	Here, we show that the eukaryotic translation elongation factor 1 gamma (eEF1 gamma) physically interacts with the RNA polymerase II (pol II) core subunit 3 (RPB3), both in isolation and in the context of the holo-enzyme. Importantly, eEF1 gamma has been recently shown to bind Vimentin mRNA. By chromatin immunoprecipitation experiments, we demonstrate, for the first time, that eEF1 gamma is also physically present on the genomic locus corresponding to the promoter region of human Vimentin gene. The eEF1 gamma depletion causes the Vimentin protein to be incorrectly compartmentalised and to severely compromise cellular shape and mitochondria localisation. We demonstrate that eEF1 gamma partially colocalises with the mitochondrial marker Tom20 and that eEF1 gamma depletion increases mitochondrial superoxide generation as well as the total levels of carbonylated proteins. Finally, we hypothesise that eEF1 gamma, in addition to its role in translation elongation complex, is involved in regulating Vimentin gene by contacting both pol II and the Vimentin promoter region and then shuttling/nursing the Vimentin mRNA from its gene locus to its appropriate cellular compartment for translation.	[Corbi, Nicoletta; Batassa, Enrico Maria; Pisani, Cinzia; Onori, Annalisa; Passananti, Claudio] Regina Elena Inst Canc Res, CNR, Ist Biol & Patol Mol, Rome, Italy; [Pisani, Cinzia] Univ Aquila, Dept Expt Med, I-67100 Laquila, Italy; [Di Certo, Maria Grazia; Strimpakos, Georgios; Mattei, Elisabetta] IRCCS Fdn S Lucia, CNR, Ist Neurobiol & Med Mol, Rome, Italy; [Fanciulli, Maurizio] Regina Elena Inst Canc Res, Dept Therapeut Programs Dev, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; University of L'Aquila; Consiglio Nazionale delle Ricerche (CNR); IRCCS Santa Lucia; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Corbi, N (corresponding author), Regina Elena Inst Canc Res, CNR, Ist Biol & Patol Mol, Rome, Italy.	passananti@ifo.it	Passananti, Claudio/K-9593-2016; Maria Grazia, Di Certo/AAW-8769-2020; Pisani, Cinzia/AAM-1890-2020; Corbi, Nicoletta/K-2313-2014; Corbi, Nicoletta/AAW-8835-2020; fanciulli, maurizio/ABH-6745-2020	Pisani, Cinzia/0000-0002-8673-3891; PASSANANTI, CLAUDIO/0000-0002-9288-5736; CORBI, NICOLETTA/0000-0002-4505-1632; STRIMPAKOS, GEORGIOS/0000-0002-6021-9704	Paul Blumel Foundation; Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 2009, IG 5697]; Telethon [GGP07177]; Progetto PRIN	Paul Blumel Foundation; Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Telethon(Fondazione Telethon); Progetto PRIN(Ministry of Education, Universities and Research (MIUR))	This work was supported by Paul Blumel Foundation; by Associazione Italiana per la Ricerca sul Cancro (AIRC) projects IG 2009 and IG 5697; by Telethon project GGP07177; Progetto PRIN 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Maghrebi M, 2002, NUCLEIC ACIDS RES, V30, P5017, DOI 10.1093/nar/gkf656; Bermano G, 2001, FEBS LETT, V497, P77, DOI 10.1016/S0014-5793(01)02438-3; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Colomina N, 2008, J BIOL CHEM, V283, P28670, DOI 10.1074/jbc.M804604200; Corbi N, 2005, J CELL SCI, V118, P4253, DOI 10.1242/jcs.02545; Corbi N, 2002, FASEB J, V16, P1639, DOI 10.1096/fj.02-0123fje; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; De Angelis R, 2003, FEBS LETT, V547, P15, DOI 10.1016/S0014-5793(03)00659-8; Ejiri S, 2002, BIOSCI BIOTECH BIOCH, V66, P1, DOI 10.1271/bbb.66.1; Eliyahu E, 2010, MOL CELL BIOL, V30, P284, DOI 10.1128/MCB.00651-09; Esposito AM, 2010, J BIOL CHEM, V285, P37995, DOI 10.1074/jbc.M110.160887; Fadeel B, 2009, BBA-GEN SUBJECTS, V1790, P1139, DOI 10.1016/j.bbagen.2009.06.004; Fan YJ, 2010, GENETICS, V184, P141, DOI 10.1534/genetics.109.109553; Fanciulli M, 2000, FASEB J, V14, P904, DOI 10.1096/fasebj.14.7.904; Fanciulli M, 1998, FEBS LETT, V427, P236, DOI 10.1016/S0014-5793(98)00431-1; Fanciulli M, 1996, FEBS LETT, V384, P48, DOI 10.1016/0014-5793(96)00277-3; Hughes JR, 2008, PLOS BIOL, V6, P785, DOI 10.1371/journal.pbio.0060098; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; JANSSEN GMC, 1988, EUR J BIOCHEM, V171, P119, DOI 10.1111/j.1432-1033.1988.tb13766.x; Katsumoto T, 1990, BIOL CELL, V168, P139; Kim S, 2007, NAT STRUCT MOL BIOL, V14, P982, DOI 10.1038/nsmb1301; Kimura M, 1997, J BIOL CHEM, V272, P25851, DOI 10.1074/jbc.272.41.25851; KINZY TG, 1994, NUCLEIC ACIDS RES, V22, P2703, DOI 10.1093/nar/22.13.2703; Klein C, 2007, NAT GENET, P3986; KOONIN EV, 1994, PROTEIN SCI, V3, P2045, DOI 10.1002/pro.5560031117; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Koschubs T, 2009, EMBO J, V28, P69, DOI 10.1038/emboj.2008.254; Le Sourd F, 2006, BBA-GENE STRUCT EXPR, V1759, P13, DOI 10.1016/j.bbaexp.2006.02.003; Leksa NC, 2009, STRUCTURE, V17, P1082, DOI 10.1016/j.str.2009.06.003; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Merrick WC, 2000, PROTEIN SYNTHESIS EL; Mimori K, 1996, GUT, V38, P66, DOI 10.1136/gut.38.1.66; Monaco L, 2003, GENE, V321, P57, DOI 10.1016/S0378-1119(03)00834-5; Morris EJ, 2000, J CELL SCI, V113, P2433; Muller M, 2007, CELL MOL LIFE SCI, V64, P171, DOI 10.1007/s00018-006-6286-1; Olarewaju Olubunmi, 2004, RNA Biol, V1, P89, DOI 10.4161/rna.1.2.1033; Passananti C, 2007, BIOCHEM CELL BIOL, V85, P477, DOI 10.1139/O07-062; Pozniakovsky AI, 2005, J CELL BIOL, V168, P257, DOI 10.1083/jcb.200408145; Rapaport D, 2005, J CELL BIOL, V171, P419, DOI 10.1083/jcb.200507147; RIIS B, 1990, TRENDS BIOCHEM SCI, V15, P420, DOI 10.1016/0968-0004(90)90279-K; Sarnowska E, 2007, NUCLEIC ACIDS RES, V35, P5499, DOI 10.1093/nar/gkm502; Schaffer AA, 2007, CURR OPIN ALLERGY CL, V7, P481, DOI 10.1097/ACI.0b013e3282f1d690; Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028; Tan Q, 2000, GENE DEV, V14, P339; Tang HL, 2008, BIOCHEM J, V410, P141, DOI 10.1042/BJ20071072; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3	47	24	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e14481	10.1371/journal.pone.0014481	http://dx.doi.org/10.1371/journal.pone.0014481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217813	Green Submitted, gold, Green Published			2022-12-27	WOS:000285838900010
J	Zhang, YA; Duan, S; Lin, XP; Zhang, W; Meng, N; Zhao, LP; Zhao, Y; Han, DM; Zhang, L				Zhang, Yuan; Duan, Su; Lin, Xiaoping; Zhang, Wei; Meng, Na; Zhao, Liping; Zhao, Yan; Han, Demin; Zhang, Luo			SNPs in the FCER1A Gene Region Show No Association with Allergic Rhinitis in a Han Chinese Population	PLOS ONE			English	Article							SERUM IGE LEVELS; RI-ALPHA GENE; PROMOTER POLYMORPHISMS; ASTHMA; EPSILON; EPISTASIS; DISEASES; VARIANTS; CHAIN; SUSCEPTIBILITY	Background: Immunoglobulin E (IgE) is a central player in the allergic response, and raised total IgE levels are considered as an indicator of atopy or potential development of atopy. A recent genome-wide scan in a German population-based cohort of adults identified the gene encoding the alpha chain of the high affinity receptor for IgE (FCER1A) as a susceptibility locus influencing total serum IgE levels. The aim of this study was to investigate whether the polymorphisms in the FCER1A gene are associated with allergic rhinitis (AR) in a Han Chinese population. Methodology/Principal Findings: A population of 378 patients with AR and 288 healthy controls was studied. Precise phenotyping of patients was accomplished by means of a questionnaire and clinical examination. Blood was drawn for DNA extraction and total serum immunoglobulin E (IgE) measurement. A total of 16 single nucleotide polymorphisms (SNPs) in FCER1A were selected and individually genotyped. None of the SNPs in the FCER1A showed an association with AR. Similarly, the lack of association was also evident in subgroup analysis for the presence of different allergen sensitivities. None of the selected SNPs in FCER1A was associated with total IgE level. Conclusions: Although FCER1A presents itself as a good candidate for contributing to total serum IgE, this study failed to find an association between SNPs in the FCER1A gene region and IgE level or AR susceptibility.	[Zhang, Yuan; Zhang, Wei; Meng, Na; Zhao, Liping; Han, Demin; Zhang, Luo] Beijing Inst Otorhinolaryngol, Minist Educ China, Key Lab Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Zhang, Yuan; Duan, Su; Zhao, Yan; Han, Demin; Zhang, Luo] Capital Med Univ, Beijing TongRen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Lin, Xiaoping] Gen Hosp Shenyang Mil Command, Ctr Allergy & Immunotherapy, Shenyang, Peoples R China	Ministry of Education, China; Capital Medical University	Zhang, YA (corresponding author), Beijing Inst Otorhinolaryngol, Minist Educ China, Key Lab Otolaryngol Head & Neck Surg, Beijing, Peoples R China.	handm@trhos.com; dr.luozhang@gmail.com		Zhang, Luo/0000-0002-0910-9884	Ministry of Science and Technology of the People's Republic of China [2007BAI18B15]; National Science Fund for Distinguished Young Scholars [81025007]; National Natural Science Foundation of China [30872846, 30973282]; Beijing Natural Science Foundation [7072017]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the National Key Technology Research and Development Program from the Ministry of Science and Technology of the People's Republic of China (2007BAI18B15), National Science Fund for Distinguished Young Scholars (81025007), National Natural Science Foundation of China (30872846 and 30973282), and Beijing Natural Science Foundation (7072017) to DH and LZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bae JS, 2007, J ALLERGY CLIN IMMUN, V119, P449, DOI 10.1016/j.jaci.2006.10.006; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Chen CM, 2009, ALLERGY, V64, P1327, DOI 10.1111/j.1398-9995.2009.02005.x; DREBORG S, 1993, ALLERGY, V47, pS48; Geha RS, 2003, NAT REV IMMUNOL, V3, P721, DOI 10.1038/nri1181; Gibson G, 2009, NAT REV GENET, V10, P134, DOI 10.1038/nrg2502; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Hasegawa M, 2003, J IMMUNOL, V171, P1927, DOI 10.4049/jimmunol.171.4.1927; Jacobsen HP, 2001, J ALLERGY CLIN IMMUN, V107, P659; John JMM, 2010, ALLERGY, V65, P875, DOI 10.1111/j.1398-9995.2009.02297.x; Kanada S, 2008, J IMMUNOL, V180, P8204, DOI 10.4049/jimmunol.180.12.8204; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Limb SL, 2005, J ALLERGY CLIN IMMUN, V115, P61, DOI 10.1016/j.jaci.2004.09.032; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Moore JH, 2005, NAT GENET, V37, P13, DOI 10.1038/ng0105-13; Mullol J, 2008, J INVEST ALLERG CLIN, V18, P327; Musilova P, 2005, ANIM GENET, V36, P507, DOI 10.1111/j.1365-2052.2005.01348.x; Ober C, 2006, GENES IMMUN, V7, P95, DOI 10.1038/sj.gene.6364284; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Potaczek DP, 2008, INT J IMMUNOGENET, V35, P339, DOI 10.1111/j.1744-313X.2008.00784.x; Potaczek DP, 2006, ALLERGY, V61, P1230, DOI 10.1111/j.1398-9995.2006.01195.x; Potaczek DP, 2007, ANN ALLERG ASTHMA IM, V98, P500, DOI 10.1016/S1081-1206(10)60770-3; Potaczek DP, 2009, IMMUNOGENETICS, V61, P649, DOI 10.1007/s00251-009-0391-x; Shikanai T, 2002, J APPL PHYSIOL, V93, P37, DOI 10.1152/japplphysiol.00993.2001; Strachan DR, 2001, J ALLERGY CLIN IMMUN, V108, P901, DOI 10.1067/mai.2001.119408; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Vychodilova-Krenkova L, 2005, INT J IMMUNOGENET, V32, P277, DOI 10.1111/j.1744-313X.2005.00522.x; Weidinger S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000166; Xu JF, 2000, AM J HUM GENET, V67, P1163, DOI 10.1086/321190; Zhang L, 2009, INT ARCH ALLERGY IMM, V149, P47, DOI 10.1159/000176306; Zhang M, 2007, IMMUNOL RES, V37, P1, DOI 10.1007/BF02686092	36	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15792	10.1371/journal.pone.0015792	http://dx.doi.org/10.1371/journal.pone.0015792			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209833	Green Submitted, Green Published, gold			2022-12-27	WOS:000285838900034
J	Cui, T; Hurtig, M; Elgue, G; Li, SC; Veronesi, G; Essaghir, A; Demoulin, JB; Pelosi, G; Alimohammadi, M; Oberg, K; Giandomenico, V				Cui, Tao; Hurtig, Monica; Elgue, Graciela; Li, Su-Chen; Veronesi, Giulia; Essaghir, Ahmed; Demoulin, Jean-Baptiste; Pelosi, Giuseppe; Alimohammadi, Mohammad; Oberg, Kjell; Giandomenico, Valeria			Paraneoplastic Antigen Ma2 Autoantibodies as Specific Blood Biomarkers for Detection of Early Recurrence of Small Intestine Neuroendocrine Tumors	PLOS ONE			English	Article							NEUROLOGICAL SYNDROMES; POOR-PROGNOSIS; CANCER; LUNG; CARCINOMAS; MANAGEMENT; PATHOLOGY; SURVIVAL; DISEASE; CELLS	Background: Small intestine neuroendocrine tumors (SI-NETs) belong to a rare group of cancers. Most patients have developed metastatic disease at the time of diagnosis, for which there is currently no cure. The delay in diagnosis is a major issue in the clinical management of the patients and new markers are urgently needed. We have previously identified paraneoplastic antigen Ma2 (PNMA2) as a novel SI-NET tissue biomarker. Therefore, we evaluated whether Ma2 autoantibodies detection in the blood stream is useful for the clinical diagnosis and recurrence of SI-NETs. Methodology/Principal Findings: A novel indirect ELISA was set up to detect Ma2 autoantibodies in blood samples of patients with SI-NET at different stages of disease. The analysis was extended to include typical and atypical lung carcinoids (TLC and ALC), to evaluate whether Ma2 autoantibodies in the blood stream become a general biomarker for NETs. In total, 124 blood samples of SI-NET patients at different stages of disease were included in the study. The novel Ma2 autoantibody ELISA showed high sensitivity, specificity and accuracy with ROC curve analysis underlying an area between 0.734 and 0.816. Ma2 autoantibodies in the blood from SI-NET patients were verified by western blot and sequential immunoprecipitation. Serum antibodies of patients stain Ma2 in the tumor tissue and neurons. We observed that SI-NET patients expressing Ma2 autoantibody levels below the cutoff had a longer progression and recurrence-free survival compared to those with higher titer. We also detected higher levels of Ma2 autoantibodies in blood samples from TLC and ALC patients than from healthy controls, as previously shown in small cell lung carcinoma samples. Conclusion: Here we show that high Ma2 autoantibody titer in the blood of SI-NET patients is a sensitive and specific biomarker, superior to chromogranin A (CgA) for the risk of recurrence after radical operation of these tumors.	[Cui, Tao; Li, Su-Chen; Giandomenico, Valeria] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Hurtig, Monica; Alimohammadi, Mohammad; Oberg, Kjell] Univ Uppsala Hosp, Dept Med Sci, Uppsala, Sweden; [Elgue, Graciela] Uppsala Univ, Div Clin Immunol, Uppsala, Sweden; [Veronesi, Giulia] European Inst Oncol, Div Thorac Surg, Milan, Italy; [Essaghir, Ahmed; Demoulin, Jean-Baptiste] Catholic Univ Louvain, Duve Inst, B-1200 Brussels, Belgium; [Pelosi, Giuseppe] European Inst Oncol, Div Pathol & Lab Med, Milan, Italy; [Pelosi, Giuseppe] Univ Milan, Sch Med, Milan, Italy; [Oberg, Kjell; Giandomenico, Valeria] Univ Uppsala Hosp, Dept Med Sci, Sci Life Lab, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University Hospital; Uppsala University; IRCCS European Institute of Oncology (IEO); Universite Catholique Louvain; IRCCS European Institute of Oncology (IEO); University of Milan; Uppsala University; Uppsala University Hospital	Cui, T (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.	valeria.giandomenico@medsci.uu.se	Veronesi, Giulia/AAA-6327-2021; Oberg, Kjell/AAG-7118-2019; Demoulin, Jean-Baptiste/E-5847-2010; Pelosi, Giuseppe/F-5073-2012	Veronesi, Giulia/0000-0001-9032-1278; Pelosi, Giuseppe/0000-0003-4725-4692; Demoulin, Jean-Baptiste/0000-0002-8016-6689	Lions Cancerforskningsfond; Tore Nilssons Stiftelse for Medicinsk Forskning and Erik; Karin och Gosta Selander Stiftelse	Lions Cancerforskningsfond; Tore Nilssons Stiftelse for Medicinsk Forskning and Erik; Karin och Gosta Selander Stiftelse	This work was supported by funding from the Lions Cancerforskningsfond, Tore Nilssons Stiftelse for Medicinsk Forskning and Erik, Karin och Gosta Selander Stiftelse. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Behr R, 2007, DEV BIOL, V306, P636, DOI 10.1016/j.ydbio.2007.03.525; Creutzfeldt W, 1996, WORLD J SURG, V20, P126, DOI 10.1007/s002689900020; Dong J, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-81; Drozdov I, 2009, CANCER-AM CANCER SOC, V115, P1638, DOI 10.1002/cncr.24180; Eichmuller SB, 2007, CURR MED CHEM, V14, P2489, DOI 10.2174/092986707782023668; Eriksson B, 2008, NEUROENDOCRINOLOGY, V87, P8, DOI 10.1159/000111034; Gozzard Paul, 2010, Pract Neurol, V10, P260, DOI 10.1136/jnnp.2010.224105; Graus F, 1997, J CLIN ONCOL, V15, P2866, DOI 10.1200/JCO.1997.15.8.2866; Hoffmann LA, 2008, J NEUROL NEUROSUR PS, V79, P767, DOI 10.1136/jnnp.2007.118588; Honnorat J, 2009, J NEUROL NEUROSUR PS, V80, P412, DOI 10.1136/jnnp.2007.138016; Jiang BH, 2010, AM J PATHOL, V177, P1095, DOI 10.2353/ajpath.2010.091178; Kaltsas G, 2010, ENDOCR-RELAT CANCER, V17, pR173, DOI 10.1677/ERC-10-0024; Klimstra DS, 2010, AM J SURG PATHOL, V34, P300, DOI 10.1097/PAS.0b013e3181ce1447; Kloppel G, 2004, ANN NY ACAD SCI, V1014, P13, DOI 10.1196/annals.1294.002; Leja J, 2009, MODERN PATHOL, V22, P261, DOI 10.1038/modpathol.2008.174; Lenth RV, 2007, J ANIM SCI, V85, pE24, DOI 10.2527/jas.2006-449; Lleo A, 2010, AUTOIMMUN REV, V9, pA259, DOI 10.1016/j.autrev.2009.12.002; Ludbrook J, 2008, ANZ J SURG, V78, P204, DOI 10.1111/j.1445-2197.2007.04405.x; Modlin IM, 2008, JNCI-J NATL CANCER I, V100, P1282, DOI 10.1093/jnci/djn275; Modlin IM, 2008, LANCET ONCOL, V9, P61, DOI 10.1016/S1470-2045(07)70410-2; Modlin IM, 2010, ANN SURG ONCOL, V17, P2427, DOI 10.1245/s10434-010-1006-3; Monstad SE, 2009, CANCER IMMUNOL IMMUN, V58, P1797, DOI 10.1007/s00262-009-0690-y; Moran CA, 2009, AM J CLIN PATHOL, V131, P206, DOI 10.1309/AJCP9H1OTMUCSKQW; Oberg K, 2009, CURR OPIN ENDOCRINOL, V16, P72, DOI 10.1097/MED.0b013e328320d845; Pujol JL, 2007, J THORAC ONCOL, V2, P168, DOI 10.1097/JTO.0b013e31802f1c9d; Rosner B, 1999, STAT MED, V18, P1387, DOI 10.1002/(SICI)1097-0258(19990615)18:11<1387::AID-SIM126>3.0.CO;2-V; Schuller M, 2005, J NEUROIMMUNOL, V169, P172, DOI 10.1016/j.jneuroim.2005.08.019; Soreide K, 2009, J CLIN PATHOL, V62, P1, DOI 10.1136/jcp.2008.061010; Stich O, 2007, J NEUROIMMUNOL, V183, P220, DOI 10.1016/j.jneuroim.2006.11.008; Syrigos KN, 1996, INT J CANCER, V66, P624, DOI 10.1002/(SICI)1097-0215(19960529)66:5<624::AID-IJC7>3.0.CO;2-V; Tan KO, 2001, J BIOL CHEM, V276, P2802, DOI 10.1074/jbc.M008955200; Tschernatsch M, 2008, EUR J NEUROL, V15, P1390, DOI 10.1111/j.1468-1331.2008.02328.x; TSUTA K, 2010, LUNG CANC; van Dijk PC, 2008, KIDNEY INT, V74, P705, DOI 10.1038/ki.2008.294; Voltz R, 1999, NEW ENGL J MED, V340, P1788, DOI 10.1056/NEJM199906103402303; Welin S, 2009, NEUROENDOCRINOLOGY, V89, P302, DOI 10.1159/000179900; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377	37	43	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e16010	10.1371/journal.pone.0016010	http://dx.doi.org/10.1371/journal.pone.0016010			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209860	Green Published, gold			2022-12-27	WOS:000285793600058
J	Gao, CM; Yam, AY; Wang, XM; Magdangal, E; Salisbury, C; Peretz, D; Zuckermann, RN; Connolly, MD; Hansson, O; Minthon, L; Zetterberg, H; Blennow, K; Fedynyshyn, JP; Allauzen, S				Gao, Carol Man; Yam, Alice Y.; Wang, Xuemei; Magdangal, Erika; Salisbury, Cleo; Peretz, David; Zuckermann, Ronald N.; Connolly, Michael D.; Hansson, Oskar; Minthon, Lennart; Zetterberg, Henrik; Blennow, Kaj; Fedynyshyn, Joseph P.; Allauzen, Sophie			A beta 40 Oligomers Identified as a Potential Biomarker for the Diagnosis of Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID-BETA-PROTEIN; A-BETA; CEREBROVASCULAR LESIONS; SYNAPTIC PLASTICITY; CEREBROSPINAL-FLUID; PREVALENCE; PATHOGENESIS; BRAIN; NEURODEGENERATION; AGGREGATION	Alzheimer's Disease (AD) is the most prevalent form of dementia worldwide, yet the development of therapeutics has been hampered by the absence of suitable biomarkers to diagnose the disease in its early stages prior to the formation of amyloid plaques and the occurrence of irreversible neuronal damage. Since oligomeric A beta species have been implicated in the pathophysiology of AD, we reasoned that they may correlate with the onset of disease. As such, we have developed a novel misfolded protein assay for the detection of soluble oligomers composed of A beta x-40 and x-42 peptide (hereafter A beta 40 and A beta 42) from cerebrospinal fluid (CSF). Preliminary validation of this assay with 36 clinical samples demonstrated the presence of aggregated A beta 40 in the CSF of AD patients. Together with measurements of total A beta 42, diagnostic sensitivity and specificity greater than 95% and 90%, respectively, were achieved. Although larger sample populations will be needed to confirm this diagnostic sensitivity, our studies demonstrate a sensitive method of detecting circulating A beta 40 oligomers from AD CSF and suggest that these oligomers could be a powerful new biomarker for the early detection of AD.	[Gao, Carol Man; Yam, Alice Y.; Wang, Xuemei; Magdangal, Erika; Salisbury, Cleo; Peretz, David; Zuckermann, Ronald N.; Connolly, Michael D.; Fedynyshyn, Joseph P.; Allauzen, Sophie] Novartis Vaccines & Diagnost, Res & Dev, Emeryville, CA USA; [Zetterberg, Henrik; Blennow, Kaj] Sahlgrens Univ Hosp, Clin Neurochem Lab, Dept Neurosci & Physiol, Molndal, Sweden; [Hansson, Oskar; Minthon, Lennart] Lund Univ, Clin Memory Res Unit, Dept Clin Sci Malmo, Malmo, Sweden	Novartis; Sahlgrenska University Hospital; Lund University	Gao, CM (corresponding author), Novartis Vaccines & Diagnost, Res & Dev, Emeryville, CA USA.	joseph.fedynyshyn@novartis.com	Hansson, Oskar/A-7134-2013; Zuckermann, Ronald/P-3436-2019; Wang, Xuemei/GXF-3702-2022; Zuckermann, Ronald N/A-7606-2014	Hansson, Oskar/0000-0001-8467-7286; Zuckermann, Ronald/0000-0002-3055-8860; Zuckermann, Ronald N/0000-0002-3055-8860	Novartis Vaccines and Diagnostics	Novartis Vaccines and Diagnostics	This work was funded by Novartis Vaccines and Diagnostics. Several of the authors are or were employed by the funder and, as such, the funders played a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Caroli A, 2009, EXPERT REV MED DEVIC, V6, P569, DOI [10.1586/erd.09.35, 10.1586/ERD.09.35]; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FUKUMOTO H, 2010, FASEB J; Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haglund M, 2006, ACTA NEUROPATHOL, V111, P430, DOI 10.1007/s00401-006-0054-z; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jellinger KA, 2005, J NEUROL SCI, V229, P37, DOI 10.1016/j.jns.2004.11.018; Jellinger KA, 2010, NEURODEGENER DIS, V7, P112, DOI 10.1159/000285518; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008; Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lau AL, 2007, P NATL ACAD SCI USA, V104, P11551, DOI 10.1073/pnas.0704260104; Leliveld SR, 2007, J NEUROSCI RES, V85, P2285, DOI 10.1002/jnr.21353; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Nguyen JT, 2000, CHEM BIOL, V7, P463, DOI 10.1016/S1074-5521(00)00130-7; Noguchi A, 2009, J BIOL CHEM, V284, P32895, DOI 10.1074/jbc.M109.000208; Pitschke M, 1998, NAT MED, V4, P832, DOI 10.1038/nm0798-832; Portelius E, 2010, ACTA NEUROPATHOL; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; SIMON RJ, 1992, P NATL ACAD SCI USA, V89, P9367, DOI 10.1073/pnas.89.20.9367; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Takeda S, 2009, BRAIN RES, V1280, P137, DOI 10.1016/j.brainres.2009.05.035; Urbanelli Lorena, 2009, Recent Pat CNS Drug Discov, V4, P160; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Weller RO, 2003, NEUROL RES, V25, P611, DOI 10.1179/016164103101202057	38	70	75	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15725	10.1371/journal.pone.0015725	http://dx.doi.org/10.1371/journal.pone.0015725			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209907	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793600030
J	Perrin, FE; Boniface, G; Serguera, C; Lonjon, N; Serre, A; Prieto, M; Mallet, J; Privat, A				Perrin, Florence E.; Boniface, Guillaume; Serguera, Che; Lonjon, Nicolas; Serre, Angeline; Prieto, Monica; Mallet, Jacques; Privat, Alain			Grafted Human Embryonic Progenitors Expressing Neurogenin-2 Stimulate Axonal Sprouting and Improve Motor Recovery after Severe Spinal Cord Injury	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; TRAUMATIC INJURY; MOUSE MODEL; AUTOFLUORESCENCE; REPAIR; RATS; PROMOTES; BRAIN; DIFFERENTIATION	Background: Spinal cord injury (SCI) is a widely spread pathology with currently no effective treatment for any symptom. Regenerative medicine through cell transplantation is a very attractive strategy and may be used in different non-exclusive ways to promote functional recovery. We investigated functional and structural outcomes after grafting human embryonic neural progenitors (hENPs) in spinal cord-lesioned rats. Methods and Principal Findings: With the objective of translation to clinics we have chosen a paradigm of delayed grafting, i.e., one week after lesion, in a severe model of spinal cord compression in adult rats. hENPs were either naive or engineered to express Neurogenin 2 (Ngn2). Moreover, we have compared integrating and non-integrating lentiviral vectors, since the latter present reduced risks of insertional mutagenesis. We show that transplantation of hENPs transduced to express Ngn2 fully restore weight support and improve functional motor recovery after severe spinal cord compression at thoracic level. This was correlated with partial restoration of serotonin innervations at lumbar level, and translocation of 5HT1A receptors to the plasma membrane of motoneurons. Since hENPs were not detectable 4 weeks after grafting, transitory expression of Ngn2 appears sufficient to achieve motor recovery and to permit axonal regeneration. Importantly, we also demonstrate that transplantation of naive hENPs is detrimental to functional recovery. Conclusions and Significance: Transplantation and short-term survival of Ngn2-expressing hENPs restore weight support after SCI and partially restore serotonin fibers density and 5HT1A receptor pattern caudal to the lesion. Moreover, grafting of naive-hENPs was found to worsen the outcome versus injured only animals, thus pointing to the possible detrimental effect of stem cell-based therapy per se in SCI. This is of major importance given the increasing number of clinical trials involving cell grafting developed for SCI patients.	[Perrin, Florence E.; Privat, Alain] Univ Basque Country UPV EHU, Dept Neurosci, IKERBASQUE Basque Fdn Sci, Bilbao, Spain; [Perrin, Florence E.; Boniface, Guillaume; Lonjon, Nicolas; Privat, Alain] St Eloi Hosp, INSERM, U583, Inst Neurosci Montpellier Pathophysiol & Therapy, Montpellier, France; [Boniface, Guillaume; Lonjon, Nicolas] Gui de Chauliac Hosp, Dept Neurosurg, Montpellier, France; [Serguera, Che; Serre, Angeline; Mallet, Jacques] Univ Paris 06, INSERM UMRS 975, Inst Cerveau & Moelle Epiniere, Hop La Pitie Salpetriere,Ctr Rech,CNRS UMR 7225, Paris, France; [Serguera, Che] CEA INSERM, MIRCen, Fontenay Aux Roses, France; [Prieto, Monica; Privat, Alain] St Eloi Hosp, Neureva Inc INM, Montpellier, France	Basque Foundation for Science; University of Basque Country; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Universite de Montpellier; CHU de Montpellier	Perrin, FE (corresponding author), Univ Basque Country UPV EHU, Dept Neurosci, IKERBASQUE Basque Fdn Sci, Bilbao, Spain.	f.perrin@ikerbasque.org	Serguera, Ché/J-8918-2012; PERRIN, Florence/AAY-6815-2021	Serguera, Che/0000-0002-9210-0636; PERRIN, Florence/0000-0002-7630-0515	European Union; Institut pour la Recherche sur la Moelle Epiniere; Academie de Medecine; Societe Francaise de Neurochirurgie; Verticale; Association Demain Debout Aquitaine	European Union(European Commission); Institut pour la Recherche sur la Moelle Epiniere; Academie de Medecine; Societe Francaise de Neurochirurgie; Verticale; Association Demain Debout Aquitaine	This study was supported by the European Union FP6 "RESCUE" STREP; the "Institut pour la Recherche sur la Moelle Epiniere"; the "Academie de Medecine"; the "Societe Francaise de Neurochirurgie"; "Verticale" and the "Association Demain Debout Aquitaine". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abematsu M, 2010, J CLIN INVEST, V120, P3255, DOI 10.1172/JCI42957; AUBIN JE, 1979, J HISTOCHEM CYTOCHEM, V27, P36, DOI 10.1177/27.1.220325; Baptiste DC, 2007, PROG BRAIN RES, V161, P217, DOI 10.1016/S0079-6123(06)61015-7; Barnabe-Heider F, 2008, CELL STEM CELL, V3, P16, DOI 10.1016/j.stem.2008.06.011; Bauchet L., 2009, Annals of Physical and Rehabilitation Medicine, V52, P330, DOI 10.1016/j.annrmp.2008.10.004; BENSON RC, 1979, J HISTOCHEM CYTOCHEM, V27, P44, DOI 10.1177/27.1.438504; BUCCARON MH, 1995, NEUROBIOL DIS, V2, P37, DOI 10.1006/nbdi.1995.0004; Buchet D, 2002, MOL CELL NEUROSCI, V19, P389, DOI 10.1006/mcne.2001.1086; CAVALIERI B, 1635, CERTAIN METHOD DEV N, P1; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Gaviria M, 2002, J NEUROTRAUM, V19, P205, DOI 10.1089/08977150252806965; HAVENITH CEG, 1993, J LEUKOCYTE BIOL, V53, P504, DOI 10.1002/jlb.53.5.504; Heinrich C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000373; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054; LONJON N, 2010, SPINAL CORD IN PRESS; Lonjon N, 2010, J NEUROSURG-SPINE, V12, P106, DOI 10.3171/2009.7.SPINE0989; Lonjon N, 2009, J NEUROSCI RES, V87, P403, DOI 10.1002/jnr.21871; MALLEY A, 1988, J LEUKOCYTE BIOL, V43, P557, DOI 10.1002/jlb.43.6.557; MARTIN D, 1992, J NEUROSCI RES, V32, P539, DOI 10.1002/jnr.490320409; NICOD LP, 1989, J LEUKOCYTE BIOL, V45, P458, DOI 10.1002/jlb.45.5.458; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Ramos-Cabrer P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012779; Ribotta MG, 2002, PROG BRAIN RES, V137, P191; RIBOTTA MGY, 1995, J NEUROSCI RES, V41, P79, DOI 10.1002/jnr.490410110; Ronaghi M, 2010, STEM CELLS, V28, P93, DOI 10.1002/stem.253; Rossi SL, 2009, CURR OPIN BIOTECH, V20, P552, DOI 10.1016/j.copbio.2009.09.008; Sahni V, 2010, NAT REV NEUROL, V6, P363, DOI 10.1038/nrneurol.2010.73; Salazar DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012272; Sarkis C, 2008, CURR GENE THER, V8, P430, DOI 10.2174/156652308786848012; Schnell L, 1999, J NEUROPATH EXP NEUR, V58, P245, DOI 10.1097/00005072-199903000-00004; Sedy J, 2007, J NEUROTRAUM, V24, P1487, DOI 10.1089/neu.2006.0252; SHAPIRO S, 1995, J SURG RES, V59, P393, DOI 10.1006/jsre.1995.1181; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Vanicky I, 2001, J NEUROTRAUM, V18, P1399, DOI 10.1089/08977150152725687; Zennou V, 2001, NAT BIOTECHNOL, V19, P446, DOI 10.1038/88115	37	34	35	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15914	10.1371/journal.pone.0015914	http://dx.doi.org/10.1371/journal.pone.0015914			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209909	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793600050
J	Krijger, PHL; Wit, N; van den Berk, PCM; Jacobs, H				Krijger, Peter H. L.; Wit, Niek; van den Berk, Paul C. M.; Jacobs, Heinz			The Fanconi Anemia Core Complex Is Dispensable during Somatic Hypermutation and Class Switch Recombination	PLOS ONE			English	Article							DNA-POLYMERASE-ETA; IMMUNOGLOBULIN GENE HYPERMUTATION; HOMOLOGOUS RECOMBINATION; TRANSLESION SYNTHESIS; REPAIR; MICE; REV1; MUTAGENESIS; MECHANISM; PATHWAY	To generate high affinity antibodies during an immune response, B cells undergo somatic hypermutation (SHM) of their immunoglobulin genes. Error-prone translesion synthesis (TLS) DNA polymerases have been reported to be responsible for all mutations at template A/T and at least a fraction of G/C transversions. In contrast to A/T mutations which depend on PCNA ubiquitination, it remains unclear how G/C transversions are regulated during SHM. Several lines of evidence indicate a mechanistic link between the Fanconi Anemia (FA) pathway and TLS. To investigate the contribution of the FA pathway in SHM we analyzed FancG-deficient B cells. B cells deficient for FancG, an essential member of the FA core complex, were hypersensitive to treatment with cross-linking agents. However, the frequencies and nucleotide exchange spectra of SHM remained comparable between wild-type and FancG-deficient B cells. These data indicate that the FA pathway is not involved in regulating the outcome of SHM in mammals. In addition, the FA pathway appears dispensable for class switch recombination.	[Krijger, Peter H. L.; Wit, Niek; van den Berk, Paul C. M.; Jacobs, Heinz] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Krijger, PHL (corresponding author), Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands.	h.jacobs@nki.nl		Jacobs, Heinz/0000-0001-6227-9850; Krijger, Peter/0000-0003-1702-348X	Netherlands Organisation for Scientific Research; Dutch Cancer Foundation [NWO 917.56.328, NKI-2008-4112]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Foundation(KWF Kankerbestrijding)	This work was funded by the Netherlands Organisation for Scientific Research (http://www.nwo.nl) and the Dutch Cancer Foundation (www.kwf.nl) (VIDI program NWO 917.56.328 and KWF grant NKI-2008-4112 to HJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo A, 2010, MOL CELL, V39, P25, DOI 10.1016/j.molcel.2010.06.026; BRENNER S, 1966, NATURE, V211, P242, DOI 10.1038/211242a0; Delbos F, 2005, J EXP MED, V201, P1191, DOI 10.1084/jem.20050292; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Faili A, 2009, J IMMUNOL, V182, P6353, DOI 10.4049/jimmunol.0900177; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Jansen JG, 2007, MOL CELL, V28, P522, DOI 10.1016/j.molcel.2007.11.005; Jansen JG, 2006, J EXP MED, V203, P319, DOI 10.1084/jem.20052227; Jolly CJ, 1997, NUCLEIC ACIDS RES, V25, P1913, DOI 10.1093/nar/25.10.1913; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kee Y, 2010, GENE DEV, V24, P1680, DOI 10.1101/gad.1955310; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Koomen M, 2002, HUM MOL GENET, V11, P273, DOI 10.1093/hmg/11.3.273; Krijger PHL, 2009, J EXP MED, V206, P2603, DOI 10.1084/jem.20091707; Langerak P, 2007, J EXP MED, V204, P1989, DOI 10.1084/jem.20070902; Martomo SA, 2005, P NATL ACAD SCI USA, V102, P8656, DOI 10.1073/pnas.0501852102; Masuda K, 2009, J IMMUNOL, V183, P1846, DOI 10.4049/jimmunol.0901240; Mirchandani KD, 2008, DNA REPAIR, V7, P902, DOI 10.1016/j.dnarep.2008.03.001; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Pace P, 2010, SCIENCE, V329, P219, DOI 10.1126/science.1192277; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Roa S, 2008, P NATL ACAD SCI USA, V105, P16248, DOI 10.1073/pnas.0808182105; Ross AL, 2006, MOL IMMUNOL, V43, P1587, DOI 10.1016/j.molimm.2005.09.017; Schenten D, 2002, EUR J IMMUNOL, V32, P3152, DOI 10.1002/1521-4141(200211)32:11<3152::AID-IMMU3152>3.0.CO;2-2; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Yamamoto K, 2005, MOL CELL BIOL, V25, P34, DOI 10.1128/MCB.25.1.34-43.2005; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740	29	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15236	10.1371/journal.pone.0015236	http://dx.doi.org/10.1371/journal.pone.0015236			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209924	Green Published, Green Submitted, gold			2022-12-27	WOS:000285793200021
J	Radtke, AL; Wilson, JW; Sarker, S; Nickerson, CA				Radtke, Andrea L.; Wilson, James W.; Sarker, Shameema; Nickerson, Cheryl A.			Analysis of Interactions of Salmonella Type Three Secretion Mutants with 3-D Intestinal Epithelial Cells	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; PATHOGENICITY ISLAND 1; FLAGELLAR PROTEIN EXPORT; ROTATING-WALL VESSEL; III SECRETION; COLONIZATION FACTORS; FIMBRIAL OPERONS; MOLECULAR-BASIS; MASTER OPERON; ANIMAL-MODELS	The prevailing paradigm of Salmonella enteropathogenesis based on monolayers asserts that Salmonella pathogenicity island-1 Type Three Secretion System (SPI-1 T3SS) is required for bacterial invasion into intestinal epithelium. However, little is known about the role of SPI-1 in mediating gastrointestinal disease in humans. Recently, SPI-1 deficient nontyphoidal Salmonella strains were isolated from infected humans and animals, indicating that SPI-1 is not required to cause enteropathogenesis and demonstrating the need for more in vivo-like models. Here, we utilized a previously characterized 3-D organotypic model of human intestinal epithelium to elucidate the role of all characterized Salmonella enterica T3SSs. Similar to in vivo reports, the Salmonella SPI-1 T3SS was not required to invade 3-D intestinal cells. Additionally, Salmonella strains carrying single (SPI-1 or SPI-2), double (SPI-1/2) and complete T3SS knockout (SPI-1/SPI-2:flhDC) also invaded 3-D intestinal cells to wildtype levels. Invasion of wildtype and TTSS mutants was a Salmonella active process, whereas noninvasive bacterial strains, bacterial size beads, and heat-killed Salmonella did not invade 3-D cells. Wildtype and T3SS mutants did not preferentially target different cell types identified within the 3-D intestinal aggregates, including M-cells/M-like cells, enterocytes, or Paneth cells. Moreover, each T3SS was necessary for substantial intracellular bacterial replication within 3-D cells. Collectively, these results indicate that T3SSs are dispensable for Salmonella invasion into highly differentiated 3-D models of human intestinal epithelial cells, but are required for intracellular bacterial growth, paralleling in vivo infection observations and demonstrating the utility of these models in predicting in vivo-like pathogenic mechanisms.	[Radtke, Andrea L.; Wilson, James W.; Sarker, Shameema; Nickerson, Cheryl A.] Arizona State Univ, Sch Life Sci, Ctr Infect Dis & Vaccinol, Biodesign Inst, Tempe, AZ 85287 USA; [Wilson, James W.] Villanova Univ, Dept Biol, Villanova, PA 19085 USA	Arizona State University; Arizona State University-Tempe; Villanova University	Radtke, AL (corresponding author), Arizona State Univ, Sch Life Sci, Ctr Infect Dis & Vaccinol, Biodesign Inst, Tempe, AZ 85287 USA.	cheryl.nickerson@asu.edu			NASA [NNJ06HE92, NNX09AH40G]; NIH [R21MH080702]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH080702] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was funded by NASA grants NNJ06HE92 and NNX09AH40G and NIH grant R21MH080702. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Barrila J, 2010, NAT REV MICROBIOL, V8, P791, DOI 10.1038/nrmicro2423; Baumler AJ, 1997, J BACTERIOL, V179, P317; Baumler AJ, 1997, INFECT IMMUN, V65, P2254; Bentrup KHZ, 2006, MICROBES INFECT, V8, P1813, DOI 10.1016/j.micinf.2006.02.020; Bevins CL, 2004, CURR OPIN GASTROEN, V20, P572, DOI 10.1097/00001574-200411000-00012; Bishop A, 2008, MICROBIOL-SGM, V154, P1914, DOI 10.1099/mic.0.2008/016998-0; Brayden DJ, 2005, DRUG DISCOV TODAY, V10, P1145, DOI 10.1016/S1359-6446(05)03536-1; Bueno SM, 2010, IMMUNOLOGY, V130, P273, DOI 10.1111/j.1365-2567.2009.03233.x; CARTER PB, 1974, J EXP MED, V139, P1189, DOI 10.1084/jem.139.5.1189; Carterson AJ, 2005, INFECT IMMUN, V73, P1129, DOI 10.1128/IAI.73.2.1129-1140.2005; CHEN TR, 1987, CANCER GENET CYTOGEN, V27, P125, DOI 10.1016/0165-4608(87)90267-6; Claret L, 2007, J BIOL CHEM, V282, P33275, DOI 10.1074/jbc.M702800200; Clark MA, 1998, INFECT IMMUN, V66, P724, DOI 10.1128/IAI.66.2.724-731.1998; CLARK MA, 1994, RES MICROBIOL, V145, P543, DOI 10.1016/0923-2508(94)90031-0; Coombes BK, 2005, INFECT IMMUN, V73, P7161, DOI 10.1128/IAI.73.11.7161-7169.2005; Darwin KH, 1999, CLIN MICROBIOL REV, V12, P405, DOI 10.1128/CMR.12.3.405; Desin TS, 2009, INFECT IMMUN, V77, P2866, DOI 10.1128/IAI.00039-09; Edwards RA, 2000, P NATL ACAD SCI USA, V97, P1258, DOI 10.1073/pnas.97.3.1258; Folkesson A, 2002, RES MICROBIOL, V153, P537, DOI 10.1016/S0923-2508(02)01348-7; Folkesson A, 1999, MOL MICROBIOL, V33, P612, DOI 10.1046/j.1365-2958.1999.01508.x; FRANCIS CL, 1993, NATURE, V364, P639, DOI 10.1038/364639a0; Fraser GM, 2003, MOL MICROBIOL, V48, P1043, DOI 10.1046/j.1365-2958.2003.03487.x; Frost AJ, 1997, VET PATHOL, V34, P369, DOI 10.1177/030098589703400501; Frye J, 2006, J BACTERIOL, V188, P2233, DOI 10.1128/JB.188.6.2233-2243.2006; Galan JE, 2000, P NATL ACAD SCI USA, V97, P8754, DOI 10.1073/pnas.97.16.8754; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; GALAN JE, 1992, J BACTERIOL, V174, P4338; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Galyov EE, 1997, MOL MICROBIOL, V25, P903, DOI 10.1111/j.1365-2958.1997.mmi525.x; GARCIADELPORTILLO F, 1994, INFECT IMMUN, V62, P4641, DOI 10.1128/IAI.62.10.4641-4645.1994; Gerlach RG, 2007, CELL MICROBIOL, V9, P1834, DOI 10.1111/j.1462-5822.2007.00919.x; Gersemann M, 2009, DIFFERENTIATION, V77, P84, DOI 10.1016/j.diff.2008.09.008; Giannasca PJ, 1999, INFECT IMMUN, V67, P946, DOI 10.1128/IAI.67.2.946-953.1999; GOODWIN TJ, 1993, P SOC EXP BIOL MED, V202, P181; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; HEESEMANN J, 1985, J CLIN MICROBIOL, V22, P168, DOI 10.1128/JCM.22.2.168-175.1985; HENLE G, 1957, J IMMUNOL, V79, P54; Henry-Stanley MJ, 2006, CYTOKINE, V34, P252, DOI 10.1016/j.cyto.2006.05.008; Hensel M, 2004, INT J MED MICROBIOL, V294, P95, DOI 10.1016/j.ijmm.2004.06.025; Hjelm BE, 2010, BIOL REPROD, V82, P617, DOI 10.1095/biolreprod.109.080408; Ho SP, 2001, AM J PHYSIOL-CELL PH, V281, pC1106, DOI 10.1152/ajpcell.2001.281.4.C1106; HORIUCHI S, 1992, MICROBIOL IMMUNOL, V36, P593, DOI 10.1111/j.1348-0421.1992.tb02059.x; Hu QH, 2008, J CLIN MICROBIOL, V46, P1330, DOI 10.1128/JCM.01255-07; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Humphries AD, 2001, FEMS MICROBIOL LETT, V201, P121, DOI 10.1016/S0378-1097(01)00250-6; Hurley BP, 2003, TRENDS MICROBIOL, V11, P562, DOI 10.1016/j.tim.2003.10.002; Jeong JH, 2008, J BACTERIOL, V190, P6340, DOI 10.1128/JB.00385-08; Jepson MA, 2001, MICROBES INFECT, V3, P1183, DOI 10.1016/S1286-4579(01)01478-2; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Keshav S, 2006, J LEUKOCYTE BIOL, V80, P500, DOI 10.1189/jlb.1005556; Kraehenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301, DOI 10.1146/annurev.cellbio.16.1.301; Kuhle V, 2004, CELL MOL LIFE SCI, V61, P2812, DOI 10.1007/s00018-004-4248-z; Kutsukake K, 1997, MOL GEN GENET, V254, P440, DOI 10.1007/s004380050437; LaMarca HL, 2005, PLACENTA, V26, P709, DOI 10.1016/j.placenta.2004.11.003; Lee FKM, 2006, FEMS MICROBIOL LETT, V261, P41, DOI 10.1111/j.1574-6968.2006.00338.x; LENNOX ES, 1955, VIROLOGY, V1, P190, DOI 10.1016/0042-6822(55)90016-7; Lim JS, 2009, BIOCHEM BIOPH RES CO, V390, P1322, DOI 10.1016/j.bbrc.2009.10.145; MACBETH KJ, 1993, INFECT IMMUN, V61, P1544, DOI 10.1128/IAI.61.4.1544-1546.1993; Macnab RM, 2004, BBA-MOL CELL RES, V1694, P207, DOI 10.1016/j.bbamcr.2004.04.005; Macnab RM, 1999, J BACTERIOL, V181, P7149, DOI 10.1128/JB.181.23.7149-7153.1999; Martinez-Argudo I, 2008, MICROBIOL-SGM, V154, P3887, DOI 10.1099/mic.0.2008/021162-0; Mastroianni JR, 2009, J BIOL CHEM, V284, P27848, DOI 10.1074/jbc.M109.050773; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Misselwitz B, 2010, INFECT IMMUN; Morgan E, 2004, MOL MICROBIOL, V54, P994, DOI 10.1111/j.1365-2958.2004.04323.x; Murray RA, 2000, INFECT IMMUN, V68, P5050, DOI 10.1128/IAI.68.9.5050-5055.2000; Nevalainen TJ, 2001, APMIS, V109, P295, DOI 10.1034/j.1600-0463.2001.d01-123.x; Nickerson CA, 2001, INFECT IMMUN, V69, P7106, DOI 10.1128/IAI.69.11.7106-7120.2001; Pullinger GD, 2007, INFECT IMMUN, V75, P5191, DOI 10.1128/IAI.00784-07; Raffatellu M, 2005, INFECT IMMUN, V73, P146, DOI 10.1128/IAI.73.1.146-154.2005; Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2; Schenk M, 2008, BEST PRACT RES CL GA, V22, P391, DOI 10.1016/j.bpg.2007.11.002; Steele-Mortimer O, 2002, CELL MICROBIOL, V4, P43, DOI 10.1046/j.1462-5822.2002.00170.x; Steele-Mortimer O, 1999, CELL MICROBIOL, V1, P33, DOI 10.1046/j.1462-5822.1999.00003.x; Straub TM, 2007, EMERG INFECT DIS, V13, P396, DOI 10.3201/eid1303.060549; Sukhan A, 2001, J BACTERIOL, V183, P1159, DOI 10.1128/JB.183.4.1159-1167.2001; Tenor JL, 2004, CURR BIOL, V14, P1018, DOI 10.1016/j.cub.2004.05.050; Townsend SM, 2001, INFECT IMMUN, V69, P2894, DOI 10.1128/IAI.69.5.2894-2901.2001; Wallis TS, 2000, MOL MICROBIOL, V36, P997, DOI 10.1046/j.1365-2958.2000.01892.x; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; WATSON PR, 1995, INFECT IMMUN, V63, P2743, DOI 10.1128/IAI.63.7.2743-2754.1995; Westphal V, 2000, AM J PATHOL, V157, P1917, DOI 10.1016/S0002-9440(10)64830-4; Yanagihara S, 1999, GENES GENET SYST, V74, P105, DOI 10.1266/ggs.74.105	85	44	46	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15750	10.1371/journal.pone.0015750	http://dx.doi.org/10.1371/journal.pone.0015750			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206750	Green Submitted, gold, Green Published			2022-12-27	WOS:000285793200050
J	Wang, Z; Du, JA; Sun, HM; Wu, H; Xiao, ZP; Zhao, M				Wang, Zhen; Du, Jiang; Sun, Haiming; Wu, Helen; Xiao, Zeping; Zhao, Min			Patterns of Childhood Trauma and Psychological Distress among Injecting Heroin Users in China	PLOS ONE			English	Article							SUBSTANCE-ABUSE TREATMENT; COCAINE RELAPSE OUTCOMES; PHYSICAL ABUSE; SEXUAL-ABUSE; COMMUNITY SAMPLE; HEALTH CONSEQUENCES; COPING STRATEGIES; WOMEN; IMPACT; MEN	Background: Childhood trauma has been reported as a possible cause of future substance abuse in some countries. This study reports the prevalence of childhood trauma and examines its association with psychological distress among injecting drug users from mainland China. Methodology: The study was conducted in three government-operated drug rehabilitation facilities in Shanghai, China in 2007. The Early Trauma Inventory Self Report-Short Form (ETISR-SF) was used to evaluate 4 types (general, emotional, physical and sexual) and severity of childhood trauma, and the Symptom Checklist-90-Revised (SCL-90-R) to evaluate psychological distress. Principal Findings: Among 341 injecting drug users who completed the study, about 80% reported one or more types of childhood trauma, specifically 53% general trauma, 56% physical abuse, 36% emotional abuse and 26% sexual abuse. Compared to female injecting drug users, males reported significantly higher scores of general trauma and physical abuse, but lower sexual abuse scores. Hierarchical linear regression analyses showed that greater physical and emotional abuse in childhood predict greater current psychopathological distress among these injecting drug users in China. Conclusions: The results reveal a high prevalence of childhood trauma among injecting drug users in China, and it is comparable to other similar studies in Western countries. It is important to consider the role of childhood trauma in the prevention and treatment of substance abuse.	[Wang, Zhen; Du, Jiang; Sun, Haiming; Xiao, Zeping; Zhao, Min] Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Sch Med, Shanghai 200030, Peoples R China; [Wu, Helen] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX USA	Shanghai Jiao Tong University; University of Texas System; University of Texas Medical Branch Galveston	Wang, Z (corresponding author), Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Sch Med, Shanghai 200030, Peoples R China.	xiaozeping@gmail.com; drzhaomin@gmail.com	Wang, Zhen/A-2389-2011	Wang, Zhen/0000-0003-4319-5314	NIH [R01-TW007279]; FOGARTY INTERNATIONAL CENTER [R01TW007279] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Funding for this study was provided by NIH grant R01-TW007279. The NIH had no role in the study design, collection, analysis, or interpretation of the data, writing the manuscript, or the decision to submit the paper for publication.	Bifulco A, 2000, SOC PSYCH PSYCH EPID, V35, P264, DOI 10.1007/s001270050238; Bremner JD, 2007, J NERV MENT DIS, V195, P211, DOI 10.1097/01.nmd.0000243824.84651.6c; Brems C, 2004, AM J DRUG ALCOHOL AB, V30, P799, DOI 10.1081/ADA-200037546; BRIERE J, 1990, CHILD ABUSE NEGLECT, V14, P357, DOI 10.1016/0145-2134(90)90007-G; Burnette ML, 2008, J SUBST ABUSE TREAT, V35, P217, DOI 10.1016/j.jsat.2007.10.002; [陈树林 Chen Shulin], 2003, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V29, P323; Chen ZL, 2007, INT J OFFENDER THER, V51, P98, DOI 10.1177/0306624X06295717; Chu TX, 2005, CELL RES, V15, P865, DOI 10.1038/sj.cr.7290360; DEROGATIS LR, 1983, ARCH GEN PSYCHIAT, V40, P1152; Dube SR, 2001, JAMA-J AM MED ASSOC, V286, P3089, DOI 10.1001/jama.286.24.3089; Feldman MB, 2007, INT J EAT DISORDER, V40, P418, DOI 10.1002/eat.20378; Goeders N, 2003, EUR NEUROPSYCHOPHARM, V13, pS5, DOI 10.1016/S0924-977X(03)90003-4; Hardt J, 2004, J CHILD PSYCHOL PSYC, V45, P260, DOI 10.1111/j.1469-7610.2004.00218.x; Heffernan K, 2000, ADDICT BEHAV, V25, P797, DOI 10.1016/S0306-4603(00)00066-6; Hussey JM, 2006, PEDIATRICS, V118, P933, DOI 10.1542/peds.2005-2452; Hyman SM, 2008, DRUG ALCOHOL DEPEN, V92, P208, DOI 10.1016/j.drugalcdep.2007.08.006; Hyman SM, 2006, AM J DRUG ALCOHOL AB, V32, P655, DOI 10.1080/10623320600919193; Michels II, 2007, ACTA PHARMACOL SIN, V28, P1505, DOI 10.1111/j.1745-7254.2007.00633.x; Kendler KS, 2000, ARCH GEN PSYCHIAT, V57, P953, DOI 10.1001/archpsyc.57.10.953; Klein H, 2007, CHILD ABUSE NEGLECT, V31, P39, DOI 10.1016/j.chiabu.2006.08.005; LI C, 2002, CHINESE J DRUG DEPEN, V11, P133; MacMillan HL, 2001, AM J PSYCHIAT, V158, P1878, DOI 10.1176/appi.ajp.158.11.1878; MacMillan HL, 1997, JAMA-J AM MED ASSOC, V278, P131, DOI 10.1001/jama.278.2.131; Medrano MA, 2002, AM J DRUG ALCOHOL AB, V28, P1, DOI 10.1081/ADA-120001278; Medrano MA, 1999, AM J DRUG ALCOHOL AB, V25, P449, DOI 10.1081/ADA-100101872; Merrill LL, 2001, J CONSULT CLIN PSYCH, V69, P992, DOI 10.1037//0022-006X.69.6.992; Min M, 2007, J TRAUMA STRESS, V20, P833, DOI 10.1002/jts.20250; Plotzker RE, 2007, AM J ADDICTION, V16, P431, DOI 10.1080/10550490701643161; Rodgers CS, 2004, CHILD ABUSE NEGLECT, V28, P575, DOI 10.1016/j.chiabu.2004.01.002; ROSS CA, 1990, AM J PSYCHIAT, V147, P1698; Sacks JY, 2008, J SUBST ABUSE TREAT, V34, P90, DOI 10.1016/j.jsat.2007.01.010; Schaaf KK, 1998, CHILD ABUSE NEGLECT, V22, P1119, DOI 10.1016/S0145-2134(98)00090-8; Schafer M, 2000, PSYCHOTHER PSYCH MED, V50, P38, DOI 10.1055/s-2000-13235; Scher CD, 2004, CHILD ABUSE NEGLECT, V28, P167, DOI 10.1016/j.chiabu.2003.09.012; Sinha R, 2006, ARCH GEN PSYCHIAT, V63, P324, DOI 10.1001/archpsyc.63.3.324; SPITZER R. L., 1994, STRUCTURED CLIN INTE; Springer KW, 2007, CHILD ABUSE NEGLECT, V31, P517, DOI 10.1016/j.chiabu.2007.01.003; Vaddiparti K, 2006, ARCH SEX BEHAV, V35, P451, DOI 10.1007/s10508-006-9044-4; [王振 WANG Zhen], 2008, [中国行为医学科学, Chinese Journal of Behavioral Medical Science], V17, P956; Wong DFK, 2002, SOC WORK HEALTH CARE, V35, P479, DOI 10.1300/J010v35n01_08; WYATT GE, 1985, CHILD ABUSE NEGLECT, V9, P507, DOI 10.1016/0145-2134(85)90060-2; Xiao ZP, 2006, AM J PSYCHIAT, V163, P1388, DOI 10.1176/appi.ajp.163.8.1388	42	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15882	10.1371/journal.pone.0015882	http://dx.doi.org/10.1371/journal.pone.0015882			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	701CZ	21209959	Green Published, Green Submitted, gold			2022-12-27	WOS:000285793200063
J	Yan, TT; Yin, WJ; Zhou, LH; Jiang, YW; Shen, ZZ; Shao, ZM; Lu, JS				Yan, Tingting; Yin, Wenjin; Zhou, Liheng; Jiang, Yiwei; Shen, Zhenzhou; Shao, Zhimin; Lu, Jinsong			Postoperative Fever: The Potential Relationship with Prognosis in Node Negative Breast Cancer Patients	PLOS ONE			English	Article							GENE-EXPRESSION; GROWTH; RECURRENCE; CARCINOMA; SURVIVAL; MICE	Background: Postoperative fever may serve as an indirect sign to reflect the alterations of the host milieu caused by surgery. It still remains open to investigation whether postoperative fever has a bearing on prognosis in patients with lymph node negative breast cancers. Methods: We performed a retrospective study of 883 female unilateral patients with lymph node negative breast cancer. Fever was defined as an oral temperature >= 38 in one week postoperation. Survival curves were performed with Kaplan-Meier method, and annual relapse hazard was estimated by hazard function. Findings: The fever patients were older than those without fever (P<0.0001). Hypertensive patients had a propensity for fever after surgery (P=0.011). A statistically significant difference was yielded in the incidence of fever among HR+/ERBB2-, ERBB2+, HR-/ERBB2-subgroups (P=0.012). In the univariate survival analysis, we observed postoperative fever patients were more likely to recur than those without fever (P=0.0027). The Cox proportional hazards regression analysis showed that postoperative fever (P=0.044, RR=1.89, 95%CI 1.02-3.52) as well as the HR/ERBB2 subgroups (P=0.013, HR=1.60, 95%CI 1.09-2.31) was an independent prognostic factor for relapse-free survival. Conclusion: Postoperative fever may contribute to relapse in node negative breast cancer patients, which suggests that changes in host milieu related to fever might accelerate the growth of micro-metastatic foci. It may be more precise to integrate both tumor-and host-related factors for the evaluation of relapse risk.	[Yan, Tingting; Yin, Wenjin; Zhou, Liheng; Jiang, Yiwei; Shen, Zhenzhou; Shao, Zhimin; Lu, Jinsong] Fudan Univ, Dept Breast Surg, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Yan, Tingting; Yin, Wenjin; Zhou, Liheng; Jiang, Yiwei; Shen, Zhenzhou; Shao, Zhimin; Lu, Jinsong] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Yan, TT (corresponding author), Fudan Univ, Dept Breast Surg, Shanghai Canc Ctr, Shanghai 200433, Peoples R China.	lujjss@yahoo.com.cn	Li-Mei, Cheng/L-2214-2013; Yin, Wenjin/L-6020-2019	Yin, Wenjin/0000-0002-2129-7443				Bull SB, 2004, J CLIN ONCOL, V22, P86, DOI 10.1200/JCO.2004.09.128; Conti B, 2004, FRONT BIOSCI-LANDMRK, V9, P1433, DOI 10.2741/1341; Conze D, 2001, CANCER RES, V61, P8851; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; FISHER B, 1989, CANCER RES, V49, P1996; Fracheboud J, 2004, BRIT J CANCER, V91, P861, DOI 10.1038/sj.bjc.6602075; Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Habel LA, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1412; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Kumar Satish, 2007, Indian Heart J, V59, P316; Majetschak M, 2000, CRIT CARE MED, V28, P1847, DOI 10.1097/00003246-200006000-00027; Marcy SM, 2004, VACCINE, V22, P551, DOI 10.1016/j.vaccine.2003.09.007; McCarter MD, 1998, SURGERY, V123, P96, DOI 10.1016/S0039-6060(98)70234-X; Mirza AN, 2002, ANN SURG, V235, P10, DOI 10.1097/00000658-200201000-00003; Mitchell JD, 2007, CYTOKINE, V38, P37, DOI 10.1016/j.cyto.2007.04.009; Murthy BL, 2007, BRIT J CANCER, V97, P1211, DOI 10.1038/sj.bjc.6604004; *NAT AC ENG CTR EN, 2006, EXPL FED REG HUM S 1; *NAT COMPR CANC NE, 2009, NCCN CLIN PRACT GUID; NOWACKI MP, 1983, DIS COLON RECTUM, V26, P263, DOI 10.1007/BF02562495; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Pile James C, 2006, Cleve Clin J Med, V73 Suppl 1, pS62; Reed JR, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2246; Schootman M, 2004, BREAST CANCER RES TR, V85, P219, DOI 10.1023/B:BREA.0000025410.41220.67; TEUCHER G, 1987, Archiv fuer Geschwulstforschung, V57, P309; Turek Z, 2009, SEMIN CARDIOTHORAC V, V13, P249, DOI 10.1177/1089253209353134; Vacek PM, 2002, CANCER, V94, P2160, DOI 10.1002/cncr.10459; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2005, J CLIN ONCOL, V23, P1631, DOI 10.1200/JCO.2005.12.005; Warren MA, 2009, MOL CANCER THER, V8, P2655, DOI 10.1158/1535-7163.MCT-09-0358; Zhang GJ, 1999, ANTICANCER RES, V19, P1427; 2002, CANC INDCIDENCE 5 CO, V8, P1	33	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15903	10.1371/journal.pone.0015903	http://dx.doi.org/10.1371/journal.pone.0015903			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209958	Green Submitted, Green Published, gold			2022-12-27	WOS:000285793200072
J	Chen, CJ; Su, LH; Lin, TY; Huang, YC				Chen, Chih-Jung; Su, Lin-Hui; Lin, Tzou-Yien; Huang, Yhu-Chering			Molecular Analysis of Repeated Methicillin-Resistant Staphylococcus aureus Infections in Children	PLOS ONE			English	Article							STRAIN-RELATEDNESS; HOSPITALS; MEC; IDENTIFICATION; COLONIZATION; EPIDEMIOLOGY; SURVEILLANCE; CRITERIA; TAIWAN; MRSA	Background: Methicillin-resistant Staphylococcus aureus (MRSA) is a major pathogen that causes severe morbidity and mortality in hospitalized patients. It is unclear whether repeated MRSA infections in pediatric patients are caused by relapse of previous infecting strains or by acquiring new strains from extrinsic sources. The study aimed to define the genetic relatedness of MRSA isolates from children with repeated infections. Methodology/Principal Findings: Children with multiple MRSA infections during 2004-2006 were identified in a teaching hospital. Repeated infections were confirmed by chart review and the responsible isolates were genotyped and screened for Panton-Valentine leukocidin (PVL) genes. Two consecutive episodes comprised an infection pair, and strain relatedness was defined for each pair as indistinguishable, highly related, or distinct if the isolates were of the same subtype, the same genotype, or different genotype, respectively. A total of 114 episodes comprising 66 infection pairs were identified in 48 children. The interval of infection pairs ranged from 15 days to 346 days, with a median duration of 57.5 days. Genotypings classified all isolates into 7 genotypes and 31 subtypes. Of 66 pairs, 46 (69.7%), 13 (19.7%) and 7 (10.6%) pairs were caused by indistinguishable, highly related and distinct strains, respectively. Subsequent infections caused by indistinguishable strains were more common for PVL-positive strains (17/18, 94.4%) than for PVL-negative strains (29/48, 60.4%, P = 0.007). The strain relatedness was not affected by the durations of interval between infections. Conclusions/Significance: Most repeated MRSA infections in children are caused by indistinguishable strains even after a long period of interval, suggesting that persistent carriage and relapse of initial infecting strains were responsible for the majority of recurrent MRSA infections.	[Chen, Chih-Jung; Lin, Tzou-Yien; Huang, Yhu-Chering] Chang Gung Childrens Hosp, Dept Pediat, Div Pediat Infect Dis, Tao Yuan, Taiwan; [Chen, Chih-Jung; Lin, Tzou-Yien; Huang, Yhu-Chering] Chang Gung Mem Hosp, Div Pediat Infect Dis, Tao Yuan, Taiwan; [Chen, Chih-Jung; Lin, Tzou-Yien; Huang, Yhu-Chering] Chang Gung Mem Hosp, Pediat Res Ctr, Tao Yuan, Taiwan; [Chen, Chih-Jung; Su, Lin-Hui; Lin, Tzou-Yien; Huang, Yhu-Chering] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Su, Lin-Hui] Chang Gung Mem Hosp, Dept Lab Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Chen, CJ (corresponding author), Chang Gung Childrens Hosp, Dept Pediat, Div Pediat Infect Dis, Tao Yuan, Taiwan.	ychuang@adm.cgmh.org.tw			Chang Gung Memorial Hospital [CMRPG 460111, CMRPG450123]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by grants from Chang Gung Memorial Hospital (CMRPG 460111 and CMRPG450123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Chen CJ, 2007, DIAGN MICR INFEC DIS, V59, P287, DOI 10.1016/j.diagmicrobio.2007.05.015; Chen Chih-Jung, 2005, Journal of Microbiology Immunology and Infection, V38, P376; D'Agata EMC, 2009, CLIN INFECT DIS, V48, P274, DOI 10.1086/595844; de Bentzmann S, 2004, J INFECT DIS, V190, P1506, DOI 10.1086/424521; de Sousa MA, 2004, FEMS IMMUNOL MED MIC, V40, P101, DOI 10.1016/S0928-8244(03)00370-5; de Sousa MA, 2003, J CLIN MICROBIOL, V41, P159, DOI [10.1128/JCM.41.1.159-163.2002, 10.1128/JCM.41.1.159-163.2003]; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Gonzalez BE, 2006, INFECT CONT HOSP EP, V27, P1051, DOI 10.1086/507923; Harbarth S, 2008, JAMA-J AM MED ASSOC, V299, P1149, DOI 10.1001/jama.299.10.1149; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Huang SS, 2008, CLIN INFECT DIS, V46, P1241, DOI 10.1086/529381; Huang YC, 2008, CLIN MICROBIOL INFEC, V14, P1167, DOI 10.1111/j.1469-0691.2008.02115.x; Huang YC, 2004, J CLIN MICROBIOL, V42, P307, DOI 10.1128/JCM.42.1.307-310.2004; Huang YC, 2006, PEDIATRICS, V118, P469, DOI 10.1542/peds.2006-0254; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Klevens RM, 2006, CLIN INFECT DIS, V42, P389, DOI 10.1086/499367; Kotilainen P, 2001, ARCH INTERN MED, V161, P859, DOI 10.1001/archinte.161.6.859; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Liao CH, 2010, CLIN MICROBIOL INFEC, V16, P463, DOI 10.1111/j.1469-0691.2009.02885.x; Muto CA, 2003, INFECT CONT HOSP EP, V24, P362, DOI 10.1086/502213; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Popovich KJ, 2008, CLIN INFECT DIS, V46, P787, DOI 10.1086/528716; Robicsek A, 2008, ANN INTERN MED, V148, P409, DOI 10.7326/0003-4819-148-6-200803180-00003; Robicsek A, 2009, CLIN INFECT DIS, V48, P910, DOI 10.1086/597296; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Wang JT, 2007, EMERG INFECT DIS, V13, P494, DOI 10.3201/eid1303.060247; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656	30	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14431	10.1371/journal.pone.0014431	http://dx.doi.org/10.1371/journal.pone.0014431			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203439	Green Published, gold, Green Submitted			2022-12-27	WOS:000285792500008
J	Chotard, L; Skorobogata, O; Sylvain, MA; Shrivastava, S; Rocheleau, CE				Chotard, Laetitia; Skorobogata, Olga; Sylvain, Marc-Andre; Shrivastava, Sanhita; Rocheleau, Christian E.			TBC-2 Is Required for Embryonic Yolk Protein Storage and Larval Survival during L1 Diapause in Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; RAB7; NEMATODE; VITELLOGENIN; DEGRADATION; LYSOSOMES; REGULATOR; PATHWAY; KINASE	C. elegans first stage (L1) larvae hatched in the absence of food, arrest development and enter an L1 diapause, whereby they can survive starvation for several weeks. The physiological and metabolic requirements for survival during L1 diapause are poorly understood. However, yolk, a cholesterol binding/transport protein, has been suggested to serve as an energy source. Here, we demonstrate that C. elegans TBC-2, a RAB-5 GTPase Activating Protein (GAP) involved in early-to-late endosome transition, is important for yolk protein storage during embryogenesis and for L1 survival during starvation. We found during embryogenesis, that a yolk:: green fluorescent protein fusion (YP170::GFP), disappeared much more quickly in tbc-2 mutant embryos as compared with wild-type control embryos. The premature disappearance of YP170:: GFP in tbc-2 mutants is likely due to premature degradation in the lysosomes as we found that YP170:: GFP showed increased colocalization with Lysotracker Red, a marker for acidic compartments. Furthermore, YP170:: GFP disappearance in tbc-2 mutants required RAB-7, a regulator of endosome to lysosome trafficking. Although tbc-2 is not essential in fed animals, we discovered that tbc-2 mutant L1 larvae have strongly reduced survival when hatched in the absence of food. We show that tbc-2 mutant larvae are not defective in maintaining L1 diapause and that mutants defective in yolk uptake, rme-1 and rme-6, also had strongly reduced L1 survival when hatched in the absence of food. Our findings demonstrate that TBC-2 is required for yolk protein storage during embryonic development and provide strong correlative data indicating that yolk constitutes an important energy source for larval survival during L1 diapause.	[Chotard, Laetitia; Skorobogata, Olga; Sylvain, Marc-Andre; Shrivastava, Sanhita; Rocheleau, Christian E.] McGill Univ, Royal Victoria Hosp, Dept Med, Div Endocrinol & Metab,Hlth Ctr,Res Inst, Montreal, PQ H3A 1A1, Canada	McGill University; Royal Victoria Hospital	Chotard, L (corresponding author), McGill Univ, Royal Victoria Hosp, Dept Med, Div Endocrinol & Metab,Hlth Ctr,Res Inst, Montreal, PQ H3A 1A1, Canada.	christian.rocheleau@mcgill.ca		Rocheleau, Christian/0000-0001-6738-5636	Canadian Institutes for Health Research (CIHR) [MOP-86719]; Canada Research Chair in Signaling and Development; le Fonds de la Recherche en Sante du Quebec (FRSQ); Natural Sciences and Engineering Research Council of Canada (NSERC); CIHR Frederick Banting and Charles Best Canada graduate scholarship; FRSQ	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Signaling and Development; le Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR Frederick Banting and Charles Best Canada graduate scholarship(Canadian Institutes of Health Research (CIHR)); FRSQ(Fonds de la Recherche en Sante du Quebec)	This study was supported by a Canadian Institutes for Health Research (CIHR) operating grant (MOP-86719) to C.E.R. C.E.R. was supported by a Canada Research Chair in Signaling and Development and is supported by le Fonds de la Recherche en Sante du Quebec (FRSQ). S.S. was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) summer studentship award. O.S. is supported by a CIHR Frederick Banting and Charles Best Canada graduate scholarship and a FRSQ Master's training award. The Research Institute at the McGill University Health Centre is supported in part by the FRSQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER ME, 1988, BIOCHEM J, V255, P1057, DOI 10.1042/bj2551057; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; Bossinger O, 1996, INT J DEV BIOL, V40, P431; BRENNER S, 1974, GENETICS, V77, P71; Britton C, 2002, MOL BIOCHEM PARASIT, V122, P21, DOI 10.1016/S0166-6851(02)00066-X; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Chotard L, 2010, MOL BIOL CELL, V21, P2285, DOI 10.1091/mbc.E09-11-0947; Corsi AK, 2000, DEVELOPMENT, V127, P2041; FAGOTTO F, 1995, J CELL SCI, V108, P3645; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; Grant B, 1999, MOL BIOL CELL, V10, p222A; HAAS A, 1995, EMBO J, V14, P5258, DOI 10.1002/j.1460-2075.1995.tb00210.x; Harfe BD, 1998, GENE DEV, V12, P2623, DOI 10.1101/gad.12.16.2623; Hong Y, 1998, DEVELOPMENT, V125, P3585; JOHNSON TE, 1984, MECH AGEING DEV, V28, P23, DOI 10.1016/0047-6374(84)90150-7; KIMBLE J, 1983, DEV BIOL, V96, P189, DOI 10.1016/0012-1606(83)90322-6; Li WD, 2009, DEVELOPMENT, V136, P2445, DOI 10.1242/dev.035949; Matyash V, 2001, MOL BIOL CELL, V12, P1725, DOI 10.1091/mbc.12.6.1725; MERESSE S, 1995, J CELL SCI, V108, P3349; Miller DM, 1995, METHOD CELL BIOL, V48, P365; Papini E, 1997, EMBO J, V16, P15, DOI 10.1093/emboj/16.1.15; Sato M, 2005, NAT CELL BIOL, V7, P559, DOI 10.1038/ncb1261; Schaheen L, 2006, DEV BIOL, V293, P382, DOI 10.1016/j.ydbio.2006.02.008; SPIETH J, 1991, J MOL EVOL, V32, P429, DOI 10.1007/BF02101283; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Vitelli R, 1997, J BIOL CHEM, V272, P4391, DOI 10.1074/jbc.272.7.4391; You YJ, 2006, CELL METAB, V3, P237, DOI 10.1016/j.cmet.2006.02.012	28	17	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15662	10.1371/journal.pone.0015662	http://dx.doi.org/10.1371/journal.pone.0015662			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203392	gold, Green Submitted, Green Published			2022-12-27	WOS:000285792500035
J	Parhamifar, L; Sime, W; Yudina, Y; Vilhardt, F; Morgelin, M; Sjolander, A				Parhamifar, Ladan; Sime, Wondossen; Yudina, Yuliana; Vilhardt, Frederik; Morgelin, Matthias; Sjolander, Anita			Ligand-Induced Tyrosine Phosphorylation of Cysteinyl Leukotriene Receptor 1 Triggers Internalization and Signaling in Intestinal Epithelial Cells	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; CYSLT(1) RECEPTOR; COLORECTAL ADENOCARCINOMAS; RAB GTPASES; LIPID RAFTS; MAST-CELLS; ENDOCYTOSIS; TRAFFICKING; ACTIVATION; SURVIVAL	Background: Leukotriene D4 (LTD4) belongs to the bioactive lipid group known as eicosanoids and has implications in pathological processes such as inflammation and cancer. Leukotriene D4 exerts its effects mainly through two different G-protein-coupled receptors, CysLT(1) and CysLT(2). The high affinity LTD4 receptor CysLT(1)R exhibits tumor-promoting properties by triggering cell proliferation, survival, and migration in intestinal epithelial cells. In addition, increased expression and nuclear localization of CysLT(1)R correlates with a poorer prognosis for patients with colon cancer. Methodology/Principal Findings: Using a proximity ligation assay and immunoprecipitation, this study showed that endogenous CysLT(1)R formed heterodimers with its counter-receptor CysLT(2)R under basal conditions and that LTD4 triggers reduced dimerization of CysLTRs in intestinal epithelial cells. This effect was dependent upon a parallel LTD4-induced increase in CysLT(1)R tyrosine phosphorylation. Leukotriene D4 also led to elevated internalization of CysLT(1)Rs from the plasma membrane and a simultaneous increase at the nucleus. Using sucrose, a clathrin endocytic inhibitor, dominant-negative constructs, and siRNA against arrestin-3, we suggest that a clathrin-, arrestin-3, and Rab-5-dependent process mediated the internalization of CysLT(1)R. Altering the CysLT1R internalization process at either the clathrin or the arrestin-3 stage led to disruption of LTD4-induced Erk1/2 activation and up-regulation of COX-2 mRNA levels. Conclusions/Significance: Our data suggests that upon ligand activation, CysLT(1)R is tyrosine-phosphorylated and released from heterodimers with CysLT(2)R and, subsequently, internalizes from the plasma membrane to the nuclear membrane in a clathrin-, arrestin-3-, and Rab-5-dependent manner, thus, enabling Erk1/2 signaling and downstream transcription of the COX-2 gene.	[Parhamifar, Ladan; Sime, Wondossen; Yudina, Yuliana; Sjolander, Anita] Lund Univ, Skane Univ Hosp, Dept Lab Med, Clin Res Ctr, Malmo, Sweden; [Vilhardt, Frederik] Univ Copenhagen, Panum Inst, Inst Cellular & Mol Med, DK-2200 Copenhagen, Denmark; [Morgelin, Matthias] Lund Univ, Dept Clin Sci, Lund, Sweden	Lund University; Skane University Hospital; University of Copenhagen; Lund University	Parhamifar, L (corresponding author), Lund Univ, Skane Univ Hosp, Dept Lab Med, Clin Res Ctr, Malmo, Sweden.	anita.sjolander@med.lu.se	Parhamifar, Ladan/C-5145-2016; Vilhardt, Frederik/AAX-4766-2021	Parhamifar, Ladan/0000-0003-4374-5734; Vilhardt, Frederik/0000-0001-8604-7165	Swedish Cancer Foundation; Swedish Medical Research Council; Foundations at Malmo University Hospital; Ruth and Richard Julin Foundation; Gunnar Nilsson's Cancer Foundation; Osterlund Foundation; Royal Physiographic Society in Lund	Swedish Cancer Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Foundations at Malmo University Hospital; Ruth and Richard Julin Foundation; Gunnar Nilsson's Cancer Foundation; Osterlund Foundation; Royal Physiographic Society in Lund	This work was supported by grants to AS by the Swedish Cancer Foundation, the Swedish Medical Research Council, the Foundations at Malmo University Hospital, the Ruth and Richard Julin Foundation, Gunnar Nilsson's Cancer Foundation, and the Osterlund Foundation and to LP and WS from the Royal Physiographic Society in Lund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai M, 2004, CELL SIGNAL, V16, P175, DOI 10.1016/S0898-6568(03)00128-1; BASCHONG W, 1985, HISTOCHEMISTRY, V83, P409, DOI 10.1007/BF00509201; Benmerah A, 2000, J BIOL CHEM, V275, P3288, DOI 10.1074/jbc.275.5.3288; Cahill CM, 2007, TRENDS PHARMACOL SCI, V28, P23, DOI 10.1016/j.tips.2006.11.003; Capra V, 2005, J CELL SCI, V118, P5625, DOI 10.1242/jcs.02668; CARLEMALM E, 1985, J MICROSC-OXFORD, V140, P55, DOI 10.1111/j.1365-2818.1985.tb02660.x; Chen ZG, 2004, MOL PHARMACOL, V66, P377; Deshpande DA, 2007, FASEB J, V21, P2335, DOI 10.1096/fj.06-8060com; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Edwards SW, 2000, TRENDS PHARMACOL SCI, V21, P304, DOI 10.1016/S0165-6147(00)01513-3; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Lopez MAG, 2009, CELL SIGNAL, V21, P1748, DOI 10.1016/j.cellsig.2009.07.010; Gobeil F, 2002, CIRC RES, V90, P682, DOI 10.1161/01.RES.0000013303.17964.7A; Goetzl EJ, 2007, FASEB J, V21, P638, DOI 10.1096/fj.06-6624hyp; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; HENLE G, 1957, J IMMUNOL, V79, P54; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Insel PA, 2005, ANN NY ACAD SCI, V1047, P166, DOI 10.1196/annals.1341.015; Jiang Y, 2007, BLOOD, V110, P3263, DOI 10.1182/blood-2007-07-100453; Joos Guy F, 2008, Pol Arch Med Wewn, V118, P689; Lynch KR, 1999, NATURE, V399, P789; Magnusson C, 2007, CANCER RES, V67, P9190, DOI 10.1158/0008-5472.CAN-07-0771; Magnusson C, 2010, EUR J CANCER, V46, P826, DOI 10.1016/j.ejca.2009.12.022; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Mezhybovska M, 2006, J BIOL CHEM, V281, P6776, DOI 10.1074/jbc.M509999200; Millar RP, 2010, MOL ENDOCRINOL, V24, P261, DOI 10.1210/me.2009-0473; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; Naik S, 2005, J BIOL CHEM, V280, P8722, DOI 10.1074/jbc.M413014200; Nielsen CK, 2005, CANCER RES, V65, P732; Ohd JF, 2000, GASTROENTEROLOGY, V119, P1007, DOI 10.1053/gast.2000.18141; Ohd JF, 2003, GASTROENTEROLOGY, V124, P57, DOI 10.1053/gast.2003.50011; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Parhamifar L, 2005, CARCINOGENESIS, V26, P1988, DOI 10.1093/carcin/bgi159; Paruchuri S, 2006, ONCOGENE, V25, P6660, DOI 10.1038/sj.onc.1209666; Paruchuri S, 2005, J BIOL CHEM, V280, P13538, DOI 10.1074/jbc.M409811200; Paruchuri S, 2003, J BIOL CHEM, V278, P45577, DOI 10.1074/jbc.M302881200; Paruchuri S, 2002, J CELL SCI, V115, P1883; Paruchuri S, 2008, J BIOL CHEM, V283, P16477, DOI 10.1074/jbc.M705822200; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Serhan CN, 1996, FASEB J, V10, P1147, DOI 10.1096/fasebj.10.10.8751717; Shmuel M, 2007, MOL BIOL CELL, V18, P1570, DOI 10.1091/mbc.E06-07-0618; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; STENSON WF, 1990, SCAND J GASTROENTERO, V25, P13, DOI 10.3109/00365529009091903; Syme CA, 2006, MOL ENDOCRINOL, V20, P3400, DOI 10.1210/me.2006-0178; Thompson Miles D., 2008, V448, P139, DOI 10.1007/978-1-59745-205-2_8; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Wikstrom K, 2003, BIOCHEM BIOPH RES CO, V302, P330, DOI 10.1016/S0006-291X(03)00187-6; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Zhu T, 2006, CAN J PHYSIOL PHARM, V84, P377, DOI 10.1139/Y05-147	53	22	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14439	10.1371/journal.pone.0014439	http://dx.doi.org/10.1371/journal.pone.0014439			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203429	Green Submitted, Green Published, gold			2022-12-27	WOS:000285792500015
J	Mukhopadhyay, P; Mukherjee, S; Ahsan, K; Bagchi, A; Pacher, P; Das, DK				Mukhopadhyay, Partha; Mukherjee, Subhendu; Ahsan, Kaimul; Bagchi, Angshuman; Pacher, Pal; Das, Dipak K.			Restoration of Altered MicroRNA Expression in the Ischemic Heart with Resveratrol	PLOS ONE			English	Article							SURVIVAL SIGNAL; NITRIC-OXIDE; CANCER; MECHANISM; STRESS; DIAGNOSIS	Background: Resveratrol, a constituent of red wine, is important for cardioprotection. MicroRNAs are known regulators for genes involved in resveratrol-mediated cardiac remodeling and the regulatory pathway involving microRNA has not been studied so far. Methods: We explored the cardioprotection by resveratrol in ischemia/reperfusion model of rat and determined cardiac functions. miRNA profile was determined from isolated RNA using quantitative Real-time PCR based array. Systemic analyses of miRNA array and theirs targets were determined using a number of computational approaches. Results: Cardioprotection by resveratrol and its derivative in ischemia/reperfusion [I/R] rat model was examined with miRNA expression profile. Unique expression pattern were found for each sample, particularly with resveratrol [pure compound] and longevinex [commercial resveratrol formulation] pretreated hearts. Longevinex and resveratrol pretreatment modulates the expression pattern of miRNAs close to the control level based on PCA analyses. Differential expression was observed in over 25 miRNAs, some of them, such as miR-21 were previously implicated in cardiac remodeling. The target genes for the differentially expressed miRNA include genes of various molecular function such as metal ion binding, sodium-potassium ion, transcription factors, which may play key role in reducing I/R injury. Conclusion: Rats pretreated with resveratrol for 3 weeks leads to significant cardioprotection against ischemia/reperfusion injury. A unique signature of miRNA profile is observed in control heart pretreated with resveratrol or longevinex. We have determined specific group of miRNA in heart that have altered during IR injuries. Most of those altered microRNA expressions modulated close to their basal level in resveratrol or longevinex treated I/R mice.	[Mukhopadhyay, Partha; Pacher, Pal] NIAAA, Lab Physiol Studies, NIH, Bethesda, MD USA; [Bagchi, Angshuman] Buck Inst Age Res, Novato, CA USA; [Mukherjee, Subhendu; Ahsan, Kaimul; Das, Dipak K.] Univ Connecticut, Sch Med, Cardiovasc Res Ctr, Farmington, CT USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Buck Institute for Research on Aging; University of Connecticut	Mukhopadhyay, P (corresponding author), NIAAA, Lab Physiol Studies, NIH, Bethesda, MD USA.	ddas@neuron.uchc.edu	., Angsuman Bagchi/U-4858-2019; Bagchi, Angshuman/AAP-1887-2021; MUKHOPADHYAY, PARTHA/G-3890-2010; Pacher, Pal/B-6378-2008; Mukherjee, Subhendu/N-6731-2016	MUKHOPADHYAY, PARTHA/0000-0002-1178-1274; Pacher, Pal/0000-0001-7036-8108; Mukherjee, Subhendu/0000-0002-4851-4428	NIH [HL 34360, HL 22559, HL 33889]; NIAAA/NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL022559, R01HL033889, R01HL034360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000375] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAAA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported in part by NIH HL 34360, HL 22559 and HL 33889 (to D. K. Das) and Intramural Research Program of the NIAAA/NIH (to P. Pacher). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, ANN NY ACAD SCI, V1091, P151, DOI 10.1196/annals.1378.063; Barringhaus KG, 2009, CIRCULATION, V119, P2217, DOI 10.1161/CIRCULATIONAHA.107.715839; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BAUERSACHS J, 2010, J CARDIOVASC PHARM; Baxter Richard A, 2008, J Cosmet Dermatol, V7, P2, DOI 10.1111/j.1473-2165.2008.00354.x; Bertelli AAA, 2009, J CARDIOVASC PHARM, V54, P468, DOI 10.1097/FJC.0b013e3181bfaff3; Bhat KPL, 2002, ANN NY ACAD SCI, V957, P210, DOI 10.1111/j.1749-6632.2002.tb02918.x; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cascio S, 2010, J CELL PHYSIOL, V224, P242, DOI 10.1002/jcp.22126; Cataluccia D, 2008, ANN NY ACAD SCI, V1123, P20, DOI 10.1196/annals.1420.004; Chen YX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-407; Dai RJ, 2008, BLOOD, V112, P4591, DOI 10.1182/blood-2008-04-152488; Das DK, 2004, BIOCHEMISTRY-MOSCOW+, V69, P10, DOI 10.1023/B:BIRY.0000016345.19027.54; DAS DK, 2010, HEART FAIL REV; Das S, 2006, J PHARMACOL EXP THER, V317, P980, DOI 10.1124/jpet.105.095133; Divakaran V, 2008, CIRC RES, V103, P1072, DOI 10.1161/CIRCRESAHA.108.183087; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Ferracin M, 2010, EXPERT REV MOL DIAGN, V10, P297, DOI 10.1586/ERM.10.11; Gurusamy N, 2010, CARDIOVASC RES, V86, P103, DOI 10.1093/cvr/cvp384; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Hattori R, 2002, AM J PHYSIOL-HEART C, V282, pH1988, DOI 10.1152/ajpheart.01012.2001; Imamura G, 2002, AM J PHYSIOL-HEART C, V282, pH1996, DOI 10.1152/ajpheart.01013.2001; Jiang X, 2010, FEBS J, V277, P2015, DOI 10.1111/j.1742-4658.2010.07632.x; Kartha RV, 2010, J CARDIOVASC TRANSL, V3, P256, DOI 10.1007/s12265-010-9172-z; Lu YJ, 2009, CARDIOVASC RES, V84, P434, DOI 10.1093/cvr/cvp232; MUKHERJEE S, J EXP CLIN IN PRESS; Mukherjee S, 2009, FREE RADICAL BIO MED, V46, P573, DOI 10.1016/j.freeradbiomed.2008.11.005; MUKHERJI SRD, 2010, CAN J PHARM IN PRESS; Mukhopadhyay P, 2009, AM J PHYSIOL-HEART C, V296, pH1466, DOI 10.1152/ajpheart.00795.2008; Nana-Sinkam P, 2010, PHARMACOGENOMICS, V11, P667, DOI 10.2217/PGS.10.57; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Qurashi A, 2010, CURR PSYCHIAT REP, V12, P154, DOI 10.1007/s11920-010-0102-1; SAUNDERS LR, 2010, AGING ALBANY; Suarez Y, 2009, CIRC RES, V104, P442, DOI 10.1161/CIRCRESAHA.108.191270; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tili E, 2010, BIOCHEM PHARMACOL, V80, P2057, DOI 10.1016/j.bcp.2010.07.003; Tili E, 2010, CARCINOGENESIS, V31, P1561, DOI 10.1093/carcin/bgq143; Ungvari Z, 2009, AM J PHYSIOL-HEART C, V297, pH1876, DOI 10.1152/ajpheart.00375.2009	38	73	78	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15705	10.1371/journal.pone.0015705	http://dx.doi.org/10.1371/journal.pone.0015705			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203465	gold, Green Published, Green Submitted			2022-12-27	WOS:000285579200031
J	Yasuniwa, Y; Izumi, H; Wang, KY; Shimajiri, S; Sasaguri, Y; Kawai, K; Kasai, H; Shimada, T; Miyake, K; Kashiwagi, E; Hirano, G; Kidani, A; Akiyama, M; Han, B; Wu, Y; Ieiri, I; Higuchi, S; Kohno, K				Yasuniwa, Yoshihiro; Izumi, Hiroto; Wang, Ke-Yong; Shimajiri, Shohei; Sasaguri, Yasuyuki; Kawai, Kazuaki; Kasai, Hiroshi; Shimada, Takashi; Miyake, Koichi; Kashiwagi, Eiji; Hirano, Gen; Kidani, Akihiko; Akiyama, Masaki; Han, Bin; Wu, Ying; Ieiri, Ichiro; Higuchi, Shun; Kohno, Kimitoshi			Circadian Disruption Accelerates Tumor Growth and Angio/Stromagenesis through a Wnt Signaling Pathway	PLOS ONE			English	Article							NF-KAPPA-B; BREAST-CANCER; CISPLATIN RESISTANCE; KELOID FIBROBLASTS; CELL LINES; NIGHT; MELATONIN; CLOCK; LIGHT; MICROENVIRONMENT	Epidemiologic studies show a high incidence of cancer in shift workers, suggesting a possible relationship between circadian rhythms and tumorigenesis. However, the precise molecular mechanism played by circadian rhythms in tumor progression is not known. To identify the possible mechanisms underlying tumor progression related to circadian rhythms, we set up nude mouse xenograft models. HeLa cells were injected in nude mice and nude mice were moved to two different cases, one case is exposed to a 24-hour light cycle (L/L), the other is a more "normal" 12-hour light/dark cycle (L/D). We found a significant increase in tumor volume in the L/L group compared with the L/D group. In addition, tumor microvessels and stroma were strongly increased in L/L mice. Although there was a hypervascularization in L/L tumors, there was no associated increase in the production of vascular endothelial cell growth factor (VEGF). DNA microarray analysis showed enhanced expression of WNT10A, and our subsequent study revealed that WNT10A stimulates the growth of both microvascular endothelial cells and fibroblasts in tumors from light-stressed mice, along with marked increases in angio/stromagenesis. Only the tumor stroma stained positive for WNT10A and WNT10A is also highly expressed in keloid dermal fibroblasts but not in normal dermal fibroblasts indicated that WNT10A may be a novel angio/stromagenic growth factor. These findings suggest that circadian disruption induces the progression of malignant tumors via a Wnt signaling pathway.	[Yasuniwa, Yoshihiro; Izumi, Hiroto; Kashiwagi, Eiji; Hirano, Gen; Kidani, Akihiko; Akiyama, Masaki; Han, Bin; Wu, Ying; Kohno, Kimitoshi] Univ Occupat & Environm Hlth, Sch Med, Dept Mol Biol, Kitakyushu, Fukuoka 807, Japan; [Yasuniwa, Yoshihiro; Ieiri, Ichiro] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacokinet, Fukuoka 812, Japan; [Wang, Ke-Yong; Shimajiri, Shohei; Sasaguri, Yasuyuki] Univ Occupat & Environm Hlth, Sch Med, Dept Pathol & Cell Biol, Kitakyushu, Fukuoka 807, Japan; [Kawai, Kazuaki; Kasai, Hiroshi] Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Environm Oncol, Kitakyushu, Fukuoka 807, Japan; [Shimada, Takashi; Miyake, Koichi] Nihon Med Sch, Dept Biochem & Mol Biol, Tokyo, Japan; [Han, Bin] China Med Univ, Shengjing Hosp, Dept Urol, Shenyang, Peoples R China; [Wu, Ying; Higuchi, Shun] China Med Univ, Affiliated Hosp 1, Dept Oncol, Shenyang, Peoples R China	University of Occupational & Environmental Health - Japan; Kyushu University; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; Nippon Medical School; China Medical University; China Medical University	Yasuniwa, Y (corresponding author), Univ Occupat & Environm Hlth, Sch Med, Dept Mol Biol, Kitakyushu, Fukuoka 807, Japan.	k-kohno@med.uoeh-u.ac.jp		wang, ke-yong/0000-0001-8295-1229	KAKENHI [17016075]; UOEH; Vehicle Racing Commemorative Foundation	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); UOEH(University of Occupational & Environmental Health - Japan); Vehicle Racing Commemorative Foundation	This work was supported by KAKENHI (17016075), UOEH Grants for Advanced Research and the Vehicle Racing Commemorative Foundation (to K. Kohno). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA SI, 1985, SOMAT CELL MOLEC GEN, V11, P117, DOI 10.1007/BF01534700; Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820; BEILDECK ME, 2010, EXP CELL RE IN PRESS; Blankesteijn WM, 2000, AM J PATHOL, V157, P877, DOI 10.1016/S0002-9440(10)64601-9; Blask DE, 2005, CANCER RES, V65, P11174, DOI 10.1158/0008-5472.CAN-05-1945; Bohring A, 2009, AM J HUM GENET, V85, P97, DOI 10.1016/j.ajhg.2009.06.001; Filipski E, 2004, CANCER RES, V64, P7879, DOI 10.1158/0008-5472.CAN-04-0674; Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072; Hansen J, 2006, CANCER CAUSE CONTROL, V17, P531, DOI 10.1007/s10552-005-9006-5; Hunt T, 2007, CELL, V129, P461, DOI 10.1016/j.cell.2007.04.015; Igarashi T, 2007, ONCOGENE, V26, P4749, DOI 10.1038/sj.onc.1210289; Innominato PF, 2009, CANCER RES, V69, P4700, DOI 10.1158/0008-5472.CAN-08-4747; Itoh T, 2009, FEBS LETT, V583, P777, DOI 10.1016/j.febslet.2009.01.022; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Jung B, 2006, CANCER RES, V66, P9789, DOI 10.1158/0008-5472.CAN-06-1776; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kawai K, 2007, GENES ENVIRON, V29, P107, DOI DOI 10.3123/JEMSGE.29.107; Kidani A, 2009, INT J ONCOL, V35, P1435, DOI 10.3892/ijo_00000462; Kikuchi A, 2007, CELL SIGNAL, V19, P659, DOI 10.1016/j.cellsig.2006.11.001; Killion JJ, 1998, CANCER METAST REV, V17, P279, DOI 10.1023/A:1006140513233; Kirikoshi H, 2001, INT J ONCOL, V19, P533; KOHNO K, 1990, J BIOL CHEM, V265, P19690; Korkmaz A, 2009, BREAST CANCER RES TR, V115, P13, DOI 10.1007/s10549-008-0103-5; Levi F, 2006, CANCER CAUSE CONTROL, V17, P611, DOI 10.1007/s10552-005-9004-7; Li J, 2001, J BIOL CHEM, V276, P18579, DOI 10.1074/jbc.M100846200; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Macheda ML, 2008, CURR CANCER DRUG TAR, V8, P454, DOI 10.2174/156800908785699324; MASCKAUCHA NTN, 2006, PHYSL BETHESDA, V21, P181; Miyamoto N, 2008, J BIOL CHEM, V283, P18218, DOI 10.1074/jbc.M802332200; NAKAGAWA M, 1993, J UROLOGY, V150, P1970, DOI 10.1016/S0022-5347(17)35948-7; Navara KJ, 2007, J PINEAL RES, V43, P215, DOI 10.1111/j.1600-079X.2007.00473.x; Nawaz S, 2009, EUR J HUM GENET, V17, P1600, DOI 10.1038/ejhg.2009.81; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rajaratnam SM, 2001, LANCET, V358, P999, DOI 10.1016/S0140-6736(01)06108-6; Russell SB, 2010, J INVEST DERMATOL, V130, P2489, DOI 10.1038/jid.2010.162; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Smith JC, 2008, J INVEST DERMATOL, V128, P1298, DOI 10.1038/sj.jid.5701149; Vinogradova IA, 2009, AGING-US, V1, P855, DOI 10.18632/aging.100092; Wakasugi T, 2007, ONCOGENE, V26, P5194, DOI 10.1038/sj.onc.1210326; Xie YL, 2004, CANCER RES, V64, P3096, DOI 10.1158/0008-5472.CAN-03-3834	41	48	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15330	10.1371/journal.pone.0015330	http://dx.doi.org/10.1371/journal.pone.0015330			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203463	Green Published, gold, Green Submitted			2022-12-27	WOS:000285579200018
J	Blumenthal, A; Trujillo, C; Ehrt, S; Schnappinger, D				Blumenthal, Antje; Trujillo, Carolina; Ehrt, Sabine; Schnappinger, Dirk			Simultaneous Analysis of Multiple Mycobacterium tuberculosis Knockdown Mutants In Vitro and In Vivo	PLOS ONE			English	Article							INDUCIBLE GENE-EXPRESSION; CONDITIONAL EXPRESSION; ISOCITRATE LYASE-1; GROWTH; IDENTIFICATION; SMEGMATIS; SURVIVAL; REQUIREMENTS; REPLICATION; MUTAGENESIS	Mycobacterium tuberculosis (Mtb) represents one of the most persistent bacterial threats to human health and new drugs are needed to limit its impact. Conditional knockdown mutants can help validate new drug targets, but the analysis of individual mutants is laborious and time consuming. Here, we describe quantitative DNA tags (qTags) and their use to simultaneously analyze conditional Mtb knockdown mutants that allowed silencing the glyoxylate and methylcitrate cycles (via depletion of isocitrate lyase, ICL), the serine protease Rv3671c, and the core subunits of the mycobacterial proteasome, PrcB and PrcA. The impact of gene silencing in multi-strain cultures was determined by measuring the relative abundance of mutant-specific qTags with real-time PCR. This achieved accurate quantification over a broad range of qTag abundances and depletion of ICL, Rv3671c, or PrcBA resulted in the expected impairment of growth of Mtb with butyrate as the primary carbon source, survival during oxidative stress, acid stress and starvation. The impact of depleting ICL, Rv3671c, or PrcBA in multi-strain mouse infections was analyzed with two approaches. We first measured the relative abundance of mutant-specific qTags in total chromosomal DNA isolated from bacteria that were recovered from infected lungs on agar plates. We then developed a two-step amplification procedure, which allowed us to measure the abundances of individual mutants directly in infected lung tissue. Both strategies confirmed that inactivation of Rv3671c and PrcBA severely reduced persistence of Mtb in mice. The multi-strain infections furthermore suggested that silencing ICL not only prevented growth of Mtb during acute infections but also prevented survival of Mtb during chronic infections. Analyses of the ICL knockdown mutant in single-strain infections confirmed this and demonstrated that silencing of ICL during chronic infections impaired persistence of Mtb to the extent that the pathogen was cleared from the lungs of most mice.				dis2003@med.cornell.edu	Ehrt, Sabine/AAU-6449-2020; Blumenthal, Antje/A-3608-2011	Blumenthal, Antje/0000-0003-3673-7015	Bill and Melinda Gates Foundation [42848]; National Institutes of Health [AI063446]; Stony Wold-Herbert Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063446] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stony Wold-Herbert Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Bill and Melinda Gates Foundation grant 42848 awarded to DS, and National Institutes of Health grant AI063446 awarded to SE. AB received support from the Stony Wold-Herbert Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; Boldrin F, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq235; Brodin P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001100; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Carroll P, 2005, APPL ENVIRON MICROB, V71, P3077, DOI 10.1128/AEM.71.6.3077-3084.2005; Carroll P, 2007, FEMS MICROBIOL LETT, V274, P73, DOI 10.1111/j.1574-6968.2007.00842.x; Cerda-Maira F, 2009, MICROBES INFECT, V11, P1150, DOI 10.1016/j.micinf.2009.08.003; Chalut C, 2006, P NATL ACAD SCI USA, V103, P8511, DOI 10.1073/pnas.0511129103; Cheo DL, 2004, GENOME RES, V14, P2111, DOI 10.1101/gr.2512204; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Dolganov GM, 2001, GENOME RES, V11, P1473, DOI 10.1101/gr.191301; Dutton RJ, 2010, P NATL ACAD SCI USA, V107, P297, DOI 10.1073/pnas.0912952107; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Dziadek J, 2002, MICROBIOL-SGM, V148, P961, DOI 10.1099/00221287-148-4-961; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Forti F, 2009, J BIOTECHNOL, V140, P270, DOI 10.1016/j.jbiotec.2009.02.001; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandotra S, 2007, NAT MED, V13, P1515, DOI 10.1038/nm1683; Gandotra S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001040; Garces A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000957; Gould TA, 2006, MOL MICROBIOL, V61, P940, DOI 10.1111/j.1365-2958.2006.05297.x; Greendyke R, 2002, MICROBIOL-SGM, V148, P3887, DOI 10.1099/00221287-148-12-3887; Guo XV, 2007, J BACTERIOL, V189, P4614, DOI 10.1128/JB.00216-07; Hernandez-Abanto SM, 2006, ARCH MICROBIOL, V186, P459, DOI 10.1007/s00203-006-0160-2; Hett EC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000001; Hett EC, 2007, MOL MICROBIOL, V66, P658, DOI 10.1111/j.1365-2958.2007.05945.x; Hisert KB, 2004, INFECT IMMUN, V72, P5315, DOI 10.1128/IAI.72.9.5315-5321.2004; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; Kim DH, 2008, AM J RESP CRIT CARE, V178, P1075, DOI 10.1164/rccm.200801-132OC; KLOTZSCHE M, 2009, NUCL ACIDS RES; LEE MH, 1991, P NATL ACAD SCI USA, V88, P3111, DOI 10.1073/pnas.88.8.3111; LoBue P, 2009, CURR OPIN INFECT DIS, V22, P167, DOI 10.1097/QCO.0b013e3283229fab; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; Mazurkiewicz P, 2006, NAT REV GENET, V7, P929, DOI 10.1038/nrg1984; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Mukherjee P, 2009, MOL MICROBIOL, V73, P103, DOI 10.1111/j.1365-2958.2009.06750.x; Munoz-Elias EJ, 2006, CELL MICROBIOL, V8, P10, DOI 10.1111/j.1462-5822.2005.00648.x; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Munoz-Elias EJ, 2006, MOL MICROBIOL, V60, P1109, DOI 10.1111/j.1365-2958.2006.05155.x; Pandey AK, 2009, TUBERCULOSIS, V89, P12, DOI 10.1016/j.tube.2008.07.007; Raghavan S, 2008, NATURE, V454, P717, DOI 10.1038/nature07219; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rigel NW, 2009, J BIOL CHEM, V284, P9927, DOI 10.1074/jbc.M900325200; Rosas-Magallanes V, 2007, INFECT IMMUN, V75, P504, DOI 10.1128/IAI.00058-06; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; SERAFINI A, 2009, J BACTERIOL; Siegrist MS, 2009, P NATL ACAD SCI USA, V106, P18792, DOI 10.1073/pnas.0900589106; Sinha KM, 2007, J BIOL CHEM, V282, P15114, DOI 10.1074/jbc.M701167200; Stallings CL, 2009, CELL, V138, P146, DOI 10.1016/j.cell.2009.04.041; Stephanou NC, 2007, J BACTERIOL, V189, P5237, DOI 10.1128/JB.00332-07; Sureka K, 2007, MOL MICROBIOL, V65, P261, DOI 10.1111/j.1365-2958.2007.05814.x; Vandal OH, 2008, NAT MED, V14, P849, DOI 10.1038/nm.1795; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; Williams KJ, 2010, PLASMID, V64, P69, DOI 10.1016/j.plasmid.2010.04.003	56	48	48	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15667	10.1371/journal.pone.0015667	http://dx.doi.org/10.1371/journal.pone.0015667			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203517	Green Published, Green Submitted, gold			2022-12-27	WOS:000285578000044
J	Hutnick, NA; Carnathan, DG; Dubey, SA; Cox, KS; Kierstead, L; Makadonas, G; Ratcliffe, SJ; Lasaro, MO; Robertson, MN; Casimiro, DR; Ertl, HCJ; Betts, MR				Hutnick, Natalie A.; Carnathan, Diane G.; Dubey, Sheri A.; Cox, Kara S.; Kierstead, Lisa; Makadonas, George; Ratcliffe, Sarah J.; Lasaro, Marcio O.; Robertson, Michael N.; Casimiro, Danilo R.; Ertl, Hildegund C. J.; Betts, Michael R.			Vaccination with Ad5 Vectors Expands Ad5-Specific CD8(+) T Cells without Altering Memory Phenotype or Functionality	PLOS ONE			English	Article							REPLICATION-DEFECTIVE ADENOVIRUS; HIV-1 VACCINE; NEUTRALIZING ANTIBODIES; IMMUNE-RESPONSES; HEALTHY-ADULTS; IN-VIVO; DNA; IMMUNOGENICITY; VIRUS; GENE	Background: Adenoviral (Ad) vaccine vectors represent both a vehicle to present a novel antigen to the immune system as well as restimulation of immune responses against the Ad vector itself. To what degree Ad-specific CD8(+) T cells are restimulated by Ad vector vaccination is unclear, although such knowledge would be important as vector-specific CD8(+) T cell expansion could potentially further limit Ad vaccine efficacy beyond Ad-specific neutralizing antibody alone. Methodology/Principal Findings: Here we addressed this issue by measuring human Adenovirus serotype 5 (Ad5)-specific CD8(+) T cells in recipients of the Merck Ad5 HIV-1 vaccine vector before, during, and after vaccination by multicolor flow cytometry. Ad5-specific CD8(+) T-cells were detectable in 95% of subjects prior to vaccination, and displayed primarily an effector-type functional profile and phenotype. Peripheral blood Ad5-specific CD8(+) T-cell numbers expanded after Ad5-HIV vaccination in all subjects, but differential expansion kinetics were noted in some baseline Ad5-neutralizing antibody (Ad5 nAb) seronegative subjects compared to baseline Ad5 nAb seropositive subjects. However, in neither group did vaccination alter polyfunctionality, mucosal targeting marker expression, or memory phenotype of Ad5-specific CD8(+) T-cells. Conclusions: These data indicate that repeat Ad5-vector administration in humans expands Ad5-specific CD8(+) T-cells without overtly affecting their functional capacity or phenotypic properties. This is a secondary analysis of samples collected during the 016 trial. Results of the Merck 016 trial safety and immunogenicity have been previously published in the journal of clinical infectious diseases [1].	[Hutnick, Natalie A.; Carnathan, Diane G.; Makadonas, George; Betts, Michael R.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Hutnick, Natalie A.; Carnathan, Diane G.; Makadonas, George; Betts, Michael R.] Univ Penn, Sch Med, Ctr AIDS Res, Philadelphia, PA 19104 USA; [Dubey, Sheri A.; Cox, Kara S.; Kierstead, Lisa; Robertson, Michael N.; Casimiro, Danilo R.] Merck Res Labs, West Point, PA USA; [Ratcliffe, Sarah J.] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Lasaro, Marcio O.; Ertl, Hildegund C. J.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Merck & Company; University of Pennsylvania; The Wistar Institute	Hutnick, NA (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	betts@mail.med.upenn.edu	Ratcliffe, Sarah J/GYR-1110-2022	Ratcliffe, Sarah J/0000-0002-6644-8284	National Institutes of Health [IPCAVD U19AI074078]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI074078] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health IPCAVD U19AI074078 to M. Betts and H. Ertl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Aste-Amezaga M, 2004, HUM GENE THER, V15, P293, DOI 10.1089/104303404322886147; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Calcedo R, 2009, J VIROL, V83, P2623, DOI 10.1128/JVI.02160-08; Casimiro DR, 2004, J VIROL, V78, P11434, DOI 10.1128/JVI.78.20.11434-11438.2004; Casimiro DR, 2003, J VIROL, V77, P6305, DOI 10.1128/JVI.77.11.6305-6313.2003; Farina SF, 2001, J VIROL, V75, P11603, DOI 10.1128/JVI.75.23.11603-11613.2001; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GRUBB BR, 1994, NATURE, V371, P802, DOI 10.1038/371802a0; Harro CD, 2009, AIDS RES HUM RETROV, V25, P103, DOI 10.1089/aid.2008.0212; Hensley SE, 2005, J IMMUNOL, V175, P6032, DOI 10.4049/jimmunol.175.9.6032; HUTNICK LK, J BIOL CHEM; HUTNICK NA, VACCINE, V28, P1932; Koup RA, 2009, J VIROL, V83, P6318, DOI 10.1128/JVI.00384-09; Krebs J W, 1998, J Public Health Manag Pract, V4, P56; Lasaro MO, 2005, MICROBES INFECT, V7, P1541, DOI 10.1016/j.micinf.2005.05.024; Leen AM, 2008, J VIROL, V82, P546, DOI 10.1128/JVI.01689-07; Magalhaes I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003790; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; O'Brien KL, 2009, NAT MED, V15, P873, DOI 10.1038/nm.1991; Prasad SA, 2001, J IMMUNOL, V166, P4809, DOI 10.4049/jimmunol.166.8.4809; Priddy FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993; Roberts DM, 2006, NATURE, V441, P239, DOI 10.1038/nature04721; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; SPERGEL JM, 1991, P NATL ACAD SCI USA, V88, P6472, DOI 10.1073/pnas.88.15.6472; Sridhar S, 2008, J VIROL, V82, P3822, DOI 10.1128/JVI.02568-07; Steinwaerder DS, 2000, HUM GENE THER, V11, P1933, DOI 10.1089/10430340050129549; Sumida SM, 2005, J IMMUNOL, V174, P7179, DOI 10.4049/jimmunol.174.11.7179; Sumida SM, 2004, J VIROL, V78, P2666, DOI 10.1128/JVI.78.6.2666-2673.2004; Tatsis N, 2007, BLOOD, V110, P1916, DOI 10.1182/blood-2007-02-062117; Xiang ZQ, 1996, VIROLOGY, V219, P220, DOI 10.1006/viro.1996.0239; Yang Y, 1996, GENE THER, V3, P137; Yang ZY, 2003, J VIROL, V77, P799, DOI 10.1128/JVI.77.1.799-803.2003	33	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14385	10.1371/journal.pone.0014385	http://dx.doi.org/10.1371/journal.pone.0014385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203546	gold, Green Published, Green Submitted			2022-12-27	WOS:000285578000005
J	Tsai, JC; Yen, MR; Castillo, R; Leyton, DL; Henderson, IR; Saier, MH				Tsai, Jennifer C.; Yen, Ming-Ren; Castillo, Rostislav; Leyton, Denisse L.; Henderson, Ian R.; Saier, Milton H., Jr.			The Bacterial Intimins and Invasins: A Large and Novel Family of Secreted Proteins	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; GRAM-NEGATIVE BACTERIA; WEB-BASED PROGRAM; OUTER-MEMBRANE; CELL-ADHESION; STRUCTURE PREDICTION; TRANSLOCATOR DOMAIN; PASSENGER PROTEINS; VIRULENCE FACTORS; SIGNAL PEPTIDE	Background: Gram-negative bacteria have developed a limited repertoire of solutions for secreting proteins from the cytoplasmic compartment to the exterior of the cell. Amongst the spectrum of secreted proteins are the intimins and invasins (the Int/Inv family; TC# 1.B.54) which are characterized by an N-terminal beta-barrel domain and a C-terminal surface localized passenger domain. Despite the important role played by members of this family in diseases mediated by several species of the Enterobacteriaceae, there has been little appreciation for the distribution and diversity of these proteins amongst Gram-negative bacteria. Furthermore, there is little understanding of the molecular events governing secretion of these proteins to the extracellular milieu. Principal Findings: In silico approaches were used to analyze the domain organization and diversity of members of this secretion family. Proteins belonging to this family are predominantly associated with organisms from the gamma-proteobacteria. Whilst proteins from the Chlamydia, gamma-, beta-and epsilon-proteobacteria possess b-barrel domains and passenger domains of various sizes, Int/Inv proteins from the alpha-proteobacteria, cyanobacteria and chlorobi possess only the predicted b-barrel domains. Phylogenetic analyses revealed that with few exceptions these proteins cluster according to organismal type, indicating that divergence occurred contemporaneously with speciation, and that horizontal transfer was limited. Clustering patterns of the b-barrel domains correlate well with those of the full-length proteins although the passenger domains do so with much less consistency. The modular subdomain design of the passenger domains suggests that subdomain duplication and deletion have occurred with high frequency over evolutionary time. However, all repeated subdomains are found in tandem, suggesting that subdomain shuffling occurred rarely if at all. Topological predictions for the b-barrel domains are presented. Conclusion: Based on our in silico analyses we present a model for the biogenesis of these proteins. This study is the first of its kind to describe this unusual family of bacterial adhesins.	[Tsai, Jennifer C.; Yen, Ming-Ren; Castillo, Rostislav; Saier, Milton H., Jr.] Univ Calif San Diego, Dept Mol Biol, La Jolla, CA 92093 USA; [Leyton, Denisse L.; Henderson, Ian R.] Univ Birmingham, Sch Immun & Infect, Birmingham, W Midlands, England	University of California System; University of California San Diego; University of Birmingham	Tsai, JC (corresponding author), Univ Calif San Diego, Dept Mol Biol, La Jolla, CA 92093 USA.	msaier@ucsd.edu	Leyton, Denisse L/A-6915-2015; Henderson, Ian/AAD-5369-2019	Leyton, Denisse L/0000-0003-4808-9289; Henderson, Ian/0000-0002-9954-4977	National Institutes of Health (NIH) [GM077402]; Medical Research Council [G0801209] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077402] Funding Source: NIH RePORTER; MRC [G0801209] Funding Source: UKRI	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by NIH (GM077402) of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TM, 2005, J BACTERIOL, V187, P522, DOI 10.1128/JB.187.2.522-533.2005; Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; Altschul SF, 2009, NUCLEIC ACIDS RES, V37, P815, DOI 10.1093/nar/gkn981; Bagos PG, 2004, NUCLEIC ACIDS RES, V32, pW400, DOI 10.1093/nar/gkh417; Barnard TJ, 2007, NAT STRUCT MOL BIOL, V14, P1214, DOI 10.1038/nsmb1322; Batchelor M, 2000, EMBO J, V19, P2452, DOI 10.1093/emboj/19.11.2452; Bateman A, 2000, J MOL BIOL, V299, P1113, DOI 10.1006/jmbi.2000.3778; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bodelon G, 2009, J BACTERIOL, V191, P5169, DOI 10.1128/JB.00458-09; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Carlsson F, 2003, J EXP MED, V198, P1057, DOI 10.1084/jem.20030543; Caron E, 2006, CURR OPIN MICROBIOL, V9, P40, DOI 10.1016/j.mib.2005.12.008; Frankel G, 1998, MOL MICROBIOL, V30, P911, DOI 10.1046/j.1365-2958.1998.01144.x; Gal-Mor O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000036; Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; JARVIS KG, 1995, P NATL ACAD SCI USA, V92, P7996, DOI 10.1073/pnas.92.17.7996; JERSE AE, 1990, P NATL ACAD SCI USA, V87, P7839, DOI 10.1073/pnas.87.20.7839; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jong WSP, 2008, BIOCHEM BIOPH RES CO, V368, P522, DOI 10.1016/j.bbrc.2008.01.122; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kelly G, 1999, NAT STRUCT BIOL, V6, P313; Kelly G, 1998, J BIOMOL NMR, V12, P189, DOI 10.1023/A:1008227103121; Kenny B, 1997, INFECT IMMUN, V65, P2528, DOI 10.1128/IAI.65.7.2528-2536.1997; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; Kim DSH, 2006, J BACTERIOL, V188, P5655, DOI 10.1128/JB.01596-05; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Kostakioti M, 2006, INFECT IMMUN, V74, P4961, DOI 10.1128/IAI.00103-06; LEONG JM, 1991, INFECT IMMUN, V59, P3424, DOI 10.1128/IAI.59.10.3424-3433.1991; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Loveless BJ, 1997, MOL MEMBR BIOL, V14, P113, DOI 10.3109/09687689709048171; Lund O., 2002, CASP5 C, pA102; Meng GY, 2006, EMBO J, V25, P2297, DOI 10.1038/sj.emboj.7601132; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Newman CL, 2004, CRIT REV MICROBIOL, V30, P275, DOI 10.1080/10408410490499872; Niemann HH, 2004, MICROBES INFECT, V6, P101, DOI 10.1016/j.micinf.2003.11.001; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; Peterson JH, 2006, J BIOL CHEM, V281, P9038, DOI 10.1074/jbc.M508681200; Remaut H, 2004, CURR OPIN STRUC BIOL, V14, P161, DOI 10.1016/j.sbi.2004.03.004; Ross NT, 2007, PROTEIN SCI, V16, P2677, DOI 10.1110/ps.073128607; Saier M. H, 1987, ENZYMES METABOLIC PA; SAIER MH, 1994, MICROBIOL REV, V58, P71, DOI 10.1128/MMBR.58.1.71-93.1994; Saier MH, 2006, J MEMBRANE BIOL, V214, P75, DOI 10.1007/s00232-006-0049-7; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Sason H, 2009, MOL BIOL CELL, V20, P544, DOI 10.1091/mbc.E08-05-0516; Sinclair JF, 2006, INFECT IMMUN, V74, P1255, DOI 10.1128/IAI.74.2.1255-1265.2006; Steen A, 2005, FEBS J, V272, P2854, DOI 10.1111/j.1742-4658.2005.04706.x; Steen A, 2003, J BIOL CHEM, V278, P23874, DOI 10.1074/jbc.M211055200; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Touze T, 2004, MOL MICROBIOL, V51, P73, DOI 10.1046/j.1365-2958.2003.03830.x; Watanabe M, 1997, BIOPHYS J, V72, P2094, DOI 10.1016/S0006-3495(97)78852-0; Wentzel A, 2001, J BACTERIOL, V183, P7273, DOI 10.1128/JB.183.24.7273-7284.2001; Yen MR, 2009, J MOL MICROB BIOTECH, V17, P163, DOI 10.1159/000239667; Yen MR, 2002, BBA-BIOMEMBRANES, V1562, P6, DOI 10.1016/S0005-2736(02)00359-0; YU J, 1992, MOL MICROBIOL, V6, P411, DOI 10.1111/j.1365-2958.1992.tb01484.x; Yu L, 2000, NATURE, V405, P1073, DOI 10.1038/35016618; Zhai YF, 2002, J MOL MICROB BIOTECH, V4, P69; Zhai YF, 2001, J MOL MICROB BIOTECH, V3, P501; Zhai YF, 2001, J MOL MICROB BIOTECH, V3, P285	61	45	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14403	10.1371/journal.pone.0014403	http://dx.doi.org/10.1371/journal.pone.0014403			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203509	gold, Green Submitted, Green Published			2022-12-27	WOS:000285578000010
J	Yu, KN; Minai-Tehrani, A; Chang, SH; Hwang, SK; Hong, SH; Kim, JE; Shin, JY; Park, SJ; Kim, JH; Kwon, JT; Jiang, HL; Kang, B; Kim, D; Chae, CH; Lee, KH; Yoon, TJ; Beck, GR; Cho, MH				Yu, Kyeong-Nam; Minai-Tehrani, Arash; Chang, Seung-Hee; Hwang, Soon-Kyung; Hong, Seong-Ho; Kim, Ji-Eun; Shin, Ji-Young; Park, Sung-Jin; Kim, Ji-Hye; Kwon, Jung-Taek; Jiang, Hu-Lin; Kang, Bitna; Kim, Duyeol; Chae, Chan-Hee; Lee, Kee-Ho; Yoon, Tae-Jong; Beck, George R., Jr.; Cho, Myung-Haing			Aerosol Delivery of Small Hairpin Osteopontin Blocks Pulmonary Metastasis of Breast Cancer in Mice	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GENE-THERAPY; TUMOR PROGRESSION; LIVER METASTASIS; EXPRESSION; LUNG; PROTEIN; VECTORS; RNA; ANGIOGENESIS	Background: Metastasis to the lung may be the final step in the breast cancer-related morbidity. Conventional therapies such as chemotherapy and surgery are somewhat successful, however, metastasis-related breast cancer morbidity remains high. Thus, a novel approach to prevent breast tumor metastasis is needed. Methodology/Principal Finding: Aerosol of lentivirus-based small hairpin osteopontin was delivered into mice with breast cancer twice a week for 1 or 2 months using a nose-only inhalation system. The effects of small hairpin osteopontin on breast cancer metastasis to the lung were evaluated using near infrared imaging as well as diverse molecular techniques. Aerosol-delivered small hairpin osteopontin significantly decreased the expression level of osteopontin and altered the expression of several important metastasis-related proteins in our murine breast cancer model. Conclusion/Significance: Aerosol-delivered small hairpin osteopontin blocked breast cancer metastasis. Our results showed that noninvasive targeting of pulmonary osteopontin or other specific genes responsible for cancer metastasis could be used as an effective therapeutic regimen for the treatment of metastatic epithelial tumors.	[Yu, Kyeong-Nam; Minai-Tehrani, Arash; Chang, Seung-Hee; Hwang, Soon-Kyung; Hong, Seong-Ho; Kim, Ji-Eun; Shin, Ji-Young; Park, Sung-Jin; Kim, Ji-Hye; Kwon, Jung-Taek; Jiang, Hu-Lin; Kang, Bitna; Cho, Myung-Haing] Seoul Natl Univ, Coll Vet Med, Toxicol Lab, Seoul, South Korea; [Kim, Ji-Eun; Kim, Ji-Hye; Cho, Myung-Haing] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Nano Fus Technol, Seoul, South Korea; [Cho, Myung-Haing] Seoul Natl Univ, Grad Grp Tumor Biol, Seoul, South Korea; [Kim, Duyeol; Chae, Chan-Hee] Seoul Natl Univ, Coll Vet Med, Pathol Lab, Seoul, South Korea; [Lee, Kee-Ho] Korea Inst Radiol & Med Sci, Div Radiat Canc Res, Mol Oncol Lab, Seoul, South Korea; [Yoon, Tae-Jong] CHA Univ, Dept Appl BioSci, Seoul, South Korea; [Beck, George R., Jr.] Emory Univ, Sch Med, Div Endocrinol Metab & Lipids, Atlanta, GA USA	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Korea Institute of Radiological & Medical Sciences; Pochon Cha University; Emory University	Yu, KN (corresponding author), Seoul Natl Univ, Coll Vet Med, Toxicol Lab, Seoul, South Korea.	mchotox@snu.ac.kr	Cho, Myung-Haing/B-7362-2014; Beck, George/AAO-2117-2020	Cho, Myung-Haing/0000-0002-3993-2011; Kwon, Jung-Taek/0000-0002-3023-5463; Park, Sungjin/0000-0001-5801-5537	National Research Foundation [NRF-2010-0000784]; Ministry of Education, Science and Technology (MEST), Korea; 21C Frontier Functional Human Genome Project [FG03-0601-003-1-0-0]; Ministry of Science and Technology; NIH/NIAMS [AR056090]; NIH/NCI [CA136059]; Research Institute for Veterinary Science, Seoul National University; NATIONAL CANCER INSTITUTE [R03CA136059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056090] Funding Source: NIH RePORTER	National Research Foundation; Ministry of Education, Science and Technology (MEST), Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); 21C Frontier Functional Human Genome Project(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Research Institute for Veterinary Science, Seoul National University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Research Foundation (NRF-2010-0000784), Ministry of Education, Science and Technology (MEST), Korea. Kee-Ho Lee was supported by the 21C Frontier Functional Human Genome Project (FG03-0601-003-1-0-0) and by the National Nuclear R&D Program of the Ministry of Science and Technology. George R. Beck Jr was supported in part by grants from NIH/NIAMS (AR056090) and NIH/NCI (CA136059). Myung-Haing Cho was also partially supported by the Research Institute for Veterinary Science, Seoul National University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adwan H, 2004, INT J ONCOL, V24, P1235; Akar U, 2010, MOL CANCER THER, V9, P1180, DOI 10.1158/1535-7163.MCT-09-1025; BEHREND EI, 1994, CANCER RES, V54, P832; BEHREND EI, 1995, ANN NY ACAD SCI, V760, P299, DOI 10.1111/j.1749-6632.1995.tb44640.x; BROWN LF, 1994, AM J PATHOL, V145, P610; Chakraborty G, 2008, J CELL MOL MED, V12, P2305, DOI 10.1111/j.1582-4934.2008.00263.x; Dai JX, 2010, CANCER IMMUNOL IMMUN, V59, P355, DOI 10.1007/s00262-009-0754-z; DENHARDT DT, 1993, FASEB J, V7, P1475, DOI 10.1096/fasebj.7.15.8262332; Denhardt DT, 1996, CRIT REV ONCOGENESIS, V7, P261, DOI 10.1615/CritRevOncog.v7.i3-4.70; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Gao Yu-feng, 2005, Zhonghua Gan Zang Bing Za Zhi, V13, P227; Gautam A, 2001, MOL THER, V3, P551, DOI 10.1006/mthe.2001.0300; Goula D, 2000, GENE THER, V7, P499, DOI 10.1038/sj.gt.3301113; Hwang SK, 2007, GENE THER, V14, P1721, DOI 10.1038/sj.gt.3303042; Hwang SK, 2009, AM J RESP CRIT CARE, V179, P1131, DOI 10.1164/rccm.200810-1553OC; Jatoi I, 1999, J CLIN ONCOL, V17, P2334, DOI 10.1200/JCO.1999.17.8.2334; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; KELEG S, 2003, MOL CANCER, V22, P14; Kim HW, 2004, CANCER RES, V64, P7971, DOI 10.1158/0008-5472.CAN-04-1231; LEIDENG, 2009, BMC GASTROENTEROL, V9, P73; Leland P, 2000, MOL MED, V6, P165, DOI 10.1007/BF03402112; Lotze MT, 2002, CANCER GENE THER, V9, P692, DOI 10.1038/sj.cgt.7700493; Oates AJ, 1997, INVAS METAST, V17, P1; Ohno K, 2010, SURG TODAY, V40, P347, DOI 10.1007/s00595-009-4082-x; Paradis V, 1998, J CLIN PATHOL, V51, P798, DOI 10.1136/jcp.51.11.798; Ravi D, 1998, ORAL ONCOL, V34, P543, DOI 10.1016/S1368-8375(98)00054-2; Rizzo P, 2008, CANCER RES, V68, P5226, DOI 10.1158/0008-5472.CAN-07-5744; Roy R, 2006, EXP CELL RES, V312, P608, DOI 10.1016/j.yexcr.2005.11.022; SENGER DR, 1989, ANTICANCER RES, V9, P1291; Shevde LA, 2010, CURR MOL MED, V10, P71, DOI 10.2174/156652410791065381; Shijubo N, 2000, CRIT REV ONCOGENESIS, V11, P135; Singh RP, 2006, J NATL CANCER I, V98, P846, DOI 10.1093/jnci/djj231; Singhal H, 1997, CLIN CANCER RES, V3, P605; Solomayer EF, 2000, BREAST CANCER RES TR, V59, P271, DOI 10.1023/A:1006308619659; Suzuki H, 2002, LUNG CANCER-J IASLC, V38, P137, DOI 10.1016/S0169-5002(02)00176-9; THAETE LG, 1989, CELL TISSUE RES, V256, P167; Tokunaga T, 1998, BRIT J CANCER, V77, P998, DOI 10.1038/bjc.1998.164; Toloza EM, 2006, J CELL BIOCHEM, V99, P1, DOI 10.1002/jcb.20851; Trono D, 2000, GENE THER, V7, P20, DOI 10.1038/sj.gt.3301105; Veronesi U, 1999, JNCI-J NATL CANCER I, V91, P368, DOI 10.1093/jnci/91.4.368; Vinh-Hung V, 2004, BREAST CANCER RES, V6, pR680, DOI 10.1186/bcr934; Weber GF, 2010, BRIT J CANCER, V103, P861, DOI 10.1038/sj.bjc.6605834; Yu P, 2010, J CANCER RES CLIN, V136, P1283, DOI 10.1007/s00432-010-0779-x; Yu PW, 2001, ONCOGENE, V20, P484, DOI 10.1038/sj.onc.1204113; Zamora-Avila DE, 2009, CANCER GENE THER, V16, P892, DOI 10.1038/cgt.2009.35	48	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15623	10.1371/journal.pone.0015623	http://dx.doi.org/10.1371/journal.pone.0015623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203518	Green Submitted, Green Published, gold			2022-12-27	WOS:000285578000039
J	Gallou-Kabani, C; Gabory, A; Tost, J; Karimi, M; Mayeur, S; Lesage, J; Boudadi, E; Gross, MS; Taurelle, J; Vige, A; Breton, C; Reusens, B; Remacle, C; Vieau, D; Ekstrom, TJ; Jais, JP; Junien, C				Gallou-Kabani, Catherine; Gabory, Anne; Tost, Joerg; Karimi, Mohsen; Mayeur, Sylvain; Lesage, Jean; Boudadi, Elsa; Gross, Marie-Sylvie; Taurelle, Julien; Vige, Alexandre; Breton, Christophe; Reusens, Brigitte; Remacle, Claude; Vieau, Didier; Ekstrom, Tomas J.; Jais, Jean-Philippe; Junien, Claudine			Sex- and Diet-Specific Changes of Imprinted Gene Expression and DNA Methylation in Mouse Placenta under a High-Fat Diet	PLOS ONE			English	Article							ORGANIC CATION TRANSPORTERS; HUMAN CHORIONIC-GONADOTROPIN; FETAL-GROWTH; NUTRIENT TRANSPORT; TROPHOBLAST DIFFERENTIATION; MATERNAL UNDERNUTRITION; EPIGENETIC REGULATION; ADAPTIVE RESPONSES; BOVINE BLASTOCYSTS; MURINE PLACENTA	Background: Changes in imprinted gene dosage in the placenta may compromise the prenatal control of nutritional resources. Indeed monoallelic behaviour and sensitivity to changes in regional epigenetic state render imprinted genes both vulnerable and adaptable. Methods and Findings: We investigated whether a high-fat diet (HFD) during pregnancy modified the expression of imprinted genes and local and global DNA methylation patterns in the placenta. Pregnant mice were fed a HFD or a control diet (CD) during the first 15 days of gestation. We compared gene expression patterns in total placenta homogenates, for male and female offspring, by the RT-qPCR analysis of 20 imprinted genes. Sexual dimorphism and sensitivity to diet were observed for nine genes from four clusters on chromosomes 6, 7, 12 and 17. As assessed by in situ hybridization, these changes were not due to variation in the proportions of the placental layers. Bisulphite-sequencing analysis of 30 CpGs within the differentially methylated region (DMR) of the chromosome 17 cluster revealed sex-and diet-specific differential methylation of individual CpGs in two conspicuous subregions. Bioinformatic analysis suggested that these differentially methylated CpGs might lie within recognition elements or binding sites for transcription factors or factors involved in chromatin remodelling. Placental global DNA methylation, as assessed by the LUMA technique, was also sexually dimorphic on the CD, with lower methylation levels in male than in female placentae. The HFD led to global DNA hypomethylation only in female placenta. Bisulphite pyrosequencing showed that neither B1 nor LINE repetitive elements could account for these differences in DNA methylation. Conclusions: A HFD during gestation triggers sex-specific epigenetic alterations within CpG and throughout the genome, together with the deregulation of clusters of imprinted genes important in the control of many cellular, metabolic and physiological functions potentially involved in adaptation and/or evolution. These findings highlight the importance of studying both sexes in epidemiological protocols and dietary interventions.	[Gallou-Kabani, Catherine; Gabory, Anne; Boudadi, Elsa; Gross, Marie-Sylvie; Taurelle, Julien; Vige, Alexandre; Junien, Claudine] Univ Paris 05, Hop Necker Enfants Malades, AP HP, Fac Med,INSERM,U781, Paris, France; [Gabory, Anne; Junien, Claudine] INRA, Ctr Rech Jouy En Josas, UMR INRA ENV Maisons Alfort CNRS Biol Dev & Repro, UMR1198, F-78350 Jouy En Josas, France; [Tost, Joerg] Ctr Natl Genotypage, Inst Genom, CEA, Lab Epigenet, Evry, France; [Karimi, Mohsen; Ekstrom, Tomas J.] Karolinska Inst, Ctr Mol Med, Lab Med Epigenet, Dept Clin Neurosci, Stockholm, Sweden; [Mayeur, Sylvain; Lesage, Jean; Breton, Christophe; Vieau, Didier] Univ Sci & Technol Lille, Unite Environm Perinatal & Croissance, EA 4489, Villeneuve Dascq, France; [Reusens, Brigitte; Remacle, Claude] Catholic Univ Louvain, Cell Biol Lab, Inst Life Sci, B-3000 Louvain, Belgium; [Jais, Jean-Philippe] Univ Paris 05, SBIM, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Karolinska Institutet; Universite de Lille - ISITE; Universite de Lille; Universite Catholique Louvain; UDICE-French Research Universities; Universite Paris Cite	Gallou-Kabani, C (corresponding author), Univ Paris 05, Hop Necker Enfants Malades, AP HP, Fac Med,INSERM,U781, Paris, France.	claudine.junien@jouy.inra.fr	Ekström, Tomas/B-7764-2013; Tost, Joerg/H-7129-2019; lesage, jean/R-5019-2018	Tost, Joerg/0000-0002-2683-0817; lesage, jean/0000-0002-6329-1613; vieau, didier/0000-0002-3254-3662; Gabory, Anne/0000-0002-0059-7375	Nestle Foundation; Fondation pour la Recherche Medicale; Association Francaise d'Etudes et de Recherche sur l'Obesite; Fournier-Pharma; Swedish Cancer Society; INRA (Institut National de la Recherche Agronomique); INSERM (ATC-Nutrition, PRNH); Association Francaise des Diabetiques; Institut Benjamin Delessert; Fondation Coeur et Artrres (FCA); ANR-Agence Nationale de la Recherche (The French National Research Agency) [ANR-06-PNRA-022-01]; Contrat Cadre d'Aide au Projet d'Innovation Strategique Industrielle [ISI IT-DIAB - 18/12/2008]	Nestle Foundation(Nestle SA); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association Francaise d'Etudes et de Recherche sur l'Obesite; Fournier-Pharma; Swedish Cancer Society(Swedish Cancer Society); INRA (Institut National de la Recherche Agronomique); INSERM (ATC-Nutrition, PRNH)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association Francaise des Diabetiques; Institut Benjamin Delessert; Fondation Coeur et Artrres (FCA); ANR-Agence Nationale de la Recherche (The French National Research Agency)(French National Research Agency (ANR)); Contrat Cadre d'Aide au Projet d'Innovation Strategique Industrielle	This work was supported by Nestle Foundation, the Fondation pour la Recherche Medicale and an Association Francaise d'Etudes et de Recherche sur l'Obesite studentship awarded to AV, a Fournier-Pharma studentship awarded to CGK, a grant from the Swedish Cancer Society awarded to TJE, and by grants from INRA (Institut National de la Recherche Agronomique), INSERM (ATC-Nutrition, PRNH), Association Francaise des Diabetiques, the Institut Benjamin Delessert, the Fondation Coeur et Artrres (FCA N degree 05-T4), the ANR-Agence Nationale de la Recherche (The French National Research Agency) under the Programme National de Recherche en Alimentation et nutrition humaine, project ANR-06-PNRA-022-01, and Contrat Cadre d'Aide au Projet d'Innovation Strategique Industrielle "IT-Diab" OSEO-ISI (ISI IT-DIAB - 18/12/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnouti Y, 2006, DRUG METAB DISPOS, V34, P477, DOI 10.1121/dmd.105.006932; Angiolini E, 2006, PLACENTA, V27, pS98, DOI 10.1016/j.placenta.2005.12.008; Apostolidou S, 2007, J MOL MED, V85, P379, DOI 10.1007/s00109-006-0131-8; Asaka J, 2006, PHARM RES-DORDR, V23, P697, DOI 10.1007/s11095-006-9665-2; Ashworth CJ, 2009, PHILOS T R SOC B, V364, P3351, DOI 10.1098/rstb.2009.0184; Attig L, 2010, CURR OPIN CLIN NUTR, V13, P284, DOI 10.1097/MCO.0b013e328338aa61; Avila L, 2010, PLACENTA; Barker DJP, 2010, INT J DEV BIOL, V54, P525, DOI 10.1387/ijdb.082760db; BARKER DJP, 1992, EUR J CLIN NUTR, V46, pS3; Bermejo-Alvarez P, 2010, P NATL ACAD SCI USA, V107, P3394, DOI 10.1073/pnas.0913843107; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Bottalico B, 2004, PLACENTA, V25, P518, DOI 10.1016/j.placenta.2003.10.017; Brideau CM, 2010, MOL CELL BIOL, V30, P3357, DOI 10.1128/MCB.01355-09; BROWN MJ, 1987, AM J OBSTET GYNECOL, V156, P716, DOI 10.1016/0002-9378(87)90085-8; Charalambous Marika, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P3, DOI 10.1097/MED.0b013e328013daa2; Charalambous M, 2010, DEV BIOL, V337, P1, DOI 10.1016/j.ydbio.2009.10.011; Clifton VL, 2010, PLACENTA, V31, pS33, DOI 10.1016/j.placenta.2009.11.010; Clifton VL, 2010, GROWTH HORM IGF RES, V20, P39, DOI 10.1016/j.ghir.2009.07.004; Coan PM, 2010, J PHYSIOL-LONDON, V588, P527, DOI 10.1113/jphysiol.2009.181214; Coan PM, 2005, PLACENTA, V26, pS10, DOI 10.1016/j.placenta.2004.12.009; Constancia M, 2005, P NATL ACAD SCI USA, V102, P19219, DOI 10.1073/pnas.0504468103; Constancia M, 2004, NATURE, V432, P53, DOI 10.1038/432053a; Cross JC, 2006, NUTR REV, V64, pS12, DOI 10.1301/nr.may.S12-S18; Cross JC, 2000, SEMIN CELL DEV BIOL, V11, P105, DOI 10.1006/scdb.2000.0156; Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3; Ehrenberg HM, 2004, AM J OBSTET GYNECOL, V191, P964, DOI 10.1016/j.ajog.2004.05.052; Ericsson A, 2007, J PHYSIOL-LONDON, V581, P1323, DOI 10.1113/jphysiol.2007.131185; Fauque P, 2010, HUM MOL GENET; Feil R, 2006, MUTAT RES-FUND MOL M, V600, P46, DOI 10.1016/j.mrfmmm.2006.05.029; Flajollet S, 2007, MOL CELL ENDOCRINOL, V270, P23, DOI 10.1016/j.mce.2007.02.004; Fortier AL, 2008, HUM MOL GENET; Fowden AL, 2008, J NEUROENDOCRINOL, V20, P439, DOI 10.1111/j.1365-2826.2008.01663.x; Fowden AL, 2009, J PHYSIOL-LONDON, V587, P3459, DOI 10.1113/jphysiol.2009.173013; Fowden AL, 2006, HORM RES, V65, P50, DOI 10.1159/000091506; Frost JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001015; Fryer Anthony A, 2009, Epigenetics, V4, P394; Gabory A, 2009, DEVELOPMENT, V136, P3413, DOI 10.1242/dev.036061; Gabory A, 2009, MOL CELL ENDOCRINOL, V304, P8, DOI 10.1016/j.mce.2009.02.015; Gallou-Kabani C, 2007, AM J PHYSIOL-ENDOC M, V292, pE1095, DOI 10.1152/ajpendo.00390.2006; Gatford KL, 2010, PLACENTA, V31, pS60, DOI 10.1016/j.placenta.2009.12.015; Gebert C, 2009, GENOMICS, V94, P63, DOI 10.1016/j.ygeno.2009.03.004; Gheorghe CP, 2009, PLACENTA, V30, P411, DOI 10.1016/j.placenta.2009.03.002; Gheorghe C, 2006, J SOC GYNECOL INVEST, V13, P256, DOI 10.1016/j.jsgi.2006.02.007; Gheorghe CP, 2007, REPROD SCI, V14, P223, DOI 10.1177/1933719107302860; Gheorghe CP, 2010, INT J DEV BIOL, V54, P507, DOI 10.1387/ijdb.082770cg; Godfrey KM, 2002, PLACENTA, V23, pS20, DOI 10.1053/plac.2002.0773; Grundemann D, 2000, HUM GENET, V106, P627, DOI 10.1007/s004390050035; GUO F, 1995, PHYSIOL BEHAV, V57, P681, DOI 10.1016/0031-9384(94)00342-4; Harlfinger S, 2005, N-S ARCH PHARMACOL, V372, P125, DOI 10.1007/s00210-005-0011-8; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Hemberger M, 2007, CELL MOL LIFE SCI, V64, P2422, DOI 10.1007/s00018-007-7113-z; Hemberger M, 2001, TRENDS ENDOCRIN MET, V12, P162, DOI 10.1016/S1043-2760(01)00375-7; Hemberger M, 2010, EPIGENETICS-US, V5, P24, DOI 10.4161/epi.5.1.10589; Hernandez A, 2007, ENDOCRINOLOGY, V148, P3968, DOI 10.1210/en.2007-0029; Hiura H, 2006, GENES CELLS, V11, P353, DOI 10.1111/j.1365-2443.2006.00943.x; Ishikawa H, 2003, BIOL REPROD, V69, P483, DOI 10.1095/biolreprod.102.012641; Janney CA, 1997, AM J CLIN NUTR, V66, P1116, DOI 10.1093/ajcn/66.5.1116; Jansson T, 2007, CLIN SCI, V113, P1, DOI 10.1042/CS20060339; Jeong KS, 2005, BIOCHEM BIOPH RES CO, V335, P1211, DOI 10.1016/j.bbrc.2005.08.015; Jones HN, 2009, FASEB J, V23, P271, DOI 10.1096/fj.08-116889; Kagami M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000992; Kaneko-Ishino T, 2010, DEV GROWTH DIFFER, V52, P533, DOI 10.1111/j.1440-169X.2010.01194.x; Karimi M, 2006, EXP CELL RES, V312, P1989, DOI 10.1016/j.yexcr.2006.03.006; Kokalj-Vokac N, 1998, CHROMOSOME RES, V6, P161, DOI 10.1023/A:1009299331871; Kulkarni A, 2010, DNA CELL BIOL; Kwong WY, 2006, REPRODUCTION, V132, P265, DOI 10.1530/rep.1.01038; Kwong WY, 2000, DEVELOPMENT, V127, P4195; Lehavi O, 2005, FETAL DIAGN THER, V20, P235, DOI 10.1159/000083911; Lesage J, 2001, ENDOCRINOLOGY, V142, P1692, DOI 10.1210/en.142.5.1692; Liang CY, 2010, METABOLISM, V59, P943, DOI 10.1016/j.metabol.2009.10.015; Lim AL, 2010, SEMIN CELL DEV BIOL, V21, P201, DOI 10.1016/j.semcdb.2009.10.008; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Luedi PP, 2005, GENOME RES, V15, P875, DOI 10.1101/gr.3303505; Maltepe E, 2010, J CLIN INVEST, V120, P1016, DOI 10.1172/JCI41211; Mao J, 2010, P NATL ACAD SCI US; McAllister EJ, 2009, CRIT REV FOOD SCI, V49, P868, DOI 10.1080/10408390903372599; McMinn J, 2006, PLACENTA, V27, P540, DOI 10.1016/j.placenta.2005.07.004; Mitchell M, 2009, BIOL REPROD, V80, P622, DOI 10.1095/biolreprod.108.072595; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; de Mello JCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010947; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; Myatt L, 2006, J PHYSIOL-LONDON, V572, P25, DOI 10.1113/jphysiol.2006.104968; Nathanielsz PW, 2007, OBSTET GYN CLIN N AM, V34, P201, DOI 10.1016/j.ogc.2007.03.006; Nelissen EC, 2010, HUM REPROD UPDATE; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Nie WX, 2005, AM J PHYSIOL-GASTR L, V288, pG207, DOI 10.1152/ajpgi.00057.2004; Noguer-Dance M, 2010, HUM MOL GENET, V19, P3566, DOI 10.1093/hmg/ddq272; Ohgane J, 2004, GENES CELLS, V9, P253, DOI 10.1111/j.1356-9597.2004.00720.x; Pelis RM, 2007, J PHARMACOL EXP THER, V323, P555, DOI 10.1124/jpet.107.126748; Pembrey M., 1996, Acta Geneticae Medicae et Gemellologiae, V45, P111; Penaloza C, 2009, FASEB J, V23, P1869, DOI 10.1096/fj.08-119388; RAZIN A, 1984, P NATL ACAD SCI-BIOL, V81, P2275, DOI 10.1073/pnas.81.8.2275; ROSSANT J, 1986, DEV BIOL, V117, P567, DOI 10.1016/0012-1606(86)90325-8; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Sekita Y, 2008, NAT GENET, V40, P243, DOI 10.1038/ng.2007.51; Sibley CP, 2010, PLACENTA, V31, pS70, DOI 10.1016/j.placenta.2009.12.020; Sibley CP, 2004, P NATL ACAD SCI USA, V101, P8204, DOI 10.1073/pnas.0402508101; Simmons DG, 2007, DEV BIOL, V304, P567, DOI 10.1016/j.ydbio.2007.01.009; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Sleutels F, 2003, EMBO J, V22, P3696, DOI 10.1093/emboj/cdg341; Smith GCS, 2007, AM J PUBLIC HEALTH, V97, P157, DOI 10.2105/AJPH.2005.074294; Sood R, 2006, P NATL ACAD SCI USA, V103, P5478, DOI 10.1073/pnas.0508035103; Steier JA, 2004, ACTA OBSTET GYN SCAN, V83, P170, DOI 10.1111/j.0001-6349.2004.00407.x; Tabano S, 2010, EPIGENETICS-US, V5, P313, DOI 10.4161/epi.5.4.11637; Theys N, 2010, J NUTR BIOC IN PRESS; Thornburg KL, 2010, PLACENTA, V31, pS54, DOI 10.1016/j.placenta.2010.01.002; Tost Jorg, 2007, V373, P89; Tycko B, 2002, J CELL PHYSIOL, V192, P245, DOI 10.1002/jcp.10129; Urakami Y, 2000, FEBS LETT, V473, P173, DOI 10.1016/S0014-5793(00)01525-8; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Verhaagh S, 2001, MECH DEVELOP, V100, P127, DOI 10.1016/S0925-4773(00)00510-4; Vucetic Z, 2010, ENDOCRINOLOGY, V151, P4756, DOI 10.1210/en.2010-0505; Wagschal A, 2006, CYTOGENET GENOME RES, V113, P90, DOI 10.1159/000090819; Waterland RA, 2006, HUM MOL GENET, V15, P705, DOI 10.1093/hmg/ddi484; Watkins AJ, 2008, BIOL REPROD, V78, P299, DOI 10.1095/biolreprod.107.064220; Weber M, 2005, PROG MOLEC, V38, P207; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Williams TM, 2009, NAT REV GENET, V10, P797, DOI 10.1038/nrg2687; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169; Wu Qing, 2006, Wei Sheng Yan Jiu, V35, P30; Yamazaki Y, 2003, P NATL ACAD SCI USA, V100, P12207, DOI 10.1073/pnas.2035119100; Zhou YL, 2010, DEVELOPMENT, V137, P2643, DOI 10.1242/dev.045724	122	177	180	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e14398	10.1371/journal.pone.0014398	http://dx.doi.org/10.1371/journal.pone.0014398			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21200436	Green Submitted, Green Published, gold			2022-12-27	WOS:000285576900012
J	Shah, N; Lin, BY; Sibenaller, Z; Ryken, T; Lee, H; Yoon, JG; Rostad, S; Foltz, G				Shah, Nameeta; Lin, Biaoyang; Sibenaller, Zita; Ryken, Timothy; Lee, Hwahyung; Yoon, Jae-Geun; Rostad, Steven; Foltz, Greg			Comprehensive Analysis of MGMT Promoter Methylation: Correlation with MGMT Expression and Clinical Response in GBM	PLOS ONE			English	Article							O6-METHYLGUANINE-DNA METHYLTRANSFERASE; PROGNOSTIC-SIGNIFICANCE; ADJUVANT TEMOZOLOMIDE; GENE-EXPRESSION; GLIOBLASTOMA; HYPERMETHYLATION; SURVIVAL; RADIOTHERAPY; CONCOMITANT; ASSAY	O-6-methylguanine DNA-methyltransferase (MGMT) promoter methylation has been identified as a potential prognostic marker for glioblastoma patients. The relationship between the exact site of promoter methylation and its effect on gene silencing, and the patient's subsequent response to therapy, is still being defined. The aim of this study was to comprehensively characterize cytosine-guanine (CpG) dinucleotide methylation across the entire MGMT promoter and to correlate individual CpG site methylation patterns to mRNA expression, protein expression, and progression-free survival. To best identify the specific MGMT promoter region most predictive of gene silencing and response to therapy, we determined the methylation status of all 97 CpG sites in the MGMT promoter in tumor samples from 70 GBM patients using quantitative bisulfite sequencing. We next identified the CpG site specific and regional methylation patterns most predictive of gene silencing and improved progression-free survival. Using this data, we propose a new classification scheme utilizing methylation data from across the entire promoter and show that an analysis based on this approach, which we call 3R classification, is predictive of progression-free survival (HR = 5.23, 95% C [2.089-13.097], p < 0.0001). To adapt this approach to the clinical setting, we used a methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) test based on the 3R classification and show that this test is both feasible in the clinical setting and predictive of progression free survival (HR = 3.076, 95% Cl [1.301-7.27], p = 0.007). We discuss the potential advantages of a test based on this promoter-wide analysis and compare it to the commonly used methylation-specific PCR test. Further prospective validation of these two methods in a large independent patient cohort will be needed to confirm the added value of promoter wide analysis of MGMT methylation in the clinical setting.	[Shah, Nameeta; Lin, Biaoyang; Lee, Hwahyung; Yoon, Jae-Geun; Foltz, Greg] Swedish Neurosci Inst, Ben & Catherine Ivy Ctr Adv Brain Tumor Treatment, Seattle, WA USA; [Sibenaller, Zita] Univ Iowa, Carver Coll Med, Dept Radiat & Oncol, Iowa City, IA USA; [Ryken, Timothy] Iowa Spine & Brain Inst, Waterloo, IA USA; [Rostad, Steven] Cellnetix Pathol & Labs, Seattle, WA USA	Swedish Medical Center; University of Iowa	Shah, N (corresponding author), Swedish Neurosci Inst, Ben & Catherine Ivy Ctr Adv Brain Tumor Treatment, Seattle, WA USA.	greg.foltz@swedish.org	Lin, Biaoyang/AAA-1258-2020	Lin, Biaoyang/0000-0002-2189-0407	Ben and Catherine Ivy Foundation; Swedish Medical Foundation	Ben and Catherine Ivy Foundation; Swedish Medical Foundation	We gratefully acknowledge the Ben and Catherine Ivy Foundation and the Swedish Medical Foundation for support of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belanich M, 1996, CANCER RES, V56, P783; Blough MD, 2007, CANCER RES, V67, P580, DOI 10.1158/0008-5472.CAN-06-2782; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Brandes AA, 2009, J CLIN ONCOL, V27, P1275, DOI 10.1200/JCO.2008.19.4969; Brandes JC, 2007, ONCOGENE, V26, P6229, DOI 10.1038/sj.onc.1210433; Cankovic M, 2007, LAB INVEST, V87, P392, DOI 10.1038/labinvest.3700520; Cao VT, 2009, NEUROSURGERY, V65, P866, DOI 10.1227/01.NEU.0000357325.90347.A1; Capper D, 2008, ACTA NEUROPATHOL, V115, P249, DOI 10.1007/s00401-007-0310-x; Criniere E, 2007, J NEURO-ONCOL, V83, P173, DOI 10.1007/s11060-006-9320-0; Eoli M, 2007, CLIN CANCER RES, V13, P2606, DOI 10.1158/1078-0432.CCR-06-2184; Everhard S, 2009, NEURO-ONCOLOGY, V11, P348, DOI 10.1215/15228517-2009-001; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Felsberg J, 2009, CLIN CANCER RES, V15, P6683, DOI 10.1158/1078-0432.CCR-08-2801; FRITZ G, 1991, MOL CELL BIOL, V11, P4660, DOI 10.1128/MCB.11.9.4660; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Grasbon-Frodl EM, 2007, INT J CANCER, V121, P2458, DOI 10.1002/ijc.23020; Hegi ME, 2004, CLIN CANCER RES, V10, P1871, DOI 10.1158/1078-0432.CCR-03-0384; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Jeuken JW, 2007, LAB INVEST, V87, P1055, DOI 10.1038/labinvest.3700664; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kitange GJ, 2009, J NEURO-ONCOL, V92, P23, DOI 10.1007/s11060-008-9737-8; Maxwell JA, 2006, MOL CANCER THER, V5, P2531, DOI 10.1158/1535-7163.MCT-06-0106; Mellai Marta, 2009, Cancer Genomics & Proteomics, V6, P219; Mikeska T, 2007, J MOL DIAGN, V9, P368, DOI 10.2353/jmoldx.2007.060167; Nakagawachi T, 2003, ONCOGENE, V22, P8835, DOI 10.1038/sj.onc.1207183; *NAT CANC I, 2010, RTOG 0525 PHAS 3 RAN; *NAT CANC I, 2010, RTOG 0825 PHAS 3 RAN; Parkinson JF, 2008, J NEURO-ONCOL, V87, P71, DOI 10.1007/s11060-007-9486-0; Pieper RO, 1996, J BIOL CHEM, V271, P13916, DOI 10.1074/jbc.271.23.13916; Polley MYC, 2010, NEURO-ONCOLOGY, V12, P274, DOI 10.1093/neuonc/nop034; Preusser M, 2008, BRAIN PATHOL, V18, P520, DOI 10.1111/j.1750-3639.2008.00153.x; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sanai N, 2009, NEUROTHERAPEUTICS, V6, P478, DOI 10.1016/j.nurt.2009.04.005; Sasai K, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-36; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Vlassenbroeck I, 2008, J MOL DIAGN, V10, P332, DOI 10.2353/jmoldx.2008.070169; WALKER MD, 1980, NEW ENGL J MED, V303, P1323, DOI 10.1056/NEJM198012043032303; Weiler M, 2010, INT J RADIAT ONCOL, V77, P670, DOI 10.1016/j.ijrobp.2009.05.031; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Yachi K, 2008, INT J ONCOL, V33, P469, DOI 10.3892/ijo_00000029	42	71	75	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e16146	10.1371/journal.pone.0016146	http://dx.doi.org/10.1371/journal.pone.0016146			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249131	Green Published, gold, Green Submitted			2022-12-27	WOS:000286512900023
J	Bover, P; Alcover, JA; Michaux, JJ; Hautier, L; Hutterer, R				Bover, Pere; Alcover, Josep A.; Michaux, Jacques J.; Hautier, Lionel; Hutterer, Rainer			Body Shape and Life Style of the Extinct Balearic Dormouse Hypnomys (Rodentia, Gliridae): New Evidence from the Study of Associated Skeletons	PLOS ONE			English	Article							MASS ESTIMATION; MALLORCA; SIZE; POPULATIONS; ADAPTATIONS; EVOLUTION; APODEMUS; ISLANDS; MAMMALS; BATE	Hypnomys is a genus of Gliridae (Rodentia) that occurred in the Balearic Islands until Late Holocene. Recent finding of a complete skeleton of the chronospecies H. morpheus (Late Pleistocene-Early Holocene) and two articulated skeletons of H. cf. onicensis (Late Pliocene) allowed the inference of body size and the calculation of several postcranial indexes. We also performed a Factorial Discriminant Analysis (FDA) in order to evaluate locomotory behaviour and body shape of the taxa. Using allometric models based on skull and tooth measurements, we calculated a body weight between 173 and 284 g for H. morpheus, and direct measurements of articulated skeletons yielded a Head and Body Length (HBL) of 179 mm and a Total Body Length of 295 mm for this species. In addition to the generally higher robustness of postcranial bones already recorded by previous authors, H. morpheus, similar to Canariomys tamarani, another extinct island species, displayed elongated zygopodium bones of the limbs and a wider distal humerus and femur than in an extant related taxon, Eliomys quercinus. Indexes indicated that Hypnomys was more terrestrial and had greater fossorial abilities than E. quercinus. This was also corroborated by a Discriminant Analysis, although no clear additional inference of locomotory abilities could be calculated.	[Bover, Pere; Alcover, Josep A.] Inst Mediterrani Estudis Avancats, Dept Biodiversitat & Conservacio, Esporles, Spain; [Bover, Pere; Alcover, Josep A.; Hutterer, Rainer] Amer Museum Nat Hist, Div Vertebrate Zool Mammal, New York, NY 10024 USA; [Michaux, Jacques J.] Univ Montpellier 2, EPHE, Montpellier, France; [Michaux, Jacques J.] Univ Montpellier 2, CNRS, ISEM, UMR 5554, Montpellier, France; [Michaux, Jacques J.] Univ Montpellier, F-34059 Montpellier, France; [Hautier, Lionel] Univ Cambridge, Dept Zool, Cambridge, England; [Hutterer, Rainer] Zool Forsch Museum Alexander Koenig, Bonn, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); American Museum of Natural History (AMNH); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier; University of Cambridge; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK)	Bover, P (corresponding author), Inst Mediterrani Estudis Avancats, Dept Biodiversitat & Conservacio, Esporles, Spain.	pere.bover@uib.es	; Alcover, Josep Antoni/Y-3796-2018	Bover Arbos, Pedro/0000-0003-2942-2840; Alcover, Josep Antoni/0000-0001-9905-2588; Hautier, Lionel/0000-0001-8701-5421	Direccion General de Investigacion, Ministerio de Ciencia e Innovacion (Spain) [CGL2007-62047/BTE]	Direccion General de Investigacion, Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work is included in the project CGL2007-62047/BTE of the Direccion General de Investigacion, Ministerio de Ciencia e Innovacion (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUSTI J, 1982, Geobios (Villeurbanne), V15, P783, DOI 10.1016/S0016-6995(82)80008-9; Alcover J.A., 1997, Endins, V21, P79; Alcover J. A., 1975, SPELEON, V22, P81; Alcover J. A., 1981, QUIMERES PASSAT ELS; Alcover JA, 1983, THESIS U BARCELONA; ANGERBJORN A, 1986, OIKOS, V47, P47, DOI 10.2307/3565918; ANYONGE W, 1993, J ZOOL, V231, P339, DOI 10.1111/j.1469-7998.1993.tb01922.x; Bate DMA, 1918, P ZOOL SOC LOND, V1918, P209, DOI [10.1111/j.1096-3642.1918. tb02091.x, DOI 10.1111/J.1096-3642.1918.TB02091.X]; Biknevicius A.R., 1993, American Museum Novitates, V3079, P1; Biknevicius AR, 1999, J ZOOL, V248, P179, DOI 10.1111/j.1469-7998.1999.tb01194.x; Bover P, 2003, J BIOGEOGR, V30, P771, DOI 10.1046/j.1365-2699.2003.00872.x; Bover P, 2007, LIBR RES 7 S INT ZOO; Bover P, 2008, J BIOGEOGR, V35, P1112, DOI 10.1111/j.1365-2699.2007.01839.x; Bover P, 2010, GEOL MAG, V147, P871, DOI 10.1017/S0016756810000336; BOYE P, 1992, Z SAUGETIERKD, V57, P29; Burjachs F., 1994, TRABAJOS PALINOLOGIA, P199; Damuth J., 1990, BODY SIZE MAMMALIAN; Egi N, 2001, PALAEONTOLOGY, V44, P497, DOI 10.1111/1475-4983.00189; Elissamburu A, 2004, J ZOOL, V262, P145, DOI 10.1017/S0952836903004485; Ginard Antelm, 2009, Endins, V33, P105; GINGERICH P D, 1990, Contributions from the Museum of Paleontology University of Michigan, V28, P79; GINGERICH PD, 1982, AM J PHYS ANTHROPOL, V58, P81, DOI 10.1002/ajpa.1330580110; Gracia Francesc, 2009, Endins, V33, P35; Hautier L, 2009, ACTA PALAEONTOL POL, V54, P181, DOI 10.4202/app.2008.0001; Holden ME, 2009, SYSTEMATIC REVISIO 2; Hopkins SSB, 2008, J MAMMAL, V89, P232, DOI 10.1644/06-MAMM-A-306.1; KAHMANN H, 1973, Saeugetierkundliche Mitteilungen, V21, P65; Kahmann H., 1974, Boletin Soc Hist nat Baleares, V19, P57; Kahmann H, 1972, VEROFF ZOOL STAATS M, V16, P20; Kahmann H, 1970, VEROFF ZOOL STAATS M, V14, P75; Legendre S., 1989, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V16, P1; Lopez-Martinez N, 1987, NUEVO MURIDO GIGANTE; MAEMPEL GZ, 1982, P K NED AKAD B PHYS, V85, P113; Michaux JR, 2002, GLOBAL ECOL BIOGEOGR, V11, P427, DOI 10.1046/j.1466-822x.2002.00301.x; Mihlbachler MC, 2002, QUATERNARY RES, V58, P289, DOI 10.1006/qres.2002.2385; Millien V, 2008, P ROY SOC B-BIOL SCI, V275, P1953, DOI 10.1098/rspb.2008.0087; Millien V, 2010, J MAMMAL, V91, P11, DOI 10.1644/08-MAMM-A-347R1.1; Millien-Parra V, 2000, MAMMALIA, V64, P221, DOI 10.1515/mamm.2000.64.2.221; Mills DH, 1976, PUB PAL I U UPPSALA, V4, P1; MOYA-SOLA S, 1984, Acta Geologica Hispanica, V19, P33; Parra V, 1998, CR ACAD SCI II A, V326, P79, DOI 10.1016/S1251-8050(97)83207-7; Perez-Obiol R, 1996, PALEOAMBIENTE CUATER, P87; Quintana J., 1995, Paleontologia i Evolucio, V26-27, P271; Quintana J, 2010, J VERTEBR P IN PRESS; Quintana J, 2010, GEOBIOS IN PRESS; Quintana Josep, 2004, Endins, V26, P7; Renaud S, 2003, J BIOGEOGR, V30, P1617, DOI 10.1046/j.1365-2699.2003.00932.x; Renaud S, 2001, BIOL J LINN SOC, V74, P557, DOI 10.1006/bijl.2001.0595; Rinderknecht A, 2008, P ROY SOC B-BIOL SCI, V275, P923, DOI 10.1098/rspb.2007.1645; Rose J, 1999, BRIT GEOMOR, P91; Rose J, 1999, J GEOL SOC LONDON, V156, P435, DOI 10.1144/gsjgs.156.2.0435; Samuels JX, 2008, J MORPHOL, V269, P1387, DOI 10.1002/jmor.10662; Sanchez-Villagra MR, 2003, SCIENCE, V301, P1708, DOI 10.1126/science.1089332; Solounias N, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)366<0001:AITROU>2.0.CO;2; Storch G., 1978, HDB SAUGETIERE EUROP, V1, P201; SUC JP, 1984, NATURE, V307, P429, DOI 10.1038/307429a0; THUNELL RC, 1979, SEDIMENT GEOL, V23, P67, DOI 10.1016/0037-0738(79)90006-X; Thunell RC, 1983, UTRECHT MICROPALEONT, V30, P111; Tuccimei P., 2000, ENDINS, V23, P59; Vesica PL, 2000, QUATERNARY SCI REV, V19, P865, DOI 10.1016/S0277-3791(99)00026-8	60	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15817	10.1371/journal.pone.0015817	http://dx.doi.org/10.1371/journal.pone.0015817			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209820	Green Published, gold			2022-12-27	WOS:000285838900038
J	Cizkova, M; Cizeron-Clairac, G; Vacher, S; Susini, A; Andrieu, C; Lidereau, R; Bieche, I				Cizkova, Magdalena; Cizeron-Clairac, Geraldine; Vacher, Sophie; Susini, Aurelie; Andrieu, Catherine; Lidereau, Rosette; Bieche, Ivan			Gene Expression Profiling Reveals New Aspects of PIK3CA Mutation in ERalpha-Positive Breast Cancer: Major Implication of the Wnt Signaling Pathway	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; CELL-GROWTH; TRANSCRIPTION FACTORS; STEM-CELLS; CARCINOMAS; SIGNATURE; PTEN; DIFFERENTIATION; IDENTIFICATION; PROGRESSION	Background: The PI3K/AKT pathway plays a pivotal role in breast cancer development and maintenance. PIK3CA, encoding the PI3K catalytic subunit, is the oncogene exhibiting a high frequency of gain-of-function mutations leading to PI3K/AKT pathway activation in breast cancer. PIK3CA mutations have been observed in 30% to 40% of ER alpha-positive breast tumors. However the physiopathological role of PIK3CA mutations in breast tumorigenesis remains largely unclear. Methodology/Principal Findings: To identify relevant downstream target genes and signaling activated by aberrant PI3K/AKT pathway in breast tumors, we first analyzed gene expression with a pangenomic oligonucleotide microarray in a series of 43 ER alpha-positive tumors with and without PIK3CA mutations. Genes of interest were then investigated in 249 ER alpha-positive breast tumors by real-time quantitative RT-PCR. A robust collection of 19 genes was found to be differently expressed in PIK3CA-mutated tumors. PIK3CA mutations were associated with over-expression of several genes involved in the Wnt signaling pathway (WNT5A, TCF7L2, MSX2, TNFRSF11B), regulation of gene transcription (SEC14L2, MSX2, TFAP2B, NRIP3) and metal ion binding (CYP4Z1, CYP4Z2P, SLC40A1, LTF, LIMCH1). Conclusion/Significance: This new gene set should help to understand the behavior of PIK3CA-mutated cancers and detailed knowledge of Wnt signaling activation could lead to novel therapeutic strategies.	[Cizkova, Magdalena; Cizeron-Clairac, Geraldine; Vacher, Sophie; Susini, Aurelie; Andrieu, Catherine; Lidereau, Rosette; Bieche, Ivan] Hop Rene Huguenin, Lab Oncogenet, Inst Natl Sante & Rech, Inst Curie,U745, St Cloud, France; [Cizkova, Magdalena] Palacky Univ, Expt Med Lab, Dept Paediat, Fac Med & Dent, CR-77147 Olomouc, Czech Republic; [Cizkova, Magdalena] Univ Hosp Olomouc, Olomouc, Czech Republic	Institut National de la Sante et de la Recherche Medicale (Inserm); Rene Huguenin Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Palacky University Olomouc; University Hospital Olomouc	Cizkova, M (corresponding author), Hop Rene Huguenin, Lab Oncogenet, Inst Natl Sante & Rech, Inst Curie,U745, St Cloud, France.	i.bieche@stcloud-huguenin.org	Bièche, Ivan/O-7399-2017	Bièche, Ivan/0000-0002-2430-5429; VACHER, Sophie/0000-0002-0042-6023	INCA (Institut National du CAncer); Ile de France; Comite Departemental des Hauts-de-Seine of the Ligue Nationale Contre le Cancer; Cartes d'Identite des Tumeurs (CIT) program	INCA (Institut National du CAncer)(Institut National du Cancer (INCA) France); Ile de France; Comite Departemental des Hauts-de-Seine of the Ligue Nationale Contre le Cancer; Cartes d'Identite des Tumeurs (CIT) program	This work was supported by INCA (Institut National du CAncer), Programme Canceropoles 2003-2007 Ile de France, and Comite Departemental des Hauts-de-Seine of the Ligue Nationale Contre le Cancer. This work is part of the Cartes d'Identite des Tumeurs (CIT) program (http://cit.ligue-cancer.net/index.php/en) launched and directed by the Ligue Nationale Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba MC, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-37; Andre F, 2008, BREAST CANCER RES TR, V108, P183, DOI 10.1007/s10549-007-9594-8; Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Baryawno N, 2010, CANCER RES, V70, P266, DOI 10.1158/0008-5472.CAN-09-0578; Benaissa M, 2005, INT J CANCER, V114, P299, DOI 10.1002/ijc.20728; Bieche I, 1999, CLIN CHEM, V45, P1148; Bu GJ, 2008, INT J CANCER, V123, P1034, DOI 10.1002/ijc.23625; Carnero A, 2009, EXPERT OPIN INV DRUG, V18, P1265, DOI 10.1517/13543780903066798; Cheng SL, 2008, J BIOL CHEM, V283, P20505, DOI 10.1074/jbc.M800851200; Dillon RL, 2007, ONCOGENE, V26, P1338, DOI 10.1038/sj.onc.1210202; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Esseghir S, 2007, CLIN CANCER RES, V13, P3164, DOI 10.1158/1078-0432.CCR-07-0224; Ford CE, 2009, CELL CYCLE, V8, P1838, DOI 10.4161/cc.8.12.8863; Gee JMW, 1999, J PATHOL, V189, P514, DOI 10.1002/(SICI)1096-9896(199912)189:4<514::AID-PATH463>3.0.CO;2-9; Johnykutty S, 2009, MODERN PATHOL, V22, P770, DOI 10.1038/modpathol.2009.24; Karakas B, 2006, BRIT J CANCER, V94, P455, DOI 10.1038/sj.bjc.6602970; Katoh M, 2005, ONCOL REP, V14, P1583; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Leris ACA, 2005, ANTICANCER RES, V25, P731; Loi S, 2010, P NATL ACAD SCI USA, V107, P10208, DOI 10.1073/pnas.0907011107; Malanchi I, 2009, CURR OPIN ONCOL, V21, P41, DOI 10.1097/CCO.0b013e32831d1faf; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Maxwell GL, 2005, CLIN CANCER RES, V11, P4056, DOI 10.1158/1078-0432.CCR-04-2001; Nakshatri H, 2000, BIOCHEM BIOPH RES CO, V270, P1144, DOI 10.1006/bbrc.2000.2562; Navab R, 2004, CANCER RES, V64, P5097, DOI 10.1158/0008-5472.CAN-03-1185; Nteliopoulos G, 2009, BRIT J HAEMATOL, V146, P637, DOI 10.1111/j.1365-2141.2009.07823.x; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rieger MA, 2004, CANCER RES, V64, P2357, DOI 10.1158/0008-5472.CAN-03-0849; Riggins RB, 2008, CANCER RES, V68, P8908, DOI 10.1158/0008-5472.CAN-08-2669; Rouzier R, 2005, P NATL ACAD SCI USA, V102, P8315, DOI 10.1073/pnas.0408974102; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Satoh K, 2004, J MAMMARY GLAND BIOL, V9, P195, DOI 10.1023/B:JOMG.0000037162.84758.b5; Shan L, 2003, AM J PATHOL, V163, P2495, DOI 10.1016/S0002-9440(10)63604-8; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Tang W, 2008, P NATL ACAD SCI USA, V105, P9697, DOI 10.1073/pnas.0804709105; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wang YQ, 2009, MOL CANCER THER, V8, P2103, DOI 10.1158/1535-7163.MCT-09-0282; Weng LP, 2001, HUM MOL GENET, V10, P605, DOI 10.1093/hmg/10.6.605; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Wu F, 2009, J MOL ENDOCRINOL, V42, P19, DOI 10.1677/JME-08-0088; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244	48	44	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15647	10.1371/journal.pone.0015647	http://dx.doi.org/10.1371/journal.pone.0015647			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209903	Green Submitted, gold, Green Published			2022-12-27	WOS:000285793600024
J	Albert, H; Manabe, Y; Lukyamuzi, G; Ademun, P; Mukkada, S; Nyesiga, B; Joloba, M; Paramasivan, CN; Perkins, MD				Albert, Heidi; Manabe, Yukari; Lukyamuzi, George; Ademun, Patrick; Mukkada, Sheena; Nyesiga, Barnabas; Joloba, Moses; Paramasivan, C. N.; Perkins, Mark D.			Performance of Three LED-Based Fluorescence Microscopy Systems for Detection of Tuberculosis in Uganda	PLOS ONE			English	Article							BACILLI	Background: Direct smear microscopy using Ziehl-Neelsen (ZN) staining is the mainstay of tuberculosis (TB) diagnosis in most high burden countries, but is limited by low sensitivity in routine practice, particularly in high human immunodeficiency virus (HIV) prevalence settings. Methods: We compared the performance of three commercial light emitting diode (LED)-based microscopy systems (Primostar(TM) iLED, Lumin(TM) and AFTER(R)) for fluorescent detection of Mycobacterium tuberculosis with ZN microscopy on slides prepared from sputum of TB suspects. Examination time for LED-based fluorescent microscopy (LED FM) and ZN slides was also compared, and a qualitative user appraisal of the LED FM systems was carried out. Results: LED FM was between 5.6 and 9.4% more sensitive than ZN microscopy, although the difference was not statistically significant. There was no significant difference in the sensitivity or specificity of the three LED FM systems, although the specificity of Fraen AFTER was somewhat lower than the other LED FM methods. Examination time for LED FM was 2 and 4 times less than for ZN microscopy. LED FM was highly acceptable to Ugandan technologists, although differences in operational performance of the three systems were reported. Conclusions: LED FM compares favourably with ZN microscopy, with equivalent specificity and a modest increase in sensitivity. Screening of slides was substantially quicker using LED FM than ZN, and LED FM was rated highly by laboratory technologists. Available commercial systems have different operational characteristics which should be considered prior to programmatic implementation.	[Albert, Heidi; Lukyamuzi, George; Ademun, Patrick; Mukkada, Sheena; Nyesiga, Barnabas] FIND, TB Res Lab, Kampala, Uganda; [Manabe, Yukari] Mulago Hosp, IDI, Kampala, Uganda; [Joloba, Moses] Natl TB Reference Lab, Kampala, Uganda; [Paramasivan, C. N.; Perkins, Mark D.] FIND, Geneva, Switzerland	Foundation For Innovative New Diagnostics; Mulago National Referral Hospital; Foundation For Innovative New Diagnostics	Albert, H (corresponding author), FIND, TB Res Lab, Kampala, Uganda.	heidi.albert@finddiagnostics.org		Joloba, Moses/0000-0002-0334-9983	Foundation for Innovative New Diagnostics (FIND)	Foundation for Innovative New Diagnostics (FIND)	This study was funded by the Foundation for Innovative New Diagnostics (FIND). FIND had a role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Affolabi D, 2010, INT J TUBERC LUNG D, V14, P160; [Anonymous], 2000, INT UN TUB LUNG DIS; Anthony RM, 2006, INT J TUBERC LUNG D, V10, P1060; BENNEDSEN J, 1966, SCAND J RESPIR DIS, V47, P114; Boehme C, 2009, INT J TUBERC LUNG D, pS124; Bonnet M, 2009, INT J TUBERC LUNG D, pS117; Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320; Cambanis A, 2007, INT J TUBERC LUNG D, V11, P40; Carl Zeiss Microimaging GmbH, 2009, PRIM ILED; Foundation for Innovative New Diagnostics, 2006, MGIT PROC MAN; Foundation for Innovative New Diagnostics, 2010, FIND PRIC PRIM ILED; HAGEMANN P. K. H., 1937, Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene, V140, P184; Marais BJ, 2008, CLIN INFECT DIS, V47, P203, DOI 10.1086/589248; Miller AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011890; Minion J, 2009, EXPERT REV MED DEVIC, V6, P341, DOI [10.1586/erd.09.26, 10.1586/ERD.09.26]; Nabeta P, 2009, INT J TUBERC LUNG S, V2009, pS123; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Revised National Tuberculosis Control Programme Laboratory, 2005, GUID QUAL ASS SMEAR; Tauns Laboratories Inc., 2010, CAP TB NEO PROD INS; Van Deun A, 2009, INT J TUBERC LUNG D, V12, P1009; WHO, 2008, GLOBAL TUBERCULOSIS; World Health Organisation, 1998, WHO LAB SERV TUB C 2; World Health Organization, 2010, FLUOR LIGHT EM DIOD	23	35	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15206	10.1371/journal.pone.0015206	http://dx.doi.org/10.1371/journal.pone.0015206			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203398	gold, Green Published, Green Submitted			2022-12-27	WOS:000285792500025
J	Fransen, F; Stenger, RM; Poelen, MCM; van Dijken, HH; Kuipers, B; Boog, CJP; van Putten, JPM; van Els, CACM; van der Ley, P				Fransen, Floris; Stenger, Rachel M.; Poelen, Martien C. M.; van Dijken, Harry H.; Kuipers, Betsy; Boog, Claire J. P.; van Putten, Jos P. M.; van Els, Cecile A. C. M.; van der Ley, Peter			Differential Effect of TLR2 and TLR4 on the Immune Response after Immunization with a Vaccine against Neisseria meningitidis or Bordetella pertussis	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-DEFICIENT MUTANT; TOLL-LIKE RECEPTOR-2; ACTIVATED PROTEIN-KINASE; DENDRITIC CELLS; ANTIBODY-RESPONSES; CONTROLLED-TRIAL; VESICLE VACCINE; I INTERFERONS; CUTTING EDGE; HOST-DEFENSE	Neisseria meningitidis and Bordetella pertussis are Gram-negative bacterial pathogens that can cause serious diseases in humans. N. meningitidis outer membrane vesicle (OMV) vaccines and whole cell pertussis vaccines have been successfully used in humans to control infections with these pathogens. The mechanisms behind their effectiveness are poorly defined. Here we investigated the role of Toll-like receptor (TLR) 2 and TLR4 in the induction of immune responses in mice after immunization with these vaccines. Innate and adaptive immune responses were compared between wild type mice and mice deficient in TLR2, TLR4, or TRIF. TRIF-deficient and TLR4-deficient mice showed impaired immunity after immunization. In contrast, immune responses were not lower in TLR2-/- mice but tended even to be higher after immunization. Together our data demonstrate that TLR4 activation contributes to the immunogenicity of the N. meningitidis OMV vaccine and the whole cell pertussis vaccine, but that TLR2 activation is not required.	[Fransen, Floris; Stenger, Rachel M.; Poelen, Martien C. M.; van Dijken, Harry H.; Kuipers, Betsy; Boog, Claire J. P.; van Els, Cecile A. C. M.; van der Ley, Peter] Netherlands Vaccine Inst, Lab Vaccine Res, Bilthoven, Netherlands; [Fransen, Floris; Boog, Claire J. P.; van Putten, Jos P. M.] Univ Utrecht, Dept Immunol & Infect Dis, Utrecht, Netherlands	Utrecht University	Fransen, F (corresponding author), Netherlands Vaccine Inst, Lab Vaccine Res, Bilthoven, Netherlands.	peter.van.der.ley@nvi-vaccin.nl		van Putten, Jos/0000-0002-4126-8172	Netherlands Vaccine Institute	Netherlands Vaccine Institute	This study was funded by the Netherlands Vaccine Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; Banus S, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-21; Cartwright K, 1999, VACCINE, V17, P2612, DOI 10.1016/S0264-410X(99)00044-4; Cervantes-Barragan L, 2009, EUR J IMMUNOL, V39, P126, DOI 10.1002/eji.200838185; COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2; de Kleijn ED, 2000, VACCINE, V18, P1456, DOI 10.1016/S0264-410X(99)00423-5; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Durand V, 2009, VACCINE, V27, P1912, DOI 10.1016/j.vaccine.2009.01.109; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Fransen F, 2007, INFECT IMMUN, V75, P5939, DOI 10.1128/IAI.00846-07; FREDRIKSEN J H, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P67; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; Greco D, 1996, NEW ENGL J MED, V334, P341, DOI 10.1056/NEJM199602083340601; Gustafsson L, 1996, NEW ENGL J MED, V334, P349, DOI 10.1056/NEJM199602083340602; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Holdsworth SR, 1999, KIDNEY INT, V55, P1198, DOI 10.1046/j.1523-1755.1999.00369.x; Holst J, 2009, VACCINE, V27, pB3, DOI 10.1016/j.vaccine.2009.04.071; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Ingalls RR, 2001, INFECT IMMUN, V69, P2230, DOI 10.1128/IAI.69.4.2230-2236.2001; Ingalls RR, 2000, J ENDOTOXIN RES, V6, P411, DOI 10.1177/09680519000060050301; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jackson DC, 2004, P NATL ACAD SCI USA, V101, P15440, DOI 10.1073/pnas.0406740101; Kimman TG, 2007, COMMUNITY GENET, V10, P201, DOI 10.1159/000106559; Latz E, 2004, J IMMUNOL, V172, P2431, DOI 10.4049/jimmunol.172.4.2431; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Luijkx TA, 2003, INFECT IMMUN, V71, P6367, DOI 10.1128/IAI.71.11.6367-6371.2003; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Mann PB, 2005, INFECT IMMUN, V73, P8144, DOI 10.1128/IAI.73.12.8144-8152.2005; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Maynard CL, 2008, IMMUNOL REV, V226, P219, DOI 10.1111/j.1600-065X.2008.00711.x; NEUBERGER MS, 1981, EUR J IMMUNOL, V11, P1012, DOI 10.1002/eji.1830111212; NICHOLSON A, 1979, SCIENCE, V205, P298, DOI 10.1126/science.451601; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Peeters CCAM, 1996, VACCINE, V14, P1009, DOI 10.1016/0264-410X(96)00001-1; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pridmore AC, 2001, J INFECT DIS, V183, P89, DOI 10.1086/317647; Pulendran B, 2004, IMMUNOL REV, V199, P227, DOI 10.1111/j.0105-2896.2004.00144.x; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Redecke V, 2004, J IMMUNOL, V172, P2739, DOI 10.4049/jimmunol.172.5.2739; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Sieling PA, 2003, J IMMUNOL, V170, P194, DOI 10.4049/jimmunol.170.1.194; Smith PL, 2005, MOL IMMUNOL, V42, P869, DOI 10.1016/j.molimm.2004.11.008; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Steeghs L, 1999, INFECT IMMUN, V67, P4988, DOI 10.1128/IAI.67.10.4988-4993.1999; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Thalen M, 1999, J BIOTECHNOL, V75, P147, DOI 10.1016/S0168-1656(99)00155-8; van Duin D, 2006, TRENDS IMMUNOL, V27, P49, DOI 10.1016/j.it.2005.11.005; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zughaier SM, 2004, INFECT IMMUN, V72, P371, DOI 10.1128/IAI.72.1.371-380.2004; Zughaier S, 2007, VACCINE, V25, P4401, DOI 10.1016/j.vaccine.2007.03.029	61	34	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15692	10.1371/journal.pone.0015692	http://dx.doi.org/10.1371/journal.pone.0015692			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203418	Green Published, Green Submitted, gold			2022-12-27	WOS:000285579200029
J	Strata, F; Stoianov, IP; de Villers-Sidani, E; Bonham, B; Martone, T; Kenet, T; Chang, EF; Vincenti, V; Merzenich, MM				Strata, Fabrizio; Stoianov, Ivilin P.; de Villers-Sidani, Etienne; Bonham, Ben; Martone, Tiziana; Kenet, Tal; Chang, Edward F.; Vincenti, Vincenzo; Merzenich, Michael M.			Perinatal Asphyxia Affects Rat Auditory Processing: Implications for Auditory Perceptual Impairments in Neurodevelopmental Disorders	PLOS ONE			English	Article							CEREBRAL-PALSY; CORTEX NEURONS; BRAIN-STEM; AUTISM; INHIBITION; SYSTEM; BIRTH; ORGANIZATION; MONKEYS; CONSEQUENCES	Perinatal asphyxia, a naturally and commonly occurring risk factor in birthing, represents one of the major causes of neonatal encephalopathy with long term consequences for infants. Here, degraded spectral and temporal responses to sounds were recorded from neurons in the primary auditory cortex (A1) of adult rats exposed to asphyxia at birth. Response onset latencies and durations were increased. Response amplitudes were reduced. Tuning curves were broader. Degraded successive-stimulus masking inhibitory mechanisms were associated with a reduced capability of neurons to follow higher-rate repetitive stimuli. The architecture of peripheral inner ear sensory epithelium was preserved, suggesting that recorded abnormalities can be of central origin. Some implications of these findings for the genesis of language perception deficits or for impaired language expression recorded in developmental disorders, such as autism spectrum disorders, contributed to by perinatal asphyxia, are discussed.	[Strata, Fabrizio] Univ Parma, Physiol Sect, Dept Neurosci, I-43100 Parma, Italy; [Strata, Fabrizio; Merzenich, Michael M.] Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, Coleman Mem Lab, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Stoianov, Ivilin P.] Univ Padua, Dept Gen Psychol, Padua, Italy; [de Villers-Sidani, Etienne] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Bonham, Ben] Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, Epstein Labs, San Francisco, CA 94143 USA; [Martone, Tiziana] Univ Turin, Div Otolaryngol, Dept Clin Physiopathol, Turin, Italy; [Kenet, Tal] Massachusetts Gen Hosp, Dept Neurol, Athinoula A Martinos Ctr Biomed Imaging MGH Marti, Charlestown, MA USA; [Chang, Edward F.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Vincenti, Vincenzo] Univ Parma, Dept Otolaryngol Head & Neck Surg, I-43100 Parma, Italy	University of Parma; University of California System; University of California San Francisco; University of Padua; McGill University; University of California System; University of California San Francisco; University of Turin; Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco; University of Parma	Strata, F (corresponding author), Univ Parma, Physiol Sect, Dept Neurosci, I-43100 Parma, Italy.	fab@phy.ucsf.edu	MARTONE, Tiziana/AAD-2706-2022; Stoianov, Ivilin/AAX-8528-2020; Stoianov, Ivilin/G-5904-2011	MARTONE, Tiziana/0000-0002-4019-6082; Stoianov, Ivilin/0000-0003-0642-259X	National Institutes of Health Conte Center [MH77970]; John C. and Edward Coleman Memorial Fund; Italian Ministry of University and Research; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077970] Funding Source: NIH RePORTER	National Institutes of Health Conte Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John C. and Edward Coleman Memorial Fund; Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health Conte Center grant MH77970 (M.M.M.), the John C. and Edward Coleman Memorial Fund (M.M.M.), and the Italian Ministry of University and Research, PRIN 2009 (F.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN P, 1980, J PHYSIOL-LONDON, V307, P273, DOI 10.1113/jphysiol.1980.sp013435; Bao SW, 2004, NAT NEUROSCI, V7, P974, DOI 10.1038/nn1293; BERMAN D, 1971, EXP NEUROL, V31, P140, DOI 10.1016/0014-4886(71)90182-8; Brosch M, 1997, J NEUROPHYSIOL, V77, P923, DOI 10.1152/jn.1997.77.2.923; Buonomano DV, 1998, J NEUROPHYSIOL, V80, P1765, DOI 10.1152/jn.1998.80.4.1765; CALFORD MB, 1995, J NEUROPHYSIOL, V73, P1876, DOI 10.1152/jn.1995.73.5.1876; Chang EF, 2005, P NATL ACAD SCI USA, V102, P16460, DOI 10.1073/pnas.0508239102; Coq JO, 2008, EXP NEUROL, V210, P95, DOI 10.1016/j.expneurol.2007.10.006; Dalman C, 2001, BRIT J PSYCHIAT, V179, P403, DOI 10.1192/bjp.179.5.403; de Villers-Sidani E, 2008, NAT NEUROSCI, V11, P957, DOI 10.1038/nn.2144; Dilenge ME, 2001, J CHILD NEUROL, V16, P781, DOI 10.1177/08830738010160110201; FARO MD, 1969, EXP NEUROL, V24, P38, DOI 10.1016/0014-4886(69)90004-1; HALL JG, 1964, ACTA OTO-LARYNGOL, V194, P191; KALTENBACH JA, 1993, HEARING RES, V67, P35, DOI 10.1016/0378-5955(93)90229-T; Khalfa S, 2004, HEARING RES, V198, P87, DOI 10.1016/j.heares.2004.07.006; Krahe R, 2004, NAT REV NEUROSCI, V5, P13, DOI 10.1038/nrn1296; Kulesza RJ, 2008, BRAIN RES, V1200, P132, DOI 10.1016/j.brainres.2008.01.009; Magnusson AK, 2008, NEURON, V59, P125, DOI 10.1016/j.neuron.2008.05.011; MIRSKY AF, 1979, DEV PSYCHOBIOL, V12, P369, DOI 10.1002/dev.420120411; Myers R E, 1975, Adv Neurol, V10, P223; MYERS RE, 1975, BIOL NEONATE, V26, P21; MYERS RE, 1972, AM J OBSTET GYNECOL, V112, P246, DOI 10.1016/0002-9378(72)90124-X; NELKEN I, 1994, HEARING RES, V72, P223, DOI 10.1016/0378-5955(94)90221-6; Oertel D, 2004, TRENDS NEUROSCI, V27, P104, DOI 10.1016/j.tins.2003.12.001; Oguni H, 2008, PEDIATR NEUROL, V38, P345, DOI 10.1016/j.pediatrneurol.2007.10.016; PETERSON BE, 1995, J NEUROSCI METH, V57, P133, DOI 10.1016/0165-0270(94)00103-N; RIBAUPIERRE FD, 1972, BRAIN RES, V48, P205, DOI 10.1016/0006-8993(72)90179-5; Rosenhall U, 2003, EAR HEARING, V24, P206, DOI 10.1097/01.AUD.0000069326.11466.7E; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Scholl B, 2008, J NEUROPHYSIOL, V100, P646, DOI 10.1152/jn.90406.2008; Schreiner C.E., 1994, AUDIT NEUROSCI, V1, P39; SCHREINER CE, 1981, NEURONAL MECH HEARIN, P191, DOI DOI 10.1007/978-1-4684-3908-320; SCHREINER CE, 2006, LISTENING SPEECH AUD, P129; Sechzer J A, 1971, Science, V172, P1221, DOI 10.1126/science.172.3989.1221; Simon EN, 2007, ARCH PEDIAT ADOL MED, V161, P1106, DOI 10.1001/archpedi.161.11.1106-a; Simon N, 1999, J AUTISM DEV DISORD, V29, P94; SMALL JG, 1975, BIOL PSYCHIAT, V10, P385; Strata F, 2005, P NATL ACAD SCI USA, V102, P19156, DOI 10.1073/pnas.0509520102; Strata F, 2004, NEUROSCIENCE, V129, P141, DOI 10.1016/j.neuroscience.2004.07.024; STRATA F, 2010, PEDIATRICS; Sutter ML, 1999, J NEUROPHYSIOL, V82, P2358, DOI 10.1152/jn.1999.82.5.2358; SYMMES D, 1966, EXP NEUROL, V16, P201, DOI 10.1016/0014-4886(66)90099-9; Szelag E, 2004, BRIT J PSYCHOL, V95, P269, DOI 10.1348/0007126041528167; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Teder-Salejarvi WA, 2005, COGNITIVE BRAIN RES, V23, P221, DOI 10.1016/j.cogbrainres.2004.10.021; Tharpe AM, 2006, EAR HEARING, V27, P430, DOI 10.1097/01.aud.0000224981.60575.d8; van Handel M, 2007, EUR J PEDIATR, V166, P645, DOI 10.1007/s00431-007-0437-8; VOLKOV IO, 1992, EXP BRAIN RES, V91, P115; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; WINDLE WF, 1969, SCI AM, V221, P77, DOI 10.1038/scientificamerican1069-76; Zhang H, 1998, J COMP PHYSIOL A, V182, P725, DOI 10.1007/s003590050217; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796; Zhou XM, 2008, P NATL ACAD SCI USA, V105, P4423, DOI 10.1073/pnas.0800009105	53	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15326	10.1371/journal.pone.0015326	http://dx.doi.org/10.1371/journal.pone.0015326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203459	gold, Green Published, Green Submitted			2022-12-27	WOS:000285579200017
J	Singh, R; Levitt, AL; Rajotte, EG; Holmes, EC; Ostiguy, N; Vanengelsdorp, D; Lipkin, WI; Depamphilis, CW; Toth, AL; Cox-Foster, DL				Singh, Rajwinder; Levitt, Abby L.; Rajotte, Edwin G.; Holmes, Edward C.; Ostiguy, Nancy; vanEngelsdorp, Dennis; Lipkin, W. Ian; Depamphilis, Claude W.; Toth, Amy L.; Cox-Foster, Diana L.			RNA Viruses in Hymenopteran Pollinators: Evidence of Inter-Taxa Virus Transmission via Pollen and Potential Impact on Non-Apis Hymenopteran Species	PLOS ONE			English	Article							KASHMIR-BEE-VIRUS; DEFORMED-WING-VIRUS; COLONY COLLAPSE DISORDER; RHOPALOSIPHUM-PADI VIRUS; LEAF MOTTLE VIRUS; QUEEN CELL VIRUS; HONEY-BEE; PARALYSIS VIRUS; SACBROOD VIRUS; VERTICAL-TRANSMISSION	Although overall pollinator populations have declined over the last couple of decades, the honey bee (Apis mellifera) malady, colony collapse disorder (CCD), has caused major concern in the agricultural community. Among honey bee pathogens, RNA viruses are emerging as a serious threat and are suspected as major contributors to CCD. Recent detection of these viral species in bumble bees suggests a possible wider environmental spread of these viruses with potential broader impact. It is therefore vital to study the ecology and epidemiology of these viruses in the hymenopteran pollinator community as a whole. We studied the viral distribution in honey bees, in their pollen loads, and in other non-Apis hymenopteran pollinators collected from flowering plants in Pennsylvania, New York, and Illinois in the United States. Viruses in the samples were detected using reverse transcriptase-PCR and confirmed by sequencing. For the first time, we report the molecular detection of picorna-like RNA viruses (deformed wing virus, sacbrood virus and black queen cell virus) in pollen pellets collected directly from forager bees. Pollen pellets from several uninfected forager bees were detected with virus, indicating that pollen itself may harbor viruses. The viruses in the pollen and honey stored in the hive were demonstrated to be infective, with the queen becoming infected and laying infected eggs after these virus-contaminated foods were given to virus-free colonies. These viruses were detected in eleven other non-Apis hymenopteran species, ranging from many solitary bees to bumble bees and wasps. This finding further expands the viral host range and implies a possible deeper impact on the health of our ecosystem. Phylogenetic analyses support that these viruses are disseminating freely among the pollinators via the flower pollen itself. Notably, in cases where honey bee apiaries affected by CCD harbored honey bees with Israeli Acute Paralysis virus (IAPV), nearby non-Apis hymenopteran pollinators also had IAPV, while those near apiaries without IAPV did not. In containment greenhouse experiments, IAPV moved from infected honey bees to bumble bees and from infected bumble bees to honey bees within a week, demonstrating that the viruses could be transmitted from one species to another. This study adds to our present understanding of virus epidemiology and may help explain bee disease patterns and pollinator population decline in general.	[Singh, Rajwinder; Levitt, Abby L.; Rajotte, Edwin G.; Ostiguy, Nancy; vanEngelsdorp, Dennis; Toth, Amy L.; Cox-Foster, Diana L.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Holmes, Edward C.] Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Lipkin, W. Ian] Columbia Univ, Ctr Infect & Immun, Mailman Sch Publ Hlth, New York, NY USA; [Toth, Amy L.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Columbia University; University of Illinois System; University of Illinois Urbana-Champaign	Singh, R (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	dxc12@psu.edu	Lipkin, W. Ian/ABE-6216-2020; vanEngelsdorp, Dennis/E-7934-2010; Holmes, Edward/Y-2789-2019; Holmes, Edward/GVR-9499-2022; dePamphilis, Claude W/P-6652-2016; Toth, Amy L/A-9196-2011	Lipkin, W. Ian/0000-0002-8768-9386; Holmes, Edward/0000-0001-9596-3552; 	Pennsylvania Department of Agriculture [ME 446716]; Experiment Station, Pennsylvania State University; USAID [EPP-A-00-04-00016-00]; North American Pollinator Protection Campaign (NAPPC)	Pennsylvania Department of Agriculture; Experiment Station, Pennsylvania State University; USAID(United States Agency for International Development (USAID)); North American Pollinator Protection Campaign (NAPPC)	Funding for this study was provided by Pennsylvania Department of Agriculture (www.agriculture.state.pa.us) (grant ME 446716 awarded to DCF and NO), Hatch funds from the Experiment Station, Pennsylvania State University (research.cas.psu.edu) (awarded to ER and RS), Integrated Pest Management Collaborative Research Support Program (IPM CRSP) USAID Cooperative agreement No. EPP-A-00-04-00016-00 (www.oired.vt.edu/ipmcrsp) (awarded to ER), and a honey bee health improvement project grant from North American Pollinator Protection Campaign (NAPPC; www.nappc.org) awarded to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; Allen M, 1996, BEE WORLD, V77, P141, DOI 10.1080/0005772X.1996.11099306; Amari K, 2007, PHYTOPATHOLOGY, V97, P892, DOI 10.1094/PHYTO-97-8-0892; ANDERSON DL, 1991, AM BEE J, V131, P767; Aparicio F, 1999, EUR J PLANT PATHOL, V105, P623, DOI 10.1023/A:1008783705183; Bailey L., 1975, Bee World, V56, P55; BAILEY L, 1964, J INSECT PATHOL, V6, P395; BAILEY L, 1969, ANN APPL BIOL, V63, P483, DOI 10.1111/j.1744-7348.1969.tb02844.x; BAILEY L, 1965, J INVERTEBR PATHOL, V7, P132, DOI 10.1016/0022-2011(65)90024-8; Baker AC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-10; Ball B.V., 1991, HONEYBEE PATHOLOGY, P193, DOI [https://doi.org/10.1007/BF00576582, DOI 10.1007/BF00576582]; Benjeddou M, 2001, APPL ENVIRON MICROB, V67, P2384, DOI 10.1128/AEM.67.5.2384-2387.2001; Bonning Bryony C., 2009, Virologica Sinica, V24, P415, DOI 10.1007/s12250-009-3044-1; Bowen-Walker PL, 1999, J INVERTEBR PATHOL, V73, P101, DOI 10.1006/jipa.1998.4807; Boyapalle S, 2007, J INVERTEBR PATHOL, V94, P130, DOI 10.1016/j.jip.2006.09.010; BOYLANPETT W, 1991, PHYTOPATHOLOGY, V81, P1407, DOI 10.1094/Phyto-81-1407; Bristow PR, 1999, PHYTOPATHOLOGY, V89, P124, DOI 10.1094/PHYTO.1999.89.2.124; Bromenshenk JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013181; Buchner R., 2000, PALDAT PALYNOLOGICAL; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Chen YP, 2007, ADV VIRUS RES, V70, P33, DOI 10.1016/S0065-3527(07)70002-7; Chen YP, 2006, J INVERTEBR PATHOL, V92, P152, DOI 10.1016/j.jip.2006.03.010; Chen YP, 2006, APPL ENVIRON MICROB, V72, P606, DOI 10.1128/AEM.72.1.606-611.2006; Chen YP, 2004, APIDOLOGIE, V35, P441, DOI 10.1051/apido:2004031; CHILDRESS AM, 1987, PHYTOPATHOLOGY, V77, P167, DOI 10.1094/Phyto-77-167; Christian PD, 1998, VIRUSES, P301; Colla SR, 2006, BIOL CONSERV, V129, P461, DOI 10.1016/j.biocon.2005.11.013; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Davis O.K., 2000, RO KAPPS POLLEN SPOR; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ellis JD, 2005, BEE WORLD, V86, P88, DOI 10.1080/0005772X.2005.11417323; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Genersch E, 2006, J INVERTEBR PATHOL, V91, P61, DOI 10.1016/j.jip.2005.10.002; Genersch E, 2010, VET RES, V41, DOI 10.1051/vetres/2010027; GILDOW FE, 1990, J INVERTEBR PATHOL, V55, P245, DOI 10.1016/0022-2011(90)90060-J; Grixti JC, 2009, BIOL CONSERV, V142, P75, DOI 10.1016/j.biocon.2008.09.027; Hung ACF, 2000, J APICULT RES, V39, P103, DOI 10.1080/00218839.2000.11101029; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Kapoor A, 2010, J VIROL, V84, P10322, DOI 10.1128/JVI.00601-10; KELLEY RD, 1986, PHYTOPATHOLOGY, V76, P317, DOI 10.1094/Phyto-76-317; Le Gall O, 2008, ARCH VIROL, V153, P715, DOI 10.1007/s00705-008-0041-x; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Martin SJ, 2001, J APPL ECOL, V38, P1082, DOI 10.1046/j.1365-2664.2001.00662.x; Mayo MA, 2002, ARCH VIROL, V147, P1271, DOI 10.1007/s007050200037; Meeus I, 2010, J INVERTEBR PATHOL, V105, P200, DOI 10.1016/j.jip.2010.06.012; Memmott J, 1999, ECOL LETT, V2, P276, DOI 10.1046/j.1461-0248.1999.00087.x; *NAT RES COUNC, 2006, STAT POLL N AM; Nielsen SL, 2008, APIDOLOGIE, V39, P310, DOI 10.1051/apido:2008007; Olivier V, 2008, VIRUS RES, V132, P59, DOI 10.1016/j.virusres.2007.10.014; Otterstatter MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002771; Palacios G, 2008, J VIROL, V82, P6209, DOI 10.1128/JVI.00251-08; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; PRISCO GD, 2010, J GEN VIROL IN PRESS; Quan M, 2009, J COMP PATHOL, V140, P225, DOI 10.1016/j.jcpa.2008.12.002; Ribiere M, 2007, APPL ENVIRON MICROB, V73, P7711, DOI 10.1128/AEM.01053-07; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruiz-Gonzalez MX, 2006, ECOL ENTOMOL, V31, P616, DOI 10.1111/j.1365-2311.2006.00823.x; Rzezutka A, 2004, FEMS MICROBIOL REV, V28, P441, DOI 10.1016/j.femsre.2004.02.001; Schmalhofer VR, 2001, OECOLOGIA, V129, P292, DOI 10.1007/s004420100726; Schwarz HH, 1997, INSECT SOC, V44, P303, DOI 10.1007/s000400050051; Shen MQ, 2005, J GEN VIROL, V86, P2281, DOI 10.1099/vir.0.80824-0; SLATKIN M, 1989, GENETICS, V123, P603; Swafford D. L., 2002, PAUP PHYLOGENETIC AN; Vanengelsdorp D, 2007, AM BEE J, V147, P599; vanEngelsdorp D, 2010, J ECON ENTOMOL, V103, P1517, DOI 10.1603/EC09429; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; Wang TH, 2001, J VIROL, V75, P11686, DOI 10.1128/JVI.75.23.11686-11699.2001; Welch A, 2009, APPL ENVIRON MICROB, V75, P7862, DOI 10.1128/AEM.01319-09; Whitton JL, 2005, NAT REV MICROBIOL, V3, P765, DOI 10.1038/nrmicro1284; Williams GR, 2010, BIOESSAYS, V32, P845, DOI 10.1002/bies.201000075; Winfree R, 2008, CURR BIOL, V18, pR968, DOI 10.1016/j.cub.2008.09.010; Yook HS, 1998, J FOOD PROTECT, V61, P217, DOI 10.4315/0362-028X-61.2.217; Yue C, 2007, J GEN VIROL, V88, P2329, DOI 10.1099/vir.0.83101-0	78	270	282	3	149	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14357	10.1371/journal.pone.0014357	http://dx.doi.org/10.1371/journal.pone.0014357			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203504	Green Published, gold			2022-12-27	WOS:000285578000004
J	Tran, E; Nielsen, JS; Wick, DA; Ng, AV; Johnson, LDS; Nesslinger, NJ; McMurtrie, E; Webb, JR; Nelson, BH				Tran, Eric; Nielsen, Julie S.; Wick, Darin A.; Ng, Alvin V.; Johnson, Lisa D. S.; Nesslinger, Nancy J.; McMurtrie, Elissa; Webb, John R.; Nelson, Brad H.			Polyfunctional T-Cell Responses Are Disrupted by the Ovarian Cancer Ascites Environment and Only Partially Restored by Clinically Relevant Cytokines	PLOS ONE			English	Article							GAMMA-INDUCING FACTOR; RECOMBINANT HUMAN INTERLEUKIN-21; IFN-GAMMA; INTERFERON-GAMMA; METASTATIC MELANOMA; PHASE-I; VACCINE; EXPRESSION; RECEPTOR; IL-12	Background: Host T-cell responses are associated with favorable outcomes in epithelial ovarian cancer (EOC), but it remains unclear how best to promote these responses in patients. Toward this goal, we evaluated a panel of clinically relevant cytokines for the ability to enhance multiple T-cell effector functions (polyfunctionality) in the native tumor environment. Methodology/Principal Findings: Experiments were performed with resident CD8+ and CD4+ T cells in bulk ascites cell preparations from high-grade serous EOC patients. T cells were stimulated with alpha-CD3 in the presence of 100% autologous ascites fluid with or without exogenous IL-2, IL-12, IL-18 or IL-21, alone or in combination. T-cell proliferation (Ki-67) and function (IFN-gamma, TNF-alpha, IL-2, CCL4, and CD107a expression) were assessed by multi-parameter flow cytometry. In parallel, 27 cytokines were measured in culture supernatants. While ascites fluid had variable effects on CD8+ and CD4+ T-cell proliferation, it inhibited T-cell function in most patient samples, with CD107a, IFN-gamma, and CCL4 showing the greatest inhibition. This was accompanied by reduced levels of IL-1 beta, IL-1ra, IL-9, IL-17, G-CSF, GM-CSF, Mip-1 alpha, PDGF-bb, and bFGF in culture supernatants. T-cell proliferation was enhanced by exogenous IL-2, but other T-cell functions were largely unaffected by single cytokines. The combination of IL-2 with cytokines engaging complementary signaling pathways, in particular IL-12 and IL-18, enhanced expression of IFN-gamma, TNF-alpha, and CCL4 in all patient samples by promoting polyfunctional T-cell responses. Despite this, other functional parameters generally remained inhibited. Conclusions/Significance: The EOC ascites environment disrupts multiple T-cell functions, and exogenous cytokines engaging diverse signaling pathways only partially reverse these effects. Our results may explain the limited efficacy of cytokine therapies for EOC to date. Full restoration of T-cell function will require activation of signaling pathways beyond those engaged by IL-2, IL-12, IL-18, and IL-21.	[Tran, Eric; Webb, John R.; Nelson, Brad H.] Univ Victoria, Dept Microbiol & Biochem, Victoria, BC, Canada; [Tran, Eric; Nielsen, Julie S.; Wick, Darin A.; Ng, Alvin V.; Johnson, Lisa D. S.; Nesslinger, Nancy J.; Webb, John R.; Nelson, Brad H.] British Columbia Canc Agcy, Trev & Joyce Deeley Res Ctr, Victoria, BC, Canada; [Nielsen, Julie S.; Nelson, Brad H.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [McMurtrie, Elissa] BC Canc Agcy, Victoria, BC, Canada	University of Victoria; British Columbia Cancer Agency; University of British Columbia; British Columbia Cancer Agency	Tran, E (corresponding author), Univ Victoria, Dept Microbiol & Biochem, Victoria, BC, Canada.	bnelson@bccancer.bc.ca	Johnson, Lisa DS/E-4218-2013; Nelson, Brad H/K-2622-2014	Johnson, Lisa DS/0000-0002-2019-6560; Nelson, Brad/0000-0002-4445-5539	British Columbia Cancer Foundation; United States Department of Defense; Natural Sciences and Research Council of Canada	British Columbia Cancer Foundation; United States Department of Defense(United States Department of Defense); Natural Sciences and Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the British Columbia Cancer Foundation, United States Department of Defense, and the Natural Sciences and Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 1997, J IMMUNOL, V159, P2125; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; Badr G, 2008, J VIROL, V82, P10017, DOI 10.1128/JVI.01083-08; BAMIAS A, 2007, GYNECOL ONCOL; Bansal A, 2008, J VIROL, V82, P6458, DOI 10.1128/JVI.00068-08; Barnett B, 2005, AM J REPROD IMMUNOL, V54, P369, DOI 10.1111/j.1600-0897.2005.00330.x; BARTON DPJ, 1995, J SOC GYNECOL INVEST, V2, P762, DOI 10.1016/1071-5576(95)94692-N; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Carpenito C, 2009, P NATL ACAD SCI USA, V106, P3360, DOI 10.1073/pnas.0813101106; Carroll RG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003289; Carson WE, 2000, BLOOD, V96, P1465, DOI 10.1182/blood.V96.4.1465.h8001465_1465_1473; Chu CS, 2008, EXPERT REV ANTICANC, V8, P243, DOI 10.1586/14737140.8.2.243; Cullen SP, 2010, CELL DEATH DIFFER, V17, P616, DOI 10.1038/cdd.2009.206; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Davis ID, 2007, CLIN CANCER RES, V13, P3630, DOI 10.1158/1078-0432.CCR-07-0410; Davis ID, 2009, CLIN CANCER RES, V15, P2123, DOI 10.1158/1078-0432.CCR-08-2663; DECESARE SL, 1995, GYNECOL ONCOL, V57, P86, DOI 10.1006/gyno.1995.1103; Duvall MG, 2008, EUR J IMMUNOL, V38, P350, DOI 10.1002/eji.200737768; Edwards RP, 1997, J CLIN ONCOL, V15, P3399, DOI 10.1200/JCO.1997.15.11.3399; Elvang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005139; Ferre AL, 2009, BLOOD, V113, P3978, DOI 10.1182/blood-2008-10-182709; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Gollob JA, 1999, J IMMUNOL, V162, P4472; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; HIRTE HW, 1992, CELL IMMUNOL, V142, P207, DOI 10.1016/0008-8749(92)90281-S; Hurteau JA, 2001, GYNECOL ONCOL, V82, P7, DOI 10.1006/gyno.2001.6255; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Imai N, 2009, CANCER SCI, V100, P1317, DOI 10.1111/j.1349-7006.2009.01179.x; Imai N, 2009, EUR J IMMUNOL, V39, P241, DOI 10.1002/eji.200838824; Iwai Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002404; Kannanganat S, 2007, J VIROL, V81, P12071, DOI 10.1128/JVI.01261-07; KRYCZEK I, 2009, BLOOD; Lenzi R, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-66; Lichterfeld M, 2004, BLOOD, V104, P487, DOI 10.1182/blood-2003-12-4341; Nakahira M, 2002, J IMMUNOL, V168, P1146, DOI 10.4049/jimmunol.168.3.1146; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; Nelson BH, 2008, IMMUNOL REV, V222, P101, DOI 10.1111/j.1600-065X.2008.00614.x; Okamoto I, 1999, J IMMUNOL, V162, P3202; Osaki T, 1998, J IMMUNOL, V160, P1742; Osaki T, 1999, GENE THER, V6, P808, DOI 10.1038/sj.gt.3300908; Paulos CM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000448; Perales MA, 2008, MOL THER, V16, P2022, DOI 10.1038/mt.2008.196; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Recchia F, 2005, INT J ONCOL, V27, P1039; Recchia F, 2010, GYNECOL ONCOL, V116, P202, DOI 10.1016/j.ygyno.2009.09.042; Rehr M, 2008, J VIROL, V82, P3391, DOI 10.1128/JVI.02383-07; Robertson MJ, 2008, CLIN CANCER RES, V14, P3462, DOI 10.1158/1078-0432.CCR-07-4740; Robertson MJ, 2006, CLIN CANCER RES, V12, P4265, DOI 10.1158/1078-0432.CCR-06-0121; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Smeltz RB, 2001, J EXP MED, V194, P143, DOI 10.1084/jem.194.2.143; Tarhini AA, 2009, CANCER-AM CANCER SOC, V115, P859, DOI 10.1002/cncr.24100; Thompson JA, 2008, J CLIN ONCOL, V26, P2034, DOI 10.1200/JCO.2007.14.5193; Valor L, 2008, VACCINE, V26, P2738, DOI 10.1016/j.vaccine.2008.03.019; Vlad AM, 2010, CANCER IMMUNOL IMMUN, V59, P293, DOI 10.1007/s00262-009-0750-3; Watford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x; Weiss JM, 2007, EXPERT OPIN BIOL TH, V7, P1705, DOI 10.1517/14712598.7.11.1705; Winstone N, 2009, EUR J IMMUNOL, V39, P975, DOI 10.1002/eji.200839167; Xu DM, 1998, J EXP MED, V188, P1485, DOI 10.1084/jem.188.8.1485; Yang T, 2007, CLIN CANCER RES, V13, P7172, DOI 10.1158/1078-0432.CCR-07-1724; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Yuan JD, 2008, P NATL ACAD SCI USA, V105, P20410, DOI 10.1073/pnas.0810114105; Zeng R, 2007, BLOOD, V109, P4135, DOI 10.1182/blood-2006-10-054973; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	68	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15625	10.1371/journal.pone.0015625	http://dx.doi.org/10.1371/journal.pone.0015625			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203522	Green Submitted, Green Published, gold			2022-12-27	WOS:000285578000040
J	Derenko, M; Malyarchuk, B; Grzybowski, T; Denisova, G; Rogalla, U; Perkova, M; Dambueva, I; Zakharov, I				Derenko, Miroslava; Malyarchuk, Boris; Grzybowski, Tomasz; Denisova, Galina; Rogalla, Urszula; Perkova, Maria; Dambueva, Irina; Zakharov, Ilia			Origin and Post-Glacial Dispersal of Mitochondrial DNA Haplogroups C and D in Northern Asia	PLOS ONE			English	Article							VOLGA-URAL REGION; GENOME VARIATION; GENETIC HISTORY; MTDNA VARIATION; MODERN HUMANS; EASTERN; DIVERSITY; PHYLOGENY; LINEAGES; SEQUENCE	More than a half of the northern Asian pool of human mitochondrial DNA (mtDNA) is fragmented into a number of subclades of haplogroups C and D, two of the most frequent haplogroups throughout northern, eastern, central Asia and America. While there has been considerable recent progress in studying mitochondrial variation in eastern Asia and America at the complete genome resolution, little comparable data is available for regions such as southern Siberia - the area where most of northern Asian haplogroups, including C and D, likely diversified. This gap in our knowledge causes a serious barrier for progress in understanding the demographic pre-history of northern Eurasia in general. Here we describe the phylogeography of haplogroups C and D in the populations of northern and eastern Asia. We have analyzed 770 samples from haplogroups C and D (174 and 596, respectively) at high resolution, including 182 novel complete mtDNA sequences representing haplogroups C and D (83 and 99, respectively). The present-day variation of haplogroups C and D suggests that these mtDNA clades expanded before the Last Glacial Maximum (LGM), with their oldest lineages being present in the eastern Asia. Unlike in eastern Asia, most of the northern Asian variants of haplogroups C and D began the expansion after the LGM, thus pointing to post-glacial re-colonization of northern Asia. Our results show that both haplogroups were involved in migrations, from eastern Asia and southern Siberia to eastern and northeastern Europe, likely during the middle Holocene.	[Derenko, Miroslava; Malyarchuk, Boris; Denisova, Galina; Perkova, Maria] Russian Acad Sci, Inst Biol Problems N, Magadan, Russia; [Grzybowski, Tomasz; Rogalla, Urszula] Nicholas Copernicus Univ, Ludwik Rydygier Coll Med, Dept Mol & Forens Genet, Inst Forens Med, Bydgoszcz, Poland; [Zakharov, Ilia] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia; [Dambueva, Irina] Russian Acad Sci, Inst Gen & Expt Biol, Ulan Ude, Russia	Institute of Biological Problems of the North; Russian Academy of Sciences; Nicolaus Copernicus University; Russian Academy of Sciences; Vavilov Institute of General Genetics; Russian Academy of Sciences	Derenko, M (corresponding author), Russian Acad Sci, Inst Biol Problems N, Magadan, Russia.	mderenko@mail.ru	Grzybowski, Tomasz/A-1676-2015; Malyarchuk, Boris/D-5783-2018; Derenko, Miroslava/J-1495-2018; Dambueva, Irina/K-3073-2018; Dambueva, Irina/AAZ-4313-2020; Rogalla, Urszula/E-3342-2014; Denisova, Galina/AAZ-4310-2020	Grzybowski, Tomasz/0000-0001-6228-6460; Malyarchuk, Boris/0000-0002-0304-0652; Derenko, Miroslava/0000-0002-1849-784X; Rogalla, Urszula/0000-0002-2778-9844; 	Presidium of Russian Academy of Sciences [09-I-P23-10]; Far-Eastern Branch of the Russian Academy of Sciences [09-III-A-06-220]	Presidium of Russian Academy of Sciences(Russian Academy of Sciences); Far-Eastern Branch of the Russian Academy of Sciences(Russian Academy of Sciences)	The study was supported by grants from the Presidium of Russian Academy of Sciences (09-I-P23-10), and the Far-Eastern Branch of the Russian Academy of Sciences (09-III-A-06-220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Burger J, 2007, P NATL ACAD SCI USA, V104, P3736, DOI 10.1073/pnas.0607187104; Chandrasekar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007447; Comas D, 1998, AM J HUM GENET, V63, P1824, DOI 10.1086/302133; Derbeneva OA, 2002, AM J HUM GENET, V71, P415, DOI 10.1086/341720; Derbeneva OA, 2002, AM J HUM GENET, V70, P1009, DOI 10.1086/339524; Derenko M. V., 1997, Molekulyarnaya Biologiya (Moscow), V31, P784; Derenko M, 2007, AM J HUM GENET, V81, P1025, DOI 10.1086/522933; Derenko MV, 2003, ANN HUM GENET, V67, P391, DOI 10.1046/j.1469-1809.2003.00035.x; Derenko MV, 2000, HUM BIOL, V72, P945; Derenko MV, 2009, THESIS I BIOL PROBLE; Egyed B, 2007, FORENSIC SCI INT-GEN, V1, P158, DOI 10.1016/j.fsigen.2007.03.001; Gilbert MTP, 2008, SCIENCE, V320, P1787, DOI 10.1126/science.1159750; Goebel T, 1999, EVOL ANTHROPOL, V8, P208; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Grzybowski T, 2007, FORENSIC SCI INT-GEN, V1, P141, DOI 10.1016/j.fsigen.2007.01.010; Hartmann A, 2009, HUM MUTAT, V30, P115, DOI 10.1002/humu.20816; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Ingman M, 2007, EUR J HUM GENET, V15, P115, DOI 10.1038/sj.ejhg.5201712; Kitchen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001596; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; Kushnerevich EI, 2008, THESIS NATL ACAD BEL, P21; LAUKHIN SA, 1993, DOKL AKAD NAUK+, V332, P352; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Malhi RS, 2010, AM J PHYS ANTHROPOL, V141, P494, DOI 10.1002/ajpa.21238; Malyarchuk B, 2008, MOL BIOL EVOL, V25, P1651, DOI 10.1093/molbev/msn114; Malyarchuk B, 2004, HUM BIOL, V76, P877, DOI 10.1353/hub.2005.0021; Malyarchuk BA, 2006, ANN HUM GENET, V70, P195, DOI 10.1111/j.1529-8817.2005.00222.x; Malyarchuk BA, 2002, ANN HUM GENET, V66, P261, DOI 10.1017/S0003480002001161; Malyarchuk BA, 2001, ANN HUM GENET, V65, P63, DOI 10.1046/j.1469-1809.2001.6510063.x; Malyarchuk BA, 2002, THESIS I BIOL PROBLE; Malyarchuk B, 2010, MOL BIOL EVOL, V27, P2220, DOI 10.1093/molbev/msq065; Malyarchuk B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010285; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Metspalu M, 2006, NUCL ACID M, V18, P181; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Nohira C, 2010, INT J LEGAL MED, V124, P7, DOI 10.1007/s00414-008-0308-5; Okladnikov AP, 1981, PALEOLITHIC CENTRAL; Perego UA, 2010, GENOME RES, V20, P1174, DOI 10.1101/gr.109231.110; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Pitulko VV, 2004, SCIENCE, V303, P52, DOI 10.1126/science.1085219; Qin Z, 2010, AM J PHYS ANTHR; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Schroeder KB, 2007, BIOL LETTERS, V3, P218, DOI 10.1098/rsbl.2006.0609; Soares P, 2008, MOL BIOL EVOL, V25, P1209, DOI 10.1093/molbev/msn068; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Starikovskaya EB, 2005, ANN HUM GENET, V69, P67, DOI 10.1046/j.1529-8817.2003.00127.x; Tabbada KA, 2010, MOL BIOL EVOL, V27, P21, DOI 10.1093/molbev/msp215; Tambets K, 2004, AM J HUM GENET, V74, P661, DOI 10.1086/383203; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Ueno H, 2009, MITOCHONDRION, V9, P385, DOI 10.1016/j.mito.2009.06.003; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; VASILEV SA, 1993, CURR ANTHROPOL, V34, P82, DOI 10.1086/204141; Volodko NV, 2008, AM J HUM GENET, V82, P1084, DOI 10.1016/j.ajhg.2008.03.019	63	78	80	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15214	10.1371/journal.pone.0015214	http://dx.doi.org/10.1371/journal.pone.0015214			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203537	Green Published, gold, Green Submitted			2022-12-27	WOS:000285576900021
J	Gardner, KE; Zhou, L; Parra, MA; Chen, XA; Strahl, BD				Gardner, Kathryn E.; Zhou, Li; Parra, Michael A.; Chen, Xian; Strahl, Brian D.			Identification of Lysine 37 of Histone H2B as a Novel Site of Methylation	PLOS ONE			English	Article							DOWN MASS-SPECTROMETRY; PROTEIN-ARGININE METHYLTRANSFERASE; ELECTRON-CAPTURE DISSOCIATION; SET DOMAIN METHYLTRANSFERASE; NUCLEOSOME CORE PARTICLE; RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; TOP-DOWN; IN-VIVO; POSTTRANSLATIONAL MODIFICATIONS	Recent technological advancements have allowed for highly-sophisticated mass spectrometry-based studies of the histone code, which predicts that combinations of post-translational modifications (PTMs) on histone proteins result in defined biological outcomes mediated by effector proteins that recognize such marks. While significant progress has been made in the identification and characterization of histone PTMs, a full appreciation of the complexity of the histone code will require a complete understanding of all the modifications that putatively contribute to it. Here, using the top-down mass spectrometry approach for identifying PTMs on full-length histones, we report that lysine 37 of histone H2B is dimethylated in the budding yeast Saccharomyces cerevisiae. By generating a modification-specific antibody and yeast strains that harbor mutations in the putative site of methylation, we provide evidence that this mark exist in vivo. Importantly, we show that this lysine residue is highly conserved through evolution, and provide evidence that this methylation event also occurs in higher eukaryotes. By identifying a novel site of histone methylation, this study adds to our overall understanding of the complex number of histone modifications that contribute to chromatin function.	[Gardner, Kathryn E.; Zhou, Li; Parra, Michael A.; Chen, Xian; Strahl, Brian D.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Gardner, KE (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	brian_strahl@med.unc.edu	Strahl, Brian/C-7601-2012	Strahl, Brian/0000-0002-4947-6259	National Institute of Diabetes, Digestive and Kidney Diseases [5 R21 DK082706-02]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK082706] Funding Source: NIH RePORTER	National Institute of Diabetes, Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Diabetes, Digestive and Kidney Diseases grant 5 R21 DK082706-02 (B. D. S. and X. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Baker SP, 2010, NAT CELL BIOL, V12, P294, DOI 10.1038/ncb2030; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Biswas D, 2006, EMBO J, V25, P4479, DOI 10.1038/sj.emboj.7601333; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Borchers CH, 2006, P NATL ACAD SCI USA, V103, P3094, DOI 10.1073/pnas.0511289103; Boyne MT, 2006, J PROTEOME RES, V5, P248, DOI 10.1021/pr050269n; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Cocklin RR, 2003, J PROTEIN CHEM, V22, P327, DOI 10.1023/A:1025334006014; Collart M A, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1312s23; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; DAI J, 2010, GENETICS; Daujat S, 2009, NAT STRUCT MOL BIOL, V16, P777, DOI 10.1038/nsmb.1629; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; DELANGE RJ, 1969, J BIOL CHEM, V244, P319; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Edmondson DG, 1996, GENE DEV, V10, P1247, DOI 10.1101/gad.10.10.1247; Fang J, 2007, MOL CELL BIOL, V27, P5055, DOI 10.1128/MCB.00127-07; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Fleming AB, 2008, MOL CELL, V31, P57, DOI 10.1016/j.molcel.2008.04.025; Freitas MA, 2004, J CELL BIOCHEM, V92, P691, DOI 10.1002/jcb.20106; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Garcia BA, 2007, CURR OPIN CHEM BIOL, V11, P66, DOI 10.1016/j.cbpa.2006.11.022; Gary JD, 1996, J BIOL CHEM, V271, P12585, DOI 10.1074/jbc.271.21.12585; Gietz RD, 2007, NAT PROTOC, V2, P35, DOI 10.1038/nprot.2007.14; HAN J, 2010, PROTEOMICS; HIRSCHHORN JN, 1995, MOL CELL BIOL, V15, P1999; HOGAN E, 1992, P NATL ACAD SCI USA, V89, P3098, DOI 10.1073/pnas.89.7.3098; HONG L, 1993, J BIOL CHEM, V268, P305; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jenuwein T, 1998, CELL MOL LIFE SCI, V54, P80, DOI 10.1007/s000180050127; Kalhor HR, 2005, BIOCHEM BIOPH RES CO, V334, P433, DOI 10.1016/j.bbrc.2005.06.111; Katz JE, 2003, MOL CELL PROTEOMICS, V2, P525, DOI 10.1074/mcp.M300037-MCP200; Kelleher NL, 2004, ANAL CHEM, V76, p196A, DOI 10.1021/ac0415657; Kim T, 2007, J BIOL CHEM, V282, P20827, DOI 10.1074/jbc.M703034200; Klose RJ, 2007, MOL CELL BIOL, V27, P3951, DOI 10.1128/MCB.02180-06; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Kyriss MNM, 2010, MOL CELL BIOL, V30, P3503, DOI 10.1128/MCB.00290-10; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee JH, 2000, BIOCHEM BIOPH RES CO, V274, P105, DOI 10.1006/bbrc.2000.3049; Liang G, 2007, NAT STRUCT MOL BIOL, V14, P243, DOI 10.1038/nsmb1204; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; Mersfelder EL, 2006, NUCLEIC ACIDS RES, V34, P2653, DOI 10.1093/nar/gkl338; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; Nakanishi S, 2009, J CELL BIOL, V186, P371, DOI 10.1083/jcb.200906005; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; Parra MA, 2006, MOL CELL BIOL, V26, P3842, DOI 10.1128/MCB.26.10.3842-3852.2006; Pesavento JJ, 2008, J BIOL CHEM, V283, P14927, DOI 10.1074/jbc.M709796200; Pesavento JJ, 2004, J AM CHEM SOC, V126, P3386, DOI 10.1021/ja039748i; Petrossian T, 2009, EPIGENOMICS-UK, V1, P163, DOI 10.2217/EPI.09.3; Petrossian TC, 2009, MOL CELL PROTEOMICS, V8, P1516, DOI 10.1074/mcp.M900025-MCP200; Polevoda B, 2006, J BIOL CHEM, V281, P2562, DOI 10.1074/jbc.M507651200; Polevoda B, 2000, J BIOL CHEM, V275, P20508, DOI 10.1074/jbc.M001891200; Porras-Yakushi TR, 2006, J BIOL CHEM, V281, P35835, DOI 10.1074/jbc.M606578200; Porras-Yakushi TR, 2005, J BIOL CHEM, V280, P34590, DOI 10.1074/jbc.M507672200; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Saunders A, 2003, SCIENCE, V301, P1094, DOI 10.1126/science.1085712; Sawada K, 2004, J BIOL CHEM, V279, P43296, DOI 10.1074/jbc.M405902200; Schlichter A, 2005, EMBO J, V24, P1222, DOI 10.1038/sj.emboj.7600607; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Siuti N, 2006, J PROTEOME RES, V5, P233, DOI 10.1021/pr050268v; Song OK, 2003, J BIOL CHEM, V278, P38109, DOI 10.1074/jbc.C300355200; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Taverna SD, 2007, P NATL ACAD SCI USA, V104, P2086, DOI 10.1073/pnas.0610993104; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; Thomas CE, 2006, J PROTEOME RES, V5, P240, DOI 10.1021/pr050266a; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Ueberheide BM, 2007, INT J MASS SPECTROM, V259, P46, DOI 10.1016/j.ijms.2006.09.001; Unnikrishnan A, 2010, NAT STRUCT MOL BIOL, V17, P430, DOI 10.1038/nsmb.1780; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Waterborg JH, 2000, J BIOL CHEM, V275, P13007, DOI 10.1074/jbc.275.17.13007; Watson AD, 2000, GENE DEV, V14, P2737, DOI 10.1101/gad.829100; Webb KJ, 2010, BIOCHEMISTRY-US, V49, P5225, DOI 10.1021/bi100428x; Webb KJ, 2008, J BIOL CHEM, V283, P35561, DOI 10.1074/jbc.M806006200; Wolffe AP, 1999, NUCLEIC ACIDS RES, V27, P711, DOI 10.1093/nar/27.3.711; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Zhang K, 2009, J PROTEOME RES, V8, P900, DOI 10.1021/pr8005155; Zhang KL, 2002, MOL CELL PROTEOMICS, V1, P500, DOI 10.1074/mcp.M200031-MCP200; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031; Zubarev RA, 1998, J AM CHEM SOC, V120, P3265, DOI 10.1021/ja973478k	107	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16244	10.1371/journal.pone.0016244	http://dx.doi.org/10.1371/journal.pone.0016244			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249157	Green Published, gold, Green Submitted			2022-12-27	WOS:000286515000036
J	Stamatakis, EA; Shafto, MA; Williams, G; Tam, P; Tyler, LK				Stamatakis, Emmanuel A.; Shafto, Meredith A.; Williams, Guy; Tam, Phyllis; Tyler, Lorraine K.			White Matter Changes and Word Finding Failures with Increasing Age	PLOS ONE			English	Article							OF-THE-TONGUE; DIFFUSION-TENSOR; OLDER-ADULTS; LANGUAGE PATHWAYS; MICROSTRUCTURE; ASYMMETRY; BRAIN; YOUNG; TIP; RETRIEVAL	Background: Increasing life expectancy necessitates the better understanding of the neurophysiological underpinnings of age-related cognitive changes. The majority of research examining structural-cognitive relationships in aging focuses on the role of age-related changes to grey matter integrity. In the current study, we examined the relationship between age-related changes in white matter and language production. More specifically, we concentrated on word-finding failures, which increase with age. Methodology/Principal Findings: We used Diffusion tensor MRI (a technique used to image, in vivo, the diffusion of water molecules in brain tissue) to relate white matter integrity to measures of successful and unsuccessful picture naming. Diffusion tensor images were used to calculate Fractional Anisotropy (FA) images. FA is considered to be a measure of white matter organization/integrity. FA images were related to measures of successful picture naming and to word finding failures using voxel-based linear regression analyses. Successful naming rates correlated positively with white matter integrity across a broad range of regions implicated in language production. However, word finding failure rates correlated negatively with a more restricted region in the posterior aspect of superior longitudinal fasciculus. Conclusions/Significance: The use of DTI-MRI provides evidence for the relationship between age-related white matter changes in specific language regions and word finding failures in old age.	[Stamatakis, Emmanuel A.] Univ Cambridge, Sch Clin Med, Div Anaesthesia, Cambridge, England; [Stamatakis, Emmanuel A.; Shafto, Meredith A.; Tam, Phyllis; Tyler, Lorraine K.] Univ Cambridge, Dept Expt Psychol, Ctr Speech Language & Brain, Cambridge CB2 3EB, England; [Williams, Guy] Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge CB2 3EB, England; [Williams, Guy] Univ Cambridge, Dept Neurosurg, Cambridge CB2 3EB, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge	Stamatakis, EA (corresponding author), Univ Cambridge, Sch Clin Med, Div Anaesthesia, Cambridge, England.	eas46@cam.ac.uk		Williams, Guy/0000-0001-5223-6654; Tyler, Lorraine/0000-0002-9943-118X; Stamatakis, Emmanuel Andreas/0000-0001-6955-9601	Medical Research Council (MRC); Dunhill Medical Trust; Queens' College, Cambridge; Medical Research Council [G19/27, G0500842] Funding Source: researchfish; MRC [G0500842, G19/27] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Dunhill Medical Trust(Dunhill Medical Trust); Queens' College, Cambridge; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by a Medical Research Council (MRC) programme grant and a Dunhill Medical Trust grant to LKT. EAS is funded by the Stephen Erskine Fellowship, Queens' College, Cambridge. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abe O, 2002, NEUROBIOL AGING, V23, P433, DOI 10.1016/S0197-4580(01)00318-9; Abe O, 2008, NEUROBIOL AGING, V29, P102, DOI 10.1016/j.neurobiolaging.2006.09.003; Andersson JLR, 2002, NEUROIMAGE, V16, P177, DOI 10.1006/nimg.2001.1039; Barrick TR, 2007, CEREB CORTEX, V17, P591, DOI 10.1093/cercor/bhk004; Bartzokis G, 2004, NEUROBIOL AGING, V25, P843, DOI 10.1016/j.neurobiolaging.2003.09.005; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Buchel C, 2004, CEREB CORTEX, V14, P945, DOI 10.1093/cercor/bhh055; BURKE DM, 1991, J MEM LANG, V30, P542, DOI 10.1016/0749-596X(91)90026-G; Burke DM, 2004, CURR DIR PSYCHOL SCI, V13, P21, DOI 10.1111/j.0963-7214.2004.01301006.x; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Cross ES, 2004, BRAIN LANG, V89, P174, DOI 10.1016/S0093-934X(03)00363-8; DAMASIO AR, 1992, NEW ENGL J MED, V326, P531, DOI 10.1056/NEJM199202203260806; Dougherty RF, 2007, P NATL ACAD SCI USA, V104, P8556, DOI 10.1073/pnas.0608961104; Enzinger C, 2005, NEUROLOGY, V64, P1704, DOI 10.1212/01.WNL.0000161871.83614.BB; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frey S, 2008, J NEUROSCI, V28, P11435, DOI 10.1523/JNEUROSCI.2388-08.2008; Glasser MF, 2008, CEREB CORTEX, V18, P2471, DOI 10.1093/cercor/bhn011; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Goodglass H., 1983, BOSTON NAMING TEST; GRIFFITHS JD, 2009, NEUROIMAGE, V47, P289; Hardin R.H., 1994, MINIMAL ENERGY ARRAN; Head D, 2004, CEREB CORTEX, V14, P410, DOI 10.1093/cercor/bhh003; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; James LE, 2000, J EXP PSYCHOL LEARN, V26, P1378, DOI 10.1037//0278-7393.26.6.1378; Jones DK, 2002, NEUROIMAGE, V17, P592, DOI 10.1006/nimg.2002.1148; Jones DK, 2005, NEUROIMAGE, V26, P546, DOI 10.1016/j.neuroimage.2005.02.013; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Klingberg T, 1999, NEUROREPORT, V10, P2817, DOI 10.1097/00001756-199909090-00022; MacLullich AMJ, 2002, NEUROLOGY, V59, P169, DOI 10.1212/WNL.59.2.169; Madden DJ, 2004, NEUROIMAGE, V21, P1174, DOI 10.1016/j.neuroimage.2003.11.004; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Marslen-Wilson WD, 2007, PHILOS T R SOC B, V362, P823, DOI 10.1098/rstb.2007.2091; MEIERRUGE W, 1992, ANN NY ACAD SCI, V673, P260, DOI 10.1111/j.1749-6632.1992.tb27462.x; Moseley M, 2002, NMR BIOMED, V15, P553, DOI 10.1002/nbm.785; Nelson HE., 1982, NATL ADULT READING T; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pantoni L, 2002, CEREBROVASC DIS, V13, P7, DOI 10.1159/000049143; Parker GJM, 2005, NEUROIMAGE, V24, P656, DOI 10.1016/j.neuroimage.2004.08.047; Powell HWR, 2006, NEUROIMAGE, V32, P388, DOI 10.1016/j.neuroimage.2006.03.011; RAZ N, 2005, COGNITIVE NEUROSCIEN; Resnick SM, 2003, J NEUROSCI, V23, P3295; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Schiavone F, 2009, J MAGN RESON IMAGING, V29, P23, DOI 10.1002/jmri.21572; Shafto MA, 2007, J COGNITIVE NEUROSCI, V19, P2060, DOI 10.1162/jocn.2007.19.12.2060; Shafto MA, 2010, J COGNITIVE NEUROSCI, V22, P1530, DOI 10.1162/jocn.2009.21321; Shipley, 1946, I LIVING SCALE; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Sullivan EV, 2006, NEUROSCI BIOBEHAV R, V30, P749, DOI 10.1016/j.neubiorev.2006.06.002; Sullivan EV, 2001, NEUROREPORT, V12, P99, DOI 10.1097/00001756-200101220-00027; Takao H, 2010, MAGN RESON IMAGING, V28, P65, DOI 10.1016/j.mri.2009.05.020; Wechsler D, 1987, MANUAL WESCHLER MEMO; Wernicke C., 1874, APHASISCHE SYMPTOMEN	57	43	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e14496	10.1371/journal.pone.0014496	http://dx.doi.org/10.1371/journal.pone.0014496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249127	Green Published, Green Submitted, gold			2022-12-27	WOS:000286512900002
J	Dehmer, M; Mowshowitz, A; Emmert-Streib, F				Dehmer, Matthias; Mowshowitz, Abbe; Emmert-Streib, Frank			Connections between Classical and Parametric Network Entropies	PLOS ONE			English	Article							INFORMATION-THEORY; COMPLEX NETWORKS; GRAPHS; INEQUALITIES	This paper explores relationships between classical and parametric measures of graph (or network) complexity. Classical measures are based on vertex decompositions induced by equivalence relations. Parametric measures, on the other hand, are constructed by using information functions to assign probabilities to the vertices. The inequalities established in this paper relating classical and parametric measures lay a foundation for systematic classification of entropy-based measures of graph complexity.	[Dehmer, Matthias] UMIT, Inst Bioinformat & Translat Res, Hall In Tirol, Austria; [Mowshowitz, Abbe] CUNY, Dept Comp Sci, New York, NY 10021 USA; [Emmert-Streib, Frank] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland	City University of New York (CUNY) System; Queens University Belfast	Dehmer, M (corresponding author), UMIT, Inst Bioinformat & Translat Res, Hall In Tirol, Austria.	matthias.dehmer@umit.at	Emmert-Streib, Frank/AAF-2878-2020; Emmert-Streib, Frank/G-8099-2011	Emmert-Streib, Frank/0000-0003-0745-5641; Emmert-Streib, Frank/0000-0003-0745-5641	U.S. Army Research Laboratory [W911NF-06-3-0001]; U.K Ministry of Defense [W911NF-06-3-0001]; Austrian Science Funds [P22029-N13]; Austrian Science Fund (FWF) [P 22029] Funding Source: researchfish	U.S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); U.K Ministry of Defense; Austrian Science Funds(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Research was sponsored by the U.S. Army Research Laboratory and the U.K Ministry of Defense and was accomplished under Agreement Number W911NF-06-3-0001. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the U.S Army Research Laboratory, the U.S. Government, the U.K. Ministry of Defense or the U.K Government. The U.S. and U.K. Governments are authorized to reproduce and distribute for Government purposes notwithstanding any copyright notation hereon. Matthias Dehmer thanks the Austrian Science Funds for supporting this work (project P22029-N13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand K, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.045102; [Anonymous], T 6 PRAG C INF THEOR; BALABAN AT, 1995, J CHEM INF COMP SCI, V35, P339, DOI 10.1021/ci00025a001; BERTZ SH, 1981, J AM CHEM SOC, V103, P5932, DOI 10.1021/ja00409a063; Bonchev D, 2005; BONCHEV D, 1995, THEOCHEM-J MOL STRUC, V336, P137, DOI 10.1016/0166-1280(94)04081-3; BONCHEV D, 1977, J CHEM PHYS, V67, P4517, DOI 10.1063/1.434593; Bonchev D., 2003, COMPLEXITY INTRO FUN, DOI DOI 10.1201/9781482288247; BONCHEV D, 1979, COMMUN MATH COMP CHE, V7, P65; Bonchev D, 2009, ENCY COMPLEXITY SYST, V5, P4820, DOI [10.1007/978-0-387-30440-3_285, DOI 10.1007/978-0-387-30440-3_285]; Bonchev D, 1983, INFORM THEORETIC IND; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; DEHMER M, 2010, INFORM SCI; Dehmer M, 2010, APPL MATH COMPUT, V215, P4263, DOI 10.1016/j.amc.2009.12.051; Dehmer M, 2008, CYBERNET SYST, V39, P825, DOI 10.1080/01969720802435925; Dehmer M, 2009, J CHEM INF MODEL, V49, P1655, DOI 10.1021/ci900060x; Emmert-Streib F, 2007, APPL MATH COMPUT, V190, P1783, DOI 10.1016/j.amc.2007.02.095; Emmert-Streib F, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-35; EmmertStreib F, 2008, ANALYSIS OF MICROARRAY DATA: A NETWORK-BASED APPROACH, P1; EMMERTSTREIB F, 2010, IET SYSTEMS IN PRESS; Foulds L.R, 1992, GRAPH THEORY APPL; Kim J, 2008, PHYSICA A, V387, P2637, DOI 10.1016/j.physa.2008.01.015; Krawitz P, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036115; Lyons R, 2010, COMB PROBAB COMPUT, V19, P303, DOI 10.1017/S0963548309990605; Mason O, 2007, IET SYST BIOL, V1, P89, DOI 10.1049/iet-syb:20060038; Mazurie A, 2008, BIOINFORMATICS, V24, P2579, DOI 10.1093/bioinformatics/btn503; Mehler A, 2010, ENTROPY-SWITZ, V12, P1440, DOI 10.3390/e12061440; Mehler Alexander, 2011, INFORM THEORY COMPLE; MOWSHOWI.A, 1968, B MATH BIOPHYS, V30, P533, DOI 10.1007/BF02476673; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P175, DOI 10.1007/BF02476948; Nikolic S, 2000, J CHEM INF COMP SCI, V40, P920, DOI 10.1021/ci9901183; PATIL A, 2007, IEEE T VEH TECHNOL, V58, P3178; RASHEVSKY N., 1955, BULL MATH BIOPHYS, V17, P229, DOI 10.1007/BF02477860; Sanchirico A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046114; Shannon C. E., 1949, MATH THEORY COMMUNIC; SIMONYI G, 1995, DIMACS SERIES DISCRE, V20, P399; SKOROBOGATOV VA, 1988, COMMUN MATH COMP CHE, V23, P105; Sole RV, 2004, LECT NOTES PHYS, V650, P189; Temkin O. N, 1996, CHEM REACTION NETWOR; TRINAJSTIC N, 1992, CHEM GRAPH THEORY, pCH10; TRUCCO ERNESTO, 1956, BULL MATH BIOPHYS, V18, P129, DOI 10.1007/BF02477836; Tutzauer F, 2007, SOC NETWORKS, V29, P249, DOI 10.1016/j.socnet.2006.10.001; Ulanowicz RE, 2001, COMPUT CHEM, V25, P393, DOI 10.1016/S0097-8485(01)00073-0; Wilhelm T, 2007, PHYSICA A, V385, P385, DOI 10.1016/j.physa.2007.06.029; Zhang Z, 1998, IEEE T INFORM THEORY, V44, P1440, DOI 10.1109/18.681320	45	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15733	10.1371/journal.pone.0015733	http://dx.doi.org/10.1371/journal.pone.0015733			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246046	gold, Green Published			2022-12-27	WOS:000286511200013
J	Kaminitz, A; Askenasy, EM; Yaniv, I; Stein, J; Askenasy, N				Kaminitz, Ayelet; Askenasy, Enosh M.; Yaniv, Isaac; Stein, Jerry; Askenasy, Nadir			Apoptosis of Purified CD4(+) T Cell Subsets Is Dominated by Cytokine Deprivation and Absence of Other Cells in New Onset Diabetic NOD Mice	PLOS ONE			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; MARROW IN-VIVO; INTERLEUKIN-2 PRODUCTION; HEMATOPOIETIC-CELLS; LYMPHOCYTES; HOMEOSTASIS; ACTIVATION; DEATH; IL-2; SUPPRESSION	Background: Regulatory T cells (Treg) play a significant role in immune homeostasis and self-tolerance. Excessive sensitivity of isolated Treg to apoptosis has been demonstrated in NOD mice and humans suffering of type 1 diabetes, suggesting a possible role in the immune dysfunction that underlies autoimmune insulitis. In this study the sensitivity to apoptosis was measured in T cells from new onset diabetic NOD females, comparing purified subsets to mixed cultures. Principal Findings: Apoptotic cells are short lived in vivo and death occurs primarily during isolation, manipulation and culture. Excessive susceptibility of CD25(+) T cells to spontaneous apoptosis is characteristic of isolated subsets, however disappears when death is measured in mixed splenocyte cultures. In variance, CD25(-) T cells display balanced sensitivity to apoptosis under both conditions. The isolation procedure removes soluble factors, IL-2 playing a significant role in sustaining Treg viability. In addition, pro-and anti-apoptotic signals are transduced by cell-to-cell interactions: CD3 and CD28 protect CD25(+) T cells from apoptosis, and in parallel sensitize naive effector cells to apoptosis. Treg viability is modulated both by other T cells and other subsets within mixed splenocyte cultures. Variations in sensitivity to apoptosis are often hindered by fast proliferation of viable cells, therefore cycling rates are mandatory to adequate interpretation of cell death assays. Conclusions: The sensitivity of purified Treg to apoptosis is dominated by cytokine deprivation and absence of cell-to-cell interactions, and deviate significantly from measurements in mixed populations. Balanced sensitivity of naive/effector and regulatory T cells to apoptosis in NOD mice argues against the concept that differential susceptibility affects disease evolution and progression.	[Kaminitz, Ayelet; Yaniv, Isaac; Stein, Jerry; Askenasy, Nadir] Schneider Childrens Med Ctr Israel, Ctr Stem Cell Res, Frankel Lab, Petah Tiqwa, Israel; [Stein, Jerry] Schneider Childrens Med Ctr Israel, Bone Marrow Transplant Unit, Petah Tiqwa, Israel; [Yaniv, Isaac] Schneider Childrens Med Ctr Israel, Dept Pediat Hematol Oncol, Petah Tiqwa, Israel; [Kaminitz, Ayelet] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Askenasy, Enosh M.] Ben Gurion Univ Negev, Soroka Med Sch, IL-84105 Beer Sheva, Israel	Tel Aviv University; Sackler Faculty of Medicine; Ben Gurion University; Soroka Medical Center	Kaminitz, A (corresponding author), Schneider Childrens Med Ctr Israel, Ctr Stem Cell Res, Frankel Lab, Petah Tiqwa, Israel.	anadir@012.net.il			Leah and Edward M. Frankel Trust	Leah and Edward M. Frankel Trust	This study was supported by a generous grant from the Leah and Edward M. Frankel Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arreaza G, 2003, CLIN IMMUNOL, V107, P103, DOI 10.1016/S1521-6616(03)00049-4; Askenasy N, 2003, EXP HEMATOL, V31, P1292, DOI 10.1016/j.exphem.2003.09.006; Askenasy N, 2002, STEM CELLS, V20, P501, DOI 10.1634/stemcells.20-6-501; Askenasy N, 2008, AUTOIMMUN REV, V7, P370, DOI 10.1016/j.autrev.2008.03.001; Asquith B, 2009, TRENDS IMMUNOL, V30, P182, DOI 10.1016/j.it.2009.01.003; Banz A, 2002, J IMMUNOL, V169, P750, DOI 10.4049/jimmunol.169.2.750; Bienvenu B, 2005, J IMMUNOL, V175, P246, DOI 10.4049/jimmunol.175.1.246; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Brusko TM, 2005, DIABETES, V54, P1407, DOI 10.2337/diabetes.54.5.1407; Chen ZB, 2005, J EXP MED, V202, P1387, DOI 10.1084/jem.20051409; Colucci F, 1996, J AUTOIMMUN, V9, P271, DOI 10.1006/jaut.1996.0034; D'Alise AM, 2008, P NATL ACAD SCI USA, V105, P19857, DOI 10.1073/pnas.0810713105; Decallonne B, 2003, J AUTOIMMUN, V20, P219, DOI 10.1016/S0896-8411(03)00025-8; Fisson S, 2003, J EXP MED, V198, P737, DOI 10.1084/jem.20030686; Fritzsching B, 2005, J IMMUNOL, V175, P32, DOI 10.4049/jimmunol.175.1.32; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Glisic-Milosavljevic S, 2007, CLIN EXP IMMUNOL, V150, P75, DOI 10.1111/j.1365-2249.2007.03475.x; Glisic-Milosavljevic S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000146; Herbelin A, 1998, J IMMUNOL, V161, P2620; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jailwala P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006527; Jiang N, 2003, BLOOD, V102, P2243, DOI 10.1182/blood-2002-10-3312; Kaminitz A, 2010, J AUTOIMMUN, V35, P145, DOI 10.1016/j.jaut.2010.06.002; Khoruts A, 1998, J EXP MED, V187, P225, DOI 10.1084/jem.187.2.225; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605; Kuniyasu Y, 2000, INT IMMUNOL, V12, P1145, DOI 10.1093/intimm/12.8.1145; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Lepault F, 2000, J IMMUNOL, V164, P240, DOI 10.4049/jimmunol.164.1.240; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Mellanby RJ, 2007, IMMUNOLOGY, V121, P15, DOI 10.1111/j.1365-2567.2007.02546.x; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Mohamood AS, 2006, INT IMMUNOL, V18, P1265, DOI 10.1093/intimm/dxl057; Nelson BH, 2004, J IMMUNOL, V172, P3983, DOI 10.4049/jimmunol.172.7.3983; Pandiyan P, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-6; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Pearl-Yafe M, 2007, STEM CELLS, V25, P1448, DOI 10.1634/stemcells.2007-0013; Pearl-Yafe M, 2006, AUTOIMMUN REV, V5, P338, DOI 10.1016/j.autrev.2006.02.005; Putnam AL, 2005, J AUTOIMMUN, V24, P55, DOI 10.1016/j.jaut.2004.11.004; Radosevic K, 1999, J AUTOIMMUN, V13, P373, DOI 10.1006/jaut.1999.0338; Raimondi G, 2007, CRIT REV IMMUNOL, V27, P61, DOI 10.1615/CritRevImmunol.v27.i1.50; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Schneider A, 2008, J IMMUNOL, V181, P7350, DOI 10.4049/jimmunol.181.10.7350; SERREZE DV, 1989, J AUTOIMMUN, V2, P759, DOI 10.1016/0896-8411(89)90003-6; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Taams LS, 2001, EUR J IMMUNOL, V31, P1122, DOI 10.1002/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; von Herrath M, 2007, NAT REV IMMUNOL, V7, P988, DOI 10.1038/nri2192; Yarkoni S, 2010, DIABETOLOGIA, V53, P356, DOI 10.1007/s00125-009-1604-4; Yarkoni S, 2008, BIOESSAYS, V30, P875, DOI 10.1002/bies.20812; Yolcu ES, 2002, IMMUNITY, V17, P795, DOI 10.1016/S1074-7613(02)00482-X; Yolcu ES, 2008, IMMUNOL CELL BIOL, V86, P650, DOI 10.1038/icb.2008.62; You S, 2005, DIABETES, V54, P1415, DOI 10.2337/diabetes.54.5.1415	62	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15684	10.1371/journal.pone.0015684	http://dx.doi.org/10.1371/journal.pone.0015684			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209873	gold, Green Submitted, Green Published			2022-12-27	WOS:000285838900026
J	Wurtzel, O; Dori-Bachash, M; Pietrokovski, S; Jurkevitch, E; Sorek, R				Wurtzel, Omri; Dori-Bachash, Mally; Pietrokovski, Shmuel; Jurkevitch, Edouard; Sorek, Rotem			Mutation Detection with Next-Generation Resequencing through a Mediator Genome	PLOS ONE			English	Article							BDELLOVIBRIO-BACTERIOVORUS	The affordability of next generation sequencing (NGS) is transforming the field of mutation analysis in bacteria. The genetic basis for phenotype alteration can be identified directly by sequencing the entire genome of the mutant and comparing it to the wild-type (WT) genome, thus identifying acquired mutations. A major limitation for this approach is the need for an a-priori sequenced reference genome for the WT organism, as the short reads of most current NGS approaches usually prohibit de-novo genome assembly. To overcome this limitation we propose a general framework that utilizes the genome of relative organisms as mediators for comparing WT and mutant bacteria. Under this framework, both mutant and WT genomes are sequenced with NGS, and the short sequencing reads are mapped to the mediator genome. Variations between the mutant and the mediator that recur in the WT are ignored, thus pinpointing the differences between the mutant and the WT. To validate this approach we sequenced the genome of Bdellovibrio bacteriovorus 109J, an obligatory bacterial predator, and its prey-independent mutant, and compared both to the mediator species Bdellovibrio bacteriovorus HD100. Although the mutant and the mediator sequences differed in more than 28,000 nucleotide positions, our approach enabled pinpointing the single causative mutation. Experimental validation in 53 additional mutants further established the implicated gene. Our approach extends the applicability of NGS-based mutant analyses beyond the domain of available reference genomes.	[Wurtzel, Omri; Pietrokovski, Shmuel; Sorek, Rotem] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Dori-Bachash, Mally; Jurkevitch, Edouard] Hebrew Univ Jerusalem, Fac Agr Food & Environm Qual Sci, Dept Plant Pathol & Microbiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Hebrew University of Jerusalem	Wurtzel, O (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	rotem.sorek@weizmann.ac.il	Wurtzel, Omri/AAG-3985-2019	Wurtzel, Omri/0000-0002-6865-5914; Pietrokovski, Shmuel/0000-0001-8573-5863	Crown Human Genome Center; M.D. Moross Institute for Cancer Research; Israel Science Foundation [1615/09, 1290/08]; NIH [R01AI082376-01]; EMBO; Minerva Foundation; Yeda-Sela Center for Basic Research; Kahn Center for Systems Biology of the Human Cell; Azrieli Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082376] Funding Source: NIH RePORTER	Crown Human Genome Center; M.D. Moross Institute for Cancer Research; Israel Science Foundation(Israel Science Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); Minerva Foundation; Yeda-Sela Center for Basic Research; Kahn Center for Systems Biology of the Human Cell; Azrieli Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Sequencing was partially supported by The Crown Human Genome Center and the M.D. Moross Institute for Cancer Research. R. S. was supported, in part, by the Israel Science Foundation FIRST program (grant 1615/09), NIH R01AI082376-01, the EMBO Young Investigator program, the Minerva Foundation, and the Yeda-Sela Center for Basic Research. O.W. was supported by the Kahn Center for Systems Biology of the Human Cell, and is grateful to the Azrieli Foundation for the award of an Azrieli Fellowship. This project was also supported by the Israel Science Foundation grant number 1290/08 to E.J.. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barel G, 2001, ARCH MICROBIOL, V176, P211, DOI 10.1007/s002030100312; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Chaisson MJ, 2009, GENOME RES, V19, P336, DOI 10.1101/gr.079053.108; COTTER TW, 1992, J BACTERIOL, V174, P6018, DOI 10.1128/JB.174.19.6018-6024.1992; Dalca AV, 2010, BRIEF BIOINFORM, V11, P3, DOI 10.1093/bib/bbp058; Dashiff Aliza, 2009, Open Microbiol J, V3, P87, DOI 10.2174/1874285800903000087; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Klockgether J, 2009, J BACTERIOL; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Liolios K, 2010, NUCLEIC ACIDS RES, V38, pD346, DOI 10.1093/nar/gkp848; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Moran NA, 2009, SCIENCE, V323, P379, DOI 10.1126/science.1167140; Mrazek J, 2007, P NATL ACAD SCI USA, V104, P8472, DOI 10.1073/pnas.0702412104; Rendulic S, 2004, SCIENCE, V303, P689, DOI 10.1126/science.1093027; Smith DR, 2008, GENOME RES, V18, P1638, DOI 10.1101/gr.077776.108; Srivatsan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000139; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Tettelin H, 2009, METHODS MOL BIOL, V551, P231, DOI 10.1007/978-1-60327-999-4_18	20	39	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15628	10.1371/journal.pone.0015628	http://dx.doi.org/10.1371/journal.pone.0015628			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209874	Green Published, gold, Green Submitted			2022-12-27	WOS:000285838900024
J	Mandalia, S; Mandalia, R; Lo, G; Chadborn, T; Sharott, P; Youle, M; Anderson, J; Baily, G; Brettle, R; Fisher, M; Gompels, M; Kinghorn, G; Johnson, M; McCarron, B; Pozniak, A; Tang, A; Walsh, J; White, D; Williams, I; Gazzard, B; Beck, EJ				Mandalia, Sundhiya; Mandalia, Roshni; Lo, Gary; Chadborn, Tim; Sharott, Peter; Youle, Mike; Anderson, Jane; Baily, Guy; Brettle, Ray; Fisher, Martin; Gompels, Mark; Kinghorn, George; Johnson, Margaret; McCarron, Brendan; Pozniak, Anton; Tang, Alan; Walsh, John; White, David; Williams, Ian; Gazzard, Brian; Beck, Eduard J.		NPMS-HHC Steering Grp	Rising Population Cost for Treating People Living with HIV in the UK, 1997-2013	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY	Background: The number of people living with HIV (PLHIV) is increasing in the UK. This study estimated the annual population cost of providing HIV services in the UK, 1997-2006 and projected them 2007-2013. Methods: Annual cost of HIV treatment for PLHIV by stage of HIV infection and type of ART was calculated (UK pounds, 2006 prices). Population costs were derived by multiplying the number of PLHIV by their annual cost for 1997-2006 and projected 2007-2013. Results: Average annual treatment costs across all stages of HIV infection ranged from 17,034 pound in 1997 to 18,087 pound in 2006 for PLHIV on mono-therapy and from 27,649 pound in 1997 to 32,322 pound in 2006 for those on quadruple-or-more ART. The number of PLHIV using NHS services rose from 16,075 to 52,083 in 2006 and was projected to increase to 78,370 by 2013. Annual population cost rose from 104 pound million in 1997 to 483 pound million in 2006, with a projected annual cost between 721 pound and 758 pound million by 2013. When including community care costs, costs increased from 164 pound million in 1997, to 683 pound million in 2006 and between 1,019 pound and 1,065 pound million in 2013. Conclusions: Increased number of PLHIV using NHS services resulted in rising UK population costs. Population costs are expected to continue to increase, partly due to PLHIV's longer survival on ART and the relative lack of success of HIV preventing programs. Where possible, the cost of HIV treatment and care needs to be reduced without reducing the quality of services, and prevention programs need to become more effective. While high income countries are struggling to meet these increasing costs, middle- and lower-income countries with larger epidemics are likely to find it even more difficult to meet these increasing demands, given that they have fewer resources.	[Mandalia, Sundhiya; Mandalia, Roshni; Lo, Gary; Youle, Mike; Gazzard, Brian; Beck, Eduard J.] NPMS HHC Coordinating & Analyt Ctr, London, England; [Mandalia, Sundhiya; Gazzard, Brian] Univ London Imperial Coll Sci Technol & Med, London, England; [Mandalia, Sundhiya; Lo, Gary; Pozniak, Anton; Gazzard, Brian; Beck, Eduard J.] Chelsea & Westminster Hosp, London, England; [Chadborn, Tim] Hlth Protect Agcy, London, England; [Sharott, Peter] London Procurement Programme, London Specialised Commissioning Grp, London, England; [Youle, Mike; Johnson, Margaret] Royal Free Hosp, London NW3 2QG, England; [Anderson, Jane] Homerton Univ Hosp NHS Fdn Trust, London, England; [Baily, Guy] London & Barts Hosp, London, England; [Brettle, Ray] Edinburgh Gen Hosp, Edinburgh, Midlothian, Scotland; [Fisher, Martin] Royal Sussex Cty Hosp, Brighton BN2 5BE, E Sussex, England; [Gompels, Mark] Southmead Hosp, Bristol, Avon, England; [Kinghorn, George] Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England; [McCarron, Brendan] James Cook Univ Hosp, Middlesbrough, Cleveland, England; [Tang, Alan] Royal Berkshire Hosp, Reading, Berks, England; [Walsh, John] St Marys Hosp, London, England; [White, David] Birmingham Heartlands Hosp, London, England; [Williams, Ian] Mortimer Market Ctr, London, England; [Beck, Eduard J.] London Sch Hyg & Trop Med, London WC1, England	Imperial College London; Imperial College London; Health Protection Agency; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Brighton; Southmead Hospital; University of Sheffield; James Cook University Hospital; Royal Berkshire Hospital; Imperial College London; Heart of England NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine	Mandalia, S (corresponding author), NPMS HHC Coordinating & Analyt Ctr, London, England.	becke@unaids.org	Kinghorn, George/AAO-1425-2021; Anderson, Jane/A-1632-2012	Anderson, Jane/0000-0001-5294-8707; Kinghorn, George/0000-0001-6608-5076	Tibotec	Tibotec	During 2008/2009, the NPMS-HHC was financially supported through a non-restrictive grant from Tibotec, with no influence on the independence of the Steering Group and its editorial policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich J, 2005, STAT SCI, V20, P401, DOI 10.1214/088342305000000331; Badri M, 2006, PLOS MED, V3, P48, DOI 10.1371/journal.pmed.0030004; BALETA A, 2010, LANCET; Beck EJ, 2008, INT J STD AIDS, V19, P297, DOI 10.1258/ijsa.2007.007236; Beck E.J., 2001, EFFECTIVE MANAGEMENT, P113; Beck EJ, 2004, AIDS, V18, P2411; Beck EJ, 2003, BRIT J SEX MED, V27, P21; BECK EJ, 2010, 18 INT AIDS C VIENN; BECK EJ, 2003, BRIT J SEX MED, V27, P19; BECK EJ, 2008, USE COST HIV SERVICE; *EUR CTR DIS PREV, 2009, HIV AIDS SURV EUR 20, P24; Grant RM, 2010, NEW ENGL J MED, V363, P1; Hall HI, 2010, JAIDS-J ACQ IMM DEF, V55, P271, DOI 10.1097/QAI.0b013e3181e8f90c; Hankins CA, 2010, AIDS, V24, pS70, DOI 10.1097/01.aids.0000390709.04255.fd; Health Protection Agency, 2010, SURV PREV HIV INF DI; Health Protection Agency, 2009, HIV UK 2009 REP; Hecht R, 2009, HEALTH AFFAIR, V28, P1591, DOI 10.1377/hlthaff.28.6.1591; *HLTH PROT AG, 2009, HLTH PROT AG SURV PR; Kahn JG, 2006, PLOS MED, V3, P2349, DOI 10.1371/journal.pmed.0030517; Loubiere S, 2010, CURR OPIN HIV AIDS, V5, P225, DOI 10.1097/COH.0b013e3283384a9d; MONTANER JS, 2010, LANCET; POATE D, 2009, UNAIDS 2 INDEPENDENT; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P1; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; *UN, 2010, 64 SESS GEN ASS AG I; WHO, 2010, ANT THER HIV INF AD; World Health Organization (WHO), 2010, MOR 5 MILL PEOPL REC; 2010, BMJ, V341, pC3977	28	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15677	10.1371/journal.pone.0015677	http://dx.doi.org/10.1371/journal.pone.0015677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209893	Green Published, Green Accepted, gold			2022-12-27	WOS:000285793600027
J	Brown, RM; Short, JL; Lawrence, AJ				Brown, Robyn Mary; Short, Jennifer Lynn; Lawrence, Andrew John			Identification of Brain Nuclei Implicated in Cocaine-Primed Reinstatement of Conditioned Place Preference: A Behaviour Dissociable from Sensitization	PLOS ONE			English	Article							STRESS-INDUCED REINSTATEMENT; MEDIAL PREFRONTAL CORTEX; CORTICOTROPIN-RELEASING-FACTOR; OPIATE-SEEKING BEHAVIOR; C-FOS EXPRESSION; LATERAL HABENULA; STRIA TERMINALIS; BED NUCLEUS; PSYCHOLOGICAL STRESS; PAIRED ENVIRONMENT	Relapse prevention represents the primary therapeutic challenge in the treatment of drug addiction. As with humans, drug-seeking behaviour can be precipitated in laboratory animals by exposure to a small dose of the drug (prime). The aim of this study was to identify brain nuclei implicated in the cocaine-primed reinstatement of a conditioned place preference (CPP). Thus, a group of mice were conditioned to cocaine, had this place preference extinguished and were then tested for primed reinstatement of the original place preference. There was no correlation between the extent of drug-seeking upon reinstatement and the extent of behavioural sensitization, the extent of original CPP or the extinction profile of mice, suggesting a dissociation of these components of addictive behaviour with a drug-primed reinstatement. Expression of the protein product of the neuronal activity marker c-fos was assessed in a number of brain regions of mice that exhibited reinstatement (R mice) versus those which did not (NR mice). Reinstatement generally conferred greater Fos expression in cortical and limbic structures previously implicated in drug-seeking behaviour, though a number of regions not typically associated with drug-seeking were also activated. In addition, positive correlations were found between neural activation of a number of brain regions and reinstatement behaviour. The most significant result was the activation of the lateral habenula and its positive correlation with reinstatement behaviour. The findings of this study question the relationship between primed reinstatement of a previously extinguished place preference for cocaine and behavioural sensitization. They also implicate activation patterns of discrete brain nuclei as differentiators between reinstating and non-reinstating mice.	[Brown, Robyn Mary; Short, Jennifer Lynn; Lawrence, Andrew John] Univ Melbourne, Florey Neurosci Inst, Parkville, Vic 3052, Australia; [Brown, Robyn Mary; Short, Jennifer Lynn] Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Lawrence, Andrew John] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne	Brown, RM (corresponding author), Univ Melbourne, Florey Neurosci Inst, Parkville, Vic 3052, Australia.	Andrew.Lawrence@florey.edu.au	Short, Jennifer/AAC-7385-2019; Brown, Robyn M/AAO-3694-2021	Brown, Robyn M/0000-0003-4167-3634	NHMRC; Besen/Pratt Foundations; Victorian Government	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Besen/Pratt Foundations; Victorian Government	This study was supported by an NHMRC Fellowship to AJL, the Besen/Pratt Foundations and the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DB, 2006, NEUROSCI BIOBEHAV R, V30, P304, DOI 10.1016/j.neubiorev.2005.09.004; Aguilar MA, 2009, BRAIN RES REV, V59, P253, DOI 10.1016/j.brainresrev.2008.08.002; Biala G, 2006, EUR J PHARMACOL, V537, P85, DOI 10.1016/j.ejphar.2006.03.017; Bilbao A, 2008, P NATL ACAD SCI USA, V105, P17549, DOI 10.1073/pnas.0803959105; Blanchard RJ, 1998, NEUROSCI BIOBEHAV R, V23, P179, DOI 10.1016/S0149-7634(98)00019-0; Bossert JM, 2005, EUR J PHARMACOL, V526, P36, DOI 10.1016/j.ejphar.2005.09.030; Boutrel B, 2005, P NATL ACAD SCI USA, V102, P19168, DOI 10.1073/pnas.0507480102; BROWN EE, 1992, J NEUROSCI, V12, P4112; Brown RM, 2009, NEUROCHEM RES, V34, P1876, DOI 10.1007/s11064-009-9967-y; Brown RM, 2009, NEUROPSYCHOPHARMACOL, V34, P844, DOI 10.1038/npp.2008.72; BROWN SA, 1995, J STUD ALCOHOL, V56, P538, DOI 10.15288/jsa.1995.56.538; Childress A, 1988, NIDA Res Monogr, V81, P74; Ciccocioppo R, 2001, P NATL ACAD SCI USA, V98, P1976, DOI 10.1073/pnas.98.4.1976; Comer SD, 2006, ARCH GEN PSYCHIAT, V63, P210, DOI 10.1001/archpsyc.63.2.210; CRAWFORD CA, 1995, PSYCHOPHARMACOLOGY, V120, P392, DOI 10.1007/BF02245810; Cruz FC, 2008, NEUROSCIENCE, V151, P313, DOI 10.1016/j.neuroscience.2007.10.019; Dackis CA, 2001, J SUBST ABUSE TREAT, V21, P111, DOI 10.1016/S0740-5472(01)00192-1; Dayas CV, 2007, BIOL PSYCHIAT, V61, P979, DOI 10.1016/j.biopsych.2006.07.034; De Vries TJ, 1998, EUR J NEUROSCI, V10, P3565, DOI 10.1046/j.1460-9568.1998.00368.x; DEJONG W, 1994, INT J ADDICT, V29, P681, DOI 10.3109/10826089409047904; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; Epstein DH, 2006, PSYCHOPHARMACOLOGY, V189, P1, DOI 10.1007/s00213-006-0529-6; Erb S, 1999, J NEUROSCI, V19, part. no., DOI 10.1523/JNEUROSCI.19-20-j0006.1999; Erb S, 2001, PSYCHOPHARMACOLOGY, V158, P360, DOI 10.1007/s002130000642; Floyd NS, 2001, J COMP NEUROL, V432, P307, DOI 10.1002/cne.1105; Font L, 2008, PHYSIOL BEHAV, V93, P733, DOI 10.1016/j.physbeh.2007.11.026; Franklin TR, 2000, EUR J NEUROSCI, V12, P2097, DOI 10.1046/j.1460-9568.2000.00071.x; Geisler S, 2008, CNS SPECTRUMS, V13, P484, DOI 10.1017/S1092852900016710; GOSSOP M, 1989, BRIT J PSYCHIAT, V154, P348, DOI 10.1192/bjp.154.3.348; Grant S, 1996, P NATL ACAD SCI USA, V93, P12040, DOI 10.1073/pnas.93.21.12040; GRAYBIEL AM, 1990, P NATL ACAD SCI USA, V87, P6912, DOI 10.1073/pnas.87.17.6912; Hamlin AS, 2008, NEUROSCIENCE, V151, P659, DOI 10.1016/j.neuroscience.2007.11.018; Harlan RE, 1998, MOL NEUROBIOL, V16, P221, DOI 10.1007/BF02741385; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Hebert MA, 1999, PHARMACOL BIOCHEM BE, V63, P349, DOI 10.1016/S0091-3057(98)00255-X; Herrera DG, 1996, PROG NEUROBIOL, V50, P83, DOI 10.1016/S0301-0082(96)00021-4; Hikosaka O, 2008, J NEUROSCI, V28, P11825, DOI 10.1523/JNEUROSCI.3463-08.2008; HOPE B, 1992, P NATL ACAD SCI USA, V89, P5764, DOI 10.1073/pnas.89.13.5764; Hrabovszky E, 2005, NEUROSCIENCE, V133, P657, DOI 10.1016/j.neuroscience.2005.03.042; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kufahl PR, 2009, SYNAPSE, V63, P823, DOI 10.1002/syn.20666; Lawrence AJ, 2006, BRIT J PHARMACOL, V148, P752, DOI 10.1038/sj.bjp.0706789; Leri F, 2002, J NEUROSCI, V22, P5713; Lu L, 2001, EUR J PHARMACOL, V415, P203, DOI 10.1016/S0014-2999(01)00840-8; MARKOU A, 1993, PSYCHOPHARMACOLOGY, V112, P163, DOI 10.1007/BF02244907; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; McDougall SJ, 2004, EUR J NEUROSCI, V20, P2430, DOI 10.1111/j.1460-9568.2004.03707.x; McFarland K, 2004, J NEUROSCI, V24, P1551, DOI 10.1523/JNEUROSCI.4177-03.2004; McFarland K, 2001, J NEUROSCI, V21, P8655; McPherson CS, 2006, INT J NEUROPSYCHOPH, V9, P377, DOI 10.1017/S1461145705005845; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Morissette MC, 2008, BEHAV BRAIN RES, V187, P17, DOI 10.1016/j.bbr.2007.08.021; Mueller D, 2000, BEHAV BRAIN RES, V115, P39, DOI 10.1016/S0166-4328(00)00239-4; Neisewander JL, 2000, J NEUROSCI, V20, P798, DOI 10.1523/JNEUROSCI.20-02-00798.2000; O'Brien C, 1992, Clin Neuropharmacol, V15 Suppl 1 Pt A, p66A; OBrien CP, 1997, AM J PSYCHIAT, V154, P1195; Paredes RG, 2003, SCAND J PSYCHOL, V44, P203, DOI 10.1111/1467-9450.00337; Parker LA, 2000, PHARMACOL BIOCHEM BE, V66, P559, DOI 10.1016/S0091-3057(00)00222-7; Paxinos G., MOUSE BRAIN STEREOTA; Peters J, 2008, J NEUROSCI, V28, P6046, DOI 10.1523/JNEUROSCI.1045-08.2008; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; Rhodes SEV, 2007, EUR J NEUROSCI, V25, P2498, DOI 10.1111/j.1460-9568.2007.05486.x; Rhodes SEV, 2004, LEARN MEMORY, V11, P611, DOI 10.1101/lm.79704; Robinson TE, 2000, ADDICTION, V95, pS91; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rogers JL, 2008, NEUROSCIENCE, V151, P579, DOI 10.1016/j.neuroscience.2007.10.012; Sanchez CJ, 2003, NEUROSCIENCE, V119, P497, DOI 10.1016/S0306-4522(03)00078-2; Sanchez CJ, 2001, BRAIN RES, V908, P86, DOI 10.1016/S0006-8993(01)02638-5; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Shaham Y, 1996, PSYCHOPHARMACOLOGY, V125, P385, DOI 10.1007/BF02246022; Sinha R, 2000, PSYCHOPHARMACOLOGY, V152, P140, DOI 10.1007/s002130000499; Spanagel R, 2000, J NEURAL TRANSM, V107, P669, DOI 10.1007/s007020070068; SUTHERLAND RJ, 1981, J COMP PHYSIOL PSYCH, V95, P781, DOI 10.1037/h0077833; TAKAGISHI M, 1991, BRAIN RES, V566, P26, DOI 10.1016/0006-8993(91)91677-S; Touzani K, 2009, NEUROBIOL LEARN MEM, V92, P464, DOI 10.1016/j.nlm.2009.06.006; Tzschentke TM, 1998, PROG NEUROBIOL, V56, P613, DOI 10.1016/S0301-0082(98)00060-4; VACHON MP, 1992, BEHAV NEUROSCI, V106, P981, DOI 10.1037/0735-7044.106.6.981; Wagner FA, 2002, AM J EPIDEMIOL, V155, P918, DOI 10.1093/aje/155.10.918; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; YOUNG ST, 1991, P NATL ACAD SCI USA, V88, P1291, DOI 10.1073/pnas.88.4.1291; Zavala AR, 2007, NEUROSCIENCE, V145, P438, DOI 10.1016/j.neuroscience.2006.12.038; Zavala AR, 2003, BRAIN RES, V990, P157, DOI 10.1016/S0006-8993(03)03452-8; Zhang FQ, 2005, NEUROSCI LETT, V386, P133, DOI 10.1016/j.neulet.2005.06.008	83	39	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15889	10.1371/journal.pone.0015889	http://dx.doi.org/10.1371/journal.pone.0015889			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209913	gold, Green Published			2022-12-27	WOS:000285793200068
J	Kotz, A; Wagener, J; Engel, J; Routier, FH; Echtenacher, B; Jacobsen, I; Heesemann, J; Ebel, F				Kotz, Andrea; Wagener, Johannes; Engel, Jakob; Routier, Francoise H.; Echtenacher, Bernd; Jacobsen, Ilse; Heesemann, Juergen; Ebel, Frank			Approaching the Secrets of N-Glycosylation in Aspergillus fumigatus: Characterization of the AfOch1 Protein	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; MANNOSYLTRANSFERASE; OCH1; LOCALIZATION; GLUCOAMYLASE; DEFICIENT; VIRULENCE; ENCODES; GLYCANS; HOC1	The mannosyltransferase Och1 is the key enzyme for synthesis of elaborated protein N-glycans in yeast. In filamentous fungi genes implicated in outer chain formation are present, but their function is unclear. In this study we have analyzed the Och1 protein of Aspergillus fumigatus. We provide first evidence that poly-mannosylated N-glycans exist in A. fumigatus and that their synthesis requires AfOch1 activity. This implies that AfOch1 plays a similar role as S. cerevisiae ScOch1 in the initiation of an N-glycan outer chain. A Delta afoch1 mutant showed normal growth under standard and various stress conditions including elevated temperature, cell wall and oxidative stress. However, sporulation of this mutant was dramatically reduced in the presence of high calcium concentrations, suggesting that certain proteins engaged in sporulation require N-glycan outer chains to be fully functional. A characteristic feature of AfOch1 and Och1 homologues from other filamentous fungi is a signal peptide that clearly distinguishes them from their yeast counterparts. However, this difference does not appear to have consequences for its localization in the Golgi. Replacing the signal peptide of AfOch1 by a membrane anchor had no impact on its ability to complement the sporulation defect of the Delta afoch1 strain. The mutant triggered a normal cytokine response in infected murine macrophages, arguing against a role of outer chains as relevant Aspergillus pathogen associated molecular patterns. Infection experiments provided no evidence for attenuation in virulence; in fact, according to our data the Delta afoch1 mutant may even be slightly more virulent than the control strains.	[Kotz, Andrea; Wagener, Johannes; Heesemann, Juergen; Ebel, Frank] Univ Munich, Max Von Pettenkofer Inst, Munich, Germany; [Engel, Jakob; Routier, Francoise H.] Hannover Med Sch, Dept Cellular Chem, Hannover, Germany; [Echtenacher, Bernd] Univ Regensburg, Inst Immunol, Regensburg, Germany; [Jacobsen, Ilse] Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogenic Mech, Jena, Germany; [Heesemann, Juergen] Univ Munich, Fac Med, Ctr Integrated Prot Sci Munich, Munich, Germany	University of Munich; Hannover Medical School; University of Regensburg; Hans Knoll Institute (HKI); University of Munich	Kotz, A (corresponding author), Univ Munich, Max Von Pettenkofer Inst, Munich, Germany.	ebel@mvp.uni-muenchen.de	Routier, Francoise/O-1611-2019; Ebel, Frank/AAF-2303-2022; Jacobsen, Ilse/B-3155-2011; Ebel, Frank/AFH-1488-2022; Wagener, Johannes/K-5904-2012; Wagener, Johannes/AAN-1359-2021	Ebel, Frank/0000-0002-1027-1440; Jacobsen, Ilse/0000-0002-6033-9984; Ebel, Frank/0000-0002-1027-1440; Wagener, Johannes/0000-0002-5952-9422; Routier, Francoise/0000-0002-7163-0590	Center of Integrated Protein Science Munich (CIPSM); Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich 576, TP B8]	Center of Integrated Protein Science Munich (CIPSM); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Center of Integrated Protein Science Munich (CIPSM), and by a grant of the Deutsche Forschungsgemeinschaft (DFG) through Sonderforschungsbereich 576, TP B8. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESHIN A, 1992, J BIOL CHEM, V267, P19291; Bates S, 2006, J BIOL CHEM, V281, P90, DOI 10.1074/jbc.M510360200; Cole L, 2000, FUNGAL GENET BIOL, V29, P95, DOI 10.1006/fgbi.2000.1190; Deshpande N, 2008, GLYCOBIOLOGY, V18, P626, DOI 10.1093/glycob/cwn044; Engel J, 2009, J BIOL CHEM, V284, P33859, DOI 10.1074/jbc.M109.070219; Goto M, 1997, APPL ENVIRON MICROB, V63, P2940, DOI 10.1128/AEM.63.7.2940-2943.1997; GRAHAM TR, 1995, MOL BIOL CELL, V6, P809, DOI 10.1091/mbc.6.7.809; Harris SL, 1996, J CELL BIOL, V132, P985, DOI 10.1083/jcb.132.6.985; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Kim MW, 2006, J BIOL CHEM, V281, P6261, DOI 10.1074/jbc.M508507200; Kotz A, 2010, FUNGAL GENET BIOL, V47, P169, DOI 10.1016/j.fgb.2009.10.001; Krappmann S, 2006, EUKARYOT CELL, V5, P212, DOI 10.1128/EC.5.1.212-215.2006; Kukuruzinska MA, 1998, CRIT REV ORAL BIOL M, V9, P415, DOI 10.1177/10454411980090040301; Lambou K, 2010, YEAST, V27, P625, DOI 10.1002/yea.1798; Laroy W, 2006, NAT PROTOC, V1, P397, DOI 10.1038/nprot.2006.60; Maras M, 1999, GLYCOCONJUGATE J, V16, P99, DOI 10.1023/A:1026436424881; McCormick A, 2010, CELL MICROB IN PRESS; Morelle W, 2005, EUKARYOT CELL, V4, P1308, DOI 10.1128/EC.4.7.1308-1316.2005; Munro S, 2001, FEBS LETT, V498, P223, DOI 10.1016/S0014-5793(01)02488-7; NAGASU T, 1992, YEAST, V8, P535, DOI 10.1002/yea.320080705; NAKAYAMA K, 1992, EMBO J, V11, P2511, DOI 10.1002/j.1460-2075.1992.tb05316.x; Neiman AM, 1997, GENETICS, V145, P637; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Schmalhorst PS, 2008, EUKARYOT CELL, V7, P1268, DOI 10.1128/EC.00109-08; Schwienbacher M, 2005, MED MYCOL, V43, P623, DOI 10.1080/13693780500089216; TAKAYANAGI T, 1994, CARBOHYD RES, V256, P149, DOI 10.1016/0008-6215(94)84234-5; Wagener J, 2008, EUKARYOT CELL, V7, P1661, DOI 10.1128/EC.00221-08; Wallis GLF, 2001, EUR J BIOCHEM, V268, P4134, DOI 10.1046/j.1432-1327.2001.02322.x; Wendland J, 2005, NAT REV MICROBIOL, V3, P421, DOI 10.1038/nrmicro1148; Yan AX, 2005, J BIOL CHEM, V280, P3121, DOI 10.1074/jbc.R400036200; Zanni E, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-86	31	34	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15729	10.1371/journal.pone.0015729	http://dx.doi.org/10.1371/journal.pone.0015729			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206755	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793200046
J	Santander, J; Xin, W; Yang, Z; Curtiss, R				Santander, Javier; Xin, Wei; Yang, Zhao; Curtiss, Roy			The Aspartate-Semialdehyde Dehydrogenase of Edwardsiella ictaluri and Its Use as Balanced-Lethal System in Fish Vaccinology	PLOS ONE			English	Article							SEROVAR TYPHIMURIUM VACCINE; RECOMBINANT PNEUMOCOCCAL PSPA; INDISPENSABLE AMINO-ACIDS; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; CHANNEL CATFISH; ENTERIC SEPTICEMIA; STREPTOCOCCUS-MUTANS; STABLE MAINTENANCE; IMMUNE-RESPONSES	asdA mutants of Gram-negative bacteria have an obligate requirement for diaminopimelic acid (DAP), which is an essential constituent of the peptidoglycan layer of the cell wall of these organisms. In environments deprived of DAP, i.e., animal tissues, they will undergo lysis. Deletion of the asdA gene has previously been exploited to develop antibiotic-sensitive strains of live attenuated recombinant bacterial vaccines. Introduction of an Asd(+) plasmid into a Delta asdA mutant makes the bacterial strain plasmid-dependent. This dependence on the Asd(+) plasmid vector creates a balanced-lethal complementation between the bacterial strain and the recombinant plasmid. E. ictaluri is an enteric Gram-negative fish pathogen that causes enteric septicemia in catfish. Because E. ictaluri is a nasal/oral invasive intracellular pathogen, this bacterium is a candidate to develop a bath/oral live (r) under bar ecombinant (a) under bar ttenuated (E) under bar dwardsiella (v) under bar accine (RAEV) for the catfish aquaculture industry. As a first step to develop an antibiotic-sensitive RAEV strain, we characterized and deleted the E. ictaluri asdA gene. E. ictaluri Delta asdA01 mutants exhibit an absolute requirement for DAP to grow. The asdA gene of E. ictaluri was complemented by the asdA gene from Salmonella. Several Asd(+) expression vectors with different origins of replication were transformed into E. ictaluri Delta asdA01. Asd(+) vectors were compatible with the pEI1 and pEI2 E. ictaluri native plasmids. The balanced-lethal system was satisfactorily evaluated in vivo. Recombinant GFP, PspA, and LcrV proteins were synthesized by E. ictaluri Delta asdA01 harboring Asd(+) plasmids. Here we constructed a balanced-lethal system, which is the first step to develop an antibiotic-sensitive RAEV for the aquaculture industry.	[Santander, Javier; Xin, Wei; Yang, Zhao; Curtiss, Roy] Arizona State Univ, Ctr Infect Dis & Vaccinol, Biodesign Inst, Tempe, AZ 85287 USA; [Yang, Zhao] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China	Arizona State University; Arizona State University-Tempe; East China University of Science & Technology	Santander, J (corresponding author), Arizona State Univ, Ctr Infect Dis & Vaccinol, Biodesign Inst, Tempe, AZ 85287 USA.	rcurtiss@asu.edu	Santander, Javier/AAU-9423-2020		United States Deparment of Agriculture (USDA) [CRIS-ARZR-2009-01801]; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT), Chile	United States Deparment of Agriculture (USDA)(United States Department of Agriculture (USDA)); Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT), Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by United States Deparment of Agriculture (USDA) grant CRIS-ARZR-2009-01801 and Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT), Gestion Propia Fellowship, Chile.	Anderson D. P., 1984, FISH IMMUNOLOGY, P110; Arias CR, 2003, J FISH DIS, V26, P415, DOI 10.1046/j.1365-2761.2003.00475.x; BERCZI I, 1966, CAN J MICROBIOL, V12, P1070, DOI 10.1139/m66-143; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; BRANGER CG, 2010, VACCINE IN PRESS; Branger CG, 2007, ADV EXP MED BIOL, V603, P387; BRENNER DJ, 1984, INT J SYST BACTERIOL, V34, P45, DOI 10.1099/00207713-34-1-45; BurnsKeliher LL, 1997, J BACTERIOL, V179, P3604, DOI 10.1128/jb.179.11.3604-3612.1997; CARDINEAU GA, 1987, J BIOL CHEM, V262, P3344; Cersini A, 1998, INFECT IMMUN, V66, P549, DOI 10.1128/IAI.66.2.549-557.1998; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; CHEN HY, 1994, NUCLEIC ACIDS RES, V22, P4953, DOI 10.1093/nar/22.23.4953; CURTISS R, 1965, J BACTERIOL, V89, P28, DOI 10.1128/JB.89.1.28-40.1965; CURTISS RI, 2007, INDUCTION HOST IMMUN; DUPREE HK, 1970, T AM FISH SOC, V99, P90, DOI 10.1577/1548-8659(1970)99<90:AAEFTG>2.0.CO;2; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Fernandez DH, 2001, PLASMID, V45, P52, DOI 10.1006/plas.2000.1499; GALAN JE, 1990, GENE, V94, P29, DOI 10.1016/0378-1119(90)90464-3; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HALVER JE, 1960, J NUTR, V72, P340, DOI 10.1093/jn/72.3.340; HALVER JE, 1957, J NUTR, V63, P95, DOI 10.1093/jn/63.1.95; Harb OS, 1998, INFECT IMMUN, V66, P1898, DOI 10.1128/IAI.66.5.1898-1903.1998; HAWKE JP, 1981, INT J SYST BACTERIOL, V31, P396, DOI 10.1099/00207713-31-4-396; Hudson AO, 2005, BBA-GEN SUBJECTS, V1721, P27, DOI 10.1016/j.bbagen.2004.09.008; Iliev DB, 2005, FEBS LETT, V579, P6519, DOI 10.1016/j.febslet.2005.10.061; JAGUSZTYNKRYNICKA EK, 1982, J GEN MICROBIOL, V128, P1135; Kang HY, 2003, FEMS IMMUNOL MED MIC, V37, P99, DOI 10.1016/S0928-8244(03)00063-4; Kang HY, 2002, INFECT IMMUN, V70, P1739, DOI 10.1128/IAI.70.4.1739-1749.2002; Klesius PH, 1999, ADV VETER MED AP, V41, P523; Konjufca V, 2006, INFECT IMMUN, V74, P6785, DOI 10.1128/IAI.00851-06; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lawrence ML, 2001, J AQUAT ANIM HEALTH, V13, P291, DOI 10.1577/1548-8667(2001)013&lt;0291:PAVOAT&gt;2.0.CO;2; LESLIE AGW, 1988, P NATL ACAD SCI USA, V85, P4133, DOI 10.1073/pnas.85.12.4133; Li MH, 1998, AQUACULTURE, V163, P297, DOI 10.1016/S0044-8486(98)00239-7; Maurer KJ, 2001, J AQUAT ANIM HEALTH, V13, P163, DOI 10.1577/1548-8667(2001)013&lt;0163:EAOOAD&gt;2.0.CO;2; MAZID MA, 1978, B JPN SOC SCI FISH, V44, P739; NAKAYAMA K, 1988, BIO-TECHNOL, V6, P693, DOI 10.1038/nbt0688-693; NOSE T, 1974, B JPN SOC SCI FISH, V40, P903; Paidhungat M, 2000, J BACTERIOL, V182, P5505, DOI 10.1128/JB.182.19.5505-5512.2000; Pavelka MS, 1996, J BACTERIOL, V178, P6496, DOI 10.1128/jb.178.22.6496-6507.1996; Petrie-Hanson L, 2007, J AQUAT ANIM HEALTH, V19, P151, DOI 10.1577/H06-026.1; Roland K, 1999, AVIAN DIS, V43, P429, DOI 10.2307/1592640; Russo R, 2009, FISH SHELLFISH IMMUN, V26, P543, DOI 10.1016/j.fsi.2009.02.011; Sambrook J, 2001, MOL CLONING LAB MANU; Santander J, 2007, INFECT IMMUN, V75, P1382, DOI 10.1128/IAI.00888-06; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Shi HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011142; Shoemaker CA, 1999, AQUACULTURE, V176, P189, DOI 10.1016/S0044-8486(99)00116-7; Shoemaker CA, 2007, VACCINE, V25, P1126, DOI 10.1016/j.vaccine.2006.09.055; Shoemaker CA, 2009, J WORLD AQUACULT SOC, V40, P573, DOI 10.1111/j.1749-7345.2009.00279.x; Thune RL, 2007, APPL ENVIRON MICROB, V73, P7934, DOI 10.1128/AEM.01115-07; Viola RE, 2001, ACCOUNTS CHEM RES, V34, P339, DOI 10.1021/ar000057q; Viola RE, 2008, ACTA CRYSTALLOGR D, V64, P321, DOI 10.1107/S0907444907068552; VOGEL HJ, 1959, P NATL ACAD SCI USA, V45, P1717, DOI 10.1073/pnas.45.12.1717; Walakira JK, 2008, J APPL MICROBIOL, V105, P2133, DOI 10.1111/j.1365-2672.2008.03933.x; Wang QY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007646; WIENTJES FB, 1985, J BACTERIOL, V164, P331, DOI 10.1128/JB.164.1.331-337.1985; Williams ML, 2005, VET MICROBIOL, V108, P281, DOI 10.1016/j.vetmic.2005.04.017; Williams ML, 2003, J AQUAT ANIM HEALTH, V15, P264, DOI 10.1577/H03-051.1; WITHOLT B, 1976, ANAL BIOCHEM, V74, P160, DOI 10.1016/0003-2697(76)90320-1; Xin W, 2008, INFECT IMMUN, V76, P3241, DOI 10.1128/IAI.01623-07	61	19	21	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15944	10.1371/journal.pone.0015944	http://dx.doi.org/10.1371/journal.pone.0015944			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209920	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793200076
J	Dube, DH; Li, B; Greenblatt, EJ; Nimer, S; Raymond, AK; Kohler, JJ				Dube, Danielle H.; Li, Bin; Greenblatt, Ethan J.; Nimer, Sadeieh; Raymond, Amanda K.; Kohler, Jennifer J.			A Two-Hybrid Assay to Study Protein Interactions within the Secretory Pathway	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATION; LINKED OLIGOSACCHARIDES; CRYSTAL-STRUCTURE; OUTER CHAIN; IN-VIVO; YEAST; GLYCOSYLATION; SYSTEM; GENE	Interactions of transcriptional activators are difficult to study using transcription-based two-hybrid assays due to potent activation resulting in false positives. Here we report the development of the Golgi two-hybrid (G2H), a method that interrogates protein interactions within the Golgi, where transcriptional activators can be assayed with negligible background. The G2H relies on cell surface glycosylation to report extracellularly on protein-protein interactions occurring within the secretory pathway. In the G2H, protein pairs are fused to modular domains of the reporter glycosyltransferase, Och1p, and proper cell wall formation due to Och1p activity is observed only when a pair of proteins interacts. Cells containing interacting protein pairs are identified by selectable phenotypes associated with Och1p activity and proper cell wall formation: cells that have interacting proteins grow under selective conditions and display weak wheat germ agglutinin (WGA) binding by flow cytometry, whereas cells that lack interacting proteins display stunted growth and strong WGA binding. Using this assay, we detected the interaction between transcription factor MyoD and its binding partner Id2. Interfering mutations along the MyoD: Id2 interaction interface ablated signal in the G2H assay. Furthermore, we used the G2H to detect interactions of the activation domain of Gal4p with a variety of binding partners. Finally, selective conditions were used to enrich for cells encoding interacting partners. The G2H detects protein-protein interactions that cannot be identified via traditional two-hybrid methods and should be broadly useful for probing previously inaccessible subsets of the interactome, including transcriptional activators and proteins that traffic through the secretory pathway.	[Dube, Danielle H.] Bowdoin Coll, Dept Chem & Biochem, Brunswick, ME 04011 USA; [Dube, Danielle H.; Greenblatt, Ethan J.; Raymond, Amanda K.; Kohler, Jennifer J.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Li, Bin; Nimer, Sadeieh; Kohler, Jennifer J.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Translat Res, Dallas, TX 75390 USA; [Greenblatt, Ethan J.] Stanford Univ, Biophys Program, Stanford, CA 94305 USA	Bowdoin College; Stanford University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Stanford University	Dube, DH (corresponding author), Bowdoin Coll, Dept Chem & Biochem, Brunswick, ME 04011 USA.	Jennifer.Kohler@UTSouthwestern.edu	Kohler, Jennifer J./B-6589-2009	Kohler, Jennifer J./0000-0001-5373-3329; Raymond, Amanda/0000-0001-8284-1265; Greenblatt, Ethan/0000-0002-3805-0113	Stanford Office of Technology Licensing; National Science Foundation [CAREER-MCB 0834336]; Welch Foundation [I-1686]; Stanford University; University of Texas Southwestern Medical Center	Stanford Office of Technology Licensing(Office of Naval Research); National Science Foundation(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); Stanford University(Stanford University); University of Texas Southwestern Medical Center	This work was supported by grants from the Stanford Office of Technology Licensing, the National Science Foundation (CAREER-MCB 0834336), the Welch Foundation (I-1686), a Walter and Idun Berry Postdoctoral Fellowship (Stanford University) to D.H.D., and a Bing Fellowship (Stanford University) to A.K.R. Additional funds were supplied by Stanford University and the University of Texas Southwestern Medical Center. J. J. K. is an Alfred P. Sloan Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer CT, 2005, MOL BIOSYST, V1, P366, DOI 10.1039/b510019d; Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Chang C, 2001, J BIOL CHEM, V276, P30956, DOI 10.1074/jbc.M102254200; Choi BK, 2003, P NATL ACAD SCI USA, V100, P5022, DOI 10.1073/pnas.0931263100; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Futschik ME, 2007, BIOINFORMATICS, V23, P605, DOI 10.1093/bioinformatics/btl683; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Guo DW, 2004, NAT BIOTECHNOL, V22, P888, DOI 10.1038/nbt985; Hamilton SR, 2003, SCIENCE, V301, P1244, DOI 10.1126/science.1088166; Hennecke F, 2005, PROTEIN ENG DES SEL, V18, P477, DOI 10.1093/protein/gzi053; HILL K, 1992, GENETICS, V130, P273; Hu XB, 2009, J BIOL CHEM, V284, P16369, DOI 10.1074/jbc.M109.001743; Jeong KJ, 2007, P NATL ACAD SCI USA, V104, P8247, DOI 10.1073/pnas.0702650104; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kim SY, 2004, MOL BIOTECHNOL, V27, P1, DOI 10.1385/MB:27:1:01; Kohler JJ, 2004, CHEMBIOCHEM, V5, P1455, DOI 10.1002/cbic.200400156; Kohler JJ, 2003, CHEM BIOL, V10, P1303, DOI 10.1016/j.chembiol.2003.11.018; Ledent V, 2001, GENOME RES, V11, P754, DOI 10.1101/gr.177001; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Lilyestrom W, 2006, GENE DEV, V20, P2373, DOI 10.1101/gad.1456306; MA PCM, 1994, CELL, V77, P451, DOI 10.1016/0092-8674(94)90159-7; Melcher K, 2000, J MOL BIOL, V301, P1097, DOI 10.1006/jmbi.2000.4034; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Munro S, 1998, TRENDS CELL BIOL, V8, P11, DOI 10.1016/S0962-8924(97)01197-5; NAKANISHISHINDO Y, 1993, J BIOL CHEM, V268, P26338; NAKAYAMA K, 1992, EMBO J, V11, P2511, DOI 10.1002/j.1460-2075.1992.tb05316.x; Nyfeler B, 2005, P NATL ACAD SCI USA, V102, P6350, DOI 10.1073/pnas.0501976102; Papanikou E, 2009, FEBS LETT, V583, P3746, DOI 10.1016/j.febslet.2009.10.072; Pollock S, 2004, EMBO J, V23, P1020, DOI 10.1038/sj.emboj.7600119; Rivera VM, 2000, SCIENCE, V287, P826, DOI 10.1126/science.287.5454.826; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang XH, 1997, J BIOL CHEM, V272, P18117, DOI 10.1074/jbc.272.29.18117; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yang W, 1996, EUR J CELL BIOL, V71, P53; YIP CL, 1994, P NATL ACAD SCI USA, V91, P2723, DOI 10.1073/pnas.91.7.2723	37	8	8	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15648	10.1371/journal.pone.0015648	http://dx.doi.org/10.1371/journal.pone.0015648			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21209940	Green Published, gold, Green Submitted			2022-12-27	WOS:000285792500034
J	Lajoie, P; Snapp, EL				Lajoie, Patrick; Snapp, Erik Lee			Formation and Toxicity of Soluble Polyglutamine Oligomers in Living Cells	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; INTRANUCLEAR NEURONAL INCLUSIONS; AMYLOID-LIKE FIBRILS; HUNTINGTONS-DISEASE; MUTANT HUNTINGTIN; NEURODEGENERATIVE DISEASES; TRANSLATIONAL DIFFUSION; NEUROLOGICAL PHENOTYPE; EXPANSION PROTEINS; MAMMALIAN-CELLS	Background: Aggregation and cytotoxicity of mutant proteins containing an expanded number of polyglutamine (polyQ) repeats is a hallmark of several diseases, including Huntington's disease (HD). Within cells, mutant Huntingtin (mHtt) and other polyglutamine expansion mutant proteins exist as monomers, soluble oligomers, and insoluble inclusion bodies (IBs). Determining which of these forms constitute a toxic species has proven difficult. Recent studies support a role for IBs as a cellular coping mechanism to sequester levels of potentially toxic soluble monomeric and oligomeric species of mHtt. Methodology/Principal Findings: When fused to a fluorescent reporter (GFP) and expressed in cells, the soluble monomeric and oligomeric polyglutamine species are visually indistinguishable. Here, we describe two complementary biophysical fluorescence microscopy techniques to directly detect soluble polyglutamine oligomers (using Httexon 1 or Htt(ex1)) and monitor their fates in live cells. Photobleaching analyses revealed a significant reduction in the mobilities of mHtt ex1 variants consistent with their incorporation into soluble microcomplexes. Similarly, when fused to split-GFP constructs, both wildtype and mHtt(ex1) formed oligomers, as evidenced by the formation of a fluorescent reporter. Only the mHtt(ex1) split-GFP oligomers assembled into IBs. Both FRAP and split-GFP approaches confirmed the ability of mHtt(ex1) to bind and incorporate wildtype Htt into soluble oligomers. We exploited the irreversible binding of split-GFP fragments to forcibly increase levels of soluble oligomeric mHtt(ex1). A corresponding increase in the rate of IBs formation and the number formed was observed. Importantly, higher levels of soluble mHtt(ex1) oligomers significantly correlated with increased mutant cytotoxicity, independent of the presence of IBs. Conclusions/Significance: Our study describes powerful and sensitive tools for investigating soluble oligomeric forms of expanded polyglutamine proteins, and their impact on cell viability. Moreover, these methods should be applicable for the detection of soluble oligomers of a wide variety of aggregation prone proteins.	[Lajoie, Patrick; Snapp, Erik Lee] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Lajoie, P (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA.	erik-lee.snapp@einstein.yu.edu	Snapp, Erik Lee/H-7152-2019	Snapp, Erik Lee/0000-0001-9482-2272; Lajoie, Patrick/0000-0002-1614-176X	CHDI; NIA [R21 1R21AG032544-01]; NIGMS [RO1GM086530-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032544] Funding Source: NIH RePORTER	CHDI; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by an Early Discovery Initiative grant from CHDI to ELS. In addition, ELS was an Ellison Medical Foundation New Scholar in Aging and is supported by NIA R21 1R21AG032544-01 and NIGMS RO1GM086530-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Arrio-Dupont M, 2000, BIOPHYS J, V78, P901, DOI 10.1016/S0006-3495(00)76647-1; Becher MW, 1998, NEUROBIOL DIS, V4, P387, DOI 10.1006/nbdi.1998.0168; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bhola PD, 2009, J CELL SCI, V122, P4296, DOI 10.1242/jcs.055590; Brooks Elizabeth, 2004, V277, P103; Buck CB, 2008, J VIROL, V82, P5190, DOI 10.1128/JVI.02726-07; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Chai YH, 2002, P NATL ACAD SCI USA, V99, P9310, DOI 10.1073/pnas.152101299; Chen S, 2001, J MOL BIOL, V311, P173, DOI 10.1006/jmbi.2001.4850; Chun WJ, 2007, J NEUROCHEM, V103, P2529, DOI 10.1111/j.1471-4159.2007.04941.x; Cong SY, 2006, EXP NEUROL, V199, P257, DOI 10.1016/j.expneurol.2005.11.008; Davies JE, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S2; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; Gervais FG, 2002, NAT CELL BIOL, V4, P95, DOI 10.1038/ncb735; Goncalves SA, TRENDS BIOCH SCI, V35, P643; Gusella JF, 2006, TRENDS BIOCHEM SCI, V31, P533, DOI 10.1016/j.tibs.2006.06.009; Hink MA, 2000, J BIOL CHEM, V275, P17556, DOI 10.1074/jbc.M001348200; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huang CC, 1998, SOMAT CELL MOLEC GEN, V24, P217, DOI 10.1023/B:SCAM.0000007124.19463.e5; Irwin S, 2005, J CELL SCI, V118, P233, DOI 10.1242/jcs.01611; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kerppola TK, 2006, NAT METHODS, V3, P969, DOI 10.1038/nmeth1206-969; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Lee CC, 2007, BIOCHEMISTRY-US, V46, P12810, DOI 10.1021/bi700806c; Legleiter J, J BIOL CHEM; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Li SW, 1996, J BIOL CHEM, V271, P568, DOI 10.1074/jbc.271.1.568; Lievens S, 2009, TRENDS BIOCHEM SCI, V34, P579, DOI 10.1016/j.tibs.2009.06.009; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; LUBYPHELPS K, 1986, J CELL BIOL, V102, P2015, DOI 10.1083/jcb.102.6.2015; Luo SQ, 2008, HUM MOL GENET, V17, P895, DOI 10.1093/hmg/ddm362; Magliery TJ, 2005, J AM CHEM SOC, V127, P146, DOI 10.1021/ja046699g; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Mukai H, 2005, P NATL ACAD SCI USA, V102, P10887, DOI 10.1073/pnas.0409283102; Munck JM, 2009, J CELL BIOL, V187, P463, DOI 10.1083/jcb.200906161; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Olzmann JA, 2008, CURR MED CHEM, V15, P47; Ordway JM, 1997, CELL, V91, P753, DOI 10.1016/S0092-8674(00)80464-X; Ossato G, 2010, BIOPHYS J, V98, P3078, DOI 10.1016/j.bpj.2010.02.058; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Peters-Libeu C, 2005, ACTA CRYSTALLOGR F, V61, P1065, DOI 10.1107/S1744309105036547; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Pollitt SK, 2003, NEURON, V40, P685, DOI 10.1016/S0896-6273(03)00697-4; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Robertson AL, 2010, P NATL ACAD SCI USA, V107, P10424, DOI 10.1073/pnas.0914773107; Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5; Rubinsztein DC, 2006, EXP NEUROL, V199, P243, DOI 10.1016/j.expneurol.2006.03.006; Rubinsztein David C, 2003, Sci Aging Knowledge Environ, V2003, pPE26, DOI 10.1126/sageke.2003.37.pe26; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Seksek O, 1997, J CELL BIOL, V138, P131, DOI 10.1083/jcb.138.1.131; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Siggia ED, 2000, BIOPHYS J, V79, P1761, DOI 10.1016/S0006-3495(00)76428-9; Sisodia SS, 1998, CELL, V95, P1, DOI 10.1016/S0092-8674(00)81743-2; Snapp Erik L, 2003, Curr Protoc Cell Biol, VChapter 21, DOI 10.1002/0471143030.cb2101s19; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Stenoien DL, 2002, NAT CELL BIOL, V4, P806, DOI 10.1038/ncb859; Takahashi T, 2008, HUM MOL GENET, V17, P345, DOI 10.1093/hmg/ddm311; Takahashi Y, 2007, J BIOL CHEM, V282, P24039, DOI 10.1074/jbc.M704789200; Tanaka M, 2003, J BIOL CHEM, V278, P34717, DOI 10.1074/jbc.M209852200; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Tobin AJ, 2000, TRENDS CELL BIOL, V10, P531, DOI 10.1016/S0962-8924(00)01853-5; Villalobos Victor, 2008, V439, P339, DOI 10.1007/978-1-59745-188-8_23; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Wilson CG, 2004, NAT METHODS, V1, P255, DOI 10.1038/nmeth1204-255; WOUTERS FS, 2001, CURR PROTOC PROTEIN, pCH19	83	80	84	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15245	10.1371/journal.pone.0015245	http://dx.doi.org/10.1371/journal.pone.0015245			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21209946	Green Published, gold			2022-12-27	WOS:000285792500026
J	Talbot, HK; Rock, MT; Johnson, C; Tussey, L; Kavita, U; Shanker, A; Shaw, AR; Taylor, DN				Talbot, H. Keipp; Rock, Michael T.; Johnson, Casey; Tussey, Lynda; Kavita, Uma; Shanker, Anita; Shaw, Alan R.; Taylor, David N.			Immunopotentiation of Trivalent Influenza Vaccine When Given with VAX102, a Recombinant Influenza M2e Vaccine Fused to the TLR5 Ligand Flagellin	PLOS ONE			English	Article							VIRUS; ANTIBODY; PROTEIN; IMMUNOGENICITY; ADULTS; MICE	Background: Currently controversy exists about the immunogenicity of seasonal trivalent influenza vaccine in certain populations, especially the elderly. STF2.46M2e (VAX102) is a recombinant fusion protein that links four copies of the ectodomain of influenza virus matrix protein 2 (M2e) antigen to Salmonella typhimurium flagellin, a TLR5 ligand. The objectives of this study were to assess the feasibility of giving VAX102 and TIV in combination in an effort to achieve greater immunogenicity and to provide cross-protection. Methodology/Principal Findings: Eighty healthy subjects, 18-49 years old, were enrolled in May and June 2009 in a double-blind, randomized, controlled trial at two clinical sites. Subjects were randomized to receive either TIV + VAX102 or TIV + placebo. Both arms tolerated the vaccines. Pain at the injection site was more severe with TIV + VAX102. Two weeks after immunization the HAI responses to the H1 and H3 antigens of TIV were higher in those that received TIV + VAX102 than in TIV + placebo (309 vs 200 and 269 vs 185, respectively), although statistically non-significant. There was no difference in the HAI of the B antigen. In the TIV + VAX102 arm, the geometric mean M2e antibody concentration was 0.5 mg/ml and 73% seroconverted. Conclusions/Significance: The combination of TIV + VAX102 has the potential to increase the immune response to the influenza A components of TIV and to provide M2e immunity which may protect against influenza A strains not contained in seasonal TIV.	[Talbot, H. Keipp] Vanderbilt Univ, Med Ctr, Dept Med, Div Infect Dis, Nashville, TN 37235 USA; [Rock, Michael T.] Vanderbilt Univ, Med Ctr, Dept Pediat, Div Infect Dis, Nashville, TN 37232 USA; [Johnson, Casey] Johnson Cty Clin Trials, Lenexa, KS USA; [Tussey, Lynda; Kavita, Uma; Shaw, Alan R.; Taylor, David N.] VaxInnate Corp, Cranbury, NJ USA; [Shanker, Anita] Hlth Decis, Durham, NC USA	Vanderbilt University; Vanderbilt University	Talbot, HK (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Infect Dis, Nashville, TN 37235 USA.	keipp.talbot@vanderbilt.edu			VaxInnate Corporation; Protein Sciences; VaxInnate; Sanofi Pasteur; Wyeth	VaxInnate Corporation; Protein Sciences; VaxInnate; Sanofi Pasteur; Wyeth(Wyeth)	This study was funded by VaxInnate Corporation (www.vaxinnate.com), which assisted in study design, data collection, analysis, and preparation of the manuscript. VaxInnate hired Johnson County Clin-Trials as a clinical trials center and Health Decisions for data management and analysis.; HKBT has received research funding from Protein Sciences, VaxInnate, Sanofi Pasteur and Wyeth. MR has no conflicts of interest. Casey Johnson works for Johnson County Clin-Trials, which was hired by VaxInnate. Anita Shanker works for Health Decisions, which was hired by VaxInnate for data management. Lynda Tussey, Uma Kavita, Alan Shaw and David Taylor work for VaxInnate. This will not interfere with sharing data.	Baldwin SL, 2009, VACCINE, V27, P5956, DOI 10.1016/j.vaccine.2009.07.081; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Cherry JD, 2004, CLIN INFECT DIS, V39, P1715, DOI 10.1086/425003; Falsey AR, 2009, J INFECT DIS, V200, P172, DOI 10.1086/599790; Fan JA, 2004, VACCINE, V22, P2993, DOI 10.1016/j.vaccine.2004.02.021; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; KENDAL AP, 1982, CONCEPTS PROCEDURES, pB17; Ohigashi Y, 2009, P NATL ACAD SCI USA, V106, P18775, DOI 10.1073/pnas.0910584106; Poland GA, 2009, J INFECT DIS, V200, P161, DOI 10.1086/599791; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; TREANOR JJ, 1990, J VIROL, V64, P1375, DOI 10.1128/JVI.64.3.1375-1377.1990; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992	13	61	65	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14442	10.1371/journal.pone.0014442	http://dx.doi.org/10.1371/journal.pone.0014442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203437	Green Published, gold, Green Submitted			2022-12-27	WOS:000285792500018
J	Espeseth, T; Sneve, MH; Rootwelt, H; Laeng, B				Espeseth, Thomas; Sneve, Markus Handal; Rootwelt, Helge; Laeng, Bruno			Nicotinic Receptor Gene CHRNA4 Interacts with Processing Load in Attention	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; PREFRONTAL ACETYLCHOLINE-RELEASE; VISUAL-ATTENTION; WORKING-MEMORY; VISUOSPATIAL ATTENTION; SELECTIVE ATTENTION; INDIVIDUAL-DIFFERENCES; SPATIAL ATTENTION; PERCEPTUAL LOAD; HUMAN BRAIN	Background: Pharmacological studies suggest that cholinergic neurotransmission mediates increases in attentional effort in response to high processing load during attention demanding tasks [1]. Methodology/ Principal Findings: In the present study we tested whether individual variation in CHRNA4, a gene coding for a subcomponent in alpha 4b2 nicotinic receptors in the human brain, interacted with processing load in multiple-object tracking (MOT) and visual search (VS). We hypothesized that the impact of genotype would increase with greater processing load in the MOT task. Similarly, we predicted that genotype would influence performance under high but not low load in the VS task. Two hundred and two healthy persons (age range = 39-77, Mean = 57.5, SD = 9.4) performed the MOT task in which twelve identical circular objects moved about the display in an independent and unpredictable manner. Two to six objects were designated as targets and the remaining objects were distracters. The same observers also performed a visual search for a target letter (i.e. X or Z) presented together with five non-targets while ignoring centrally presented distracters (i.e. X, Z, or L). Targets differed from non-targets by a unique feature in the low load condition, whereas they shared features in the high load condition. CHRNA4 genotype interacted with processing load in both tasks. Homozygotes for the T allele (N = 62) had better tracking capacity in the MOT task and identified targets faster in the high load trials of the VS task. Conclusion: The results support the hypothesis that the cholinergic system modulates attentional effort, and that common genetic variation can be used to study the molecular biology of cognition.	[Espeseth, Thomas; Sneve, Markus Handal; Laeng, Bruno] Univ Oslo, Dept Psychol, Ctr Study Human Cognit, Oslo, Norway; [Rootwelt, Helge] Oslo Univ Hosp, Rikshosp, Dept Med Biochem, Oslo, Norway	University of Oslo; University of Oslo; National Hospital Norway	Espeseth, T (corresponding author), Univ Oslo, Dept Psychol, Ctr Study Human Cognit, Oslo, Norway.	thomas.espeseth@psykologi.uio.no			Norwegian Research Council [177458/V50]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This study was supported by Norwegian Research Council grant 177458/V50 to Thomas Espeseth. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GA, 2007, J VISION, V7, DOI 10.1167/7.13.14; Beck A.T., 1987, BECK DEPRESSION INVE; Beck DM, 2005, J EXP PSYCHOL HUMAN, V31, P592, DOI 10.1037/0096-1523.31.3.592; Bellgrove MA, 2008, ANN NY ACAD SCI, V1129, P200, DOI 10.1196/annals.1417.013; Bentley P, 2004, NEURON, V41, P969, DOI 10.1016/S0896-6273(04)00145-X; Braff DL, 2004, PSYCHOPHARMACOLOGY, V174, P75, DOI 10.1007/s00213-004-1848-0; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bundesen C, 2005, PSYCHOL REV, V112, P291, DOI 10.1037/0033-295X.112.2.291; Cavanagh P, 2005, TRENDS COGN SCI, V9, P349, DOI 10.1016/j.tics.2005.05.009; Changeux JP, 2010, NAT REV NEUROSCI, V11, P389, DOI 10.1038/nrn2849; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; COULL J, 2005, NEUROBIOLOGY ATTENTI; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; DARK VJ, 1985, J EXP PSYCHOL GEN, V114, P472, DOI 10.1037/0096-3445.114.4.472; Deco G, 2009, EUR J NEUROSCI, V30, P347, DOI 10.1111/j.1460-9568.2009.06833.x; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DINGLEDINE R, 1977, J PHYSIOL-LONDON, V271, P135, DOI 10.1113/jphysiol.1977.sp011994; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Dukas R, 2009, VIENNA SER THEOR BIO, P147; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Espeseth T, 2007, NEUROSCIENCE, V147, P974, DOI 10.1016/j.neuroscience.2007.04.027; Evans DE, 2009, ADDICT BIOL, V14, P32, DOI 10.1111/j.1369-1600.2008.00130.x; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Fan J, 2003, P NATL ACAD SCI USA, V100, P7406, DOI 10.1073/pnas.0732088100; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; FAN J, 2008, TOPICS INTEGRATIVE N; Feng Y, 2004, AM J HUM GENET, V75, P112, DOI 10.1086/422194; Flores CM, 1996, J NEUROSCI, V16, P7892; Forster S, 2007, PSYCHOL SCI, V18, P377, DOI 10.1111/j.1467-9280.2007.01908.x; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Furey ML, 2000, SCIENCE, V290, P2315, DOI 10.1126/science.290.5500.2315; Giessing C, 2006, NEUROSCIENCE, V137, P853, DOI 10.1016/j.neuroscience.2005.10.005; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; Gioanni Y, 1999, EUR J NEUROSCI, V11, P18, DOI 10.1046/j.1460-9568.1999.00403.x; Gitelman DR, 1999, BRAIN, V122, P1093, DOI 10.1093/brain/122.6.1093; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Green AE, 2008, NAT REV NEUROSCI, V9, P710, DOI 10.1038/nrn2461; Greenwood PM, 2009, P NATL ACAD SCI USA, V106, P3633, DOI 10.1073/pnas.0807891106; Greenwood PM, 2009, J COGNITIVE NEUROSCI, V21, P2139, DOI 10.1162/jocn.2008.21164; Greenwood PM, 2005, J COGNITIVE NEUROSCI, V17, P1611, DOI 10.1162/089892905774597281; HAMMOND EJ, 1987, NEUROLOGY, V37, P346, DOI 10.1212/WNL.37.2.346; Han ZY, 2000, EUR J NEUROSCI, V12, P3664, DOI 10.1046/j.1460-9568.2000.00262.x; Hasselmo ME, 2004, PROG BRAIN RES, V145, P207, DOI 10.1016/S0079-6123(03)45015-2; HODA JC, 2007, SOC NEUR M NOV 3 7 S; Horowitz TS, 1998, NATURE, V394, P575, DOI 10.1038/29068; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; Jacobsen LK, 2007, NEUROPSYCHOPHARMACOL, V32, P2453, DOI 10.1038/sj.npp.1301398; Jacobsen LK, 2006, NEUROPSYCHOPHARMACOL, V31, P1550, DOI 10.1038/sj.npp.1300981; KAHNEMAN D, 1983, J EXP PSYCHOL HUMAN, V9, P497, DOI 10.1037/0096-1523.9.4.497; Kahneman D., 1973, ATTENTION EFFORT; Kosslyn SM, 2002, AM PSYCHOL, V57, P341, DOI 10.1037//0003-066X.57.5.341; Kozak R, 2006, CEREB CORTEX, V16, P9, DOI 10.1093/cercor/bhi079; LABERGE D, 1990, J NEUROSCI, V10, P613; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Lavie N, 1997, PSYCHOL SCI, V8, P395, DOI 10.1111/j.1467-9280.1997.tb00432.x; Lawrence NS, 2002, NEURON, V36, P539, DOI 10.1016/S0896-6273(02)01004-8; Lena C, 1998, J PHYSIOL-PARIS, V92, P63, DOI 10.1016/S0928-4257(98)80140-X; Levin ED, 2007, BIOCHEM PHARMACOL, V74, P1182, DOI 10.1016/j.bcp.2007.07.019; Markett SA, 2010, J COGNITIVE NEUROSCI, V22, P1944, DOI 10.1162/jocn.2009.21354; Marutle A, 1999, J NEUROCHEM, V72, P1161, DOI 10.1046/j.1471-4159.2000.0721161.x; Meinke A, 2006, NEUROSCIENCE, V141, P201, DOI 10.1016/j.neuroscience.2006.03.072; MESULAM MM, 1995, ANN NY ACAD SCI, V757, P169, DOI 10.1111/j.1749-6632.1995.tb17472.x; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; MESULAM MM, 1990, PROG BRAIN RES, V84, P231; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Mier D, 2010, MOL PSYCHIATR, V15, P918, DOI 10.1038/mp.2009.36; MILLER J, 1991, PERCEPT PSYCHOPHYS, V49, P270, DOI 10.3758/BF03214311; MORAY N, 1967, ACTA PSYCHOL, V27, P84, DOI 10.1016/0001-6918(67)90048-0; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90066-8; NORDBERG A, 2006, BRAIN CHOLINERGIC SY, P181; Oksama L, 2004, VIS COGN, V11, P631, DOI 10.1080/13506280344000473; Parasuraman R, 2005, PSYCHOL SCI, V16, P200, DOI 10.1111/j.0956-7976.2005.00804.x; Parikh V, 2008, J NEUROSCI, V28, P3769, DOI 10.1523/JNEUROSCI.5251-07.2008; Parikh V, 2008, ANN NY ACAD SCI, V1129, P225, DOI 10.1196/annals.1417.021; Parikh V, 2007, NEURON, V56, P141, DOI 10.1016/j.neuron.2007.08.025; PEAVLER WS, 1974, PSYCHOPHYSIOLOGY, V11, P559, DOI 10.1111/j.1469-8986.1974.tb01114.x; PETERSEN SE, 1987, NEUROPSYCHOLOGIA, V25, P97, DOI 10.1016/0028-3932(87)90046-7; Phillips JM, 2000, PSYCHOPHARMACOLOGY, V150, P112, DOI 10.1007/s002130000437; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Sarter M, 2006, BRAIN RES REV, V51, P145, DOI 10.1016/j.brainresrev.2005.11.002; Schneider W., 2002, E PRIME VERSION 20 C; Scholl BJ, 2009, COMPUTATION, COGNITION, AND PYLYSHYN, P49; Steinlein OK, 2008, BIOCHEM PHARMACOL, V76, P1175, DOI 10.1016/j.bcp.2008.07.012; Steinlein OK, 1997, HUM MOL GENET, V6, P943, DOI 10.1093/hmg/6.6.943; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Thiel CM, 2005, NEUROPSYCHOPHARMACOL, V30, P810, DOI 10.1038/sj.npp.1300633; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; UNDERWOOD BJ, 1975, AM PSYCHOL, V30, P128, DOI 10.1037/h0076759; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Weiser M, 2004, AM J PSYCHIAT, V161, P1219, DOI 10.1176/appi.ajp.161.7.1219; Winterer G, 2007, HUM MOL GENET, V16, P2165, DOI 10.1093/hmg/ddm168; Winterer G, 2010, CURR OPIN PSYCHIATR, V23, P112, DOI 10.1097/YCO.0b013e3283366643; Witte EA, 1997, PSYCHOPHARMACOLOGY, V132, P324, DOI 10.1007/s002130050352; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411; YANTIS S, 1990, J EXP PSYCHOL HUMAN, V16, P135, DOI 10.1037/0096-1523.16.1.135; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	103	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14407	10.1371/journal.pone.0014407	http://dx.doi.org/10.1371/journal.pone.0014407			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203548	Green Published, Green Submitted, gold			2022-12-27	WOS:000285578000013
J	Krug, AZ; Jablonski, D; Roy, K; Beu, AG				Krug, Andrew Z.; Jablonski, David; Roy, Kaustuv; Beu, Alan G.			Differential Extinction and the Contrasting Structure of Polar Marine Faunas	PLOS ONE			English	Article							LATITUDINAL DIVERSITY GRADIENT; ARCTIC-OCEAN; EVOLUTIONARY DYNAMICS; NORTHERN ALASKA; BIODIVERSITY; PATTERNS; ANTARCTICA; BIVALVES; CLIMATE; EOCENE	Background: The low taxonomic diversity of polar marine faunas today reflects both the failure of clades to colonize or diversify in high latitudes and regional extinctions of once-present clades. However, simple models of polar evolution are made difficult by the strikingly different faunal compositions and community structures of the two poles. Methodology/Principal Findings: A comparison of early Cenozoic Arctic and Antarctic bivalve faunas with modern ones, within the framework of a molecular phylogeny, shows that while Arctic losses were randomly distributed across the tree, Antarctic losses were significantly concentrated in more derived families, resulting in communities dominated by basal lineages. Potential mechanisms for the phylogenetic structure to Antarctic extinctions include continental isolation, changes in primary productivity leading to turnover of both predators and prey, and the effect of glaciation on shelf habitats. Conclusions/Significance: These results show that phylogenetic consequences of past extinctions can vary substantially among regions and thus shape regional faunal structures, even when due to similar drivers, here global cooling, and provide the first phylogenetic support for the "retrograde" hypothesis of Antarctic faunal evolution.	[Krug, Andrew Z.; Jablonski, David] Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; [Roy, Kaustuv] Univ Calif San Diego, Div Biol, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA; [Beu, Alan G.] Inst Geol & Nucl Sci Ltd, Lower Hutt, New Zealand	University of Chicago; University of California System; University of California San Diego; GNS Science - New Zealand	Krug, AZ (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.	akrug@uchicago.edu			NASA Astrobiology; National Science Foundation	NASA Astrobiology; National Science Foundation(National Science Foundation (NSF))	This research was supported by grants from NASA Astrobiology and the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson RB, 2001, AM ZOOL, V41, P27, DOI 10.1668/0003-1569(2001)041[0027:GCCATO]2.0.CO;2; Aronson RB, 1997, GEOLOGY, V25, P903, DOI 10.1130/0091-7613(1997)025<0903:RCSITL>2.3.CO;2; Aronson RB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004385; Arrigo KR, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004551; Barnes DKA, 2006, GLOBAL ECOL BIOGEOGR, V15, P121, DOI 10.1111/j.1466-822x.2006.00216.x; BERKE S, 2010, COMMUNICATION; Beu AG, 2009, PALAEOGEOGR PALAEOCL, V284, P191, DOI 10.1016/j.palaeo.2009.09.025; Bieler R, 2006, ZOOL J LINN SOC-LOND, V148, P223, DOI 10.1111/j.1096-3642.2006.00255.x; Brinkhuis H, 2006, NATURE, V441, P606, DOI 10.1038/nature04692; BROUWERS EM, 1993, PALAIOS, V8, P140, DOI 10.2307/3515168; Carr ME, 2006, DEEP-SEA RES PT II, V53, P741, DOI 10.1016/j.dsr2.2006.01.028; Clarke A, 2003, TRENDS ECOL EVOL, V18, P573, DOI 10.1016/j.tree.2003.08.007; Clarke A, 2005, TRENDS ECOL EVOL, V20, P1, DOI 10.1016/j.tree.2004.10.004; Clarke A, 2010, PHILOS T R SOC B, V365, P3655, DOI 10.1098/rstb.2010.0270; Clarke A, 2008, J EXP MAR BIOL ECOL, V366, P48, DOI 10.1016/j.jembe.2008.07.008; Dayton P.K., 1990, P631; DAYTON PK, 1994, AM ZOOL, V34, P90; Dierssen HM, 2010, P NATL ACAD SCI USA, V107, P17073, DOI 10.1073/pnas.0913800107; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; FREDERIKSEN NO, 2000, 00493136 US GEOL SUR; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; Golonka J, 2003, MAR PETROL GEOL, V20, P211, DOI 10.1016/S0264-8172(03)00043-6; HAIN S, 1992, POLAR BIOL, V12, P303; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Ivany LC, 2008, GEOL SOC AM BULL, V120, P659, DOI 10.1130/B26269.1; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Kembel S. W., 2010, PICANTE R TOOLS INTE; Krug AZ, 2009, ASTROBIOLOGY, V9, P113, DOI 10.1089/ast.2008.0253; Linse K, 2006, DEEP-SEA RES PT II, V53, P985, DOI 10.1016/j.dsr2.2006.05.003; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; Mace GM, 2003, SCIENCE, V300, P1707, DOI 10.1126/science.1085510; MARINCOVICH L, 1993, J PALEONTOL, V67, P1; McClain CR, 2005, MAR ECOL PROG SER, V297, P181, DOI 10.3354/meps297181; Miller A.I, 2007, PRINCIPLES PALEONTOL; Moran K, 2006, NATURE, V441, P601, DOI 10.1038/nature04800; Orme C. D. L., 2009, CAIC COMP ANAL USING; Page TJ, 2002, POLAR BIOL, V25, P818, DOI 10.1007/s00300-002-0414-7; Phillips RL, 2003, CRETACEOUS RES, V24, P499, DOI 10.1016/S0195-6671(03)00068-5; Piepenburg D, 2005, POLAR BIOL, V28, P733, DOI 10.1007/s00300-005-0013-5; Poulin E, 2002, TRENDS ECOL EVOL, V17, P218, DOI 10.1016/S0169-5347(02)02493-X; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; R Core Team, 2018, R LANG ENV STAT COMP; RAUP DM, 1991, ANAL PALEOBIOLOGY SH, V4, P207; Ricklefs Robert E., 1993, P350; Roy K, 2000, P NATL ACAD SCI USA, V97, P13150, DOI 10.1073/pnas.97.24.13150; Roy K, 1998, P NATL ACAD SCI USA, V95, P3699, DOI 10.1073/pnas.95.7.3699; Roy K, 2009, SCIENCE, V325, P733, DOI 10.1126/science.1173073; Sastry A.N., 1979, P113; Smetacek V, 2005, NATURE, V437, P362, DOI 10.1038/nature04161; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stilwell JD, 2003, PALAEOGEOGR PALAEOCL, V195, P319, DOI 10.1016/S0031-0182(03)00364-X; Taylor JD, 2007, J MAR BIOL ASSOC UK, V87, P565, DOI 10.1017/S0025315407054409; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Valentine JW, 2008, PALEOBIOLOGY, V34, P169, DOI 10.1666/0094-8373(2008)034[0169:IDALG]2.0.CO;2; Valentine James W., 2009, P3; Vermeij G.J, 1987, EVOLUTION ESCALATION; VERMEIJ GJ, 1991, PALEOBIOLOGY, V17, P281, DOI 10.1017/S0094837300010617; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zelaya DG, 2005, SCI MAR, V69, P113, DOI 10.3989/scimar.2005.69s2113	59	27	28	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15362	10.1371/journal.pone.0015362	http://dx.doi.org/10.1371/journal.pone.0015362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203524	Green Published, Green Submitted, gold			2022-12-27	WOS:000285578000031
J	Li, FX; Yang, ZL; Lu, Y; Wei, Y; Wang, JH; Yin, DZ; He, RQ				Li, Fangxu; Yang, Zhilai; Lu, Yang; Wei, Yan; Wang, Jinhui; Yin, Dazhong; He, Rongqiao			Malondialdehyde Suppresses Cerebral Function by Breaking Homeostasis between Excitation and Inhibition in Turtle Trachemys scripta	PLOS ONE			English	Article							LIPID-PEROXIDATION; SLEEP-DEPRIVATION; MAILLARD REACTION; OXIDATIVE STRESS; REACTIVE OXYGEN; IN-VITRO; BRAIN; MECHANISMS; DAMAGE; MALONALDEHYDE	The levels of malondialdehyde (MDA) are high in the brain during carbonyl stress, such as following daily activities and sleep deprivation. To examine our hypothesis that MDA is one of the major substances in the brain leading to fatigue, the influences of MDA on brain functions and neuronal encodings in red-eared turtle (Trachemys scripta) were studied. The intrathecal injections of MDA brought about sleep-like EEG and fatigue-like behaviors in a dose-dependent manner. These changes were found associated with the deterioration of encoding action potentials in cortical neurons. In addition, MDA increased the ratio of gamma-aminobutyric acid to glutamate in turtle's brain, as well as the sensitivity of GABAergic neurons to inputs compared to excitatory neurons. Therefore, MDA, as a metabolic product in the brain, may weaken cerebral function during carbonyl stress through breaking the homeostasis between excitatory and inhibitory neurons.	[Li, Fangxu; Yang, Zhilai; Lu, Yang; Wei, Yan; Wang, Jinhui; He, Rongqiao] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Li, Fangxu; Yin, Dazhong] Hunan Normal Univ, Coll Life Sci, Changsha, Hunan, Peoples R China; [He, Rongqiao] Chinese Acad Sci, Inst Psychol, Lab Mental Hlth, Beijing 100080, Peoples R China; [Lu, Yang] Univ Sci & Technol China, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Hunan Normal University; Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Li, FX (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	dazhongyin@hotmail.com; herq@sun5.ibp.ac.cn			NSFC [30970695]; 973-Projects [2010CB912303, KSCX2-YW-R-119, KSCX2-YW-R-256, 863-2008AA02Z411]	NSFC(National Natural Science Foundation of China (NSFC)); 973-Projects(National Basic Research Program of China)	This work was supported by the NSFC 30970695, 973-Projects 2010CB912303, KSCX2-YW-R-119, KSCX2-YW-R-256 and 863-2008AA02Z411. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboitiz F, 1999, CEREB CORTEX, V9, P783, DOI 10.1093/cercor/9.8.783; ANDERSEN P, 1974, HDB ELECTROENCEPHALO; Annunziato L, 2002, NEUROBIOL AGING, V23, P819, DOI 10.1016/S0197-4580(02)00069-6; AYALAGUERRERO F, 1988, PHYSIOL BEHAV, V44, P333, DOI 10.1016/0031-9384(88)90034-0; Beal MF, 2002, FREE RADICAL BIO MED, V32, P797, DOI 10.1016/S0891-5849(02)00780-3; BENTE D, 1979, PHARMAKOPSYCH NEURO, V12, P137, DOI 10.1055/s-0028-1094604; Bettendorff L, 1996, SLEEP, V19, P65, DOI 10.1093/sleep/19.1.65; Bo P, 2003, BRAIN RES PROTOC, V11, P155, DOI 10.1016/S1385-299X(03)00042-4; BUTLER AB, 1980, COMP NEUROLOGY TELEN, P344; Chen N, 2006, BIOCHEM BIOPH RES CO, V340, P151, DOI 10.1016/j.bbrc.2005.11.170; CHIO KS, 1969, BIOCHEMISTRY-US, V8, P2821, DOI 10.1021/bi00835a019; Dalle-Donne I, 2003, TRENDS MOL MED, V9, P169, DOI 10.1016/S1471-4914(03)00031-5; Davi G, 2005, ANTIOXID REDOX SIGN, V7, P256, DOI 10.1089/ars.2005.7.256; ESTERBAUE H, 1990, MEMBRANE LIPID OXIDA, P16; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; ESTERBAUER H, 1992, FREE RADICAL BIO MED, V13, P341, DOI 10.1016/0891-5849(92)90181-F; FINCH CE, 1990, LONGEVITY SENESCENCE, P284; FLANIGAN WF, 1973, ELECTROEN CLIN NEURO, V34, P521, DOI 10.1016/0013-4694(73)90069-2; Floyd RA, 2002, NEUROBIOL AGING, V23, P795, DOI 10.1016/S0197-4580(02)00019-2; FLOYD RA, 1992, ANN NEUROL, V32, pS22, DOI 10.1002/ana.410320706; Fraser SF, 2002, J APPL PHYSIOL, V93, P1650, DOI 10.1152/japplphysiol.01247.2001; Gonzalez J, 1999, AM J PHYSIOL-REG I, V277, pR86, DOI 10.1152/ajpregu.1999.277.1.R86; Griffiths HR, 1996, FEBS LETT, V388, P161, DOI 10.1016/0014-5793(96)00542-X; Guezennec CY, 1998, INT J SPORTS MED, V19, P323, DOI 10.1055/s-2007-971925; HALLIWELL B, 1999, FREE RADICAL BIO MED, P458; JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2; Keller JN, 1997, NEUROSCIENCE, V80, P685, DOI 10.1016/S0306-4522(97)00065-1; KIKUGAWA K, 1981, CHEM PHARM BULL, V29, P3003; KOSUGI H, 1994, BIOL PHARM BULL, V17, P1645; KRIJZER F, 1993, NEUROPSYCHOBIOLOGY, V28, P122, DOI 10.1159/000119015; KRUEGER JM, 1995, BEHAV BRAIN RES, V69, P177, DOI 10.1016/0166-4328(95)00015-L; Lee RS, 2001, J NEUROSCI, V21, P1757; Li FX, 2008, PROG BIOCHEM BIOPHYS, V35, P393; Li GL, 2005, NEUROENDOCRINOL LETT, V26, P61; Li L, 2005, NEUROENDOCRINOL LETT, V26, P799; LINDSLEY DB, 1950, ELECTROEN CLIN NEURO, V2, P483, DOI 10.1016/0013-4694(50)90086-1; Lutz PL, 2003, EXP GERONTOL, V38, P797, DOI 10.1016/S0531-5565(03)00111-6; LUTZ PL, 2003, BRAIN OXYGEN CAUSES, P11; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; MARNETT LJ, 1985, PROSTAGLANDINS, V30, P241, DOI 10.1016/0090-6980(85)90188-1; MONNIER VM, 1991, GERONTOLOGY, V37, P152; Nie CL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000629; O'Brien PJ, 2005, CRIT REV TOXICOL, V35, P609, DOI 10.1080/10408440591002183; Piepponen TP, 2001, J CHROMATOGR B, V757, P277, DOI 10.1016/S0378-4347(01)00156-6; REINER A, 1993, COMP BIOCHEM PHYS A, V104, P735, DOI 10.1016/0300-9629(93)90149-X; Thomas M, 2000, J SLEEP RES, V9, P335, DOI 10.1046/j.1365-2869.2000.00225.x; Thorpe SR, 2003, AMINO ACIDS, V25, P275, DOI 10.1007/s00726-003-0017-9; TSAI LL, 1993, BRAIN RES, V602, P221, DOI 10.1016/0006-8993(93)90686-H; Venditti P, 1996, ARCH BIOCHEM BIOPHYS, V331, P63, DOI 10.1006/abbi.1996.0283; Wang Sheng-Xu, 2002, Di Yi Jun Yi Da Xue Xue Bao, V22, P888; Yin DZ, 2005, EXP GERONTOL, V40, P455, DOI 10.1016/j.exger.2005.03.012; Yin DZ, 1996, FREE RADICAL BIO MED, V21, P871, DOI 10.1016/0891-5849(96)00175-X; Yin DZ, 1995, GERONTOLOGY, V41, P159; Yoyama Y., 1995, ADV EUROL SCI, V39, P14	54	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15325	10.1371/journal.pone.0015325	http://dx.doi.org/10.1371/journal.pone.0015325			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203547	Green Published, gold, Green Submitted			2022-12-27	WOS:000285578000028
J	Belgiovine, C; Frapolli, R; Bonezzi, K; Chiodi, I; Favero, F; Mello-Grand, M; Dei Tos, AP; Giulotto, E; Taraboletti, G; D'Incalci, M; Mondello, C				Belgiovine, Cristina; Frapolli, Roberta; Bonezzi, Katiuscia; Chiodi, Ilaria; Favero, Francesco; Mello-Grand, Maurizia; Dei Tos, Angelo P.; Giulotto, Elena; Taraboletti, Giulia; D'Incalci, Maurizio; Mondello, Chiara			Reduced Expression of the ROCK Inhibitor Rnd3 Is Associated with Increased Invasiveness and Metastatic Potential in Mesenchymal Tumor Cells	PLOS ONE			English	Article							RHO-GTPASES; IN-VIVO; INVASION; MIGRATION; MOTILITY; MECHANISMS; PLASTICITY; SARCOMA; ACTIVATION; MODES	Background: Mesenchymal and amoeboid movements are two important mechanisms adopted by cancer cells to invade the surrounding environment. Mesenchymal movement depends on extracellular matrix protease activity, amoeboid movement on the RhoA-dependent kinase ROCK. Cancer cells can switch from one mechanism to the other in response to different stimuli, limiting the efficacy of antimetastatic therapies. Methodology and Principal Findings: We investigated the acquisition and molecular regulation of the invasion capacity of neoplastically transformed human fibroblasts, which were able to induce sarcomas and metastases when injected into immunocompromised mice. We found that neoplastic transformation was associated with a change in cell morphology (from fibroblastic to polygonal), a reorganization of the actin cytoskeleton, a decrease in the expression of several matrix metalloproteases and increases in cell motility and invasiveness. In a three-dimensional environment, sarcomagenic cells showed a spherical morphology with cortical actin rings, suggesting a switch from mesenchymal to amoeboid movement. Accordingly, cell invasion decreased after treatment with the ROCK inhibitor Y27632, but not with the matrix protease inhibitor Ro 28-2653. The increased invasiveness of tumorigenic cells was associated with reduced expression of Rnd3 (also known as RhoE), a cellular inhibitor of ROCK. Indeed, ectopic Rnd3 expression reduced their invasive ability in vitro and their metastatic potential in vivo. Conclusions: These results indicate that, during neoplastic transformation, cells of mesenchymal origin can switch from a mesenchymal mode of movement to an amoeboid one. In addition, they point to Rnd3 as a possible regulator of mesenchymal tumor cell invasion and to ROCK as a potential therapeutic target for sarcomas.	[Belgiovine, Cristina; Chiodi, Ilaria; Mondello, Chiara] CNR, Ist Genet Mol, I-27100 Pavia, Italy; [Frapolli, Roberta; D'Incalci, Maurizio] Ist Ric Farmacol Mario Negri, Milan, Italy; [Bonezzi, Katiuscia; Taraboletti, Giulia] Ist Ric Farmacol Mario Negri, Bergamo, Italy; [Favero, Francesco; Mello-Grand, Maurizia] Fdn Edo Elvo Tempia, Canc Genom Lab, Biella, Italy; [Dei Tos, Angelo P.] Osped Gen Treviso, Treviso, Italy; [Giulotto, Elena] Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; ULSS 2 Marca TV; Ospedale Ca' Foncello Treviso; University of Pavia	Belgiovine, C (corresponding author), CNR, Ist Genet Mol, I-27100 Pavia, Italy.	mondello@igm.cnr.it	Frapolli, Roberta/AAA-6729-2020; Taraboletti, Giulia/J-4089-2018; Mondello, Chiara/B-8305-2015; Belgiovine, Cristina/E-4575-2015; Dei Tos, Angelo/AAN-3244-2020; D'Incalci, Maurizio/AAA-9021-2020	Frapolli, Roberta/0000-0003-2907-273X; Taraboletti, Giulia/0000-0001-8780-5001; Mondello, Chiara/0000-0002-8379-9246; Belgiovine, Cristina/0000-0002-6986-9594; Dei Tos, Angelo/0000-0002-1228-8940; D'Incalci, Maurizio/0000-0001-8784-1360; CHIODI, ILARIA/0000-0002-4734-4017; Favero, Francesco/0000-0003-3684-2659; GIULOTTO, ELENA/0000-0002-4705-2049	Fondazione Cariplo [2006-0734]	Fondazione Cariplo(Fondazione Cariplo)	This work was supported by Fondazione Cariplo (grant 2006-0734). I.C. post-doctoral fellowship has been supported by Fondazione Cariplo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belletti B, 2008, MOL BIOL CELL, V19, P2003, DOI 10.1091/mbc.E07-09-0894; Belletti B, 2010, MOL CELL BIOL, V30, P2229, DOI 10.1128/MCB.00723-09; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carragher NO, 2006, ONCOGENE, V25, P5726, DOI 10.1038/sj.onc.1209582; Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; Deaglio S, 2007, BLOOD, V110, p244B; Farina KL, 1998, CANCER RES, V58, P2528; Frame MC, 2002, CURR OPIN GENET DEV, V12, P36, DOI 10.1016/S0959-437X(01)00261-1; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gadea G, 2008, CURR BIOL, V18, P1456, DOI 10.1016/j.cub.2008.08.053; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Guasch RM, 1998, MOL CELL BIOL, V18, P4761, DOI 10.1128/MCB.18.8.4761; Haldar M, 2008, CLIN ORTHOP RELAT R, V466, P2156, DOI 10.1007/s11999-008-0340-2; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Klein RM, 2009, CANCER RES, V69, P2224, DOI 10.1158/0008-5472.CAN-08-3201; Maga G, 2008, P NATL ACAD SCI USA, V105, P20689, DOI 10.1073/pnas.0811241106; MICUDA S, CURR CANC DRUG TARGE, V10, P127; Molloy TJ, 2008, BREAST CANCER RES TR, V112, P297, DOI 10.1007/s10549-007-9872-5; Mondello C, 2003, BIOCHEM BIOPH RES CO, V308, P914, DOI 10.1016/S0006-291X(03)01484-0; Pankova K, 2010, CELL MOL LIFE SCI, V67, P63, DOI 10.1007/s00018-009-0132-1; Parri M, 2009, CANCER RES, V69, P2072, DOI 10.1158/0008-5472.CAN-08-1845; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Podsypanina K, 2008, SCIENCE, V321, P1841, DOI 10.1126/science.1161621; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Riento K, 2005, EMBO J, V24, P1170, DOI 10.1038/sj.emboj.7600612; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Riento K, 2005, BIOCHEM SOC T, V33, P649, DOI 10.1042/BST0330649; Rosel D, 2008, MOL CANCER RES, V6, P1410, DOI 10.1158/1541-7786.MCR-07-2174; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Steinbauer M, 2003, CLIN EXP METASTAS, V20, P135, DOI 10.1023/A:1022618909921; Taraboletti G, 2004, EUR J CANCER, V40, P881, DOI 10.1016/j.ejca.2004.01.002; Villalonga P, 2004, MOL CELL BIOL, V24, P7829, DOI 10.1128/MCB.24.18.7829-7840.2004; Weinberg RA, 2008, CANCER CELL, V14, P283, DOI 10.1016/j.ccr.2008.09.009; Weinberg RA, 2008, APMIS, V116, P548, DOI 10.1111/j.1600-0463.2008.001168.x; Weinberg RA, 2008, CARCINOGENESIS, V29, P1092, DOI 10.1093/carcin/bgn104; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wyckoff JB, 2000, CANCER RES, V60, P2504; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Zongaro S, 2005, CANCER RES, V65, P11411, DOI 10.1158/0008-5472.CAN-05-1140	47	41	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14154	10.1371/journal.pone.0014154	http://dx.doi.org/10.1371/journal.pone.0014154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21209796	Green Published, Green Submitted, gold			2022-12-27	WOS:000284755100032
J	Cinova, J; De Palma, G; Stepankova, R; Kofronova, O; Kverka, M; Sanz, Y; Tuckova, L				Cinova, Jana; De Palma, Giada; Stepankova, Renata; Kofronova, Olga; Kverka, Miloslav; Sanz, Yolanda; Tuckova, Ludmila			Role of Intestinal Bacteria in Gliadin-Induced Changes in Intestinal Mucosa: Study in Germ-Free Rats	PLOS ONE			English	Article							CELIAC-DISEASE; ALTERED EXPRESSION; MATRIX METALLOPROTEINASES; MICROBIAL-FLORA; COLONIC MUCINS; GOBLET CELLS; INNATE; DEFENSE; GUT; TRANSGLUTAMINASE	Background and Aims: Celiac disease (CD) is a chronic inflammatory disorder of the small intestine that is induced by dietary wheat gluten proteins (gliadins) in genetically predisposed individuals. The overgrowth of potentially pathogenic bacteria and infections has been suggested to contribute to CD pathogenesis. We aimed to study the effects of gliadin and various intestinal bacterial strains on mucosal barrier integrity, gliadin translocation, and cytokine production. Methodology/Principal Findings: Changes in gut mucosa were assessed in the intestinal loops of inbred Wistar-AVN rats that were reared under germ-free conditions in the presence of various intestinal bacteria (enterobacteria and bifidobacteria isolated from CD patients and healthy children, respectively) and CD-triggering agents (gliadin and IFN-gamma) by histology, scanning electron microscopy, immunofluorescence, and a rat cytokine antibody array. Adhesion of the bacterial strains to the IEC-6 rat cell line was evaluated in vitro. Gliadin fragments alone or together with the proinflammatory cytokine interferon (IFN)-gamma significantly decreased the number of goblet cells in the small intestine; this effect was more pronounced in the presence of Escherichia coli CBL2 and Shigella CBD8. Shigella CBD8 and IFN-gamma induced the highest mucin secretion and greatest impairment in tight junctions and, consequently, translocation of gliadin fragments into the lamina propria. Shigella CBD8 and E. coli CBL2 strongly adhered to IEC-6 epithelial cells. The number of goblet cells in small intestine increased by the simultaneous incubation of Bifidobacterium bifidum IATA-ES2 with gliadin, IFN-gamma and enterobacteria. B. bifidum IATA-ES2 also enhanced the production of chemotactic factors and inhibitors of metalloproteinases, which can contribute to gut mucosal protection. Conclusions: Our results suggest that the composition of the intestinal microbiota affects the permeability of the intestinal mucosa and, consequently, could be involved in the early stages of CD pathogenesis.	[Cinova, Jana; Stepankova, Renata; Kofronova, Olga; Kverka, Miloslav; Tuckova, Ludmila] Acad Sci Czech Republ, Dept Immunol, Inst Microbiol Vvi, Prague, Czech Republic; [De Palma, Giada; Sanz, Yolanda] Natl Spanish Res Council CSIC, IATA, Microbial Ecophysiol & Nutr Grp, Valencia, Spain	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA)	Cinova, J (corresponding author), Acad Sci Czech Republ, Dept Immunol, Inst Microbiol Vvi, Prague, Czech Republic.	Cinova7@seznam.cz	De Palma, Giada/AAP-8806-2020; Kofroňová, Olga/H-7239-2014; Gajdosova, Jana/AAP-5872-2020; Kverka, Miloslav/H-2507-2014; stepankova, renata/J-9735-2014; Sanz, Yolanda/H-5498-2012	De Palma, Giada/0000-0002-2063-7741; Kofroňová, Olga/0000-0002-5435-4088; Kverka, Miloslav/0000-0002-1335-5252; stepankova, renata/0000-0001-7504-6300; Sanz, Yolanda/0000-0002-1615-1976	Grant Agency of the Czech Republic [310/07/0414, 303/08/0367, P304/10/P406]; Academy of Sciences [IAA500200801, IAA500200710, KJB50020094]; Ministry of Education [AV CR-C.S.I.C. 09/10, 2B06155]; Institutional Research Concept [AVOZ50200510]; Consejo Superior de Investigaciones Cientificas (CSIC, Spain) [2006CZ0030, 2008CZ0023]; Spanish Ministry of Science and Innovation [AGL2008-01440/ALI, CSD2007-00063]; Junta de Ampliacion de Estudios - Consejo Superior de Investigaciones Cientificas (JAE-CSIC; Spain)	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Academy of Sciences(Egyptian Academy of Scientific Research & Technology (ASRT)); Ministry of Education; Institutional Research Concept; Consejo Superior de Investigaciones Cientificas (CSIC, Spain); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Ampliacion de Estudios - Consejo Superior de Investigaciones Cientificas (JAE-CSIC; Spain)	This work was supported by grants 310/07/0414, 303/08/0367, P304/10/P406 of the Grant Agency of the Czech Republic; IAA500200801, IAA500200710, KJB50020094 of the Academy of Sciences; AV CR-C.S.I.C. 09/10, Project 2B06155 of the Ministry of Education; and Institutional Research Concept AVOZ50200510. This work was also supported by grants 2006CZ0030 and 2008CZ0023 from Consejo Superior de Investigaciones Cientificas (CSIC, Spain) and AGL2008-01440/ALI and Consolider Fun-C-Food CSD2007-00063 from the Spanish Ministry of Science and Innovation. The scholarship to G. De Palma from Junta de Ampliacion de Estudios - Consejo Superior de Investigaciones Cientificas (JAE-CSIC; Spain) is fully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcelo A, 2000, GUT, V46, P218, DOI 10.1136/gut.46.2.218; BARRESI G, 1988, HISTOCHEMISTRY, V88, P105, DOI 10.1007/BF00493292; Beauchesne E, 2009, NEUROCHEM INT, V55, P275, DOI 10.1016/j.neuint.2009.03.014; Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; Collado MC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-232; Ciccocioppo R, 2006, AM J CLIN PATHOL, V125, P502, DOI 10.1309/DTYRA91G8R0KTM8M; Cinova J, 2007, J CLIN IMMUNOL, V27, P201, DOI 10.1007/s10875-006-9061-z; Collado MC, 2009, J CLIN PATHOL, V62, P264, DOI 10.1136/jcp.2008.061366; Collado Maria Carmen, 2007, Curr Issues Intest Microbiol, V8, P9; CRABTREE JE, 1989, GUT, V30, P1339, DOI 10.1136/gut.30.10.1339; Daum S, 1999, GUT, V44, P17, DOI 10.1136/gut.44.1.17; De Palma G, 2010, J LEUKOCYTE BIOL, V87, P765, DOI 10.1189/jlb.0709471; Deplancke B, 2001, AM J CLIN NUTR, V73, p1131S; Dharmani P, 2009, J INNATE IMMUN, V1, P123, DOI 10.1159/000163037; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Drago S, 2006, SCAND J GASTROENTERO, V41, P408, DOI 10.1080/00365520500235334; Dubois PC, 2008, CLIN EXP IMMUNOL, V153, P162, DOI 10.1111/j.1365-2249.2008.03704.x; Enss ML, 1996, SCAND J GASTROENTERO, V31, P868, DOI 10.3109/00365529609051994; ENSS ML, 1992, J EXP ANIM SCI, V35, P110; Fina D, 2008, GUT, V57, P887, DOI 10.1136/gut.2007.129882; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Forsberg G, 2004, AM J GASTROENTEROL, V99, P894, DOI 10.1111/j.1572-0241.2004.04157.x; Izquierdo E, 2008, CURR MICROBIOL, V56, P613, DOI 10.1007/s00284-008-9135-7; Kandori H, 1996, EXP ANIM TOKYO, V45, P155, DOI 10.1538/expanim.45.155; Kopecny J, 2008, FOLIA MICROBIOL, V53, P214, DOI 10.1007/s12223-008-0028-8; Kverka M, 2007, CLIN CHEM, V53, P955, DOI 10.1373/clinchem.2006.077107; Lindfors K, 2008, CLIN EXP IMMUNOL, V152, P552, DOI 10.1111/j.1365-2249.2008.03635.x; Maiuri L, 2005, GASTROENTEROLOGY, V129, P1400, DOI 10.1053/j.gastro.2005.07.054; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Medina M, 2007, CLIN EXP IMMUNOL, V150, P531, DOI 10.1111/j.1365-2249.2007.03522.x; Meresse B, 2008, GUT, V57, P879, DOI 10.1136/gut.2007.141994; Nadal I, 2007, J MED MICROBIOL, V56, P1669, DOI 10.1099/jmm.0.47410-0; Palova-Jelinkova L, 2005, J IMMUNOL, V175, P7038, DOI 10.4049/jimmunol.175.10.7038; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Salmela MT, 2002, GUT, V51, P540, DOI 10.1136/gut.51.4.540; Sanchez E, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-50; Sander GR, 2005, FEBS LETT, V579, P4851, DOI 10.1016/j.febslet.2005.07.066; SARTOR RB, 1994, GASTROENTEROLOGY, V106, P533, DOI 10.1016/0016-5085(94)90614-9; Schuppan D, 2009, GASTROENTEROLOGY, V137, P1912, DOI 10.1053/j.gastro.2009.09.008; Sepp E, 1997, ACTA PAEDIATR, V86, P956, DOI 10.1111/j.1651-2227.1997.tb15178.x; Shan L, 2004, BIOCHEM J, V383, P311, DOI 10.1042/BJ20040907; SHARMA R, 1995, GUT, V36, P209, DOI 10.1136/gut.36.2.209; SHARMA R, 1995, DIGEST DIS SCI, V35, P110; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; Stepankova R, 1996, SCAND J GASTROENTERO, V31, P551, DOI 10.3109/00365529609009127; STEPANKOVA R, 1979, FOLIA MICROBIOL, V24, P11, DOI 10.1007/BF02927241; Stepniak D, 2006, HUM IMMUNOL, V67, P460, DOI 10.1016/j.humimm.2006.03.011; Tlaskalova-Hogenova H, 2002, INT ARCH ALLERGY IMM, V128, P77, DOI 10.1159/000059397; Tripathi A, 2009, P NATL ACAD SCI USA, V106, P16799, DOI 10.1073/pnas.0906773106; Tuckova L, 2000, J LEUKOCYTE BIOL, V67, P312, DOI 10.1002/jlb.67.3.312; Ukena SN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001308; Vader LW, 2003, GASTROENTEROLOGY, V125, P1105, DOI 10.1016/S0016-5085(03)01204-6; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Visser J, 2009, ANN NY ACAD SCI, V1165, P195, DOI 10.1111/j.1749-6632.2009.04037.x; Wilson M, 2002, BACTERIAL DIS MECH, DOI [10.1017/CBO9781139164665, DOI 10.1017/CBO9781139164665]; Zebrowska A, 2005, MEDIAT INFLAMM, P373, DOI 10.1155/MI.2005.373	56	97	100	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16169	10.1371/journal.pone.0016169	http://dx.doi.org/10.1371/journal.pone.0016169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249146	Green Submitted, Green Published, gold			2022-12-27	WOS:000286515000024
J	Deleyrolle, LP; Ericksson, G; Morrison, BJ; Lopez, JA; Burrage, K; Burrage, P; Vescovi, A; Rietze, RL; Reynolds, BA				Deleyrolle, Loic P.; Ericksson, Geoffery; Morrison, Brian J.; Lopez, J. Alejandro; Burrage, Kevin; Burrage, Pamela; Vescovi, Angelo; Rietze, Rodney L.; Reynolds, Brent A.			Determination of Somatic and Cancer Stem Cell Self-Renewing Symmetric Division Rate Using Sphere Assays	PLOS ONE			English	Article							IN-VITRO PROPAGATION; NEURAL STEM; PROSPECTIVE IDENTIFICATION; TGF-BETA; DIFFERENTIATION; PROLIFERATION; GENERATION; TUMORS; LINES; EGF	Representing a renewable source for cell replacement, neural stem cells have received substantial attention in recent years. The neurosphere assay represents a method to detect the presence of neural stem cells, however owing to a deficiency of specific and definitive markers to identify them, their quantification and the rate they expand is still indefinite. Here we propose a mathematical interpretation of the neurosphere assay allowing actual measurement of neural stem cell symmetric division frequency. The algorithm of the modeling demonstrates a direct correlation between the overall cell fold expansion over time measured in the sphere assay and the rate stem cells expand via symmetric division. The model offers a methodology to evaluate specifically the effect of diseases and treatments on neural stem cell activity and function. Not only providing new insights in the evaluation of the kinetic features of neural stem cells, our modeling further contemplates cancer biology as cancer stem-like cells have been suggested to maintain tumor growth as somatic stem cells maintain tissue homeostasis. Indeed, tumor stem cell's resistance to therapy makes these cells a necessary target for effective treatment. The neurosphere assay mathematical model presented here allows the assessment of the rate malignant stem-like cells expand via symmetric division and the evaluation of the effects of therapeutics on the self-renewal and proliferative activity of this clinically relevant population that drive tumor growth and recurrence.	[Deleyrolle, Loic P.; Reynolds, Brent A.] Univ Florida, McKnight Brain Inst, Dept Neurosurg, Gainesville, FL 32611 USA; [Deleyrolle, Loic P.; Ericksson, Geoffery; Rietze, Rodney L.; Reynolds, Brent A.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Morrison, Brian J.; Lopez, J. Alejandro] Griffith Univ, Brisbane, Qld 4111, Australia; [Morrison, Brian J.; Lopez, J. Alejandro] Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Burrage, Kevin; Burrage, Pamela] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Vescovi, Angelo] Univ Milano Bicocca, Milan, Italy; [Rietze, Rodney L.] Pfizer Regenerat Med, Cambridge, England	State University System of Florida; University of Florida; University of Queensland; Griffith University; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Queensland; University of Milano-Bicocca; Pfizer	Deleyrolle, LP (corresponding author), Univ Florida, McKnight Brain Inst, Dept Neurosurg, Gainesville, FL 32611 USA.	loic.deleyrolle@neurosurgery.ufl.edu; brent.reynolds@neurosurgery.ufl.edu	Burrage, Kevin/J-1289-2012; Lopez, J. Alejandro/P-4129-2019; Vescovi, Angelo Luigi/A-4919-2015; Burrage, Pamela/J-1274-2012; Lopez, J. Alejandro/B-9290-2008	Lopez, J. Alejandro/0000-0001-9370-1516; Vescovi, Angelo Luigi/0000-0002-1742-4112; Lopez, J. Alejandro/0000-0001-9370-1516; Burrage, Kevin/0000-0002-8111-1137	National Institutes of Health (NIH); National Health and Medical Research Council (NHMRC)	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Institutes of Health (NIH) and the National Health and Medical Research Council (NHMRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anderson ARA, 2008, NAT REV CANCER, V8, P227, DOI 10.1038/nrc2329; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Blackmore DG, 2009, STEM CELLS, V27, P2044, DOI 10.1002/stem.120; Boman BM, 2001, CANCER RES, V61, P8408; BOMAN BM, 2007, BIOCH BIOPHYS RES CO; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Dick JE, 2009, NAT BIOTECHNOL, V27, P44, DOI 10.1038/nbt0109-44; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dingli D, 2006, STEM CELLS, V24, P2603, DOI 10.1634/stemcells.2006-0136; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Foroni C, 2007, CANCER RES, V67, P3725, DOI 10.1158/0008-5472.CAN-06-4577; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gold LI, 1999, CRIT REV ONCOGENESIS, V10, P303; GOLMOHAMMADI MG, 2008, STEM CELLS; HALL PA, 1989, DEVELOPMENT, V106, P619; Hill RP, 2006, CANCER RES, V66, P1891, DOI 10.1158/0008-5472.CAN-05-3450; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Louis SA, 2008, STEM CELLS, V26, P988, DOI 10.1634/stemcells.2007-0867; McLenachan S, 2009, GROWTH HORM IGF RES, V19, P212, DOI 10.1016/j.ghir.2008.09.003; Morrison BJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2111; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; OGAWA M, 1993, BLOOD, V81, P2844; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Pluchino S, 2008, BRAIN, V131, P2564, DOI 10.1093/brain/awn198; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Reynolds BA, 2009, CELL STEM CELL, V5, P466, DOI 10.1016/j.stem.2009.10.017; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Weiss S, 1996, J NEUROSCI, V16, P7599; WICHA, 2006, CANCER RES, V66, P1895; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153	49	48	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15844	10.1371/journal.pone.0015844	http://dx.doi.org/10.1371/journal.pone.0015844			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246056	Green Published, gold			2022-12-27	WOS:000286511200019
J	Mori, T; Hirai, M; Kuroiwa, T; Miyagishima, S				Mori, Toshiyuki; Hirai, Makoto; Kuroiwa, Tsuneyoshi; Miyagishima, Shin-ya			The Functional Domain of GCS1-Based Gamete Fusion Resides in the Amino Terminus in Plant and Parasite Species	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; PLASMODIUM-BERGHEI; FERTILIZATION; CHLAMYDOMONAS; CELL; FERTILITY; ENDOSPERM; FUS1; GCS1	Fertilization is one of the most important processes in all organisms utilizing sexual reproduction. In a previous study, we succeeded in identifying a novel male gametic transmembrane protein GCS1 (GENERATIVE CELL SPECIFIC 1), also called HAP2 (HAPLESS 2) in the male-sterile Arabidopsis thaliana mutants, as a factor critical to gamete fusion in flowering plants. Interestingly, GCS1 is highly conserved among various eukaryotes covering plants, protists and invertebrates. Of these organisms, Chlamydomonas (green alga) and Plasmodium (malaria parasite) GCS1s similarly show male gametic expression and gamete fusion function. Since it is generally believed that protein factors controlling gamete fusion have rapidly evolved and different organisms utilize species-specific gamete fusion factors, GCS1 may be an ancient fertilization factor derived from the common ancestor of those organisms above. And therefore, its molecular structure and function are important to understanding the common molecular mechanics of eukaryotic fertilization. In this study, we tried to detect the central functional domain(s) of GCS1, using complementation assay of ArabidopsisGCS1 mutant lines expressing modified GCS1. As a result, the positively-charged C-terminal sequence of this protein is dispensable for gamete fusion, while the highly conserved N-terminal domain is critical to GCS1 function. In addition, in vitro fertilization assay of Plasmodium berghei (mouse malaria parasite) knock-in lines expressing partly truncated GCS1 showed similar results. Those findings above indicate that the extracellular N-terminus alone is sufficient for GCS1-based gamete fusion.	[Mori, Toshiyuki; Miyagishima, Shin-ya] RIKEN, Adv Sci Inst, Miyagishima Initiat Res Unit, Saitama, Japan; [Hirai, Makoto] Gunma Univ, Grad Sch Med, Dept Parasitol, Gunma, Japan; [Kuroiwa, Tsuneyoshi] Rikkyo Univ, Res Informat Ctr Extremophile, Coll Sci, Dept Life Sci, Tokyo 171, Japan	RIKEN; Gunma University; Rikkyo University	Mori, T (corresponding author), RIKEN, Adv Sci Inst, Miyagishima Initiat Res Unit, Saitama, Japan.	moritoshi@riken.jp	Mori, Toshiyuki/F-8488-2013	Miyagishima, Shin-ya/0000-0002-9111-0832; Berger, Frederic/0000-0002-3609-8260	Sumitomo Foundation [090356, 080354];  [21112008];  [22112519];  [21022044];  [20590426]; Grants-in-Aid for Scientific Research [21112008] Funding Source: KAKEN	Sumitomo Foundation; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	1. Sumitomo Foundation to TM (090356) and MH (080354). http://www.sumitomo.or.jp/html/kiso/kisokagaku.htm 2. Grant-in-Aid for Scientific Research on Innovative Areas to T. M. (21112008) and M. H. (22112519). http://www.jsps.go.jp/j-grantsinaid/01_seido/01_shumoku/index.html 3. Grant-in-Aid for Scientific Research on Priority Areas to H. M. (21022044) http://www.jsps.go.jp/j-grantsinaid/01_seido/01_shumoku/index.html 4. Grant-in-Aid for Scientific Research (C) to H. M. (20590426) http://www.jsps.go.jp/j-grantsinaid/01_seido/01_shumoku/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aw SJ, 2010, DEVELOPMENT, V137, P2683, DOI 10.1242/dev.052928; Blagborough AM, 2009, VACCINE, V27, P5187, DOI 10.1016/j.vaccine.2009.06.069; Chen Z, 2008, DEVELOPMENT, V135, P65, DOI 10.1242/dev.010108; Dessens JT, 1999, EMBO J, V18, P6221, DOI 10.1093/emboj/18.22.6221; Faure JE, 2002, PLANT J, V30, P481, DOI 10.1046/j.1365-313X.2002.01305.x; Ferris PJ, 1996, MOL BIOL CELL, V7, P1235, DOI 10.1091/mbc.7.8.1235; Frank AC, 2009, PLANT PHYSIOL, V151, P1390, DOI 10.1104/pp.109.144204; Hirai M, 2008, CURR BIOL, V18, P607, DOI 10.1016/j.cub.2008.03.045; Hirai M, 2010, ACTA TROP, V114, P157, DOI 10.1016/j.actatropica.2009.08.005; Ingouff M, 2009, CURR BIOL, V19, pR19, DOI 10.1016/j.cub.2008.11.025; Ingouff M, 2007, CURR BIOL, V17, P1032, DOI 10.1016/j.cub.2007.05.019; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Johnson MA, 2004, GENETICS, V168, P971, DOI 10.1534/genetics.104.029447; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Liu YJ, 2008, GENE DEV, V22, P1051, DOI 10.1101/gad.1656508; Liu YJ, 2010, DEVELOPMENT, V137, P1473, DOI 10.1242/dev.044743; Misamore MJ, 2003, MOL BIOL CELL, V14, P2530, DOI 10.1091/mbc.E02-12-0790; Mori T, 2006, NAT CELL BIOL, V8, P64, DOI 10.1038/ncb1345; Ron M, 2010, GENE DEV, V24, P1010, DOI 10.1101/gad.1882810; Steele RE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007680; Suzuki G, 2009, PLANT CELL PHYSIOL, V50, P1857, DOI 10.1093/pcp/pcp142; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4; von Besser K, 2006, DEVELOPMENT, V133, P4761, DOI 10.1242/dev.02683; Wong JL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000882; Wong JL, 2010, TRENDS CELL BIOL, V20, P134, DOI 10.1016/j.tcb.2009.12.007	25	34	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15957	10.1371/journal.pone.0015957	http://dx.doi.org/10.1371/journal.pone.0015957			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209845	Green Published, gold, Green Submitted			2022-12-27	WOS:000285838900052
J	Zhang, L; Xiao, H; Karlan, S; Zhou, H; Gross, J; Elashoff, D; Akin, D; Yan, XM; Chia, D; Karlan, B; Wong, DT				Zhang, Lei; Xiao, Hua; Karlan, Scott; Zhou, Hui; Gross, Jenny; Elashoff, David; Akin, David; Yan, Xinmin; Chia, David; Karlan, Beth; Wong, David T.			Discovery and Preclinical Validation of Salivary Transcriptomic and Proteomic Biomarkers for the Non-Invasive Detection of Breast Cancer	PLOS ONE			English	Article							NIPPLE ASPIRATE FLUID; FLIGHT MASS-SPECTROMETRY; ANHYDRASE-IX EXPRESSION; GENE-EXPRESSION; CLINICAL UTILITY; DNA METHYLATION; GROWTH-FACTOR; WOMEN; MARKERS; SERUM	Background: A sensitive assay to identify biomarkers using non-invasively collected clinical specimens is ideal for breast cancer detection. While there are other studies showing disease biomarkers in saliva for breast cancer, our study tests the hypothesis that there are breast cancer discriminatory biomarkers in saliva using de novo discovery and validation approaches. This is the first study of this kind and no other study has engaged a de novo biomarker discovery approach in saliva for breast cancer detection. In this study, a case-control discovery and independent preclinical validations were conducted to evaluate the performance and translational utilities of salivary transcriptomic and proteomic biomarkers for breast cancer detection. Methodology/Principal Findings: Salivary transcriptomes and proteomes of 10 breast cancer patients and 10 matched controls were profiled using Affymetrix HG-U133-Plus-2.0 Array and two-dimensional difference gel electrophoresis (2D-DIGE), respectively. Preclinical validations were performed to evaluate the discovered biomarkers in an independent sample cohort of 30 breast cancer patients and 63 controls using RT-qPCR (transcriptomic biomarkers) and quantitative protein immunoblot (proteomic biomarkers). Transcriptomic and proteomic profiling revealed significant variations in salivary molecular biomarkers between breast cancer patients and matched controls. Eight mRNA biomarkers and one protein biomarker, which were not affected by the confounding factors, were pre-validated, yielding an accuracy of 92% (83% sensitive, 97% specific) on the preclinical validation sample set. Conclusions: Our findings support that transcriptomic and proteomic signatures in saliva can serve as biomarkers for the non-invasive detection of breast cancer. The salivary biomarkers possess discriminatory power for the detection of breast cancer, with high specificity and sensitivity, which paves the way for prediction model validation study followed by pivotal clinical validation.	[Zhang, Lei; Xiao, Hua; Zhou, Hui; Akin, David; Yan, Xinmin; Wong, David T.] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA; [Zhang, Lei; Xiao, Hua; Zhou, Hui; Akin, David; Yan, Xinmin; Wong, David T.] Univ Calif Los Angeles, Dent Res Inst, Los Angeles, CA 90024 USA; [Karlan, Scott] Cedars Sinai Med Ctr, Saul & Joyce Brandman Breast Ctr, Los Angeles, CA 90048 USA; [Gross, Jenny; Karlan, Beth] Cedars Sinai Med Ctr, Womens Canc Res Inst, Los Angeles, CA 90048 USA; [Elashoff, David] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90024 USA; [Chia, David] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90024 USA; [Wong, David T.] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol & Oncol, Los Angeles, CA 90024 USA; [Wong, David T.] Univ Calif Los Angeles, David Geffen Sch Med, Div Head & Neck Surg Otolaryngol, Los Angeles, CA 90024 USA; [Wong, David T.] Univ Calif Los Angeles, Henry Samueli Sch Engn & Appl Sci, Los Angeles, CA 90024 USA; [Wong, David T.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Zhang, L (corresponding author), Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA.	leizhang@ucla.edu; dtww@ucla.edu	Lester, Jenny/B-5933-2012; Xiao, Hua/I-7429-2013	Xiao, Hua/0000-0002-2831-0436	National Institutes of Health [UO1DE016275, R21CA126733]; California Breast Cancer Research [16IB-0004]; NATIONAL CANCER INSTITUTE [R21CA126733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [U01DE016275, R01DE017170] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Breast Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants from the National Institutes of Health (UO1DE016275 and R21CA126733) to DTW; and Innovative, Exploratory & Developmental Awards (IDEA) from California Breast Cancer Research Program (16IB-0004) to LZ. URLs: http://www.nih.gov and http://www.cbcrp.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaroe J, BREAST CANC RES, V12, pR7; Abba MC, 2009, CANCER PREV RES, V2, P175, DOI 10.1158/1940-6207.CAPR-08-0104; Anderson KS, 2008, J PROTEOME RES, V7, P1490, DOI 10.1021/pr700804c; Berg WA, 2004, RADIOLOGY, V233, P830, DOI 10.1148/radiol.2333031484; Bigler LR, 2009, CLIN LAB MED, V29, P71, DOI 10.1016/j.cll.2009.01.004; Bigler LR, 2002, J ORAL PATHOL MED, V31, P421, DOI 10.1034/j.1600-0714.2002.00123.x; Brooks MN, 2008, MOL MED REP, V1, P375; Brown NM, 2006, BREAST CANCER RES TR, V97, P41, DOI 10.1007/s10549-005-9085-8; Buehring GC, 2006, BREAST CANCER RES TR, V98, P63, DOI 10.1007/s10549-005-9132-5; Buyse M, 2006, JNCI-J NATL CANCER I, V98, P1183, DOI 10.1093/jnci/djj329; Cheang MCU, 2008, ANNU REV PATHOL-MECH, V3, P67, DOI 10.1146/annurev.pathmechdis.3.121806.151505; Danovi D, 2004, MOL CELL BIOL, V24, P5835, DOI 10.1128/MCB.24.13.5835-5843.2004; Davis MA, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1619; Drukier AK, 2006, J PROTEOME RES, V5, P1906, DOI 10.1021/pr0600834; Duffy MJ, 2006, CLIN CHEM, V52, P345, DOI 10.1373/clinchem.2005.059832; Edgar R, 2006, NAT BIOTECHNOL, V24, P1471, DOI 10.1038/nbt1206-1471; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; Gao K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005875; Gast MCW, 2009, INT J BIOL MARKER, V24, P130, DOI 10.1177/172460080902400302; Gast MCW, 2009, BREAST CANCER RES TR, V116, P17, DOI 10.1007/s10549-008-0263-3; Guffanti A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-163; Hinestrosa MC, 2007, NAT REV CANCER, V7, P309, DOI 10.1038/nrc2113; Hu S, 2008, CLIN CANCER RES, V14, P6246, DOI 10.1158/1078-0432.CCR-07-5037; Hu S, 2007, ARTHRITIS RHEUM-US, V56, P3588, DOI 10.1002/art.22954; Hussain SA, 2007, BRIT J CANCER, V96, P104, DOI 10.1038/sj.bjc.6603530; Jotwani AC, 2009, MOL DIAGN THER, V13, P349, DOI 10.2165/11318220-000000000-00000; Kaufman E, 2002, CRIT REV ORAL BIOL M, V13, P197, DOI 10.1177/154411130201300209; Kuopio T, 1998, CANCER RES, V58, P432; Levenson VV, 2007, BBA-GEN SUBJECTS, V1770, P847, DOI 10.1016/j.bbagen.2007.01.017; Li JN, 2005, CLIN CANCER RES, V11, P8312, DOI 10.1158/1078-0432.CCR-05-1538; Li Y, 2004, CLIN CANCER RES, V10, P8442, DOI 10.1158/1078-0432.CCR-04-1167; Lonneborg A, 2009, EXPERT REV ANTICANC, V9, P1115, DOI [10.1586/era.09.31, 10.1586/ERA.09.31]; Lyakhov IG, 2008, NUCLEIC ACIDS RES, V36, P3828, DOI 10.1093/nar/gkn189; Martens JWM, 2009, FUTURE ONCOL, V5, P1245, DOI [10.2217/fon.09.89, 10.2217/FON.09.89]; Melnikov AA, 2008, J MOL DIAGN, V10, P93, DOI 10.2353/jmoldx.2008.070077; Mikhitarian K, 2005, CLIN CANCER RES, V11, P3697, DOI 10.1158/1078-0432.CCR-04-2164; Morris SR, 2007, CURR OPIN ONCOL, V19, P547, DOI 10.1097/CCO.0b013e3282f0ada3; Nagaraja GM, 2006, ONCOGENE, V25, P2328, DOI 10.1038/sj.onc.1209265; Namkoong J, 2007, CANCER RES, V67, P2298, DOI 10.1158/0008-5472.CAN-06-3665; Navarro MA, 1997, BREAST CANCER RES TR, V42, P83, DOI 10.1023/A:1005755928831; Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736; Pawlik TM, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-68; Pepe MS, 2008, J NATL CANCER I, V100, P1432, DOI 10.1093/jnci/djn326; Sauter ER, 2005, EXPERT REV MOL DIAGN, V5, P873, DOI 10.1586/14737159.5.6.873; Span PN, 2007, BRIT J CANCER, V96, P1309, DOI 10.1038/sj.bjc.6603715; Stepulak A, 2009, HISTOCHEM CELL BIOL, V132, P435, DOI 10.1007/s00418-009-0613-1; Streckfus C, 2005, Adv Dent Res, V18, P17; Streckfus C, 2000, CLIN CANCER RES, V6, P2363; Streckfus CF, 2006, J ORAL PATHOL MED, V35, P292, DOI 10.1111/j.1600-0714.2006.00427.x; Streckfus CF, 2002, ORAL DIS, V8, P69, DOI 10.1034/j.1601-0825.2002.1o834.x; Streckfus CF, 2008, CANCER INVEST, V26, P159, DOI 10.1080/07357900701783883; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vlahou Antonia, 2003, Clin Breast Cancer, V4, P203, DOI 10.3816/CBC.2003.n.026; Voskuil DW, 2004, BREAST CANCER RES TR, V84, P225, DOI 10.1023/B:BREA.0000019954.59130.d3; Zhang L, 2010, GASTROENTEROLOGY, V138, P949, DOI 10.1053/j.gastro.2009.11.010; Zhang L, 2009, MOL DIAGN THER, V13, P245, DOI 10.2165/11317160-000000000-00000	57	133	144	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15573	10.1371/journal.pone.0015573	http://dx.doi.org/10.1371/journal.pone.0015573			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217834	Green Published, Green Submitted, gold			2022-12-27	WOS:000285838900022
J	Tsang, LWK; Hu, NH; Underhill, DA				Tsang, Leanna W. K.; Hu, Ninghe; Underhill, D. Alan			Comparative Analyses of SUV420H1 Isoforms and SUV420H2 Reveal Differences in Their Cellular Localization and Effects on Myogenic Differentiation	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; H4K20 TRIMETHYLATION; GENE-EXPRESSION; H4-LYSINE 20; METHYLATION; LYSINE-20; H4; CHROMATIN; MONOMETHYLATION; PR-SET7	Background: Methylation of histone H4 on lysine 20 plays critical roles in chromatin structure and function via mono( H4K20me1), di-(H4K20me2), and trimethyl (H4K20me3) derivatives. In previous analyses of histone methylation dynamics in mid-gestation mouse embryos, we documented marked changes in H4K20 methylation during cell differentiation. These changes were particularly robust during myogenesis, both in vivo and in cell culture, where we observed a transition from H4K20me1 to H4K20me3. To assess the significance of this change, we used a gain-of-function strategy involving the lysine methyltransferases SUV420H1 and SUV420H2, which catalyze H4K20me2 and H4K20me3. At the same time, we characterized a second isoform of SUV420H1 (designated SUV420H1_i2) and compared the activity of all three SUV420H proteins with regard to localization and H4K20 methylation. Principal Findings: Immunofluorescence revealed that exogenous SUV420H1_i2 was distributed throughout the cell, while a substantial portion of SUV420H1_i1 and SUV420H2 displayed the expected association with constitutive heterochromatin. Moreover, SUV420H1_i2 distribution was unaffected by co-expression of heterochromatin protein-1 alpha, which increased the targeting of SUV420H1_i1 and SUV420H2 to regions of pericentromeric heterochromatin. Consistent with their distributions, SUV420H1_i2 caused an increase in H4K20me3 levels throughout the nucleus, whereas SUV420H1_i1 and SUV420H2 facilitated an increase in pericentric H4K20me3. Striking differences continued when the SUV420H proteins were tested in the C2C12 myogenic model system. Specifically, although SUV420H1_i2 induced precocious appearance of the differentiation marker Myogenin in the presence of mitogens, only SUV420H2 maintained a Myogenin-enriched population over the course of differentiation. Paradoxically, SUV420H1_i1 could not be expressed in C2C12 cells, which suggests it is under post-transcriptional or post-translational control. Conclusions: These data indicate that SUV420H proteins differ substantially in their localization and activity. Importantly, SUV420H2 can induce a transition from H4K20me1 to H4K20me3 in regions of constitutive heterochromatin that is sufficient to enhance myogenic differentiation, suggesting it can act an as epigenetic 'switch' in this process.	[Tsang, Leanna W. K.; Hu, Ninghe; Underhill, D. Alan] Univ Alberta, Sch Human Dev, Dept Med Genet, Edmonton, AB, Canada; [Underhill, D. Alan] Univ Alberta, Dept Oncol, Sch Canc Engn & Imaging Sci, Fac Med & Dent, Edmonton, AB, Canada	University of Alberta; University of Alberta	Tsang, LWK (corresponding author), Univ Alberta, Sch Human Dev, Dept Med Genet, Edmonton, AB, Canada.	alan.underhill@ualberta.ca		Underhill, Darrell/0000-0003-0957-7407	Canadian Institutes of Health Research [MOP-69015]; Alberta Health Services-Alberta Cancer Foundation [21433, 24571]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Health Services-Alberta Cancer Foundation	This research was supported by grants to D. A. U. from the Canadian Institutes of Health Research (MOP-69015) (http://www.cihr-irsc.gc.ca/e/193.html) and Alberta Health Services-Alberta Cancer Foundation (ACB#21433 and ACB#24571) (http://www.cancerboard.ab.ca/Research/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Si-Ali S, 2004, EMBO J, V23, P605, DOI 10.1038/sj.emboj.7600074; Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Benetti R, 2007, J CELL BIOL, V178, P925, DOI 10.1083/jcb.200703081; Biron VL, 2004, DEV BIOL, V276, P337, DOI 10.1016/j.ydbio.2004.08.038; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chen IHB, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-38; Couture JF, 2008, P NATL ACAD SCI USA, V105, P20659, DOI 10.1073/pnas.0806712105; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Czvitkovich S, 2001, MECH DEVELOP, V107, P141, DOI 10.1016/S0925-4773(01)00464-6; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Gonzalo S, 2005, NAT CELL BIOL, V7, P420, DOI 10.1038/ncb1235; Houston SI, 2008, J BIOL CHEM, V283, P19478, DOI 10.1074/jbc.M710579200; Isaac CE, 2006, MOL CELL BIOL, V26, P3659, DOI 10.1128/MCB.26.9.3659-3671.2006; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Karachentsev D, 2005, GENE DEV, V19, P431, DOI 10.1101/gad.1263005; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; Lu X, 2008, NAT STRUCT MOL BIOL, V15, P1122, DOI 10.1038/nsmb.1489; Mal AK, 2006, EMBO J, V25, P3323, DOI 10.1038/sj.emboj.7601229; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Sakaguchi A, 2007, J CELL BIOL, V176, P155, DOI 10.1083/jcb.200607178; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Sarg B, 2002, J BIOL CHEM, V277, P39195, DOI 10.1074/jbc.M205166200; Sautel CF, 2007, MOL CELL BIOL, V27, P5711, DOI 10.1128/MCB.00482-07; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Sims JK, 2008, MOL CELL BIOL, V28, P4459, DOI 10.1128/MCB.00410-08; Sims JK, 2006, J BIOL CHEM, V281, P12760, DOI 10.1074/jbc.M513462200; Souza PP, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-41; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; Tomczak KK, 2003, FASEB J, V17, P403, DOI 10.1096/f.03-0568fje; Tryndyak VP, 2006, CANCER BIOL THER, V5, P65, DOI 10.4161/cbt.5.1.2288; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Van Den Broeck A, 2008, CLIN CANCER RES, V14, P7237, DOI 10.1158/1078-0432.CCR-08-0869; Walsh K, 1997, CURR OPIN GENET DEV, V7, P597, DOI 10.1016/S0959-437X(97)80005-6; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Yahi H, 2008, J BIOL CHEM, V283, P23692, DOI 10.1074/jbc.M802647200; Yang HB, 2008, J BIOL CHEM, V283, P12085, DOI 10.1074/jbc.M707974200; Yang HB, 2009, BIOCHEM CELL BIOL, V87, P151, DOI 10.1139/O08-131	59	22	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e14447	10.1371/journal.pone.0014447	http://dx.doi.org/10.1371/journal.pone.0014447			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206904	Green Submitted, Green Published, gold			2022-12-27	WOS:000285793200005
J	Baroni, F; Torres, JJ; Varona, P				Baroni, Fabiano; Torres, Joaquin J.; Varona, Pablo			History-Dependent Excitability as a Single-Cell Substrate of Transient Memory for Information Discrimination	PLOS ONE			English	Article							GRADED PERSISTENT ACTIVITY; MEMBRANE-POTENTIAL FLUCTUATIONS; TERM SYNAPTIC PLASTICITY; NEURONS IN-VIVO; PREFRONTAL CORTEX; CORTICAL-NEURONS; WORKING-MEMORY; NETWORK STATES; TEMPORAL INFORMATION; NEURAL INFORMATION	Neurons react differently to incoming stimuli depending upon their previous history of stimulation. This property can be considered as a single-cell substrate for transient memory, or context-dependent information processing: depending upon the current context that the neuron "sees" through the subset of the network impinging on it in the immediate past, the same synaptic event can evoke a postsynaptic spike or just a subthreshold depolarization. We propose a formal definition of History-Dependent Excitability (HDE) as a measure of the propensity to firing in any moment in time, linking the subthreshold history-dependent dynamics with spike generation. This definition allows the quantitative assessment of the intrinsic memory for different single-neuron dynamics and input statistics. We illustrate the concept of HDE by considering two general dynamical mechanisms: the passive behavior of an Integrate and Fire (IF) neuron, and the inductive behavior of a Generalized Integrate and Fire (GIF) neuron with subthreshold damped oscillations. This framework allows us to characterize the sensitivity of different model neurons to the detailed temporal structure of incoming stimuli. While a neuron with intrinsic oscillations discriminates equally well between input trains with the same or different frequency, a passive neuron discriminates better between inputs with different frequencies. This suggests that passive neurons are better suited to rate-based computation, while neurons with subthreshold oscillations are advantageous in a temporal coding scheme. We also address the influence of intrinsic properties in single-cell processing as a function of input statistics, and show that intrinsic oscillations enhance discrimination sensitivity at high input rates. Finally, we discuss how the recognition of these cell-specific discrimination properties might further our understanding of neuronal network computations and their relationships to the distribution and functional connectivity of different neuronal types.	[Baroni, Fabiano; Varona, Pablo] Univ Autonoma Madrid, Escuela Politecn Super, Dept Ingn Informat, Grp Neurocomputac Biol, Madrid, Spain; [Torres, Joaquin J.] Univ Granada, Dept Electromagnetismo & Fis Mat, Granada, Spain; [Torres, Joaquin J.] Univ Granada, Inst Carlos Theoret & Computat Phys, Granada, Spain	Autonomous University of Madrid; University of Granada; University of Granada	Baroni, F (corresponding author), Univ Autonoma Madrid, Escuela Politecn Super, Dept Ingn Informat, Grp Neurocomputac Biol, Madrid, Spain.	fabiano.baroni@uam.es	Baroni, Fabiano/R-8180-2019; Torres, Joaquín J./AAE-6228-2019; Varona, Pablo/B-5583-2012; Torres, Joaquín J./C-1385-2012	Baroni, Fabiano/0000-0001-6047-8100; Varona, Pablo/0000-0002-1754-8991; Torres, Joaquín J./0000-0001-6175-9676	Spanish MICINN (Ministerio de Ciencia e Innovacion) [BFU2009-08473]; Spanish CAM (Comunidad Autonoma de Madrid) [S-SEM-0255-2006]; Spanish JA (Junta de Andalucia) [MICINN FIS2009-08451, FQM-01505]	Spanish MICINN (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish CAM (Comunidad Autonoma de Madrid)(Comunidad de Madrid); Spanish JA (Junta de Andalucia)(Junta de Andalucia)	FB and PV are supported by projects BFU2009-08473 financed by the Spanish MICINN (Ministerio de Ciencia e Innovacion) and S-SEM-0255-2006 by the Spanish CAM (Comunidad Autonoma de Madrid). JJT is supported by projects MICINN FIS2009-08451 and FQM-01505 financed by the Spanish JA (Junta de Andalucia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanel HDI, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.148104; Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Adrian ED, 1923, J PHYSIOL-LONDON, V58, P0209; Anderson RB, 2001, MEM COGNITION, V29, P1061, DOI 10.3758/BF03195767; Arnold L, 2003, SPRINGER MONOGRAPHS; Baeg EH, 2003, NEURON, V40, P177, DOI 10.1016/S0896-6273(03)00597-X; Baker SN, 2000, J NEUROPHYSIOL, V84, P1770, DOI 10.1152/jn.2000.84.4.1770; Baroni F, 2007, NEUROCOMPUTING, V70, P1611, DOI 10.1016/j.neucom.2006.10.042; Baroni F, 2010, J PHYSIOL-PARIS, V104, P91, DOI 10.1016/j.jphysparis.2009.11.007; Bertschinger N, 2004, NEURAL COMPUT, V16, P1413, DOI 10.1162/089976604323057443; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; Buzsaki G., 2006, RHYTHMS BRAIN; Chelaru MI, 2008, P NATL ACAD SCI USA, V105, P16344, DOI 10.1073/pnas.0807744105; Cole KS, 1932, J GEN PHYSIOL, V15, P641, DOI 10.1085/jgp.15.6.641; Cole KS, 1941, J GEN PHYSIOL, V25, P29, DOI 10.1085/jgp.25.1.29; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Destexhe A, 2006, SCIENCE, V314, P85, DOI 10.1126/science.1127241; DEVALOIS RL, 1962, SCIENCE, V136, P986, DOI 10.1126/science.136.3520.986; Durstewitz D, 2008, EUR J NEUROSCI, V27, P217, DOI 10.1111/j.1460-9568.2007.05976.x; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Fellous JM, 2003, NEUROSCIENCE, V122, P811, DOI 10.1016/j.neuroscience.2003.08.027; Fontanini A, 2008, J NEUROPHYSIOL, V100, P1160, DOI 10.1152/jn.90592.2008; Fourcaud-Trocme N, 2003, J NEUROSCI, V23, P11628; Fuhrmann G, 2002, J NEUROPHYSIOL, V87, P140, DOI 10.1152/jn.00258.2001; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; Gilboa G, 2005, J NEUROSCI, V25, P6479, DOI 10.1523/JNEUROSCI.0763-05.2005; Hill AV, 1936, PROC R SOC SER B-BIO, V119, P305, DOI 10.1098/rspb.1936.0012; Hooper SL, 1998, NAT NEUROSCI, V1, P720, DOI 10.1038/3721; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Izhikevich EM, 2001, NEURAL NETWORKS, V14, P883, DOI 10.1016/S0893-6080(01)00078-8; Izhikevich EM, 2003, TRENDS NEUROSCI, V26, P161, DOI 10.1016/S0166-2236(03)00034-1; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; Johnson HA, 2007, J NEUROSCI, V27, P5915, DOI 10.1523/JNEUROSCI.0447-07.2007; Karmarkar UR, 2007, NEURON, V53, P427, DOI 10.1016/j.neuron.2007.01.006; Kavalali ET, 2007, J PHYSIOL-LONDON, V585, P669, DOI 10.1113/jphysiol.2007.137745; Kintos N, 2008, J COMPUT NEUROSCI, V24, P374, DOI 10.1007/s10827-007-0061-7; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kleppe IC, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.041909; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Lapicque L., 1907, J PHYSIOL PATH GEN, V9, P620, DOI DOI 10.1007/S00422-007-0189-6; Latorre R, 2006, BIOL CYBERN, V95, P169, DOI 10.1007/s00422-006-0077-5; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Legenstein R, 2007, NEURAL NETWORKS, V20, P323, DOI 10.1016/j.neunet.2007.04.017; Li CG, 2006, PLOS COMPUT BIOL, V2, P925, DOI 10.1371/journal.pcbi.0020103; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Loewenstein Y, 2003, NAT NEUROSCI, V6, P961, DOI 10.1038/nn1109; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Moreno R, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.288101; Nadim F, 2008, J NEUROSCI, V28, P11806, DOI 10.1523/JNEUROSCI.3796-08.2008; Nayak TK, 2007, J MEMBRANE BIOL, V219, P19, DOI 10.1007/s00232-007-9058-4; Oram MW, 1999, J NEUROPHYSIOL, V81, P3021, DOI 10.1152/jn.1999.81.6.3021; Pakdaman K, 2002, NEURAL COMPUT, V14, P781, DOI 10.1162/089976602317318956; Prinz AA, 2004, TRENDS NEUROSCI, V27, P218, DOI 10.1016/j.tins.2004.02.004; Proekt A, 2004, P NATL ACAD SCI USA, V101, P9447, DOI 10.1073/pnas.0402002101; QUINTANA J, 1992, NEUROREPORT, V3, P721, DOI 10.1097/00001756-199208000-00018; Quintana J, 1999, CEREB CORTEX, V9, P213, DOI 10.1093/cercor/9.3.213; Rabinovich MI, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000072; Rabinovich MI, 2006, REV MOD PHYS, V78, P1213, DOI 10.1103/RevModPhys.78.1213; Rainer G, 1999, J NEUROSCI, V19, P5493; Richardson MJE, 2003, J NEUROPHYSIOL, V89, P2538, DOI 10.1152/jn.00955.2002; RIPLEY S. H., 1953, PHYSIOL COMPARATA ET OECOL, V3, P1; Rudolph M, 2007, J NEUROSCI, V27, P5280, DOI 10.1523/JNEUROSCI.4652-06.2007; Saideman SR, 2007, J NEUROSCI, V27, P6664, DOI 10.1523/JNEUROSCI.0315-07.2007; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Schaefer AT, 2006, PLOS BIOL, V4, P1010, DOI 10.1371/journal.pbio.0040163; Scheich H, 2005, COMPUTATIONAL NEUROS, P343; Schreiber S, 2004, J NEUROPHYSIOL, V92, P408, DOI 10.1152/jn.01116.2003; SEGUNDO JP, 1963, J EXP BIOL, V40, P643; Seung HS, 2000, J COMPUT NEUROSCI, V9, P171, DOI 10.1023/A:1008971908649; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shamir M, 2006, NEURAL COMPUT, V18, P1951, DOI 10.1162/neco.2006.18.8.1951; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; Sikstrom S, 2002, COGNITIVE PSYCHOL, V45, P95, DOI 10.1016/S0010-0285(02)00012-9; Soltesz I, 2005, DIVERSITY NEURONAL M; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Steriade M, 2004, NAT REV NEUROSCI, V5, P121, DOI 10.1038/nrn1325; Stern EA, 1997, J NEUROPHYSIOL, V77, P1697, DOI 10.1152/jn.1997.77.4.1697; Szucs A, 2003, J NEUROPHYSIOL, V89, P1363, DOI 10.1152/jn.00732.2002; Takeda K, 2002, J NEUROPHYSIOL, V87, P567, DOI 10.1152/jn.00249.2001; Tateno T, 2004, CHAOS, V14, P511, DOI 10.1063/1.1756118; Teramae JN, 2005, J COMPUT NEUROSCI, V18, P105, DOI 10.1007/s10827-005-5474-6; THOMSON AM, 1994, TRENDS NEUROSCI, V17, P119, DOI 10.1016/0166-2236(94)90121-X; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Tsuda I, 2001, BEHAV BRAIN SCI, V24, P793, DOI 10.1017/S0140525X01000097; Turrigiano GG, 1996, J NEUROPHYSIOL, V75, P963, DOI 10.1152/jn.1996.75.2.963; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Voogd J, 1998, TRENDS NEUROSCI, V21, P370, DOI 10.1016/S0166-2236(98)01318-6; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; White JA, 1998, J COMPUT NEUROSCI, V5, P5, DOI 10.1023/A:1008841325921; WIERSMA CAG, 1950, PHYS COMP OECOL, V2, P20; Winograd M, 2008, P NATL ACAD SCI USA, V105, P7298, DOI 10.1073/pnas.0800360105; Wolf DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001700; Wolfe J, 2010, CURR OPIN NEUROBIOL, V20, P306, DOI 10.1016/j.conb.2010.03.006; Zeck GM, 2007, EUR J NEUROSCI, V26, P367, DOI 10.1111/j.1460-9568.2007.05670.x; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248; Zhurov Y, 2006, J NEUROSCI, V26, P7056, DOI 10.1523/JNEUROSCI.5277-05.2006; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	109	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15023	10.1371/journal.pone.0015023	http://dx.doi.org/10.1371/journal.pone.0015023			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203387	Green Published, Green Submitted, gold			2022-12-27	WOS:000285792500021
J	Gonzalez-Roca, E; Garcia-Albeniz, X; Rodriguez-Mulero, S; Gomis, RR; Kornacker, K; Auer, H				Gonzalez-Roca, Eva; Garcia-Albeniz, Xabier; Rodriguez-Mulero, Silvia; Gomis, Roger R.; Kornacker, Karl; Auer, Herbert			Accurate Expression Profiling of Very Small Cell Populations	PLOS ONE			English	Article							SINGLE-CELL; GENE-EXPRESSION; MESSENGER-RNA; STEM-CELLS; AMPLIFICATION; CDNA; QUANTITIES; LEVEL	Background: Expression profiling, the measurement of all transcripts of a cell or tissue type, is currently the most comprehensive method to describe their physiological states. Given that accurate profiling methods currently available require RNA amounts found in thousands to millions of cells, many fields of biology working with specialized cell types cannot use these techniques because available cell numbers are limited. Currently available alternative methods for expression profiling from nanograms of RNA or from very small cell populations lack a broad validation of results to provide accurate information about the measured transcripts. Methods and Findings: We provide evidence that currently available methods for expression profiling of very small cell populations are prone to technical noise and therefore cannot be used efficiently as discovery tools. Furthermore, we present Pico Profiling, a new expression profiling method from as few as ten cells, and we show that this approach is as informative as standard techniques from thousands to millions of cells. The central component of Pico Profiling is Whole Transcriptome Amplification (WTA), which generates expression profiles that are highly comparable to those produced by others, at different times, by standard protocols or by Real-time PCR. We provide a complete workflow from RNA isolation to analysis of expression profiles. Conclusions: Pico Profiling, as presented here, allows generating an accurate expression profile from cell populations as small as ten cells.	[Gonzalez-Roca, Eva; Garcia-Albeniz, Xabier; Rodriguez-Mulero, Silvia; Gomis, Roger R.; Auer, Herbert] Inst Res Biomed, Barcelona, Spain; [Garcia-Albeniz, Xabier] Hosp Clin Barcelona, Barcelona, Spain; [Gomis, Roger R.] Inst Catala Recerca & Estudis Avancats, Barcelona, Spain; [Kornacker, Karl] Ohio State Univ, Div Sensory Biophys, Columbus, OH 43210 USA	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; Hospital Clinic de Barcelona; ICREA; University System of Ohio; Ohio State University	Gonzalez-Roca, E (corresponding author), Inst Res Biomed, Barcelona, Spain.	herbert.auer@irbbarcelona.org	Rodriguez-Mulero, Silvia/J-9758-2014; Auer, Herbert/AAV-2332-2020; Gomis, Roger R/E-9788-2016	Rodriguez-Mulero, Silvia/0000-0001-5818-7304; Gomis, Roger R/0000-0001-6473-2858; Garcia-Albeniz, Xabier/0000-0002-9814-2343; Gonzalez-Roca, Eva/0000-0002-1126-0321	Foundation Banco Bilbao Vizcaya Argentaria (Fundacion BBVA); Foundation Genoma Espanya; Institut d'investigacions Biomediques August Pi i Sunyer (IDIBAPS)	Foundation Banco Bilbao Vizcaya Argentaria (Fundacion BBVA); Foundation Genoma Espanya; Institut d'investigacions Biomediques August Pi i Sunyer (IDIBAPS)	This work was supported by the Foundation Banco Bilbao Vizcaya Argentaria (Fundacion BBVA, www.fbbva.es) to RRG, by the Foundation Genoma Espanya (www.gen-es.org) to EG, SR and HA and by Institut d'investigacions Biomediques August Pi i Sunyer (IDIBAPS, www.idibaps.org) to XG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer H, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-111; Bainbridge MN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-246; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Clement-Ziza M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-246; Eklund AC, 2006, NAT BIOTECHNOL, V24, P1071, DOI 10.1038/nbt0906-1071; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Iscove NN, 2002, NAT BIOTECHNOL, V20, P940, DOI 10.1038/nbt729; Janes KA, 2010, NAT METHODS, V7, P311, DOI [10.1038/nmeth.1442, 10.1038/NMETH.1442]; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; Kurimoto K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl050; Kurn N, 2005, CLIN CHEM, V51, P1973, DOI 10.1373/clinchem.2005.053694; Nygaard V, 2006, NUCLEIC ACIDS RES, V34, P996, DOI 10.1093/nar/gkj499; Pascal LE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-246; Pradervand S, 2008, BIOTECHNIQUES, V44, P759, DOI 10.2144/000112751; Sambrook J, 2001, MOL CLONING LAB MANU; Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Subkhankulova T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r18; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Tietjen I, 2003, NEURON, V38, P161, DOI 10.1016/S0896-6273(03)00229-0; Tomlins SA, 2006, NEOPLASIA, V8, P153, DOI 10.1593/neo.05754; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Viale Agnes, 2007, J Biomol Tech, V18, P150; Wilson CL, 2004, BIOTECHNIQUES, V36, P498, DOI 10.2144/04363RN05; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018; Zhang P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007844; Zhumabayeva B, 2001, BIOTECHNIQUES, V30, P158, DOI 10.2144/01301pf01	29	54	58	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14418	10.1371/journal.pone.0014418	http://dx.doi.org/10.1371/journal.pone.0014418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203435	Green Submitted, Green Published, gold			2022-12-27	WOS:000285792500005
J	Little, SA; Kembel, SW; Wilf, P				Little, Stefan A.; Kembel, Steven W.; Wilf, Peter			Paleotemperature Proxies from Leaf Fossils Reinterpreted in Light of Evolutionary History	PLOS ONE			English	Article							MARGIN ANALYSIS; TERRESTRIAL PALEOCLIMATE; COEXISTENCE APPROACH; NEOTROPICAL FORESTS; ANGIOSPERM LEAVES; TERTIARY FLORAS; SOUTH-AMERICA; EARLY EOCENE; CLIMATE; SHAPE	Present-day correlations between leaf physiognomic traits (shape and size) and climate are widely used to estimate paleoclimate using fossil floras. For example, leaf-margin analysis estimates paleotemperature using the modern relation of mean annual temperature (MAT) and the site-proportion of untoothed-leaf species (NT). This uniformitarian approach should provide accurate paleoclimate reconstructions under the core assumption that leaf-trait variation principally results from adaptive environmental convergence, and because variation is thus largely independent of phylogeny it should be constant through geologic time. Although much research acknowledges and investigates possible pitfalls in paleoclimate estimation based on leaf physiognomy, the core assumption has never been explicitly tested in a phylogenetic comparative framework. Combining an extant dataset of 21 leaf traits and temperature with a phylogenetic hypothesis for 569 species-site pairs at 17 sites, we found varying amounts of non-random phylogenetic signal in all traits. Phylogenetic vs. standard regressions generally support prevailing ideas that leaf-traits are adaptively responding to temperature, but wider confidence intervals, and shifts in slope and intercept, indicate an overall reduced ability to predict climate precisely due to the non-random phylogenetic signal. Notably, the modern-day relation of proportion of untoothed taxa with mean annual temperature (NT-MAT), central in paleotemperature inference, was greatly modified and reduced, indicating that the modern correlation primarily results from biogeographic history. Importantly, some tooth traits, such as number of teeth, had similar or steeper slopes after taking phylogeny into account, suggesting that leaf teeth display a pattern of exaptive evolution in higher latitudes. This study shows that the assumption of convergence required for precise, quantitative temperature estimates using present-day leaf traits is not supported by empirical evidence, and thus we have very low confidence in previously published, numerical paleotemperature estimates. However, interpreting qualitative changes in paleotemperature remains warranted, given certain conditions such as stratigraphically closely-spaced samples with floristic continuity.	[Little, Stefan A.; Wilf, Peter] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Little, Stefan A.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Kembel, Steven W.] Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Davis; University of Oregon	Little, SA (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	dslittle@ucdavis.edu		Wilf, Peter/0000-0001-6813-1937; Kembel, Steven/0000-0001-5224-0952	David and Lucile Packard Foundation	David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This work was supported by the David and Lucile Packard Foundation to Peter Wilf, which funded Stefan Little's position at Pennsylvania State University 2006-2009 (http://www.packard.org/home.aspx, http://www.packard.org/fellowsDetails.aspx?RootCatID = 3&CategoryID = 70&ItemID = 2951). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2008, GLOBAL PLANET CHANGE, V60, P523, DOI 10.1016/j.gloplacha.2007.07.001; Aizen MA, 2008, GLOBAL ECOL BIOGEOGR, V17, P164, DOI 10.1111/j.1466-8238.2007.00350.x; Backhaus A, 2010, NEW PHYTOL, V187, P251, DOI 10.1111/j.1469-8137.2010.03266.x; Bailey IW, 1916, AM J BOT, V3, P24, DOI 10.2307/2435109; Bailey IW, 1915, SCIENCE, V41, P831, DOI 10.1126/science.41.1066.831; Bensmihen S, 2008, HFSP J, V2, P110, DOI 10.2976/1.2836738; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham RJ, 1997, BIOTROPICA, V29, P384, DOI 10.1111/j.1744-7429.1997.tb00034.x; Burnham RJ, 2001, AM J BOT, V88, P1096, DOI 10.2307/2657093; Bylesjo M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-82; CASCI T, 2010, NATURE REV GENETICS, V11, P594; CHALONER WG, 1990, J GEOL SOC LONDON, V147, P343, DOI 10.1144/gsjgs.147.2.0343; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; Currano ED, 2010, ECOL MONOGR, V80, P547, DOI 10.1890/09-2138.1; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; Dilcher DL., 1973, VEGETATION VEGETATIO, P39; Doyle JA, 2007, COUR FOR SEKENBG, V258, P21; Feild TS, 2005, PLANT CELL ENVIRON, V28, P1179, DOI 10.1111/j.1365-3040.2005.01354.x; Feild TS, 2005, NEW PHYTOL, V166, P383, DOI 10.1111/j.1469-8137.2005.01333.x; Feng XZ, 2009, PLANT CELL, V21, P2999, DOI 10.1105/tpc.109.069054; Fricke HC, 2004, AM J SCI, V304, P612, DOI 10.2475/ajs.304.7.612; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Green WA, 2006, PALAEONTOL ELECTRON, V9; Greenwood DR, 2007, COUR FOR SEKENBG, V258, P95; Greenwood DR, 2005, NEW PHYTOL, V166, P355, DOI 10.1111/j.1469-8137.2005.01380.x; Greenwood DR, 2004, PALAIOS, V19, P129, DOI 10.1669/0883-1351(2004)019<0129:PEULAI>2.0.CO;2; GREENWOOD DR, 1995, GEOLOGY, V23, P1044, DOI 10.1130/0091-7613(1995)023<1044:ECCALT>2.3.CO;2; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; HICKEY LJ, 1975, ANN MO BOT GARD, V62, P538, DOI 10.2307/2395267; Hinojosa LF, 2006, J BIOGEOGR, V33, P331, DOI 10.1111/j.1365-2699.2005.01350.x; HINOJOSA LF, 2010, GLOBAL ECOL BIOGEOGR, DOI DOI 10.1111/J.1466-8238.2010.00595.X; Huff PM, 2003, PALAIOS, V18, P266, DOI 10.1669/0883-1351(2003)018<0266:DFFPEF>2.0.CO;2; Hunt R.J., 2003, GEOLOGICAL SOC AM SP, V369, P395, DOI DOI 10.1130/0-8137-2369-8.395; Jordan GJ, 1997, AUST J BOT, V45, P527, DOI 10.1071/BT96035; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; Kowalski EA, 2002, PALAEOGEOGR PALAEOCL, V188, P141, DOI 10.1016/S0031-0182(02)00550-3; Krieger JD, 2007, PALAIOS, V22, P212, DOI 10.2110/palo.2005.p05-079r; Liang MM, 2003, PALAEOGEOGR PALAEOCL, V198, P279, DOI 10.1016/S0031-0182(03)00471-1; Albarran-Lara AL, 2010, INT J PLANT SCI, V171, P310, DOI 10.1086/650317; Manchester SR, 1999, ANN MO BOT GARD, V86, P472, DOI 10.2307/2666183; Manchester SR, 1998, REV PALAEOBOT PALYNO, V102, P153, DOI 10.1016/S0034-6667(97)00056-0; McIver EE, 1999, ANN MO BOT GARD, V86, P523, DOI 10.2307/2666184; Miller IM, 2006, EARTH PLANET SC LETT, V245, P95, DOI 10.1016/j.epsl.2006.02.022; Mosbrugger V, 1997, PALAEOGEOGR PALAEOCL, V134, P61, DOI 10.1016/S0031-0182(96)00154-X; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peppe DJ, 2010, TECTONICS, V29, DOI 10.1029/2009TC002549; PEPPE DJ, 2010, NEW PHYTOL IN PRESS; Poole I, 2005, PALAEOGEOGR PALAEOCL, V222, P95, DOI 10.1016/j.palaeo.2005.03.011; Poorter L, 2008, ECOLOGY, V89, P1908, DOI 10.1890/07-0207.1; R Core Team, 2020, R LANG ENV STAT COMP; Royer DL, 2008, NEW PHYTOL, V179, P808, DOI 10.1111/j.1469-8137.2008.02496.x; Royer DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007653; Royer DL, 2009, AM J BOT, V96, P738, DOI 10.3732/ajb.0800282; Royer DL, 2006, INT J PLANT SCI, V167, P11, DOI 10.1086/497995; Royer DL, 2005, AM J BOT, V92, P1141, DOI 10.3732/ajb.92.7.1141; Spicer RA, 2009, PALAEOGEOGR PALAEOCL, V283, P91, DOI 10.1016/j.palaeo.2009.09.009; Stranks L, 1997, PALAEOGEOGR PALAEOCL, V131, P15, DOI 10.1016/S0031-0182(96)00147-2; Uhl D, 2003, REV PALAEOBOT PALYNO, V126, P49, DOI 10.1016/S0034-6667(03)00058-7; Upchurch Jr G.R., 1993, EVOLUTION W INTERIOR, P243; Utescher T, 2000, PALAIOS, V15, P430, DOI 10.2307/3515514; Venables WN., 2002, MODERN APPL STAT S 4; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Wilf P, 1997, PALEOBIOLOGY, V23, P373, DOI 10.1017/S0094837300019746; Wilf P, 2000, GEOL SOC AM BULL, V112, P292, DOI 10.1130/0016-7606(2000)112<0292:LPEECC>2.3.CO;2; Wilf P, 2003, P NATL ACAD SCI USA, V100, P599, DOI 10.1073/pnas.0234701100; Wing S.L., 2000, WARM CLIMATES EARTH, P197; Wing SL, 2005, SCIENCE, V310, P993, DOI 10.1126/science.1116913; WING SL, 1993, PHILOS T ROY SOC B, V341, P243, DOI 10.1098/rstb.1993.0109; WING SL, 1987, ANN MO BOT GARD, V74, P748, DOI 10.2307/2399449; Wolfe J.A., 1993, US GEOLOGICAL SURVEY, V2040, P1; WOLFE JA, 1971, PALAEOGEOGR PALAEOCL, V9, P27, DOI 10.1016/0031-0182(71)90016-2; WOLFE JA, 1986, NATURE, V324, P148, DOI 10.1038/324148a0; WOLFE JA, 1987, PALAEOGEOGR PALAEOCL, V61, P33, DOI 10.1016/0031-0182(87)90040-X; WOLFE JA, 1987, PALEOBIOLOGY, V13, P215; WOLFE JA, 1995, ANNU REV EARTH PL SC, V23, P119, DOI 10.1146/annurev.earth.23.1.119; WOLFE JA, 1982, CLIMATE EARTH HIST, P154; Wolfe JA, 1979, US GEOLOGICAL SURVEY, V1106, P1, DOI DOI 10.3133/PP1106; WOLFE JA, 1966, US GEOLOGICAL SURV B, V398, P1; Wright IJ, 2007, ANN BOT-LONDON, V99, P1003, DOI 10.1093/aob/mcl066; [No title captured]	86	85	87	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15161	10.1371/journal.pone.0015161	http://dx.doi.org/10.1371/journal.pone.0015161			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203554	Green Submitted, gold, Green Published			2022-12-27	WOS:000285578000020
J	Inoue, M; Yasuda, K; Uemura, H; Yasaka, N; Inoue, H; Sei, Y; Horikoshi, N; Fukuma, T				Inoue, Masahiro; Yasuda, Kouichi; Uemura, Haruki; Yasaka, Natsumi; Inoue, Hiroshi; Sei, Yoshitatsu; Horikoshi, Nobuo; Fukuma, Toshihide			Phosphorylation-Dependent Protein Interaction with Trypanosoma brucei 14-3-3 Proteins that Display Atypical Target Recognition	PLOS ONE			English	Article							14-3-3-PROTEINS; BINDING; ISOFORMS; CYTOKINESIS; SPECIFICITY; GENOME; KINASE; ZETA	Background: The 14-3-3 proteins are structurally conserved throughout eukaryotes and participate in protein kinase signaling. All 14-3-3 proteins are known to bind to evolutionally conserved phosphoserine-containing motifs (modes 1 and/or 2) with high affinity. In Trypanosoma brucei, 14-3-3I and II play pivotal roles in motility, cytokinesis and the cell cycle. However, none of the T. brucei 14-3-3 binding proteins have previously been documented. Methodology/Principal Findings: Initially we showed that T. brucei 14-3-3 proteins exhibit far lower affinity to those peptides containing RSxpSxP (mode 1) and RxY/FxpSxP (mode 2) (where x is any amino acid residue and pS is phosphoserine) than human 14-3-3 proteins, demonstrating the atypical target recognition by T. brucei 14-3-3 proteins. We found that the putative T. brucei protein phosphatase 2C (PP2c) binds to T. brucei 14-3-3 proteins utilizing its mode 3 motif (-pS/pTx(1-2)-COOH, where x is not Pro). We constructed eight chimeric PP2c proteins replacing its authentic mode 3 motif with potential mode 3 sequences found in Trypanosoma brucei genome database, and tested their binding. As a result, T. brucei 14-3-3 proteins interacted with three out of eight chimeric proteins including two with high affinity. Importantly, T. brucei 14-3-3 proteins co-immunoprecipitated with an uncharacterized full-length protein containing identified high-affinity mode 3 motif, suggesting that both proteins form a complex in vivo. In addition, a synthetic peptide derived from this mode 3 motif binds to T. brucei 14-3-3 proteins with high affinity. Conclusion/Significance: Because of the atypical target recognition of T. brucei 14-3-3 proteins, no 14-3-3-binding proteins have been successfully identified in T. brucei until now whereas over 200 human 14-3-3-binding proteins have been identified. This report describes the first discovery of the T. brucei 14-3-3-binding proteins and their binding motifs. The high-affinity phosphopeptide will be a powerful tool to identify novel T. brucei 14-3-3-binding proteins.	[Inoue, Masahiro; Yasuda, Kouichi; Yasaka, Natsumi; Inoue, Hiroshi; Fukuma, Toshihide] Kurume Univ, Sch Med, Dept Infect Med, Div Eukaryot Microbiol, Kurume, Fukuoka 830, Japan; [Uemura, Haruki] Nagasaki Univ, Inst Trop Med, Dept Protozool, Nagasaki 852, Japan; [Sei, Yoshitatsu] NIDDK, Gastroenterol Sect, Digest Dis Branch, Bethesda, MD USA; [Horikoshi, Nobuo] SW Texas State Univ, Div Mol Radiat Biol, Dept Radiat Oncol, Sch Med, Dallas, TX USA	Kurume University; Nagasaki University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Texas State University System; Texas State University San Marcos	Inoue, M (corresponding author), Kurume Univ, Sch Med, Dept Infect Med, Div Eukaryot Microbiol, Kurume, Fukuoka 830, Japan.	inouedna@med.kurume-u.ac.jp	Horikoshi, Nobuo/Y-8245-2019	Horikoshi, Nobuo/0000-0001-8464-8178	Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research [2009, 20590434]; Institute of Tropical Medicine, Nagasaki University [2008-20-D-2, 2009-21-E-8]; Ishibashi Foundation for the Promotion of Science	Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Institute of Tropical Medicine, Nagasaki University; Ishibashi Foundation for the Promotion of Science	This research was supported by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (C), 2009, 20590434, by the Cooperative Research Grant(s) (2008-20-D-2, 2009-21-E-8, 9) of the Institute of Tropical Medicine, Nagasaki University, and by a grant from the Ishibashi Foundation for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Coblitz B, 2006, FEBS LETT, V580, P1531, DOI 10.1016/j.febslet.2006.02.014; DAS A, 1994, J CELL SCI, V107, P3477; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Inoue M, 2005, J BIOL CHEM, V280, P14085, DOI 10.1074/jbc.M412336200; IRIE K, 1994, SCIENCE, V265, P1716, DOI 10.1126/science.8085159; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Manak MS, 2007, BIOCHEMISTRY-US, V46, P1055, DOI 10.1021/bi061366c; Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Rosenquist M, 2000, J MOL EVOL, V51, P446, DOI 10.1007/s002390010107; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Tzivion G, 2000, J BIOL CHEM, V275, P29772, DOI 10.1074/jbc.M001207200; Van der Hoeven PCJ, 2000, BIOCHEM J, V345, P297, DOI 10.1042/0264-6021:3450297; Wilker E, 2004, J MOL CELL CARDIOL, V37, P633, DOI 10.1016/j.yjmcc.2004.04.015; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wu M, 2006, ANAL BIOCHEM, V349, P186, DOI 10.1016/j.ab.2005.11.030; Xiao Bing, 1995, Nature (London), V376, P188, DOI 10.1038/376188a0; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yaffe Michael B, 2004, Biochem J, V379, pe1, DOI 10.1042/BJ20040284	23	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15566	10.1371/journal.pone.0015566	http://dx.doi.org/10.1371/journal.pone.0015566			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203569	Green Submitted, Green Published, gold			2022-12-27	WOS:000285576900032
J	Kim, WT; Yun, SJ; Park, C; Kim, IY; Moon, SK; Kwon, TG; Choi, YH; Kim, WJ				Kim, Won Tae; Yun, Seok Joong; Park, Cheol; Kim, Isaac Yi; Moon, Sung-Kwon; Kwon, Tae Gyun; Choi, Yung Hyun; Kim, Wun-Jae			Identification of C16orf74 as a Marker of Progression in Primary Non-Muscle Invasive Bladder Cancer	PLOS ONE			English	Article							CELL LUNG-CANCER; PANCREATIC TRYPSINOGEN; TUMOR-MARKERS; CARCINOMA; GENE; EXPRESSION; MUTATIONS; HYPERMETHYLATION; METASTASIS; HYPOXIA	Purpose: Methylation-induced silencing of PRSS3 has been shown to be significantly associated with invasive bladder cancer, and expression of the C16orf74 gene locus has been shown to correlate positively with PRSS3. The aim of the current study was to evaluate the relationship between C16orf74 expression level and progression in non-muscle invasive bladder cancer (NMIBC). Materials and Methods: C16orf74 mRNA levels were examined by real-time reverse transcriptase polymerase chain reaction (RT-PCR) analysis of 193 tumor specimens from patients with primary NMIBC. Expression data were analyzed in terms of clinical and experimental parameters. Kaplan-Meier curves and multivariate Cox regression models, respectively, were used to determine progression-free survival and to identify independent predictive parameters of progression. Results: Analysis using Kaplan-Meier curves revealed prolonged progression-free survival of high-C16orf74-expressors as compared to low-expressors (p < 0.001). Multivariate Cox regression analysis revealed that low C16orf74 mRNA expression levels are a significant risk factor for disease progression in patients with primary NMIBC (HR: 10.042, CI: 2.699-37.360, p = 0.001). Conclusions: Decreased expression of C16orf74 correlates significantly with progression in primary NMIBC. C16orf74 expression level represents a potentially useful marker for predicting progression in primary NMIBC patients.	[Kim, Won Tae; Yun, Seok Joong; Park, Cheol; Kim, Wun-Jae] Chungbuk Natl Univ, Coll Med, Dept Urol, Cheongju, South Korea; [Kim, Isaac Yi] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Sect Urol Oncol, Canc Inst New Jersey, New Brunswick, NJ USA; [Moon, Sung-Kwon] Chungju Natl Univ, Dept Food & Biotechnol, Chungju, South Korea; [Kwon, Tae Gyun] Kyungpook Natl Univ, Sch Med, Dept Urol, Taegu, South Korea; [Choi, Yung Hyun] Dong Eui Univ, Dept Biomat Control, Pusan, South Korea	Chungbuk National University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Kyungpook National University; Dong-Eui University	Kim, WT (corresponding author), Chungbuk Natl Univ, Coll Med, Dept Urol, Cheongju, South Korea.	wjkim@chungbuk.ac.kr		KWON, TAE GYUN/0000-0002-4390-0952; Yun, Seok-Joong/0000-0001-7737-4746	Ministry of Education, Science and Technology [2010-0001730]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0001730). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babjuk M, 2008, EUR UROL, V54, P303, DOI 10.1016/j.eururo.2008.04.051; Birkhahn M, 2010, EUR UROL, V57, P12, DOI 10.1016/j.eururo.2009.09.013; Bland JM, 1996, BRIT MED J, V312, P1079; Chan MWY, 2003, INT J CANCER, V104, P611, DOI 10.1002/ijc.10971; Creighton J, 1999, LANCET, V354, P42, DOI 10.1016/S0140-6736(99)01814-0; Diederichs S, 2004, CANCER RES, V64, P5564, DOI 10.1158/0008-5472.CAN-04-2004; Ebbesen P, 2009, J ENZYM INHIB MED CH, V24, P1, DOI 10.1080/14756360902784425; Eguchi S, 2010, CANCER GENET CYTOGEN, V200, P16, DOI 10.1016/j.cancergencyto.2010.03.007; Greene Frederick L, 2002, Bull Am Coll Surg, V87, P13; Grinblatt JA, 1997, NEW ENGL J MED, V337, P1394; Habuchi T, 2005, UROLOGY, V66, P64, DOI 10.1016/j.urology.2005.08.065; Hall MC, 2007, J UROLOGY, V178, P2314, DOI 10.1016/j.juro.2007.09.003; HIRAHARA F, 1995, INT J CANCER, V63, P176, DOI 10.1002/ijc.2910630205; Hockla A, 2009, BREAST CANC IN PRESS; Kim WJ, 2005, CANCER RES, V65, P9347, DOI 10.1158/0008-5472.CAN-05-1647; Kim WJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-3; KOIVUNEN E, 1991, INT J CANCER, V47, P592, DOI 10.1002/ijc.2910470419; KOSHIKAWA N, 1992, CANCER RES, V52, P5046; Liou LS, 2006, UROLOGY, V67, P25, DOI 10.1016/j.urology.2006.01.034; Liu CY, 2008, MOL MED, V14, P575, DOI 10.2119/2008-00056.Liu; Marsit CJ, 2006, CARCINOGENESIS, V27, P112, DOI 10.1093/carcin/bgi172; Marsit CJ, 2005, MOL CARCINOGEN, V44, P146, DOI 10.1002/mc.20125; Messing EM, 2007, CAMPBELLWALSHS UROLO, P2417; Messing EM, 2002, CAMPBELLS UROLOGY, P2750; Minn A, 1998, GLIA, V22, P338, DOI 10.1002/(SICI)1098-1136(199804)22:4<338::AID-GLIA3>3.0.CO;2-#; OHTA T, 1994, BRIT J CANCER, V69, P152, DOI 10.1038/bjc.1994.25; Ross JS, 2000, CANCER CYTOPATHOL, V90, P75, DOI 10.1002/(SICI)1097-0142(20000425)90:2<75::AID-CNCR2>3.3.CO;2-N; SIDRANSKY D, 1991, SCIENCE, V252, P706, DOI 10.1126/science.2024123; Szmola R, 2003, J BIOL CHEM, V278, P48580, DOI 10.1074/jbc.M310301200; TANI T, 1990, NUCLEIC ACIDS RES, V18, P1631, DOI 10.1093/nar/18.6.1631; Wang R, 2009, CANCER RES, V69, P3810, DOI 10.1158/0008-5472.CAN-08-4405; Winter SC, 2007, CANCER RES, V67, P3441, DOI 10.1158/0008-5472.CAN-06-3322; Yamashita K, 2003, CANCER RES, V63, P6575; Zhou XF, 2006, NEOPLASIA, V8, P925, DOI 10.1593/neo.06430	34	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15260	10.1371/journal.pone.0015260	http://dx.doi.org/10.1371/journal.pone.0015260			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203532	Green Published, Green Submitted, gold			2022-12-27	WOS:000285576900025
J	Liu, JQ; Lee, TF; Bigam, DL; Cheung, PY				Liu, Jiang-Qin; Lee, Tze-Fun; Bigam, David L.; Cheung, Po-Yin			Effects of Post-Resuscitation Treatment with N-acetylcysteine on Cardiac Recovery in Hypoxic Newborn Piglets	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; RANDOMIZED CONTROLLED-TRIAL; MYOCARDIAL-ISCHEMIA; PERINATAL ASPHYXIA; OXIDATIVE STRESS; 100-PERCENT OXYGEN; INDUCED APOPTOSIS; NEURONAL CELLS; TROPONIN-I; DYSFUNCTION	Aims: Although N-acetylcysteine (NAC) can decrease reactive oxygen species and improve myocardial recovery after ischemia/hypoxia in various acute animal models, little is known regarding its long-term effect in neonatal subjects. We investigated whether NAC provides prolonged protective effect on hemodynamics and oxidative stress using a surviving swine model of neonatal asphyxia. Methods and Results: Newborn piglets were anesthetized and acutely instrumented for measurement of systemic hemodynamics and oxygen transport. Animals were block-randomized into a sham-operated group (without hypoxiareoxygenation [H-R, n = 6]) and two H-R groups (2 h normocapnic alveolar hypoxia followed by 48 h reoxygenation, n = 8/group). All piglets were acidotic and in cardiogenic shock after hypoxia. At 5 min after reoxygenation, piglets were given either saline or NAC (intravenous 150 mg/kg bolus + 20 mg/kg/h infusion) via for 24 h in a blinded, randomized fashion. Both cardiac index and stroke volume of H-R controls remained lower than the pre-hypoxic values throughout recovery. Treating the piglets with NAC significantly improved cardiac index, stroke volume and systemic oxygen delivery to levels not different from those of sham-operated piglets. Accompanied with the hemodynamic improvement, NAC-treated piglets had significantly lower plasma cardiac troponin-I, myocardial lipid hydroperoxides, activated caspase-3 and lactate levels (vs. H-R controls). The change in cardiac index after H-R correlated with myocardial lipid hydroperoxides, caspase-3 and lactate levels (all p, 0.05). Conclusions: Post-resuscitation administration of NAC reduces myocardial oxidative stress and caused a prolonged improvement in cardiac function and in newborn piglets with H-R insults.	[Liu, Jiang-Qin; Lee, Tze-Fun; Cheung, Po-Yin] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Bigam, David L.; Cheung, Po-Yin] Univ Alberta, Dept Surg, Edmonton, AB, Canada	University of Alberta; University of Alberta	Liu, JQ (corresponding author), Univ Alberta, Dept Pediat, Edmonton, AB, Canada.	poyin@ualberta.ca	Cheung, Po-Yin/C-2804-2013	Cheung, Po-Yin/0000-0002-7141-1523	Canadian Institutes of Health Research [MOP51306]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The study was supported by the operating grant (MOP51306) from the Canadian Institutes of Health Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2008, J PHARMACOL SCI, V106, P571, DOI 10.1254/jphs.FP0071664; Adamy C, 2007, J MOL CELL CARDIOL, V43, P344, DOI 10.1016/j.yjmcc.2007.06.010; Ahola T, 2003, J PEDIATR-US, V143, P713, DOI 10.1067/S0022-3476(03)00419-0; Atkuri KR, 2007, CURR OPIN PHARMACOL, V7, P355, DOI 10.1016/j.coph.2007.04.005; Barberi I, 1999, EUR J PEDIATR, V158, P742, DOI 10.1007/s004310051192; Benrahmoune M, 2000, FREE RADICAL BIO MED, V29, P775, DOI 10.1016/S0891-5849(00)00380-4; Bolanos JP, 2010, IUBMB LIFE, V62, P14, DOI 10.1002/iub.280; Borutaite V, 2010, ENVIRON MOL MUTAGEN, V51, P406, DOI 10.1002/em.20564; Carbonell LF, 2007, MED CHEM, V3, P29, DOI 10.2174/157340607779317580; Carter BS, 1998, J PEDIATR-US, V132, P619, DOI 10.1016/S0022-3476(98)70349-X; Cheung PY, 2000, J MOL CELL CARDIOL, V32, P1669, DOI 10.1006/jmcc.2000.1203; Clark SJ, 2006, EUR J PEDIATR, V165, P87, DOI 10.1007/s00431-005-0001-3; Conesa EL, 2001, AM J PHYSIOL-REG I, V281, pR730, DOI 10.1152/ajpregu.2001.281.3.R730; Cuzzocrea S, 2000, CARDIOVASC RES, V47, P537, DOI 10.1016/S0008-6363(00)00018-3; Duilio C, 2001, AM J PHYSIOL-HEART C, V280, pH2649, DOI 10.1152/ajpheart.2001.280.6.H2649; FERRARI G, 1995, J NEUROSCI, V15, P2857; Fiordaliso F, 2004, J MOL CELL CARDIOL, V37, P959, DOI 10.1016/j.yjmcc.2004.07.008; Foresti R, 2001, AM J PHYSIOL-HEART C, V281, pH1976, DOI 10.1152/ajpheart.2001.281.5.H1976; Gensini GF, 1998, CRIT CARE MED, V26, P1986, DOI 10.1097/00003246-199812000-00025; HARRISON PM, 1991, NEW ENGL J MED, V324, P1852, DOI 10.1056/NEJM199106273242604; Ho FY, 2006, BIOCHEM BIOPH RES CO, V345, P1131, DOI 10.1016/j.bbrc.2006.04.178; Hsu BG, 2006, LIFE SCI, V79, P2010, DOI 10.1016/j.lfs.2006.06.040; Hu CP, 2007, AM J PHYSIOL-HEART C, V293, pH1833, DOI 10.1152/ajpheart.00488.2007; Johnson ST, 2007, SHOCK, V28, P484, DOI 10.1097/shk.0b013e31804f775d; Kanik E, 2009, J MATERN-FETAL NEO M, V22, P239, DOI 10.1080/14767050802430834; Kin H, 2008, SHOCK, V29, P761, DOI 10.1097/SHK.0b013e31815cfd5a; Korge P, 2008, CIRC RES, V103, P873, DOI 10.1161/CIRCRESAHA.108.180869; Kyaw M, 2004, J PHARMACOL SCI, V95, P483, DOI 10.1254/jphs.SC0040061; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Lavrik IN, 2005, J CLIN INVEST, V115, P2665, DOI 10.1172/JCI26252; LE CT, 1995, EUR HEART J, V16, P553, DOI 10.1093/oxfordjournals.eurheartj.a060950; Lee TF, 2008, INTENS CARE MED, V34, P190, DOI 10.1007/s00134-007-0880-z; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Liu J, 2007, J TROP PEDIATRICS, V53, P44, DOI 10.1093/tropej/fml053; MARTINANCEL A, 1995, J PEDIATR-US, V127, P786, DOI 10.1016/S0022-3476(95)70174-5; Noren H, 2003, AM J OBSTET GYNECOL, V188, P183, DOI 10.1067/mob.2003.109; Perlman JM, 2010, CIRCULATION, V122, P8516, DOI 10.1161/CIRCULATIONAHA.110.971127; Prybytkowski E, 1996, ARCH BIOCHEM BIOPHYS, V325, P91; Qin FZ, 2003, AM J PHYSIOL-HEART C, V285, pH822, DOI 10.1152/ajpheart.00015.2003; Rajakumar PS, 2008, INDIAN J PEDIATR, V75, P1223, DOI 10.1007/s12098-008-0242-z; Rajan GP, 2004, J TRAUMA, V57, P801, DOI 10.1097/01.TA.0000135157.93649.72; Shah P, 2004, ARCH DIS CHILD-FETAL, V89, P152, DOI 10.1136/adc.2002.023093; Shen X, 2006, DIABETES, V55, P798, DOI 10.2337/diabetes.55.03.06.db05-1039; Song JQ, 2009, APOPTOSIS, V14, P1061, DOI 10.1007/s10495-009-0382-2; TALLEY AK, 1995, MOL CELL BIOL, V15, P2359; Timmers L, 2009, J AM COLL CARDIOL, V53, P501, DOI 10.1016/j.jacc.2008.10.033; Vento M, 2005, AM J RESP CRIT CARE, V172, P1393, DOI 10.1164/rccm.200412-1740OC; WALTHER FJ, 1985, J PEDIATR-US, V107, P781, DOI 10.1016/S0022-3476(85)80417-0; Wei Y, 2009, PEDIATR CARDIOL, V30, P741, DOI 10.1007/s00246-009-9421-6; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; Zhao ZQ, 2004, CURR OPIN PHARMACOL, V4, P159, DOI 10.1016/j.coph.2003.10.010	51	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15322	10.1371/journal.pone.0015322	http://dx.doi.org/10.1371/journal.pone.0015322			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203535	gold, Green Published, Green Submitted			2022-12-27	WOS:000285576900028
J	Parker, PG; Buckles, EL; Farrington, H; Petren, K; Whiteman, NK; Ricklefs, RE; Bollmer, JL; Jimenez-Uzcategui, G				Parker, Patricia G.; Buckles, Elizabeth L.; Farrington, Heather; Petren, Kenneth; Whiteman, Noah K.; Ricklefs, Robert E.; Bollmer, Jennifer L.; Jimenez-Uzcategui, Gustavo			110 Years of Avipoxvirus in the Galapagos Islands	PLOS ONE			English	Article							DISEASE; POPULATIONS; EXTINCTION; THREATS; EPIZOOTIOLOGY; CONSERVATION; MOCKINGBIRD; DIVERSITY; GENETICS; ORIGIN	The role of disease in regulating populations is controversial, partly owing to the absence of good disease records in historic wildlife populations. We examined birds collected in the Galapagos Islands between 1891 and 1906 that are currently held at the California Academy of Sciences and the Zoologisches Staatssammlung Muenchen, including 3973 specimens representing species from two well-studied families of endemic passerine birds: finches and mockingbirds. Beginning with samples collected in 1899, we observed cutaneous lesions consistent with Avipoxvirus on 226 (6.3%) specimens. Histopathology and viral genotyping of 59 candidate tissue samples from six islands showed that 21 (35.6%) were positive for Avipoxvirus, while alternative diagnoses for some of those testing negative by both methods were feather follicle cysts, non-specific dermatitis, or post mortem fungal colonization. Positive specimens were significantly nonrandomly distributed among islands both for mockingbirds (San Cristobal vs. Espanola, Santa Fe and Santa Cruz) and for finches (San Cristobal and Isabela vs. Santa Cruz and Floreana), and overall highly significantly distributed toward islands that were inhabited by humans (San Cristobal, Isabela, Floreana) vs. uninhabited at the time of collection (Santa Cruz, Santa Fe, Espanola), with only one positive individual on an uninhabited island. Eleven of the positive specimens sequenced successfully were identical at four diagnostic sites to the two canarypox variants previously described in contemporary Galapagos passerines. We conclude that this virus was introduced late in 1890's and was dispersed among islands by a variety of mechanisms, including regular human movements among colonized islands. At present, this disease represents an ongoing threat to the birds on the Galapagos Islands.	[Parker, Patricia G.; Whiteman, Noah K.; Ricklefs, Robert E.; Bollmer, Jennifer L.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA; [Parker, Patricia G.] WildCare Inst, St Louis, MO USA; [Buckles, Elizabeth L.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Farrington, Heather; Petren, Kenneth] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA; [Jimenez-Uzcategui, Gustavo] Charles Darwin Fdn, Dept Vertebrates, Puerto Ayora, Ecuador	University of Missouri System; University of Missouri Saint Louis; Cornell University; University System of Ohio; University of Cincinnati	Parker, PG (corresponding author), Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.	pparker@umsl.edu	Jimenez-Uzcategui, Gustavo/AAN-7374-2020; Jiménez-Uzcátegui, Gustavo/AAJ-3802-2020	Jimenez-Uzcategui, Gustavo/0000-0001-8520-7534; Whiteman, Noah/0000-0003-1448-4678; Petren, Kenneth/0000-0002-7936-6042	E. Desmond Lee Endowment in Zoological Studies	E. Desmond Lee Endowment in Zoological Studies	This work was supported by the E. Desmond Lee Endowment in Zoological Studies associated with PGP's position. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbogast BS, 2006, EVOLUTION, V60, P370, DOI 10.1111/j.0014-3820.2006.tb01113.x; Atkinson CT, 2009, J AVIAN MED SURG, V23, P53, DOI 10.1647/2008-059.1; Bataille A, 2009, P ROY SOC B-BIOL SCI, V276, P3769, DOI 10.1098/rspb.2009.0998; Bataille A, 2009, P NATL ACAD SCI USA, V106, P10230, DOI 10.1073/pnas.0901308106; Causton CE, 2006, ANN ENTOMOL SOC AM, V99, P121, DOI 10.1603/0013-8746(2006)099[0121:AITAIF]2.0.CO;2; Conway Ainslee, 1947, ENCHANTED ISLANDS; CURRY RL, 1989, J ANIM ECOL, V58, P441, DOI 10.2307/4841; DASZAK P, 2003, J PARASITOL, V89, pS37; de Castro F, 2005, ECOL LETT, V8, P117, DOI 10.1111/j.1461-0248.2004.00693.x; DEEM SL, GALAPAGOS R IN PRESS; Gadberry MD, 2005, BIOINFORMATICS, V21, P1263, DOI 10.1093/bioinformatics/bti134; Gifford E. W., 1919, Proceedings of the California Academy of Science (4th Series), V2; Hoeck PEA, 2010, BIOL LETTERS, V6, P212, DOI 10.1098/rsbl.2009.0778; Hoeck PEA, 2010, PHILOS T R SOC B, V365, P1127, DOI 10.1098/rstb.2009.0311; Jarvi SI, 2008, CONSERV GENET, V9, P339, DOI 10.1007/s10592-007-9346-7; JIMENEZUZCATEGU.G, 2007, BRENESIA, V67, P29; JIMENEZUZCATEGU.G, 2008, CENSO CUCUVE FLOREAN; KLEINDORFER S, 2006, J AVIAN BIOL, V22, P247; Levin II, 2009, BIOL CONSERV, V142, P3191, DOI 10.1016/j.biocon.2009.06.017; Lindstrom KM, 2004, P ROY SOC B-BIOL SCI, V271, P1513, DOI 10.1098/rspb.2004.2752; Petren K, 2005, MOL ECOL, V14, P2943, DOI 10.1111/j.1365-294X.2005.02632.x; Santiago-Alarcon D, 2006, WILSON J ORNITHOL, V118, P194, DOI 10.1676/05-010.1; Sato A, 2001, MOL BIOL EVOL, V18, P299, DOI 10.1093/oxfordjournals.molbev.a003806; Smith KF, 2006, CONSERV BIOL, V20, P1349, DOI 10.1111/j.1523-1739.2006.00524.x; STEADMAN DW, 1991, QUATERNARY RES, V36, P126, DOI 10.1016/0033-5894(91)90021-V; STEADMAN DW, 2006, EXT BIOG TROP PAC, pR9; STEADMAN DW, 1986, SMITHSONIAN CONTRIB, V4131, P1; Thiel T, 2005, J WILDLIFE DIS, V41, P342, DOI 10.7589/0090-3558-41.2.342; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tripathy D. N., 1993, V4, P5; Van Riper C, 2002, AUK, V119, P929, DOI 10.1642/0004-8038(2002)119[0929:EAEOAP]2.0.CO;2; van Riper C, 2001, STUD AVIAN BIOL-SER, P221; van Riper Charles III, 2007, P131, DOI 10.1002/9780470344668.ch6; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; VARGAS H, 1987, J FIELD ORNITHOL, V58, P101; WARNER RE, 1968, CONDOR, V70, P101, DOI 10.2307/1365954; Watkins G., 2007, GALAPAGOS RISK SOCIO; Whiteman NK, 2005, IBIS, V147, P844, DOI 10.1111/j.1474-919x.2005.00468.x; Whiteman NK, 2006, P ROY SOC B-BIOL SCI, V273, P797, DOI 10.1098/rspb.2005.3396; Wikelski M, 2004, ECOL SOC, V9	40	59	62	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e15989	10.1371/journal.pone.0015989	http://dx.doi.org/10.1371/journal.pone.0015989			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249151	Green Published, gold			2022-12-27	WOS:000286515000009
J	Jufvas, A; Stralfors, P; Vener, AV				Jufvas, Asa; Stralfors, Peter; Vener, Alexander V.			Histone Variants and Their Post-Translational Modifications in Primary Human Fat Cells	PLOS ONE			English	Article							INSULIN-RESISTANCE; GENE-EXPRESSION; PHOSPHORYLATION; H2B; PROTEIN; LYSINE; H3; ACETYLATION; METHYLTRANSFERASE; REPLICATION	Epigenetic changes related to human disease cannot be fully addressed by studies of cells from cultures or from other mammals. We isolated human fat cells from subcutaneous abdominal fat tissue of female subjects and extracted histones from either purified nuclei or intact cells. Direct acid extraction of whole adipocytes was more efficient, yielding about 100 mu g of protein with histone content of 60%-70% from 10 mL of fat cells. Differential proteolysis of the protein extracts by trypsin or ArgC-protease followed by nanoLC/MS/MS with alternating CID/ETD peptide sequencing identified 19 histone variants. Four variants were found at the protein level for the first time; particularly HIST2H4B was identified besides the only H4 isoform earlier known to be expressed in humans. Three of the found H2A potentially organize small nucleosomes in transcriptionally active chromatin, while two H2AFY variants inactivate X chromosome in female cells. HIST1H2BA and three of the identified H1 variants had earlier been described only as oocyte or testis specific histones. H2AFX and H2AFY revealed differential and variable N-terminal processing. Out of 78 histone modifications by acetylation/trimethylation, methylation, dimethylation, phosphorylation and ubiquitination, identified from six subjects, 68 were found for the first time. Only 23 of these modifications were detected in two or more subjects, while all the others were individual specific. The direct acid extraction of adipocytes allows for personal epigenetic analyses of human fat tissue, for profiling of histone modifications related to obesity, diabetes and metabolic syndrome, as well as for selection of individual medical treatments.	[Jufvas, Asa; Stralfors, Peter; Vener, Alexander V.] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden	Linkoping University	Jufvas, A (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.	alexander.vener@liu.se		Stralfors, Peter/0000-0002-1196-1806	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grants from the Swedish Research Council to P.S. and to A.V.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboulaich N, 2004, BIOCHEM J, V383, P237, DOI 10.1042/BJ20040647; Akan P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004479; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Bonenfant D, 2006, MOL CELL PROTEOMICS, V5, P541, DOI 10.1074/mcp.M500288-MCP200; Brasacchio D, 2009, DIABETES, V58, P1229, DOI 10.2337/db08-1666; Carlberg I, 2003, P NATL ACAD SCI USA, V100, P757, DOI 10.1073/pnas.0235452100; Chandrasekharan MB, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12314; Chandrasekharan MB, 2010, MOL CELL BIOL, V30, P3216, DOI 10.1128/MCB.01008-09; Chandrasekharan MB, 2009, P NATL ACAD SCI USA, V106, P16686, DOI 10.1073/pnas.0907862106; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Cosgrove MS, 2005, BIOCHEM CELL BIOL, V83, P468, DOI 10.1139/O05-137; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; Danielsson A, 2005, FEBS J, V272, P141, DOI 10.1111/j.1432-1033.2004.04396.x; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; DRABENT B, 1991, GENE, V103, P263, DOI 10.1016/0378-1119(91)90284-I; Draker R, 2009, BIOCHEM CELL BIOL, V87, P19, DOI 10.1139/O08-117; El-Osta A, 2008, J EXP MED, V205, P2409, DOI 10.1084/jem.20081188; Gamble MJ, 2010, CELL CYCLE, V9, P2568, DOI 10.4161/cc.9.13.12144; Garcia BA, 2008, J PROTEOME RES, V7, P4225, DOI 10.1021/pr800044q; Garcia BA, 2007, J BIOL CHEM, V282, P7641, DOI 10.1074/jbc.M607900200; Gevry N, 2009, GENE DEV, V23, P1522, DOI 10.1101/gad.1787109; Golebiowski F, 2005, MOL CELL BIOCHEM, V279, P133, DOI 10.1007/s11010-005-8285-1; Guillemette B, 2006, BIOCHEM CELL BIOL, V84, P528, DOI 10.1139/O06-077; Hardy S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000687; HAYASHI T, 1982, J BIOCHEM-TOKYO, V92, P1995, DOI 10.1093/oxfordjournals.jbchem.a134131; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jiang T, 2007, P NATL ACAD SCI USA, V104, P60, DOI 10.1073/pnas.0606775103; Jung HR, 2010, MOL CELL PROTEOMICS, V9, P838, DOI 10.1074/mcp.M900489-MCP200; Kabra Dhiraj G, 2009, Biochim Biophys Acta, V1792, P574, DOI 10.1016/j.bbadis.2009.03.003; KUROKAWA M, 1988, CARCINOGENESIS, V9, P419, DOI 10.1093/carcin/9.3.419; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Li Y, 2008, J BIOL CHEM, V283, P26771, DOI 10.1074/jbc.M802800200; Lu AP, 2009, J PROTEOME RES, V8, P4207, DOI 10.1021/pr9000652; MARASHI F, 1984, P NATL ACAD SCI-BIOL, V81, P1936, DOI 10.1073/pnas.81.7.1936; Martianov I, 2005, P NATL ACAD SCI USA, V102, P2808, DOI 10.1073/pnas.0406060102; Martin-Gronert MS, 2010, J NUTR, V140, P662, DOI 10.3945/jn.109.111237; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; Molina H, 2008, ANAL CHEM, V80, P4825, DOI 10.1021/ac8007785; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Musri MM, 2007, BIOCHEM CELL BIOL, V85, P397, DOI 10.1139/O07-068; Musri MM, 2006, J BIOL CHEM, V281, P17180, DOI 10.1074/jbc.M601295200; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Oge A, 2007, DIABETOLOGIA, V50, P1099, DOI 10.1007/s00125-007-0617-0; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ost A, 2010, MOL MED, V16, P235, DOI 10.2119/molmed.2010.00023; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; OZBAL CC, 1994, CANCER RES, V54, P5599; Raychaudhuri N, 2008, J BIOL CHEM, V283, P13611, DOI 10.1074/jbc.M800128200; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schwanbeck R, 1997, J BIOL CHEM, V272, P27476, DOI 10.1074/jbc.272.43.27476; Shevchenko A, 2002, MOL BIOTECHNOL, V20, P107, DOI 10.1385/MB:20:1:107; Sobott F, 2009, J AM SOC MASS SPECTR, V20, P1652, DOI 10.1016/j.jasms.2009.04.023; STRALFORS P, 1989, EUR J BIOCHEM, V182, P379, DOI 10.1111/j.1432-1033.1989.tb14842.x; Su XD, 2009, PROTEOMICS, V9, P1197, DOI 10.1002/pmic.200800333; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Tanaka M, 2001, DEVELOPMENT, V128, P655; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Thakar A, 2009, BIOCHEMISTRY-US, V48, P10852, DOI 10.1021/bi901129e; Tolstorukov MY, 2009, GENOME RES, V19, P967, DOI 10.1101/gr.084830.108; Trelle MB, 2007, EXPERT REV PROTEOMIC, V4, P491, DOI 10.1586/14789450.4.4.491; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Villeneuve LM, 2008, P NATL ACAD SCI USA, V105, P9047, DOI 10.1073/pnas.0803623105; Waterborg JH, 2000, J BIOL CHEM, V275, P13007, DOI 10.1074/jbc.275.17.13007; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; Young NL, 2009, MOL CELL PROTEOMICS, V8, P2266, DOI 10.1074/mcp.M900238-MCP200; YU L, 1994, J BIOL CHEM, V269, P4144; Zalensky AO, 2002, J BIOL CHEM, V277, P43474, DOI 10.1074/jbc.M206065200	71	26	27	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e15960	10.1371/journal.pone.0015960	http://dx.doi.org/10.1371/journal.pone.0015960			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249133	Green Published, gold			2022-12-27	WOS:000286512900014
J	Chowdhury, SR; Savithri, HS				Chowdhury, Soumya Roy; Savithri, Handanahal S.			Interaction of Sesbania Mosaic Virus Movement Protein with VPg and P10: Implication to Specificity of Genome Recognition	PLOS ONE			English	Article							CELL-TO-CELL; DEPENDENT RNA-POLYMERASE; COCKSFOOT-MOTTLE-VIRUS; NATIVELY UNFOLDED VPG; LINKED PROTEIN; SERINE-PROTEASE; CAPSID PROTEIN; POTYVIRUS; BINDING; REPLICATION	Sesbania mosaic virus (SeMV) is a single strand positive-sense RNA plant virus that belongs to the genus Sobemovirus. The mechanism of cell-to-cell movement in sobemoviruses has not been well studied. With a view to identify the viral encoded ancillary proteins of SeMV that may assist in cell-to-cell movement of the virus, all the proteins encoded by SeMV genome were cloned into yeast Matchmaker system 3 and interaction studies were performed. Two proteins namely, viral protein genome linked (VPg) and a 10-kDa protein (P10) c v gft encoded by OFR 2a, were identified as possible interacting partners in addition to the viral coat protein (CP). Further characterization of these interactions revealed that the movement protein (MP) recognizes cognate RNA through interaction with VPg, which is covalently linked to the 59 end of the RNA. Analysis of the deletion mutants delineated the domains of MP involved in the interaction with VPg and P10. This study implicates for the first time that VPg might play an important role in specific recognition of viral genome by MP in SeMV and shed light on the possible role of P10 in the viral movement.	[Chowdhury, Soumya Roy; Savithri, Handanahal S.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Chowdhury, SR (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	bchss@biochem.iisc.ernet.in			Department of Biotechnology, New Delhi, India; Indian Institute of Science, Bangalore, India [BT/PR9527/INF/22/75/2007/25-9.2009]; University Grant Commission, New Delhi, India	Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India); Indian Institute of Science, Bangalore, India; University Grant Commission, New Delhi, India(University Grants Commission, India)	The authors thank the Department of Biotechnology, New Delhi, India and Indian Institute of Science, Bangalore, India, grant number BT/PR9527/INF/22/75/2007/25-9.2009, for financial support. Soumya Roy Chowdhury thanks the University Grant Commission, New Delhi, India, for the senior research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzhanova DV, 2001, EMBO J, V20, P6997, DOI 10.1093/emboj/20.24.6997; BHUVANESHWARI M, 1995, STRUCTURE, V3, P1021, DOI 10.1016/S0969-2126(01)00238-6; Bonneau C, 1998, VIROLOGY, V244, P79, DOI 10.1006/viro.1998.9100; Carrington JC, 1996, PLANT CELL, V8, P1669, DOI 10.1105/tpc.8.10.1669; Carrington JC, 1998, PLANT J, V14, P393, DOI 10.1046/j.1365-313X.1998.00120.x; Carvalho CM, 2003, J GEN VIROL, V84, P2271, DOI 10.1099/vir.0.19101-0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHOWDHURY SR, 2010, MOL CHARACTERIZATION; Dolja V V, 1995, Virology, V206, P1007, DOI 10.1006/viro.1995.1023; DOLJA VV, 1994, EMBO J, V13, P1482, DOI 10.1002/j.1460-2075.1994.tb06403.x; Dunoyer P, 2004, J VIROL, V78, P2301, DOI 10.1128/JVI.78.5.2301-2309.2004; Goodfellow I, 2005, EMBO REP, V6, P968, DOI 10.1038/sj.embor.7400510; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; GORBALENYA AE, 1988, FEBS LETT, V235, P16, DOI 10.1016/0014-5793(88)81226-2; Govind K, 2010, VIROLOGY, V401, P280, DOI 10.1016/j.virol.2010.02.025; Grzela R, 2008, J BIOL CHEM, V283, P213, DOI 10.1074/jbc.M705666200; Gu CJ, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1132, DOI 10.1134/S0006297909100095; HASHIMOTO Y, 1986, ARCH VIROL, V90, P301, DOI 10.1007/BF01317378; Herzog E, 1998, VIROLOGY, V248, P312, DOI 10.1006/viro.1998.9287; Kaiser WJ, 2006, J GEN VIROL, V87, P363, DOI 10.1099/vir.0.81456-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawrence DM, 2001, J VIROL, V75, P8712, DOI 10.1128/JVI.75.18.8712-8723.2001; Lee JY, 2001, TRENDS MICROBIOL, V9, P5, DOI 10.1016/S0966-842X(00)01901-6; Leonard S, 2000, J VIROL, V74, P7730, DOI 10.1128/JVI.74.17.7730-7737.2000; LI B, 1993, FASEB J, V7, P957, DOI 10.1096/fasebj.7.10.8344494; Lokesh GL, 2001, ARCH VIROL, V146, P209, DOI 10.1007/s007050170170; Lucas WJ, 2006, VIROLOGY, V344, P169, DOI 10.1016/j.virol.2005.09.026; Meier M, 2006, VIRUS GENES, V32, P321, DOI 10.1007/s11262-005-6917-x; Morozov SY, 2003, J GEN VIROL, V84, P1351, DOI 10.1099/vir.0.18922-0; NAIR S, 2009, FEBS LETT; Nair S, 2008, VIROLOGY, V382, P83, DOI 10.1016/j.virol.2008.08.034; Nair S, 2010, VIROLOGY, V396, P106, DOI 10.1016/j.virol.2009.09.025; OSMAN TAM, 1992, J GEN VIROL, V73, P223, DOI 10.1099/0022-1317-73-2-223; Rantalainen KI, 2008, VIROLOGY, V377, P280, DOI 10.1016/j.virol.2008.04.025; Rojas MR, 1997, VIROLOGY, V237, P283, DOI 10.1006/viro.1997.8777; Rojas MR, 1998, CELL, V95, P105, DOI 10.1016/S0092-8674(00)81786-9; ROULEAU M, 1994, VIROLOGY, V204, P254, DOI 10.1006/viro.1994.1530; Sarmiento C, 2007, VIRUS RES, V123, P95, DOI 10.1016/j.virusres.2006.07.013; Satheshkumar PS, 2005, J MOL BIOL, V353, P447, DOI 10.1016/j.jmb.2005.08.021; Satheshkumar PS, 2005, J BIOL CHEM, V280, P30291, DOI 10.1074/jbc.M504122200; Satheshkumar PS, 2004, J MOL BIOL, V342, P1001, DOI 10.1016/j.jmb.2004.07.022; Savithri HS, 2010, CURR SCI INDIA, V98, P346; Scholthof HB, 2005, TRENDS PLANT SCI, V10, P376, DOI 10.1016/j.tplants.2005.07.002; Sivakumaran K, 1998, VIROLOGY, V252, P376, DOI 10.1006/viro.1998.9489; SKRYABIN KG, 1988, FEBS LETT, V240, P33, DOI 10.1016/0014-5793(88)80335-1; Tamm T, 2000, VIRUS RES, V66, P197, DOI 10.1016/S0168-1702(00)00125-8; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Vucetic S, 2007, J PROTEOME RES, V6, P1899, DOI 10.1021/pr060393m; YOSHIDA N, 1988, J BIOCHEM, V104, P451, DOI 10.1093/oxfordjournals.jbchem.a122488	52	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15609	10.1371/journal.pone.0015609	http://dx.doi.org/10.1371/journal.pone.0015609			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246040	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000286511200010
J	Cummings, V; Hewitt, J; Van Rooyen, A; Currie, K; Beard, S; Thrush, S; Norkko, J; Barr, N; Heath, P; Halliday, NJ; Sedcole, R; Gomez, A; McGraw, C; Metcalf, V				Cummings, Vonda; Hewitt, Judi; Van Rooyen, Anthony; Currie, Kim; Beard, Samuel; Thrush, Simon; Norkko, Joanna; Barr, Neill; Heath, Philip; Halliday, N. Jane; Sedcole, Richard; Gomez, Antony; McGraw, Christina; Metcalf, Victoria			Ocean Acidification at High Latitudes: Potential Effects on Functioning of the Antarctic Bivalve Laternula elliptica	PLOS ONE			English	Article							OXYGEN-CONSUMPTION; SOUTHERN-OCEAN; TEMPERATURE; IMPACT; EVOLUTIONARY; DISSOLUTION; GROWTH; KING; VULNERABILITY; ADAPTATION	Ocean acidification is a well recognised threat to marine ecosystems. High latitude regions are predicted to be particularly affected due to cold waters and naturally low carbonate saturation levels. This is of concern for organisms utilising calcium carbonate (CaCO3) to generate shells or skeletons. Studies of potential effects of future levels of pCO(2) on high latitude calcifiers are at present limited, and there is little understanding of their potential to acclimate to these changes. We describe a laboratory experiment to compare physiological and metabolic responses of a key benthic bivalve, Laternula elliptica, at pCO(2) levels of their natural environment (430 mu atm, pH 7.99; based on field measurements) with those predicted for 2100 (735 mu atm, pH 7.78) and glacial levels (187 mu atm, pH 8.32). Adult L. elliptica basal metabolism (oxygen consumption rates) and heat shock protein HSP70 gene expression levels increased in response both to lowering and elevation of pH. Expression of chitin synthase (CHS), a key enzyme involved in synthesis of bivalve shells, was significantly up-regulated in individuals at pH 7.78, indicating L. elliptica were working harder to calcify in seawater undersaturated in aragonite (Omega(Ar) = 0.71), the CaCO3 polymorph of which their shells are comprised. The different response variables were influenced by pH in differing ways, highlighting the importance of assessing a variety of factors to determine the likely impact of pH change. In combination, the results indicate a negative effect of ocean acidification on whole-organism functioning of L. elliptica over relatively short terms (weeks-months) that may be energetically difficult to maintain over longer time periods. Importantly, however, the observed changes in L. elliptica CHS gene expression provides evidence for biological control over the shell formation process, which may enable some degree of adaptation or acclimation to future ocean acidification scenarios.	[Cummings, Vonda; Barr, Neill; Heath, Philip] Natl Inst Water & Atmospher Res, Mahanga Bay Aquaculture Facil, Wellington, New Zealand; [Hewitt, Judi; Thrush, Simon] Natl Inst Water & Atmospher Res, Hillcrest, New Zealand; [Van Rooyen, Anthony; Beard, Samuel; Sedcole, Richard; Metcalf, Victoria] Lincoln Univ, Dept Wine Food & Mol Biosci, Lincoln, New Zealand; [Currie, Kim] Natl Inst Water & Atmospher Res, Dunedin, New Zealand; [Norkko, Joanna] Abo Akad Univ, Turku, Finland; [McGraw, Christina] Univ Otago, Dept Chem, Dunedin, New Zealand	National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Lincoln University - New Zealand; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Abo Akademi University; University of Otago	Cummings, V (corresponding author), Natl Inst Water & Atmospher Res, Mahanga Bay Aquaculture Facil, Wellington, New Zealand.	v.cummings@niwa.co.nz	Metcalf, Victoria/C-1933-2013	Halliday, Jane/0000-0002-9718-0348; Metcalf, Victoria/0000-0002-0833-7965; Norkko, Joanna/0000-0001-9885-8408; McGraw, Christina/0000-0001-5841-0748; Thrush, Simon/0000-0002-4005-3882; Cummings, Vonda/0000-0003-1076-3995	New Zealand Foundation for Research, Science and Technology [COX01707]; National Institute of Water and Atmospheric Research	New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology); National Institute of Water and Atmospheric Research	This research was funded by the New Zealand Foundation for Research, Science and Technology International Polar Year project COX01707, and the National Institute of Water and Atmospheric Research Capital Expenditure fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele D, 2001, ANTARCT SCI, V13, P111, DOI 10.1017/S0954102001000189; Ahn In-Young, 2001, Ocean and Polar Research, V23, P419; AHN IY, 1993, J EXP MAR BIOL ECOL, V171, P75, DOI 10.1016/0022-0981(93)90141-A; Andersson AJ, 2008, MAR ECOL PROG SER, V373, P265, DOI 10.3354/meps07639; [Anonymous], 2009, BIOGEOSCI DISCUSS, DOI DOI 10.5194/BGD-6-3109-2009; Brockington S, 2001, POLAR BIOL, V24, P523, DOI 10.1007/s003000100251; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Chang ES, 2005, INTEGR COMP BIOL, V45, P43, DOI 10.1093/icb/45.1.43; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Clark D, 2009, MAR BIOL, V156, P1125, DOI 10.1007/s00227-009-1155-8; Clark MS, 2008, POLAR BIOL, V31, P1059, DOI 10.1007/s00300-008-0447-7; Clark MS, 2008, CELL STRESS CHAPERON, V13, P39, DOI 10.1007/s12192-008-0014-8; Clark MS, 2009, CELL STRESS CHAPERON, V14, P649, DOI 10.1007/s12192-009-0117-x; CLARKE A, 1987, MAR ECOL PROG SER, V38, P89, DOI 10.3354/meps038089; Comeau S, 2009, BIOGEOSCIENCES, V6, P1877, DOI 10.5194/bg-6-1877-2009; Cottingham KL, 2005, FRONT ECOL ENVIRON, V3, P145, DOI 10.1890/1540-9295(2005)003[0145:KWTDTL]2.0.CO;2; Cummings V, 2006, ANTARCT SCI, V18, P633, DOI 10.1017/S0954102006000666; Dickson A.G., 2007, GUIDE BEST PRACTICES; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Ellis JI, 1997, ENVIRON MONIT ASSESS, V48, P157, DOI 10.1023/A:1005752603707; Ericson JA, 2010, MAR BIOL, V157, P2689, DOI 10.1007/s00227-010-1529-y; Fabbri E., 2008, ISJ, V5, P135; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Franzellitti S, 2005, BIOCHEM BIOPH RES CO, V336, P1157, DOI 10.1016/j.bbrc.2005.08.244; Green MA, 2009, LIMNOL OCEANOGR, V54, P1037, DOI 10.4319/lo.2009.54.4.1037; Guinotte JM, 2008, ANN NY ACAD SCI, V1134, P320, DOI 10.1196/annals.1439.013; Harper EM, 2006, ZOOL J LINN SOC-LOND, V148, P395, DOI 10.1111/j.1096-3642.2006.00260.x; Harper EM, 2000, J ZOOL, V251, P179, DOI 10.1111/j.1469-7998.2000.tb00602.x; Hauton C, 2009, BIOGEOSCI DISCUSS, V6, P919, DOI DOI 10.5194/BGD-6-919-2009; Havenhand JN, 2009, BIOGEOSCIENCES, V6, P3009, DOI 10.5194/bg-6-3009-2009; Heilmayer O, 2003, MAR BIOL, V143, P477, DOI 10.1007/s00227-003-1079-7; HOEGHGULDBERG O, 1995, J EXP BIOL, V198, P19; Ishimatsu A, 2004, J OCEANOGR, V60, P731, DOI 10.1007/s10872-004-5765-y; Kleypas JA, 2006, WORKSH HELD 18 20 AP; Langenbuch M, 2003, J EXP BIOL, V206, P3895, DOI 10.1242/jeb.00620; Lenton A, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038227; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; McClintock JB, 2009, ANTARCT SCI, V21, P449, DOI 10.1017/S0954102009990198; MCGRAW CM, LIMNOL OCEA IN PRESS; McNeil BI, 2008, P NATL ACAD SCI USA, V105, P18860, DOI 10.1073/pnas.0806318105; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Miller AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005661; MORELY SA, 2009, COMP BIOCH PHYSL A, V153, P154; Morley SA, 2007, OECOLOGIA, V153, P29, DOI 10.1007/s00442-007-0720-4; Moy AD, 2009, NAT GEOSCI, V2, P276, DOI 10.1038/NGEO460; Munday PL, 2009, P ROY SOC B-BIOL SCI, V276, P3275, DOI 10.1098/rspb.2009.0784; Norkko A, 2007, ECOLOGY, V88, P2810, DOI 10.1890/06-1396.1; Norkko J, 2006, J EXP MAR BIOL ECOL, V337, P38, DOI 10.1016/j.jembe.2006.06.003; Norkko J, 2005, J EXP MAR BIOL ECOL, V326, P144, DOI 10.1016/j.jembe.2005.05.014; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Park H, 2007, CELL STRESS CHAPERON, V12, P275, DOI 10.1379/CSC-271.1; Peck LS, 2005, ANTARCT SCI, V17, P497, DOI 10.1017/S0954102005002920; Peck LS, 2004, FUNCT ECOL, V18, P625, DOI 10.1111/j.0269-8463.2004.00903.x; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Philipp E, 2005, MECH AGEING DEV, V126, P598, DOI 10.1016/j.mad.2004.12.003; Portner HO, 1999, COMP BIOCHEM PHYS A, V124, P179, DOI 10.1016/S1095-6433(99)00105-1; Raven J.A., 2005, 1205 ROYAL SOC, DOI DOI 10.1080/02688690801911598; Revelle R., 1957, GEOL SOC AM MEM, V67, P239; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; ROPER DS, 1991, MAR ENVIRON RES, V31, P197, DOI 10.1016/0141-1136(91)90011-V; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Schonitzer V, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-71; Schwarz AM, 2003, POLAR BIOL, V26, P789, DOI 10.1007/s00300-003-0556-2; Somerfield PJ, 2002, J ANIM ECOL, V71, P581, DOI 10.1046/j.1365-2656.2002.00624.x; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; TAYLOR AC, 1995, COMP BIOCHEM PHYS A, V112, P333, DOI 10.1016/0300-9629(95)00106-9; Tomanek L, 1999, J EXP BIOL, V202, P2925; Twitchett R.J., 2009, BIOGEOSCIENCES DISCU, V6, P2267, DOI [DOI 10.5194/BGD-6-2267-2009, 10.5194/bgd-6-2267-2009]; Urban HJ, 1998, ANTARCT SCI, V10, P153, DOI 10.1017/S0954102098000200; Waldbusser GG, 2011, ESTUAR COAST, V34, P221, DOI 10.1007/s12237-010-9307-0; Weiss IM, 2006, FEBS LETT, V580, P1846, DOI 10.1016/j.febslet.2006.02.044; Weiss IM, 2006, J STRUCT BIOL, V153, P264, DOI 10.1016/j.jsb.2005.11.006; Widdicombe S, 2008, J EXP MAR BIOL ECOL, V366, P187, DOI 10.1016/j.jembe.2008.07.024; Wood HL, 2008, P ROY SOC B-BIOL SCI, V275, P1767, DOI 10.1098/rspb.2008.0343; Zhang HN, 1996, MAR CHEM, V52, P17, DOI 10.1016/0304-4203(95)00076-3	77	121	122	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e16069	10.1371/journal.pone.0016069	http://dx.doi.org/10.1371/journal.pone.0016069			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21245932	Green Published, gold			2022-12-27	WOS:000286511200033
J	Logie, JJ; Ali, S; Marshall, KM; Heck, MMS; Walker, BR; Hadoke, PWF				Logie, James J.; Ali, Sadaf; Marshall, Kathryn M.; Heck, Margarete M. S.; Walker, Brian R.; Hadoke, Patrick W. F.			Glucocorticoid-Mediated Inhibition of Angiogenic Changes in Human Endothelial Cells Is Not Caused by Reductions in Cell Proliferation or Migration	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR GENE; IN-VITRO; ANGIOSTATIC STEROIDS; DEXAMETHASONE; RAT; EXPRESSION; MECHANISM; MATRIX; VIVO	Background: Glucocorticoid-mediated inhibition of angiogenesis is important in physiology, pathophysiology and therapy. However, the mechanisms through which glucocorticoids inhibit growth of new blood vessels have not been established. This study addresses the hypothesis that physiological levels of glucocorticoids inhibit angiogenesis by directly preventing tube formation by endothelial cells. Methodology/Principal Findings: Cultured human umbilical vein (HUVEC) and aortic (HAoEC) endothelial cells were used to determine the influence of glucocorticoids on tube-like structure (TLS) formation, and on cellular proliferation (5-bromo-2'-deoxyuridine (BrdU) incorporation), viability (ATP production) and migration (Boyden chambers). Dexamethasone or cortisol (at physiological concentrations) inhibited both basal and prostaglandin F(2 alpha) (PGF(2 alpha))-induced and vascular endothelial growth factor (VEGF) stimulated TLS formation in endothelial cells (ECs) cultured on Matrigel, effects which were blocked with the glucocorticoid receptor antagonist RU38486. Glucocorticoids had no effect on EC viability, migration or proliferation. Time-lapse imaging showed that cortisol blocked VEGF-stimulated cytoskeletal reorganisation and initialisation of tube formation. Real time PCR suggested that increased expression of thrombospodin-1 contributed to glucocorticoid-mediated inhibition of TLS formation. Conclusions/Significance: We conclude that glucocorticoids interact directly with glucocorticoid receptors on vascular ECs to inhibit TLS formation. This action, which was conserved in ECs from two distinct vascular territories, was due to alterations in cell morphology rather than inhibition of EC viability, migration or proliferation and may be mediated in part by induction of thrombospodin-1. These findings provide important insights into the anti-angiogenic action of endogenous glucocorticoids in health and disease.	[Logie, James J.; Ali, Sadaf; Marshall, Kathryn M.; Heck, Margarete M. S.; Walker, Brian R.; Hadoke, Patrick W. F.] Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh	Logie, JJ (corresponding author), Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland.	phadoke@staffmail.ed.ac.uk		Marshall, Kathryn/0000-0002-3645-1909	Medical Research Council; Medical Research Scotland; Wellcome Trust; British Heart Foundation	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Scotland; Wellcome Trust(Wellcome Trust); British Heart Foundation(British Heart Foundation)	JJL was funded by a Medical Research Council studentship and KMM was funded by a postdoctoral fellowship from Medical Research Scotland. MMSH is a Wellcome Trust University Award holder. PWFH and BRW are funded by the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banciu M, 2006, J CONTROL RELEASE, V113, P1, DOI 10.1016/j.jconrel.2006.03.019; BERK BC, 1988, J CELL PHYSIOL, V137, P391, DOI 10.1002/jcp.1041370302; BLEI F, 1993, J CELL PHYSIOL, V155, P568, DOI 10.1002/jcp.1041550315; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Bussolati B, 2001, AM J PATHOL, V159, P993, DOI 10.1016/S0002-9440(10)61775-0; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chen WL, 2006, OCUL IMMUNOL INFLAMM, V14, P215, DOI 10.1080/09273940600732380; Christy C, 2003, HYPERTENSION, V42, P580, DOI 10.1161/01.HYP.0000088855.06598.5B; COLVILLENASH PR, 1992, ANN RHEUM DIS, V51, P919, DOI 10.1136/ard.51.7.919; FOLKMAN J, 1983, SCIENCE, V221, P719, DOI 10.1126/science.6192498; FOLKMAN J, 1987, ANN SURG, V206, P374, DOI 10.1097/00000658-198709000-00016; Gille J, 2001, J INVEST DERMATOL, V117, P1581, DOI 10.1046/j.0022-202x.2001.01573.x; GREEN JP, 1965, BRIT J SURG, V52, P523, DOI 10.1002/bjs.1800520710; Hadoke PWF, 2009, BRIT J PHARMACOL, V156, P689, DOI 10.1111/j.1476-5381.2008.00047.x; Harada I, 1992, Nihon Seikeigeka Gakkai Zasshi, V66, P763; Hasan Q, 2000, PEDIATRICS, V105, P117, DOI 10.1542/peds.105.1.117; Kraling BM, 1999, J CELL SCI, V112, P1599; LONGENECKER JP, 1984, J CELL BIOL, V98, P534, DOI 10.1083/jcb.98.2.534; LONGENECKER JP, 1982, J CELL PHYSIOL, V113, P197, DOI 10.1002/jcp.1041130203; Luo JC, 2004, EUR J PHARMACOL, V485, P275, DOI 10.1016/j.ejphar.2003.11.038; Machein MR, 1999, NEUROPATH APPL NEURO, V25, P104; Matsuda S, 2005, INVEST OPHTH VIS SCI, V46, P1062, DOI 10.1167/iovs.04-0761; McHugh B, 2004, J CELL BIOL, V167, P673, DOI 10.1083/jcb.200405155; Meadows KN, 2001, J BIOL CHEM, V276, P49289, DOI 10.1074/jbc.M108069200; MORALES DE, 1995, CIRCULATION, V91, P755, DOI 10.1161/01.CIR.91.3.755; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; Nauck M, 1998, EUR J PHARMACOL, V341, P309, DOI 10.1016/S0014-2999(97)01464-7; Oberleithner H, 2003, J MEMBRANE BIOL, V196, P163, DOI 10.1007/s00239-003-0635-6; Pross C, 2002, J VASC SURG, V35, P1253, DOI 10.1067/mva.2002.123332; Pufe T, 2003, BONE, V33, P869, DOI 10.1016/j.bone.2003.08.002; Rae M, 2009, J CLIN ENDOCR METAB, V94, P1443, DOI 10.1210/jc.2008-1879; Rao R, 2007, J BIOL CHEM, V282, P16959, DOI 10.1074/jbc.M701214200; Small GR, 2005, P NATL ACAD SCI USA, V102, P12165, DOI 10.1073/pnas.0500641102; Stitt AW, 2005, DIABETES, V54, P785, DOI 10.2337/diabetes.54.3.785; STOKES CL, 1990, MICROVASC RES, V40, P279, DOI 10.1016/0026-2862(90)90025-M; Tamura M, 2002, J CLIN ENDOCR METAB, V87, P3504, DOI 10.1210/jc.87.7.3504; Wang YS, 2002, GRAEF ARCH CLIN EXP, V240, P42, DOI 10.1007/s00417-001-0398-y; Weinstein RS, 2010, AGING CELL, V9, P147, DOI 10.1111/j.1474-9726.2009.00545.x; Wen FQ, 2003, J ALLERGY CLIN IMMUN, V111, P1307, DOI 10.1067/mai.2003.1455; Wilasrusmee C, 2003, CLIN TRANSPLANT, V17, P6, DOI 10.1034/j.1399-0012.17.s9.1.x; Yang Shumei, 2004, Current Vascular Pharmacology, V2, P1, DOI 10.2174/1570161043476483; Yano A, 2006, CLIN CANCER RES, V12, P3003, DOI 10.1158/1078-0432.CCR-05-2085; Zou YH, 2006, J OCUL PHARMACOL TH, V22, P19, DOI 10.1089/jop.2006.22.19	43	67	69	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e14476	10.1371/journal.pone.0014476	http://dx.doi.org/10.1371/journal.pone.0014476			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217824	Green Published, gold			2022-12-27	WOS:000285838900005
J	Eriksen, M; Porneki, AD; Skov, V; Burns, JS; Beck-Nielsen, H; Glintborg, D; Gaster, M				Eriksen, Mette; Porneki, Ann Dorte; Skov, Vibe; Burns, Jorge S.; Beck-Nielsen, Henning; Glintborg, Dorte; Gaster, Michael			Insulin Resistance Is Not Conserved in Myotubes Established from Women with PCOS	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; GLYCOGEN-SYNTHASE ACTIVITY; SKELETAL-MUSCLE CELLS; TYPE-2 DIABETIC SUBJECTS; REDUCED LIPID OXIDATION; GLUCOSE-METABOLISM; ACQUIRED DEFECTS; GENETIC-ORIGIN; PIOGLITAZONE; PREVALENCE	Background: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among premenopausal women, who often develop insulin resistance. We tested the hypothesis that insulin resistance in skeletal muscle of patients with polycystic ovary syndrome (PCOS) is an intrinsic defect, by investigating the metabolic characteristics and gene expression of in vitro differentiated myotubes established from well characterized PCOS subjects. Methods: Using radiotracer techniques, RT-PCR and enzyme kinetic analysis we examined myotubes established from PCOS subjects with or without pioglitazone treatment, versus healthy control subjects who had been extensively metabolically characterized in vivo. Results Myotubes established from PCOS and matched control subjects comprehensively expressed all insulin-sensitive biomarkers; glucose uptake and oxidation, glycogen synthesis and lipid uptake. There were no significant differences between groups either at baseline or during acute insulin stimulation, although in vivo skeletal muscle was insulin resistant. In particular, we found no evidence for defects in insulin-stimulated glycogen synthase activity between groups. Myotubes established from PCOS patients with or without pioglitazone treatment also showed no significant differences between groups, neither at baseline nor during acute insulin stimulation, although in vivo pioglitazone treatment significantly improved insulin sensitivity. Consistently, the myotube cultures failed to show differences in mRNA levels of genes previously demonstrated to differ in PCOS patients with or without pioglitazone treatment (PLEK, SLC22A16, and TTBK). Conclusion: These results suggest that the mechanisms governing insulin resistance in skeletal muscle of PCOS patients in vivo are not primary, but rather adaptive. Trial Registration: ClinicalTrials.gov NCT00145340	[Eriksen, Mette; Beck-Nielsen, Henning; Glintborg, Dorte; Gaster, Michael] Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark; [Porneki, Ann Dorte; Burns, Jorge S.; Gaster, Michael] Univ So Denmark, Clin Mol Endocrinol, Dept Endocrinol, Odense Univ Hosp, Odense, Denmark; [Porneki, Ann Dorte; Burns, Jorge S.; Gaster, Michael] Univ So Denmark, Ctr Med Biotechnol, Odense, Denmark; [Skov, Vibe] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, Human MicroArray Ctr, DK-5000 Odense, Denmark; [Skov, Vibe] Odense Univ Hosp, Dept Clin Genet, Human MicroArray Ctr, DK-5000 Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Eriksen, M (corresponding author), Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark.	Michael.Gaster@ouh.regionsyddanmark.dk	Burns, Jorge S./J-3395-2012; Glintborg, Dorte/AAE-3676-2019; Burns, Jorge/AAF-5291-2019	Burns, Jorge S./0000-0002-8602-1536; Glintborg, Dorte/0000-0002-8338-8025; Brandt Eriksen, Mette/0000-0001-6785-261X	Danish Council for Independent Research; Novo Nordisk Foundation; Danish Diabetes Association; Region of Southern Denmark [09/13388]; Augustinus Foundation	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Diabetes Association; Region of Southern Denmark; Augustinus Foundation	The Danish Council for Independent Research (http://en.fi.dk/councils-commissions/the-danish-council-for-independent-research/scientific-research-councils/medical-sciences/medical-sciences), the Novo Nordisk Foundation (http://www.novonordiskfonden.dk/), the Danish Diabetes Association (http://www.diabetes.dk/Forskning.aspx), Region of Southern Denmark grant no. 09/13388 (http://www.regionsyddanmark.dk/wm157175) and the Augustinus Foundation (no URL) are thanked for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004274; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Baig A, 2009, PROTEOMICS, V9, P4254, DOI 10.1002/pmic.200900060; Ban A, 2008, J VET MED SCI, V70, P761, DOI 10.1292/jvms.70.761; BECKNIELSEN H, 1994, J CLIN INVEST, V94, P1714, DOI 10.1172/JCI117518; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bjorntorp P, 1996, J INTERN MED, V239, P105, DOI 10.1046/j.1365-2796.1996.364690000.x; Boden G, 2003, METABOLISM, V52, P753, DOI 10.1016/S0026-0495(03)00055-6; Book CB, 1999, J CLIN ENDOCR METAB, V84, P3110, DOI 10.1210/jc.84.9.3110; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Ciaraldi TP, 2009, J CLIN ENDOCR METAB, V94, P157, DOI 10.1210/jc.2008-1492; Ciaraldi TP, 1998, METABOLISM, V47, P940, DOI 10.1016/S0026-0495(98)90348-1; Corbould A, 2005, AM J PHYSIOL-ENDOC M, V288, pE1047, DOI 10.1152/ajpendo.00361.2004; Corbould A, 2007, METABOLISM, V56, P716, DOI 10.1016/j.metabol.2006.12.021; DAMSBO P, 1991, DIABETOLOGIA, V34, P239, DOI 10.1007/BF00405082; Deligeoroglou E, 2009, GYNECOL ENDOCRINOL, V25, P603, DOI 10.1080/09513590903015619; DUNAIF A, 1995, J CLIN INVEST, V96, P801, DOI 10.1172/JCI118126; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Feinstein DL, 2005, BIOCHEM PHARMACOL, V70, P177, DOI 10.1016/j.bcp.2005.03.033; Frederiksen CM, 2008, DIABETOLOGIA, V51, P2068, DOI 10.1007/s00125-008-1122-9; Gaster M, 2006, BBA-MOL CELL BIOL L, V1761, P100, DOI 10.1016/j.bbalip.2005.12.003; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; Gaster M, 2004, BBA-MOL BASIS DIS, V1690, P85, DOI 10.1016/j.bbadis.2004.05.006; Gaster M, 2004, DIABETES, V53, P542, DOI 10.2337/diabetes.53.3.542; Gaster M, 2002, DIABETES, V51, P921, DOI 10.2337/diabetes.51.4.921; Gaster M, 2001, BBA-MOL BASIS DIS, V1537, P211, DOI 10.1016/S0925-4439(01)00071-0; Gaster M, 2001, APMIS, V109, P735, DOI 10.1034/j.1600-0463.2001.d01-140.x; Gaster M, 2001, APMIS, V109, P726, DOI 10.1034/j.1600-0463.2001.d01-139.x; Gaster M, 2007, BBA-MOL BASIS DIS, V1772, P755, DOI 10.1016/j.bbadis.2007.03.007; Gaster M, 2007, J LIPID RES, V48, P207, DOI 10.1194/jlr.M600319-JLR200; Gaster M, 2009, BIOCHEM BIOPH RES CO, V387, P651, DOI 10.1016/j.bbrc.2009.07.064; Gaster M, 2009, BIOCHEM BIOPH RES CO, V382, P766, DOI 10.1016/j.bbrc.2009.03.102; Glintborg D, 2004, FERTIL STERIL, V82, P1570, DOI 10.1016/j.fertnstert.2004.06.040; Glintborg D, 2008, J CLIN ENDOCR METAB, V93, P3618, DOI 10.1210/jc.2008-0760; Glintborg D, 2008, DIABETES CARE, V31, P328, DOI 10.2337/dc07-1424; Glintborg D, 2008, CLIN ENDOCRINOL, V68, P165, DOI 10.1111/j.1365-2265.2007.03015.x; Glintborg D, 2006, FERTIL STERIL, V86, P385, DOI 10.1016/j.fertnstert.2005.12.067; Glintborg D, 2010, GYNECOL ENDOCRINOL, V26, P281, DOI 10.3109/09513590903247873; Henry RR, 1996, J CLIN INVEST, V98, P1231, DOI 10.1172/JCI118906; Henry RR, 1996, DIABETES, V45, P400, DOI 10.2337/diabetes.45.4.400; HENRY RR, 1995, DIABETES, V44, P936, DOI 10.2337/diabetes.44.8.936; Hojlund K, 2008, DIABETES, V57, P357, DOI 10.2337/db07-0706; Hother-Nielsen O, 1995, ENDOCRINOL METAB, V2, P275; Kahsar-Miller MD, 2001, FERTIL STERIL, V75, P53, DOI 10.1016/S0015-0282(00)01662-9; Knochenhauer ES, 1998, J CLIN ENDOCR METAB, V83, P3078, DOI 10.1210/jc.83.9.3078; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Lebouvier T, 2009, J ALZHEIMERS DIS, V18, P1, DOI 10.3233/JAD-2009-1116; Li ZX, 2008, MED HYPOTHESES, V70, P638, DOI 10.1016/j.mehy.2006.09.076; Liu SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011272; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LYKKESFELDT G, 1985, CLIN ENDOCRINOL, V23, P385, DOI 10.1111/j.1365-2265.1985.tb01096.x; MANDARINO LJ, 1987, J CLIN INVEST, V80, P655, DOI 10.1172/JCI113118; Mayerson AB, 2002, DIABETES, V51, P797, DOI 10.2337/diabetes.51.3.797; Miyazaki Y, 2002, J CLIN ENDOCR METAB, V87, P2784, DOI 10.1210/jc.87.6.2784; Olefsky JM, 2000, TRENDS ENDOCRIN MET, V11, P362, DOI 10.1016/S1043-2760(00)00306-4; Ortenblad N, 2005, BBA-MOL BASIS DIS, V1741, P206, DOI 10.1016/j.bbadis.2005.04.001; Park JH, 2008, J CLIN INVEST, V118, P2316, DOI [10.1172/JC133655, 10.1172/JCI33655]; San Millan JL, 2004, J CLIN ENDOCR METAB, V89, P2640, DOI 10.1210/jc.2003-031252; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Skov V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002466; Skov V, 2007, DIABETES, V56, P2349, DOI 10.2337/db07-0275; Stoffers DA, 2003, DIABETES, V52, P734, DOI 10.2337/diabetes.52.3.734; Teede H, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-41; Venkatesan AM, 2001, RECENT PROG HORM RES, V56, P295, DOI 10.1210/rp.56.1.295; Wensaas AJ, 2009, DIABETES, V58, P527, DOI 10.2337/db08-1043; Xita N, 2006, J CLIN ENDOCR METAB, V91, P1660, DOI 10.1210/jc.2005-2757; Xita N, 2002, EUR J ENDOCRINOL, V147, P717, DOI 10.1530/eje.0.1470717; Xu N, 2010, FERTIL STERIL, V94, P781, DOI 10.1016/j.fertnstert.2009.10.020; Zhuo GC, 2010, BIOCHEM GENET, V48, P157, DOI 10.1007/s10528-009-9308-5	69	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e14469	10.1371/journal.pone.0014469	http://dx.doi.org/10.1371/journal.pone.0014469			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209881	gold, Green Submitted, Green Published			2022-12-27	WOS:000285793600011
J	Sborgi, L; Barrera-Vilarmau, S; Obregon, P; de Alba, E				Sborgi, Lorenzo; Barrera-Vilarmau, Susana; Obregon, Patricia; de Alba, Eva			Characterization of a Novel Interaction between Bcl-2 Members Diva and Harakiri	PLOS ONE			English	Article							CELL-DEATH; BH3-ONLY PROTEINS; BH3 DOMAINS; APOPTOSIS; FAMILY; RECOGNITION; REGULATORS; MECHANISM; SURVIVAL; LIGANDS	Interactions within proteins of the Bcl-2 family are key in the regulation of apoptosis. The death-inducing members control apoptotic mechanisms partly by antagonizing the prosurvival proteins through heterodimer formation. Structural and biophysical studies on these complexes are providing important clues to understand their function. To help improve our knowledge on protein-protein interactions within the Bcl-2 family we have studied the binding between two of its members: mouse Diva and human Harakiri. Diva has been shown to perform both prosurvival and killing activity. In contrast, Harakiri induces cell death by interacting with antiapoptotic Bcl-2 members. Here we show using ELISA and NMR that Diva and Harakiri can interact in vitro. Combining the NMR data with the previously reported three-dimensional structure of Diva we find that Harakiri binds to a specific region in Diva. This interacting surface is equivalent to the known binding area of prosurvival Bcl-2 members from the reported structures of the complexes, suggesting that Diva could function at the structural level similarly to the antiapoptotic proteins of the Bcl-2 family. We illustrate this result by building a structural model of the heterodimer using molecular docking and the NMR data as restraints. Moreover, combining circular dichroism and NMR we also show that Harakiri is largely unstructured with residual (13%) alpha-helical conformation. This result agrees with intrinsic disorder previously observed in other Bcl-2 members. In addition, Harakiri constructs of different length were studied to identify the region critical for the interaction. Differential affinity for Diva of these constructs suggests that the amino acid sequence flanking the interacting region could play an important role in binding.	[Sborgi, Lorenzo; Barrera-Vilarmau, Susana; Obregon, Patricia; de Alba, Eva] CSIC, Ctr Invest Biol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Sborgi, L (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	dealbae@cib.csic.es	Barrera-Vilarmau, Susana/ABD-1039-2020	Barrera-Vilarmau, Susana/0000-0003-4868-6593	European Commission [IRG-046412]; Spanish Ministerio de Ciencia e Innovacion [BFU2008-03278, CSD2009-00088]; Comunidad de Madrid and Agencia CSIC IV PRICIT [CCG08-CSIC/SAL-3777]	European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad de Madrid and Agencia CSIC IV PRICIT	This work was supported by the European Commission Marie Curie International Reintegration Grant [IRG-046412 to EDA], by the Spanish Ministerio de Ciencia e Innovacion through the Programa Ramon y Cajal to EDA, and Plan Nacional I+D+I (grant BFU2008-03278 to EDA), by Comunidad de Madrid and Agencia CSIC IV PRICIT (grant CCG08-CSIC/SAL-3777 to EDA), and by Spanish Ministerio de Ciencia e Innovacion through the Consolider-Ingenio 2010 program (grant CSD2009-00088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Bernabeu A, 2007, BBA-BIOMEMBRANES, V1768, P1659, DOI 10.1016/j.bbamem.2007.02.023; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; DAVID CS, 2000, CELL, V103, P839; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Fernandez-Luna JL, 2008, CELL SIGNAL, V20, P1921, DOI 10.1016/j.cellsig.2008.04.015; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Hinds MG, 2007, CELL DEATH DIFFER, V14, P128, DOI 10.1038/sj.cdd.4401934; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Horne WS, 2008, ANGEW CHEM INT EDIT, V47, P2853, DOI 10.1002/anie.200705315; Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686; Inohara N, 1998, J BIOL CHEM, V273, P32479, DOI 10.1074/jbc.273.49.32479; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Liu Q, 2010, J BIOL CHEM, V285, P19615, DOI 10.1074/jbc.M110.105452; Lomonosova E, 2008, ONCOGENE, V27, pS2, DOI 10.1038/onc.2009.39; MEYERS JK, 1997, BIOCHEMISTRY-US, V36, P10923; OLTVAI ZN, 1994, CELL, V79, P189, DOI 10.1016/0092-8674(94)90188-0; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Rautureau GJP, 2010, PROTEINS, V78, P2181, DOI 10.1002/prot.22728; Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7; Rohl CA, 1996, PROTEIN SCI, V5, P2623, DOI 10.1002/pro.5560051225; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Sborgi Lorenzo, 2010, Biomol NMR Assign, V4, P65, DOI 10.1007/s12104-010-9208-y; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Song QZ, 1999, EMBO J, V18, P167, DOI 10.1093/emboj/18.1.167; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Uversky VN, 2010, STRUCTURE, V18, P1069, DOI 10.1016/j.str.2010.08.003; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n	43	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15575	10.1371/journal.pone.0015575	http://dx.doi.org/10.1371/journal.pone.0015575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209886	Green Published, Green Submitted, gold			2022-12-27	WOS:000285793600020
J	Hammond, SM; Gogliotti, RG; Rao, V; Beauvais, A; Kothary, R; DiDonato, CJ				Hammond, Suzan M.; Gogliotti, Rocky G.; Rao, Vamshi; Beauvais, Ariane; Kothary, Rashmi; DiDonato, Christine J.			Mouse Survival Motor Neuron Alleles That Mimic SMN2 Splicing and Are Inducible Rescue Embryonic Lethality Early in Development but Not Late	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; SINGLE NUCLEOTIDE; DETERMINING GENE; CARDIAC DEFECTS; MODEL; EXPRESSION; SMA; MICE; INACTIVATION; PHENOTYPE	Spinal muscular atrophy (SMA) is caused by low survival motor neuron (SMN) levels and patients represent a clinical spectrum due primarily to varying copies of the survival motor neuron-2 (SMN2) gene. Patient and animals studies show that disease severity is abrogated as SMN levels increase. Since therapies currently being pursued target the induction of SMN, it will be important to understand the dosage, timing and cellular requirements of SMN for disease etiology and potential therapeutic intervention. This requires new mouse models that can induce SMN temporally and/or spatially. Here we describe the generation of two hypomorphic Smn alleles, Smn(C-T-Neo) and Smn(2B-Neo). These alleles mimic SMN2 exon 7 splicing, titre Smn levels and are inducible. They were specifically designed so that up to three independent lines of mice could be generated, herein we describe two. In a homozygous state each allele results in embryonic lethality. Analysis of these mutants indicates that greater than 5% of Smn protein is required for normal development. The severe hypomorphic nature of these alleles is caused by inclusion of a loxP-flanked neomycin gene selection cassette in Smn intron 7, which can be removed with Cre recombinase. In vitro and in vivo experiments demonstrate these as inducible Smn alleles. When combined with an inducible Cre mouse, embryonic lethality caused by low Smn levels can be rescued early in gestation but not late. This provides direct genetic evidence that a therapeutic window for SMN inductive therapies may exist. Importantly, these lines fill a void for inducible Smn alleles. They also provide a base from which to generate a large repertoire of SMA models of varying disease severities when combined with other Smn alleles or SMN2-containing mice.	[Hammond, Suzan M.; Gogliotti, Rocky G.; Rao, Vamshi; DiDonato, Christine J.] Childrens Mem Res Ctr, Human Mol Genet Program, Chicago, IL USA; [Hammond, Suzan M.; Gogliotti, Rocky G.; Rao, Vamshi; DiDonato, Christine J.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Beauvais, Ariane; Kothary, Rashmi] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Beauvais, Ariane; Kothary, Rashmi] Univ Ottawa, Ctr Neuromuscular Dis, Ottawa, ON, Canada; [Kothary, Rashmi] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Kothary, Rashmi] Univ Ottawa, Dept Med, Ottawa, ON, Canada	Northwestern University; Feinberg School of Medicine; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa	Hammond, SM (corresponding author), Childrens Mem Res Ctr, Human Mol Genet Program, Chicago, IL USA.	c-didonato@northwestern.edu	Rao, Vamshi/AAK-3259-2020	Rao, Vamshi/0000-0002-0130-2292; Kothary, Rashmi/0000-0002-9239-7310; Hammond, Suzan/0000-0002-5640-7569	National Institutes of Health [1RO1NS060926, 1R21HD058311]; Canadian Institutes of Health Research (CIHR); Families of Spinal Muscular Atrophy; NIH [T32 AG000260]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD058311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Families of Spinal Muscular Atrophy; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was funded by the National Institutes of Health [1RO1NS060926 and 1R21HD058311] to CJD, the Canadian Institutes of Health Research (CIHR) to RK and the Families of Spinal Muscular Atrophy to CJD. RK is a recipient of a University Health Research Chair from the University of Ottawa. RG is supported by a NIH training grant [T32 AG000260] "Drug Discovery Training in Age-related Disorders." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alias L, 2009, HUM GENET, V125, P29, DOI 10.1007/s00439-008-0598-1; Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562; Baumer D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000773; Bevan AK, 2010, HUM MOL GENET, V19, P3895, DOI 10.1093/hmg/ddq300; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Butchbach MER, 2010, HUM MOL GENET, V19, P454, DOI 10.1093/hmg/ddp510; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Cifuentes-Diaz C, 2001, J CELL BIOL, V152, P1107, DOI 10.1083/jcb.152.5.1107; Coady TH, 2007, MOL THER, V15, P1471, DOI 10.1038/sj.mt.6300222; Araujo APDC, 2009, J PEDIATR-US, V155, P292, DOI 10.1016/j.jpeds.2009.01.071; DiDonato CJ, 1997, GENOME RES, V7, P339, DOI 10.1101/gr.7.4.339; DiDonato CJ, 2001, HUM MOL GENET, V10, P2727, DOI 10.1093/hmg/10.23.2727; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Frugier T, 2000, HUM MOL GENET, V9, P849, DOI 10.1093/hmg/9.5.849; Gabanella F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000921; Garcia P, 2005, GENESIS, V43, P189, DOI 10.1002/gene.20170; GENNARELLI M, 1995, BIOCHEM BIOPH RES CO, V213, P342, DOI 10.1006/bbrc.1995.2135; Hastings ML, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000208; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Heier CR, 2010, HUM MOL GENET, V19, P3906, DOI 10.1093/hmg/ddq330; HEIER CR, 2009, HUM MOL GENET; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Hua YM, 2010, GENE DEV, V24, P1634, DOI 10.1101/gad.1941310; Jodelka FM, 2010, HUM MOL GENET, V19, P4906, DOI 10.1093/hmg/ddq425; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Levin SI, 2004, GENESIS, V39, P234, DOI 10.1002/gene.20050; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Meyer K, 2009, HUM MOL GENET, V18, P546, DOI 10.1093/hmg/ddn382; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; Narver HL, 2008, ANN NEUROL, V64, P465, DOI 10.1002/ana.21449; Papaioannou VE, 2005, MOUSE PHENOTYPES HDB; Passini MA, 2010, J CLIN INVEST, V120, P1253, DOI 10.1172/JCI41615; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Raffai RL, 2002, J BIOL CHEM, V277, P11064, DOI 10.1074/jbc.M111222200; Riessland M, 2010, HUM MOL GENET, V19, P1492, DOI 10.1093/hmg/ddq023; ROBERTS DF, 1970, ARCH DIS CHILD, V45, P33, DOI 10.1136/adc.45.239.33; Schmid A, 2007, J CHILD NEUROL, V22, P1004, DOI 10.1177/0883073807305667; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Shababi M, 2010, HUM MOL GENET, V19, P4059, DOI 10.1093/hmg/ddq329; Singh NK, 2006, MOL CELL BIOL, V26, P1333, DOI 10.1128/MCB.26.4.1333-1346.2006; Skordis LA, 2003, P NATL ACAD SCI USA, V100, P4114, DOI 10.1073/pnas.0633863100; Viollet L, 1997, GENOMICS, V40, P185, DOI 10.1006/geno.1996.4551; Vitte JM, 2004, AM J PATHOL, V165, P1731, DOI 10.1016/S0002-9440(10)63428-1; Voronina VA, 2005, GENESIS, V41, P160, DOI 10.1002/gene.20109; Wang CH, 2007, J CHILD NEUROL, V22, P1027, DOI 10.1177/0883073807305788; Wirth B, 2000, HUM MUTAT, V15, P228, DOI 10.1002/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	55	57	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15887	10.1371/journal.pone.0015887	http://dx.doi.org/10.1371/journal.pone.0015887			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21249120	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793200067
J	Jayadev, S; Case, A; Eastman, AJ; Nguyen, H; Pollak, J; Wiley, JC; Moller, T; Morrison, RS; Garden, GA				Jayadev, Suman; Case, Amanda; Eastman, Alison J.; Nguyen, Huy; Pollak, Julia; Wiley, Jesse C.; Moeller, Thomas; Morrison, Richard S.; Garden, Gwenn A.			Presenilin 2 Is the Predominant gamma-Secretase in Microglia and Modulates Cytokine Release	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; INFLAMMATORY RESPONSES; INTERFERON-GAMMA; RECEPTOR; ACTIVATION; EXPRESSION; ALPHA; NOTCH; TRANSDUCTION; MUTATIONS	Presenilin 1 (PS1) and Presenilin 2 (PS2) are the enzymatic component of the gamma-secretase complex that cleaves amyloid precursor protein (APP) to release amyloid beta (Ab) peptide. PS deficiency in mice results in neuroinflammation and neurodegeneration in the absence of accumulated Ab. We hypothesize that PS influences neuroinflammation through its gamma-secretase action in CNS innate immune cells. We exposed primary murine microglia to a pharmacological gamma-secretase inhibitor which resulted in exaggerated release of TNF alpha and IL-6 in response to lipopolysaccharide. To determine if this response was mediated by PS1, PS2 or both we used shRNA to knockdown each PS in a murine microglia cell line. Knockdown of PS1 did not lead to decreased gamma-secretase activity while PS2 knockdown caused markedly decreased gamma-secretase activity. Augmented proinflammatory cytokine release was observed after knockdown of PS2 but not PS1. Proinflammatory stimuli increased microglial PS2 gene transcription and protein in vitro. This is the first demonstration that PS2 regulates CNS innate immunity. Taken together, our findings suggest that PS2 is the predominant gamma-secretase in microglia and modulates release of proinflammatory cytokines. We propose PS2 may participate in a negative feedback loop regulating inflammatory behavior in microglia.	[Jayadev, Suman; Case, Amanda; Eastman, Alison J.; Moeller, Thomas; Garden, Gwenn A.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Nguyen, Huy] Univ Iowa, Dept Neurosci, Iowa City, IA USA; [Pollak, Julia] Univ Washington, Dept Neurobiol & Behav, Seattle, WA 98195 USA; [Wiley, Jesse C.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Morrison, Richard S.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Iowa; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Jayadev, S (corresponding author), Univ Washington, Dept Neurol, Seattle, WA 98195 USA.	sumie@u.washington.edu	Garden, Gwenn/CAF-9344-2022; Jayadev, Suman/B-6362-2019; Nguyen, Huy/AAF-9560-2019; Möller, Thomas/W-8974-2019; Nguyen, Huy/GWQ-6433-2022	Nguyen, Huy/0000-0002-5896-9661; Garden, Gwenn/0000-0002-8753-6515	National Institutes of Health (NIH) [NS055652, NS056031, NS062269]; American Federation for Aging Research [RAG08083]; Alzheimer Association New Investigator Grant [NIRG-06-26411]; Friends of Alzheimer Disease; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS055652, R01NS056031, R21NS062269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005136] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Federation for Aging Research; Alzheimer Association New Investigator Grant; Friends of Alzheimer Disease; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by: National Institutes of Health (NIH) NS055652 (S.J.), American Federation for Aging Research RAG08083 (S.J.), Alzheimer Association New Investigator Grant NIRG-06-26411 (S.J.), NIH NS056031 (R. S. M.), NIH NS062269 (G. A. G.) and a grant from the Friends of Alzheimer Disease (G. A. G.). Human brain autopsy tissue was procured from the Alzheimer Disease Research Center NIH AG05136. Alzheimer disease patient autopsy tissue was provided by the Alzheimer Disease Research Center, University of Washington Medical Center (P50 AG05136). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Balcaitis S, 2005, GLIA, V50, P48, DOI 10.1002/glia.20146; Bamberger ME, 2002, NEUROSCIENTIST, V8, P276, DOI 10.1177/1073858402008003013; Barry SC, 2001, HUM GENE THER, V12, P1103, DOI 10.1089/104303401750214311; Beglopoulos V, 2004, J BIOL CHEM, V279, P46907, DOI 10.1074/jbc.M409544200; Blasko I, 2001, J NEUROIMMUNOL, V116, P1, DOI 10.1016/S0165-5728(01)00279-X; Carey BW, 2007, BIOCHEM J, V401, P121, DOI 10.1042/BJ20060847; Chakrabarty P, 2010, J IMMUNOL; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Choi SH, 2008, NEURON, V59, P568, DOI 10.1016/j.neuron.2008.07.033; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Elzinga BM, 2009, J BIOL CHEM, V284, P1394, DOI 10.1074/jbc.M803108200; Feng RB, 2004, P NATL ACAD SCI USA, V101, P8162, DOI 10.1073/pnas.0402733101; Floden AM, 2005, J NEUROSCI, V25, P2566, DOI 10.1523/JNEUROSCI.4998-04.2005; GIFFORD GE, 1987, J NATL CANCER I, V78, P121, DOI 10.1093/jnci/78.1.121; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Grandbarbe L, 2007, GLIA, V55, P1519, DOI 10.1002/glia.20553; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hass MR, 2009, SEMIN CELL DEV BIOL, V20, P201, DOI 10.1016/j.semcdb.2008.11.014; Heilig EA, 2010, J BIOL CHEM; Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95; Hu XY, 2008, IMMUNITY, V29, P691, DOI 10.1016/j.immuni.2008.08.016; HUBERMAN M, 1994, J NEUROIMMUNOL, V52, P147, DOI 10.1016/0165-5728(94)90108-2; Jayadev S, 2010, BRAIN, V133, P1143, DOI 10.1093/brain/awq033; Kang DE, 2005, J BIOL CHEM, V280, P31537, DOI 10.1074/jbc.M500833200; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kuhn PH, 2007, J BIOL CHEM, V282, P11982, DOI 10.1074/jbc.M700356200; Lai MT, 2003, J BIOL CHEM, V278, P22475, DOI 10.1074/jbc.M300974200; Lee J, 2002, NEUROMOL MED, V2, P29; Lee JK, 2009, J NEUROIMMUNE PHARM, V4, P419, DOI 10.1007/s11481-009-9176-0; Lee MK, 1996, J NEUROSCI, V16, P7513, DOI 10.1523/jneurosci.16-23-07513.1996; Lee SM, 2006, FASEB J, V20, pA173; Lees JR, 2008, J EXP MED, V205, P2633, DOI 10.1084/jem.20080155; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Maccioni RB, 2009, ANN NY ACAD SCI, V1153, P240, DOI 10.1111/j.1749-6632.2008.03972.x; Mastrangelo MA, 2009, AM J PATHOL, V175, P2076, DOI 10.2353/ajpath.2009.090059; Mastrangelo P, 2005, P NATL ACAD SCI USA, V102, P8972, DOI 10.1073/pnas.0500940102; Monsalve E, 2006, J IMMUNOL, V176, P5362, DOI 10.4049/jimmunol.176.9.5362; Mrak RE, 2009, J ALZHEIMERS DIS, V18, P473, DOI 10.3233/JAD-2009-1158; Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001; Ong CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002823; Palaga T, 2008, EUR J IMMUNOL, V38, P174, DOI 10.1002/eji.200636999; Pennypacker KR, 1998, MOL BRAIN RES, V56, P57, DOI 10.1016/S0169-328X(98)00028-X; Placanica L, 2009, J BIOL CHEM, V284, P2967, DOI 10.1074/jbc.M807269200; Pocivavsek A, 2009, J NEUROIMMUNOL, V214, P25, DOI 10.1016/j.jneuroim.2009.06.010; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Saban MR, 2002, AM J PATHOL, V160, P2095, DOI 10.1016/S0002-9440(10)61159-5; Satoh JI, 1999, NEUROPATH APPL NEURO, V25, P492; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Schulte A, 2007, BIOCHEM BIOPH RES CO, V358, P233, DOI 10.1016/j.bbrc.2007.04.100; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Takeda T, 2005, FASEB J, V19, P2069, DOI 10.1096/fj.05-3744fje; Tarkowski E, 2003, J NEUROL NEUROSUR PS, V74, P1200, DOI 10.1136/jnnp.74.9.1200; Terai K, 1996, BRAIN RES, V739, P343, DOI 10.1016/S0006-8993(96)01073-6; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Town T, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-24; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Tysoe C, 1998, AM J HUM GENET, V62, P70, DOI 10.1086/301672; Walker ES, 2005, J NEUROCHEM, V92, P294, DOI 10.1111/j.1471-4159.2004.02858.x; Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455; Wiley JC, 2005, J NEUROCHEM, V94, P1189, DOI 10.1111/j.1471-4159.2005.03266.x; Wolozin B, 1996, SCIENCE, V274, P1710, DOI 10.1126/science.274.5293.1710; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Yagi T, 2008, P NATL ACAD SCI USA, V105, P979, DOI 10.1073/pnas.0707755105; Yamamoto M, 2007, AM J PATHOL, V170, P680, DOI 10.2353/ajpath.2007.060378; Zurhove K, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164263	70	39	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15743	10.1371/journal.pone.0015743	http://dx.doi.org/10.1371/journal.pone.0015743			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206757	Green Published, Green Submitted, gold			2022-12-27	WOS:000285793200049
J	Brockington, M; Torelli, S; Sharp, PS; Liu, K; Cirak, S; Brown, SC; Wells, DJ; Muntoni, F				Brockington, Martin; Torelli, Silvia; Sharp, Paul S.; Liu, Ke; Cirak, Sebahattin; Brown, Susan C.; Wells, Dominic J.; Muntoni, Francesco			Transgenic Overexpression of LARGE Induces alpha-Dystroglycan Hyperglycosylation in Skeletal and Cardiac Muscle	PLOS ONE			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; WALKER-WARBURG-SYNDROME; HUMAN LARGE GENE; LAMININ-BINDING; PROTEIN GENE; DEFECTIVE GLYCOSYLATION; ABNORMAL GLYCOSYLATION; MENTAL-RETARDATION; LARGE FAMILY; O-GLYCAN	Background: LARGE is one of seven putative or demonstrated glycosyltransferase enzymes defective in a common group of muscular dystrophies with reduced glycosylation of alpha-dystroglycan. Overexpression of LARGE induces hyperglycosylation of alpha-dystroglycan in both wild type and in cells from dystroglycanopathy patients, irrespective of their primary gene defect, restoring functional glycosylation. Viral delivery of LARGE to skeletal muscle in animal models of dystroglycanopathy has identical effects in vivo, suggesting that the restoration of functional glycosylation could have therapeutic applications in these disorders. Pharmacological strategies to upregulate Large expression are also being explored. Methodology/Principal Findings: In order to asses the safety and efficacy of long term LARGE over-expression in vivo, we have generated four mouse lines expressing a human LARGE transgene. On observation, LARGE transgenic mice were indistinguishable from the wild type littermates. Tissue analysis from young mice of all four lines showed a variable pattern of transgene expression: highest in skeletal and cardiac muscles, and lower in brain, kidney and liver. Transgene expression in striated muscles correlated with alpha-dystroglycan hyperglycosylation, as determined by immunoreactivity to antibody IIH6 and increased laminin binding on an overlay assay. Other components of the dystroglycan complex and extracellular matrix ligands were normally expressed, and general muscle histology was indistinguishable from wild type controls. Further detailed muscle physiological analysis demonstrated a loss of force in response to eccentric exercise in the older, but not in the younger mice, suggesting this deficit developed over time. However this remained a subclinical feature as no pathology was observed in older mice in any muscles including the diaphragm, which is sensitive to mechanical load-induced damage. Conclusions/Significance: This work shows that potential therapies in the dystroglycanopathies based on LARGE upregulation and alpha-dystroglycan hyperglycosylation in muscle should be safe.	[Brockington, Martin; Torelli, Silvia; Cirak, Sebahattin; Muntoni, Francesco] UCL, Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England; [Brockington, Martin; Torelli, Silvia; Cirak, Sebahattin; Muntoni, Francesco] Great Ormond St Hosp Sick Children, London, England; [Sharp, Paul S.; Liu, Ke; Wells, Dominic J.] Univ London Imperial Coll Sci Technol & Med, Dept Cellular & Mol Neurosci, London, England; [Brown, Susan C.; Wells, Dominic J.] Univ London Royal Vet Coll, Dept Vet Basic Sci, London, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Imperial College London; University of London; University of London Royal Veterinary College	Brockington, M (corresponding author), UCL, Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England.	f.muntoni@ich.ucl.ac.uk	Cirak, Sebahattin/AAZ-6829-2020; Cirak, Sebahattin/AAX-9593-2020	Brown, Sue/0000-0001-8112-933X; Wells, Dominic/0000-0002-1425-6344	Institute of Child Health and Great Ormond Street Hospitals Biomedical Research Centre [BRC 08DN25]; Association Francaise contres les Myopathies [AFM 1399, AFM 13992, 14175]; Muscular Dystrophy Association of America [MDA 68721]; Wellcome Trust; Great Ormond Street Hospital Children's Charity; Medical Research Council [G0200171, G0601943] Funding Source: researchfish; MRC [G0601943, G0200171] Funding Source: UKRI	Institute of Child Health and Great Ormond Street Hospitals Biomedical Research Centre; Association Francaise contres les Myopathies(Association Francaise contre les Myopathies); Muscular Dystrophy Association of America(Muscular Dystrophy Association); Wellcome Trust(Wellcome TrustEuropean Commission); Great Ormond Street Hospital Children's Charity; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Institute of Child Health and Great Ormond Street Hospitals Biomedical Research Centre (BRC 08DN25) to FM, Association Francaise contres les Myopathies (AFM 1399 to FM, AFM 13992 and 14175 to SCB) and Muscular Dystrophy Association of America (MDA 68721 to FM). MB was the recipient of a Wellcome Trust Value in People award. FM is supported by Great Ormond Street Hospital Children's Charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar MT, 2003, J BIOL CHEM, V278, P19956, DOI 10.1074/jbc.M207073200; Balci B, 2005, NEUROMUSCULAR DISORD, V15, P271, DOI 10.1016/j.nmd.2005.01.013; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Brockington M, 2005, HUM MOL GENET, V14, P657, DOI 10.1093/hmg/ddi062; Brockington M, 2001, HUM MOL GENET, V10, P2851, DOI 10.1093/hmg/10.25.2851; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Brown SC, 1999, J CELL SCI, V112, P209; Chiba A, 1997, J BIOL CHEM, V272, P2156; Clement E, 2008, ANN NEUROL, V64, P573, DOI 10.1002/ana.21482; Colognato H, 1999, J CELL BIOL, V145, P619, DOI 10.1083/jcb.145.3.619; DURBEEJ M, 1995, J CELL BIOL, V130, P79, DOI 10.1083/jcb.130.1.79; Durbeej M, 1998, J HISTOCHEM CYTOCHEM, V46, P449, DOI 10.1177/002215549804600404; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Endo Tamao, 2006, V347, P43; Ervasti JM, 1997, J BIOL CHEM, V272, P22315, DOI 10.1074/jbc.272.35.22315; Fahim AT, 2009, THROMB RES, V123, P785, DOI 10.1016/j.thromres.2008.07.004; Fujimura K, 2005, BIOCHEM BIOPH RES CO, V329, P1162, DOI 10.1016/j.bbrc.2005.02.082; Godfrey C, 2007, BRAIN, V130, P2725, DOI 10.1093/brain/awm212; Godfrey C, 2006, ANN NEUROL, V60, P603, DOI 10.1002/ana.21006; Grewal PK, 2005, GLYCOBIOLOGY, V15, P912, DOI 10.1093/glycob/cwi094; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; Han R, 2009, P NATL ACAD SCI USA, V106, P12573, DOI 10.1073/pnas.0906545106; Herbst R, 2009, NEUROMUSCULAR DISORD, V19, P366, DOI 10.1016/j.nmd.2009.02.011; Holt KH, 2000, FEBS LETT, V468, P79, DOI 10.1016/S0014-5793(00)01195-9; Hoyte K, 2002, BRAIN RES MOL BRAIN, V109; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Ikeguchi Y, 2004, BIOCHEM J, V381, P701, DOI 10.1042/BJ20040419; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kanagawa M, 2009, HUM MOL GENET, V18, P621, DOI 10.1093/hmg/ddn387; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Lefeber DJ, 2009, AM J HUM GENET, V85, P76, DOI 10.1016/j.ajhg.2009.06.006; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Martin PT, 2006, NAT CLIN PRACT NEURO, V2, P222, DOI 10.1038/ncpneuro0155; Martin PT, 2003, GLYCOBIOLOGY, V13, p55R, DOI 10.1093/glycob/cwg076; Martin PT, 2003, GLYCOBIOLOGY, V13, p67R, DOI 10.1093/glycob/cwg077; Matsumura K, 1997, J BIOL CHEM, V272, P13904, DOI 10.1074/jbc.272.21.13904; Mercuri E, 2003, ANN NEUROL, V53, P537, DOI 10.1002/ana.10559; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Muntoni F, 2004, CURR OPIN NEUROL, V17, P205, DOI 10.1097/00019052-200404000-00020; Muntoni F, 2008, NEUROTHERAPEUTICS, V5, P627, DOI 10.1016/j.nurt.2008.08.005; Muntoni F, 2007, CURR OPIN NEUROL, V20, P590, DOI 10.1097/WCO.0b013e3282efc157; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Patnaik SK, 2005, J BIOL CHEM, V280, P20851, DOI 10.1074/jbc.M500069200; Peyrard M, 1999, P NATL ACAD SCI USA, V96, P598, DOI 10.1073/pnas.96.2.598; Poppe M, 2004, ANN NEUROL, V56, P738, DOI 10.1002/ana.20283; Stalnaker SH, 2010, J BIOL CHEM, V285, P24882, DOI 10.1074/jbc.M110.126474; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Wairkar YP, 2008, J NEUROSCI, V28, P3781, DOI 10.1523/JNEUROSCI.0478-08.2008; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	53	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14434	10.1371/journal.pone.0014434	http://dx.doi.org/10.1371/journal.pone.0014434			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203384	Green Published, Green Accepted, gold			2022-12-27	WOS:000285792500011
J	Chan, SSK; Li, HJ; Hsueh, YC; Lee, DS; Chen, JH; Hwang, SM; Chen, CY; Shih, E; Hsieh, PCH				Chan, Sunny Sun-Kin; Li, Hui-Jing; Hsueh, Ying-Chang; Lee, Desy S.; Chen, Jyh-Hong; Hwang, Shiaw-Min; Chen, Chen-Yun; Shih, Emily; Hsieh, Patrick C. H.			Fibroblast Growth Factor-10 Promotes Cardiomyocyte Differentiation from Embryonic and Induced Pluripotent Stem Cells	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; PEPTIDE NANOFIBERS; HEART DEVELOPMENT; CARDIAC MYOCYTES; PRECURSOR CELLS; FGF FAMILY; MOUSE; THERAPY; SPECIFICATION; GENERATION	Background: The fibroblast growth factor (FGF) family is essential to normal heart development. Yet, its contribution to cardiomyocyte differentiation from stem cells has not been systemically studied. In this study, we examined the mechanisms and characters of cardiomyocyte differentiation from FGF family protein treated embryonic stem (ES) cells and induced pluripotent stem (iPS) cells. Methodology/Principal Findings: We used mouse ES cells stably transfected with a cardiac-specific a-myosin heavy chain (aMHC) promoter-driven enhanced green fluorescent protein (EGFP) and mouse iPS cells to investigate cardiomyocyte differentiation. During cardiomyocyte differentiation from mouse ES cells, FGF-3, -8, -10, -11, -13 and -15 showed an expression pattern similar to the mesodermal marker Brachyury and the cardiovascular progenitor marker Flk-1. Among them, FGF-10 induced cardiomyocyte differentiation in a time-and concentration-dependent manner. FGF-10 neutralizing antibody, small molecule FGF receptor antagonist PD173074 and FGF-10 and FGF receptor-2 short hairpin RNAs inhibited cardiomyocyte differentiation. FGF-10 also increased mouse iPS cell differentiation into cardiomyocyte lineage, and this effect was abolished by FGF-10 neutralizing antibody or PD173074. Following Gene Ontology analysis, microarray data indicated that genes involved in cardiac development were upregulated after FGF-10 treatment. In vivo, intramyocardial co-administration of FGF-10 and ES cells demonstrated that FGF-10 also promoted cardiomyocyte differentiation. Conclusion/Significance: FGF-10 induced cardiomyocyte differentiation from ES cells and iPS cells, which may have potential for translation into clinical applications.	[Chan, Sunny Sun-Kin; Li, Hui-Jing; Lee, Desy S.; Hsieh, Patrick C. H.] Natl Cheng Kung Univ & Hosp, Inst Clin Med, Tainan, Taiwan; [Chan, Sunny Sun-Kin; Li, Hui-Jing; Lee, Desy S.; Hsieh, Patrick C. H.] Natl Cheng Kung Univ & Hosp, Res Ctr Clin Med, Tainan, Taiwan; [Hsueh, Ying-Chang; Hsieh, Patrick C. H.] Natl Cheng Kung Univ & Hosp, Inst Basic Med, Tainan, Taiwan; [Chen, Jyh-Hong] Natl Cheng Kung Univ & Hosp, Dept Med, Tainan, Taiwan; [Hwang, Shiaw-Min] Food Ind Res & Dev Inst, Bioresource Collect & Res Ctr, Hsinchu, Taiwan; [Chen, Chen-Yun; Hsieh, Patrick C. H.] Natl Yang Ming Univ, Program Mol Med, Taipei 112, Taiwan; [Chen, Chen-Yun; Hsieh, Patrick C. H.] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Shih, Emily] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; University of Washington; University of Washington Seattle	Chan, SSK (corresponding author), Natl Cheng Kung Univ & Hosp, Inst Clin Med, Tainan, Taiwan.	phsieh@mail.ncku.edu.tw	Li, Huijing/AAU-5279-2020; Shih, Emily/AAS-3943-2021	Shih, Emily/0000-0002-2426-513X	National Science Council [NSC 97IR082, NSC 96-2314-B-006-032]; National Health Research Institutes [NHRI EX97-9722SI]; National Cheng Kung University [97I006]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes(National Health Research Institutes, Japan); National Cheng Kung University	This work was supported by grants from the National Science Council [NSC 97IR082, NSC 96-2314-B-006-032] (http://web1.nsc.gov.tw), the National Health Research Institutes [NHRI EX97-9722SI] (http://www.nhri.org.tw), and the National Cheng Kung University Landmark Project [97I006] (http://web.ncku.edu.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Brand T, 2003, DEV BIOL, V258, P1, DOI 10.1016/S0012-1606(03)00112-X; Chan SSK, 2009, BIOCHEM BIOPH RES CO, V387, P723, DOI 10.1016/j.bbrc.2009.07.122; Christoforou N, 2008, J CLIN INVEST, V118, P894, DOI 10.1172/JCI33942; Conway SJ, 1999, MECH DEVELOP, V81, P187, DOI 10.1016/S0925-4773(98)00235-4; Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103; Dell'Era P, 2003, CIRC RES, V93, P414, DOI 10.1161/01.RES.0000089460.12061.E1; Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; King T, 1998, MECH DEVELOP, V79, P29, DOI 10.1016/S0925-4773(98)00166-X; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Kwon C, 2009, NAT CELL BIOL, V11, P951, DOI 10.1038/ncb1906; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Marguerie A, 2006, CARDIOVASC RES, V71, P50, DOI 10.1016/j.cardiores.2006.03.021; Martinez-Fernandez A, 2009, CIRC RES, V105, P648, DOI 10.1161/CIRCRESAHA.109.203109; Matsuura K, 2009, J CLIN INVEST, V119, P2204, DOI 10.1172/JCI37456; Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795; Nakashima Y, 2009, BIOCHEM BIOPH RES CO, V390, P821, DOI 10.1016/j.bbrc.2009.10.056; Narazaki G, 2008, CIRCULATION, V118, P498, DOI 10.1161/CIRCULATIONAHA.108.769562; Nelson TJ, 2009, CIRCULATION, V120, P408, DOI 10.1161/CIRCULATIONAHA.109.865154; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Quevedo HC, 2009, P NATL ACAD SCI USA, V106, P14022, DOI 10.1073/pnas.0903201106; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Saga Y, 1999, DEVELOPMENT, V126, P3437; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3; Tran TH, 2009, STEM CELLS, V27, P1869, DOI 10.1002/stem.95; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	32	37	41	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14414	10.1371/journal.pone.0014414	http://dx.doi.org/10.1371/journal.pone.0014414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203390	Green Submitted, Green Published, gold			2022-12-27	WOS:000285792500004
J	Karyala, P; Namsa, ND; Chilakalapudi, DR				Karyala, Prashanthi; Namsa, Nima D.; Chilakalapudi, Durga Rao			Translational Up-Regulation and High-Level Protein Expression from Plasmid Vectors by mTOR Activation via Different Pathways in PC3 and 293T Cells	PLOS ONE			English	Article							P70 S6 KINASE; PHOSPHOLIPASE-D; TUBEROUS SCLEROSIS; MAMMALIAN TARGET; ELONGATION-FACTOR-2 KINASE; PHOSPHOINOSITIDE 3-KINASE; GENE-PRODUCT; PHAS-I; PHOSPHORYLATION; GROWTH	Background: Though 293T cells are widely used for expression of proteins from transfected plasmid vectors, the molecular basis for the high-level expression is yet to be understood. We recently identified the prostate carcinoma cell line PC3 to be as efficient as 293T in protein expression. This study was undertaken to decipher the molecular basis of high-level expression in these two cell lines. Methodology/Principal Findings: In a survey of different cell lines for efficient expression of platelet-derived growth factor-B (PDGF-B), beta-galactosidase (beta-gal) and green fluorescent protein (GFP) from plasmid vectors, PC3 was found to express at 5-50-fold higher levels compared to the bone metastatic prostate carcinoma cell line PC3BM and many other cell lines. Further, the efficiency of transfection and level of expression of the reporters in PC3 were comparable to that in 293T. Comparative analyses revealed that the high level expression of the reporters in the two cell lines was due to increased translational efficiency. While phosphatidic acid (PA)-mediated activation of mTOR, as revealed by drastic reduction in reporter expression by n-butanol, primarily contributed to the high level expression in PC3, multiple pathways involving PA, PI3K/Akt and ERK1/2 appear to contribute to the abundant reporter expression in 293T. Thus the extent of translational upregulation attained through the concerted activation of mTOR by multiple pathways in 293T could be achieved through its activation primarily by the PA pathway in PC3. Conclusions/Significance: Our studies reveal that the high-level expression of proteins from plasmid vectors is effected by translational up-regulation through mTOR activation via different signaling pathways in the two cell lines and that PC3 is as efficient as 293T for recombinant protein expression. Further, PC3 offers an advantage in that the level of expression of the protein can be regulated by simple addition of n-butanol to the culture medium.	[Karyala, Prashanthi; Namsa, Nima D.; Chilakalapudi, Durga Rao] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Karyala, P (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	cdr@mcbl.iisc.ernet.in	Karyala, Prashanthi/AAP-5229-2020	Karyala, Prashanthi/0000-0002-1099-5262	Department of Biotechnology, Government of India, New Delhi [BT/PR2180/BRB/15/215/2000]; Department of Science and Technology, Government of India, New Delhi [SR/SO/BB-63/2004]	Department of Biotechnology, Government of India, New Delhi(Department of Biotechnology (DBT) India); Department of Science and Technology, Government of India, New Delhi(Department of Science & Technology (India))	This work was supported by the Department of Biotechnology (Grant BT/PR2180/BRB/15/215/2000) during 2001-2004 and Department of Science and Technology (Grant SR/SO/BB-63/2004) during 2005-2008, Government of India, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no current external funding sources for this study.	Avila-Flores A, 2005, J BIOL CHEM, V280, P10091, DOI 10.1074/jbc.M412296200; Avruch J, 2001, Prog Mol Subcell Biol, V26, P115; BARRETT TB, 1987, P NATL ACAD SCI USA, V84, P1099, DOI 10.1073/pnas.84.4.1099; BARRETT TB, 1984, P NATL ACAD SCI-BIOL, V81, P6772, DOI 10.1073/pnas.81.21.6772; Berven LA, 2000, IMMUNOL CELL BIOL, V78, P447, DOI 10.1046/j.1440-1711.2000.00928.x; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Browne GJ, 2004, MOL CELL BIOL, V24, P2986, DOI 10.1128/MCB.24.7.2986-2997.2004; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Cantrell DA, 2001, J CELL SCI, V114, P1439; Cazzolli R, 2006, IUBMB LIFE, V58, P457, DOI 10.1080/15216540600871142; Cockcroft S, 2001, CELL MOL LIFE SCI, V58, P1674, DOI 10.1007/PL00000805; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Exton JH, 2002, REV PHYSIOL BIOCH P, V144, P1, DOI 10.1007/BFb0116585; Exton JH, 2002, FEBS LETT, V531, P58, DOI 10.1016/S0014-5793(02)03405-1; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; FOECKING MK, 1986, GENE, V45, P101, DOI 10.1016/0378-1119(86)90137-X; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 2001, GENE DEV, V15, P2852; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GOUSTIN AS, 1985, CELL, V41, P301, DOI 10.1016/0092-8674(85)90083-2; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Houle MG, 1999, BBA-MOL CELL BIOL L, V1439, P135, DOI 10.1016/S1388-1981(99)00090-6; Hui L, 2005, J BIOL CHEM, V280, P35829, DOI 10.1074/jbc.M504192200; IGARASHI H, 1987, ONCOGENE, V1, P79; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Inoki K, 2006, TRENDS CELL BIOL, V16, P206, DOI 10.1016/j.tcb.2006.02.002; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Kim CH, 1997, GENE, V199, P293, DOI 10.1016/S0378-1119(97)00384-3; Kumar V, 2000, EMBO J, V19, P1087, DOI 10.1093/emboj/19.5.1087; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Lehman N, 2007, FASEB J, V21, P1075, DOI 10.1096/fj.06-6652com; Li Y, 2003, J BIOL CHEM, V278, P13663, DOI 10.1074/jbc.M300862200; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; MARTINET Y, 1986, NATURE, V319, P158, DOI 10.1038/319158a0; Mothe-Satney I, 2000, MOL CELL BIOL, V20, P3558, DOI 10.1128/MCB.20.10.3558-3567.2000; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Patursky-Polischuk I, 2009, MOL CELL BIOL, V29, P640, DOI 10.1128/MCB.00980-08; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Proud CG, 2004, BIOCHEM J, V403, P217; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; RAO CD, 1986, P NATL ACAD SCI USA, V83, P2392, DOI 10.1073/pnas.83.8.2392; RAO CD, 1988, MOL CELL BIOL, V8, P284, DOI 10.1128/MCB.8.1.284; ROBBINS KC, 1983, NATURE, V305, P605, DOI 10.1038/305605a0; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Ryazanov AG, 1997, P NATL ACAD SCI USA, V94, P4884, DOI 10.1073/pnas.94.10.4884; Sans MD, 2004, BIOCHEM BIOPH RES CO, V319, P144, DOI 10.1016/j.bbrc.2004.04.164; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schlaeger EJ, 1998, NEW DEV NEW APPL ANI, P105; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Stauber RH, 1998, BIOTECHNIQUES, V24, P462, DOI 10.2144/98243rr01; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Wurm F, 1999, CURR OPIN BIOTECH, V10, P156, DOI 10.1016/S0958-1669(99)80027-5; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Yang X, 2008, J Anim Sci, V86, pE36	69	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14408	10.1371/journal.pone.0014408	http://dx.doi.org/10.1371/journal.pone.0014408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203441	Green Published, gold, Green Submitted			2022-12-27	WOS:000285792500003
J	Lowe, CD; Montagnes, DJS; Martin, LE; Watts, PC				Lowe, Chris D.; Montagnes, David J. S.; Martin, Laura E.; Watts, Phillip C.			High Genetic Diversity and Fine-Scale Spatial Structure in the Marine Flagellate Oxyrrhis marina (Dinophyceae) Uncovered by Microsatellite Loci	PLOS ONE			English	Article							DINOFLAGELLATE COCHLODINIUM-POLYKRIKOIDES; NITZSCHIA-PUNGENS BACILLARIOPHYCEAE; ALEXANDRIUM-CATENELLA; POPULATION-STRUCTURE; MOLECULAR EVIDENCE; SPRING BLOOM; MARKERS; DISPERSAL; TIDE; DIFFERENTIATION	Free-living marine protists are often assumed to be broadly distributed and genetically homogeneous on large spatial scales. However, an increasing application of highly polymorphic genetic markers (e.g., microsatellites) has provided evidence for high genetic diversity and population structuring on small spatial scales in many free-living protists. Here we characterise a panel of new microsatellite markers for the common marine flagellate Oxyrrhis marina. Nine microsatellite loci were used to assess genotypic diversity at two spatial scales by genotyping 200 isolates of O. marina from 6 broad geographic regions around Great Britain and Ireland; in one region, a single 2 km shore line was sampled intensively to assess fine-scale genetic diversity. Microsatellite loci resolved between 1-6 and 7-23 distinct alleles per region in the least and most variable loci respectively, with corresponding variation in expected heterozygosities (H-e) of 0.00-0.30 and 0.81-0.93. Across the dataset, genotypic diversity was high with 183 genotypes detected from 200 isolates. Bayesian analysis of population structure supported two model populations. One population was distributed across all sampled regions; the other was confined to the intensively sampled shore, and thus two distinct populations co-occurred at this site. Whilst model-based analysis inferred a single UK-wide population, pairwise regional F-ST values indicated weak to moderate population sub-division (0.01-0.12), but no clear correlation between spatial and genetic distance was evident. Data presented in this study highlight extensive genetic diversity for O. marina; however, it remains a substantial challenge to uncover the mechanisms that drive genetic diversity in free-living microorganisms.	[Lowe, Chris D.; Montagnes, David J. S.; Martin, Laura E.; Watts, Phillip C.] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Lowe, CD (corresponding author), Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England.	clowe@liv.ac.uk		Watts, Phillip/0000-0001-7755-187X	Natural Environment Research Council [NE/F005237/1]; NERC [NE/F005237/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a Natural Environment Research Council grant (NE/F005237/1) awarded to PCW, CDL and DJSM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpermann TJ, 2006, MOL ECOL NOTES, V6, P1057, DOI 10.1111/j.1471-8286.2006.01432.x; Alpermann TJ, 2009, MOL ECOL, V18, P2122, DOI 10.1111/j.1365-294X.2009.04165.x; Begun AA., 2004, RUSS J MAR BIOL, V30, P51, DOI [10.1023/B:RUMB.0000020569.49887.7e, DOI 10.1023/B:RUMB.0000020569.49887.7E]; BLOOR P. A., 2001, MICROSATELLITE LIB E; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Bolch CJS, 2007, HARMFUL ALGAE, V6, P465, DOI 10.1016/j.hal.2006.12.008; Buskey EJ, 1998, J PLANKTON RES, V20, P1553, DOI 10.1093/plankt/20.8.1553; Caron DA, 2009, J EUKARYOT MICROBIOL, V56, P105, DOI 10.1111/j.1550-7408.2008.00381.x; Casteleyn G, 2009, MAR BIOL, V156, P1149, DOI 10.1007/s00227-009-1157-6; Cho SY, 2009, MOL ECOL RESOUR, V9, P915, DOI 10.1111/j.1755-0998.2008.02474.x; Darling KF, 2007, P NATL ACAD SCI USA, V104, P5002, DOI 10.1073/pnas.0700520104; Darling KF, 2000, NATURE, V405, P43, DOI 10.1038/35011002; Darling KF, 2004, P NATL ACAD SCI USA, V101, P7657, DOI 10.1073/pnas.0402401101; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans KM, 2005, J PHYCOL, V41, P506, DOI 10.1111/j.1529-8817.2005.00084.x; Fenchel T, 2004, BIOSCIENCE, V54, P777, DOI 10.1641/0006-3568(2004)054[0777:TUOSSP]2.0.CO;2; Field D, 1996, P ROY SOC B-BIOL SCI, V263, P209, DOI 10.1098/rspb.1996.0033; Finlay BJ, 2004, PROTIST, V155, P237, DOI 10.1078/143446104774199619; Foissner W, 2008, BIODIVERS CONSERV, V17, P235, DOI 10.1007/s10531-007-9248-5; Foissner W, 2006, ACTA PROTOZOOL, V45, P111; Gardner MG, 1999, J HERED, V90, P301, DOI 10.1093/jhered/90.2.301; Giovannoni SJ, 2005, NATURE, V437, P343, DOI 10.1038/nature04158; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Halkett F, 2005, TRENDS ECOL EVOL, V20, P194, DOI 10.1016/j.tree.2005.01.001; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Iglesias-Rodriguez MD, 2006, HEREDITAS, V143, P99; Iglesias-Rodriguez MD, 2006, J PHYCOL, V42, P526; Iglesias-Rodriguez MD, 2002, MOL ECOL NOTES, V2, P495, DOI 10.1046/j.1471-8286.2002.00289.x; JONSSON PR, 1994, J EXP MAR BIOL ECOL, V175, P77, DOI 10.1016/0022-0981(94)90177-5; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Lowe CD, 2005, J EUKARYOT MICROBIOL, V52, P250, DOI 10.1111/j.1550-7408.2005.00034.x; Lowe CD, 2011, J PLANKTON RES, V33, P555, DOI 10.1093/plankt/fbq110; Lowe CD, 2010, PROTIST, V161, P212, DOI 10.1016/j.protis.2009.11.003; MacLeod A, 2001, PHILOS T R SOC B, V356, P1035, DOI 10.1098/rstb.2001.0892; Masseret E, 2009, APPL ENVIRON MICROB, V75, P2037, DOI 10.1128/AEM.01686-08; McCauley LAR, 2009, J PHYCOL, V45, P454, DOI 10.1111/j.1529-8817.2009.00650.x; Montagnes DJS, 2011, J PLANKTON RES, V33, P615, DOI 10.1093/plankt/fbq111; MONTAGNES DJS, 2010, J PLANKTON IN PRESS; Montresor M, 2003, POLAR BIOL, V26, P186, DOI 10.1007/s00300-002-0473-9; Nagai S, 2007, MOL ECOL NOTES, V7, P993, DOI 10.1111/j.1471-8286.2007.01750.x; Nagai S, 2006, MOL ECOL NOTES, V6, P756, DOI 10.1111/j.1471-8286.2006.01331.x; Nagai S, 2006, MOL ECOL NOTES, V6, P120, DOI 10.1111/j.1471-8286.2005.01160.x; Nagai S, 2004, MOL ECOL NOTES, V4, P83, DOI 10.1046/j.1471-8286.2003.00576.x; Nagai S, 2009, MOL ECOL, V18, P2337, DOI 10.1111/j.1365-294X.2009.04193.x; Nagai S, 2007, J PHYCOL, V43, P43, DOI 10.1111/j.1529-8817.2006.00304.x; Nishitani G, 2007, MOL ECOL NOTES, V7, P827, DOI 10.1111/j.1471-8286.2007.01717.x; Nishitani G, 2009, CONSERV GENET, V10, P1561, DOI 10.1007/s10592-008-9793-9; Nishitani G, 2009, CONSERV GENET, V10, P713, DOI 10.1007/s10592-008-9628-8; Pawlowski J, 2007, MOL ECOL, V16, P4089, DOI 10.1111/j.1365-294X.2007.03465.x; PEREZUZ B, 1995, FEMS MICROBIOL ECOL, V16, P193, DOI 10.1016/0168-6496(94)00083-9; Pritchard J, 2003, DOCUMENTATION STRUCT; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Refseth UH, 1997, ELECTROPHORESIS, V18, P1519, DOI 10.1002/elps.1150180905; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Rynearson TA, 2006, LIMNOL OCEANOGR, V51, P1249, DOI 10.4319/lo.2006.51.3.1249; Rynearson TA, 2005, MOL ECOL, V14, P1631, DOI 10.1111/j.1365-294X.2005.02526.x; Rynearson TA, 2004, J PHYCOL, V40, P34, DOI 10.1046/j.1529-8817.2004.03089.x; Sambrook J, 2001, MOL CLONING LAB MANU; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; WATTS PC, 2010, J PLANKTON IN PRESS; Watts PC, 2006, MAR BIOL, V149, P1093, DOI 10.1007/s00227-006-0288-2; Watts PC, 2010, ICES J MAR SCI, V67, P607, DOI 10.1093/icesjms/fsp274; Weetman D, 2006, MAR ECOL PROG SER, V317, P157, DOI 10.3354/meps317157; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weisse T, 2006, J PLANKTON RES, V28, P55, DOI 10.1093/plankt/fbi100; Weisse T, 2008, BIODIVERS CONSERV, V17, P243, DOI 10.1007/s10531-007-9249-4; WRIGHT S, 1951, ANN EUGENIC, V15, P323	71	18	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15557	10.1371/journal.pone.0015557	http://dx.doi.org/10.1371/journal.pone.0015557			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203414	Green Submitted, Green Published, gold			2022-12-27	WOS:000285579200023
J	Zheng, W; Watts, LT; Holstein, DM; Prajapati, SI; Keller, C; Grass, EH; Walter, CA; Lechleiter, JD				Zheng, Wei; Watts, Lora Talley; Holstein, Deborah M.; Prajapati, Suresh I.; Keller, Charles; Grass, Eileen H.; Walter, Christi A.; Lechleiter, James D.			Purinergic Receptor Stimulation Reduces Cytotoxic Edema and Brain Infarcts in Mouse Induced by Photothrombosis by Energizing Glial Mitochondria	PLOS ONE			English	Article							CEREBRAL-ISCHEMIA; ENHANCES NEUROPROTECTION; ASTROCYTES; METABOLISM; RELEASE; CHLORIDE; STROKE; RAT; ACTIVATION; MECHANISM	Treatments to improve the neurological outcome of edema and cerebral ischemic stroke are severely limited. Here, we present the first in vivo single cell images of cortical mouse astrocytes documenting the impact of single vessel photothrombosis on cytotoxic edema and cerebral infarcts. The volume of astrocytes expressing green fluorescent protein (GFP) increased by over 600% within 3 hours of ischemia. The subsequent growth of cerebral infarcts was easily followed as the loss of GFP fluorescence as astrocytes lysed. Cytotoxic edema and the magnitude of ischemic lesions were significantly reduced by treatment with the purinergic ligand 2-methylthioladenosine 2' diphosphate (2-MeSADP), an agonist with high specificity for the purinergic receptor type 1 isoform (P2Y(1)R). At 24 hours, cytotoxic edema in astrocytes was still apparent at the penumbra and preceded the cell lysis that defined the infarct. Delayed 2MeSADP treatment, 24 hours after the initial thrombosis, also significantly reduced cytotoxic edema and the continued growth of the brain infarction. Pharmacological and genetic evidence are presented indicating that 2MeSADP protection is mediated by enhanced astrocyte mitochondrial metabolism via increased inositol trisphosphate (IP3)-dependent Ca2+ release. We suggest that mitochondria play a critical role in astrocyte energy metabolism in the penumbra of ischemic lesions, where low ATP levels are widely accepted to be responsible for cytotoxic edema. Enhancement of this energy source could have similar protective benefits for a wide range of brain injuries.	[Zheng, Wei; Watts, Lora Talley; Holstein, Deborah M.; Keller, Charles; Grass, Eileen H.; Walter, Christi A.; Lechleiter, James D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Prajapati, Suresh I.; Keller, Charles] Univ Texas Hlth Sci Ctr San Antonio, Greenhey Childrens Canc Res Inst, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Zheng, W (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.	lechleiter@uthscsa.edu	Watts, Lora Talley/A-2724-2012; ZHENG, WEI/B-9482-2012	Watts, Lora Talley/0000-0002-2337-1504; Keller, Charles/0000-0003-2505-7487; Zheng, Wei/0000-0003-3193-2655	National Institutes of Health [AG29461, AG19316]; NATIONAL INSTITUTE ON AGING [P01AG019316, R01AG029461] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded in part by National Institutes of Health AG29461 and AG19316 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Brown AM, 2007, GLIA, V55, P1263, DOI 10.1002/glia.20557; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Cherniak C, 1990, J Cogn Neurosci, V2, P58, DOI 10.1162/jocn.1990.2.1.58; Chu XF, 2007, BRAIN RES, V1149, P157, DOI 10.1016/j.brainres.2007.02.061; Chvatal A, 2007, J ANAT, V210, P671, DOI 10.1111/j.1469-7580.2007.00724.x; Darby M, 2003, J NEUROPHYSIOL, V89, P1870, DOI 10.1152/jn.00510.2002; Dienel GA, 2005, GLIA, V50, P362, DOI 10.1002/glia.20157; Dietrich HH, 2009, J VASC RES, V46, P253, DOI 10.1159/000167273; Fisher M, 2004, STROKE, V35, P367, DOI 10.1161/01.STR.0000115296.67346.28; Fonnum F, 1997, GLIA, V21, P106; Fujita T, 2009, GLIA, V57, P244, DOI 10.1002/glia.20749; GACHET C, 1995, BRIT J HAEMATOL, V91, P434, DOI 10.1111/j.1365-2141.1995.tb05319.x; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; GRASS E, 2009, ECORI TARGETED UNPUB; Haberg A, 2006, NEUROCHEM INT, V48, P531, DOI 10.1016/j.neuint.2005.12.025; Hajnoczky G, 2000, J BIOENERG BIOMEMBR, V32, P15, DOI 10.1023/A:1005504210587; Heo JH, 2005, FREE RADICAL BIO MED, V39, P51, DOI 10.1016/j.freeradbiomed.2005.03.035; Hertz L, 2007, J CEREBR BLOOD F MET, V27, P219, DOI 10.1038/sj.jcbfm.9600343; Howard G, 2007, STROKE, V38, P2446, DOI 10.1161/STROKEAHA.106.478032; Ishikawa M, 2005, CIRCULATION, V111, P1690, DOI 10.1161/01.CIR.0000160349.42665.0C; James G, 2002, EUR J PHARMACOL, V447, P247, DOI 10.1016/S0014-2999(02)01756-9; Kimelberg HK, 2005, GLIA, V50, P389, DOI 10.1002/glia.20174; Klohs J, 2008, STROKE, V39, P2845, DOI 10.1161/STROKEAHA.107.509844; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Leary MC, 2003, CEREBROVASC DIS, V16, P280, DOI 10.1159/000071128; Leis JA, 2005, GLIA, V50, P407, DOI 10.1002/glia.20145; LeMaistre JL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-209; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Meairs S, 2006, CEREBROVASC DIS, V22, P75, DOI 10.1159/000093098; Mongin AA, 2002, AM J PHYSIOL-CELL PH, V283, pC569, DOI 10.1152/ajpcell.00438.2001; Nakase T, 2003, CELL COMMUN ADHES, V10, P413, DOI 10.1080/714040461; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Nedergaard M, 2005, GLIA, V50, P281, DOI 10.1002/glia.20205; Pangrsic T, 2006, J NEUROCHEM, V99, P514, DOI 10.1111/j.1471-4159.2006.04042.x; PASANTESMORALES H, 1994, AM J PHYSIOL, V266, pC165, DOI 10.1152/ajpcell.1994.266.1.C165; PAUSER S, 1995, MAGN RESON IMAGING, V13, P269, DOI 10.1016/0730-725X(94)00109-G; Risher WC, 2009, GLIA, V57, P207, DOI 10.1002/glia.20747; Rosenblum WI, 2007, J NEUROPATH EXP NEUR, V66, P771, DOI 10.1097/nen.0b013e3181461965; Siushansian R, 2001, J COMP NEUROL, V440, P387, DOI 10.1002/cne.1392; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; Uckermann O, 2006, J NEUROSCI RES, V83, P538, DOI 10.1002/jnr.20760; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Verkhratsky A, 1996, TRENDS NEUROSCI, V19, P346, DOI 10.1016/0166-2236(96)10048-5; WATSON BD, 1985, ANN NEUROL, V17, P497, DOI 10.1002/ana.410170513; Watts Lora T., 2009, P569, DOI 10.1007/978-0-387-79492-1_23; Woitzik J, 2008, FRONT BIOSCI-LANDMRK, V13, P1500, DOI 10.2741/2776; Wu J, 2007, J NEUROSCI, V27, P6510, DOI 10.1523/JNEUROSCI.1256-07.2007; Wunder A, 2009, NEUROSCIENCE, V158, P1161, DOI 10.1016/j.neuroscience.2008.10.005; YING WL, 1991, BIOCHEMISTRY-US, V30, P4949, DOI 10.1021/bi00234a016	52	56	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14401	10.1371/journal.pone.0014401	http://dx.doi.org/10.1371/journal.pone.0014401			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203502	gold, Green Submitted, Green Published			2022-12-27	WOS:000285578000008
J	Baandrup, JD; Markvardsen, LH; Peters, CD; Schou, UK; Jensen, JL; Magnusson, NE; Orntoft, TF; Kruhoffer, M; Simonsen, U				Baandrup, Jonas D.; Markvardsen, Lars H.; Peters, Christian D.; Schou, Uffe K.; Jensen, Jens L.; Magnusson, Nils E.; Orntoft, Torben F.; Kruhoffer, Mogens; Simonsen, Ulf			Pressure Load: The Main Factor for Altered Gene Expression in Right Ventricular Hypertrophy in Chronic Hypoxic Rats	PLOS ONE			English	Article							MONOAMINE-OXIDASE-A; PULMONARY-HYPERTENSION; CARDIAC-HYPERTROPHY; MICROARRAY ANALYSIS; HEART-FAILURE; MESSENGER-RNA; RECEPTOR; ENDOTHELIN; TISSUE; CELL	Background: The present study investigated whether changes in gene expression in the right ventricle following pulmonary hypertension can be attributed to hypoxia or pressure loading. Methodology/Principal Findings: To distinguish hypoxia from pressure-induced alterations, a group of rats underwent banding of the pulmonary trunk (PTB), sham operation, or the rats were exposed to normoxia or chronic, hypobaric hypoxia. Pressure measurements were performed and the right ventricle was analyzed by Affymetrix GeneChip, and selected genes were confirmed by quantitative PCR and immunoblotting. Right ventricular systolic blood pressure and right ventricle to body weight ratio were elevated in the PTB and the hypoxic rats. Expression of the same 172 genes was altered in the chronic hypoxic and PTB rats. Thus, gene expression of enzymes participating in fatty acid oxidation and the glycerol channel were downregulated. mRNA expression of aquaporin 7 was downregulated, but this was not the case for the protein expression. In contrast, monoamine oxidase A and tissue transglutaminase were upregulated both at gene and protein levels. 11 genes (e.g. insulin-like growth factor binding protein) were upregulated in the PTB experiment and downregulated in the hypoxic experiment, and 3 genes (e.g. c-kit tyrosine kinase) were downregulated in the PTB and upregulated in the hypoxic experiment. Conclusion/Significance: Pressure load of the right ventricle induces a marked shift in the gene expression, which in case of the metabolic genes appears compensated at the protein level, while both expression of genes and proteins of importance for myocardial function and remodelling are altered by the increased pressure load of the right ventricle. These findings imply that treatment of pulmonary hypertension should also aim at reducing right ventricular pressure.	[Baandrup, Jonas D.; Markvardsen, Lars H.; Magnusson, Nils E.; Simonsen, Ulf] Aarhus Univ, Dept Pharmacol, DK-8000 Aarhus, Denmark; [Peters, Christian D.; Schou, Uffe K.] Aarhus Univ, Water & Salt Res Ctr, Dept Anat, Aarhus, Denmark; [Jensen, Jens L.] Aarhus Univ, Inst Math, Dept Theoret Stat, DK-8000 Aarhus, Denmark; [Orntoft, Torben F.; Kruhoffer, Mogens] Aarhus Univ Hosp, Mol Diagnost Lab, Dept Clin Biochem, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Baandrup, JD (corresponding author), Aarhus Univ, Dept Pharmacol, Univ Pk 240, DK-8000 Aarhus, Denmark.	us@farm.au.dk	Jensen, Jens Ledet/B-7172-2008	Jensen, Jens Ledet/0000-0002-8776-5764; Magnusson, Nils Erik/0000-0002-9614-0133; Markvardsen, Lars Hoj/0000-0002-5562-9768; Love, Uffe Schou/0000-0002-2409-0499; Peters, Christian Daugaard/0000-0002-4917-1535	Danish Heart Foundation; Danish Lung Foundation; Danish Research Council	Danish Heart Foundation; Danish Lung Foundation; Danish Research Council(Det Frie Forskningsrad (DFF))	Jonas Baandrup was supported by the Danish Heart Foundation, and Ulf Simonsen was supported by the Danish Lung Foundation and the Danish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; Balasubramanian S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011470; Bianchi P, 2005, CIRCULATION, V112, P3297, DOI 10.1161/CIRCULATIONAHA.104.528133; Bianchi P, 2005, FASEB J, V19, P641, DOI 10.1096/fj.04-2518fje; Buermans HPJ, 2005, PHYSIOL GENOMICS, V21, P314, DOI 10.1152/physiolgenomics.00185.2004; Bull TM, 2004, AM J RESP CRIT CARE, V170, P911, DOI 10.1164/rccm.200312-1686OC; Bull Todd M, 2007, Proc Am Thorac Soc, V4, P117, DOI 10.1513/pats.200605-128JG; Butler TL, 2006, AM J PHYSIOL-HEART C, V291, pH705, DOI 10.1152/ajpheart.00090.2006; Chang KH, 2007, P NATL ACAD SCI USA, V104, P10595, DOI 10.1073/pnas.0702072104; Chen JSK, 1999, INT J BIOCHEM CELL B, V31, P817, DOI 10.1016/S1357-2725(99)00045-X; Chen SJ, 1995, J APPL PHYSIOL, V79, P2122, DOI 10.1152/jappl.1995.79.6.2122; Cheng HQ, 2010, CIRC RES, V107, P348, DOI 10.1161/CIRCRESAHA.110.218735; Chin KM, 2005, CORONARY ARTERY DIS, V16, P13, DOI 10.1097/00019501-200502000-00003; Dupont J, 2001, ENDOCRINOLOGY, V142, P4969, DOI 10.1210/en.142.11.4969; Ecarnot-Laubriet A, 2002, BBA-MOL BASIS DIS, V1586, P233, DOI 10.1016/S0925-4439(01)00101-6; Elmedal B, 2004, BRIT J PHARMACOL, V141, P105, DOI 10.1038/sj.bjp.0705580; Essop MF, 2007, J PHYSIOL-LONDON, V584, P715, DOI 10.1113/jphysiol.2007.143511; Faber JE, 2007, AM J PHYSIOL-HEART C, V292, pH2316, DOI 10.1152/ajpheart.00792.2006; Faber JE, 2006, AM J PHYSIOL-HEART C, V291, pH2272, DOI 10.1152/ajpheart.00404.2006; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Gaynor SL, 2005, CIRCULATION, V112, pI212, DOI 10.1161/CIRCULATIONAHA.104.517789; Geraci MW, 2001, CIRC RES, V88, P555, DOI 10.1161/01.RES.88.6.555; Gharib SA, 2005, PHYSIOL GENOMICS, V22, P14, DOI 10.1152/physiolgenomics.00265.2004; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; Hwang DM, 2000, GENOMICS, V66, P1, DOI 10.1006/geno.2000.6171; Iglarz M, 2010, CLIN SCI, V119, P453, DOI 10.1042/CS20100222; Jiang YL, 2007, ACTA BIOCH BIOPH SIN, V39, P73, DOI 10.1111/j.1745-7270.2007.00249.x; Kisch-Wedel H, 2003, INTENS CARE MED, V29, P1574, DOI 10.1007/s00134-003-1891-z; Kogler H, 2003, CIRC RES, V93, P230, DOI 10.1161/01.RES.0000085042.89656.C7; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Litz J, 2006, MOL CANCER THER, V5, P1415, DOI 10.1158/1535-7163.MCT-05-0503; Maeda N, 2004, P NATL ACAD SCI USA, V101, P17801, DOI 10.1073/pnas.0406230101; MILANO CA, 1994, P NATL ACAD SCI USA, V91, P10109, DOI 10.1073/pnas.91.21.10109; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; Montalescot G, 1998, AM J CARDIOL, V82, P749, DOI 10.1016/S0002-9149(98)00439-1; Mulder P, 1997, CIRCULATION, V96, P1976, DOI 10.1161/01.CIR.96.6.1976; Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4; Park HK, 2001, PHARMACOL RES, V43, P265, DOI 10.1006/phrs.2000.0777; Redout EM, 2007, CARDIOVASC RES, V75, P770, DOI 10.1016/j.cardiores.2007.05.012; Rodriguez MJ, 2001, CELL TISSUE RES, V304, P215, DOI 10.1007/s004410100361; Schou Uffe K., 2007, Journal of Experimental Animal Science, V43, P237, DOI 10.1016/j.jeas.2006.10.004; Sharma S, 2004, AM J PHYSIOL-HEART C, V286, pH1185, DOI 10.1152/ajpheart.00916.2003; Sheikh F, 2008, J CLIN INVEST, V118, P3870, DOI 10.1172/JCI34472; Sivasubramaniam SD, 2003, CELL TISSUE RES, V313, P291, DOI 10.1007/s00441-003-0765-6; Skowronski MT, 2007, AM J PHYSIOL-RENAL, V292, pP956, DOI 10.1152/ajprenal.00314.2006; Small K, 1999, J BIOL CHEM, V274, P21291, DOI 10.1074/jbc.274.30.21291; Wakayama Y, 2004, CELL TISSUE RES, V316, P123, DOI 10.1007/s00441-004-0857-y	47	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15859	10.1371/journal.pone.0015859	http://dx.doi.org/10.1371/journal.pone.0015859			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246034	gold, Green Published, Green Submitted			2022-12-27	WOS:000286511200023
J	Danilova, N; Kumagai, A; Lin, J				Danilova, Nadia; Kumagai, Asako; Lin, Jenny			p53 Upregulation Is a Frequent Response to Deficiency of Cell-Essential Genes	PLOS ONE			English	Article							DNA-DAMAGE; RIBOSOME BIOGENESIS; ZEBRAFISH; ACTIVATION; APOPTOSIS; LEADS; MUTATIONS; MODEL; MICE; IDENTIFICATION	Background: The role of p53 in the prevention of development of embryos damaged by genotoxic factors is well recognized. However, whether p53 plays an analogous role in preventing birth defects from genetic mutations remains an unanswered question. Genetic screens for mutations affecting development show that only a fraction of developmentally lethal mutations leads to specific phenotypes while the majority results in similar recurrent phenotypes characterized by neuronal apoptosis and developmental delay. Mutations in cell-essential genes typically fall into this group. The observation that mutations in diverse housekeeping genes lead to a similar phenotype suggests a common mechanism underlying this phenotype. For some mutants, p53 inhibition was shown to attenuate the phenotype. Methodology/Principal Findings: To find out how common p53 involvement is in this phenotype, we analyzed zebrafish mutants from various categories of cell essential genes. Several thousand zebrafish mutants have been identified; many of them are kept at stock centers and available for the research community. We selected mutants for genes functioning in DNA replication, transcription, telomere maintenance, ribosome biogenesis, splicing, chaperoning, endocytosis, and cellular transport. We found that mutants have similar phenotypes including neural apoptosis, failure to develop structures originated from the neural crest cells, and hematopoietic defects. All mutants share p53 upregulation and similar changes in several p53-dependent and independent molecular pathways. Conclusion/Significance: Our results suggest that mutations in housekeeping genes often canalize on the p53-mediated phenotype. p53 prevents the development of embryos with defects in such genes. p53-mediated changes in gene expression may also contribute to many human congenital malformations.	[Danilova, Nadia; Kumagai, Asako; Lin, Jenny] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Danilova, N (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	ndanilova@ucla.edu			Diamond Blackfan Anemia Foundation; National Institutes of Health [R01HL97561]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097561] Funding Source: NIH RePORTER	Diamond Blackfan Anemia Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Diamond Blackfan Anemia Foundation and the National Institutes of Health research grant R01HL97561. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Azuma M, 2006, J BIOL CHEM, V281, P13309, DOI 10.1074/jbc.M601892200; Barkic M, 2009, MOL CELL BIOL, V29, P2489, DOI 10.1128/MCB.01588-08; COPP AJ, 1995, TRENDS GENET, V11, P87, DOI 10.1016/S0168-9525(00)89008-3; Danilova N, 2011, BRIT J HAEMATOL, V152, P217, DOI 10.1111/j.1365-2141.2010.08396.x; Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290; Danilova Nadia, 2008, Birth Defects Research, V84, P215, DOI 10.1002/bdrc.20129; Demidenko ZN, 2010, P NATL ACAD SCI USA, V107, P9660, DOI 10.1073/pnas.1002298107; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Driever W, 1996, DEVELOPMENT, V123, P37; Frank KM, 2000, MOL CELL, V5, P993, DOI 10.1016/S1097-2765(00)80264-6; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Gottlieb E, 1997, EMBO J, V16, P1381, DOI 10.1093/emboj/16.6.1381; Gudkov AV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001180; HAFTER P, 1996, DEVELOPMENT, V123, P1; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hall PA, 1997, CURR BIOL, V7, pR144, DOI 10.1016/S0960-9822(97)70074-5; Heyer BS, 2000, GENE DEV, V14, P2072; Hu WW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001073; Kirch HC, 1999, ONCOGENE, V18, P2728, DOI 10.1038/sj.onc.1202626; Korotchkina LG, 2010, AGING-US, V2, P344, DOI 10.18632/aging.100160; Lane D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000893; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; NICOL CJ, 1995, NAT GENET, V10, P181, DOI 10.1038/ng0695-181; Norimura T, 1996, NAT MED, V2, P577, DOI 10.1038/nm0596-577; Panic L, 2006, MOL CELL BIOL, V26, P8880, DOI 10.1128/MCB.00751-06; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Plaster N, 2006, CELL DEATH DIFFER, V13, P223, DOI 10.1038/sj.cdd.4401747; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; THISSE C, 1993, DEVELOPMENT, V119, P1203; Trede NS, 2007, P NATL ACAD SCI USA, V104, P6608, DOI 10.1073/pnas.0701919104; Vilborg A, 2010, J MOL MED, V88, P645, DOI 10.1007/s00109-010-0609-2	35	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15938	10.1371/journal.pone.0015938	http://dx.doi.org/10.1371/journal.pone.0015938			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209837	Green Published, Green Submitted, gold			2022-12-27	WOS:000285838900051
J	Palstra, AP; Tudorache, C; Rovira, M; Brittijn, SA; Burgerhout, E; van den Thillart, GEEJM; Spaink, HP; Planas, JV				Palstra, Arjan P.; Tudorache, Christian; Rovira, Mireia; Brittijn, Sebastiaan A.; Burgerhout, Erik; van den Thillart, Guido E. E. J. M.; Spaink, Herman P.; Planas, Josep V.			Establishing Zebrafish as a Novel Exercise Model: Swimming Economy, Swimming-Enhanced Growth and Muscle Growth Marker Gene Expression	PLOS ONE			English	Article							SKELETAL-MUSCLE; DANIO-RERIO; BRACHYDANIO-RERIO; HUMAN-DISEASE; SYSTEM; ADULT; TROUT; RECEPTORS; MYOSTATIN; PERFORMANCE	Background: Zebrafish has been largely accepted as a vertebrate multidisciplinary model but its usefulness as a model for exercise physiology has been hampered by the scarce knowledge on its swimming economy, optimal swimming speeds and cost of transport. Therefore, we have performed individual and group-wise swimming experiments to quantify swimming economy and to demonstrate the exercise effects on growth in adult zebrafish. Methodology/Principal Findings: Individual zebrafish (n = 10) were able to swim at a critical swimming speed (U-crit) of 0.548+/-0.007 m s(-1) or 18.0 standard body lengths (BL) s(-1). The optimal swimming speed (U-opt) at which energetic efficiency is highest was 0.396+/-0.019 m s(-1) (13.0 BL s(-1)) corresponding to 72.26+/-0.29% of U-crit. The cost of transport at optimal swimming speed (COTopt) was 25.23+/-4.03 mu mol g(-1) m(-1). A group-wise experiment was conducted with zebrafish (n = 83) swimming at U-opt for 6 h day(-1) for 5 days week(-1) for 4 weeks vs. zebrafish (n = 84) that rested during this period. Swimming zebrafish increased their total body length by 5.6% and body weight by 41.1% as compared to resting fish. For the first time, a highly significant exercise-induced growth is demonstrated in adult zebrafish. Expression analysis of a set of muscle growth marker genes revealed clear regulatory roles in relation to swimming-enhanced growth for genes such as growth hormone receptor b (ghrb), insulin-like growth factor 1 receptor a (igf1ra), troponin C (stnnc), slow myosin heavy chain 1 (smyhc1), troponin I2 (tnni2), myosin heavy polypeptide 2 (myhz2) and myostatin (mstnb). Conclusions/Significance: From the results of our study we can conclude that zebrafish can be used as an exercise model for enhanced growth, with implications in basic, biomedical and applied sciences, such as aquaculture.	[Palstra, Arjan P.; Rovira, Mireia; Planas, Josep V.] Univ Barcelona, IBUB, Fac Biol, Dept Fisiol, Barcelona, Spain; [Palstra, Arjan P.; Tudorache, Christian; Brittijn, Sebastiaan A.; Burgerhout, Erik; van den Thillart, Guido E. E. J. M.; Spaink, Herman P.] Leiden Univ IBL, Inst Biol, Sylvius Lab, Leiden, Netherlands	University of Barcelona; Leiden University; Leiden University - Excl LUMC	Palstra, AP (corresponding author), Univ Barcelona, IBUB, Fac Biol, Dept Fisiol, Barcelona, Spain.	palstra@ub.edu	Palstra, Arjan/B-4122-2013; Burgerhout, Erik/AAI-4527-2020; Spaink, Herman P./S-3586-2017	Spaink, Herman P./0000-0003-4128-9501; Rovira, Mireia/0000-0003-4050-1662; Tudorache, Christian/0000-0002-6208-9608; Planas, Josep/0000-0002-6525-9617	Ministerio de Ciencia e Innovacion, Spain [CSD2007-0002]; European Commission (REPRO-SWIM) [219971]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Commission (REPRO-SWIM)(European CommissionEuropean Commission Joint Research Centre)	This study was supported by a grant from the Ministerio de Ciencia e Innovacion, Spain (CSD2007-0002 to J. V. Planas). A. P. Palstra was supported by a Marie Curie Intra-European Fellowship from the European Commission (REPRO-SWIM) with Grant Agreement number 219971. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amali AA, 2004, DEV DYNAM, V229, P847, DOI 10.1002/dvdy.10454; [Anonymous], 2003, STRENGTH POWER SPORT; Batt J, 2005, FASEB J, DOI [10.1096/04-3640fje, DOI 10.1096/04-3640FJE]; Biga PR, 2006, AM J PHYSIOL-REG I, V291, pR1327, DOI 10.1152/ajpregu.00905.2005; Bower NI, 2008, J EXP BIOL, V211, P3859, DOI 10.1242/jeb.024117; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103; Briggs JP, 2002, AM J PHYSIOL-REG I, V282, pR3, DOI 10.1152/ajpregu.00589.2001; Bruunsgaard H, 2005, J LEUKOCYTE BIOL, V78, P819, DOI 10.1189/jlb.0505247; Chauvigne F, 2003, GEN COMP ENDOCR, V132, P209, DOI 10.1016/S0016-6480(03)00081-9; Davison W, 1997, COMP BIOCHEM PHYS A, V117, P67, DOI 10.1016/S0300-9629(96)00284-8; DAVISON W, 1977, J EXP BIOL, V70, P1; DAVISON W, 1989, COMP BIOCHEM PHYS A, V94, P1, DOI 10.1016/0300-9629(89)90775-5; de Lange P, 2007, FASEB J, V21, P3431, DOI 10.1096/fj.07-8527rev; de Vocht A, 1999, BASISHANDBOEK SPSS 8; Di Prinzio CM, 2010, GENE EXPR PATTERNS, V10, P214, DOI 10.1016/j.gep.2010.03.001; Duan CM, 1997, AM ZOOL, V37, P491; EAST P, 1987, CAN J ZOOL, V65, P843, DOI 10.1139/z87-134; Fox BK, 2010, GEN COMP ENDOCR, V166, P573, DOI 10.1016/j.ygcen.2009.11.012; Gerhard GS, 2003, EXP GERONTOL, V38, P1333, DOI 10.1016/j.exger.2003.10.022; HAMMER C, 1995, COMP BIOCHEM PHYS A, V112, P1, DOI 10.1016/0300-9629(95)00060-K; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; Johnston IA, 2009, J EXP BIOL, V212, P1781, DOI 10.1242/jeb.029918; Kari G, 2007, CLIN PHARMACOL THER, V82, P70, DOI 10.1038/sj.clpt.6100223; KAUFMANN R, 1990, J EXP BIOL, V150, P343; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; LeMoine CMR, 2010, J COMP PHYSIOL B, V180, P151, DOI 10.1007/s00360-009-0398-5; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUCAS MC, 1992, J FISH BIOL, V41, P175, DOI 10.1111/j.1095-8649.1992.tb02648.x; Martin CI, 2005, J EXP BIOL, V208, P2083, DOI 10.1242/jeb.01605; Maures T, 2002, ENDOCRINOLOGY, V143, P1858, DOI 10.1210/en.143.5.1858; McClelland GB, 2006, J PHYSIOL-LONDON, V577, P739, DOI 10.1113/jphysiol.2006.119032; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; Mommsen TP, 2001, COMP BIOCHEM PHYS B, V129, P207, DOI 10.1016/S1096-4959(01)00312-8; Morales R, 2001, ELEC J BIOTECH, V4, P51; Palstra A, 2008, COMP BIOCHEM PHYS A, V151, P37, DOI 10.1016/j.cbpa.2008.05.011; Patton EE, 2001, NAT REV GENET, V2, P956, DOI 10.1038/35103567; Pedersen BK, 2000, PHYSIOL REV, V80, P1055, DOI 10.1152/physrev.2000.80.3.1055; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Picha ME, 2008, J ENDOCRINOL, V199, P81, DOI 10.1677/JOE-07-0649; PLAUT I, 1994, J EXP BIOL, V194, P209; Plaut I, 2000, J EXP BIOL, V203, P813; Stockhammer OW, 2009, J IMMUNOL, V182, P5641, DOI 10.4049/jimmunol.0900082; TOTLAND GK, 1987, AQUACULTURE, V66, P299, DOI 10.1016/0044-8486(87)90115-3; Trede NS, 2004, IMMUNITY, V20, P367, DOI 10.1016/S1074-7613(04)00084-6; Tudorache C, 2007, J FISH BIOL, V71, P1630, DOI 10.1111/j.1095-8649.2007.01620.x; van den Thillart G, 2004, J FISH BIOL, V65, P312, DOI 10.1111/j.0022-1112.2004.00447.x; van der Meulen T, 2006, AM J PHYSIOL-REG I, V291, pR1040, DOI 10.1152/ajpregu.00116.2006; van der Sar AM, 2004, TRENDS MICROBIOL, V12, P451, DOI 10.1016/j.tim.2004.08.001; van der Sar AM, 2009, MOL IMMUNOL, V46, P2317, DOI 10.1016/j.molimm.2009.03.024; VANRAAMSDONK W, 1983, ANAT EMBRYOL, V167, P125; Videler JJ, 1993, FISH SWIMMING, P1, DOI [10.1007/978-94-011-1580-3, DOI 10.1007/978-94-011-1580-3]; WALKER MG, 1978, J FISH BIOL, V13, P475, DOI 10.1111/j.1095-8649.1978.tb03457.x; Xu C, 2003, J EXP BIOL, V206, P4067, DOI 10.1242/jeb.00635; Xu XP, 2008, VIROLOGY, V376, P1, DOI 10.1016/j.virol.2007.12.026	56	87	90	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e14483	10.1371/journal.pone.0014483	http://dx.doi.org/10.1371/journal.pone.0014483			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217817	Green Published, gold			2022-12-27	WOS:000285838900012
J	Voelz, K; Johnston, SA; Rutherford, JC; May, RC				Voelz, Kerstin; Johnston, Simon A.; Rutherford, Julian C.; May, Robin C.			Automated Analysis of Cryptococcal Macrophage Parasitism Using GFP-Tagged Cryptococci	PLOS ONE			English	Article							INTRACELLULAR PARASITISM; ALVEOLAR MACROPHAGES; FLUORESCENT PROTEINS; PULMONARY CRYPTOCOCCOSIS; MONONUCLEAR PHAGOCYTES; NEOFORMANS INFECTION; MURINE MACROPHAGES; BRITISH-COLUMBIA; VANCOUVER-ISLAND; HUMAN-MONOCYTES	The human fungal pathogens Cryptococcus neoformans and C. gattii cause life-threatening infections of the central nervous system. One of the major characteristics of cryptococcal disease is the ability of the pathogen to parasitise upon phagocytic immune effector cells, a phenomenon that correlates strongly with virulence in rodent models of infection. Despite the importance of phagocyte/Cryptococcus interactions to disease progression, current methods for assaying virulence in the macrophage system are both time consuming and low throughput. Here, we introduce the first stable and fully characterised GFP-expressing derivatives of two widely used cryptococcal strains: C. neoformans serotype A type strain H99 and C. gattii serotype B type strain R265. Both strains show unaltered responses to environmental and host stress conditions and no deficiency in virulence in the macrophage model system. In addition, we report the development of a method to effectively and rapidly investigate macrophage parasitism by flow cytometry, a technique that preserves the accuracy of current approaches but offers a four-fold improvement in speed.	[Voelz, Kerstin; Johnston, Simon A.; May, Robin C.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Rutherford, Julian C.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Birmingham; Newcastle University - UK	Voelz, K (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	R.C.May@bham.ac.uk	Voelz, Kerstin/A-8888-2011; Johnston, Simon/G-4515-2010; May, Robin Charles/ABA-9266-2021	Voelz, Kerstin/0000-0003-0973-4353; May, Robin Charles/0000-0001-5364-1838; Johnston, Simon/0000-0002-3429-9536	Medical Research Council [G0601171]; Wellcome Trust [088148MF]; Darwin Trust; Advantage West Midlands (AWM); Biotechnology and Biological Sciences Research Council [BB/H006605/1] Funding Source: researchfish; BBSRC [BB/H006605/1] Funding Source: UKRI; MRC [G0601171] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Darwin Trust; Advantage West Midlands (AWM); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was funded by grants from the Medical Research Council, grant G0601171 (http://www.mrc.ac.uk/), the Wellcome Trust, grant 088148MF (http://www.wellcome.ac.uk) and a Darwin Trust PhD studentship to KV. The A1R confocal used in this research was obtained through Birmingham Science City Translational Medicine Clinical Research and Infrastructure Trials Platform, with support from Advantage West Midlands (AWM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez M, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-16; Alvarez M, 2008, CELL MICROBIOL, V10, P1622, DOI 10.1111/j.1462-5822.2008.01152.x; Alvarez M, 2006, CURR BIOL, V16, P2161, DOI 10.1016/j.cub.2006.09.061; Alvarez M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-51; Bajpai R, 2008, MOL REPROD DEV, V75, P818, DOI 10.1002/mrd.20809; BOBAK DA, 1988, J IMMUNOL, V141, P592; BOLANOS B, 1989, J MED VET MYCOL, V27, P203; BRUMMER E, 1994, CELL IMMUNOL, V157, P1, DOI 10.1006/cimm.1994.1200; BULMER GS, 1967, J BACTERIOL, V94, P1480, DOI 10.1128/JB.94.5.1480-1483.1967; BULMER GS, 1975, INFECT IMMUN, V11, P73, DOI 10.1128/IAI.11.1.73-79.1975; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; CAMPBELL GD, 1966, AM REV RESPIR DIS, V94, P236; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Charlier C, 2009, INFECT IMMUN, V77, P120, DOI 10.1128/IAI.01065-08; Chretien F, 2002, J INFECT DIS, V186, P522, DOI 10.1086/341564; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Cross CE, 1997, IMMUNOLOGY, V91, P289, DOI 10.1046/j.1365-2567.1997.00238.x; Del Poeta M, 2004, EUKARYOT CELL, V3, P1067, DOI 10.1128/EC.3.5.1067-1075.2004; DIAMOND RD, 1973, INFECT IMMUN, V7, P231, DOI 10.1128/IAI.7.2.231-236.1973; Dong XL, 2004, NUCLEIC ACIDS RES, V32, pW660, DOI 10.1093/nar/gkh410; Feldmesser M, 2001, TRENDS MICROBIOL, V9, P273, DOI 10.1016/S0966-842X(01)02035-2; Feldmesser M, 2000, INFECT IMMUN, V68, P4225, DOI 10.1128/IAI.68.7.4225-4237.2000; Geunes-Boyer S, 2009, INFECT IMMUN, V77, P2783, DOI 10.1128/IAI.00088-09; Goldman DL, 2000, INFECT IMMUN, V68, P832, DOI 10.1128/IAI.68.2.832-838.2000; Goldman DL, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e66; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; GRIFFIN FM, 1981, P NATL ACAD SCI-BIOL, V78, P3853, DOI 10.1073/pnas.78.6.3853; Hu GG, 2010, EUKARYOT CELL, V9, P74, DOI 10.1128/EC.00289-09; Idnurm A, 2005, NAT REV MICROBIOL, V3, P753, DOI 10.1038/nrmicro1245; Kechichian TB, 2007, INFECT IMMUN, V75, P4792, DOI 10.1128/IAI.00587-07; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Knodler LA, 2005, INFECT IMMUN, V73, P7027, DOI 10.1128/IAI.73.10.7027-7031.2005; KOZEL TR, 1988, INFECT IMMUN, V56, P2794, DOI 10.1128/IAI.56.11.2794-2800.1988; Lee H, 2007, MOL MICROBIOL, V65, P1018, DOI 10.1111/j.1365-2958.2007.05844.x; Levitz SM, 1997, J CLIN INVEST, V100, P1640, DOI 10.1172/JCI119688; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lorenz MC, 1997, EMBO J, V16, P7008, DOI 10.1093/emboj/16.23.7008; Luberto C, 2003, J CLIN INVEST, V112, P1080, DOI 10.1172/JCI200318309; Ma HS, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-15; Ma HS, 2006, CURR BIOL, V16, P2156, DOI 10.1016/j.cub.2006.09.032; Ma HS, 2009, P NATL ACAD SCI USA, V106, P12980, DOI 10.1073/pnas.0902963106; MacDougall L, 2007, EMERG INFECT DIS, V13, P42, DOI 10.3201/eid1301.060827; MILLER MF, 1991, INFECT IMMUN, V59, P24, DOI 10.1128/IAI.59.1.24-28.1991; Missall TA, 2006, EUKARYOT CELL, V5, P518, DOI 10.1128/EC.5.3.518-529.2006; MITCHELL TG, 1972, INFECT IMMUN, V5, P491, DOI 10.1128/IAI.5.4.491-498.1972; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; Monari C, 2003, EUR J IMMUNOL, V33, P1041, DOI 10.1002/eji.200323388; Nadrous HF, 2003, CHEST, V124, p95S, DOI 10.1016/S0012-3692(16)60136-8; Okagaki LH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000953; Oliveira DL, 2010, INFECT IMMUN, V78, P1601, DOI 10.1128/IAI.01171-09; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; RALPH P, 1975, J IMMUNOL, V114, P898; Santangelo R, 2004, INFECT IMMUN, V72, P2229, DOI 10.1128/IAI.72.4.2229-2239.2004; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shao XP, 2005, J IMMUNOL, V175, P3244, DOI 10.4049/jimmunol.175.5.3244; Shi MQ, 2010, J CLIN INVEST, V120, P1683, DOI 10.1172/JCI41963; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Tucker SC, 2002, P NATL ACAD SCI USA, V99, P3165, DOI 10.1073/pnas.052702799; Velagapudi R, 2009, INFECT IMMUN, V77, P4345, DOI 10.1128/IAI.00542-09; Voelz K, 2009, INFECT IMMUN	60	38	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15968	10.1371/journal.pone.0015968	http://dx.doi.org/10.1371/journal.pone.0015968			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209844	Green Published, gold, Green Accepted			2022-12-27	WOS:000285838900055
J	Binder, M; Lechenne, B; Ummanni, R; Scharf, C; Balabanov, S; Trusch, M; Schluter, H; Braren, I; Spillner, E; Trepel, M				Binder, Mascha; Lechenne, Barbara; Ummanni, Ramesh; Scharf, Christan; Balabanov, Stefan; Trusch, Maria; Schlueter, Hartmut; Braren, Ingke; Spillner, Edzard; Trepel, Martin			Stereotypical Chronic Lymphocytic Leukemia B-Cell Receptors Recognize Survival Promoting Antigens on Stromal Cells	PLOS ONE			English	Article							IMMUNOGLOBULIN GENES; RHEUMATOID-ARTHRITIS; VIMENTIN; ANTIBODIES; LYMPHOMAS; CLL; CALRETICULIN; SPECIFICITY; EXPRESSION; APOPTOSIS	Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. Survival of CLL cells depends on their close contact with stromal cells in lymphatic tissues, bone marrow and blood. This microenvironmental regulation of CLL cell survival involves the stromal secretion of chemo- and cytokines as well as the expression of adhesion molecules. Since CLL survival may also be driven by antigenic stimulation through the B-cell antigen receptor (BCR), we explored the hypothesis that these processes may be linked to each other. We tested if stromal cells could serve as an antigen reservoir for CLL cells, thus promoting CLL cell survival by stimulation through the BCR. As a proof of principle, we found that two CLL BCRs with a common stereotyped heavy chain complementarity-determining region 3 (previously characterized as "subset 1") recognize antigens highly expressed in stromal cells - vimentin and calreticulin. Both antigens are well-documented targets of autoantibodies in autoimmune disorders. We demonstrated that vimentin is displayed on the surface of viable stromal cells and that it is present and bound by the stereotyped CLL BCR in CLL-stroma co-culture supernatant. Blocking the vimentin antigen by recombinant soluble CLL BCR under CLL-stromal cell co-culture conditions reduces stroma-mediated anti-apoptotic effects by 20-45%. We therefore conclude that CLL BCR stimulation by stroma-derived antigens can contribute to the protective effect that the stroma exerts on CLL cells. This finding sheds a new light on the understanding of the pathobiology of this so far mostly incurable disease.	[Binder, Mascha; Lechenne, Barbara; Ummanni, Ramesh; Balabanov, Stefan; Trepel, Martin] Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr Hamburg, Hubertus Wald Tumorzentrum, Dept Hematol & Oncol, Hamburg, Germany; [Scharf, Christan] Ernst Moritz Arndt Univ Greifswald, Dept Otorhinolaryngol, Greifswald, Germany; [Trusch, Maria; Schlueter, Hartmut] Univ Med Ctr Hamburg Eppendorf, Dept Clin Chem, Hamburg, Germany; [Braren, Ingke; Spillner, Edzard] Univ Hamburg, Dept Chem, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Ernst Moritz Arndt Universitat Greifswald; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg	Binder, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr Hamburg, Hubertus Wald Tumorzentrum, Dept Hematol & Oncol, Hamburg, Germany.	m.trepel@uke.de	Balabanov, Stefan/E-9765-2014; Riedner, Maria/W-5546-2019; Scharf, Christian/A-7931-2011; Schluter, Hartmut/D-1371-2015; Spillner, E./G-3799-2010	Scharf, Christian/0000-0001-6806-6450; Schluter, Hartmut/0000-0002-9358-7036; spillner, edzard/0000-0003-0999-5254; Binder, Mascha/0000-0003-0663-3004	German Jose Carreras International Leukemia Foundation [R07/29f]; German Cancer Aid [108239]	German Jose Carreras International Leukemia Foundation; German Cancer Aid(Deutsche Krebshilfe)	This study was funded by the German Jose Carreras International Leukemia Foundation (grant R07/29f to MT) and the German Cancer Aid (grant 108239 to MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan K, 2009, BLOOD, V113, P149, DOI 10.1182/blood-2008-02-138560; Bertinetti C, 2006, EUR J HAEMATOL, V77, P395, DOI 10.1111/j.1600-0609.2006.00740.x; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; BOHN W, 1992, EXP CELL RES, V201, P1, DOI 10.1016/0014-4827(92)90341-5; Braren I, 2007, BIOTECHNOL APPL BIOC, V47, P205, DOI 10.1042/BA20060170; Braren I, 2007, CLIN CHEM, V53, P837, DOI 10.1373/clinchem.2006.078360; BUCHNER M, 2009, BLOOD, V114, P2356; Burger JA, 2000, BLOOD, V96, P2655; Burger JA, 2002, LEUKEMIA LYMPHOMA, V43, P461, DOI 10.1080/10428190290011921; Burger JA, 2001, J CLIN INVEST, V107, P305, DOI 10.1172/JCI11092; Burger JA, 2009, BLOOD, V114, P3367, DOI 10.1182/blood-2009-06-225326; Burger JA, 2009, BLOOD, V113, P3050, DOI 10.1182/blood-2008-07-170415; Chiorazzi N, 2005, ANN NY ACAD SCI, V1062, P1, DOI 10.1196/annals.1358.002; Chiorazzi N, 2003, ANNU REV IMMUNOL, V21, P841, DOI 10.1146/annurev.immunol.21.120601.141018; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Chu CC, 2008, BLOOD, V112, P5122, DOI 10.1182/blood-2008-06-162024; Deaglio S, 2005, BLOOD, V105, P3042, DOI 10.1182/blood-2004-10-3873; Dighiero G, 2008, LANCET, V371, P1017, DOI 10.1016/S0140-6736(08)60456-0; DIGHIERO G, 1991, BLOOD, V78, P581; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Fais F, 1998, J CLIN INVEST, V102, P1515, DOI 10.1172/JCI3009; Ghiotto F, 2006, MOL MED, V12, P300, DOI 10.2119/2006-00080.Ghiotto; Herve M, 2005, J CLIN INVEST, V115, P1636, DOI 10.1172/JCI24387; Johnson S, 2001, TRENDS CELL BIOL, V11, P122, DOI 10.1016/S0962-8924(01)01926-2; Kurtova AV, 2009, BLOOD, V114, P4441, DOI 10.1182/blood-2009-07-233718; Lagneaux L, 1998, BLOOD, V91, P2387, DOI 10.1182/blood.V91.7.2387.2387_2387_2396; Li SS, 2005, J IMMUNOL, V174, P654, DOI 10.4049/jimmunol.174.2.654; MATUTES E, 1994, LEUKEMIA, V8, P1640; Messmer BT, 2004, J EXP MED, V200, P519, DOI 10.1084/jem.20040544; Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb898; Murray F, 2008, BLOOD, V111, P1524, DOI 10.1182/blood-2007-07-099564; MYHRINDER AL, 2008, BLOOD; Niedermeier M, 2009, BLOOD, V113, P5549, DOI 10.1182/blood-2008-06-165068; Nijenhuis S, 2004, CLIN CHIM ACTA, V350, P17, DOI 10.1016/j.cccn.2004.07.016; Nishio M, 2005, BLOOD, V106, P1012, DOI 10.1182/blood-2004-03-0889; Obeid M, 2008, J IMMUNOL, V181, P2533, DOI 10.4049/jimmunol.181.4.2533; Osterroth F, 1999, J IMMUNOL METHODS, V229, P141, DOI 10.1016/S0022-1759(99)00111-8; Panayiotidis P, 1996, BRIT J HAEMATOL, V92, P97, DOI 10.1046/j.1365-2141.1996.00305.x; Pedersen IM, 2002, BLOOD, V100, P1795, DOI 10.1182/blood.V100.5.1795.h81702001795_1795_1801; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Quiroga MP, 2009, BLOOD, V114, P1029, DOI 10.1182/blood-2009-03-212837; QUIROGA MP, 2008, BLOOD, V112, P2064; Redondo-Munoz J, 2008, BLOOD, V112, P169, DOI 10.1182/blood-2007-08-109249; Refaeli Y, 2008, PLOS BIOL, V6, P1208, DOI 10.1371/journal.pbio.0060152; Stamatopoulos K, 2005, BLOOD, V106, P3575, DOI 10.1182/blood-2005-04-1511; Stamatopoulos K, 2007, BLOOD, V109, P259, DOI 10.1182/blood-2006-03-012948; Stevenson FK, 2004, BLOOD, V103, P4389, DOI 10.1182/blood-2003-12-4312; STHOEGER ZM, 1989, J EXP MED, V169, P255, DOI 10.1084/jem.169.1.255; Thorselius M, 2006, BLOOD, V107, P2889, DOI 10.1182/blood-2005-06-2227; Tobin G, 2005, UPSALA J MED SCI, V110, P97, DOI 10.3109/2000-1967-075; Tobin G, 2003, BLOOD, V101, P4952, DOI 10.1182/blood-2002-11-3485; Tobin G, 2007, LEUKEMIA LYMPHOMA, V48, P1081, DOI 10.1080/10428190701342034; Ummanni R, 2008, CANCER LETT, V266, P171, DOI 10.1016/j.canlet.2008.02.047; VERRECK FAW, 1995, TISSUE ANTIGENS, V45, P270, DOI 10.1111/j.1399-0039.1995.tb02451.x; Vossenaar ER, 2004, ARTHRITIS RES THER, V6, pR142, DOI 10.1186/ar1149; Xu B, 2004, MOL CELL BIOL, V24, P9198, DOI 10.1128/MCB.24.20.9198-9206.2004; Zucchetto A, 2009, CANCER RES, V69, P4001, DOI 10.1158/0008-5472.CAN-08-4173	57	52	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15992	10.1371/journal.pone.0015992	http://dx.doi.org/10.1371/journal.pone.0015992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209908	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793600053
J	Enell, LE; Kapan, N; Soderberg, JAE; Kahsai, L; Nassel, DR				Enell, Lina E.; Kapan, Neval; Soderberg, Jeannette A. E.; Kahsai, Lily; Nassel, Dick R.			Insulin Signaling, Lifespan and Stress Resistance Are Modulated by Metabotropic GABA Receptors on Insulin Producing Cells in the Brain of Drosophila	PLOS ONE			English	Article							SHORT NEUROPEPTIDE-F; RECTIFYING K+ CHANNELS; PANCREATIC BETA-CELLS; IN-VITRO; MUSHROOM BODIES; ANTENNAL LOBE; DIABETIC RATS; B RECEPTORS; BODY-SIZE; NEURONS	Insulin-like peptides (ILPs) regulate growth, reproduction, metabolic homeostasis, life span and stress resistance in worms, flies and mammals. A set of insulin producing cells (IPCs) in the Drosophila brain that express three ILPs (DILP2, 3 and 5) have been the main focus of interest in hormonal DILP signaling. Little is, however, known about factors that regulate DILP production and release by these IPCs. Here we show that the IPCs express the metabotropic GABA(B) receptor (GBR), but not the ionotropic GABA(A) receptor subunit RDL. Diminishing the GBR expression on these cells by targeted RNA interference abbreviates life span, decreases metabolic stress resistance and alters carbohydrate and lipid metabolism at stress, but not growth in Drosophila. A direct effect of diminishing GBR on IPCs is an increase in DILP immunofluorescence in these cells, an effect that is accentuated at starvation. Knockdown of irk3, possibly part of a G protein-activated inwardly rectifying K+ channel that may link to GBRs, phenocopies GBR knockdown in starvation experiments. Our experiments suggest that the GBR is involved in inhibitory control of DILP production and release in adult flies at metabolic stress and that this receptor mediates a GABA signal from brain interneurons that may convey nutritional signals. This is the first demonstration of a neurotransmitter that inhibits insulin signaling in its regulation of metabolism, stress and life span in an invertebrate brain.	[Enell, Lina E.; Kapan, Neval; Soderberg, Jeannette A. E.; Kahsai, Lily; Nassel, Dick R.] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden	Stockholm University	Enell, LE (corresponding author), Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden.	dnassel@zoologi.su.se			Swedish Research Council [621-2001-1605]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Research Council (Grant 621-2001-1605, D.R.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeghate E, 2002, TISSUE CELL, V34, P1, DOI 10.1054/tice.2002.0217; Adeghate E, 2001, PEPTIDES, V22, P99, DOI 10.1016/S0196-9781(00)00361-2; ANDRADE R, 1986, SCIENCE, V234, P1261, DOI 10.1126/science.2430334; Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Belgacem YH, 2006, J NEUROBIOL, V66, P19, DOI 10.1002/neu.20193; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Broughton SJ, 2010, AGING CELL, V9, P336, DOI 10.1111/j.1474-9726.2010.00558.x; Buch S, 2008, CELL METAB, V7, P321, DOI 10.1016/j.cmet.2008.02.012; Buckingham SD, 2005, MOL PHARMACOL, V68, P942, DOI 10.1124/mol.105.015313; Cao C, 2001, CELL TISSUE RES, V304, P317, DOI 10.1007/s004410100367; Chen XX, 2005, J NEUROSCI, V25, P3787, DOI 10.1523/JNEUROSCI.5312-04.2005; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; DiAngelo JR, 2009, MOL CELL BIOL, V29, P6341, DOI 10.1128/MCB.00675-09; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dong H, 2006, DIABETOLOGIA, V49, P697, DOI 10.1007/s00125-005-0123-1; Doring F, 2002, J BIOL CHEM, V277, P25554, DOI 10.1074/jbc.M202385200; DRUCKER DJ, 1987, P NATL ACAD SCI USA, V84, P3434, DOI 10.1073/pnas.84.10.3434; Enell L, 2007, J COMP NEUROL, V505, P18, DOI 10.1002/cne.21472; Evans JM, 2005, J EXP BIOL, V208, P3771, DOI 10.1242/jeb.01829; Featherstone DE, 2000, NEURON, V27, P71, DOI 10.1016/S0896-6273(00)00010-6; FELDMAN JM, 1970, ENDOCRINOLOGY, V86, P66; FERNANDEZ R, 1995, EMBO J, V14, P3373, DOI 10.1002/j.1460-2075.1995.tb07343.x; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; Geminard C, 2006, DIABETES, V55, pS5, DOI 10.2337/db06-S001; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Giannakou ME, 2007, TRENDS BIOCHEM SCI, V32, P180, DOI 10.1016/j.tibs.2007.02.007; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; GU XH, 1993, LIFE SCI, V52, P687, DOI 10.1016/0024-3205(93)90229-V; Hamasaka Y, 2005, J NEUROBIOL, V65, P225, DOI 10.1002/neu.20184; Harrison JB, 1996, CELL TISSUE RES, V284, P269, DOI 10.1007/s004410050587; Hosie AM, 1997, TRENDS NEUROSCI, V20, P578, DOI 10.1016/S0166-2236(97)01127-2; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Isabel G, 2005, AM J PHYSIOL-REG I, V288, pR531, DOI 10.1152/ajpregu.00158.2004; Johard HAD, 2008, J COMP NEUROL, V507, P1479, DOI 10.1002/cne.21636; Kaplan DD, 2008, GENE DEV, V22, P1877, DOI 10.1101/gad.1670508; Karpac J, 2009, AGING CELL, V8, P288, DOI 10.1111/j.1474-9726.2009.00476.x; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1998, P NATL ACAD SCI USA, V95, P14991, DOI 10.1073/pnas.95.25.14991; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kolodziejczyk A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002110; Koyrakh L, 2005, J NEUROSCI, V25, P11468, DOI 10.1523/JNEUROSCI.3484-05.2005; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Lee KS, 2008, NAT CELL BIOL, V10, P468, DOI 10.1038/ncb1710; Liu X, 2009, J NEUROSCI, V29, P1573, DOI 10.1523/JNEUROSCI.4763-08.2009; Mehren JE, 2006, LEARN MEMORY, V13, P686, DOI 10.1101/lm.317806; Mezler M, 2001, EUR J NEUROSCI, V13, P477, DOI 10.1046/j.1460-9568.2001.01410.x; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Okada R, 2009, J COMP NEUROL, V514, P74, DOI 10.1002/cne.21971; Okamoto N, 2009, DEV CELL, V17, P885, DOI 10.1016/j.devcel.2009.10.008; Peschke E, 1997, J PINEAL RES, V23, P156, DOI 10.1111/j.1600-079X.1997.tb00349.x; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Sonoda N, 2008, P NATL ACAD SCI USA, V105, P6614, DOI 10.1073/pnas.0710402105; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Wang Y, 2004, ARTERIOSCL THROM VAS, V24, pE23; Wu Q, 2005, P NATL ACAD SCI USA, V102, P13289, DOI 10.1073/pnas.0501914102; Xu E, 2006, CELL METAB, V3, P47, DOI 10.1016/j.cmet.2005.11.015; Yamanaka N, 2005, J BIOL CHEM, V280, P14684, DOI 10.1074/jbc.M500308200; Yamanaka N, 2006, P NATL ACAD SCI USA, V103, P8622, DOI 10.1073/pnas.0511196103; Yamanaka N, 2010, P NATL ACAD SCI USA, V107, P2060, DOI 10.1073/pnas.0907471107; Yamanaka N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003048; Yang CH, 2008, SCIENCE, V319, P1679, DOI 10.1126/science.1151842; Zhang H, 2009, P NATL ACAD SCI USA, V106, P19617, DOI 10.1073/pnas.0905083106	72	56	58	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15780	10.1371/journal.pone.0015780	http://dx.doi.org/10.1371/journal.pone.0015780			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209905	Green Published, gold			2022-12-27	WOS:000285793600039
J	Straetemans, M; Bierrenbach, AL; Nagelkerke, N; Glaziou, P; van der Werf, MJ				Straetemans, Masja; Bierrenbach, Ana L.; Nagelkerke, Nico; Glaziou, Philippe; van der Werf, Marieke J.			The Effect of Tuberculosis on Mortality in HIV Positive People: A Meta-Analysis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; NEGATIVE PULMONARY TUBERCULOSIS; ISONIAZID PREVENTIVE THERAPY; INFECTED PATIENTS; DISEASE PROGRESSION; RISK-FACTORS; SURVIVAL; COHORT; EPIDEMIOLOGY	Background: Tuberculosis is a leading cause of death in people living with HIV (PLWH). We conducted a meta analysis to assess the effect of tuberculosis on mortality in people living with HIV. Methods: Meta-analysis of cohort studies assessing the effect of tuberculosis on mortality in PLWH. To identify eligible studies we systematically searched electronic databases (until December 2008), performed manual searches of citations from relevant articles, and reviewed conference proceedings. Multivariate hazard ratios (HR) of mortality in PLWH with and without tuberculosis, estimated in individual cohort studies, were pooled using random effect weighting according to "Der Simonian Laird method" if the p-value of the heterogeneity test was <0.05. Results: Fifteen cohort studies were systematically retrieved. Pooled overall analysis of these 15 studies estimating the effect of tuberculosis on mortality in PLWH showed a Hazard Ratio (HR) of 1.8 (95% confidence interval (CI): 1.4-2.3). Subanalysis of 8 studies in which the cohort was not exposed to highly active antiretroviral therapy (HAART) showed an HR of 2.6 (95% CI: 1.8-3.6). Subanalysis of 6 studies showed that tuberculosis did not show an effect on mortality in PLWH exposed to HAART: HR 1.1 (95% CI: 0.9-1.3). Conclusion: These results provide an indication of the magnitude of benefit to an individual that could have been expected if tuberculosis had been prevented. It emphasizes the need for additional studies assessing the effect of preventing tuberculosis or early diagnosis and treatment of tuberculosis in PLWH on reducing mortality. Furthermore, the results of the subgroup analyses in cohorts largely exposed to HAART provide additional support to WHO's revised guidelines, which include promoting the initiation of HAART for PLWH co-infected with tuberculosis. The causal effect of tuberculosis on mortality in PLWH exposed to HAART needs to be further evaluated once the results of more cohort studies become available.	[Straetemans, Masja; van der Werf, Marieke J.] KNCV TB Fdn, Unit Res, The Hague, Netherlands; [Straetemans, Masja; van der Werf, Marieke J.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Bierrenbach, Ana L.; Glaziou, Philippe] World Hlth Org, Stop TB Dept, Geneva, Switzerland; [Nagelkerke, Nico] United Arab Emirates Univ, Dept Community Med, Al Ain, U Arab Emirates	KNCV Tuberculosis Foundation; University of Amsterdam; Academic Medical Center Amsterdam; World Health Organization; United Arab Emirates University	Straetemans, M (corresponding author), Royal Trop Inst, KIT Biomed Res, NL-1105 AZ Amsterdam, Netherlands.	m.straetemans@kit.nl	Bierrenbach, Ana L/F-3185-2014	Bierrenbach, Ana L/0000-0002-6837-0636; Glaziou, Philippe/0000-0002-0649-1272; van der Werf, Marieke J./0000-0001-8021-1358	Dutch Ministry of Foreign Affairs	Dutch Ministry of Foreign Affairs	This study has been funded by the Dutch Ministry of Foreign Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron L, 2004, CLIN MICROBIOL INFEC, V10, P388, DOI 10.1111/j.1469-0691.2004.00758.x; Bachhuber MA, 2009, INT J TUBERC LUNG D, V13, P1038; Badri M, 2001, INT J TUBERC LUNG D, V5, P225; Boeree MJ, 2005, TROP MED INT HEALTH, V10, P723, DOI 10.1111/j.1365-3156.2005.01433.x; BRAUN MM, 1991, AM REV RESPIR DIS, V143, P501, DOI 10.1164/ajrccm/143.3.501; Bromeyer L, 2008, MED HYPOTHESES, V71, P741, DOI 10.1016/j.mehy.2008.06.012; Chi BH, 2009, JAIDS-J ACQ IMM DEF, V52, P125, DOI 10.1097/QAI.0b013e3181ab6d8b; Churchyard GJ, 2007, J INFECT DIS, V196, pS52, DOI 10.1086/518662; Churchyard GJ, 2000, INT J TUBERC LUNG D, V4, P705; Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corbett EL, 2001, INT J TUBERC LUNG D, V5, P205; Costagliola D, 2005, CLIN INFECT DIS, V41, P1772, DOI 10.1086/498315; Deeks JJ, 2001, SYSTEMATIC REV HLTH, P285, DOI DOI 10.1002/9780470693926.CH15; Del Amo J, 1999, AIDS, V13, P1151, DOI 10.1097/00002030-199907090-00002; Del Amo J, 2003, JAIDS-J ACQ IMM DEF, V33, P184, DOI 10.1097/00126334-200306010-00011; Dembele M, 2010, INT J TUBERC LUNG D, V14, P318; Desai M, 2008, PAR 39 WORLD C LUNG; Dutch Cochrane Centre, FORM BEOORD COH OND; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Fairall LR, 2008, ARCH INTERN MED, V168, P86, DOI 10.1001/archinternmed.2007.10; Fewell Z, 2004, STATA J, V4, P402, DOI 10.1177/1536867X0400400403; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Glaziou P, 2009, CLIN CHEST MED, V30, P621, DOI 10.1016/j.ccm.2009.08.017; Guwatudde D, 2003, AM J EPIDEMIOL, V158, P887, DOI 10.1093/aje/kwg227; Harries AD, 2008, INT J TUBERC LUNG D, V12, P241; Hsieh SM, 1998, AIDS, V12, P1301, DOI 10.1097/00002030-199811000-00011; Hung CC, 2003, AIDS, V17, P2615, DOI 10.1097/00002030-200312050-00008; Jones-Lopez EC, 2006, AM J TROP MED HYG, V74, P154, DOI 10.4269/ajtmh.2006.74.154; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Leroy V, 1997, AM J EPIDEMIOL, V145, P293; Lopez-Gatell H, 2007, AM J EPIDEMIOL, V165, P1134, DOI 10.1093/aje/kwk116; Lopez-Gatell H, 2008, AIDS, V22, P1869, DOI 10.1097/QAD.0b013e32830e010c; MAHER D, 2008, TUBERCULOSIS DEATHS; Manas E, 2004, INT J TUBERC LUNG D, V8, P451; Manosuthi W, 2006, JAIDS-J ACQ IMM DEF, V43, P42, DOI 10.1097/01.qai.0000230521.86964.86; Mendelson M, 2007, BRIT MED BULL, V81-82, P149, DOI 10.1093/bmb/ldm009; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moreno S, 1997, ARCH INTERN MED, V157, P1729, DOI 10.1001/archinte.157.15.1729; Mugusi FM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-409; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Munsiff SS, 1998, J ACQ IMMUN DEF SYND, V19, P361, DOI 10.1097/00042560-199812010-00006; Nahid P, 2007, AM J RESP CRIT CARE, V175, P1199, DOI 10.1164/rccm.200509-1529OC; NUNN P, 1992, AM REV RESPIR DIS, V146, P849, DOI 10.1164/ajrccm/146.4.849; OKWERA A, 1994, LANCET, V344, P1323, DOI 10.1016/S0140-6736(94)90693-9; Pai M, 2004, NATL MED J INDIA, V17, P86; PERRIENS JH, 1995, NEW ENGL J MED, V332, P779, DOI 10.1056/NEJM199503233321204; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Senn SJ, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-10; Shafer RW, 1996, AIDS, V10, P269, DOI 10.1097/00002030-199603000-00005; SMALL PM, 1991, NEW ENGL J MED, V324, P289, DOI 10.1056/NEJM199101313240503; Song R, 2008, MEX CIT 17 INT AIDS; Sow PS, 2007, JAIDS-J ACQ IMM DEF, V44, P262, DOI 10.1097/QAI.0b013e31802bf109; Schmaltz CAS, 2009, JAIDS-J ACQ IMM DEF, V52, P623, DOI 10.1097/QAI.0b013e3181b31e56; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; van der Sande MAB, 2004, AIDS, V18, P1933, DOI 10.1097/00002030-200409240-00009; Wells G.A., NEWCASTLE OTTAWA SCA; Westreich D, 2008, BOST 15 C RETR OPP I; Westreich D, 2009, AIDS, V23, P707, DOI 10.1097/QAD.0b013e328325d115; Whalen CC, 2000, AIDS, V14, P1219, DOI 10.1097/00002030-200006160-00020; WHO, 2010, ANT THER HIV INF AD; *WHO, 2008, JOINT WORLD HLTH ORG; *WHO, 2009, GLOB TUB CONTR SHORT; Williams BG, 2003, SCIENCE, V301, P1535, DOI 10.1126/science.1086845; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0	67	40	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15241	10.1371/journal.pone.0015241	http://dx.doi.org/10.1371/journal.pone.0015241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209936	Green Submitted, Green Published, gold			2022-12-27	WOS:000285793600015
J	Verhulst, NO; Andriessen, R; Groenhagen, U; Kiss, GB; Schulz, S; Takken, W; van Loon, JJA; Schraa, G; Smallegange, RC				Verhulst, Niels O.; Andriessen, Rob; Groenhagen, Ulrike; Kiss, Gabriella Bukovinszkine; Schulz, Stefan; Takken, Willem; van Loon, Joop J. A.; Schraa, Gosse; Smallegange, Renate C.			Differential Attraction of Malaria Mosquitoes to Volatile Blends Produced by Human Skin Bacteria	PLOS ONE			English	Article							GAMBIAE-SENSU-STRICTO; HUMAN AXILLARY ODOR; L-LACTIC ACID; ANOPHELES-GAMBIAE; AEDES-AEGYPTI; PSEUDOMONAS-AERUGINOSA; DIPTERA-CULICIDAE; ELECTROPHYSIOLOGICAL RESPONSES; PYRUVATE FERMENTATION; OVIPOSITION RESPONSES	The malaria mosquito Anopheles gambiae sensu stricto is mainly guided by human odour components to find its blood host. Skin bacteria play an important role in the production of human body odour and when grown in vitro, skin bacteria produce volatiles that are attractive to A. gambiae. The role of single skin bacterial species in the production of volatiles that mediate the host-seeking behaviour of mosquitoes has remained largely unknown and is the subject of the present study. Headspace samples were taken to identify volatiles that mediate this behaviour. These volatiles could be used as mosquito attractants or repellents. Five commonly occurring species of skin bacteria were tested in an olfactometer for the production of volatiles that attract A. gambiae. Odour blends produced by some bacterial species were more attractive than blends produced by other species. In contrast to odours from the other bacterial species tested, odours produced by Pseudomonas aeruginosa were not attractive to A. gambiae. Headspace analysis of bacterial volatiles in combination with behavioural assays led to the identification of six compounds that elicited a behavioural effect in A. gambiae. Our results provide, to our knowledge, the first evidence for a role of selected bacterial species, common on the human skin, in determining the attractiveness of humans to malaria mosquitoes. This information will be used in the further development of a blend of semiochemicals for the manipulation of mosquito behaviour.	[Verhulst, Niels O.; Andriessen, Rob; Kiss, Gabriella Bukovinszkine; Takken, Willem; van Loon, Joop J. A.; Smallegange, Renate C.] Univ Wageningen & Res Ctr, Entomol Lab, Wageningen, Netherlands; [Groenhagen, Ulrike; Schulz, Stefan] Tech Univ Carolo Wilhelmina Braunschweig, Inst Organ Chem, D-3300 Braunschweig, Germany; [Schraa, Gosse] Univ Wageningen & Res Ctr, Microbiol Lab, Wageningen, Netherlands	Wageningen University & Research; Braunschweig University of Technology; Wageningen University & Research	Verhulst, NO (corresponding author), Univ Wageningen & Res Ctr, Entomol Lab, Wageningen, Netherlands.	niels.verhulst@wur.nl	Verhulst, Niels/AAH-4288-2019; Smallegange, Renate C./L-1566-2019; van Loon, Joop J.A./B-3744-2009	Smallegange, Renate C./0000-0002-6946-9777; Verhulst, Niels/0000-0002-1106-9711; Schulz, Stefan/0000-0002-4810-324X; van Loon, Joop J.A./0000-0002-4260-0501	Foundation for the National Institutes of Health (NIH) through the Grand Challenges in Global Health Initiative (GCGH) [121]; Deutsche Forschungsgemeinschaft	Foundation for the National Institutes of Health (NIH) through the Grand Challenges in Global Health Initiative (GCGH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was funded by a grant from the Foundation for the National Institutes of Health (NIH) through the Grand Challenges in Global Health Initiative (GCGH#121) and by the Deutsche Forschungsgemeinschaft (U. G. and S. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan SA, 2006, J VECTOR ECOL, V31, P71, DOI 10.3376/1081-1710(2006)31[71:AOMTVA]2.0.CO;2; ANTHONY RM, 1992, CLIN EXP DERMATOL, V17, P102, DOI 10.1111/j.1365-2230.1992.tb00174.x; Ara K, 2006, CAN J MICROBIOL, V52, P357, DOI 10.1139/W05-130; Bernier UR, 2007, J AM MOSQUITO CONTR, V23, P288, DOI 10.2987/8756-971X(2007)23[288:LCOAAA]2.0.CO;2; Bernier UR, 2002, J AM MOSQUITO CONTR, V18, P186; Bernier UR, 2003, J MED ENTOMOL, V40, P653, DOI 10.1603/0022-2585-40.5.653; Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Bojar RA, 2002, WORLD J MICROB BIOT, V18, P889, DOI 10.1023/A:1021271028979; Boland W., 1984, ANAL VOLATILES, P371; Braks MAH, 1999, J CHEM ECOL, V25, P663, DOI 10.1023/A:1020970307748; Braks MAH, 2001, PHYSIOL ENTOMOL, V26, P142, DOI 10.1046/j.1365-3032.2001.00227.x; COLLINS MD, 1983, INT J SYST BACTERIOL, V33, P870, DOI 10.1099/00207713-33-4-870; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DEJONG R, 1995, EXPERIENTIA, V51, P80, DOI 10.1007/BF01964925; Dickschat JS, 2005, CHEM BIODIVERS, V2, P837, DOI 10.1002/cbdv.200590062; Eschbach M, 2004, J BACTERIOL, V186, P4596, DOI 10.1128/JB.186.14.4596-4604.2004; Feltman H, 2001, MICROBIOL-SGM, V147, P2659, DOI 10.1099/00221287-147-10-2659; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; GOWER DB, 1994, J STEROID BIOCHEM, V48, P409, DOI 10.1016/0960-0760(94)90082-5; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; James A G, 2004, Int J Cosmet Sci, V26, P149, DOI 10.1111/j.1467-2494.2004.00214.x; James AG, 2004, WORLD J MICROB BIOT, V20, P787, DOI 10.1007/s11274-004-5843-8; Killeen GF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-161; Kline DL, 2007, J AM MOSQUITO CONTR, V23, P241, DOI 10.2987/8756-971X(2007)23[241:STAMTT]2.0.CO;2; KLOOS WE, 1975, APPL MICROBIOL, V30, P381, DOI 10.1128/AEM.30.3.381-395.1975; Knols BGJ, 1997, B ENTOMOL RES, V87, P151, DOI 10.1017/S0007485300027292; Knols BGJ, 1995, T ROY SOC TROP MED H, V89, P604, DOI 10.1016/0035-9203(95)90406-9; Lindh JM, 2008, J MED ENTOMOL, V45, P1039, DOI 10.1603/0022-2585(2008)45[1039:OROAGS]2.0.CO;2; Logan JG, 2008, J CHEM ECOL, V34, P308, DOI 10.1007/s10886-008-9436-0; Logan JG, 2007, PEST MANAG SCI, V63, P647, DOI 10.1002/ps.1408; Maxwell CA, 1998, MED VET ENTOMOL, V12, P325, DOI 10.1046/j.1365-2915.1998.00108.x; MCGINLEY KJ, 1978, APPL ENVIRON MICROB, V35, P62, DOI 10.1128/AEM.35.1.62-66.1978; MORRISON AJ, 1984, REV INFECT DIS, V6, pS627; Mukabana Wolfgang R., 2002, Malaria Journal, V1, pUnpaginated, DOI 10.1186/1475-2875-1-17; Noble W, 2004, SKIN MICROFLORA MICR; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951; Ponnusamy L, 2010, MICROB ECOL, V59, P158, DOI 10.1007/s00248-009-9565-1; Posey KH, 1998, J MED ENTOMOL, V35, P330, DOI 10.1093/jmedent/35.3.330; Qiu YT, 2006, MED VET ENTOMOL, V20, P280, DOI 10.1111/j.1365-2915.2006.00627.x; Qiu YT, 2004, MED VET ENTOMOL, V18, P429, DOI 10.1111/j.0269-283X.2004.00534.x; RENNIE PJ, 1990, INT J COSMETIC SCI, V12, P197, DOI 10.1111/j.1467-2494.1990.tb00535.x; RENNIE PJ, 1991, BRIT J DERMATOL, V124, P596, DOI 10.1111/j.1365-2133.1991.tb04958.x; Romero-Garcia S, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-23; SARKANY I, 1962, ARCH DERMATOL, V85, P578, DOI 10.1001/archderm.1962.01590050008002; Schreiber K, 2006, J BACTERIOL, V188, P659, DOI 10.1128/JB.188.2.659-668.2006; Schulz S, 2007, NAT PROD REP, V24, P814, DOI 10.1039/b507392h; SHELLEY WB, 1953, AMA ARCH DERM SYPH, V68, P430, DOI 10.1001/archderm.1953.01540100070012; Smallegange RC, 2005, CHEM SENSES, V30, P145, DOI 10.1093/chemse/bji010; Smallegange RC, 2010, J MED ENTOMOL, V47, P338, DOI 10.1603/ME09015; Smallegange RC, 2009, J CHEM ECOL, V35, P933, DOI 10.1007/s10886-009-9668-7; Spitzen J, 2008, PHYSIOL ENTOMOL, V33, P116, DOI 10.1111/j.1365-3032.2008.00612.x; STOTZKY G, 1976, Critical Reviews in Microbiology, V4, P333, DOI 10.3109/10408417609102303; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; TAKKEN W, 1991, INSECT SCI APPL, V12, P287, DOI 10.1017/S1742758400020816; Taylor D., 2003, International Journal of Cosmetic Science, V25, P137, DOI 10.1046/j.1467-2494.2003.00181.x; TOMITA B, 1987, APPL ENVIRON MICROB, V53, P1541, DOI 10.1128/AEM.53.7.1541-1547.1987; Torr SJ, 1997, B ENTOMOL RES, V87, P299, DOI 10.1017/S0007485300037251; Trexler JD, 2003, J MED ENTOMOL, V40, P841, DOI 10.1603/0022-2585-40.6.841; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Verhulst N. O., 2008, P NETH ENTOMOL SOC, V19, P129; Verhulst NO, 2010, FEMS MICROBIOL ECOL, V74, P1, DOI 10.1111/j.1574-6941.2010.00908.x; Verhulst NO, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-302; Wauters G, 1998, J CLIN MICROBIOL, V36, P1430, DOI 10.1128/JCM.36.5.1430-1432.1998; WELSCH M., 1948, AN TONIE VAN LEEUWENHOEK JOUR MICROBIOL AND SEROL, V14, P193, DOI 10.1007/BF02272692; Wilson M., 2008, BACTERIOLOGY HUMANS; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	68	96	101	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15829	10.1371/journal.pone.0015829	http://dx.doi.org/10.1371/journal.pone.0015829			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209854	Green Published, gold			2022-12-27	WOS:000285793600045
J	Chung, HR; Dunkel, I; Heise, F; Linke, C; Krobitsch, S; Ehrenhofer-Murray, AE; Sperling, SR; Vingron, M				Chung, Ho-Ryun; Dunkel, Ilona; Heise, Franziska; Linke, Christian; Krobitsch, Sylvia; Ehrenhofer-Murray, Ann E.; Sperling, Silke R.; Vingron, Martin			The Effect of Micrococcal Nuclease Digestion on Nucleosome Positioning Data	PLOS ONE			English	Article							HISTONE-DNA INTERACTIONS; CHROMATIN-STRUCTURE; SACCHAROMYCES-CEREVISIAE; IN-VIVO; EUKARYOTIC GENOME; HIGH-RESOLUTION; YEAST; ORGANIZATION; CLEAVAGE; REVEALS	Eukaryotic genomes are packed into chromatin, whose basic repeating unit is the nucleosome. Nucleosome positioning is a widely researched area. A common experimental procedure to determine nucleosome positions involves the use of micrococcal nuclease (MNase). Here, we show that the cutting preference of MNase in combination with size selection generates a sequence-dependent bias in the resulting fragments. This strongly affects nucleosome positioning data and especially sequence-dependent models for nucleosome positioning. As a consequence we see a need to re-evaluate whether the DNA sequence is a major determinant of nucleosome positioning in vivo. More generally, our results show that data generated after MNase digestion of chromatin requires a matched control experiment in order to determine nucleosome positions.	[Chung, Ho-Ryun; Vingron, Martin] MPI Mol Genet, Dept Computat Mol Biol, Berlin, Germany; [Dunkel, Ilona; Sperling, Silke R.] MPI Mol Genet, Grp Cardiovasc Genet, Dept Vertebrate Genom, Berlin, Germany; [Heise, Franziska; Ehrenhofer-Murray, Ann E.] Univ Duisburg Essen, Genet Abt, ZMB, Essen, Germany; [Linke, Christian; Krobitsch, Sylvia] MPI Mol Genet, Neurodegenerat Disorder Grp, Otto Warburg Lab, Berlin, Germany	University of Duisburg Essen	Chung, HR (corresponding author), MPI Mol Genet, Dept Computat Mol Biol, Berlin, Germany.	chung@molgen.mpg.de		Rickert-Sperling, Silke/0000-0002-7135-3298				Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; AXEL R, 1975, BIOCHEMISTRY-US, V14, P2921, DOI 10.1021/bi00684a020; Cartwright IL, 1999, METHOD ENZYMOL, V304, P462; Chung HR, 2009, J MOL BIOL, V386, P1411, DOI 10.1016/j.jmb.2008.11.049; CLARK RJ, 1971, NATURE-NEW BIOL, V229, P101, DOI 10.1038/newbio229101a0; COCKELL M, 1983, J MOL BIOL, V170, P423, DOI 10.1016/S0022-2836(83)80156-9; DINGWALL C, 1981, NUCLEIC ACIDS RES, V9, P2659, DOI 10.1093/nar/9.12.2659; Fan XC, 2010, P NATL ACAD SCI USA, V107, P17945, DOI 10.1073/pnas.1012674107; FEDOR MJ, 1989, MOL CELL BIOL, V9, P1721, DOI 10.1128/MCB.9.4.1721; Field Y, 2009, NAT GENET, V41, P438, DOI 10.1038/ng.324; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; HORZ W, 1981, NUCLEIC ACIDS RES, V9, P2643, DOI 10.1093/nar/9.12.2643; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kharchenko PV, 2008, GENOME RES, V18, P1554, DOI 10.1101/gr.075952.107; KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Lantermann AB, 2010, NAT STRUCT MOL BIOL, V17, P251, DOI 10.1038/nsmb.1741; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; LEFFAK IM, 1981, BIOCHIM BIOPHYS ACTA, V656, P86, DOI 10.1016/0005-2787(81)90030-7; Li SS, 2002, J BIOL CHEM, V277, P44651, DOI 10.1074/jbc.M206623200; LOHR D, 1984, NUCLEIC ACIDS RES, V12, P8457, DOI 10.1093/nar/12.22.8457; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; NEDOSPASOV SA, 1980, BIOCHEM BIOPH RES CO, V92, P532, DOI 10.1016/0006-291X(80)90366-6; OOHARA I, 1987, J MOL BIOL, V196, P399, DOI 10.1016/0022-2836(87)90700-5; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007; Radman-Livaja M, 2010, DEV BIOL, V339, P258, DOI 10.1016/j.ydbio.2009.06.012; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Ryan MP, 1999, METHOD ENZYMOL, V304, P376; Sasaki S, 2009, SCIENCE, V323, P401, DOI 10.1126/science.1163183; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Segal E, 2009, CURR OPIN STRUC BIOL, V19, P65, DOI 10.1016/j.sbi.2009.01.004; STEIN A, 2009, NUCL ACIDS RES; Thastrom A, 2004, J MOL BIOL, V338, P695, DOI 10.1016/j.jmb.2004.03.032; Tillo D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-442; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Visnapuu ML, 2009, NAT STRUCT MOL BIOL, V16, P1056, DOI 10.1038/nsmb.1655; Weese D, 2009, GENOME RES, V19, P1646, DOI 10.1101/gr.088823.108; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; WORCEL A, 1983, NUCLEIC ACIDS RES, V11, P421, DOI 10.1093/nar/11.2.421; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zaret KS, 1999, METHOD ENZYMOL, V304, P612; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636	50	86	89	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15754	10.1371/journal.pone.0015754	http://dx.doi.org/10.1371/journal.pone.0015754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206756	gold, Green Published, Green Accepted			2022-12-27	WOS:000285793200051
J	James, SW; Porco, D; Decaens, T; Richard, B; Rougerie, R; Erseus, C				James, Samuel W.; Porco, David; Decaens, Thibaud; Richard, Benoit; Rougerie, Rodolphe; Erseus, Christer			DNA Barcoding Reveals Cryptic Diversity in Lumbricus terrestris L., 1758 (Clitellata): Resurrection of L. herculeus (Savigny, 1826)	PLOS ONE			English	Article							MITOCHONDRIAL; FORESTS; OLIGOCHAETA; DEFOLIATION	The widely studied and invasive earthworm, Lumbricus terrestris L., 1758 has been the subject of nomenclatural debate for many years. However these disputes were not based on suspicions of heterogeneity, but rather on the descriptions and nomenclatural acts associated with the species name. Large numbers of DNA barcode sequences of the cytochrome oxidase I obtained for nominal L. terrestris and six congeneric species reveal that there are two distinct lineages within nominal L. terrestris. One of those lineages contains the Swedish population from which the name-bearing specimen of L. terrestris was obtained. The other contains the population from which the syntype series of Enterion herculeum Savigny, 1826 was collected. In both cases modern and old representatives yielded barcode sequences allowing us to clearly establish that these are two distinct species, as different from one another as any other pair of congeners in our data set. The two are morphologically indistinguishable, except by overlapping size-related characters. We have designated a new neotype for L. terrestris. The newly designated neotype and a syntype of L. herculeus yielded DNA adequate for sequencing part of the cytochrome oxidase I gene (COI). The sequence data make possible the objective determination of the identities of earthworms morphologically identical to L. terrestris and L. herculeus, regardless of body size and segment number. Past work on nominal L. terrestris could have been on either or both species, although L. herculeus has yet to be found outside of Europe.	[James, Samuel W.] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Porco, David; Rougerie, Rodolphe] Biodivers Inst Ontario, Canadian Ctr DNA Barcoding, Guelph, ON, Canada; [James, Samuel W.; Porco, David; Decaens, Thibaud; Richard, Benoit; Rougerie, Rodolphe] Univ Rouen, Ecol Lab, UPRES EA ECODIV 1293, FED SCALE,UFR Sci & Tech, Mont St Aignan, France; [Erseus, Christer] Univ Gothenburg, Dept Zool, Gothenburg, Sweden	University of Kansas; Universite de Rouen Normandie; University of Gothenburg	James, SW (corresponding author), Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA.	sjames@ku.edu	James, Samuel/T-2190-2019; Rougerie, Rodolphe/D-2930-2009; Decaens, Thibaud/AAA-5287-2020; Richard, Benoit/H-2967-2012; James, Samuel/D-6010-2013; Porco, David/D-7781-2011	Rougerie, Rodolphe/0000-0003-0937-2815; Richard, Benoit/0000-0003-4522-027X; James, Samuel/0000-0001-6758-5726; 	Natural Science and Engineering Research Council of Canada (NSERC); Genome Canada; United States National Science Foundation [DEB 0516439]; Region Haute Normandie; Conseil Regional de Haute Normandie through the Grand Reseau de Recherche Sciences de l'Environnement et Gestion des Risques; SCiences Appliquees a L'Environnment research federation; ArtDatabanken (Swedish Taxonomy Initiative); Royal Society of Arts and Sciences in Goteborg; NSERC	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Canada(Genome Canada); United States National Science Foundation(National Science Foundation (NSF)); Region Haute Normandie(Region Normandie); Conseil Regional de Haute Normandie through the Grand Reseau de Recherche Sciences de l'Environnement et Gestion des Risques(Region Normandie); SCiences Appliquees a L'Environnment research federation; ArtDatabanken (Swedish Taxonomy Initiative); Royal Society of Arts and Sciences in Goteborg; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Most of this research was supported through grants from Natural Science and Engineering Research Council of Canada (NSERC) and Genome Canada to Paul Hebert (Biodiversity Institute of Ontario). S. W. James was supported by United States National Science Foundation Grant DEB 0516439 and by a Marie Curie France Regions grant from the Region Haute Normandie. R. Rougerie and D. Porco were supported by post-doctoral fellowship grant from the Conseil Regional de Haute Normandie through the Grand Reseau de Recherche Sciences de l'Environnement et Gestion des Risques. T. Decaens, B. Richard, R. Rougerie, D. Porco, and S. James were supported by the SCiences Appliquees a L'Environnment research federation through the Functions and Determinants of BIODIVersity program. C. Erseus was supported by ArtDatabanken (Swedish Taxonomy Initiative) and The Royal Society of Arts and Sciences in Goteborg. None of these funding agencies had any role in the conducting of the study or in the preparation of the manuscript. It is fair to say than until this work is published, most of them remain unaware of its existence. Paul Hebert, as director of the Canadian Centre for DNA Barcoding at the Biodiversity Institute of Ontario, made it a priority to direct the necessary resources toward the study, but the resources were ultimately derived from grants by NSERC and Genome Canada. Dr. Hebert cannot be cast in the role of a funding agency, but rather in the role of a laboratory director making decisions about how to use existing support.	Bely AE, 2004, MOL PHYLOGENET EVOL, V30, P50, DOI 10.1016/S1055-7903(03)00180-5; BOORE JL, 1995, GENETICS, V141, P305; BOUCHE M B, 1972, Revue d'Ecologie et de Biologie du Sol, V9, P697; Chang CH, 2007, ORG DIVERS EVOL, V7, P231, DOI 10.1016/j.ode.2006.06.001; DARWIN C, 1881, FORMATION VEGETABLE; Decaens T, 2008, APPL SOIL ECOL, V39, P321, DOI 10.1016/j.apsoil.2008.01.007; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hale CM, 2005, ECOSYSTEMS, V8, P911, DOI 10.1007/s10021-005-0066-x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hendrix PF, 2008, ANNU REV ECOL EVOL S, V39, P593, DOI 10.1146/annurev.ecolsys.39.110707.173426; International Commission on Zoological Nomenclature, 1999, INT CODE ZOOLOGICAL, V4th; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; LANDSBERG J, 1989, TRENDS ECOL EVOL, V4, P96, DOI 10.1016/0169-5347(89)90054-2; Linnaeus C, 1767, SYSTEMA NATURAE REGN, VI, DOI 10.5962/bhl.title.542; Michaelsen W., 1900, Das Tierreich, VLief. x, pUnpaginated; Muzika RM, 2001, USDA NE EXP, V277, P117; Perez-Losada M, 2005, PEDOBIOLOGIA, V49, P317, DOI 10.1016/j.pedobi.2005.02.004; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Richard B, 2010, MOL ECOL RESOUR, V10, P606, DOI 10.1111/j.1755-0998.2009.02822.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Savigny J.-C., 1826, MEMOIRES DACADEMIE R, V5, P176; Sims R.W., 1973, Bulletin of Zoological Nomenclature, V30, P27; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tomlin A. D., 1983, Earthworm ecology - from Darwin to vermiculture, P331	27	129	137	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15629	10.1371/journal.pone.0015629	http://dx.doi.org/10.1371/journal.pone.0015629			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206917	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793200031
J	Schafer, I; von Leitner, EC; Schon, G; Koller, D; Hansen, H; Kolonko, T; Kaduszkiewicz, H; Wegscheider, K; Glaeske, G; van den Bussche, H				Schaefer, Ingmar; von Leitner, Eike-Christin; Schoen, Gerhard; Koller, Daniela; Hansen, Heike; Kolonko, Tina; Kaduszkiewicz, Hanna; Wegscheider, Karl; Glaeske, Gerd; van den Bussche, Hendrik			Multimorbidity Patterns in the Elderly: A New Approach of Disease Clustering Identifies Complex Interrelations between Chronic Conditions	PLOS ONE			English	Article							METABOLIC SYNDROME; RISK PROFILE; POPULATION; PREVALENCE; SYMPTOMS; DEPRESSION; DEMENTIA; ANXIETY; COMORBIDITY; STROKE	Objective: Multimorbidity is a common problem in the elderly that is significantly associated with higher mortality, increased disability and functional decline. Information about interactions of chronic diseases can help to facilitate diagnosis, amend prevention and enhance the patients' quality of life. The aim of this study was to increase the knowledge of specific processes of multimorbidity in an unselected elderly population by identifying patterns of statistically significantly associated comorbidity. Methods: Multimorbidity patterns were identified by exploratory tetrachoric factor analysis based on claims data of 63,104 males and 86,176 females in the age group 65+. Analyses were based on 46 diagnosis groups incorporating all ICD-10 diagnoses of chronic diseases with a prevalence >= 1%. Both genders were analyzed separately. Persons were assigned to multimorbidity patterns if they had at least three diagnosis groups with a factor loading of 0.25 on the corresponding pattern. Results: Three multimorbidity patterns were found: 1) cardiovascular/metabolic disorders [prevalence female: 30%; male: 39%], 2) anxiety/depression/somatoform disorders and pain [34%; 22%], and 3) neuropsychiatric disorders [6%; 0.8%]. The sampling adequacy was meritorious (Kaiser-Meyer-Olkin measure: 0.85 and 0.84, respectively) and the factors explained a large part of the variance (cumulative percent: 78% and 75%, respectively). The patterns were largely age-dependent and overlapped in a sizeable part of the population. Altogether 50% of female and 48% of male persons were assigned to at least one of the three multimorbidity patterns. Conclusion: This study shows that statistically significant co-occurrence of chronic diseases can be subsumed in three prevalent multimorbidity patterns if accounting for the fact that different multimorbidity patterns share some diagnosis groups, influence each other and overlap in a large part of the population. In recognizing the full complexity of multimorbidity we might improve our ability to predict needs and achieve possible benefits for elderly patients who suffer from multimorbidity.	[Schaefer, Ingmar; von Leitner, Eike-Christin; Hansen, Heike; Kolonko, Tina; Kaduszkiewicz, Hanna; van den Bussche, Hendrik] Univ Med Ctr Hamburg Eppendorf, Dept Primary Med Care, Hamburg, Germany; [Schoen, Gerhard; Wegscheider, Karl] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Koller, Daniela; Glaeske, Gerd] Univ Bremen, Div Hlth Econ Hlth Policy & Hlth Serv Res, Ctr Social Policy Res, Bremen, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bremen	Schafer, I (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Primary Med Care, Hamburg, Germany.	in.schaefer@uke.uni-hamburg.de			German Federal Ministry of Education and Research [01ET0725, 01ET0731]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The study was funded by the German Federal Ministry of Education and Research (http://www.bmbf.bund.de/; grant numbers 01ET0725 and 01ET0731). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Busse R., 2007, WISSENSCHAFTLICHES G; Choi HK, 2008, RHEUMATOLOGY, V47, P1567, DOI 10.1093/rheumatology/ken305; Cornell JE, 2007, APPL MULTIVARIATE RE, V2007, P163, DOI [10.22329/amr.v12i3.658, DOI 10.22329/AMR.V12I3.658]; Crue BL, 2009, PAIN MED, V10, P6, DOI 10.1111/j.1526-4637.2008.00536.x; Federal Association of SHI Physicians in Germany, 2007, BAS DAT SHI CAR GERM; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; Hackett ML, 2005, STROKE, V36, P1330, DOI 10.1161/01.STR.0000165928.19135.35; Hallman WK, 2003, AM J PUBLIC HEALTH, V93, P624, DOI 10.2105/AJPH.93.4.624; Hartman TCO, 2008, FAM PRACT, V25, P266, DOI 10.1093/fampra/cmn041; Haug TT, 2004, PSYCHOSOM MED, V66, P845, DOI 10.1097/01.psy.0000145823.85658.0c; Haug TT, 2002, SCAND J GASTROENTERO, V37, P294, DOI 10.1080/003655202317284192; Hildrum B, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-220; John R, 2003, GERONTOLOGIST, V43, P649, DOI 10.1093/geront/43.5.649; Knibb RC, 1999, J PSYCHOSOM RES, V47, P545, DOI 10.1016/S0022-3999(99)00055-0; Kroenke K, 1997, AM J MED, V103, P339, DOI 10.1016/S0002-9343(97)00241-6; Kubinger K., 2003, PSYCHOL SCI, V45, P106, DOI DOI 10.1177/014662169101500105; Lakatta Edward G, 2002, Heart Fail Rev, V7, P29; Locatelli F, 2001, KIDNEY INT, V60, P741, DOI 10.1046/j.1523-1755.2001.060002741.x; LYNESS JM, 1995, J AM GERIATR SOC, V43, P216, DOI 10.1111/j.1532-5415.1995.tb07325.x; Marengoni A, 2009, J AM GERIATR SOC, V57, P225, DOI 10.1111/j.1532-5415.2008.02109.x; O'Hara R, 2003, ANN GEN HOSP PSYCHIA, V2, P11; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; Rho YH, 2005, J KOREAN MED SCI, V20, P1029, DOI 10.3346/jkms.2005.20.6.1029; Riedel O, 2010, J NEUROL, V257, P1073, DOI 10.1007/s00415-010-5465-z; Schellevis FG, 1993, CHRONIC DIS GEN PRAC; Seliger SL, 2004, J AM SOC NEPHROL, V15, P1904, DOI 10.1097/01.asn.0000131529.60019.fa; van den Bussche H, 2010, BMC PUBLIC IN PRESS; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; WOLF PA, 1991, STROKE, V22, P312, DOI 10.1161/01.STR.22.3.312; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; YOSHITAKE T, 1995, NEUROLOGY, V45, P1161, DOI 10.1212/WNL.45.6.1161; Zentralinstitut fur die kassenarztliche Versorgung, 2007, DAT ADT PAN ZENTR KA	34	96	98	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15941	10.1371/journal.pone.0015941	http://dx.doi.org/10.1371/journal.pone.0015941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	701CZ	21209965	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793200075
J	Bonfiglio, S; Achilli, A; Olivieri, A; Negrini, R; Colli, L; Liotta, L; Ajmone-Marsan, P; Torroni, A; Ferretti, L				Bonfiglio, Silvia; Achilli, Alessandro; Olivieri, Anna; Negrini, Riccardo; Colli, Licia; Liotta, Luigi; Ajmone-Marsan, Paolo; Torroni, Antonio; Ferretti, Luca			The Enigmatic Origin of Bovine mtDNA Haplogroup R: Sporadic Interbreeding or an Independent Event of Bos primigenius Domestication in Italy?	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; GENETIC DIVERSITY; CONTROL REGION; CATTLE; PHYLOGEOGRAPHY; SEQUENCE; ANCIENT; TAURUS; LINEAGES; AFRICAN	Background: When domestic taurine cattle diffused from the Fertile Crescent, local wild aurochsen (Bos primigenius) were still numerous. Moreover, aurochsen and introduced cattle often coexisted for millennia, thus providing potential conditions not only for spontaneous interbreeding, but also for pastoralists to create secondary domestication centers involving local aurochs populations. Recent mitochondrial genomes analyses revealed that not all modern taurine mtDNAs belong to the shallow macro-haplogroup T of Near Eastern origin, as demonstrated by the detection of three branches (P, Q and R) radiating prior to the T node in the bovine phylogeny. These uncommon haplogroups represent excellent tools to evaluate if sporadic interbreeding or even additional events of cattle domestication occurred. Methodology: The survey of the mitochondrial DNA (mtDNA) control-region variation of 1,747 bovine samples (1,128 new and 619 from previous studies) belonging to 37 European breeds allowed the identification of 16 novel non-T mtDNAs, which after complete genome sequencing were confirmed as members of haplogroups Q and R. These mtDNAs were then integrated in a phylogenetic tree encompassing all available P, Q and R complete mtDNA sequences. Conclusions: Phylogenetic analyses of 28 mitochondrial genomes belonging to haplogroups P (N=2), Q (N=16) and R (N=10) together with an extensive survey of all previously published mtDNA datasets revealed major similarities between haplogroups Q and T. Therefore, Q most likely represents an additional minor lineage domesticated in the Near East together with the founders of the T subhaplogroups. Whereas, haplogroup R is found, at least for the moment, only in Italy and nowhere else, either in modern or ancient samples, thus supporting an origin from European aurochsen. Haplogroup R could have been acquired through sporadic interbreeding of wild and domestic animals, but our data do not rule out the possibility of a local and secondary event of B. primigenius domestication in Italy.	[Bonfiglio, Silvia; Achilli, Alessandro; Olivieri, Anna; Torroni, Antonio; Ferretti, Luca] Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; [Achilli, Alessandro] Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06100 Perugia, Italy; [Negrini, Riccardo; Colli, Licia; Ajmone-Marsan, Paolo] Univ Cattolica Sacro Cuore, Ist Zootecn, Piacenza, Italy; [Liotta, Luigi] Univ Messina, Dipartimento Morfol Biochim Fisiol & Prod Anim, Messina, Italy	University of Pavia; University of Perugia; Catholic University of the Sacred Heart; University of Messina	Bonfiglio, S (corresponding author), Univ Pavia, Dipartimento Genet & Microbiol, Via Palestro 3, I-27100 Pavia, Italy.	luca.ferretti@unipv.it	Torroni, Antonio/E-1557-2011; Achilli, Alessandro/I-9236-2012; Bonfiglio, Silvia/AAC-1988-2019; OLIVIERI, ANNA/I-9235-2012; Colli, Licia/AAC-2985-2021; Ferretti, Luca/D-2337-2013; AJMONE MARSAN, Paolo/M-2466-2018	Torroni, Antonio/0000-0002-4163-4478; Achilli, Alessandro/0000-0001-6871-3451; OLIVIERI, ANNA/0000-0002-3941-8098; Ferretti, Luca/0000-0001-5044-8442; NEGRINI, Riccardo/0000-0002-8735-0286; Liotta, Luigi/0000-0002-3242-1817; Bonfiglio, Silvia/0000-0002-4422-1580; AJMONE MARSAN, Paolo/0000-0003-3165-4579	Progetto SELMOL-Selezione Molecolare (Italian Ministry of Agricultural, Food and Forestry Policies); Italian Ministry of the University; Fondazione Alma Mater Ticinensis	Progetto SELMOL-Selezione Molecolare (Italian Ministry of Agricultural, Food and Forestry Policies); Italian Ministry of the University(Ministry of Education, Universities and Research (MIUR)); Fondazione Alma Mater Ticinensis	This research received support from Progetto SELMOL-Selezione Molecolare (Italian Ministry of Agricultural, Food and Forestry Policies) (to LF), Progetti Ricerca Interesse Nazionale 2007 (Italian Ministry of the University) (to AT, LF and PA-M), FIRB-Futuro in Ricerca 2008 (Italian Ministry of the University) (to AA and AO), and Fondazione Alma Mater Ticinensis (to AT and LF). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2008, CURR BIOL, V18, pR157, DOI 10.1016/j.cub.2008.01.019; Achilli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005753; Ajmone-Marsan P, 2010, EVOL ANTHROPOL, V19, P148, DOI 10.1002/evan.20267; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; Beja-Pereira A, 2006, P NATL ACAD SCI USA, V103, P8113, DOI 10.1073/pnas.0509210103; Bollongino R, 2006, BIOL LETTERS, V2, P155, DOI 10.1098/rsbl.2005.0404; Bollongino R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003418; Bradley DG, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P317; Bradley DG, 1998, EVOL ANTHROPOL, V6, P79, DOI 10.1002/(SICI)1520-6505(1998)6:3<79::AID-EVAN2>3.0.CO;2-R; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; Brugal J.-P., 1987, Actes du Congres National des Societes Savantes Section des Sciences, V112, P53; CAESAR, COMMENTARIES GALLIC, V6, pCH28; Cai X, 2007, GENETICA, V131, P175, DOI 10.1007/s10709-006-9129-y; Chen SY, 2010, MOL BIOL EVOL, V27, P1, DOI 10.1093/molbev/msp213; CLUTTONBROCK J, 1989, WALKING LARDER PATTE, V22, P368; Edwards CJ, 2007, P ROY SOC B-BIOL SCI, V274, P1377, DOI 10.1098/rspb.2007.0020; Edwards CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009255; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Ginja C, 2010, ANIM GENET, V41, P128, DOI 10.1111/j.1365-2052.2009.01976.x; Gou X, 2010, J ANIM BREED GENET, V127, P154, DOI 10.1111/j.1439-0388.2009.00807.x; Grill A, 2009, MOL ECOL, V18, P2687, DOI 10.1111/j.1365-294X.2009.04215.x; Hanotte O, 2002, SCIENCE, V296, P336, DOI 10.1126/science.1069878; Helmer Daniel, 2005, P86; Hiendleder S, 2008, CYTOGENET GENOME RES, V120, P150, DOI 10.1159/000118756; Kim E, 2010, J ANIM SCI, V88, P2551, DOI 10.2527/jas.2009-2235; Lai SJ, 2006, MOL PHYLOGENET EVOL, V38, P146, DOI 10.1016/j.ympev.2005.06.013; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Lei CZ, 2006, ANIM GENET, V37, P579, DOI 10.1111/j.1365-2052.2006.01524.x; LOFTUS RT, 1994, P NATL ACAD SCI USA, V91, P2757, DOI 10.1073/pnas.91.7.2757; Mannen H, 2004, MOL PHYLOGENET EVOL, V32, P539, DOI 10.1016/j.ympev.2004.01.010; MASON H, 1984, EVOLUTION DOMESTIC A, V12, P452; Meadow R.H., 1993, HARAPPAN CIVILIZATIO, V2nd, P295; Meadows JRS, 2007, GENETICS, V175, P1371, DOI 10.1534/genetics.106.068353; Mona S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-83; Naderi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001012; Pellecchia M, 2007, P R SOC B, V274, P1175, DOI 10.1098/rspb.2006.0258; Priskin K, 2007, ACTA BIOL HUNG, V58, P131, DOI 10.1556/ABiol.58.2007.Suppl.10; Randi E, 2004, MOL ECOL, V13, P3071, DOI 10.1111/j.1365-294X.2004.02279.x; Stock F, 2009, ANIM GENET, V40, P694, DOI 10.1111/j.1365-2052.2009.01905.x; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088; VANVUURE CT, OEROS SPOOR TERUG; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; VIRGIL, GEORGICS, V3, P531; Zeder MA, 2006, TRENDS GENET, V22, P139, DOI 10.1016/j.tig.2006.01.007	45	68	70	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15760	10.1371/journal.pone.0015760	http://dx.doi.org/10.1371/journal.pone.0015760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21209945	gold, Green Published, Green Submitted			2022-12-27	WOS:000285792500038
J	Yadav, UCS; Aguilera-Aguirre, L; Ramana, KV; Boldogh, I; Srivastava, SK				Yadav, Umesh C. S.; Aguilera-Aguirre, Leopoldo; Ramana, Kota V.; Boldogh, Istvan; Srivastava, Satish K.			Aldose Reductase Inhibition Prevents Metaplasia of Airway Epithelial Cells	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; LIPID-PEROXIDATION PRODUCT; INCREASED OXIDATIVE STRESS; SMOOTH-MUSCLE-CELLS; JAK-STAT PATHWAY; ALLERGIC-ASTHMA; MUCUS PRODUCTION; SIGNAL TRANSDUCER; BRONCHIAL-ASTHMA; GENE-EXPRESSION	Background: Goblet cell metaplasia that causes mucus hypersecretion and obstruction in the airway lumen could be life threatening in asthma and chronic obstructive pulmonary disease patients. Inflammatory cytokines such as IL-13 mediate the transformation of airway ciliary epithelial cells to mucin-secreting goblet cells in acute as well as chronic airway inflammatory diseases. However, no effective and specific pharmacologic treatment is currently available. Here, we investigated the mechanisms by which aldose reductase (AR) regulates the mucus cell metaplasia in vitro and in vivo. Methodology/Findings: Metaplasia in primary human small airway epithelial cells (SAEC) was induced by a Th2 cytokine, IL-13, without or with AR inhibitor, fidarestat. After 48 h of incubation with IL-13 a large number of SAEC were transformed into goblet cells as determined by periodic acid-schiff (PAS)-staining and immunohistochemistry using antibodies against Mucin5AC. Further, IL-13 significantly increased the expression of Mucin5AC at mRNA and protein levels. These changes were significantly prevented by treatment of the SAEC with AR inhibitor. AR inhibition also decreased IL-13-induced expression of Muc5AC, Muc5B, and SPDEF, and phosphorylation of JAK-1, ERK1/2 and STAT-6. In a mouse model of ragweed pollen extract (RWE)-induced allergic asthma treatment with fidarestat prevented the expression of IL-13, phosphorylation of STAT-6 and transformation of epithelial cells to goblet cells in the lung. Additionally, while the AR-null mice were resistant, wild-type mice showed goblet cell metaplasia after challenge with RWE. Conclusions: The results show that exposure of SAEC to IL-13 caused goblet cell metaplasia, which was significantly prevented by AR inhibition. Administration of fidarestat to mice prevented RWE-induced goblet cell metaplasia and AR null mice were largely resistant to allergen induced changes in the lung. Thus our results indicate that AR inhibitors such as fidarestat could be developed as therapeutic agents to prevent goblet cell metaplasia in asthma and related pathologies.	[Yadav, Umesh C. S.; Ramana, Kota V.; Srivastava, Satish K.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX USA; [Aguilera-Aguirre, Leopoldo; Boldogh, Istvan] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [Aguilera-Aguirre, Leopoldo; Boldogh, Istvan] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Yadav, UCS (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX USA.	ssrivast@utmb.edu	Ramana, Kota/C-5460-2012; Yadav, Umesh/C-7858-2012; Aguilera-Aguirre, Leopoldo/B-9864-2012	Aguilera-Aguirre, Leopoldo/0000-0001-7964-7402; Ramana, Kota/0000-0001-6502-7800	American Asthma Foundation [AAF08-0219]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES018948, P30ES006676] Funding Source: NIH RePORTER	American Asthma Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by American Asthma Foundation (http://americanasthmafoundation.org) grant (AAF08-0219) to SKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar R, 2008, CLIN EXP ALLERGY, V38, P1847, DOI 10.1111/j.1365-2222.2008.03119.x; AIKAWA T, 1992, CHEST, V101, P916, DOI 10.1378/chest.101.4.916; Almolki A, 2004, AM J PHYSIOL-LUNG C, V287, pL26, DOI 10.1152/ajplung.00237.2003; Casalino-Matsuda SM, 2006, AM J RESP CELL MOL, V34, P581, DOI 10.1165/rcmb.2005-0386OC; Chang HH, 2009, J AGR FOOD CHEM, V57, P10471, DOI 10.1021/jf902403p; Chen G, 2009, J CLIN INVEST, V119, P2914, DOI 10.1172/JCI39731; Cho YS, 2004, J ALLERGY CLIN IMMUN, V114, P429, DOI 10.1016/j.jaci.2004.04.004; Cohn L, 2002, NOVART FDN SYMP, V248, P201; Dabbagh K, 1999, J IMMUNOL, V162, P6233; Darcan-Nicolaisen Y, 2009, J IMMUNOL, V182, P7501, DOI 10.4049/jimmunol.0713433; Evans CM, 2009, CURR OPIN PULM MED, V15, P4, DOI 10.1097/MCP.0b013e32831da8d3; Fujisawa Takao, 2005, Current Drug Targets - Inflammation and Allergy, V4, P505; Fujisawa T, 2008, RESPIROLOGY, V13, P191, DOI 10.1111/j.1440-1843.2008.01237.x; Henricks PAJ, 2001, PULM PHARMACOL THER, V14, P409, DOI 10.1006/pupt.2001.0319; Heo HJ, 2009, PHYTOTHER RES, V23, P1458, DOI 10.1002/ptr.2801; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Hoshino A, 2004, INT IMMUNOL, V16, P1497, DOI 10.1093/intimm/dxh151; Hwang YYC, 2005, FASEB J, V19, P795, DOI 10.1096/fj.04-2780fje; Izuhara K, 2009, CURR MED CHEM, V16, P2867, DOI 10.2174/092986709788803196; Jung WK, 2008, LIFE SCI, V82, P797, DOI 10.1016/j.lfs.2008.01.014; Kim HJ, 2008, AM J RESP CELL MOL, V39, P598, DOI 10.1165/rcmb.2007-0262OC; KONRAD F, 1995, ANAESTHESIST, V44, P651, DOI 10.1007/s001010050200; Kuperman D, 1998, J EXP MED, V187, P939, DOI 10.1084/jem.187.6.939; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Li L, 2010, CANC RES; Mak JCW, 2006, CURR OPIN PULM MED, V12, P7, DOI 10.1097/01.mcp.0000198067.50457.71; Mandal D, 2010, CELL SIGNAL, V22, P1485, DOI 10.1016/j.cellsig.2010.05.017; Mathew A, 2001, J EXP MED, V193, P1087, DOI 10.1084/jem.193.9.1087; Moon DO, 2008, BIOCHEM BIOPH RES CO, V375, P275, DOI 10.1016/j.bbrc.2008.08.025; Nadeem A, 2003, J ALLERGY CLIN IMMUN, V111, P72, DOI 10.1067/mai.2003.17; Park CS, 2009, ANN ALLERG ASTHMA IM, V103, P238, DOI 10.1016/S1081-1206(10)60188-3; Park KS, 2007, J CLIN INVEST, V117, P978, DOI 10.1172/JCI29176; Pearlman DS, 1999, J ALLERGY CLIN IMMUN, V104, pS132, DOI 10.1016/S0091-6749(99)70308-8; Rahman I, 2006, EUR J PHARMACOL, V533, P222, DOI 10.1016/j.ejphar.2005.12.087; Ramana KV, 2006, J BIOL CHEM, V281, P33019, DOI 10.1074/jbc.M603819200; Ravindranath TM, 2009, J IMMUNOL, V183, P8128, DOI 10.4049/jimmunol.0900720; Reader JR, 2003, AM J PATHOL, V162, P2069, DOI 10.1016/S0002-9440(10)64338-6; Severgnini M, 2004, AM J PHYSIOL-LUNG C, V286, pL1282, DOI 10.1152/ajplung.00349.2003; Shahar E, 2004, ANN ALLERG ASTHMA IM, V92, P654, DOI 10.1016/S1081-1206(10)61432-9; Shum Bennett O. V., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000707; Simon AR, 2002, AM J PHYSIOL-LUNG C, V282, pL1296, DOI 10.1152/ajplung.00315.2001; Simon AR, 1998, AM J PHYSIOL-CELL PH, V275, pC1640, DOI 10.1152/ajpcell.1998.275.6.C1640; Spycher SE, 1997, FASEB J, V11, P181, DOI 10.1096/fasebj.11.2.9039961; Srivastava S, 2000, FREE RADICAL BIO MED, V29, P642, DOI 10.1016/S0891-5849(00)00351-8; Srivastava S, 1995, BIOCHEM BIOPH RES CO, V217, P741, DOI 10.1006/bbrc.1995.2835; Srivastava SK, 2005, ENDOCR REV, V26, P380, DOI 10.1210/er.2004-0028; Sugiura H, 2008, ANTIOXID REDOX SIGN, V10, P785, DOI 10.1089/ars.2007.1937; Takeyama K, 2000, J IMMUNOL, V164, P1546, DOI 10.4049/jimmunol.164.3.1546; Tammali R, 2006, CANCER RES, V66, P9705, DOI 10.1158/0008-5472.CAN-06-2105; Turner J, 2009, BIOCHEM SOC T, V37, P877, DOI 10.1042/BST0370877; Venkayya R, 2002, AM J RESP CELL MOL, V26, P202, DOI 10.1165/ajrcmb.26.2.4600; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wright DT, 1996, AM J PHYSIOL-LUNG C, V271, pL854, DOI 10.1152/ajplung.1996.271.5.L854; Yadav UCS, 2009, J IMMUNOL, V183, P4723, DOI 10.4049/jimmunol.0901177; Yadav UCS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006535; Zhen GH, 2007, AM J RESP CELL MOL, V36, P244, DOI 10.1165/rcmb.2006-0180OC	56	28	32	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14440	10.1371/journal.pone.0014440	http://dx.doi.org/10.1371/journal.pone.0014440			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203431	Green Published, gold, Green Submitted			2022-12-27	WOS:000285792500016
J	Onodera, S; Hicks, TP				Onodera, Satoru; Hicks, T. Philip			Carbocyanine Dye Usage in Demarcating Boundaries of the Aged Human Red Nucleus	PLOS ONE			English	Article							SUPERIOR COLLICULUS; OLIVARY PROJECTIONS; GAIT MODIFICATIONS; PYRAMIDAL TRACT; RHESUS-MONKEY; MOTOR CORTEX; SPINAL-CORD; BRAIN-STEM; CAT; NEURONS	Background: Though the adult human magnocellular Red nucleus (mNr) is essentially vestigial and its boundaries with neighbouring structures have never been well demarcated, human studies in utero have shown a well developed semilunar mNr wrapping around the caudal parvicellular Red nucleus (pNr), similar to what is seen in quadrupeds. In the present study, we have sought to better delineate the morphological determinants of the adult human Red nucleus (ahRn). Methods and Findings: Serial sections of ahRn show fine myelinated fibers arising from pNr and turning toward the central tegmental tract. Dil was deposited within a well restricted region of ahRn at the fasciculus retroflexus level and the extent of label determined. Nissl-stained serial sections allowed production of a 3-D mNr model, showing rudimentary, vestigial morphology compared with its well developed infant homologue. Dil within this vestigial mNr region at the level of the oculomotor nerve showed labeled giant/large mNr neurons, coarse fiber bundles at the ventral tegmental decussation and lateral lemniscal label. Conclusions: Large amounts of Dil and a long incubation time have proven useful in aged human brain as a marker of long axons and large cell bodies of projecting neurons such as the rubrospinal projection and for clarifying nuclear boundaries of closed nuclei (e. g., the large human pNr). Our 3D model of adult human mNr appeared shrunken in shape and axially rotated compared with the infant mNr, the rotation being a common feature among mammalian mNr.	[Onodera, Satoru] Iwate Med Univ, Sch Med, Dept Anat, Morioka, Iwate 020, Japan; [Hicks, T. Philip] Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada; [Hicks, T. Philip] Lakehead Univ, Fac Grad Studies, Thunder Bay, ON P7B 5E1, Canada; [Hicks, T. Philip] No Ontario Sch Med, Div Med Sci, Thunder Bay, ON, Canada	Iwate Medical University; Lakehead University; Lakehead University; Northern Ontario School of Medicine	Onodera, S (corresponding author), Iwate Med Univ, Sch Med, Dept Anat, Morioka, Iwate 020, Japan.	sonodera@iwate-med.ac.jp						Belhaj-Saif A, 2000, J NEUROPHYSIOL, V83, P3147, DOI 10.1152/jn.2000.83.5.3147; Burman K, 2000, J COMP NEUROL, V423, P197; Burman K, 2000, J COMP NEUROL, V423, P179, DOI 10.1002/1096-9861(20000724)423:2<179::AID-CNE1>3.0.CO;2-#; Drew T, 1996, CAN J PHYSIOL PHARM, V74, P426, DOI 10.1139/cjpp-74-4-426; GROFOVA I., 1960, CESKOSLOVENSKA MORFOL, V8, P215; HEFFNER R, 1975, BRAIN BEHAV EVOLUT, V12, P161, DOI 10.1159/000124401; HOLSTEGE G, 1988, BEHAV BRAIN RES, V28, P33, DOI 10.1016/0166-4328(88)90075-7; Horn KM, 2002, J NEUROPHYSIOL, V87, P469, DOI 10.1152/jn.00949.2000; IGUTI I, 1946, KAIBOUGAKU ZASSI, V23, P1; Jiang MC, 2002, NEUROSCIENCE, V110, P105, DOI 10.1016/S0306-4522(01)00544-9; Lavoie S, 2002, J NEUROPHYSIOL, V88, P1791, DOI 10.1152/jn.2002.88.4.1791; LEIVA J, 1992, ARCH ITAL BIOL, V130, P191; MANNEN H, 1988, DENDROCYTOMYELOARCHI; MASSION J, 1988, BEHAV BRAIN RES, V28, P1, DOI 10.1016/0166-4328(88)90071-X; MILLER RA, 1973, J COMP NEUROL, V152, P327, DOI 10.1002/cne.901520403; MUFSON EJ, 1990, NEUROBIOL AGING, V11, P649, DOI 10.1016/0197-4580(90)90031-T; NATHAN PW, 1982, BRAIN, V105, P223, DOI 10.1093/brain/105.2.223; Ogawa T, 1939, J COMP NEUROL, V70, P181, DOI 10.1002/cne.900700203; OLSZEWSKI J, 1982, CYTOARCHITECHTURE HU; Onodera S, 1999, NEUROSCIENTIST, V5, P217, DOI 10.1177/107385849900500411; Onodera S, 2004, BRAIN RES, V1015, P194, DOI 10.1016/j.brainres.2004.04.042; Onodera S, 1998, J COMP NEUROL, V396, P461; ONODERA S, 1984, J COMP NEUROL, V227, P37, DOI 10.1002/cne.902270106; Onodera S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006623; PADEL Y, 1981, J COMP NEUROL, V202, P421, DOI 10.1002/cne.902020311; Papez JW, 1940, ARCH NEURO PSYCHIATR, V44, P776, DOI 10.1001/archneurpsyc.1940.02280100078006; Paxinos G., 1995, ATLAS HUMAN BRAINSTE; Pong M, 2002, J NEUROPHYSIOL, V87, P453, DOI 10.1152/jn.00950.2000; Ruigrok Tom J. H., 1995, P277; Sarnat H., 2015, J PEDIAT NEUROL, V1, P3, DOI DOI 10.1055/S-0035-1557162; Satoh Y, 2003, BRAIN RES, V978, P51, DOI 10.1016/S0006-8993(03)02763-X; SCHOEN LHR, 1964, PROG BRAIN RES, V11, P203; SOBEL LI, 1977, THESIS ALBANY MED CO; SPENCE SJ, 1988, J COMP NEUROL, V268, P357, DOI 10.1002/cne.902680306; STROMINGER NL, 1979, J COMP NEUROL, V183, P33, DOI 10.1002/cne.901830104; STROMINGER NL, 1985, BRAIN RES, V343, P184, DOI 10.1016/0006-8993(85)91176-X; Tardif E, 2005, EXP BRAIN RES, V166, P316, DOI 10.1007/s00221-005-2373-z; Tomonaga M., 2003, COGNITIVE BEHAV DEV; Ulfig N, 2002, NEUROSIGNALS, V11, P95, DOI 10.1159/000058546; Ulfig N, 2001, ANAT EMBRYOL, V203, P95, DOI 10.1007/s004290000147; van Kan PLE, 2002, EXP BRAIN RES, V142, P151, DOI 10.1007/s00221-001-0924-5; Van Kan PLE, 2001, J NEUROPHYSIOL, V85, P1461, DOI 10.1152/jn.2001.85.4.1461; VERHAART W. J. C., 1938, PSYCHIATR EN NEUROL BLADEN, V42, P335; Voogd J., 2003, HUMAN NERVOUS SYSTEM, P321; Whishaw IQ, 1996, BEHAV BRAIN RES, V74, P79, DOI 10.1016/0166-4328(95)00161-1; Yamaguchi K, 2008, DEV NEUROSCI-BASEL, V30, P325, DOI 10.1159/000142733; Yamaguchi K, 2006, BRAIN DEV-JPN, V28, P431, DOI 10.1016/j.braindev.2006.01.001	47	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e14430	10.1371/journal.pone.0014430	http://dx.doi.org/10.1371/journal.pone.0014430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203458	gold, Green Published, Green Submitted			2022-12-27	WOS:000285579200011
J	Canonne, J; Marino, D; Noel, LD; Arechaga, I; Pichereaux, C; Rossignol, M; Roby, D; Rivas, S				Canonne, Joanne; Marino, Daniel; Noel, Laurent D.; Arechaga, Ignacio; Pichereaux, Carole; Rossignol, Michel; Roby, Dominique; Rivas, Susana			Detection and Functional Characterization of a 215 Amino Acid N-Terminal Extension in the Xanthomonas Type III Effector XopD	PLOS ONE			English	Article							CAMPESTRIS PV.-VESICATORIA; PLANT DEFENSE RESPONSE; MULTIPLE ANTIBIOTIC-RESISTANCE; PATHOGEN PSEUDOMONAS-SYRINGAE; PROTEIN-TYROSINE-PHOSPHATASE; INNATE IMMUNITY; ESCHERICHIA-COLI; SECRETION SYSTEM; DISEASE-RESISTANCE; INCOMPATIBLE INTERACTIONS	During evolution, pathogens have developed a variety of strategies to suppress plant-triggered immunity and promote successful infection. In Gram-negative phytopathogenic bacteria, the so-called type III protein secretion system works as a molecular syringe to inject type III effectors (T3Es) into plant cells. The XopD T3E from the strain 85-10 of Xanthomonas campestris pathovar vesicatoria (Xcv) delays the onset of symptom development and alters basal defence responses to promote pathogen growth in infected tomato leaves. XopD was previously described as a modular protein that contains (i) an N-terminal DNA-binding domain (DBD), (ii) two tandemly repeated EAR (ERF-associated amphiphillic repression) motifs involved in transcriptional repression, and (iii) a C-terminal cysteine protease domain, involved in release of SUMO (small ubiquitin-like modifier) from SUMO-modified proteins. Here, we show that the XopD protein that is produced and secreted by Xcv presents an additional N-terminal extension of 215 amino acids. Closer analysis of this newly identified N-terminal domain shows a low complexity region rich in lysine, alanine and glutamic acid residues (KAE-rich) with high propensity to form coiled-coil structures that confers to XopD the ability to form dimers when expressed in E. coli. The full length XopD protein identified in this study (XopD(1-760)) displays stronger repression of the XopD plant target promoter PR1, as compared to the XopD version annotated in the public databases (XopD(216-760)). Furthermore, the N-terminal extension of XopD, which is absent in XopD(216-760), is essential for XopD type III-dependent secretion and, therefore, for complementation of an Xcv mutant strain deleted from XopD in its ability to delay symptom development in tomato susceptible cultivars. The identification of the complete sequence of XopD opens new perspectives for future studies on the XopD protein and its virulence-associated functions in planta.	[Canonne, Joanne; Marino, Daniel; Noel, Laurent D.; Roby, Dominique; Rivas, Susana] INRA, CNRS, Lab Interact Plantes Microorganismes LIPM, UMR 2594 441, F-31326 Castanet Tolosan, France; [Pichereaux, Carole; Rossignol, Michel] Univ Toulouse, Inst Federatif Rech IFR40, Inst Pharmacol & Biol Struct, Toulouse, France; [Arechaga, Ignacio] Univ Cantabria, Dept Biol Mol, E-39005 Santander, Spain; [Arechaga, Ignacio] IBBTEC CSIC UC IDICAN, Inst Biomed & Biotecnol Cantabria, Santander, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC)	Canonne, J (corresponding author), INRA, CNRS, Lab Interact Plantes Microorganismes LIPM, UMR 2594 441, F-31326 Castanet Tolosan, France.	Susana.Rivas@toulouse.inra.fr	Arechaga, Ignacio/K-2198-2014; Marino, Daniel/C-5433-2012; noel, laurent/A-4885-2009	Arechaga, Ignacio/0000-0002-1342-9370; noel, laurent/0000-0002-0110-1423; Pichereaux, Carole/0000-0002-7559-5358	French Ministry of National Education and Research; Fondation pour la Recherche Medicale (FRM); Toulouse Midi-Pyrenees Genopole; Midi-Pyrenees Regional Council [CR07003760]; GIS-IBISA (Infrastructure en Biologie Sante et Agronomie); French ANR-Jeunes Chercheurs [ANR JC08_324792]	French Ministry of National Education and Research; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Toulouse Midi-Pyrenees Genopole; Midi-Pyrenees Regional Council(Region Occitanie); GIS-IBISA (Infrastructure en Biologie Sante et Agronomie); French ANR-Jeunes Chercheurs(French National Research Agency (ANR))	J.C. was funded by a grant from the French Ministry of National Education and Research. Mass Spectrometry work was supported by grants from the Fondation pour la Recherche Medicale (FRM; 'Grands Equipements'), the Toulouse Midi-Pyrenees Genopole, the Midi-Pyrenees Regional Council (grant CR07003760) and the GIS-IBISA (Infrastructure en Biologie Sante et Agronomie). This work was supported by a French ANR-Jeunes Chercheurs grant (ANR JC08_324792) to S. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch RB, 2006, NAT REV MOL CELL BIO, V7, P601, DOI 10.1038/nrm1984; Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Alekshun MN, 1999, TRENDS MICROBIOL, V7, P410, DOI 10.1016/S0966-842X(99)01589-9; Alekshun MN, 2000, MOL MICROBIOL, V35, P1394, DOI 10.1046/j.1365-2958.2000.01802.x; Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Arnold R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000376; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Blanvillain S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000224; Boudart G, 2005, PROTEOMICS, V5, P212, DOI 10.1002/pmic.200400882; BOURDINEAUD JP, 1989, J BACTERIOL, V171, P2458, DOI 10.1128/jb.171.5.2458-2465.1989; Bretz JR, 2003, MOL MICROBIOL, V49, P389, DOI 10.1046/j.1365-2958.2003.03616.x; Buttner D, 2007, MOL PLANT MICROBE IN, V20, P1063, DOI 10.1094/MPMI-20-9-1063; Buttner D, 2002, EMBO J, V21, P5313, DOI 10.1093/emboj/cdf536; Chin KH, 2006, PROTEINS, V65, P239, DOI 10.1002/prot.21017; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Chosed R, 2007, J BIOL CHEM, V282, P6773, DOI 10.1074/jbc.M608730200; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Espinosa A, 2003, MOL MICROBIOL, V49, P377, DOI 10.1046/j.1365-2958.2003.03588.x; FINAN TM, 1986, J BACTERIOL, V167, P66, DOI 10.1128/jb.167.1.66-72.1986; Froidure S, 2010, P NATL ACAD SCI USA, V107, P15281, DOI 10.1073/pnas.1009056107; Fu ZQ, 2007, NATURE, V447, P284, DOI 10.1038/nature05737; Gauthier A, 2003, J BACTERIOL, V185, P6747, DOI 10.1128/JB.185.23.6747-6755.2003; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Gohre V, 2008, ANNU REV PHYTOPATHOL, V46, P189, DOI 10.1146/annurev.phyto.46.120407.110050; Gu KY, 2005, NATURE, V435, P1122, DOI 10.1038/nature03630; Guttman DS, 2002, SCIENCE, V295, P1722, DOI 10.1126/science.295.5560.1722; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; Hotson A, 2003, MOL MICROBIOL, V50, P377, DOI 10.1046/j.1365-2958.2003.03730.x; INNES RW, 1993, J BACTERIOL, V175, P4859, DOI 10.1128/JB.175.15.4859-4869.1993; Jones JB, 1998, ANNU REV PHYTOPATHOL, V36, P41, DOI 10.1146/annurev.phyto.36.1.41; Jones JB, 2004, SYST APPL MICROBIOL, V27, P755, DOI 10.1078/0723202042369884; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Kazan K, 2006, TRENDS PLANT SCI, V11, P109, DOI 10.1016/j.tplants.2006.01.004; Kim JG, 2008, PLANT CELL, V20, P1915, DOI 10.1105/tpc.108.058529; Koebnik R, 2006, J BACTERIOL, V188, P7652, DOI 10.1128/JB.00795-06; LEVENGOOD SK, 1991, P NATL ACAD SCI USA, V88, P5939, DOI 10.1073/pnas.88.14.5939; Lloyd SA, 2002, MOL MICROBIOL, V43, P51, DOI 10.1046/j.1365-2958.2002.02738.x; Lloyd SA, 2001, TRENDS MICROBIOL, V9, P367, DOI 10.1016/S0966-842X(01)02100-X; Lloyd SA, 2001, MOL MICROBIOL, V39, P520, DOI 10.1046/j.1365-2958.2001.02271.x; Loake G, 2007, CURR OPIN PLANT BIOL, V10, P466, DOI 10.1016/j.pbi.2007.08.008; Lower M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005917; LUMMERZHEIM M, 1993, MOL PLANT MICROBE IN, V6, P532, DOI 10.1094/MPMI-6-532; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; MURRAY NE, 1977, MOL GEN GENET, V150, P53, DOI 10.1007/BF02425325; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Noel L, 2002, J BACTERIOL, V184, P1340, DOI 10.1128/JB.184.5.1340-1348.2002; Noel L, 2001, MOL MICROBIOL, V41, P1271, DOI 10.1046/j.1365-2958.2001.02567.x; Nomura K, 2006, SCIENCE, V313, P220, DOI 10.1126/science.1129523; Ohta M, 2001, PLANT CELL, V13, P1959, DOI 10.1105/tpc.13.8.1959; Oke V, 1999, MOL MICROBIOL, V32, P837, DOI 10.1046/j.1365-2958.1999.01402.x; Petnicki-Ocwieja T, 2002, P NATL ACAD SCI USA, V99, P7652, DOI 10.1073/pnas.112183899; Poueymiro M, 2009, MOL PLANT MICROBE IN, V22, P538, DOI 10.1094/MPMI-22-5-0538; Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705; Rivas S, 2004, EMBO J, V23, P2156, DOI 10.1038/sj.emboj.7600224; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Rosebrock TR, 2007, NATURE, V448, P370, DOI 10.1038/nature05966; Rossier O, 1999, P NATL ACAD SCI USA, V96, P9368, DOI 10.1073/pnas.96.16.9368; Rossier O, 2000, MOL MICROBIOL, V38, P828, DOI 10.1046/j.1365-2958.2000.02173.x; Russmann H, 2002, MOL MICROBIOL, V46, P769, DOI 10.1046/j.1365-2958.2002.03196.x; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Samudrala R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000375; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Thieme F, 2007, MOL PLANT MICROBE IN, V20, P1250, DOI 10.1094/MPMI-20-10-1250; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; Vauterin L, 2000, PHYTOPATHOLOGY, V90, P677, DOI 10.1094/PHYTO.2000.90.7.677; Vorholter FJ, 2003, J BIOTECHNOL, V106, P193, DOI 10.1016/j.jbiotec.2003.08.011; Wengelnik K, 1999, J BACTERIOL, V181, P6828, DOI 10.1128/JB.181.21.6828-6831.1999; Wengelnik K, 1996, J BACTERIOL, V178, P3462, DOI 10.1128/jb.178.12.3462-3469.1996; White FF, 2009, MOL PLANT PATHOL, V10, P749, DOI 10.1111/j.1364-3703.2009.00590.x; Wu AJ, 2004, PLANT CELL, V16, P2809, DOI 10.1105/tpc.104.024141; Xiang TT, 2008, CURR BIOL, V18, P74, DOI 10.1016/j.cub.2007.12.020; XIAO YX, 1994, J BACTERIOL, V176, P3089, DOI 10.1128/JB.176.10.3089-3091.1994; Xing W, 2007, NATURE, V449, P243, DOI 10.1038/nature06109; Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006; Zhu HQ, 2004, BIOINFORMATICS, V20, P3308, DOI 10.1093/bioinformatics/bth390; Zipfel C, 2008, CURR OPIN IMMUNOL, V20, P10, DOI 10.1016/j.coi.2007.11.003	86	23	24	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15773	10.1371/journal.pone.0015773	http://dx.doi.org/10.1371/journal.pone.0015773			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203472	Green Published, gold			2022-12-27	WOS:000285578000052
J	Chano, T; Ikebuchi, K; Tomita, Y; Jin, YF; Inaji, H; Ishitobi, M; Teramoto, K; Ochi, Y; Tameno, H; Nishimura, I; Minami, K; Inoue, H; Isono, T; Saitoh, M; Shimada, T; Hisa, Y; Okabe, H				Chano, Tokuhiro; Ikebuchi, Kaichiro; Tomita, Yasuhiko; Jin, Yufen; Inaji, Hideo; Ishitobi, Makoto; Teramoto, Koji; Ochi, Yasuko; Tameno, Hitosuke; Nishimura, Ichiro; Minami, Kahori; Inoue, Hirokazu; Isono, Takahiro; Saitoh, Masao; Shimada, Taketoshi; Hisa, Yasuo; Okabe, Hidetoshi			RB1CC1 Together with RB1 and p53 Predicts Long-Term Survival in Japanese Breast Cancer Patients	PLOS ONE			English	Article							AUTOPHAGY; FIP200; EXPRESSION; CELLS; GENE; COMPLEX; PROTEIN; IDENTIFICATION; TUMORIGENESIS; PHENOTYPE	RB1-inducible coiled-coil 1 (RB1CC1) plays a significant role in the enhancement of the retinoblastoma tumor suppressor (RB1) pathway and is involved in breast cancer development. However, RB1CC1's role in clinical progression of breast cancer has not yet been evaluated, so, as a first step, it is necessary to establish its usefulness as a tool to evaluate breast cancer patients. In this report, we have analyzed the correlation between abnormalities in the RB1CC1 pathway and long-term prognosis, because disease-specific death in later periods (>5 years) of the disease is a serious problem in breast cancer. Breast cancer tissues from a large cohort in Japan were evaluated by conventional immunohistochemical methods for the presence of the molecules involved in the RB1CC1 pathway, including RB1CC1, RB1, p53, and other well-known prognostic markers for breast cancer, such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2. The correlation between the immunohistochemical results and clinical outcomes of 323 breast cancer patients was analyzed using a Kaplan-Meier log-rank test and a multivariate Cox proportional hazards regression analysis. Absence of nuclear RB1CC1 expression was associated with the worst prognosis (Log-rank test, Chi-Square value = 17.462, p<0.0001). Dysfunction of either one of RB1CC1, RB1, or p53 was associated with the highest risk for cancer-specific death, especially related to survival lasting more than 5 years (multivariate Cox proportional hazard ratio = 3.951, 95% Confidence Interval = 1.566-9.967, p = 0.0036). Our present data demonstrate that the combined evaluation of RB1CC1, RB1 and p53 by conventional immunohistochemical analysis provides an accurate prediction of the long-term prognoses of breast cancer patients, which can be carried out as a routine clinical examination.	[Chano, Tokuhiro; Ikebuchi, Kaichiro; Ochi, Yasuko; Tameno, Hitosuke; Nishimura, Ichiro; Minami, Kahori; Okabe, Hidetoshi] Shiga Univ Med Sci, Dept Clin Lab Med, Otsu, Shiga 52021, Japan; [Ikebuchi, Kaichiro; Ochi, Yasuko; Tameno, Hitosuke; Shimada, Taketoshi; Hisa, Yasuo] Kyoto Prefectural Univ Med, Dept Otolaryngol Head & Neck Surg, Kyoto, Japan; [Tomita, Yasuhiko; Jin, Yufen] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Pathol, Osaka, Japan; [Inaji, Hideo; Ishitobi, Makoto] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Breast & Endocrine Surg, Osaka, Japan; [Teramoto, Koji] Shiga Univ Med Sci, Dept Thorac Surg, Otsu, Shiga 52021, Japan; [Inoue, Hirokazu] Shiga Univ Med Sci, Dept Microbiol, Otsu, Shiga 52021, Japan; [Isono, Takahiro] Tokyo Med & Dent Univ, Dept Cent Res Lab, Tokyo, Japan; [Saitoh, Masao] Tokyo Med & Dent Univ, Dept Cellular Physiol Chem, Tokyo, Japan	Shiga University of Medical Science; Kyoto Prefectural University of Medicine; Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka Medical Center for Cancer & Cardiovascular Diseases; Shiga University of Medical Science; Shiga University of Medical Science; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Chano, T (corresponding author), Shiga Univ Med Sci, Dept Clin Lab Med, Otsu, Shiga 52021, Japan.	chano@belle.shiga-med.ac.jp	Chano, Tokuhiro/F-5816-2018	Chano, Tokuhiro/0000-0002-9959-1183	Ministry of Education, Culture, Sports, Science, and Technology, Japan [20012025]; Japanese Society of Laboratory Medicine Fund for the Promotion of Scientific Research	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society of Laboratory Medicine Fund for the Promotion of Scientific Research	This study was supported in part by KAKENHI (Grant-in-Aid for Scientific Research on Priority Areas; No. 20012025) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japanese Society of Laboratory Medicine Fund for the Promotion of Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, preparation of the manuscript.	Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Bialik S, 2008, ADV EXP MED BIOL, V615, P177, DOI 10.1007/978-1-4020-6554-5_9; BORG A, 1992, CANCER RES, V52, P2991; Ceccarelli C, 1998, J CLIN PATHOL, V51, P818, DOI 10.1136/jcp.51.11.818; Chano T, 2002, NAT GENET, V31, P285, DOI 10.1038/ng911; Chano T, 2002, ONCOGENE, V21, P1295, DOI 10.1038/sj.onc.1205178; Chano T, 2006, INT J MOL MED, V18, P425; Chano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011404; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Derenzini M, 2007, HISTOL HISTOPATHOL, V22, P505, DOI 10.14670/HH-22.505; Elledge RM, 1998, BREAST CANCER RES TR, V52, P79, DOI 10.1023/A:1006163101948; Gan B, 2008, CELL SIGNAL, V20, P787, DOI 10.1016/j.cellsig.2007.10.021; Gan BY, 2006, J CELL BIOL, V175, P121, DOI 10.1083/jcb.200604129; Gan BY, 2005, J CELL BIOL, V170, P379, DOI 10.1083/jcb.200411106; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hara T, 2009, AUTOPHAGY, V5, P85, DOI 10.4161/auto.5.1.7180; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Ikebuchi K, 2009, INT J CANCER, V125, P861, DOI 10.1002/ijc.24466; Irvin WJ, 2008, EUR J CANCER, V44, P2799, DOI 10.1016/j.ejca.2008.09.034; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Maiuri MC, 2009, CELL DEATH DIFFER, V16, P87, DOI 10.1038/cdd.2008.131; Martin N, 2008, MOL CELL BIOL, V28, P2771, DOI 10.1128/MCB.01210-07; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Melkoumian ZK, 2005, CANCER RES, V65, P6676, DOI 10.1158/0008-5472.CAN-04-4142; Mersin H, 2008, BREAST, V17, P341, DOI 10.1016/j.breast.2007.11.031; MORSELLI E, 2009, BIOCHIM BIOPHYS ACTA; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Schmidt-Kittler O, 2003, P NATL ACAD SCI USA, V100, P7737, DOI 10.1073/pnas.1331931100; Tischkowitz M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-134; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709	33	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15737	10.1371/journal.pone.0015737	http://dx.doi.org/10.1371/journal.pone.0015737			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203526	gold, Green Published, Green Submitted			2022-12-27	WOS:000285578000051
J	Liao, W; Qiu, CJ; Gentili, C; Walter, M; Pan, ZY; Ding, JR; Zhang, W; Gong, QY; Chen, HF				Liao, Wei; Qiu, Changjian; Gentili, Claudio; Walter, Martin; Pan, Zhengyong; Ding, Jurong; Zhang, Wei; Gong, Qiyong; Chen, Huafu			Altered Effective Connectivity Network of the Amygdala in Social Anxiety Disorder: A Resting-State fMRI Study	PLOS ONE			English	Article							CEREBRAL BLOOD-FLOW; PREFRONTAL CORTEX; GRANGER CAUSALITY; DEFAULT-MODE; FUNCTIONAL CONNECTIVITY; RECOGNITION BIAS; CRITICAL FACES; PHOBIA; BRAIN; INFORMATION	The amygdala is often found to be abnormally recruited in social anxiety disorder (SAD) patients. The question whether amygdala activation is primarily abnormal and affects other brain systems or whether it responds "normally" to an abnormal pattern of information conveyed by other brain structures remained unanswered. To address this question, we investigated a network of effective connectivity associated with the amygdala using Granger causality analysis on resting-state functional MRI data of 22 SAD patients and 21 healthy controls (HC). Implications of abnormal effective connectivity and clinical severity were investigated using the Liebowitz Social Anxiety Scale (LSAS). Decreased influence from inferior temporal gyrus (ITG) to amygdala was found in SAD, while bidirectional influences between amygdala and visual cortices were increased compared to HCs. Clinical relevance of decreased effective connectivity from ITG to amygdala was suggested by a negative correlation of LSAS avoidance scores and the value of Granger causality. Our study is the first to reveal a network of abnormal effective connectivity of core structures in SAD. This is in support of a disregulation in predescribed modules involved in affect control. The amygdala is placed in a central position of dysfunction characterized both by decreased regulatory influence of orbitofrontal cortex and increased crosstalk with visual cortex. The model which is proposed based on our results lends neurobiological support towards cognitive models considering disinhibition and an attentional bias towards negative stimuli as a core feature of the disorder.	[Liao, Wei; Pan, Zhengyong; Ding, Jurong; Chen, Huafu] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China; [Qiu, Changjian; Zhang, Wei] Sichuan Univ, W China Hosp, Mental Hlth Ctr, Chengdu 610064, Peoples R China; [Gentili, Claudio] Univ Pisa, Dept Psychiat Neurobiol Pharmacol & Biotechnol, AUO Pisa, Unit Clin Psychol, Pisa, Italy; [Walter, Martin] Otto Von Guericke Univ, Dept Psychiat, Clin Affect Neuroimaging Lab, Magdeburg, Germany; [Gong, Qiyong] Sichuan Univ, W China Sch Med, W China Hosp, Huaxi MR Res Ctr HMRRC,Dept Radiol, Chengdu 610064, Peoples R China	University of Electronic Science & Technology of China; Sichuan University; University of Pisa; Otto von Guericke University; Sichuan University	Liao, W (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China.	qygong05@126.com; chenhf@uestc.edu.cn	zhang, julie/G-2932-2011; Gong, Qiyong/W-3052-2019	Gong, Qiyong/0000-0002-5912-4871; Walter, Martin/0000-0001-7857-4483; Gentili, Claudio/0000-0002-2579-8755	Natural Science Foundation of China [61035006, 90820006, 30625024]; 863 Program [2008AA02Z408]; 973 Project [2008CB517407]; DFG-SFB [779 (A6)]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 Program(National High Technology Research and Development Program of China); 973 Project(National Basic Research Program of China); DFG-SFB(German Research Foundation (DFG))	This research was supported in partly by the Natural Science Foundation of China (Grant Nos. 61035006, 90820006 and 30625024 to HC, GQ); in partly by the 863 Program (Grant No. 2008AA02Z408 to HC, GQ); in partly by the 973 Project (Grant No. 2008CB517407 to WZ) and by the DFG-SFB 779 (A6) to MW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav Irit, 2007, Neural Plasticity, V2007, DOI 10.1155/2007/30873; Arrais KC, 2010, J PSYCHIATR RES, V44, P535, DOI 10.1016/j.jpsychires.2009.11.003; Baddeley R, 1997, P ROY SOC B-BIOL SCI, V264, P1775, DOI 10.1098/rspb.1997.0246; BARONCOHEN S, 1994, BRIT J PSYCHIAT, V165, P640, DOI 10.1192/bjp.165.5.640; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Birbaumer N, 1998, NEUROREPORT, V9, P1223, DOI 10.1097/00001756-199804200-00048; Bishop SJ, 2007, TRENDS COGN SCI, V11, P307, DOI 10.1016/j.tics.2007.05.008; Bogels SM, 2004, CLIN PSYCHOL REV, V24, P827, DOI 10.1016/j.cpr.2004.06.005; BROTHERS L, 1990, BEHAV BRAIN RES, V41, P199, DOI 10.1016/0166-4328(90)90108-Q; Chen HF, 2009, NEUROIMAGE, V47, P1844, DOI 10.1016/j.neuroimage.2009.06.026; Clark D. M., 1995, SOCIALPHOBIA DIAGNOS, P69, DOI DOI 10.1017/S1352465808004487; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Coles ME, 2005, BEHAV RES THER, V43, P109, DOI 10.1016/j.brat.2003.12.001; Cooney RE, 2006, PSYCHIAT RES-NEUROIM, V148, P55, DOI 10.1016/j.pscychresns.2006.05.003; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; DAVID O, 2009, NEUROIMAGE, DOI DOI 10.1016/J.NEUROIMAGE.2009.1009.1073; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Delamillieure P, 2010, BRAIN RES BULL, V81, P565, DOI 10.1016/j.brainresbull.2009.11.014; Deshpande G, 2010, NEUROIMAGE, V52, P884, DOI 10.1016/j.neuroimage.2009.11.060; Dolan RJ, 2007, PHILOS T R SOC B, V362, P787, DOI 10.1098/rstb.2007.2088; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Engel K, 2009, J NEURAL TRANSM, V116, P703, DOI 10.1007/s00702-008-0077-9; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Etkin A, 2009, ARCH GEN PSYCHIAT, V66, P1361, DOI 10.1001/archgenpsychiatry.2009.104; Foa EB, 2000, J ANXIETY DISORD, V14, P501, DOI 10.1016/S0887-6185(00)00036-0; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Ferrari MCF, 2008, REV BRAS PSIQUIATR, V30, P251, DOI 10.1590/S1516-44462008000300013; Freitas-Ferrari MC, 2010, PROG NEURO-PSYCHOPH, V34, P565, DOI 10.1016/j.pnpbp.2010.02.028; FRISTON K, 2009, NEUROIMAGE, DOI DOI 10.1016/J.NEUROIMAGE.2009.1009.1031; Friston KJ, 2009, PLOS BIOL, V7, P220, DOI 10.1371/journal.pbio.1000033; Gao Q, 2008, NEUROSCI LETT, V443, P1, DOI 10.1016/j.neulet.2008.07.036; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gentili C, 2009, BRAIN RES BULL, V79, P409, DOI 10.1016/j.brainresbull.2009.02.002; Gentili C, 2008, BRAIN RES BULL, V77, P286, DOI 10.1016/j.brainresbull.2008.08.003; Ghashghaei H, 2007, NEUROIMAGE, V34, P905, DOI 10.1016/j.neuroimage.2006.09.046; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Guyer AE, 2008, ARCH GEN PSYCHIAT, V65, P1303, DOI 10.1001/archpsyc.65.11.1303; HAMILTON JP, 2010, MOL PSYCHIA IN PRESS, DOI DOI 10.1038/MP.2010.1046; Iidaka T, 2001, J COGNITIVE NEUROSCI, V13, P1035, DOI 10.1162/089892901753294338; Jiao Q, 2011, HUM BRAIN MAPP, V32, P154, DOI 10.1002/hbm.21065; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; Liao W, 2010, BIOL CYBERN, V102, P57, DOI 10.1007/s00422-009-0350-5; Liao W, 2009, IEEE T MED IMAGING, V28, P1825, DOI 10.1109/TMI.2009.2025126; Liebowitz M R, 1987, Mod Probl Pharmacopsychiatry, V22, P141; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lorberbaum JP, 2004, NEUROREPORT, V15, P2701; Lundh LG, 1996, BEHAV RES THER, V34, P787, DOI 10.1016/0005-7967(96)00035-6; Mantini D, 2009, NEUROIMAGE, V44, P265, DOI 10.1016/j.neuroimage.2008.08.019; Marinazzo D, 2011, NEUROIMAGE, V58, P330, DOI 10.1016/j.neuroimage.2010.01.099; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Mitchell JP, 2006, BRAIN RES, V1079, P66, DOI 10.1016/j.brainres.2005.12.113; Mogg K, 1997, BEHAV RES THER, V35, P297, DOI 10.1016/S0005-7967(96)00109-X; Ohayon MM, 2010, J PSYCHOSOM RES, V68, P235, DOI 10.1016/j.jpsychores.2009.07.018; Phan KL, 2005, NEUROREPORT, V16, P183, DOI 10.1097/00001756-200502080-00024; Phan KL, 2006, BIOL PSYCHIAT, V59, P424, DOI 10.1016/j.biopsych.2005.08.012; Pujol J, 2009, PSYCHOL MED, V39, P1177, DOI 10.1017/S003329170800500X; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; ROEBROECK A, 2009, NEUROIMAGE, DOI DOI 10.1016/J.NEUROIMAGE.2009.1009.1036; Schneider F, 1999, BIOL PSYCHIAT, V45, P863, DOI 10.1016/S0006-3223(98)00269-8; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331; Simmons A, 2008, NEUROREPORT, V19, P1033, DOI 10.1097/WNR.0b013e328305b722; Skuse D, 2006, PHILOS T R SOC B, V361, P2129, DOI 10.1098/rstb.2006.1935; Skuse DH, 2009, TRENDS COGN SCI, V13, P27, DOI 10.1016/j.tics.2008.09.007; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Stein MB, 2002, ARCH GEN PSYCHIAT, V59, P1027, DOI 10.1001/archpsyc.59.11.1027; Stein MB, 2008, LANCET, V371, P1115, DOI 10.1016/S0140-6736(08)60488-2; Stevens MC, 2009, HUM BRAIN MAPP, V30, P2356, DOI 10.1002/hbm.20673; Straube T, 2004, BIOL PSYCHIAT, V56, P921, DOI 10.1016/j.biopsych.2004.09.024; Tillfors M, 2002, BIOL PSYCHIAT, V52, P1113, DOI 10.1016/S0006-3223(02)01396-3; Tillfors M, 2001, AM J PSYCHIAT, V158, P1220, DOI 10.1176/appi.ajp.158.8.1220; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Warwick JM, 2008, PROG NEURO-PSYCHOPH, V32, P1251, DOI 10.1016/j.pnpbp.2008.03.017; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198	83	116	123	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15238	10.1371/journal.pone.0015238	http://dx.doi.org/10.1371/journal.pone.0015238			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203551	Green Published, gold, Green Submitted			2022-12-27	WOS:000285578000025
J	VanGuilder, HD; Bixler, GV; Kutzler, L; Brucklacher, RM; Bronson, SK; Kimball, SR; Freeman, WM				VanGuilder, Heather D.; Bixler, Georgina V.; Kutzler, Lydia; Brucklacher, Robert M.; Bronson, Sarah K.; Kimball, Scot R.; Freeman, Willard M.			Multi-Modal Proteomic Analysis of Retinal Protein Expression Alterations in a Rat Model of Diabetic Retinopathy	PLOS ONE			English	Article							DIAZEPAM-BINDING INHIBITOR; DIFFERENCE GEL-ELECTROPHORESIS; GLYCATION END-PRODUCTS; CONTRAST SENSITIVITY; SERUM CERULOPLASMIN; VITREOUS FLUID; MESSENGER-RNA; CELLS; CRYSTALLIN; LOCALIZATION	Background: As a leading cause of adult blindness, diabetic retinopathy is a prevalent and profound complication of diabetes. We have previously reported duration-dependent changes in retinal vascular permeability, apoptosis, and mRNA expression with diabetes in a rat model system. The aim of this study was to identify retinal proteomic alterations associated with functional dysregulation of the diabetic retina to better understand diabetic retinopathy pathogenesis and that could be used as surrogate endpoints in preclinical drug testing studies. Methodology/Principal Findings: A multi-modal proteomic approach of antibody (Luminex)-, electrophoresis (DIGE)-, and LC-MS (iTRAQ)-based quantitation methods was used to maximize coverage of the retinal proteome. Transcriptomic profiling through microarray analysis was included to identify additional targets and assess potential regulation of protein expression changes at the mRNA level. The proteomic approaches proved complementary, with limited overlap in proteomic coverage. Alterations in pro-inflammatory, signaling and crystallin family proteins were confirmed by orthogonal methods in multiple independent animal cohorts. In an independent experiment, insulin replacement therapy normalized the expression of some proteins (Dbi, Anxa5) while other proteins (Cp, Cryba3, Lgals3, Stat3) were only partially normalized and Fgf2 and Crybb2 expression remained elevated. Conclusions/Significance: These results expand the understanding of the changes in retinal protein expression occurring with diabetes and their responsiveness to normalization of blood glucose through insulin therapy. These proteins, especially those not normalized by insulin therapy, may also be useful in preclinical drug development studies.	[VanGuilder, Heather D.; Bixler, Georgina V.; Brucklacher, Robert M.; Freeman, Willard M.] Penn State Coll Med, Dept Pharmacol, Hershey, PA USA; [Kutzler, Lydia; Bronson, Sarah K.; Kimball, Scot R.] Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	VanGuilder, HD (corresponding author), Penn State Coll Med, Dept Pharmacol, Hershey, PA USA.	wfreeman@psu.edu	Freeman, Willard/GYQ-5841-2022	Bronson, Sarah/0000-0002-5456-953X; Freeman, Willard/0000-0001-7027-999X	Juvenile Diabetes Research Foundation	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	This work was supported by funding from the Juvenile Diabetes Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello L M, 1998, J Am Optom Assoc, V69, P690; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Amos AF, 1997, DIABETIC MED, V14, pS7, DOI 10.1002/(SICI)1096-9136(199712)14:5+<S7::AID-DIA522>3.3.CO;2-I; Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200; Andley UP, 2008, INT J BIOCHEM CELL B, V40, P317, DOI 10.1016/j.biocel.2007.10.034; Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Barber AJ, 2000, INVEST OPHTH VIS SCI, V41, pS851; BARBER EF, 1987, J NUTR, V117, P1615, DOI 10.1093/jn/117.9.1615; Barmack NH, 2004, J NEUROSCI, V24, P1023, DOI 10.1523/JNEUROSCI.3936-03.2004; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bartoli M, 2009, INVEST OPHTH VIS SCI, V50, P4934, DOI 10.1167/iovs.08-2158; BORMANN J, 1991, NEUROPHARMACOLOGY, V30, P1387, DOI 10.1016/S0028-3908(11)80006-7; Brachvogel B, 2001, MECH DEVELOP, V109, P389, DOI 10.1016/S0925-4773(01)00532-9; Brucklacher RM, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-26; Campochiaro PA, 1996, J NEUROSCI, V16, P1679; Canning P, 2007, EXP DIABETES RES, DOI 10.1155/2007/51837; Chan PS, 2010, J DIABETES COMPLICAT, V24, P55, DOI 10.1016/j.jdiacomp.2008.10.002; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Choe L, 2007, PROTEOMICS, V7, P3651, DOI 10.1002/pmic.200700316; Chu TJ, 2008, PHYSIOL GENOMICS, V34, P185, DOI 10.1152/physiolgenomics.90201.2008; Compere V, 2010, J MOL ENDOCRINOL, V44, P295, DOI 10.1677/JME-09-0176; COSTA E, 1991, LIFE SCI, V49, P325, DOI 10.1016/0024-3205(91)90440-M; CUNNINGHAM J, 1995, METABOLISM, V44, P996, DOI 10.1016/0026-0495(95)90095-0; Daimon M, 1998, DIABETES CARE, V21, P1525, DOI 10.2337/diacare.21.9.1525; Davis MD, 1998, INVEST OPHTH VIS SCI, V39, P233; DENKO CW, 1979, AGENTS ACTIONS, V9, P333, DOI 10.1007/BF01970657; DESHMUKH VK, 1985, PHARMACOL RES COMMUN, V17, P633, DOI 10.1016/0031-6989(85)90070-0; DILEO MAS, 1994, DIABETOLOGIA, V37, P911, DOI 10.1007/BF00400947; Fernandez E, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.27; Fort PE, 2009, MOL CELL PROTEOMICS, V8, P767, DOI 10.1074/mcp.M800326-MCP200; Frank RN, 2009, ARCH OPHTHALMOL-CHIC, V127, P330, DOI 10.1001/archophthalmol.2008.607; Freeman WM, 2010, PHARMACOGENOMICS J, V10, P385, DOI 10.1038/tpj.2009.60; Freeman WM, 2009, NEUROSCIENCE, V159, P183, DOI 10.1016/j.neuroscience.2008.12.004; Freeman Willard M, 2009, J Ocul Biol Dis Infor, V2, P202; Frost-Larsen K, 1981, Dev Ophthalmol, V2, P222; Gao BB, 2008, J PROTEOME RES, V7, P2516, DOI 10.1021/pr800112g; Gao BB, 2007, NAT MED, V13, P181, DOI 10.1038/nm1534; Gao BB, 2009, J PROTEOME RES, V8, P5541, DOI 10.1021/pr9006415; Garcia-Ramirez M, 2007, DIABETOLOGIA, V50, P1294, DOI 10.1007/s00125-007-0627-y; Garcia-Ramirez M, 2009, DIABETOLOGIA, V52, P2633, DOI 10.1007/s00125-009-1548-8; Gerhardinger C, 2005, INVEST OPHTH VIS SCI, V46, P349, DOI 10.1167/iovs.04-0860; Gotow T, 1996, NEUROSCIENCE, V75, P507, DOI 10.1016/0306-4522(96)00295-3; HANSEN HO, 1991, BIOCHEM J, V277, P341, DOI 10.1042/bj2770341; Henderson NC, 2009, IMMUNOL REV, V230, P160, DOI 10.1111/j.1600-065X.2009.00794.x; HYVARINEN L, 1983, ACTA OPHTHALMOL, V61, P94; Joussen AM, 2002, FASEB J, V16, P438, DOI 10.1096/fj.01-0707fje; Joussen AM, 2001, AM J PATHOL, V158, P147, DOI 10.1016/S0002-9440(10)63952-1; Kim HW, 2009, CURR EYE RES, V34, P976, DOI 10.3109/02713680903249913; Kim T, 2007, PROTEOMICS, V7, P4203, DOI 10.1002/pmic.200700745; Kirwin SJ, 2009, INVEST OPHTH VIS SCI, V50, P5396, DOI 10.1167/iovs.09-3474; Klein R, 2008, OPHTHALMOLOGY, V115, P1859, DOI 10.1016/j.ophtha.2008.08.023; KNUDSEN J, 1990, BIOCHEM J, V265, P927, DOI 10.1042/bj2650927; KNUDSEN J, 1993, MOL CELL BIOCHEM, V123, P129, DOI 10.1007/BF01076484; Kowluru RA, 2004, INVEST OPHTH VIS SCI, V45, pU87; Kumar PA, 2005, ARCH BIOCHEM BIOPHYS, V444, P77, DOI 10.1016/j.abb.2005.09.021; Lazzarini R, 2010, IMMUNOPHARM IMMUNOT, V32, P402, DOI 10.3109/08923970903468821; Liu SQ, 2007, CELL MOL IMMUNOL, V4, P65; LOWE WL, 1995, METABOLISM, V44, P1038, DOI 10.1016/0026-0495(95)90102-7; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; Masuzawa K, 2006, EXP BIOL MED, V231, P1090; Munemasa Y, 2009, INVEST OPHTH VIS SCI, V50, P3869, DOI 10.1167/iovs.08-3138; Nathan DM, 2008, ARCH OPHTHALMOL-CHIC, V126, P1707, DOI 10.1001/archopht.126.12.1707; Oikari S, 2008, ACTA PHYSIOL, V194, P57, DOI 10.1111/j.1748-1716.2008.01860.x; Pugliese G, 2000, DIABETES, V49, P1249, DOI 10.2337/diabetes.49.7.1249; Qian ZY, 2008, J NEUROCHEM, V105, P1287, DOI 10.1111/j.1471-4159.2008.05229.x; Quin GJ, 2007, PROTEOMICS, V7, P2636, DOI 10.1002/pmic.200600486; Shin JH, 2009, NEUROSCI RES, V64, P355, DOI 10.1016/j.neures.2009.04.006; Simo R, 2008, ARCH OPHTHALMOL-CHIC, V126, P1076, DOI 10.1001/archopht.126.8.1076; Sinha D, 2008, MOL CELL NEUROSCI, V37, P85, DOI 10.1016/j.mcn.2007.08.016; SOKOL S, 1985, ARCH OPHTHALMOL-CHIC, V103, P51; Spaide RF, 2006, RETINA-J RET VIT DIS, V26, P275, DOI 10.1097/00006982-200603000-00004; Stitt AW, 2005, PHARMACOL REP, V57, P156; Stitt AW, 2005, DIABETES, V54, P785, DOI 10.2337/diabetes.54.3.785; Tajima E, 1999, NEUROLOGY, V53, P619; Tang WH, 2008, J PROTEOME RES, V7, P3661, DOI 10.1021/pr070492f; Taylor CF, 2007, NAT BIOTECHNOL, V25, P887, DOI 10.1038/nbt1329; Umstead TM, 2010, PEDIATR RES, V67, P641, DOI 10.1203/PDR.0b013e3181dceef5; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; VanGuilder HD, 2008, EUR J NEUROSCI, V28, P1, DOI 10.1111/j.1460-9568.2008.06322.x; VanGuilder HD, 2010, J NEUROCHEM, V113, P1577, DOI 10.1111/j.1471-4159.2010.06719.x; Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6; VLASSARA H, 1995, MOL MED, V1, P634, DOI 10.1007/BF03401604; Wu WW, 2006, J PROTEOME RES, V5, P651, DOI 10.1021/pr050405o; Yang LP, 2009, INVEST OPHTH VIS SCI, V50, P2319, DOI 10.1167/iovs.08-2642; Ying X, 2008, J MOL NEUROSCI, V35, P253, DOI 10.1007/s12031-007-9010-1; Zaunreiter M, 2005, BRAIN RES, V1032, P1, DOI 10.1016/j.brainres.2004.10.026	86	40	41	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16271	10.1371/journal.pone.0016271	http://dx.doi.org/10.1371/journal.pone.0016271			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249158	Green Submitted, Green Published, gold			2022-12-27	WOS:000286515000037
J	Evani, SJ; Murthy, AK; Mareedu, N; Montgomery, RK; Arulanandam, BP; Ramasubramanian, AK				Evani, Shankar J.; Murthy, Ashlesh K.; Mareedu, Naresh; Montgomery, Robbie K.; Arulanandam, Bernard P.; Ramasubramanian, Anand K.			Hydrodynamic Regulation of Monocyte Inflammatory Response to an Intracellular Pathogen	PLOS ONE			English	Article							CHLAMYDIA-PNEUMONIAE INFECTION; ACTIVATED PLATELETS; SMOOTH-MUSCLE; MURIDARUM; ATHEROSCLEROSIS; TRACHOMATIS; MECHANISMS; ADHESION; IMMUNITY; EXPRESSION	Systemic bacterial infections elicit inflammatory response that promotes acute or chronic complications such as sepsis, arthritis or atherosclerosis. Of interest, cells in circulation experience hydrodynamic shear forces, which have been shown to be a potent regulator of cellular function in the vasculature and play an important role in maintaining tissue homeostasis. In this study, we have examined the effect of shear forces due to blood flow in modulating the inflammatory response of cells to infection. Using an in vitro model, we analyzed the effects of physiological levels of shear stress on the inflammatory response of monocytes infected with chlamydia, an intracellular pathogen which causes bronchitis and is implicated in the development of atherosclerosis. We found that chlamydial infection alters the morphology of monocytes and trigger the release of pro-inflammatory cytokines TNF-alpha, IL-8, IL-1 beta and IL-6. We also found that the exposure of chlamydia-infected monocytes to short durations of arterial shear stress significantly enhances the secretion of cytokines in a time-dependent manner and the expression of surface adhesion molecule ICAM-1. As a functional consequence, infection and shear stress increased monocyte adhesion to endothelial cells under flow and in the activation and aggregation of platelets. Overall, our study demonstrates that shear stress enhances the inflammatory response of monocytes to infection, suggesting that mechanical forces may contribute to disease pathophysiology. These results provide a novel perspective on our understanding of systemic infection and inflammation.	[Evani, Shankar J.; Montgomery, Robbie K.; Ramasubramanian, Anand K.] Univ Texas San Antonio, Dept Biomed Engn, San Antonio, TX USA; [Murthy, Ashlesh K.; Mareedu, Naresh; Arulanandam, Bernard P.] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA; [Murthy, Ashlesh K.; Arulanandam, Bernard P.; Ramasubramanian, Anand K.] Univ Texas San Antonio, S Texas Ctr Emerging Infect Dis, San Antonio, TX USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA)	Evani, SJ (corresponding author), Univ Texas San Antonio, Dept Biomed Engn, San Antonio, TX USA.	anand.ramasubramanian@utsa.edu	Arulanandam, Bernard P/O-9501-2014; evani, shankar jaikishan/Z-3198-2019		Office of Vice-President of Research, UTSA (AKR BPA); South Central Affiliate of the American Heart Association [10BGIA4330021]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074860] Funding Source: NIH RePORTER	Office of Vice-President of Research, UTSA (AKR BPA); South Central Affiliate of the American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Collaborative Research Seed Grant Program from the Office of Vice-President of Research, UTSA (AKR BPA) and faculty start-up funds (AKR), and partially by Beginning Grant-in-Aid from the South Central Affiliate of the American Heart Association (10BGIA4330021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Bas S, 2008, J IMMUNOL, V180, P1158, DOI 10.4049/jimmunol.180.2.1158; BEATTY WL, 1994, MICROBIOL REV, V58, P686, DOI 10.1128/MMBR.58.4.686-699.1994; Campbell LA, 2004, NAT REV MICROBIOL, V2, P23, DOI 10.1038/nrmicro796; Campbell LA, 2010, MICROBES INFECT, V12, P598, DOI 10.1016/j.micinf.2010.04.001; Cunningham KS, 2005, LAB INVEST, V85, P9, DOI 10.1038/labinvest.3700215; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Dechend R, 1999, CIRCULATION, V100, P1369, DOI 10.1161/01.CIR.100.13.1369; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Fitzgerald JR, 2006, NAT REV MICROBIOL, V4, P445, DOI 10.1038/nrmicro1425; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Gieffers J, 2004, EUR RESPIR J, V23, P506, DOI 10.1183/09031936.04.00093304; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359; Joyee AG, 2007, J IMMUNOL, V178, P1048, DOI 10.4049/jimmunol.178.2.1048; Kaiko GE, 2008, J IMMUNOL, V180, P2225, DOI 10.4049/jimmunol.180.4.2225; Kanda K, 1998, ENDOTHELIUM-J ENDOTH, V6, P33, DOI 10.3109/10623329809053403; Kasirer-Friede A, 2010, BLOOD, V115, P2274, DOI 10.1182/blood-2009-08-238238; Kroll MH, 1996, BLOOD, V88, P1525; Kumar RA, 2006, BIORHEOLOGY, V43, P681; Kumar Y, 2008, CELL HOST MICROBE, V4, P159, DOI 10.1016/j.chom.2008.05.018; KUO CC, 1995, CLIN MICROBIOL REV, V8, P451, DOI 10.1128/CMR.8.4.451; Levi M, 2003, CARDIOVASC RES, V60, P26, DOI 10.1016/S0008-6363(02)00857-X; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li WD, 2007, CLIN VACCINE IMMUNOL, V14, P1537, DOI 10.1128/CVI.00274-07; Liu W, 2006, MICROBES INFECT, V8, P478, DOI 10.1016/j.micinf.2005.07.026; Lynch AS, 2008, ANNU REV MED, V59, P415, DOI 10.1146/annurev.med.59.110106.132000; Mamata Y, 2007, INT J MED MICROBIOL, V297, P109, DOI 10.1016/j.ijmm.2006.11.004; Muhlestein Joseph B., 2003, Cardiology Clinics, V21, P333, DOI 10.1016/S0733-8651(03)00054-7; Netea MG, 2000, EUR J IMMUNOL, V30, P541, DOI 10.1002/1521-4141(200002)30:2<541::AID-IMMU541>3.0.CO;2-X; Nomura S, 2000, CLIN EXP IMMUNOL, V121, P437, DOI 10.1046/j.1365-2249.2000.01324.x; Pawar P, 2004, J IMMUNOL, V173, P1258, DOI 10.4049/jimmunol.173.2.1258; Qiu HY, 2008, J IMMUNOL, V181, P2092, DOI 10.4049/jimmunol.181.3.2092; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schmid-Schonbein GW, 2001, BIORHEOLOGY, V38, P185; Skelding KA, 2006, VACCINE, V24, P355, DOI 10.1016/j.vaccine.2005.07.104; Suchland RJ, 2009, ANTIMICROB AGENTS CH, V53, P4604, DOI 10.1128/AAC.00477-09; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Virok D, 2003, J INFECT DIS, V188, P1310, DOI 10.1086/379047; Wagner DD, 2003, ARTERIOSCL THROM VAS, V23, P2131, DOI 10.1161/01.ATV.0000095974.95122.EC; Watson C, 2008, CLIN SCI, V114, P509, DOI 10.1042/CS20070298; Welter-Stahl L, 2006, CELL MICROBIOL, V8, P1047, DOI 10.1111/j.1462-5822.2006.00686.x	44	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e14492	10.1371/journal.pone.0014492	http://dx.doi.org/10.1371/journal.pone.0014492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249123	Green Submitted, Green Published, gold			2022-12-27	WOS:000286512900001
J	Sadeh, A; Truskanov, N; Mangel, M; Blaustein, L				Sadeh, Asaf; Truskanov, Noa; Mangel, Marc; Blaustein, Leon			Compensatory Development and Costs of Plasticity: Larval Responses to Desiccated Conspecifics	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; TRADE-OFFS; HISTORY; GROWTH; METAMORPHOSIS; SALAMANDRA; CONTEXT; CONSEQUENCES; EVOLUTIONARY; SELECTION	Understanding constraints on phenotypic plasticity is central to explaining its evolution and the evolution of phenotypes in general, yet there is an ongoing debate on the classification and relationships among types of constraints. Since plasticity is often a developmental process, studies that consider the ontogeny of traits and their developmental mechanisms are beneficial. We manipulated the timing and reliability of cues perceived by fire salamander larvae for the future desiccation of their ephemeral pools to determine whether flexibility in developmental rates is constrained to early ontogeny. We hypothesized that higher rates of development, and particularly compensation for contradictory cues, would incur greater endogenous costs. We found that larvae respond early in ontogeny to dried conspecifics as a cue for future desiccation, but can fully compensate for this response in case more reliable but contradictory cues are later perceived. Patterns of mortality suggested that endogenous costs may depend on instantaneous rates of development, and revealed asymmetrical costs of compensatory development between false positive and false negative early information. Based on the results, we suggest a simple model of costs of development that implies a tradeoff between production costs of plasticity and phenotype-environment mismatch costs, which may potentially underlie the phenomenon of ontogenetic windows constraining plasticity.	[Sadeh, Asaf; Blaustein, Leon] Univ Haifa, Fac Nat Sci, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel; [Sadeh, Asaf; Blaustein, Leon] Univ Haifa, Fac Nat Sci, Inst Evolut, IL-31999 Haifa, Israel; [Truskanov, Noa] Univ Haifa, Dept Biol, Fac Nat Sci, IL-31999 Haifa, Israel; [Mangel, Marc] Univ Calif Santa Cruz, Dept Appl Math & Stat, Jack Baskin Sch Engn, Santa Cruz, CA 95064 USA; [Mangel, Marc] Univ Bergen, Dept Biol, Bergen, Norway	University of Haifa; University of Haifa; University of Haifa; University of California System; University of California Santa Cruz; University of Bergen	Sadeh, A (corresponding author), Univ Haifa, Fac Nat Sci, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel.	asaffield@yahoo.com		Sadeh, Asaf/0000-0002-2704-4033	ISF [961-2008]; NSF [EF-0924195]	ISF(Israel Science Foundation); NSF(National Science Foundation (NSF))	This study was funded by ISF grant 961-2008 awarded to LB and Shirli Bar-David. The work of MM was partially supported by NSF grant EF-0924195. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFORD RA, 1988, AM NAT, V131, P91, DOI 10.1086/284775; Altwegg R, 2002, ECOLOGY, V83, P2542, DOI 10.2307/3071813; Arendt J, 2005, FUNCT ECOL, V19, P982, DOI 10.1111/j.1365-2435.2005.01050.x; Auer SK, 2010, ECOL LETT, V13, P998, DOI 10.1111/j.1461-0248.2010.01491.x; Auld JR, 2010, P ROY SOC B-BIOL SCI, V277, P503, DOI 10.1098/rspb.2009.1355; Berg MP, 2010, EVOL ECOL, V24, P617, DOI 10.1007/s10682-009-9347-8; Billerbeck JM, 2001, EVOLUTION, V55, P1863; Bourdeau PE, 2010, OECOLOGIA, V162, P987, DOI 10.1007/s00442-009-1488-5; Callahan HS, 2008, ANN NY ACAD SCI, V1133, P44, DOI 10.1196/annals.1438.008; Day T, 2002, AM NAT, V159, P338, DOI 10.1086/338989; Denver RJ, 1998, ECOLOGY, V79, P1859, DOI 10.1890/0012-9658(1998)079[1859:APIAMR]2.0.CO;2; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Eitam A, 2005, OECOLOGIA, V146, P36, DOI 10.1007/s00442-005-0185-2; Ficetola GF, 2006, EVOL ECOL, V20, P143, DOI 10.1007/s10682-005-5508-6; Gervasi SS, 2008, FUNCT ECOL, V22, P100, DOI 10.1111/j.1365-2435.2007.01340.x; Gilbert S. F., 2009, ECOLOGICAL DEV BIOL; HARRIS RN, 1999, TADPOLES BIOL ANURAN; HENSLEY FR, 1993, ECOLOGY, V74, P2405, DOI 10.2307/1939591; Hoverman JT, 2007, ECOLOGY, V88, P693, DOI 10.1890/05-1697; Inness CLW, 2008, P ROY SOC B-BIOL SCI, V275, P1703, DOI 10.1098/rspb.2008.0357; Kaplan RH, 2006, EVOLUTION, V60, P142; Lane SJ, 2002, J ANIM ECOL, V71, P780, DOI 10.1046/j.1365-2656.2002.00644.x; LEIPS J, 1994, ECOLOGY, V75, P1345, DOI 10.2307/1937459; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Mangel M, 2005, AM NAT, V166, pE155, DOI 10.1086/444439; Marquez-Garcia M, 2009, EVOL ECOL RES, V11, P803; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; O'Laughlin BE, 2000, OECOLOGIA, V124, P343, DOI 10.1007/s004420000392; Padilla DK, 1996, EVOL ECOL, V10, P105, DOI 10.1007/BF01239351; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rose CS, 2005, TRENDS ECOL EVOL, V20, P129, DOI 10.1016/j.tree.2005.01.005; Sadeh A, 2009, ECOL LETT, V12, P1158, DOI 10.1111/j.1461-0248.2009.01371.x; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Shemesh H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010824; Sheridan MA, 1998, AM ZOOL, V38, P350; SMITHGILL SJ, 1979, AM NAT, V113, P563, DOI 10.1086/283413; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Spencer M, 1999, ECOL LETT, V2, P157; Steinfartz S, 2000, MOL ECOL, V9, P397, DOI 10.1046/j.1365-294x.2000.00870.x; Sultan SE, 2007, TRENDS ECOL EVOL, V22, P575, DOI 10.1016/j.tree.2007.06.014; WARBURG MR, 1992, HERPETOL J, V2, P54; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; West-Eberhard Mary Jane, 2003, pi; WILBUR HM, 1973, SCIENCE, V182, P1305, DOI 10.1126/science.182.4119.1305	46	18	19	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15602	10.1371/journal.pone.0015602	http://dx.doi.org/10.1371/journal.pone.0015602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246048	Green Published, Green Submitted, gold			2022-12-27	WOS:000286511200009
J	Stat, M; Bird, CE; Pochon, X; Chasqui, L; Chauka, LJ; Concepcion, GT; Logan, D; Takabayashi, M; Toonen, RJ; Gates, RD				Stat, Michael; Bird, Christopher E.; Pochon, Xavier; Chasqui, Luis; Chauka, Leonard J.; Concepcion, Gregory T.; Logan, Dan; Takabayashi, Misaki; Toonen, Robert J.; Gates, Ruth D.			Variation in Symbiodinium ITS2 Sequence Assemblages among Coral Colonies	PLOS ONE			English	Article							GREAT-BARRIER-REEF; HAPLOTYPE RECONSTRUCTION; SCLERACTINIAN CORALS; ALGAL ENDOSYMBIONTS; CLIMATE-CHANGE; CLADE-D; DIVERSITY; SPECIFICITY; SYMBIONTS; ASSOCIATIONS	Endosymbiotic dinoflagellates in the genus Symbiodinium are fundamentally important to the biology of scleractinian corals, as well as to a variety of other marine organisms. The genus Symbiodinium is genetically and functionally diverse and the taxonomic nature of the union between Symbiodinium and corals is implicated as a key trait determining the environmental tolerance of the symbiosis. Surprisingly, the question of how Symbiodinium diversity partitions within a species across spatial scales of meters to kilometers has received little attention, but is important to understanding the intrinsic biological scope of a given coral population and adaptations to the local environment. Here we address this gap by describing the Symbiodinium ITS2 sequence assemblages recovered from colonies of the reef building coral Montipora capitata sampled across Kane'ohe Bay, Hawai'i. A total of 52 corals were sampled in a nested design of Coral Colony(Site(Region)) reflecting spatial scales of meters to kilometers. A diversity of Symbiodinium ITS2 sequences was recovered with the majority of variance partitioning at the level of the Coral Colony. To confirm this result, the Symbiodinium ITS2 sequence diversity in six M. capitata colonies were analyzed in much greater depth with 35 to 55 clones per colony. The ITS2 sequences and quantitative composition recovered from these colonies varied significantly, indicating that each coral hosted a different assemblage of Symbiodinium. The diversity of Symbiodinium ITS2 sequence assemblages retrieved from individual colonies of M. capitata here highlights the problems inherent in interpreting multi-copy and intra-genomically variable molecular markers, and serves as a context for discussing the utility and biological relevance of assigning species names based on Symbiodinium ITS2 genotyping.	[Stat, Michael; Bird, Christopher E.; Pochon, Xavier; Concepcion, Gregory T.; Toonen, Robert J.; Gates, Ruth D.] Univ Hawaii, Hawaii Inst Marine Biol, Sch Ocean & Earth Sci & Technol, Kaneohe, HI USA; [Chasqui, Luis] Inst Invest Marinas & Costeras Jose Benito Vives, Santa Marta, Colombia; [Chauka, Leonard J.] Univ Dar Es Salaam, Inst Marine Sci, Zanzibar, Tanzania; [Logan, Dan] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Takabayashi, Misaki] Univ Hawaii, Dept Marine Sci, Hilo, HI 96720 USA	University of Hawaii System; University of Dar es Salaam; Victoria University Wellington; University of Hawaii System; University Hawaii Hilo	Stat, M (corresponding author), Univ Hawaii, Hawaii Inst Marine Biol, Sch Ocean & Earth Sci & Technol, Kaneohe, HI USA.	stat@hawaii.edu	Stat, Michael/K-5290-2012; Toonen, Rob/K-2891-2012; Pochon, Xavier/K-5844-2019; Toonen, Rob/V-6230-2019	Toonen, Rob/0000-0001-6339-4340; Toonen, Rob/0000-0001-6339-4340; Pochon, Xavier/0000-0001-9510-0407; Stat, Michael/0000-0002-1663-3422	Edwin Pauley Foundation; Global Environment Facility-World Bank Coral [OCE-0752604, OIA-0554657]; Swiss National Science Foundation [PBGEA-115118]; University of Hawaii [R/CR-16 NA050AR4171048]	Edwin Pauley Foundation; Global Environment Facility-World Bank Coral; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Hawaii	This research was funded by the Edwin Pauley Foundation; the Global Environment Facility-World Bank Coral Reef Targeted Research Project (www.gefcoral.org); the National Science Foundation (OCE-0752604 to RDG and OIA-0554657 administered by University of Hawai'i), the Swiss National Science Foundation (PBGEA-115118 to XP), and University of Hawaii Sea Grant College Program (Project #R/CR-16 NA050AR4171048 to MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego D, 2008, P ROY SOC B-BIOL SCI, V275, P2273, DOI 10.1098/rspb.2008.0180; Apprill AM, 2007, MOL ECOL, V16, P1127, DOI 10.1111/j.1365-294X.2006.03214.x; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Baker AC, 2007, MAR ECOL PROG SER, V335, P237, DOI 10.3354/meps335237; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; Cantin NE, 2009, CORAL REEFS, V28, P405, DOI 10.1007/s00338-009-0478-8; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Concepcion GT, 2008, CORAL REEFS, V27, P323, DOI 10.1007/s00338-007-0323-x; Concepcion GT, 2006, MOL ECOL NOTES, V6, P1208, DOI 10.1111/j.1471-8286.2006.01493.x; Correa AMS, 2009, CORAL REEFS, V28, P437, DOI 10.1007/s00338-008-0464-6; Correa AMS, 2009, CORAL REEFS, V28, P81, DOI 10.1007/s00338-008-0456-6; Correa AMS, 2011, GLOBAL CHANGE BIOL, V17, P68, DOI 10.1111/j.1365-2486.2010.02242.x; Correa AMS, 2009, MAR BIOL, V156, P2403, DOI 10.1007/s00227-009-1263-5; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Frade PR, 2008, CORAL REEFS, V27, P913, DOI 10.1007/s00338-008-0406-3; Garren M, 2006, CORAL REEFS, V25, P503, DOI 10.1007/s00338-006-0146-1; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Goulet TL, 2006, MAR ECOL PROG SER, V321, P1, DOI 10.3354/meps321001; Harrigan RJ, 2008, MOL ECOL RESOUR, V8, P1239, DOI 10.1111/j.1755-0998.2008.02241.x; HECK KL, 1975, ECOLOGY, V56, P1459, DOI 10.2307/1934716; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HOLLAND SM, ANAL RAREFACTION 2 0; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hunter RL, 2007, J PHYCOL, V43, P120, DOI 10.1111/j.1529-8817.2006.00309.x; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; Jarman SN, 2002, MAR BIOTECHNOL, V4, P347, DOI 10.1007/s10126-002-0029-6; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kemp DW, 2008, CORAL REEFS, V27, P289, DOI 10.1007/s00338-007-0333-8; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2004, MAR ECOL PROG SER, V284, P147, DOI 10.3354/meps284147; LaJeunesse TC, 2004, CORAL REEFS, V23, P596, DOI 10.1007/s00338-004-0428-4; LaJeunesse TC, 2003, LIMNOL OCEANOGR, V48, P2046, DOI 10.4319/lo.2003.48.5.2046; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; LaJeunesse TC, 2007, MOL PHYLOGENET EVOL, V45, P417, DOI 10.1016/j.ympev.2007.06.017; LaJeunesse TC, 2010, P ROY SOC B-BIOL SCI, V277, P2925, DOI 10.1098/rspb.2010.0385; LaJeunesse TC, 2009, P ROY SOC B-BIOL SCI, V276, P4139, DOI 10.1098/rspb.2009.1405; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Loh WKW, 2001, MAR ECOL PROG SER, V222, P97, DOI 10.3354/meps222097; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; Mieog JC, 2007, CORAL REEFS, V26, P449, DOI 10.1007/s00338-007-0244-8; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; Oliver TA, 2009, MAR ECOL PROG SER, V378, P93, DOI 10.3354/meps07871; Pochon X, 2007, CORAL REEFS, V26, P867, DOI 10.1007/s00338-007-0279-x; Pochon X, 2001, MAR BIOL, V139, P1069; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; Rodriguez-Lanetty M, 2001, MAR BIOL, V138, P1175; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Sampayo EM, 2007, MOL ECOL, V16, P3721, DOI 10.1111/j.1365-294X.2007.03403.x; Schultz J, 2006, NUCLEIC ACIDS RES, V34, pW704, DOI 10.1093/nar/gkl129; Seibel PN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-498; Seibel Philipp N, 2008, BMC Res Notes, V1, P91, DOI 10.1186/1756-0500-1-91; Selig C, 2008, NUCLEIC ACIDS RES, V36, pD377, DOI 10.1093/nar/gkm827; Shannon C.E., 1963, MATH THEORY COMMUNIC; Stat M, 2008, CORAL REEFS, V27, P763, DOI 10.1007/s00338-008-0412-5; Stat M, 2008, P NATL ACAD SCI USA, V105, P9256, DOI 10.1073/pnas.0801328105; Stat M, 2006, PERSPECT PLANT ECOL, V8, P23, DOI 10.1016/j.ppees.2006.04.001; Stat M, 2009, MAR ECOL PROG SER, V386, P83, DOI 10.3354/meps08080; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; Toller WW, 2001, BIOL BULL, V201, P348, DOI 10.2307/1543613; van Oppen MJH, 2005, CORAL REEFS, V24, P482, DOI 10.1007/s00338-005-0487-1; van Oppen MJH, 2001, P ROY SOC B-BIOL SCI, V268, P1759, DOI 10.1098/rspb.2001.1733; Wright S, 1943, GENETICS, V28, P114	73	77	77	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15854	10.1371/journal.pone.0015854	http://dx.doi.org/10.1371/journal.pone.0015854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246044	Green Published, gold, Green Submitted			2022-12-27	WOS:000286511200022
J	Sanchis-Moysi, J; Idoate, F; Dorado, C; Alayon, S; Calbet, JAL				Sanchis-Moysi, Joaquin; Idoate, Fernando; Dorado, Cecilia; Alayon, Santiago; Calbet, Jose A. L.			Large Asymmetric Hypertrophy of Rectus Abdominis Muscle in Professional Tennis Players	PLOS ONE			English	Article							CROSS-SECTIONAL AREA; TRUNK MUSCLES; MRI; STRENGTH; MASS; ACTIVATION; WRESTLERS; STIFFNESS; SYMMETRY; ANATOMY	Purpose: To determine the volume and degree of asymmetry of the musculus rectus abdominis (RA) in professional tennis players. Methods: The volume of the RA was determined using magnetic resonance imaging (MRI) in 8 professional male tennis players and 6 non-active male control subjects. Results: Tennis players had 58% greater RA volume than controls (P = 0.01), due to hypertrophy of both the dominant (34% greater volume, P = 0.02) and non-dominant (82% greater volume, P = 0.01) sides, after accounting for age, the length of the RA muscle and body mass index (BMI) as covariates. In tennis players, there was a marked asymmetry in the development of the RA, which volume was 35% greater in the non-dominant compared to the dominant side (P<0.001). In contrast, no side-to-side difference in RA volume was observed in the controls (P = 0.75). The degree of side-to-side asymmetry increased linearly from the first lumbar disc to the pubic symphysis (r = 0.97, P<0.001). Conclusions: Professional tennis is associated with marked hypertrophy of the musculus rectus abdominis, which achieves a volume that is 58% greater than in non-active controls. Rectus abdominis hypertrophy is more marked in the non-dominant than in the dominant side, particularly in the more distal regions. Our study supports the concept that humans can differentially recruit both rectus abdominis but also the upper and lower regions of each muscle. It remains to be determined if this disequilibrium raises the risk of injury.	[Sanchis-Moysi, Joaquin; Dorado, Cecilia; Calbet, Jose A. L.] Univ Las Palmas Gran Canaria, Dept Phys Educ, Las Palmas Gran Canaria, Spain; [Idoate, Fernando] Clin San Miguel, Dept Radiol, Pamplona, Spain; [Alayon, Santiago] Hosp San Roque Maspalomas, Dept Diagnost Imaging, Grp San Roque, Maspalomas, Gran Canaria, Spain	Universidad de Las Palmas de Gran Canaria	Sanchis-Moysi, J (corresponding author), Univ Las Palmas Gran Canaria, Dept Phys Educ, Las Palmas Gran Canaria, Spain.	jsanchis@def.ulpgc.es	Cecilia, Dorado-Garcia/B-4586-2010; Idoate Saralegui, Fernando/K-7485-2013; Sanchis-Moysi, Joaquin/B-5561-2012; SANCHIS-MOYSI, JOAQUIN/H-7017-2015; Dorado García, Cecilia/ABC-2792-2021; Calbet, Jose A L/H-6693-2015	Cecilia, Dorado-Garcia/0000-0001-6616-6810; Idoate Saralegui, Fernando/0000-0001-5600-6055; SANCHIS-MOYSI, JOAQUIN/0000-0001-6602-7087; Calbet, Jose A L/0000-0002-9215-6234; antunez, Ariel/0000-0002-2548-7885	Catedra Real Madrid Club de Futbol [2009/04RM]	Catedra Real Madrid Club de Futbol	This study was granted by Catedra Real Madrid Club de Futbol (2009/04RM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alyas F, 2007, BRIT J SPORT MED, V41, P836, DOI 10.1136/bjsm.2007.037747; ANDERSSON E, 1988, MED SCI SPORT EXER, V20, P587; ASKAR OM, 1977, ANN ROY COLL SURG, V59, P313; Bancroft LW, 2007, SEMIN MUSCULOSKEL R, V11, P16, DOI 10.1055/s-2007-984410; Barker KL, 2004, SPINE, V29, pE515, DOI 10.1097/01.brs.0000144405.11661.eb; Barker PJ, 2006, SPINE, V31, P397, DOI 10.1097/01.brs.0000195869.18844.56; Calbet JAL, 1998, CALCIFIED TISSUE INT, V62, P491, DOI 10.1007/s002239900467; Chow John W, 2009, Sports Med Arthrosc Rehabil Ther Technol, V1, P24, DOI 10.1186/1758-2555-1-24; Connell D, 2006, AM J ROENTGENOL, V187, P1457, DOI 10.2214/AJR.04.1929; David P, 2008, J STRENGTH COND RES, V22, P1855, DOI 10.1519/JSC.0b013e31817bd529; Ellenbecker T.S., 1996, ISOKINET EXERC SCI, V6, P15, DOI 10.3233/IES-1996-6103; Elliott B, 2006, BRIT J SPORT MED, V40, P392, DOI 10.1136/bjsm.2005.023150; HAINLINE B, 1995, CLIN SPORT MED, V14, P241; Hides J, 2006, SPINE, V31, pE175, DOI 10.1097/01.brs.0000202740.86338.df; Hides J, 2008, BRIT J SPORT MED, V42, P809, DOI 10.1136/bjsm.2007.044024; Hides JA, 2007, SPINE, V32, P1687, DOI 10.1097/BRS.0b013e318074c386; Hodges PW, 2005, J BIOMECH, V38, P1873, DOI 10.1016/j.jbiomech.2004.08.016; HUTCHINSON MR, 1995, MED SCI SPORT EXER, V27, P826; Ikeda Y, 2009, J STRENGTH COND RES, V23, P2231, DOI 10.1519/JSC.0b013e3181b8676f; Iwai K, 2008, J STRENGTH COND RES, V22, P350, DOI 10.1519/JSC.0b013e3181635d25; KANEHISA H, 1994, EUR J APPL PHYSIOL, V68, P148, DOI 10.1007/BF00244028; Knudson D, 2000, INT J SPORTS MED, V21, P321, DOI 10.1055/s-2000-3776; Kubo J, 2007, J STRENGTH COND RES, V21, P1251; Kubo T, 2010, J STRENGTH COND RES, V24, P1472, DOI 10.1519/JSC.0b013e3181d32eb1; Lee RC, 2000, AM J CLIN NUTR, V72, P796, DOI 10.1093/ajcn/72.3.796; LEHMAN RC, 1988, CLIN SPORT MED, V7, pR11; Maquirriain J, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.036129; Mirka G, 1997, CLIN BIOMECH, V12, P172, DOI 10.1016/S0268-0033(97)00061-2; Moreside JM, 2008, J ELECTROMYOGR KINES, V18, P527, DOI 10.1016/j.jelekin.2007.01.003; Norris C M, 1993, Br J Sports Med, V27, P19; Perez-Gomez J, 2008, EUR J APPL PHYSIOL, V102, P685, DOI 10.1007/s00421-007-0648-8; Rankin G, 2006, MUSCLE NERVE, V34, P320, DOI 10.1002/mus.20589; Sanchis-Moysi J, 2010, INT J SPORTS MED, V31, P416, DOI 10.1055/s-0030-1248331; Sanchis-Moysi J, 2010, SCAND J MED SCI SPOR, V20, P524, DOI 10.1111/j.1600-0838.2009.00969.x; Sanchis-Moysi J, 2010, EUR J APPL PHYSIOL, V110, P83, DOI 10.1007/s00421-010-1470-2; TIMM KE, 1995, ISOKINET EXERC SCI, V5, P43; Urquhart DM, 2005, MANUAL THER, V10, P144, DOI 10.1016/j.math.2004.08.011	37	39	39	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15858	10.1371/journal.pone.0015858	http://dx.doi.org/10.1371/journal.pone.0015858			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209832	Green Published, Green Submitted, gold			2022-12-27	WOS:000285838900043
J	Sproule, TJ; Sled, JG; Wentzell, J; Wang, B; Henkelman, RM; Roopenian, DC; Burgess, RW				Sproule, Thomas J.; Sled, John G.; Wentzell, Jill; Wang, Bing; Henkelman, R. Mark; Roopenian, Derry C.; Burgess, Robert W.			A Mouse Model of Heritable Cerebrovascular Disease	PLOS ONE			English	Article							BINDING-PROTEIN; MUTATIONS; GENE; MALFORMATIONS; KRIT1	The study of animal models of heritable cerebrovascular diseases can improve our understanding of disease mechanisms, identify candidate genes for related human disorders, and provide experimental models for preclinical trials. Here we describe a spontaneous mouse mutation that results in reproducible, adult-onset, progressive, focal ischemia in the brain. The pathology is not the result of hemorrhage, embolism, or an anatomical abnormality in the cerebral vasculature. The mutation maps as a single site recessive locus to mouse Chromosome 9 at 105 Mb, a region of shared synteny with human chromosome 3q22. The genetic interval, defined by recombination mapping, contains seven protein-coding genes and one processed transcript, none of which are changed in their expression level, splicing, or sequence in affected mice. Targeted resequencing of the entire interval did not reveal any provocative changes; thus, the causative molecular lesion has not been identified.	[Sproule, Thomas J.; Wentzell, Jill; Wang, Bing; Roopenian, Derry C.; Burgess, Robert W.] Jackson Lab, Bar Harbor, ME 04609 USA; [Sled, John G.; Henkelman, R. Mark] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada	Jackson Laboratory; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Sproule, TJ (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	Robert.burgess@jax.org	HENKELMAN, MARK/W-6847-2019; Sled, John G/D-8268-2012	Sled, John G/0000-0002-4461-283X; Burgess, Robert/0000-0002-9229-3407	National Institutes of Health [R21 NS051338]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS051338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the National Institutes of Health, R21 NS051338. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; CORTELL S, 1969, J APPL PHYSIOL, V26, P158, DOI 10.1152/jappl.1969.26.1.158; Hassan A, 2000, BRAIN, V123, P1784, DOI 10.1093/brain/123.9.1784; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; Marchuk DA, 2003, HUM MOL GENET, V12, pR97, DOI 10.1093/hmg/ddg103; Marxen M, 2004, MED PHYS, V31, P305, DOI 10.1118/1.1637971; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Urness LD, 2000, NAT GENET, V26, P328, DOI 10.1038/81634; Zawistowski JS, 2002, HUM MOL GENET, V11, P389, DOI 10.1093/hmg/11.4.389	14	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15327	10.1371/journal.pone.0015327	http://dx.doi.org/10.1371/journal.pone.0015327			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217823	Green Published, gold, Green Submitted			2022-12-27	WOS:000285838900019
J	Williams, DS; Bird, MJ; Jorissen, RN; Yu, YL; Walker, F; Zhang, HH; Nice, EC; Burgess, AW				Williams, David S.; Bird, Matthew J.; Jorissen, Robert N.; Yu, Yen Lin; Walker, Franscesa; Zhang, Hui Hua; Nice, Edouard C.; Burgess, Antony W.			Nonsense Mediated Decay Resistant Mutations Are a Source of Expressed Mutant Proteins in Colon Cancer Cell Lines with Microsatellite Instability	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; COLORECTAL-CANCER; FRAMESHIFT-MUTATION; DNA-REPAIR; DATABASE; IDENTIFICATION; ESTABLISHMENT; SURVEILLANCE; INHIBITION; PEPTIDES	Background: Frameshift mutations in microsatellite instability high (MSI-High) colorectal cancers are a potential source of targetable neo-antigens. Many nonsense transcripts are subject to rapid degradation due to nonsense-mediated decay (NMD), but nonsense transcripts with a cMS in the last exon or near the last exon-exon junction have intrinsic resistance to nonsense-mediated decay (NMD). NMD-resistant transcripts are therefore a likely source of expressed mutant proteins in MSI-High tumours. Methods: Using antibodies to the conserved N-termini of predicted mutant proteins, we analysed MSI-High colorectal cancer cell lines for examples of naturally expressed mutant proteins arising from frameshift mutations in coding microsatellites (cMS) by immunoprecipitation and Western Blot experiments. Detected mutant protein bands from NMD-resistant transcripts were further validated by gene-specific short-interfering RNA (siRNA) knockdown. A genome-wide search was performed to identify cMS-containing genes likely to generate NMD-resistant transcripts that could encode for antigenic expressed mutant proteins in MSI-High colon cancers. These genes were screened for cMS mutations in the MSI-High colon cancer cell lines. Results: Mutant protein bands of expected molecular weight were detected in mutated MSI-High cell lines for NMD-resistant transcripts (CREBBP, EP300, TTK), but not NMD-sensitive transcripts (BAX, CASP5, MSH3). Expression of the mutant CREBBP and EP300 proteins was confirmed by siRNA knockdown. Five cMS-bearing genes identified from the genome-wide search and without existing mutation data (SFRS12IP1, MED8, ASXL1, FBXL3 and RGS12) were found to be mutated in at least 5 of 11 (45%) of the MSI-High cell lines tested. Conclusion: NMD-resistant transcripts can give rise to expressed mutant proteins in MSI-High colon cancer cells. If commonly expressed in primary MSI-High colon cancers, MSI-derived mutant proteins could be useful as cancer specific immunological targets in a vaccine targeting MSI-High colonic tumours.	[Williams, David S.; Bird, Matthew J.; Yu, Yen Lin; Walker, Franscesa; Zhang, Hui Hua; Nice, Edouard C.; Burgess, Antony W.] Ludwig Inst Canc Res, Epithelial Biochem Lab, Melbourne Branch, Parkville, Vic, Australia; [Williams, David S.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Williams, David S.] Melbourne Hlth, Dept Anat Pathol, Parkville, Vic, Australia; [Jorissen, Robert N.; Burgess, Antony W.] Ludwig Inst Canc Res, Ludwig Colon Canc Initiat Lab, Melbourne Branch, Parkville, Vic, Australia	Ludwig Institute for Cancer Research; University of Melbourne; Ludwig Institute for Cancer Research	Williams, DS (corresponding author), Ludwig Inst Canc Res, Epithelial Biochem Lab, Melbourne Branch, Parkville, Vic, Australia.	David.Williams@austin.org.au; Tony.Burgess@ludwig.edu.au	Nice, Edouard C/B-1026-2011	Bird, Matthew/0000-0003-3185-0780; Jorissen, Robert/0000-0001-9634-2803	NHMRC Program [487922]; CASS (Contributing to Australian Scholarship & Science) Foundation Science and Medicine Grant; Cancer Council Victoria; Royal College of Pathologists of Australasia of Australasia Kitamura/Kanematsu Memorial Award and Technical Assistance Grant; Victorian Government, Australia	NHMRC Program(National Health and Medical Research Council (NHMRC) of Australia); CASS (Contributing to Australian Scholarship & Science) Foundation Science and Medicine Grant; Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Royal College of Pathologists of Australasia of Australasia Kitamura/Kanematsu Memorial Award and Technical Assistance Grant; Victorian Government, Australia	This project was partially funded by NHMRC Program Grant number 487922. Funding support for this work was also provided by a CASS (Contributing to Australian Scholarship & Science) Foundation Science and Medicine Grant (DSW, AWB, ECN), the Cancer Council Victoria (EN) and a Royal College of Pathologists of Australasia Kitamura/Kanematsu Memorial Award and Technical Assistance Grant (DSW). This work was also supported by funds from the Operational Infrastructure Support Program provided by the Victorian Government, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW SM, 1990, CANCER RES, V50, P5225; Bader SA, 2007, BRIT J CANCER, V96, P660, DOI 10.1038/sj.bjc.6603592; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Boland CR, 1998, CANCER RES, V58, P5248; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Chang EY, 2009, ARCH SURG-CHICAGO, V144, P511, DOI 10.1001/archsurg.2009.40; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cresswell KS, 2005, BIOCHEM BIOPH RES CO, V326, P417, DOI 10.1016/j.bbrc.2004.11.048; Des Guetz G, 2009, EUR J CANCER, V45, P1890, DOI 10.1016/j.ejca.2009.04.018; DREWINKO B, 1976, CANCER RES, V36, P467; Duval A, 2002, ANN GENET-PARIS, V45, P71, DOI 10.1016/S0003-3995(02)01115-2; El-Bchiri J, 2005, HUM MOL GENET, V14, P2435, DOI 10.1093/hmg/ddi245; Engel C, 2010, CLIN GASTROENTEROL H, V8, P174, DOI 10.1016/j.cgh.2009.10.003; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Ionov Y, 2004, ONCOGENE, V23, P639, DOI 10.1038/sj.onc.1207178; Ionov Y, 2004, P NATL ACAD SCI USA, V101, P1273, DOI 10.1073/pnas.0307276101; Ishikawa T, 2003, CANCER RES, V63, P5564; Jenkins MA, 2007, GASTROENTEROLOGY, V133, P48, DOI 10.1053/j.gastro.2007.04.044; Jorissen RN, 2008, CLIN CANCER RES, V14, P8061, DOI 10.1158/1078-0432.CCR-08-1431; KIRKLAND SC, 1985, CANCER RES, V45, P3790; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Linnebacher M, 2001, INT J CANCER, V93, P6, DOI 10.1002/ijc.1298; Linnebacher M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/841451; Lynch HT, 2008, GASTROENTEROLOGY, V134, P1246, DOI 10.1053/j.gastro.2008.02.008; Middleton D, 2003, TISSUE ANTIGENS, V61, P403, DOI 10.1034/j.1399-0039.2003.00062.x; Niv Y, 2007, WORLD J GASTROENTERO, V13, P1767; Ogino S, 2009, CLIN CANCER RES, V15, P6412, DOI 10.1158/1078-0432.CCR-09-1438; Pastor F, 2010, NATURE, V465, P227, DOI 10.1038/nature08999; Phillips SM, 2004, BRIT J SURG, V91, P469, DOI 10.1002/bjs.4472; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Reuschenbach M, 2009, FAM CANC; Ripberger E, 2003, J CLIN IMMUNOL, V23, P415, DOI 10.1023/A:1025329819121; Saeterdal I, 2001, P NATL ACAD SCI USA, V98, P13255, DOI 10.1073/pnas.231326898; Saeterdal I, 2001, CANCER IMMUNOL IMMUN, V50, P469, DOI 10.1007/s002620100222; Schuler Mathias M., 2007, V409, P75; Schwitalle Y, 2008, GASTROENTEROLOGY, V134, P988, DOI 10.1053/j.gastro.2008.01.015; Schwitalle Yvette, 2004, Cancer Immun, V4, P14; Shen LJ, 2004, P NATL ACAD SCI USA, V101, P3035, DOI 10.1073/pnas.0308345101; Speetjens FM, 2008, INT J CANCER, V123, P838, DOI 10.1002/ijc.23570; Stoffel EM, 2008, CANCER PREV RES, V1, P470, DOI 10.1158/1940-6207.CAPR-08-0098; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; TOM BH, 1976, IN VITRO CELL DEV B, V12, P180; Tougeron D, 2009, MODERN PATHOL, V22, P1186, DOI 10.1038/modpathol.2009.80; von Kleist S, 1975, J Natl Cancer Inst, V55, P555; Watanabe T, 2006, CANCER RES, V66, P9804, DOI 10.1158/0008-5472.CAN-06-1163; Weise A, 2010, NUCLEIC ACIDS RES, V38, P1964, DOI 10.1093/nar/gkp1197; Wen J, 2008, BIOCHEM SOC T, V36, P514, DOI 10.1042/BST0360514; WHITEHEAD RH, 1987, CANCER RES, V47, P2683; WHITEHEAD RH, 1991, INT J CANCER, V48, P693, DOI 10.1002/ijc.2910480511; WHITEHEAD RH, 1985, JNCI-J NATL CANCER I, V74, P759; Woerner SM, 2003, ONCOGENE, V22, P2226, DOI 10.1038/sj.onc.1206421; Woerner SM, 2001, INT J CANCER, V93, P12, DOI 10.1002/ijc.1299; Woerner SM, 2010, NUCLEIC ACIDS RES, V38, pD682, DOI 10.1093/nar/gkp839; You KT, 2007, PLOS BIOL, V5, P1098, DOI 10.1371/journal.pbio.0050109; Zhang HH, 2009, INT J CANCER, V125, P297, DOI 10.1002/ijc.24289	57	44	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e16012	10.1371/journal.pone.0016012	http://dx.doi.org/10.1371/journal.pone.0016012			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209843	Green Published, gold			2022-12-27	WOS:000285838900056
J	Pollok, B; Krause, V; Legrain, V; Ploner, M; Freynhagen, R; Melchior, I; Schnitzler, A				Pollok, Bettina; Krause, Vanessa; Legrain, Valery; Ploner, Markus; Freynhagen, Rainer; Melchior, Ilka; Schnitzler, Alfons			Differential Effects of Painful and Non-Painful Stimulation on Tactile Processing in Fibromyalgia Syndrome and Subjects with Masochistic Behaviour	PLOS ONE			English	Article							CO2-LASER STIMULATION; WIDESPREAD PAIN; POTENTIALS; HYPERVIGILANCE; BRAIN; HEAT; PERCEPTION; MODULATION; MECHANISMS; RESPONSES	Background: In healthy subjects repeated tactile stimulation in a conditioning test stimulation paradigm yields attenuation of primary (S1) and secondary (S2) somatosensory cortical activation, whereas a preceding painful stimulus results in facilitation. Methodology/Principal Findings: Since previous data suggest that cognitive processes might affect somatosensory processing in S1, the present study aims at investigating to what extent cortical reactivity is altered by the subjective estimation of pain. To this end, the effect of painful and tactile stimulation on processing of subsequently applied tactile stimuli was investigated in patients with fibromyalgia syndrome (FMS) and in subjects with masochistic behaviour (MB) by means of a 122-channel whole-head magnetoencephalography (MEG) system. Ten patients fulfilling the criteria for the diagnosis of FMS, 10 subjects with MB and 20 control subjects matched with respect to age, gender and handedness participated in the present study. Tactile or brief painful cutaneous laser stimuli were applied as conditioning stimulus (CS) followed by a tactile test stimulus (TS) 500 ms later. While in FMS patients significant attenuation following conditioning tactile stimulation was evident, no facilitation following painful stimulation was found. By contrast, in subjects with MB no attenuation but significant facilitation occurred. Attenuation as well as facilitation applied to cortical responses occurring at about 70 ms but not to early S1 or S2 responses. Additionally, in FMS patients the amount of attenuation was inversely correlated with catastrophizing tendency. Conclusion: The present results imply altered cortical reactivity of the primary somatosensory cortex in FMS patients and MB possibly reflecting differences of individual pain experience.	[Pollok, Bettina; Krause, Vanessa; Schnitzler, Alfons] Univ Dusseldorf, Inst Clin Neurosci & Med Psychol, Dusseldorf, Germany; [Pollok, Bettina; Krause, Vanessa; Schnitzler, Alfons] Univ Dusseldorf, Dept Neurol, D-4000 Dusseldorf, Germany; [Legrain, Valery] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium; [Legrain, Valery] Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium; [Ploner, Markus] Tech Univ Munich, Dept Neurol, Munich, Germany; [Freynhagen, Rainer] Benedictus Krankenhaus Tutzing, Pain Ctr Lake Starnberg, Dept Anaesthesiol Crit Care Med Pain Therapy & Pa, Tutzing, Germany; [Melchior, Ilka] Univ Dusseldorf, Dept Anaesthesiol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Ghent University; Universite Catholique Louvain; Technical University of Munich; Heinrich Heine University Dusseldorf	Pollok, B (corresponding author), Univ Dusseldorf, Inst Clin Neurosci & Med Psychol, Dusseldorf, Germany.	bettina.pollok@uni-duesseldorf.de	Schnitzler, Alfons/AAT-1054-2021; Ploner, Markus/C-3281-2013; Pollok, Bettina/B-5290-2012; Schnitzler, Alfons/Q-5520-2019; Schnitzler, Alfons/K-4625-2014	Ploner, Markus/0000-0002-7767-7170; Schnitzler, Alfons/0000-0002-6414-7939; Schnitzler, Alfons/0000-0002-6414-7939; Freynhagen, Rainer/0000-0002-3759-1508	Volkswagenstiftung [I/80919]; Bundesministerium fur Bildung und Forschung (BMFZ) [01GW0533 (TP 4)]	Volkswagenstiftung(Volkswagen); Bundesministerium fur Bildung und Forschung (BMFZ)(Federal Ministry of Education & Research (BMBF))	The study was funded by the Volkswagenstiftung (I/80919) and by the Bundesministerium fur Bildung und Forschung (BMFZ: 01GW0533 (TP 4)). Please note that the Volkswagenstiftung is a non-commercial funder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APA, 2000, DIAGN STAT MAN MENT; APKARIAN AV, 1994, SOMATOSENS MOT RES, V11, P259, DOI 10.3109/08990229409051393; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Bolanowski SJ, 2000, SOMATOSENS MOT RES, V17, P195; BROMM B, 1984, HUM NEUROBIOL, V3, P33; Carrillo-de-la-Pena MT, 2006, J PAIN, V7, P480, DOI 10.1016/j.jpain.2006.01.452; DeSantana JM, 2008, CURR PAIN HEADACHE R, V12, P338, DOI 10.1007/s11916-008-0057-7; Diers M, 2008, J CLIN NEUROPHYSIOL, V25, P153, DOI 10.1097/WNP.0b013e31817759c5; Dohrenbusch R, 2001, SCHMERZ, V15, P38, DOI 10.1007/s004820170047; Edwards RR, 2006, ARTHRIT RHEUM-ARTHR, V55, P325, DOI 10.1002/art.21865; GIBSON SJ, 1994, PAIN, V58, P185, DOI 10.1016/0304-3959(94)90198-8; Gracely RH, 2004, BRAIN, V127, P835, DOI 10.1093/brain/awh098; Hari R, 1999, PHILOS T R SOC B, V354, P1145, DOI 10.1098/rstb.1999.0470; Hollins M, 1996, PAIN, V67, P89, DOI 10.1016/0304-3959(96)03083-7; Julien N, 2005, PAIN, V114, P295, DOI 10.1016/j.pain.2004.12.032; Kosek E, 1997, PAIN, V70, P41, DOI 10.1016/S0304-3959(96)03295-2; Lautenbacher S, 1997, CLIN J PAIN, V13, P189, DOI 10.1097/00002508-199709000-00003; Laux L, 1981, STATE TRAIT ANGST IN; Legrain V, 2002, PAIN, V99, P21, DOI 10.1016/S0304-3959(02)00051-9; Lorenz J, 2003, NEUROPHYSIOL CLIN, V33, P293, DOI 10.1016/j.neucli.2003.10.004; Lorenz J, 1998, Z RHEUMATOL, V57, P19; McDermid AJ, 1996, PAIN, V66, P133, DOI 10.1016/0304-3959(96)03059-X; Meeus M, 2007, CLIN RHEUMATOL, V26, P465, DOI 10.1007/s10067-006-0433-9; Montoya P, 2006, ARTHRITIS RHEUM-US, V54, P1995, DOI 10.1002/art.21910; Peters ML, 2000, PAIN, V86, P283, DOI 10.1016/S0304-3959(00)00259-1; Ploner M, 2004, J NEUROPHYSIOL, V92, P1825, DOI 10.1152/jn.00260.2004; Rossi A, 1998, NEUROSCI LETT, V248, P155, DOI 10.1016/S0304-3940(98)00354-1; Staud R, 2006, NAT CLIN PRACT RHEUM, V2, P90, DOI 10.1038/ncprheum0091; Staud Roland, 2002, Curr Rheumatol Rep, V4, P299, DOI 10.1007/s11926-002-0038-5; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Tiede W, 2010, PAIN, V148, P36, DOI 10.1016/j.pain.2009.08.029; Tommerdahl M, 1996, J NEUROPHYSIOL, V75, P2662, DOI 10.1152/jn.1996.75.6.2662; Tran TD, 2003, CLIN NEUROPHYSIOL, V114, P1704, DOI 10.1016/S1388-2457(03)00151-2; Williams DA, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2094; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203	35	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15804	10.1371/journal.pone.0015804	http://dx.doi.org/10.1371/journal.pone.0015804			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203391	gold, Green Submitted, Green Published			2022-12-27	WOS:000285792500039
J	Bhatia, S; Fei, MJ; Yarlagadda, M; Qi, ZB; Akira, S; Saijo, S; Iwakura, Y; van Rooijen, N; Gibson, GA; St Croix, CM; Ray, A; Ray, P				Bhatia, Shikha; Fei, Mingjian; Yarlagadda, Manohar; Qi, Zengbiao; Akira, Shizuo; Saijo, Shinobu; Iwakura, Yoichiro; van Rooijen, Nico; Gibson, Gregory A.; St Croix, Claudette M.; Ray, Anuradha; Ray, Prabir			Rapid Host Defense against Aspergillus fumigatus Involves Alveolar Macrophages with a Predominance of Alternatively Activated Phenotype	PLOS ONE			English	Article							BETA-GLUCAN RECEPTOR; CD4(+) T-CELLS; DENDRITIC CELLS; ALLERGIC INFLAMMATION; PNEUMOCYSTIS-CARINII; TYPE-2 INFLAMMATION; CANDIDA-ALBICANS; BINDING PROTEIN; INNATE IMMUNITY; TH2 RESPONSES	The ubiquitous fungus Aspergillus fumigatus is associated with chronic diseases such as invasive pulmonary aspergillosis in immunosuppressed patients and allergic bronchopulmonary aspergillosis (ABPA) in patients with cystic fibrosis or severe asthma. Because of constant exposure to this fungus, it is critical for the host to exercise an immediate and decisive immune response to clear fungal spores to ward off disease. In this study, we observed that rapidly after infection by A. fumigatus, alveolar macrophages predominantly express Arginase 1 (Arg1), a key marker of alternatively activated macrophages (AAMs). The macrophages were also found to express Ym1 and CD206 that are also expressed by AAMs but not NOS2, which is expressed by classically activated macrophages. The expression of Arg1 was reduced in the absence of the known signaling axis, IL-4R alpha/STAT6, for AAM development. While both Dectin-1 and TLR expressed on the cell surface have been shown to sense A. fumigatus, fungus-induced Arg1 expression in CD11c(+) alveolar macrophages was not dependent on either Dectin-1 or the adaptor MyD88 that mediates intracellular signaling by most TLRs. Alveolar macrophages from WT mice efficiently phagocytosed fungal conidia, but those from mice deficient in Dectin-1 showed impaired fungal uptake. Depletion of macrophages with clodronate-filled liposomes increased fungal burden in infected mice. Collectively, our studies suggest that alveolar macrophages, which predominantly acquire an AAM phenotype following A. fumigatus infection, have a protective role in defense against this fungus.	[Bhatia, Shikha; Fei, Mingjian; Yarlagadda, Manohar; Qi, Zengbiao; Ray, Anuradha; Ray, Prabir] Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA; [Fei, Mingjian; Ray, Anuradha; Ray, Prabir] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA; [Akira, Shizuo] WPI Immunol Frontier Res Ctr, Host Def Lab, Osaka, Japan; [Saijo, Shinobu; Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Tokyo, Japan; [Saijo, Shinobu; Iwakura, Yoichiro] Japan Sci & Technol Agcy, CREST, Saitama, Japan; [van Rooijen, Nico] Vrije Univ Amsterdam, Dept Mol Cell Biol, Med Ctr, Amsterdam, Netherlands; [Gibson, Gregory A.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA USA; [St Croix, Claudette M.] Univ Pittsburgh, Sch Med, Dept Environm & Occupat Hlth, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Tokyo; Japan Science & Technology Agency (JST); Vrije Universiteit Amsterdam; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bhatia, S (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA.	rayp@pitt.edu	Iwakura, Yoichiro/E-5457-2011; Van Rooijen, Nico/Z-1578-2019; St Croix, Claudette/AAA-3338-2022; Akira, Shizuo/C-3134-2009	Iwakura, Yoichiro/0000-0002-9934-5775; 	U.S. National Institutes of Health [HL 084932, HL060207, AI 048927, HL 077430]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084932, R01HL060207, R01HL077430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048927] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funding from the U.S. National Institutes of Health grants HL 084932 (to A.R. and P.R.), HL060207 (to P.R.) and AI 048927 and HL 077430 (to A.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Arora M, 2006, P NATL ACAD SCI USA, V103, P7777, DOI 10.1073/pnas.0508492103; Arora S, 2005, J IMMUNOL, V174, P6346, DOI 10.4049/jimmunol.174.10.6346; Bellocchio S, 2004, J IMMUNOL, V172, P3059, DOI 10.4049/jimmunol.172.5.3059; Borsuk P, 1999, ACTA BIOCHIM POL, V46, P391, DOI 10.18388/abp.1999_4172; Bosschaerts T, 2008, J IMMUNOL, V180, P6168, DOI 10.4049/jimmunol.180.9.6168; Bowman JC, 2001, ANTIMICROB AGENTS CH, V45, P3474, DOI 10.1128/AAC.45.12.3474-3481.2001; Bozza S, 2002, J IMMUNOL, V168, P1362, DOI 10.4049/jimmunol.168.3.1362; Donnelly S, 2008, FASEB J, V22, P4022, DOI 10.1096/fj.08-106278; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; Gibson PG, 2006, SEM RESP CRIT CARE M, V27, P185, DOI 10.1055/s-2006-939521; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Herre J, 2004, CRIT REV IMMUNOL, V24, P193, DOI 10.1615/CritRevImmunol.v24.i3.30; Ho Victor W. H., 2009, V531, P173, DOI 10.1007/978-1-59745-396-7_12; Hohl TM, 2007, EUKARYOT CELL, V6, P1953, DOI 10.1128/EC.00274-07; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Jabado N, 2000, J EXP MED, V192, P1237, DOI 10.1084/jem.192.9.1237; Jenkinson CP, 1996, COMP BIOCHEM PHYS B, V114, P107, DOI 10.1016/0305-0491(95)02138-8; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Krishnamoorthy N, 2008, NAT MED, V14, P565, DOI 10.1038/nm1766; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Loke P, 2007, J IMMUNOL, V179, P3926, DOI 10.4049/jimmunol.179.6.3926; Loke P'ng, 2002, BMC Immunol, V3, P7, DOI 10.1186/1471-2172-3-7; Ma J, 2003, CELL MOL LIFE SCI, V60, P2334, DOI 10.1007/s00018-003-3020-0; Mambula SS, 2002, J BIOL CHEM, V277, P39320, DOI 10.1074/jbc.M201683200; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314; Meier A, 2003, CELL MICROBIOL, V5, P561, DOI 10.1046/j.1462-5822.2003.00301.x; MELGERT BN, 2009, AM J RESP CELL MOL B; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Muller U, 2007, J IMMUNOL, V179, P5367, DOI 10.4049/jimmunol.179.8.5367; Munder M, 2005, BLOOD, V105, P2549, DOI 10.1182/blood-2004-07-2521; Munitz A, 2008, J ALLERGY CLIN IMMUN, V122, P1200, DOI 10.1016/j.jaci.2008.10.017; Mylonas KJ, 2009, J IMMUNOL, V182, P3084, DOI 10.4049/jimmunol.0803463; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; Nair MG, 2003, IMMUNOL LETT, V85, P173, DOI 10.1016/S0165-2478(02)00225-0; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Olszewska A, 2007, FUNGAL GENET BIOL, V44, P1285, DOI 10.1016/j.fgb.2007.07.001; Oriss TB, 2005, J IMMUNOL, V174, P854, DOI 10.4049/jimmunol.174.2.854; Park SJ, 2009, CLIN MICROBIOL REV, V22, P535, DOI 10.1128/CMR.00014-09; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000393; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Philippe B, 2003, INFECT IMMUN, V71, P3034, DOI 10.1128/IAI.71.6.3034-3042.2003; QIAN QF, 1994, J IMMUNOL, V152, P5000; Raes G, 2002, J LEUKOCYTE BIOL, V71, P597; Ramaprakash H, 2009, INFECT IMMUN, V77, P108, DOI 10.1128/IAI.00998-08; Rubin-Bejerano I, 2003, P NATL ACAD SCI USA, V100, P11007, DOI 10.1073/pnas.1834481100; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Shirey KA, 2010, MUCOSAL IMMUNOL, V3, P291, DOI 10.1038/mi.2010.6; Steele C, 2003, J EXP MED, V198, P1677, DOI 10.1084/jem.20030932; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Stienstra R, 2008, J BIOL CHEM, V283, P22620, DOI 10.1074/jbc.M710314200; Stutz AM, 2003, J IMMUNOL, V170, P1789, DOI 10.4049/jimmunol.170.4.1789; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Welch JS, 2002, J BIOL CHEM, V277, P42821, DOI 10.1074/jbc.M205873200; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Xu H, 2008, P NATL ACAD SCI USA, V105, P6690, DOI 10.1073/pnas.0708809105; Zhang BC, 2009, J CELL BIOCHEM, V107, P134, DOI 10.1002/jcb.22110; Zhao AP, 2008, GASTROENTEROLOGY, V135, P217, DOI 10.1053/j.gastro.2008.03.077; Zhao AP, 2003, J IMMUNOL, V171, P948, DOI 10.4049/jimmunol.171.2.948	71	75	76	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15943	10.1371/journal.pone.0015943	http://dx.doi.org/10.1371/journal.pone.0015943			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246055	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000286511200026
J	Ritner, C; Wong, SSY; King, FW; Mihardja, SS; Liszewski, W; Erle, DJ; Lee, RJ; Bernstein, HS				Ritner, Carissa; Wong, Sharon S. Y.; King, Frank W.; Mihardja, Shirley S.; Liszewski, Walter; Erle, David J.; Lee, Randall J.; Bernstein, Harold S.			An Engineered Cardiac Reporter Cell Line Identifies Human Embryonic Stem Cell-Derived Myocardial Precursors	PLOS ONE			English	Article							CARDIOMYOCYTES; DIFFERENTIATION; EXPRESSION; HEART; ANTIGEN-1; BIOLOGY	Unlike some organs, the heart is unable to repair itself after injury. Human embryonic stem cells (hESCs) grow and divide indefinitely while maintaining the potential to develop into many tissues of the body. As such, they provide an unprecedented opportunity to treat human diseases characterized by tissue loss. We have identified early myocardial precursors derived from hESCs (hMPs) using an alpha-myosin heavy chain (alpha MHC)-GFP reporter line. We have demonstrated by immunocytochemistry and quantitative real-time PCR (qPCR) that reporter activation is restricted to hESC-derived cardiomyocytes (CMs) differentiated in vitro, and that hMPs give rise exclusively to muscle in an in vivo teratoma formation assay. We also demonstrate that the reporter does not interfere with hESC genomic stability. Importantly, we show that hMPs give rise to atrial, ventricular and specialized conduction CM subtypes by qPCR and microelectrode array analysis. Expression profiling of hMPs over the course of differentiation implicate Wnt and transforming growth factor-beta signaling pathways in CM development. The identification of hMPs using this alpha MHC-GFP reporter line will provide important insight into the pathways regulating human myocardial development, and may provide a novel therapeutic reagent for the treatment of cardiac disease.	[Ritner, Carissa; Wong, Sharon S. Y.; King, Frank W.; Mihardja, Shirley S.; Liszewski, Walter; Erle, David J.; Lee, Randall J.; Bernstein, Harold S.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Erle, David J.; Lee, Randall J.; Bernstein, Harold S.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Lee, Randall J.; Bernstein, Harold S.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA USA; [Bernstein, Harold S.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ritner, C (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	harold.bernstein@ucsf.edu		Ritner, Carissa/0000-0002-4968-6838; Erle, David/0000-0002-2171-0648	NHLBI [HL085377, HL007544]; California Institute for Regenerative Medicine [RC1-00104]; NIH/NCRR UCSF-CTSI [UL1 RR024131]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL085377, T32HL007544] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NIH/NCRR UCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Public Health Service Grant (HL085377) from NHLBI, a Comprehensive Research Grant (RC1-00104) from the California Institute for Regenerative Medicine, and a gift from the Pollin Foundation to H.S.B., and funds from an NIH/NCRR UCSF-CTSI Grant (UL1 RR024131) to D.J.E. S.S.Y.W. and F.W.K. were supported by a National Research Service Award (HL007544) from NHLBI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banach K, 2003, AM J PHYSIOL-HEART C, V284, pH2114, DOI 10.1152/ajpheart.01106.2001; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brade T, 2006, CARDIOVASC RES, V72, P198, DOI 10.1016/j.cardiores.2006.06.025; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Chien KR, 2008, SCIENCE, V322, P1494, DOI 10.1126/science.1163267; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Epting CL, 2004, J CELL SCI, V117, P6185, DOI 10.1242/jcs.01548; Epting CL, 2008, EXP CELL RES, V314, P1125, DOI 10.1016/j.yexcr.2007.11.010; Gaur M, 2010, CYTOTHERAPY, V12, P807, DOI 10.3109/14653249.2010.491821; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Graichen R, 2008, DIFFERENTIATION, V76, P357, DOI 10.1111/j.1432-0436.2007.00236.x; GULICK J, 1991, J BIOL CHEM, V266, P9180; Halbach MD, 2003, CELL PHYSIOL BIOCHEM, V13, P271, DOI 10.1159/000074542; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Huber I, 2007, FASEB J, V21, P2551, DOI 10.1096/fj.05-5711com; Inzunza J, 2004, MOL HUM REPROD, V10, P461, DOI 10.1093/molehr/gah051; King FW, 2009, STEM CELLS DEV, V18, P1441, DOI 10.1089/scd.2009.0012; Kita-Matsuo H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005046; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; NG WA, 1991, CIRC RES, V68, P1742, DOI 10.1161/01.RES.68.6.1742; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Poelmann RE, 2000, CELL TISSUE RES, V301, P43, DOI 10.1007/s004410000227; RITNER C, 2010, JOVE-J VIS EXP, V42, pE2036, DOI DOI 10.3791/2036; SANCHEZ A, 1991, J BIOL CHEM, V266, P22419; Schorpp M, 1996, NUCLEIC ACIDS RES, V24, P1787, DOI 10.1093/nar/24.9.1787; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Suter DM, 2006, STEM CELLS, V24, P615, DOI 10.1634/stemcells.2005-0226; Wong SSY, 2010, REGEN MED, V5, P763, DOI 10.2217/RME.10.52; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91; Xu XQ, 2008, CYTOTHERAPY, V10, P376, DOI 10.1080/14653240802105307; Yoon BS, 2006, DIFFERENTIATION, V74, P149, DOI 10.1111/j.1432-0436.2006.00063.x	35	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2011	6	1							e16004	10.1371/journal.pone.0016004	http://dx.doi.org/10.1371/journal.pone.0016004			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KM	21245908	Green Published, gold, Green Submitted			2022-12-27	WOS:000286510500008
J	Sipos, M; Jeraldo, P; Chia, N; Qu, AI; Dhillon, AS; Konkel, ME; Nelson, KE; White, BA; Goldenfeld, N				Sipos, Maksim; Jeraldo, Patricio; Chia, Nicholas; Qu, Ani; Dhillon, A. Singh; Konkel, Michael E.; Nelson, Karen E.; White, Bryan A.; Goldenfeld, Nigel			Robust Computational Analysis of rRNA Hypervariable Tag Datasets	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MICROBIAL DIVERSITY; SPECIES RICHNESS; PHYLOGENETIC ANALYSES; SECONDARY STRUCTURE; COMMUNITIES; ALGORITHMS; EVOLUTION; DATABASE; NUMBER	Next-generation DNA sequencing is increasingly being utilized to probe microbial communities, such as gastrointestinal microbiomes, where it is important to be able to quantify measures of abundance and diversity. The fragmented nature of the 16S rRNA datasets obtained, coupled with their unprecedented size, has led to the recognition that the results of such analyses are potentially contaminated by a variety of artifacts, both experimental and computational. Here we quantify how multiple alignment and clustering errors contribute to overestimates of abundance and diversity, reflected by incorrect OTU assignment, corrupted phylogenies, inaccurate species diversity estimators, and rank abundance distribution functions. We show that straightforward procedural optimizations, combining preexisting tools, are effective in handling large (10(5)-10(6)) 16S rRNA datasets, and we describe metrics to measure the effectiveness and quality of the estimators obtained. We introduce two metrics to ascertain the quality of clustering of pyrosequenced rRNA data, and show that complete linkage clustering greatly outperforms other widely used methods.	[Sipos, Maksim; Jeraldo, Patricio; Chia, Nicholas; Qu, Ani; White, Bryan A.; Goldenfeld, Nigel] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Sipos, Maksim; Jeraldo, Patricio; Chia, Nicholas; Goldenfeld, Nigel] Univ Illinois, Loomis Lab Phys, Urbana, IL USA; [White, Bryan A.] Univ Illinois, Dept Anim Sci, Urbana, IL USA; [Dhillon, A. Singh] Washington State Univ, Avian Hlth & Food Safety Lab, Puyallup, WA USA; [Konkel, Michael E.] Washington State Univ, Sch Mol Biosci, Puyallup, WA USA; [Nelson, Karen E.] J Craig Venter Inst, Rockville, MD USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Washington State University; Washington State University; J. Craig Venter Institute	Sipos, M (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.	nigel@uiuc.edu	Jeraldo, Patricio/H-8178-2019	Jeraldo, Patricio/0000-0003-0282-4217; Konkel, Michael/0000-0002-8950-0903; Chia, Nicholas/0000-0001-9652-691X	National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service [2005-35212-15287]; Department of Energy [DOE-2005-05818]; National Science Foundation [NSF-EF-0526747]; Institute of Genomic Biology; L.S. Edelheit Family Biological Physics Fellowship	National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Institute of Genomic Biology; L.S. Edelheit Family Biological Physics Fellowship	These studies were supported by the Food Safety Research Response Network, a Coordinated Agricultural Project, funded through the National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service, grant number 2005-35212-15287. Other support was provided by the Department of Energy through grant number DOE-2005-05818 and the National Science Foundation through grant number NSF-EF-0526747. N.C. acknowledges support from the Institute of Genomic Biology Fellows Program. P.J. acknowledges support from the L.S. Edelheit Family Biological Physics Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-57; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Gardner PP, 2005, NUCLEIC ACIDS RES, V33, P2433, DOI 10.1093/nar/gki541; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Huse SM, 2010, ENV MICROBIOLOGY; Krznaric D, 1998, DISCRETE COMPUT GEOM, V19, P131, DOI 10.1007/PL00009332; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Maulik U, 2002, IEEE T PATTERN ANAL, V24, P1650, DOI 10.1109/TPAMI.2002.1114856; May ACW, 2004, STRUCTURE, V12, P737, DOI 10.1016/j.str.2004.04.001; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; Morrison DA, 1997, MOL BIOL EVOL, V14, P428, DOI 10.1093/oxfordjournals.molbev.a025779; Mouillot D, 1999, RES POPUL ECOL, V41, P203; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; OLSEN GJ, 1986, ANNU REV MICROBIOL, V40, P337, DOI 10.1146/annurev.mi.40.100186.002005; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qu A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002945; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Yu YN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-57; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	53	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15220	10.1371/journal.pone.0015220	http://dx.doi.org/10.1371/journal.pone.0015220			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217830	Green Published, Green Submitted, gold			2022-12-27	WOS:000285838900017
J	Georgiadis, A; Tschernutter, M; Bainbridge, JWB; Balaggan, KS; Mowat, F; West, EL; Munro, PMG; Thrasher, AJ; Matter, K; Balda, MS; Ali, RR				Georgiadis, Anastasios; Tschernutter, Marion; Bainbridge, James W. B.; Balaggan, Kamaljit S.; Mowat, Freya; West, Emma L.; Munro, Peter M. G.; Thrasher, Adrian J.; Matter, Karl; Balda, Maria S.; Ali, Robin R.			The Tight Junction Associated Signalling Proteins ZO-1 and ZONAB Regulate Retinal Pigment Epithelium Homeostasis in Mice	PLOS ONE			English	Article							BOX-BINDING PROTEIN; MESENCHYMAL TRANSITION; PROLIFERATIVE VITREORETINOPATHY; DIABETIC-RETINOPATHY; CELL-PROLIFERATION; GENE-EXPRESSION; E-CADHERIN; TRANSCRIPTION; BARRIER; DIFFERENTIATION	Cell-cell adhesion regulates the development and function of epithelia by providing mechanical support and by guiding cell proliferation and differentiation. The tight junction (TJ) protein zonula occludens (ZO)-1 regulates cell proliferation and gene expression by inhibiting the activity of the Y-box transcription factor ZONAB in cultured epithelial cells. We investigated the role of this TJ-associated signalling pathway in the retinal pigment epithelium (RPE) in vivo by lentivirally-mediated overexpression of ZONAB, and knockdown of its cellular inhibitor ZO-1. Both overexpression of ZONAB or knockdown of ZO-1 resulted in increased RPE proliferation, and induced ultrastructural changes of an epithelial-mesenchymal transition (EMT)-like phenotype. Electron microscopy analysis revealed that transduced RPE monolayers were disorganised with increased pyknosis and monolayer breaks, correlating with increased expression of several EMT markers. Moreover, fluorescein angiography analysis demonstrated that the increased proliferation and EMT-like phenotype induced by overexpression of ZONAB or downregulation of ZO-1 resulted in RPE dysfunction. These findings demonstrate that ZO-1 and ZONAB are critical for differentiation and homeostasis of the RPE monolayer and may be involved in RPE disorders such as proliferative vitroretinopathy and atrophic age-related macular degeneration.	[Georgiadis, Anastasios; Tschernutter, Marion; Bainbridge, James W. B.; Balaggan, Kamaljit S.; Mowat, Freya; West, Emma L.; Ali, Robin R.] UCL, Dept Genet, UCL Inst Ophthalmol, London, England; [Matter, Karl; Balda, Maria S.] UCL, Dept Cell Biol, UCL Inst Ophthalmol, London, England; [Munro, Peter M. G.] UCL, Electron Microscopy Unit, UCL Inst Ophthalmol, London, England; [Thrasher, Adrian J.; Ali, Robin R.] UCL, Mol Immunol Unit, UCL Inst Child Hlth, London, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Georgiadis, A (corresponding author), UCL, Dept Genet, UCL Inst Ophthalmol, London, England.	m.balda@ucl.ac.uk; r.ali@ucl.ac.uk	Matter, Karl/C-4880-2008; MOWAT, FREYA/AAD-5102-2021; West, Emma L/C-5252-2013; Georgiadis, Anastasios/G-8777-2012	Matter, Karl/0000-0001-8026-7220; Georgiadis, Anastasios/0000-0001-5079-3588; West, Emma/0000-0002-7006-3686; Ali, Robin/0000-0003-3126-6517; Mowat, Freya/0000-0002-8726-8768; /0000-0002-8427-6746; Thrasher, Adrian/0000-0002-6097-6115; Bainbridge, James/0000-0003-1318-8201	European Union [LSHG-CT-2005-512036]; Medical Research Council; National Institute for Health Research Biomedical Centre for Ophthalmology; BBSRC [BB/H002294/1] Funding Source: UKRI; MRC [G0900098, G0700743, G0400678] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H002294/1] Funding Source: researchfish; Medical Research Council [G0900098, G0700743, G0400678] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1223] Funding Source: researchfish	European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Biomedical Centre for Ophthalmology; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Great Ormond Street Hospital Childrens Charity	This project was supported by the European Union (Integrated Project EVI-GENORET: LSHG-CT-2005-512036), Medical Research Council and the National Institute for Health Research Biomedical Centre for Ophthalmology. JWBB is a Wellcome Trust Advanced Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali RR, 1996, HUM MOL GENET, V5, P591, DOI 10.1093/hmg/5.5.591; Anderson JM, 2004, CURR OPIN CELL BIOL, V16, P140, DOI 10.1016/j.ceb.2004.01.005; Antonetti DA, 1999, J BIOL CHEM, V274, P23463, DOI 10.1074/jbc.274.33.23463; Arakawa Y, 2004, BIOCHEM BIOPH RES CO, V322, P297, DOI 10.1016/j.bbrc.2004.04.208; Bainbridge JWB, 2006, GENE THER, V13, P1191, DOI 10.1038/sj.gt.3302812; Bainbridge JWB, 2001, GENE THER, V8, P1665, DOI 10.1038/sj.gt.3301574; Balda MS, 2000, EMBO J, V19, P2024, DOI 10.1093/emboj/19.9.2024; Balda MS, 2003, TRENDS CELL BIOL, V13, P310, DOI 10.1016/S0962-8924(03)00105-3; Balda MS, 2003, J CELL BIOL, V160, P423, DOI 10.1083/jcb.200210020; Buchert M, 2009, GASTROENTEROLOGY, V137, P156, DOI 10.1053/j.gastro.2009.03.037; Casaroli-Marano RP, 1999, INVEST OPHTH VIS SCI, V40, P2062; Chinnadurai G, 2009, CANCER RES, V69, P731, DOI 10.1158/0008-5472.CAN-08-3349; Defoe DM, 2007, MOL VIS, V13, P273; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Katsuno T, 2008, MOL BIOL CELL, V19, P2465, DOI 10.1091/mbc.E07-12-1215; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; Kroll P, 2007, OPHTHALMOLOGICA, V221, P78, DOI 10.1159/000098253; Leal EC, 2007, INVEST OPHTH VIS SCI, V48, P5257, DOI 10.1167/iovs.07-0112; Lee H, 2007, INVEST OPHTH VIS SCI, V48, P4291, DOI 10.1167/iovs.07-0086; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lima WR, 2010, J AM SOC NEPHROL, V21, P478, DOI 10.1681/ASN.2009070698; Lopes VS, 2007, MOL BIOL CELL, V18, P3914, DOI 10.1091/mbc.E07-03-0268; Matter K, 2007, J CELL SCI, V120, P1505, DOI 10.1242/jcs.005975; Moiseyev G, 2006, J BIOL CHEM, V281, P2835, DOI 10.1074/jbc.M508903200; Pannequin J, 2007, MOL CANCER RES, V5, P1147, DOI 10.1158/1541-7786.MCR-07-0198; Paris L, 2008, BBA-BIOMEMBRANES, V1778, P646, DOI 10.1016/j.bbamem.2007.08.004; Pastor JC, 1998, SURV OPHTHALMOL, V43, P3, DOI 10.1016/S0039-6257(98)00023-X; Pena C, 2006, INT J CANCER, V119, P2098, DOI 10.1002/ijc.22083; Rizzolo LJ, 2007, INT REV CYTOL, V258, P195, DOI 10.1016/S0074-7696(07)58004-6; Sanchez-Tillo E, 2010, ONCOGENE, V29, P3490, DOI 10.1038/onc.2010.102; Sourisseau T, 2006, MOL CELL BIOL, V26, P2387, DOI 10.1128/MCB.26.6.2387-2398.2006; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Tamiya S, 2010, INVEST OPHTH VIS SCI, V51, P2755, DOI 10.1167/iovs.09-4725; Tsapara A, 2006, MOL BIOL CELL, V17, P1322, DOI 10.1091/mbc.E05-06-0507; Tschernutter M, 2005, GENE THER, V12, P694, DOI 10.1038/sj.gt.3302460; Wu KHC, 2003, BRIT J OPHTHALMOL, V87, P1159, DOI 10.1136/bjo.87.9.1159; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	40	81	84	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15730	10.1371/journal.pone.0015730	http://dx.doi.org/10.1371/journal.pone.0015730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209887	Green Published, Green Submitted, gold			2022-12-27	WOS:000285793600031
J	Peters, R; Wolf, MJ; van den Broek, M; Nuvolone, M; Dannenmann, S; Stieger, B; Rapold, R; Konrad, D; Rubin, A; Bertino, JR; Aguzzi, A; Heikenwalder, M; Knuth, AK				Peters, Rowayda; Wolf, Monika J.; van den Broek, Maries; Nuvolone, Mario; Dannenmann, Stefanie; Stieger, Bruno; Rapold, Reto; Konrad, Daniel; Rubin, Arnold; Bertino, Joseph R.; Aguzzi, Adriano; Heikenwalder, Mathias; Knuth, Alexander K.			Efficient Generation of Multipotent Mesenchymal Stem Cells from Umbilical Cord Blood in Stroma-Free Liquid Culture	PLOS ONE			English	Article							EX-VIVO EXPANSION; MOBILIZED PERIPHERAL-BLOOD; HUMAN-BONE-MARROW; PROGENITOR CELLS; CRITICAL PARAMETERS; UNRELATED DONOR; SELF-RENEWAL; ADULT; TRANSPLANTATION; EXPRESSION	Background: Haematopoiesis is sustained by haematopoietic (HSC) and mesenchymal stem cells (MSC). HSC are the precursors for blood cells, whereas marrow, stroma, bone, cartilage, muscle and connective tissues derive from MSC. The generation of MSC from umbilical cord blood (UCB) is possible, but with low and unpredictable success. Here we describe a novel, robust stroma-free dual cell culture system for long-term expansion of primitive UCB-derived MSC. Methods and Findings: UCB-derived mononuclear cells (MNC) or selected CD34(+) cells were grown in liquid culture in the presence of serum and cytokines. Out of 32 different culture conditions that have been tested for the efficient expansion of HSC, we identified one condition (DMEM, pooled human AB serum, Flt-3 ligand, SCF, MGDF and IL-6; further denoted as D7) which, besides supporting HSC expansion, successfully enabled long-term expansion of stromal/MSC from 8 out of 8 UCB units (5 MNC-derived and 3 CD34(+) selected cells). Expanded MSC displayed a fibroblast-like morphology, expressed several stromal/MSC-related antigens (CD105, CD73, CD29, CD44, CD133 and Nestin) but were negative for haematopoietic cell markers (CD45, CD34 and CD14). MSC stemness phenotype and their differentiation capacity in vitro before and after high dilution were preserved throughout long-term culture. Even at passage 24 cells remained Nestin(+), CD133(+) and > 95% were positive for CD105, CD73, CD29 and CD44 with the capacity to differentiate into mesodermal lineages. Similarly we show that UCB derived MSC express pluripotency stem cell markers despite differences in cell confluency and culture passages. Further, we generated MSC from peripheral blood (PB) MNC of 8 healthy volunteers. In all cases, the resulting MSC expressed MSC-related antigens and showed the capacity to form CFU-F colonies. Conclusions: This novel stroma-free liquid culture overcomes the existing limitation in obtaining MSC from UCB and PB enabling so far unmet therapeutic applications, which might substantially affect clinical practice.	[Peters, Rowayda; van den Broek, Maries; Dannenmann, Stefanie; Knuth, Alexander K.] Univ Zurich Hosp, Clin Oncol, CH-8091 Zurich, Switzerland; [Wolf, Monika J.; Nuvolone, Mario; Aguzzi, Adriano; Heikenwalder, Mathias] Univ Zurich Hosp, Dept Pathol, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Stieger, Bruno] Univ Zurich Hosp, Dept Med, Inst Clin Pharmacol, CH-8091 Zurich, Switzerland; [Stieger, Bruno] Univ Zurich Hosp, Dept Med, Inst Toxicol, CH-8091 Zurich, Switzerland; [Rapold, Reto; Konrad, Daniel] Univ Childrens Hosp, Div Diabetol & Endocrinol, Zurich, Switzerland; [Rubin, Arnold; Bertino, Joseph R.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Nuvolone, Mario] Univ Pavia, Dept Internal Med, Amyloid Ctr, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, Italy; [Heikenwalder, Mathias] Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Virol, Munich, Germany	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University Children's Hospital Zurich; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; IRCCS Fondazione San Matteo; University of Pavia; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Peters, R (corresponding author), Univ Zurich Hosp, Clin Oncol, CH-8091 Zurich, Switzerland.	rowayda.peters@gmail.com	knuth, alexander/H-2608-2014; Stieger, Bruno/U-6323-2017; Aguzzi, Adriano/A-3351-2008; van den Broek, Maries/L-6532-2019; Heikenwalder, Mathias/AAA-2269-2020; Nuvolone, Mario/K-4763-2018; van den Broek, Maries/G-4128-2016	knuth, alexander/0000-0002-9318-2784; Stieger, Bruno/0000-0002-7190-5785; Nuvolone, Mario/0000-0001-8334-1684; Konrad, Daniel/0000-0001-9067-4356; Aguzzi, Adriano/0000-0002-0344-6708; van den Broek, Maries/0000-0002-9489-3692	Oncosuisse [OCS 02113-08-2007]; Roche Research Foundation; Atlantic Philanthropies, Cancer Research Institute; Stiftung fur Forschung der Onkologie (SFO); Collegio Ghislieri, Pavia, Italy; European Research Council; Novartis Research Foundation	Oncosuisse; Roche Research Foundation; Atlantic Philanthropies, Cancer Research Institute; Stiftung fur Forschung der Onkologie (SFO); Collegio Ghislieri, Pavia, Italy; European Research Council(European Research Council (ERC)European Commission); Novartis Research Foundation	This work was supported by Prof. Dr. Max-Cloetta, the Oncosuisse (OCS 02113-08-2007) (M.H.), the Roche Research Foundation (M.J.W.), Atlantic Philanthropies, Cancer Research Institute and Stiftung fur Forschung der Onkologie (SFO). M.N. was partly supported by an investigator fellowship of Collegio Ghislieri, Pavia, Italy. A.A. was supported by an Advanced Grant of the European Research Council and by a generous grant of the Novartis Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo-Mazzucato C, 2010, NAT REV ENDOCRINOL, V6, P139, DOI 10.1038/nrendo.2009.274; Baal N, 2004, THROMB HAEMOSTASIS, V92, P767, DOI 10.1160/TH04-02-0079; Bieback K, 2004, STEM CELLS, V22, P625, DOI 10.1634/stemcells.22-4-625; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Bron D, 2008, B CANCER, V95, P314, DOI 10.1684/bdc.2008.0589; BRUGGER W, 1995, NEW ENGL J MED, V333, P283, DOI 10.1056/NEJM199508033330503; CASTROMALASPINA H, 1980, BLOOD, V56, P289; Cho KA, 2009, CELL BIOL INT, V33, P772, DOI 10.1016/j.cellbi.2009.04.023; Fang BJ, 2009, ANN HEMATOL, V88, P261, DOI 10.1007/s00277-008-0599-0; Fehrer C, 2005, EXP GERONTOL, V40, P926, DOI 10.1016/j.exger.2005.07.006; Florek M, 2005, CELL TISSUE RES, V319, P15, DOI 10.1007/s00441-004-1018-z; FRIEDENSTEIN AJ, 1992, BONE MINER, V18, P199, DOI 10.1016/0169-6009(92)90807-P; Harris DT, 2008, STEM CELL REV, V4, P269, DOI 10.1007/s12015-008-9039-8; He QL, 2007, STEM CELLS, V25, P69, DOI 10.1634/stemcells.2006-0335; Hematti Peiman, 2008, Transplant Rev (Orlando), V22, P262, DOI 10.1016/j.trre.2008.05.002; Hough R, 2009, BRIT J HAEMATOL, V147, P593, DOI 10.1111/j.1365-2141.2009.07841.x; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kulterer B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-70; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Liu CH, 2005, CYTOKINE, V32, P270, DOI 10.1016/j.cyto.2005.11.003; Loges S, 2004, STEM CELLS DEV, V13, P229, DOI 10.1089/154732804323099163; MacMillan ML, 2009, BONE MARROW TRANSPL, V43, P447, DOI 10.1038/bmt.2008.348; Mareschi K, 2001, HAEMATOLOGICA, V86, P1099; Nguyen VA, 2009, J CELL MOL MED, V13, P522, DOI 10.1111/j.1582-4934.2008.00340.x; Novotny NM, 2008, CYTOKINE, V43, P215, DOI 10.1016/j.cyto.2008.05.015; Oda M, 2009, INT J HEMATOL, V89, P374, DOI 10.1007/s12185-009-0266-9; Perdikogianni C, 2008, CYTOTHERAPY, V10, P452, DOI 10.1080/14653240701883079; Perey L, 1998, BRIT J HAEMATOL, V103, P618, DOI 10.1046/j.1365-2141.1998.01062.x; Peters R, 1998, BLOOD, V92, P2041, DOI 10.1182/blood.V92.6.2041.418k34_2041_2052; Peters R, 2002, BRIT J HAEMATOL, V119, P792, DOI 10.1046/j.1365-2141.2002.03873.x; Piacibello W, 1999, BLOOD, V93, P3736, DOI 10.1182/blood.V93.11.3736.411k01_3736_3749; Piacibello W, 1997, BLOOD, V89, P2644, DOI 10.1182/blood.V89.8.2644; Poloni A, 2008, CYTOTHERAPY, V10, P690, DOI 10.1080/14653240802419310; Pozzi S, 2006, EXP HEMATOL, V34, P934, DOI 10.1016/j.exphem.2006.03.007; Rebelatto CK, 2008, EXP BIOL MED, V233, P901, DOI 10.3181/0712-RM-356; Rocha V, 2004, CURR OPIN HEMATOL, V11, P375, DOI 10.1097/01.moh.0000145933.36985.eb; Rojewski MT, 2008, TRANSFUS MED HEMOTH, V35, P168, DOI 10.1159/000129013; Salven P, 2003, BLOOD, V101, P168, DOI 10.1182/blood-2002-03-0755; Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182; Semenov OV, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.869; Sensebe L, 2010, VOX SANG, V98, P93, DOI 10.1111/j.1423-0410.2009.01227.x; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Solves P, 2008, CRYOBIOLOGY, V56, P152, DOI 10.1016/j.cryobiol.2008.02.002; Stieger B, 2006, SWISS MED WKLY, V136, P552; Sueblinvong V, 2009, CURR OPIN PHARMACOL, V9, P268, DOI 10.1016/j.coph.2009.03.002; Tondreau T, 2005, STEM CELLS, V23, P1105, DOI 10.1634/stemcells.2004-0330; Valtieri M, 2008, J CELL PHYSIOL, V217, P296, DOI 10.1002/jcp.21521; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Wagner W, 2010, TISSUE ENG PART B-RE, V16, P445, DOI [10.1089/ten.teb.2009.0825, 10.1089/ten.TEB.2009.0825]; Wexler SA, 2003, BRIT J HAEMATOL, V121, P368, DOI 10.1046/j.1365-2141.2003.04284.x; Yao CL, 2004, EXP HEMATOL, V32, P720, DOI 10.1016/j.exphem.2004.05.021; Zeddou M, 2010, CELL BIOL INT, V34, P693, DOI 10.1042/CBI20090414	52	22	31	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15689	10.1371/journal.pone.0015689	http://dx.doi.org/10.1371/journal.pone.0015689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209896	gold, Green Published, Green Accepted			2022-12-27	WOS:000285793600028
J	Schwank, S; Sutherland, CJ; Drakeley, CJ				Schwank, Samana; Sutherland, Colin J.; Drakeley, Chris J.			Promiscuous Expression of alpha-Tubulin II in Maturing Male and Female Plasmodium falciparum Gametocytes	PLOS ONE			English	Article							HUMAN MALARIA PARASITE; SEX-RATIO; SEQUENCE-ANALYSIS; COMMITMENT; PROTEIN; PFG377; GENES; STAGE; DENSITY	Background: Antimalarial interventions designed to impact on the transmissible sexual stages of Plasmodium falciparum are evaluated by measurement of peripheral gametocyte carriage in vivo and infectivity to mosquitoes. Drug or vaccine-elicited effects may differentially affect the relative abundance of mature male and female sexual forms, and this can be measured by estimation of sex ratios before and after intervention in vivo and in vitro. Measuring the impact of anti-gametocyte drugs on sexual commitment of immature gametocyte stages in vitro is not currently possible as male and female parasites cannot be distinguished by morphology alone prior to stage IV. Methodology/Principal Findings: We have modified an existing immunofluorescence-based approach for distinguishing male and female gametocytes during development in vitro, by using highly synchronised magnetically-enriched gametocyte preparations at different stages of maturity. Antibodies recognising alpha-tubulin II ( males) and Pfg377 ( females) were used to attempt to discriminate the sexes. Transcription of these two proteins was not coordinated during in vitro development, with pfg377 transcripts accumulating only late in development, immediately prior to immunofluorescent signals from the PfG377 protein appearing in stage IV gametocytes. Contrary to previous descriptions of this protein as male-specific in P. falciparum, alpha-tubulin II recognised both male and female gametocytes at stages I to IV, but evidence of differential expression levels of this protein in late stage male and female gametocytes was found. Using antibodies recognising PfG377 as the primary marker and alpha-tubulin II as a secondary marker, robust estimates of sex ratio in in vitro cultures were obtained for gametocytes at stage IV or later, and validated by light microscopic counts. However, sex ratio estimation was not possible for early stage gametocytes due to the promiscuity of alpha-tubulin II protein expression, and the relatively late accumulation of PfG377 during the development process. Conclusions/Significance: This approach is a feasible method for the evaluation of drug impacts on late-stage gametocyte sex ratio in in vitro studies. Additional sex-specific antigens need to be evaluated for sex ratio estimation in early stage gametocyte preparations.	[Schwank, Samana; Sutherland, Colin J.; Drakeley, Chris J.] London Sch Hyg & Trop Med, Dept Immunol & Infect, Fac Infect & Trop Dis, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Schwank, S (corresponding author), London Sch Hyg & Trop Med, Dept Immunol & Infect, Fac Infect & Trop Dis, London WC1, England.	colin.sutherland@lshtm.ac.uk	Sutherland, Colin/AAN-3939-2020	Sutherland, Colin/0000-0003-1592-6407	Europaeischer Landersverein der Industrie; UK Health Protection Agency; Wellcome Trust [063516]	Europaeischer Landersverein der Industrie; UK Health Protection Agency; Wellcome Trust(Wellcome TrustEuropean Commission)	The work was supported by a PhD Studentship to SS, awarded by the Europaeischer Landersverein der Industrie. CJS was supported by the UK Health Protection Agency. CJD was supported by Wellcome Trust grant #063516. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alano P, 1995, MOL BIOCHEM PARASIT, V74, P143, DOI 10.1016/0166-6851(95)02491-3; BAKER DA, 1995, MOL BIOCHEM PARASIT, V72, P193, DOI 10.1016/0166-6851(95)00073-A; Bell A, 1998, PARASITOL TODAY, V14, P234, DOI 10.1016/S0169-4758(98)01246-0; BRUCE MC, 1990, PARASITOLOGY, V100, P191, DOI 10.1017/S0031182000061199; Carter R, 1993, Methods Mol Biol, V21, P67; de Koning-Ward TF, 2008, MOL MICROBIOL, V67, P278, DOI 10.1111/j.1365-2958.2007.06039.x; DELVES CJ, 1990, MOL BIOCHEM PARASIT, V43, P271, DOI 10.1016/0166-6851(90)90151-B; Drew DR, 2007, MOL BIOCHEM PARASIT, V156, P199, DOI 10.1016/j.molbiopara.2007.08.004; Fennell BJ, 2008, INT J PARASITOL, V38, P527, DOI 10.1016/j.ijpara.2007.09.005; Field J., 1956, MICROSCOPIC DIAGNOSI, V2; Fivelman QL, 2007, MOL BIOCHEM PARASIT, V154, P119, DOI 10.1016/j.molbiopara.2007.04.008; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Guinet F, 1996, J CELL BIOL, V135, P269, DOI 10.1083/jcb.135.1.269; HOLLOWAY SP, 1990, MOL BIOCHEM PARASIT, V43, P257, DOI 10.1016/0166-6851(90)90150-K; HOLLOWAY SP, 1989, MOL MICROBIOL, V3, P1501, DOI 10.1111/j.1365-2958.1989.tb00136.x; Khan SM, 2005, CELL, V121, P675, DOI 10.1016/j.cell.2005.03.027; Kooij TWA, 2005, MOL BIOCHEM PARASIT, V144, P16, DOI 10.1016/j.molbiopara.2005.07.003; McRobert L, 2004, INFECT IMMUN, V72, P6597, DOI 10.1128/IAI.72.11.6597-6602.2004; MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203; Mitri C, 2009, P ROY SOC B-BIOL SCI, V276, P3721, DOI 10.1098/rspb.2009.0962; Peatey CL, 2009, J INFECT DIS, V200, P1518, DOI 10.1086/644645; RAWLINGS DJ, 1992, MOL BIOCHEM PARASIT, V56, P239, DOI 10.1016/0166-6851(92)90173-H; Reece SE, 2008, NATURE, V453, P609, DOI 10.1038/nature06954; Ribaut C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-45; Saeed M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002280; Severini C, 1999, MOL BIOCHEM PARASIT, V100, P247, DOI 10.1016/S0166-6851(99)00050-X; Silvestrini F, 2000, PARASITOLOGY, V121, P465, DOI 10.1017/S0031182099006691; SINDEN RE, 1982, PARASITOLOGY, V84, P1, DOI 10.1017/S003118200005160X; Smith TG, 2000, PARASITOLOGY, V121, P127, DOI 10.1017/S0031182099006265; Sowunmi A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-297; Sowunmi A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-169; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; van Schaijk BCL, 2006, MOL BIOCHEM PARASIT, V149, P216, DOI 10.1016/j.molbiopara.2006.05.015; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700	34	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e14470	10.1371/journal.pone.0014470	http://dx.doi.org/10.1371/journal.pone.0014470			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209927	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000285793600012
J	Cherif, A; Barley, K				Cherif, Alhaji; Barley, Kamal			Cliophysics: Socio-Political Reliability Theory, Polity Duration and African Political (In)stabilities	PLOS ONE			English	Article							GLOBAL ANALYSIS; CIVIL-WAR; CONFLICT; DEMOCRACY; REPRESSION; PEACE	Quantification of historical sociological processes have recently gained attention among theoreticians in the effort of providing a solid theoretical understanding of the behaviors and regularities present in socio-political dynamics. Here we present a reliability theory of polity processes with emphases on individual political dynamics of African countries. We found that the structural properties of polity failure rates successfully capture the risk of political vulnerability and instabilities in which 87.50%, 75%, 71.43%, and 0% of the countries with monotonically increasing, unimodal, U-shaped and monotonically decreasing polity failure rates, respectively, have high level of state fragility indices. The quasi-U-shape relationship between average polity duration and regime types corroborates historical precedents and explains the stability of the autocracies and democracies.	[Cherif, Alhaji] Univ Oxford, Math Inst, Oxford, England; [Cherif, Alhaji; Barley, Kamal] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ USA	University of Oxford; Arizona State University; Arizona State University-Tempe	Cherif, A (corresponding author), Univ Oxford, Math Inst, Oxford, England.	alhaji.cherif@maths.ox.ac.uk	Barley, Kamal/GLT-3930-2022; Barley, Kamal K/F-9579-2011	Barley, Kamal K/0000-0003-1874-9813; Cherif, Alhaji/0000-0001-8654-2772	National Science Foundation; Louis Stokes Alliances for Minority Participation Fellowships; ASU Graduate College; Sloan Graduate Fellowships	National Science Foundation(National Science Foundation (NSF)); Louis Stokes Alliances for Minority Participation Fellowships; ASU Graduate College; Sloan Graduate Fellowships	The authors were supported in part by National Science Foundation through a Graduate Research Fellowship (to A. C.) and Louis Stokes Alliances for Minority Participation Fellowships (to A. C., K. B.), ASU Graduate College Doctoral Enrichment Fellowship (to A. C.), and Sloan Graduate Fellowships (to A. C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvinen J, 1997, J PEACE RES, V34, P496; Bratton Michael., 1997, DEMOCRATIC EXPT AFRI; CASPER G, 1996, NEGOTIATING DEMOCRAC, P287; CHERIF A, 2008, THESIS CORNELL U ITH; Collett D, 1994, MODELLING SURVIVAL D; Collier P, 1998, OXFORD ECON PAP, V50, P563, DOI 10.1093/oep/50.4.563; Ellingsen T, 2000, J CONFLICT RESOLUT, V44, P228, DOI 10.1177/0022002700044002004; Ellingsen T., 1997, CAUSES CONFLICT 3 WO, P69; FRANCISCO RA, 1995, J CONFLICT RESOLUT, V39, P263, DOI 10.1177/0022002795039002003; GURR TR, 1993, INT POLIT SCI REV, V14, P161, DOI 10.1177/019251219301400203; GURR TR, 1974, AM POLIT SCI REV, V68, P1482, DOI 10.2307/1959937; Hauge W, 1998, J PEACE RES, V35, P299, DOI 10.1177/0022343398035003003; Heldt B, 1997, J PEACE RES, V34, P101, DOI 10.1177/0022343397034001008; Hibbs D., 1973, MASS POLITICAL VIOLE; Horowitz Donald L., 1993, CHALLENGE ETHNIC CON, V4, P18; Huntington Samuel P., 1991, 3 WAVE DEMOCRATIZATI; JAGGERS K, 1995, J PEACE RES, V32, P469, DOI 10.1177/0022343395032004007; Krain M, 1997, INT INTERACT, V23, P109, DOI 10.1080/03050629708434903; LEVY J, HDB WAR STUDIES, P259; LICHBACH MI, 1987, J CONFLICT RESOLUT, V31, P266, DOI 10.1177/0022002787031002003; Lichbach MI, 1995, REBELS DILEMMA EC CO; Marshall M., 2010, POLITY 4 PROJECT POL; Moore WH, 1998, AM J POLIT SCI, V42, P851, DOI 10.2307/2991732; MULLER EN, 1990, J CONFLICT RESOLUT, V34, P624, DOI 10.1177/0022002790034004003; ROBERT GKJ, 1989, POLICY 2 CODEBOOK; VanHanen T, 1999, J PEACE RES, V36, P55, DOI 10.1177/0022343399036001004; Vanhanen T, 2000, J PEACE RES, V37, P251, DOI 10.1177/0022343300037002008; Ward MD, 1998, AM POLIT SCI REV, V92, P51, DOI 10.2307/2585928; Zanger SC, 2000, J PEACE RES, V37, P213, DOI 10.1177/0022343300037002006	29	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15169	10.1371/journal.pone.0015169	http://dx.doi.org/10.1371/journal.pone.0015169			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	701CZ	21206911	Green Submitted, gold, Green Published			2022-12-27	WOS:000285793200017
J	Lu, Y; Li, XQ; Lu, HQ; Fan, Z				Lu, Yang; Li, Xinqun; Lu, Haiquan; Fan, Zhen			1, 9-Pyrazoloanthrones Downregulate HIF-1 alpha and Sensitize Cancer Cells to Cetuximab-Mediated Anti-EGFR Therapy	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; METASTATIC COLORECTAL-CANCER; INDUCIBLE FACTOR 1-ALPHA; N-TERMINAL KINASE; PLATINUM-BASED CHEMOTHERAPY; PHASE-II MULTICENTER; ANTITUMOR-ACTIVITY; GENE-EXPRESSION; MUTATION STATUS; KRAS MUTATIONS	Cetuximab, a monoclonal antibody that blocks the epidermal growth factor receptor (EGFR), is currently approved for the treatment of several types of solid tumors. We previously showed that cetuximab can inhibit hypoxia-inducible factor-1 alpha (HIF-1 alpha) protein synthesis by inhibiting the activation of EGFR downstream signaling pathways including Erk, Akt, and mTOR. 1, 9-pyrazoloanthrone (1, 9 PA) is an anthrapyrazolone compound best known as SP600125 that specifically inhibits c-jun N-terminal kinase (JNK). Here, we report 1, 9 PA can downregulate HIF-1 alpha independently of its inhibition of JNK. This downregulatory effect was abolished when the oxygen-dependent domain (ODD) of HIF-1 alpha (HIF-1 alpha-DODD, the domain responsible for HIF-1 alpha degradation) was experimentally deleted or when the activity of HIF-1a prolyl hydroxylase (PHD) or the 26S proteasomal complex was inhibited, indicating that the 1, 9 PA downregulates HIF-1 alpha by promoting PHD-dependent HIF-1 alpha degradation. We found that the combination of 1, 9 PA and cetuximab worked synergistically to induce apoptosis in cancer cells in which cetuximab or 1, 9 PA alone had no or only weak apoptotic activity. This synergistic effect was substantially decreased in cancer cells transfected with HIF-1 alpha-DODD, indicating that downregulation of HIF-1 alpha was the mechanism of this synergistic effect. More importantly, 1, 9 PA can downregulate HIF-1 alpha in cancer cells that are insensitive to cetuximab-induced inhibition of HIF-1 alpha expression due to overexpression of oncogenic Ras (RasG12V). Our findings suggest that 1, 9 PA is a lead compound of a novel class of drugs that may be used to enhance the response of cancer cells to cetuximab through a complementary effect on the downregulation of HIF-1 alpha.	[Lu, Yang; Li, Xinqun; Lu, Haiquan; Fan, Zhen] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Lu, Y (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA.	zfan@mdanderson.org			National Institutes of Health [5R01CA129036]; Center for Targeted Therapy of The University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [R01CA129036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Targeted Therapy of The University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a National Institutes of Health award 5R01CA129036 (to Z.F.) and a grant from the Center for Targeted Therapy of The University of Texas MD Anderson Cancer Center (to Z.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Baselga J, 2005, J CLIN ONCOL, V23, P5568, DOI 10.1200/JCO.2005.07.119; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Frattini M, 2007, BRIT J CANCER, V97, P1139, DOI 10.1038/sj.bjc.6604009; Freeman DJ, 2008, CLIN COLORECTAL CANC, V7, P184, DOI 10.3816/CCC.2008.n.024; Giaccia A, 2003, NAT REV DRUG DISCOV, V2, P803, DOI 10.1038/nrd1199; Han ZN, 2001, J CLIN INVEST, V108, P73, DOI 10.1172/JCI12466; Harari PM, 2009, SEMIN RADIAT ONCOL, V19, P63, DOI 10.1016/j.semradonc.2008.09.009; Herbst RS, 2005, J CLIN ONCOL, V23, P5578, DOI 10.1200/JCO.2005.07.120; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jhawer M, 2008, CANCER RES, V68, P1953, DOI 10.1158/0008-5472.CAN-07-5659; Jimeno A, 2009, J CLIN ONCOL, V27, P1130, DOI 10.1200/JCO.2008.19.8168; Jin W, 2003, BRIT J CANCER, V89, P185, DOI 10.1038/sj.bjc.6601048; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Karashima T, 2002, CLIN CANCER RES, V8, P1253; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Lee E, 2002, MOL CELLS, V14, P9; Li X, 2006, ONCOGENE, V25, P525, DOI 10.1038/sj.onc.1209075; Li XQ, 2008, MOL CANCER THER, V7, P1207, DOI 10.1158/1535-7163.MCT-07-2187; Li XQ, 2010, CANCER RES, V70, P5942, DOI 10.1158/0008-5472.CAN-10-0157; Li XQ, 2005, BREAST CANCER RES, V7, pR589, DOI 10.1186/bcr1259; Liang K, 2003, MOL CANCER THER, V2, P1113; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Liu B, 2000, BRIT J CANCER, V82, P1991; Lu Y, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-63; Luwor RB, 2005, ONCOGENE, V24, P4433, DOI 10.1038/sj.onc.1208625; Mazure NM, 1997, BLOOD, V90, P3322, DOI 10.1182/blood.V90.9.3322; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Semenza GL, 2009, CURR PHARM DESIGN, V15, P3839, DOI 10.2174/138161209789649402; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Vermorken JB, 2007, J CLIN ONCOL, V25, P2171, DOI 10.1200/JCO.2006.06.7447; Zhong H, 2000, CANCER RES, V60, P1541; Zundel W, 2000, GENE DEV, V14, P391; 2009, N ENGL J MED, V360, P1408; 2007, BR J CANC, V96, P1166	44	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15823	10.1371/journal.pone.0015823	http://dx.doi.org/10.1371/journal.pone.0015823			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209911	Green Submitted, Green Published, gold			2022-12-27	WOS:000285793200059
J	Stockholm, D; Edom-Vovard, F; Coutant, S; Sanatine, P; Yamagata, Y; Corre, G; Le Guillou, L; Thi, MANN; Paldi, A				Stockholm, Daniel; Edom-Vovard, Frederique; Coutant, Sophie; Sanatine, Peggy; Yamagata, Yoshiaki; Corre, Guillaume; Le Guillou, Laurent; Thi My Anh Neildez-Nguyen; Paldi, Andras			Bistable Cell Fate Specification as a Result of Stochastic Fluctuations and Collective Spatial Cell Behaviour	PLOS ONE			English	Article							GENE-EXPRESSION; STEM-CELLS; IN-VITRO; DIFFERENTIATION; NOISE; HETEROGENEITY; EQUILIBRIUM; PLASTICITY; DYNAMICS; MEMORY	Background: In culture, isogenic mammalian cells typically display enduring phenotypic heterogeneity that arises from fluctuations of gene expression and other intracellular processes. This diversity is not just simple noise but has biological relevance by generating plasticity. Noise driven plasticity was suggested to be a stem cell-specific feature. Results: Here we show that the phenotypes of proliferating tissue progenitor cells such as primary mononuclear muscle cells can also spontaneously fluctuate between different states characterized by the either high or low expression of the muscle-specific cell surface molecule CD56 and by the corresponding high or low capacity to form myotubes. Although this capacity is a cell-intrinsic property, the cells switch their phenotype under the constraints imposed by the highly heterogeneous microenvironment created by their own collective movement. The resulting heterogeneous cell population is characterized by a dynamic equilibrium between "high CD56" and "low CD56" phenotype cells with distinct spatial distribution. Computer simulations reveal that this complex dynamic is consistent with a context-dependent noise driven bistable model where local microenvironment acts on the cellular state by encouraging the cell to fluctuate between the phenotypes until the low noise state is found. Conclusions: These observations suggest that phenotypic fluctuations may be a general feature of any non-terminally differentiated cell. The cellular microenvironment created by the cells themselves contributes actively and continuously to the generation of fluctuations depending on their phenotype. As a result, the cell phenotype is determined by the joint action of the cell-intrinsic fluctuations and by collective cell-to-cell interactions.	[Stockholm, Daniel; Edom-Vovard, Frederique; Coutant, Sophie; Sanatine, Peggy; Yamagata, Yoshiaki; Corre, Guillaume; Thi My Anh Neildez-Nguyen; Paldi, Andras] Genethon, Evry, France; [Coutant, Sophie; Yamagata, Yoshiaki; Corre, Guillaume; Thi My Anh Neildez-Nguyen; Paldi, Andras] Univ Evry Val dEssonne, INSERM, U951, Evry, France; [Coutant, Sophie; Yamagata, Yoshiaki; Corre, Guillaume; Thi My Anh Neildez-Nguyen; Paldi, Andras] Ecole Prat Hautes Etud, UMR951, Evry, France; [Le Guillou, Laurent] Univ Paris 06, LAPNE, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite	Stockholm, D (corresponding author), Genethon, Evry, France.	paldi@genethon.fr	Neildez, Thi My Anh/J-6900-2013; Le Guillou, Laurent/B-7712-2009; corre, guillaume/T-9696-2019; Le Guillou, Laurent/Q-6886-2019; Paldi, Andras/J-5757-2013; Stockholm, Daniel/J-7912-2013	Le Guillou, Laurent/0000-0001-7178-8868; corre, guillaume/0000-0002-0755-8336; Le Guillou, Laurent/0000-0001-7178-8868; Coutant, Sophie/0000-0003-1255-8418	"Region Ile-de-France," "Conseil General de l'Essonne," "Genopole Recherche" of Evry, the University of " Evry Val d'Essonne"; "Fondation pour la Recherche Medicale" (Paris); AXA Research Fellowship	"Region Ile-de-France," "Conseil General de l'Essonne," "Genopole Recherche" of Evry, the University of " Evry Val d'Essonne"(Region Ile-de-France); "Fondation pour la Recherche Medicale" (Paris)(Fondation pour la Recherche Medicale); AXA Research Fellowship(AXA Research Fund)	This study was supported in part by equipment funds from "Region Ile-de-France," "Conseil General de l'Essonne," "Genopole Recherche" of Evry, the University of " Evry Val d'Essonne" and from the "Fondation pour la Recherche Medicale" (Paris). GC is a recipient of an AXA Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Khalil R, 2009, CELL STEM CELL, V5, P298, DOI 10.1016/j.stem.2009.06.001; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Benchaouir R, 2007, CYTOM PART A, V71A, P251, DOI 10.1002/cyto.a.20367; Brock A, 2009, NAT REV GENET, V10, P336, DOI 10.1038/nrg2556; Capkovic KL, 2008, EXP CELL RES, V314, P1553, DOI 10.1016/j.yexcr.2008.01.021; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chang HH, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-11; EDOM F, 1994, DEV BIOL, V164, P219, DOI 10.1006/dbio.1994.1193; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; Furusawa C, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040003; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hoffmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002922; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Iezzi S, 2002, P NATL ACAD SCI USA, V99, P7757, DOI 10.1073/pnas.112218599; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; KANEKO K, 1994, PHYSICA D, V75, pR7, DOI 10.1016/0167-2789(94)90271-2; Kashiwagi A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000049; KUPIEC JJ, 1983, SPECULAT SCI TECHNOL, V6, P471; Laforge B, 2005, PROG BIOPHYS MOL BIO, V89, P93, DOI 10.1016/j.pbiomolbio.2004.11.004; Neildez-Nguyen TMA, 2008, DIFFERENTIATION, V76, P33, DOI 10.1111/j.1432-0436.2007.00219.x; Orkin SH, 2002, NAT IMMUNOL, V3, P323, DOI 10.1038/ni0402-323; Paldi A, 2003, CELL MOL LIFE SCI, V60, P1775, DOI 10.1007/s00018-003-23147-z; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Stockholm D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000394; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Wang L, 2009, P NATL ACAD SCI USA, V106, P6638, DOI 10.1073/pnas.0806137106; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	32	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14441	10.1371/journal.pone.0014441	http://dx.doi.org/10.1371/journal.pone.0014441			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203432	Green Published, Green Submitted, gold			2022-12-27	WOS:000285792500017
J	Murphy, S; Martin, S; Parton, RG				Murphy, Samantha; Martin, Sally; Parton, Robert G.			Quantitative Analysis of Lipid Droplet Fusion: Inefficient Steady State Fusion but Rapid Stimulation by Chemical Fusogens	PLOS ONE			English	Article							PROTEIN-KINASE INHIBITORS; CHOLESTEROL; TRANSPORT; PERILIPIN; LIPOLYSIS; CAVEOLIN; SIZE; PROPRANOLOL; ASSOCIATION; MECHANISM	Lipid droplets (LDs) are dynamic cytoplasmic organelles containing neutral lipids and bounded by a phospholipid monolayer. Previous studies have suggested that LDs can undergo constitutive homotypic fusion, a process linked to the inhibitory effects of fatty acids on glucose transporter trafficking. Using strict quantitative criteria for LD fusion together with refined light microscopic methods and real-time analysis, we now show that LDs in diverse cell types show low constitutive fusogenic activity under normal growth conditions. To investigate the possible modulation of LD fusion, we screened for agents that can trigger fusion. A number of pharmacological agents caused homotypic fusion of lipid droplets in a variety of cell types. This provided a novel cell system to study rapid regulated fusion between homotypic phospholipid monolayers. LD fusion involved an initial step in which the two adjacent membranes became continuous (< 10 s), followed by the slower merging (100 s) of the neutral lipid cores to produce a single spherical LD. These fusion events were accompanied by changes to the LD surface organization. Measurements of LDs undergoing homotypic fusion showed that fused LDs maintained their initial volume, with a corresponding decrease in surface area suggesting rapid removal of membrane from the fused LD. This study provides estimates for the level of constitutive LD fusion in cells and questions the role of LD fusion in vivo. In addition, it highlights the extent of LD restructuring which occurs when homotypic LD fusion is triggered in a variety of cell types.	[Murphy, Samantha] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Murphy, S (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	s.martin@uq.edu.au; R.Parton@imb.uq.edu.au	Parton, Robert G/C-5673-2009; Martin, Sally/A-7150-2010	Parton, Robert G/0000-0002-7494-5248; Martin, Sally/0000-0001-9294-5404	National Health and Medical Research Council of Australia [455865]; Diabetes Australia; Australian Cancer Research Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia; Australian Cancer Research Foundation	This work was supported by grants from the National Health and Medical Research Council of Australia to RGP and SM (grant number 455865) and from Diabetes Australia to SM. Confocal microscopy was performed at the ACRF/IMB Dynamic Imaging Facility for Cancer Biology, established with funding from the Australian Cancer Research Foundation. The Institute for Molecular Bioscience is a Special Research Centre of the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Binns D, 2006, J CELL BIOL, V173, P719, DOI 10.1083/jcb.200511125; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Bostrom P, 2005, ARTERIOSCL THROM VAS, V25, P1945, DOI 10.1161/01.ATV.0000179676.41064.d4; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Brown DA, 2001, CURR BIOL, V11, pR446, DOI 10.1016/S0960-9822(01)00257-3; CHONG PL, 1989, BIOCHEMISTRY-US, V28, P8358, DOI 10.1021/bi00447a014; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; De Carlo S, 2004, J LIPOSOME RES, V14, P61, DOI 10.1081/LPR-120039704; Eastman SW, 2009, J CELL BIOL, V184, P881, DOI 10.1083/jcb.200808041; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; FROST SC, 1985, J BIOL CHEM, V260, P2646; Fukumoto S, 2002, HISTOCHEM CELL BIOL, V118, P423, DOI 10.1007/s00418-002-0462-7; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; HERBETTE LG, 1986, BIOPHYS J, V49, P91, DOI 10.1016/S0006-3495(86)83605-0; Hoffmann C, 2004, N-S ARCH PHARMACOL, V369, P151, DOI 10.1007/s00210-003-0860-y; Kellner-Weibel G, 2001, J LIPID RES, V42, P768; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Le Lay S, 2006, TRAFFIC, V7, P549, DOI 10.1111/j.1600-0854.2006.00406.x; LIU P, 2007, BIOCHIM BIOPHYS ACTA, V1173, P784; MAK IT, 1988, CIRC RES, V63, P262, DOI 10.1161/01.RES.63.1.262; Martin S, 2005, J BIOL CHEM, V280, P42325, DOI 10.1074/jbc.M506651200; Miyoshi H, 2008, J CELL BIOCHEM, V105, P1430, DOI 10.1002/jcb.21964; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; MURPHY S, 2008, BIOCHIM BIOPHYS ACTA, V1791, P441; Nagayama M, 2007, J LIPID RES, V48, P9, DOI 10.1194/jlr.M600155-JLR200; Olsen MK, 1998, J CELL PHYSIOL, V176, P525, DOI 10.1002/(SICI)1097-4652(199809)176:3<525::AID-JCP9>3.0.CO;2-Q; Ozeki S, 2005, J CELL SCI, V118, P2601, DOI 10.1242/jcs.02401; Pol A, 2005, MOL BIOL CELL, V16, P2091, DOI 10.1091/mbc.E04-08-0737; Pol A, 2004, MOL BIOL CELL, V15, P99, DOI 10.1091/mbc.E03-06-0368; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Sturmey RG, 2006, REPRODUCTION, V132, P829, DOI 10.1530/REP-06-0073; SUREWICZ KW, 1981, BIOCHEM PHARMACOL, V30, P839, DOI 10.1016/S0006-2952(81)80004-4; Targett-Adams P, 2003, J BIOL CHEM, V278, P15998, DOI 10.1074/jbc.M211289200; Turro S, 2006, TRAFFIC, V7, P1254, DOI 10.1111/j.1600-0854.2006.00465.x; Valetti C, 1999, MOL BIOL CELL, V10, P4107, DOI 10.1091/mbc.10.12.4107; Vereshchagina N, 2008, J CELL SCI, V121, P3383, DOI 10.1242/jcs.035220; Welte MA, 2005, CURR BIOL, V15, P1266, DOI 10.1016/j.cub.2005.06.062; Welte MA, 2009, BIOCHEM SOC T, V37, P991, DOI 10.1042/BST0370991; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Yamaguchi T, 2007, J LIPID RES, V48, P1078, DOI 10.1194/jlr.M600493-JLR200; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	45	68	70	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15030	10.1371/journal.pone.0015030	http://dx.doi.org/10.1371/journal.pone.0015030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203462	Green Submitted, Green Published, gold			2022-12-27	WOS:000285579200012
J	Dalken, B; Jabulowsky, RA; Oberoi, P; Benhar, I; Wels, WS				Daelken, Benjamin; Jabulowsky, Robert A.; Oberoi, Pranav; Benhar, Itai; Wels, Winfried S.			Maltose-Binding Protein Enhances Secretion of Recombinant Human Granzyme B Accompanied by In Vivo Processing of a Precursor MBP Fusion Protein	PLOS ONE			English	Article							YEAST PICHIA-PASTORIS; HIGH-LEVEL EXPRESSION; CODON USAGE BIAS; ESCHERICHIA-COLI; METHYLOTROPHIC YEAST; ANTIBODIES; RECEPTOR; SYSTEM; PURIFICATION; ERBB2/HER2	Background: The apoptosis-inducing serine protease granzyme B (GrB) is an important factor contributing to lysis of target cells by cytotoxic lymphocytes. Expression of enzymatically active GrB in recombinant form is a prerequisite for functional analysis and application of GrB for therapeutic purposes. Methods and Findings: We investigated the influence of bacterial maltose-binding protein (MBP) fused to GrB via a synthetic furin recognition motif on the expression of the MBP fusion protein also containing an N-terminal alpha-factor signal peptide in the yeast Pichia pastoris. MBP markedly enhanced the amount of GrB secreted into culture supernatant, which was not the case when GrB was fused to GST. MBP-GrB fusion protein was cleaved during secretion by an endogenous furin-like proteolytic activity in vivo, liberating enzymatically active GrB without the need of subsequent in vitro processing. Similar results were obtained upon expression of a recombinant fragment of the ErbB2/HER2 receptor protein or GST as MBP fusions. Conclusions: Our results demonstrate that combination of MBP as a solubility enhancer with specific in vivo cleavage augments secretion of processed and functionally active proteins from yeast. This strategy may be generally applicable to improve folding and increase yields of recombinant proteins.	[Daelken, Benjamin; Jabulowsky, Robert A.; Oberoi, Pranav; Wels, Winfried S.] Chemotherapeut Forschungsinst Georg Speyer Haus, Frankfurt, Germany; [Benhar, Itai] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, Ramat Aviv, Israel	Tel Aviv University	Dalken, B (corresponding author), Chemotherapeut Forschungsinst Georg Speyer Haus, Frankfurt, Germany.	wels@em.uni-frankfurt.de		Benhar, Itai/0000-0002-0824-7177; Wels, Winfried/0000-0001-9858-3643	Deutsche Forschungsgemeinschaft [DFG WE 2589/2-1]; DFG Graduiertenkolleg [GRK 1172]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG Graduiertenkolleg(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft, DFG WE 2589/2-1 and DFG Graduiertenkolleg GRK 1172. The funding agency had no role in conducting the study and in preparing the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bach H, 2001, J MOL BIOL, V312, P79, DOI 10.1006/jmbi.2001.4914; Biburger M, 2005, J MOL BIOL, V346, P1299, DOI 10.1016/j.jmb.2004.12.052; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; Cullen SP, 2008, CELL DEATH DIFFER, V15, P251, DOI 10.1038/sj.cdd.4402244; Dalken B, 2006, CELL DEATH DIFFER, V13, P576, DOI 10.1038/sj.cdd.4401773; DIGUAN C, 1988, GENE, V67, P21, DOI 10.1016/0378-1119(88)90004-2; Ehrmann M, 1998, MOL MICROBIOL, V29, P685, DOI 10.1046/j.1365-2958.1998.00915.x; Fahnert B, 2004, ADV BIOCHEM ENG BIOT, V89, P93; FULLER RS, 1989, SCIENCE, V246, P482, DOI 10.1126/science.2683070; Gerstmayer B, 1997, FEBS LETT, V407, P63, DOI 10.1016/S0014-5793(97)00294-9; Gerstmayer B, 1997, J IMMUNOL, V158, P4584; Giesubel U, 2006, BIOCHEM J, V394, P563, DOI 10.1042/BJ20050687; HARWERTH IM, 1992, J BIOL CHEM, V267, P15160; Hayhurst A, 2000, PROTEIN EXPRES PURIF, V18, P1, DOI 10.1006/prep.1999.1164; Hoves S, 2010, J LEUKOCYTE BIOL, V87, P237, DOI 10.1189/jlb.0909608; Jacquet A, 1999, PROTEIN EXPRES PURIF, V17, P392, DOI 10.1006/prep.1999.1150; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Krysan DJ, 1999, J BIOL CHEM, V274, P23229, DOI 10.1074/jbc.274.33.23229; LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187; Li ZG, 2010, PROTEIN EXPRES PURIF, V72, P113, DOI 10.1016/j.pep.2010.03.004; Pham CTN, 1998, J BIOL CHEM, V273, P1629, DOI 10.1074/jbc.273.3.1629; Pham CTN, 1999, P NATL ACAD SCI USA, V96, P8627, DOI 10.1073/pnas.96.15.8627; POWER RF, 1990, J BIOL CHEM, V265, P1419; Pryor KD, 1997, PROTEIN EXPRES PURIF, V10, P309, DOI 10.1006/prep.1997.0759; Rohrbach F, 2005, J IMMUNOL, V174, P5481, DOI 10.4049/jimmunol.174.9.5481; Rosenblum MG, 2009, CURR PHARM DESIGN, V15, P2676, DOI 10.2174/138161209788923958; SAMUELSSON E, 1994, BIOCHEMISTRY-US, V33, P4207, DOI 10.1021/bi00180a013; Shaki-Loewenstein S, 2005, J IMMUNOL METHODS, V303, P19, DOI 10.1016/j.jim.2005.05.004; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Sinclair G, 2002, PROTEIN EXPRES PURIF, V26, P96, DOI 10.1016/S1046-5928(02)00526-0; Sorensen HP, 2003, PROTEIN EXPRES PURIF, V32, P252, DOI 10.1016/j.pep.2003.07.001; Sun JR, 1999, BIOCHEM BIOPH RES CO, V261, P251, DOI 10.1006/bbrc.1999.0989; Tudyka T, 1997, PROTEIN SCI, V6, P2180; UHLEN M, 1992, Current Opinion in Biotechnology, V3, P363, DOI 10.1016/0958-1669(92)90164-E; van Dongen JJM, 1999, LEUKEMIA, V13, P1901, DOI 10.1038/sj.leu.2401592; VANDEVEN WJM, 1990, MOL BIOL REP, V14, P265, DOI 10.1007/BF00429896; Yoda T, 2000, J MED VIROL, V60, P475, DOI 10.1002/(SICI)1096-9071(200004)60:4<475::AID-JMV17>3.0.CO;2-B; Zhang Y, 1998, PROTEIN EXPRES PURIF, V12, P159, DOI 10.1006/prep.1997.0834	40	15	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14404	10.1371/journal.pone.0014404	http://dx.doi.org/10.1371/journal.pone.0014404			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203542	gold, Green Submitted, Green Published			2022-12-27	WOS:000285578000011
J	Guo, JE; Hall, KD				Guo, Juen; Hall, Kevin D.			Predicting Changes of Body Weight, Body Fat, Energy Expenditure and Metabolic Fuel Selection in C57BL/6 Mice	PLOS ONE			English	Article							THERMOGENESIS; OBESITY; MASS	The mouse is an important model organism for investigating the molecular mechanisms of body weight regulation, but a quantitative understanding of mouse energy metabolism remains lacking. Therefore, we created a mathematical model of mouse energy metabolism to predict dynamic changes of body weight, body fat, energy expenditure, and metabolic fuel selection. Based on the principle of energy balance, we constructed ordinary differential equations representing the dynamics of body fat mass (FM) and fat-free mass (FFM) as a function of dietary intake and energy expenditure (EE). The EE model included the cost of tissue deposition, physical activity, diet-induced thermogenesis, and the influence of FM and FFM on metabolic rate. The model was calibrated using previously published data and validated by comparing its predictions to measurements in five groups of male C57/BL6 mice (N = 30) provided ad libitum access to either chow or high fat diets for varying time periods. The mathematical model accurately predicted the observed body weight and FM changes. Physical activity was predicted to decrease immediately upon switching from the chow to the high fat diet and the model coefficients relating EE to FM and FFM agreed with previous independent estimates. Metabolic fuel selection was predicted to depend on a complex interplay between diet composition, the degree of energy imbalance, and body composition. This is the first validated mathematical model of mouse energy metabolism and it provides a quantitative framework for investigating energy balance relationships in mouse models of obesity and diabetes.	[Guo, Juen; Hall, Kevin D.] NIDDKD, Lab Biol Modeling, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Guo, JE (corresponding author), NIDDKD, Lab Biol Modeling, Bethesda, MD 20892 USA.	kevinh@niddk.nih.gov	Hall, Kevin/F-2383-2010	Hall, Kevin/0000-0003-4062-3133; Guo, Juen/0000-0003-2876-5884	NIH, NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK013038] Funding Source: NIH RePORTER	NIH, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the NIH, NIDDK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arch JRS, 2006, INT J OBESITY, V30, P1322, DOI 10.1038/sj.ijo.0803280; Bjursell M, 2008, AM J PHYSIOL-ENDOC M, V294, pE251, DOI 10.1152/ajpendo.00401.2007; Butler AA, 2010, DIABETES, V59, P323, DOI 10.2337/db09-1471; Cannon B, 2009, P NUTR SOC, V68, P401, DOI 10.1017/S0029665109990255; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Chow CC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000045; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Geweke J., 1992, BAYESIAN STAT, V4, P169, DOI DOI 10.21034/SR.148; Golozoubova V, 2004, MOL ENDOCRINOL, V18, P384, DOI 10.1210/me.2003-0267; Gregory P., 2005, BAYESIAN LOGICAL DAT; Guo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000511; Guo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005370; Hall KD, 2008, INT J OBESITY, V32, P573, DOI 10.1038/sj.ijo.0803720; Hall KD, 2006, AM J PHYSIOL-ENDOC M, V291, pE23, DOI 10.1152/ajpendo.00523.2005; Hall KD, 2010, BRIT J NUTR, V104, P4, DOI 10.1017/S0007114510000206; Hall KD, 2010, IEEE ENG MED BIOL, V29, P36, DOI 10.1109/MEMB.2009.935465; Hall KD, 2010, AM J PHYSIOL-ENDOC M, V298, pE449, DOI 10.1152/ajpendo.00559.2009; Hall KD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007940; Hall KD, 2009, CELL METAB, V9, P3, DOI 10.1016/j.cmet.2008.12.006; Hall KD, 2008, AM J CLIN NUTR, V88, P1495, DOI 10.3945/ajcn.2008.26333; HimmsHagen J, 1997, SCIENCE, V276, P1132, DOI 10.1126/science.276.5315.1132; Kaiyala KJ, 2010, DIABETES, V59, P1657, DOI 10.2337/db09-1582; Kleiber M., 1975, FIRE LIFE INTRO ANIM; Kozak LP, 2010, CELL METAB, V11, P263, DOI 10.1016/j.cmet.2010.03.009; Longo KA, 2010, AM J PHYSIOL-REG I, V298, pR747, DOI 10.1152/ajpregu.00476.2009; NELSON KM, 1992, AM J CLIN NUTR, V56, P848, DOI 10.1093/ajcn/56.5.848; TAM J, 2008, CELL METABOLISM	27	46	46	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15961	10.1371/journal.pone.0015961	http://dx.doi.org/10.1371/journal.pone.0015961			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246038	gold, Green Submitted, Green Published			2022-12-27	WOS:000286511200029
J	Bellistri, GM; Casabianca, A; Merlini, E; Orlandi, C; Ferrario, G; Meroni, L; Galli, M; Magnani, M; Monforte, AD; Marchetti, G				Bellistri, Giusi Maria; Casabianca, Anna; Merlini, Esther; Orlandi, Chiara; Ferrario, Giulio; Meroni, Luca; Galli, Massimo; Magnani, Mauro; Monforte, Antonella d'Arminio; Marchetti, Giulia			Increased Bone Marrow Interleukin-7 (IL-7)/IL-7R Levels but Reduced IL-7 Responsiveness in HIV-Positive Patients Lacking CD4+Gain on Antiviral Therapy	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS-1; CD8 T-CELLS; INFECTED PATIENTS; CD127 EXPRESSION; GENE-EXPRESSION; IN-VIVO; CD4(+); SUPPRESSION; RECEPTOR	Background: The bone marrow (BM) cytokine milieu might substantially affect T-lymphocyte homeostasis in HIV-positive individuals. Interleukin-7 (IL-7) is a bone marrow-derived cytokine regulating T-cell homeostasis through a CD4+-driven feedback loop. CD4+ T-lymphopenia is associated with increased free IL-7 levels and reduced IL-7R expression/function, which are only partially reverted by highly active antiretroviral therapy (HAART). We investigated the BM production, peripheral expression and signaling (pStat5+ and Bcl-2+ CD4+/CD8+ T cells) of IL-7/IL-7R alpha in 30 HAART-treated HIV-positive patients who did not experience CD4+ recovery (CD4+ <= 200/mu l) and who had different levels of HIV viremia; these patients included 18 immunological nonresponders (INRs; HIV-RNA <= 50), 12 complete failures (CFs; HIV-RNA > 1000), and 23 HIV-seronegative subjects. Methods: We studied plasma IL-7 levels, IL-7R alpha+CD4+/CD8+ T-cell proportions, IL-7R alpha mRNA expression in PBMCs, spontaneous IL-7 production by BM mononuclear cells (BMMCs), and IL-7 mRNA/IL-7R alpha mRNA in BMMC-derived stromal cells (SCs). We also studied T-cell responsiveness to IL-7 by measuring the proportions of pStat5+ and Bcl-2+ CD4+/CD8+ T cells. Results: Compared to HIV-seronegative controls, CFs and INRs presented elevated plasma IL-7 levels and lower IL-7R alpha CD4+/CD8+ cell-surface expression and peripheral blood production, confirming the most relevant IL-7/IL-7R disruption. Interestingly, BM investigation revealed a trend of higher spontaneous IL-7 production in INRs (p = .09 vs. CFs) with a nonsignificant trend toward higher IL-7-R alpha mRNA levels in BMMC-derived stromal cells. However, upon IL-7 stimulation, the proportion of pStat5+ CD4+ T cells did not increase in INRs despite higher constitutive levels (p = .06); INRs also displayed lower Bcl-2+ CD8+ T-cell proportions than controls (p = .04). Conclusions: Despite severe CD4+ T-lymphopenia and a disrupted IL-7/IL-7R profile in the periphery, INRs display elevated BM IL-7/IL-7R alpha expression but impaired T-cell responsiveness to IL-7, suggesting the activity of a central compensatory pathway targeted to replenish the CD4+ compartment, which is nevertheless inappropriate to compensate the dysfunctional signaling through IL-7 receptor.	[Bellistri, Giusi Maria; Merlini, Esther; Monforte, Antonella d'Arminio; Marchetti, Giulia] Univ Milan, San Paolo Hosp, Clin Infect Dis, Dept Med Surg & Dent, Milan, Italy; [Ferrario, Giulio; Meroni, Luca; Galli, Massimo] Univ Milan, Luigi Sacco Hosp, Chair Infect Dis & Trop Med, Dept Clin Sci, Milan, Italy; [Casabianca, Anna; Orlandi, Chiara; Magnani, Mauro] Univ Urbino, Inst Biol Chem Giorgio Fornaini, I-61029 Urbino, Italy	San Paolo-Polo Universitaria Hospital; University of Milan; University of Milan; Luigi Sacco Hospital; University of Urbino	Bellistri, GM (corresponding author), Univ Milan, San Paolo Hosp, Clin Infect Dis, Dept Med Surg & Dent, Milan, Italy.	giulia.marchetti@unimi.it	Gori, Andrea/AAC-6078-2022; Marchetti, Giulia/GPX-7655-2022; Magnani, Mauro/A-1919-2008; GALLI, MASSIMO/L-7282-2017; MARCHETTI, GIULIA CARLA/K-4384-2018	orlandi, chiara/0000-0003-3288-7286; Magnani, Mauro/0000-0001-6456-6626; GALLI, MASSIMO/0000-0001-8887-6215; MARCHETTI, GIULIA CARLA/0000-0002-4498-4828	Fondo Interno Ricerca Scientifica e Tecnologica (FIRST) - Universita degli Studi di Milano; Istituto Superiore di Sanita, Italy [30G.50, 30G.63, 50G]	Fondo Interno Ricerca Scientifica e Tecnologica (FIRST) - Universita degli Studi di Milano; Istituto Superiore di Sanita, Italy	Financial support was provided by a grant from Fondo Interno Ricerca Scientifica e Tecnologica (FIRST) 2009 - Universita degli Studi di Milano, and from Istituto Superiore di Sanita, "National research program on AIDS", 30G.50; 30G.63, 50G; 2006, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpdogan O, 2005, TRENDS IMMUNOL, V26, P56, DOI 10.1016/j.it.2004.11.002; Badolato R, 2008, CLIN INFECT DIS, V46, P1911, DOI 10.1086/588481; Bahner I, 1997, BLOOD, V90, P1787, DOI 10.1182/blood.V90.5.1787; Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; Bazdar DA, 2009, J INFECT DIS, V199, P1019, DOI 10.1086/597210; Bolotin E, 1999, BONE MARROW TRANSPL, V23, P783, DOI 10.1038/sj.bmt.1701655; Bovolenta C, 1999, BLOOD, V94, P4202, DOI 10.1182/blood.V94.12.4202.424k22_4202_4209; Colle JH, 2007, AIDS, V21, P101, DOI 10.1097/QAD.0b013e3280115b6a; Colle JH, 2006, JAIDS-J ACQ IMM DEF, V42, P277, DOI 10.1097/01.qai.0000214823.11034.4e; Colle JH, 2006, CLIN EXP IMMUNOL, V143, P398, DOI 10.1111/j.1365-2249.2006.03022.x; DELUCA A, 1993, BRIT J HAEMATOL, V85, P20, DOI 10.1111/j.1365-2141.1993.tb08640.x; Douek Daniel C., 2003, AIDS Reviews, V5, P172; Dragsted UB, 2004, J INFECT DIS, V190, P148, DOI 10.1086/420786; Faller EM, 2006, JAIDS-J ACQ IMM DEF, V43, P257, DOI 10.1097/01.qai.0000230319.78288.f4; Fry TJ, 2002, BLOOD, V99, P3892, DOI 10.1182/blood.V99.11.3892; Fry TJ, 2001, BLOOD, V97, P2983, DOI 10.1182/blood.V97.10.2983; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Grabar S, 2000, ANN INTERN MED, V133, P401, DOI 10.7326/0003-4819-133-6-200009190-00007; Henriques CM, 2010, BLOOD, V115, P3269, DOI 10.1182/blood-2009-10-246876; Isgro A, 1999, AIDS, V13, P2486, DOI 10.1097/00002030-199912030-00027; Isgro A, 2008, CLIN INFECT DIS, V46, P1902, DOI 10.1086/588480; Kohler JJ, 2003, J LEUKOCYTE BIOL, V73, P407, DOI 10.1189/jlb.0702358; Levy Y, 2009, J CLIN INVEST, V119, P997, DOI 10.1172/JCI38052; MacPherson J, 2001, J ACQ IMMUN DEF SYND, V28, P454; Mercier F, 2008, CLIN EXP IMMUNOL, V152, P72, DOI 10.1111/j.1365-2249.2008.03610.x; Moses A, 1998, BLOOD, V91, P1479, DOI 10.1182/blood.V91.5.1479.1479_1479_1495; Napolitano LA, 2001, NAT MED, V7, P73, DOI 10.1038/83381; Neuhaus T, 2003, CELL PROLIFERAT, V36, P75, DOI 10.1046/j.1365-2184.2003.00262.x; Nicastri E, 2005, J MED VIROL, V76, P153, DOI 10.1002/jmv.20352; Okamoto Y, 2002, BLOOD, V99, P2851, DOI 10.1182/blood.V99.8.2851; Paiardini M, 2005, J IMMUNOL, V174, P2900, DOI 10.4049/jimmunol.174.5.2900; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Rethi B, 2005, AIDS, V19, P2077, DOI 10.1097/01.aids.0000189848.75699.0f; Sasson SC, 2006, J INFECT DIS, V193, P505, DOI 10.1086/499309; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Sereti I, 2009, BLOOD, V113, P6304, DOI 10.1182/blood-2008-10-186601; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tan RM, 2008, JAIDS-J ACQ IMM DEF, V47, P553, DOI 10.1097/QAI.0b013e31816856c5; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632	41	12	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e15663	10.1371/journal.pone.0015663	http://dx.doi.org/10.1371/journal.pone.0015663			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21209878	gold, Green Published			2022-12-27	WOS:000285838900025
J	Li, MX; Sham, PC; Cherny, SS; Song, YQ				Li, Miao-Xin; Sham, Pak C.; Cherny, Stacey S.; Song, You-Qiang			A Knowledge-Based Weighting Framework to Boost the Power of Genome-Wide Association Studies	PLOS ONE			English	Article							FALSE DISCOVERY RATE; INTERACTION NETWORK; ALZHEIMERS-DISEASE; PROTEIN; PRIORITIZATION; INTERACTOME; INFERENCE; DATABASE; TRAITS; GENES	Background: We are moving to second-wave analysis of genome-wide association studies (GWAS), characterized by comprehensive bioinformatical and statistical evaluation of genetic associations. Existing biological knowledge is very valuable for GWAS, which may help improve their detection power particularly for disease susceptibility loci of moderate effect size. However, a challenging question is how to utilize available resources that are very heterogeneous to quantitatively evaluate the statistic significances. Methodology/Principal Findings: We present a novel knowledge-based weighting framework to boost power of the GWAS and insightfully strengthen their explorative performance for follow-up replication and deep sequencing. Built upon diverse integrated biological knowledge, this framework directly models both the prior functional information and the association significances emerging from GWAS to optimally highlight single nucleotide polymorphisms (SNPs) for subsequent replication. In the theoretical calculation and computer simulation, it shows great potential to achieve extra over 15% power to identify an association signal of moderate strength or to use hundreds of whole-genome subjects fewer to approach similar power. In a case study on late-onset Alzheimer disease (LOAD) for a proof of principle, it highlighted some genes, which showed positive association with LOAD in previous independent studies, and two important LOAD related pathways. These genes and pathways could be originally ignored due to involved SNPs only having moderate association significance. Conclusions/Significance: With user-friendly implementation in an open-source Java package, this powerful framework will provide an important complementary solution to identify more true susceptibility loci with modest or even small effect size in current GWAS for complex diseases.	[Li, Miao-Xin; Song, You-Qiang] Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Li, Miao-Xin; Sham, Pak C.; Cherny, Stacey S.] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Li, Miao-Xin; Sham, Pak C.; Song, You-Qiang] Univ Hong Kong, Ctr Reprod Dev & Growth, Hong Kong, Hong Kong, Peoples R China; [Sham, Pak C.; Cherny, Stacey S.] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Li, MX (corresponding author), Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China.	songy@hkucc.hku.hk	Song, You-Qiang/E-5207-2011; Cherny, Stacey S/B-3315-2008; Li, Miaoxin/B-7079-2013; Song, You-qiang/C-4401-2009	Cherny, Stacey S/0000-0002-0269-3352; Song, You-Qiang/0000-0001-9407-2256	Research Grant Council of Hong Kong [HKU7688/05M, HKU7752/08M]; Research Fund for the Control of Infectious Diseases (RFCID) [08070652]	Research Grant Council of Hong Kong(Hong Kong Research Grants Council); Research Fund for the Control of Infectious Diseases (RFCID)	This work was supported by the Research Grant Council of Hong Kong (HKU7688/05M and HKU7752/08M, YQS) and the Research Fund for the Control of Infectious Diseases (RFCID) (no. 08070652, YQS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie EA, 2006, BIOINFORMATICS, V22, P773, DOI 10.1093/bioinformatics/btk031; Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Altshuler D, 2007, NAT GENET, V39, P813, DOI 10.1038/ng0707-813; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Benjamini Y, 1997, SCAND J STAT, V24, P407, DOI 10.1111/1467-9469.00072; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Blekhman R, 2008, CURR BIOL, V18, P883, DOI 10.1016/j.cub.2008.04.074; Brown KV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r95; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Dreses-Werringloer U, 2008, CELL, V133, P1149, DOI 10.1016/j.cell.2008.05.048; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Genovese CR, 2006, BIOMETRIKA, V93, P509, DOI 10.1093/biomet/93.3.509; Greco D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001880; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hemminger BM, 2006, BIOINFORMATICS, V22, P626, DOI 10.1093/bioinformatics/btk025; HOLM S, 1979, SCAND J STAT, V6, P65; Hua JP, 2007, BIOINFORMATICS, V23, P57, DOI 10.1093/bioinformatics/btl536; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kulkarni V, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S3; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Li QZ, 2009, J STAT PLAN INFER, V139, P2431, DOI 10.1016/j.jspi.2008.11.007; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Nizzari M, 2007, J BIOL CHEM, V282, P13833, DOI 10.1074/jbc.M610146200; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Pahl R, 2009, BIOSTATISTICS, V10, P297, DOI 10.1093/biostatistics/kxn036; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Reumers J, 2006, BIOINFORMATICS, V22, P2183, DOI 10.1093/bioinformatics/btl348; Reynolds CH, 2008, J BIOL CHEM, V283, P18177, DOI 10.1074/jbc.M709715200; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Roeder K, 2007, GENET EPIDEMIOL, V31, P741, DOI 10.1002/gepi.20237; Schjeide BMM, 2009, ARCH NEUROL-CHICAGO, V66, P250, DOI 10.1001/archneurol.2008.552; Seripa D, 2005, NEUROBIOL AGING, V26, P455, DOI 10.1016/j.neurobiolaging.2004.04.001; Sethupathy P, 2008, TRENDS GENET, V24, P489, DOI 10.1016/j.tig.2008.07.004; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tabor HK, 2002, NAT REV GENET, V3, P391, DOI 10.1038/nrg796; Taguchi K, 2005, ANN NEUROL, V57, P585, DOI 10.1002/ana.20433; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang PL, 2006, BIOINFORMATICS, V22, pE523, DOI 10.1093/bioinformatics/btl241; WASSERMAN L, 2006, WEIGHTED HYPOTHESIS; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27	54	31	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2010	5	12							e14480	10.1371/journal.pone.0014480	http://dx.doi.org/10.1371/journal.pone.0014480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RA	21217833	Green Submitted, Green Published, gold			2022-12-27	WOS:000285838900009
J	Ayuni, EL; Gazdhar, A; Giraud, MN; Kadner, A; Gugger, M; Cecchini, M; Caus, T; Carrel, TP; Schmid, RA; Tevaearai, HT				Ayuni, Erick L.; Gazdhar, Amiq; Giraud, Marie Noelle; Kadner, Alexander; Gugger, Mathias; Cecchini, Marco; Caus, Thierry; Carrel, Thierry P.; Schmid, Ralph A.; Tevaearai, Hendrik T.			In Vivo Electroporation Mediated Gene Delivery to the Beating Heart	PLOS ONE			English	Article							IMMEDIATE-EARLY PROMOTER; SKELETAL-MUSCLE; THERAPEUTIC ANGIOGENESIS; ELECTRIC PULSES; EXPRESSION; ELECTROTRANSFER; EFFICACY; DISEASE; LIVER; LUNG	Gene therapy may represent a promising alternative strategy for cardiac muscle regeneration. In vivo electroporation, a physical method of gene transfer, has recently evolved as an efficient method for gene transfer. In the current study, we investigated the efficiency and safety of a protocol involving in vivo electroporation for gene transfer to the beating heart. Adult male rats were anesthetised and the heart exposed through a left thoracotomy. Naked plasmid DNA was injected retrograde into the transiently occluded coronary sinus before the electric pulses were applied. Animals were sacrificed at specific time points and gene expression was detected. Results were compared to the group of animals where no electric pulses were applied. No post-procedure arrhythmia was observed. Left ventricular function was temporarily altered only in the group were high pulses were applied; CK-MB (Creatine kinase) and TNT (Troponin T) were also altered only in this group. Histology showed no signs of toxicity. Gene expression was highest at day one. Our results provide evidence that in vivo electroporation with an optimized protocol is a safe and effective tool for nonviral gene delivery to the beating heart. This method may be promising for clinical settings especially for perioperative gene delivery.	[Ayuni, Erick L.; Giraud, Marie Noelle; Kadner, Alexander; Caus, Thierry; Carrel, Thierry P.; Tevaearai, Hendrik T.] Univ Hosp Bern, Dept Cardiovasc Surg, CH-3010 Bern, Switzerland; [Gazdhar, Amiq; Schmid, Ralph A.] Univ Hosp Bern, Div Gen Thorac Surg, CH-3010 Bern, Switzerland; [Gugger, Mathias] Univ Bern, Dept Pathol, CH-3000 Bern, Switzerland; [Cecchini, Marco] Univ Hosp Bern, Dept Urol, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern	Ayuni, EL (corresponding author), Univ Hosp Bern, Dept Cardiovasc Surg, CH-3010 Bern, Switzerland.	ralph.schmid@insel.ch	Gazdhar, Amiq/AAJ-6835-2020; Kadner, Alexander/ADL-0427-2022; Kadner, Alexander/GYJ-0985-2022; Caus, Thierry/AFD-3883-2022; Gazdhar, Amiq/AAN-6024-2020; gf, mn/N-1593-2016; Carrel, Thierry/AAI-5910-2021	Gazdhar, Amiq/0000-0002-4807-8785; Kadner, Alexander/0000-0003-3024-6514; Caus, Thierry/0000-0001-9120-9026; gf, mn/0000-0003-3228-6827; Schmid, Ralph Alexander/0000-0003-0699-079X	Olga Mayenfisch Foundation, Zurich Switzerland; Swiss National Science Foundation [3200-068304-2006, 310000-118270-2007]	Olga Mayenfisch Foundation, Zurich Switzerland; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by a grant from the Olga Mayenfisch Foundation, Zurich Switzerland and by two grants from the Swiss National Science Foundation (3200-068304-2006 to RAS and 310000-118270-2007 to AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara H, 1998, NAT BIOTECHNOL, V16, P867, DOI 10.1038/nbt0998-867; Baskar JF, 1996, J VIROL, V70, P3207, DOI 10.1128/JVI.70.5.3207-3214.1996; Bertrand A, 2003, AM J PHYSIOL-CELL PH, V285, pC1071, DOI 10.1152/ajpcell.00104.2003; Blair-Parks K, 2002, J GENE MED, V4, P92, DOI 10.1002/jgm.231; Bonnafous P, 1999, BBA-BIOMEMBRANES, V1461, P123, DOI 10.1016/S0005-2736(99)00154-6; BYRNES AP, 1995, NEUROSCIENCE, V66, P1015, DOI 10.1016/0306-4522(95)00068-T; Contag CH, 1997, PHOTOCHEM PHOTOBIOL, V66, P523, DOI 10.1111/j.1751-1097.1997.tb03184.x; Freedman SB, 2002, ANN INTERN MED, V136, P54, DOI 10.7326/0003-4819-136-1-200201010-00011; Fromes Y, 1999, GENE THER, V6, P683, DOI 10.1038/sj.gt.3300853; Gazdhar A, 2006, J GENE MED, V8, P910, DOI 10.1002/jgm.911; Gehl J, 1999, BBA-GEN SUBJECTS, V1428, P233, DOI 10.1016/S0304-4165(99)00094-X; Gill DR, 2001, GENE THER, V8, P1539, DOI 10.1038/sj.gt.3301561; Gothelf A, 2003, CANCER TREAT REV, V29, P371, DOI 10.1016/S0305-7372(03)00073-2; Harrison RL, 1998, FEBS LETT, V435, P1, DOI 10.1016/S0014-5793(98)00987-9; Heller R, 1996, FEBS LETT, V389, P225, DOI 10.1016/0014-5793(96)00590-X; Lin CR, 2002, GENE THER, V9, P1247, DOI 10.1038/sj.gt.3301790; Lin CR, 2002, NEUROSCI LETT, V317, P1; Loser P, 1998, J VIROL, V72, P180; Marshall E, 1999, SCIENCE, V286, P2244, DOI 10.1126/science.286.5448.2244; MARSHALL WG, GENE THER, V17, P419; Mathiesen I, 1999, GENE THER, V6, P508, DOI 10.1038/sj.gt.3300847; Mir LM, 1999, P NATL ACAD SCI USA, V96, P4262, DOI 10.1073/pnas.96.8.4262; Mitani K., 2002, Current Gene Therapy, V2, P135, DOI 10.2174/1566523024605591; Neumann E., 1989, ELECTROPORATION ELEC; Nikolski VP, 2005, EUROPACE, V7, pS146, DOI 10.1016/j.eupc.2005.04.011; Nunamaker EA, 2003, AM J PHYSIOL-HEART C, V285, pH2240, DOI 10.1152/ajpheart.00350.2003; Parsa CJ, 2005, J GENE MED, V7, P595, DOI 10.1002/jgm.704; Rubenstrunk A, 2004, CELL BIOL TOXICOL, V20, P25, DOI 10.1023/B:CBTO.0000021079.69089.4f; Tavakoli R, 2006, J GENE MED, V8, P242, DOI 10.1002/jgm.859; Vale PR, 2000, CIRCULATION, V102, P965, DOI 10.1161/01.CIR.102.9.965; Wang YN, 2001, AM J TRANSPLANT, V1, P334, DOI 10.1034/j.1600-6143.2001.10408.x; Wetterwald A, 2002, AM J PATHOL, V160, P1143, DOI 10.1016/S0002-9440(10)64934-6; Wright MJ, 2001, GENE THER, V8, P1833, DOI 10.1038/sj.gt.3301614	33	38	38	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e14467	10.1371/journal.pone.0014467	http://dx.doi.org/10.1371/journal.pone.0014467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209934	Green Published, gold			2022-12-27	WOS:000285793600010
J	Di Stefano, B; Buecker, C; Ungaro, F; Prigione, A; Chen, HH; Welling, M; Eijpe, M; Mostoslavsky, G; Tesar, P; Adjaye, J; Geijsen, N; Broccoli, V				Di Stefano, Bruno; Buecker, Christa; Ungaro, Federica; Prigione, Alessandro; Chen, Hsu-Hsin; Welling, Maaike; Eijpe, Maureen; Mostoslavsky, Gustavo; Tesar, Paul; Adjaye, James; Geijsen, Niels; Broccoli, Vania			An ES-Like Pluripotent State in FGF-Dependent Murine iPS cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GROUND-STATE; SELF-RENEWAL; FIBROBLASTS; EPIBLAST; KLF4; INDUCTION; OCT4	Recent data demonstrates that stem cells can exist in two morphologically, molecularly and functionally distinct pluripotent states; a naive LIF-dependent pluripotent state which is represented by murine embryonic stem cells (mESCs) and an FGF-dependent primed pluripotent state represented by murine and rat epiblast stem cells (EpiSCs). We find that derivation of induced pluripotent stem cells (iPSCs) under EpiSC culture conditions yields FGF-dependent iPSCs from hereon called FGF-iPSCs) which, unexpectedly, display naive ES-like/ICM properties. FGF-iPSCs display X-chromosome activation, multi-lineage differentiation, teratoma competence and chimera contribution in vivo. Our findings suggest that in 129 and Bl6 mouse strains, iPSCs can dominantly adopt a naive pluripotent state regardless of culture growth factor conditions. Characterization of the key molecular signalling pathways revealed FGF-iPSCs to depend on the Activin/Nodal and FGF pathways, while signalling through the JAK-STAT pathway is not required for FGF-iPS cell maintenance. Our findings suggest that in 129 and Bl6 mouse strains, iPSCs can dominantly adopt a naive pluripotent state regardless of culture growth factor conditions.	[Di Stefano, Bruno; Ungaro, Federica; Broccoli, Vania] Ist Sci San Raffaele, Div Neurosci, Stem Cells & Neurogenesis Unit, I-20132 Milan, Italy; [Buecker, Christa; Chen, Hsu-Hsin; Welling, Maaike; Geijsen, Niels] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA USA; [Buecker, Christa; Chen, Hsu-Hsin; Geijsen, Niels] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Prigione, Alessandro; Adjaye, James] Max Planck Inst Mol Genet, Dept Vertebrate Genom, Mol Embryol & Aging Grp, Berlin, Germany; [Eijpe, Maureen] Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands; [Mostoslavsky, Gustavo] Boston Univ, Sch Med, Dept Stem Cell Biol & Regenerat Med, Boston, MA 02118 USA; [Tesar, Paul] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Welling, Maaike; Geijsen, Niels] Hubrecht Inst Dev Biol & Stem Cell Res, Utrecht, Netherlands; [Di Stefano, Bruno] Fdn IRCCS Policlin San Matteo, Pavia, Italy; [Geijsen, Niels] Univ Utrecht, Sch Vet, Dept Clin Sci Compan Anim, Utrecht, Netherlands	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Max Planck Society; Erasmus University Rotterdam; Erasmus MC; Boston University; Case Western Reserve University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); IRCCS Fondazione San Matteo; Utrecht University	Di Stefano, B (corresponding author), Ist Sci San Raffaele, Div Neurosci, Stem Cells & Neurogenesis Unit, I-20132 Milan, Italy.	ngeijsen@mgh.harvard.edu; broccoli.vania@hsr.it	Di Stefano, Bruno/K-5020-2017; Tesar, Paul/GPK-5942-2022; Tesar, Paul J/C-9848-2014; Di Stefano, Bruno/H-7232-2015; Ungaro, Federica/J-6047-2018; Broccoli, Vania/K-3464-2016; Prigione, Alessandro/ABA-1584-2021; Alessandro, Prigione/B-2959-2013	Di Stefano, Bruno/0000-0003-2532-3087; Tesar, Paul/0000-0003-1532-3155; Tesar, Paul J/0000-0003-1532-3155; Di Stefano, Bruno/0000-0003-2532-3087; Ungaro, Federica/0000-0001-5395-7795; Broccoli, Vania/0000-0003-4050-0926; Alessandro, Prigione/0000-0001-9457-1952; Buecker, Christa/0000-0003-3055-2642; Welling, Maaike/0000-0003-3253-3410; Mostoslavsky, Gustavo/0000-0002-0784-2169	Telethon [GGP07181]; Italian Ministry of Health; National Institutes of Health and Dutch Science Organization (NWO); Bundesministerium fur Bildung und Forschung [01GN0807]; Max Planck Society; Gottlieb Daimler- and Karl Benz-Foundation; National Science Council (Taiwan, ROC)	Telethon(Fondazione Telethon); Italian Ministry of Health(Ministry of Health, Italy); National Institutes of Health and Dutch Science Organization (NWO)(Netherlands Organization for Scientific Research (NWO)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Gottlieb Daimler- and Karl Benz-Foundation; National Science Council (Taiwan, ROC)(Ministry of Science and Technology, Taiwan)	This work was supported by funding from Telethon (GGP07181) and Italian Ministry of Health (Young Research Award) to V.B., from National Institutes of Health and Dutch Science Organization (NWO) to N.G., and from the Bundesministerium fur Bildung und Forschung (01GN0807) and the Max Planck Society to J.A. C.B. was supported by the Gottlieb Daimler- and Karl Benz-Foundation. H.H.C. was supported by the National Science Council (Taiwan, ROC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Di Stefano B, 2009, STEM CELLS DEV, V18, P707, DOI 10.1089/scd.2008.0180; Greber B, 2007, STEM CELLS, V25, P455, DOI 10.1634/stemcells.2006-0476; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Levine AJ, 2006, DEVELOPMENT, V133, P209, DOI 10.1242/dev.02192; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	20	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e16092	10.1371/journal.pone.0016092	http://dx.doi.org/10.1371/journal.pone.0016092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209851	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000285793600060
J	Gharaibeh, RZ; Fodor, AA; Gibas, CJ				Gharaibeh, Raad Z.; Fodor, Anthony A.; Gibas, Cynthia J.			Accurate Estimates of Microarray Target Concentration from a Simple Sequence-Independent Langmuir Model	PLOS ONE			English	Article							OLIGONUCLEOTIDE ARRAYS; DNA MICROARRAYS; THERMODYNAMICS; HYBRIDIZATION; CALIBRATION; PLATFORM; PROBES	Background: Microarray technology is a commonly used tool for assessing global gene expression. Many models for estimation of target concentration based on observed microarray signal have been proposed, but, in general, these models have been complex and platform-dependent. Principal Findings: We introduce a universal Langmuir model for estimation of absolute target concentration from microarray experiments. We find that this sequence-independent model, characterized by only three free parameters, yields excellent predictions for four microarray platforms, including Affymetrix, Agilent, Illumina and a custom-printed microarray. The model also accurately predicts concentration for the MAQC data sets. This approach significantly reduces the computational complexity of quantitative target concentration estimates. Conclusions: Using a simple form of the Langmuir isotherm model, with a minimum of parameters and assumptions, and without explicit modeling of individual probe properties, we were able to recover absolute transcript concentrations with high R 2 on four different array platforms. The results obtained here suggest that with a "spiked-in" concentration series targeting as few as 5-10 genes, reliable estimation of target concentration can be achieved for the entire microarray.	[Gharaibeh, Raad Z.; Fodor, Anthony A.; Gibas, Cynthia J.] Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28223 USA	University of North Carolina; University of North Carolina Charlotte	Gharaibeh, RZ (corresponding author), Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28223 USA.	cgibas@uncc.edu		Gibas, Cynthia/0000-0002-1288-9543	National Institutes of Health [R01GM72619]; University of North Carolina; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072619] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health via grant number R01GM72619 to C.J.G. and by the University of North Carolina via tuition support for R.Z.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdueva D, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl435; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Binder H, 2006, J PHYS-CONDENS MAT, V18, pS491, DOI 10.1088/0953-8984/18/18/S02; Bishop J, 2006, BIOPHYS J, V90, P831, DOI 10.1529/biophysj.105.072314; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Burden C.J., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1095, DOI 10.2202/1544-6115.1095]; Burden CJ, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/016004; Chudin E, 2002, GENOME BIOL, V3; Dalma-Weiszhausz DD, 2006, METHOD ENZYMOL, V410, P3, DOI 10.1016/S0076-6879(06)10001-4; Fan JB, 2006, METHOD ENZYMOL, V410, P57, DOI 10.1016/S0076-6879(06)10003-8; Gharaibeh RZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011048; Gharaibeh RZ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-452; Hekstra D, 2003, NUCLEIC ACIDS RES, V31, P1962, DOI 10.1093/nar/gkg283; Held GA, 2003, P NATL ACAD SCI USA, V100, P7575, DOI 10.1073/pnas.0832500100; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Kreil DP, 2006, METHOD ENZYMOL, V410, P73, DOI 10.1016/S0076-6879(06)10004-X; Langdon WB, 2009, BRIEF BIOINFORM, V10, P259, DOI 10.1093/bib/bbp018; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li SZ, 2008, NUCLEIC ACIDS RES, V36, P6585, DOI 10.1093/nar/gkn740; McCall MN, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn430; Mei R, 2003, P NATL ACAD SCI USA, V100, P11237, DOI 10.1073/pnas.1534744100; Mulders GCWM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-64; Pozhitkov AE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1122; R Core Team, 2020, R LANG ENV STAT COMP; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi LM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S2-S11; Willey James C., 2004, V258, P13; Wolber PK, 2006, METHOD ENZYMOL, V410, P28, DOI 10.1016/S0076-6879(06)10002-6; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zhang L, 2003, NAT BIOTECHNOL, V21, P818, DOI 10.1038/nbt836	34	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e14464	10.1371/journal.pone.0014464	http://dx.doi.org/10.1371/journal.pone.0014464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21209932	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793600007
J	Miller, BH; Schultz, LE; Gulati, A; Su, AI; Pletcher, MT				Miller, Brooke H.; Schultz, Laura E.; Gulati, Anisha; Su, Andrew I.; Pletcher, Mathew T.			Phenotypic Characterization of a Genetically Diverse Panel of Mice for Behavioral Despair and Anxiety	PLOS ONE			English	Article							TAIL SUSPENSION TEST; DEPRESSION-RELATED BEHAVIOR; INBRED STRAINS; MAJOR DEPRESSION; ANTIDEPRESSANT ACTIVITY; IN-SILICO; HIPPOCAMPAL NEUROGENESIS; LABORATORY ENVIRONMENT; QUANTITATIVE TRAITS; RECEPTOR MUTANT	Background: Animal models of human behavioral endophenotypes, such as the Tail Suspension Test (TST) and the Open Field assay (OF), have proven to be essential tools in revealing the genetics and mechanisms of psychiatric diseases. As in the human disorders they model, the measurements generated in these behavioral assays are significantly impacted by the genetic background of the animals tested. In order to better understand the strain-dependent phenotypic variability endemic to this type of work, and better inform future studies that rely on the data generated by these models, we phenotyped 33 inbred mouse strains for immobility in the TST, a mouse model of behavioral despair, and for activity in the OF, a model of general anxiety and locomotor activity. Results: We identified significant strain-dependent differences in TST immobility, and in thigmotaxis and distance traveled in the OF. These results were replicable over multiple testing sessions and exhibited high heritability. We exploited the heritability of these behavioral traits by using in silico haplotype-based association mapping to identify candidate genes for regulating TST behavior. Two significant loci (-logp >7.0, gFWER adjusted p value <0.05) of approximately 300 kb each on MMU9 and MMU10 were identified. The MMU10 locus is syntenic to a major human depressive disorder QTL on human chromosome 12 and contains several genes that are expressed in brain regions associated with behavioral despair. Conclusions: We report the results of phenotyping a large panel of inbred mouse strains for depression and anxiety-associated behaviors. These results show significant, heritable strain-specific differences in behavior, and should prove to be a valuable resource for the behavioral and genetics communities. Additionally, we used haplotype mapping to identify several loci that may contain genes that regulate behavioral despair.	[Miller, Brooke H.] Scripps Res Inst Scripps Florida, Dept Neurosci, Jupiter, FL USA; [Schultz, Laura E.; Gulati, Anisha; Pletcher, Mathew T.] Scripps Res Inst Scripps Florida, Dept Mol Therapeut, Jupiter, FL USA; [Su, Andrew I.] Novartis Res Fdn, Genom Inst, San Diego, CA USA	Scripps Research Institute; State University System of Florida; University of Florida; Scripps Research Institute; State University System of Florida; University of Florida; Novartis	Miller, BH (corresponding author), Scripps Res Inst Scripps Florida, Dept Neurosci, Jupiter, FL USA.	Pletcher@pfizer.com		Su, Andrew I./0000-0002-9859-4104	State of Florida; National Institute of Mental Health [F32MH084528]; Pfizer Global Research and Development; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH084528] Funding Source: NIH RePORTER	State of Florida; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Pfizer Global Research and Development(Pfizer); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a grant from the State of Florida and National Institute of Mental Health grant F32MH084528 (http://www.nimh.nih.gov). Pfizer Global Research and Development provided no funding in support of this work other than covering publication fees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abkevich V, 2003, AM J HUM GENET, V73, P1271, DOI 10.1086/379978; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Bolivar VJ, 2000, BEHAV GENET, V30, P285, DOI 10.1023/A:1026545316455; Bothe GWM, 2005, COMPARATIVE MED, V55, P326; Burmeister M, 1999, BIOL PSYCHIAT, V45, P522, DOI 10.1016/S0006-3223(98)00316-3; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cervo L, 2005, J NEUROSCI, V25, P8165, DOI 10.1523/JNEUROSCI.1816-05.2005; Chaki S, 2004, NEUROPHARMACOLOGY, V46, P457, DOI 10.1016/j.neuropharm.2003.10.009; Chesler EJ, 2002, NAT NEUROSCI, V5, P1101, DOI 10.1038/nn1102-1101; Clement Y, 1996, BRAIN RES, V709, P229, DOI 10.1016/0006-8993(95)01297-4; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Crawley Jacqueline N., 2007, WHATS WRONG MY MOUSE; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; Crowley JJ, 2005, PSYCHOPHARMACOLOGY, V183, P257, DOI 10.1007/s00213-005-0166-5; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Cryan JF, 2004, MOL PSYCHIATR, V9, P326, DOI 10.1038/sj.mp.4001457; Daly M, 2006, INBRED LAB MOUSE HAP; David DJP, 2003, PSYCHOPHARMACOLOGY, V166, P373, DOI 10.1007/s00213-002-1335-4; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; Eisener-Dorman AF, 2010, MAMM GENOME; El Yacoubi M, 2003, P NATL ACAD SCI USA, V100, P6227, DOI 10.1073/pnas.1034823100; ELEFTHERIOU BE, 1972, J ENDOCRINOL, V55, P415, DOI 10.1677/joe.0.0550415; Flint J, 2001, NAT REV GENET, V2, P437, DOI 10.1038/35076585; Grubb SC, 2004, BIOINFORMATICS, V20, P2857, DOI 10.1093/bioinformatics/bth299; Grubb SC, 2009, NUCLEIC ACIDS RES, V37, pD720, DOI 10.1093/nar/gkn778; Guo Y, 2007, P NATL ACAD SCI USA, V104, P17735, DOI 10.1073/pnas.0700724104; Guo YY, 2006, NAT BIOTECHNOL, V24, P531, DOI 10.1038/nbt1195; Harrill AH, 2009, GENOME RES, V19, P1507, DOI 10.1101/gr.090241.108; Hayes KR, 2009, DRUG METAB DISPOS, V37, P1269, DOI 10.1124/dmd.109.026856; Heisler LK, 1998, P NATL ACAD SCI USA, V95, P15049, DOI 10.1073/pnas.95.25.15049; Holmes A, 2003, BIOL PSYCHIAT, V54, P953, DOI 10.1016/j.biopsych.2003.09.003; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Jacobson LH, 2007, BEHAV GENET, V37, P171, DOI 10.1007/s10519-006-9106-3; Jones BC, 1996, PHYSIOL BEHAV, V59, P361, DOI 10.1016/0031-9384(95)02010-1; Jones I, 2002, MOL PSYCHIATR, V7, P424, DOI 10.1038/sj.mp.4000989; Justice M, CLIN HEMATOLOGY PARA; Kempermann G, 2006, P NATL ACAD SCI USA, V103, P780, DOI 10.1073/pnas.0510291103; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Lad HV, 2007, MAMM GENOME, V18, P482, DOI 10.1007/s00335-007-9029-1; Lira A, 2003, BIOL PSYCHIAT, V54, P960, DOI 10.1016/S0006-3223(03)00696-6; Liu X, 2006, BIOL PSYCHIAT; Liu XQ, 2003, BRAIN RES BULL, V60, P223, DOI 10.1016/S0361-9230(03)00033-9; Liu Y, 2009, CANCER RES, V69, P7844, DOI 10.1158/0008-5472.CAN-09-1833; Mayorga AJ, 2001, J PHARMACOL EXP THER, V298, P1101; Mayorga AJ, 2001, PSYCHOPHARMACOLOGY, V155, P110, DOI 10.1007/s002130100687; McClurg P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-61; McClurg P, 2007, GENETICS, V176, P675, DOI 10.1534/genetics.106.066241; McGuffin P, 2005, HUM MOL GENET, V14, P3337, DOI 10.1093/hmg/ddi363; Mhyre TR, 2005, GENES BRAIN BEHAV, V4, P209, DOI 10.1111/j.1601-183X.2004.00102.x; Michaelson JJ, 2009, METHODS, V48, P265, DOI 10.1016/j.ymeth.2009.03.004; Miller BH, 2010, MAMM GENOME; Miller BH, 2008, NEUROPSYCHOPHARMACOL, V33, P1312, DOI 10.1038/sj.npp.1301497; NAGGERT JK, DIET EFFECTS BONE MI; PAIGEN B, PLASMA LIPIDS MICE 6; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Pletcher MT, 2004, PLOS BIOL, V2, P2159, DOI 10.1371/journal.pbio.0020393; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Reed DR, 2007, PHYSIOL BEHAV, V91, P593, DOI 10.1016/j.physbeh.2007.03.026; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Seburn KL, METABOLIC CHARACTERI; SHANKS N, 1990, PHARMACOL BIOCHEM BE, V36, P515, DOI 10.1016/0091-3057(90)90249-H; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Su WL, 2010, MAMM GENOME, V21, P143, DOI 10.1007/s00335-010-9249-7; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Svenson KL, 2007, J APPL PHYSIOL, V102, P2369, DOI 10.1152/japplphysiol.01077.2006; Tang PLF, 2009, J BONE MINER RES, V24, P1013, DOI [10.1359/jbmr.081258, 10.1359/JBMR.081258]; Tannenbaum B, 2003, BIOL PSYCHIAT, V53, P292, DOI 10.1016/S0006-3223(02)01487-7; Tomida S, 2009, NAT GENET; TORDOFF MG, SURVEY CALCIUM SODIU; TRULLAS R, 1989, PSYCHOPHARMACOLOGY, V99, P287, DOI 10.1007/BF00442824; Tsankova NM, 2006, NAT NEUROSCI; TUNNICLIFF G, 1973, BRAIN RES, V61, P428, DOI 10.1016/0006-8993(73)90551-9; Turri MG, 2001, CURR BIOL, V11, P725, DOI 10.1016/S0960-9822(01)00206-8; Urani A, 2005, NEUROSCI BIOBEHAV R, V29, P805, DOI 10.1016/j.neubiorev.2005.03.020; VANDERHEYDEN JAM, 1987, PSYCHOPHARMACOLOGY, V92, P127, DOI 10.1007/BF00215493; Wahlsten D, 2003, J NEUROBIOL, V54, P283, DOI 10.1002/neu.10173; WHO, 2001, MENT HLTH NEW UND; Williams R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004649; Willott JF, STARTLE PREPULSE INH; WIMER RE, 1969, BRAIN RES, V16, P257, DOI 10.1016/0006-8993(69)90098-5; Wu CL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000070; Yoshikawa T, 2002, GENOME RES, V12, P357, DOI 10.1101/gr.222602; Zhang XD, 2005, NEURON, V45, P11, DOI 10.1016/j.neuron.2004.12.014	85	58	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e14458	10.1371/journal.pone.0014458	http://dx.doi.org/10.1371/journal.pone.0014458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21206921	gold, Green Published, Green Submitted			2022-12-27	WOS:000285793200011
J	Oguey, C; Foloppe, N; Hartmann, B				Oguey, Christophe; Foloppe, Nicolas; Hartmann, Brigitte			Understanding the Sequence-Dependence of DNA Groove Dimensions: Implications for DNA Interactions	PLOS ONE			English	Article							B-II TRANSITIONS; NF-KAPPA-B; MINOR-GROOVE; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURES; HELIX GEOMETRY; NUCLEIC-ACIDS; PROTEIN; RECOGNITION; COMPLEXES	Background: The B-DNA major and minor groove dimensions are crucial for DNA-protein interactions. It has long been thought that the groove dimensions depend on the DNA sequence, however this relationship has remained elusive. Here, our aim is to elucidate how the DNA sequence intrinsically shapes the grooves. Methodology/Principal Findings: The present study is based on the analysis of datasets of free and protein-bound DNA crystal structures, and from a compilation of NMR P-31 chemical shifts measured on free DNA in solution on a broad range of representative sequences. The P-31 chemical shifts can be interpreted in terms of the BI <-> BII backbone conformations and dynamics. The grooves width and depth of free and protein-bound DNA are found to be clearly related to the BI/BII backbone conformational states. The DNA propensity to undergo BI <-> BII backbone transitions is highly sequence-dependent and can be quantified at the dinucleotide level. This dual relationship, between DNA sequence and backbone behavior on one hand, and backbone behavior and groove dimensions on the other hand, allows to decipher the link between DNA sequence and groove dimensions. It also firmly establishes that proteins take advantage of the intrinsic DNA groove properties. Conclusions/Significance: The study provides a general framework explaining how the DNA sequence shapes the groove dimensions in free and protein-bound DNA, with far-reaching implications for DNA-protein indirect readout in both specific and non specific interactions.	[Oguey, Christophe] CNRS, Lab Phys Theor & Modelisat, UMR 8089, Cergy Pontoise, France; [Oguey, Christophe] Univ Cergy Pontoise, Cergy Pontoise, France; [Foloppe, Nicolas; Hartmann, Brigitte] INSERM, UMR S665, Paris, France; [Foloppe, Nicolas; Hartmann, Brigitte] Univ Paris Diderot, Inst Natl Transfus Sanguine, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); CY Cergy Paris Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Oguey, C (corresponding author), CNRS, Lab Phys Theor & Modelisat, UMR 8089, Cergy Pontoise, France.	nf_research@hotmail.com; brigitte.hartmann@univ-paris-diderot.fr	oguey, christophe/A-4168-2012		INSERM UMR [S665]; CNRS; Institut National de la Transfusion Sanguine (INTS)	INSERM UMR; CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Transfusion Sanguine (INTS)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was funded by INSERM UMR S665, CNRS, Institut National de la Transfusion Sanguine (INTS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bewley CA, 1998, ANNU REV BIOPH BIOM, V27, P105, DOI 10.1146/annurev.biophys.27.1.105; Crothers DM, 1999, DNA BENDING ADENINE, P445; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; DICKERSON RE, 1994, P NATL ACAD SCI USA, V91, P3579, DOI 10.1073/pnas.91.9.3579; Djuranovic D, 2005, BIOPHYS J, V89, P2542, DOI 10.1529/biophysj.104.057109; Djuranovic D, 2004, BIOPOLYMERS, V73, P356, DOI 10.1002/bip.10528; Djuranovic D, 2003, J BIOMOL STRUCT DYN, V20, P771, DOI 10.1080/07391102.2003.10506894; Dostal L, 2004, BIOCHEMISTRY-US, V43, P9600, DOI 10.1021/bi049192r; FRATINI AV, 1982, J BIOL CHEM, V257, P4686; GORENSTEIN DG, 1994, CHEM REV, V94, P1315, DOI 10.1021/cr00029a007; Gorenstein DG, 1984, PHOSPHORUS 31 NMR PR; HARTMANN B, 1993, NUCLEIC ACIDS RES, V21, P561, DOI 10.1093/nar/21.3.561; Hartmann B, 1996, Q REV BIOPHYS, V29, P309, DOI 10.1017/S0033583500005874; Heddi B, 2008, J MOL BIOL, V382, P956, DOI 10.1016/j.jmb.2008.07.047; Heddi B, 2006, J AM CHEM SOC, V128, P9170, DOI 10.1021/ja061686j; Heddi B, 2010, NUCLEIC ACIDS RES, V38, P1034, DOI 10.1093/nar/gkp962; Heddi B, 2010, J MOL BIOL, V395, P123, DOI 10.1016/j.jmb.2009.10.023; Huang DB, 2005, J MOL BIOL, V346, P147, DOI 10.1016/j.jmb.2004.11.042; Isaacs RJ, 2001, J MOL BIOL, V311, P149, DOI 10.1006/jmbi.2001.4855; Jones S, 1999, J MOL BIOL, V287, P877, DOI 10.1006/jmbi.1999.2659; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; Luscombe NM, 2002, J MOL BIOL, V320, P991, DOI 10.1016/S0022-2836(02)00571-5; Moravek Z, 2002, NUCLEIC ACIDS RES, V30, P1182, DOI 10.1093/nar/30.5.1182; NEKLUDOVA L, 1994, P NATL ACAD SCI USA, V91, P6948, DOI 10.1073/pnas.91.15.6948; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; Prabakaran P, 2006, STRUCTURE, V14, P1355, DOI 10.1016/j.str.2006.06.018; Reddy SY, 2003, P NATL ACAD SCI USA, V100, P15475, DOI 10.1073/pnas.1936251100; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; SRINIVASAN AR, 1987, J BIOMOL STRUCT DYN, V4, P895, DOI 10.1080/07391102.1987.10507690; STOFER E, 1994, BIOPOLYMERS, V34, P337, DOI 10.1002/bip.360340305; Suck Dietrich, 1994, Journal of Molecular Recognition, V7, P65, DOI 10.1002/jmr.300070203; Suzuki M, 1996, J MOL BIOL, V255, P677, DOI 10.1006/jmbi.1996.0055; Svozil D, 2008, NUCLEIC ACIDS RES, V36, P3690, DOI 10.1093/nar/gkn260; Tian Y, 2009, J PHYS CHEM B, V113, P2596, DOI 10.1021/jp711203m; Tisne C, 1999, J MOL BIOL, V293, P139, DOI 10.1006/jmbi.1999.3157; Tolstorukov MY, 2004, J MOL BIOL, V337, P65, DOI 10.1016/j.jmb.2004.01.011; van Dam L, 2000, J MOL BIOL, V304, P541, DOI 10.1006/jmbi.2000.4194; Varnai P, 2002, NUCLEIC ACIDS RES, V30, P5398, DOI 10.1093/nar/gkf680; Wellenzohn B, 2002, BIOCHEMISTRY-US, V41, P4088, DOI 10.1021/bi015642t; Winger RH, 1999, J BIOMOL STRUCT DYN, V17, P223, DOI 10.1080/07391102.1999.10508355; YANAGI K, 1991, J MOL BIOL, V217, P201, DOI 10.1016/0022-2836(91)90620-L; YOON C, 1988, P NATL ACAD SCI USA, V85, P6332, DOI 10.1073/pnas.85.17.6332; YOUNG MA, 1995, BIOPHYS J, V68, P2454, DOI 10.1016/S0006-3495(95)80427-3; Zacharias M, 2006, BIOPHYS J, V91, P882, DOI 10.1529/biophysj.106.083816	46	56	56	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15931	10.1371/journal.pone.0015931	http://dx.doi.org/10.1371/journal.pone.0015931			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21209967	Green Published, gold, Green Submitted			2022-12-27	WOS:000285793200074
J	Ifkovits, JL; Wu, K; Mauck, RL; Burdick, JA				Ifkovits, Jamie L.; Wu, Katherine; Mauck, Robert L.; Burdick, Jason A.			The Influence of Fibrous Elastomer Structure and Porosity on Matrix Organization	PLOS ONE			English	Article							ELECTROSPUN SCAFFOLDS; NANOFIBROUS SCAFFOLDS; BIODEGRADABLE ELASTOMER; ANNULUS FIBROSUS; TISSUE; CARDIOMYOCYTES; INFILTRATION; REPLACEMENT; ANISOTROPY; FIBERS	Fibrous scaffolds are finding wide use in the field of tissue engineering, as they can be designed to mimic many native tissue properties and structures (e. g., cardiac tissue, meniscus). The influence of fiber alignment and scaffold architecture on cellular interactions and matrix organization was the focus of this study. Three scaffolds were fabricated from the photocrosslinkable elastomer poly(glycerol sebacate) (PGS), with changes in fiber alignment (non-aligned (NA) versus aligned (AL)) and the introduction of a PEO sacrificial polymer population to the AL scaffold (composite (CO)). PEO removal led to an increase in scaffold porosity and maintenance of scaffold anisotropy, as evident through visualization, mechanical testing, and mass loss studies. Hydrated scaffolds possessed moduli that ranged between similar to 3-240 kPa, failing within the range of properties (<300 kPa) appropriate for soft tissue engineering. CO scaffolds were completely degraded as early as 16 days, whereas NA and AL scaffolds had similar to 90% mass loss after 21 days when monitored in vitro. Neonatal cardiomyocytes, used as a representative cell type, that were seeded onto the scaffolds maintained their viability and aligned along the surface of the AL and CO fibers. When implanted subcutaneously in rats, a model that is commonly used to investigate in vivo tissue responses to biomaterials, CO scaffolds were completely integrated at 2 weeks, whereas similar to 13% and similar to 16% of the NA and AL scaffolds, respectively remained acellular. However, all scaffolds were completely populated with cells at 4 weeks post-implantation. Polarized light microscopy was used to evaluate the collagen elaboration and orientation within the scaffold. An increase in the amount of collagen was observed for CO scaffolds and enhanced alignment of the nascent collagen was observed for AL and CO scaffolds compared to NA scaffolds. Thus, these results indicate that the scaffold architecture and porosity are important considerations in controlling tissue formation.	[Ifkovits, Jamie L.; Wu, Katherine; Mauck, Robert L.; Burdick, Jason A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Mauck, Robert L.] Univ Penn, Dept Orthopaed Surg, McKay Orthopaed Res Lab, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Ifkovits, JL (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.	burdick2@seas.upenn.edu		Mauck, Robert/0000-0002-9537-603X	American Heart Association; Ashton Foundation; National Institutes of Health [R01AR056624]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056624] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Ashton Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by an American Heart Association predoctoral fellowship and an Ashton Foundation Fellowship to Jamie Ifkovits and a National Institutes of Health grant (R01AR056624). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker BM, 2008, BIOMATERIALS, V29, P2348, DOI 10.1016/j.biomaterials.2008.01.032; Baker BM, 2007, BIOMATERIALS, V28, P1967, DOI 10.1016/j.biomaterials.2007.01.004; Baker BM, 2009, EXPERT REV MED DEVIC, V6, P515, DOI [10.1586/erd.09.39, 10.1586/ERD.09.39]; Blackwood KA, 2008, BIOMATERIALS, V29, P3091, DOI 10.1016/j.biomaterials.2008.03.037; Chien KR, 2008, SCIENCE, V322, P1494, DOI 10.1126/science.1163267; Courtney T, 2006, BIOMATERIALS, V27, P3631, DOI 10.1016/j.biomaterials.2006.02.024; Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316; Fromstein JD, 2008, TISSUE ENG PT A, V14, P369, DOI 10.1089/tea.2006.0410; Ifkovits JL, 2009, ACS APPL MATER INTER, V1, P1878, DOI 10.1021/am900403k; Ifkovits JL, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034104; Khademhosseini A, 2006, J BIOMED MATER RES A, V79A, P522, DOI 10.1002/jbm.a.30821; Lavik E, 2004, APPL MICROBIOL BIOT, V65, P1, DOI 10.1007/s00253-004-1580-z; Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j; Li JL, 2007, J BIOL CHEM, V282, P34984, DOI 10.1074/jbc.M703513200; MAUCK RL, 2009, TISSUE EN B IN PRESS; METTER RB, ACTA BIOMATER, V6, P1219; Nam J, 2007, TISSUE ENG, V13, P2249, DOI 10.1089/ten.2006.0306; Nam J, 2009, TISSUE ENG PT A, V15, P513, DOI 10.1089/ten.tea.2007.0353; Nerem RM, 2006, TISSUE ENG, V12, P1143, DOI 10.1089/ten.2006.12.1143; Nerurkar NL, 2007, J ORTHOP RES, V25, P1018, DOI 10.1002/jor.20384; Nerurkar NL, 2009, NAT MATER, V8, P986, DOI [10.1038/NMAT2558, 10.1038/nmat2558]; Rockwood DN, 2008, BIOMATERIALS, V29, P4783, DOI 10.1016/j.biomaterials.2008.08.034; Stankus JJ, 2008, J BIOMAT SCI-POLYM E, V19, P635, DOI 10.1163/156856208784089599; Sundararaghavan H. G., MACROMOL BIOSCI, V10, P265; Tan AR, 2008, J BIOMED MATER RES A, V87A, P1034, DOI 10.1002/jbm.a.31853; Tzezana R, 2008, TISSUE ENG PART C-ME, V14, P281, DOI 10.1089/ten.tec.2008.0201; van Amerongen MJ, 2006, BIOMATERIALS, V27, P2247, DOI 10.1016/j.biomaterials.2005.11.002; Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602; Webb AR, 2004, EXPERT OPIN BIOL TH, V4, P801, DOI 10.1517/14712598.4.6.801; Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3; Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051; Zhu XL, 2008, BIOMACROMOLECULES, V9, P1795, DOI 10.1021/bm800476u	32	24	24	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15717	10.1371/journal.pone.0015717	http://dx.doi.org/10.1371/journal.pone.0015717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203510	Green Published, Green Submitted, gold			2022-12-27	WOS:000285578000049
J	Soliman, S; Heiner, M				Soliman, Sylvain; Heiner, Monika			A Unique Transformation from Ordinary Differential Equations to Reaction Networks	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; PETRI NETS; SYSTEMS; LANGUAGE; TOOL	Many models in Systems Biology are described as a system of Ordinary Differential Equations, which allows for transient, steady-state or bifurcation analysis when kinetic information is available. Complementary structure-related qualitative analysis techniques have become increasingly popular in recent years, like qualitative model checking or pathway analysis (elementary modes, invariants, flux balance analysis, graph-based analyses, chemical organization theory, etc.). They do not rely on kinetic information but require a well-defined structure as stochastic analysis techniques equally do. In this article, we look into the structure inference problem for a model described by a system of Ordinary Differential Equations and provide conditions for the uniqueness of its solution. We describe a method to extract a structured reaction network model, represented as a bipartite multigraph, for example, a continuous Petri net (CPN), from a system of Ordinary Differential Equations (ODEs). A CPN uniquely defines an ODE, and each ODE can be transformed into a CPN. However, it is not obvious under which conditions the transformation of an ODE into a CPN is unique, that is, when a given ODE defines exactly one CPN. We provide biochemically relevant sufficient conditions under which the derived structure is unique and counterexamples showing the necessity of each condition. Our method is implemented and available; we illustrate it on some signal transduction models from the BioModels database. A prototype implementation of the method is made available to modellers at http://contraintes.inria.fr/similar to soliman/ode2pn.html, and the data mentioned in the "Results'' section at http://contraintes.inria.fr/similar to soliman/ode2pn_data/. Our results yield a new recommendation for the import/export feature of tools supporting the SBML exchange format.	[Soliman, Sylvain] INRIA Paris Rocquencourt, Equipe Projet Contraintes, Paris, France; [Heiner, Monika] Brandenburg Tech Univ Cottbus, Dept Comp Sci, Cottbus, Germany	Brandenburg University of Technology Cottbus	Soliman, S (corresponding author), INRIA Paris Rocquencourt, Equipe Projet Contraintes, BP105, Paris, France.	Sylvain.Soliman@inria.fr	Heiner, Monika/AAG-1022-2019; Soliman, Sylvain/B-7445-2009	Heiner, Monika/0000-0003-1815-1205; Soliman, Sylvain/0000-0001-5525-7418	French ANR SYSCOMM [ANR-08-SYSC-003]	French ANR SYSCOMM(French National Research Agency (ANR))	SS received support from French ANR SYSCOMM 2008 project Calamar (ANR-08-SYSC-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli D, 2007, LECT NOTES CONTR INF, V357, P181, DOI 10.1007/978-3-540-71988-5_9; BAUSE F, 1994, ABSTR PETR NET NOT; Brightman FA, 2000, FEBS LETT, V482, P169, DOI 10.1016/S0014-5793(00)02037-8; Clark Andy, 2010, COGNITIVE LIFE THING, P23; Dematte L, 2008, LECT NOTES COMPUT SC, V5016, P313; Dematte L, 2008, BRIEF BIOINFORM, V9, P437, DOI 10.1093/bib/bbn023; Dittrich P, 2007, B MATH BIOL, V69, P1199, DOI 10.1007/s11538-006-9130-8; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; EULER L, 1809, MEMOIRES ACAD SCI ST, V1, P3; Feinberg M., 1977, CHEM REACTOR THEORY, P1; Funahashi A, 2008, P IEEE, V96, P1254, DOI 10.1109/JPROC.2008.925458; GEND C, 2001, P 2 INT C SYST BIOL, P326; Gilbert D, 2006, LECT NOTES COMPUT SC, V4024, P181; Goss PJE, 1998, P NATL ACAD SCI USA, V95, P6750, DOI 10.1073/pnas.95.12.6750; Heiner M, 2004, LECT NOTES COMPUT SC, V3099, P216; HEINER M, 2010, SYMBOLIC SYSTEMS BIO; Heiner M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008600; Heiner M, 2009, NAT COMPUT SER, P367, DOI 10.1007/978-3-540-88869-7_19; Heiner M, 2008, LECT NOTES COMPUT SC, V5016, P215; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Kaleta C, 2009, BIOINFORMATICS, V25, P1915, DOI 10.1093/bioinformatics/btp332; Koh G, 2006, BIOINFORMATICS, V22, pE271, DOI 10.1093/bioinformatics/btl264; Le Novere N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092; NABLI F, 2010, CMSB 10, P14; Palsson BO., 2006, SYSTEMS BIOL PROPERT; Rohr C, 2010, BIOINFORMATICS, V26, P974, DOI 10.1093/bioinformatics/btq050; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; Shinar G, 2010, SCIENCE, V327, P1389, DOI 10.1126/science.1183372; Singh A, 2006, BIOTECHNOL BIOENG, V95, P850, DOI 10.1002/bit.21026; SOLIMAN S, 2009, P 6 VIENN C MATH MOD, V35, P2304; VARMA A, 1994, BIO-TECHNOL, V12, P994, DOI 10.1038/nbt1094-994; Yamada S, 2003, FEBS LETT, V534, P190, DOI 10.1016/S0014-5793(02)03842-5	33	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14284	10.1371/journal.pone.0014284	http://dx.doi.org/10.1371/journal.pone.0014284			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203560	Green Published, gold, Green Submitted			2022-12-27	WOS:000285578000001
J	Carraro, V; Maurin, AC; Lambert-Langlais, S; Averous, J; Chaveroux, C; Parry, L; Jousse, C; Ord, D; Ord, T; Fafournoux, P; Bruhat, A				Carraro, Valerie; Maurin, Anne-Catherine; Lambert-Langlais, Sarah; Averous, Julien; Chaveroux, Cedric; Parry, Laurent; Jousse, Celine; Oerd, Daima; Oerd, Tonis; Fafournoux, Pierre; Bruhat, Alain			Amino Acid Availability Controls TRB3 Transcription in Liver through the GCN2/eIF2 alpha/ATF4 Pathway	PLOS ONE			English	Article							ASPARAGINE SYNTHETASE GENE; UNFOLDED PROTEIN RESPONSE; C/EBP-BETA; CELL-DEATH; ENDOPLASMIC-RETICULUM; MOLECULAR-MECHANISMS; HISTONE ACETYLATION; INSULIN-RESISTANCE; TRIBBLES HOMOLOG; LIPID-METABOLISM	In mammals, plasma amino acid concentrations are markedly affected by dietary or pathological conditions. It has been well established that amino acids are involved in the control of gene expression. Up to now, all the information concerning the molecular mechanisms involved in the regulation of gene transcription by amino acid availability has been obtained in cultured cell lines. The present study aims to investigate the mechanisms involved in transcriptional activation of the TRB3 gene following amino acid limitation in mice liver. The results show that TRB3 is up-regulated in the liver of mice fed a leucine-deficient diet and that this induction is quickly reversible. Using transient transfection and chromatin immunoprecipitation approaches in hepatoma cells, we report the characterization of a functional Amino Acid Response Element (AARE) in the TRB3 promoter and the binding of ATF4, ATF2 and C/EBP beta to this AARE sequence. We also provide evidence that only the binding of ATF4 to the AARE plays a crucial role in the amino acid-regulated transcription of TRB3. In mouse liver, we demonstrate that the GCN2/eIF2 alpha/ATF4 pathway is essential for the induction of the TRB3 gene transcription in response to a leucine-deficient diet. Therefore, this work establishes for the first time that the molecular mechanisms involved in the regulation of gene transcription by amino acid availability are functional in mouse liver.	[Carraro, Valerie; Maurin, Anne-Catherine; Lambert-Langlais, Sarah; Averous, Julien; Parry, Laurent; Jousse, Celine; Fafournoux, Pierre; Bruhat, Alain] INRA, UMR Nutr Humaine 1019, F-63122 St Genes Champanelle, France; [Carraro, Valerie; Maurin, Anne-Catherine; Lambert-Langlais, Sarah; Averous, Julien; Parry, Laurent; Jousse, Celine; Fafournoux, Pierre; Bruhat, Alain] Univ Clermont 1, UMR Nutr Humaine 1019, UFR Med, Clermont Ferrand, France; [Chaveroux, Cedric] McGill Univ, Goodman Canc Ctr, Montreal, PQ, Canada; [Oerd, Daima; Oerd, Tonis] Estonian Bioctr, Tartu, Estonia	INRAE; Universite Clermont Auvergne (UCA); McGill University; Estonian Biocentre	Carraro, V (corresponding author), INRA, UMR Nutr Humaine 1019, F-63122 St Genes Champanelle, France.	pierre.fafournoux@clermont.inra.fr; alain.bruhat@clermont.inra.fr	Örd, Tõnis/G-8113-2012; Örd, Daima/H-4467-2012	Örd, Tõnis/0000-0001-8778-2508; Chaveroux, Cedric/0000-0002-4116-3354	Institut National de la Recherche Agronomique (INRA, France); Estonian Science Foundation [7683]	Institut National de la Recherche Agronomique (INRA, France); Estonian Science Foundation	This work was supported by grants from the Institut National de la Recherche Agronomique (INRA, France). T. Ord is supported by Grant 7683 from the Estonian Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Barbosa-Tessmann IP, 2000, J BIOL CHEM, V275, P26976; Bezy O, 2007, MOL CELL BIOL, V27, P6818, DOI 10.1128/MCB.00375-07; Breitwieser W, 2007, GENE DEV, V21, P2069, DOI 10.1101/gad.430207; Bruhat A, 2000, MOL CELL BIOL, V20, P7192, DOI 10.1128/MCB.20.19.7192-7204.2000; Bruhat A, 2002, J BIOL CHEM, V277, P48107, DOI 10.1074/jbc.M206149200; Bruhat A, 1997, J BIOL CHEM, V272, P17588, DOI 10.1074/jbc.272.28.17588; Bruhat A, 2007, NUCLEIC ACIDS RES, V35, P1312, DOI 10.1093/nar/gkm038; Bruhat A, 2009, BIOFACTORS, V35, P249, DOI 10.1002/biof.40; Chan MC, 2007, MOL CELL BIOL, V27, P5776, DOI 10.1128/MCB.00218-07; Chaveroux C, 2009, MOL CELL BIOL, V29, P6515, DOI 10.1128/MCB.00489-09; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; Deval C, 2009, FEBS J, V276, P707, DOI 10.1111/j.1742-4658.2008.06818.x; Ding JX, 2008, EXP CELL RES, V314, P1566, DOI 10.1016/j.yexcr.2008.01.026; Du KY, 2009, MOL ENDOCRINOL, V23, P475, DOI 10.1210/me.2008-0284; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Gietzen DW, 2004, J NUTR, V134, P717, DOI 10.1093/jn/134.4.717; Hao SZ, 2005, SCIENCE, V307, P1776, DOI 10.1126/science.1104882; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; He L, 2006, J BIOL CHEM, V281, P11126, DOI 10.1074/jbc.M510724200; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kimball Scot R, 2004, Nutr Metab (Lond), V1, P3, DOI 10.1186/1743-7075-1-3; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P9774, DOI 10.1073/pnas.86.24.9774; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Matsushima R, 2006, J BIOL CHEM, V281, P29719, DOI 10.1074/jbc.M511636200; Maurin AC, 2005, CELL METAB, V1, P273, DOI 10.1016/j.cmet.2005.03.004; Ord D, 2007, EXP CELL RES, V313, P3556, DOI 10.1016/j.yexcr.2007.07.017; Ord T, 2009, GENE, V444, P24, DOI 10.1016/j.gene.2009.06.001; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Ord D, 2005, BIOCHEM BIOPH RES CO, V330, P210, DOI 10.1016/j.bbrc.2005.02.149; Ord D, 2003, EXP CELL RES, V286, P308, DOI 10.1016/S0014-4827(03)00070-3; Pan YX, 2007, BIOCHEM J, V401, P299, DOI 10.1042/BJ20061261; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Prudente S, 2005, DIABETES, V54, P2807, DOI 10.2337/diabetes.54.9.2807; Prudente S, 2009, J CLIN ENDOCR METAB, V94, P190, DOI 10.1210/jc.2008-1365; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Schwarzer R, 2006, CELL SIGNAL, V18, P899, DOI 10.1016/j.cellsig.2005.08.002; SHAN J, PHYSL GENOMICS; SIERRA F, 1990, MOL BIOL MED, V7, P131; Siu F, 2001, J BIOL CHEM, V276, P48100, DOI 10.1074/jbc.M109533200; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Thiaville MM, 2008, BIOCHEM J, V410, P473, DOI 10.1042/BJ20071252; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Yaman I, 2002, J BIOL CHEM, V277, P41539, DOI 10.1074/jbc.M204850200; Yao XH, 2008, AM J PHYSIOL-REG I, V294, pR1797, DOI 10.1152/ajpregu.00804.2007; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	51	48	50	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15716	10.1371/journal.pone.0015716	http://dx.doi.org/10.1371/journal.pone.0015716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203563	Green Published, gold, Green Submitted			2022-12-27	WOS:000285576900037
J	Kovtun, O; Mureev, S; Johnston, W; Alexandrov, K				Kovtun, Oleksiy; Mureev, Sergey; Johnston, Wayne; Alexandrov, Kirill			Towards the Construction of Expressed Proteomes Using a Leishmania tarentolae Based Cell-Free Expression System	PLOS ONE			English	Article							PROTEIN; EVOLUTION; PHOSPHATASE; DISEASE	The adaptation of organisms to a parasitic life style is often accompanied by the emergence of novel biochemical pathways absent in free-living organisms. As a result, the genomes of specialized parasitic organisms often code for a large number (> 50%) of proteins with no detectable homology or predictable function. Although understanding the biochemical properties of these proteins and their roles in parasite biogenesis is the next challenge of molecular parasitology, analysis tools developed for free-living organisms are often inadequate for this purpose. Here we attempt to solve some of these problems by developing a methodology for the rapid production of expressed proteomes in cell-free systems based on parasitic organisms. To do so we take advantage of Species Independent Translational Sequences (SITS), which can efficiently mediate translation initiation in any organism. Using these sequences we developed a single-tube in vitro translation system based on the parasitic protozoan Leishmania tarentolae. We demonstrate that the system can be primed directly with SITS containing templates constructed by overlap extension PCR. To test the systems we simultaneously amplified 31 of L. tarentolae's putative translation initiation factors and phosphatases directly from the genomic DNA and subjected them to expression, purification and activity analysis. All of the amplified products produced soluble recombinant proteins, and putative phosphatases could be purified to at least 50% purity in one step. We further compared the ability of L. tarentolae and E. coli based cell-free systems to express a set of mammalian, L. tarentolae and Plasmodium falciparum Rab GTPases in functional form. We demonstrate that the L. tarentolae cell-free system consistently produced higher quality proteins than E. coli-based system. The differences were particularly pronounced in the case of open reading frames derived from P. falciparum. The implications of these developments are discussed.	[Kovtun, Oleksiy; Mureev, Sergey; Johnston, Wayne; Alexandrov, Kirill] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	University of Queensland	Kovtun, O (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	k.alexandrov@uq.edu.au	Mureev, Sergey/ABB-4757-2020; Kovtun, Oleksiy/F-7443-2015; Alexandrov, Kirill/A-5830-2013; Kovtun, Oleksiy/AAE-5397-2019; mureev, sergey/K-3521-2014; Johnston, Wayne/D-2095-2017	Kovtun, Oleksiy/0000-0001-6374-7863; Alexandrov, Kirill/0000-0002-0957-6511; Kovtun, Oleksiy/0000-0001-6374-7863; mureev, sergey/0000-0001-9999-3150; Johnston, Wayne/0000-0002-7485-8363	ARC [DP003363, FT0991611]; University of Queensland	ARC(Australian Research Council); University of Queensland(University of Queensland)	This work was supported in part by grant ARC grants DP003363 and FT0991611 to K. A. O.K was supported by a fellowship of the University of Queensland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADHIN MR, 1990, J MOL BIOL, V213, P811, DOI 10.1016/S0022-2836(05)80265-7; Azizi H, 2009, PARASITOLOGY, V136, P723, DOI 10.1017/S0031182009005873; BAI GE, 1988, FASEB J, V2, P3010, DOI 10.1096/fasebj.2.14.2846396; Birkholtz LM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-197; Dursina B, 2002, BIOCHEMISTRY-US, V41, P6805, DOI 10.1021/bi016067w; Goshima N, 2008, NAT METHODS, V5, P1011, DOI 10.1038/nmeth.1273; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hirano N, 2006, PROTEINS, V64, P343, DOI 10.1002/prot.21008; Hoffmann Michael, 2004, Biotechnol Annu Rev, V10, P1, DOI 10.1016/S1387-2656(04)10001-X; Mureev S, 2009, NAT BIOTECHNOL, V27, P747, DOI 10.1038/nbt.1556; Myler P. J., 2009, Infectious Disorders - Drug Targets, V9, P493; Myler PJ, 2008, ADV EXP MED BIOL, V625, P133, DOI 10.1007/978-0-387-77570-8_11; Nguyen UTT, 2009, NAT CHEM BIOL, V5, P227, DOI 10.1038/nchembio.149; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Rak A, 2004, CELL, V117, P749, DOI 10.1016/j.cell.2004.05.017; SARABHAI A, 1967, J MOL BIOL, V27, P145, DOI 10.1016/0022-2836(67)90357-9; Schwarz D, 2007, NAT PROTOC, V2, P2945, DOI 10.1038/nprot.2007.426; Spirin AS, 2009, BIOCHEMISTRY-US, V48, P10688, DOI 10.1021/bi901379a; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Waldo Geoffrey S., 2003, V230, P343; ZHUO S, 1993, J BIOL CHEM, V268, P17754	22	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e14388	10.1371/journal.pone.0014388	http://dx.doi.org/10.1371/journal.pone.0014388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203562	gold, Green Published, Green Submitted			2022-12-27	WOS:000285576900006
J	Umeda, T; Takashima, N; Nakagawa, R; Maekawa, M; Ikegami, S; Yoshikawa, T; Kobayashi, K; Okanoya, K; Inokuchi, K; Osumi, N				Umeda, Toshiko; Takashima, Noriko; Nakagawa, Ryoko; Maekawa, Motoko; Ikegami, Shiro; Yoshikawa, Takeo; Kobayashi, Kazuto; Okanoya, Kazuo; Inokuchi, Kaoru; Osumi, Noriko			Evaluation of Pax6 Mutant Rat as a Model for Autism	PLOS ONE			English	Article							MENTAL-RETARDATION; PREPULSE INHIBITION; ULTRASONIC VOCALIZATION; SPECTRUM DISORDERS; RECEPTOR GENE; WAGR SYNDROME; CREST CELLS; MOUSE MODEL; SMALL-EYE; SEROTONIN	Autism is a highly variable brain developmental disorder and has a strong genetic basis. Pax6 is a pivotal player in brain development and maintenance. It is expressed in embryonic and adult neural stem cells, in astrocytes in the entire central nervous system, and in neurons in the olfactory bulb, amygdala, thalamus, and cerebellum, functioning in highly context-dependent manners. We have recently reported that Pax6 heterozygous mutant (rSey(2)/+) rats with a spontaneous mutation in the Pax6 gene, show impaired prepulse inhibition (PPI). In the present study, we further examined behaviors of rSey(2)/+ rats and revealed that they exhibited abnormality in social interaction (more aggression and withdrawal) in addition to impairment in rearing activity and in fear-conditioned memory. Ultrasonic vocalization (USV) in rSey(2)+ rat pups was normal in male but abnormal in female. Moreover, treatment with clozapine successfully recovered the defects in sensorimotor gating function, but not in fear-conditioned memory. Taken together with our prior human genetic data and results in other literatures, rSey(2)/+ rats likely have some phenotypic components of autism.	[Umeda, Toshiko; Osumi, Noriko] Tohoku Univ, Grad Sch Med, Div Dev Neurosci, Sendai, Miyagi 980, Japan; [Takashima, Noriko] RIKEN, Brain Sci Inst, Lab Behav & Dev Disorders, Wako, Saitama, Japan; [Takashima, Noriko; Ikegami, Shiro; Inokuchi, Kaoru] Mitsubishi Kagaku Inst Life Sci MITILS, Tokyo, Japan; [Nakagawa, Ryoko; Okanoya, Kazuo] RIKEN, Brain Sci Inst, Lab Biolinguist, Wako, Saitama, Japan; [Maekawa, Motoko; Yoshikawa, Takeo] RIKEN, Brain Sci Inst, Lab Mol Psychiat, Wako, Saitama, Japan; [Ikegami, Shiro] Saitama Inst Technol, Dept Psychol, Fukaya, Japan; [Kobayashi, Kazuto] Fukushima Med Univ, Inst Biomed Sci, Dept Mol Genet, Sch Med, Fukushima, Japan; [Inokuchi, Kaoru] Toyama Univ, Dept Biochem, Fac Med, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan	Tohoku University; RIKEN; Mitsubishi Kagaku Institute of Life Sciences (MITILS); RIKEN; RIKEN; Saitama Institute Technology; Fukushima Medical University; University of Toyama	Umeda, T (corresponding author), Tohoku Univ, Grad Sch Med, Div Dev Neurosci, Sendai, Miyagi 980, Japan.	osumi@med.tohoku.ac.jp	Yoshikawa, Takeo/F-9599-2019; Osumi, Noriko/T-2823-2019; Inokuchi, Kaoru/AAI-9693-2020	Osumi, Noriko/0000-0003-0548-6452; Inokuchi, Kaoru/0000-0002-5393-3133	Special Coordinate Funds for Promoting Science and Technology; Japanese Science and Technology Agency; MEXT (the Ministry of Education, Culture, Sports, Science and Technology) of Japan	Special Coordinate Funds for Promoting Science and Technology; Japanese Science and Technology Agency(Japan Science & Technology Agency (JST)); MEXT (the Ministry of Education, Culture, Sports, Science and Technology) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Special Coordinate Funds for Promoting Science and Technology (to N.O.), Japanese Science and Technology Agency (to N.O., T.Y. and K.I.), and Global COE (Centers of Excellence) Program from MEXT (the Ministry of Education, Culture, Sports, Science and Technology) of Japan (to N.O.). T.U. and R.N. are Japan Society for the Promotion of Science Research fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GM, 2002, J AM ACAD CHILD PSY, V41, P1513, DOI 10.1097/00004583-200212000-00025; ARRANZ M, 1995, LANCET, V346, P281, DOI 10.1016/S0140-6736(95)92168-0; Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Becker A, 1999, PSYCHOPHARMACOLOGY, V144, P333, DOI 10.1007/s002130051015; Becker KG, 2004, MED HYPOTHESES, V62, P309, DOI 10.1016/S0306-9877(03)00332-3; Bill BR, 2009, CURR OPIN GENET DEV, V19, P271, DOI 10.1016/j.gde.2009.04.004; Bouwknecht JA, 2004, EUR J PHARMACOL, V494, P35, DOI 10.1016/j.ejphar.2004.04.036; Brauer D, 2009, J NEURAL TRANSM, V116, P607, DOI 10.1007/s00702-009-0222-0; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Branchi I, 2001, BEHAV BRAIN RES, V125, P49, DOI 10.1016/S0166-4328(01)00277-7; Brieden T, 2002, PHARMACOPSYCHIATRY, V35, P83, DOI 10.1055/s-2002-31523; Burnet PWJ, 1996, NEUROSCIENCE, V73, P531, DOI 10.1016/0306-4522(96)00062-0; Cook Edwin H. Jr., 1996, Current Opinion in Pediatrics, V8, P348, DOI 10.1097/00008480-199608000-00008; COSTALL B, 1989, PHARMACOL BIOCHEM BE, V33, P573, DOI 10.1016/0091-3057(89)90390-0; Danaceau JP, 2003, J ANAL TOXICOL, V27, P440, DOI 10.1093/jat/27.7.440; Davis LK, 2008, HUM GENET, V123, P371, DOI 10.1007/s00439-008-0484-x; Dworzynski K, 2009, J AUTISM DEV DISORD, V39, P1197, DOI 10.1007/s10803-009-0736-1; Fischbach BV, 2005, PEDIATRICS, V116, P984, DOI 10.1542/peds.2004-0467; Free SL, 2003, NEUROIMAGE, V20, P2281, DOI 10.1016/j.neuroimage.2003.07.001; Freitag CM, 2010, EUR CHILD ADOLES PSY, V19, P169, DOI 10.1007/s00787-009-0076-x; FRITH U, 1993, SCI AM, V268, P108, DOI 10.1038/scientificamerican0693-108; Geschwind DH, 2009, ANNU REV MED, V60, P367, DOI 10.1146/annurev.med.60.053107.121225; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; Graziano C, 2007, AM J MED GENET A, V143A, P1802, DOI 10.1002/ajmg.a.31808; Guo HL, 2000, BIOCHEM BIOPH RES CO, V273, P661, DOI 10.1006/bbrc.2000.2870; Haba H, 2009, NEUROSCI RES, V65, P116, DOI 10.1016/j.neures.2009.05.011; HANSON I, 1995, TRENDS GENET, V11, P268, DOI 10.1016/S0168-9525(00)89073-3; Hardan AY, 2009, PSYCHIAT RES-NEUROIM, V174, P57, DOI 10.1016/j.pscychresns.2009.03.005; Hartley SL, 2009, J AUTISM DEV DISORD; Huang CH, 2008, AM J MED GENET B, V147B, P903, DOI 10.1002/ajmg.b.30720; Hughes JR, 2009, EPILEPSY BEHAV, V16, P569, DOI 10.1016/j.yebeh.2009.09.023; Ikegami S, 2000, NEUROSCIENCE, V98, P637, DOI 10.1016/S0306-4522(00)00161-5; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Kanakubo S, 2006, GENES CELLS, V11, P919, DOI 10.1111/j.1365-2443.2006.00992.x; Kew JNC, 2000, J NEUROSCI, V20, P4037; Klin A, 2007, J AUTISM DEV DISORD, V37, P748, DOI 10.1007/s10803-006-0229-4; Levy SE, 2009, LANCET, V374, P1627, DOI 10.1016/S0140-6736(09)61376-3; Maekawa M, 2005, GENES CELLS, V10, P1001, DOI 10.1111/j.1365-2443.2005.00893.x; Maekawa M, 2009, NEUROSCI LETT, V462, P267, DOI 10.1016/j.neulet.2009.07.021; Maekawa M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005085; Malandrini A, 2001, CLIN GENET, V60, P151, DOI 10.1034/j.1399-0004.2001.600210.x; MATSUO T, 1993, NAT GENET, V3, P299, DOI 10.1038/ng0493-299; McAlonan GM, 2002, BRAIN, V125, P1594, DOI 10.1093/brain/awf150; McEuen JG, 2009, ENDOCRINOLOGY, V150, P3709, DOI 10.1210/en.2008-1721; Mitchell TN, 2003, ANN NEUROL, V53, P658, DOI 10.1002/ana.10576; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nishina S, 1999, BRIT J OPHTHALMOL, V83, P723, DOI 10.1136/bjo.83.6.723; Ospina MB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003755; Osumi N, 2001, TOHOKU J EXP MED, V193, P163, DOI 10.1620/tjem.193.163; Osumi N, 1997, DEVELOPMENT, V124, P2961; Perry W, 2007, BIOL PSYCHIAT, V61, P482, DOI 10.1016/j.biopsych.2005.09.025; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; RIGDON GC, 1992, J PHARMACOL EXP THER, V263, P486; Ronald A, 2006, J AM ACAD CHILD PSY, V45, P691, DOI 10.1097/01.chi.0000215325.13058.9d; Sakurai K, 2008, J NEUROSCI, V28, P4604, DOI 10.1523/JNEUROSCI.5074-07.2008; Sano H, 2003, J NEUROSCI, V23, P9078; SCHMAHL W, 1993, ACTA NEUROPATHOL, V86, P126, DOI 10.1007/BF00334879; Senju A, 2009, NEUROSCI BIOBEHAV R, V33, P1204, DOI 10.1016/j.neubiorev.2009.06.001; Shinohara T, 2001, HUM MOL GENET, V10, P1163, DOI 10.1093/hmg/10.11.1163; Shors TJ, 2001, J NEUROSCI, V21, P6292, DOI 10.1523/JNEUROSCI.21-16-06292.2001; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Sisodiya SM, 2001, NAT GENET, V28, P214, DOI 10.1038/90042; Spivak B, 2004, NEUROPSYCHOBIOLOGY, V50, P157, DOI 10.1159/000079108; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; Swerdlow NR, 2000, J NEUROSCI, V20, P4325; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; Tuoc TC, 2009, J NEUROSCI, V29, P8335, DOI 10.1523/JNEUROSCI.5669-08.2009; Van Steenwinckel J, 2009, NEUROSCIENCE, V161, P838, DOI 10.1016/j.neuroscience.2009.03.087; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wellmann K, 2010, NEUROTOXICOL TERATOL, V32, P158, DOI 10.1016/j.ntt.2009.11.005; Wells CE, 2009, BEHAV BRAIN RES, V197, P234, DOI 10.1016/j.bbr.2008.08.013; WING L, 1981, PSYCHIAT RES, V5, P129, DOI 10.1016/0165-1781(81)90043-3; Xu S, 2008, CYTOGENET GENOME RES, V122, P181, DOI 10.1159/000172086; Young DM, 2010, P NATL ACAD SCI USA, V107, P11074, DOI 10.1073/pnas.1005620107; [No title captured]	79	45	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15500	10.1371/journal.pone.0015500	http://dx.doi.org/10.1371/journal.pone.0015500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203536	Green Published, gold			2022-12-27	WOS:000285576900031
J	Handel, AE; Williamson, AJ; Disanto, G; Dobson, R; Giovannoni, G; Ramagopalan, SV				Handel, Adam E.; Williamson, Alexander J.; Disanto, Giulio; Dobson, Ruth; Giovannoni, Gavin; Ramagopalan, Sreeram V.			Smoking and Multiple Sclerosis: An Updated Meta-Analysis	PLOS ONE			English	Article							LIFE-STYLE FACTORS; CIGARETTE-SMOKING; RHEUMATOID-ARTHRITIS; ORAL-CONTRACEPTIVES; RISK-FACTOR; PROGRESSION; EXPOSURE; DISEASE; MS; EPIDEMIOLOGY	Background: Multiple sclerosis (MS) is a leading cause of disability in young adults. Susceptibility to MS is determined by environmental exposure on the background of genetic risk factors. A previous meta-analysis suggested that smoking was an important risk factor for MS but many other studies have been published since then. Methods/Principal Findings: We performed a Medline search to identify articles published that investigated MS risk following cigarette smoking. A total of 14 articles were included in this study. This represented data on 3,052 cases and 457,619 controls. We analysed these studies in both a conservative (limiting our analysis to only those where smoking behaviour was described prior to disease onset) and non-conservative manner. Our results show that smoking is associated with MS susceptibility (conservative: risk ratio (RR) 1.48, 95% confidence interval (CI) 1.35-1.63, p<10(-15); non-conservative: RR 1.52, 95% CI 1.39-1.66, p<10(-19)). We also analysed 4 studies reporting risk of secondary progression in MS and found that this fell just short of statistical significance with considerable heterogeneity (RR 1.88, 95% CI 0.98-3.61, p = 0.06). Discussion: Our results demonstrate that cigarette smoking is important in determining MS susceptibility but the effect on the progression of disease is less certain. Further work is needed to understand the mechanism behind this association and how smoking integrates with other established risk factors.	[Handel, Adam E.; Disanto, Giulio; Ramagopalan, Sreeram V.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Handel, Adam E.; Disanto, Giulio; Ramagopalan, Sreeram V.] Univ Oxford, Dept Clin Neurol, Oxford, England; [Williamson, Alexander J.] Univ Oxford, Dept Phys & Theoret Chem, Oxford, England; [Dobson, Ruth; Giovannoni, Gavin; Ramagopalan, Sreeram V.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst Cell & Mol Sci, London, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford; University of London; Queen Mary University London	Handel, AE (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	g.giovannoni@qmul.ac.uk; sreeramr@well.ox.ac.uk	Handel, Adam/F-2489-2011	Ebers, George/0000-0003-4771-4177; McKeating, Jane/0000-0002-7229-5886; Handel, Adam/0000-0001-8385-6346	Wellcome Trust [075491/Z/04]; Medical Research Council [G0801976]; MRC [G0801976] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Wellcome Trust [GRANT NUMBER 075491/Z/04] and Medical Research Council [GRANT NUMBER G0801976]. SVR is a Goodger Scholar at the University of Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONOVSKY A, 1965, ARCH NEUROL-CHICAGO, V13, P183, DOI 10.1001/archneur.1965.00470020073010; Ascherio A, 2007, ANN NEUROL, V61, P504, DOI 10.1002/ana.21141; Bland JM, 2000, BRIT MED J, V320, P1468, DOI 10.1136/bmj.320.7247.1468; Carlens C, 2010, AM J RESP CRIT CARE, V181, P1217, DOI 10.1164/rccm.200909-1338OC; CLAYTON D, 1993, STAT MODELS EPIDEMIO, pR8; Dahl J, 2007, EUR J NEUROL, V14, P1113, DOI 10.1111/j.1468-1331.2007.01913.x; De Jager PL, 2009, LANCET NEUROL, V8, P1111, DOI 10.1016/S1474-4422(09)70275-3; Fowles Jeff, 2006, N Z Med J, V119, pU1931; Frutos-Alegria MT, 2002, REV NEUROLOGIA, V34, P813, DOI 10.33588/rn.3409.2001502; Frutos-Alegria MT, 2002, REV NEUROLOGIA, V34, P1013, DOI 10.33588/rn.3411.2001503; Fusby JS, 2010, INHAL TOXICOL, V22, P785, DOI 10.3109/08958378.2010.483258; George J, 1997, SCAND J IMMUNOL, V45, P1, DOI 10.1046/j.1365-3083.1997.d01-366.x; Ghadirian T, 2001, CAN J PUBLIC HEALTH, V92, P281, DOI 10.1007/BF03404961; GRAHAM NMH, 1990, EPIDEMIOL REV, V12, P149, DOI 10.1093/oxfordjournals.epirev.a036050; Green RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006860; Handel AE, 2010, NAT REV NEUROL, V6, P156, DOI 10.1038/nrneurol.2010.1; HANDEL AE, 2010, EUR J NEUROL; Hawkes CH, 2007, MULT SCLER J, V13, P610, DOI 10.1177/1352458506073501; Healy BC, 2009, ARCH NEUROL-CHICAGO, V66, P858, DOI 10.1001/archneurol.2009.122; Hedstrom AK, 2009, NEUROLOGY, V73, P696, DOI 10.1212/WNL.0b013e3181b59c40; Hernan MA, 2005, BRAIN, V128, P1461, DOI 10.1093/brain/awh471; Hernan MA, 2001, AM J EPIDEMIOL, V154, P69, DOI 10.1093/aje/154.1.69; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Jafari N, 2009, MULT SCLER J, V15, P1363, DOI 10.1177/1352458509345907; Koch M, 2007, NEUROLOGY, V69, P1515, DOI 10.1212/01.wnl.0000277658.78381.db; Koch-Henriksen N, 2010, LANCET NEUROL, V9, P520, DOI 10.1016/S1474-4422(10)70064-8; Lundstrom E, 2009, ARTHRITIS RHEUM, V60, P1597, DOI 10.1002/art.24572; Mack WP, 1999, OPHTHAL PLAST RECONS, V15, P260, DOI 10.1097/00002341-199907000-00007; Mahdi H, 2009, NAT GENET, V41, P1319, DOI 10.1038/ng.480; Motz GT, 2010, J IMMUNOL, V184, P4460, DOI 10.4049/jimmunol.0903654; Munger KL, 2009, NEUROLOGY, V73, P1543, DOI 10.1212/WNL.0b013e3181c0d6e0; Munger KL, 2003, EPIDEMIOLOGY, V14, P141, DOI 10.1097/00001648-200303000-00006; Nortvedt MW, 2005, NEUROL SCI, V26, P334, DOI 10.1007/s10072-005-0498-2; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Orton SM, 2006, LANCET NEUROL, V5, P932, DOI 10.1016/S1474-4422(06)70581-6; Pekmezovic T, 2006, NEUROEPIDEMIOLOGY, V27, P212, DOI 10.1159/000096853; da Silva KRP, 2009, ARQ NEURO-PSIQUIAT, V67, P229, DOI 10.1590/S0004-282X2009000200011; PITTAS F, 2009, J NEUROL; Ramagopalan SV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000369; Riise T, 2003, NEUROLOGY, V61, P1122, DOI 10.1212/01.WNL.0000081305.66687.D2; Regal AR, 2009, NEUROLOGIA, V24, P177; Russo C, 2008, J NEUROL, V255, P64, DOI 10.1007/s00415-007-0668-7; Scolding N, 1998, LANCET, V352, P340, DOI 10.1016/S0140-6736(05)60463-1; SENECALQUEVILLON M, 1986, MUTAT RES, V161, P65, DOI 10.1016/0027-5107(86)90100-4; Simon KC, 2010, NEUROLOGY, V74, P1365, DOI 10.1212/WNL.0b013e3181dad57e; Smith KJ, 1999, BRAIN PATHOL, V9, P69; Sundstrom P, 2008, MULT SCLER J, V14, P1031, DOI 10.1177/1352458508093615; Sundstrom P, 2008, EUR J NEUROL, V15, P579, DOI 10.1111/j.1468-1331.2008.02122.x; Thorogood M, 1998, BRIT J OBSTET GYNAEC, V105, P1296, DOI 10.1111/j.1471-0528.1998.tb10008.x; Tremlett H, 2008, NEUROEPIDEMIOLOGY, V31, P271, DOI 10.1159/000166602; Turner AP, 2007, ARCH PHYS MED REHAB, V88, P1394, DOI 10.1016/j.apmr.2007.08.003; VILLARDMACKINTOSH L, 1993, CONTRACEPTION, V47, P161, DOI 10.1016/0010-7824(93)90088-O	52	176	177	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16149	10.1371/journal.pone.0016149	http://dx.doi.org/10.1371/journal.pone.0016149			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249154	Green Published, gold, Green Submitted			2022-12-27	WOS:000286515000022
J	Zhao, YH; Calon, F; Julien, C; Winkler, JW; Petasis, NA; Lukiw, WJ; Bazan, NG				Zhao, Yuhai; Calon, Frederic; Julien, Carl; Winkler, Jeremy W.; Petasis, Nicos A.; Lukiw, Walter J.; Bazan, Nicolas G.			Docosahexaenoic Acid-Derived Neuroprotectin D1 Induces Neuronal Survival via Secretase- and PPAR gamma-Mediated Mechanisms in Alzheimer's Disease Models	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; AMYLOID-PRECURSOR-PROTEIN; HUMAN BRAIN-CELLS; POLYUNSATURATED FATTY-ACID; PIGMENT EPITHELIAL-CELLS; STRESS-INDUCED APOPTOSIS; OXIDATIVE STRESS; A-BETA; IN-VITRO; SIGNALING PATHWAY	Neuroprotectin D1 (NPD1) is a stereoselective mediator derived from the omega-3 essential fatty acid docosahexaenoic acid (DHA) with potent inflammatory resolving and neuroprotective bioactivity. NPD1 reduces A beta 42 peptide release from aging human brain cells and is severely depleted in Alzheimer's disease (AD) brain. Here we further characterize the mechanism of NPD1's neurogenic actions using 3xTg-AD mouse models and human neuronal-glial (HNG) cells in primary culture, either challenged with A beta 42 oligomeric peptide, or transfected with beta amyloid precursor protein (beta APP)(sw) (Swedish double mutation APP695(sw), K595N-M596L). We also show that NPD1 downregulates A beta 42-triggered expression of the pro-inflammatory enzyme cyclooxygenase-2 (COX-2) and of B-94 (a TNF-alpha-inducible pro-inflammatory element) and apoptosis in HNG cells. Moreover, NPD1 suppresses A beta 42 peptide shedding by down-regulating beta-secretase-1 (BACE1) while activating the alpha-secretase ADAM10 and up-regulating sAPP alpha, thus shifting the cleavage of beta APP holoenzyme from an amyloidogenic into the non-amyloidogenic pathway. Use of the thiazolidinedione peroxisome proliferator-activated receptor gamma (PPAR gamma) agonist rosiglitazone, the irreversible PPAR gamma antagonist GW9662, and overexpressing PPAR gamma suggests that the NPD1-mediated down-regulation of BACE1 and A beta 42 peptide release is PPAR gamma-dependent. In conclusion, NPD1 bioactivity potently down regulates inflammatory signaling, amyloidogenic APP cleavage and apoptosis, underscoring the potential of this lipid mediator to rescue human brain cells in early stages of neurodegenerations.	[Zhao, Yuhai; Lukiw, Walter J.; Bazan, Nicolas G.] Louisiana State Univ, Neurosci Ctr Excellence, Sch Med, Hlth Sci Ctr, New Orleans, LA USA; [Calon, Frederic; Julien, Carl] Ctr Hosp Univ Laval Res Ctr CHUL, Mol Endocrinol & Oncol Res Ctr, Quebec City, PQ, Canada; [Winkler, Jeremy W.; Petasis, Nicos A.] Univ So Calif, Dept Chem, Loker Hydrocarbon Res Inst, Los Angeles, CA 90089 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Laval University; University of Southern California	Zhao, YH (corresponding author), Univ Texas Hlth Sci Ctr, Houston, TX USA.	wlukiw@lsuhsc.edu; nbazan@lsuhsc.edu	Winkler, Jeremy/C-3198-2008; Petasis, Nicos/B-3162-2009; Bazan, Nicolas/AAN-4121-2020; Calon, Frederic/AAF-4390-2020; Julien, Carl/AAU-5309-2021	Petasis, Nicos/0000-0002-8864-4446; Bazan, Nicolas/0000-0002-9243-5444; Calon, Frederic/0000-0002-4203-0887	National Institutes of Health, National Center for Research Resource [P20 RR016816]; Edward G. Schlieder Educational Foundation; Eye, Ear, Nose & Throat Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038834] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Research Resource(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Edward G. Schlieder Educational Foundation; Eye, Ear, Nose & Throat Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health, National Center for Research Resource grant (P20 RR016816), the Edward G. Schlieder Educational Foundation, and the Eye, Ear, Nose & Throat Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar M, 2005, P NATL ACAD SCI USA, V102, P10858, DOI 10.1073/pnas.0502903102; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Anders A, 2001, FASEB J, V15, P1837, DOI 10.1096/fj.01-0007fje; Antony R, 2010, J BIOL CHEM, V285, P18301, DOI 10.1074/jbc.M109.095232; Astarita G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012538; Avramovich Y, 2002, J BIOL CHEM, V277, P31466, DOI 10.1074/jbc.M201308200; Bazan NG, 2006, TRENDS NEUROSCI, V29, P263, DOI 10.1016/j.tins.2006.03.005; Bernardo A, 2006, CURR PHARM DESIGN, V12, P93, DOI 10.2174/138161206780574579; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Calandria JM, 2009, J BIOL CHEM, V284, P17877, DOI 10.1074/jbc.M109.003988; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Camacho IE, 2004, J NEUROSCI, V24, P10908, DOI 10.1523/JNEUROSCI.3987-04.2004; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; d'Abramo C, 2005, BIOCHEM J, V391, P693, DOI 10.1042/BJ20050560; Faghiri Z, 2010, EXP EYE RES, V90, P718, DOI 10.1016/j.exer.2010.03.002; Fotuhi M, 2009, NAT CLIN PRACT NEURO, V5, P140, DOI 10.1038/ncpneuro1044; Fuenzalida K, 2007, J BIOL CHEM, V282, P37006, DOI 10.1074/jbc.M700447200; Galasko D, 2010, BIOMARK MED, V4, P27, DOI 10.2217/BMM.09.89; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; Golde Todd E., 2006, Current Alzheimer Research, V3, P421, DOI 10.2174/156720506779025189; Gonzalez-Periz A, 2006, FASEB J, V20, P2537, DOI 10.1096/fj.06-6250fje; Green KN, 2007, J NEUROSCI, V27, P4385, DOI 10.1523/JNEUROSCI.0055-07.2007; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haass C, 2010, NAT MED, V16, P1201, DOI 10.1038/nm.2223; Haass C, 2010, CELL, V142, P356, DOI 10.1016/j.cell.2010.07.032; Henke BR, 2004, PROGR MED CHEM, V42, P1, DOI 10.1016/S0079-6468(04)42001-3; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Inestrosa NC, 2005, EXP CELL RES, V304, P91, DOI 10.1016/j.yexcr.2004.09.032; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Jang JH, 2005, FREE RADICAL BIO MED, V38, P1604, DOI 10.1016/j.freeradbiomed.2005.02.023; JULIEN C, 2008, NEUROBIOL AGING, V159, P296; Kojro E, 2006, FASEB J, V20, P512, DOI 10.1096/fj.05-4812fje; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; Lukiw WJ, 2008, J BIOL CHEM, V283, P31315, DOI 10.1074/jbc.M805371200; Lukiw WJ, 2007, J INORG BIOCHEM, V101, P1265, DOI 10.1016/j.jinorgbio.2007.06.004; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Luna-Medina R, 2005, J BIOL CHEM, V280, P21453, DOI 10.1074/jbc.M414390200; Ma QL, 2007, J NEUROSCI, V27, P14299, DOI 10.1523/JNEUROSCI.3593-07.2007; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Marion-Letellier R, 2008, AM J CLIN NUTR, V87, P939, DOI 10.1093/ajcn/87.4.939; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; MCLACHLAN DRC, 1988, MOL BRAIN RES, V3, P255, DOI 10.1016/0169-328X(88)90048-4; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Mukherjee PK, 2007, P NATL ACAD SCI USA, V104, P13158, DOI 10.1073/pnas.0705963104; Musiek ES, 2008, J BIOL CHEM, V283, P19927, DOI 10.1074/jbc.M803625200; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oksman M, 2006, NEUROBIOL DIS, V23, P563, DOI 10.1016/j.nbd.2006.04.013; Peng Y, 2007, NEUROSCIENCE, V150, P386, DOI 10.1016/j.neuroscience.2007.09.022; Quinn JF, 2010, JAMA-J AM MED ASSOC, V304, P1903, DOI 10.1001/jama.2010.1510; Roberts LJ, 2005, BRAIN PATHOL, V15, P143; Rossner S, 2006, PROG NEUROBIOL, V79, P95, DOI 10.1016/j.pneurobio.2006.06.001; Sahlin C, 2007, EUR J NEUROSCI, V26, P882, DOI 10.1111/j.1460-9568.2007.05719.x; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Sastre M, 2006, P NATL ACAD SCI USA, V103, P443, DOI 10.1073/pnas.0503839103; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; SCOTT BL, 1989, P NATL ACAD SCI USA, V86, P2903, DOI 10.1073/pnas.86.8.2903; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Serhan CN, 2006, J IMMUNOL, V176, P1848, DOI 10.4049/jimmunol.176.3.1848; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shie FS, 2009, CURR MED CHEM, V16, P643, DOI 10.2174/092986709787458399; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Turner RS, 1996, J BIOL CHEM, V271, P8966, DOI 10.1074/jbc.271.15.8966; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Yamamoto K, 2005, BIOORG MED CHEM LETT, V15, P517, DOI 10.1016/j.bmcl.2004.11.053; Yang HQ, 2007, EUR J NEUROSCI, V26, P381, DOI 10.1111/j.1460-9568.2007.05648.x; Zhao Y, 2006, FASEB J, V20, P1162, DOI 10.1096/fj.05-5007com; Zhao YH, 2007, NEUROREPORT, V18, P1187, DOI 10.1097/WNR.0b013e32821c56c4	68	195	206	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15816	10.1371/journal.pone.0015816	http://dx.doi.org/10.1371/journal.pone.0015816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246057	Green Submitted, gold, Green Published			2022-12-27	WOS:000286511200016
J	Liang, YL; Gao, H; Lin, SY; Goss, JA; Brunicardi, FC; Li, KY				Liang, Yulong; Gao, Hong; Lin, Shiaw-Yih; Goss, John A.; Brunicardi, Francis C.; Li, Kaiyi			siRNA-Based Targeting of Cyclin E Overexpression Inhibits Breast Cancer Cell Growth and Suppresses Tumor Development in Breast Cancer Mouse Model	PLOS ONE			English	Article							RNA INTERFERENCE; IN-VIVO; HEPATOCELLULAR-CARCINOMA; LINES; GENE; PHOSPHORYLATION; ACTIVATION; EXPRESSION; STRATEGIES; APOPTOSIS	Cyclin E is aberrantly expressed in many types of cancer including breast cancer. High levels of the full length as well as the low molecular weight isoforms of cyclin E are associated with poor prognosis of breast cancer patients. Notably, cyclin E overexpression is also correlated with triple-negative basal-like breast cancers, which lack specific therapeutic targets. In this study, we used siRNA to target cyclin E overexpression and assessed its ability to suppress breast cancer growth in nude mice. Our results revealed that cyclin E siRNA could effectively inhibit overexpression of both full length and low molecular weight isoforms of cyclin E. We found that depletion of cyclin E promoted apoptosis of cyclin E-overexpressing cells and blocked their proliferation and transformation phenotypes. Significantly, we further demonstrated that administration of cyclin E siRNA could inhibit breast tumor growth in nude mice. In addition, we found that cyclin E siRNA synergistically enhanced the cell killing effects of doxorubicin in cell culture and this combination greatly suppressed the tumor growth in mice. In conclusion, our results indicate that cyclin E, which is overexpressed in 30% of breast cancer, may serve as a novel and effective therapeutic target. More importantly, our study clearly demonstrates a very promising therapeutic potential of cyclin E siRNA for treating the cyclin E-overexpressing breast cancers, including the very malignant triple-negative breast cancers.	[Liang, Yulong; Gao, Hong; Goss, John A.; Brunicardi, Francis C.; Li, Kaiyi] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Lin, Shiaw-Yih] Univ Texas Houston, MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Liang, YL (corresponding author), Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA.	kli@bcm.tmc.edu	Liang, Yulong/A-2171-2013; Gao, Haichun/A-2160-2014	Liang, Yulong/0000-0001-8219-9575; Gao, Haichun/0000-0002-2647-6563	Susan Komen Breast Cancer Foundation; National Institutes of Health [NIH R01]	Susan Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by grants from the Susan Komen Breast Cancer Foundation (to K. Li) and National Institutes of Health (NIH R01, to K. Li). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bales E, 2005, CANCER RES, V65, P692; Bedrosian I, 2004, ONCOGENE, V23, P2648, DOI 10.1038/sj.onc.1207408; Bertrand JR, 2002, BIOCHEM BIOPH RES CO, V296, P1000, DOI 10.1016/S0006-291X(02)02013-2; Bortner DM, 1997, MOL CELL BIOL, V17, P453, DOI 10.1128/MCB.17.1.453; Braasch DA, 2002, BIOCHEMISTRY-US, V41, P4503, DOI 10.1021/bi0122112; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Buchholz TA, 2003, CANCER J, V9, P33, DOI 10.1097/00130404-200301000-00007; Chiao PJ, 2002, CANCER, V95, P1696, DOI 10.1002/cncr.10829; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Foulkes WD, 2004, CANCER RES, V64, P830, DOI 10.1158/0008-5472.CAN-03-2970; Goyal BR, 2009, FUND CLIN PHARMACOL, V23, P367, DOI 10.1111/j.1472-8206.2009.00694.x; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Harwell RM, 2000, CANCER RES, V60, P481; Hough SR, 2003, NAT BIOTECHNOL, V21, P731, DOI 10.1038/nbt0703-731b; Jang SJ, 1999, EUR J SURG ONCOL, V25, P157, DOI 10.1053/ejso.1998.0619; Jin W, 2003, BRIT J CANCER, V89, P185, DOI 10.1038/sj.bjc.6601048; KEYOMARSI K, 1994, CANCER RES, V54, P380; Keyomarsi K, 2002, NEW ENGL J MED, V347, P1566, DOI 10.1056/NEJMoa021153; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Knuefermann C, 2003, ONCOGENE, V22, P3205, DOI 10.1038/sj.onc.1206394; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Li KY, 2003, CANCER RES, V63, P3593; Li KY, 1999, ONCOGENE, V18, P2617, DOI 10.1038/sj.onc.1202605; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nielsen NH, 1996, BRIT J CANCER, V74, P874, DOI 10.1038/bjc.1996.451; OVERMOYER BA, 1995, SEMIN ONCOL, V22, P2; Porter DC, 2001, MOL CELL BIOL, V21, P6254, DOI 10.1128/MCB.21.18.6254-6269.2001; Sauer K, 1995, Prog Cell Cycle Res, V1, P125; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Takahashi N, 2002, CANCER RES, V62, P6909; van Hille B, 1999, ANTI-CANCER DRUG, V10, P551, DOI 10.1097/00001813-199907000-00007; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Wilda M, 2002, ONCOGENE, V21, P5716, DOI 10.1038/sj.onc.1205653; Wingate H, 2005, J BIOL CHEM, V280, P15148, DOI 10.1074/jbc.M409789200; Wingate H, 2009, CELL CYCLE, V8, P1062, DOI 10.4161/cc.8.7.8119	42	68	70	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12860	10.1371/journal.pone.0012860	http://dx.doi.org/10.1371/journal.pone.0012860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	21203399	Green Published, Green Submitted, gold			2022-12-27	WOS:000281963200020
J	Li, YH; Lu, WY; King, TD; Liu, CC; Bijur, GN; Bu, GJ				Li, Yonghe; Lu, Wenyan; King, Taj D.; Liu, Chia-Chen; Bijur, Gautam N.; Bu, Guojun			Dkk1 Stabilizes Wnt Co-Receptor LRP6: Implication for Wnt Ligand-Induced LRP6 Down-Regulation	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN-6; KREMEN PROTEINS; WINGLESS; INTERNALIZATION; DICKKOPF-1; MECHANISM; ENDOCYTOSIS; ACTIVATION; INDUCTION; PATHWAYS	Background: The low density lipoprotein receptor-related protein-6 (LRP6) is an essential co-receptor for canonical Wnt signaling. Dickkopf 1 (Dkk1), a major secreted Wnt signaling antagonist, binds to LRP6 with high affinity and prevents the Frizzled-Wnt-LRP6 complex formation in response to Wnts. Previous studies have demonstrated that Dkk1 promotes LRP6 internalization and degradation when it forms a ternary complex with the cell surface receptor Kremen. Methodology/Principal Findings: In the present study, we found that transfected Dkk1 induces LRP6 accumulation while inhibiting Wnt/LRP6 signaling. Treatment with Dkk1-conditioned medium or recombinant Dkk1 protein stabilized LRP6 with a prolonged half-life and induces LRP6 accumulation both at the cell surface and in endosomes. We also demonstrated that Kremen2 co-expression abrogated the effect of Dkk1 on LRP6 accumulation, indicating that the effect of Kremen2 is dominant over Dkk1 regulation of LRP6. Furthermore, we found that Wnt3A treatment induces LRP6 down-regulation, an effect paralleled with a Wnt/LRP6 signaling decay, and that Dkk1 treatment blocked Wnt3A-induced LRP6 down-regulation. Finally, we found that LRP6 turnover was blocked by an inhibitor of caveolae-mediated endocytosis. Conclusions/Significance: Our results reveal a novel role for Dkk1 in preventing Wnt ligand-induced LRP6 down-regulation and contribute significantly to our understanding of Dkk1 function in Wnt/LRP6 signaling.	[Li, Yonghe; Lu, Wenyan; King, Taj D.] So Res Inst, Drug Discovery Div, Dept Biochem & Mol Biol, Birmingham, AL 35255 USA; [Li, Yonghe; Liu, Chia-Chen; Bu, Guojun] Washington Univ, St Louis Childrens Hosp, Dept Pediat, Sch Med, St Louis, MO 63110 USA; [Bu, Guojun] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Bijur, Gautam N.] Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA	St. Louis Children's Hospital; Washington University (WUSTL); Washington University (WUSTL); University of Alabama System; University of Alabama Birmingham	Li, YH (corresponding author), So Res Inst, Drug Discovery Div, Dept Biochem & Mol Biol, Birmingham, AL 35255 USA.	y.li@sri.org; bu@wustl.edu		Du, Hanjian/0000-0002-2353-8802	National Institutes of Health [CA124531, AG031784, AG027924]; NATIONAL CANCER INSTITUTE [R01CA124531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG027924, R01AG027924, R01AG031784] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding: This work was supported in part by grants from the National Institutes of Health CA124531 (to Y.L.), and AG031784 and AG027924 (to G. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bache KG, 2004, EMBO J, V23, P2707, DOI 10.1038/sj.emboj.7600292; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bafico A, 1998, ONCOGENE, V16, P2819, DOI 10.1038/sj.onc.1201797; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Davidson G, 2002, DEVELOPMENT, V129, P5587, DOI 10.1242/dev.00154; Dubois L, 2001, CELL, V105, P613, DOI 10.1016/S0092-8674(01)00375-0; Ellwanger K, 2008, MOL CELL BIOL, V28, P4875, DOI 10.1128/MCB.00222-08; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Hassler C, 2007, DEVELOPMENT, V134, P4255, DOI 10.1242/dev.005942; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Khan Z, 2007, MOL CELL BIOL, V27, P7291, DOI 10.1128/MCB.00773-07; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Li YH, 2005, J CELL SCI, V118, P5305, DOI 10.1242/jcs.02651; Li YH, 2004, ONCOGENE, V23, P9129, DOI 10.1038/sj.onc.1208123; Li Yonghe, 2005, Future Oncol, V1, P673, DOI 10.2217/14796694.1.5.673; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mao BY, 2003, GENE, V302, P179, DOI 10.1016/S0378-1119(02)01106-X; Marois E, 2006, DEVELOPMENT, V133, P307, DOI 10.1242/dev.02197; Mi KH, 2005, J CELL BIOCHEM, V95, P328, DOI 10.1002/jcb.20400; Monaghan AP, 1999, MECH DEVELOP, V87, P45, DOI 10.1016/S0925-4773(99)00138-0; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Obermoeller LM, 1997, J BIOL CHEM, V272, P10761; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Rives AF, 2006, DEV BIOL, V293, P268, DOI 10.1016/j.ydbio.2006.02.006; Sakane H, 2010, J CELL SCI, V123, P360, DOI 10.1242/jcs.058008; Schulze J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010309; Semenov MV, 2008, J BIOL CHEM, V283, P21427, DOI 10.1074/jbc.M800014200; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Seto ES, 2006, J CELL BIOL, V173, P95, DOI 10.1083/jcb.200510123; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Yamamoto H, 2008, DEV CELL, V15, P37, DOI 10.1016/j.devcel.2008.04.015; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003	40	93	97	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11014	10.1371/journal.pone.0011014	http://dx.doi.org/10.1371/journal.pone.0011014			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20543981	Green Published, gold, Green Submitted			2022-12-27	WOS:000278494900026
J	Johns, MC; Eick, AA; Blazes, DL; Lee, SE; Perdue, CL; Lipnick, R; Vest, KG; Russell, KL; DeFraites, RF; Sanchez, JL				Johns, Matthew C.; Eick, Angelia A.; Blazes, David L.; Lee, Seung-eun; Perdue, Christopher L.; Lipnick, Robert; Vest, Kelly G.; Russell, Kevin L.; DeFraites, Robert F.; Sanchez, Jose L.			Seasonal Influenza Vaccine and Protection against Pandemic (H1N1) 2009-Associated Illness among US Military Personnel	PLOS ONE			English	Article							T-CELL RESPONSES; AVIAN INFLUENZA; PREEXISTING IMMUNITY; ANTIBODY-RESPONSES; RISK-FACTORS; A H1N1; LIVE; VIRUS; TRIVALENT; INFECTION	Introduction: A novel A/H1N1 virus is the cause of the present influenza pandemic; vaccination is a key countermeasure, however, few data assessing prior seasonal vaccine effectiveness (VE) against the pandemic strain of H1N1 (pH1N1) virus are available. Materials and Methods: Surveillance of influenza-related medical encounter data of active duty military service members stationed in the United States during the period of April-October 2009 with comparison of pH1N1-confirmed cases and location and date-matched controls. Crude odds ratios (OR) and VE estimates for immunized versus non-immunized were calculated as well as adjusted OR (AOR) controlling for sex, age group, and history of prior influenza vaccination. Separate stratified VE analyses by vaccine type (trivalent inactivated [TIV] or live attenuated [LAIV]), age groups and hospitalization status were also performed. For the period of April 20 to October 15, 2009, a total of 1,205 cases of pH1N1-confirmed cases were reported, 966 (80%) among males and over one-half (58%) under 25 years of age. Overall VE for service members was found to be 45% (95% CI, 33 to 55%). Immunization with prior season's TIV (VE = 44%, 95% CI, 32 to 54%) as well as LAIV (VE = 24%, 95% CI, 6 to 38%) were both found to be associated with protection. Of significance, VE against a severe disease outcome was higher (VE = 62%, 95% CI, 14 to 84%) than against milder outcomes (VE = 42%, 95% CI, 29 to 53%). Conclusion: A moderate association with protection against clinically apparent, laboratory-confirmed Pandemic (H1N1) 2009-associated illness was found for immunization with either TIV or LAIV 2008-09 seasonal influenza vaccines. This association with protection was found to be especially apparent for severe disease as compared to milder outcome, as well as in the youngest and older populations. Prior vaccination with seasonal influenza vaccines in 2004-08 was also independently associated with protection.	[Johns, Matthew C.; Blazes, David L.; Vest, Kelly G.; Russell, Kevin L.; Sanchez, Jose L.] Armed Forces Hlth Surveillance Ctr, Div GEIS Operat, Silver Spring, MD USA; [Eick, Angelia A.; Lee, Seung-eun] Armed Forces Hlth Surveillance Ctr, Henry M Jackson Fdn Adv Mil Med, Silver Spring, MD USA; [Perdue, Christopher L.; Lipnick, Robert] Armed Forces Hlth Surveillance Ctr, Div Commun Stand & Training, Silver Spring, MD USA	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Johns, MC (corresponding author), Armed Forces Hlth Surveillance Ctr, Div GEIS Operat, Silver Spring, MD USA.	matthew.c.johns@us.army.mil		Mulvihill, Daniel/0000-0003-2502-5274; Geeves, Michael/0000-0002-9364-8898	US Military; BBSRC [BB/F011784/1] Funding Source: UKRI	US Military; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by the baseline funding of the US Military's Defense Health Program for the Armed Forces Health Surveillance Center (AFHSC). No non-government funding was accepted for this effort. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AFHSC, 2009, TRI SERV REP EV GUID; Almirall J, 2008, EUR RESPIR J, V31, P1274, DOI 10.1183/09031936.00095807; Bernstein DI, 2003, PEDIATR INFECT DIS J, V22, P28, DOI 10.1097/00006454-200301000-00010; Block SL, 2007, ANTIMICROB AGENTS CH, V51, P4001, DOI 10.1128/AAC.00517-07; Boon ACM, 2004, J IMMUNOL, V172, P2453, DOI 10.4049/jimmunol.172.4.2453; *CDC, 2010, ADV COMM IMM PRACT P; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; Cohen J, 2010, SCIENCE, V327, P1563, DOI 10.1126/science.327.5973.1563; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Eick AA, 2009, VACCINE, V27, P3568, DOI 10.1016/j.vaccine.2009.03.088; Engler RJM, 2008, ARCH INTERN MED, V168, P2405, DOI 10.1001/archinternmed.2008.513; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; FOSTER DA, 1992, AM J EPIDEMIOL, V136, P296, DOI 10.1093/oxfordjournals.aje.a116495; Garcia-Garcia L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3928; Gargiullo P., 2009, Morbidity and Mortality Weekly Report, V58, P1241; Gaydos JC, 2006, EMERG INFECT DIS, V12, P23, DOI 10.3201/eid1201.050965; Gerhard W, 2001, CURR TOP MICROBIOL, V260, P171; Gioia C, 2008, EMERG INFECT DIS, V14, P121, DOI 10.3201/eid1401.061283; Goy K, 2008, INFLUENZA OTHER RESP, V2, P115, DOI 10.1111/j.1750-2659.2008.00046.x; Grabenstein JD, 2006, EPIDEMIOL REV, V28, P3, DOI 10.1093/epirev/mxj003; Gray GC, 1999, EMERG INFECT DIS, V5, P379, DOI 10.3201/eid0503.990308; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Gualano RC, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-53; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Iuliano AD, 2009, CLIN INFECT DIS, V49, P1811, DOI 10.1086/649555; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kelly H, 2009, EUROSURVEILLANCE, V14, P33; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Loeb M, 2010, EMERG INFECT DIS, V16, P719, DOI 10.3201/eid1604.091588; Martinez O, 2009, INT REV IMMUNOL, V28, P69, DOI 10.1080/08830180802593540; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; Monto AS, 2009, NEW ENGL J MED, V361, P1260, DOI 10.1056/NEJMoa0808652; Nichol KL, 1998, ARCH INTERN MED, V158, P1769, DOI 10.1001/archinte.158.16.1769; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Ohmit SE, 2008, J INFECT DIS, V198, P312, DOI 10.1086/589885; Orenstein EW, 2007, INT J EPIDEMIOL, V36, P623, DOI 10.1093/ije/dym021; ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055; Roti M, 2008, J IMMUNOL, V180, P1758, DOI 10.4049/jimmunol.180.3.1758; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; RUSSELL KL, 2006, TXB MILITARY MED REC, P227; Skowronski DM, 2008, J INFECT DIS, V197, P490, DOI 10.1086/524146; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Skowronski DM, 2009, J INFECT DIS, V199, P168, DOI 10.1086/595862; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Wang Z, 2009, JAMA-J AM MED ASSOC, V301, P945, DOI 10.1001/jama.2009.265; *WHO, 2009, AD HOC POL ADV WORK; WHO, 2009, SUMM REP HIGH LEV CO; Xing Z, 2009, EMERG INFECT DIS, V15, P1847, DOI 10.3201/eid1511.090685; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231	55	65	66	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10722	10.1371/journal.pone.0010722	http://dx.doi.org/10.1371/journal.pone.0010722			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502705	Green Published, gold, Green Submitted			2022-12-27	WOS:000277845400024
J	Wu, CL; Kandarian, SC; Jackman, RW				Wu, Chia-Ling; Kandarian, Susan C.; Jackman, Robert W.			Identification of Genes that Elicit Disuse Muscle Atrophy via the Transcription Factors p50 and Bcl-3	PLOS ONE			English	Article							NF-KAPPA-B; DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; ACTIVATION; EXPRESSION; PROTEIN; TARGET; INFLAMMATION; HOMODIMERS; ATROGIN-1	Skeletal muscle atrophy is a debilitating condition associated with weakness, fatigue, and reduced functional capacity. Nuclear factor-kappaB (NF-kappa B) transcription factors play a critical role in atrophy. Knockout of genes encoding p50 or the NF-kappa B co-transactivator, Bcl-3, abolish disuse atrophy and thus they are NF-kappa B factors required for disuse atrophy. We do not know however, the genes targeted by NF-kappa B that produce the atrophied phenotype. Here we identify the genes required to produce disuse atrophy using gene expression profiling in wild type compared to Nfkb1 (gene encodes p50) and Bcl-3 deficient mice. There were 185 and 240 genes upregulated in wild type mice due to unloading, that were not upregulated in Nfkb1(-/-) and Bcl-3(-/-) mice, respectively, and so these genes were considered direct or indirect targets of p50 and Bcl-3. All of the p50 gene targets were contained in the Bcl-3 gene target list. Most genes were involved with protein degradation, signaling, translation, transcription, and transport. To identify direct targets of p50 and Bcl-3 we performed chromatin immunoprecipitation of selected genes previously shown to have roles in atrophy. Trim63 (MuRF1), Fbxo32 (MAFbx), Ubc, Ctsl, Runx1, Tnfrsf12a (Tweak receptor), and Cxcl10 (IP-10) showed increased Bcl-3 binding to kappa B sites in unloaded muscle and thus were direct targets of Bcl-3. p50 binding to the same sites on these genes either did not change or increased, supporting the idea of p50: Bcl-3 binding complexes. p65 binding to kappa B sites showed decreased or no binding to these genes with unloading. Fbxo9, Psma6, Psmc4, Psmg4, Foxo3, Ankrd1 (CARP), and Eif4ebp1 did not show changes in p65, p50, or Bcl-3 binding to kB sites, and so were considered indirect targets of p50 and Bcl-3. This work represents the first study to use a global approach to identify genes required to produce the atrophied phenotype with disuse.	[Wu, Chia-Ling; Kandarian, Susan C.; Jackman, Robert W.] Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA	Boston University	Wu, CL (corresponding author), Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA.	rjackman@bu.edu		TSAO, PO-NIEN/0000-0002-6114-1769; WU, CHEN-CHI/0000-0002-5047-2204; HSIEH, WU-SHIUN/0000-0002-0609-3311; Lee, Chien-Nan/0000-0002-1725-0407; LIN, SHIN-YU/0000-0002-0753-2793; Wu, Chia-Ling/0000-0002-0595-9064	National Institutes of Health [R01 AR041705, R01 AR041705-15S1]; Boston University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041705] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by National Institutes of Health grants R01 AR041705 and R01 AR041705-15S1 to SK and a Boston University Dudley Allen Sargent grant to CW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2005, CANCER CELL, V8, P421, DOI 10.1016/j.ccr.2005.10.004; Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Andrews JL, 2010, P NATL ACAD SCI USA, V107, P19090, DOI 10.1073/pnas.1014523107; Bar-Shai M, 2008, FREE RADICAL BIO MED, V44, P202, DOI 10.1016/j.freeradbiomed.2007.03.019; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Caamano JH, 1996, MOL CELL BIOL, V16, P1342; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Dogra C, 2007, FASEB J, V21, P1857, DOI 10.1096/fj.06-7537com; Frenette J, 2000, AM J PATHOL, V156, P2103, DOI 10.1016/S0002-9440(10)65081-X; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heissmeyer V, 1999, EMBO J, V18, P4766, DOI 10.1093/emboj/18.17.4766; Hunter RB, 2004, J CLIN INVEST, V114, P1504, DOI 10.1172/JCI200421696; Hunter RB, 2002, FASEB J, V16, P529, DOI 10.1096/fj.01-0866com; Judge AR, 2007, AM J PHYSIOL-CELL PH, V292, pC372, DOI 10.1152/ajpcell.00293.2006; Kandarian SC, 2006, MUSCLE NERVE, V33, P155, DOI 10.1002/mus.20442; Koncarevic A, 2007, FASEB J, V21, P427, DOI 10.1096/fj.06-6665com; Kuehn H., 2008, CURR PROTOC BIOINFOR, DOI [DOI 10.1002/0471250953.BI0712S22, 10.1002/0471250953.bi0712s22]; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; OHMORI Y, 1993, J BIOL CHEM, V268, P6677; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Peterson JM, 2008, INT REV IMMUNOL, V27, P375, DOI 10.1080/08830180802302389; RHOADS MG, 2010, EUR J CANC; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Salminen A, 2010, AGEING RES REV, V9, P298, DOI 10.1016/j.arr.2009.11.001; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; SCHULTE LM, 1993, AM J PHYSIOL, V264, pC1308, DOI 10.1152/ajpcell.1993.264.5.C1308; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tachibana Keisuke, 2005, Nucl Recept, V3, P3, DOI 10.1186/1478-1336-3-3; Taillandier D, 1996, BIOCHEM J, V316, P65, DOI 10.1042/bj3160065; Van Gammeren D, 2009, FASEB J, V23, P362, DOI 10.1096/fj.08-114249; Wang XX, 2005, GENE DEV, V19, P1715, DOI 10.1101/gad.1318305; Witt SH, 2005, J MOL BIOL, V350, P713, DOI 10.1016/j.jmb.2005.05.021; Yamazaki Y, 2010, BIOCHEM J, V427, P171, DOI 10.1042/BJ20091346	44	57	62	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16171	10.1371/journal.pone.0016171	http://dx.doi.org/10.1371/journal.pone.0016171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21811586	gold, Green Published, Green Submitted			2022-12-27	WOS:000286515000025
J	Tang, YQ; Jaganath, IB; Sekaran, SD				Tang, Yin-Quan; Jaganath, Indu Bala; Sekaran, Shamala Devi			Phyllanthus spp. Induces Selective Growth Inhibition of PC-3 and MeWo Human Cancer Cells through Modulation of Cell Cycle and Induction of Apoptosis	PLOS ONE			English	Article							PROSTATE-CANCER; AMARUS; EXPRESSION; ACID; EXTRACT; PLANTS	Background: Phyllanthus is a traditional medicinal plant that has been used in the treatment of many diseases including hepatitis and diabetes. The main aim of the present work was to investigate the potential cytotoxic effects of aqueous and methanolic extracts of four Phyllanthus species (P. amarus, P. niruri, P. urinaria and P. watsonii) against skin melanoma and prostate cancer cells. Methodology/Principal Findings: Phyllanthus plant appears to possess cytotoxic properties with half-maximal inhibitory concentration (IC50) values of 150-300 mu g/ml for aqueous extract and 50-150 mu g/ml for methanolic extract that were determined using the MTS reduction assay. In comparison, the plant extracts did not show any significant cytotoxicity on normal human skin (CCD-1127Sk) and prostate (RWPE-1) cells. The extracts appeared to act by causing the formation of a clear "ladder'' fragmentation of apoptotic DNA on agarose gel, displayed TUNEL-positive cells with an elevation of caspase-3 and -7 activities. The Lactate Dehydrogenase (LDH) level was lower than 15% in Phyllanthus treated-cancer cells. These indicate that Phyllanthus extracts have the ability to induce apoptosis with minimal necrotic effects. Furthermore, cell cycle analysis revealed that Phyllanthus induced a Go/G1-phase arrest on PC-3 cells and a S-phase arrest on MeWo cells and these were accompanied by accumulation of cells in the Sub-G1 (apoptosis) phase. The cytotoxic properties may be due to the presence of polyphenol compounds such as ellagitannins, gallotannins, flavonoids and phenolic acids found both in the water and methanol extract of the plants. Conclusions/Significance: Phyllanthus plant exerts its growth inhibition effect in a selective manner towards cancer cells through the modulation of cell cycle and induction of apoptosis via caspases activation in melanoma and prostate cancer cells. Hence, Phyllanthus may be sourced for the development of a potent apoptosis-inducing anticancer agent.	[Tang, Yin-Quan; Sekaran, Shamala Devi] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Jaganath, Indu Bala] MARDI, Ctr Biotechnol, Serdang, Malaysia	Universiti Malaya; Institute Penyelidikan Dan Kemajuan Pertanian	Tang, YQ (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	shamalamy@yahoo.com	tang, yin/GXZ-6989-2022; Devi, Shamala Devi/B-9735-2010; Tang, Yin-Quan/J-5859-2013; Sekaran, Shamala Devi/B-8482-2008; Tang, Yin-Quan/K-5725-2017	Devi, Shamala Devi/0000-0002-0478-0425; Sekaran, Shamala Devi/0000-0002-0478-0425; Tang, Yin-Quan/0000-0001-7327-2830; Jaganath, Indu/0000-0002-3272-9598	University Malaya [UM PS183/2009B]; Malaysian Agricultural and Research Development Institute (MARDI) [53-02-03-1002]	University Malaya(Universiti Malaya); Malaysian Agricultural and Research Development Institute (MARDI)	This study was funded by the Postgraduate Research Grant, University Malaya (UM PS183/2009B)(www.um.edu.my) and Malaysian Agricultural and Research Development Institute (MARDI) (53-02-03-1002)(www.mardi.gov.my). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM CANC SOC, 2009, CANC FACTS FIG 2009, P19; Asha VV, 2007, FITOTERAPIA, V78, P134, DOI 10.1016/j.fitote.2006.10.009; Baek SJ, 2004, CARCINOGENESIS, V25, P2425, DOI 10.1093/carcin/bgh255; BLUMBERG BS, 1990, VACCINE, V8, pS86, DOI 10.1016/0264-410X(90)90225-B; *CANC RES UK, 2010, SKIN CANC UK INC STA; Che XH, 2010, BASIC CLIN PHARMACOL, V106, P30, DOI 10.1111/j.1742-7843.2009.00465.x; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; CRAGG GM, 2007, BIOACTIVE NATURAL PR; Deichmann M, 1999, J CLIN ONCOL, V17, P1891, DOI 10.1200/JCO.1999.17.6.1891; Fan TJ, 2005, ACTA BIOCH BIOPH SIN, V37, P719, DOI 10.1111/j.1745-7270.2005.00108.x; Faried A, 2007, INT J ONCOL, V30, P605; Guchelaar H J, 1992, Clin Oncol (R Coll Radiol), V4, P388, DOI 10.1016/S0936-6555(05)81134-3; Hastak K, 2005, FASEB J, V19, P789, DOI 10.1096/fj.04-2226fje; Huang ST, 2004, LIFE SCI, V75, P339, DOI 10.1016/j.lfs.2003.12.013; Jeena KJ, 1999, CANCER LETT, V136, P11, DOI 10.1016/S0304-3835(98)00294-8; Ji BC, 2009, J AGR FOOD CHEM, V57, P7596, DOI 10.1021/jf901308p; Jin UH, 2005, LIFE SCI, V77, P2760, DOI 10.1016/j.lfs.2005.02.028; Kasibhatla S, 2003, MOL CANCER THER, V2, P573; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim SJ, 2006, BIOCHEM BIOPH RES CO, V339, P463, DOI 10.1016/j.bbrc.2005.11.040; Kloucek P, 2005, J ETHNOPHARMACOL, V99, P309, DOI 10.1016/j.jep.2005.01.062; Lansky EP, 2005, INVEST NEW DRUG, V23, P11, DOI 10.1023/B:DRUG.0000047101.02178.07; Lee CD, 1996, EUR J CLIN INVEST, V26, P1069, DOI 10.1046/j.1365-2362.1996.410595.x; Madson JG, 2009, AM J PATHOL, V174, P2357, DOI 10.2353/ajpath.2009.080638; Maecker HL, 2000, CANCER RES, V60, P4638; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Mailloux A, 2001, EUR J CELL BIOL, V80, P442, DOI 10.1078/0171-9335-00171; Mazumder A, 2006, NAT PROD RES, V20, P323, DOI 10.1080/14786410600650404; Mazunder UK, 2005, EURO B DRUG RES, V13, P15; Molinari M, 2000, EMBO REP, V1, P71, DOI 10.1093/embo-reports/kvd018; Ott M, 1997, EUR J CLIN INVEST, V27, P908, DOI 10.1046/j.1365-2362.1997.2020749.x; Prakash A, 1995, PHYTOTHER RES, V9, P594, DOI 10.1002/ptr.2650090813; Puri N, 2004, FASEB J, V18, P1373, DOI 10.1096/fj.04-1774com; Rajeshkumar NV, 2000, J ETHNOPHARMACOL, V73, P215, DOI 10.1016/S0378-8741(00)00311-1; Rajeshkumar NV, 2002, J ETHNOPHARMACOL, V81, P17, DOI 10.1016/S0378-8741(01)00419-6; RAPHAEL KR, 2002, J EXP BIOL, V40, P905; Ren WY, 2003, MED RES REV, V23, P519, DOI 10.1002/med.10033; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Shoeb M., 2006, BANGL J PHARMACOL, V1, P35, DOI [10.3329/bjp.v1i2.486, DOI 10.3329/BJP.V1I2.486]; Soini Y, 1998, AM J PATHOL, V153, P1041, DOI 10.1016/S0002-9440(10)65649-0; Sun J, 2006, CANCER LETT, V241, P124, DOI 10.1016/j.canlet.2005.10.027; VARMA A, 2009, ECAM IN PRESS; VENKATESWARAN PS, 1997, P NATL ACAD SCI USA, V84, P274; WINGO PA, 1995, CA-CANCER J CLIN, V45, P8, DOI 10.3322/canjclin.45.1.8; Zhang Z, 2003, P NATL ACAD SCI USA, V100, P11636, DOI 10.1073/pnas.1934692100; Zhou MX, 2002, J PHARMACOL EXP THER, V303, P124, DOI 10.1124/jpet.102.037192; Zhou S, 1997, Zhongguo Zhong Yao Za Zhi, V22, P109	47	105	108	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2010	5	9							e12644	10.1371/journal.pone.0012644	http://dx.doi.org/10.1371/journal.pone.0012644			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IV	20838625	Green Published, gold, Green Submitted			2022-12-27	WOS:000281687100013
J	Chen, SL; Yao, H; Han, JP; Liu, C; Song, JY; Shi, LC; Zhu, YJ; Ma, XY; Gao, T; Pang, XH; Luo, K; Li, Y; Li, XW; Jia, XC; Lin, YL; Leon, C				Chen, Shilin; Yao, Hui; Han, Jianping; Liu, Chang; Song, Jingyuan; Shi, Linchun; Zhu, Yingjie; Ma, Xinye; Gao, Ting; Pang, Xiaohui; Luo, Kun; Li, Ying; Li, Xiwen; Jia, Xiaocheng; Lin, Yulin; Leon, Christine			Validation of the ITS2 Region as a Novel DNA Barcode for Identifying Medicinal Plant Species	PLOS ONE			English	Article							LAND PLANTS; AUTHENTICATION; IDENTIFICATION; TAXONOMY; PHYLOGENETICS; COMPLEMENTS; RBCL; TOOL	Background: The plant working group of the Consortium for the Barcode of Life recommended the two-locus combination of rbcL + matK as the plant barcode, yet the combination was shown to successfully discriminate among 907 samples from 550 species at the species level with a probability of 72%. The group admits that the two-locus barcode is far from perfect due to the low identification rate, and the search is not over. Methodology/Principal Findings: Here, we compared seven candidate DNA barcodes (psbA-trnH, matK, rbcL, rpoC1, ycf5, ITS2, and ITS) from medicinal plant species. Our ranking criteria included PCR amplification efficiency, differential intra-and inter-specific divergences, and the DNA barcoding gap. Our data suggest that the second internal transcribed spacer (ITS2) of nuclear ribosomal DNA represents the most suitable region for DNA barcoding applications. Furthermore, we tested the discrimination ability of ITS2 in more than 6600 plant samples belonging to 4800 species from 753 distinct genera and found that the rate of successful identification with the ITS2 was 92.7% at the species level. Conclusions: The ITS2 region can be potentially used as a standard DNA barcode to identify medicinal plants and their closely related species. We also propose that ITS2 can serve as a novel universal barcode for the identification of a broader range of plant taxa.	[Chen, Shilin; Yao, Hui; Han, Jianping; Song, Jingyuan; Shi, Linchun; Zhu, Yingjie; Ma, Xinye; Gao, Ting; Pang, Xiaohui; Li, Ying; Li, Xiwen; Jia, Xiaocheng; Lin, Yulin] Peking Union Med Coll, Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100021, Peoples R China; [Liu, Chang] Univ Hong Kong, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Luo, Kun] Hubei Univ Chinese Med, Dept Pharm, Wuhan, Hubei, Peoples R China; [Leon, Christine] Royal Bot Gardens, Richmond TW9 3AB, Surrey, England	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College; University of Hong Kong; Hubei University of Chinese Medicine; Royal Botanic Gardens, Kew	Chen, SL (corresponding author), Peking Union Med Coll, Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100021, Peoples R China.	slchen@implad.ac.cn; songjingyuan@hotmail.com	xiwen, li/W-1990-2019; Zhu, Yingjie/W-3315-2017; Yao, hui/AAM-2391-2021; Yang, Pengcheng/N-1037-2014; Wei, Yuanyuan/H-7963-2014	Zhu, Yingjie/0000-0003-1849-6019; Yang, Pengcheng/0000-0001-5496-8357; Jiang, Feng/0000-0002-7407-7604; Han, Jianping/0000-0002-7976-6708; Wei, Yuanyuan/0000-0003-0635-6879; Kang, Le/0000-0003-4262-2329	International Cooperation Program of Science and Technology [2007DFA30990]; Special Foundation of Ministry of Health [200802043]; Hong Kong Research Grant Council (HKU) [7526/06M]	International Cooperation Program of Science and Technology; Special Foundation of Ministry of Health; Hong Kong Research Grant Council (HKU)(University of Hong KongHong Kong Research Grants Council)	This work is supported by the International Cooperation Program of Science and Technology ( No. 2007DFA30990) and the Special Foundation of Ministry of Health ( No. 200802043) granted to S. L. C. This work is also supported by grants from the Hong Kong Research Grant Council (HKU 7526/06M) to C. L. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Blaxter M, 2003, NATURE, V421, P122, DOI 10.1038/421122a; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Chiou SJ, 2007, PLANTA MED, V73, P1421, DOI 10.1055/s-2007-990227; Coleman AW, 2007, NUCLEIC ACIDS RES, V35, P3322, DOI 10.1093/nar/gkm233; Coleman AW, 2003, TRENDS GENET, V19, P370, DOI 10.1016/S0168-9525(03)00118-5; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Gregory TR, 2005, NATURE, V434, P1067, DOI 10.1038/4341067b; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hollingsworth PM, 2008, HEREDITY, V101, P1, DOI 10.1038/hdy.2008.16; Keller A, 2009, GENE, V430, P50, DOI 10.1016/j.gene.2008.10.012; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2008, P NATL ACAD SCI USA, V105, P2761, DOI 10.1073/pnas.0800476105; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Marshall E, 2005, SCIENCE, V307, P1037, DOI 10.1126/science.307.5712.1037; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miao M, 2008, PROTIST, V159, P519, DOI 10.1016/j.protis.2008.05.002; Miller SE, 2007, P NATL ACAD SCI USA, V104, P4775, DOI 10.1073/pnas.0700466104; Min XJ, 2007, MOL ECOL NOTES, V7, P365, DOI 10.1111/j.1471-8286.2007.01698.x; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Muller T, 2007, RNA, V13, P1469, DOI 10.1261/rna.617107; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Newmaster SG, 2008, MOL ECOL RESOUR, V8, P480, DOI 10.1111/j.1471-8286.2007.02002.x; Pennisi E, 2007, SCIENCE, V318, P190, DOI 10.1126/science.318.5848.190; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; Schindel DE, 2005, NATURE, V435, P17, DOI 10.1038/435017b; Schultz J, 2005, RNA, V11, P361, DOI 10.1261/rna.7204505; Schultz J, 2009, MOL PHYLOGENET EVOL, V52, P520, DOI 10.1016/j.ympev.2009.01.008; Seifert KA, 2007, P NATL ACAD SCI USA, V104, P3901, DOI 10.1073/pnas.0611691104; Shaw D, 1997, DRUG SAFETY, V17, P342, DOI 10.2165/00002018-199717050-00006; Song JY, 2009, J ETHNOPHARMACOL, V124, P434, DOI 10.1016/j.jep.2009.05.042; Sucher NJ, 2008, PLANTA MED, V74, P603, DOI 10.1055/s-2008-1074517; Thomas C, 2009, SCIENCE, V325, P526, DOI 10.1126/science.325_526; Yao H, 2009, PLANTA MED, V75, P667, DOI 10.1055/s-0029-1185385	41	1051	1385	22	300	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2010	5	1							e8613	10.1371/journal.pone.0008613	http://dx.doi.org/10.1371/journal.pone.0008613			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KN	20062805	Green Published, gold, Green Submitted			2022-12-27	WOS:000273414100007
J	Zhang, Y; Zhu, SL; Yan, DM; Liu, GY; Bai, RY; Wang, DY; Chen, L; Zhu, H; An, HQ; Kew, O; Xu, WB				Zhang, Yong; Zhu, Shuangli; Yan, Dongmei; Liu, Guiyan; Bai, Ruyin; Wang, Dongyan; Chen, Li; Zhu, Hui; An, Hongqiu; Kew, Olen; Xu, Wenbo			Natural Type 3/Type 2 Intertypic Vaccine-Related Poliovirus Recombinants with the First Crossover Sites within the VP1 Capsid Coding Region	PLOS ONE			English	Article							POLIOMYELITIS; GENOMES; VIRUS; CHILD; CIRCULATION; SEROTYPE-2; SEQUENCES; OUTBREAK; MUTATION; STRAINS	Background: Ten uncommon natural type 3/type 2 intertypic poliovirus recombinants were isolated from stool specimens from nine acute flaccid paralysis case patients and one healthy vaccinee in China from 2001 to 2008. Principal Findings: Complete genomic sequences revealed their vaccine-related genomic features and showed that their first crossover sites were randomly distributed in the 39 end of the VP1 coding region. The length of donor Sabin 2 sequences ranged from 55 to 136 nucleotides, which is the longest donor sequence reported in the literature for this type of poliovirus recombination. The recombination resulted in the introduction of Sabin 2 neutralizing antigenic site 3a (NAg3a) into a Sabin 3 genomic background in the VP1 coding region, which may have been altered by some of the type 3-specific antigenic properties, but had not acquired any type 2-specific characterizations. NAg3a of the Sabin 3 strain seems atypical; other wild-type poliovirus isolates that have circulated in recent years have sequences of NAg3a more like the Sabin 2 strain. Conclusions: 10 natural type 3/type 2 intertypic VP1 capsid-recombinant polioviruses, in which the first crossover sites were found to be in the VP1 coding region, were isolated and characterized. In spite of the complete replacement of NAg3a by type 2-specific amino acids, the serotypes of the recombinants were not altered, and they were totally neutralized by polyclonal type 3 antisera but not at all by type 2 antisera. It is possible that recent type 3 wild poliovirus isolates may be a recombinant having NAg3a sequences derived from another strain during between 1967 and 1980, and the type 3/type 2 recombination events in the 39 end of the VP1 coding region may result in a higher fitness.	[Zhang, Yong; Zhu, Shuangli; Yan, Dongmei; Liu, Guiyan; Bai, Ruyin; Wang, Dongyan; Chen, Li; Zhu, Hui; An, Hongqiu; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Beijing, Peoples R China; [Zhang, Yong; Zhu, Shuangli; Yan, Dongmei; Liu, Guiyan; Bai, Ruyin; Wang, Dongyan; Chen, Li; Zhu, Hui; An, Hongqiu; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing, Peoples R China; [Bai, Ruyin] Taishan Med Univ, Taishan City, Peoples R China; [Kew, Olen] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Shandong First Medical University & Shandong Academy of Medical Sciences; Centers for Disease Control & Prevention - USA	Zhang, Y (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Beijing, Peoples R China.	wenbo_xu1@yahoo.com.cn	zijlstra, andries/G-4564-2013; Zhang, Yiqiang/D-9613-2012; zhang, yong jie/B-9054-2009	zijlstra, andries/0000-0001-8460-8803; Li, Tao-Sheng/0000-0002-7653-8873; Zhang, Yiqiang/0000-0003-0691-6645; zhang, yong jie/0000-0002-6331-2189; Waisman, David/0000-0002-5097-9662; Zhang, Yong/0000-0002-2692-5437	National Key Technology R&D Program of China [2008BAI56B00]; National Key Science and Technology Projects of China [2008ZX10004-008]; World Health Organization [I8/181/978]; NATIONAL CANCER INSTITUTE [K01CA120711] Funding Source: NIH RePORTER	National Key Technology R&D Program of China(National Key Technology R&D Program); National Key Science and Technology Projects of China; World Health Organization(World Health Organization); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Key Technology R&D Program of China (Project No. 2008BAI56B00), National Key Science and Technology Projects of China (Project No. 2008ZX10004-008), and a grant I8/181/978 from the World Health Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JP, 1997, J INFECT DIS, V175, pS176, DOI 10.1093/infdis/175.Supplement_1.S176; BALANANT J, 1991, VIROLOGY, V184, P645, DOI 10.1016/0042-6822(91)90434-D; Belnap DM, 2000, P NATL ACAD SCI USA, V97, P73, DOI 10.1073/pnas.97.1.73; Blomqvist S, 2004, J VIROL, V78, P4876, DOI 10.1128/JVI.78.9.4876-4883.2004; Blomqvist S, 2003, J GEN VIROL, V84, P573, DOI 10.1099/vir.0.18708-0; Cuervo NS, 2001, J VIROL, V75, P5740, DOI 10.1128/JVI.75.13.5740-5751.2001; Dedepsidis E, 2008, FEMS IMMUNOL MED MIC, V52, P343, DOI 10.1111/j.1574-695X.2008.00381.x; Freistadt MS, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-28; Friedrich F, 1996, ACTA VIROL, V40, P27; FURIONE M, 1993, VIROLOGY, V196, P199; HIRST GK, 1962, COLD SPRING HARB SYM, V27, P303, DOI 10.1101/SQB.1962.027.001.028; JARVIS TC, 1992, EMBO J, V11, P3135, DOI 10.1002/j.1460-2075.1992.tb05386.x; Jorba J, 2008, J VIROL, V82, P4429, DOI 10.1128/JVI.02354-07; Karakasiliotis L, 2004, MOL CELL PROBE, V18, P103, DOI 10.1016/j.mcp.2003.09.009; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kew OM, 2004, B WORLD HEALTH ORGAN, V82, P16; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; KOHARA M, 1988, J VIROL, V62, P2828, DOI 10.1128/JVI.62.8.2828-2835.1988; KOHARA M, 1985, J VIROL, V53, P786, DOI 10.1128/JVI.53.3.786-792.1985; Liang XF, 2006, J INFECT DIS, V194, P545, DOI 10.1086/506359; LIPSKAYA GY, 1991, J MED VIROL, V35, P290, DOI 10.1002/jmv.1890350415; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Martin J, 2002, J VIROL, V76, P10921, DOI 10.1128/JVI.76.21.10921-10928.2002; Martinez CV, 2004, J INFECT DIS, V190, P409, DOI 10.1086/421703; MINOR PD, 1986, J GEN VIROL, V67, P1283, DOI 10.1099/0022-1317-67-7-1283; MINOR PD, 1989, J GEN VIROL, V70, P1117, DOI 10.1099/0022-1317-70-5-1117; MINOR PD, 1992, J GEN VIROL, V73, P3065, DOI 10.1099/0022-1317-73-12-3065; MINOR PD, 1993, DEV BIOL STAND, V78, P17; Minor P, 2009, VACCINE, V27, P2649, DOI 10.1016/j.vaccine.2009.02.071; RICOHESSE R, 1987, VIROLOGY, V160, P311, DOI 10.1016/0042-6822(87)90001-8; Rousset D, 2003, EMERG INFECT DIS, V9, P885; Shahmahmoodi S, 2008, VIRUS RES, V137, P168, DOI 10.1016/j.virusres.2008.07.006; Shimizu H, 2004, J VIROL, V78, P13512, DOI 10.1128/JVI.78.24.13512-13521.2004; Stanway G, 2005, VIRUS TAXONOMY, P757; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tao ZX, 2010, VIRUS RES, V150, P56, DOI 10.1016/j.virusres.2010.02.014; TOYODA H, 1984, J MOL BIOL, V174, P561, DOI 10.1016/0022-2836(84)90084-6; VANDERAVOORT HGAM, 1995, J CLIN MICROBIOL, V33, P2562, DOI 10.1128/JCM.33.10.2562-2566.1995; World Health Organization, 2004, POL LAB MAN, V4th; YANG CF, 1992, VIRUS RES, V24, P277, DOI 10.1016/0168-1702(92)90124-R; Yang CF, 2003, J VIROL, V77, P8366, DOI 10.1128/JVI.77.15.8366-8377.2003; Zhang Y, 2010, J GEN VIROL, V91, P421, DOI 10.1099/vir.0.014258-0; Zhang Y, 2010, ARCH VIROL, V155, P197, DOI 10.1007/s00705-009-0564-9	43	190	199	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15300	10.1371/journal.pone.0015300	http://dx.doi.org/10.1371/journal.pone.0015300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	20463924	Green Published, gold, Green Submitted			2022-12-27	WOS:000285576900026
J	Zhang, Y; Schulte, W; Pink, D; Phipps, K; Zijlstra, A; Lewis, JD; Waisman, DM				Zhang, Yi; Schulte, Wendy; Pink, Desmond; Phipps, Kyle; Zijlstra, Andries; Lewis, John D.; Waisman, David Morton			Sensitivity of Cancer Cells to Truncated Diphtheria Toxin	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; ACUTE MYELOID-LEUKEMIA; FACTOR FUSION PROTEIN; GROWTH-FACTOR; DENILEUKIN DIFTITOX; CYNOMOLGUS MONKEYS; MOUSE MODEL; IN-VIVO; EXPRESSION; CYTOTOXICITY	Background: Diphtheria toxin (DT) has been utilized as a prospective anti-cancer agent for the targeted delivery of cytotoxic therapy to otherwise untreatable neoplasia. DT is an extremely potent toxin for which the entry of a single molecule into a cell can be lethal. DT has been targeted to cancer cells by deleting the cell receptor-binding domain and combining the remaining catalytic portion with targeting proteins that selectively bind to the surface of cancer cells. It has been assumed that "receptorless'' DT cannot bind to and kill cells. In the present study, we report that "receptorless'' recombinant DT385 is in fact cytotoxic to a variety of cancer cell lines. Methods: In vitro cytotoxicity of DT385 was measured by cell proliferation, cell staining and apoptosis assays. For in vivo studies, the chick chorioallantoic membrane (CAM) system was used to evaluate the effect of DT385 on angiogenesis. The CAM and mouse model system was used to evaluate the effect of DT385 on HEp3 and Lewis lung carcinoma (LLC) tumor growth, respectively. Results: Of 18 human cancer cell lines tested, 15 were affected by DT385 with IC(50) ranging from 0.12-2.8 mu M. Furthermore, high concentrations of DT385 failed to affect growth arrested cells. The cellular toxicity of DT385 was due to the inhibition of protein synthesis and induction of apoptosis. In vivo, DT385 diminished angiogenesis and decreased tumor growth in the CAM system, and inhibited the subcutaneous growth of LLC tumors in mice. Conclusion: DT385 possesses anti-angiogenic and anti-tumor activity and may have potential as a therapeutic agent.	[Zhang, Yi; Phipps, Kyle; Waisman, David Morton] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Zhang, Yi; Phipps, Kyle; Waisman, David Morton] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Schulte, Wendy; Pink, Desmond; Zijlstra, Andries; Lewis, John D.] Innovascreen Inc, Halifax, NS, Canada; [Zijlstra, Andries] Vanderbilt Univ, Dept Pathol, Nashville, TN USA; [Lewis, John D.] Univ Western Ontario, Dept Oncol, London, ON, Canada	Dalhousie University; Dalhousie University; Vanderbilt University; Western University (University of Western Ontario)	Zhang, Y (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada.	david.waisman@dal.ca	zijlstra, andries/G-4564-2013; Zhang, Yiqiang/D-9613-2012; zhang, yong jie/B-9054-2009	zijlstra, andries/0000-0001-8460-8803; Li, Tao-Sheng/0000-0002-7653-8873; Zhang, Yiqiang/0000-0003-0691-6645; zhang, yong jie/0000-0002-6331-2189; Waisman, David/0000-0002-5097-9662; Zhang, Yong/0000-0002-2692-5437	Nova Scotia Health Research Foundation (NSHRF); Dalhousie University; NCIC/Terry Fox Foundation [018176]; NATIONAL CANCER INSTITUTE [K01CA120711] Funding Source: NIH RePORTER	Nova Scotia Health Research Foundation (NSHRF); Dalhousie University; NCIC/Terry Fox Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the Nova Scotia Health Research Foundation (NSHRF). YZ is supported by a studentship from the Cancer Research Training Program, Dalhousie University. JDL is supported by grant #018176 from the NCIC/Terry Fox Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagley RG, 2003, CANCER RES, V63, P5866; BENITEZKING G, 1989, J CELL SCI, V93, P53; Black JH, 2003, LEUKEMIA, V17, P155, DOI 10.1038/sj.leu.2402744; CHADWICK DE, 1993, LEUKEMIA LYMPHOMA, V11, P249, DOI 10.3109/10428199309087002; Chan CH, 1996, BLOOD, V88, P1445, DOI 10.1182/blood.V88.4.1445.bloodjournal8841445; Cherepanov P, 2000, FASEB J, V14, P1389, DOI 10.1096/fj.14.10.1389; Cohen KA, 2004, LEUKEMIA LYMPHOMA, V45, P1647, DOI 10.1080/10428190410001663572; COLLIER RJ, 1975, BACTERIOL REV, V39, P54, DOI 10.1128/MMBR.39.1.54-85.1975; Duvic M, 2008, FUTURE ONCOL, V4, P457, DOI 10.2217/14796694.4.4.457; Falnes PO, 1998, EMBO J, V17, P615, DOI 10.1093/emboj/17.2.615; Feuring-Buske M, 2000, EXP HEMATOL, V28, P1390, DOI 10.1016/S0301-472X(00)00542-7; FITZGERALD D, 1989, J NATL CANCER I, V81, P1455, DOI 10.1093/jnci/81.19.1455; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; GILL DM, 1973, J BIOL CHEM, V248, P654; Gonzalez-Moreno O, 2005, INT J CANCER, V114, P870, DOI 10.1002/ijc.20789; Hall PD, 1999, LEUKEMIA, V13, P629, DOI 10.1038/sj.leu.2401357; Hogge DE, 2006, CLIN CANCER RES, V12, P1284, DOI 10.1158/1078-0432.CCR-05-2070; HONJO T, 1971, J BIOL CHEM, V246, P4251; Hotchkiss CE, 1999, TOXICOL APPL PHARM, V158, P152, DOI 10.1006/taap.1999.8691; IWAMOTO R, 1994, EMBO J, V13, P2322, DOI 10.1002/j.1460-2075.1994.tb06516.x; KIND C, 1975, ANAT EMBRYOL, V147, P127, DOI 10.1007/BF00306727; Kreitman RJ, 2006, AAPS J, V8, pE532, DOI 10.1208/aapsj080363; Kwon M, 2001, BIOCHEMISTRY-US, V40, P13246, DOI 10.1021/bi0113420; Lewis JD, 2006, NAT MED, V12, P354, DOI 10.1038/nm1368; Li G, 2002, P NATL ACAD SCI USA, V99, P832, DOI 10.1073/pnas.022649699; MADSHUS IH, 1992, CURR TOP MICROBIOL, V175, P1; Mercapide J, 2002, CLIN CANCER RES, V8, P1740; MOYNIHAN MR, 1981, INFECT IMMUN, V32, P575, DOI 10.1128/IAI.32.2.575-582.1981; MURPHY JR, 1986, P NATL ACAD SCI USA, V83, P8258, DOI 10.1073/pnas.83.21.8258; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; PAPPENHEIMER AM, 1993, PROTEIN SCI, V2, P292; Ramage JG, 2003, LEUKEMIA RES, V27, P79, DOI 10.1016/S0145-2126(02)00077-2; Ramakrishnan S, 1996, CANCER RES, V56, P1324; Turturro F, 2007, EXPERT REV ANTICANC, V7, P11, DOI 10.1586/14737140.7.1.11; Urieto JO, 2004, PROTEIN EXPRES PURIF, V33, P123, DOI 10.1016/j.pep.2003.09.003; Wild R, 2004, BREAST CANCER RES TR, V85, P161, DOI 10.1023/B:BREA.0000025407.02896.ec; WILLIAMS DP, 1990, J BIOL CHEM, V265, P20673; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5; Zijlstra A, 2004, J BIOL CHEM, V279, P27633, DOI 10.1074/jbc.M313617200; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031	40	190	199	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10498	10.1371/journal.pone.0010498	http://dx.doi.org/10.1371/journal.pone.0010498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463924	Green Submitted, Green Published, gold			2022-12-27	WOS:000277379400031
